>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 1; Drug: Control
bRjbRibRgbRgbLsbRgbRgbRgbRibRsbRcbRgbLibRhRsmbRcbRsRsmbLobRobRiRsmbRcR
smbLsLsmbRcbLhLsLoRcbRcbReLsbRsbLsbRjRgbLcbRsbRcbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 2; Drug: Control
bLgbLgbRsbLsbLgbLgbLgbLsbLgbLsbLsbLgbLgbLgbLgbLgbLgbLgbLgbLsbLsbLgbLgL
sbLsbLsLsmbLgbLgbLsbLsbLgLsbLgbLsLsmbLgbLgbRsbLgbLiLsbLibRsLsbLgbLsbLi
bLsbRsLsbLibRsbLibLibLsbLgbRiRsmbRibRibRibRcbRgbLiLsbLibLibLgbLsbLsbLi
LsbRsbLibLibRhbLsbLcLsmbLcbRibLsbRgbRobLhbLcbLhbLibRcbRibRiRsmbLgbRhbL
ibRibRcbRiLsbRcbLsbRhRsmbRibRgRsmbRgbRgbLjbLcLsmbLibLibRgbLibLgbRibRhb
RibRgbRgRsmbLibRibRibLcbRhbRibRgbLjbRcbRcbRsbRibRibLsbRcbLjbRhbRsbRibR
gbRgbRgbRibLhbRgbRjbRibRibLsbLiLsbLibLibRgbRgbLcbLiRsbRiRsmbRgbLcbLgbL
gbRsbLibLibRibLibRgRsmbLiLsbRgbRcbLiRsbLcbRiRsmbRsbLcbLiLsbRjbLhLsbLiL
sbLibRhbLibRhbLibLcRsbRjbLibLiRsbRjbLibLibRgRsmbLsbLibRsLsbLiLsbLgbLib
RgbRsbLibLgbRsbLibRgLsbLsLsmbLiLsbRsbLgLsbLgbLsbRgbLibLgbRiLsbLibLiLsb
LgbRibLiLsbLgbLgRsbRgLsbLhbRjbLibLsbRjbLibRgbLibLgbLsbLgbLgbRibLibLgbR
gbLibLibRjbLibRgbLhbRgbLibRsbLibRsLsbLgbLgbLgbRjLsbLibLiRsbRibLibRsLsb
LibLiLsbLibRibRgbLibLgLsbLsbRsbLgLsbLibRgbRiLsbRjbRibRibLeLsbLibLibLib
LibLgbRhbLibLibLgLsbLgbRsbLgRsbLsbLgLsLsmbRgbLgbRsRsmbLibLgbRgbLgbLibL
gbRjLsbLibRjbLgbLibLsbLgbLgbLgbRsbRsbLgLsbLgbRgbLgbLgbRsbRsLsbLsbLgLsb
RsbLgLsbLsbLsbLgbLsbLsbLgbLgbLgLsbLgLsbLgbLsLsmbRgbLgbRsbLibLibRibLibR
jbRjbRibLibRibLcbRibRcLsbRcRsLsRsmbRibLiRsbLibRjbRhbRiLsbLibLcLsLsmmbL
ebRhLsbLibLibLiRsbRcbLibLiRsbRgbLsbLgbLgbLgbLsbLgbRjLsbLibLgLsRsbRgbLi
LsbRgbLiLsbLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 3; Drug: Control
bLibRsbLiLsbLgLsbLsbLgbLiRsbLsbRsbLibLgbLgbLgLsbLsLsmbLgLsbRgLsbLibLsb
LgbLgbRibRcbRiLsbRsbRibLsbLjbRcbRcbLibLgbRiLsbRcLsbLgLsbRcbLjbLibLcbLc
LsmbLibRcRsmbLcbLobRoLsbLsLsmbLgLsbLgbLsbRjbLcbRgbRgbLoRsRsmbLgbRibLib
LobLgbsbLsbLebLibRibLiLsbLsbRcbLibLobRibLobLobLhbRibLcbLcRsbLcbRhbRsLs
bRibRgbRhbRcbLibRjbLjbLibLgLsbRjbRcbRibRcbLibRgRsmbRibRibRcbRibLgbLgbR
cbLjbLoRsbLoRsbRgLsRsbLiLsbRibRcbLgbLgbRgbLjbLobLgbLsbLibLsbLgbLibRsRs
mbLibLsbLsbLgbLsbLgbLsbLibRgbLoRsbRhRsmbRcbRoLsbLibLjbRcbRhbLiRsLsbLeb
RobLobLcbLsbRcbLsbLsbRsbRobLcbRobLiLjbLcbRebRcbRcbLhLsbLjbLcbRgbRjbRib
RgbLjbLibLgbRsbLgLsbLsLsLgmbLsLgLsbLgLsLgbLgbLgbLsbRsLsbLibLsbRgbLgbsb
LgbLgLsbRgbLgbLgbLgbLsbLsbRsbLsbLgbLgbLsbLgLsbLsbLgbLgbLgbLgbRgbLibLgb
LgbRiLsbRcbRibLcbRcbRobRcbRibRibRiRsmbLsbRiLsLsmbRobRgbRgLsbLcbLibRjbL
ibLgbRsRsmbsbLibLibLiRsbLcbRibLoLobLibLgbRjbRcbLjbLcbLcbLoRsbLjbLhbRjb
LibLibLgbLgbLgLsbRgbLibLgbLsbLsbLgbLsbLsbLgLsbLgLsbLsbLgbLsbLgbLgLsbRj
bLcbRhbRcbRgbRgbRgbRibRcLsbRgbRgbRhbRgbLgbRsLibLibLgRsbRsLsbLibLgbRsbL
gbLgbLgbsbLgLsbRsLsbLgbLgbLgbLgbLsbLcbLgbRibLibRhRsmbLcbLoRsRsmbLcLsmb
LcbLibLcbRsbRcbLgbRcbRgLsbLgbRobRiLsbRibLsbRgbRgbLsbLgbLibLgbLsbLgbRsb
LgLsbLsbLgLsbRsbLgbRsbLiLsbRsbLgbLobRibRibRsbRgbRibRgbRsRsmbRibLjbLcLs
mbRcbRcbRcbRhbRhbLgbRjbRibRsbRgbLsbRgLsbRibLsbLhbRcbRobLibLgLsbRgbLgbL
hbLgbRjbLiLsbRibLsLsmbRsLhRsbLobLcbLibRcRsmbRcbLibRibLjbRibRgRsmbRgbRi
RsmbRgbLibRsbRgLsbLsLsmbRibLcbLcbRibLibRcbLjbLiLsbLgbRsLgbRsbsbLhbRgbR
gbLgbLibLsLsmbLgbLgbRsbLgbRgbReRsmbRcbLgbLsbLibLcbLoRsbLobLibRgbLibLsR
sbLsLhbRibLgbLgLsbRsbLsbLgbLgbLgbLsbRsRsmbLsbLgLsbLsbLgLsbLsbLgRsbLsLs
mbLgbLgbLgbLgbLsLsmbLsLsmbLgLsbLibLsbLiLsbLibLcbRobRcbRcbLgbRcLsbLgLsL
smbRcbRhbRsbRgbRgbLibRibRibRgbLsbRgbRsbRibLsbRgbLgbRgbRgbRgbRhbLgbRgbL
obLobLgbLgbLgbLgbRgbLiRsbRgLsbRgbLcLsmbLcbLobLsbRgbLsbLjbLibRsbLgbLsbL
gbRgLgbLgbRsbLgbRsbLsLgbLgbLgbLsbLgLsbRsLsbLgbLgLsbLgbLjbRgbLgbLsRsbLg
RsbLsbLgbLgbLsbLiLsbLgbRcbRcbLcbRobRcbRcbLibLsLsmbLibLgRsbLibRcbRsRcbL
ibLibLibRgbLgbLsbLgbLsbRsbLibLgbRgbLsLsmbLgbLsLsmbLgbLsLsmbLsbLsbLgLsb
LgbRsbLgbRsRsmbLibRibLibLobLoRsLsbLcbLgbRsbLibLgbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 4; Drug: Control
bLsbLsbLgbLsbRsLgbLsbLgbLgbLgLsbLsbLgbLgLsbRsLsRsbLgLsbRgbLibLiLsbRjbR
ibLibRibLhLsbLhbRcbRibLjbRcbRcbRobRhbRgbLjbRibLcbRibRsbLcbRjbRcbRibRgb
RcbRcbRhbRibRgbLsRsbLibLibLiRsbRibRjRsmbRgbRebLibRhbRcbLebRcbLjLsmbRob
LebRcbLibLibLibRsbsbsbLcbRcbLhbLhbRcbRcbLibRibRcbRcLsbLcbRcbRhbLibRjRs
mbLgbRgbRsRsmbLibLibRiRsmbLcbLgbRsbLcbLibRgbLsbLgRsbLibLibLiRsbRgbLgbs
bRgbRgRsmbRgbLjbLebRibLibLgbLsLsmbRsbLiRsbLsbLhRsbLcbLcbLhbLibLhbLsbLi
bRgbRibLgbLibLibLibRjbLcbRhbLcbRjbLibLcbLcbLcbRcbLjbRcbRhbLjbRiRsmbRib
RgbRibLjbRcLsbLibRhbRiRsmbLibLgbRcbLcbLobRibLsbLibLibRgbLiLsbLgbLibLhb
RcbLcbRcbRcLsbLcRsbRcbLgRsbRhbLgbRgbRgRsmbLsbRgLsbLjbRibsbRgbRgLsbRsbR
sbRgRsmbLsRsbRsbRgbRgbLsRsbRgbRibLgbRibLjbRibRiLsbLibRibRiRsmbLhbRiRsm
bRiRsmbRsbRjLsbRsbLsbLsbRgbLsbRsbRsbRsbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 5; Drug: Control
bRsLgbLgbLgLsbLsLsmbRsbLgbLsbLsbRsbLsbLgbLsbLgbLgLsbLgLsbRjbRcbRsbRsbR
gbRibRibRsbRsRsmbRsbRiRsmbRgbRgbRgbRsbRsbLsbRibRibRgbRsbLgbRibRiLsbLgb
RcbRibLiLsbLgbRcRsmbRibRgbRgbRsLsbLgbRibRibLgbRibRsbRiLsbRibLibRgbRsbR
cRsmbLgbLibLhbLhbRiRsmbLcRsbRibLcbRjbLibLibRsLsbLibRibLobLsbRgbLcbRgbL
hbLgbRibLhbLiRsbRcbRcbRibRgbRiLsbRobLibRibLcbLibRsbRibRebRibLsbRhRsmbR
cbLcbLibLsbRsbRsbLibLcLsmbRebLcbLobLgbRibRhbRibLjbRgbRgbRsbRgbLsbLjbRe
bRhbLhbRgbRsbRcbLibLcLsmbLiRsbLibLsbRhbLhLsbRjbRhRsmbRgRsmbLgbRcLsbRcb
LibLgbRgbRiRcbRobLibRibLgLsbLgbRjbRibRiRsmbRibLgbRsbRibLsbRibRibLibLcb
LibLjbLgbLsbLiRsbLibRhRsmbRiRibLsLsmbRgbRibRsbRsRsmbRsbRgRsmbRgbRgbRgb
RgRsmbLsbRgbRsbRsLsbRjbLsbLsRgbRibLjbRibLgbRibLsbRgbRgbLsbRibLjbRcbLib
RhbLgLsbRobRoRsmbLgbLebLgbRibRibRibLjbLcbLibLsbLibRjbLgbLibLsLsmbLgLsb
LgbLgRsbRsbLibLgbLgbRjbLibLgbRjbLibLsbLgbLibLgbRgbLibRjbRcbLcbLhRsbRjb
LcbLobLibLgbRgbRiRsmbRibLsbRsbRgbRgbLsRsbRsbRgbLsbRgbRsRsmbRsbRgbRsbRg
bRgbRgRsmbRsbRsbRsbRsRsmbRgbRsbRsRsmbRsbRgRsmbRibRsbRgbRgbRsbRgbRsbRgb
RgbRgbRsbRgLsbRiLsLsmbRgbRsbRgbLcRsbLiRsbLgbLibRebRcRsmbLcbRcbRobLibLg
bRgbRcbLjbRjbRibRcbLhbRibLgbRcbLgbRiRsmbLsbRibLgbRgbRsRsmbRsbRgbRsLsbR
gbRgbRgbRsbRgbRibRgRsLsmbLgbRiRsmbLjRsbLibLibLgbRhbRhbRhLsbLgbRibLgLsb
LiLsbLibLsbLgbLgbRjbRhbRsbRibRgRsmbRsRsmbRsbRgbRgbRgbRcbLibLgbLjbLiLsb
RhbLcbLibRibLcbRsbLibLgbLgbLsbLibLcbLhLsbRhbRibRibLgbRibLsbRibLsbRibLg
bRibRsbRgbRgbRsbRgbRsbRsbRgbRgbRiLsbLgbLsLsmbRiRsmbRsbRibRibRgbRsbLsbL
gbLcLsmbLibLibRgRsmbLhbLhLsbLibRsbRgbLjbLibLibRjLsbLcbRhbRcbLgbRibRhRs
mbRhbLgLsbRsbRgRsmbRgbRgbRgbLgbRhbLgbRsbRiRsmbLsRsbRgbRgbRsbRgbRsRsmbR
sbRsbRgRsmbRgbLsbRibLjbLhbRhbRibLhbLibRjbLsbLgbLgbLgbLsLsmbLsbLsbLsbLg
bLgbLibRcbLjbRibRibRgbRgbRgbRsbRgbRgbRgbLgbRiRsmbRgbLsbRibLgbRgbRsbRgb
RgbRsbRsbRgRsmbRgbRsbRsLsbRsRsmbRgbRgLsbRgbLgbRibRhbLgbLsbRiRsmbRsbLjb
RjbRhbRibRiLsbLiLsbLeRsbLjbLgbLgbRcbRibRcRsmbLibLsLsRsmbLgbLibRibRcbRi
bLgLsbRibRsbRsbRgbLsbRgbLsbRgRsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 6; Drug: Control
bLgbRiRsmbRgbRgbLsRsLsbRibLcbLsbLibLgbLsbLsbLsbRcbRiRsmbLebRcbLibRhbLs
bRibRgRsLsmbLgbRibRgRgbLibRibLjbLcLsmbLcbLcLsmbLibLcbLcLsmbRhbRhbRobLc
bRibLjbLcbLibLhbLcbRcbRibLsbRsLsbLcbLibLsbRjbRcbRhbRibLsbLiLsRsbRibRcb
RiRsmbLsbLgLsbRgbLcLsmbLsbRsbLibLobLsbLgbRjbRiRsmbRgLsbLhbLobLibRgbLhb
RsbLibLgbRjbRcbRcbRsbLibRcRsmbRgRsRsmmbRgbRibLhbRgbRibLcbLcbRibLcbLibR
gbLibLibRsRsmbLibLgbLibLgbRgbRebRgbLcbRsbLhbRgbRsLiLsLsmbLgLsbRsbLsLiL
sbLibLgbRgbRgbLhbLhbRgLsbRibLcLsmbLgbRsbLiLsbLgbLgbLgbLgbRgbLsbLiLsbLi
bRsbRgbRsbLcLsmbLiLsbLgRiLsbLibRjbRcbRibRsbRibLcbRcbRoRhbRcbRsRgbRgbRg
bRgbRgbRgbLsRgbLgLsbLcbLhbRgbLibLiLsbRhbLiRsLsbRsLsbRcbRcbLjbLcbLgbLgb
LsbLsbLsbLgbLcbRcbRcRsmbRgbRgbRsRsmbRsLsbRibRgLsbLiLsbLjbRjbRibRgbRsbR
gbLgbRsbLjbLcbRgbLibLgbRjbRcbRhLsRsbLibLibRcbRcbLhbLgbRsbLibRjbRcbLsbR
iRsmbRibLjbLcbLibLsLsmbLsbLsbLgbLsbLsbLsRsbLsbLgbLgbLgLsbLsbLsbLgbLsbL
gbLgbRsbLsbRjbRiLsbLjbLcbLgbLgbRgbLgbLgbRcbRcbLibLsbRibsbsbLgbRcbLibLj
bLibLgbLsbLsLsLsmmbRsLsbRsLsLsmbLgLsbLgbRsbLgbLsRsbLibLgbLsbLgbLgbLsbL
gbLsLsmbLsbLsbLgLsbLgbRjbRcbRcbLcLsmbRoLsbLhbLcbRjbLcbRsbLibLsbLgbLsbL
gLsbLsbLsbLgbLsbLgbLgLsLsmbLsbLsLsLsmmbLgbLsLsmbLgbLsbLgbLsLsmbLgbRsbR
cbRibLjbLcbRcbRcLsbLibRcRsmbLjLsmbRiRsmbRsLsbRhbRcbLsbRibLjbLibRsbLiLs
bLsbRsRsmbLgLsbLsbLsbLgLsbLgbLsbRsbLsLsmbLgLsbLsbLgbLsLsmbLsbLsLsmbLsb
LsLsmbLgbLsbLgbLgbLsLsRsmbLsLsmbLgbLsLsmbLsLsmbLgbLsLsmbLgbLgbLgbLgbLs
bLgbLsbLgbLgbRcbRoRsmbLobLcbLcbRibLhbLibLsbLibRsbLsLsmbLibLsbLsbLgbRhb
RcRsmbRiRsmbLibLibLcbRjbRcbLsbRibLgbLsbsbRgRsmbRibLhbLcLibRjbLhbLsbLgb
LibLibLiLsbLibRgRsmbRibLjbRhbLcLsLcmbRibLcLsmbRgRsmbLhRsbRsbLgLsbLsbLs
RsbLsLsmbLibRgbRjbRhbRsRgRsRsmmbLsRsbRibRgbRsRsmbLsRgbLsbLcbLgbRcbRibR
gbRgbLsbRgbRgbRgLsbRibRgbLhbLcbLibLgbRgbLgbLgbRsbRobLcbRhbRgbRsbRgLsbR
gbLsbRsbRgbLjbLibLibLsbLsbLgbLibRjbRoRsmbRgRsmbRsLsbRsbRgbRgbRiLsbRgbR
iLsbLiLsbLjbLhbRcbRoRsmbRgRsmbLsbRgbLjbRhbLgRsbRibRgbRgRsmbLjbRgbRgbRg
bLobLgbLgbRsbLgbRcbRgbLsbRgbRgRsmbLgbRgbRibRsbLgbRhbLgbLcLsmbLsbLsbLsb
LgbLiRsbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 7; Drug: NDMC 1 µM
bLibLgLsbLsbLsbLsLsmbLgbLsLgbLsLsmbLsbRsLsbLgLsLsmbRsbLgLsbRsbLgbLibLi
bRgbLsbLgbLgLsLsmbLgbLsLgbLgLsLsmbLgbLgbRsbLibRjbLibRsbLiRsbRjbRcRsRsm
mbRgbLsbRgbRgbLsbRibRibLibRibLgbLibRgbLibLsbLoLgRsbRibRgRsmbRsRiRsmbRg
bLgRsLsbRiLsbLgbRiLsbLgbLjbRiRsmbRibLjbLjLsmbLgbLiRsbLiRsbLsbLibRgbLib
LibLsbLsbLsbLhbRgbLhbLcbLgbRcbRhRsRimbLgbLsRcRhbRibLcbRcbLjLgbLcbRjbRc
bRgbLgbLgbRgbRgbRiRsmbLgbRibLgbRcbRgbRibRsbRgbRsbLgbRcbLcLsmbRcbRcbLcb
LibLobLiRsbRjbRsbRibLjbRibRhbRibRcbRiLsbLibLsbLgLiRsRsmbRibRibRgRgLsRi
bLgbLcbLcbRgbLibRsRsLeLgmbLgbLgbLsbLibRsbRibLhbRgbLeLsLsLsmmbLgbLiLsbL
gbRsbLsbLgbLsbRibRibRgbLsRsbRgbLjbLcRsbRgbLsRsbLibRjbLcbRibLjbLsRsLsbL
gbLsbLgbLjbRsbRsbLibLgbLibRhbRgbLcbLhbRgbLhbLsbRsbLsbLgbRgbLibRjLsbLib
RjbLibRjbLgLsbLgbLobRiRsmbRibRgbRgbRibLgbLjbRibRsbRgRsmbRsbLsbRgbRgbRs
bRgbRgbRgRsmbRsRsmbRsbRgbRsbRgbRsLgbsbRgbLsbLgRsbRjbLsbLgbRibLjbLjbLcb
RhRsmbRcbRgbLgbLjbRcbRhbRibLhbLcbRjbRjbLcLsmbLcLsLhmbRhbRhbRiRsmbRhbRs
RiRsRsRsmmmbRgbRsbRsRsmbRgbRgbLsbRgRsmbRgbRgbLsbRsRsmbRgbsbLjbLcLsmbRc
bRibLsbRgbRsbLsbLjbLjLsmbRcbRhRsmbLibLjbRjbRcbRibLgbRhbLjRsbLhLsbRcbRi
bLjRsbRgbRsbRsbRsbRsbRsRsmbRgbLgbRgbRgbLsbRgbRgbRgbRsRsmbLibLibLiLsbRs
bRsLibRcbRcbRibRsbLsbLsbRgbRibRgbLgbRgbRgbRgbRgLsbRsRsmbRsRsmbRgbLsbRg
LsbRgbRgbLibRiRsmbRgbRgLsbRsbRsbRsbLjbLjbLibLgbLibLgbRibLiRsbRjRsmbRcL
sbLsRcbRibRgbRgbLibLibLsbLgbRsbLibRjbLibRibLobRhbLiLsbRjbRibLcbLcbRcbL
cbRsbRjbRcbRiRsmbRsbLibRgbLgbRhbRibRibLgbLgbRcbRhRsmbLgbLibRgbRcbLgbRh
bLgbRibRgbLebRgbRgbLsbRibLgbRgbRsbRgbRiLsbLjbLiLsbRjbRgRsmbRibLjbRgbRi
LsbRibLcbLsbRibRibRgLsRsbLjbLsbRhbLgbLsbRgbRsbRgLsbRiRsmbRgLsLsLsmmbRg
bRgbRsRsmbRsbRgbRsbRgRsmbRsbLsbRgbLsRsbRsbRgRsmbRsbRgbRjbLcbLcbRcbLcbL
gbRcbRhbLgbLsRibLsbLjbLhbRebRhbRgbRibLibLibLsbLcLsmbLgbLjbRebRcbLgbLgb
RibRsbRsRsmbRsbRsbRgbRcbLgbLcbRcbRibRibRgbLibRjbLjbRibLgbLibLibLgbRjbR
obRibLgLjbLcbsbLgbLgbRhbLcbRibRsLibRsLsbLsLsmbLibRsLsbLhbRcbLhbRjbLsLi
bLgbRsbLjRsbLgbRjbRcbRibLsbLsLsLsmmbRgbRgLsbLsbRgbRsbRgbRsbRsbRgbRsbRg
LsbRsbRgbRgbRgbRgbRgbRsbRjbLjbRibLcbLcbRcbRcbLcbRhbRjbLgbLibLcbRcbRcbL
jbRcbRsbRsbLjbLgbLcbRjRsmbRjbRibLgRsbRsRsmbRgRsmbRgRsRsmmbRsRsmbRsLsbR
sRsmbRsRsmbRsbLibRobLibLhbRcbRibLibRjbLcbRcbLjbRibRhRcbRibRibRjbLgbLcb
RhbRcbRgbLjbReLsbLgbLsbRibRgRsmbRgbRsbRsbRsbRhbLiLsbLcbLibLibRsRsmbLcb
LibLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 8; Drug: NDMC 1 µM
bLsbLgbLgbLgbLgbLibLgbLgbRgbsbLibLibLibRcbLgbLibLibLcbLibLibLgbLibLgbL
ibRhRsmbRgbLgLsLsmbLibLibLsbLibRibLjbLsLhbLibLgbLgLsbLgbRjbRcbLibRcbRo
bLgbRcbRcLsbLibLcbLiLsbLcbLcbLcbLcbLcbLcbLobLcbLcbLibLibLsbLgLsbLibLsb
LgbLgbLsbLsbLibLgbLsRsLsbLgLsbRsbsbLhbRgRsmbRsbLgbLgbLgbRgbLgbLsbLgbLg
bLsbRgbLibLsLsmbRsRibRcbLsbRibLgbRgbRiLsbLjbLobLhbLgbLibLsbLsbRgbRcbRi
bRgbLsbRgbRgbLiRiLsbRhbRcbRsbLibRgbLiRsbLgLsbLgbRgbRgbRhbLcLsmbLhRsbRi
RsmbLhbLgbRgbLgbLibLiLsbLgbLgbLibRsbRgbLcbRibLcbLgbLsbRjbLcbLsbLibLibR
sbLibLsbRgbLgbLgbRcbRobLgbLsRsbLgbLgbRcRsmbRoLsbLgbLgLsbRobLibRobRibLs
bLgbRcbLgbRibRibLgbRcbLgbLsLsmbLgbLgbLsbRsLsbLgbRobRibLgbLsbRibLgbRibR
ibLgbLsbRgbRhbLgbRcbLgbRcbLgLsbRhbLgbLsRsbRibLcLsmbLibLibLgbLsbRsbLgbR
cLsbRibLsbRgbRgbRgbRsbRgLsRsbRgbRgbLgbLgbRibRsbRibLgbRiLsbRiLsbRgLsbLg
bRsRibRgbLcLsmbLobRgbLcbRiLsbLibRsLsbLcbRgbLgbLsRsbLsbLgbLgLsbLsbLgbLg
bRsbRibRibLjbLibLgLsbLsbLgbRsLsbLgbLgLsbLsbLgbLgbLgbRsRsmbRsRsmbLgbRob
LibRcbRgbLgbRibRcbLgbLibRcRsmbLiLsbRcbLcbLhbLsbLsLsmbLgLsbLgbRsLsbLgbR
sbLsLsmbLgbLibRibLgbLgbLgbRsbLgbLiLsbRsbLsbRsbLgbLgbLgbLgbLgbRsbLgbLgL
sbLgbLgbLgbLgbLgLsbLgLsLsmbRcbRcbLibRcbLsbLsbRgbRgbLjbLgbLgbRsbLgbLgbL
sLsmbLsbLsbLgbLgbRjbLibLgLsbLgbLgbLgbLgbLgbLsbLsbLgbLsbRgbLjbRcbLgLsbL
sLibLibRgbLgLsRsbLgbLsbLsbRsbLsLgbLgbLsbLsbLsLsmbLsbLsLsmbLgbLgbLgLsbL
gLsbRsLsbLgbLgbRgLsbLgbLsbLgbLsbLgRsbLgLsbLgbLgbLsbLgbRgbLgbLgbLgRsbLg
LsbLsbLgRsbLgRsbLhbRibRcbLgbRobLgbLibLibRcbRobLcbLcbRgbLsbLiRsbRgbLibL
ibRcbLobLibRibLgbLibLsLsmbRsbLgbLgbLgRsbRsbLgRsbLgbLgbLhbRhbLgbLgLsbLi
RsbRjbLibLibRobRcbLibRsbLgbLibLiLsbLgbLsLsmbLgbLgbLsbLsLsmbLgbLsbLsbLg
bLgbLsbLgLsbLgbLgbLgbRjbLcbRibRcbLjbLcLsmbRjLsbRhbRiRsmbLsbRobLibLgbLi
bLiRsbRsRgbLcbRgbRjbRibRibLoLsmbRsRsmbLgbLsbLsbRjbRcLsbLibLobRgbLgbLsL
smbRsbLgbLgbRsbLgbRsRsmbLgbLgLsRsbLsbLsLsmbLgbLgbRgbLgRsbLsbLgLsbLsLsm
bLgbLsbLsbLgbLgLsbRjbLhbRsbRjbRibRibRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 9; Drug: NDMC 1 µM
bRobRcbRgbRgbRibsbLjbRibRibRibRibRibLgLsbRsbLjbLibRebLibRibRjbLjbLibRc
bLjbRhbRcbLibRcbLibLjbRcbLjbLsLsmbRcbLibRhRsmbLjbLcbRhbRcbRcbRibLjbLib
RibRcbRhbLsLsLsmmbLgLsbRsLsbLgbLsbLjbRjbLibReLsbRcbRjRsmbRhbRsRsmbLhbR
cbLibRcbLjbRcbRcbLjbRcbRhbLibRibRhbRibLsbRiLsbLjbRhbLibLjLsmbRobRcbRcb
RsbLgLsbLgLsbRoLsbRibRsbRsLsbRibLjbRcbRibLjbRhbRcbLiLsbLgLsbRsLsRsbRcb
RcbRgbLibLibRcRcbRgbRsbRibLhbLcbRcbRcLsbRcbLsbLcbRgbRibRsbRsbRcbLgbRcb
LjbRcbLjbRhRsmbLcbLcbRcbsbRcbLhRsbRcbRcbRcbRiRsmbLebRcbsbRhbRiLsbRgbRi
bLgbLsbLgbLgLsLsmbRsbRgbRcbLjLsmbRcbLcbRcbLgbRcbRhbRsbLgbRhbLgLsbLsbRh
bLibRcbRsbRcLsbLjLsmbLjbLgbLgbLsbLgbLgbRjLsbLsbLgbRcbRibLjbRhbLjbRibRc
bRcLsbRibRibRibLgLsbRjbRgbLgbsbLjbRcbRibLjbRcbLjbLhbLobRcbRhbLjLsmbLib
LibRoLsbRcLsbRcbLsLsmbRibLgbRcbLhbLcbRcbRhbLjbRcLsbRsbLiLsbLjbLiRsbLgb
RjbRcbLjbLibLibLgbLsbLgbLgbLsbLgbLsbsbRsbLsbLgbLsLsmbLgbRobRiLsbRibRib
LibRibLgLsbLiLsbLgbLibLgbRsbRjbRcLsLsmbLjbRibLjbLibRibRhbLjbRobRgbLsbL
gbLgbLsbLsbLgLsbLgbRcbRibLjbRgbRgbRgbLsbRjbLjbRjbLibRibLcbRhbLhbRcbRcb
LjbRgbLgbLgbLsbRgbRgbLjbRcbRcbRiRsmbRibLjbLibLibLgbLgbLgbLgbLsbRsbRsbL
gbLgLsLsmbRsbLibLgRsbRjLsbLsRsbLgbRsbRsRsmbLsbLgbLsbRsLsLsmbLsbLsbRsLs
LsmbRsLsbLsLsmbLsbLgbLgbLgbRcLsbRibLjbRibLjbRgbRsLsbRiLsbLsbRsRsRsmmbR
jbLjbLoRsbRcbLjLsmbRcbLjbRcbRibLjbRcbLsbRibRsbRibRsRibRgbRgbLjbRibRibR
gbLjbLcbLsRjbRibRibLibLjbLjbLibRibLiRsbLgbLsLsLsmmbLsbLgLsbLgbLsbLsbLs
LsmbLsbLgLsbLgRsbRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 10; Drug: NDMC 1 µM
bRjbLgbRsbLibLcbLgLsbRgbRibLjbLobLebRgbLsbRsRsmbRsbRgbRibRjbRsLsbLsbLi
bLsbLsbLgbRjbRhbLibLibRcbRjbRsbRsRsmbLjbRjbLgbRibLjbRcbLgbRibRgbLibLjb
LjbRcbRhbLjbRiRsmbLgbRibLgbRjbLhbRjbLjbRjbLgbLjbLgbRsbRjbLibLgbLhbLjbR
ibLiLsbRcbRebLibLsbRebLibLibRgbLibLsbLgbRsLsbLiLsbLjbRgbLhLsbLibLsbRiR
smbRsbRgbLhLsbLiLsbLsLsmbRgbLibLsbLgbRibLjbLgbLsbLsbLgbLibLibLsbRjbLcb
RibLsLsmbLibRsbLiLsbLibLsbRcRsmbLsRcbLibLgbRiRsmbRhbLsbRgbLsbLsbRsbRib
RsbRsbRsbLgbRgbLsbRgbLsbRgbLsbRibLibLsbRibRgRsmbLsbRgbRsbLsbRsbRiRsmbL
gbRibRcbLibRgbRhRsRsmmbLibRcbLgbRibLgbRhbRgbLibLsbLsbRcbRsbLgbRcbRibLg
bsbLibLsbLsRsLsbLsbLhbLsbRsRsLsmbLibLsLsmbLsbLsLsmbLibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 11; Drug: NDMC 1 µM
bRgbRgbRgLsRsbRsbRsbRgbRsRsmbRgbRsRsmbRsbRsbRsbRsbRsLsbRsbRsRsmbRsbRsR
sRsmmbRsLsRsbRsbRgbsbRgbRgRsmbRsbRsbRgbRgbRgbLjbRibLgbRibRgbLgbRgbRjbL
jbRiRsmbLhLsbRgbRiRsmbLcbRhRsmbLhbRibRgbLjbRibRgbRcbRibLibLgbRhbRgbRjb
LibRcbRgbRsbLsbRsRsmbRsbRgRiLsbRiLsbLhbLcbLcLsmbRebLgbLibLgbsbRsbLsbLg
bLgbLgbLsbLsbLgbLibRcbRcbRgbRsbRibLgbRgRiLsbRgbRibLgbLgLsbRcbRibLsbRsb
RibLibRiLsbRgbRgbRgLsbLibRjbLgLsbRibRgbLibLjbRcRsmbLcbLhbRebLcbRibRcbL
jbLobRhLsbRcbRgbLibRibRibLjbRibRgbRibLjbLgLsbLsbRsLsbRsbRibsbRgbLhbLob
RhbRibRibRgbRsbRgbRgbRsbRsbRsbRsbRgbRgbRsbRgRsmbRsbRgRsmbRsRsmbRsbRsbR
sbRsbRsbRgbRiLsbLgbLgLsbRjRsmbRibRgbLibLobRgbLiRsbLsbLgbLsbLgbLiLcbsbR
gRsmbsbLibRsbLhbLgbLgbLsLsmbLsLsmbRsbLsLsmbLsbLsbLgbLsbRsLsbLsbRsbLgbL
gbLsbLsbLsbLsbLgbRsRsmbsbLgLsbLiRcbRibRgbLsbsbRgRsmbRgbRsbRgbRsbRsRsmb
RsbRgbRgLsbRgbRsbRgbRsbRsbRgbRsbRgbRgRsmbRsbLibRiRsmbRgbLjbRhbLibRibRs
bRgRsmbRsbRgRsLsmbRsRsmbRgRsmbRsLsbRsbRgbRsRsmbRsbRgLsbRiLsbLcbRgbRibL
sbRgbRgbRgbRgbRsbRgbRgRsmbRhLsbLibLcbLgbLgLsbLsbLgbLjbLibRibLcbRjbRhbR
ibLgbRgbRgbLsbRgRsmbRgbRgbRgbRgbRgbRsRsmbRgbRgbRsbLsbRsbRsbRgRsmbRsLsb
RsbRgbRsbsbRsbRgbRibRsLsbLibLgLsbLgLsbLgbLsbLgbRsRsmbLibRibLibRibRhLsb
RgbLgbLgbLgbRjbRgbRibLsLsmbRiLsbLsbRgbRsbRsbRgLsbLjbRsbRgRsmbRsbRsbRsL
sbRgbRsbRgbRgbRsbRsbRsbRgbRgbRgbRgRsmbRsLsbRsbsbRsbRsbRsbRsbRsbRsbRsbR
sbRsRsmbRgbRsbLsbRsLsRsbRsbRsRsmbRgLsbRsbRsbRsbRgbRgRsmbRgLsbRgbRsbRgb
LcbRibRgbLiLsbLgbLsRsbLgbLsLsmbLsbLsLgLsbLgLsbRsbLgbLsbLsbLsbLsbRsbLcR
sbRcbRcbRgRsmbRibLcbLgbLsbLsbLgbLibLgbLsbLsLsmbLsLsmbRobRgLsbLsbRgRsmb
RsbRsbRgRsmbRibRgbRgbRgbLjbLcbRjbRjbRgbRgLsbRsbRsbRgbRgRsRsmmbRsbRsbRs
bRsbRsbRgbRsbLsbRgRgbRgbRgbRsbRsbRsbRsbRsRsmbRgbRgbRsRsmbRsbRiLsbLjbLg
bLibRsLsbLsLsmbLsbLsbLsLsmbLsRsbLgbLgLsbLgbLsbLsbLgbLsLsRsmbLgbLsbLsLg
RsbLibRcbLibLgbLgLsbLgLsbLsbLsbLsLsmbRjbRibLibRibLibRibLibLiRsbLgbRcbR
gRsmbRgbRgbRgbRgbLsbRgbRsbRsbRsRsmbRgbRgbRsbRgbRsLsLsmbRsbRsbRsRsmbRgb
RgLsbRgbLjbLhbRjbRibRgbRibRgbRgbRgbRgbRgbRsbRgLsbLcbLgbRgbLgbLsRsbsbLs
bLsbLsbLsbLgbRsbRsbLgbLsbRsbLgLsbLgbLsLsmbRsbRsLgLsLsmbLgbLsbLgLsLsmbR
sbRjbRgbRgRsmbRgbRsbRgbRsbLjbRgbRgRgRsmbRsbRsbRsbRsLsbRsbRsbRgbRgbRgbR
gbRibRgRsmbRsbRgbRsRsmbRsRsmbRgbLsbRgbRgbRsbRsbRgbRsbRgbRgbRgbRsbRgbLj
bLhbLgRsbLgLsLsmbLsbLsbLsLsLsLgLsmmbLgbLsLsmbLsLsmbLsbLgbLsLsmbRsbLibL
sbRsLibRgbLgLsbLgLsbRsbLgbLsLsmbLgbLgbLgbLsLsmbLgbRsLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 12; Drug: NDMC 1 µM
bLibLibLgbLsbLsbRiRsmbRcbRiRsRsmmbRgbRibRibRiRsmbRgbRsbRgbRgbRsbsbRhbL
gRsbRibRsbRiLsRsbLgbRiRsmbLgbRibLjLsmbLcbsbRcRsmbLjbLcbLsbLiRsbLjbLibL
cbLibLjbLhbRjbLcbLiRsbLibLibLibLibRjbLibLcbLcbRsbLobLibLibRgbLcbLhbLib
LhbRgbLcbLhbRgbRibLcbLibLgbLhbLgbRgRsmbLoLsLsmmbLgbRibLcbLcbLhbLibLibL
cLsmbRcbRcbLobsbsbRsLgbRsbLgbLgRsbRjbLcbLcbRibLsbLcbRjbLcbLiLsbLhLibRi
bRiRsmbLsLsmbRibRibRibRibRgRsmbRsbLibRibRhbLcbLcRsbLgRsbLgbRgbLiLsLsmb
LiLsRsbRibRiLsbLgbLcbRhbRjbLcbRcbRiRsLsmbRibLgbLsbRibLjbRoLsbRoLsbLibR
iRsmbLgbLibRibRgbRibLibRibRibRobRobRhRsmbRibRgbRgbRibRibLibLcbLhbRibRi
bRibLjbLcbRiRsmbRcbLibLcbRjbRcbLibRibRgRsRsmmbRibLjbRibLsLsmbRgbRsbRgb
LsbRsbRoRsmbLsbLibRiRsmbRiLsbRibLgbRibRgbRsbRsRsmbRsbLsbRsbRgRsmbLsLsm
bRsbLebRcbRobRhbRsbRsbRibLibRcbRgLsbLjbsbLgRsbRcbLibLgbRgbLgbRgRsmbLgb
LgbLsbRsbRsLsbLgRsRsmbRsbLgLsbRcbLjbRcbLibLjbLhbLsbRhbRgbLsbRgRsmbsbRj
RsmbRsbRsbLcbLsLgbLgbRjbRibRsbRsbRgRsRsmmbRsbRsbRgRsmbRgbRsbRgbRsbRgbL
sRgRsmbRgLsbRgbRiRsmbRgbRsRsmbRgRsmbRgLsbRgRsRsmmbRgbRgbRgbRsbRsRsLsmb
RibRsbRgRsmbRgbRgRsmbRgbRgbRgRsmbRgRsmbLsbRsbRgRsmbRibRgLsbRibLgbRibRc
bLibLsRcbLjbRhbRgbRgbLjbRcbRibLgbRhbLgbRgRsmbLjbLcbRibLsbLcbLcbRebLhbR
cbLibLibLibRibRhbRsbLsbRibRgbRgbLgbLgbRcRsmbLibRhRsmbLibRibRsLsbRsbRgb
RsbRgbRgbRsbRsbRsbRgbRgbRgbRgbRcbLhLsbsbLhbRjbRcbLgbRibRgbRsbRsbRgLsbR
gbLsbRsbRsbRibRibRgbLsbRgbRgbRsRsmbRgbRsRgbRgbRibLibLcbRibReLsRsbLgbRg
bRibLibRobRcRsmbRibRhbRiLsbRgbRgbRgbLcbLgbLsbLgbRcRsmbLgbRibRgbRsbRgbL
ibRcbRibRibLibRcbLiLsbRibRibRibRiRsmbLibLibRibRsbRcbLgbRcbRobRcbRjRsmb
RhbRhbRiRsmbLibLibRibRibRgRsmbLsbRcbLibRiLsRsbRgbRgbRgbRgbLhLsbLcbLibR
jbRibLsbLsRsbLhbLgbLgbLgbRjbRjbRgLsRsRsmbRsbRgRsmbRsbRsbRsbRgbRsbRgbRs
bRgRsRsRgmmbRsbRgbRsbRsbRsbRgbRgbRgbLsbLobRibLibLsbRibRgbRsRsmbRsbRgbR
gbRgbRsLsbRgbRgRsmbRsbRgRsmbRsbRgRsmbRsbRiLsbRgbRsRsmbRgRsmbRsbRgbRsbR
gbRgbRsRsmbRgbRgbRgbRsbRgbLgRsbRiLsbLjbRiRsmbRgbRgLsbRgbRgbRgbRgbRgbRj
bLibRibRgbRgLsbRibRgbRgbLcLsmbRcbRcRsmbLgbRibRcRsmbRiLsbRgbLhbLhbRibLg
bLibRhbRgRsmbRjbRibLjbLcbLgbLibRjRsmbRcbLgbLeLobRebLibLibLgbLibLibRiRs
mbLiRsbLibLiRsRsmbLibRiRsmbLjLsRsmbRhbRcbLibLgbLcbRhbRhRsmbLibLcbRcRsm
bRibRsbLjbLiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 13; Drug: NDMC 3 µM
bLjbLibLgLsbLgLsbLsLsmbLgbLsbLsbLgbLgbLgbLgbLgbLgRsbRsbLgbLsbRjbLgbRob
LcbLgRsbLgbLibRsbRsbRsbLsRsbRcbLcbLgbRgbLcbLgbRgbRsbLsbLibLibLgbLcLsmb
RcbLgbRibLhbLsbLgbRsbLsbLcbLibLcbRsLsbRcbRcbRsbLgbLgLgbRjbLcbLoLsmbLcb
LgbLgbLgLsbLgbRsbLsbLsbRsbLhbRgLsbRsbLsbLibLsbLsRsbLibRjRsmbRobRibRibL
gbLgbLsbRcRsmbRiRsmbLibLsbRcbRibRsbRsbLgbLibLjbLibRobRcbRiRsRsmmbRgRsm
bLgRsbRsbRjRobRsbLgbLiRsbRgLsbLibLibRgbLgbLgLsbLsbLsbLibLsbRsbLgbLsbLs
bLgbLgbLgLsLibLgbLgLsLsRsmbLgLsbLsbLsbLgbRcbRcbRhbRcbRsbLgbRhRhbRibLgb
LsbRcbRiLsbLgLsbLgbRsbRcbLibRgbRibRgbLsbRgbRibLcbLcRsbLsbRsbRjbLcRsbRj
bLcbRsbLhbLiRsLsbLgbRibRibLobLibRgbLibLsbLgLsbLgbLibRibRgLsbLgbLibLgbR
gbLsLsmbLgLsLsLsmmbLsLsLsmmbLgbLsLsmbLgbRsbLsbLgbLibLsbLgbRhbRebLsbRob
RcRsmbLcbRgRsRiRsmmbRhbLgLsbRcbRibLsbRsbRsRsmbRibRgbLsLsmbRgRsmbLsbRgb
RiLsbRgbRsbRsbRibLjbRibRibLgbRibRibLibLcbLgbRsbLgbRgbLsbLibLsbLgbLgbLg
bRsbLsbRibLoRcbRcbLobLcRsbRgbLcbLgRsbsbLgbLgbLgbLsbLgbLsbLsbLsbLgbLsbL
sbRsbLgbLsbLgbLgbLgbLgbLgbRgbLibRsbRobRhbRobRhbLcbLgbRgbLgRsbLsbLsLsmb
LsbLobRhRsLsmbRgLsbRgLsbRgbRgbLcbLobLiLsbRibLcbRcbRcbLgbRibRgbLcbLobRi
bLcRsbLgbLsLsmbLgbLgbLsbLgbLsbLsbLsbLgbLgbRsbLgbRsbLgbRsbLgLsbLsbLhbRg
bLgRsbLgbLibRjbLhbRibLcbLcbRiRsmbLsbRsbRsRsRgmbRiRsmbRcbLgbLgbLibLgbRg
bLoRsbRcbLcLsRcmbRcbLibRcbRhbLsbLgbLgbLibLjLsmbLgbLsbLgbLhbRhbRcbLobLo
RsbRsbLgbLgRsbLgRsbLgbLsRsbLgbLgbLgbLiRsbRsbRsbRgbRcbRcbRibLibRgbRibRh
bLibRgbRibRhbLgRsbRgbRibLjbRsLcbRsbLcbRgbLibLsbRsLsbLgLsbLgbLgRsbLsRsb
LgRsbLgbLsbLgbRsbLgbLgbLgbLsLsmbLgbLgbLsbLsbLsbLgbRhbRcbLcbLobLibLsbRs
bLsLibLgbLgRsLsbLgbLsbLsRsbLibLcRsbRiRsmbRhbLjbRibRcbRcbRcbRcbRhRiLsbR
hbLibLcRsbRsRsmbLgbLgbLibLcLsmbLhbRcbRcRcbRhbRhRsmbLibRiRsmbRsbRgbRsbR
sbRgRsmbRgbRjLsbRiLsbLiRsbRgRsmbRibLsbRgRsmbRibRgLsbRsbRgbRgbRgbLcbLiR
sbLgbRsbLsbRsbRsbLiRsRsmbLgbLibRsRsmbRsbLhbRobRobRcbRibRsbLsbRsbRgbRib
RgbLcbLibRgbRibRgbLcLsmbLgLsbLsbLsbRsLsbLgLsbRsbLsbLgLsbLsLsmbLebRsbLs
bRsbLgbLgbLsbRsRsmbLgbLibRsbRcbRiLsLsmbRgbLcbLcbRgbLsbLgbLgbLgbLsbLgbR
gLsbLgbRjbLibRcbLcbRjbLhRgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 14; Drug: NDMC 3 µM
bLsbLgbRibLsbRsbRgbsbsbRsbRgbLsRsbRgbLgbRgbLcbLibRgbLibLgbLsbLgLsbRsbR
hbRibRcbLsRsbLibLgbRcbRibLibLcbRgbLhbLiLgLsbLibLsbLibRgbLcbRibRcbLjLsm
bLcbLcbRgbLcbLgbRsbRgLsbLcbLibLgbLcbLgbLsbLgbLcbLcbRiRsmbRcbRcbRcbRibL
gbLsbLcbLcbLhbRgbLsbRibRibLcbRobRhbLsbLgbLgbRsbLgbRcbRiRsmbLgbLhbLibLi
bRsRgbRsbLcLsmbRiLsRsbRcbRsbRgRsmbRgbRgbRsbLjbRcbLgbLsRsRobRibRiRsmbRi
bRibLgLsbLcbLiRsbRgbRcbRibRibLobLibLsbLgbRgbLcRsbRibRhbRcbLhbLiLsbRcbR
hbLgbRibLjbLoLsRsmbLebLcbRgbRibRibLjbLcbLgbLsbLgbLsbLgbLsbLcbRgbLibLsb
LgbRsbLsbLibRjbRcRsmbRhbLiLsbLjbRcbLgbRhLsbLibRhRsmbLjbRcRsmbLhbRcbLjb
LcbLsbLgbLgLsRsbRsbLgbLgLsbLsbLgLsbLgLgbLibLhRgbRjbRibRcbLibRhbRgbLsRs
bRsbRgbLsbRibLjbRgbLcbRsLhbRjbLibRsbLgbLsbLgbLgbLsbLsbLgbLsLsmbLsLsmbR
sbRcbRobLebLhbRjRsmbRobRgbLgbRiRsmbRsbRgbRgbRsbRibLebLcRibLcbRgbLgbLsb
LsbLgbLsbLsLsmbLgLgLgLgbLsbLgbLsLsLsmmbLgbLsbLgLgbLgbLgbLsbLgbLgbLgLsb
LgbLgbLgbLgRsLsbLgbRcbRcRsmbLibRiLsbLsbLsbRibRgbRibLgbLjLsmbLcbRjbLcbR
ibLiLsbRsbLcbRhbLhbLsLsmbLgbRsbRsLsbLibRsbLibRsRsmbLoRsbLobRsRibRcbRib
RgRsmbRgRgbRcRsmbLebLjbLcbRgbLhbRibRoLsbLjbRobLsbRgbRgbRgbRgbRiLsbLgbL
ibLsbLibLgLsbRsbLibRjbLibLhRsbRjbLibLsbLsbLsbLgbLsbLsbLgbLsbLgbLgbLgbR
hbRcbRsbRsRsmbRgbRgbRgbRsbRibLcbLoRsbRiRsmbLcLsLsmmbRjbLibLgbLibRhbRcb
RhbLibLgbRjbRiRsmbRibRhbLjbLobRjbRcbRsbRiRgbLsLsRsmbRgRsmbRgbRgbRgbRgb
RgbRgbLcbLcRsbRibRhRsmbRiLgbLjbLiLsbLibLsbLsbLsbLgLsbLsbLsbLgbLsbLsRsb
LgbRsLsbLibLsbLgbLgbLgbLgbLgLsbLsbLgLsbLgbLsbLgLsbLsbLgbLsbLgLsbLsbLgb
LsbLsbLsbLcbRibRcbLsbRhbLsbLgbRibRhbRiLsbLebRibRcbLibLgbRgbRgbRsbLsRsb
RhLsbRcbRhbRcRsmbRibRgbRsbRhbLcbLcbRhbLcbRibRibRoLsbLibLibLhbRsbRibRgb
RgbRsbRiLsbLjbLobRcbRhbLcbLcbRjbLibLgbLgbLsbLsLsmbLsLgLiLgLgLibLgbLsbL
gbLgbLgLsbLgbRsbLgRsbRoLsbRibLjbLjbRcbRibLjbLcLsmbLcbRibLoRsbRcbRobLgb
RiLsLgbLjbLgLsbLsbLgbLgbLsLsmbLgbLgbLgbLgbLsbLgbLgbLgbRsbLgbRcbLjbLcbR
jbRcbRgbRiRsmbLgbRgbLsbRiLsbLcbLcbRibRcbLjbLobLsRcbRcbLgbLsbRiRsmbRsbR
gbRsbRibRibLibLebRibLjbRhLsLsmbLibLoLsmbLsbLsbLgbLgbsbLgbRsbLsbsbLgLsL
sRsLsmbLgbLgbLgbLgRsbLgbLibRebRcbLjbRibLsLsmbLsRsbLcbRjbLobRhRsmbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 15; Drug: NDMC 3 µM
bRgbLibLsbRsbRsbLsLsmbLibLgbRjbLjbRjbRgbRsbRsbRsbRsRsmbLsLsmbRgbLjbLgb
RsbLgbLgbRsbLgbLgLsLsmbLgbLgRsbRgbLsbLsbLsbRsLsbLsbLgbLsbsbLsbLsbLgbRg
LsbLgbLgbLsbLsbRsbsbLsbLgbLgLsbLgbLgbLgbRsbLgbRsbLsLsmbLgbRsbLgLsbRgbR
sbLgLsLsmbLgbsbsbLsbLsbLsbLgbRsbLsLsmbLsbLsLsLsmmbLsbLsbRsLsbLsbLsbLsb
sbLgbLgbRhbLsRibLjbLcbLibLgbRsbRsRsmbRsbLibLgbLsbRsbLgbLsbLgbLgbLgbRsb
LsLsmbLsbLgbLgbLsbLsbLsbLsbLsbLsbLgbLgbLgbLgRsbLgbRsLsbLgbLsbLgbLsbLsb
LsRsbLgbLgbLsbLgbLgLsbLsbLgbLgLsbLgbLsbLsRsbRsbLgbRgbLibRjbLibLibRiLsb
RcbRibRibLjbRcbRcbLibLgbRgbRgbRhbRibLgbRibRhbLgbLibLjLsmbLsLhLsbRgbLib
RsbRsbLibLgbLsbRgbLibRjbLgbLiLsbLsLsmbLsLsmbLsRsLsbLsbLgbLsbLgbLsbLgLs
bLsbLsbLgbLsbLsbLsbLsbLsbLsLsmbLgbLgbLgLsbLsbLgLsbLgRsbRjbRiRiRsLsLsmm
bRgbLjbLcbLiLsbLibLibRibRsLsbLcbLhbLsLsmbRgbRsLsbLjbLibLgbLsbLsbLgbLsb
LgbRcbRiLsbRgbRgLsbRsbRgLsbLsbLsbRsbRsbRgRsmbLcbLgbLibRsRsmbLsRsbLgLsb
LsbRsRsmbLgbLgbLsbRhbRgbLcbLibRsbLgbLsbLgLsbLgbLsbLsbLgbLsLsmbLgbLgLsb
RsbLgRsbRsLsbLgbLgbLgLsbLgbLsbLgbLsbLsbLgbLgbRgbLsbLgbLsbLgbLibRgbRsLs
LibRjLsbRcRsmbRibRgbRgbRibRsLjbLebLgbLgbLgbRsbRsLsbLibLgbRsbLsbLgbLsbL
sbLsbLgLsbLgbRsbLgbLsbLgLsbLgbLgbRsbLgLsbLgbLgbLgbRcbRibRibLibRibRgbRi
bRibRibLiLsbLsbRsbRsbRibRhbLjbLgbLhbLhbRgbLsLsmbLgbLgRsbLgbLsbLsLsmbRs
bLibRibLgbLsbRsLgbLgbLgRsbRjbRebRiLsbRgbLsbLjbRibRibLobLgbLgbLsbLgbLib
LsbLgbLsbLsLsmbLsbLsLsmbLsbLgbLgbRsbLgLgbLgLsbRsLsbLgbLsbLsbLsbLgbRjbR
sRsmbLgbRjbRibRibLgLsbRibLjbRcbRhbRgbLibLhbRgbRgbLjbLhbLgbRsbLsbLsbLgb
LgbLgbRgbRsLsbLgLsbLsbLsLsmbLsbLsbLsRsbLsbLgLsbLgbLgbLgbLsLsmbLgbLgbLs
bLgbLsbLgbLgbLgbRsbRhbRibRgbRgbLsLsmbRgbRgbRibRibLgLsbRibRcbLibRgbRsbR
sLsRibRibRiLsbRgRsmbLsbsbRgbLsbRgbRgbRsRsLsmbRgbRsbRsLsbRibLgbRgRsmbRg
bRgbRsbRsbRsbLjbLibRsbLibLgbLgbLsbLgLsbLgLsRsbLsbLgbLsLsmbRsbLgbLsLgbR
sLsbLsbLsbLsbLsbLsbLsLgbLsLsmbLsbLsbLsbLgbLgbLsLsmbLsbLsbLgbLgLsbLgbRc
bRiLsbRgbRiLsbRgbRsbLsbRgbLcLiLsbLgLsbLgbLsLsmbLgbLsbLgbLsRsbLsbLgRsbL
sLsmbLsLsmbLsbLsbRsbLsbLsLsmbLgbLsbLgbLgbLsbLsRsbLsLsmbLsbLgbLgbLgbLgb
RsbLgLsbRgbLgbLgLsbRsRsLsmbLsbLgbLsbLgbLgbLgbLgbLsLsRsmbRsLgbLgRsbLgbL
gb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 16; Drug: NDMC 3 µM
bRgRsmbRgbRsbRsbRsRibRsbRgbLgLsbRgRsmbRsLsbRgRsRsmmbLgbRibRibLgbRsbRgb
LsbRibLcbRsRsmbLibLiRsLsbRsLsbLcbRibRibRcbLjbLhLsbLibLibLcbLibRgbRgbLi
bLcbLcbRcbLibLcbLcLsmbLgLsbRhbRibRibRgbRibLgbRgbRsbRhbRgbLgbRibLjRsbLc
bLcbRsLiLgbLibLsbLiLsbLibRgbRebRoLsbLcbRobRobRsbLsRsRsmbLgbLhbRsbLibLs
bRgbLcbRgbRgbLcbLhRsbRcRsmbRgbLgbRcbRibRsbLgbRhbRcLsbLibRgbLibLcRsRsmb
LcbRibRgbLiRsbLgbLcLsmbRgLsbLcbRibRibRsbRibRgbRsRsmbRgbRsbRsRsmbRsRsmb
RgRsRsmmbRgbRiRsmbLgbLgbRhbLjbLgbRjRgbRsbRgbLsLsmbRgbRibRsbRsbRsRsmbRg
RsmbRsbRgLsbRgbLibLcLsmbLibLibLibRgbLsbRgRhbLhbRcbLibRibRgbRsRsmbRgbRs
bRsbRgbRgbRsbRsbRsbRibRgbRgbRgbRgbRsRsmbRgbRgbRgRsmbRsbRgbRsbRibRgbRsb
RgbRgRsmbRgbRgbRgbLcbLcLsRsmbRgbLibLgRsbLgbLgbLgbLcbRgbLgbLibRibRhbRib
LjbRhbLhbRebRsbRsbRsLsbRgbLsbLsbRibRsbRgRsLsRsRsmmbRgbRsbRsRsRsmmbsbRs
LsRgRsmbRgbRgbRsbRsRsmbRgbRgRsmbRgRsmbRgRsmbRgbRgbRibRhLsbLcbRcbLcbRcb
RibLibRibRiRsmbRsbRgbRsbRsbRsRsmbRgRsmbRsRsmbRgbRsbRsbRgbRgRsRsmmbRgbR
gbRsbRsbRgbRsbRsbRgbRgbRsbRsbLjbLcbLcbRibLcbLhbRcbLjbRcRsmbRgRsmbRsbRs
bRsbRgRsmbRsbRsbRgbRgRsRgmbRgbRgLsbLsRsbRibRsbRsbRgRsRsmmbRgbRsRsRgRsR
sRgmmmbRsbRgRsmbRgRsRsmmbRgbRgRsmbRgbRgbLgbLcLsmbLobRibLcbLibLsLsmbRsb
RsbLgLsbRsbLibLibRjbRcbLjbLcbRjbRcbLjbRibRgbRgbRgbRsbRgbRgRgbRgbRgbRgb
RgbRgbRgbRsbRsbRsbRgbRgbRsbRsbLhLsbLibRgbLibLgbLgbLsbLgbRgbLibRjbLcbRc
bRsRcLsbLcbLcbRgbLgbLgLsLsmbLsbLsbLhbRibLgbLgbLgbLgbLgbLgbLgRsLsbRjbLi
bLgbLsbLgLsbLgbLsbLiRsbRjbLhbRjbLcbRsLibRibRgbRgbLsRsbRgbRsbRsbRsbRgbR
gbRgbRsLsbRibRgbRgLsRsbLcLsmbRcRsmbRcbLibLibLcRsbLcbLgbLibRsLibLsbRcbR
ibLsRobLibRsbRibRsbLsbRibLgbRibRibLgbLsbRibRsbLsbRsbRgRsmbRgbRgbRibLhb
RobRibLibLgbRcbLjbLcbRibLsRobRcbLhbRcLsRsbLhbRiRsmbRgbRibRsbRgLsbRibLh
bLjLsmbLcbLsbRsbLgbRibRibRgRsmbRgbLsbRgbRgbRsbRgbRsbRsbLsbRsbRsbRsRgLs
RgRgbRgbRgRgbRgbRgbRgbLjbLcbRjbLcbRcbRcbLcbLcLsmbRsbLibRgRsmbRibRgbRib
RsRsmbRibLgbRgbRsRsmbRgRsmbRsbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgRsmbRsRsRsm
mbRgbRiLsLcbLgbRcbRiLsbLjbRcbLcbLibRcbRcbRibLhbRcLsbLibRhRsmbRsRsmbLsb
RgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 17; Drug: NDMC 3 µM
bsbLibRgbLgRsbLsbLibRsbLibLgbRsbLgbRgbLibRjbLibRjbLgbRsbLgbLgbLgbLgbLg
LsbLsbLgbLsbRgbLibRsbLsbLgbLgbLsbLgRsbRebRsbRibLgRsbRhbLgbLgbRgbRibLsb
RibLgbRibLgbRibRsbRsbRgbRgbRsbLibLjLsmbRcbLjbRcbLcbLcbLcLsmbLibLjLsmbL
cbRcbRoRsmbLibLebLcbLcLsmbLcbLhbLibLibLjLsmbRcbRsRsmbRsbLsbLhLsbLcbLib
RgbLgbLibLibRcbRibLjbRobRcbLiLsRsbRcbLjLgLsbRcbLibRobRgbLjbLcLsmbLcbRi
bLsbLibRsbLibLgbRibRibRcbLgbRcRsmbLsRsbLjbRcbLibLsbRgbRgbRgbRgbLgbRiLs
bLibRcbRibRgbRibLsbLsbRcbLjbRcbLiLsbLiLsbRgbLhbRibLiLsbLgbLjRsbLgRsRsm
bRsbLjbLcLsmbRibRibLiRsbLhbLibLsbRsbRgbRgbRibRsRibLibRebLjLjbLcbLcbLhb
RgbLgbLsbRibLibRjbLhbLgLsbLjLsmbLcbLcbLjbRhbLcbLibRgbRgRsmbRsbLiLsbLiL
sbLcbLjLsLsmmbLhbLibRgbLibLsbRsbLgbLsbRsbLgbRjbLibLsbRjbRcbRebLiLsbRgb
RhbLjRsbRjRsmbRgLsbRhbLsbLgbLgLsbLgbLhbLibLcLsmbLhbLibRcbLsbRgbLsbRgbL
sbRgbLgbLsRsbRcbLhbLcbLhbRibLhbRcbLcbLibRsRsmbLsbLiLsbLiLsbRebRiLsbLsb
RhbRsbRsbRibLgbRiRsmbRgbLgbRiRsmbRsbRgbRgbLsRsbLjbLjbLibRsbsbLibRgbLgb
LhbLcLsmbLjLsmbLibLgbRhbRsbRgLsbRgbRgbRjbLjbLcbLcLsmbLiRsbRibRgbLibLgb
LsbRsbLsbLgbLgbLsbRgbLgbRcbLgbRibLsbRibLgLsbRgRsLsmbRgbRsbRibLgbLsRsbR
ibRgRsmbRgbRgbRsbRsbLgbRgbLjbLcbLiRsbRgbRsRsmbLibLgbRgbLibRsbRsbLgbLib
RsbRsbLibLgbRjbLibLibLcbLcbLibLebLibLgbRgRsmbLgRsbLgbLsbLsbLsLsmbLgbLs
RsbRjbRcbLgLsbRibLsbRibLgbRsbRgLsbRsRsmbRsbRgbRsbRgLsbRsbRsbRsRsmbRsRs
mbRsbRsbRgbLsRsbRcbLgLsbLibLgbLsbLsbLgbLsbLsLsmbLsbLgbLsbLsbLsbLsbLsbL
sbLgbLsbLsbRjbRjbRgRsmbRgbRsRsmbRibRsbRgbLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 18; Drug: NDMC 3 µM
bLsbRgbLgRsbRgbRgbLgbRiRsmbRiLsbLjbRibRsbRgbRsbRgRsRsRsmmmbRgbRsbRgbLs
bRibRibRiLsbRgbRsbRgbRsbRsbRgbRgbRsbLsbRgbLobLsbLibRsbRgbLiLsbRgLsbLhb
LgbLsbLgbRgbLcbLgbRgbLcbRibRcbRcbRibLibRgbRgbLhbLhbLhbRgbRsbLgLsbLsbRo
bRgbRgbRsbRgbLibRibLgbRibRsbRgbLebLcLsmbLiLsbLsRgbRjbLcbLibLgbRibLhbLc
bRiRsmbRibLjbLhRsbRjbRcbLsbLgbRcbRcbRgLsbRgLsbRgbLsbRgbRibLjLsmbLebLhb
RiRsmbLhbRjbRebRiLsbRibRgRsLsmbRcbLsbLjLsmbRgbRiRsmbRgLsbRgbLcbLsbLiRs
bLsbRhbRgbRgbRgbLsbRsbRgbRibLcbLoLsmbLsLsmbLsbLgbRgbRsLcbRhbRibLjbLibL
sbLgbLgbLgbRcbRibRgbLjbRibRibLgbLibLjLsmbRibLibLobRibRgbRgbLsbRgbRibRg
bRsRsmbRsbRgbRgbRcbLibLiLsbRibLiLsbLgbLsbRsbLgLsbLgbLgbLgbLgbRgbLibLhb
LcbRibLgbRgbRgbRgbLjbLhbLgbRgbLibRjbLibLiRsLsbLhRsbRgbRgbRibRjLsbLjbRj
bLjbRhbLsbLjbRcbLjbLhbRcbRiRsmbRgbRgbRgbLsbRibLgLsbRhbRibRhbLiLsbLibRi
bRibLjbLobRibLhbRibLgbLgbLsbLsbLsbLgbRebRobLgbRgbRgbRgbRsbRgRsmbRgLsbL
gLsbRgbRgbLcbRibRibRgLsbRgbRgbLsbRibLsRsbRgRsmbLsbRsbRgRsmbRsbRsbRgbRi
LsbLiLsbLhbLgLsbLsbLgbRcbRcbLjbRhbRibRoRsmbLibLcbRgbLibLhbRgbRcbRgbRgb
RgbLjbRgbRgbRgbRgbRgbLcbRjbRibRiRsmbLjbLcbLibsbRgbLcRsbRgbRsbLhbRjbRjb
RibRgbLsbRsbRgbLsbRgbRgbLgbRhLsbLibLcbLibRgbLcbRgbLibLgbRiLsbLibRgbLib
RgbLcbRhbLiLsbLibRibRsLcbRgbRiRsmbRcbRibLjbRgbRsbRibLgbRibLibLcLsLsmmb
LcbRibRjbRibLjbLcLsmbLibRsbLibLcbRibsbRgbRibRiRsmbLsbRgbLsbRibRsbRsLsb
RgbRiLsbLibLgRsbLjbLgbRjRsmbRibRgbLjRsbRibLgbRgbRjLsbLsbLcLsmbLgLsbRsR
smbLsbLsbLsbLsbLgbLgRsbLgRsbLibRebRibRgbLcbLcbRibLgLsbLgbLsbLgRsbLsbRs
bLsbLgbRsbLgbLgbLgRsbRjRsmbLgbLibLhbRibRcLsbRgLsbLebRsLcRsbRjbRiLsbRsb
RibLjbLcbLgbLsbLgbLsbLsbLgbLgLsbLgbLgbRsbLgLsLsmbLgbLsLsmbLsbLsbLgLsbL
gbLgRsbLibRsbLgbLsbLgLsbLgbLgLiLsLsmbLgLsbLgbLgLsbLgbLgbLgbLgbLiRsbRib
LsbLgbRjbRibRgbRibRcbRibRibRibRgLsLsmbLjbLcLsmbRsbLgbLgbLgbRsbRgbLgLsb
LgLsbLsLsmbLsbRsLsLsmbRsbLgLsbLgbLibLgLsbRsbRjbRiLsbRgRsmbRsbLibLgbRsL
sbLibLiLsbRgLsbLgbLiLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 19; Drug: NDMC 10 µM
bLibRcbLibLgLsbLsbLsbLibRgbLiLsbLgLsbLgbLgLsbLgLsbRsbLgbLgbLgLsbLgLsbL
gLsRsbLibLsbLgLsbLiLsbLgbLgLsbLgbLgbLgbLsbLsbLgLsbRcbRibRibRibRgbRsbRi
bRcbRibRibRibRibRiLsbRcLsbRibRibRiRsmbRibRgLsbRhRsRhmbRiRsmbRgbRcbRibR
iLsbRibRcbLjbLcbLcbLiLsbRibRcbRhbRibRcLsbRhbRgLsRsbRsRiLsbRgRsmbRgRsmb
RibLgbRjbRhbRgbsbLgLsbLgbRcbRcLsbLibRcbRhbLsLsmbRsbRsRgbRhbRibLgbLgbRc
bRcLsbRibRcbLjbLgbLibLibRsbLgbLgRsbLibLibLcLsmbRcbRebRcbRhbRhLsRsbLsbL
jbLibRjbLjbLibRsbLsLsmbLibLibRibRcbRcLsbRibRiRsmbRgbRibRsbLjbLhbRgbLib
LgRsbsbLgbLgbLsbLsbLsbLgbLsRsbLiLsLgbLibRsLsbLibLgLsbLsLsmbLgbLgbRcbRi
bRsbRiLsbRcbRcRsmbRibRibRgbLgbLcbRjbRjbLcbLcbRibRibRcbRcLsbLhbLgbLcbLc
bRgbLibRgbLhbLiRsbRibRjbLcbLcbLcbRgbLibLcbRibLsbLgLsbLgbLgbRsbLgbLgbRs
bLgbRsLgbLsbLgLsLsmbRsLsbLjbLcbRibLcbLcbRgbRsbRjbRhRsmbRgbLjbLibLibRjb
RhRsmbRibLjbLsbRgbRsbLcbLibLsbLcbLhbLibLgbLcbRjbRsLcbRgbLsLsmbLgbLgbLs
RsbLibLibRibsbRjbRibLcbRibRiLsbRgbRjbLcbRjbRibLgbRibRsbRgbRsbRgbRsbRgb
RsbRgRsmbRcbLsRcbRjbLcbLcRsbRibLcbRgbRjbRcbLhbLjbRjbRibRgbRgbsbRgRsmbL
sbRgRsmbRibRsbRgbRgbRsRsmbRgbLibRebLhbRsRibRhRsmbLsRjbRcbLibRhbRibRsbL
ibRgRsmbRibLcbRcbLhbLcbRibLcbRgLsbLobLcbLsbRsbLhbLibLibRibRcRsmbLcLsmb
RgbRcbRgbRcbLcbLibLhbRjbRcbRgLsbRsLsbLibLcLsmbLibLibRibRgbLcbRgbLibLsb
LsbRsbLgbLgbLsbLsbLgRsbLsbLiRsLsRsbLgLsbLsLsmbLgLibLgbLsbLgLsbLibLgbLg
LsbLgbLgbLsbLgLsbLgbLgLiLibLgLsbLgLhLgbLgbLgLgLgLsbLibRgbLsLsLsmmbRsbL
gbLsbLsbLsbLgbRsbLgbRcbRcbLsbRjbRcbLhbLjLsmbLcbRjbLcbLcbLcbRibRhbRibRc
bRcbRgbLsbLcLgbLibLibRcbLcLsmbRiRsmbLiLsbRsbLsbLgbLgbLsbRsbLgbLgLsbLsL
smbLgLsLgLiLgLgLiLeLeLeLeLiLsLiLsLgbLgLsbLgLsbLgLsbLgbLgbLgbLsLsLsmmbL
gLsbLgLsbRjbLcbRcbRobsbRhbRcbLhbLhbLhbLhbRgbRiLsRsbLcbLibLhLsbRibRibLc
bLibLibLsbLcbLsLsLsmmbLsRsbLhLsbLibRgbLibRsbLgbLgbLsbLsLsmbLsbLgLsbLgb
LgLsLsLgLeLiLiLeLeLeLiLsLiLsmbLgbLgbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 20; Drug: NDMC 10 µM
bRobRiRsLsmbLibLsbLsbRgbRibRsLsbRibRiRsmbLjbRibRgbRgbRsbLobRibRgLsbRgb
LhLsbRcLsbReRsRsmmbRibRiRsmbLibLibRcbRsbRhbLibRibRibLgbRibRcbRibRibLsR
hRsLsmbLgRsbRgRsmbRgRsmbRgbRgLsbRibRcbLibRibRsbLibLibLibRcbRobRhbLsbRc
bLgbRcbLsbLcbLiRsbLhRsbRgLsbLgbRgbRibRobRcbLgbLgLsRsbLgbLgbLjbRoRsmbRo
LsbRibLgLsbLgRsbLcbLibRgbRgbLibRibRgbLibLibRibLcbRibLcbRjbLcbLibLibLgL
sbLsbsbRsbLcbLibLjRsbRcbLcbRcbRobLgbRsbRgbRcLsbRcbLcLsmbRgRsmbLgRsbLib
LgbLgbLibRcbLcbRcbLsLibRgbLiRsbRgbLgbLsbLgbRsLsbLiLsbRgbLibLiRsRsmbLgb
LgbRgLsbLibLgbLhbRgbRibRgbLcbRibRobLsbLgbRoLsRsbRcLsbLibRgLsbLibLhbLib
LiRsbLcLsmbRibLcbLcRsbLsbLgbRgbLcbLcbRgRsmbRgLsbLgbRibLsbRgbLibLebRibL
cbRjbLiLsbRsbLgLsbLgLsbRsbLsbLgbLgbLsbLgbLsbLgbLibLgbLibRhbRhbRobLiLsb
LcbRjRsmbLcLsmbRgRsmbLsLsRsRjmbRcLsbLgLsLsmbRgbRibLibRcLsbLgbRcbLibRib
LsbRgbRsbLsbRgbLsbRsRsmbRgRsmbRgbLsbRgRsmbRsbRsbRhRsmbLcbRobLcLsmbRcbL
ebRcbLsbRgbsbRgbRsRsmbRibLibLibLibLgbLgbLgbLgRsbRgbRjbRcbLcbRcRsmbRibR
gLsbRsbLgbRgbRgbRgLsLsmbLibLcbRjbRibLcbLsbRjbRibLebRjRsmbRibLgbRgbLsbR
gLsbRgbRibLibLibLgbRcbRoLsbLhLsbRibRibRiLsLsmbRibRibLhbRgbLsbLibLibRib
RibLjbLibLgbRsbLsLsLsmmbLgbRsbLgLsbLgbRsbLgbRsbLgbLiRsbRgbLcbLcRsbRhRs
mbRibRcLsbLhbLcbRjbLhbRjLsbLibLiRgbLgbRjbRibRibLcbLhRsbRgLsbLibLgbRgbL
iLsbRgbLgRsbRsLsbLiLsbLgbLgbLsbRsbRsLsbLgRsbLgbLsbLsRsbLgbLsbLgbRsbLgb
LsbLsbLgbLsbLgbLsbLsbRsbRcbLibRibRibLjbLcbRsbRsbLgbLgbLgbLgRsbLibLibRg
bRibLjbLibLsbLsbRjbRhbLjbRibLcbRjbLcbRsbLgbLsbLsLsRsmbLgbLsbLgbLgbRgLs
bLibLiRsbRhbLiLsbRsRjbRjbLcbRsbLgbRsbLibRgbLsbLgbLsbLsbLgLsbLgbLsbLgbL
gbRgbLgbRsbLibRgbLibLgbRgbLibLsbRsbRgbLgbLgbRsbLgbRjbLcbRibLibRjLsbRob
LhbRcLsbLcbLcbRibRcbLcbLcLsmbRgbLgbLgbRsbLgbLsbLgbRgbLgbLgbLiRsbRibLcL
smbRhRsmbLibRgbLibLgbRjbRhbRiLsbRiLsLsmbLhbLcbRjbRjbRgbRibLcbLcbRsbRgb
RibRsbRsbRsbLcbLgbLgbLsRsbLsbLsbLsbLsbLgbLsbLgbLgbLsbLibRibRibRiLsbLcL
smbLcbRiLsLsmbLgLsbLsRsbLgLsbLgLsLgbLgbLgbLgbLgbRsbLgbLgLsbRsbRsbLgLsb
LgbRgbLiLsbRjbRibRiRsmbLcRsLcbRibRoLsbLebLcLsRsRsmmbRiRcbRoRsmbLcbLhbL
gbRgbRgbLhLsbRobRhbRcbRcRsRsmmbRcRsRsmmbRibLgbLibLibLsLsmbLsbLsbRsbLib
LibRjbLhbRibRcbLcbRcbLcbRcbLcbRcbLcbLcbRiRsmbLsbLgbLgbLsbLgbLgbRsbLgLs
RsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 21; Drug: NDMC 10 µM
bRgLsbRhLjLsmbLibLhbLgbLibLiRsbRsLsbRobLibLeLsbLiRsbLcLsmbLsbRibRcbRib
LgbLcbRcbLjbLobLeLsbRcbRibRsbRgbLjbLjbRsbLibLsbRsbRgbLgLsbLibRcbLcbRcb
RcbRjRsmbsbLsbLcbRibLjLgbRibLcLsmbRjRsmbLcbRibLiLsLsmbRebRcbRsbRsbLsbL
sbLsbLgbLsRsbRcbRcbLcbRibRgRsmbRgbLjbRjbLjLgbRibLebRhbLcbLcbLcLsmbLjbR
ibRcbLsLsmbRcbRcRsmbLcbRjRsmbRcbRcbLhbLhbRsRgbLibLgbLsLsLsmmbLsbLhbLoR
sbLhbRibLhbLebRhbLhbRsbRibRibLjbLhbRjbLibLibLibRsbLsbRsbLobLhbLcbRibRi
bRsbLsbLsbRibRsbRsbRgbRibRibLgbRibLjbLcbRibLcbLcbRcbLcbRgbRgRsmbRcRsmb
RcbLhbLgbLgbLsbRcRsmbRsbLsbRibLgbLibRjbRibRgbLsbLsbLjbLgbLgbLgbRcbRobL
ibLjbRiRsmbRibLsbRsbRsbRibRsbRibRsbRgbRsbRsbLjbRcbRcbRiRsmbRibLibLibRi
bLobRcbRcbLibRibLsbRgbRibLjbRgbLsbRgbRsbLibLiRsbRibLebRebLcbRjbLcbRcbL
cbRcbRcLsLsmbLibLjLsmbLhbRcbLhbRcRsmbRcbLibLhbLgbRhbRgRsmbRsbLgbRgbRgb
RsbRgLsbLsbRsbRsbRgbRsbRhbLgbRgbRsbLsbRsLsbRgRsmbLsRsbRgbRsbRsbRgbLsbR
gbRsbRgbRgbRsRsmbRiRsmbRgLsbRgbRibLiRsbRsRsmbRiRsmbRgbRsbRgbRiRsmbRgbL
cbLcLsmbRgbLibRibRibRgbLsbRsbRsRsmbRgbRgRsmbRgRsmbRiRsmbRgRsmbRsbRgbRi
bLcbLobLcbLcbLcbLhLsbLgbLgbLsbRebLsbRibRgLsbLgbRiRsRsmmbRsbRgbRcbLibLg
bRibRibLjRsbRibRgbRsbRsbRibLsbRibLsbRgbRsRsmbRgRsmbRgbRsbRgRsmbLcbLhbR
cRsmbRhbLgbRgbRgbRibLgbRsbRsbRiRsmbRgbRgbRsbRibRgbRiLsbLebLcbRebLobLcb
LcbLhbLibRjbRcRsmbLjbRcRsmbLgRsbRiRsmbRsbRgbRgbRgbRsbRgRsmbRgbRgbRibRg
bRsbRgbRhbLibLhbLcbRhbLobRhbRjbRibLgbRibRibRsbLgbRsRsmbRgbRgbLsbLsRsbR
gbRsbRgbRiRsmbRsbRsbRibRibLcbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 22; Drug: NDMC 10 µM
bRibRsbRgbRsbRgbLsRsbRibLjLsRsmbLoLsmbLibRsbLgRsbRsLiLsbRsbLibRgbLibLs
bLgbLgbRgbLgbLsLsmbLgRsbLgbRsbLgRsbLsbLsLsmbLgLsbLgbLibLgbLgbRsbRgbLib
LgbLsLsmbLgbRjLsbRcbsbLsRiRsmbLibRgbRgbRgbRgbRsbRgbRsbRgbRgbRjLsbRcbLg
bLgbLiLsbLibLibRsbLgbLgbLibRcRsmbLsbLcbRgRsmbRibRcbLibRcLsbLgbLsbRcbRg
bLgbLibLhbLgbLibLhbLgbLgbRiRsmbsbRibLibLgbLcbRcLsbLcbLgbLsbRibLibLgbLs
bLgbLgbLsbLgbRsbLgbLsbLgRsbLsRsbLsbRgbLsLsmbRsLsRsbLgLsLsmbLsLsmbLiRsb
LgbLsbLiLsbRgbLibRgRsmbLgbRsbRsbLgbLgbLgbLgbRgLsbRsbLibRsbLgbLgbLsLsmb
LgbLgbLsLsmbLgbLsbLsRsbLsbLgLsbLsbsbLgbLgbRjbLhbRcbRibRgbRgbRgbLjbRhbR
sbLibLhbLibLgbLgbLgbLsbLgbLsbLsbLgbLsbLgbLgbLsbLgbLgbLgbLsLsmbLibRiLsb
LiRsbLsRsbRgbRcbRhLsbLibLcbLibLgbRiLiLsbLsbLsbLgbLgbRgbLgbLsbLsLsmbLgL
sRsRsmbLgLsbLsRsbLsbLgRsbLgbLgbLsbLgbLgbLgbLgbLsbLsbLgbLgbRcRgbLgbRgbR
gbLcbLgbLsbLgbLsbLsbLsbLgbLsbLgbLgbRsLsbLgLsbLsbLsRsbLgbLsbLibLibRiRsm
bRibRgbRibLjLsmbLhbLcbRhLsbLcbRsbLibRsbLgbLgbLsbLsbLgbLsLsmbRsbLgbLsbL
gbLgbLiRsbLcLsmbRibRhbRgbRibRgbRgLsbLjLsmbLcLsmbLsLsLsmmbLsLsmbLsbLgbL
sbLgbLgbLgRsbLgbRcbLhbLsbLgbLgbRsLsbRgbLiLsLsmbsbLsRsbLgLsbLgbRsLsbLsb
LgbLsbLsbLsbLgbLsLsmbLsRsbLsRsbLgbLgbLsbsbLsLsmbRsbLgbLgbLgLsbRsLsLsmb
LsbLgbLgbLsRsbLgRsbLsbLsbLgbLsbLgbLsbLgbLsbLgbRsbLgbRjbRobLjbLcbRcbRcb
LiLsbLjLsmbLgLsbLsbLsbLsLsmbLobLcRcbRibLsbRgLsbLibLiLsbLgbLsbLgbRgbLgL
sbLsbLsbLgbRsbLgbLsRsLsbLsbLsbLgRsbRsLsRsbLgbLsLsRsmbLsRsbLgLsbLsbLgbR
sbLgbLsbLgbLgbLsLsmbLgbLsbLgLsbLcbLibLibLsbLsRsLsbLgLsbLgbLgbLgLsLsmbR
sbLgbLsbLgbLsLsmbLgbLgbLsbLgbLgbLsbRsLsbLgbLsbLsbLgbLgLsbLgbLibRgbRjRs
mbRgbRibLjLsmbLobLsbLsbLibLgbRsbLibLsbLgbLsLsmbLgbRsbLsRsLsbLgbRsRsmbL
gbLgLsLsmbRsbLgLsLsmbRsLsbLgbLgLsbLsLsmbLgbLsLsmbLsbLgRsbLsLsmbLgLsbLs
bLgbRsbsbsbLgbLgbRjbsbRobRibLjbRibLjbLjbLibLsbLsbLsLsmbLsLsmbLgLsbLgLs
bLsbLgLsbLsbLgLsbLsbLgbLsbLgbLgbLsbLgbLgbLsRsbLsLsmbLgbRjbRcbLjbRcRsmb
RcbLibLibLibRgRsmbLibLgLsbRgRsmbLibRgRsmbLibRsRsmbRhbLcbLgLsbRiRsmbLjb
LhbLibLgbLgbRsbRiRsmbLibLibLgbLgbRsbLsLsLsmmbLsbLsbLsbLsbLhbLcbLgbRgbL
iLsbLgbRsbLgLsbRsbLgbLsbLgbRsbRgLsbLibLobLibRhbRibLcbRjbRhbRhbLjbRiLsb
RgRsmbLsRsbRgRsmbRsbRsbRsbRgbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 23; Drug: NDMC 10 µM
bRsLsbLsbRibRgbRsbLsLsmbRgRsmbRgbRsbRsRsmbRgbRgbRgbLjbRgbRgbLcRsbLibLg
bLgbLgbLgbLsbLsbLgbLgbLsLsmbLgbLgbLgbLgbLgbLsbRsbLgLsbLgbLgbLgbLgRsbLg
bLsbRgRsmbLjbLsbsbLgbRgbLiRsbLibLsbLsbLgRsbRhbRgLsbLjLsmbLhbLibLsbLgRs
bLgLsbRsRsmbRsbLsbsbRsbLjbLjLsRsmbLgbRibLsLsmbLibLgbLsLsmbsbRjbRiRsmbR
jRsmbLsbRsbRgbLjLsmbLhLsbsbRgbRjbsbRsbLibLjLsmbRjbRjRsmbRjbLhbLjbLgbLs
RsbLjbLjbRjbRebLhbRhbRibLjbRgbLjbRjRsmbLcbLcbRsbLsbRsbLibRibLibRjbLjLs
mbRgbRgbLiLsbRjbRhRsmbLjbRiRsmbRibRgbLibLjbRsbLsbRibRjbLibLjLsmbRjRsmb
RjbRgbLgbLjLsmbRjbReRsmbLiRsbLcLsmbRjbRcbRcbRcbRibLibLibLibLsbLgbLjbRi
LsbLhbRgbRibRjbLjbRjLsbLjbLgbRjbLjbRjRsmbRjbLjbLjbRgbLgLsbRsbRjbRhRsmb
LibRibLsLsmbLsbLgbRjbLibRhbRibRgbLhbLgbLsbLsbLsbLsbLsbRsbsbLsRsbLgbLgR
sbLsbsbRsbLsbLibLgbRsbLhRsbLsbLsbLsbRgbRjbRibRcbRibLibRhbRcbRibRgbRhbL
iLsbRhbRibRhbRcbLcbLsbLsbLgbLsbLsLsLsmmbsbLgbLsbLsLsmbsbLibLiLsbLjbRjb
RcbRjbLjLsmbLgbLibRibLjLsmbLibLibLgbRgbRsbLsbRibRcbLibRgbsbRsLsbLsLsmb
LgbRjbRcbLibLjbLibLsbLgLsbRsRsmbsbLsbLgbLgbRjbsbLibRgbLibRsLsbLgbLgbLs
RsbsbRsRsmbLibLgbRibLiLsbRsbLsbRsLsbLgbLsbLsLsmbLgLsbLgRsbLsLsRsLsmbLs
bLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 24; Drug: NDMC 10 µM
bLcRsbLoRsbLsbLsRsbLsbRibRgbRgbRgbRgbRgbRgbRsbLjbLcbLibRibRcRsmbRcbRgb
RgbRgbLgbRgbsbLsbRibLcbsbLhRsbLibRsbRsbLibLibRcbLcbRhbLhbLgbRgbLibLsLg
bLgRsbLgbRsbRjbLcbRgbRjbLcRsbLcbLgbRgbLsbLibLgbRibRgbRjbRibLhbRiRsmbLh
bRgRhbRgbRiLsLsmbRgRsmbLsbLjbLhbLibLgbLibRgbLobLcbRcbLhbRibLsbRibRgbRs
bRgbRsbRsbRgbRgbLsbRsbRgbRgLsbRgbLcbRobLcLsmbRcbRgbRibRibLsbLcbLgbLgbL
ibLibRgbLibRsRsmbLcbLibRsbLgbRsbLsbLhbRsbLgbRsbLgbLsbLgRsbRjbRobLcbLeL
sbLibRgbLjbRgbRgbLcbRsbRibRcbLsRsbRgbRgbRgbLgbLobLobLibLsbLgbLibLgbLsb
LgbRgbLibLobLcbRcbLcbRcbLcbLcbRsbRgbLsbLsbLhbRgbRsbLgbLgbLgbRgRsmbLcLs
mbLcbRgbLsbLgbLsbRsbRgbLcbLibRgbRgbLgRsbLibRgbLiRsbRgbRsbLcbRgbLsbLsbL
sLgbLoRsbRgRsmbLgbLgbRsbLsLcbRgLsbLebsbRgbLgbLsLsmbLgbRsbLhbLiLsbRgbRg
bLibLiRsbLgLsbRibLcbRobRibLsbRgbRgbLsbRibRgbRgLsbLsbRgbLsbLobLhbRgbLsb
LiRsbLgbRibRjbRibRgbRgbRsLsbRsbRsbRgLsbRsbRgbsbRsbRgRsmbsbLjbLobLcbLcR
sbRsbLsbLgLsbRsbRibRibLsbRgbLjbLobRibLcRsbLsbLgbRsbRibLibLiRsbLgLsbRgb
RjbRjbRgbRibRgbRgbRgbRsbRibLsbLsbLsbRjbRsbRgbRgbRgbRgLsbRsbRsbRsbLsLsm
bRibRgbLcLobRibLgbLhbRjbRibRgbRsbRsbRgbRsbRgbLsbRgbRsbRgbLhbLcLsmbLiRs
bRibLhbLgbLibRsbLhbLibRobLibLsbLgbLibLsbLgbLsbLgRsbLgbLsbRgbLgbLibRgbL
ibLgbRsbLsbLgbLgbLiRsbLibLsbRgbRgbLcbLgbRgbLgbLgbRgbLgbLgbLgbRgRsmbLhR
sbRcbLhLsbRcbRcbLibLcbRobLcbRoLsbLibRgbRsbRcbLobLhbLhbRgRsmbRgbRgbRgbL
jbLsbLgbLgbLgbLgbLsbLgbLsbLsbLsbLgbLgbRhbRcbRgbRsbRgbRsRsmbLsRsbRsbRib
LobLgbLibLsbLgbLibRgbLibRgbLgbLgbLsbLsbLsbLsbLgRsbLgbLgLgLgRsbLgLsbRsb
LgbsbRsbLsbLgbLsbLgRsbLgbLsbLsbLgbLgbLsbLsbLsbLsbLgbLgLsbLsbLsLsmbLsbL
sRsbLsbLsLgbLjbRsRsmbRsbRsLsbLsLsmbLgbLgLsbLgbLgbLgLsbLgbLsbRsbLgbLsbR
sbLhRsbRibRhbRibLobRsbRjbRibRgbLjbRgbRiRsmbRhbLcbRibRibRhbRcbRibRgbRiL
sbRgbRgbRsbRibRgbLobLoRsRsmbRoLsRsbLibLcbLibRgbRsbRsRsmbRibRgbRgbRgbRs
bRsbRgbLgbLjbLiRsbRcbRibLjbLcbRgbsbLsbLsbLsbLgLsbLsbLsbLgLsbLgbLgLsbLs
bLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 25; Drug: Control
bsbRsbLgbRjbRibLhbLgbLibRhbRibLsLsmbRgLsbRsbRebLsbRibRsbRgbRsbRiLsbLjb
LjbLibRjbLibLgbLgbRjbLiRgbLibLgbLgbRsbLgbLsbLgbRhbRcbLjLhbLibRibRibRhb
LjbLcLsmbLibLibLsbLiRsLsbLsbLgbLibRjbRcbRgbLsbRibRibLgRsbRgbRgRgRsmbRs
bRibLsbRgbRibLiRsbLjbLcLsmbLobLibLhbLcbRcRsmbRcRsmbRgbRgbRsbRibLjbRgRs
mbLibRgbLgbLsbLibLgRsbLjbLibLibRibRgRsmbRsbRsLsbRcbRiLsbLcLoRsbLibLiRs
bLsbRibLibLsLsmbLgbLgbRsLsbLgLgbLsbLibLibLgbRgbRibLibLsbLgbRjbLibLgbLg
bRsbLgbLsbLsbLgbLgbLsbLgRsLsLsmbLgbLgbRjbLhbRjbRcbRibRibLsbLibLibLibRj
bRhRsmbRgbRsbRsRsmbRsbRgbRsbRsbRsbRgbRsRibRgbRsbRsLsbRibRgbRibLjbLcbRc
bRhbLiLsbRhbRgbRgbRgbRsbRgbRsbRgbRgbRgLsbRgRsmbRgbRgRsmbRibLibRibRibRg
bRgRsmbRsbRgbRgbRsRsmbRsbRgbRgbLsbRgbLsbRsbRgLsbLsbRsbRsbLsbRgbRsbRsRs
mbRgbRgRsmbRgRsmbRgbLsbLsbRgbRibRgbLibRibLjbRibLsRibLebLibLibRjbLcbRhb
LobLibLhbRibLgbLibRibRcLsbLibRcbRcbLibLgbLibLgbRibRibRhbLibLjbRcbRsbRg
bLjbRibLsbLsbRsbRsbRsRsmbRgRsmbRsbRgbRgbRsbRsbLsbRibRhbRhRsmbLebLhbLib
LiLsbsbLiRsbRibLcRsbRibLiLsbRsLsbsbLibLibLibLcbRsbLibRibLgbRjRgbLgbRiR
smbLsRgbRsRsmbRgbRgbRsbRgLsbRsbRgbRsbRsbRgbLsbRgbRgRsmbsbRgbRgbRsbRgbR
gbRgbLsbRgbRibLjbLjbLoLsmbRcbRjbRibRibRgbRgbRsbRsLsbRgbRsbRsbRgbRsbRsR
smbRgRsmbRsbRsbRgRsmbRgbRsbRgbLgbRhbLcbLcbLibRjbLibRobRsbRsbRsbLsbRibR
sbLsRsbRsRsmbRgbRsRsmbRgRsmbLjbRhbLgbRgbRgRsmbLsRsbRgRsmbRjLsbLjbLjbRh
bRibLgbRibLjbRcRsmbRcLsbLgbLgbRsbLsRsbLibRgbRobRobLibLibRcbRibRcRsmbLi
bRhbLgbRgRsmbLsbRgRsmbRsbRsbRsRsmbRgbRgRsmbRgbRsbRibRcbLibRgbLibLgbLgb
RsbRcbRcLsbLibRibLjbLsRjbLjbRibRibRgbLsLsmbRsbRsbRsRsmbRgbRsbRsbRsRsmb
RgLsbRgbRsbRsbsbRgLsbRgbRgbRsRgbRgbRsbRgbRsbRsbLsbRgbRgbRiRiLsbLibLibL
gbRhbRibLsbRsRsmbRgbRsbRgbRgbRgbRgbRhbLiRsbRiRsmbLsbRiRsmbLsbRjbRgLsbL
jbLjbLibLibRjbRcLsbLgbRgbRibRsbRsRsmbRsbRgbRsbRsbRgbRsLsbRgbRsRsmbRsbR
sRsmbRsRsmbRgbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 26; Drug: Control
bLgbLgbLsbLgbLsLsmbRsbLgLsbLgbRsbLsbLgbLgLsbRsLsbLsbLsbLgbLsbRsLsbLgbL
gRsbLsLsmbLsbLgbLibRgbLibLgbRsLsbRsbRsbRsbLgbRgbLhbRgbRsRsmbLgbRsbLgRs
bLgLsbLsbLsbRsbRsLsbLibRibLgbLibRsLsbLsbLsbLgbRsbLgbLsbRgLsbRsLsbLsbLi
RsbLobRsLsbLjbRibRgbLobLobLsbLgRsbRsbRsbLcRsLsbLgbRsbLgbLgbLgRsRsmbRgb
RjbLibLobRgbLsLsmbRhbRgbLsbRibRgbLgLsbRibLcbRcbRcbRibRgbRgbLsbRgbRcbLi
RsbLcRsbLiLsbLibRsbRsbLsbLgbLjbLobRibLoRsbLsbLiRsbRgLsbsbLcbRibLgbLsbL
gLsbLgbRgLsbLibRgbLgbLgbLsbRsbLsLsmbLgLsbLgbLgbLgbRsbRsbLgbLgbLsbLgbLg
bLcbRsbRgLsbRgbLsbRiLsbLcbLoRsbRiRsmbRsbLoLsmbLsbLsbRgLsbLgbRsbRjbLobR
cRsmbRsbRsbLsLsmbLgbRibLoLsLsmmbRsbLibRgbLgbLhbRgbLhbRgbLibLgbLsbLgbRs
bLcbLoRsRsRsmmbLobLobRibLgLsbRhbRcbLhbRibRibLgbLgLsbLjbRoLsbLjbRhbLjbR
ibRsRsmbRsLsbRsbRgbRgbRgbLibRibLsbRgbRgbLsbRsbRsbRgbRsbRsbRsbRgLsbLobL
ibLgbRgbLibRgbLsbLgLsbLgbLgLsbLsLsmbLgbLsbLgbRsbLgbLsbLsbLsbLgbLsbLgRs
bLibLjbLcbRiRsmbRsbLcbRcRsmbRiLsbLcbLobRcRsmbRcbLgbRiRsmbRibRibLsbRiLs
bRibRsbRgbRgbRgbLsbRsLsbLsRsbRsbRgbRsbRsbRgLsbRiLsbLsbRsRsmbRsbRgbRsbR
gbRgbRsbRsbRgbRgbRsRsmbRsbRsbRgbRgbRgbRsbRsbRsbRgLsbLgbRgbLjbRgbRgbRsb
RgbLsRsbRsRsmbRgbLjbLcLsmbLibRgbRebRibLgbRgbRgbLgbRgbRgbRsbRsbRgbRgbRg
bRsbRsbRgbRgbRsbRgRsmbRsbRsbRgbRgbRjbLibRibRsbLgbRibRsbRsRsmbRgbRsbRsb
RsbRgLsbRgbRgbLibLobLobRgbRsLsbLibRcbRgbLgbRobLiLsbLjbsbRhbRsbRgbRsbRg
bRgbRgbLsbRgRsmbRsbRsbRgbRsbRsbRgbRgRsmbLgLsbLcLsmbLibRcRsmbLibRebRsLs
bLobRsLsbLsbLjbLibLgbLgbRgbLhbLibLgbLcbRgbRsbLgRsbRsbLibLcbLsbLhbRibLi
bRsbLibRsbLcbLibLgbLgbRsbLsbLsbLgbLibRibLibLoRsRsLcLsmmbsbLsbLgbLgLsbL
gbRgbLibRjLsRhbLhbLibLsbRgbLcbRgbLsRsbLgLsbLsbLgbRebRhbRibLsbRgbRsRsmb
RjbRcbRibRgbRgbLcbRibRjRsmbLcbRibLcbRibLeRsbRsbLoRsbRgbRgbLgbLiLsbLgbL
sbLgbRgbLibLibRibRgbLhbRsbLhbRgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 27; Drug: Control
bLgbLgbRsbLsbLsbLgbLsLsmbLsbLgLsRsbLsbLgbLiLsbLsbLsbLgbRsLsbLsbLibLgLs
LsRsmbLgbLgbLgbLsbLgbRjbLibRsbLgbRgbLibRjbRjbRiLsbRhbLsbRgbRibRibRibRg
bLsbLgbRiLsbLgbRibRibRgbLgbRibRgbLibRibLgbRibLgbRhbLgbRibLgbRiLsbRgbLg
bLibRhbLgbRibRgbLgbRibLgbRiLsbLgbRibLgbRibLgbRiRsmbRsbLgbLsbRibLsbRgLs
bLgLsbRgbRsbRsbRgbRsbRgbRgbRgbLgbRgbRibLhLsbRcbLhbRcbRcbRibLgbLsLsmbLi
bRgbLhbRgbLhbLcbLgbLiLsbRsRsmbLcbLgbRsbLibLgbRibRibRhLsbRibRibLgbRsbRi
RsmbRibLcbLgRsbLgbLgbRgbLcRsbLibLgbLgbRsbLibLibRgbLgbLibLibRibLcbRgbLo
LsmbLgLsbRsbLibRibLibLsbRsbLibRgbLobLgbLsbLsbLgbLsbLsbRgLsbLibLgbLgbRg
bLgbLibRgLsbLsbLibRgbLibLgbLsbLibRiLsbLibRjbLibRgbLgbLgbRsbRsLsRsbLiRs
LsbRgbLsbLibLgbLgbLgRsbRgbLgbLgbRsbLibLibLsbLsbLsLsRsmbLsbRsbLgbLgbRgb
RgbLibLiLsbLgbRgbLhbRjbLiLsbLgLsbLgbLgbLiRsRsmbRgbLibLibRgbLgbLgbLsbLs
bLgbLgbLsbLsbLgbLgLsbRjbLibLgbRsbLiRsbRsRsmbLgbLgbLgbLgbLgbLgbLsLsmbLs
bRsbLiLsbRgbLiLsbLgbLsLsmbRsbLgLsbRsRsmbLibLgbLgbLgbLgbLgbRibRsbLibLgb
RsbRgbRgLsbRibLgbRibRsbLsbLcbRhbRibLoLobLsbRgbRsbRgRsmbRgbRgbLsbLsbRhb
RgbRgbRgbLgbRgbRibRsbRsbRsbRgbRgbRsbRsRsmbLgbRgbRgbRsbRgbLsbRgbLsbRgbR
gbLgbRgbLsbRgbLsbRgbLsLsmbRgbRgbRsbRgbRgbRgbRgbLjRsbLhRsbRcbRhbLgbRibR
gRsmbRsbRgbLsRsbRsbLsbRgLsbLsbLjbLhbRjbRiLsRsbRibLcbLgbRgbLiRsbLhbLcbL
sbLgbLibLibLgbLgbRcbRibLsRsbRgbRgbLsbLhbRjbRcRsLsmbLsbRgLsbRgbRgbRsbRs
bRgbRsbRgLsbRgbRgLsbLgLsbRibLgbLjbLiLsbLibRjbRcRsmbRgbLsbRgRsmbRsbRsbR
gbRgbRgbLsbRsbRgbRgbRsbRsbRsbLsbRsbRgbRgbRgbLsbRgbLsbRgbLgbRgbRgbLjbRi
bRibLsbRibLsbRgbRsbRsbRsbRgLsbRgbLgbRgbLgbRebLibLibRjbLibLgbRsbRsbLebR
ibRibRibLhbRjbLcbRgbLsbRcbRibLsbRgbRsbRsbRsbRgbRsbLsRsbRsbLsbRgbLsbRsb
RiRsmbLsbRsLsbRsRsmbLsbRgbRgbRgbLjbRgRsmbRsRsmbRsbRgRsmbRsbRgbLsbRgbRg
bRgbRgbLgbRgbLcbLiRsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 28; Drug: Control
bLebLhbRgbRgbRcbRhbRgbRgbRiRsmbRiRsRgmbRibRsbRibLcbRcbRcbLibRsbRibRgbL
gRsbRsRsmbRgbRsbRsLsRsbRibRgbLjbRgRsmbRsRsmbRsbRgbRsRsmbRsbRgbRhbRsbRg
bLsbRgRsmbRgbRgbLsbRsbLobRgRsmbRsbLsbRhRsmbLcbLcbRsRsmbLiRsbLgbLcbRgRs
mbRibRgbRsbRgbRgRsmbLcbLcbRsbLibLgbLcbLebLoRsbLgbRsbRsbLgLhbRcbLobLcbR
hbLcLsmbLcbLibLsbRhbRibRgbRibLhbLcbLibRsbLhbLcbLcbLcbLobRibLsbLcbLcbRc
bRibLibLsbRhbRjbRcbLibLcbLobLibRgbLcbRibRcbRcbRobRgbRibRcbLjbRobRcbRgb
RgbRsbLcbRobRoLsbRgLsbLsbLgbLgbLiRsbLcbRgbRhbLiRsbLibLgbRiRsmbLobLsbLi
RsbLgbLcbRjbRsRsmbRsbRgbLjbRsRsmbLjbRcbLsbRibRibLibLjbLjbRjbLjbRhRsmbR
sbRibLgbLgbRsRgbRgbLsbsbRsbRsRsmbRsRsmbRsbLsbRgbRgbRgLsbRgbLgbRgbRgbLs
bRgbLibRibLgbRgbRgbLsbRiRsmbRibRgRsmbLsbRgbLgbRhbRiRsmbRsbLiRsbLhbLibR
sbLsLibRgbLgbLibLgbLsbRsbLibLsRsbLgbLiRgbRjbLcbLibLsbRgbLcbLcbLhRsbRsb
RsbRgbRjbLgRsRsmbLsbRibRcRsmbLiLsbRgbLgbLhbLibRgRsmbLibLsbRgRsmbLibLib
LgRsbLibRebRcbRibLgRsbRsbRgbRsRsmbRgRsmbLsbRgbRgbRgbRsbRsLsbRgbRsbRsbL
gbRsRsmbRsRsmbRgbRsRsmbRsbRgRsmbRsbRibLibLcbLhbRcbRcbLgbLjbLcRsbRcbLjb
LibLibLcbRgbRgbRgbLsbRibRsLsbRibLgbRsbRgRsLsmbRsbRgbRgRsmbRsRsmbRgbRgb
RsbRsRsmbRgbRsbRibLibLeLsLsmbLcbRcbRgbRibLibLibLgbRsbLgRsbLgbLgLsbLgbL
ibLcbRibRibRgbLgbLgbLibRgbRjbLjbLcbLcbLcbLjbLibLgLsbLgbLgbLsbLgbLsbLgb
RsLsbLsbRsbLgbLgbLibLgbRhbLsRjbLcbRsbLibLibRgbLgbLibLcbRgbLibLibRcbRsb
RsRsmbRgbRgbRsbRsbRgLsbRgbRgbRibLiLsbRcRsmbLibRibLgbRibLgbRhbLibLcbLib
LgRsbRgbRjbRgbLibRibRibLsbLgbLgbRibRiLsbLiRsbRgbRibLjbLcbRgbLoRsbRibRi
bRjRsmbRsbRsbRsRsmbRsbRsbRgbRsbRsbRgbRhbLibLgbRsbRcbRgbRgbRsbRgbRgbRsb
RsbRibLgbRgbRgbRibRibLibLgbLgLsbLibLhbRgbRsbLcbLcbRibRibRgbLcbLgbLsRsb
RsbLiRsbRgbLibLgRsbRibLcbLibRgbRgbLsbRgRsmbLhbLgLebRibRibLgRsRsmbRibLg
bRobRhbLhbRibRgbRsbRibRgbRcbLiRsbRhbLgbRibRibLgbLiLsbLibLibLgbLgbLsbLi
bRgbLhbRgbLibRsbLgbLgbRsbLgbLsbLgbRgbLibRsbLibRsbLibLibRgbRgbRgbRhbRib
LhbRcbLjbLobLcbRibLgbRsbLcRsbRjbLibLgbLgbLgbLgbLsbLgbLgbLibRgbLibRgbLi
bRsbLibLsbLibRibRgbLiRsbLsbLgbLgbLgbLgbRjbRcbLgbsbLcbRjRsmbLhbRibLibRs
bRibRibRgbRsbRsbRsbLgbRibLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 29; Drug: Control
bRgbRgbRsbRgRsmbRiRsRgmbRsbRgbRgbRsbRgbRgbRgbRgRsmbRgbRsbRgbLjbRibLebL
hbLiLsbRgbLibLsbRsbLgbLgbLsLcLibLgbLhbLgbRjbRcRsmbRhbLibRcbRibLibLgbLi
bLiLgLsbsbLibLgbLsbLibRibRgbRibLjbLibRjbRhbLsbRhbLgRsbRibRibLibRibLgbL
jbLhLsbLgbLibRibLcbRibLhbLibRiRsmbRjRsmbRcbRibRibLsbRibRibLibLibLibLib
RibRcLsbRcLsbRibRibRgbLgbLhbRibRgbLjbLcbLcbLsbLibRgbLobLgRsbRsbLgbLibL
gbRsLgRsbLsbRgbLibLgbLgbRsLsbLgbLgbRjbRsbRebRhbRgbRgbRibLgbLiLsbLibLgR
sbLgbRsbLibRsbLgbRsbRsLibRgbLibLgbLgbLgbLgbRsbLibRibLhRsbRibLjbLgbLgbL
ibRiRsmbRsRjbRibRhLsbLiLsbRhbRibLcbRhbLjbRcLsbRibLcbRiRcbLibLibLgbRsLs
bRsbLgbLgLgbLgRsbLsLsmbLgbLsLsmbLgbLcbRibLgLsbLibLgbLsbLsbLgbRsLsbLgLs
bLsLjbsbRsLsRsbLgbRibLibLcbRiRsmbRibRgbLjbLibLgbLsLgbRsbRjbLhbRibLhbRi
bLiRsbLsbLsbLgRsbLgbLsbLgbLgbRgbRsbLgbLsbLibRsbLsbLgbLgLsbLgbLsbLgRsbL
ibRjbRjbRhbLibLibLiRsbRsbLiLsRsbRsbLjbRibLsRcRsmbRibRsbRgbRsbRsbRgbRsb
LcRsbLhbRgLsRsbLibRibLgbRsbLgRsbLgbLgRsbLgbRibRcbRibRhLsbLgbRibLhbRibR
ibRibLibLiLibLgbRibLibLgbLibRgbLibRsbLgbRsbLiRsRsmbLgLsLibLsbLsLsLgmbL
gRsbLgbLsbLsLsmbLsbLgbLgbLsbRsbLibRgbLibLgbRsbLsbLsLsmbLsbRsLsbLgbLsbL
sbLgbLgLsLsmbLgbLgLsbLsbLgbRsbLgLsbLgbLsbRsbRsbLsbRhbLebRcbRsRhbRibRgb
RcRsmbRhbRsbLgbRsbLibLiLsRsbRjbRcbLjbLcRsbRjbRhbRibRhbRibRibRibRgbLgbL
gbLiRsbLibRjLsbLgbRsLsbLibRibLhbRjbRcbRhbLgbRebRibLhbRibLsbRcbRibRibRs
bLibRgbRibRibLcbLibLiRsbLhbRibRjbLjbRiRhRsmbRibRgbLgbLjbLibLibRgbRsbLi
RjbLgbLgLsbLgbLsbLgbRsbLgbLibRibLibLgbLgbLgbLsbLgbLsLsmbLgRsbLgbLjbsbL
sbLsbLgbRgbLgbLgbLgbLsbLgbLgRsbLhbRibRhbRiRsmbLjbRhbLgbLgbLibLibRgLsbR
cbRsbRiLsbRsbLsbLcbLibLibLgbRibLcbLcRgbLgbLibLgbLgRsbRsbLsbLgbLgbLibLg
RsbRgbLibLibRjbLhbLgRsbRjbLibRjbLsRsbLhbRibLgbLgbRsbLgbLgbLgbLgbLsbLgb
LsbLgbLgbRibLibLibLsbRgbLiLsbRibLcbLcbRgRsmbLcbRiRsmbRibRhbRgbRgbLjbRj
bRibLibRibLcbRobRhbRhRsRsmmbRibRibsbRiRibLsbRsbRgbRsbRgRsmbLsRsRsmbRiR
sRsmmbRgbRgbRgbRgbLibRgbLsRiLsbLgbRgbRibLibLhbLgbLgbLgbLsbLsbLgbLsbLgb
RjbRcbRibRsbRgbRsbRgLsbRgbRibLgbLjbRiRiLsbRiLsbRsbRiRsmbRibLibLibRcbRc
bLhbLcbRcbRcbRcbRsbRhbRsRibRgbRsRsmbRsbRsLsbRsbRsbRsbRgbRsbRsbRgbRgbLs
LsmbRsRiRsmbRgRsRgRgmbRsbRsbRgbRgbRgbRsbRsbRgbRgbRgbLjbLjbLiLsbLgbRjbR
hRsmbRiRsmbLiRsbRibLjbsbLcbLsLoRhbRgbRsbRcbLgRsbRibRgbLiRsbLibLibRjbRi
bRibLsbRgbRsbRgbRsbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 30; Drug: Control
bLhbRgbLgbRgbRsbLiLsbLgLsbLsbLgbLgbLsbLgbLgbLgRsbLsbLgbLgLsbLgbLgbLgbL
gbLiLsbLsLsmbLsbRcbRobLgbLgbRcbLibRibRsbLobLibRsbLibRjbLibRsbLibLsbLgb
RsbLiRsbLgbRsLsbLgbLibLibLiLsbLibRjbRibRhbLsbRcLsbRcbRgbLcbRcbRhbLhbLi
bLobRibLgbRsbLoRsbLcbRgbLgbLcbLhbRibLsbRgbLibLibLibLgbRibRgbRobRsbRgbR
sbLgbRcLsbRcRsmbLibLgbLibRobLgbRgLsbLcbLgbRgbLiRsbLibLcbLgbLibRhbRcbLi
bLsbLibLgbRgbLcbLcbRibRgbRgbRsbLgLsbLibRgbLcbRgbLobRcbLibRsbRgbLoRsbLc
bRibRcbLgbLsbLcbLobLibRhbLhbLoRsbRgbRgbRcRsmbLgbLgbLibRgbRgbLhbRgLsbLi
bRsbLibRgLsbLhbRgbLcbLcbRgbRibRhbLhbRibRcbLgbLibLhbLibLgbRgLsbLhLsbRgb
RobLgbLgbLsbLsbRoLsbLsbLgbLsbLgbLibRobLsLsmbLgbRsRsmbRcbLcbRobLgRsbLgb
LgLsbRgbLibLhbLgRsbRibLgbRibRiRsmbRobRsbLibRsbRcbLgRsbRjbLgbRsbLobRsbL
ibRgLsbLibRgbLcLsmbRgbRgbLiLsbRgbLjbLgbLgRsbRgbRjbRiLsbLhbLobLcbRibLcb
RcbLsbRgbLgbRebRibRgbRgbRgbRsbRjbLgbRjbLjbLsbLobRjbLobRgbRebLsbLhbRgbL
ibLsbLjbRgbLsbLiLsbLibLgbRibLcbLcbLobLcbRgbRjbRibLjbLobRgbLibRcbLhbLsb
LibLsbLgbRsbLgbRgbLibRsbLgbLsbLgbLgbRgbRgbRjbRibRcLiLsbLcbLibRjbLsbRob
LcbLobRgbRgbLiLsLiRsbRjbLibRgbLsbLgbRsbLiRsbLgbRsbLibRgLsbLgbLsbLsbLgb
RsbLgLgbLgbLgbLibRjbLcbRibRcbRibLgbLjbRgbRgbRcbRhLsbRibRiLsbLhbRhbLcbR
ebRibLgbLgbRhbRgbRgbRhbRgbLgbRgRsLsmbRobRgLgbRgbLgLsbLhbRjbLibLgbLgbRs
bLgbRsbLibRgbLibLgbLgRgbLiLsbRjbRcbRgLsbRsbRgRsmbRiLsbLibLcbLgbLsbLsbL
sbRsbLgbLsbLgbLgbLsbLsRsbLgbRgLsbRcbRebLsRsbRjbRsbRobRcbLgRsbLcbRibRib
RibRjbLibRebLsbLgbRsbRsbLiLsbLibRsbLgbLgbLgbRgbLibLsbRsbRsbLibLsbLgbLs
bRsbLgbLibRsbLibLgbRhbRcRibRibRgbLcLsmbLcbRibLiLsbLibRsbLibLgbLibRgbLg
bLgLsbLgLsbLsLsmbLsbLsbLgbLsbLgbLgbLsbLgbRgbLibRjbRcbRiLsbLibLhbLibRsb
LgbRsbLsbLgbLgbLgbLsbLsbRjbRhbRibLjbRcLsbLcbLoRsbLiLsbRhbRsbRsbLoRgbRs
bLgbLiRsRsmbLibRgbLibRsLsbLgbLsbLgbLsbLgbLgbLgbRsbLibRgbLgbLgbRgbLgbLs
bLgLsbLsbLgbLibLibRcbRcbRibRibLjbLcbRcbRoLsRobRcbRgbRgbRibLobLgbRgbLgL
sbLgLsbLgbLsbLgLsbRsbLgbLgbLgbRgbLgbLgRsbRgbLgbLgLsbLsbRsbLgbLsbLibLgb
LgbRgRsmbLgbRgLsbRebRibLjbRibLjbsbLgbLsLsmbLgbRsbLgbLsbLgRsbRjbLcbRibR
jLsbLjbRcbRibLibRobLsbLibRebLcbRgbLgbLgLsbLgbLgbRgbLgbRsbLgbRibRobRebR
oLsbLgbLsbRgbLobRjbLhbRjbLibLgbRsLsbLibRsRgLsbLibLsbLgbLsbLibRsbRsbLgb
RsbLgbRsbLsbLgbLgbLgbLibLgbLcbRhbLhbRhbLhbRcbLcbLsbLgLsbLsbLsbLgbLgbRs
bLgbLiRsbRcbRhLsbRibRsLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 31; Drug: NDMC 1 µM
bLgbLsbLsbLsbLgbLsbLsbLsLsmbLgbLgbRsLsbLgbLsbLsbLgbLgbLgbLgbLgbRgbLibR
sbLgRsbLsbRgbLiLsbRjRsmbLsbLibRgbRsbLsLsLsRsLsmmbLiLsbRjbLibLiLsbLibLs
bRcbLoLgbLgbLgbLgbRsbLgbRsbLgLsbRsbLibLgbLgbLgbLsbLgRsbLsbRoRsmbRsRhRs
mbRibRibRiRsmbRebRhRsmbRibRgbLjbRibLibRhbLsbRibLibsbRiRsmbRgbLibRgbRgb
LgbLobLsbLgbLgbLgbLgbLcbLgbLgbRgbRcbRgbRcbLiLsbLgbLiRsbLsbLsbLgbLhbLjL
smbLhbRibLibLibLoLsmbLgbRcRsmbLibRgbRgbLcbLhbLcbRjbLcbLcbRibLibLsbLsbL
gbLjbRcbRibRibRsbRibLcbLgbLgbLgbLsbLgbLgbLsbLsbLgLsbLsbLgbRjbLcLsmbRiL
sbRibLsRsbsbRsbRgbRobRhbRhbRgbRgbRgbRhbLhbRibRgbLjbRcbRcbRibRhbRsbRiRs
mbRibLhbRibRibLsbLsbRhLsbRsbRibRiLsbLhbRhbRibRibRibRibRibLgLsbRibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 32; Drug: NDMC 1 µM
bRsLsbRibRsbRsbLgbLgbLgbLibLgbLsbLgbLsbLgLsbLsbLgbLsbLsbRsbRjbRcbLjbRg
bLiLsbLhbLiRsbLgbLgbsbLsRsbRgRsmbRgbLgbLibLibRhbRcbLjbRibsbRgbsbRibLsb
RhbLibRiRsmbLjbRgbRgbRgbRgbLsbRgbLjbRhRsmbLjLjbLcbLibLgbLsbRjRsmbRibRj
bRsbLebRcbLibLgbLibLsbLgbLgbLibRgbRhbLjbLcLsmbLcbRgbLcbLhbLgbRjbLgbRjb
RoRsmbLjLibRcbLgbLjbRoRsmbRibRibLibRcbLhbLcbLgbLobLsbRsbRgbLgbLgbRsbRi
bLibLgbLsbRsbLgbRsRsmbLsbLgbLgbLsbRebRcbLsbRsbLsbRibRsbLsbRgbRibLgbRgb
RgbLsbRgbRsbRsbRsbRgRsmbRsbRsbRsbRsbRgbRgRsmbRgbRgbRibRibLcbLsbLsbRibL
cbRsbReLsbLgbLgbRibRjbRcbLcbLhbRiRsmbLgbRsbLgbLsbLgbLgbLsbRsbLibLjbRib
LcRsbLibLgbRibLiLsbRcbRhbRibLsbRjbLgbRgbLsRsbRgbRsbRibLjLsmbRgbLjLsmbR
oRibLibRcbRebLgbRibLhLsbRcRsmbRcbRibLgbLgLsbRcbRibLgbRibLsbRibLsbRsbLs
LsmbRsbRsbRsbRsbRsbRsbRibRgbRsbRsbLgbRoRsRsmmbLgbRgbRsbLsRsbRibLgbRibR
cbLiRsbRhbLjbRibLjbRgbRgbLgRsbRibLsRsbRsbRgbRsbRgbRsRsmbRgbRsbRgLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 33; Drug: NDMC 1 µM
bRgRsmbRsbRgbRsbRsbRgbRsbRgbRgbRgbLgRsbRgbLsbRgbLjRsbsbRgbLcbLhbRgRsmb
LhbLibLibLcbLgbLgbRcbRcbLsbRibLgbRibLsbLgbRiRsRsmmbLgbRibRibRsbLgRsbRi
bLjbLcbLibRsbLibLsbLsbLgbLgbRibLcbLibLibRiRsmbRiRsRsmmbLgbRcbRcbLiRsbR
cbRiRsmbRsbRgbRoLsbRsRsmbLgbRgbLibRibRsbRobRiRsmbLsbLibLibLiRsbLsbRsRs
mbRhbLobLhRsbLibLibLgRsbRhbRhbRhbRhbRhbRgbRsbRcLsbRibRgRsmbLibRcRsmbLg
bRibRgbLsRsbLsbRsbRhbLgbLjLsmbLcbLiRsbLibLibLgbLgbLgbLgbRibRobRibRibRi
bRgbRibRgbRhbLsbLsbRsbRgbRcbLibRsRsRsmmbRgbRgbLsRsbRgbRsbRsbRgbRsbLsbR
oLsbRsbLgbLgRsbLgbLibLhbLibLibLibRhbRibRsbRgbLgbLcbLibLibLgbLgbLgbLgbR
gbLgbRcRsmbLhbLcbLiRsbRjbRsbLgbLibLsbLibLsbLgbLsbLgbLgRsbRgbLibRiRsmbR
cRsmbRibRsbRgbRsbRgbRgbRgRsmbLibRibRibLgbRiRsmbRibRgbLgRsbRibLgbsbRhbL
sbRibRsbRgRsmbRsbRgRsmbLsRsbRgbRsbRsbRgbRgbRsbRsbRgRsmbRgRsmbRgbRgbLcb
RsbLcbLhbLsbLgbLsbLgbLgbLgRsbLibLibRibLsbLhbRjbLcbRibLibRcbLcbLhbRiLcb
RhbRcbLjbLibLsRsbLibLgbLgbRhbRibRgbRgbRgbRsLsbRsbRgbRsbRsbRsbRgbRgRsmb
RgRsmbRsbRgbRsbRsRsmbRsbRsRsmbRgbRgbRgRsmbRgbRsbLsbRgLsbLsbRgLsRsbLsbR
gbRgbRgbRgbRgbLgbRibRibRibLiRsbLcbLibRjbLcbLibLibLgbRsbLgbRjbRcRsmbLib
RibRsRsmbRgbRsRsmbRsbRgbRsRsmbRsRsRsRsmmmbRsbRgbRgbRgRsmbRsbRgLsbRsbRs
bRgRsRsLsmmbRsbRgbRibRhRsmbLibLibRibRiRsmbRgbRgbRgbLibsbRibLgRsbRgbRsb
RgbRsbRsbRsbRgbRgRsmbLhbLiRsbLhRsbLibRibLgbLibLibLgbLgbRcbLhbLibRcbRcb
LjLsmbRsbRibRsRsmbRgbRgbRgbLgbRhbLgbRgbLsRsbRgbRgLsbRibLgRsbLgRsbRibRg
bRgbRgbLgbRibRgbLjbRibLjbRiRsmbRgRsmbLcLsmbLibLgbLgbLgbLgbLgRsbLgbLsbL
sbLgbRjbRcbRibRibLgRsbRibRgLsbRgbRgbRgRsmbLgbRgbRsRsmbRsbRgbRsbRsbRgbR
gLsbLjLsmbLjbRcbRhbLjbRhRsmbLsbLhbLcbRgLsbLibLibRibRjbRibLcbLcbLgbRhbR
ibRsbRgbRsbRgbRgbRsbsbRsRsmbRgbsbLsbRgbRgbRgbLjRsRsmbRibRgbRsbRgbRgbLs
bRgbRhLibRibLibLibLibRsRsmbLgbLsbLsbLgRsbLibRibRcbLjbRcbRibLgbRhRsmbLi
bLgbLsbLibLgbRsbLibLsbRsbLgLsbLgbLibLibRibLsbLgbLibLgbRibLibLiRsbLhRsb
LsRsbLgbRibLibRibRsbRsbRgbRgRsmbRsRsmbRsbLsRsLsbRsbRsbRgbRsbRsbRsbRgbR
gbRgbRsRsmbRsRsmbLgbLjbLibRcRsmbRibRibLiLsbLgbRibRibLsbLgbRhRsmbLibRcL
sbLcbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 34; Drug: NDMC 1 µM
bLgLsbRgLsbLhbLibLgbLgbLsbLsbLgbLgLsbLgbLsbRsbLsbLgbLsbLsbLgbLgbLgbLgb
LgbRcbRibLgbRibRibRibRiRsmbRsLsbRsRsmbRgbLgbLgbRjbRibRgbRgbRibRibRsbLi
bLibLgbLgbRsbLsbLibRcbRcbLsbLsbRibRgbRgbRcRsmbRibLibRsbRcbRhbRgbRgbRjb
RibLibRgbLgbLgbRgbRibRsRsmbRgbRsRsmbRsbRsLsbRibLgbLsbRibLjbLcbRjbLcbLc
RsbLobRsRsmbLsbRsbRgbLcLsmbRgRsmbRcbRjbLgbLsbRsbRsbRgbRgbRgbRsRsmbRsbR
sbLsbRgbRsRsmbLsbRjbLebLcbRjbRjbRhbLgRsRsmbRgbRhbLgbLsbRsbRgbRgbLsbRgR
smbRsbRsRsmbRsbRsbRsbRsbRgRsmbLsbLsRgbRgbRsbRsbRsbRsbRgbRsbRsbRsLsbRsb
RsbRgbLibLsbRibLsbRiLsbLibLobLcRsRsmbRgbLjbLgbRcbLibLcbLibRjbLgbLjbRjb
RjbRjRsmbLibLsbLsbRibLsbRgbRgbRibRibLjbLjbLgbRcbRgbRsbRsbRjbLibLoLsmbL
iRsbLgbLhbLsLibLibRgbLsbRjbRsLsbLsbRibLsbRibRsbLsbLsbRgbRsbRsbRsbRgLsR
sbRsbRsbRsbRgbRgbRgRgLsbLiLsbLsbLhbLhbRibLjbRcbRcbRsbLgbLgbLgbLgbLibRj
bLibRsLsbLgbRjbRobLjbLibLgbRgbLgbRgbLsbRgbLibLsbLsbsbLgLsbLgbLsbLsLsmb
RsbLgLsbLgbLsbLsbRsbLgbLsLsmbRsbLcbLcbLcbRgbLgbLjbLgbRjbRcbLcbRcbLhbLh
bRgLsbLgbLibRebRibLhbLgbLiLsbRibRgbLgLsbLgbLhbLcLsmbRgbRibRsbRsbRgbLgb
LsbLjbRcbRibLibRgbRibLsbRgbRgbRgbRsbRgbLsbLsbRsbRgbRsbRsbRgbRgRsLsmbRs
bRsbRgbRjbRgbLiLsbRsbLcbLibRibLsbRsbRgbRsbRsbRgbRsbRsLsbRsbRgbRsbRsRsm
bRgLsbRsbRgbRsbRgbRgbRsbRgbRsbRsbRiRsmbRgbRgbRsbRgRsmbRgLsbRsbRgbRgLsb
RsRsmbLjbRcbRcbLcbRebLcbLsbRhRsmbRgbLibLjbLibLcbRcbRibRibLgbRgRsmbLsbR
sbRgbRsbLsbLjbLibRcbRgbLjbLcbRjbLhbRjRsmbLibRgbLgbLgbRcbRibLsbRsRsmbRg
RsmbRgbLsbRgbRgbRsbRsbRsbRgRgbRgbRsbRsbRgbLsbRgbRsbRsbRgbLsbRgbLsbRgbL
jbRgbLcbRibLcbLcbLhbLcbRgbRibRgbRsbRgbRiRsmbLgLsbRgbRsLsbRsLsbLsRiLsbR
gRsmbRgbRgbLsLsmbRgbLsbRgbRgbRsbRgRsmbLsRsbRgbRgbRgbRsbRgbLsbRgbLjbLcb
RjbLcbRcRsmbRhbLjbLhLsbLsbLcLsmbLgbLgbLhRsbRsbLgbLibLibRibRgbRgbRgbRgb
RsbRsbRsbRsRsmbRgRsmbRsLsRsbRgbRsbRgbRgbRgbRsbLsbRsbRgbLsbRsbRsbRgbRgb
RgbRgbRgbRsLsbRgbLjbLcbRcRsmbRiRsmbRgbRsbRsbRsbRgRsmbRgbRgbRgRsmbLsRsb
RgbRgbLsbLgbRgbRgbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 35; Drug: NDMC 1 µM
bLsbRsbRsbRsbRgbRgbRsbRgbLsbRgbRsbRgRsmbRgbRibLjbLhbLibLibRibRjbRhbLjb
RcbLhbLcbLibRsbRjbRsbRhbLibRcbLibLgbLcbRibLcbRhbLjbLibLcbLgbRsbRgbLjbR
cRsmbRiRsmbLibRgbLgbRcbLiLsLsmbLgbRcbRgbLsbRsbLgbRibRibLsbRibLgbRhbLib
RcbLcbLcbLhLsbLsbRsLsbLgbRsbLhbRgbLsbLibRgRsmbLibLcbLsbLgbLjbLibLcbRib
LcbLhLsbLcbRgbLibRgbRibRsbLsbLsbRjbLgbLjbLcbRsbLgbRgbLjbLhbLhbLibLibRi
bRibRgbRiLsbLibLcbRgbLobLhbRsbsbRsbRgbLgbRibRhRsmbLgbLgbRibLsbRiLsbLjb
LcbLibRjbLibRibLcbRibLgbLgbRsbLgbRsbsbLgbLgbRsbRsbLcLsmbRsbLgbLibLibLi
bLgbLjbRibRcLsbRcRsmbLcLsLsmmbRibLibLjbLibRgbRhbLgRsbRibLsbLgRsbRibRgR
smbLgbRgbLsbLsbRsbRsbRibLcbLcRsbRsbRgbLibRjbRobRgbLgbLjbLibRgbRhbRibLg
bLjbLiLsbLhbRjbRcbRjRsmbLibLjbLjbLibLibLgLsbRsbLgbLsbLsbLsbLcbLcLsmbLi
LsbRhbRsbRsbRsRsmbRibLjbLcbLcbRibLibLgbLsbLibLibLibRsbRibLgbLhbRsbLhLs
bRgbLcbLcbLibLsbRibRgbLgbLsbRiLsbLjbRibLgbRibRgbLjbRibRibRgbLibLibLibR
jbRcbRibLibRobLgbRsRsmbRibRgbRgbRibRibLibRibRgbLgbLgLsbLsRsbLgbLsbLgbL
gbRsbRsbLgbRsbLsbLgbLsbLsRsbRsbLibRsbLgbLgbRsbLgbRgLsbLgbLsbLsbLgbLsbL
gbLgbRsbRsbLsbLgbLjbLgRsbRgbLgbRgLsbLiLsRsbLgLsbRgLsbLibRsbLibRobRcbRi
bLiLsbRiRsmbRibRjbRibRgbLgbRgbRsbLgRsbRgbLjbRhbLjbLjbLsbLibLsbLibLsbRs
bLgbRsLsbLsbLgbLsbLsbLgbLsbLgbLgbLgLsbLsbLibLiLsbLibLiLsbLgbLgbLgbLgbL
gbLgRsRsmbLgbLsbRsbLhLsLsLsmmbRcbLsRebRibRgbRsbRgbRgbRgRsmbRgRsmbRgbLi
bLcRsbLibLcbRsbLsbLgbRibRibLcbRcbRsbRsbRgbRibRgRsmbRsbRgbLobLgRsRsmbLi
bRgLsbLibLgbLibLjbLibRsbRhbRibLibLcbLhbLibLgbLgbRgbRibLcbLcbRsbRgbLcbR
ibRjbRhbLsbRsbRgbRsbRsRsmbRsbRgbRibsbRibRibRgbLibRibRibLgbLgbRibRgbRgb
LsbLsbLjbLgbLgbLgbRcbRgbRgbRsbRsbRgbLgbRibLgbRsbRibRgbLgbRibLgbRgbRibL
ibLibRcbRhRsmbLibRgbLsbRgbRsbRgbLgbRibLjbRcbLibRcbLhbRibRibLsRsbRgbRsb
RsbRsbRgLsbRgbRgbLjbRibLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 36; Drug: NDMC 1 µM
bLhbRhbRgRsmbRibRgbLsRsbRsbRgbRibLibRhbLcRsbLeRsLsbLibLiRsbLsbLebRobLh
LsbRibRsbLibRcbLcbRcbLcbRcbRoRsmbRibRsbRsbRobLcbRcbRobLsRsLsbLibLhbRgb
LibLcbRobRcRsLsmbLgbRcbLgbRibLcbLcbLcbRcRsmbRcbLgbRibLcbRcbRibRcbRibLi
bRgbRcbLcbLoLsmbRcbLcbRcbRhbLebLcLsRsmbLcLsmbRhbRibLibRgbRibLgbRjbRsbL
sbRsbRibRhbRsbLgbLibLgbRibLibLibLsLsmbLcRsbLobLhbLhbLgbLgbRgbLcbRcbRob
LcbRobRcbLsbLibLsbLhbLgbLsbLgbLgbLgbLhbRcbLgbLgLsbLjbRebRiRsLsmbRcbLcb
RoLsbRhbRhbRjbLsbLgbLhbLgbLjbRcbRebLcbRebLibLsbLgbLcbRcbRibLibLgbRcbLc
bRcbRebLsbRgbRibLiLsRsbRgbRcbRgbRjbLsbRcbLebLcLsmbLibLgbLgbLsRsbLgbRjb
LhLsbRsbLibRsRsmbLjbRgbLjbRcRsmbRebLgLsLsmbLgbsbsbRjbRcLsbRcbRsbRsbRgb
RibLibRibRibRibRcbRsbRsbRcbLcbLcLsmbLobLoLsmbRcbRcbLcRsbRobLgbLibLcbRs
bLgLsbLgLsbLsbLgbLgbLsbLgLsbRsLsbLgbLhbRsRcLsbRcRsmbRgbLgbLgbRibRgbRgR
smbRgbRibRsbRsbRibLgbLcLsmbLgbLgbRsbLgLsbRgbLibRsbLgbLgbLgbLcRsbRcRsmb
LibRjbRhRsmbRobLebRgRebRgbRgbRsbRsbRsbRgbLebLiRsbRhbLcbLsRcbRobLibLgbR
cbRsbLsbLhLsbRjbLsLjbLhbRcbLhbLsbLgbRsbLsLsmbLsbLgbLsbLgbLgbLgbLsbLgbR
gbLiRsbRsbLibRjbLibLebRcbLcbRobRibRgLjbRibLcbLhbRibRsbLhbLgbLsbLgbLgbR
jbLcbRjbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 37; Drug: NDMC 3 µM
bRsbRsbRgbRgRsmbRgbRgbRsbRgbRsbLjbLibLibRibRcbRhbLsbRibRsbLsbRgbRgbRsb
RsLsbRsLsbRgLsbRgRiRsmbLsbLcbLsbLibLsLsRsmbLiLsbLgbLgbLibLgbRgbLibRjbL
ebRibRiRsmbRgbLsbLcRsbLibRsbLgbLgbLhbLgLsbLgbLibRjbLcbLcbRgbLibLgbLcbL
gbLgbLgbRibRgbLjbLhRsbLiRsbRgLsbLibRgRsmbLiLsbLsbRsbLgbLgLsbLsbLsbLsbL
iLsbLsLsmbLgbRsLsbRsbLibLibRgbRgRsmbRgbLcbsbLiLsbLibRgbRcbRibRgbLjbLcb
LibRibLobRhbLiLsbLgbLcbRibRjbRiRsmbLsbRgbRgbRsbRibLgbLibRibRsbRgbRhbLi
bLibLibRcbRcbLcbRoRsmbRoRsmbLibRsLsbLgbLsbLsbLibRgLsbRcbRcLsbRibLsbLib
LibLsRsbRobLgbLsbRcbRhbLsLsmbRcRsmbRgbLgbLebRgLsbLibRgbLcbRjRsmbRobRcb
RsRsmbLgbRsbRibRgbLsLsmbRgbLsbRsbRsbRgbRibRsbRgbRiRsmbRgbRsbRgRsmbLsbR
sbRsbRgbRgbRgbRgbRsRsmbRgReRsRsmmbRsRsLombLgbRgbLibRjbRobRsbLcLsmbLsbL
gbLsLsmbLgbLgbLsbLibLhbRsbRsRibRibRhbRibLgbRcbRibLgbLgbLiLsbLsRsbRcbRi
RsmbLjbRibRcbLcbRgbRsRsmbRibRoLgLsbLiLsbRgbRcbRgbRgbRgbRsLjbLcRsbRhbLo
bRebLcbRgbLibRjbLhbRgbLcLsmbLsbLibRgbRhRsmbRgbRsbRgbLobRobRhbRhbLjbLcb
LcbRibLhbRgbLgbsbLgbLsLsmbLsRsbLsbLgbRjbLgbLibRiLsbLcbLhbRibRibLibRjbR
ibRsbRsbRgbRsLsbLsbRgbRsRsmbRsbRgbLgbRsbRibLsbRgbLsbRsbRsbRsLsbRsbRsbR
ibLsbRgbRgbRsbRsbRgbRsbRgLsbRgLsbRibLhbLcbLiLsbLsLsmbRibLibLibRjbLcbRc
bRgbLgbRgbRsbRsbLsbRibRsRsLsmbRgbRgbRgbRgRsRgmbRgRsmbRgbRgbRsbRgbRsbRs
bRgbRgbRibRgRsmbRgRsmbRibLjbLjbLibLibRcbRoLsLsmbLgbRibRgbLjbLibLibRibL
ibLgLsbLsbLsbRjbRiLsbRsbRgbRsbRsRsmbRsRsmbRsRsmbRgbRgbRsRsmbRsRsmbRsbL
ebLibRcbRhbLhbLobLcLsmbLcbRsLcbRcbRibRiLsRsbLjbRgbRhLsRobLibLgbLgbLibR
ibRcbRibRgbRsbRsbRgbRgbRsbRsbRsRsmbRsbRsRsmbRibLcLsmbLcbRibRhbLsbRiRsm
bRsbRgbRjLhbLibReLsbRibRsbRsRgbRsbRgbRgbRgbRsbRgbRgbRsbRsbRsRsmbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 38; Drug: NDMC 3 µM
bLsbLiRsbRgRsmbLgbLsbLgbLgLsbLsbLsbLsbLgbLgbLgbRsbLgbLsbLgbRsbLgbLgbLi
bLgLsbLgbLsLsmbLibRsRsmbLgbLgbLgbRgbLgbRgbLgRsbRjLsbLibLibLcbLgLsbLgbL
gbLgbLibLsbRsbRgRsmbLhbRgbLibLsbRgbLibRsLsbRsbLibRsbLgbLsbLsbRsLsbLgbL
gbLibLgbLsLsmbRsbRgbRibRibRsRsmbLsbLsbRgbRgbRgbRgLsbRsbLsbLgbRgbRgbRgb
RgbRsRsmbRgbRgbRgbLsbRsRsmbRsbRgbRgbRgbRsbRibRgbLjbRcbRibRibLsLsmbLibL
ibRsRsmbsbLsbRsbLcbLgLsbRsbRibRgbLcbLsbLsbLgbsbLsbLgbLsbLgbRsbsbRsbReb
RibRgbRsbRsbRgbRsbRgbRgLsbRgbRsRsmbRsbRgbRgbLsRsbRgbRgbRsbRgRsmbRsbRsb
RgLsbRgbRgRsmbRsbRsbRgbRgRsmbRgbRgbRsbRsRsmbRgRsmbLsRsbReRsmbRgbRgRsmb
RsbRgbRgbRgRsmbRgbRsbRsbRgbRsbRsbRgbRgbRiRsmbRgbRcbLibLcbLgbLsbLgbRcbR
ibRsbLgbRibRgbRsbRgbRibRgbRsbRsbRsbRgbRgLsbRsbRgbRsbRsbRgRsmbRsbRsbRsb
RsbRgbRgbLiLsbRcbRibRgbLgbLgbLhRsbRgbLibRcbRiRsLsmbRgbRgRsmbRsbRsbRgbR
sRsmbRgbLcbLibRgbLibRjbLiLsbLgbLsbLgRsbLibRgbLibRsbLgbRsbLgbRsbLgbLsbL
gbLsbLgbLgbLsbLgbLgLsbRgbLibRgbLiLsbRhbLsRhLsbRsbLgLsbRgbRgbRibRibRiRs
mbLgbLsbRibRgbRibRgbRgbRgbRgbRgRsmbRsbRgbRsbRsbRsbRsbRsRsmbRgbRsbRsbRs
bRgLsbLsLsmbRgRsmbRsRsmbRgbRsLsbLjbRgbRgbRsbRsbRsbRsbRgbRsbRsRsmbRgbRs
bRsbRsbRgbRgbRsbRgbRgbRsbRgRsmbRsbRgbRsbRsbRgbRgbRsbRsbRgbRgbRsbRgbRsb
RgbRgbRsRsmbRgbLjbRibRcRsmbLibLiLsbRgbRibRgbRgbRgbRsbRgbRsbRsbRsbRgbRs
bRgbRgbRgbRsbsbLsbRgbLsRsbRgbRgbRsRsmbRsbRgRsmbRsbRsbRsRsmbRgbLsbLsRgb
RgbRgbRsbRsRsRsmmbRgbRgbLsLsmbRibLhLsbLgbLibLibLibLgbRibLsbRsbLgbLiLsb
LibRsbLgLsbLgbLgbLgbRjbLgbLsbLibRgLsbLgbLsbLgbLgLsbLsRsbLgbRsbLgLsbRsb
LibRjbLiLsbRsbLsbLsRsbLgbLsLsmbLsbLsbLsLsmbsbLsbLgLsbLsbLgbLsbLgbRsbLg
bLgbLgbRsbLgbRjbLiRsLsbRsbRsLsbLsLsLsmmbLsRsbLgbLsLsmbLgbLsbLsbLgbLgbL
gbLgbLgbLgbLibRiRsmbRibRgbRgbRibRsbRibRgRsmbRgbRgbLibRibRiRsmbRgbRgbRs
RsmbRsRsmbRgbRsbRsbRsRsmbRsbRgbRibRgbRsbRsbRsbRsbRgbRgbRgbRgbLjbLcbLib
LibLiLsbRiRsmbLibLgbLgbLibRsbLibRsbLgbLsbLsbLsLsmbLsbLgbLgbLsbLsbLgbRs
bLiRsLsbLsbLgbLsLsmbLgbLsbLsbLsbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 39; Drug: NDMC 3 µM
bLgbLgbLgbLgbLsbLsbLsbLsbLsbRsbLgbLsbLsbLgbLiLsbLiLsbRcbLjbLcbRhbLibRh
bLgbLcbLcbLcRsbLgbLibRjbRcbRibRsLsbRsbRgbLgbRibRcbLhbLoLsmbLcbLgLsbRcb
LcbLcLsmbLgbRsRsmbRoLsbRgbRsbLsbRibRgbRgbRsbRgbRsbLjbLobLcbRcbLcbLobLi
bLobLgbLsbLgbRgbRgLsbRsbLibRgbLibRcbLsbRsbLcbLiRsbLgbLsbLsbRsbLgbRgLsb
RjbLcLsmbRsbLcbLcbLibLibLgbLibLgbLgbRgbRsbsbRhbRcbLjbLgbLibLibLsbRsbLs
bLgbLgbLgbRsLsbRsbLgbLgbLsbRsbLgbLsbLgbRjbRcbRhbLibRsLsbRsbLsbLsbLibLs
bRibRibLjbRcbRobRgbLgLsbLgbLibLsbRibLibLgRsbRsbRgbRsbLsbRjbRcbLsbLsLsm
bLiLsbLibLsbLgbLgbRsRsmbLibLgbLsbLgbRgbLhbLgbLsLsmbLsRsbRgbLgbRgbRjbRh
bLcbLsbLgbLgLgbLsbLsbLibLsbRsbLgRsbLgbRjbRcbRcLsRsbLjbLcbRibRiRsmbLcLs
RsmbLhbLoLsmbLcbLhbLsbRsbLsbLgLsbLgbRgbLgbLibLibLibRjbRsbLgbRsbRgbLgbL
ibRcbRcbRhbRgbLsbLgbLsbRsbLjbLgbRjbRcbLgbRgbRgbRibLsbLjbRibLjbLcLsmbRj
bRibLcbLiRsbRsbLgbLgbLgbLgbRsbRsbLsbRsbRgbRcbLjbRobRhbRgbRsbLsbLgbLsbL
gbRgbRjRsRsmmbRsLobRcbRcbLhbRcbLgbLsbRgbRhLsbRcbRgbRgLsbLsbLibRibLibRi
RsmbRhbLcLsmbRhLsbRhbLcbRcbRcbLibLgbRgbRibLjbLhbLcbRiRsmbRgbLgbLibRsbL
gbLgbLgRsbRhbLcbLsRjbRsbLcLsmbLibRgbLsbRgbLsbLibLsbLiLsbRibRjbRcbLibLc
bLcbLibLgbRsbLibLgbRsLibRgbLibLibLoLsLsmmbRgbLsLsmbLsbRsRibLsbRsRsmbLs
bRgbLsbRgbRsbRsbRgbLcbLibRjbRcbLcbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 40; Drug: NDMC 3 µM
bRsbsbRsbRsbRsbRgRsmbRsbRgbRsbRsLsbsbRgbRgbRibLjbRsbLcbRjbRiRsmbRibLcb
LjbRjbLjbLibRjbRcbsbLjbRhbLhbLcbRjbLcbLcbRjbRgbRgbRsbRiRsmbLiRsbRibRiR
smbLhLsbRibLcbRibRcRsmbRibRiRsmbRhbRibRebLcbLcbLcbRgbRibRibRjRsmbRcLsb
RibRibRibRibLcbLcRsbLgbLsbRsbLgbLjbLsbRsRsmbRjLsbRibRcbRibRgbRhbLcRsbL
cbLcRsbRsRhbLjbLobRjbRibRibRsbRgbRgRsmbLgRsbRgbLcbLoRsbLhbLcbLibLcbLgb
RsbRjbRjRsmbRcbRcRsmbRibLsbLgbLibRibRsRhbRcbRibLgbRsbRgbRgbRibRibRsRsm
bRgLsbRibRibRsbRgbRsbRsbRgbRsbLsbRgbRsbLsbRgbLjbLcbLjbLhbLobLcLsmbLibR
gbLsbRsbRibRgbRgbLgbRsbRgbRgbRsbLsRgRsmbRgbRgbRsLsbLsLsmbRgbRgbRgbLjbR
ibRsRsmbRsRsmbRgbRgbRgbRibLhLsbLiLsbLibLgbLiRsbRsRsmbRgbLcbRibLcbLhbRi
bRjbLgbLgbRjbLsbRsbRgbRgbRibRcbLcbLhbLcLsmbLgbLgbLsLsmbLibRgbRjbRjRgbR
ibLsbRgLsbRgbRgbRsbRsbRsbRsbRsLsbRsbRgRsmbRsbRgbRsbRibRgbRgRsmbLsbRgbR
gbLcLsmbLoRsbLiRsbLibLibRgRsmbRgbRibRsbRgbRgbRgLsbLcbLiLsbRsbLgbLsbRcL
sbLibLhbRgbsbLgbLiRsbLgbRgbLgbLgbLgbLcbLcbLhbLibLibLgbLsbLgbRjbRcbLsbs
bRibLsbLsbRgbRgbRgbRgbRgbRsbRsRsmbRgbRgbRgRsmbLjbRibRgbRgbRsRsLsRsmbRs
RsmbRgbRgbLsbRgbRsbsbRsRsmbRiRsmbRgbRsbRibLcbLcbLgRsbRgbLhRsbRsLsbLsbL
ibLibLibLiLsbRgbRgbLibLibLgbLsbLsbLgbLsLsmbLsRsbLsLsmbLgbLgbLsLsmbLgbL
gLsbLsbLgbRsbLsbLgLsbLgbLibLobLhbLcLsmbLibRsbLsbLobRibLjbLibLgLsbRgbLi
LsbLgbLsbLsbLgbLgLsbLgbLgbLgbLsLsmbLgLsbLsbLgLsbRsLgbRsbLgbLgbRsbLiRsb
RgbRsbLibLsRsbLgbLsRsbLsRsbLibLgbRsbLgbLgRsbLsbLgbLgRsbLgLsbRsbLgbRsRs
mbRjbRhbRiLsRsbLgbRgRsmbRibRcbRgbRibLgbRgbRiLsbRibLjbRibLobLoLobLibRgb
RiRsmbRgRsmbLcbLobRgbLibRsbLgbLsLsmbLsbRsbLgLsbLsbLgbLgbLsLsmbLgRsbRjb
RhbRhbLhbRibLhbLcbRsRsmbRibLgbLgbRsRibRibLgRsbRiRsLsmbRibRhbRiRsmbRgbL
gbRibRibLcbLcRsbRgbLgRsLsbLsbLgbLgbLhLsbLgbRgbRgbLgbLgbLibRsbLsbRebRib
RgbRibLiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 41; Drug: NDMC 3 µM
bRhbLibLgbLsbLsbRsbRsbsbLcbRgbRsbRjbRibRibRsbRiLsbRgbRsLsbRgbRibRsbRgb
RgbRsbRgRsRsmmbRgRsmbLgbRiLsbRsbRsbRgbRibRgbLsbRibLsLsmbRsbRiRsmbRsbRs
bRgbRsRsmbRgRsRsLsmmbRgbRsbRsbRsbRgbRgbRgbRsbRgbRsbRgbRgbRgRsmbRgbRgbR
gbRgbRgRsmbRibRgbRgbRgLsbRgbRgbRgbRgbLibRgbRiRsmbLcbLhLsbLebRgbLcbRsbR
gbLcbLsLsmbLgbRsbRsbLibRsLsbLibRgbLibRgbLibLgLsbRgbLcbLcbLhbLibLibRgbL
jbLibLsbRgbLibRgbLiRsbLiLgbLgbLibLibRibRsbLcbLhbLcbLibRibRcbLgbLebLibR
jbLhbRcbRibRhbLibLebLibRsbRcRsmbRcbLibRhbLgbRgbLsbRsbRgbRsbRsRsmbRsRgb
RiRsRgRsmmbRgRsmbRgbRgbRgRsmbRgbRgbRgbRgRsmbRgbRibRibRibRgRsmbRgRgbRsb
RgbRgRgRibRgbReRiRgRsmbRibRiRibRibRgRsmbRibRgRibRibRgReRiRsmbRsbLcbReR
smbLebRjbRcbLgbRiLsbLsbRibLjLsmbRibLgbRibRsbRgReRebRgbRibRibRibReRiRsR
eRhRsmmbRibLcLsmbRcRsmbRgbRsbLsbLibRjbLhbRjbRebRibLcbLcLsmbLgbLsbRebRg
bRsbRibLiRsLsbRibLjbRebLcbLcbRibLiLsbLgbLcbRjbRibRibLsbRgbRsbRsRsmbRgb
RgbRgRsRimbRibRgbRgbReRiRsmbRsRgbRiRsmbRiReRebRibRgbRgbLsRsbRgbRiRsRgm
bRiRsmbRsbRiLsbRibLoLsmbRhbRhbLibRcbLgRsbRibRsbRsbRsRsLsmbRibRgbReRibR
ibRibRsRibRgbRgbRiRebRgbRgRsmbRibRgbRgbRgbRibRgbRgbRibLhbRibRcLsLsmbLe
bRgbRcRsmbLibRibLcbLoLsmbRhbRibRibLgLsbRibRgbRgbRiRebRibRgRsmbRgbRgbRs
RgRsmbRgReReRiRiRibReRiRiRebRebLsbRgbRgbRgbRgbRgbRsbRgRsmbRibLsbRgbRib
RgLsbRiRebRibRgbRgbRgbReRiRsmbReRiRiRiRebLjbLibLgbLgRsbRibRhbRibLsbRsb
RgbRgbRgbRgbRsbRsbRibRiReRibRgbsbRgbRibLiLsbRgbRgLsbReLsRebLebLiRsbRib
RgbReRsmbRgRsmbRgbRgbRgbRsbRgbRgbRgbRgbRgRsRembReRsmbRiRiRsRhRsmmbRebR
iRebRgbRjbLgbRiRsmbRgbReRsRiRimbRgbRibRgbRebRgRsLsmbRsbRgRsmbRgbRgbRgb
RiRgbRgbRgbRibReRiRebRgbRiRsRimbRgbRgbRgbRibRgRsmbRebRgbLcbLibRhbRibLg
bRibLgbRhbLiRsbRjbLcbLibRcRsmbRgbRsbRgbRgbRgbRibRebRgbRiLsbLjbLhbLibLg
bLsbRcbRibLgbRgbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 42; Drug: NDMC 3 µM
bsbLcbLibRgLsbLgbLjbLgbLsbLgbLgbLgbLsbLgbLsbRsLsbRgRsmbLibRibLiRsbRsLs
bRsbLgbRsbLgbRsbLgbLsbLsLsRsmbsbLiLsbLsbRsbLibLsbLsRsRsmbLibLsbLsbLsbL
gbsbLsbLgbRsLsbLsbLgbLgRsRsmbRsbLgbRgbLjRsbLcbRhbLgbRibRiRsmbLsbRgbLjb
LiRsbLiLebLibLgLsbLgbLiLsLsmbLgbLgLsbLibRibRoRsmbRgbRsbRgbRgbRcbRgbRib
LgbLiLsbLgbLgbLsbLsbLsbLgbLsbLsbLibLcbRhbLgbRcbLcbRgbRhRsmbLibLiRsbLsb
LibLhbRgbLcLsmbRhbLgbLcLsmbLgbLsLsmbLiRsRsmbLgbLgbLgbLcbRibRgbLjbLibRc
bRiRsmbLsbRsbRibLsbRiLsbLsbRgbRgbRibRgLsbLjbRgbRgbRsbRsRsmbLsbRsbRgbLj
bRhbLsbRsRsmbRibLgbRcbRhbLgbLibLgbLgbLsLsmbLgbRsbRjbRsLhbLibRsRsRsmmbL
hRsRsmbRjRsmbRoLsbRibRgbLsbRibLgbRibRsbLsbRgbRsbRgbRsRsmbRsbRsbRsbRgbR
sbRibLjbRgLsbRgbRgRsmbRsbRsbRsbRgRsmbRsLsbRsbRsbRsbRibRgbRgbRsbRgbLjbR
ibLjbRiRsmbLjbRsbRsbRgbRsRsmbRgbRiLsbLibRgbRibLsbLsbRibRsbRsbRsbRibLsb
RgbRgbRsbRsRsmbRsRsmbRsbRcbRcLsbLibLibRsbLgbLsLsmbLsbLobRoRsRsmmbLibRi
bLcRsbLgbLsbLgbRsbRsbLsbLibLsbLgLsbRsLsbLgLsbLsbLsbLgLsbLgbsbLsbLgbLsb
LgbLsbLgbLsLsLsmmbLjbLsbLsbLgLsRsbLsRsbRsbLgbLgbLcbRcbRcbLibLibLsbLgbL
sbRgbLgLsbLgbRebRgbLsbRgbLsRsbRiLsbLgbLjbLgbLgRsbRjbsbsbRgRsmbRgbRsbRj
bRsRsmbRgLsRsRsmbLsbRgbLcbLibRgbLibsbLsbsbRsbLiLsbLiLsbLgbLcbRibRcbRjb
LjbRibRsbLsbRgbLsbRgbRsbLsRsbRsbRgbLgbRibRgRsmbRgbRibLgbLjbLjbLgbLiLcb
ReLsbRibLgbLhbRsbRsbLiLsbLibLibRgbRibRjbRibRsbRgbRsbRsRsmbRsbRsbsbRsbR
ibLsbRgRsLsmbRgRsmbRgbRsbLsRsRsmbRsRsmbRsbRgbRsbRgbRgbRgRsmbRsbRgbRsbR
sbRgbRsbRgbRsbRsbRsbRgbRsbRgbLsbLsbRgbLgbLsbRibRgbRsbRgLsbRgbRgbRsRsmb
RsRsmbRgRsRsRsmmmbRgRsmbRgbRsbRgbRsbRgbRsbRgbLsbRgbRhbLhRsbLebLgRsbRsb
LgbLsbLsLsmbLsRsbLsLsmbLsbRsLsbLgbsbRsLsbLgbRsbLgbRsbLgbLsbLsbLgRsbRsb
RsbLgbLsLsmbLgbRsbLhbLhbLhbRsbRsRgRsmbRgLsbLcbLgbLhbRsRsmbLsbLsbRsLsbL
gbLsbLgLsbRgbRsbRsLgLsbLgbsbRsbLsLgbRsLsbLgbRsLsbLgbLgRsLsLsmbLsbLgRsb
LibReRsmbRibRsbRsbRsbRsbLhbLgbRjbRsbLjbRcbLhbLgbLgbLjbLgbLgbLcbLcbRibR
ibLgbLibLgLsbRsRsmbRhLsbRgbRsbLsbRsbRgbRsbRgbRsRsmbRsbRsbRibRibLhbRcbL
hRsbRsRiRsmbRibRgbRsbRgbRibRsbRgbLsbLsbRibRsbRsbRsbLsbRgRsmbRsbLsbRgbL
gbRiRsmbRgLsbsbRgbLsbRsbRsbRgbRsbRgbRgbRsbRgbRgbRsbRsbRsbRgbRgRsmbRsbR
sRsmbLsRgLsbLsbRibRiLsbRgbRsbLgbLcbLgbRjbRibRgbRgRgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 43; Drug: NDMC 10 µM
bRibRsbRgbRgbRgbRgbRgbRgbRgRsmbRgbRgLsRsbRgRsmbRgLsbRibLcbLibRibRcbRib
LcbRgbRhLsbLcbRjbRhbsbRsbRgbRsbLjbRhbRcbLibRgRsmbRoLsbRcLsRsbRiRsmbRgR
smbRobRobLgRsLsbLgbLibRibLcbLcbLcbLobRgbRobRibLgbRhbLgbLjbRibRcLsbRibR
ibRsbRgbRcbLsbRgbRibRibLgbLgbRcbRcbLibLsbRgbLcbLobLibRgRsmbRgRgbRgbRgb
LgbRjRsmbRcbRgbLgLsbRgbLgbRcbRcbLhbLcLsmbRcbLobLsbRgbLiRsbRcbRcRsmbLjb
RibRibRcbLibRiRsmbRcbRibRgbRgbLgLsbRsbRibLjbsbLjbLgLsbLhLsbRcbRobRibRh
bRibLgbRcbLgbRhbLsbRibLgbRiLsbLibRcbRhbLibRhbLgLsbLsbRcRsmbLjbLcbRhbRc
bLcbLgbLiRsbLsbLcbLgbRsbLibLibLsbLgLsbLgbLsbLgbLjbLsbLiLsbLsbLgbLgRsbL
sbLiLiRibRhRsmbRibRiLsbRhbRibLgbRcbLcbRcbRoLsbLsbLcbLcRsbRcbRcbLcLsmbL
obRibRgbRcRsmbRcLsbRsbLsbRcbLibRobLsbLgbRsbRjbRiLsbLcbRcbLcbLiLsbLsbLg
bLgbLsbLsRsbLgLsbLsbLgbLiLsbLgLeLgLsbLgLsbRjbRibLcbLsbLgbLsLsmbRsbLgLs
bRjbLhbLgbRsRgLsRsbRoRsmbRibRgRsLsmbRgbRcbRgbRebRobLgbLsbLibRjbRcLsbRi
bLibRcbRcbRgRsmbLgbLibRobRhRsmbRhbRsbRibRiRsmbRhbLsbLjbLibRcbRoLsbRiLs
bRcbRhbLgbRiRsmbLsbRibRgbLibRiRsmbLjbRibLsbRibLcRsbRibRhRsmbLgbRibRsbR
gRsmbRgbRgbRsbLsRgbRgbRsbRgbRsbRgbRgRgbRgbRgbLcLsmbLcLsmbLcbLsbLhbLcLi
bRsbsbRcLsbRibLjbRcbLhbLcbRcbRcbLsbRcbRgbLsRsbLsbRhRsmbLsbLsRhbLiLsbRg
bRiRsmbRsbRgRsmbRsbRsbRgbRgRsmbLcbRcbRcbLcbRgbRhbRibLgbRcbLibRibLcbRsb
LobRsbRhbRhRsmbRibRcRsRsmmbLibRcRsmbLcbRobRibLgbRiLsbRhbLcbLibLiRsbRsb
LgbLgbLiRsbRibLcbRibLhbLcLgRsbRibRibLgbRibRibLibRobLcbLcbLibRjbRcLsbRc
LsbRsbRibRsLsRsbRibLsbRiRsRsmmbLsbRiRsmbLjbRibRiLsbLjbLcbRgRsmbRcbRibL
sbRsbRiLsbLgLsbRhbLhbLcbRcbRibRsbRibRsbRgbRgbRgRsmbRsbRsbRgbRsbRgbLsbR
ibRgRsmbRgbLjbRhLsbRibLiLsbRoRsmbRcRsmbRcRsmbLgbLjbRcbRsRsLsmbRibLhbLc
bRjbRcbLjbRiRsmbRgbRgLsbRgbRsRsRsmmbRsbRgRibRgbRsbRgbRhbLcbLoRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 44; Drug: NDMC 10 µM
bRgbLibLiLsbLgbLgbLsbLsbLgbLsbLsbLibLobRibRcbLsbRsbRcbLobRcbLjbLcbRgbL
gbLgbRjbLibLibRcbRhbRiLsbRibLsLsmbRgbRjbLjbLsLcbLsbLiRsbLsbLgLsbLsbLib
LgbLgbRibLcRsbRcbRoLsbRibRsbRgbLgbLsRcLsbRibLgbRibRibRibLibLsbRibRcRsm
bLgbRibLsbRiLsLsmbRibRgbRibRibLibRhbsbRcbLjbRgbRgbLsbRhbLibLcLsLsmmbLi
bLsbRsbLiRsbLibLhbLhbRiRsmbLsbLcLsmbLgLsbRobRhbLjbLobRibLhbLoRsRsmbLcb
RibRibLgbLobLhbLibLsbLsRsbLsbRcbLcbLobRgRsmbRiRsmbRibLcbLcRsbLsbRibRcb
LgbRhbLgbRgbRgbLgLsbRcbLgRsbRgbLsbRsbRsbRsbRsbRsbRsbRgbRsbRsbRsbRsRsmb
RgbRsbRgbRsbRsbRsbRsRsmbRsbRgbRsbLsbRcbRcbRiRsmbRibRibRibRsbRgbRsbRgbR
sbRsbRsbRsRsmbRsbRsbRsbRsbRgbRgbRsbRsbLsLsmbRgbLsbRibLcLsmbLoRsRsmbRgb
LhLsbLcRsbRgbLibRsbLibRgbLgbLiRsbRgbLibRsbRsbLjLsmbRjbLcbLsbRibRobRibR
gbLsbLjbRcbRgbRgLsbRgRsmbRgbLsbRgbRgbLsRsbLgbRgbRgbRcbRhbRgbLibRcbRibR
iRsmbRsbRibRgbRgbRsbRgRsmbLgLsbRibRsbRgbRsbRgbLsbRgbRgbRibRgbLgbRiRsmb
LjbRcRsmbLcbLhbLsbLsbLsbLsLsmbLgbLsbLgbLgbLsbLgLsbRsbLgbRgbRcbRibLgbRi
bLjbRibLjbRgbRgbRsbRsRibRsbRgbLeRsbLgbLgbLsbLsbLsbLgbLsbLsbLsbLsbLgbRg
bLibLcbRibLcbRibRibRgRsmbRgbLgbRgbLsbRgbLsbRgbLsbRiLsbLobLobLiRsbLgLsb
LgbRjbLibRgbLibRgbLcbLcbLibRibRiLsbLcbLibLibRsbLgRsbLsLsmbRsbLgbLgbLsb
LsRsbLgRsbRgbRcbRgbRgRsmbRsRgRgbRsbRsbRsbRsLsbRibLhbLcbRsbRjbRibRibRgb
LjbLcbLsbRcbLsbRsbRgbLsbRjbRgbLgbLgbRgbRgbRsbLsRsbLjbLcbRjbLgRsbLgLsbL
gLsRsbLsbLcbRibRcRsmbRsbRibLjbRcbRibRhbRibRhRsmbRsbRgbRsbRgbLsbRgbLsbR
gbRsRsmbLsbRgbLsbRibRgbRibRiLsbRcLsRsbRgbRhbLsbLjbLgbLsLsmbRcbRcRsmbLj
bLcLsmbLibRcbRibRibRiLsRsbLsbLibRiLsRhLsbRibRgbRgbRsbRgbRsbLjbLsRiRsmb
RsbRibLibRibRhbRibRibRibRsbRgbRsbRgbRgRsmbLsLsRsmbRgbRsbRsbRgbRsbRsbRg
RsRsmmbRgbRsRsmbRgbRsbRgbRsbRgbRgbRsRsmbRsLsRiRgbRgbRsbRgRsmbLsbRgbRgb
LjbLhbLgbLsbLgRsLsbLgLsbLsbRsbLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 45; Drug: NDMC 10 µM
bLgbLsbLsRsbLgbLgbLgbLgbRobLgbsbLsbRsRsmbLgbRhbRibLjLsmbRgbRibLsbRgbRs
RgbLsbRgbLsbRgbRgbRsbLsRsbRgbRsLebRhbRibRibLgLsbRsbLsbLsbLibLgbRjbLcbR
cbRcbRgbRsbRgbLsbRsbRgbLsbRsbRgbLsbRibLsbRgbRgRsmbRgbRsbRsRsmbLibRibLg
bLsbLjbLcbLgbRibLhbRjbRcbRcLsbRcRsmbRsbRibRgbRsbRsbRgbRiLsbLgRsbLsbRsb
RiLsbLgbRgbRiLsbRibRcbRgbLsLsmbLibLiLsRsbLibRhbRcLsRsbRobRcbLsbLsbLiLs
bLgbLsbLgbLjbRibLjbRcbRcRsmbRsbRibLgbRsRsmbRsbRgLsbRgbLsbRibLsbRsbRgRs
mbRiRgbRgRsmbRgbRgRsmbRgbRsbRgbRgbRsbRgbRgbRgbLsbRgbLjLsmbLhbRsbLsbLsb
RiRsmbLsbRjbLibRgRsmbRsbsbRsbRgbRsbRsbRgLsbRgRsmbRgbRgbRgRsRsRsmmmbRsb
RgbRgbRgRsmbRgRsmbRsbRgbRgbLibLibRjbRiRsmbRcbLibRsbLsbRgLsbRgRsmbRgbRg
bLgbRsbRgbLsbLsbRgbLsbRgbRsbRsbRsbRsbRgbRgbRsRsmbRgRsRsmmbRhRsmbRibRib
RgbRibRibLsLsmbRcbRibRgbLgbRibRibLgbRiRsLsRsmbRsbRsbRgbRgRsRsmmbRgRsmb
RgbLsbRgbRgbRgbRsbRgbRgbRgbRsbRsbRsbRgbRsbRgbRsRsmbRsRsRsmmbRgRsmbRgbR
sbRgRsmbRsbRsbRsbRgbRgbRgbRgbRgbRgRsmbRgbLsLsmbRsbRibLjbLhbRjbRebRsbRg
bRgbRsbRgbRgbRsRsmbLsbRgbRgbLsRsbRsbRgRsmbRgLsbRgbRsRsmbRgRsmbRsbRsbRs
bRgbRibRibLibLjbLibLgbRebLcLsmbRcbLjbLcbLcbLibRgRsmbRsbLgbLgbLjbLgbLsb
LsLsmbLibLibRgbLibLgbRsbLsbLgbLgbLgLsbLgRsbRjbsbRcRsmbRgbRsbRsbLsbRgbR
gRsmbRsRgbRgbRgbRsbRgbRgRsmbRgbRsbRsbRsbRgbRgbRgbLcbLhbRjbLibLiLsbLibL
gbLgRsbRsbLsbRgbRibRibLjbLsbRsRsmbRgRsRsmmbRsbRgbRsbRsbRgbRgbRgbRgbRgb
RgbRgbRibRgbRibLeLsbLcbLsbLibLsbRsbRsLgbLgbLgbLgLiLsbRibLgbLgbLgLsbLgL
sbLgbLgbLsbLgbLgbLsbRsRsmbsbRsbLibRjbRcbLsbLsbRgbRgbRsRsLsmbRsbLsLsmbR
ibRgRsmbRgRsRsRsmmmbRgRsmbsbRsbRgbRgbRsbRsbRgbRsRsmbLhbLgbLhRsbRcbRhbR
cbLibLsbRsbRsbRgRsmbRgRsmbLsbRsbLjbLibLhbRgbRjbRcbLsbRsbLsbRsbLsbLsbRh
bLsRsbRsbRgbRsbRgbRgbRgbRibRgbRgbRgLsbRgbRgbRgbLibRsbRibLgRsLsbRsbRgbR
sbRgbRsRsmbRsRsmbRsbRgbLgRsbRsbRsbRgbRgLsbRgbRgbRgbLgbRsbRgRsmbRibLibL
gbLibLgbLgbLibRcbRebRsbRgRsmbRgbRsbRsbRsbRsbRsbRgbRgbRibLibRibRgbRgbRs
bRgbRgbRibLgbLsbRgbRsbRsbRgRsRsmmbLsbRgbRgRsmbRgbRebRsbRgbRgbRgbRibLib
sbRgbRgRsRsmmbRgbRsbRsRsmbRgbRgRsmbRsbRsbRgbRgRsmbLgbRsRgbLsbRgbRgbRgR
smbRebRsLsbRgRsmbRsLsbRgRsmbLsbRgbRgbRsRsmbRsRsmbLjLcbLibRsbLibRsbLibL
ibLsbRsbLsbRsbLgbLibRibRibLsbRgbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 46; Drug: NDMC 10 µM
bRgRsmbRsbRgbRsLsbRsbLsbRgbRgbRsbRgbRsbRsbRgbRsbRgbRgbRsbLsbRgbRsbRgbR
sbRsbRsRsmbLsbRgLsbRjbRgbRgbRsbRsbRgbRsbRsbRibRgbRsbRsbRsRsmbLsbRhRsmb
RibLcLsmbRcbRjbRjbRjRsmbRiLsbRibRgbRsbLsLsmbLcbLcbLjLsmbRgbLgbLsbRsRsm
bRgRsmbLcbRsbRgbLcbLhbLhLsbRsbLiLsbLcbLgbLibLsbLibLcbLcLsmbRibLcbLhbLc
bLcbLcbLcbLibRgRsmbRibRgbRsbRibRgbLsbRsbRsRsRsmmbRsbRsbRgRsmbRsbRgbRsb
RgbRgRsmbRsbRsbRsRsmbRgLsbLsbRsbRsbRgbRgbRgbRgbRgbRibRcbRcbRcbRibRcbLg
bRobRsbRcbRibLsbRibLibRgRsmbRobRibRibRibRsRsmbRgbRcbRibRgbRsRsmbLsRsbL
ibLgbLibLcbRcbLgLsbRgbLgbRcRsmbRhbRcLsbRibRiRsmbLgbRibLsbRsbLsbRsbLsbR
iLsbRgbRsbRsLsbLsLsmbRibLgbRsbRgbRsLsbRgbRcbLcbLiLsbLiLsbLobRibRgbRgbR
ibRsRsmbRsbRsbRsbRgbRsbRgbRgbLgbRgbRsbRsRsmbRgRsmbRsRsmbRgbRgRsmbRgbRg
bRgbRgbRsbRsbRgRsmbRgbRcbRcRsRsmmbRhRsmbRibLjbRcbRsbRiRsmbRgbLibRcbRgb
RsbRibRgRsRsmmbLsRsLsbRsRsmbRsbRsbRsbRgbRsbRgbRsbRsRsmbRsRsmbRsbRgbRsb
RgbRgbRsRsmbRgbRsRsmbRgRsmbRgRsmbRgbRgbRgRsmbRgbLsbRhbRobLgbLcbLcbLcbR
cbLjbLebRobLsbRibLgRsbRsbRsbRgbRsbRgbRsbRgRsmbRsbRgbRsbRgbRsbLsRgbRjbR
cbRcbRcbRgbRgRsmbLibLcbLibRibLobRjbLibRjbRsLcbLcLsmbRibLhbLibLibRgRsmb
LibRjbRebLsbRiLsbLjbRgbRsbRgRsmbRsbRgRsmbRgbRsbRsRsmbRgRsmbRsbRsRsmbRg
bRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbRgRsRgRsmmbRgbRgRsmbRgRsmbRgbRgbRgbRgbR
gbLgbRgbLsbRibLcbLobRjbRhRsmbRgbRgbRhbRcbRhbRiRsmbRsRsmbRgbRsbRgbRgbRg
RsmbRgbRsRsmbRgbRgbRgbRgbRsbRsbRgbRgbRgbLebLhbRcbRhbLcbRiRsmbRgbRgbRgb
RgbRgbRgbRsRsmbRsbRgbRsRsmbRgbRsbRgbRgbRgbRsbRsbRgLsbLsbRsbRibRgRsRsmm
bRgRgbRibRgbRgbRgbRgbRgRsmbLgbRcbLcbLeLsbLcLsmbLcbLcbLiLsbLcbRibLobReb
RebLsRsbRibLsbRgbRsbRsbRgbLsRsbRsbRsRgbRgbRgbRgRsRsmmbRgRsmbRgbRgbRgbR
gRsmbRsbRgbRsbRgbRgRsmbRsRsmbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbLjRsbRibRsR
smbRibLgbRgRsmbRsLsbRgRibRgRsmbRgbRgbRibRgbRgRsRsmmbRsRsLsmbRiLsbLhbLh
bLeRsbRhbRcLsbLjbLcLibRjbLcLsmbLcbRjbRcRsmbRibLibRhbLgbRsbRcbRcRsmbRcb
RcRsmbLgbRgbRsRsmbRsbRgRsmbRsbRgbRgLsbRiRsRgmbRgbRgbRgRsmbRgbRgbRsRsmb
RgbRgbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgRsmbRgRsmbRgbRgRsmbRgbRgbRgbRgbR
gbRgbLsbRgRsRsRsmmmbsbRgbRgbRgRgbRgRsmbRgbRgRsRsmmbRgRsmbRgbRgbRgbRgRs
mbRgbLhbLebLobRcbRibRiRsmbRcLsbRcbRcRsmbLibRibRgbRgbRibRsbLgbRgbRgRsmb
RgbLsbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 47; Drug: NDMC 10 µM
bsbLsRsbRgbLsRsRsmbRgbRgbRsbRgLsRsbLsbRgbRgbRgbRgLsbRsRsmbRgRsmbRibRib
RgbRsbLjbLgbLiRsLsbRjRsmbRobRibLibLibRgbRsLibRgbLibRgbLgbLibRjbLibRsbR
jbLibRjbLsRcbLjbRiLsbRgbRibLcbLcbRjbsbLibLgbRgbLibRgbLhbRibLobLgbLsbRs
bLibLhbRhbLcbLobRgbRgbRjbRcbRcLsbRcRsmbLibRcbRsLsbRgbRgbRsbRsbRobRcRsL
smbRibRiRsmbRibRibRgbRibLiLsbRsbLibRcbLgbRgbRgbLoRsbLibLhbRhbRiRsmbRib
RgbRgbRhLsbRobRcbLsbRjbRgbRgbLcbLcbLsbLgLsRsbLgbRsbLgbLsbLsbLsbLsbLgbL
gbLcbRibRjbRibRibLgbLjbLobRibLcbRjbLibLgRsbRgbLsbLgbRjbRjbLgbRgbRgLsbR
gbRgbRsbLsbRhbLhbLcbLibRjbLibLgbRjbLjbLgbLgLsbLsbLgbLgbLgbRjbLsbRjbRgL
sbLsbRgbRsRsmbRgbRsbRsbRgbRsbRsbRgbRsbRgbLsbRgbLcbLibRcbLjRsbRgbRgbRsb
RgbRgLsbLjbLcbLhbRgLsbLgbLibRgbLiRsbLiRsbLjLsmbRebLhbRjbLibLiRsbRoRsLs
mbRibLibRgRsmbRgbLsbRgbRgbRgRsmbLsbRgbRgLsbLsbRgbRgbRsRsLsmbRsbRgbRgbR
sRsmbRgbLsbLsbRsbRsbRgbRgRsmbLsbRgbRgbRsbRgbLsbRgbLsbRgbRsbLjbRhbRgLsb
LjbLsbLcbRjbLcbRsbLhbLgbLibLgbLibLjbRgbLgbRcbRebLgbRjbLibLibLsbLibLibR
jbRjbLgbLsbLibRjbLgbLgbLgbsbRsLsLsmbRsRsmbLgLsbLsbRsbLsbLgbLgbRsLsbLgb
LgbLsbRsbLgLgbLsbLsbLgbLsbRjbLibLgbLsbRsbLgbLgbLsbsbLgbLsLsmbLgLsbLsLs
mbLsbLsbLgRsbLsbLgbLsbLgbRsbLsLsmbLgLsLsmbRsRsmbRsbRsbLsbLobRgbLgbRgbL
cbLcbLcbRibLcbRgbLibLsbLsRsbLsbLsbLsbLgRsbLsbLgbRsRsmbLgbLsbRsLsbLgbLs
bLsbLsbLgbLgLsbLgbLsbRsbLsbLsbLgLsbRsbLsbLibRjbLsbRcbRsbRibLsbLcbLgbLs
bLgbLsbLgbLgbLgbLgbLibLcbRcbRhbRiRsmbLcbLgbLsLsmbLsbLgLsbLsRsLsbLsRsbR
sbLsbLgbLsbLgLsbLgbLsbLsbLgbRsbLsLsmbLsbRsbRsbLjRsbRgbLgbRgbLsbLsbLsLs
mbLgLsbRsbLgbLsLsmbLgLsbLsbLsLsmbLgbLsbLsbLgbRsbLsLgRsbLgbLibRgbLiRsbR
sbLgLsbRsbLgLsbLsbLsbLgLsbRcbLjbRoLhLsbLhbLsbLgbRsRsmbLsbRsbRsbRibLjLs
mbLibLsbLsLsLsmmbLsLsLgLgmbLgbLgbLgbRsLsbLgbLsbLsLsLsmmbLsbLgLsbLgLsbL
sbLsbRsbRjbRjbRjbRobRhbRcbRcbLgbRgbLcbLcbRjbLcbRjbLgLsbLgbRsbLgbLsbLgL
sbLsbLgbLsbLgbRgbLgbLgRsbLgLsbLgbLsbLsbLgbRgbsbLibRgbLiLsbLsRgbLsbLibR
sLsLsmbLiRsbRgbRjbRjbLhbRobLcbRcbLcbLibRibRcbRgLsbRgbLcRsbLibRgbLsRsbL
sbLsRsbLgbRibLjbLhRsbRsbLgbLgbLiRsbRibLjRsbRjbLjLsmbRjbRcbRgbRibRsbLgb
LjbLobRsbLibRjbLibRgbLsbLibRsbLibRgbRcbRibLjbRhbRobRgbRibRhbRgbRgbRgbR
sRsmbRgbLcbLcbRibRjLsbLebRhbLcbLgbLsLsmbLsbLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110224; End: 110724;
Recording: 1-1; Individual: 48; Drug: NDMC 10 µM
bLiLsbRgbLibLsLsmbLsbLgbLsbLibLsbLgLsbLgbLsbLgbRjRsmbRcbLcLsmbLiLsbLob
LjbRcbRsLsbRiRsmbRgbRiLsLsmbRobRibRobRcbRgbRgbRsLsbLgLsbRjbRibRgbRgRsm
bRibRgbLjLsmbRjbRebRibLobLhbLhbLcbRjbLsLsmbRcbRcbRobRcbRcbRgbLobLsbLgb
LgLsbLoRsbRiRoLibLgLsbLgbLgbLcbRhbRiRsmbRgRsmbsbRgbRobRcbLcLhbLcbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 1; Drug: Control
bLobLsbRgbLibLgbLibRebLjbLibLibRcRsmbLobLjbRiRsmbRoRsmbLsLsmbRsbRgbLcL
smbLobRiRsmbRhbRhbLcbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 2; Drug: Control
bLsbLgbLsbLgbLsbLsbLgbLsLsmbLgbLgbRsbLiLsbRgbLibRsbLibRsLsbLgbLgbRgbLs
LsmbLibRcbRibRibRhbRgbRgbRgbRgbLhbLiLsbLsbLsbLgbLgbLsbLgbLgbLgbLsLsmbR
sLsbLgbRgbLibLgbRgLsbLibLgbRgbLibLsbLgbLsbLsbLgbLgbLgbLsbLgLsbRsbLsbLg
bLgbLgLsbLgbLsbLsbLsLsmbLgbLgbLsbLgbLsbLgbLgLsbRjbLibLibRhbLibLiLsbLgb
RhbRibRgbRgbLcbLgbRsbLgbLibLgbRsbRsRsmbLibRsLsbLiLsbLsbLgbLsbLgbLgbLsb
LsbLsbLiLsbLsbLsRsbLgbLgbLgbRibLibLgbLgRsbLgbLgLsbRgbLibRgbLibRgbRsLgL
sbLgbRgbRjbRhbLjbLcbRibLcbLsbRgbLibLsbRsbLibRgbLibLgbLsbLsbLsbLsLsmbLg
bLgbLgbLsLsmbLgbLgbRgbLiLsbLibRibLcbRgbRsbRjbRibRibRgbLiLsbRgLsbLgbLsb
LgbLgbLgbLgbRgbRjbRibLjLsmbRhbRibLjbRcbLjbLhbRcRsmbRibRobRhLsbRibLhbRg
bRibRgbRiLsbRgbLjbLcbRgbLcLsmbRgbLiLsbRjbLhbRgbLgLsbLgbRgbLsbLibRsbRjb
RgbRgRsmbRgRsmbRgbRgbRibRgbRibRgbRgbLcLjbLhbLibRibRibRibRibLhRsbRibRib
LjbRiRsmbRibLjbRibRgbLsLsmbRgbRsbRgbRsbRgbRibRibRibLsbRiLsRsbLjbRiRsmb
RgbLsbRgbRgRsmbRgbRsbRsbRsRsmbRsbRsLsbRgbRgLsbRgbRgbLibRgbRgRsmbRsbLgb
RgbRgbRsRsmbRgbRgRsmbRibRgbRsbLsRgbRgbLsbRibRgbLgbRibRgRsmbRibLjbRiRsm
bLcbLsbRobRgbRhbRhLsbLhbRgbLebLibRsbLgbLgLsbLgbRsbRsRsmbLibLsbLsbLibLs
bLgbLgLsbLsbLsLsmbLgbLsbLgbLgLsbRsbLgbLsbLsbLgbLgbLsbLgbRsbLgbLsLsmbLg
LsbRjbLgbsbLgbLsbLgbLsbLgbRjbLibRsbLsbLgbLsbLgbLgbLgbLgbLsbLsbLsLsmbLg
bLgbLsbLgbLgbRgbLibLgbRjbRibLjbRjbLcbLiLsbRjLsbRjbRcbLhbLcbLsbLiLsLsmb
RsbLgbLgbLsbLgLsLsmbsbRgbLgbLgLsbLgLsbLsbLgbLsbLgbLgbLsbLgbLsbLgbRgbLi
bLgbLsbLgLsbLsbLgbLsbLgLsbRsbLgLsbsbLgbLsLsmbLgbLgbRsbLgLsbLgbLgbRjbLi
bLgLsbRgbLiLsbRgbLiLsbLgbRgbLiLsbRgbLsLibRgbLgLsbRsLsRsbLgbLgbLsbRsbLi
bLgbRsbLgbRsbLgbLgbLgbLsbLgbLgbLsLsmbLgbLgbRsLsbLibRsbLgLsbRsbLiLsbRgb
LgLsbRsbLibLgbRsbLibLgbRgbLibLgbRsbLibLgbLsbLsbLsbLsbLgbRsbLsbLgbRsbLg
bLgbLgbLgbLgbLgbLgbLgbLgbLsbLgbRsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 3; Drug: Control
bLobRibRsLsbLibLgLsbLgLsbRoRsLsRcLsmbLibRsbRibRibRsbLgbRsbRgLsbLsbRgbR
obLhbLsbRgbRebLcbLibRsbRsbLgbLgbLsbLsbLgbLibLgbLibRcbRhbLsbRibRgbRgbRs
bRsbLgbRgbRsLsbLobLgRsbLgbRjbLiLsbRjRsmbRibRgbRsbRgbRsbRgLjbLobRcbRgbL
cbLibRgLsbLgLsbLgbLsbLsLsmbLsbLsbLgbLgbRjbRcbRcbLibRibRibLiLsbLibLgbLs
bRgbLgbLgLsbLsbLgRsbLibRjbRibRibRibLgLsbLjLsmbLibRibLibRobRhLsbRcbLhbR
cbRcbRibLgbRibRiRsmbRgLsbLgLsbLjLsmbLibRgbLiLsbLsLgLsbLgbRsbLgbLgbRsbR
sbLgbLgbLsbRgbLgbLibRcbRobLibLobLcbLcbLcbRgbLcbLibRgbLiLsbLgbRsbsbLgbL
sLsmbLgbLgbRsbLgbRjRsmbRcbRibRcLsbLibRsbLibLibLibRgbLhbRcbLsRcbRiLsbLg
bRgbRgbRgbLjbLcRsbLjbRjbLibRsbLgbLsbRsbLgbLgbLgbLgbLgbLgbRjbLiRsbLgbLg
bLgbLsbLgLsbLgLsbLcLsmbRcbRsbLgLsbLibRibRjbRibRibRgbLibRcbLhbRobLibRoR
smbLgbRhbLgbLsLibLibRcbRibLgbRibRcbRcbRibRgbLjbRjbLcbLsbLsbLibLsbLgbLg
RsbRsbLibLsbLgbLsbLgbRsbLsbLsbLgbLgbLsbLgbRcbRcLiRsbRobLhbLsbLjbLgbLgL
sbRsbLgLsbLsLsmbLgbLgbRcbRiRsmbRcbLiLsbLiLsbLgLsbLibLsbRsbLgbLibRgbLgb
LgbLsbLgbRgbRhbLibLibRjLsbLgLsbLsbLgbLgbRsbRsbLgLsbLsLsmbLgbLsbLsbRsbL
ibLsbLsbLgbLgbLsbLsbLgLsbLgLsbLgbLgLsbRjbRcbRibLhbLibLjbLgbLibRsbRgbLi
bLgbRgbLibLoRsbRibRobLsRsbLibLsbLgLsbLgbLgbLgbRjbLibRibRcbRiLsbRcbLibL
ibRgbLibLgbLgRsbLibRsbLgbLjbLgbLgbRsbLgbRgbRjbRjbRgbRsbRgLgbRibLcbLobR
gbRibRsbLibLiRsbLgbLsbLsbLgbLsbLgbLgbLgbLgbLgbLiLsbRibLsbLibRsLsbLgbLs
bLgLsbLgLsbLgbLgbLgbLgbLsbLgLsbLgbLgbRgbLiLsbRjbLsbLibLibLgbLsbLsbRibR
cbRcbLiLsbRibLcLsmbLobRgbRibRibRgbRhbLsbLgbLjbLiLsbRsbRsLsbLcbRhbLgbLi
bRsbLibRgbLhbRgbRsbLgbLsbRsbLgbRsRsmbLibLgbLgbLgbLgLsLsmbLsbLgbLhRsbLc
bLcbLibRjbLobRobLibLsbLgbRsbLgbLgbLsbLsbLgLsLsmbLgbLsbRsLsbLibRgbRcRsm
bRibRsbLsbRgbLobRgbLhbLcbRibLgbRgLsbRjbLjLsmbLibLgbLsLsmbLsbLgbLgbRgbL
gbLsbLgbLgLsbRsbLibLibRsbLsLsmbLibLsbLgbLgbRgbLibRjbLiLsbLgbLsbRgbLibL
sbLgRsbLgbLsbLgbLgLsLsRgmbRjRsmbRobLcbRcbRsbRgbLjbLcbRibLcbRibLcbLobRi
bRgbLgbLsbLiLsbLgbRsLsbLibRjbLibLgbLibLgbRgbRcbLgbLibLiRsbRgbRsRsmbsbL
ibRcbRgbRgbLcbLibLibRibLibLgbLsbLgbLiRsbLibRhLsbLibLgbLhbRgbRsbLcRsbRg
bLhbRgbLsbLibLsbLsbLgbLsbLgbLgbLgbLibLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 4; Drug: Control
bRsbRgbRgbRsbRgbRsbRgbRsbRsbRsbRsbRgbRibLgbLjbRhbLcbLcbRcbRibRibLibRib
RibLjbRiRsmbRiRsmbLiLsbRgbRiLsbRcbRebLibRibLgbRsbLcbLibLibLgbLgbLgLsLs
mbRgbLibLibRjbLibRjbLibRcbRibLcbRibLibRcbRcbLhbRcLsbRhbLibLgbRsLsbRobR
ibLjbRcbLibRhbLgLsbRgbRgRsLsmbRibRgbLsLsmbLgbRgbRgbRgbRsRsmbRgbLsbRiRs
mbRhbLjbRgbRibLhbRibRgbLgbRgRsmbRgbRsRsmbRgLsbRgRsmbRgbRgbRgbLsbLsLsmb
RibLgbRgbLsbRsbRgLsbRhbLiLsbRgRsmbRgbLsbRgRsmbLsbLhbLgLsbRjbRcbRhbLgbL
gbRibRibLebRcbRibLgbRhbLebRhbLsbRgbLsbRgbLsbRgbLsbLsRsRsmbLsRsbRsbRgbR
gRsmbRsbRsbRgbRsbRsbRsbRgbRsbRgbRsbLcbLcRsRsmbRhbRiRsmbRgbRsbLsbRgLsbL
gRsbRibLsbRgbLsbRsbRsbRgbLsbRgbRgbRgbRgbRsLsbRgbRgbRgbRsbRgbRsRsmbRgbR
sbRsbRsbRsbRgbRgbRgbRgbRgbLcbLcbRiLsbRcbLcbRjbRibRibLsbLgbLibLibLgbLgb
LsbLgbRsbRcbRcbLcbLgbLhbRibRhbLeLsbLibRjbRjbLcbRcbLhbLibRhbLobRjRsmbRi
bRgRsmbRgbRsRsmbLsbRgbLsbRgRsmbLsLsmbRgbRgbRgbRsbRsbRgRsmbLgbLcbRjbLcb
LjRsbsbRcbRiRsmbLgbRibLgbRibLsbRibLgbRgbRsbLsbRgbLsbRgRsLsmbLsbRsbRgbR
gRsmbRsRsmbRsRsmbRsLsbRibRgbsbRgbRgbRsbRgbRgbRsbRsRsLsmbRsbRgbRgbRsbRg
bRgRsmbRgbLsbRgbLsRsbRiLsbRgbLjbRibRgLsbRgbRsbRsbRgbLsbRgbRsbRsbRgbRsb
RgbRsbRgRsmbLsbRsbRgbLibLgbLgbLgbRobLjbRiRsmbLiRsbRgRsmbLjbLgbLgbLsbLs
bLobLgLsbRobLsbRibLcbLobRcbRobRibLibLgLsbRcbLibRcbLibRiRsmbRgbRgbRgbLj
bRcbLjLsmbRjRsmbRibRsbRgbRiRsmbLcbRebLjbLiRsbRiLsbRibRgbRgLsLsmbLjbsbL
hbLibRgbRibLsbRgbLsbLibRebRibLjbRgbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 5; Drug: Control
bRgbRgbLgbRiRsmbLsbRibLsbRgbRsbRgbsbLsbRibLsbLsbRhbLibRiRsmbLgbRibRcbL
ibLgbLgbRcRsmbRcbLibRibRsRsLsmbLjbRgbRiRsmbLjbLsbRhbLgbRsbRgbRsbRsbRsb
RibRgbLsRsbRgbRgbRsbRgbRgbRgbRgbRgbLibRiRsmbRiRsmbLhRsbLjbLibLibRjbReb
LibLcbLibLsbRjbLibLibRjbLobLgbLibRsbRibRibLgbLhbRjbRoLsbRhLsbLibLgLsbL
hbRibLiLsbRjbLcbLgbRsbRiRsmbLibLhbRiLsbRobRibLgbRibRsbRgbRgRsmbLsbLsbR
ibRsbLsRsbRibLsbRgRibRsbRgbRgbRsbRgbRgbRgbLgbRibLgbRibLgLsbRibRiRsmbLs
bRiRsmbLsbRgbRgbRsbRgbRgbRsbRgbRgbLsbRgbRgbRgbRsbRgbRgbRgbRibLibRgbRib
LgbLebLiRsbLsbRjbRibRibLsRsbRgRsmbLgbRibLibRibRsbRibRsbRgbRgbRgbRgbRgb
RgLsbLgbRsbRibRgbRsbRiLsbRcbLibLibRgbLibLiLsbLibRibLcbRhbRobRcLgLsbRib
RcbLibRiRsmbRibLsbRgbLsbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgRsmbRgbL
gbRgRsmbLsbRiRsmbLgbsbRibRgRsRsmmbRgbRgbRgLsbRgbRgRsmbLsbRgbRgbRgbRgbR
gbLsbRibRgbLgbLebLcbRibLcbRebRhRsmbRcbLcLsmbRcbRcbLibRsbLgbLibLhbRebRc
bRibRibRibLibRibRibLibRibRibLjbRcbLgbLsbRibRsbRgRsmbRgbRgbRgbRgbLsbRgL
sbRgbLsLsmbRgLsbRsbRgbRgbRgbRgbRsRsmbRgbRgbRgbRibLhbLibRjbRibRhbLsbRsb
LibLcRsbLibLgbLgbLsbLhLsbRcbRhRsLsmbRibLsbLsbRibLsbRiRsmbLjbLcbLibLibR
ibLibLibRjbLibRjbRjRgbRibRgbRsbRgbRgbLsbRgbLgbRibRibLiLsbRibRibLjbLcbL
iRsbRjbRibRiRsmbLsbRgbRsbRsbRsRsmbRgbRgbRgbRgbLgbLsbRibLsbLsRsbRibRgbR
sbRsRsmbRgbRgbRgbRgRsmbRsbRgbRsbRsbRibRsbRsbRgbRgbRibLjbRiRsmbLcbLhbLi
bRjbRibRibRgbLgbRibLobLgbLgbRjbRcbRcbRiRsmbLiLsbLgbLjLsmbLgbLgbLsbLibR
ibRjbRibRsRsmbRsbRgRsmbRsbRsbRgbRgbRibLobLobLgbRjbLibRsbLgbLsbLgRsRsmb
LgbRjbLgbLibRjbLcbRcbRgbRgRsmbLsRsbRsRsmbRgbRgbLgbRibLjbLjbLibLibRhbLh
bRjbLsbLgbLsbLgbRsbLgRsbLsbLgbRsbLgbLgRsbRhbRhbLgbLjbRibRgbLsbRsRsmbRs
RsmbRsbRgbRibLsbRibRsbRsbRibLgbLjbRhbLjbLhbLgbLgbLsbLibLobRibRjbRjbLgb
RhRsmbLsRsbRsbRgbRgbRsbRgbRsRsmbRgbRgbRgbRsbRsbRgbRgbLgbLebLibRhbLibLi
bRibReRsmbRibLsbRiRsmbRgbRsbRgbRgRsmbLebLsLibLhbRibLibLsbLsbLgbLgbLsLs
mbLsbLgbRgbLgRsbLgbRsbLsbLgbLibRjbRebLgbRgbRibLjbRiRsmbLsbRibLsLsmbRgb
RgbRsbRgbRsbRsRsmbRgbRsbRiLsbRobRcbRhRsmbLjbRibRsLsbRgbRsbRsbRgbRsbRsb
RgbRgbRgbLjbLcLsmbLibRibRhRsmbLibRhbLsbRsbRgbRsbRgbRsbLgbRgbRsbRsbRsbR
sRsmbRgbRgbRsLsbRgLsbRsbRgRgbRgbRgbRgbLgbRiRsmbRsbRgRsmbRgbRgbRsLsbRgb
RsbRiRsRsmmbRgRsmbRgbRgbRgLsbLgLsbRiRsmbLjbRibLcbLhbRcRsmbRibLsbRiRsmb
RsRsmbRibLgbRibRibLgbRiRsmbRgbRsbRgbRgbRsbRsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 6; Drug: Control
bRgbLgbLsbRibRibRgbLgbsbRgbRgbRsbRsbRsbRgbRgRsmbRsbRhbLcbLcbLsbLgbLiLc
bLcbLibLgbLibRhbLiLsbLgLsbLsLsmbLsbLsbLsbLgRsbLsLsmbLsLsmbLsLsLsmmbLgb
LgbLgLsbLsLsmbLgLsbRsRsmbLgLsbLgbRcbRcbLebRcbLibLcbLgLsbRsbLibLsbRsbLi
bLsLsmbLibLsLgLsbLgbLsbLsLsmbLgRsbLgLsbLgbLgbLgbLsbLsLsmbLsbLgbLgbLhbL
gbRjbRcbRhbLsRsbRgbRgbRibRcbLibLjbsbLibLibRgbLgbLgbRsRsRsmmbLiRgRsmbLg
bLgLsbRsbLgLsLsmbLibLiLsbRsbLgbLgRsbLgbLsLsmbLgbLsbLgLsbLgbLgLsbLsbLgL
sbLgLsbLsbLgbLsLsmbLgbLgbRsbLibRjbRcbRcbRibLibRcbLiLsbRcbRcbRibRibRibL
ibLhLsbLibLcbLcbRgRsmbRgbRgbLjbLsbLcLsmbRgLsbLgbLgLsbLgLsbLgbLsbLsbLgb
LsbLgLsbLsLsmbLsRsbLgbLgLsbLgbLgbLgLiLsbLgLsbLgbLgbLgbLsbLibRhbRcbRcbL
ibRcbLibRcRsmbLibLoLsmbLsLibRsbLibLcbLgbLgbRhRsmbLjbRcbRgbRsbRsRsmbRsR
smbRsbRsbRsbRsRsmbLsbRhbLebLcLsLsmmbLhbRibLgbLcbRibRhRsmbRgbLsbLjbLcbR
jbLsbLibLgbLgbLsLgbLgLgbLgbLgbLgbRsLsbLibRsLsbLsLsmbLgbLgbLgLgLsbLebLg
bLgLsbLsbLgLsbLsLsmbLsbLgbLgbLibRibRcLsRsbRiLsbRsbLiLsbRhRibRcbRcRsRsm
mbRibLcbLibLiLsbLsbLgbLsbLgbRjbLcbLcLsLsmmbLhLsbLibLibRsbLgbLsbLgbLsLs
mbLgbRjbLhbRcbRcbRiRsmbLgRsbRibRsbLcbLibRgRsmbLibLcbLibLgbLiLsbLibRcbR
ibRibLibRcbRgLsbRgRsmbsbRsRsmbLsbRgbRgbRibLibRibRibLjbLcbRgbLibLgbRibL
ibLibRsbLibLsbLgLsbLsbLgbLsbRgbRcbRiRsmbRcbRgbRsRsmbLsbRgbRgbRsRsmbRsb
RgRsmbRsbRgbRgRsmbRsRsmbRgbRgbLsbRgRsmbRsbRgbRgRsRsmmbRsRsmbRgbRsRsRsm
mbRsbRgRsmbRgbLsLsmbRibLjbLhbLgbRjbRcbLsRiRsmbRgRsmbLsbRgbRgbRgbRgbLib
RibRibLhLsbLhLsbLgLsRsbLgbLsRsbLsbLgLsbLsLsmbLgLsbLgbLsbLgbLgbLgbLgbLs
bsbLgbLsbRjbRibLjbLcbLibRgbLibRibLsbRcRsmbRgRsmbRiRsRsmmbLgbRibLjbLcLs
mbLgbLibRjbRobRgbLgbRgbLsbLsbsbRgbRgbRsbRgbLsbLsLsmbRgRsmbRiLsbLjbLcRs
bLsbLibRsLsbLgbLsbRcbRgRsmbLsbRgbRibRsbRsbRsbRsbRsbLjbRgbLebLhRsbRcbRc
RsLsmbLibRibRgbRsbRgbRsLsbRsbRgRsRsmmbRgbLsbRgRsmbRsbRsRsmbRsLsbsbRsbR
gRsLsmbRgbRgRsmbRsbLsbLibRjbLjbRebRibLibRibRsbLsbRgbRgbRgbLjbRhbLgbRib
RsbRsbRsbRsbRgbRsbRsRsmbRgRsmbRgRsmbRgbRgbLsRsbRgRsmbsbRgbLsRsbLcbLcbL
cbLibRjbRgbLgRsbRjbRiRsmbLjbRgbRibRsbRgRsRsmmbRgbRsLsbRsbLsRsbRsbRsbRs
bLsbLjbLibRibRiRsmbLjbRibRibLgbRsbRgRsmbRsbRsbRjbLjLsmbLjbLcLsmbLcbLib
RhbLgbRsRsmbRhbLibRhbLgbRhbLsbRgbRibLjbRcRsmbLebLcbLibRjbRcRgbRiRsmbLi
bRibRsRsmbRsbRgRsmbLsbRgbLibLiLsbRjbRcRsmbRibLibRibRgRsmbRobLhbRibLcbR
ibLhbRjbLhbLobLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 7; Drug: NDMC 1 µM
bRibRgLsRsbRgbRgbLibLibLgRsbLjbLsbRgbLibRjbRjRsmbLhbLgbRgbRgRsmbLjbRcb
LcbRcbLcbRcbLsLsmbRibRgbRgbRgbLibRcbLjbRjbLsbRhbRgLsbLsbLgbLgbRhbRcbLc
bLibLibLibRjbLiLsbLibLgRsbRsbLsbLibRibRjbLcbRhLcbRsbRgLsbLibRsbLgbLgbL
iRsRibRgbLcbLibRgbLgbLcbRgbRsbRjbRibLibLobLibLgbLibRgbRgbLibLhLsbLsbLs
bLsbLiLsbRjRsmbLcbLgbRebRibLibRhbLgbRibRgbRgRsmbRgbLcbRgbRgbRgbRsbRsbR
sbRgLsbRsbRsbLsbRgLgbRiRsmbRibLibRibRibLhbLgbRibRgbRibLgbRiLsbRsbLsbRi
bRgbRsbRsbRibLjbLibRgbLhbLcbLhbRgbLgbRibLgbRibLgbRgbRsbRsbRsbRgRsRsmmb
LsbRgRsmbRsRsRsmmbRgbRsRsRsmmbRgLsbRsbRsbRsbRgbLjbRhbLibLjbRcbLgbRgbRi
bLsLsmbLgbLjbLhbRibLcbRcbLcbRcbLgbLsLsLsmmbLcbLcRsLibRsbRsRhRsmbLgbRcb
LibLsbLibLgbLgbRgbLhRsbLobRjbLhLhLsLgbLgLsbLgbsbLgbLhLgbRsbRgbRsbRsbLc
bRhbRjbLcbLcbRjbRcbRibRiRsmbLgbLgbRobLjbRibRgbLibRjbRgbLjbLjLsmbRgbRgb
LcbRsbRsbLjbLgbLsRsbLcbRsbRgbRgbRgbRgbLiLsbLcbLgbLibRibRiRsmbLibLgbLsb
LcbRcbRsbLgbLgbLsLsmbLsRhbLjLsmbLgbLgRsbRsbLsLsmbRsbRebLcLsmbLibLibRib
RcbRhbRhRsmbRsbRgbRcbLibLcbLiRsbLgbLgbRiLsbLibRsbLsLsmbLgbLibRgLsbLibR
jbRcbLgbRibLgRsbRgbRgbLsRsbRsbRgbRgbLsbRgbRjbLjbLcLsmbLcbRgbLibRsbRgbL
hbLibRjbLibLibRcbRsbRibRgbLsbRgbRsbRsRsmbRsbRsbRgLsbRgbRsbRgbLsbRgRsmb
LsbRjbRgbLgbRgbLsLsmbRgbRsbRgbRgbRsbLhbLcbRcbRcbLcbRcbLgbLsbRgbRsbLhbL
ibRcbRhbRgbRgbLibRibRgbLsLjbRibRgbRsbLsbRibLjbLjbLcbRebRiRsmbRgbRsbRgb
RsbRsbRgbRsbRsbRsbRgbLsRgRsRsRgmmbRgRsmbRibRgbLsbRgbRsRsmbRsbRsbRibRgb
RsbRgRsmbRgbRibRgbLhbRibRgbRibLgbLgRsbRhbLgbRjbRibRcbRcbLgbRhbRibRhbRs
RsmbRibRibLhbLiLsbLgbLjbRsRobRibRgbRsbRsRsmbLsRsbLsbRibLjbRgbRsbRsRsmb
RsbRsRsmbRgbRgRgRgRgbRgRsRsLsmmbLjbLhbRcbRcRsmbLcbRobLoLsmbRsLeLcbLcbR
ibRhbLjbLibRjRsmbRcbRibLcbRcbRgbRcRsLsLsmmbRgbRgbRibLibRgbRsbLsbRgbRsb
RsbRsbRsbRsbRgLsLsmbRgLsbRgbLjLsmbRcbLibLcbRjbLgbLcRsbRcbLcbLhbRhbRjbR
jRsmbLibLcbRcbRibRibLgbLsbRcbRibLgbLibRhbRibLgbRgLsbRsbLgbRibRgbRsbRgb
LsbRgbRgbLgbRgbRsbRsRgbRsbRsbLsRsRgbLsbLsbRibRcbLsbLgbRjbLiLsbRibRibLi
bRhbRibRcbRcbLgbLjbRjbLgbRjbRcbRcRsmbLcbRcbLcbRcbLsbLsLsmbRgbRgbLsLsmb
RgbLjbRcbRibLibRibRsbRsRsmbLgbLhLsbLgbLgbLcbLgbLsbLgbRibLhbRjbRibLsbRi
bRsRsmbRsbRsRsRsmmbRsRsmbRgbRsbRgRibRiLsbRibRgbLiLsbRcbRiRsmbLibRhbLib
RibRsbRgRsmbLgbRcbLjbRibRiLsbLgbRsbRibRcLsLgLsLiLiLsbLgbLgbLsbLgbRjRsm
bLibLiRsRsRsmmbRibRjRsmbRgbLibRjbRibLcbRcbLsbRibLsRsbRgbLsbRgbRsRsRsmm
bRsRsmbRsbRsbRgbLsRsbRgbRgbLjbRcbRjbRhbLiLsbLgbLgbLgbRibLgbLgbLibLsbLg
bLgbRjRsmbLibLsbRjbReRcbRibLgbRibLsbRibRcbRobRsbLsLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 8; Drug: NDMC 1 µM
bLjbLcbLibLgbRibLibLibLcbLgRsLsbLsbRgbRiRsmbLobLiRsbLsbRjbLcbRgbLgbLgb
LsbLsbLgLsbLgLsbLgbLsbRsLsbLgbLsbLgbRsRsmbLgLsbLgLsbLsbLsbLgRsbLsbLgbL
gbLgbRsbLgbLhbRhRsmbRobRgbRibLibRcRsmbRcbRhbLsbRgbRiRsmbRibLjbLsLcbLgR
sbLsbLgbLgbRsbLgbLgbLsLsmbLgbLsLsmbLgbLgLsbLgLsbLsbLgLsbLsLsmbLgLsbLgb
LgbLgbLsbLsbLgbLgLsbLgbRcbRobLiLsbRibRibLsbRcbLgbLibLibLgbLgbLsbLgbLgb
LsbLsbLsRsbLgLsbLgbLgbLgbLgLsbLgbRsbLgLsbLgbLsbRgbsbLgbLgbRjbRcbRhbLgb
RgbLjbLiLsbLgbLgbLsRsbRsbLgLsbLgbLsbRsbLgbLsbLgbLsbLgLsbLgbLgbLgbLgbLg
bLgbRcbRoLsLsLsmmbLgLsbLsbRhbRhbLgbRcbRoRsmbLibLibLibRiLsbRcbLcbLobRiL
sbRjbRoLsbRibRcbRibLibLcbRcRcLsbLgbRcbLibLcbRibLgbLgLsbLgbRsbLgbLgbLgb
LgbLgbLsbLgRsbRsbLgLsRsLsbRsbLgbLsbLgbLgbRjbRcbLgbRiRsmbLgbRibLobLibRh
bLobLgbLgLsbLsbLgbRsbLsbRjbRcRibLjbRiRsmbLsbRibRgLsbRgbRibLjbRcbRiLsbL
sLgbRgRsmbRiLsbLgbRibLcbLcbRjRsRsmmbRibLobLcbLibLibLgbLibLsbLgbLgLsbLs
bLgbLsbLgbLsLsmbLgbLgbLgbRsRsRsmmbRsbLgbLgbLgbLobLobLcbLgLsbLgbLgLsbLs
LsmbRsbLgbLgRsbRsbLgbLgbLgbRcbRobLibLcLsmbLgbLgLsbLsLsmbLgLsbRhbRibLsb
RgbRiLsLibLoRsbLsbLgbLsbRsbLiRsbRsbLgbLsbLsbLsLsmbLebRgbLibLsbLgbLsbLs
bLgbLgbLjbLiRsRsmbLgbRjbLibRgbLiLsbLiRsbRibLibRibRebLsLsmbLsbLgbLsbLsb
LgLsbLsbLgbLgbLgbRibRcbRsbRsbRjbLibLhbLjbLsbLgbLgbLsbLgbLgbLgbRsbLibLj
bRhbLjbLibRebRjLsbLsLsmbLgbRsbLgLsbLgbLgbLsbLgbRsbLjbLsLsmbLgbRjbLcbLi
bRibLibRcbRhbRcbLsbLsbLgLsbLsbLgbLgbLgbLgbLsbLgbLgbRoLsbRibLsLsmbRsbLi
bLibRjLsRsbLiLsbRgbLgLsbLgLsbLsLsmbLsLsmbLgLsbLgbRcbRcbRcbLgLsbLgbLibL
cRsbRhbRcbLjbRiRsmbRibLibLcbLibLsbRsbLgbLsbLgbLgLsbRsbLgbRjbRcbRgbLsLs
mbRcbLsLsmbLcbRsbLibRiLsbRhbRiLsbLgbRibRsLsbRsbRgLsbRibLibLjbLhLsbRjLs
bLibRgbLiLsbLsbLsbLsbLsbLgbLsbLgbLsbLsLsmbLgLsbLsbLsbLgbRsbLgbLgbRsbLg
bLsbLgbLsbLsbLgbLsLsmbLsLsmbLgbLsbLgRsbLgLsbRsbRsLsbLibLsbRjbRhbRibsbR
ibRibLgLsbRsbRgbLibLibRjbLcbRcbLgbLhbRgbLibRgbLibRsbLgbRsbLibLsbLsbLsb
LsLsmbLsbLgLsbLgLsLsmbRsLsbLsbLsbRsbLgbLsbLgbLgbRjbLibLsbLsbLgbLsbLsLs
mbLgLsbLsbLgbLsbLgLsbLgbRsRsLsmbLsLsmbLsbLsbLgbLgLsbLgLsbLcbRhbRcRsmbR
ibLibLhbLgbLgLsbLsbRsLsbLgbLsbLgbLsbLsbLsLsmbLgbLgbLgbRsLsbLsLgbRsbLib
LibRibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 9; Drug: NDMC 1 µM
bLjbRcbRibLcLsmbRibRibLibRhbLibLibLgbLgbLsLsLsmmbRsLsbLsbLsbLgbLsbLsbL
sbLsbRjbRcbRhbLgbRibRjbRcbRibRibRcbRhbLsLsmbLgbRibsbLibRgbRcbRcbsbsbRi
bLsbLsbLsLsmbLgbLgbRgbLibLgRsRsmbLjRsbLgbRgbRsbRgbLsLsmbLgbLgbLgbLgbLg
bRsRibLgbRjbRhbRjRsmbRsbRgbLgbRcbLiLsbRcbLgLsbRcbRsbRibRcbLsbRgbRgbLgb
RcbRcbRhbLsbLsLsmbRhbRibLjbLcbRcRsmbLibLjbRgbLibRiLsbRcbRcbLgbLibLoRsb
RcbLibLibRgbLgbLgLsbRsLsbRsbLsbsbsbLgbRjLsbLgbRjRsLsmbRcbRcbLjbLjLsmbL
sbLgbLgLsbLsLsmbLgLsbLgbLgRsbRibLjbRjRsmbRsLsbLgbLgbLsLsmbLgbRgLsbLgbR
jbLsbRcbRibRibLsbLsbLsbLiLsbLibRgLsbLjLsmbLjbRibRcbRgLsbRsbRsbRgbRgbLi
bRiLsbRibRcLsbLgLsbLgbLsbRsbLgLsbLgLsLsmbLgbRcRsmbRibLhbRcbLjbRgbLgbLi
bLibRjbLgbLgLsbLsbLsLsmbLgbLsbLgRsbLgbLgbRsbLsbRcRsmbRhbRsbRibLibRibLg
LsbRibRhbLgLsbLsbLsLsmbRsLsbLsLsmbLgbLibLgbLgRsbLgbLsbRsbLgbLsRsLsbLsb
LgRsbRcbRibRibRibRiLsbLjbRhLsbLgLsbRgbRgbRsbRsbRgbRgbLjbLobRjRsmbRhbLs
bLjbLcbRhRsmbRibLjLsmbLjLsmbLsLsLsLsmmmbLsbLsLsmbLsbLsbLsbRsbLgbRibRhb
LibRcRsmbRhbRhbLgLsbLgLsbRsbRsRsmbRibLcbRcbLjbRibRcLsbLhbLobLibRsRsmbL
sbLgbRsbLgbLgbLgbLsbLgLsbRiLsbRgbLiLsbLsbLgbRsbLgbLibRjbLgbRsbRebRhbLi
bLjbLibLgbLsbRsbRcRsmbRibRibLjbRiLsbLgbRiRsmbLgbRsbsbRgLsbRsRsmbRsRsmb
RsRsmbRsbRgbRgbRsbRgbRgbRsbRibRgRsmbRibLibRibLjbRsbLcbLibRjbLcbRiLsbLi
bRjbRcbLjbLibLgLsbLgbRsbLibLgbLsbLibLgbRibRsbLsbLsbLgbLibRjbLcbRcbLibL
iLsbRsbLsbLgbRsbLsbLgbRsLsbLsbRsLsbLgbRhbLibRjbLiLsbRcbRiLsbRsbRiLsRsb
LsbRgRsmbRgbRgbLobRhbRgbLsRibRhLsbLibLibLibLsbLgbRcbRhbRgbLibLibRcbLsR
ibLjbRibRgbLgbRgbRgbRibLjbRhbLibLhbRjbRiRsmbRibRgbRsbRgbRsRsmbRgRsmbRs
RsmbRsbRgbLjbRibLibRgbRgbRsbRsbRgbRibRgbLsLsmbRibLjRsbRibLcbRibRibLsRs
bRsbRgbRsbRgbRgbLjbRjbLibLgbLgbLsbsbLsbLjbRcbRcbRgbRgbRiRsmbLgbRgbRgbR
gLsbLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 10; Drug: NDMC 1 µM
bLcbLsbLsbLibLgbLsbRibRgbRsbsbRgbRhLsbRsbLgbRgbLcbLgbLsLsmbLsbLjLsmbLs
LsmbRjbRsbRsbRgbLebLgbRgbRsbRsbRibRibRgbLibRsbRgbRibLsbLsbRhRsmbLibLcb
LsbRgbRsbLhbLsbLsbLgbLgRsbLibLsbRibLgbRjRsmbRibRsbRgbRibLibRibRgbRsbLs
bRgRsmbRiLsbRsbRsbLgbRibRgLsbRsbRsbsbLsbRibRgbLibRsLsbRibLsbRsRsmbRibR
sbRsLsbRgbLgbLsbRoLsbRcbRsbLgbRgbLibLibRgbRibRibRibRsLsbRgbRibLgbLibLi
bRjbRsLiLsbRsbLibRgbLibRhbRobLibRebLgbRibRsbRgbLsbLcbLgbRsbLgRsbLgLsbL
sbLsbLiLsbRgbLiLsbRjbRcbRibRibRhLsbRsbRibRsbLsbLibLsbLgLsbRobRgbRgbRsb
RsbRsbRsbRebLebLhbLsbRjbLgbLgbRgbLibLsbLgLsbLgLsLsmbLsbRsbLgbRjbRcbRib
RibLjbLcbLgbLibLsbRsbLibLgbLsbLgLsbLsRsbLjbLsbLibLgLsbRgLsbRjbLebRgbLi
LsbLgRsbLsbLgbRgbLgbRgbLibRsbLgbLiLsbRibRcbLgbRcLsbLiLsbRiRsmbLgbsbRgb
RibLgbRibLjbLibRjbRibRibLjbLcbRsbLibRjbLibRjbLibRgbLibRjbLcbRgbLiLsbRg
bLibLsRgbLibRjbLcbRibLsbLhbRibLcbRjbRcRsmbLsbRibRgRsmbRgbLjbLobsbLgbLs
LsLgmbLgbRjbRcbLjbRcbRgbRgRsmbRgbRgbLgbRgRsmbLiLsbRsbRsbLgLsbLsbLsLsmb
LgLsbLsbLsbRgbLgbRsLgLsRsbLiRsbLibLsbLgRsbLsbLsbRjbLhbLgbLsbLsbLsbLgbL
gbLgbLsbLsbLsbLsbLsbLgRsbLgLsbLgLsbRsbLhRgbRgbRcbLgbRgbRgbRsbLjbRibLjb
RibRgbRgbLgbRibRibLobLgLsbRjbRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 11; Drug: NDMC 1 µM
bLibLibRhbRsbRgbRgbRgbRsbRsRsmbLgbRgbRgbRgbRgbRsbRsRsmbRgbLgRsbRgbRgbR
sLsbRgbLjLsmbLcbRjbRibRgRsRgmbRsbRsbRsRsmbRsbRgRsmbRsbRgRsmbRgRsmbRsbR
gbRgLsbRgbRsRsmbRsbRsbRgbRgRsmbRsbRsbRsbRgRsLsmbRsbRsRsmbRsbRgRsmbRgRs
mbRsbRsbRgRsmbRgbRgRsmbRgbLjbRibRgbRsRsmbRsRgbRgbLsLsmbRsRgRsRgmbRgbRs
RsRsmmbRgbLsbRgbRgbRgbRsbRgbRgbRsRsmbRgbRgbRgbRsbRsbRgbLcbLgLsbLgLsbLs
bLibLgbRsbLsbLiLgbLgLsbLsLsmbRsLsbLibRsRsmbRgbLibRhLsRibLjbLhbLgRsbRcb
LjbRjbRibLsbRgbRgbLsbRgbRgbRgLsbRgbLsbRgbRgbRgRsmbRgbRgbRgbRsbRsbRsbRg
bRsbRsbRsbRsbLsbRgbRgbRgbRsbRgbRsRsmbRsbRsLsbRsbRgbRgbLhbLibLsLsLgLsmb
LsbRsbLsbLgbLsbLgbsbRsbRsbLsbLgbLgLsbRsbRjbLibRjRsmbRcbRibLjbRgbRgRsmb
RgRsmbRgbRgbRsbRsbRsbRsbRgRsmbRgbsbRsbRsbRgbRgRsmbRsbRsbRsbRsbRgbRsbRg
bLsbRibRgRsmbRgRsmbRgLsbRsRsLsmbRgbRsbRsbRgbRgRsmbRgbRsbRsbRgbRgbRgbRs
RsmbRgLsbLgbRgbRgbRgbRgbLjbLibLsbLgbLgbLgLsbRsbRcbRgbRgbRgbRgbRgbRsbRg
bLgbRgbRgbLjbRibRgRsRsmmbRgbRgRsmbRgbRsbLsbRgbRgbRgRsmbRsbRgbRsRsmbRgR
smbRgbRgbRgbRsbRgbRgRsmbRsbRsbRsbRsbRsbRgbRgbRgbLibLcbRjbRhbLcbRcbRcLi
bRgbRgbRsbRgbRiLsbLjbLsbRhbLcbRibRiLsbRgbsbRgbRgbRgLsRsbRgbRgbRgbRgbRs
bRgbRgbRgLgbRgLsbRsLsbRsbRgbLsbRgRsmbRgRsmbRgbLsbRgbRgbRgbRsLsRsbRsRsm
bRgbRsRsmbRsRsmbRgLsRsbRgbRgbRsRsLsmbRsbRgLsRsbRgbRgbRgbRsbLsRsbsbRgbR
gbRgbRgLsbRsRsmbRgbLsRsbRgbRgbLjRgbRgbRsRsmbRgbRgRsmbRsbRsbRgbRgbLsbRg
RsmbRsLsbRgbRgbRsbRgbRgbRgbRgbRgbRsbRgbRgbRgbRsbRsbRgRsmbRsbRsbRgbLsRs
LsbRgbRsRsRgmbRsbLsRgLsbRgbRgbRgbRsbRgbRsbRsLsbRgbLjbRhRsmbLcLsmbRibRg
bRgbRgbRsbRsbRgRsmbRgbRgbRiRsmbRgbRsbLsbRgRsmbRgbRsbRsbRsbRgRsmbRgbRgb
RibLhbRiRsmbRibLjbRibRgbRgbLgLsbRgbRgbRjbLobLibRsbRcbRibLiLsbRgbRgbRsR
sRsmmbRsRsmbRsbLsbRgbRsRsmbRsbRsRsRgRsmmbRsbRgbRgbLjbLhbLcbRibLcbRibRi
bLibRjbRibRgbRgbLsbRgbRsRgLsRsLsbRgRsmbRgbLsRsRsmbRsbRgbRsLsbLsRsbRjbR
gLsbLibRhRsmbLibLcbRcbLjbLgLsbRjLsbRibLibRibRgbRsbRgbRgbRsbLsbRgbRsbRg
bRgLsbRgbLjLhbLcbRiLsbLjRsbLgLsbLsbRsRsmbRsbLibRjbRcRsmbLjbLibLsbLgbsb
LsRsbLsbLgbLsbLgbRcbRgbRgbRgbLsbRgbLsbLsbRgbRgRsmbRgbRibLgLsbRgbRgbRgb
RibRgbLsLsmbRsbRsLsRsRsRsmmbRgbRsbRsbRsbLsRsRsmbLsbRgLsbRgbRsRsmbRsbRg
RsmbRgbRsbRsRsmbRgLsbRsbRgbRgRgRgbRgRibRsbRsRsmbRsbRgRsRgmbRsbRsbRsRsm
bRgbRsbRsbRsbRgbLcbLibLgLsbLgbLgLsbsbRgbLgLsRsbLsbLsbLsLsmbLsbRsbLgbRg
bRibLjbLibRhbRgbRgRsmbRgbRgbRgbRsbRgRsmbRgbLsbRsbRgbRgLsbLjbRibRgbRsbR
sbRsRsmbRgRsmbRsRsmbRsRsRsmmbRgbRsRsmbRsbRsRsmbRgbRsRsmbRsbRsRsLsmbRgR
sRgRsRsRgRsmmmmbRgLsbLsbRgbRgbRsRsRsmmbRgLsbRsbRsbRsbRgLsbRsRsmbLsbRgb
RgRsmbRgbRgbRsbRgbLsLsmbRgbRgbRgbRgbRgbRgbRsbRsbRgbRgRsmbRgbRgRsRsRsmm
mbRsbRsbRgbRgLsbLjbLibLgbRhbLibLgbLgbRjbLibLgbLsbRjbRjbRibRgbLcbLjbRgb
RibRibsbRsRsmbRsbRsRsmbRsRsmbRgRsmbRgRsmbRgLsbRgbRgbRgRsmbRgbRgRsmbRgR
smbRgbRgbRgbRsLsbRibLcbRibRsbRgbRsbRgbRgbRsbRgRgRsRsmmbRgRsmbRgbRgRsmb
RgbRgbRgbRgbRgbRgbRgRsmbRgbRgLsbLebRgbRibRgRsmbRgbRsbRgbLgRgbRgbRgRsmb
RsbRsRgbRsbRsRsLsmbRgbRsLsbRgRsmbRsRsmbRgbRsRsmbRgRsmbRgRsmbRsbRgRsmbR
sRsmbRsRsmbRgRsmbRgbRgbRgRsmbRsRsmbRgbLjbLibRibRibRgbRgbLhbLiLsbLcbRib
RjbRgbRibLcbLibRgbRcbLhbLsbLsbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 12; Drug: NDMC 1 µM
bLgbRhbRibRibLiRsbRibLjbRcbRibRibRibLibRibRibRgbLgRsRsmbRibRsRsmbRibRi
bLgbRgbRgbLsbRsbRsRsmbRgbRgRgbRgbRgbRsbRgbRgbRgbRibRhRsmbLibRiLsbRibLi
LsbLgbRibRibRgbRsLsbRibLsbRsbRgbRgRsmbRsbRibLjbRcbLibLibRcbRsbRgbRsbRg
RsmbRgbRgLsbRsbRgbRsbLsRsRsmbRgRsmbRgbRiLsbRgbRgRsRsmmbRibRgbRiRsmbRgb
RsbRibRgbRgLsbRibLibRiRsmbRiRsmbLibRibRgRsmbRsbRgbRgRsmbRsRsmbRgbRgbRg
RgbRgbRgbRsbRgRsmbRgbRibLcRsbRcbRhbRibLhbRibLcbRhbRibRcbRcbRibRibRsRib
LjbsbRibLgLsbLjbLhRsbLgRsbLsbLjbRobsbLcbRgLsbLhbRcRsmbRcRsRsmmbRsbRibL
jRsbLcbRcbRibRjbLsbLiRsLsRsbRsbRsbLjRsbRhRsmbLjbRibRsbRgbRiRsmbLgbLsbR
hbLibRcbLgbLjbLcbRsRjbRcbRebLjLsmbRjbRibRiRsRsmmbLsRsbRgRsmbRsbRsbRibL
gbRhbRibLsLsLsmmbRibLibRibRebLjbRhRsmbLgLsLsmbRsLsbLibsbLgbRjbRsbRibRc
RsLgLsmbRgbRibRsbRiRsmbRibLgbRibRcbLibRsRsmbRibRgbRcbLibRhbLiLsbRibLgb
RibRibLjbRcbRobRibRhbRgLsbRsbRsbRgRsmbLsbRgbLjbRhbLgbRgbRgbRgbLgbRibLc
bLgbLgbReRsmbRsbRjbsbsbLsRsbRibLjbRcbRiRsmbLiLsbRobRcbRgbRiLsbLgbRcLsb
LibRcbLibRibLgbLjLsmbRhbRsbLsbRgbRgRsmbRsbRgLsbRibRhbLhbRibLsbLgbLsbRh
RsmbRsbRibRibLjbLcbRjbRcbLibRibRgbLsbRibRcbRcLsbRibRcbLgbRcbRgRsmbLiLs
bLhLsbRsbLgbLjbLibLibRjbLsRsbLiRsbLgbRiRsmbLibLsbLgbLsbLgbLgbLgbLibRiR
smbLibRgbLibLsbLgbRjRsmbLgbRsbLibLsbLibLgbLibRjbRhbLsbLsRsbRibLsbRgbRg
LsbLsRsbRgbRsbRgbRsLsbRsLsbRibRoRsmbLgbLibLgbRgbRjbRiRsmbLsRgbRibLjbLc
bLibRgbLibLgbLgLsbLgbLsbLgbLsbLgLsbLgbLgLsbLgbRibLgbsbLjbLibRcbRcRsmbL
sbRgRsmbRgbRsRsmbRsRsmbRgbRgbRsbRgRsmbRsbRsbRgbRsbRsRsmbRgbRibRobRcbRi
RsmbRgbLsRsbRsbRsRsmbLsbLsbRgRsmbRibRgRsmbRgbRsbRsbRgbRgRsmbRgbRgbRgbR
gRsmbRgbRgbRibLhLsLsmbRibLgbRgbRibRibRsbRsRsmbRsbRgRsmbRsbLsRgbRsbRgRg
bRgbRgbLjbLhbLibRjbRibRsbRgRsmbRsRsmbRsRsmbRgbRgbRgRgRgbRgbRgbRgbRibLi
bRgLsbRsLsbRibRiRsmbRgbRgbRgbRgRsmbRgbRgbRsbRsbRgbRibRgbRibLgbRibRsRsR
iRsmmbRgbRgbRgbRgbRgRsmbRgRsmbRsbRsbRsbLsRsbRsbRgRsRsmmbRgbRgRsRgmbRgb
RgRsmbRgbRgbRsRsmbRiLsbLcbRhbLibLhbLiRsbLcbLhbRcbLjbRobRibLibRibLibRiR
smbRiRsmbRsRsmbRsLsbRgbRgbRgbRsbRgRsmbLgRsbRgbRsbRgbRgbRgbRsbRsRsmbRgR
smbRsbRgbRsbRgbRgbRgbRgbRibLibLgbRiRsmbRsbLsbRjRsmbRibRgbLibRcLsbRgbRg
bRsbRsRsRgmbRgRsmbRgRsmbRgbRsbRsbRgRibRgbRsRibRgRsmbRgLsbRsbRgRsmbLgbR
iLsbRsbRiRsmbLgLcbRhbRsbLhLsbRjbLjbLibRibRhLsbRgbRsbRgRsmbRgRsRgRsRimm
bRgRsmbRgRgLsbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 13; Drug: NDMC 3 µM
bLsbLgbLsLsmbLsLsmbLgLsLsmbLsbLgLsbLgbLgbLgbRcbRibLcbRcbRgbLjbLcbRcbRo
LsbRoLsbRcbRgRsmbRgbRgbRsbRgRsmbRgbRsRgbRgRsmbsbLjbLobLibRcbLcbLiRgLsb
LibRjbRcbRsbRiLsbLgbRiLsbRgbLgbRgLgbLcbLgRsbLsbLibLsbLsLsmbLgbLgbLsbRs
bLgRsbLsRsbLsbLgLsbRsRsmbLgbLgLsLsmbLgbLsbLsbLgbLsbLgLsbLsbLgLsbLgbLsb
LgbLgbRjbRobLcbLhbLcbLgbLibRibLhbLibRcbRcbLibRcLsbRibRgbLebLcbRhLsbLcb
RjbLgbLibLsbLsLsmbLsLgbLsbLgbLgbLgbLhRsRibLcbLsbLgbLsbLgbLsLsmbLgbRsbL
gbLgLsbLgbLgbLgbLibRibLcbRcbRcbRcbLiRsbRibRcbLgbRibLgbRibRgbRsbRgLsbRg
bLcbLibRgbLhbRhbLcRsbRsbLgbLibLgRsbLgbLiLsLsmbRgbLhRibLibLsbLgbLgbLsbL
sbLgbLsbLgbLgbLgbLgRsbLgbLsbLsbLgbLiLsbRgbRcbLoLsmbLibRsbLgbLsLsmbLgbL
sbLgbLibRsRsmbLiRsbRgbLiLsRsbLgbLsbLsbLgbLgbLgbLgRsbRjbRoRsRsmmbLobLhb
RgbLhbRhRsmbLcbRibLcbRibLibRgbLgbRgbLhbLsbRsbLibLgLsbLgbLsbLgLsLsmbLgb
LgbLsbLsLsmbRsbRjRcbRobRoRsmbRibRcRsmbLsbRgbLsLsRsLimbLoRsRsmbRibLcbRh
bLcbRsbLcbRibRsbLcbLcbLgbLgbRhbRibLibRjRsmbRcbRcbRcLsRsbLgbRhbLobLhbRi
bLibLgbLsbLgbLsbLsbLgbLsbLgbLsbLsbLgbLgLsbLsbLsbLsbLsbLsLsmbLgbLsbLgbL
sbLgLsbRjLsbRoLsbLjbLcbRgbLcbRcbRcbRcbLhbRibRibRibRcbRhbLgbLibLgbLsbLs
bLgbRsbLgbLjbsbLsRsLsbLgbLsbLsbLgLsLsmbLgbLibRjbLiLsbLiLsbLsLsmbLsbLgb
LgbLsbLgLsbRcLsbRcbRiRsRsLsmmbRcbRcbRgbRcbLcLsmbLcRsbRcbRcbLibLcbLjLsL
smmbLobRgLsbRibLibLobLibRjbLcbRibLgLsbLgbLsbLsbLgbLgLsbRsbLgbLgLsbLsbL
sbLsbLgbRsbLibRgbLgbLsLsLsmmbLsbLgbLsbLgbLgbLgbLsbLsbLgbRcbRcbRcbRcbRc
bLgbLibRcbRhbLibRibLgbRiLsbLjbRibRiLsbLcbLobRjbRcRsmbLebLcbRibLcbLsbLg
bLsbLsbLgbRgbLgLsbLsbLsRsbLiRsbLsbLsbLsbLsbLgRsbLsbRsbLibRcbRgbRoRobRc
bRgLsbLhLsLsLcmbLibRgbLibLsLsmbLsbLsbLgbLgbLsbLgbLsLsmbRsRsmbLsLsmbLgL
sRsbRsbLgbLgRsbRjbRcRsmbLcbRoRcbRcbRibLgRsbRibLsbRibRgbLsLsLsmmbLgbRib
RgbLgbRgbRgbLcbLcRsbRcbLobRcbLcbRgbLgbLgbRsbLgbLsbLgLsbLgbLgbRjbRcbRhb
RgbRcbRsbLibLibRibRhbLcRsbLibRsbLgbLgLsLsmbRsLsbLgbLsbLsbLgRsLsbLgbLsR
sbLgLsbLsRsbLsbLgLsbLgLsRsLsbLibLibRjbRcRcbLgbLjbRcRsmbLgbRiRsmbRibRsL
gbRibRgLsbLibLibLibRsbLibLsLsmbLsLsmbLsbLgbLsLsRsmbLsLsLsmmbLgbLsbLgbL
hLsbRhbLcLsmbRcbRobRcbLibLgRsLsbLgbLgbLgbLgbRsbRgbLibRcbLcbRcbLcRibLcb
LgbLgbLgbLsbLsLsmbLsbLgbRsLsRsbRsbLgRsbRsLsbLgbRsbRsLsbLiLsbRcbRcbLhbL
hbRhbRhbLjbLhbLgbRcRsmbRhbLhbRoLsbLgbRibRgbRibLiLsbLsbRgbRgbRgbLsbLcbL
cRsbRsbRgRsmbLcbRebRibRhLsbLibLiRsbLibRsRsmbLibLsRsbLgbLsbRgbLsbLiLsbR
jbLhbLibLgLgbLsbLibLsbLgLsbLgbLsbLgbRcbRoLsLsmbRhbLcbLcbRibLcbRibLcbRh
bRhbLcbLibRgLsbLgLsbRsbLgbLhRsbRgbRjbLobRibLcbRjbLibLgbLsLsRsmbLgbLgLs
bRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 14; Drug: NDMC 3 µM
bRiLsbLgbLgbLgbLibRcbRcbLjbLcbLcbLhbLhbRgbLgbRibRgLsRsbRgbLjbRibRibLgb
RsbRgbRsLsbRgbRiRsmbLgbRjbsbRgbRsbRsbRsbRgRsRsmmbLsbRgbRgRsmbRgbLoLcRi
RsmbLgbLiRsbRjbLibLsbLsbRcbLibRcbLgbRgbRsLsbRgLsbRsbRgRsmbLgbRibLibsbL
ebRobLsbRobLgLsbLgbRibRgbRsbRgRsmbRsbRhLsbLgbLibRibRgRsmbRgbRibRgbLgbR
ibLsbRgbRsbRgRsmbRsbLsbRsRibRgRsmbRgbLsbRgbRgbRsbRgbRiRsmbRsbRgbLsbRgb
RgRsmbLsRsbRsRsmbLsbRiRsmbLgbRsbRiRsmbLibRibLsbRgbRiRsmbLcbRjbRobLgbRc
bLgbLibLcbLibRcbRcLsbLibLcbRobRiRsmbLjbRgbRibRgbRsbRgbRsbRgbRgbRgbRsbR
gRsmbRgRsmbLjbRcbLebLcLsmbRsbLgbLgRsbLsbRjbLsbRcbLgbRibRgbRgbRsbRgbRgb
RsbRgbLjbLibRcbLcbLibRcbRsbRgLsbLsRsbRgbRgbRgbRsbRsbRgbRsbRgbRsLsbRsbR
ibLibRibLjbRgbRibRsbLsbRgRsmbRsbRsbRgRgbRibRsbRgbRgbLsbRgbLgbRibRsbRgb
RibLsbLsbRibLgbRiRsmbLgRgRsmbRgbLcbRhbRsbRsbRgbRgbRgRsmbRgbRgbRsbRgbRg
bRsbRiLsbLcbRcbLibLcbLgbRjbRobRgbRsbLjbLsbRcbLibRibRgbLsRsbRgbRgRsmbRg
bRsbRgbRgbRgbLsbRgLsbLgbRgbRibLjbRibLgbRgbRgbRsbRgbRgbLsbRgbLcbRibRcbL
ibLibLgbLsbLgbLgbLgbLobRgbLsbRhbRcbLibRgbLsbRgRibRgbLsbLjbRcbRsRsmbRgb
RgbRgbRsbRibRgbLgbLjbRhbLsbRgbRsRsmbRgbRibLjbLhLgbRcbRcbRibRcbLjbLibRs
bLibRgbLhbRibLibLsbLgbsbsbLgbLgbLhRcbRibRsbRcbLcbLjbLhbRibRjbRcbLcLsmb
LcRsbLhbLcbRibRibRgbRibRgbRsbRgbLsbRhbLhbLcbRhbRsbRcbLsbRsbLsRgbRgbRgb
RgRsmbRgbRgbRgbRsbRgbRsbRgRsmbRgbRgbRsbRgbRsbRsbRgbRsbRgbRgbLjbRibRgbL
cbRjbRsLsbLibLgbRjbLcbRjbRcbLjbRcbLsbRibRibLjbRcbLiLsbLjbLhbRjbRhbRgbR
gbRsbRsbRibLsbRgbRgbRsbRsbLjbRgbRgbLsbRgbRgbRsbRgbRibLsLsmbLsbRiRsmbLj
bLcbRsbRjbRobLgbRhbLgbRiRsLsmbLsbRgLsbRgbRgRsmbRsbRgbLgbRgbRsbRsRgLsbR
gbRgbRgbRgbRgbLgbRibRgbLsRsbRsbRgbRgbRsbRgbRgbRsbRgbLjbLjbLibLibRcLsbR
ibRiRsmbRgLgbRibLjbLsbRibLgbRibRgbLsbLsbRibRgbLgbLgbLhbLibRcbRcbRibLgb
RsbRhbLsbRgbLgbRgbLsbRgbLgbRsbRiRsmbLjbRcbLgbRsbRgbRgbRsRsmbRgbRgbRsbR
gbRsbRgbRsbRgbRsbRgbLgbRibLgbLjbRiRsmbRgbLhbRjbLjbRcbLibRiRsRsLsmmbLsb
RgbRgbRsbRibRgbRgRsmbRgbRgbLgbRibLcbRcbLibRcbLcLsmbLobRcbRcbLsbRsbRhbL
sbRibRgRsmbRgRsmbRgRsmbRsRsmbRgbRgbLsbRgRsmbRsRsmbRgbRsbRgbRsbRgbRsbRs
bRgRsmbRsRibRsbRibLgRsbRhRsRsmmbLgbLjbRcbRibLcbRibRcbLgbLgbLhbLgbLgbLg
bRjbRcbLgRsbLcbRoLsbRsbRiLgbRgRgbRibRgbRgRsmbRgbRgbLjbLeLsbRjbRibRsbRi
RsmbRgbRsbRibLgbRiLsbRgbLsbRgbRsRsmbRgbRgLsbRgbRgbRgbRgbRgRsmbRgbRgbRg
bRgbRsbRgbLhbLcbRcRsmbRibLibRcbLibLcbLibRjLsbRcRsmbRcbLsLsmbLgbRcbLhbR
cRsmbLibRcbLgbRiLsbRgRsmbRsRsmbRgbRgbRibRgbLhbLcbRhbRcbLjbsbLjbLibRjbR
cbRgRsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 15; Drug: NDMC 3 µM
bLgbLgbLgbRsbLgLsbLgbLgbLgbLgbLsbLgLsbLsbLgbLsLsmbLgbRsLsbLgbLgbLsbLgb
LgbLgbLsbLgLsbRsRsRsmmbRjbRhRibRiRhbLgbLibLgLsbRhbRcRsmbRibRhbRsbRgbRs
bRsbRibRgbRgbLjbRgbRsbLjbLhbLgbLgbLgbLgbLsbLsbLsbRsbLsLsmbLgbLgbLgbLgL
sbLgbLsbLgbLgLsbLgbLgbLgbLgbLgbLgbLsbLgLsbLgbLgRsbLgLsbLgbRjbRhbRsRibR
gLsbLcbLgLsbLgLsbRsbLsbsbLgbLgLsRsbLsLsmbLgbLgbLsRsbLgbLsbLgRsLsbLgbLg
bLsbLgbLgbLgLsbLgLsbLsbLsLsmbLgbLsbLgbLgRsbLgLsbRsbLgLsbLsbLgbRsLsbLgb
LgLsbLsLsmbLgbRsLsRsbLgbRsbLgbRsLsbLgbLgLsbLgbLgbLsLgbLgRsLsbLsLsmbLgb
LsbLgbLgbLgbLgbLgbLgbLgbsbLibRcbRcbRsRsmbRgbRiLsLsmbLcbLgbRsLgLsRgbLib
LsbLsbLgbLgbLgbLgLsLsmbLgbLgbLibLiLsbRibRibRjbRgbRgRsmbRgbRibRhbRibLib
LsbLgbRcRiRgbRgbRgRsmbRgbRgbRsbRsbLhbLibLsbLgbLgLsbLsbLgbLgLsbLsbsbLgb
LgbLsLsLsmmbLsLgbLsLsmbLgLsbLgbLgbLsLsmbLgbLsbLgLsbLgbLgbLgbLsbLsLgbLg
bLgbLgLsbLsLgbLgbLgbLgbRibRibRgRsmbRgbRgRsmbRgbRgbRgbRsbLoLsmbLcbLgbLg
LsbLgbLsRsbLgbLgLsbLgRsbLsbLgLsbRsLsbLgbLgbLgbLgbLgbRgbLgLsLsLgmbLsLsm
bLsbLgLsbLgbLgbLsLsmbLgbLgbLgbRjbLibRibLibLsLsmbLgbLsbLgbLgbLgbLsbLgbR
sbLgRsbLgLsLsmbLgbRgbLibLgbRgbLibRgbLgbLgbLgbLgbLgLsbLgLsbLsbLgLgLsbLg
LsbLgbLgLsbLsbLgbLgbRgRsmbLgbLsbLgbLsbLgbLgbLgbLsbLgbLgbLsLsmbLgbLibRj
bRibRibRgLsbRsbRsRgbRgbRibLgRsbRibRibLsbRgbRsbRgbRgbLsLsmbRibRcbRibLiL
sbLibRobLgbRibRgbRgbRgLsbRgLsbRgbLsbRibLjbLhbLgLgLsbLgbLibLgbRsLsbLgbL
gbLgbLsbLsbLgbLgbLgbRjbRhRibRgbRsbLsLsmbLibLgbLsbLgbRgLsbLgbLgLsbLgbLg
bLgbLsLsLsLsmmmbLgLsLsmbLgbLgbRsbLgbLgbLsbLgbLgbLgRsbLgbRcRiLsRsRgbRgb
RsbLjbLhRsbLjbLgbRsbLgbLgLsLsmbLsbLsLsRsmbLsbLsbLsbLgbLgbLgbLgbLgbRhbR
ibRgbRgbLsbLjbLcLsmbRgbLiLsbLgbLgbLgbLsbLsLsmbLgbLgbLsLsmbLgbLgbLgLsbR
gbLsLgbLsbLgbLgbRsLsLsRsmbLsbLgbLsLsmbLgbLgbLgbLsbLgbLgbRsLsLsmbLgbLgb
LgbLgRsbRjbLsRiRiLsRgbRgbRsbRsbRsbLsbRgbLjbLibLsLsmbLgbLgLsbLsLsRsmbLg
LsbLgLsbLsbLgbLsRsbLgLsbLgLsbLgLsbLgbLgbRjbRibRgbRgbLjbLgbLgLsbLsbLsbL
gLsbLgbLgRsbLgbLgLsLsmbRsbLgbLgbLsbLgbLsbLsLsmbLsLsmbLiLsbLgbLgbLgbLgb
LgbLgbLgbRsbLgLsbRsLsbLibLgLsbLsLsmbLsLsLsmmbLsbLgbLgbRsbLgbLgbRsbLgbL
gbLsbLgbLgbLsbLsLsmbLgbLgLsbLgbLsbLgbLgbLgbLgbLsbLgbLgbLgbLgLsbLsRsbLg
bLsbLgRsbLgLsbLsLsmbLsRsbLgbLgbLgbLgbRsbLgbLgbLsLsmbLgbLgbLgbRjbRsbLgb
RsbLgbLgLsbLsLsmbRsLgLsRsbLsbLgbRsLgbLgbLgbRsLsbLgLsbLgbLsbLgbLgbLibRg
bLibLsbLgRsbLgbLgbLibRgLsbRcbRibRgbRgbRgRsmbRsLsbRibLjbLibLibLgLsLsmbL
gbLgbLgbLgLsbLgbLsbLgbLsbLgbLsbLsLsmbLgLsbsbLgbLgLsbLgLsLsmbLsbLgLsLsm
bLgbLgbLgLsbLsLsmbLgbRsbLgbLsbLsLsmbLgbLgbLgLsLsmbLsbLgbLsRsbLsLsmbLgL
sbLgbLsbLgLsbLsLsmbLgbLsbLsbLgLsbLgbLgbLgbLsbLgLsbLsbLgbLsLsmbLgbLgbLg
bLgLsbLgLsbLgbLgbRsLsbLgbLgbLsbLgbLgbRjbRiRsmbRiRgbRgbRgbRgbRibLjRsbLi
bLibLgbLgbLgbLsbLgbLgRsbLsbLgbLgLsbLgbLgbLsbLsbLgLsbLgbLsLsmbLgbLgbLsb
LsbLgbLgbLgbLsbLsbLgRsbLgbLsbLgbLgbLsbLgLsLsmbLgbLgLsbLgLsbLsRsbLsbLsL
smbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 16; Drug: NDMC 3 µM
bRsbRgbRsbRibRgbRsbRsbRgbLhbLcbRsbLcbRobRcLhbLjbLhbRiRsmbRcbRibLiRsbRi
bLjbLibRobRcbLibRgbRibLsbRibRibLgbRibLsbRgbRgbRsbRsbRiRsmbLjbRcLsRsbLg
bRibRsbRsbRsRsmbRibRgbRsbRgbRgRsmbRsRsRgmbRgRgRgRsmbRgbRgbRiRsRsRgmmbR
gRsmbRgbRsbRgbLjbLcLsmbLhbRiLhbLibLibRgbRgbLcbLcbRibLhbRiRsmbLcbRgRsmb
LibLibRsbLibLsbLgbLgbRjbLibLcLsmbRjbLhbRjbLcRsbRsbLiLsbLgbLgbLsbLibRiR
smbRjbRgbRgbRsbRsRsmbRgbRgRibRgRsmbRgbRsbRibRgbRibRgbRgbLcbLhbRibLhLsb
RibLcbRibLhbRsRsmbLibLsbLsLsRsmbRsbRcbLjbRcbRibRsLsbRgbRsRsmbRgbRgbRgb
RgbRgbLgbLcbLhbRibLhLsbRsLsbLgLsbLgbLsbLgbLgLsbLsbLgbLgbLgbLgbLgbRcbLs
RcbLjbRcLsbLibLcbLgbLgbLsbLgLgbLiLsbLgLsbLibLgbRjbRcbLhbLcbRcbRhbRgbRg
bLsbRgbRsbRhbLiRsbRhbLibRcbLiRsbsbRcbLiLsbRcbLgbRgbRgbRibLsRsbRgbRgbRg
bRsbRgbRgbRcbLiRsbRibLjbLcbLhbRcbLcLsmbLsbLgbLgLsbLsbLgbLgbRsLhbRibLsR
sbLiLsbLgbLsbLsbLgLsLsmbLgbLsbLsbLgbRsbLgbLgLsbLsbRsbLsbLgbLsLsmbRgbRc
bLsRsbRgRsmbRsbLcbLgbLibLsbLsbLgbLgLsbRsbLsbLgbRsbLsLsmbLgbLsbRjbRcbLc
bRjbLsRhRsmbRibLsbRgbLsbRgbLcbLcRsbRgbRibRgbRsRsmbRsRgbRgbRgRgbLsRsbRs
bLcbLibRjbLhLsbRjbLcbRsLsRsbLibRgbLgbLsbLsbLsbLsLsRsmbLgbLgbLsbLsLsmbL
sbLsbLgbLgbRsbLibLgRsbLsLsmbLsbLgbRjbRcbRgbRsbRgbRgbRsbRsbLcbLibLgbRgb
LibRjbLcbRibLcbRcbRcbRgbRsbRsbRgbRgbRsbRsbRgbRsbLsbRgbRgbLsbRgbRgbRsLs
bLsbLcbLgbLgbLgbRgbLibLsbLgbLsLsmbRsLsLsmbLgbLgbLgLsbLsLsmbLgbRjbLcLsm
bRibLhLsbRjbLibRsbLgbLibLgbLhbRibRsbLiLsbLgbLsbLsbRsbLibLgRsbRcRsmbRob
LebRibRgRsmbRibLcbRcbLibRcbRhbLhbRcbLgbLhbRjbRibRjbRibRgbLsbRgbLjbRibR
jLsbLjbRhLsbLibRcRsmbLibRcbLgbRgRsmbRsbRgbLsbRibLibRcRsmbLibRcbLgbRibR
sbRhbLjLsmbRibRibRgbLibRcbLibRcbLsbLcbLsbLibLgbLsbLsbLgbLgbRiRsRsmmbRg
RsmbRiRsmbRgbLobLibLsbRsLsbLgbLgbLgbLsbLsRsbLgbLsbLgbRjbRhbLcbLcRsbRcR
smbLcLsmbLibRgbLibRjbLiRsbRsLsbLgbLsbLgbRsbLgbRgbLibRgbLgbLgbLgbRjbLcb
RcbRcLsbLjbLibRjbsbRcbLibRgbRgbRsbLsRsbLebLgbLsbLgLsbLgbLgbLsbLsbRsbLg
bLgbRsbLgbLgbLcRsbRgbRsbLibRgbRobRiLsbLgbRiRsmbLjbLhbLibLgbLsLsmbLsbLg
bLsbLsbLsbLgbLsbLgbLsbLsbLsbLhbLgbLsbLibLibRcbRhbLgbRibRsbRgbLcbLgbLgb
LgbLsbLgbLsbLsbLsbLgbLsbLgbRgbLgLsLsRgmbRcbRibLcbRcbLjbRjbLgbLibLjbLgb
LgbLsbLsbRsbLgbRjbLgbLgbLgbLsbLgbLsbRgRsmbRcbRibLjLsmbRhbLjbRcbLibRebR
sbRsbRsbRsbLhbLgbRsbLibRjbLhbRjLsbLibLsLsmbLgbLsbLsbLsbLsLsRsmbRsbLgbL
sbLsLgbRsbRhbRibLcbRsbRsbRgbLobLibRcRsmbLibLibLibRibLhbRgbLgbsbLgbLsbL
sbLsbLgLsbLiRsbRgRsmbRjbRsRibLjbRibRsbRgRsmbLsbRsbRgbRsbRsbRsbRsRsmbRs
RsmbRgbRgbRgbRsbRgRsmbRgbLgbRgRsmbRsRsRsLsRsmmbRgbRgbRgbRgbRsRsRsmmbRg
RsRsLsmmbRibLjbLcRsbLgbLsbLiLsbLsbRsbRsLgbLgbRcbRgbRgbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 17; Drug: NDMC 3 µM
bRgbLsbRgbRgbLgbRibLjbRgbRgbLjbRebLjbRhbLibRsbLhbLgbLsbLsbLjbRjbLibRsb
RsbRsbLjbRsbLgbLsLsmbLsLsmbLgbLgbLgbLgbRjbLibLsbRgbLsbLgbRsbLgbLgRsbRs
bRebRhbLgbRgbRgRsmbLsbRgbLsLsmbRsbRgbRsRsmbRsRsmbRsbRsbRsbRgbRgbRgbRgb
RgbRgbRgRsmbRsbRsbRsbRgRsmbRsbRsbRsRsmbRsbRsbRgbRgbRgbRgbRgRsmbRsbRsbR
gbRsbRgRsmbRsbRsbRsbLsRsbRsbRgbRsbRgbRsbRsbRgbRgbRsbRgbRsbRgbRsbRgLsbR
sbRgbRsbRsRgbRsbRgbLsbRgbRsRsmbRsbRsRsmbRsbRgbRsbRgbRgbRgbRgbRgbRgbRsb
RsbRgbRsbRgbRgbRsRsmbRgbRgbRgbRgbLsbRgbRsbRsRsmbRsbRsLsbRgbRsbRsbRgbRs
bRgbRsbRgbLcRsbLcbRgbLhbRhbLjbLibRhRsmbRjbLcbRcbRcbLgRsbLsbLjbRibLjbRc
bLiRsbLsbRcbLibLsbRcbLgLsbLsbRibLjLsmbRcbLgbRgbLsbLsbLgbLhbLgbRibLibRs
RsRsmmbRjbRibLsRsRjRsmbLibRebLhbLgbLjbRoLsRsbLgbLgbLsbRgbRjbRsRebLhLsb
LjbLibRcbRcbLibRcbLgbLibLhbLgbLsbLgRsbRsbLgbRjbRcbRgLsRsbRgbRsbRsbRsbR
gbRgbRsbRsbRsbRgbRgbRgbRsbRsbRjLsbLsbLsbRcbLgbRibRiRsmbLsbLgbLjbLibLgb
LgbRcbLcbLibRsbRibRibLjbRibLsRsbRibLsRsbRsbRgbRgbRsbRgbRgbRgLsbRgbRgbR
gbRsRsmbRsRsmbRgbRgbRgbRgRsmbRsbRgRsmbRgbRgbRsbRsbRsLsbRgbRsbRgRsLsRsm
bRsbRsbRgbRsbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbLsbRgbRgbRibLjbRibLjRsbL
ibLgbLgbLibRibLhbRebRcbLiLsbLjLsmbLgbLsbLgbLgbRcRsmbLsbRibRhLgbLsbLcbL
ibRcbRcbRcRsmbLibLgbLgbLgbLsbLgbRsbLsbLsbLgbLiRsbRebRcbLgbLjbLgbLiLsbL
gbRebLjbRcbLsbLsbLjbRhbRibLgbRibLjbRgbRgbLsbRiRsmbLgbRgRsmbRgbRsbRgbRs
bRgbRgbRsbLjRsbRgbRgbLsbLcbLsbLgbLibRcbRgbRibLjbLcbLhbLiLsbLgbLgLsbLgb
LgbLibLgbRibRgbRiRsmbRibLgbRsbRhbLibRgbRgbRgbLjbRcbRcbLjLsLsmmbLibLibL
gbRgbRhbLjbRgbRibRgbLjbLebLjLsmbRhRsmbRcbLjbRibRcLsbLibLsbLgbLsbLsbLjR
sRsmbLsRsbLgbRcbRgbRgRsmbLgbRibRsbRsbRsbRgLsbRgRsmbRsRsmbRsbRsbRiLsLsm
bLibRgbRsbRgbLhbRjRgbRgbRsbRsbRgbRgbLsbLsRgbRsbRiLsbLgbRibRsRsmbLgbRgR
smbRsbRsbRgbRsbRsbRgbRgbRgbRgbRsRsmbRgbRgbRsbRsbRsbRsLsbRgRsmbRsbRgRsm
bRsRsmbRsbRgRsmbLsRsbRibRsbRgRsmbRgbRsbRsbRgbRgbRsbRgbRgbRsbRgbRsRgRsm
bRgbRgbRgbRgbRsRsmbRgbRgbRgbRgRsmbRgbRsbRsbRsbRgbRsbRgRsmbRgRsmbLsRsbR
ibLjbRibLjbRibRibRsRsmbRsbRsbRsbLjbLibLgbLgbLgbLgbRjbRhbRgRsmbRgRsmbRg
bRsbRgbRgbRgRgbRibRsRsmbRsRsLsmbLsbRiRsmbRgRsmbRsbRgbRgRsmbRgbRsbRsRsm
bRgRgRgRsRsRgRsmmmbRgbRgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 18; Drug: NDMC 3 µM
bRgbLibRjbLiLsbRjbLgbLgbLgbLgLgbLsbLsbLjbLsLsmbLsbLsbLibRsbLgbRsbLgLsb
LsLsmbLgbLgLsLgbLgLiLsLibLibLgbLgbLgbLgbRjbRcbRibLcbLcbRjbRhbRiLsRsbRg
bLsbRsbRsbLsLcbRsbLiRsbLgLsbRsbLgbLsbLgbLgbLgbLgbLsbLgRsLsbLgbLsbLgbLg
LsbLibLgbLibLgbLgbLsbRcbRcbLibRhbRibLjbLobRibLcbRsbRhbRibRgbLebLhbRjbL
cbRibLgbRsbLiLsbRsbLibRjbLhbRgbLibRsbLgbRgbLibLibLhbLcbLhbLiLsbLgbLsbL
ibRobRjbRcbRibLibLjbLibRsRsmbLgbLgbLgbLgbRcbRibRgbLsbLjbRsLsbRibRibLcb
LibLibRgbLibRgbLgbLgLsbLsbLgbLsLsmbLsbLgbLgbRgbLibLgbLsbLsbLgbLgbLsbLg
bLsbLgbRcRsmbRibRgbRiLsbLcbLcbRsRsmbLibRgbLibRgLsbLibLgbLgbLgbLgbLsRcR
ibRgbRsbRgbRibRgbLibLhbLibRgLsbLcbRibLhbRgbLsbLsbLgbLgbLsbLgbLgbLgRsbL
gbLgRsbRgbLiLsbLsbLsbLgLsbLgLsLgbLgbLgbLgbLsbLsbLsbLgbLibRjbLgbLjbLibR
cbRgbRsbRsbRgbRiLsbLcbLcbLiLsbRgLsbLibLgbRgLsbLibRsbLgbRsLsbLgbLgbRgbL
ibRsbLgLsbLgLsbLgbLgbLgLibLgRsbLgbLsbLgbLgbRgbRcRsmbRibLebLcbRiLsbLibR
jbLcbRibLgbLibLobRibRibRibLibRgLsbLibLsbLsLgLsbLgbLhbRgbLibRgLsbLiRsbR
jbLibRsLsbLgbRsbLgbLsbLgbRsLsbLgLsRsbRsRsmbLibRgLsbLibLgbLgbLgLsbLgbLs
bLgbLsbRsbLgRsbRjbRcbLcbLebRibLsLsmbLgbRsRsmbLgLsLsmbLgbLibLgbLsbRgbLh
RsbRgbLsbLiLsbLobRcbRjbRibRsRibRsbRgbLgbLcLsmbLibRgbLibLgbRgbLgbLgbRgb
LgbLgbRcbRgRsmbRgLsbLgbRibRhRsmbLhbRhRsmbRgLsbRsRsmbRibLcLsmbLsbRgbLcL
smbRjbRjbRgbLsLsmbRgRsmbRibLcbLcbRjbLcbLibRgbLiLsbsbRsbLgLsbLsbLsLsmbL
gbLsbLgbLgbLgbLsbLgbRgbLgbRjbLgLsbLgbRcbLcbLcbRibRiRsmbRiRsmbRgbLsbRsb
RgbRgbLebLcbLsbRibLibLibRibRjbRgbRgbRgbRcbLcbLibRibRjRsmbRibLjbLgbLgbL
sbRcbLebLsLsmbLgbLsLsmbLsLsmbLgbLgLgbLsLsmbLgbLsbLsbLsbLgLsbLgbLgbRibL
ibLgbRjbLhbLgLsLsmbLibRibLgbLsLsmbLsbLgbLgbLibRjbRcbRibRiRsmbRsbRgbsbL
cbLibRgLsbLgLsbRsRsmbLsLsmbRhbRsRcbLibLhbLgbLibRgbLgbsbLsbLjbLsbLsbRsb
sbLgbLgbLsbLgLsLgLgLsbLgbLgbLgbLgbRgbLgbRebRibRgLsbRgbRcbLhbLhLsbLibLi
bRjbRiRsmbRibRgbLcbLgbRsLsbLgRsbLgbLgbLsbLsbLiLsbLgLiLsbLgbLsbRsbLgLsb
LibRhbLhbRibLgbRsbLsbLibRibRoLsbRcbRcbRsbRibLsRhbRgbRgbLobLcbRiRsmbRiR
smbRibRsbRibLjbLcbLsLsmbLiLsRgbRibRgbRgbLsRsbRgbRibRibLibLcbLibRsRibRs
RibLcbLsLibRgbLibsbsbLgLsbLsbLgbLgLgbLgLsbLsbLsbLsbLsbLsbRsbLgbLsbLgLs
bLsbRjbRibRibLhbLjbLibLsLsmbRsbRibRgbRgbLcbLsbLibLgbLsbLsLsmbLgbLsLsmb
LgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 19; Drug: NDMC 10 µM
bLibRhbRobRgbLcbRsbRsbLobLibRgbLhbRiLsbLcRsbLcbRsbLhbLgLsRsbLgbLsbLsLi
RsLgLgLeLeLeLiLsbLgbLgbLiLgLsLiLsLgLiLsLibLeLiLhLeLeLsLiLsLiLebLiLgLiL
sbLiLsLeLeLiLsbLgbLgbLgbLibRebRcbRiRsmbRibRhbLgbRibRibLcbLcbRjRsmbLcbR
cbRcRsmbRcbRcbRiRsmbLcbRibRcbRcbLcbRhbRcLsbRcbRibRibRhbLjbRibRjbLjbLcb
LcbRgbRgbRjbLcbLcbRhLsbRhbRcbLiLsbLgLsbRibRibLsbRhLsbRgLsbLgbRcRsmbLib
RibLsLsmbRibRiLsbLhbLcbLibRjbRhbRibRgLsbRibLhbLcbLiRsbLiRsbLcLsmbRsbRi
bRgbRgbRibRgbLgbRcbRgLsbRiLsbRgLsbRcbRgbRibLhbLibLgbLibLcbLibRibRibLgb
RgRsmbRgbRgbRsbRibRsbRgbLhbLcbLibLibLibRjbLibRsbLibLgLsbLgbLgbLsLsmbLg
LeLibLgbLibRgbLgbLgbLgbLgbRsLsbLibRcbRcbRcbLhbRcbRsRhbLhbLibRibRibRibR
ibRibLibLiLsbRgbRgbRjbLjbLcbRcbLcbLsLsmbRsLgbLgbLsLsmbLgLgLsLgbLgLsbLi
bLiRsbRgbLgbLibLhbRibRiLsbRibLjbLcLsmbLcLsmbRibRibRibRgbRsbRiLsLsmbLgb
RgbLcbRgRsmbLobLcbRibLsRsbLibLgLsbLgbLsbLsbLgLsRsbLgbLgbLsbLiLsbLgbLib
LsbRgbLibRgbLibLgbLgLsbLsbLsbLsbLsbLgbLgbLgLsRsbLsbLibLgLiLhLeLsLgLeLh
LiLiLsLiLsLsLgLeLeLsLgLsmbLgLibLiLsbLgbLgbLgbLiRsLcRsbLibLibLgbsbLjbRj
bRcbRibLibRibLhbRibLcbLcbRgbRjbLhbLhbRibRhbRcbLiLsbLhbRhbRibLsbRiLsbRc
bRsbRhbLjbLgLsbLgbRjRhLsLsmbRgbRsbRgbRsbRgbRgLsbLgbLcbLiRsbLgbRibRcbRi
bRibRcbRibRjbRibRsbRgbRsbLibLgbLgbLsbLgbRsLsbLgLgLgLsLsLgLiLeLsLiLeLsL
gmbLibLgbLiRsbRibRhbRibRiLsbLcbLcbLibRgbLibLibRgbRjbLhbRcbRcLsbLsbLgbL
ibLhbRhRsmbRobRgbRcbRibRgbRibRibLsbRgbRiLsbLibRgbRhbLjbLhbLibRjbRcbRgb
RgbRsbLsbLcbRcbRjbLcbRibLsbLibLgbLgLsLgLsLgbLgLiLsbLgbLgLgbLsLeLgbLgLs
bLgbLgbLgbLibRoRebLcbRjbLibLsRgbLibLsbLsbLgLsLsmbLsbLibLgLsbLgLsLgLsbL
sLsmbLsbRsbLibRjbLgbLgLsLsmbLgLsLsLhmbLebLsLgLiLsLsLiLsLgmbLeLiLsbLgbR
jbRgbRcbRcbLcbLcbRcbRebRsbLhbLiLsbLibRhbRcbLsbRibLcbLibRgbLibRgbLoLsmb
RibRcRsmbRibRsLsbRcbRibRibRibLhbLibLgbLibLgbRsbLibLsLsLiLiLsmbLibLgLsb
LgLsbLgLsbLsLiLgLiLiLiLibLgbLgbLibRjbLiRsbRgbRiLsbLibLibRcbLcbRoRsmbRc
bLgLsbRcbRiRsmbRhRsmbRibLgbRsLcbLhbRcbRcbRgbRgbRgbLgbRibLcbRjLsbRcbLib
RgbRiLsbRibRcbRcLsbRcLsRsbRibRgbRgbRgbLjbRcbRgbRsbRsbRgbLsbRibRgbLjbLj
bLibLgLsbLsLsRgmbRjbLibLgLsLgLgLeLeLiLeLiLsbLgbLgbLgbLgLiLsLiLhLiLeLeL
eLsbLgbRjbRebRhbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 20; Drug: NDMC 10 µM
bLhbRhbRsRjbLcbLcbRgbRibRiRsmbRibLcbRcbLcbLgbLgRgbLgbLsbLgbLsbLsbLgbLs
RsbLgLsbLsLsmbLgbLgbLsLsmbLgLsbLsbLsbLgbLgRsbLgbLsRsRgbLgbRsbLiLsbRcLs
bLcbLgbLsbLgbLsbLsbLsbRsRsmbLibRgbLiRsLsbLgbLgLsbLcRsbRsLsLsRsmbLsbLgb
LsbLgbLgbRjbLibLsbRsLsbLibLsbLibLsbRjbRcbRcLsbRibRibRibLsLsmbRgbRibRib
LjbRhbLjbRoLsbRgbRgbLhbRobLhLsbRcbRhbRcbRgbRibLcbLgbLgLsbLsbLsbLsLsmbL
sbLgbLgbRsRhbRcLsLsmbRiLsbLibLcbRgbLibLgbRsbLgbLsbLsbLsbLgbLsLsmbLsbLh
bRiRsmbRhbRiRsmbRhRsmbLibRgRsmbRibLcbLcbRgbLgRsbLgbLsbLgbLsbLsLsmbLgbL
gbLgbLsbLgRsbLsbLgbRjLsbLibRsbLgbLgbRibLibLgbRgbLhbRgbLgbLibRjbLcbRibL
ibRgbLhRsbRgbLibLgbRsLsRsbLgbRsLsbLibRjbLibRjbLcbRibLobRgLsbLibRhbRobL
hbLiLsbRcbLjbRoLsbLcbLibLibLsbLsbLgbLgLsbLgbLsbLgbLgLsbLsbLibLgbRgbRgb
RjbRibRibRibRhLsbRhRsmbRcbRcbRgRgbLiLsLsmbLgbLibLsLsmbLgRsLsbLsbLsbLgR
sbLgLsbLgbLgbLgLsbRjbLcbRibLcRsbRgbLibRibLcRsbRibRjbLcbLibRgbLibRsbLgb
RsbLibRjbLiLsbLsbLgbRsLsbLgbLgbLgbLgLsbLgbLsbLsbLgbLgbLsbRsbLgbLgbRgbL
iRsbRjbRhbRibLcbRoLhLsbLcbLibLgbRgbLcbLgRsbLsbRgLsbLibRjbRhLsbLjLsmbLi
bLsbLgbRgbLgbLsbLsbLsbLibRgLsbLibLibLsbLsbLgbLgbRibRhRsmbRhbLcbRhbLcbR
cbLobLgbLgbRgLsbLibLsbLgbLsbRsbLgbLgbRcbRhLsbLibRcbLcbRibRibsbRibRcbLh
bRibRiRsmbLhLsbRjbRiLsbLjbLcbRjLsbRibLcbLibRgLsbLiLsLsRsRsmmbRsbLgbLsb
LgbLgbLsbLgbLgbLgLsbLgbLjRsbRjbLibRjbLibRjbLibRibRcbRibRsRsmbRgbRcbRib
RsbRgbLhbLibRgbLhbRgbLgbLiLsbLsbLsbLgLsbLsLgbRiLsbLibRibLhRsbLgbRgLsbL
hRsbRibRjbLjbRcbRibRiLsbRcbLibLibRibRiLsbLsbRibRsbRsbRobRgbLgbRibLjbRh
bLibRcRsmbLcbRcbLsLcbLoLsmbRgRsmbRibRgbRsRiRsmbLcbRcbRgbRgbRsLsbRsbRgb
RgbRgbRgbRhbLcLsmbLhbLibLsbLibRjbLibLgLsbLgLsbLsbLsbLiLsbLibLhbLibRsbR
ibRsbRgbRsbRibRsbRgbLsbRgbRgbLjRsbRcLsLsmbLebLcRsbLiRsbRgbLgbLiLsbRcbR
gbRgbRsbRgbRgbRgbLgbRgbRgbRgLsbRgLsbRgbLibRibRsbRgbRgRsmbRsbRiRsmbLcbR
cbLjbLcbRgbLibLgbLsLsmbLsbLsbLgbLsRsbLgLsbLsbLsbLgLsbLibRgbLibLiLsbRcb
LcbLibRibLibLhbLibRibRibLhbsbLibRsbLgbLgbLsbLgbLgbLgLsbLgbLsbLgbLsLsmb
LgbLgbLgLsbLgbLgbLsbLgbLgbRjbLibLgbLgbLsbRgbRjbRjbRibLsbRgbRobRiLsbRhb
RhbLcbRobRibRgRsmbLjbRhbRibRgbLebRjbRiLsbLjbRibLjbLcLsmbLgbRgbLiRsbLsb
LgbLsbLsbLgbLsbLsLsmbLgbRgbLgbLgbLsbLgbLgbLgbRsLsbLgbLsbLgRsbRcRsmbLjb
LcbRobRhLsbRcbRibRgbRiLsbRibRibLgbLcbLgbLsbLgbLsbLgLsbLsbLsbLgbLgbLsbL
gRsbRgbLibRhbRibLjbRcbRsbRgbRibLhRsbRcbRibRibLgRsbRiLsRsbRsRibRhLsLsmb
LibRcbLjRsbRcbLhbRcbLjbRhbRibLhbLcLsmbRibLgbLgLsbLsbLgbLsbLsbLsbLgLsbL
sbLibRibLibLgbLsbLsbLgbRgbLibRgRsmbLiRsbRgbLibRgbLgbLgbLsbLsbLsLsmbLsb
LsbLgbLgbLsbLgbRgbLgbRgbLibRgLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 21; Drug: NDMC 10 µM
bRsbRibRgbRibLibLgbRsbRibLjbRibLsbRibLsbRibRsbRgbRsRsmbRsbRsRgbRgRsmbR
sbRibRsbRgRsmbLebLobLibReRsmbLhbLhbsbsbRibRebLgRsbRsbLjbLcbRibLibLibRj
bRjbRibLgbRibRsbRgbRgbRibRgbLgbRsLsRsbRibRsbRgbRgbRsbRgbRibRsRgbRsbRib
RibLibLjLsmbLiRsbRjbReLsbLgbRcbLibRiRsmbLjbLcLsmbRjbRhbRsbRgbRsRsmbRgb
RgRsmbRgRsmbRgbRgbRgbRgbRsbRgRsmbRgRsmbRcbLgRsbRibLsbRibRgRsmbRibRgbLg
RcRsmbLibLibRsbRcbRibLjbRibLjbRhbLgbRibRibLsbRgbRgbRsbRgLsbRgbLsbRgbRh
bLhbRobRcbLcbLcbRibLhbLibRjbLiLsbLibRjbLcbRibLibLsLsmbLsLibRebRcbLiRsb
RhbLgbRibLsbRgRsmbRgRsmbRgbLsbRgbRsbRgbRsbRgbRgRsmbRibLibLjbRcRsmbLsbR
iRsmbLsRsbRsbRgbLsbRgLsRsbLsLsmbRgRsRsmmbRgbRgbRgbRgbRgbRgbRgbRsbRibLi
bRiRsmbLsbRibsbRsbRgbLjbRibRsRsmbRsbRgbRgbRgbRgbRgbRibRibLcbLcbRebLcbL
obRhbRcbLhbLgbLibLcLsRsmbLibRgbLgbRcbRgLsbRsbRgbLcbLcbRebLobRcbLobRcRs
mbLjbLcbReRsmbRcbLibLobRjbRcbLhbRibRgbRsbRgbRibLgbRibLsRsbRgbRsbRgbRgb
RgLsbRgRsmbRgbRgRsmbRgbRgbRgbsbRsbRgbLgbRiRsmbRibLibLhbLibRcbRcbLibRib
RgbRsbRgbLsbRsbRsbRgbRibRsbRibLsbRgbRgRsmbRiLsbLcbLebLibRjbRcbLsbRhRsm
bLgbRibRibLcbLcbLcbRcbRcbLibLcbLobRcbLibLibLibLibRjbsbRcbRsbRibRsbRgLs
bRibRgbRgbRsbRsbRibRgbRgbRgbRcbRhbRcbLjbLiRsbLibRjbLhbLiRsbRcRsmbLhbLg
bRsbLhRsbRcbRcRsmbLiRsbRebLibRcRsmbLgRsbRgLsbRibLgRsbRibLgbRibRsbRgbRs
bRgbRsbRgbRgRsmbRgbRgbRgbLsbRsbRgbRgbLsRsbRgRsmbRsbRgRsmbRgRsmbRsbRgbR
gbRgRsRimbRgbRiRsLsmbRgLsbRgbRsbRsbRibsbRsbRgbRgRsmbRgbRiRsmbRgRsmbRsb
RibLibRhbLsbRsRsmbRiRsmbRobLibLibRiRsmbLibLcbsbRcbLibRgbLcbLobLibLsbRc
bLjbLobRcRsmbRibRsbLjbRibRgbLsRsbRgbRgbRsRsmbLsbRibRgbLoLsLsmmbLibLibR
sbRibLcbLibRibLcbLsbRjbLibLgLsbLgbLsLsLsmmbLgbRjbsbRcbLsbRgbRgbRsRsmbR
iRsmbRgbRgbRsbRgbRgRsmbRibRcbLjLgbLibRhRsmbLibLcRsbLibRgbLsLoRsbRiRsmb
RcbRsbRgbRgRsmbRgbLsbRcbLibRcbLibLibLibLobLoRsbRibLibLibLibRjbLibLiRsb
LgRsbLiRsbLsbLsRsbLsbRebLsbRiRsmbRsbRgbRgRgbRibRgbRgbRgRsmbRgRsmbLhbLh
bRcRsRsmmbRobLcbLcbRcbLcbRcbRcbLhbRibRgbLsbRgbRibLsbRgbRibRibLhbLcbLgb
RgLsbLibLiRsbRibRibRibLgbRibRgRsmbLgbRgbRsbRibRgbRsbRgbRsbRgbRsbRgbRgR
smbRibRiLsbLibLibLgbLgbLgRsbRoRsmbRgRsmbLsbRibLcbLcbRsbLibLgbLgbRjbReb
RibLsbLsbRgbRgRsmbRgbRgRgRsmbRgbRgbRgbRgbRiLsbLobLobLiRsbLgbLsRsbLgbLi
bRebLjbLibLgbLsRsbLgbLgbLgRsbRjbRcbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 22; Drug: NDMC 10 µM
bLsbRsLsbRibRiLsLsmbLsbRgbRsRsmbRsbRgbRsRsmbRsbRgbRgbRgRsmbLjbRibLsbLc
bLibLsbRcbRibLhLsbRsbRcbLhbLiLsbRsbLsLsRsmbLsbLsbLgbLsRsbLsbRhbRgbRgbL
sbRibRgbRgRsmbRgRsLsmbRsbRsbRsLsRsbRgbRsbLsLsRsmbRgbRsLsRsbLsRsbRsbRsb
RgbRsbRsbRgRsmbRgbLhbLibLgbRcbRibRgbRgbRsbRsbRgbRsRsmbRgLsbLsRgLsbLjbL
ibsbLiRsbRjbRsbLjbRibRibRgbLsbRibLibRgbRsbRgbRsbRsLsbRgbLsbRgbRsRsmbRs
bRsbRsbRgbRgbsbRgbRgbRsRsmbRgbRsbRgLsbLgRsbLjbLibLgbLgLsLsmbLsRsbLgbLs
bLsRsbLsbLhbRcbRhbRibRgLsbLcbRjbRhbRiLsbLjbLjbRcbLjbLcRsbLhbRjbRcRsmbL
jRsLsLsmbLhbRibRibLobRgbRgbRgbRsbLsbRcbLgbRsRcbLgbLgbRgbRibRgbLsbRgbRg
bLjbLibRcbLjbRcbLgbRibLsbRsbRgbLsbRgbRgbRgbRsbRgbRibLibLobLibRgbLhbRjb
LhbRgRsmbLcbRibLcbLsbRgLsbRibRibLsbRgbRsbLsLsmbRsbLsbRgRsmbRgRsmbRsbRg
bLsRsbRgbLgRsbRibLgbsbLcbRcbRsLsRsbRcRsmbLibRiRsmbRcLsLsLimbLhbRjbLcbR
ibRcbRibLsbRgbLsbsbRgbLsbRsbRgbRsbRgbRgbRsbRsbLsbLsbRibRgbLgbLjbLhbLib
RsRsmbRjbLcbRibLcbRibLoRsRsmbRjRsRsmmbLcbRsbRibRjbRsbRgbRgRsmbRgbLsbRg
bLgRsbRibLibRhbLiLsbLcbLcLsmbsbRjRsmbRebLjbRcLsbRgbRsbLibRcRsmbLsLsmbR
ibRgbRsbRsbLsbRgbRgRsmbRsRsmbRsbRsbRsbRgbLsbRgbLsbRgbRgLsbLsbRsbLsbRjb
RsLsbRsbRgbRgbLsRsbRsbRgbLjbRgbLcLsLimbLibRibRibRibLjbLcbRcRsmbRcLsbLi
bLjbLsLsLimbsbLcbRibRibLjbLgbRcbRibLjbLcbLibRjbLibRibLibRcbRibRsbRgRsm
bRgRsmbRsbLgLsbRgRsmbLsbLjbsbLhbRebRibRibLgRsbRsbRgRsLsmbLsRsbLsbsbsbR
sbRgbRsbRgbRsbRgbRsbRsbRgbRsRsmbRgbLsbRgbRgbLhbLiLsRsbRsLsbLgbLcLsRsmb
LebLibLgLsbLgbRibLobLsRibRgbLhbLgbLcbLhbLibRiRsmbRsLsRsbLibLcbLgbRibLg
bLibRgbLibRcbRsRsmbRsbLsbLibRcbLjbLibRcRsmbRcbLgbLjbLibLibRibRcRsmbLib
LgbRsLsbLcRibRjRsmbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbLjbLcbLibRgbLibRgbRcb
RhbLgbRcbLibRiRsmbRiLsbLgLsbRgbRgbRsbRsRsRsmmbRgRsmbRsbRsbRsRsmbRsbRsR
smbRgbRsbRsbRsbRgbRgbRgbRgbRsbRgbLjbLcbLibRjbLibRgbRobRibLgbLjbLcbRhRs
mbRhbLgbRgbRiRsmbRgRsmbLsbRsbsbLsbLsRsbRsbRgbRsbRsbRgbLsbRsRsmbRsbRgbR
gbRgRsmbRgbRsbRgbRsbRgRsmbRsRsmbLcbLgbLsbRcbRcbLgbRcbLgbRhbLibRsLibReb
RibLsbRsbRsbRsbRgbRgbRgbRgbRgRsmbRgbRgbRsRsmbRgbRgbRgLsbRgbRsbRsbsbRsb
RgRsmbRgbRhbLiRsbLibLiRsbLsbLgbLgbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 23; Drug: NDMC 10 µM
bRsbLjbRibsbsbLjbRjbRjbLcLsmbLibRiRsmbLcbRhbRjbLiLsbLcbRibLjLsmbRgRsmb
RsbLsbLgbLcbLjbLjbLjbLjbLibRibRibLgbLgbLcbLibLsbLsbLsbRgbLhLsbLsbRsbLi
bLgLsbRgbLgbRsLsbLgRsbsbRsbLgbRibsbLibRgbLibLsbLgbsbLsbLgbLsbLsbLsbLgb
LgRsbRibRjbLjLsmbRibLcbRgbLebRsbLsLsmbLibLgbRsbLgbLsbRsbLjbLgbRibLcRsb
LgLsbLsbRsbLgLsbLgbRgLsbLsbLgbLsbLsbLsLsmbLsbLsbLsLsmbLgbLgLsbLsbLcLsm
bRibRsbLiLsbRgbLibLgRsbRgbLgbRsbLgbLgRsbLgRsbLgbRgbRsbLsLsmbLgbLgbLgRs
bLgbLgbLgbRgbRsRgbLhbLiLsbRibRibLjLsmbLsbLsbLcbLibRsbLgbLsLsmbLsbLibLi
bRgbLsbLgbLgbLsbLsbRsbLibLhRsLhbLibLjLsmbLgRsbLgbLgLsbLgbRcbRgbLjbLhbR
sLsbLsLsmbLsbLgbLsbLsbLsLsmbLgLsbRcbRibRgbRgbLsbRibLjbLcbRgbLibRsbLiLs
bRsbLsbLsLsmbLgbRsRsmbsbLgbLgRsbsbRsbsbLsbLsbRsbLgbRibRjbRgbLibLgbLgbL
sbLsbLsbsbLsbLgbLsbLsLsmbLsbLgbLsbLgbLsLsmbLsLsmbLgbLsLsmbLsLsmbLgbLsb
LsbLjbLibRibLcbRibRgbLcbLgbLgbRgLsbRgbRibRibLhbLcbLgbRsbLibRsbLgbLsbLs
bLsbLsRsbsbLsLsmbLgbLsbRsbLsbLsbRsbLsbLsbLsbLsLsLsmmbLgbLsbLsbLsbLgbLs
bLsRsbLgbRsLsbLgbLsbLgbLsLsmbLsbLjRsbRcbRcbLjbRhbRibLjbLcbLiLsbRibRgLs
LsmbLjbLiRsbRibRgLcbLgbLibLgLsbRgbRsbRgRiRsRgmbRsbRgbLsbLjbRibLhLsbLcb
RgbLcbLsLsmbLgbsbRgbRgbLcRsbRibRsbLibRsbRsbLsbLsbLsLsmbRsbLgbLgbRibRib
RibLjbLcRsbLsLsmbLsbLsRsbLgbLsLsmbRsbLsbLibRsbLsbLgbLsbLsbRsLsbLsbLsbL
sbsbLsLjbLsbRsLsbLjbRsLsbLsbLsbLsLsmbLsRsbLsbLsbLsbLgLsbLsbLgbRsLsRsbL
gbLsbLgbLgbLgLsbRgbLjbsbRsbRibLibRibsbLhbLhLsbLiLsRsbLibLiLsbLibLgbLgR
sbLgbLsbLsbLsLsmbLgbsbLgLsbLgLgbLgLsbLgbLgbLsLsmbLgLsbLsLsLsmmbLsbLibL
ibRhbRcbLsRiRsmbRgLsbLjbRhbsbLhbLhbRiLsbLjbLibRiLsbRsRsmbLhbRibLibRgLs
bLgbLgLsbLsLsmbLgbLsbLsRsbLgLsbLgbLgbLsLsmbLgbLgbLsbLsbLgLsbLsbLsbLgbR
jbRcbRibLhbRcbRibRibRibLsbLsbLjLsLsmmbLibLsLsmbLgbRibRhbLjLsmbLibLibsb
LgLsLgLiLgbLsLsmbLgbLibRsLsbLsbLsbRsbLcbRibRhbRhbRcbRiRsmbRibRibRsLcbL
sLcbRiRsLsLsmmbLibLjbRsbLsbLgbLgbLsbLgLsbLgLsbLsLsmbLgbLsbLgbLgbLsbLjb
LsbLsLgbRsbRsbLgRsbLsbLsbLsLsmbLgRsbLsbLgbLsLsmbLgbLgbLgbLgRsbLgbLsbLg
bLgbsbLsbRsLsLsmbLsbLsbLsLsmbLsLsmbLsLsLgLsLsLgmmbLgbLgLsbLgbLgbLsbLgb
RsbLsLsmbLgbLgLsRsbLsbLsLsLsLgmmbLsLsLsmmbLsbLgbLsbLgLsbLsLsmbLsbLsbLs
bLsLsmbLibRhbLebRibLhbRibLcbLgbLsbLgbRcbRibRhLsbRcbRhbRibLibLibLsbLgLs
bLsbLsbLsbLsbRsLsbLibRgbLibRgbLibLsLsmbRsbLgbLsbLgbLsbLjbRjLsbRcbLcLcb
RgbRhbLcbLgLsbLiLsbLgbRgbLibRsbLsbLibRsbLgbLgbRjbLibRgbLibRsbLjbLsbLsb
LsbLsbLsLibLgLsLsmbLgbLgbLgbLgbLgRsbRgbLjbRjRcRsmbLjbsbLhbRgbLhbRibLib
RibLibRgbLibLsLsLsRsmmbLsbsbLsbsbLsbsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 24; Drug: NDMC 10 µM
bLsbLsbLiLsbLsbRsbLgbsbLgbLgRsbRcbRibLcbLoLsmbRibRgbRgbLhLsbLcbRsbRgbL
ibLgbRsbLgbLsbLsbLgbLcRsRsmbRibLgbLibLsbRcbRibLcbLcbRibRjbRibLcbLhbRgb
LibLibRgbLibLibLcRsbRgRsmbRgRsmbRgbRgbRgRsmbRhbLsbRibRibLgbRcbRgbRibLs
bRgbRgbLsbLsbRjbRibRgbRgbRgbRgbRgbLcbLcbLgbRgbRjbLibRjbLhbRibLsLsmbLjb
RgLsbLsLsmbRsLsbRsbLsbLgRsbLsbLsRsbRsbLgbLgLsbLsbLsLsmbLsbLsbLsLsmbLsL
smbLgLsbLsbLsbLsLsmbsbLsbLgbLsbsbRsbLjbRsbLsLjbLsRsbLjbRsLsbLgbLsRsbsb
sbLgbLgbLgbLsbLgbRsbLgbLgbLgLsbLgbRjbRobsbRjbLjbRibLobLcbRgbLsbLibLsbR
sbLibRgbLibRgbRsbLibLgbRsLsbLgbLsbLgbLsbLsRsbLgbLgbRhLsbRibLcbRibLjbLg
bLsbLsbLgLsbLibLgbLgbRsbLgbRsbRgbLiLsbLsbRsbLgbLgbLsbLiRsbRcbRcbRibLib
LsbLibLgbLgRsbLsLsmbLgbLsbRsRsmbRoLsbRgbRgbLgbRgRsmbLobLgRsbRgLsbLiRsL
sbRjbsbLibRgbRobRgbRsbRgbRsbRsRsmbRgbRsbLsRsbRsbRsbRsbRsRsmbRsbRgbRgbR
sbRgbLcbLgbRgbLgbLsbLgbLgbLsbLsbLgbLsbLsbLsbRsbLgbLibRcbRhbLsbLjbLibRj
bRobRibLjbLjbLgbLgbLsbLsLsmbLsbLgbLgbLgbRsbLgbLsbLgbLsbLgRsbLsbLsbLgbL
sbLsbLsbLgbLgbLgbLsbLgbLsLsmbLsbLsbLsLsmbLgLsbLgbLgLsbLsbsbLgbLgLsbLsL
gbLgbLgLsbLgbLgLsbLgbLgLsbLsbLgbLsLsmbLgbLgRsbRcLsbRcbLgbLcbRjbRiRsLsm
bLibRgbRcbLcbLibRcbRobRhbLsbLgbLjbLgbLsbLgbRjbLibRibRjbLebRgbLgbRsRsmb
LiLsbLgbLsbLgbLsbLgbRgbRcbRgbRgbRiRsmbLcbLibLibLgRsbLgbLsLsmbLsbLsbLgb
LibLsbLgLsbLiLsbLgbLgLgbLgLsbLsbLgbLgbLgbLsbRgbLibsbRgbLiLsbLibRobRhLs
bRgbRgbRibLgbLcbRsbLgbLgbRsbLibRibLhbRibRebRgbRgbLobLobRiRsmbLibLibRgb
LgbLsbLgbLsLsmbLsLsmbLsLsmbLgbLsLsmbLsbLgbLgLsbLgbLgbLgbLsbLsLsmbLgbLs
RsbLgLsbLgbLgbLgbRjbLiLsbRsbRsbLgLsbLsbLsLsmbLsbLgbLsbLgbLsbLgbLsbsbLs
bLgLgLsbLibLgbLsbLgbLsbLgbLsbLgbLsLsmbLgLsLsmbLsRsbLsRsbLgbRsbLgLsbLgb
LsbLgbLgbLsbLsbLgbRhbLsRibRibLjbLibRobRibLcbLcbRibLobRibLcbLobRgbRiLsb
RsbLoLsRsmbRsbLibRsbLgbLgLsbLsbLgbRsbLibRibRibRgLsbRgbRsbRgbRcRsmbRibR
ibRgbRiLsbRjbRgbRgbRsLsbRgbLcbRgbLibRjbLhbRgbRjbRibRgbRsbRgbRgbLgbLcbL
ibLsLsmbLsbLsLsmbLgbLsbRsbLibRjbRobRibRsbRgbRgbLsbRsbRsbRgbLjLsmbLgbLg
bLsbLgbLsbLsbLsbLgLsbLgbLsbLgbLibLibRgbRsbLibLgbLgbRiLsbLibRjbLcbRcbLi
bRjbLcbRebRcbLcbLibLsbLgbLgbLsbLsbLsbLgbLgbLsbRsbLgbLsbLgbLsLsmbLgbsbL
ibLgbLgbLgbLsbLgLsbLgbRsbLibRcbRobLebsbLibLsbRjbLcbRhbRgRsmbLsbRsbRiLs
LsmbRibRiRsmbRhLsbRibRibRiRsmbRibRsbLgbLjbLiRsbRsbLsbLsbLgbLgbLsbLsbLs
bLgbLsbLgbLsbLgLgbLgbLibLgbLsbLibLgbsbLsbLgbLsbLsLsmbLgbLgRsbsbLsbLgbL
gbLgbLsbLgbLgbLgbLgbLibRoRsmbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 25; Drug: Control
bRgbLsbRibRsRsmbRsbRsbLgbRsbLgbLcbRsbLsRsbRcbLsbLgbRibRcbLibRsbRibRsbR
gbRsbRsbRibLjbRjbLgbRsbRgbRgbRibLibLsbRibRsbRgbRsbRiLsbLjbLcbLhbLibLgR
sbLibLibRsbLhbLibRibRcbRgRsmbRsbRsbRsRgbRsbRsbRsbRsbRsLsbRgbRsbRsbRgbR
gbRgbRgbLgbRibRibRhbLibLgbRibRhbRcbLhbRibLsRsbRgRgbRgRgRgbRsbLsbsbRgRg
RiRiRsmbRgbRgbRcbLobLcbRjbLcbLibRibLcbRgbLibLibRgbRgbRibRgbRsbRsRsmbRg
bRgbRgRgRgRsmbRgbRgRsmbRgLsbRsbRgbLjbRibRcbLhbRsbLgbRhbLhbRsLcbRjbRibR
hbLibRiRsmbRibLsbRgRsRsmmbRgbRgRgRgRsmbRgRsmbRgbRgbRgbRibLibRibLibLhbR
gbRjbRibLibRibLgbLsbRgRsmbRsbRsbRgbRsbRgLsbRgLsbRgbRgbRsbsbRgbRgbLjbRc
bLibRibRsbRgbRgbRgRsmbLsbRgbRsbLsbRgbRgRsmbRsbRgbLsbLsbRsbLsRgRsRgRsRg
RgmmbRgbRgbRgbRgbLsbRjbRhRgbLibLibLibRcRsRsmmbLsRcbLibLhbRcbRhbLgbLjbR
cRsmbRibRibLibRgbLiLsbLcbRgbRsbLibRibLibRgbLibRgbLibLiRsbRgbRsLibRgbLi
bRgbLibRgbLibRibLcbRjRsmbRjbLobLibLibLgbLgbRgbLcbLgbLjRsbLibLgbRibRibR
sbLjbLibRsbLsbLibLsbLibRsbLiLsbRsLsbLgbLgbRjbLiRsbRibLibLhLsbRgbRibLib
LiRsbLibRibLibRgbRgbLcLsmbLiRsRibLibLsbLsbLsbLgLsbLgbRsbLibRjbRjbRibLi
bLhbLgbLsbLgbsbRsbLibRjbLobRgRsmbRjbLobRgRsmbLcbRgbLibRsbLgbLgbLsLsmbR
gbLibLgbLgbLsbLgbLsLsmbRsbLgbLgbLsbLsLsmbLsbLibLiLsbRgbRgbRjbRibLcLcLs
RsmbRiRsmbRibLjbLcbLibRgRsmbLibRgbLgLsRsbLgbRsbLgbLibRgbLjbLibLcbRibLc
bLcbRibLhRsbRiRsmbRibRsbLsRiRsRsmmbRsbRibRgbLcbLibLiLsbRjRsmbLibLsbLib
LsbLsbLgbLsbLgbLsbLgbLsbRsbsbLgRsbLsLsmbLsbLsbLsRsbLgbLsLsmbLgLsbLsbLg
bRsbLgbLgbLgbLgbLsbLsbRsbLsbLgRgbLgbLsbLgRsbLgbLgLsbLsbLgLsLsmbLgLsbLg
LsbLgLsbLgbLgLsbLgbLibLibRsbLiRsLsbRgLsbLgbLsbLsbsbLgbLgbRsbLsbLgbLgbL
gbLgbRgbLibRgbLibLgbLgLsbLgRsbsbLsbLjbsbLsbLgLgLsbLsLsRsmbLgbLgLsLsmbL
gbLibLgbLsbLgLsbRsbLgRgbLiRgbLibLsbLgbLgbLgbLgbLgLsbLibLgbRgbLiLsbLgRs
bLsbLgbRsbLgRgbLgbLiRsbRibRcbRcbLgbRibRcbRibLibRibLibLibLhbRibLibLsRsb
LgbLsbLjbLsbLsbLsLsmbLgLsbLjbRsLsbLsbLgbLgbLgbLiLgbLgLsbLgbLgbLsbRgbLh
bRhbLiLsbLsbRsbLibRjbRobRhbLsbRcbLgbRsbRibLgbRibRhRsmbLibLebLibLiRsbRi
bRibLcbLgbRgbLibLibRgbLcbRiLsbLsLcbRibLhbLsbRsbLgbLibLgbRgbRibRgbLibLi
bLcbRibRjRsmbLobRiLsbLobRibLhbRjLsbLcbRibLibRjbLibRgbLgbLsbLgbRsRsmbLi
bLgbLgbLibLsLsRsmbRibRiRsmbRgbLsbLgbLobLcbLgbLibLhbLibRibRjbRhbLhbRcbR
ibRiLsbLiLsbLibLgbLibLibRhbRcbRibLibRibLjRsbRibRsbLibRibRsbLgRsbRibLsb
RgbLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 26; Drug: Control
bLcbRibLibRgbLgbLgbLsbLsbLsbLgbLobRibLgLsbRsbLiLsbLhbRgbRjbLgbLsbLgbLs
bLgbLsbLgLsbLgbLsbLsbLsbLgbRsRsmbLsbLgbLgbLsbLgbLsbLgbLgbLgbRsbRsbLgbL
sbLgbLsLsmbLsbLgLsbLsbLgbLsbLgbRsbsbLgbLibRgbRhbRjbRibRsbRgbLcbLgbLgbL
gbRgbLgbLgbLibLgbLiLsbRibRgbLgbRsbRjbRhbLgRsLsbLobRgbRhbLibRsbRgbLibLi
bRjbRcbLebRcbRgbLibRcbRibRsLsbRsbRgbRsbLgbRibRsbLsbRibLibRhbLibRoLsbLi
LsbRgbLjbRibRibRgLsbRgbRgbLcbLibLsLsRsmbLgbRgbLhbRgLsbLgbLgbLsbLsbLsbL
sbLsbLgbLgbLgbLsbLsbLgbRsbLgbRjbLgbRsbLsbLgbLgbLgbLsbLgbRjbRobRgbRibLh
bRhbRibLebRcbLhbRcbRibRsLsbRsbRsbRgbRsbRgbLgLsbRibLgbRibRibLiLsbLjLsmb
RhbRibLsLsmbRiRsmbLsLsmbRiLsbLgbRibRsbRgLsbRgbRsbRsbRgbRsbRgbRsbRsbRsb
RgbLjbRhbLibLjbLcLsmbLgbLgbLsbLgbRgbRsbLoRsbRgbRgbRgbRgbRgbLiRsbLibLsb
RsbLibLsbLgbLgbRsbRsLsbLsbLibLsbLsbRsbLibRhbLhbRgbLibRgRsmbLgbLgbLgbLg
bLgRsbRgbRsbLgbLsbLgbLsLsmbLgLsbLsbLjbLgbLgbLsbRgbLiRsbLsbRsbLibRgbLcb
RgbRibRiLsbRjbLsbLibLobRjbRcbLcRsbLobRobLgbRibLjbLcbRjbLgbRjbRhbLjbRib
RiRsmbLsbLcbLcbLgbRsbRsbLibRgbLsbLgbRsRsmbLjbRsbLgbLsLsmbLgbLgLsbLsbLs
bLgbLsbLgbRsbLgbLgLsbRsbLgbLsbLgbLgbLsLsmbLibRjLsbRcbRhbLhbRhbRgbLjbLj
bRibRibRhbRibRgbRsbLgbRgbLiLsbRsbLgLsLsmbLsLsmbLgbLgbLsLsmbLsbLgbLsbLs
LgbLgbLsbLgbLgbLsbLsbLgbRgLsbLsbLsLsmbLgRsbLgbLsbLibRsbRibLcbRsbLibRjb
LhbRcRsmbLcbLibLsbLsbLgbLgLsbLgbLgbRsbLsbLsbRsbRsbLgbRsbLgbLobLgbLibLc
bLibRibLgbRgLsbLcbRgbLibLsLsLsmmbLibLgLsbRgbLgbLibRsbLsbLgbLsbLgbLgbLg
bLsbRgbLiLsbLibRgRsmbRhbLhbLgbLgLsbRgLsbLgbLgRsbLsbLsLsmbLgbLgbLcbRgbL
sbLsLsmbLibLibRsbLgbRsbLsbLgbLgbLgbLgbRgbLgbLsbRsLsbLgbLgRsbLsbLsbLgLs
bLsLsmbLsbLgLsbLsLsmbLgbLsLsLsmmbLgbLsbLsbLsbLgbLsLsmbLgLsbRjbRcRsmbLc
bRsLibRjbRcbLcbLcLsmbRsbLiLsbRibLgLsbLsbLibLsbLsLsmbLgbLgbLsLsmbLgbLgL
sbLgbLgbLgbLgRsbLcbRcbLibLsbRibRibRibLjbRcbRhbRibLgbLgbLgLsbLgbLgbLgbL
gbLsLsmbLsbLgbLsbLsbLsbLgbLiRsbLibLcbRcbRibLibRhbLhbRsbRjbRiLsbLsbRgbR
ibLjbLobLcbRhbLobRgbLgLsbRsLsbLgbLsbLsbLgRsbLsbLhbRgbLcbLcLsmbRebLhbRi
bRsbRibLgbLibRhbRibLjbLobRgbLgbLsbLsbLgbLibLiRsbRiRsmbLsLsmbLibRsbLsbL
sbLgbLsbLsbLgbLsLsmbLgbLsbLsbLsbLsbLgLsbLsLsmbLsbLsbLgbLgbLsRsbRsbLgbL
gbLsbLgLsbRgbLgbsbRsbRsbLsLsLgRsmbsbLgLsbLsbRsbLgbLgbLgbLgRsbRgbRsbLgb
LgLsbRsLsbLsbLcbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 27; Drug: Control
bRibRgLsbLgbRgbRgbRgbRsRsmbRsbRgbLsRsbRgbRgbRsbRgbRgbLgbRgbRsbRgbRgbRs
bRgbRgbRibLibRibRgRsmbRibLgbRibRibLjbLcbLcbRjbLibLiRsbLsbLibLsbRcbLgbR
iRsmbRsbRgbRgbLgbRibLsbRgbLsRsbRsbRibRgbRsbRsbRsbRsbRsbRibRgbRgbLgbRib
RgbLjbRhbLibLcbLcbLgbRsbRibLibLgbLgbRsbLibRcbRcbRibLgLsbLcbLgbRhbRhbLj
bRibRibRsbRgbLsbRgbRsbRsLsbRsbRgbRsRsmbRsbRgbRgbRsbRgbRgbRgbLsbRgbLsbR
gbRgLsbLjLsLsmmbRiRsmbRiRsmbLibRibRibRsbRsbRsLsbRgbRgRsmbLsLsmbRgbRgbR
gbRibLgbRgbRsRsmbRsRsmbRgbRgbRgbRgbRibLgbRgbRgbLsbRgbsbLibRsbRhbRgbRsR
smbRgbRgbRsbRsbRsbRsbRsbRgbRgbLjbRhRsmbLjbLibRibRgbLsbRgbRgbRgbRgRsmbR
gbLsbRgbLgbRibLgbRibLgbRibLsbRsbRgbRgbLgbRgRsmbRsbRsbRgbRhbLibRibLsbLs
bRibRgbLgbLsbRibRsbRsbRgbRgbRgbLgbRgbRgbRsbRsRsmbRgRsmbRgbRsbRsbRgbRsb
LcbLgbLiRsbRhbRhbRibRgbRgbLgbRgbRibRgbLgLsbRcRsmbLibRcbLgbRgbLobLgbRib
LsbRibLgbRibRibRhbLgbRgbRsbRsbRibLjbRibRiRsRsmmbRsRsRsmmbRsbRsbRsbRsbL
sbRsbRibRgbRsbRgbRgbRsbRgRsmbRsbRsRsmbRgbRgbRsbRgRsmbRsbRsbRsbRsbRgbLs
bRgbRsbRgbRgbLsbRsRsmbLsbRgbRsbRgbRgbLjbLcbLibRsbLsLiLsbRjRsmbRcbsbLsb
RebLgLsbRhbLgbRgbRibLsbRibRsLsbRgRsmbRsbLjbRhbRcLsbLsRsbLgbRcbLibRcbLs
LsmbLgLsbLibLibRsRsmbLgbLgbLibLiRsbLcbLgbLgbLibLibLgbLgbRjRsmbLiRsLsbL
hbRibRsLsbLibLsbLgbLgbLgbRgbLibLsbLiRsLsbLibLsbLgRsbLgbLgbLsbRsbLibRjR
smbRcbRibLsbRsbLsRgbRgbLjbLcbLibLsbRsbRebLiRsbRibLibLgbLibRhbRhbRiRsmb
LsLsmbRiLsRsbLgbRgRsmbRsRsmbLsbRgbRgbRgbRsRsmbRsbLsbRgbRgbLgbRgbRsbRgb
LsbRgbRgbRgbRsbRsbRsbRsbRgRsmbRibRibLgbRgbRsbRgRsmbLsbRgbRsbRsbRgbRsbR
gRsmbLsbRgbRgbLsbRibLgbRibsbRibRsbRsbRsbRgRsmbLsRsbRgbRgbRgbRsbRgRsmbR
sbRgbRgLsbRibRhbLjbLhbLgbRcbLcbRcbRibRsRsmbRgbRsRsmbRgLsbRsbRgbRsbRsbR
sbRgbRgbRsbRgRsmbsbRgRsmbRgbRsbRgbRgbRgbLgbRgbLgbRgbRgbRhbLcbRcbLjbRib
LsRsbRibLsbRgbRsbRgbLsbRgbRgbRgbRgbLhLsbLibLsbLgbRgbLgLsLsmbLgbRgbRcRs
mbRibRsbLsbRsbRgbRgbRsbRsbRgbRgbRibRibLibRcbLgbRibRgbRgbLgbRibLsbRgbRs
bRgbRsbRsRsmbLsRsbRgbLsbRgRsmbRiRsmbLgbRgbRgbLgbRibRgbRgbLibLibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 28; Drug: Control
bLsbLsbLgbLsbLgRsbLsbLsRsbLgbLgRsRsLsmbLiLsRsRsmbLibRgRsmbLibLibRibReb
LibLcbLgRsbRgbRiRsmbRsbRgbRsbRsbRibLsbRibLibLgbRcbLjbRjbLcbLobRibRcRsm
bRsbRsbRsbRibRgbLsRsbRgbRsbRsbRgRsmbRsbRsbRsbRsRgbLsRsbLsLsmbLjbLobRjR
sRsmmbRcbRgbRgbLsbRgbRgRsmbRgbLsbRgRsLsRsmbRgbRgbRsbRgbRgbRgbRgbRgbRgb
RgbRsbsbLobRgbLgbRibLiRsbRibLsbRsbRibRhbRibRhbLsbRcLsbRgbRsbRgbRgbRsbL
sRsbRsbRgRsmbLsbRgbRsbRsbRgbRsRsmbRsbRgbRgbRibLibLhbLcbRcbLobRhRsmbLjb
RsbLgbRibLsbLcLsmbLobRibRibLjbLiRsbRsbLgbLibLgRsbLibRibRgbRgbLcbRcbLcb
LcbRibRjbRsRjbRsbRgbRgbRsRsmbRgbRgbRsbRgbRiLsbRsRsmbRgbLsbRibLibRibLcb
LobRibLibRsbLgRsbLgbLsbLgbRgbRcbRgbRgbRgbLibRgbRgbRsbRgbRsbRsbRsRsmbRg
bRsbRgbRgbRgbLgbLebLhbRgbRhbRcbLibLcbRcbRibLgRsbRibLibRibLgbRibRsbLgbR
ibRgbRsbLsbRibLsbRgbLgbRgRsmbRgbRgbLgbLobLhRgbRgbRcbRsbLsbRibRgbLiLsbR
iRsmbLibRiLsbRsbRibRcbLibLgbLibRsbLibLibRibRcbLjbLcbRsbRibRibRiRsmbRsb
LgbRgbRgbRiRsmbRsbRgRsmbRsLsbLsLsmbRgbRgbRgbRgbRsbRgRsmbRsbRgbRsbRgbLj
bRibRiRsmbLgbRgbRgbRgbRgbLsbRsbRgbLgbLgbRsbLibLcLsmbLibLsbLgbRsbRsRsmb
RjbRcbLsRsbRgbLsRsbRibRgbLiRsbRsRibLgbLcbLibRibLcbRiRsmbRjRsmbRsbRsRcb
LgbRiRsmbLgbRgRsmbRiRsmbLsbRgRsmbRsbLgbRiRsmbRsbRsbRgbRsbRsbLsbRgLsbLi
RsbLcbLhbRiRsmbRcRsmbRibLibRiRsmbLgLsbRiRsmbRsbRgbRsRsmbLsbRgbRgbRgbRg
bRsbLgbLgRsbRibRgbLgbRgbRgbRgbRgbLsRsbRgbRsbRgbRgbRgRsmbRsRsmbRibLgRsL
gbRhbLgbRhbRsbRgbLibRebLcbLcRsbLiRsbRiLsbLgbLgbLsbRobRgbLsbRsRsmbRsRgb
LhbRibRgbLibLcLsmbRcbRcbRhbLgbLgbLjbsbReRsmbRibLgbLibLiLsbRsbRcbRibRsL
sbLcbRobRibLgbRgRsmbRgRsmbLgbRibLgRsbRibLgbRibLgbLebLcbLcbRibRgbRgbLhb
RgbLcbRsbRgLsbRsbLhRsLsbLgbRibLcbRgbLibLibLcbRiRsmbRibRgbRsbRgbRsbRgbL
gbLibLcRsbRibLcbLgbRibLhbRgbLhbRgbLibLibRgbLcbRibLcbRgbLibRsbRgbLcRsbR
sbLgbLgLsbLgbLgbLsbLgbLsbLgbRgbLiLsbLsRsbLgLsbRgbLiRgbLgbLsLsmbLgbLsbL
gbLgbLgbRjbRcbLgbRsbLgRsbRhbLibLhbLhbRiRsmbLgbLgbLsbLgRsbLgRsLsbRcRsmb
RsbRgRsmbRsbRgbRibRsbLgbRgbRgbLgbRiLsbLgbRiRsmbLgbRgbLcbRjbRobRcbRgbLg
bLebRhbRgbRgRsmbLibRebLgbRcLsbLgbLgbRhbRiLgbLibRcbLgbRgbRgbRsRsmbRgbLg
bRibLsbRgbRgbLgbRhbLibLgbRcbRiRsmbLgbLgbRcbLgbLebLcbRsbRgbLibLgbLsbLgb
LgbLsbLsbLgbLgbRjbRcbRgbLsbRibLibRhbLsbLhbLcbRsRsmbLibLsbLsbLsbLsbLgbL
gbLgbLsbLgbLgRsbLgbLsbLgbRsbRiRsmbRgbRgbLgbRgLsbRgbRgRsmbLsbRsbRgbRgbL
sbRgRsmbRgbRsbRsbLsLsmbRgbLsbRgbRgRsmbRgbLsbRgbRiLsbLebLibLibRgbLgLsRs
bLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 29; Drug: Control
bRsRsmbRgRsmbRgbRsbRgbRsbRsbRsRsmbRsRgbRgbRgbLhbLhbLibRsLsbLsbLgbLsbLg
bLgLsbRsbLgbRcbRiRsmbLibRibRibLsbLhbLcbLibRcbLibLgbLgbRsbLgbLgbRjbRhbR
hbRsbLsbRgbRsRsmbRgbRgbRgbLgbLcbLibLgbRibLibLgLsbLsLsmbLgLsbLgbLiLsbLg
bLgbRgbLsLsmbLgbLgLsbLgbLsbLsRsbLsbsbLgbLcRsbRgbLibLibLgbRjbRcbLiLsbRc
bRgbRgbRsRsmbRsbRgLsbLsbRsLsbRsRsmbRiRsmbRgbRsbRsbRsRgRsmbRgbRibRsRsmb
RsRgbRgbRsbLsbRgbRgbLjbRsRibLjbLcbLgbRsbRibLjbLcbRsbLcbRjbRsRiRsmbRgRs
mbRsLsbRgbRsRsmbRsbRgbRgbRsbRgRsmbRgbRsbRsbRgRsmbRsbRsbRsbRgbRgbRgbRsR
gbLjbLibLiRsbRjbLjbLibRjbRhbRgbRgbRsbRsbRgbLcbRjbRibLibLebRibRsbLhbRjR
smbLsRibLjRsbRibLjbRhbLcbRcbLibRgbRgbRgRsmbRsbRgbLgbRibRgbLsbLibLcbLsR
gbLibRjbLgbLgbLibLsbLiLsbRcbRcbRiLsbLgbRibRgbRgbLgbLsbRgRsmbRibLjbRibL
gbsbRibLjbRsLcbLiRjbLibLibRcbLhbRhbRcbLsbRibRibLjLsmbLibRcbRgLsbRsRsmb
RsRsmbRgRsLsmbRsbRgRsmbRgRsmbRgbRgbRgRsmbRgbRsbRsbRsbRgbLgbRsbRsbRsbRs
bRgbRsbRgbRsbLsRgbRibLsRsbRgbRgbLjbLhbLibLsRjbRcRsmbRgbLsRsbRgbRgbRgbR
sbRgbRsRsmbRgbLsbLcbLibLgbLgbRsRsmbLibLgbLgbLibRibRhbRibLjbLhbLibLhRsb
RsLsbRjbLibRibLibLhbLibRgbRcbLgbRiRiRsRsmmbRibLsbRgbRibRhbRsLibLibLibR
ibLhbLibLsbLgbLgbLsbLgbLsbLibRjLsbLgLsbLsbLgRsbLgbLgbLgbLgbRjbLgbRcRsR
imbLiRsLjbRhbRibLgbLcbRjbRgbRsRsLsmbRsLibLiLsbRjbLibRjbLcbRhbRcRsmbRib
RgbLibRcbRibLgbLibLjbRgbLcbRibLgbLgbRsbLgbLgbRsbLgbLgbLsLsmbLsbRsbLgbL
gLsbRjLsbLiRsbLsbLgbLsbLgbLsbLsbLsbLgbLgbLsbLsbLsbLsbLsbLsbLsbRsbLgbLs
bLgbLsbLibLsbRsLgbLiRsbLgbLgLsbLgbLgbLsbLsLsRsmbLgbLsbLgLsbLsbLsbLsbRg
bLgbLsbLsbRcbLhLsbRcbRibLjbLcbLgbLgbRgbLgRsbRsLsbLgbLsbLgRsbLiRsbRgbLi
RgbRibLibRibRgbLsLsmbRgbLgLsbLjRsLibLibRibLhbLhbRhbLcLsmbLsRibLiLsLibL
ibLgbRgbLgbLgRsbsbLgbRsbLgbLgbRgbLgbLibRgbLgbLgbLgbLgbLsLsmbLgbLgbRsbL
gbLsbLgbLgbLgbLsbLgbLsbRsRsLimbRgbRibRibLgbRibRgbRhbRibRiRsmbRiRhbLsRs
bRgbRgbRgRsmbRgbLsbRsbRibRgbRgbLgbRibRiLgbLgbLibLibRjRcLsRibRiRgbLgbRi
RsRimbRiRsmbLgbLgbRgRsmbRibRsbLgbLcLiLiRsRibLhLibRibLibLsbLgbLsbLgbLgb
LsbLgbLsbLgbLgbLgbLsbRcbRibRgbRgbLjbLhbLhbRiRsmbRhRsmbLcbLcRsbRibRcbRc
LsbRibRibLibRibRibRsbLjbLibRcbRhbLsbLibRiRsRgLsRiLsRsmbLgbRibRgbRgRsmb
RgbRsbRgbRsbRgbRsbRgLsbRgbRsbRsbRsbRibLgbLeLsbLhRsbLibLgLsbLsbLgbRgbLs
bLjbLibLibRjbLibLsLsmbLsbLgbLgRgRsmbRjbRjRsmbRsbRsbRgbRgLsbLsbRgLsbRgL
sbRgbLjbLcbRjbRcRsmbRiRsmbLhbRcbLibRcbRibLibRsbLibLgbRjbRibRibRgbLsRsb
LhbLibLgbLgLsbLgbRcbLsbRcRsmbRibRibRiLiLsbLiLibLgbLsbLgbLgbLsbLsbLgLsb
LsbLsbLgbLgbLgbLgRsbLgbLgbLsbLsbLsbLsbLsbLgbLgRsbLgRsbLgbRsbLgbLgbLsbL
gbRgbLgbRsbLgbLgbLgbLgbLsbLsbLsbLgbLsbLsbLsbLsRsbLsbLsbRsbLgbLsbRsbLgb
LsLsmbLiLsbLibRjLsbLibRsbRhbRibLgbLjbRgRsmbRsLcbRibLhRsbRibLhbLgRibLib
LiRibLgbLibLsbLiLsbLgbLgbLgbLgbLsbLgbLgbRgbLgLsbLsbLgbLgRsbRjbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 30; Drug: Control
bLjbRiRsmbRgbLibLcbLcbRiLsbLcbRgbRgbLibLgbLgbLgbRsbLgRsbRsbLgLsbLgbLsb
sbLsbLgbLsbLgbLgbLgbLgbLgbRgbLgbLiRsbRhbRcbRibLjbRjRsmbRsLsbRibLsbLcbL
cbRgbLibRgbRgbLibLgRsbLgbRsbLgbLgbLsbLgbLgLsbLgbLgbLgbLgbLgbRsbRibRcbR
iLsbLcbLobRcbLibLgbLsbLgbLsbLsLsmbLgLgbLgLsbLgbLgRsbLibRsLsLsmbLsbLgbL
sbLsbLgbLsLsmbLsRsbLgbLgbLgbRcbRoLsbRhbRsLibLjbLebLgbRgbLibRsbLgbLsbLg
LsbLsbLgbLsbLibRgbLgbRsbLibLibRsbLibRibLibLibRgbLibRsbLiLsbLgbRsLsbLgb
LgbRibLgbRgbLibLibRcbRobRcbLibLgbRgbRibRgbRibRibLiLsbLibRoLsbRhLibLibL
hbRsbLgLsRsbLsbLsbLgLgLgbLgbLgbLsbRsbLgLsbLhbLcbRcbLgbRgbLgbRoLsbLjLsm
bLebLgbRsbLgLsbLsbLgRsbLgbLgbLsLsmbLgbLgLsLsmbLgRsbLibLiRsRsRgmbLgbLiL
sbRsbLibRibLobLcLobLibRgbLibRsbRgbRhbRoLsLsmbLcbLgLsbRgLsbLibRjbLhbRgb
LgbLgbLsbLgbLgbRsbLiRsbRsbLgLsbLsbLsbLiLsbLgbLsbLgbLgLsbLgbLgbRibRcRsL
smbRiLsbLgLsLjbRsLsbLsbLsbLgbLgbLgbLsbLsbLgbLsbLsbLgLsbLgLsbLsbLgLsRsb
LgbRjbsbLcbRcbRsRcLsbLoLoLsmbRsbRcbLibLobRibLcbRibLibLibRjbLoLsRsmbRhL
sbRgbLhLsbRsbLibRsbLsbLgbLgbLgbRsbLgbLsRjbLhbRgbLiRsbRgbLibRsbLibRjbLc
bRgRgbRebRsRsmbRiLsbLjbLobRibRsbRjbRibLsbLobLibLcbRibLibLibRcbLjbLobRi
bLgbRcbRhRsmbRhbLibLibLcbRgbLiRsbLibRgbLsbLgbLsbLgbLgbLsbLgbRsbLgLsLsm
bLsbLsbLsbLgbLgbRjbRoRsmbLiRsbRgbLcbLibRgbLibRibLobRibRibRsbRjbRobLgbL
ibRcbRibRibLibLgLsbRibRibLjbRcbLibLhbLibRibLsLsLsmmbLgLsbLsbLsbLgbRsbL
ibRsbLgbRsbLgLsRsbLgbLsbLsbLsbLgRsbLgLsbRjbRcbRsbRgLsbRhLsLsmbLibRobRg
bRgbRsbLgbRsbRcbLibsbRgbRgbRsbLsbLjbsbLibRhbRoLsbRgbLgbLhLsbRcbRhbLhbL
cLsmbRsbLiLsbRsbLsbLibRjbRsbLsbLibRebRcbRsbLcbRcbLjbLiLsbLsbLgbLsbLibL
sRsbRsbLgbLgbLjbLiLsbLibRjbsbRcbLjbRhLsLsmbRhbRjbLibRjbLhbRgbLibRsbRsL
gLsbLgbLsbLgbLiRjbsbLcbRebLoRgRsmbRsbLcbLibLsbLcRgLsbLsbLobRsRsmbRjbLg
bRsbLgbLgLgLsRsbLgbLgbLgLsbLgbLsbRsLgbLgbLibLgbRgbLibRgRsmbLgLsbLibRcb
RcbLcbLhbLibRgbLiRsbLgLsbRgLsRsbLiLsLsmbLgLsbLsbLgLsLsmbLgLsbLgLsbLgbL
sbLsLsmbLgbLgbLsbLgbLsbLgLsbLgbLgbRjbLhLsbRhbLibRsLsbRcbRcbLiLsbLcbsbL
cRsRhbRsbLsbRgbLobLcbLibLgbLsbRsbLgLsbLiRgLsbLiRgbRsLsbRgbLibRgbLibRjb
LiLsbRgRsmbLibLsbRsbLsbLgbLgbLgbRsbLgLsbRsbLsLsmbLgbLgbRsbLiRsLsbLgbLg
bLgbLgbLgbRhbRcbRsbsbRgbRgbRsbRgbRhLsbLibRhbLibRgbLiLsbLsbLgbLsLsmbLsb
LsbLgbRsbLgbLibRgbRcbLobLoRibLibRgbRgbLcbLibLibRibRjbLibLhbRgbRsLgbLgb
LsLsmbLgRsbLibLsbRgbLgbLgbLsLsmbLgbLgbLgbRhbLobLoRsbRiLsbRhbRhbRsbLhbL
cRsbRgbRsbLcbRgbLiLsLsmbRsRsmbLgLsbLgbLsbLgbRsbLgbLgbRcbRcLsbLgbLsRcbR
sbLibLibLibRjRcbRibLibLcbRcRobLiRsbLcbLgbLgbLgbLgbRsbLiRgbLibRgbLiRgbL
sbLgbRsbLgRsLsbLgLsbLgbLsbLsbLgbLgbLgbRsbLgbLgbRsbLgLsbLgLsLsmbLgbLgbL
gbRsbLgbLsRsbLgbLgbLgbLsbLgbLgbRjbRibRjRsmbLcbLibLsbLsbLgLsbLgRsLsLsmb
LgbRgbLibRsbLgLsbRsLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 31; Drug: NDMC 1 µM
bLibRibLhbLhLsbLsbLgbRgbRobRcbLibRibRhLsbRsbRgbRgbLjbRibRhbLcbLgLsbRcb
LjbRcbRibLibRgbLsbRcbRcbRsLsbLibLgbRibRgbRgbLibRibLibRhbLibRhLsbRiLsbL
gbLgbRsbRgbRgbRgLsbRibRgbLcbRcbLjbLsRhbRsbRsbRsbRgbRgbLsbRgbRgbRsbRgbR
gRsmbRgbLsbLsRibLhbLcbLgbLsbLibLgbLgbRgbRibRibRcRsmbLibRcbLhbLobLhLsLs
mbLsLibLgbRsbLibLgbLgbRgbRjbRibRibLibLcRsbLibLgbRgbLsbLibLibRsbRsbRgbL
ibLgLsbLibLsbLsbRgbRibRgbLjbLcLsmbRibLcbRgbLcbLibRsLhLsbLgbRgbLibLsbRs
bLgbLgbRibLgbLibRjbRjRibLobLcbRgbRibLibLibLgLsbLibLsbLgbLsbLgbRsbLiLsb
RjbLhbRibLcbRgbLiLsLsmbLgLsbRsbLgLsbRgbLibRsbLiRgbLibRgbLhbLsbLsbLsbLi
LsbLibLibLibRibRgbLcbRjbLcbRsbRjbLiRsbLibLgbLsbLgbRhbRcbLjbLsbLsbRgbRh
bLibRibRibRcLsbLibLgbLsbLgbLibRjRsmbLgbLgbRjbLcRsbRhbLebRibLibLeLsbRsL
sbLcbRgbRsbLibLsbLiRsbRgbLibRgbLgbLgbLgbRgbLsLibLiLsbRgbLibRgbLgLsbLib
LibRsbRsbLibLsbLgbLgRsbLgbRgbRsbLgbLibRgLsbLsLsmbLsbLsbLsLsmbLgLsbLsbL
gbLsbLsbLsbLgbLgbLsbLsbLgbLgbLsbLgbLgbLgbRgbLibRsbLgbRsLsbLiLsRsLsRsbL
gbLsLsmbLgbLgbLsbLgbLsbLgbLsbLgbLgbLgbLsbLgbLgbLgbLgbRgbLiLsbRjbLibLgb
LsbLgbLsbLgbLgbRsbLgbRgbLibRgbLibRgbLibRsbRsbRjbLibLgLsLsmbLsbLsbLgbLg
bLgbLsbLibLgbLgbLsbLsRsbLgLsbLgLsbLgLsbLgbLibLiLsbLgbLgbLsbLibLibRibRh
bRibLjLsmbLibLibRsbLgbLgLgbLgLgbLgbLgLsbLgbLgbLgbLgbRsbLibLgLsbRsbLsbL
gbLgbRsbLibLsbRsbLgLsbLgbLgbLsbLgbLgbRsbLiLsbRgbLibRgbRsbLhbRsbRjbRcbR
ibLjbRibRgbRgbLjbRcbLebLobRgbLiLsbLsbLcRsbRgbRibLcbLibLcbRibLcbRibLobL
cbRgRsmbRsbRsbLobLcbRibLibLebRsLsbLcLsmbRgbLsbRgbRjLsbLjbRhbRcbRhbRibR
ibLjbLcbRiLsbLgbLsRsbLsLsmbLgbLgbLgbLgbLgLgLgbLgbRgbLibRgbLibLgbLgRsbL
gbLgLgbLgbLgbLsbLgbLgbRjbRcbRhLsbLcbRsRcLsbLcbRcLsbLsbRgbRgbLgbRibRibL
ibRibLjbRibRgbLeLsbRgbLhbRibRjbRhbLjbRibRgbRgbLsbRgRsmbLgbRgRsmbRsbRgR
smbRsbRgbLjbLoLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 32; Drug: NDMC 1 µM
bLcbLibLgLsbRgRsmbRgbLgbRsbLsbLibLgbLgbRgbLsLsmbLgbsbRsbRsbLgbLgbLibRo
RsmbRibLgbRsbRgbLsbRsbRgbRgbRgbLgbRsRsmbRgRsmbLjLsmbLibLsbLgbLsbLsRsbL
gbLgRsbRibRibLsbRgbRgLsbRibLcbLgbRsbLsbLgbLgbLibLobRjbRibRcbRcbRgbRsbL
gbRibRibLsbRibLjLsmbRhbLibRiRsmbRsbRsbRgbLgbRibLgbRibLgbRibLgbRhbLjbRi
bRibLgbLsLsmbRibRsbLsbRgbRiLsbRhbLibRjbRgbLcbLobLsbLgRsbLgbLsbLsbLsbLi
bLgbRibRjbRgbRgbRgbRgbRgbRsbLibLoRsbRsbRsbLgbLgbLsbLibRjbRhbRgbLgbRiRs
LsmbLjbRibLsbRibLgbRibLgbRgbLsbRibLgbRsbRgbRgbLsbRsbRgRsmbRsbRgbRgbLsb
RgbRsbRsRsmbRgbRsbRsbRsbLsbLsbRgbRsbRgLsbRgbRsbLsbRgbRhRsmbLibRgbRgbLc
bLcbLsbRibRibLibRhbRcbLgLsbRibLsbRgbRsbRsbRsbRgbRsbLsbRibRgRsmbLgbRgbR
gbLjbLibLsbLsbLgbRsbRgbRibLsbLsbRgbRgbRgbRgbRgbLsbLgbRibLibRibLgbRgbLs
bRgRsmbRgbLjbRcbLibLgRsbRcbLibRgbRgbLsbRsbRsRsmbRgbRsbRsbRsbRsbRsbRgbR
sbRgbLsbRiRsmbRgbLgbRibLgLsbRsbRsbLsbLibLcbRibLibLjLsmbRgbLsbLsbLgbLib
LcbRibRibLhbRjbRgbRgbLhbLibRgbLibLhbRibRibLsbLgbLgbRjRsmbLjbRcbRsbRsbL
sbRsbRgbRsbLgbRgLsbLgbRibRsbLsbRsbRgbRsbRgbLjbRjRsRsmmbRibLgbRgRsmbLgb
LgbRibRsbRibLgbRgRsmbRgbLsbLsbRgbLhbLgbRgbLibLsbLsbLsbRsbLgbLgLsbLgbLg
RsbRjbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 33; Drug: NDMC 1 µM
bRsbLgbRjbLhbLgbRhbLcbsbLibRhbRcbLsbRibRsRsmbRgRsmbLgbRgbLsbRsbRgbRsRs
mbRsbRsRsmbRsbRsRsmbRgbRgbRgbRsbLjbRcLsbLibRgRsmbRgbRsRsmbRsbRsbRsRsmb
RgbLgbRgbLsbRgbRgRsmbRsRsmbRgbRsbRsRsmbRgbRgbRgbRgbLsbRgRsmbRsRsmbRgbR
gRsmbRsRsmbRsbRgLsbRgRsmbRgRsmbRsLsbLsbRsRsmbRsbRgbRsRsRsRgmmbRgbRgbRg
bRsbRgbLcbLibRcbLcbLobLiLsbLibLgbRhbLcbLhbLibRhRsmbLhbRibRgbLcbRsLsbRc
bRibLgbRobLgbRcbRgbLgbLgbLgbLsRsbLsbRobRibLsbLgbRsLsbRibLsbRgRsmbRsbRs
RsmbRsbRgRsmbRgbRgbRsRsmbLsRsbRsbRsbRsbRgbRsbRsbRgbRgbRgbLjbLcbRcLsbRi
bLjbRibLibRibLjbRsbLcbRsbRjRsmbRibRibRgbRsbRibLjbRibRibLsbRibLgbLcRsbR
hbLcbRobRibLgbLcbLhbLiRsbLibLibLibLgLsbRgbRiRsmbRiRsmbLibLibLhbRibRcbL
gbRgbRibLibRiRsmbRibLsbRibLgbRibRgRsmbLgbRibRgRsmbLgbRiRsmbLiRsbRhbLcb
LcbLibRibRiRsmbRsRibLjbRibLcbLcbRsLibLgRsLsbRobRibRibLgbRiRsmbLgRsbRib
RgbLjbRibLsbRgbRgLsbRsbLsbRgRsRsmmbRsRsmbRgbRgbRgbRgbLjbRhbRibLibRgbRg
bLsRsbRgbRjRsmbRgbRsbRgbLgbLibLiRsbRcbLeLsbLibLibRsRsmbLibLgbReRsmbRiR
smbLgbRgRsmbRsLsbRsbRgbRsRsRsmmbRsbRibLgbLcbRjbRhbLhbLcbRcbLoLibLgbRsR
sRsmmbLgbLhbLsbLgbLgbLgbRgbLhbRibRcbRibRiRsmbLgbLgbRibRibLgbRgRsRsmmbR
gbRsRsmbRsRsmbRsRsRgRgRsmmbRsbRsbRsLsbRgbRgbLsbRgRsmbRsbRsbRgRsmbRgbLj
bLjbLibRcbRibRibLjbsbsbRibLjbRibLsRsLsbsbLsRsbRibRgbRsbLsbRgRsmbLgRsbR
gbRsbRsbRsbRgbRgRsmbRsbRsRsmbRsbRsLsbRsRsRsmmbRgRsmbLgbRgbRibLibRiRsmb
RgbRgbRgbLgRsbRibRibLcbLjLsmbLsLibRcbRiRsmbLsbRgRsmbRibRibLsRsbRsbLsbR
gbLgbRibLgbRibLgRsbRgbLsbRiRsLsRsmbRgRgRgbRgRgRgRsmbRsbRsbRgbRgbLgbRgb
RsbRibLibLcLsmbRhbLoRsbLcbLgbLibLiRsbRhbRcbLibRcbRhbLgbRibLsbRibLjbRib
LjbRiRsmbLjbRgbRgRsLsRsmbRgRsmbRsbRsRsRsmmbRsbRsbRsbRsbRgbLcbLcbRcbRiR
smbLgbRibRgLsbRcbLibLgRsbLibRibRibLibRcbRcbLibLgbLgbLgbRjRsmbLgbRcbRcb
RjRsRsmmbRibLibLibLhbLhbRcRsmbLibRgbRgbRsbRibRgbLgbLjbRhbLibRiRsmbLsbR
sRsmbRsbRgbLgbRibRcLgbRhbLgbLgbLiRsbRcRsmbRcbLgbRcbLgbLibRcbLgRsbLcbLi
bRibRibRibRibRsbRgbLsbRiLsbLsbRgbRsbRsbRgbLsbRgbRsbRgbRgbsbRsRgbRsbRsR
sRsLsmmbRgRsmbRgRgbRgRsRgmbRgbRgRsmbRibLibRgbRibRgbLhbLibLgbLibLiRsbLh
RsbLibRibLgLsbRibRcbLhbRcbRcRsmbRiRsmbRsbRibLgbLibLibLgbRgbRcbLcbLgbLi
bRibRcbRsbRgbRsLsbRgRsmbLsbRgbRsbRsbRsbRsRsmbRgbRsRsRsmmbRsRsmbRgRsmbR
gbRsRsmbRsbRsRsmbRgRsmbRsbRgbRjbLjbLcbLgbRcbRhbRibLiLsbRibLibLgbRjbRib
RcbLgbRsbRsLsbRgbLjbLhbLcbLibLhbLgbLibRibLgbRsbRjRsmbLsRsbRgbRgbRsbRsb
RgbRgbLsbRgbRgbRsRsmbRgbRgbLjRsbRibLjbRhbLsbRsbRgbRsbRsbRgbRgbLibRiRsm
bLiRsbLcbLgbLgbLgbRebRsbRcbLiLsLsmbRcbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 34; Drug: NDMC 1 µM
bRsRsmbsbRgbRsbRgbRgbLsbRgbsbRgbRsbRsbRsRsmbRgbRsRsmbRgbRgbRsbRgbLsbRg
bRsbRgbRsbRgbRgRsmbRgbRsbRsbRgbRgLsRsbLibLjRsbRiRsmbRgbLhbRcLsbRgRsmbR
gbRsbRsbRgbRgbRibLjbLsLhbRibLhbLibRobLjbLcRsbRibLhLsbRjbLobLhbLhbLgbRg
bLsbLgbLgbLgbRebRibRsbRgRsmbRsRsmbRsbRsbRsbsbLsbRsbRgbRsbRgLsRsbRsRsmb
RgbRgbRgbLsbsbRgbRsbRgbLsbRjbLcbLsLibRcbRibLgbRsbRibRgbLgbLobRgbLcbRcb
RgbRjbRgbRsRsmbLgbLcbLcbLibLibLcRsbRibLgbRcbRgLsbLibLibLgbRjbLjbRibLsb
RjbRsLsbLgLsbRhLsbLcbLibRiRsmbLcRsLsbRgbsbLgbLgbLgbLiRsbLgbLiRsbLibLgb
RsbLsbLsbLgbRsbRsbLgbRjbRjbRgbRgbRsbRgbRhbLhbRibLjbRibLcbLhbLhbRjbLcbL
ibRibLsbRgbRgRsmbRgbRgbRsbRsLsbRgbRgLsbLsbRgbRsbRgbRgRsmbRgbRgRsmbRgbR
gbLhLcbRhbRhbRibLcbLcbLcbLsbLgLsbLsbLibRgbLgLsbRibRsbRgRsmbLsbRgbRsbRs
bRsbRgbRgbRgbRgRsmbRgbRsbRgbRgbRgbRjbRhLsLsmbRcbRcbRhbLgbLibRcLsbRcbLh
bLcLsLsmmbRjRsmbRcLsbLibRgbLgbLcbLcbRhRsmbRibLcbLcbLibLsbLgbLgbLgbLgbR
sbRsbLgbRsRsmbLsbLgbLgbLsbLgbLgLsbLsbLobLoRsbRgbLgRsbRgbRgbLsbRsbRibLo
LsmbLibRjbLibRcbRibRsbsbRsbLgbRgbRgbLsbLsbRgbRsbRsRsmbRgbRsbRsbRgbRsbR
gbLsbRsbRsbRgRsRgmbRgLsbRgbRgRsmbRsRsmbRgbRsbRgbLsbRgbRgRsLsmbLobLsbRg
bRsbRsRsmbRsbRsbRsbRsbRibRjbLibLibRjbRiRsmbLjbRcRsmbLibRgbRgbRsbLsbLgb
LcbRebLobRobLcbLcbLcbLgbLibRsRsmbLibLgbLgbRgRsmbRsLgbLjRsbRjbLgbLgLsbL
sRjbRhbLibRjbRgbRsbRsLsbRibRibLjLsmbLebLcbRibRibRgbRgbRsbRgbRsbRsbRsbR
sbRjbLjbRiLsbRgRsmbRsbLsRsbRsbRsRsmbRgbLsbRgRsmbRsbLsRsLsbRsbRgbRsbRsb
RgbRgRsmbRgbRsLsbRsRsmbRsRsmbRgbRsbRgLsbRgbRsRsmbRsbRsbRgbRgbRgbRgbRgR
smbRgbRgRsmbRsbRgbRgbRiLsRcRibRibLhbRcbRgbLjbLsbRibRgbLcbLgbRsbLgbLgbR
cRsmbLsbRgbRsbRsbRsbRsbRsbRgbRsbRsbRgLsbRgRsRsRgRgmmbRgRsmbRsRgbRgbRsR
smbRgbRsRsRgRsmmbRsbRgbRgbRsbLjRsbRgbRsbRsbLsRsbRsRsmbRgbRsbRsbRgRsmbR
gLsbRgbLcbRibRcbRhbRobRjbRibRgbLsbRgbLsRsbRgbRgbLjbRibRgbRibRgbLgbRsRs
mbRgbsbRgbRsbRsbRsbRsLsRsbRgbLjbRjbRibRgbLgbRgbRgbLcLsLiLsmbLgbRsRjbLc
RsbLsbRjbLcbRjRsmbLibLhbRebRjbRibLibRjbRsbRgbRsbRgbRsbRsbRgbRgbRsbRsbR
sbRgbRsRsmbRsLsbRsbRsbRsRsmbRsbRsbRsbRsbRgbRsbRgbRsbRgbRgbRsbRgbRgbRiR
smbRibLibRsbLibRgbLibLjLsmbLibLgRsbLibLobLibRsbRibRibLobLcbRcbRhbLcbLc
bRhbLibLcbLgbLibLgbRsbLsbLgbLibLsbRgbLhbRsbLgbLibLcbLcbLcRsbRibRgbRgbR
gbLsbLgbLjbRcbLjbLhbLibRgbLgbLgbRgRsmbLgbRsbLgRsbRcbLsRsbLhbLibRebRgbR
eLibLgbLhbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 35; Drug: NDMC 1 µM
bRhbRcbRcbRcbLsbRgbRsRsmbRgbRgbRibRgbRsbRsbRibLgbLjbLcbRgbRjbRibRhLsbL
cbRibRgbLjbLcbRjbRcbLsbRgbRgbLsbRsbRgbRsbRgbRsRsmbRgbRsbRsbRgbRgbRgbLs
bLjbRjbLjbLcbLgbRcbRibRibLgbRgbRsbRgbRsbRgbLsbRsbLsbRsbRgbRgbLgbRgbRgb
RsbRsbRsbRsbRgbRgbRsbRgbRgRsmbRgbRgbLgbRibRgbRgbLcLsmbLcbRibRjbRibRgbL
gbRhbLibRibLgbRibRgbRsbRgbLjbRibRiRsmbLhbRibLgbRgbRsRibRibLibsbLsbLsbR
ibRsbRgbRsbRgRsmbRgbRgbRgbRsbRgRsmbRsbRgbRgRsmbRibLibRhbLcbLcbLiRsbRjR
smbRjbRjbRgbRgbRgbLsbRgbRgbLgRsbRibLgbLjbRcbLcbRhbLjbRcbLhbRhLsbRsbRsb
RgRsmbRgbRgbRibRgLsbRsRsmbRsbRgbRibRgbLjbLjbLcbRcbRcbRgRsmbLcLsmbLcbRj
bRjbRgbRsbLsbRgRsmbRsbRsbRgbRgbRgRsmbRsbRgbRgbRsbRsRsmbRgbRgbLsbRgbLcb
LiRsbRjbRhbLgbRibsbsbLhLsbRjbRjbRgRsmbLsbLcbLiRsbRjbRhbRibLgbRgbLgbRib
LobRiRsmbRgbLsbRiRsRsmmbRgbRsbRsbRsbRgbRsLsbRgbRsbLgbRibRjbLgbRhbRiLsb
LhbRibLibLjbLibRjbRgbRgbLjbRiLsbLgbRgbRgbRsbRgbRgbRgbRsbRgbRgbLsRsbRgb
RgbLgbRiRsmbLjbRhbLhbLcbRcbLibRhbLgRsbRibRsbRgbRgbRgbRiRsmbRgbLgbRibRg
RgbRgbRgbRsLsbRgbLsbRgbRgRsmbRgbRsbRgbRgbRsbRgbRgbRgbLgbRibLjbRcbLcbRi
bRibLcbLcbLsbRjbLibRcbRcRsmbLibLjbRcbLgRsbRhbLjbRcbRgbLgbLgbRhRsRsmmbL
gbRibRgRsmbLsbRgbRgbRibLibLhbRsbLibLsbRjbLiLsbLibLiRsbLhbLsLsmbLsRsbRi
bRibRgRsRsmmbRsbRgbRsbRgbRsRsmbRgRsmbRsbRgRsmbRgbRsbRibRiLsbLibRibRsbR
sbRibLjbLjbLibLcbRcbRjRsmbRibLsRsbRgLsbLsLsmbLsLsmbRsbRsbRgbRsbRsbRgRs
mbRgbRgbRgbRgbRgLsLsmbRsbLibRhRsmbRibLibRiRsmbLiRsbRiLsbRhbLhbLjbLibRj
bRhbLgLsbRobRsLibRebRiRsmbLibLsbRgbRcbLgbRhbRibLibLgbRibRibLjbRcbLhbRh
bRgbLiRsLsbRcbLiLsbLibRibRgbRgRgbRsbRgbRgbLgbRibRibLgbRibLgbRibLsbRibL
jbLibLcbLcbRhbLibLibLhLsbLhbLibRsbLiLsbLsbRebLobRibRobRsbLsbRgbRgRsmbL
gbRibRsbRibLgbRgbRgRsmbRgbRgbRgbRgbRhLsbLibRcbLcbLcbRhbRcbRgbLsbRibLgb
RibLjbRiRsmbLgbRibLgbRibRgbRsbRgbRgbRgbRcbLgbRcbLibLcbLgbLibRgRsmbRcbR
iLsbRsLsbRgbRgbRsLsbRsRsmbRsbRgbRibLhbRcbLgbRiRsmbRgRsRsmmbRsLsbRgbRgb
RgbRgbLsbRibLsbRhbLibLcbLibRjbRhbRobLsbLibLebLcLsmbLhLsbLhbLgbLhRsbRib
LibLibLibLibLgbLgbLgbLibLibLgbRjbLibLcbRhbLibRgbLibLgbLgbLiRsbRiLsbLcb
RibLhbRgbLsbLibRsbLibLibRiRsmbRibLcbRjbRcbLgbLsbRibRsbRsbRibRiRsmbLgbR
ibRibLgbRgbRgbRsbRgbRgbRgRsmbRsbLsRsbRibRgRgRgbRgbRgbRgbRsbRsbRgbRgbRg
bRsbRibLsLjbRcbLhbRcbLcbLhLsLsmbRcbRcbRcbLibRgbRsRsmbRhbRibLgRsbRiRsmb
RgbRgbRgbLsbRgbLsbRsbRsRsmbRgbRsbRsbRiRgbRgRsmbRgRsmbRgbRgbRgbRgbLjbRg
bRibLjbLoLsmbRcbRcbLcbRiLsbRgRsmbRgbRgbLibRiRsmbRgRsRsRimmbRgRiRgbRgbR
gbRgbRgbRgbRibRgRsmbRsRsmbRibRiRsLsmbRgbRgbRgRsmbLjbsbLcRsbLiLsbLsbLib
RjbRebLgbRibRsbLsRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 36; Drug: NDMC 1 µM
bLcLsmbLgbLsbLgbLgbLgLsbLgbLsbRsbLgbRcbRibRibLcbsbsbLcbLsbLibLgbLgbLsb
LgbLgbLgbLgbLsbLgbRcbRibRibLebLhLsbLibRcRsmbRcbLjbRcbLcbLcbRcbLcbLgbLg
bLibRibLcbRcbRiRsmbLcbLgbLcbRcbRibRgbRsLsbLsbRibLibLcbLhbRjbLobRcbLjbL
gLsbLhbRhbRsbRhbRibLjbRibRgbLjbRibLsbRgbLebLiRsbLgRsbRcbLobRcbRobRobLe
bLsbLsLsmbLibLsbLsbLgbLsbLsbLgbLgLsbLibRcbRhRsmbRgbRgbLcbLobRibRibRcbR
gbRgbRibLibRcbLibRhbLsbRgbRcbRhbLhbLgbRgbRibRibRgbRibRgbRgbRhbRibRibLi
bLcbLibRcbRcLgbRgbRgbRgbRgRsmbRibLebLcbRcbLgbLhbLjLsmbRibRibRibLgbRiRs
mbRgbRgbLgbRibRgLsbLhbLeLsbLibLibRcbRhbRsbRsbRgRsmbRsbRgbRsbRiRsmbRsbR
ibLibLebLhbRcbRobLibsbRiRsmbRgbRsRsmbRgbRsRsmbRsbRgRsmbRsbLgbLhbLgbRsb
LibLsbRsbLsbLhbRcRsmbRoRsLsmbLibRibLgbRiRsmbRsbRibLcbLcbRjbLcbRcRsmbRc
bLsbLjbRhbLebLcbRgbLibRgbLhLsRsbLhbRcRsmbLhLsbLgbLsbLgbLgbLsbRjbLcRsbL
ibRibLhbRsbLsbLgbLsbLsbLsbRsbLibRebRebLibRjbLcbRebRibLjbRcbLjbRhbRcbLi
bLhbRiRsmbRgbLsbLcbLjbRobLgbRibRcbLcbRcbRgbRgbLcbLcbLhbRebRjbLjbLgbLeb
RjbRcbRibRibRgbRsbRsbLcbLhRsbRsbRcbRebLibLgbRjbRsbRibRsbRcbLcbRcLsbRib
LcbLcbRhbLibLhbLebRcbRebLgbLibLhbReRsmbLebRjbLobRgbRgbRcRsRsmmbRibRcbL
cbRcbRgbLcbLcbRsbLsbRebRjbLcbLsLsmbRibLibLiLsbLgLsbRgbLibLgbLgbLgbLsbL
cbLsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 37; Drug: NDMC 3 µM
bLiRsbRiLsbLibLgbLgbRjbLiRsbRjbRhbLjbRjRsmbRibRibRibLibLibLibLgbRgbLcb
RjRsmbLoLsLsmmbRibRjbLobRsbLibLgbLsbLsbLgbLgbLgbLibRibRjRsmbLcbLcRiRsm
bRibLhbLiRsbRgRsmbLibRibLcbLcbLcbRcbRibLcbLcbLibLiRsbLgbRiRsmbRjbRibRi
RsmbLgbRcbLibRibRibLsbRibRgbRsRsmbRsbRsbRgbRsRsmbRgLsRsbRiLsbLibLibLhb
LibLibRibRgbLsbRgbRgbRsbRsbRcbRiLsbLcLsmbLibRjbRibRibRgbLsbRgbRgbRgbRs
bLsRsbRsbRgbRibLgbRibRgbLibRgbRibLjbRcLsbRcbRhRsmbRgbLsbRjbRgbRjLsbLib
RibLsbRgbRgbRsbRgbRgbRgbRsbRgbRsbRsbRgbLgbRgbLsbRibLsbRgbRgbRsbRgbLsLs
mbRibLcbLobRibLcbRibRjbLhbLcbLibRcbRibRgbLsbRgbRibLgbRgbLsbRsRsmbLcbRh
RsmbLcLsmbRjbRcbRgbRgRsmbLgbLcbRibRcbRsbRiRsmbRsbRsbRgbRgbRsbRgbRsbRgb
RgbRgbLgbLjbLiLsbRcbRibLgbRgbRsbRsbRsbRiRsmbRsbRsbRsRsmbRgRsmbRgbRgbRg
RsmbRsbRgbRsbRgbRsbRgbRgbLsbRsbLcbLhbRhbLcLsmbLhbRobRcbRcbLsbRgbLebRjb
RcbLibRibLsbRiLsbRgbRgbLgbLgbRibRibLeLsbRibRibRsbRsRsmbRsbRgbRsbRgbRgR
smbRsRsmbRgbRgbRgbRgbRgbRgbRgLsbLjbLcbLcbRhbRcbRibRibRibLcbRibRgRsmbLs
bRibLsbRjbRcRsLsLeLsmbLhLsbRibRobRcbRcbLhbRcbRcbLgbLgbLcbRcbRobRibLiRs
bLgbLibRsbRcbRhbLibRibRsbRgbRsbRgRsmbRgbRsbLsbLsbRsRsmbRgbLsRsbRsLsRsb
RgbRgbRgbRgRsmbLsbRibLjbLcbRjbRobLibLcRsbLibLcbLibLibLibRjbLhbRibRcbRh
bLibRibRibLjbRibRgbRsbRgbRgbRgbRsbRsRsmbRgbLsbLcbRjbRcbLibRiRsRsmmbLsb
RgbRgbRsbRgbRgbRsRsLsmbRgbRgRsmbRgbRsbRibLgbRibRsbRgbRgRgbLjbRcbLcbLcL
sLsmmbsbLcbRibRcRsmbRibLsbRgRsmbRgRsmbRsRsmbRgRsmbRgbRgbRsbRgbLgbRiLsb
RiRsRsmmbRgRsmbRgbRgbRgbRgbRgbRgbRgbLcbLcLsmbRcbLcbRhRsmbRhbRcbLebLcbR
jbRobRcRsmbLibRibLibRcRsmbRobLgLsbRsbRhbRhRsmbRgbLgbRibRgbRsRsmbRsbRgb
RsbRobLibLibLibRhbRcbRhbLhbRhbLcbLcbRgbLibLgLsbRsbLibRcRsmbRcRsmbLsbRi
bLgbRibLsbRgbRsbRgbRsbRsRsLsmbRsbRgbRgbRsRsmbRgRgbRgbRsbRgbRgbLgbRiRsR
smmbLjbRhbRsbRgbRsbRsRsRgRgRsmmbRgRgbRgbRgbRgbRibRgbRgRsRgmbRgbRibRobL
ibLhbRibRobRcbRcbRiRsmbLibRibRcbRibLibRibRibLibRiRsRsmmbRgbRgRsmbRibLi
bRcLsbLgbRibLgbRhbLgbRcbLibRcbRcbRgbRsbRcbRgbLsbRgbRsbRsbRgbRgbRgbRibL
ibRhbRsbRsRsmbRsbRgbRgbLsRsbRiRsRsmmbRsbRgbRsbRgRsmbRgbRgRgbRsbRsRgRsm
bRgbRgbRgbRgRsmbRsbRiRsmbLgbRiRsRsmmbLeLsbLcRsbRcbRiRsmbRibRgbRsbRgRsm
bRgbLgbRgbRsRsmbRgRsRgmbRgLsbRgRsmbRgRsmbRgbRiRsmbLsbRibRsLsbRibRhRsmb
LhbLibLibRjbRcbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 38; Drug: NDMC 3 µM
bLsbLgbLgbLsbLsbLgbLsbLgLsbLsbLgbLgbRsLsbLgbRsLsbLgbRgLsbRsLgLsbLsLsmb
LsbLgLsbLsbLgbLgbRsbLgbLgbLsbLgbLsRsbLgLsLsmbsbLgbLgLsbLsbLgLsbLsbLgLs
bLsLsmbLgbLsbLgbRsLsLsLgmbLsLsmbLgbLgLsbLsLsmbLgbLsbLgRsbRgbLiLsbLgbRg
bLiRsbRsbLcbRibLibRsbLiLsRsbRsLsbLgbRsbLgbLsLsmbLgbLsbLsbLgbLgbLgbLsbL
gbLgLsbLgbLgLsbLsLsmbLsLsmbLgRsbLgbLgbLsbLgbLsLsmbLsbLgbLgbLgbLgbLgbLg
bLgbLgbLgbLsbLgbLsbLgbLgbLgbLsLsmbLsbLgbLsbLgLsbLgbLgbLgLsbLgbLgbLsbLg
bRgbRjbRibRibLjbRibLhbLcbRibLibLsbLgbLsRsbLsbLgLsbLsLsmbLibRsLsbLgbLsb
LiRsRsmbRgLsbLibRsRsmbLibRjbLcbRgbRsbRhRsmbRiRsmbRgbRiRhbRgbRgbRgbRibR
gbRgbLgbRibRibLsbRgbRgbRsRsRsmmbRsbRsbRgbRsRsmbRgRsmbRgbRgbLsbRibLibLc
LsmbLibRgbLibRsbLibLibRgbLcbRgbLibRgbLibRsbLgbRgRsmbLibRgLsbLgLsbLsRsb
LgbRsbLgbLgbRgbLhbRgLsbLibRsbLgbLgbLsbLsbLsbLsbLgLsbLgLsbRsLsbRibRgLsb
RsRsmbRsbRgbRsbRgbsbRgbRgRsmbRsRsmbRgbRgLsbLjbLhbLgLsbLgbLsbLgbLsbLsLs
mbLsLsmbLsbLgbLsbLiLsbRsbLgbLsbLsLsmbLgLsbLsLsmbLsbLgLsbLgbLsbLgbLsbLg
bLgLsbLgbLgbLsbLgLsbRsbLgbsbRsbLgbLsbLgbLsLsmbLsbLibRgRsmbLibRgbLiLsLs
mbLgbLsbLsbLgbLgLsbLsbLgbRsRsmbLgLsbRsLsbLgbLsbLsLsmbLgbLsbLgbLsLsmbLg
LsbLsbLgbRcbRibRgbRsRsmbRgbRsRsmbRsbRgbRiLsLsmbLcbLcbRjLsbRhRsmbRiRsmb
LjbLcbLhbRsbRgbRgbLhbLgbLsbLgbRsLsbLiLsbRsbLgbLsLsmbLgbLsbLgLsbRgbLiLs
LsRsLsmbLgbLsbLgbLgbLgbLsbsbLsbLgbLsbLsbLgbLsRsbLgbLgbLsbLgbLgbRgbLiLs
bRsbLgbLsLsmbLgLsbLgbRjbLhbRibLibRsLsbLgbLsbLsbLgbLsbLgbLsbLgbRgbLibLi
bRiLsbLiRsbLsLsmbLgbRsbLiRsbRsbLiLsbRsbLibLgbRgbLiLsbLgbRgbLgbLgbRgbLh
bLiLsbRgbRsbRibRiLsbRibRgbRibLibRgbRiRsmbRgbRiLsbRhbRgRsmbLsLsmbsbLsbR
ibRibRsRibLjbLcLsmbLcbRibRgbLoRsRsmbRgbRsbLibLgbLsbRgbLibRgLsbLibRsbLi
RsbLgLsbLsbLsbRsbLgRsbRsLsbLsbLsbLsbLsRsbLgbLgbRsbLiLsbRsRsmbLiLsbRsLs
bLgRsbLsLsmbLsLsmbLsLsLsmmbLsbLgbLgbLsbLgbLsbLsbLgbLgbLsLsmbLsbLgbLsbL
gLsbLgbLsbLgbLsbLgbLgLsbLsbLgbLsbLgbRsLsbLsLsmbLgbLsLsmbLgLsbLsbLgbLsL
smbLgbRsRsLsmbLgLsbLgbLgbLgLsbLsbLgbLsbLsLsmbLgbLsbLgbLsbLsLsmbLsbLgbL
sbLgbLsbLgbRsLsbLgbLgbRgbLibLgbLiLsbRgLsbLgbLsbLgbLsRsbLibRsLsbLgbRsLs
bLgbLgbRsbLsbLgbLgbLsbLgbLsLsmbLgRsbLsLsmbLsbLgLsbRsbRibRiRsmbRgbRhbLj
LsmbLjbLcLsLsmmbRgbLibRsbLgLsbLsLsmbLsbLsbLsRsbLsbLgRsbLsLsmbLgbLgbLsb
LgLsbLgbLgLsbLsbLsbLgbLgbLgbLgbRsbLgbLgbLsbLgbLsLsmbLgbLgbLgLsbLgbLgbL
gRsbLsLsmbLgbLsbLgLsbLgbLsLsmbLgbLsbLsbLgbLsbLsbLgbLgbLsbLgbLsbLgbLgbL
gbLgLsbLgbLgbLgLsLsmbRgbLgbLsbLgbLgbLgbLsbLgbRsRsmbRcRsmbRiRibRsbRgbRh
bLjbRibRibLcbLcbLsbLsbLsLsmbLiLsLsLsmmbLgbLgbLgbLsLsmbLsbLsbLsbLgLsbLg
bLsLsmbLgbLsbLgbLsLsmbLgbLsbLgbLsbLgbLsLsmbLgLsbLgbLsbLgbLgbLgRsLsbLib
RgbLibRjRsmbLcbRibRiRsmbRgbRgbRhLsLsLgmbLibLsRcbRibRibRibRibRgbLiLsbLh
bRgbLcLsmbRibLcLsmbRgbLobRibRcbRhbRcbRibRgbRiRsmbRibRiLsbRsbLiLsbLhbLi
bRgbLibRsbRjbRgbRgRsmbRgbRgbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 39; Drug: NDMC 3 µM
bRsbRgbRsRsmbRibsbLjbRiLsbRgbRgbRsbRsbRsbRgbRsbRgbRgbLgbRibLjbLcLsmbLh
bRsbsbLgLsbRsbLgbLgbRsbLsbLsbLsbLgbLgbLgbRsbLsbLgbLsLsmbRgbLgLsbRsbLgb
LibLgbRgbLgbLgbRjbRcbRgbLcLsmbRjbRcbLibLiLsbLibLsLsmbRsbLibLgbRsbLgLsb
RsbLgbLgbLsbLsbLsbLgbLgbRgbsbsbLibRjbLibLgbLsLsmbLsLsmbLgbLgbRibRibLib
LgRsbLgbLsbRsbLibRsbRgbLibLgbRgbRgbRjbRgbRgLsbRibRsbRsbRgbRgbLgbLjbLiL
sbLibRjbLibRgbLibRsRsmbRsbLgbLgbLsLsmbLgbLsbLsbLsbLsLsmbLsbLgbLsLsmbLs
bLsbLgbLsbLsbLgbLsbRsbLgbRsbLsbLibLiRsbRgbLsbRjbRibLhbRjbRcbLhbLcbRibL
cbRsLsbLibRsLsbRsbLsbLsLsmbLsbLsLsmbLsLsmbRsbLibRsbLgLsbLsLsmbRsLsbLgb
LsbLgbLsbLsbLsbLsbLsbLgbRgbLibRcbLcbLcbLcbLcbLibLibLibLgbLgbRgbRsbRsbR
gbLgbLgLsbLsbLgLsbLibRgbLgbRsLsbLsbLsbLsbLgbLsbLgLsbLsbLgbRsbLsbLgbLsb
LsbRsbLgbLgbRgbLibRjbLjbRgbLibLgbLgbRsbLsbLsbLsbLsbLgbRsbRsbLgbLgbLgRs
bLgbRgbLibLsbRgbLibRgbRhbRibRibLiLsbLgbLhbLcbRiRsmbRgbLgbLsbLsbLgbLgbL
sLsmbLsbRgbRjbRibLjbRgbRibLobLcbLibRgbRsbLibRsbRgbLgLsbLgbLsbRgbLibLib
RjbLebLcbLcbLgbRibRgbRibLjbRiRsmbRgbLhLsbLcbLsbLhbLsbLsbRgbLgbLgbRgbRs
bLibLgbRgbRgbLgbLgbLsbLsLsmbLsbLgbLgbRsbLgbRjbLibRjbLibLgbLsbLsbLgbLgb
LsbRsLsbLgbRsbRsLsbLibLsLsmbLgbLsbLsbLsLsmbLsLsmbLgbLgbLgbLgbLsbLgbLsL
smbLsLsmbLgbLsbLgbLgbLgbRjbRcbRgbRiRsmbRiRsmbRibRibRsbLgbRgbLgbLgbLgbR
gbRsbLgbLsLsmbRsbLgbLgbRsbLgbRsbLgbLgbLsbLsbRsbLgbLsbLgbLsbLgbLgbLgbLs
bLgRsbRhbRcbLibLcbLibRibRcbRhbLibLhbRcbRcRsLsmbLhbRhbRgbRibRgbRibLsbLg
bLibRibRgbLgbLibLibRsbLgbLsLsLsmmbLsLsLsmmbLsbLgbRsbRsbLgbLgbLgRsbLgbR
gbLibRgbLibLgbRibRhbRibLjbLibLhbRibRhbRibLgLsbRibRgbRibRgbLjbRgbRgbsbL
gbRgbRibLcbLcLsmbRibRjbRibRgbLjbRgbRibRsLsbLibRibLgbRgbLsbRjbLcbLgLsbL
sbRsLsbLibLsbLsbRgbRsLsbLhbRibLibLgbLgbRsbRgbLibLsbRsRsmbLgbLgbLgRsRsm
bLgRsbRsbLgbLgbLsbLsbLsbLsbLgbRsbLgbRgbLibRgbLcbRcbRgbLcbLcbRibLibRsbL
gbLibRgbRgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 40; Drug: NDMC 3 µM
bLgbRsbRjbRibRsbLsbRgbRgbLsLsmbRgbRsbRgbRsbRsbRgbLjbRgbRgbRsRsmbLsRsbR
sbRsbRsbRsbRsbRgbRgRsLjLsmmbRgbRgbsbRsbRsRsmbRgbRsbRgbRgbRgbRsbRgbRgRs
mbRgbRsbRgRsmbRsbRgRgbRgbRgbRgbRgbLjbLcbLhbRcbRhbLjbLibLibRibLcbRibLcb
LcbLcbLobRibRcbLjbLgbRhbRhRsmbRibRsRgbRsbRsbRgRsmbRgbRgbRsbRgbRgbRgRsm
bRsbRgbRsRsmbRsbRgbRsbRgbRsbLjbLcbLiRsbRgbLhbLcbLcbLhLsbLibLgbRgbLibRj
bRobRsbRibRgRsmbRsbRsbRsbRgbRgbRgbRibLhbRibRibRibLhbRhbRcbLibRgRsLsmbL
iRsbLcbRjbRibRibRgbRsbRsbRgRgRgbRgRsRgmbRgbRsbRsRsmbRsbRgRsmbRgbRgbRsb
RsbRgbRgbRgbLjbRgRsmbsbRsbRgRsmbRsbRgLsbRgRsRsRsmmmbRgRsRgRsRgRsRgRsmm
mmbRgbRgbRsbRsRsmbRsRsmbRgbLjbLobRebLobLibLhbRiRsmbRhbRibLjbLcbLibLgbR
gbRjbRiRsmbLsRsbRgbRgbRsbRibRhbRibRhbLcbRibRcRsmbRibLibRsbRiRsmbRibLgb
RibRibLibLjbRibRhbRsRsmbRgbRgbRsbRgbRgbRsbRgbRsbRsbRgbLsRsbRgbRsRsmbRg
RgRsRsRsRsmmmmbRsbRgRsLsmbRsbRgbRgbLjbLobRjbRsbRibLjbLibRjbLgLsbLibRib
RibRsRsmbRgRsmbRgRsRgRgmbRsRsmbRgbRgbRgRgRsRgRsmmbRgRgRgRiRibRgbRgRsmb
RgbRgbRsbRgRsmbRgbLgbRgRsmbRsbLcbRsbLhbRhbRebLjbLsbLhRsbLibRjbLcbRebRg
bRcbLgbRibRsbRsbRgRsmbLsLsmbRibLjbRhbLgRsbRgbRibRibLibRcbRcRsmbRibRibL
ibLibRsbRsLsbLibRgbRjbRibRgbRgbRsbRgbRsbRsbRgbRsbRsbRsbRsbRsbRgbRgbRsb
RgRsmbRsRsmbRgbRsRsmbRgbRsRsmbRsRsmbRgRsmbRgbRgbRgRsmbRsbRgbRgRsLgmbRi
bLcbLhbRjbLcRsbRcbRhbRgbRiRsmbLjbLcRsbLhbRhbRcbRibLjbRjLsbRgbLibRgbRib
LibRcbLcbLcbRjbLhbRgbLiRsbLsbLgbLsbLsbRsLsbLgbLgLsbLibRibRhRiRsmbRgbRi
bLgbLibRiRsLsmbRibRgRsmbLjbRgbsbRsRsmbRgbRsbRsbRsRsRsmmbRgbRsbRsbRgbRg
RsmbRsRsmbRsbRsbRgLsbLjbRgRsmbRgbRgbRgbRgbRgRsmbLcbLcbRjRsmbRjbRgRsmbR
sbRsbRgRsmbRsbRgbRgRgbRgbRsbRsRsmbRsbRgRgRsRgRsRiRsRgRsmmmmbRgRsmbRsRs
mbRsRsRsRsmmmbRgRsRsmmbRgRsmbRsRsmbRgbRsbRgbRgbRsRsmbRgbRgbLgbRgbRgbRg
LsbLcbLhbLiRsbRhbLibRcbRibLsRsbRsLsbRgRsmbRgbRgbRgbRgbRsbRsbLjbRgbLsbR
gbRgbRgRiRgbRsbRgbRgbRgbRgRgRsRsRgmmbRgbRgbLjbLobRjRsmbRcbRgbRgRsRsRgR
eRiRiRhLsmmbRsbRgbRgbLsRsbRgbRgRsRgRsmmbRgRsmbRgRsRiRsRgRimmbRgRsmbRgb
RsbRiLsRsbLcbLcbLiRsbRjLsbLiRsbRjbLhLsRsbRcbRobLsbRibLjbRibLgbRiRsmbRh
bLibRiRsRsmmbLibLcbRsbLibLgbRibLsLsLsmmbRjbRhbLjbRhRsmbLgbLcbRsbRhRsmb
LjbRgbRgbRsbRgRsmbRgbRgLjbRibRgbLgRsRgRsmbRgbRsbRsbRgRgbRsRsmbRgbRgbRg
bRsbRibLibLcbRsbLgbLsbLibRjbRcbRgbRsRsmbRsbRsbRgbRgRgbRsbRgbRsbRgbLsbR
gbRsRsRsmmbRgbRgbRgRgRgbRsbLsRsbRgbRsRsmbRgbRgbRgbLjbRibLobLibLibLcbRi
bRcRsmbRiLgbRgbRsbRgRsmbLsbRgbRgbRgRsmbLgbRiRsmbRgLgbLcbRsbLiRsbLhRsbR
ibRobRgbRgLsLgbRgRsmbRgbRsbRsbRgRgbRgRsmbRgRgbRgbRgRiRgRgRgRsmbRebRgRs
mbRgRsmbRgRsRiRsRgRsRiRsmmmmbRgRsmbRgbRsbRsbRgbLgbLcbLibRsbLibLgbLiLcR
sbLcbLhbRjbLsbLobLgbRgRsmbRhbRiLgbRgbRgRsmbRgLgLsbRgbRsbRgRsmbRgRgbRgb
LjbLibLiLsbLsbLsbLgRsbRjbRcbLjbRcbRsbRgbRibRibLibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 41; Drug: NDMC 3 µM
bRiLsbLjbLcbLgbLibRjbRcbLgbRhbLibRibRsbRibLjbRiRsmbRgbLsbLcRsbLibRebRg
bRibRsbRgRsmbRsRsmbRsbRgbRgbRsbRgbRsbRgbRgRsmbRgbRsbRgbRgbRgReReRsmbRg
RsmbReRgbLebLibLibRjbRibRgbLjbRibRibLibLgbLcLsmbRhbRibRgRsRsRimmbRgbRg
bRgLsbRibRiLsbLebRgbLsRibRsbRgbRgRsmbRsbRgbRgRsmbReRebRiRsmbRgbRibRsbR
gbRgRsmbLjbRibRibRsbRgRsmbRiRiRsRsRemmbRgbRibLgbRibLcbLiRsbLgbRcbRibRs
bLsbRgbRsbRgRsmbLsbRiRibRgbRgbRgRsmbRgbReRsRsRemmbRgbRgRsmbRgbRsbRgbRg
bRgbRebRgRsmbRibReReRsmbRgbRibsbRibLibLhRsbLibRebRsbRgRsmbRsbRgbRiReRg
RiReRiRsmbLgbRibRsbRibLcbLcbRibRcbLjbRjRsmbLibRibRgbRgRsmbRgbRgbRebRgR
smbReRibRcbLebRgbRibLjbRibLsbRjbLibLcbsbRsLiLsbRjbRsbRibRibLsbRiRsmbRg
RgRsmbReReRhRsReRembRgbRgbLjbLcbRjbRibLcbLiRsbRibRibRgbRsbRibRsbRibRib
RgbRgRsRsmmbRiRiRhRsRhRiReRsRimmbRsLsbRibLgbRibRibLjbRibLsLsmbRsLjbLib
LgbLhbRiLsbLhbLsRibLibLgbLgbLgbRcbLsbRiRsRsmmbLgbRcbLibLjbLebRsbLiLsbL
gbLsbLgbLgbLgbLsbLibRjbLibLibLsbLgbLsbLsLsLgmbLgbLsLsmbLgbLhbRhbLobLcb
RibRhbRibLcbLgbLgbLhbLgbRibRibRiLsbRgbRsbRsbRgbRgbRebRgbRibRibLjbRibLs
bRibLjbRgRsmbRgbRsbRgbRgbRgRsmbRiRsmbRiRhReRsmbRgbRgbRebRiRiRebRibRgbR
gbRibRiRsmbRgRsmbRgRsmbRibRgbRgbLjbRibLcbLibLsbLsRsbRibRibRgbLsbRsRsmb
RibRgRsRgmbRgReReRsRiReRimbRgbRibLcbRibRgbRsRsmbRibLjbRibLibLcbRjbRsRs
mbRgbRibRgbRgbRibRgRsmbRebRgRgbRgbRgLsbRsbRibLgbRgbRiReRiRsRsmmbRsLsRs
bRiRsmbRgRebRibRgbRgRsmbRsbRgbLsbLjbLibLgbRcbRsbRiRsRgmbRibRibLsRibRgb
ReRsmbRiRebReRgbRgbRgbRgbRgbRibRiReRgRsmbRibLjbRibLjbRibRgLsLsmbLgbRgb
RsbRgbRsReRsRhRsRgReReRsRiRsRimmmmbRibRibRibReRgbRgbRgRsReRiRsRsRemmmb
RibRgbLgbRibRibLhbLibRhbRhbLsbRibRsbRgbRsbRgbRgbRibLgRsbRgbRgReRsRsRiR
emmbRgbRgbRgbRsLjbReRsmbRibRibLebLhbLgbRibRibRgbRgbRsbRgbRgbRgbRgRsmbR
gbRgbLjbLcbLibLcbRcbRibRsbLsbRgbRsbRgbRgbRgbRgRsmbRgbRgbLsReRiRsRsRsmm
mbRgRsmbRsbRcLsbLcbLcbRjbLibLhLsbRebRcbLjbLcLsmbRebRibRgbRgbRsRgbRibRi
bReRgRsRsReRsRiRsRiReRsReRsRimmmmmmbRgRsRgmbRgbRgbRgbLgbRgRsRsmmbRgbRg
bLgLsbRsbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 42; Drug: NDMC 3 µM
bLsbRgbRgbRsbRsbRsbRgbLsbRsRsmbRsbLsbRsRsmbRgbRgbRsbLsbRsbRgbLsbRibLgb
RsbRgbRgRsmbRsbRsbRsRsmbRsRsmbRsbRsbRgbRsbRibLsbRsbRgbRgLsbRgbLsbLjbRj
bRgRsmbRgbRsbRsRsmbRsRsRsLsmmbRsbRgLsbRsRsmbRsRsLsmbRsbRgbRgbRgbRsbRsb
RgbLsLsmbRgbLsbRiLgbRjbRsbRsRsmbLibRjbRsRsmbRgbRgbRgbRsbRgbRgbLsbRgbRs
RsmbRgbRsbRsbRgbLsbRgbLsRsbRibRgRsmbRgbLsbRgRsmbRgRsmbRsbRgbLsbRgLsbRs
bRsRgbRgbRsbLsbRsbRgbRsbRgbRsbRsbRibLibLjbLjbRjRsmbRhbLibRcbRiLsbLgbRs
RsmbRibLgbRgbRsRsmbRgRsRsmmbRgbLsbRgbRsbRgbRsbRsRsmbRsbRgbLsbRsbRsbRsb
RsbRsbRsbRgbRsbRgbRgbRsbRsbRsbRsbRgLsbRsbRgbRsRsmbRgbLgbRibLgRsbLcbsbR
cRsmbRgLsbRibRgRsmbRibRibRsbLsRsbRgbRgbRgRsmbRsbRgbRsbRgbRgRsmbRiLsbLi
RsbLjLsmbLcbRcbLcbRjbRcLsLsmbLgbRsbRgbsbRgRsmbRsbRsbRsbRgRsmbRgbRsbsbR
sRsLsmbsbRsbRsbRsRsmbRgbLjbLoLsmbLsbRcbLibRibRibLibRcbRibLsbRsbRibLgRs
bRgbLsbRsbRsbRgbRsbRsRsRsmmbRibLgbRibLgLsbLsLsmbLgbRgbLgbRsbRsbLcbLgLs
bRjbRhbLgbRgLsbLsbRsbRgbRgbRsbRgbRsbRibLsbRjbLjbRgbRibLibRsRhbRcbLgbRg
bRsRsmbsbRsRsmbLsRsRsmbRgRsmbRsRsmbRgRsRsmmbRsRgbRsbRsbRgbRgbRsbRsbRsb
RgbRgbsbLoRsbRjbRjbRcbLsbRgbRgRsmbLgLsbRibRibLjbRiRsmbLsbLsbRibRsbRsbR
gbRgbRgbRsbRsbRsRsmbLsbRsbRibLcbRsbRsbRcbRsLgRsbRgbRsRsmbRgbRsbRsbRsRs
LsmbRsbRsbRsbRgRsRsmmbRsbRsbRsbRsbRibRgbRsRsmbLsbRsbRjbRgbLsbLsRsbRgRs
mbLjbRibRsbRsbLsbRsbRgRsmbRgbRgbRgbRsbRsLsbRgLsbRgbRsbRsbRsbsbRgbRgbLo
bLgbRsbsbLibLibLibLgbLgbLsbRhbRgbLsbRgbRgbRsbRsbRsRsLsRsmbRsbRibLgbRgb
LsbRibRsbsbRgbRsbRgbRsbRsbRgbRgbLebRebRcLsbLsRsbRgbRgRsmbRgRsmbRsbRsbR
sbRsbRgbRsRsLsmbRgbRsbRgbRgbLiRsbRgbLsRsbRibLjbRjbLgRsbRibRsbRgbRsbRgb
LsbRsRsmbRsbRgbRsbRsbRgbRgbLsbRibRiRsmbLsbLgLsRsbLibLibLgLsbLsbLiRsbLc
bLibLibRcbRiLsbLcbLcbRsbLsbsbLgbRibsbLhLsbRoRobLjbsbsbRsRcRsmbLsbRgRsm
bRsbLsbRgbRgRsmbRgbLsbRgLsbLsbRgbRgbRgbLsRsbRibLjbLjbLhbRjbRjbLsbLsbRs
bRgRsRsmmbRsRsRimbRgbRsRsmbRgRsmbRgbLgbRibLgRsbLsbRibLjbLibLcbRjbLcbLc
LsLsmmbRcbLsbLsbRibRgbRgbRsbRgbRsRsmbRsbRsbRgbRiRsmbLibRcbLhbLhbLsbLcL
cbLibRjRsmbRsRibRibRibRsbLjbRibLgbRibLsbRibLsbRgbRgRsmbLgRsLsbRibLjbLj
bLibRcbRcbRsbLsLgbRsRjRsmbRsbRgbRgbRgbRsbLsbRibLsbRgbRgbRsbRgbLsRsbRgb
RgbRsbRgbRgbRgbRibLibLjbLgbLsbLgbRcbRoLsbLiRsbLcbRcbRgbRgRsmbRgbRgbLsb
RiRsmbLgLsbRibLibLjbRcLsbRibRsbLgbLsbRibRibLsRsbRsRsmbRgbRsbRgbRsbRgbR
sbRgbRsRsmbRgbLgbRhbLsRsbLsbRibRsbLsbLsRsbRiRsmbLsbRgbRgbRsbRsbRgbRsbR
gbRsbRgbRsbRgbRgbRsbRsbRgbRgbLsbRgbRgbRsLsRsbLsRsbRgbLsbRgbLsRsRsmbRib
LgRsbRgbLsbLjbReRsRsmmbLcbRebRsLsbRcbLibLibLobLcbLibLgbLibLgbLgbLsbLgb
Lgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 43; Drug: NDMC 10 µM
bsbRgbRibLibRcbLgbRibRsbRsRsmbRgbRgRsmbRsbRgbLgbLcbRcRsmbRsbLsbRsbLgbL
sbRhbRgRsmbRsbRsbRgbRgbRsbRsbRgbRibRsbRsbRsRsmbRsbRgbRsbRsRsmbRgbLcbLi
bLsRcbRgLsRsbRgbRsRsmbRgLsbRgLsRsbRgRsmbRsbRsbRgbRsbLcbLhbRibLcbRhbRhR
smbRiLsbLgbRiLsbLcbLcbLhRsbRibRsbRhRsmbRibLgbRcbLjLgbLjbRcbRhRsmbRiLsb
LgbLiLsbRsRsLsmbRibRibLjbRcbLgRsbRibLsbRgbLsRsbRgbLsbRgRsmbRsRsmbRgRsm
bRgbRsbRgRsmbRgLsbRsbRgbLjbLcbRibLcRsbRibLobRcbRoLsbRcbLibRgbRibRiRsmb
RsbLsbRgbLjbRsbRhbLsbRibLsRsbRgRibRsRgbRsbRgbRgbRgbRgbRsbRsRsmbRgbRsLs
bRgbRebRsbRsRsmbRgbRgRsmbLhbRcbLgbRhbLcbRcbRsbRsbLcbLiRsbRgRsmbRjbRebL
ibLcbRsRjbRhbRgLsbRiLsbLsbRibLjbRcbLcbLobRgbLoLsRsmbRsRhbRcbRiRsmbRgbR
sbRsbRibLgbRibRgbRgbRgbRgbLjbRcbLibRiLsbRgbRsRsmbRsbRsbRgRsmbRgRsmbRgb
LsbRiLsbLcbLcRsbRcbRcRsmbLhLsbLibLhbRhbRcbRibRgbLibLcbLsLsLsmmbLsbLsRc
bRcbRibLsLsmbLsRsbRcLsbLgLsbRibRgbRgbLsbRgRsRsmmbLobRhbRcbRhbLibLhbLgb
RcbRibLsbRcbLgbRibRcRsmbLcbLgbRsbRcbRgbRgbLsbRgbRsbRgRsmbRgbRsbRgbRsbR
gRsmbRsbRsbRsbRibLoLsmbLibRcbRiRsmbRibLgLsbRcbLibLhbRibRcbRibRhbLjbRiR
smbRsRsmbRibRcbLcbLgLsbLibLgbLsbLsbLcLsLsRhRsmmmbRcRsmbRcbRcbRibLgbRob
RiRsLsmbLjbRcbLgbRibLsbLsbRibRibLhbRoRcRsmbLcbRsbLhLsbLsRgbLibLibRgbLi
bLobLibRjbRgRsRsmmbRsbLsRsbRgbRsbRiRsmbRsbRsbRgbRsRsmbLcbLeRsbRgRsmbLg
bLibLgbRcbRjbRgbRibLjbsbRcbLibRcbRcbLgbRiRsLsmbsbLsRsbLcbLibLgbRgbLgRs
bRobLjbRjbRobLgbRhbLjbLgbRsbRobRhRsmbLibRibLgbRcbRjbLgbRgbsbRiRsmbLjbR
gbRibLsRsbRsbRsRsmbRgbRsbRsbRsbRsbRsbLcbRibLjbRjRsmbLsbRibRcbLhbLcLsmb
LibRebLsbLgbRibLjbRcLsbLgbRobLcbRcbLgbLhbRgbRibRiRsmbRgbsbLgbRiRsmbRgb
RgRsmbRsbLsbRibLsbRgbLcLsmbLsbLgbLgbRiRebRcbLjbRiRsmbRgbRgLsbRibRsbRsb
RgbRsbLjbRibRgbLjbRsLcbLcRsbRiLsbRhbLibRhbLibRcRsmbLibLcbLgbRgbRiRsmbR
sbRsRsmbRgLsbRgbRsRsmbRgRsmbRsRsmbRgRsmbRibLhbLcbRjbRcRsmbRsRcbLibLcbR
cbRgbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 44; Drug: NDMC 10 µM
bLibLcLsmbRcbLobRsbLgLsbLsbLsbLgbRsbsbRgbLgbLgLsbRgbLsbLgRsbLsbLsRsbLs
RsbLgbLsLsmbLsRsbLgbLsLsmbLgbLsbLgLsbLgbRsLsbLgbLsbLsbRjbLjbLsbRjbRcRs
mbLsbRgbRgRsmbRsbRgbRsbRgRsmbRgbLsbRgbRiRsmbLebLcLsmbRjbLiLsbRjbRoLsLs
mbLgbRibRgbRgbLsbRibRgbRcbRcbRhbRibRcbLgbRgbRgbRsbRjbRgbRgbRsbRgbRsRsm
bRgbRsbRsbRibRsbRiRsmbLibRibRiLsbRsbLsLsmbRgbLsbRgbRsbRsbRgbLsbRgbRgbL
sbRgRsmbRsbRsbRsLsbRgbRgbLsbRsbRgbRsRsmbRibLjbLcLsmbLgbLgbLsbLibRcbRcL
sbLgLsbRibLgbRgbRsbRsbRgbRgbRgbLsbRsbRsbRsbRsbRibLsbRiRsmbRgbLgbRgbRgb
RsbRgRsmbRsRsmbRgbRsbRgbRibLobLoRsbRjbRibRibRsbLjbLiRsbRcbLhbLiRsbLgbL
sLsmbLsbLsbLgbRgbLibLhbLhbLibRibRiRsmbLjbLcRgbLibRcbRhbRibRibRibRsbRiR
smbRsLsbRsbRibRgbLsbRgRgbRsRsmbLgbRgbRgbRgRsmbRgbRgRsmbLsbRsbLsbRgbLsb
RibRsbLsbRgLsbLsbRsbRibRgbLjbLjbLhbRgLsbRcbRcbRgbLibRsbRibRsLsbRsbRgbR
gbRsRsmbRgbRhbRibRibRibLsbRgbRgbLsRsRgRsmbRsbRsRsmbRsRsmbRgbRgbRsbRgLs
bRsbLsbRgRsmbRgbLsRsRsmbRgbRgbLsbLsRsLsbRgLsbRgbRgLsbLsRsbRgbLsbRgRsmb
RgRibRsbRgbRgbRgbRgbLsbRgbLsbRsRgbRsbRgbRgbLgRsRgbRsbLgbLhbLibLgRsRsmb
RsbLiLsbLsbLgbLsLsLsmmbLgbLgbLgbLsLsmbLgbLgRsbLsbLgbRcLsLsmbRibRsbRsLs
bRsbRgbLsbLibLcbRhbLcbRibLobRcbLhbLiRsbLcbLibRiRsmbRibLgbLcbLiLsbRjbLc
RsbRgRsmbLcbRibLoRsbLibLibRgbRcRsmbRsbRibRsbRsbRsbRsbRgbRsbRsbLsbRgbRs
bLsbRsbRgRsmbRgRgLsbLsbLhbLgbRsRsmbRjbRcbLgbRhbLgbRgbLsbRibRgLsbRibRcb
RibRcbLjbRcbLsbRgbLsbRsbRgbRsbRgbRgRgRsmbRgbRsbRsbRibLjbRibRsRgbRsbRgb
RgbRgbLsbLibRcbRcbRiLsbLsbLhbLcbRcbRcbRhbRgbLgbLcbLibLgbRgLsbLibRgbLib
RsRsmbLibRibLobLcbLibLhbLsLsmbLhbRgbLibRgbLibRobRgbRgbRiLsbRcLibRcbRcb
LsRsbRibRsbRgbLsRsbRsRsmbRgbRsRgRsmbRsbRgbRgbRgbRsbRgbRgbRgbRsbRsLsRsb
RgLsbLsbRgbRgbLsRgbRgRsmbRsbRgbLsRsbRgbRgRgbRgbLjbLcRsbRjbRhbLcbLhbRjb
LcbRhbRibRibRibLgbLcLsmbLibRcbRcbRgLsbRgLsbLgRsbRibLcbLcbRebLibRcbLgbR
cbRcbLgbRibLiLsbLgbRsLsbLgLsbLsbLgbLsbLsbLsRsbLsbLgbLgbLgbLsLsmbLsbLsb
LgbLgLsbLgbLcbLcbRcbRgbLobLibRjbLobLsbRgbLobRibLcbLgbLgbLsbRgRsmbLibRj
bLibLgLsbRgLsbLhbLhLsbRibRhbRoLgbRhRsmbLsbRgbRgbLsbRgLsbRgbRgRsmbLsbRg
bRgbRsbRgbRgbLsbRgbLsbRgbRsbLsbRgRsmbLjbRgbRgbRgRsmbLsbRsbRgbRgbLjbLib
LibRgbLiLsbLsbLgbLgbLgbLsbLsbLibLcbLiLsbLibLibLsbLsbLgLsLsmbLsLsmbLsLs
mbLsRsbLgbRcbLsRcLsbRgbRibLsbRiLgbLjbLibLsRsbLgLsRsbLgbRsbLsbLiRsbLiLs
bRib

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 45; Drug: NDMC 10 µM
bLjbLjbLgbLgbLgbLsbLgbLgbLsbLgbRsbRjRsmbRcbLgbRsbRibLgRibRsbRsbRgRsmbR
gbRibLgbLsbRibRgbRgbLgbLgbLsbLobRgbLgbLgbLgbLgbRsLsbLgbLsbLiRsbRsbLsbR
gbLgbLgbLibRjbRcRsmbRsbRgbRgbRgLsbRsbRgbRsbRgbRgbRgLsbRgbRgbLgbRibRsbL
sbLjbRibRibLsbRsbRgbReRgLsbRgbRibLgbRibLsRsbRgbRsLsbLsbRsbRgRsmbRgbRsb
RsRsmbLsbRsbRcbLgbLsbRgbRsRsmbRgRsmbRgbRgRsmbRgbRsbRsbRgLsbRsbLsRsbRsb
LsbRgbRsbRsbRsbRgRsmbRgbLsbRsbRsbRsbRgbRgRsmbRsLebRebLjbRcbRhbLsbRsbLg
bLsbLgbLgbLsbLgLsbLgbLsbLsbLgbRibRcbRhbLhbRibRsbRsRsmbRgbLsbRgbRgbRsbL
gbRgbRgbLsbRsbRsbRgbRgbRsbRsbRgbRgbRgLsbRhRsmbLibLibRjbRgbRgbRsbLsbLsb
LjbRhbLibRhbLgRsbRsbLjbLobRcbRcbRibRgbLsbLgbLgbRibRiRsRsmmbRsbRsbRsbRs
bRgbRgbLjLsmbRibRsbRsbRsRsmbRsLsbRhbRibRsbRibLgbLibLgbRsbLgbLgbLgRsbRj
bLhbRebRcbLsbRgbRsRsmbRsbRgbRgbRgRsRsmmbRgbRsbLsbRgRsmbRsbRgbRgbRgRsmb
RsbRgbRgbLgbRiRsmbLgbRsbLsbRhbLgbRibRgRsmbLgbRsRsmbRgRsmbRsRgbRsbRsRsm
bRgRsmbRsRsmbRsRsmbRsbRsbRgRsmbRgRgRsRgRsmmbRgbRgbRgbRgbLsbRgbRgbRsbRs
RsmbLsRsbRgbRgRsmbLsbRgbRsbRgLsbRgbRsbLsbRgbLsbRibLgLsbLcbLgbRsbLgbLgL
sbRjbRcbLibLibLgRsbLsRsbRjbRobRsbRibLsbRsRsmbLjbRibRsRgbRsbRsbRgbRgRsm
bRgbRsbRgbRsRsmbRsRsmbRsbRgbRsRsmbRsRsmbRgRsmbRsRgbRgbRsbRsRsmbRgbRgbR
gbRgbLsbRgbRsbLsbRgRsRgmbRgRsmbRgRsmbRgRsmbRgbRibLibRibLibRibRsbRibRgb
LhbLgbRcRsmbRebRebRsbRsLsbLgbLjbLibLgbRebLibLibLhRsbLibRgbRibLgbLsbLgb
LiLsbLgRsbLsRjbLibLibLsbRgbLibRsbLgbLgbLibRjbLibRgLsbLgbRsbLgbLsbLgbLg
bLgbLgbLsbLsbRgbLibRhbRcRsmbLsbRgbRgbRsbRsbRsLsbRsRsmbRsbRgbRgbRgbRsbR
sbRsbRgbLgbRgbRsRsmbRsbRgRsmbLsbRsbRgRsmbRgbRsbRgbLgbRgbRsbLsRsRsmbRgb
RgbRgRsmbRgbRibRsRsmbRsbRsbRsbRsbRgbRsRsmbRgbRgbRcRcbRgbRibRgbLjbLibRj
bLgbLsbLibLibLgbLgbLsbLgRsbLgbLgbRsbRsbLsbLgbLibLgbLgbLgLsbRobRcLsbRiL
sbRgbRgbLgbLsbLgbRjbRgbLsbLsbRcbLgbRgbRibRsbLgbRcbRibLibRgRsmbRgbRsbRs
bRsbRibLgbRgbRsbsbRhbLjbLhbRsRjRsmbLjbLhbLhbLsbLgbLgbLsbRjbRibLsbRgRsm
bRibLgbRibLjbRibLsbRsbLsbRgbRgbRiLsLsRsmbRsRsRsmmbRgRgRgRsmbRgRsmbRgbR
gRsmbLsbRsbRhbRgbRgbRgbRsbRgbRgbRgbRgbRibLiRsbRsbRibLsbRgbRibRgbLgbLsb
LsbRibLgbRgbReLjRsbLjbLibRsbLgbLgbLgbLgbLsbLsbLsbLsRsbRhbRsbRsbRsbRgbR
gbRgbRgbRgLsbRgbLsRsbRsbRgRsmbRgbRgbRibLgRsbLgbRibLgbLjbLibLgbLsLsmbLg
bRcbLsRsRsmbRsbRsRsmbRgbRsbRsbRgbRsRsmbRgbRgbRgLsbRgbRgbRsbRsRsmbRsbRg
bRsbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 46; Drug: NDMC 10 µM
bRgbRsbRgbLsbLsRgbRgRsRsRgRsmmmbRgRiLsbRibRgbRsbRgbRgbRgRsRsmmbRibRgbR
iRsmbRgbRgRsmbRgbRgRsmbLcbLcbLcbLgbRibRhbLgRsbsbLcbLibRibLcbLhbLgbRgbL
ibRcbLsbRibRgbRgbLsbRgbRgbRgbRgbRsbRsbRgbRsbRgbRsbRgRsmbRgbRsRsmbRgbRg
bRgRsmbRgbRgbRibRgbRgbRgbLsbRhbRobRcbRhbLjbRibLjbRsRibLgLsbRgbRsbRgRsm
bLgbRibLsbRgbRgbRiRibRsRsmbRgbRgbRgbRgRsRiRiRsmmbRsRsRsmmbRgRsmbRgbRgR
sRsmmbRgbRsbRsRgRsRgRsmmbRibRgbRibRibRgbRgbRgbRgLsRsRsmbRgbRiRsmbRgRsm
bRgRsmbRgbRgbRgbRsbRgLsbRsbRgRsmbRsbRsbRibLhLebLhbLgbLibLiRsbRhbLhbLib
RgRsRsmmbLoLsmbLgbRibLiLsbLibLiRsbRibRibRibLgbRgbRgbRgbRibRgRsmbRiRgbR
gbRgbRgbRgbRsbRgbLgbRibRgRibRsRsmbRiRsmbRgRsRsmmbRgRsmbRiRsmbRgbRibRgb
RgbRibRgRsmbRgbRibRgRsLsmbRgRsmbRgbRgbRiRsRsmmbRgRsmbRgRsmbRgRiRsmbRgR
smbRsRiRsRiRiRsRgRsmmmbRgbRsbRgbRgRsmbRgbRgbRgLsbRibLcbLcbLibRjbLcbLib
LebLibLhbRhbRcRsmbRsbLsRsbRhbLibLcLcbRgbLibLibRjbRobLgbRiRsmbLsbLcbLcR
sbLibRibRibRcbLcbLhbRibLsbRibRsRsmbRsRgbRgRgbRgbRgRgRibRibRiRibRgbRgRs
mbLsbRcbRobRcbRiRsmbLsRsbRibRcRhbRgbRhRsmbLsRsbRibRgbRgRiRiRsmbRgRibRi
bRgbLgbLcbRjbRcbRgbRgbLjLsmbLobLibLiLsbLsbLibRcbRsbRgbRsRsmbRgbRsbRgbR
iRsmbRgRgRiRibRsbRgbRgbRsbRgbRgbRgbRiRcbRhbRibLsbRibLsbRgbRgbRsbRgReRg
RgbRiRgRgRsmbRgRgLsbRgLsLgbRibRgbLsbRibLsbRibRsbRiRsReRiRimbRgRsmbRgbR
gbRibRgbRsbRgLsbLjbLcbLibLsbLgbLgbLgLsbRcbRibLjbsbRsRcbLhbLobLibRjbRcb
LgbRhbLiLsbLcbLhbLcbRibLiLsbRibLgbLhbLibLcbRcbRhbRsbRiRsmbRgbRgbLsbRsb
RgRsmbRgbRgbRsbRsbRjLsbLhbLjLsmbLibLcbLcLhLsbLibLiLsbLibRjRsmbRcbLgbRi
bLsbLsbRcbRobLsRcLsbLsbLibLiRsbRjbRobLjbRiRsRsmmbLsRsbRgbRsRsmbRiRgRiR
sRimbRibRgbRgRsmbRgbRibLcbLobRjbLcRsbRjbLhbLcbLcLsmbLcbLcLcLsmbLibRibL
ibLsbLgbLgbLhLsbRcbLhbRcbLcbLibRibRcbLsbRibLsbRgbRsbRgRiRibRgRibRgRibR
gbLcbRcbLibRsRibLjbLobLgbLibRcbRsbRgbRsLsbRgbRsbRsbLcbLibLgbLsbLsLsmbL
sbLgbLsbLsbRsbLgLsbLgbLsbLgbRjbLibLsbRsLiLsbRcbRhbLgbsbRcbLgbLjbLsbLcb
RibRcRsmbLjbRgbLsbRgbRgbRsRsmbRgRsmbRgbRgbRgRsmbRgRsmbRiRsRiRiRsRsRsmm
mmbRsReRiRiRsmbRgbRjLsbLobLcLsmbRibLobLobRibRiRsRsRsmmmbRiRsmbLibLibRj
bLobRcbRcRsmbLibLsbLibRjbRibRiRsmbRsbRsbRsbRgbRsRsRgRsRgRgRiRiRiRsRimm
mbRiRsmbRgRebRgRgRgbRgRsmbRgRiRsRsmmbLjbLcbLibLibRcbRcbRgRsRsmmbRgRsmb
RgbRgRsmbRiRsRgmbRsRibRgRsRimbRgbLjbRcbLcbLcbRsbLcbRcbRcbLgbRibLsRsbRg
LsRsbRgRsReRiRsRiRiRsRimmmbLsRibLhbLoLsmbLcbRcbRcbRsbLsbRjRsRsmmbLibRc
bRoRsmbRcbRiRsmbLsLsmbRiRsmbRgReRiRiRiRsRimbRgRsRsmmbRgbRgbRgRibRiRsRi
RiRgmbRgbRgbRgbRiRsRsmmbRgRsmbRgbRgRsmbRgbRsbRgbRibReRhRgRsReRsReRiRgm
mbRgbLcbLhRsLsbLsbLsRhbRgbLgRsbsbRibRobRcRsmbRhRsmbRibLibLcbLgbLcbLhbL
ibLgbLibLibRiLcbRibRjRhbRiLsbLibLcbLhbRhbRcbRibLibLibLibLiLibRiRsmbLib
RcbLgbRcRsRsmmbLgLsbRcbLgbLsbRcbLhbRibRgbLgbRcLgbsbLjbLhbRjbLcbLcbRibR
ibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 47; Drug: NDMC 10 µM
bLsbLsbLsLsmbLsbLgbLsbLsbLsbLsbLgbLgRsbLgbLgbLgbLsbLsbLsbLgbLsbLgbLibR
gbLgbRjbLgbRjbLgRsbRsRsmbLibRjbLgLsbLsbLsbLgbLsbLibLsRsbLgbLsbLgbLgbLg
LsLsmbLsbLibLibRgbLibLiRsRsmbRibRcbLjRsbLhbLjbLhbRsbLgbRsbLibRgbLgLsbL
sbRsRsmbLibRsRsmbLibRgbLiRsbLgbRjbRcbRcbRibRjbRibRibLgbLibRsbLjLsmbRjb
RsbLsRsbLibRjbRobLebLhbRjbRhbLhbLsbLgbLsbLsRsLsbLsbLsbLsbLsbRjbRibLjbL
cbRibRjbLibRsbLgbLgbLsbLsbLgLsbLsbLsbLsLsmbLgbLsbLgbLgLsbRsbRsbLsbRjbR
hbRgbLibLcbRgbLibRcbLjbRibLcbRjbRgbRgRsmbRgbLcRsbLgbRsRsmbLibRsbRsbRjL
sbLgbLsbLgbLgbLgbLibRibRhbRcbLhbsbLcbRsbLgbLsbLsbLibRgbLeLsbLsbLsbLgbL
sbRibRiRsmbRibLiRsbRgbRgbRibRgbRgbRibLgbRgbRibRibRibRgbLiLsbRcbLibLibR
obRgRsmbLsbRgRsmbRsbRgbRsbRsbRgLsbLjbLcbLsbLgLsbLgbLsbLgLsRsbLgLsbLsLs
mbLgbsbRhbRibLjbLcbRgbRebRsbLcbLgbLgbRsbLsbRsbLsbLsbLsbRsbLgbLsbLgbLgb
RsbsbsbLsbRsbLsbLibRsRsmbLsbRsRibLjbLcbRibLgbLsbLgLsLsLsmmbRsbLgbLgbLs
bRsLsbLsbLgbRsLsbLgLsbLsbLsbLsbLgbRsLsLsmbLgbRjbsbLgbRsbRsbLibRjbsbLgb
LsbLgLsbLsbLsbLsbLgbLgbLsbLgbLsRsbLsbLgLsbLsbLgbRsRsmbLgbLsLsmbLgbLsbL
sbLsbLsbLgbLsbLsbLsbLgbLsLsmbLgLsbLgbLsbLgLsLibLgbLsbLibRcbRhbRhbRgbRg
bRibRibLibLiLsbLgbLsbLgLsbLobRcbRhbRgbRibRsbRgRsmbRsRsmbRgbLsbRgbRgbRg
bRsbRgbRgbLgbRibRsbRgbLsbRsbRgbRgLsbLgbRcbRcbLhbRiLsbLibRibLcbRgbLcbRi
bRjbRibRibRgbRgRsmbLsbLjLibLgbLgbLgbRsLgRsbLsRsbLgbLgbLsLsLsmmbRsbLgLs
bRsRsmbLibRjbRoRsmbRsbRgRsmbRsbLebsbLgbRsbLgLsLsmbRsLsbLsbLgbRsbLsLsmb
LgbLgbLsbLsbLgbRsbLsbLgLsbLsRsLsbLgbRsRsmbLsbLgbLsbLgbLgLsbLgLsbLsbLsb
LsbLgLsbLsLsmbLgbLgbRjbLhbRibLcbRhRsmbLcbRibLiLsbLiRsbRjbLibRjbRcRsmbR
gbRsbRgbRsRsmbRgbRgRsmbRsRibLiRsbRgbRibRgRsmbRibRibRsbRsbLsbLgbRgbRgbR
ibLcbLebRcbLhbRgbLgbLgbLgbLgLsbLgbLsLgLsbRsbLgbRsbLsLsmbLsbLgbLsLsLsmm
bsbLgbRsbLgbLgbLgbLsLgLsbLgLsbLsbLgbLgbRcbRibRsbRsbRibRgRsmbLsRgbRgbRg
bRgbRgbRibLhbLiLsbLcbRibLibRsbLgLsbLgbLgbLgLsbLsbLgbLsbLgLsbLsbLibRcbR
ebRsRibRhbLhRsbRcbLibLhbLiLsbRsRsmbLgbLgbLgRsLsbLsbLgbLgLsbLgbLgbLgbLg
bLgbLgbRjbRhbRibLgbRgbRgbRhbRibLgbLsbRgbRgbRgbRibLhbLibLcbRcbRibRsbLcb
LibRjbRcbLcbRgbRobLsbLiRsbRjbLiLsbRgbLgbLsRsbLsbLgbLsLsmbLsbLgbLsbLgbL
gbLsbLgbRsLsLsmbLsLsmbLsbLgbLgbLsbLgbLgLsbLgbRcbRibLhbLcbLiLsbRsbLiLsb
LsRsLsLgbLsbLsbLsbLgLsLsRsmbLsbLsbLgLsbLgbLsbLgbLgLgbLibRjRsmbLibRsbLg
bLsLgLsLgLgbLgbRjbLcbLsbRibLibLibRibLjbRjbRcbLhbLsLhbRgbLiLsbRjbLibRgb
LibRgbLgbRjLsLsmbLibLsRsbLsbLsbLgbLgbLsbLsbLgbLgbLgbRibLibRhbRsbLibRgb
LgbLgbLgbLgbLgbLsbLgbRcbLjbLcbRjbLibRsbLgLsbRsLsbLgLsbLgLsbRsbLgLsbLgb
LgbLsbLgLgbLibRjbsbRcbRgbRgRsmbLcbLcRsbRjbRibLobLoRsbRgRsmbLibRgbLibRg
LibRsbLibRgbLgbLsbLibLgbRsLsbLgbLgbLgbLgbLgLsLsmbLsRsbLgbLgRsbLgbLsbLg
bLgbRcbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 110725; End: 111225;
Recording: 2-1; Individual: 48; Drug: NDMC 10 µM
bLsbRcRhbLcbRsbLoLsLsmmbRsLsbLibLibLcbLcbLsbRsRsmbRsbRjbRcbLsLsmbLhLsb
LiLsLsmbLcbRcbLibLgLsbLibRibLcbRibLibRjbLcRsbLcbLgbRibRgbLcbLhbLibReRs
mbRcRsmbLgbRoLgLsRsbRgbLjbLcbLsbRibRcbLjbRcbLibLsLsmbRibRsbRgbLjbLobLg
bLibRibLibLsbsbRcbRcRsRsmmbRhbRibLjbLibRibRjRsmbRibRjRsmbRjbRcRsmbRcbR
jbsbsbRcbRjbRebLjLgLsbRjbRcbRgbRsLsbRgbLoRsbRjbRgbsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 1; Drug: Control
bRibLobLiRsbLjbLgbLgbLgbLgbRjbLgbRsbLgbLsbLgRsbLgbLgLsbLgbLsbLgbLsbLsL
iRsbLibLsbRiRsmbRsbLsRsbLgbLgbRsbRjLsbRibRgbRgbRgbRgbRgbLgbLgbRgbRgbRi
bLsbRcbRgbRobRcbRgbRobRebLcbRgbLobLgbRgbRgbRsbLsbLgRsbRjbRgbRsbRobLgbR
gbRgbRgbRsbRsbRhbRsbLjbRibRjbLjbRcbLgbLibLsbLgbLsbLgRsbLibRgbLgbRobRgb
RibLjLsmbRibRgbRgbRsbRjbLsbRjbRsbRsbRsRsmbLjbRibLjbRcbLcbRibLjbRibLjbR
ibLgbRibLsbRcbRibLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 2; Drug: Control
bRobRgbLsRsbRsbRsbRgbRsbLcbLhbLgRsbRsbLsbLgLsbLsLsmbLgbLgbLsbLgbLgbLgb
LebRsbLsbLgbLibLgbLgLsbLgLsbLsbLsbLsbLgbLcbRgbLsbLsbLgRsLsbLsbLiLsbLgb
LsRsbLsbLgbRsbLcbRsLsbRgbRsbLibLibLibLibRibLgLsbRsbLsbLhbLibLgbLsbLsbL
gbRsbLsbLibLibLgbLgbLsbLsbRgbLcLsmbLibLibLsbLiLsbLibRsbLgbLgbLgbRsbLib
LsbLgbLgbLgbRsbLgbLgbLgbLgbLgbLsbRsbLgbRsbLsbLgbLgbLgbLibLibLgbRsbRgbR
gbRgbRsbLebLgbLsbLgbLsbLsbLsLsmbLsLsmbLsLsmbLgbLsbLgbLgbLsbLsbRsbLgRsR
smbLibLgbLgbLgbLgbLgbLgbLgbLsbLgbLsbLsbLsbLgbLsbLgbLgbLgbLgLsbLgbLgbLs
LsmbLsbLgbLgbLgbLgbLsbLgLsbLsbLgbLgbLsbLgbLgbLgbLgbLgbLsbLgbLgbRsbLgbL
sbLibLgbLsbLsbLsbLsbLgbLsbLsbLgbLgbLgbLsbLgbLsbLgbLgbLgbLgbLibLgbLgLib
LgbLgLsbLgbLgbLgbLgbLsbLgbLgbLgLsbLgbLsbLsbLgbLgLsbLsbLgbLgbLgbLsbLgbL
sbLsbLgLsbLsbLibLgbLsbLgbLsRsbLsbLgbLsbLgLsbLgLsbLgLsbLgbLgbLgbLsbLgLs
bLgbLgbLgbLgbLgbLgbLgbLgbLsbLgbLsbLgbLsbLgbLgbLgbLgbLsLgLsbLgbLsbLgbLs
bLiLsbLgbRsbLgbLibLsbLgbLgLsbLiLsbLgLsbLgbLgbLgbLgbLgbLgbLgbRgbLibLsbL
gbLsbLgbLgbLgLsbLgbLsbLsbLgbLgbLsbLibLibRibRsbRjbRgbRgbRgbLsbRgbRiLsLs
mbLcbRjbRcbRobRcbRibLjbLhLsbLibRgLsbLgbRgbLhbLgLsbLsbLgbLgbLgbLgbLgbLg
LsbLgbLgbLgLsbLsbRsbLcbRibLibRsbLibLgbLgbRsbLsLsmbLgbLgbLgbLgbRebLhbRi
RsmbLibLibLibLgbLgbLsbLgbLsLsmbLgbLgbLgbLsbLgLsbLgbLgbLgbLsbLsbLgbLsLs
mbLgbLgLsbLgbLgbLgbLgbLgbRgbLsLsmbLibLsbLsbLgbLgbLgbLgbLgLsbLsLsmbLgbR
sbLgbLgbLgLsbLgbLgbLgbLgbLgbLsbLgLsbLsbLibLsLsmbLgbLgbLgbLsbLgbLgbLgbL
sbLgbLgbLgbLgbLsbLgbLsLsLsmmbLgbLsLsmbLgbLgbLgbLgbLsLsmbLgLsbLgbLgbLsb
LgbRgbLcbLsbRsbLibLgbLgbLsbLgbLgbLgbLibLgLsbLgbLsbLgbLgbLgbLsbLsLsmbLi
LgbLgbLgbLsbLgbRsbLgbLsbLgbLgbLgbLsLsmbRgbLiLsLgLsbLgLsbLgbLibLgbLgbLg
LsbLgbLgbLgbLgbLgbLgLsbLgbLsRsbLgbLibLgLsbLgbLgbLgbLsbLgbLgbLgbLgbLsLs
mbLsbLgbLgbLgbLgbLgbLgbLgbLsbLgbLgbLgbLibLgbLsbLgbLsbLibLibRgbLiRsbLgb
LgbLgbLgbLibLgbLgbLibLgbLgbLgbRsbLibLsbLiLibLgLibLgbLgbLhbLgbLgbLiLgLs
bLgbLiLgbLibLgLsbLgbLiLsLsLsmmbLiLsbLgbRsbLibRiLsbLiLsbRjbLiRsbLgLsbLg
bLibLgbLgbLibLgbLgLsbLgbLgbLgbLgbRsbLiLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLg
bLgLsbLsLgLsbLgbLgbLgLsbLgbLgbLgbLgbRsbLgbLgRsbLsbRsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 3; Drug: Control
bRobRibRhbRibLgbLgRsbLsbLibLjbRibRsbLgbLibLgbRsbLsbLgbLsbLsbLgbLibLsbL
gbLgbRgbLgbLgbLgbLgbLgbLgbLgbLsbLgbLgbLgbLsLsmbLgbLsbLgbLgbLjbLjbRjbRs
bRibRibLsbRibLjLsmbLibLgbLgbLgbLgbRsbLgbLsbLgbLsLsmbRsbLsbLgbLgbLgbRgb
LjbLobLobLibRgbLibRsbLgbLgbLgbLgbRsbLgLsbLgbLgbLsLsmbLgLgLgLgbLsbLgbLg
bLgLgbLgLsLgbLgbLiRsbLcLobLhbRjbLibLgbRgbLsbLgbLgbLgbLsbLsbLoRsLsbRgbL
jbLjLsmbRjRsmbLjbRibLgbLsbLsbRgLgbLjbRjbLjbLibLiRsbLgbLgbLgbLibLgbRsbL
gbLgbLibLgbRgbRjbLhbLjbRsbLgbLsLsmbLgbLgbLgbLibLsbLgbLgbLsbLsbRgbLibRj
bLebLiLgbRsbRgbRsbLsbLsbLiLsbLgbLgbRgbLgbLgbLgbLgbLsbLsbLgRsbRgbLsbLgb
LsbLgbRsbLgLsLsmbLsbLgbLgbRsLsbLgbLgbLgbRgbLgbLibRsbLgbLcRsbLibLgbRsLs
bRsbRsbLgbRjbRgbRgbRgRsmbLsbLcbLibLsbLibLibLgbRgLibLgbLgbRsbLsbLgbRgLs
bLibLsbLsbLgbLgLsbLgbLgbLsLgLgLsLsmbLgLgbLgbLgLsbLgLsLgbLsbLgbLgbLibLg
bLsLsmbLsbRgbLibLgbLibLcbLcbLgbLjbLjbLibLgbLibLibLgbRsbLibRsbLibLibLsb
LgbLgbLibRsbRsbLgbLibRsLsbLgbLgRsbLgbLgLsLiLgLgLgbLibLgLsbLsbLgbLsbLgb
RsLsbLgLsLgLsbLgbLsbLgbLgRsbLgLgLsbLgbLgbLsbLibLgbLgbLgbLsLgbLibLjbLcb
LcbLhbLiLsbLsbLiLsbLgbLgLsLgLsbLsbLiLsbLgbLgbLsbLgbLgRsbLgbLsLibRsLsbL
gbLgbLgbLgLgbLiLibRgbLgbLibLsbLibLgbLgbLgbLiLgbLibLgLgbLibLgbLgbRsbLgb
LgLsbLgbLgbLgbLgLsbLgbLgLibLgbRsbLgbLgLgLsbLsbLgRsbLibLibLgbRgbLgbLibR
jbLibLibRibLgbLgbLsLsmbLibLgRsbLgLsLgLsLsLgLgLgmbLgLgLgbLgbLgLsLgLsLsm
bLgbLgLgLsbLibLcbLibRgbLgbLhLsbLcLsmbLibRsbLibLgbLsbLiLsbLgbRsbLibRgbL
ibRsbLjbLibLibLgbRibRsbLjbLebLibLibLhbLgbLibLoRsbLcbLibLibLgbLsLgRsbLi
LsbLgbLsLibLgbRgLsbLiLsLgbLsbLgLsLsLsmmbLsbLgbLgbRsbLgbLgbLsbLgbLgLgLs
bLgLsbLgbLsLsmbLgLsLgbLgLgLsLgLgbLibLgbLgLsbLgbLgLgLsbLgLsbLgbLgbLgLsb
RsLsbLgLibLgLsbLiLsbLiLsLiLgLgLgLsLgLgLsLiLsbLgLsbLgLgbLgbLgbLibLgLsLg
bRsbLgLsbLgLsLsLsmmbLgbLgbLsLsmbLgbLiRsbLgbLsbLgbLibLgbLgbLibLgLiLgbLi
bRsbLiLsbLgbRsbLsbLgbLgbLgRsbRsbRsbLibLgbLgLgLgLgLgbLgLgLsbLiLgLsbLgbL
sbLgbLgLsbLgLgLgLsbLiRsLsRgLsbLibLobLcbLcbLibRgbLibLgLibLgRgRsmbLibLgL
ibLgbLsbLsLsmbLgRsbLiLsbLgLsLgbLgbLgLgLgLibLgLsLsLiLsmbLgLgLsbLgLsLsmb
LsbLgbLgbLgLgLsLgLibLgbLgRsLsbLiLsRsLiLsbLgbLgLsLgLsLgbLiLsLsmbLgbLgLg
LsLiLsLgLsbLgbLsbLgLsLgLibLgbLgLgbLgLsLgbLibLgbLgbLgLgbLgbLgbLgRsLsLsL
smmbLgbRsRsmbLiLsbLgbRgbLibLsbLsbLibLgRsbLgLsLgbLgLsbLcbLcbLibLibRjbRc
bLcbLcLsmbLibRgbLibRgbLcbLcbLhbRgbLhbLibLibLgbLgbLsbLiLsbLsLsmbLgbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 4; Drug: Control
bRobRcbRjbRgbRgbRjbRcbLobLjbLsbLsbRobRsLsbLgbRsbLgRsbLgbLsLsmbRsbLgbLg
bLsbLsbLgbLgbRgbLsbLiRsbLgbRcbRhbRibLsbRoLsbLgbLgbLgbLgbLibLgbRjbLjbRo
bRhRsmbLgbLgbRibRibLjbRgbRgbRibLsbLgbLgbLgbLgbRcLsbRobLgbLgbLibLibRsbR
sbRobRcRsmbLgbLibLjbRcbRsbRcbRgbLibLgbLgbLgbRsbLsbLgbLgbRsbLgbLgbLgbRc
bLjbLiRsbLgbLgbLgbLgbRsbLgbLsbLgbRsbLgbLgbLibRsbLgbLsbLgbLgbLgbLsbLsbL
sbRsbLgbLsbRsLgbLsbLgbLgbLsbRsRsmbLgbRsbLsbLgbRsbLgbRgbLgbLgbLsbLibLsb
LsLsmbLgbLgbLibLgbRsbLgbRsbLgbLgbLgbLgbLgbLgbLgbLgbRibLibLgbLgbLgbLsbL
sbLibLsbLsbLgLsbRsbLgbLgbRgbLgbRjbRobRgbLgbRhbLgbRibRsbRgbRiLsbLsbLsbR
sbRibRsbRgbLsbRsbRsbRibLsRsbRgbRcRsmbLgbLgbLgbLgbLgbLgLsbRsLsbLsbLgbLg
bLgbLgbLgbLgLsbRsRsLsmbLgLsLsmbRsbLgbRgbLgLsbLgLsbRsbLgbLgbRsbLgbLgbLg
bLgbRgbRsbLibLsbLiLsbLgbLgbLsRsbLgbLgbLgRsbLgLsbRsbLibLsbLgbLgbLsbLgbL
gbLgbLsbLgbLgLsbLgbLgbRsbLgbRhbRibLgbRcbLibLgbLibLjbLsbLcbLhbLibLibLib
LgbRsbLgbRsbRcbRgRsLsmbRiLsbLgRsbRibRgbLsbRibLgbLibLibRgbLgbRsbLiLsbLc
bReRsRimbLsbRobRibLsbLgbRgbLgbLibRcbLsLjLsmbLibRjbLiLsbLgbLgbRsbLsbLgL
sLsmbRsRsLsmbLgbLsbLgLsbLsLsmbLsbLgbLgbLsbLgbRsbLgbLgLsbLsbLgbLgbLgbRs
bLsbLgbLsbRcbRibLgbRibLgbLsbRgbRibLsbRgbRgbRgbRgbLsLsmbLsLjbRibLjbRibR
gbLibLgbLgRsbLsbLsbLgLsbLgbLsbLsbLgbLsLsmbLgRsLsbLgbLgLsbLgbLgbLsbLgLs
bLsLsmbLgbLgbLgbLgbLgLsLsmbLsbLgbLsbLibLsbLgbLgbLgbLsbLgbLsbLsbLgbLgbL
gbRsbLgbRsbLgLsbLgbLsbLgbLgbLgbLsLsmbLgbLgbLgbRgbRjbRcRsmbRibLgbRgbLib
RsbLgbLsbLgbLsbLgbLsbLgbRsLsbLgbLgbLsbLgbRsLsbLsbLgbLgbLsbLgbLgLsbLgbL
gbRsbLibRgbLibLgbLgbLgbLsbLgbRsbLgbLgbLgbLgbLgLsbLgbLibLibLsbRcRsmbRib
RgbRgbLsRsbLjLjbLgbLgbLgbLsbLgbLgbRsbLcRsRcbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 5; Drug: Control
bsbRobRsbLsbLgbRebRgbRgbRgbLsbRgbLsbRibRsbRsbRgbRgbRsbRsbRgbRcbRsbRgbL
gbRhbLgbLcbRgbLgbLibLobRgbLibLgbLibRgbLhbRgbLgbLgbLgbRibLsbLsbLgbLhRsb
RsbRsbLgbRsbLsbLibRgbLibLibLibRsbLgbRgbLsbLsbLjbLgLsbLgbRsbLgbLsLsmbLg
bLsbLgbLibLibRsbLgbRgRsRgmbLsbLcbRjbLibLsbLgbLgbRsbLgRsbLgbRibLsbRibLg
bRibRgRsmbRsbLsRibLsbRgRsmbRsRsmbRcbLsLgbLgbRcbRibRgRsmbRsbRsbRgbRsbRg
bRgbRsbRsbRgbRgbRgRsmbRsbRgLsbRgbRgbRgbRiRsmbRgbLgbRgbRgbLjbRjbRjRsmbR
sbRibRobRjRsmbRsbRgbRjbRgbLgbRgbRsbLsbRsRsmbRgbRsbRgRsmbRsbRgbRgbRgbRg
RsmbRgbRgbRsRsmbRgbLsbRgbRgbRgbRsbRsbRgbLsbLjbLjbRibRiRsmbRsRsmbRgbRgR
smbRgbRsbRgbRsbRgbRsbRgbRsbRgbRibRcbRhbRibRibLjbLiLsbRibRibRibLgbRgbLg
bRgbRgRsmbRgbRgbRgLsbLsbRsbRgbRsbLjLoRsRsmbLgLsbLibLibLgbLsbLgbLibRibR
gbRgbLsbRgbRgbRgbRsbRgbRsbRsRsmbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRsbRgRsm
bRgRsmbRgbRsLsbRsbRgbRgbRgbRsbRgLsbRsbRsRsmbRgbRgbRsLsbRgbRgbRgbRsbRsb
LoLsmbRhbRoLsLsmbRcbRjLsbLjLibRcbRibRgbRsRsmbRgbLsbRgbRgLsRsbRgbRgbRgb
RgbRsbRgbRgRsmbRsbRgbRgbRsRsmbRgbRsbRsbRjbLibRibRgbRsRgbRgbRsRsmbRgbRg
bLcbLhbLcRsbRhbRibRibRgbRgbRgbRgbLsbRsbRgRsmbRsbRsbRgbRgbRgbLsbRgRibRg
bRgbRgbRgRsmbRgbLsRgLsbRgbRgLsbRgbRsbRgRsmbRgbLjbRiRsmbRsbRibRgbRgbRgb
RgbRgbRgbRgbRsbRgbRgbRsbRgbRsbLcbRsLgLsbLibRjbLgbLibLibRjbLibLsbLgbLsb
LgbRgbLgbLsbLibLgbLibLgbRgbLibRgbLcbRjbRjbLsbLibLiRsbRsbLibLibRsbLiRsb
LgbLgbLibLgbRjbLibRsbLgbLcbRgbLgbRgbLiLsbRsbLibRgRsmbLgLsbsbLibLsbLgLs
bLgbLgbLgbRgbLgbLgLsbRgbLibLsbLibLgbLsbRgbLiRsbRsbLibLsLsmbLsbLgbLsbLi
bLgbRgbLibLibRsbLgbLgbRgbLsbLgbLgLsLsmbRsbLsbLhbRgRsmbRcbRgbRcbLgbRsRs
mbLhbLibLcbRibRibRgbLjbRibLcbLgbLsLsmbLibRgbLgbLsbLsbRsbLibLsbLsbRsRsm
bLgbRgbLgbRjbRibRsRsRsmmbLsbRgbRsbRgbRsbRgRsmbRgLsbRgbRsbRgRsmbRsbRgbR
gbRgbRgbRgbRgbLsRsbRsRsRsmmbRgRsmbRgbRgbRgbRsbLjLsLcmbLibRibLobRibRibL
cbRjbLcbRibLgbLibLgbLgbLgbLgbRjbRiRsmbRsbRgbsbRgbRsbRgLsbRsRsmbRgRsmbR
sbRsbRgbRiRsmbLsRsRsmbRgbRsRsmbRgbRgbRgbRsRgLsbRgbRgbRsbRgbRgbRgLsbRgL
sbRgbLgbLebLsbLibRgbLgLsbLgbLsbLibRsbLibLgLsbLgbLgRsbRgbLgbLgbRgbLgbRs
bLgLsbRgbLgbLgLsbRsbLgbLsbLgLsbRsbLgLsbLgLsLsmbRgbLgbRgbLiRsbRibRibLsb
RgRsmbRsLsbRgRsmbRgbRsbRiRsRsmmbRgbLsbRgbLsRsbRgRsRgmbRgbRgbRgbRsbRgbR
gbRsbRgbRgbRgbLsbRgbLgbRcbRobRebRiLsbLhbLibRebRcbLjbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 6; Drug: Control
bLobLgbLibLgbLgbLibLgbLgbRgbLiLsbLgbLgLsbLsbLgbRsbLsLgbLsLsLgmbLgLgLgb
LgbLgbRsbLgLsLsmbLgbLjRsbLiRsbLhbRjbRcbLhbLhLsbLibLjbLibLgbRgbRsRsmbLj
bLgRsbLgbLiRsbLsLgbLgbLsbRsbLsbLgbLsbLsbLsbLgbLobLcbLiLsbLgbRgbLibLibL
ibRgbRgbRgRjRsmbRgbRgbRsbRgRsmbLsRsbRgRsmbRsbRgbRsbRgbRsbRsRsRgLsmbRgR
sRsLsmmbRsRgRgbRgRsmbRiRsRsmmbRsRsRsmmbRgbRsbRsbRgbRibRibRcbRhbLgbLhbL
ibLsbRsRsmbRgLsbRsLsbLjbLcLsmbLcbRsbLcbLjbRjRgbRgbLsbLhbsbLsbLsRjbLiLs
bLgbRjbLgRsbLgbRjbRhLsbRjLsbRiLsbRjRsmbLibLgLsbLgbLjbRibRgbRcbRhRsmbLs
bLsLsmbRsRsmbRsbRibRgbRgbRsbRgRsmbRgbRsRsmbRgbRgbRgbRgbRsbLsbRgbRgbRsb
RsbRsbRgbLgbLhbLjLsmbLibRsbRsbLibLgbLgbRsLsLsmbLgbLsbLgLsbLsbLgbLsbLgb
LgLsbLsLsLsmmbLsLiLgbLibLgbLgRsbLsbLsbRsLsbLibRgbLibLgLsbRsbLgbLsbLiRs
bLiRsbLibLgbLgbLibLgbLgbLsbLgbLsLgLsbLgbLgLsbLgbLsbLsLiLsLiLsbLgLgLsbL
gLsbLgbLgLsLsLsmmbLgLsbLgLsbLgbLsLibLiLsbLgLsbLgbLgLsbLgbLgLsbRsLgLsbL
sbLgLsbLgbLsLsmbLsbLgbLgRsbLibRjbRjbLjbRcbRebRgbRiRsmbRgbLibLibLcbRgbR
sbLibLgbLgbLgbLgbRgbLsbLsbLiRsbLhRsbLcRsbLibRgbRibLsRgbRsLsbRgRsmbRgbR
sbRgbRiLsbLjbRgbRsRibLsRsbRgbRsbRgbLsbRgbLgbRibLgbRsbRgRsmbLsbRgLsRsbR
ibRcbRgRsmbLibRcbRcbRhLsLsmbRsbRibLsbLsbLgLsbLgbLibLcRsbLibLgbRhRsmbLg
bRgRsmbRgbLsRsbRsRsmbRgbRsbRsbRgRsmbRgRsmbRgbRsRsmbRibLsbRiLsRsbRsbRgb
RibRhbRgLsbLsbRcbRhRsmbLgbLibLgLsbLiLsbLibLsbLgLsRsLsbLhbRsbRhbRcbRgbL
cbLobLgbRsbLhbRjbLibLcbLhbLgbLgbLibLsbLsbLgLibLgLsbLgbLgbLgbLgLsbLgbLg
bLgbLgLsLgLgbLgLsLgLsLsmbLgbLgbLgLsbLgLgLsbLgLsbLgLsbLgbLgbLgbLgRsbLib
LgLsbLgLsbLgbLgbLgbLgbLsbRsbLsLhbLibLsbLgbLgbLgbLgLsbRcLsbRcbLgbRcbLgb
RibRibLgbRibRgbRgbRsbRgbRgbRgbRsbRgbRibLibLhbLgbRjbRcbLjbRhLsbLjbRiLsb
RsbRibLibLjbLibLsbLgbRsbLsLsLgmbLgLsbLsLsmbLgbLgLsbLgbLgLsbLgLsbLgLsLs
LsmmbLsbLibLgbLgLsbLgbLgbLgbLgLsbLgbLgbRsbLibLsbLgLgLgbLgLsbLgbLgbLgLs
bLsLsmbLsbLsLgbLgbLgbLgbRsbLgLsbLgLibLgbLgLsLsmbLgbLibLiRsbLhbLcbLibLj
bLibsbLcRsbLhbLcLsmbLsbLibLiRsbLibLgbRibLibLsbLibLgbLiRsbLsbLibLgbLgbL
gbLsLsmbLsbLsbLibLsbLgbLgbLgbLsbLgbLgLsRsbLsLsmbLgLsbLibLsbLgbLsbLgbLs
bLgbLgLsbLgbLsbLjbLsbLsLsmbLgbLsbLgbLsbLgbLibLcRsbLhbLibRjbRcbLsLibLhL
sbLgbLgbLgLsRsbLibLsbLgbLsbLiLsbLgbLsLsmbLibLgbLgbLgbLgbLgLsbLgbLgbLgb
LgLsLsmbLgbRsbLgLsbLgLsbLgLsbLgbLgLgbLgbLgLsbLgbLgbLgbLgbLgbLgLsbLsbLg
LiLsbLgLsLsmbLgRsbLgRsbLgbLgbLgbLgbLgLsbLgLsbLgLibLgbLgLibLgbLgLgbLiRs
bLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 7; Drug: NDMC 1 µM
bLobLsLsRsmbRhbRcbRjLsbRjbLhbRibRibLsbLgbLgbRsbRgbLibLjbRjbRjRgbLjbLhb
RgbLhLsLcbRibRgbRgbRgbLsLsmbRjRsmbRgbRgbLsRsbRgbRgRsmbRsRsmbRgbRsbRsRs
RsmmbRgRgRgRsRsmmbLsRsbRsbRgRsmbLsbRgbRsbRsbRgbRgbLgbRgbLibLcbLibRcbRj
LsbRgbLibLcbRiLsbRgbRgbLjbLhbRjRsmbRibRgbRsbLsLsmbRgbRgbLsbRgLsbLgRsbR
sRsmbRgbRsbLsbRsbRgRsRsmmbRsRsmbRsbRsbRgbRgbRsbRiLsbLjbLjbLibRcbRibLjb
RjbRhbRsbRsbRjbRgbLgLsbRhRsmbLsbRgRsmbRgRsmbLsbRsbLsRsbRgbRgbLsbRgbRsb
RsRiLsbRsbLjbRjbLjbRjbLjbLiLsbLibRibRibRgRsmbLibRgbLgbLjbLibRgbRgRsmbR
jbRcbLibLcLsmbLoLebLsLsmbLibRjbLibRiRsmbLgLsLgLsbLgbRsbLibRgbLgLsLgbLs
RsbLgLsbLgLgbLibLgbLsbRgbLsbRjbLjLsmbLiRsbRsbLgbLibLsbLgbRsbLgbLsbLgbL
gLsLsLgLsmbLsLsLsmmbLgbRsbLsLgLsLsmbLsbLsLsmbRsbLgLsbLgRsLsbLgbLsLsmbL
gbRsbLgLsbRsbLgbLgbLgbLgbLsbLgLsbLgRsbLgbLgLsbRsbLgbLgbLgbLsbLibLcRsbL
cbLjbLibRjLsbLsbLibLibLsbLgbRgbLgbLsbLgbLgbLsRsbLibLsLsLsLsmmmbRsLsLgR
sLsbLiLsbRsbLgbLibLsbLgLsbLgLsbLgLgLgRsbLsRsbLgLsLsLgmbLgLsLsmbLgLgbLg
LiLsLsLsmmbRsbLibRsbLgbRsLsbLcbLibLhbRgbLhbLhbLhbRhbRgbRiRsmbRgbLgbRsb
RgLsRsbLsbRsRgbRsbRgbRgbRgbRsRsRsmmbRgRsmbRibRsbsbRsLsbLjbLjbRjbLjbRjb
RcbRcbRhLsRsbRibRsRsmbRibRgbLjRsbRgbRsbRsbRgbLsbRgRgRgRsRgRgRsRgmmbRgR
smbRgRsRsmmbRsbRgbLsbRiRsmbRsbRsbRgbRsLsbRgLsbLibRgbLibLcRsbRjbLhbRgbL
cbRgbLibRjLsbLsLgRsbRiRhbsbRsbRgRsRsmmbLsbRgbRgbRgbRiRsmbRgRsmbRgLsbLs
RsbRsbRgbLsbRgbRibLgbRgbRgbRgbRsbRgbRgbLibLibRhbRiRsmbLsRgbRgRsmbRgbLc
bLiRgbRebRibRsbLjLoLsLsmmbLibLhbRgLsbLgbLgbRjbLhbLcbRibLgLsbRsbLcbLhbR
gbLibLibRjLsbRjbRcbLjbLibRsbLgbLsbLgLsbRsbLgRsLsbLiRsbRsbLibRsbLgbLsbs
bRsbRsLibRsbLgLsbLsLgbLsLsmbRsbRsLiLsLsmbLgLsbLgLsbLgbLgbRsLsbLibRgbLi
bLsLsmbsbLsbLgbLsbLgLgLsbLsbLsbsbLgbLgLsbRsbLiRsRsLsLiLgLiLgmbLgLsbLib
LsbLgbLgbLgbRsbLgLsbRgbLgbRcbRcbRibRhbRibRgbLcLsmbRjbLgLsLibLgbRgbLibL
sLsmbLgLiLsLsRsmbLgbLibLgbRjLiLsLgLiLgbLsLgLsLsmbLgLiLgLibLgbLgLsLsLsL
sLiLgLgLgLsmmmbsbRsRsmbLgLsbLgLgbRsbLsLgLsLsLsLgLsmmbRsLibLgbLgbLgLsbL
gLsbLgbsbLsLsmbLgbLgLgbLgLsbLgLsLsmbLsLiLsLgLgLgbLsLgLsbLsLgLsLgLgLsbL
gRsLsbRsbLgLsbLsLiLsLsLgLiLsmbLgLsLsmbLgbLgbLgbRcbRhbRgbRcLsLsmbRhbRcb
LjbRcRsmbLibRgbRgLsbRgbLsbRgbRsbRsbRibRgLsbLgbRibLgRsbRiRsmbLsbRsLsRsb
RiRsRiRgRsmmbRsbRgRsmbRsbRsRsRsmmbRsRiRgRgbRsbRgRsmbRibRsbRgRsmbLsRsbR
gbRsbRgbRgRgbRgRibRsLsRsbRsbRibRgbLsbRjbLhbRibLjbLcbLibLcRsbRgbLiLsbLi
bLcbRhRsmbLibLcbLibRiRsmbLibRibLibRjbLhbRjbLcbRjbLcbLsbLgbLgbLcLiLsbLi
bLgbRibRcbLgRsbRgRsmbLsbRgRsmbRgbRgbLsbRsbLcbLcbLcbLibLhbRcRsmbRiRsmbL
sbLgbRgbRgbLsbRiRsmbLsbRgLsbRgbLgbRiLsbRgbLsbRgbRgbLsbRgbRgRgRgbRgbRgR
smbRsbRgRgbRgbRsbRgRsmbLsLsmbLjLjbLjbReLsbRcbLsbRibRgbRhbLiLsbLibLsbLi
bRjbRiRsLsmbRibRgbRsbLcLgLsbLjbLjbRgbLcRsRiLsbLhbRgbLibRgbLsLibRibLcbL
hbRibLsbRgbRcbRobRhbRcbRgbLjLsmbRibLjbLjLsmbRcbRgbRgRsmbLjbRiLsbRiRsmb
RsbLsRsbRiRsmbRgbRgbRgbLsReRsmbRsbRgRsmbLsbRiRsmbLgbLcbLcbRgbLoRsbRiRs
mbRsbLiRsbLibRebRibLgbRibLgbRgbRibRgbRibRgbLsLsLsmmbRibRiRsLsmbLsbRiRs
mbRsbRsbRgbRgRsmbRgRgRsRsRsRgmmmbLsbRgRsRsRsRgmmmbRsbRsbLsLjbLibRjbRcb
LjbLcRsbLgLsbRsbLibRjbRjbRibRgbRibLgLsbLibRibLcbRiLsbLiLsbLibRgbRcbRhR
smbLgbLsbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 8; Drug: NDMC 1 µM
bLoLsLsmmbRsbLibLjbRjRibRsbRgbLgbRibLgbRhbRgbRibRibLgbLgbLgbLsbRcbRhbR
ibRsbLgLsbRcbRibLgLsbLgbLibLgbRebRibRiLsbLgbRibLgbRoRsLsmbRibRibRgbLgb
RgbLgbRjbRjbRibLgbRibLgbRibLsbRibLsLsmbRobRibLsRsbLibLgLsLsLsmmbLgLsbL
gbLgbLsbLsbLgbLsbLsbLsbLgbLsbLsbsbLgbRsbLgbLsbLsLsmbLgbLiLsLsmbLsRsbLg
bRoRsmbRsRhbLgRsbRibLsRsbRhbLibRcLsbRhbLgbLgbRobLsbRcbRcbLgbLgbLsbLgLs
bLibLsbLgLsbLsbRsRsmbLgLsbLgbLsbLgbLgbLsbLgbLsbRsbLgLsbLsbLsLsmbLgbLgb
LsLsmbLgbLgbLgLsbLgbLgLsLsmbRsbLgbLgLsbLsbRjbLjbLgbLgbLgbLsbLgLsbLsLsm
bLsbLgLsLsmbLgbLgbLgbLgbLsLsmbRsbLgbLgbLsbRgbLgbLgbRcbRhbLgbRibLsLsmbR
gRsmbLsbRibLsLsmbRibRsbRsbRibLsbRiRsmbLgbRiLsbLgbRcbRhLsRsbLgbLgbLgbRo
bRhbLsbLibRgbRhbRsbRgLsbLsLsLsmmbRhLsbRgbLsbRibLgbRobRibLsbRcbLibLgLsb
LgbLgLsbLgbLibLibRgRsmbLgbLgbLgLsbLgbLsbLsbRsbLgbLgbLsbRsbLgbRgbLgbLgb
LgbLgbRcbRhbLsbRhbLsbRiLsbLjbRcbRhLsbRgbLgbLiLsbLgbLsRsbLjbLgbRgbLgLsb
LgLsbLgbLsbLsbLgLsbLsLsmbLgLsbLsbLsbLsbRsbLgLsbLsbLgbLsbLgbLgLsbLsbLsb
LgbLsbRsLsbRsbLgLsbLibRobRoLsLsmbLgbRibLgbLjbLcbLsLsmbLgbLsbLgLsbLgLsL
smbLgbRgbLibLsLsmbRsbLgbLgbLsbLsbLgbLsbLsLsmbLsLsmbLsbLgbLgbLgbLgbLgbR
sbLgbLsLsmbLsbLgbLgbLsbLgbRsbLgbLgbLsbLsbLgLsbLgbRsbLgbLgLsbLgbRcbRcbR
ibRibLgLsbLobRsbRiLsbLgbRoLsbLsbLgLsbRcRsRsmmbRiLsLsmbRsLsbLgbRcbLsbRi
bRcbLgRsbRiLsbLgLsbRhbRgbRibRgbLsRsbRgbLsbRgbRsbRsbRiLgbRgbRgbLebLibLi
bRibRsbRhbRcLsbLgbRgbLsbLibLgbRsbLgbLgLsbRsbLgRsbLgbRsbLgLsbLgLsbLgbRs
RsmbLgRsbsbLsbLgbLgbLsbRsbLgLsRsbLgbRsLsbLgbLgbLsbLgLsbLsbLgbLsbLgLsbL
gbLgbLsLsmbRobLjbLobRgbLiLsbRcbRgbRiLsbRibLgbLgbRobLgRsbRcLsbLgbRhLsbL
gLsbRhLsbRgbLsbRibRgRsmbLsbRiLsbLgbRibRibLgbRibLgbRibRgbLgbLjbRibLsbRg
bRibLgbRcLsLsmbRibLibLiLsLsmbLgbRobRhbRiLsbLgbLgbRcbLsbRhbLgLsbLibLcbL
ibLsbRibLsRsbRibRsbRgRsmbLsbRibLsbRgbRibLsbRcbRgbLgbRiLsbRgLsRsbRcLsbL
sbRibLsbRgRsmbRsLsbRgbRsbRsbRgbRsbRsbRgbRgbRgbLgbRgbRgbRgLsbRsbRgbLsbR
gbRsbLsbRiRsmbLsbRibLjbRhbLgRsbRsbRhbRibLgLsbLgbLjbLgbLgbRsbLgLsbRsbLg
bLgbLsbLsLsmbLgbLsbLsLgbRsbLgRsbLgbRjbRcLsbLgbRibLsbRiLsLsmbRibLsbRibR
sRsmbRgbLgLsbRgbRibLgbRsbRgLsbRibRobLiLsbRsbRgbLcLsmbRsbLsbRhbRgbLcLsm
bRgbLibRsRsmbLgbLgLsbRjbLgbsbRsbLibRjbLgbLgbRgbLgbLgbRsbLgbRsbRsbLgbLg
bRsbLgbLgLsbLsbLgbLsbLgbRsLsbLgbRgbLgbRjLsbLgbLgLsbLgbLgbRoLsbRibRibLg
bRibRcLsbRcbRiLsbRgLsbLsbLibLgbRjLsbLgbLibLgbLsbLsbRsbLgbLgbLgbRsbLgbL
sbLgbLsLsmbLsbLgbLsbLgbLsbLgbRgbLgbLsbLsbLsbLgLsbLsLsmbLgbLgLsbLgbLgbR
sbLgbLsbLgbLgLsbLgbLgbRsbRsbLibRsbLgbLgbLsbLgLsbLgLsbLsbLgLsbRsbLgbRsb
LsbLgLsbLsbLgbLgLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 9; Drug: NDMC 1 µM
bLobLjbLgbLcbRsbRobLgbRcLsbLgLsbLsbLibRcbRobLgbRsbRgbRgbRsbRsbRgRsmbRs
RsLsmbRsbRsbsbRgbRibLsbLsbLcbLsbLibLcbRgbLgbLsbLjbRcbLjbRibRcLsbRcbLgb
LsbLgbLsbLgbLgbLgbLgbLsbRsbLsLsmbLgbLsbLsbLsbLsLsmbLgbLgbLgRsbLsbLsbLs
bLsbLgbLgLsbLsbLsLsmbRsbLgbLsbLsLsLsmmbLsbLgLsbLgRsLsbLgbLgLsbLgbLgbLg
RsbLjRsRsmbRcbLgbLgLsbLsLsmbLgLsbLsbLsLsmbLsLsmbLsLsmbLsLsmbLgLsbLsbLg
LsbLsbLgbLgbLsbLsbLsbLgLsbRsbRsbLsbLgbLgbLgbLgLsLsLsmmbLgbRsbLgbLgLsbL
sbLsLsmbLgbLsbLsbLgbLsLsmbLsLsmbLsLsmbLsbLgbLgbRsLsbLgLsbLsLsmbLsbLgbL
gbLgbLgLsbRgbLgbLgbRsLsbLsbLsbLgbLsLsmbLgLsbLsbLsbLgRsbLgbLsbLgbLsbLgb
LgLsbLgbLsLsmbLsLsmbLsbLgbLgbRsLsbRsbsbLsbLgbLsLsmbLgbLgbLgbRjbLibLibL
ibLgbLibLgbRjbRibRgbLsRsbLsbRibLsbRcbLgbLgbRibRiRsmbRibRiLgbLsbLjbLcbR
sbLgbLsbLgbLgbLgRsbLsbLgbLgbRgLsbLcbRibRgbLibLgbRsbLsbsbLsbLsbLgLsbLgb
LsLsmbRsbLsbsbLgbLgbRsLsbLgbLsbLsbLsbLsbLsbLsLsmbLgLsbLsbLgbLsLsLsmmbL
gbLgbRsbsbLgLsbLsLsmbLgbRsbLsLsmbLgbLgLsbLsbLgbRsbRjbLibRsbLgRsbLgLsbR
sLsbLgLsbLsbLibRgbLgbLgbRjbLgbLsbRsbLgLsbLgbLsbLgRsbLsbLibLsbRsLsbLsbL
ibLiRsbLgLsLsmbRgbLjbLgLsbLsbLsbLgbLsLsmbLsLsLsmmbRsbLjRsbRjbLgbLgLsLs
mbRjbLsbLgbRgRsRcmbsbRcbRcbRhbRgbLibLibLibRgbLgbRsbRsbLgbRjbRhbLjbRibL
jbLcbRjbLcbLibLgbRgbRgbLibLsbLsbLgbLhbRibRsLsbLhbRjbLcbRgbLgbLsbLsLsmb
LgbLsbLsbLgbLsLsmbLgbRsbRgbLibLiRsLsbRsbLgbLgbRcbLgbLgbRsLsbLsLsmbRsbL
sbLgLsbRsLsbLgLsbLsbRsbLgbRsLsbLsbLsRsbLgbLgbsbRhbRibLsbLibLibLgbLibRs
bLibLsbLgbRgbLgbLgbRsRsmbLgbLgbLgLsbLgbLgbLgbLsbLsLsmbLsbLgLsLsmbLsLsm
bLsbLsLsLsmmbLsLsmbLgbLgbRsbLsbLsLsmbLgLsbLgbLgLsbRjbLibRibLiLsbLsbLsb
LsbLsbLsLsmbLgLsbRsbLgbRsbLgLsbLgLsbLgbLsbRgbLibLgbLgbRjbLibLibLgLsLgb
LsbLgbLiLgbLgbRgbRsbLibLgbLgbRsbLgbLgbLcbLiLsbLibLgbLgbLgLsLsmbLgLsbLs
bRsLsLsLsRsmmbLgLsbLsLsmbLsbLsLsmbRsbLgLsbLgLsbRsbLsbLgbLgbLgbRgbLsbLg
LsbLsbLgLsbLsbLsLsmbsbLgLsbLsbLsLsmbLsLsmbLsLsmbLgLsbRsRsmbLgbLgbLsLsm
bLgbRsbLsLsmbLsLsmbLsbLsbLgbLgLsbLgRjbLgbRjbRcLsbRibRcbLsbRoRsmbRhbRsL
sbLgbRjbRcbLjbRibRibRsbLsRsbLgbLjbLibRsbLgbRgbLibLcbRsbRibRgbLsbLiLsbR
ibRibLjbRcLsbLgbRcLsbLgbLibLibLgbLgbLjbRcbRibLsbRibRhbRibLgbLgbLgbLibL
gLsbRjLsbLjbRcLsbRcbLgbRcLsRsbLgbRcbLgbRibRsbLjbRibRcLsbLsLgbLjbRcRsmb
LibLcbRjbRcbLjbRgbRiLsbLgbRgbLsLsmbRsbRibLsbRsbRgbRsbRsbRsbRsRsmbRsRsm
bRsbRsbRgbLsRsbRiLsbLjbLcbRgbLoRsbRgbLibLgbLgRsbRgbLsbLsbLsLsmbLsbLsbR
sLsLsmbLsLsmbRebRibLjbRsRsmbRibLsLsRsRsmmbRhbRgbRcbRsbRsbRjbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 10; Drug: NDMC 1 µM
bRhbRgbRcbRhbRgbRibLcbLgbLibLgbLsbRgbRgbRgbRibRsbRibRgbLibLgbRcbRibRgb
RibLibLibLibRibLgbRsbRjbLcbRcbLibRcbRjbRcbLibRibRibLjbRhbRibRgbRgbRgbR
obRcbRibRgbRjbRgbLebRibRcbRsRibRgbRgbLsbRgbLsbLcbRsbRjbRibRgbLibRibRgb
RsbRgbRgRsmbLgbRgbLsbRgbRsbLgbRsbRgbRgbLgbLibRsbLibLgbLsbLcbLsLsmbRibR
gbRsLsbRsbRjbRibLibRibRcbRgbRgbLgbLgbLgbLgbLibRibLibRibRcLsbRgbRsbRgbR
gbRobRgLibRsbRsbRgRsmbRgbRgRgbRsbLsbRgbLjbLjbRjbRjbRjbRhbLhbLgbLgbLgbR
sbLgbRsRsmbLjbRgbLgbLsLsmbLgLsbLsLsmbLgbLsbLsbLgbLgbRgbLgbRgbLgbLjbLsb
RsRsmbLgbLgbLgbRsbLgbLgbLsbLgbRsbLjbRgLsbLgbLsbLgbLsLsmbLgbLgLsbLgbRsb
LjbRsbRsbLgbLgbLsbLsbRsbLsbLibRcbLsbLobLibLgbLsbRcbRgbRiRsmbRebLgbRibR
gbLsbRgbRgRsmbRgbRibLjLsmbRebLibRebRibLsbRibLibRhRsmbLgbRibLjLsmbRibRj
bLsLsmbLgbRhbRibLibRhbRsbRsbRgbRgbRgbRgbLjbRibRgRsmbLsbRgLsbLgbRgLsbRo
bRiRsmbRgbRsbRgbRgbRgbRibRgbLhbLibRhbRibLgbRibRgbRiRsmbRibLgbRsbLebLsR
iLsbLibLgLsbLhbLgbRgbLibRcbRgbRcbLibRgbRgLsbLibLgbLsbLgbRsbLgbLgbRebRc
RsmbLsbRibLsbRgbRsbRibRsbLibRsbRcbRjbRgbRcbRebLibLibLgbRsbLgbLgLsbRhRs
mbRsbLgbRiLsbLsRcLsbRgbLsbLiRsbLebRcbLebLgbLsbLgbLgbLsbLgRgbLiLsRsLsbR
gbLibLsLsmbRgLsbLgbRgbLibLiLsbRsbLsLibLjbRjbLobLjbRcbLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 11; Drug: NDMC 1 µM
bLoLibLibRsbRsbRsbRgbLcbLsbRsbLobRsbRgbLjbLhbRgbRgbRjbsbRcbRsbLibRgbRg
bRgbRsbRgbRsbRgbRsbLsbRgbRgbRgbRgbLsbRgbRgbRgbRgbRsRsmbRsbRsRsmbRsbRsb
RgLsbLsbRgbLcbLibLsRgbLhbLsbRgbRgbRgbRebsbLgbRsbRsbRsbRgbRgbRsRsmbRsbR
sRsmbRgbRsRsmbRsbRgbLsbRsbRgbRgbLhbLobRjbLgbLgbRsbLibLsLsmbLsbLobRgbRs
bRsbRebLgbRibRgbRsbRsbRgbLsRsbRsRsRsmmbRsbRsRsmbRsbRsRsmbRgbRsbRsbRsRs
mbRsbRsRsRsmmbRgRsmbRgbRsbRsRsmbRsRsRsRsmmmbRgRsmbRsbRsRsmbRgbRgRsmbRg
bRsRsmbRsRsmbRsRsmbRsbRgbRgRsmbRsbRsRsmbRsbRsbRsbRsbRsLsbRgbRsRsmbRsbR
gRsRsmmbRsbRsRsmbRsbRgLsbRgLsbRsRsLsmbRsbRsRsmbRsRsmbRsRsRsmmbRsRsmbRg
bRgRsmbRgRsmbRsbRsbRgRsmbRsRsmbRsRsmbRgbRgbRsRsmbRsRsRsRsmmmbRsbRgbRsR
smbRsbRgbRgbRsRsmbRgLsbRgbRgbRgbRsbRsbRsbRgRsmbRsRsmbRgbRsbRgRsmbRgLsb
RsRsmbRsbRgbRgbRgRsmbRsbRsbRsRsmbRsRsmbRgbRgbRsbRsRsmbRsRsmbRgbRsbRgbR
gRsmbRgbRgbRsbRgRsmbRgRsRgmbRgbRgRgRsmbRgRsmbRsRsmbRgRsmbRgRsRsmmbRgRs
mbRsRgbRsbRgRsmbRgbRgRsmbRgbRgRsmbRgRsmbRsRsLsRsmbRgbRgbRgLsbRgbRgbRsR
smbRsbRgbRsbRgbLsLsmbRgbRgbRsbRgbRgbRgRsmbRsbRsRsmbRgbRsRsmbRgbRgbRgRg
bRgbRgbRsbRsbRgRsRsRgmmbRsbRgbRgbRsLsbRgbRgbReRsLsmbRgRsRsLsmmbRiRsmbL
sbRgbRgbLjbLhbRcbRibRgbLcbRcbRgbLgbRgbRgRsmbRsRsmbRsRsmbRsLsRsbRgbRsbR
gbRsbRgbRsLsbRgbRgRsmbRgbRgbRgbRgbRsRsmbRsbRsRgbRgbRsLsRsbRgbRgbRgbRsb
RsbRsbRgbRgRsmbRgRsRsmmbRsbRgRsmbRsRsmbRgbRsbRgbRgbRgbRsbRsbRgLsbRgbLs
bRgbRgRsmbRsLsbRsbRgLsRgbRgbRsbRgRsmbRsbRgbRgbRgbRsRsmbRgRsRgmbRsbRgbR
sbRgbLsbRgRsRgmbRgbRsbRgbRsRsmbRgRibRjRsmbLjLsmbRibLjbLoRsbLcbLibRsRsm
bLibLsLsLimbLsbLsLsmbLgLsbLgbLgLgbLgLsLsLimbLsbLgbLgbLgLsbLsbLsbLgLsbL
sLsmbLgbRsbLgbLgbLsLsmbLgbLsbLsLsLimbLsbLgLsbRsbLibRsbLgRsbRjLsbLiLsLs
LsLsmmmbLgbLsLsmbLsLsmbLsbLgbLibLgbLsbLibLibLibLibLgbRibLsbLibLhLsLiRs
bLsbLgLsLgbRsbLgbRsbLiLsbRsbLibRsbLgbLsLsmbLsbLsLsmbLgLsbLgLsbLsLsLgLs
LsmmbRsLsbLgbLsbLgLsLsmbLgLsbLgbLsLsmbLsLsLimbLgbLgLsbLgRsbLsbLgLsLsmb
LsLsmbLsLsmbLgbLgbLgbLsbLsbLgLgLgLsbLgLibLgbLsbLgbLsLsLsmmbLgLiLsLsmbL
gbLgbLsLsLsLsmmmbLgbLgLsLsmbLgLgbLgLsbLgLsLsLgLsmbLgLgLsLsmbLgLsLsmbLg
LsLsmbLgbLgLsbLgbLgbLsbLgLsLsLsmmbLgLsbLsbLgLsbLsbLsbLgLsbLgLgbLgbLgbL
gbLgLsbLsLsmbLgbLsLsmbLgbLgbLgbLgLsbLgLsbRsRsmbLgLsbLsLgbLgbRsbLsLsLgm
bLgLsbLgLsLsmbLgbLsLgLsbLgLsbLsLsLsmmbLgLsLiLsLsmbLibsbLsLsLsmmbLgLsbL
sLsmbLgLsLsmbLsLsmbLgLsbLgbLgbLgLsbLgbLsbLgbLsbLgLgbLsLsRsmbLgLsLsmbLs
LsmbLsbLgLsbLgLsbLsbLsLsmbLgLsLsmbLgLsbLgbLgLsbLgLsRsbLgLsbLgbLgLsbLgb
LgbRjbRhbRsbRgRsmbLjLsLsRimmbLhLsbLibRjbRsRcbLjbRcbLjbLibLibLibLgbLgbL
sbLcbRsbLgLsLsmbRsbLgLsbLsLiLsbLgLsbLgbLsbLsbLgbLgLgbLsLsmbRsLsLsLsLgL
smmbLgbLgLsbLgLsbLsLsLiLsmbLsbLgbLgLsbLgbLgLsbRsbLgLsLsmbLgbLgbRsLsbRs
bLgLsLsmbLsbLsbLgbLgLsbLgLsLsmbLgLsbLsLsmbLgbLsbLsLsmbLgLsLsmbLgbLgLsb
LsLsmbLgLsbLgbLibRcbRibLibLiLsbRcbRibRibRebRibLibLibLgLsbRibLjbRibRgbL
sbRgbRgbLsRsbRgbRgbRgbLjbLcbRgbLhLsbRgbLgLgLsbLgLsbLgLsbLgbLgbLsLsmbLg
LsbLgLsbLsbLgbLgLsLsLgmbLsbLsbLgLsbLgLsLsLsLimmbLsLsLgLsLsmmbLgbLsbLgL
sbLsLsLsmmbLgbLgLsbLgbLgbLgLsbLgbRhbRibLjLibRcbRiLsbRibLibRhRsmbLgbLgb
LjLsLimbRsbLgbLgbLsbLiLsbLgbLgLgLsbLgLsbLgbLgbLgbRsbLgbLgRsbLgbLgbLsbL
gLsLsmbLgLsLsmbLsbLsLsmbLsLsLimbLsbLsLsmbLsbLgbLsbLsbLgbLgLgbLgLsbLgLs
LibLgbLibLgLsbLgLsbLsbLsbLgLsLsmbLgbLsLsmbLgLsbLsLsmbLgLsbRoLsbRcbRiLs
bRibLgbRcbLjbRibLgbRibRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 12; Drug: NDMC 1 µM
bLobLsLibRjbLcbLibLibRibRgRsmbRgbLcbLiRsbLsRsbLibLibRiRsmbLgbLhbRjbLcb
LhbLhbLibLgbRibRiRsmbRsbRgbLcbLibLhbRibLgLsbLibLibLibRibLsLsmbLhbLcbLi
bLiRsbLgLsbRjbLibLgLsbRsbLgbLsbLsbLgbLsLsRsmbLgbLgRsRsmbRsbLgbLgLsbLgL
sbLgRsbLgLsbLgbRsbLibRgbLgbLiLsbLgbRibLsbRjbRobLgLsbLsbLhbLgbLsRsbRsbL
ibLgbRibLibLcRsbLsbLgbRjRsmbLibRjRsmbLibRsbRgbRgbLsbRsbRsbLibLjbLgbLgL
sLsmbLibLgRsRgbLgLsLsmbLibRjbLibRsbLgLsLsmbLsbLgbLsLsmbRsRsmbLgRsbLgbL
sRsbLjbRsRsmbLjbLsbLgLsbRsLsbRsbLibLiRgbRibLcbLibLgbLgbLgbLibLgbRsbLib
RgbLcbLibLsbLsbLgbRsbRjbRiRgbRgbRgbRsRsmbRsRsmbRgbRgbRibLcbLcbLibLibRs
bLiLsbLgbLgLsbLibLgbLgLsbRibLsbLibLgbLgbRjbLgLsbRgbLgbLgRgbLgbLsbRsbLg
bLsLsmbLibRebsbRhbRibsbLsbRjbLsRsbRsbRgbRgbLsbRgbRgbRibRsRsmbRgbRgbRsb
LsbRsbLsbRgLsbLsLsmbRibLibLhbLibLiRsbRgLsbLibLibRsRsmbLgbLsLjbLibRsbLg
RsLsbsbLsbLgbLgbLgbRsbLgbRsbLsbRobRsbLgbLgbRsRsmbLgRsbRsbLgLsbRsbLgbLs
RsbRsLgbLgLsbRsRsmbLibRsbLgLsLsmbRsbLgbLgLsbRsbLgbRebLsbLibRsbLgbLgbLg
bRgRsmbLgbRsbLgbLjbLsbLgbLgbLgbRsRsmbLibLgbRsbLgLsbLgbRsbLgbRsRjbsbRcb
LiLsbLgbRoLsbRgbLcRsbRhRsmbLibLcbLibRsRsmbLgbLsRsbLsbLgbRsbLgbLgLsbLgR
sbLjbRsbRsbLsbLjbLgRsbLgbRsRsmbLgbLgbLsbLgbRsbLibLjbLgbRsbLibRgbLgbLib
RgbLibLsbLsbLgbLgbLgRsbRsbLgLsbRsbLgbLsbLgLsbLsbLgRsbLgLsbLsbLgbRsbRsL
gbLgbLgbRibRcbRsbLsbRcbRibLsbRsbRcbRibRgRsmbLgbLsRsbRcbLsbRiLsbLgRsbRh
bRgLsRsbLibRiRsmbRsbRgbLgbRibLsLsmbLibLgbLgbLiRsbLgbRgbRgbLsLgbLgLsbRg
bLiRgLsbRsLgLsbLgLsLsmbLsbLgbsbRsbLiLsbLgLsbLsRsbLgbLsbLibRgbLibLsbLgb
LibRgbLsbLgbRsbLgbLgbRsbLiLsbRgRsmbLgbRsLsbLgbLgbRsRsmbLsLiRsbLjRsbLgb
LibLsbLgbLgbLgbLsbLibLgbRsbLgbLgbRsbLsLsmbLgbLgbLgLsbLsbLgLsbLgbLgbLsb
LgLsbRsbLibLgbLgbLsbLgRsLsbLgbRsbLibRsbLibLsbLgbLgbRsbLgLsbLsbLibRgRsm
bLgbLsbLgLsbRsbLgbLsbLgRsLsbLiRgbLsLibRgbLgLsbRsbLiLsbLgbLgLsLgbRsLgRs
bLgbRsbLgbLgbLgbRsbLsbRsRsmbLsLgbRgbLibLsbLgbLsRsbLgbLsbLgbRsbLgbLgbLg
bLibRibLhbLcLsmbRibLcLsmbLiLsbRgbLibLibLsRsbLiRsbLgbRsbLgbLsLsmbLsLsmb
LsbLsRsbLsbLibLgLsbLsbLsbLgbLsbLgLsbLsbLgbRsbLgRsbLibLsbRsbLibLsbLsLgb
sbLgLsbLsLsmbLgbLgbLsbLgbRsbLgbLgRsbLgbLsbLsbRsbLgbLgbLgbLgRsbLgbLgbLg
bLsbLgbLsLsmbLgLsbLsbLgbLgbLsbLgLgbLsLsmbLsbLsLgbLsbLibLibLhbRibRgbLjb
LibRjbRibLhbRhbRsLsbRhbRoLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 13; Drug: NDMC 3 µM
bLoLsmbLgbRgbRgbRgbRsbLgbRsRgbRgbLsbRgbRgbRsbRsbLsRsRsmbRsbRgRsmbLsbRs
RsmbRcbRibLibRiRsmbRgbRgbRcbRibRgbLsbRgbRgbLsbLgLgbLgbRcbRhbLgbLgbRgbR
gbRcbRibLjLsLsmmbRjbRcbLsbLgbLgbLsbLsbLgbLgbLsLsmbLsbLgbLgbLsbLsLsmbRs
bRcbRjbRiLsbLsbRsbRgbLgLsLgbLgbLgbRcbLjbRhbLgbRgbLsbLibLibRsbLjbLjbRgR
smbLibLgbLgbLsLsmbLgbLgLsbRsRsmbLgbLgbLibLsbLgbLgbLsbRsbLsbLsbLsbLgbLs
bLgbLibLsbLsbLgbRsbLibLcbLgbLgbRsbRgbLgbRibRsbRibRsRsmbRcLsbRiLsbRgbRs
bLibLgbLsbLgbRcbLhRsbLibRibLgbLibRgLsbLsbLsbLgbLgbRsbLgbLsbLgLgbLsbLgb
LsLsLsmmbLgLsbLsbLsbLsbLgbLsbLgRsbLgbLgbLgbRgbLgbRsbLgbRcbRcbLjbRibRgb
LsbRcbLcbLibLsbLsbLibLibLsbRjbRcbLjLsmbRobLjbRcbLsLsmbLibRgbRgbLsbRgbL
jbLibRsLsRsbLsbRjbRibLjbLiRsbLibLsLsmbLgbLsbLsbLsLsmbLgbLsLsRsmbLgbLgb
LgbLsLsmbRsbLsbLgLsbLgbLsRsLsbLsbLgLsbLsbLgbRcbLibLibLjbRcbRcRsLjmbRib
LhbLgbLgRsbLsLgLsbLsbRcbRibLhbLjbRibLjbRibLjbLobLcRsbLgbLsbLgRsbRcbLcb
RibRgbLgbRiRsmbRsbRgRsmbRsbLibLgbRsbRsbRsbRgbRiLsbRsbRsbRsLsbRgRsmbRsR
smbRsLsbLjbLibLibsbLgbRsLsbLsbLibRsbLgbLsbLgbLgbLsbLgbLsbLsbLgLsbLgbRs
bLgbLibLgbLsRsbRsLgbLsbLgLsbLsLsmbLibLgLsLsmbLsbLibLiLsbLsLgbLsbLsLgLs
bLgbLsRsbLgbLgLgbLibLgLsbLsbLgbLsbLgbRjbLibLgbLsbLgbLsbRsLiRsbLsbLgRjb
RjbRcLsbRhbLibRcbRibRibLiLsbRsbRcbRcbRibRgRsmbLgbLibRsbLiRsbLsRsbRsbRi
bsbLjbLibLibRsRgbLibRgbLibRgLsbLgbLgbLsLsmbLsLsmbLgLsbLsbLgbLgbLgbLgRs
LgRsbLsbLgLsbLsbLibLsbLgbLgbLgbLsbLsbLgRsbRibRibLhbLiLsbLgbRgbLiLsbLsb
LsLgLsbLsbLgbLgbLsbLgbLgbLgbLgbLibRcbLibRsbLibLsRsLsbLgLsbLsbLgbLgLsRj
bLibRsbLcLsmbRibRjRsmbLhbLcLsmbLsbLsbLibLsbLgLsbLiRsbRcbRhLsbLjbRibRcL
sbRebRibRgbRcbRgbLgbRcbLsbLgbRibRibRcbRhRsmbRibRgbRgbRsbRgRsmbRgbRsbRs
RgRsRsmmbLsbRgLsLsmbLsbRiRiRsRsmmbLsbRsRgbRsbRgbLsbLsbRiRsRsmmbRsRibRg
bLsbRgbRsbRsbRgbRiRsmbRiRsmbRgbRgLsbRgbRgbRgbRgbRgbRsbLibRibRhbLobLgbL
gRgbLgbLgbLiLsbLgbLgLsbLsbLibRsRsmbLsbLgbRsbRcbRhbLgbRiLjbRgbRibLgbRgb
RgbRiLsLjbRsbRiRsmbRsbRgbRgRsmbRsLsbRgbRsRsmbRgbRgLsbRsbRgRsmbLsRsbLsL
smbRgRsmbRsbRgRsmbRsbRgRsmbRgbRsbLjbLiLsbRcbLjbRibRgbRsbRsRsmbRsbRgbRg
RgLsRgRsmbRsbRsbRibLsRsbRibRcRsmbRibRibRgbRcbLiRsRsmbLjbRibRgbRgbRgbLi
bLcbLcbLibLsbRsbRcLsRsbRhRsmbRgLsRsLsbRibLibLcbRsbLsbLibLiLsLsmbLsbLib
RgbLgbLgLsbLsRsLibLsLsmbLgbLsLibLgLgbLiLsbLsbLsbLiRsbLgLsLgLsbLgLsbLgb
LsbLibLgbRgbLgbRsbLibLgbRgbLgbRsbLibLcRsbLcLsmbLibRcbRibRhbLiLsbRgbRcb
RcbRibRibLjbLibLiLsLsmbRgbRcbRibLibRgbRgbRhLsbLibLibLgbLiRgbLibRsRsmbL
ibRgbLibRsLsbLsbLhRgLsbsbLgLsbLgbLsbLgbLiRsRgLsbLibLibRsbLgbRjbLhbLsRs
bLsLibRsbLibLibRsbRsbLgbRcbRiLgbRcbRgbRgbRcLsbRibRhbRgbRibRsbRsbRibLsR
sbRibRsbRibRsRsmbRsbRiRsmbLjbRcbRsLsbRibRsbRgbRgbRsRsmbRsbRhbLgbLsbRib
RgbLgbRibLjbLsRsbLcbRgbRcbLsRcLsbRcbRibRcbRgRsmbRibLibRcbLgbRgRsmbRiLs
bLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 14; Drug: NDMC 3 µM
bLibLgbLcbLhbLiRsbLgbLibLgbLgbLcRsbLibLgbLgbRgbRgbLsbLgbLibRjRcbLjbRcb
LgbRgbRcbRhbRcbRjbRgbRgbLsLsmbRsRgbRgbLjbLcbLibLcbLsbLibLsbLsbRsbLcbRc
bLcbLcRsbLgbLsbLgbLjLsRsmbLgbLgLsbRgbLibRgbLsRsbLgbsbRgbRcbRcRsmbRsbLg
RsbLgbRjbRcbLsLsRsmbRsbLgbRcbRsbLsbLsbRiRsmbRsbRibRgbLsLgRsbRsbRgbRsbR
sRsmbRsLsbRiRsmbRgbRgRiRibRgbRgbRibRgbRsbRgbRgLsbLgbLcbLhbRibLgbLgbLgb
LgbLibsbsbLsbRobRcLsbLgbLibRobLsLsmbRcRsmbRibLsbRsbRgbRgbLibRgLsbRgbRs
RsmbRibRiLsbLjLsmbLcbLibRgbRjRibRgbLsbLsbRgbRgbRgRsmbRgRsmbRgbRgbRgbLg
bRsLsbRiRsmbRobRcbRhbRgbRgbRgbRsbLgbRiRsmbRsbRgRiRsmbRgbRiRsRsmmbRgRsm
bRgbRgLsbRiLsbRgRsmbLsbRgbRgbRgbRiRsmbRgbRgbLsbRsbRibRiRgbRgbRgbRgbRgb
RgbRgbLsLsLsmmbRgbRgbLsbRgbLsbRgRsmbRgbRgbRgbLsLsmbRgbRibRgLsbRibRgRiR
smbRgbRgbRgbRgbRgbLsbRgRsRsmmbRiRiRibRgbRgRsRimbRgbRsbRsbRsbRgRsRiRsRi
mmbRgbRgbRgbLgbRgbRgRsmbRgLsbRgRsmbRgbRsbRgbRgLsbLsbRgbRjLsbLhbRiRsmbR
gbRgbRgbRgbRgbRgbRgbRsbLgbRgbLsbRgLsbRsbRgRsmbLsbRgRsmbRgbRgbRgbRsbRgb
RgbLgbRebRibLsRsbRsbRgRsmbRiRibRgbRsbRjbRgbRgbLsbRgRsmbRgbRgbRgbRgRsRs
mmbRgbRibRgbLibLgbRcbRiLsbRcRsmbRcbRcbRcbRgRgRsmbRgbRibRgbLsbsbRgbRgRs
mbRgbRgbLsbRgbRibRgbRgbRgbRgbRgbLgbRibRiLsbLibRgbLcbLibLcbLcbRcbRcbRgb
RibRgRsmbRsbRgRsmbRgLsbRjbLjbLiRsbLjLgbLhbRcRcbRgRsmbReRiRiReRibRgbRsb
RgbRsbRgbLsbRgbRgbRobRjLsbLiRsbRgRsRsmmbRgRgRsRiRsmmbRibRibRgbRgbRgbRs
bRgbRgbRgbRsbLsbRgLsbRgbRsbRgRsmbRsbRgRsmbRgbRgRsmbRgRsmbRgRsmbRgbRgbR
gbLgLsbRgbRsbRgbLgbRgbRgLsbRsbRgRsmbLibLcbRibRhbRgRsRsmmbRsbRsbRiRiRgb
RibRgbRsbRgbRgRsmbRgbRiLsbRhbLjLsmbRcbRcbRcbRibRgRsLsRimbRgbRgRsmbRgbR
gLsbRgRsmbRiLsbLjLsmbRcRsmbRiRsRsmmbRcbRsLsbRcRcbRgRgbRhbRibRgbRgbRiLs
bRsbRgbRgbLjLsmbLsbLsbRibRgbRsRsmbRibRsbRgbLgbRhLsLsmbRcbRcbRcbRcLsRsb
LebRcLsbLcbLibLibLgRsbLjbLcbLcbRiRsRsmmbLsbLibRsbLibLgbRcbRcbLsbRgbRib
RibLgbRhbRibLgbRibLibLsLgLsbLhbRibLiRsbLgLsLsmbLgLsbLgbRsLsbLgLsbLgbLg
bLsLhbRiRsRsmmbRgbRibRibRsbLsbRgbRsbRjbRobRibRcbRgRsRimbRgbLsbRibLsbRg
bRsbRibRgbRsbRgbRgbRgbRgLsbRgbRgbRibRgbRgbRgLsbRgbRgbLsbRibRibLsbRibLs
bLsRgbRgbRgbRgLgbRgbRsbRgRsmbRsbRgbRgRsmbRgbRgbRgbRgRsmbRgbRgbRgbRsbRg
bRsbRsbRgbRgbRgbRgbLsbRibRsbRgbRibRgbRgbRgbRsbRgbRsRiRsmbRgRsRimbRgbRg
bRgbRibRgbRgbRgbRgbRgbRgbRgLsbRgbRgbLjbLibLgbLibRobRibRgbLsbRcbRcbRibR
ebRgbRiRsmbLsbRgbRjbLcbLhbLgbRibLgbLibLibRjbLibRoRsmbRsbLgbRibLgbRsRsm
bRsRiLsbLgbRibRibRgbLsbRgbRgbLsbRgLsbRgbRgbRgbLsbRgLsbRgbRgbRgbRgRsmbL
sRsRgbRgbLsbRgbLsbRibRgbRibRgbRgbRgbRgbRgRsmbRgLsbLjbLobLcbLcbLhbRcbRc
RhbLgbLgbLgbRjRibLcLsmbRcbRsbRgbLsbRibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 15; Drug: NDMC 3 µM
bRobLsbRgbRgRsmbRhLsbRibRibRgbRsbRsLsbLjbsbLsbRibRgbRibRhbLgLsLsmbRsbL
sbLsbRcRsmbRcbRibLgLsbLgbLgbLibLgbLsbRsbLibLgbLsbLsbLgbLgbLsbLgbRsbLgb
LsLsmbLiLsbLgLsbLgbLgbLgbLsbLsbRsbLgbRsbRsbLgbLsbLgbLgbLsbLsLsmbLgbLgL
sbLsLsmbLgbLibRgbLibLibRgbRgbRsbRsbRjbLhbLibLgbLsRsbLgLsbRsbLgbLsLsmbL
gbLgLsbRsbLsLgbLsbLgbLgbLsbLsbLsbLgLsbLsbRsbLgRsbLsbLgbLgLsbLgbLsbLgLs
LsLgLsmbLgLsbLgbLsbLgbLsbLsbLgbLgbLgbLgLsbLsbLsbLgbLgbLgbLgbLgLsbLsbLg
bLsLsmbLgbLgbLsbLgbRsbLgbLsbLgLsbLgLsbLgbLsbLsbLgbLsbLgLsbLgbLsbLgbRsb
LsLsmbRsbLsbLgbLsbLgRsbLgbRsbLgLsbLsbLgbLgbLsLsmbLibLsbLibLsbLsbLgLsbL
sbLgbRsLgLsbLsbLsbLgbLgbLsbLsbLsLsLsmmbLsbLgbRsbLgLsbLsLsRsmbLgbLsbLgb
RsbLgbLgLsbLsbLgbLgbLsbLgbLgbLsLsmbLgbLsbLgbLgbLgLsbLsbLgbLsbLgbRsLsbL
gbLsbLgLsbLsbLsbLsRsLsbLgbLgLsbLgbLgbRsRsmbLgbLibLsbLsbLgLsLsmbRsbLsbL
gRsbLgbLgLsbRsRsmbLgbLgbLsbLgbRsbLgbRsbLgbLgLsbLsbLgbLgbLgbLsbLgbLsbLs
bLgbLsbLgLsbLsbLgLsbLsbLgbLsbLsbLgbLgLsbLsbLgbLsbLgbLgLsbLgbLgLsbRsbLg
LsbLgbLgbLgbLgLsbLgbLsbLgbRjbLjbRebLjbLibLibLgbLsbLsbRibRhbRgbLsRibRsL
sbRgbLsbRibLsbRgbLsLsmbRibRgLhbLibLsbRgbLiLsbLibLibRsbLgbLsLgbLgbLsbLg
bLsbLgbRsbLgLsbLgLsLsmbLgbLgbLgbRgLsbLgbLsbLsbLgbLgbLgLsbLsbLgbLsLsmbL
gbLsbLsbLgbLgbRsbLgbLsbLsbLgbLgbRsbLgbLgRsbLsbLgLsRsLsbLgbLgLsbLsLsmbL
sbLgbLsbLgbLgbLgbLgLsbLgbRsbLsLsmbLsbLgbLsbLgLsLsmbLgLsLsmbLsbLsLgbLgL
sbLsLsmbLgLsbLgbLsbLgbLgLsbLsbLsbLgLsLsmbRsbLgbLsbLgbLsbLgLsLsmbLsbLgb
LsbLgbLgbLgbLgRsRsmbLgbLgbLsbLsbLgbLgbRsbLgbLgbLgbLsbLgbLsLsmbLsbLgbLg
bLsbLgbLsbLgLsbLgbLgbLgbLgbLsLsmbLgbLgbLsbLgbLsbLsbLgbLgLsbLsLsmbLibLg
bLgbLgbLgbLgbLgLsbLgLsbLgRsbLgbLgbLgbLgLsbLgbRgbLgLsbLgLsbLgLsLsmbLsLs
LsmmbLsbLgbLgbLgbLgbLgLsLsRsmbLsLsmbLgLsbLsbLgbLgbLgLsbLgbLsbLgLsLsmbL
gbLsbLgbLgLsbRsbLibLgbLgLsbLgLsLsmbLsbLgbRsLsLsmbLgbLsbLgbLgbRsLsLsmbL
gbLgLsbLgbLgbRsbLibLgbLgbLsLsmbLgbLsbLgbLgLsbLgLsbLgbLgbLgLsbLgbLsbLgb
LsLsmbLgLsbLgLsbLsbLgbLsbLgLsbLgLsbLsLsmbLsbLgbLsLsmbLibLsbLgRsbLgLsbL
sbLgbLgLsbLgbLsbLsbLgbLgbRgbLiLsbLgLsbLgbLgbLibLibLibLgbRsbRjLsRgbRgRs
mbRsLsbRibRgRsmbRgLsbRsRibLsbRgbRibRsbLjbRgRiRsmbRsRsmbLgbRiLsbLsLsmbR
iLsRsbRgbLsbRiLgbRiLsbRibRgLgbRiRsRimbLsLsmbRgbRgbLsbRsbRibRgbRgbLsbRg
bRgbLsbRibRhLsRsLsRgbLgRsbRibRgbRgbLsbRsbRgRsmbLsRibRsbRgbRsbRsRsmbRgL
sbRgRsLsmbRibRibRibRibRibRibRgbLsbRgbRibRsbRgbRgbRgbRibRgLsbLsbLjbRibR
iLsbRgbRgbRgLsRsbRgbRgbRgLsbRgbRsbRsLsbRgbRsbRsLsRgbRgRsmbRgbLsbRgbRgb
LsbRgbRsbRibRsbRgRsmbRsbLsRgbRgbLsbRgRsmbRgRsmbRgLsRsbRgbLsbRgbRsbRibL
gLsbRibRgRsmbRgLsbLsbRgbLsbRgbLsLsmbRiRsmbRsbRsbRgbRsRgRsmbRsRsmbRsbRg
RsmbRgbRsbRgbRgbLsbRgbRibLsbRgLsbRgLsbLsbRgLsbRgRsmbRsRsmbRsbRgbRgbLsR
sbRsbRibRibRgbLsLsmbRibRgbRsbRgbRsRsmbLsRsbRsbRgbRibRgbLsbRgbRgRsmbLsL
smbRgbRgbRsbRgRgRsmbRsRibRgRsmbRgbRgbRgbRsbLsLsmbRgbRgbRsbRgRsmbRgbRsR
smbRgbRgbRgbRgRsmbRsbRsRgbLsRgbLgbRibRsRgbRgbRgbRsbRsbLsbRgbRgbRgbLjbR
ibRgbRgbLsLsmbRiRsmbRsbRgbRgLsbRgbRgLsbRsRgRsmbRsbRgbLsLsmbsbRgbRsRgbR
gRsmbLsbRsbRgRsmbRgRsmbLsLsmbRgbRiRsmbRibRsbRgbLsbRgbRgbRsbRgbRgbLsLsm
bRsRgbRgbRsbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 16; Drug: NDMC 3 µM
bRoLsbRcbRibRgbLhbLibRsbLibRsbLgbLcbRgbRsbLibLsbRsbLibLgbRsbLgbLgbLobR
ibRgbRsbRgbLjbLsLibLcRgbLcRsbRibRiRsmbRsbRgbLobRjbLcbLhbRsbLcbLhbRgRsm
bRsbRgbRgbRsbRgbRgbRgLsbRsLsbRsbRsRsmbRsRsmbRsbRsbRsbRsbRsbRsbRsbRsbRg
bRsbRgbRsbRgbRgbRsbRgbLjbLcbLibRgbLibLcLobLhbLiLsbLjbLobLcbLcbRiRjbLhb
LibLibRjbLgLsbRsbLsLsmbLcRsRsRimbLsbLgbLgbLsbLsLsmbLgbRsbLgbLgbLsLsmbL
gbLsbLsbRsbLgbLsLsmbLibLoRsbLibRibRsbRsbLsbRgbRgbRsLsbRgbRsbRsRsRsmmbR
gLsbRsbRgbLsbRsbRgbRsbRsRsmbRgLsbRgbRgbRsbRgbRsbRgbRsbRsbRgbRsbRgbRsbR
sbRsbLsbRgbRsbRgbRgbRgbRgbRsbRsbRsbLjbRgbRibRgbRsbLcbLhbRibLebRibRebLs
bRibRgbRgLsbRsbRgbRgbRsbRgRsRgmbRgbRsbRsbRsbRgbRgbRsbRsbRsbLsbLsbRgbRg
RgbRgRsmbRsbRgLsbRsRsmbRgRsmbRgRsmbRgbLsbRgbRgbRgbRgbRibLsbRsRsmbRgbRg
RsmbRgbRgbRgbRsbRgbRgbRgbRgbRgbRgbRsbRgbRgbRgbRsbRgbLsbRgbLsbRsbRgbRgb
RgbLjbLibRibRgbRebLgbRcbLsbLgbRgbRiRsmbRgbRgbRsbRgbRsLsbRsRsmbRsbRsbRg
bRgbRgbLsbRgbLsbRgbLsbRsbRibLsbRsbRgbRsbRsbRsRsmbRgbRgbRsbRsbRsbRsbRgb
RsbRsbLsbLsbRibRgbRsLsbRgbRgbLgbRgbRgbLgbRgRsmbRgbRsbRhbRgbLgRsRsmbRgb
RibRgbLhLsLsmbLebLcbRibLibRsLcbLcbLcbLgbRgbLibRobRiRsmbRsbRibRsLsbRgRs
mbRgbRgbRsbRgRsmbRgRgRsmbRgbRgbRsbRgbRsbRgbRgRsmbRgbRgRsmbRgbRgbRgbRib
RibRsLsbRgbLhbRibRhbLibRibRsbRgbRgbRgbRgbRgbRsbRgbRsbRgbRiLsLsmbRibLhL
sbRgbRibLgRsLsbRcbLsbRsbRgLsbRgRsmbRsbRgRsmbRgbRsbRgbLsbRgRsmbRibRsbRg
bRsbRgRsmbRgbRsbRgbRgbRgbRsbRgbRgRsmbRgbRsbRgbRgbRsLsbRgRgRibRgbRgbRgb
RgbRgRsmbRgbRgbRgbRgLsbRgbRgbRgbRsbRgbRsbRgbRsbRgbRibRgbRgbRsRsmbRgbRg
bRsRsRimbRgbRsbRgbRsRgbRgbLgRsbRibLjbLcbLhbLibRgLsbRebLcLsRsLombLibLgb
LibRibLibLgbLgLsbRjbLibLsbLobRebRsbLcbLibRcbRobRcbLibLiRgbLjbLiLgLsbLg
bLibLsbLibLcbLcRsbRibRgLsbRsRsmbRgRsmbRgbLgbRibRsbRgbRgbRgbRgRgRsRgRgm
bRgRgRsmbRsbRibRgRgbRgbRgRgRsmbRgbRgRgbRgRsmbRsbRgbLsbRibRgRsmbRgbRgbR
gbRsRgRgRibRgbRgbRgbRgbLcbLcbLcbRibRsbRebLsbRgRsmbRiRsmbRsbRgRsmbRgbRg
bRibRgRsmbRgbRgRsRgmbRgbRsbRibRgbLgbRibRgRsmbRgbRgbRgbRgbRgbRsbRgbRgbR
gbRsbRgbRgbRgbRsbRgbRsbRgbRgbLsbRgbRgbRgbRsbRgbRsbRgbLsbRgbRsbRibRgbRs
RibRgbRsRsRimbRgbRgbRgbRsLsbRgbRgLsRsbRgbRgbRgbLsbRibRgbRgbLsbRibRgbLg
bRgbRgbRgRgRsmbRgbRiRsmbRgbRgRsRsmmbRiLsbRibRsbLsbRibLjbLhbRcbLcbRjbRo
bRhbRcbLebLiLsbRsbLibRcbRobLiRsbLhbLibLobLibLcbLcbLibLibRibRjbLibLibLc
RsbLsbLgbLgbLibLhbLsbRobRcbLsbRjbLjbRcbLibRcbRsbRibRibRgbRgbRgLsRsbLsR
sbRgbRgbRgbRgbRgbRsRsmbRgbRsbRgRsmbRsbRsbRsbRgbRgbRsbRsbRgLsLsRsmbRgbR
gbRgbRgbRsbRgbRgbRgbRsbRgRsmbLsbRgbRgbLsLjbRibLjbRobLibRsbRcbRcbRibLib
LibLsLsmbLibLibLhRgbLcbRgRsmbRhbLjLibRjLsbRcbRcbLibLhbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 17; Drug: NDMC 3 µM
bRsRobRgbRgbRgbRgbRsbLjLibLjbRjbRiRgbRgbRsbLibRgbRgRsmbRsbRgbRgbRgbRgb
RgbLsbRgRsmbsbRgbRgbRgbLsbRsRsmbRgbRsbRsbRsRsRsmmbRsRsmbRgbRsbRgbLgbRi
bRibRsbRgRsmbLsbRibRsbRgbRibRsbLsbRgbLgbLobLebLgbRibRsbLibRcbLgbRsbRjL
sbLsbLsbRgbRgbRgbRgbRgbRgbRsbRsbRsbRgbRsRsmbRgbRsbRsbRgbRgbRgbRsbRsRsm
bRsbRsbRgbRgbLsRsbRgbLsbRgbRgbLsbRsbRibRsbRsbRgbLsbRgbRgbRsbRgbRsbRsbR
sbRsbsbRjbLjbRibLsbRsRsmbRsbRsbRgRsmbRsbRsbRsRsmbRgbLsRsbRsLsbRgRsmbRi
bRgbRgbRgbLsbRsbRsbRgbLsbLsbRsbLcbRgbLsbRcbRsbRgbRsbRgbLgbRibLgbRiLsbL
sbRgbRsbLsbRgbLsRsLsbRgLsbRgbRsbRsbRsbRsbRibRgbRsbRsbRgbRsbRsRsmbRgRsm
bRgbRgbRsbRgRsmbRsRsmbRsbRgbRsbRgbLsbRgbRsbRsbRsbRgbLsbRgbLsRsbLsbRsbR
sbRsbRgbRsbRsbRsbRgbRgbRsbRsbRgbRsbRsbRgbRsbRgbRsbRsbRsbRgbLgbRgbRgRsm
bRgbRgbRgbRsbRgbRsbRsbRsbRgbLgbRgbRgRsmbRgRsmbRgbReRsmbRibRsbRgbRsbRgb
RgbRsbRsbRsbLsRgbRibLhbRgbLjbRibLcbLcbRjbRibRgRsmbRgbRgbRgbRgbLgbRgbLs
bRgbLsbRgbLsRsLsbLsRsbRgbRgbRiRgRibRgbRgbRsLsbRgbRgbLgbRgbRsRgRsmbRgbR
sbRgbRsbRsRsmbRgRsmbRgbRgbRsbRgRsRsmmbRgbRgLsbRsbRibRsbRgbRsLsbRsbRgbR
gbRgbRsbRgbLsbRsbRiLsbRgbRgbLgbRgbRgRsRsmmbRgbRgbRgbRsbRsLsbRsbRsbRsRs
LsmbRgbRgbRgbRsRsRgRgRembRiRsmbRgbRgbRgbRsbRsRsmbRgbRgRsmbLsbRiRhbRgRs
mbRgbRsbRgbRsbRsbRiRsmbRgbRsbRgRsmbRgbRsbRgLsbRsbRsbRsRsmbRsbLsbRsRsmb
RgRsRsmmbRsbRiRsmbRsbRgbRgbRsbRgbRsRsmbRgRsmbRsbRgbRsbRgbRgbLsbRgLsbLs
RsbLsRgRsRsmmbRgbRgbRsLsRsbRgRsmbRgbRgbRsbRgbRsbRgbRgbLsbRgbRsbRgbRiRs
mbRsbRsbRgbRgbRsbRgbRgbLsbRsbRgbRgbRgbRgbRgbRgRsRsmmbRsbRgbRiRsRsmmbRg
bRgbRgbRgRsmbRgRsmbRgbRgRsRsmmbRsRsmbRgbRsRsmbRgbLsRsRsmbRgRsmbRgbRgbR
sbRsbRgbRsbRgRsmbRgbRgbRsbRgbRgbRsbRgbRsRsmbRsbRsbRgbRsbRgRsmbRgbRsbRg
bLsbRgbLsbRgbRgbRgbRgbRgLsbRgbLsbRibRgbRgbRgbRsRsmbRsbRgbRgbRgRsmbRgbR
sbRgRsmbRsRsRsRgRsRsRsRgRsmmmmmmbRgbRgbRgbRsbRibRgbRiLsbRsbRsbRiRsmbRg
bRgbRgbRgRsmbRsbRsRsmbRiRsRgmbRgbRsRsmbRsRsRsmmbRsbRgbRibRsbRgbRsRsmbR
sbRgbRsRsmbRgbRsbRgbRgRsRimbRgRsmbRgRsmbRgRsmbRsRsmbRgbRgbRsbRgRgbRgRs
mbRsbRgRsRsmmbRgbRsbRgRsmbRsbRgbRgbRgRsmbRsbRgbRgRsmbRgbRgbRsbRgbLsbRg
bRsRsmbRibRsbRgbRgbRsbRgbRgbRsbRgRsRsmmbRsRsRsmmbRgRsmbRgbRsbRgbRgbRsR
smbRgbRsRsmbRgbRgbRgbRgbRgRsRsRsmmmbRsbRgbRgbRsRsmbRgRsmbRgRsmbRgbRgbR
sRsmbRsRsmbRgbRgbRgbRsRsRgRsmmbRgbRgbRgRsmbRgRsmbRsbRgRsmbRgbLsbRgbRgb
LsbRgbRgbRgbLgbRgbRsbRgbRgbRgRsmbRgbRibRibRibRgbRgbLsbRibLjbLsbLgbLgbL
iRsbLhbRjbRebRsbRgbRgbRgbRgRgRsmbRgbRgbLgLsbRibRsbRgbRsbRgbRgbRgRsmbRs
RsmbRsRsmbRgbRsbRgLsbRsbRgbRsbRsbRibRgbRgbRgbRgbRsbRgbLsbRgRsmbRsbRgRs
mbRgbRsbRsbRgbRsbRgRsmbLsbRgbLsbRibRsbRgbRsbRibRgbLgbRgbRsbRsLsbRgbLgL
sbRiRsmbRsRsRsmmbRgbRgbRsbRgbRsbRsRsLsmbRgbRsbRgbRsbRgbRgbRsbRhbRibLib
RibRgRsmbRgbLibRgbLibRjbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 18; Drug: NDMC 3 µM
bLobsbLcbLcbLsbRgbLsbRsbLgbLgbRcbRgbRgbRsbRgbLsRsbRgbRgbLsbLsbRgRsmbRs
bLsbRgbRgbLgbRgbRgbLcLsmbRcLsbLgbRsbLgbRgbRgbRgbLgbRgbLgbLgbLsbLgbLgbL
sbLgRsbRsbLibRibRsLsbRjbRiLsbRiLsbLsbRgbRjLsbRgbRgbLgbLgbRjbRgLsbRsbRg
bRgbRsbRsbRgRsmbRgbRgbLsbRsbRsbRibRgbRsbRgbRgbRsRsmbRsbRgbRgbRgbRgbRgb
RgbRsLsbRgbRsbRgLsbRgbRjRsmbRhLsbRibRhbRibRibRibRgbRgLsLsmbRsbLsbRgbLg
bRgRsmbLjbLcbLobLcbRjbRgRsmbRsbRsbRsbRsbRsbRsbRsbRjbLgbRibRsbRibRgbLsb
RjbLsLsmbLsbRgRsmbRsbRsbRsbRgbRsbRgbRsLsbRgbRgbRsbRgbRgbRgbRibRgbLsbRg
RibRgRsmbRgRsmbRgRibRgRsmbRiRsmbRgbRsbLjbLibRiRsmbRgbLsbLsRibLgbRgbLsb
RiRsmbLsLsmbRgbRsRsRgRsmmbRgRsRgmbRgbRgRsmbRgRsmbRgRgRsmbRgbRsbRibRgRg
RsmbRgbRgbRsbRgbRgbRsbRgbRibLjbLhbLcbLcbRgbLsbRgbRgLsbLibLgLsbLsbLsbLs
RsbRsbLgLsbLgLsbRsLgLsLsLsmmbLgLsbLsbLgbLgbLsbLsbLgbLgLgbLgbLsbLgbRgbR
sbLibLgbLibLhbLibLibLsbLiLsbRgbLibReRsmbLhLsbLibLgRgbLsLsmbRgbLjLsmbLs
bLgbLgbRgbLibRsbLgRsbRsbLiLsbLiRsbLcbLhLsbLibLiLsbLibRsbLibRsRsmbLiLsb
LsLsmbLgRsbLiLsbLgLsbLgbLgbLsbRsbRsbLibLobRcRsmbRhbRcRsLsmbRgRsmbLibRc
bLebLibLsbRsLsbLgLsbRjLsRsbLgLsbLsbLsbLgbLsbLsbLhbLcbLibRjbLjLsmbRjbLc
bRgbLhbRibLiLsLsmbRsLsLsmbLgLsbLsbLsbLgbLgbRsbLsbLgbRsbLibRibLebRiLsbL
sbLibLibLsbLsLsmbLgRsbLsLsmbLibLgbLgbLgbLsLsmbLiLsbLgbLsbRgbLsbLgbLsbL
gLsbLsbLgbLsLsmbLgbLgbLgbLgLsbLgbLgbRjLsbLgbLsLsmbLgbRsbLgbLgLsRsbLgbL
gbLgRsbLibLsLsmbLgbLsbLgbLgbRgbLgLsbLsLsmbLgbLgbLgbLgbRsbLgbLgLsbLsbLg
bLgbLgbRsbLibLgbLgbLgLsbLgbLgbLgRsLsbLiLsbLgbLgbLgbLgbLgLgLgbLiLsbLgbL
sLsmbLiLsbLgLsbLgbLgLgbLiRsbLgbLsbLibLgbLgLsRsbLgLsbLgbLgbLgbLsbLgbLsL
smbLibLgbLgbLiLsbRsbLibLhRsLsbLibLhbLgLsLsmbLiLsbLsbLgbLgbLsLsLsLsmmmb
LibLsbLgLsbLgbLgbLgRsbLsbLgbLgRsbLibLgbLibLiRsbLibLcbLibRgbRibRsRiLsbR
ibLhbLcbLibLgbLgbLgbLibLgbLsbLgbRsbLibLsbLgbLgbLibLcbRgLsbRhbLcbLcbRgb
LgbLibLiRsbLgbRsbLibRsLsbLgbLgLsbLgLsLsmbLgbLgbLgLsLgLsbLiLsLgbLgbLgbL
sbRgbLiLsbLsLgbLgLsLsmbLsbLgbLgbLgbLgLsbLsLsLsmmbLgbRsLsbLgbLgbLsbLsLs
mbLiLsbRsbRcbRcbLgRsbRiRsmbRibLgbRgLsbRiLsbLjbRibRibRibLgbRibRibRibRib
RcbLjLsmbRibLgRsbRhbRibLjbRibLibLibRcbRibLsbRibRsbRgLsLgbRibRgbLibRibR
sRsmbLsbRiRsmbLsbRgbRgbRsbRgLsbRsbRibRgRsmbRgbRgbRsRsmbRgbRsLsbRgRsmbR
gbLsRgbRgbRgbRgbRgbRibRibLibRibRcbLjbLcbLcLsRsmbLibLsbRgbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 19; Drug: NDMC 10 µM
bRibRcbRibRgbRjbRiRsmbRcbRibRhbRibRgbRibRibRibRibRgbRibRibRgbLsbRgbRsb
RsRgRsRsReRsRgRsRiRsRgRimmmmmbRgbRibRjbLsLsmbLsLiLsbLjbLcbLibRsRsmbLhb
LhRgRsmbRsbLcbRsLsbLiLsbLsRsbLibLibLsRsbLsbLibRiRsmbRiLsbRgbRsRgbRsRsm
bRsbRjbRgbRsbRsbLgRsRsRimbRgbRsbRgbRgbRgbRgbRsbRgbRiLsbRgbRgbRibRibRgb
LsbRsLsRsbLsRcRsmbRibRgbRsbLgbRsbRsbRibRgbRsbRgbLsbRgbRibLgbRibRibLiLs
bRebRibLgbLibRgbRgbRgbRsRsmbRgbRibRsbLsbRgbRhbRgbRsLsbLsLsmbLgLsbLjbLi
bRsbRgLsRsbLjbLgRsbLjbLibRgbRgbRjbLcbLcbRiRsmbLibLebRgbRgbLgRsbLiLsbLg
LsbLsbLgbRsLsLsmbRsbLibLgLsLgbLgLgRsbLsbRsRsRsmmbLcbRgbLhbLhLsbRgbLcbR
sLsbLgbLgbLgbLgLgLiLgLiLsLiLgLsLgLsLsLgmbLgLsLiLiLgLsbLibLiLiLsLsLgmbL
gLgLsLgLiLiLgLsLiLgbLgbLgbLsLsmbLgLgbLgRsbLgLgLiLiLhLiLgLsLsmbLsLsmbLg
bRsbLgbLcbRibRsbLhLsbRibRcbRcbRcbRibRhbLsbRibLgbRgbRsLsbRiRsmbLsRsRgRg
bRgRgRsRgRgRgRiRiRimbRgRsRiRsRgRiRsLsRimmmbRgRgRsRiRgmbRhRsRiRhRiRiRsm
mbRiRsmbRgRsRgmbRgRibRgLsbRgbRgLsbRiRsRiRsmmbRgLsRiRsLsmbRgRgRsRsRiRsR
gRiRsmmmmbRgRsmbRgLsbRgbRsRsRiRgRsmmbRgRgRsRsLsmmbRiRgRsmbRgRsmbRsbRsR
iRsRgRiRhRgRiRsmmbRsRsmbRgRsmbRsRgRsRgRsRiRhmmbRiRsmbRsbRgbRsbRibLsRsb
RgRiRgRsRiRsRgReRiRgmmbRsbRsRgRsRsmmbRgRgRsmbRgRiRsmbRgRsRgmbRgbRsbRgb
RgLsRsbRgRiRiReRhRgbRgbRgbRgbRgbRjLsbLgbRiRgbRgbRsRsmbRjLsbLgbRgbRjbRg
bLibLhLsbLhbLibLibLsbLsLsRsmbRjbLhbLibLsLsmbLcbRgRgbLcLsmbRjbLgbLgbLgb
LgLsLgLsLsmbLgLsbLgLgLiLiLgLsbLgbLgLsLsLsLgmmbRjbLgbLsRsbLgRsbLgbLiRgb
LhbLcbLibRibsbRibLcbLcRsRsmbLgbLgbLgbLeLhLebLgbLgLsbLgLsbLgbLgbRsbRjbL
jbLcbLsbLsbRcRsmbRibLgbRgbRgbLsbRgbLsbRcbRibLgbRibRgbRjbLcbLgbRsbLsbLg
bLgbLgLgLsbLgbLgLsLiLiLiLsLsLgmbLgbLiLsbLgbLiLiLiLhLgLsLgbLgbLjbLgRsbL
cbLcbRcRsmbRhLsbRcbLibRgbLsbRiRsmbRjRsmbLibRsRibRiRsRsmmbRgRgRiRsRgRgR
gmbRgRsmbRsRibRgRsRiRhmbRgRiRgbRgbRiRiRsmbRgRiRsLsmbRgRsRiRsRsmmmbRgbR
gbRgRsRgRsRgRsRiRgRgRimmmbRsRgReRgRibRibRgRibRgRgRsmbRgRgReRsmbRiRsRiR
sRiRhmmbRgbRgLsRsbRgbRsbRgLsbRiLsbRiRsmbLhbRsRsmbRibRjbRcbLsLibLebLhLs
bLibRsbLibLsbLgbRsbLgLsbLgLsLiLiLiLiLsLgbLgbLgbLgbRsLeLibLjRsRsmbRebLi
bLgbLgbLiLsbLgLsLiLsLgbLgLgbRjbLjbLgbLsRsbRsbRhbRhbLgbRgLsbRiLsbLsbLjL
smbRibRhbLibRibRibLgbRgbRgbRsRsmbRgRsmbLsbRgRsmbRgRsRgRsRsRgRsmmmmbRgR
gRsRsmmbRgbRiRibRsRsmbRgbRgbRsbRgLsbRgRsmbRgRhRsRimbRgRsmbRgbRgbRgRibR
sRibRgRsmbRibRgbRgbRgbRgbRgbRjbLhbRibRgbRgLsbRiRsRsmmbRsRsmbLjbLhbRibR
gbRibRgbRgbRibRcbRgbRcbRcbRgLsbRhbRgbRgbRsbRcbRiRsmbLibLcbsbRgbLcbRsRs
LsmbLgLsbRsbLsbLibLsbLiLsLsLiLiLgmbLsLgbLgbLgbLsbLgLsbLgbLjbLgRsRsmbRg
bRgbLcbLcbLiRsLsbRgbRcLsbRcbLcbLsLsmbRcRsmbLsbLsLeLsbLibRgbLcbRgbRjbLi
bLibLsbLgbLgLiLsLibLgLsbLgLsLgLsLgLgLsLsmbLgLgbLgLsbLgLsRsbLsRsLgLsbLi
LgLsbLgbLgbRhbRcRsmbLjbRibRhbRsRsmbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 20; Drug: NDMC 10 µM
bRobRgbRgLsbLibRhLsbLcbLcRsbLhbLjbRibLjbRibRgbLibRgbLgbLiLsbLsbLibLgRg
bLgbRsLgbLsbRcbRibRcbRcbRhbRjbRibLgbRsLsbLiLsbLibLgbLgbLsLsmbRsLsbLgbR
sbRsLsbLsLsmbRsbLsbLgbLsbLsbRgLsbLsLsmbLgLsbLgbRsRsmbLsbLgbLgbLsbLgbLg
bLgbLgbLgbRgRsLsmbLsbLsbLgbLibRobRibRgLsbLhbLibRgbRgbRgbRibLgbRjbLjbRi
LsbRibLjbLcbRibRcbLjbRgLsbRibRgLsbRsbRgbRiLsbLgbLjbRebRgbRibRibRgbRgLs
bLgbRgbRsbLsbRjbRsbRibRgbRgbRgbLsbRibRgbRgLsLsmbLgbRsRsmbRsLsRiRgLsbRg
bRgbRgbRibRsbRgbLsbRgRsLsmbLsLsmbRgbRgbRjbRgRsmbRgbRibRibRcbRibRjbLhbR
gbRsbLibRebLibLiLsbLsbRgbLgbRobLcRsbRibLgbRsbRgbLjbRebLibLjbRjbLiRsbLg
bLgLsLsmbLsbLsbLsbLgbRsbLibRcbRibLsbLgbRgbLsbRiRsLsmbLgLsbRsRgRsmbRgRs
mbRgRsmbLsLsmbRsbRgbLsbRoLjbRcbLgbRibRgbRgbRgbRgbsbLjbRibLgbRcbRibLsbL
gbRhbRjbLibRjbLibLgbRsbLgbLgbRcLsbRebRibLjbLibLgbRjbLibLgbRsbLgbLgbLjb
RjbLibLgbLgbLiLsbLsbLgbLgRsRsmbRibLhbLjbRobLjbRobRcLsLsmbLgbRebLsbLcbR
sbRibRiLsbLjbLcbLcbLibRjbLgbLgbRjbRhbLibRhbLsRsLsbRsbRibLgbLebRsLcRsbR
iRsmbLsRsbRgLsbLhbRjbRcbRhbRcbRgbLgbLsbLsLsmbLiLsbRgbRsbLibRsLsbLjbReb
RcbRiLsbLgbRsbLsbRibRgbRiLsLsmbRgbRibRibRibLgbRibLgbRibLsbRgbRibRsbRgb
RgbLjbRgbRsbRgbLjbLcLsmbLcRsRgbLgLsbRsRsmbLgbRcbLgbRgbRgbRibRgbRsbRsbR
gbLsbRgRsRimbRgbRsbRgbRgRsmbRgbRgbLjbRibRgRsmbRgbRhbRcbLcbRhRibLsbLebR
jbLibRobLjbRhbRsbRiLsbLhbRibRgbLgbRiRsmbLsbLgbRibRibLjbRsbLjbLgbRcbRgR
smbLsbRibLgRsbRiRsLsmbRsbRsbRsRsmbRiRsRiRsmmbRsbRsbRgRsLsmbRibRgbRgbRi
bRibLebRcbRhbRgbLiRsbLibRjLsbLibRjbLcbLsbLsbLcbRgbRibLcbLcbLhbLiRsbLib
RibRcbLcbRcLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 21; Drug: NDMC 10 µM
bLcbLobLibLgbLsbRebRibRsbLgbRcRsmbRhRsmbRhbLsbRibRjRsmbRsbRiRsmbLsLsmb
RsbRiRsmbRgbLsbRgbLsLcbLibLibLgbLgbLgbLgLsbLgbLibLobRjRgbRgbLgbLgbRjRs
mbLjbLoLsmbLjbLibLibLgbLgbLibLjbLgbRsbLgLsbLgbsbLsRsbLibRibLgbLgbRsLgb
LgbLgbRibLibLobLhbLhbLsbLjbRibLsbLibLgbRgbLgbLibLgbLsbLsRsbLsbLgbRjbLi
bLgbLsbLsLsLsmmbLgbLsbLsLsmbLgbLsLsmbLsbLgLsbLgbLgbLsbLsbLsbLgbLsbLgRs
bRebLcbRgbRibLcbRsbLcLsmbLgbLibLibLgbLsbLgbRsbLgbRsbLibLgbLsbLjbRgbRcb
RcbLhbRgbLibLsbsbLgLsbLsLgbLibLgbLsbLgbRsbLgbRgbRjbLjbRjbRibLcbRcbLcbR
ibLibLibLsbRibRgbRsbRgRsmbLsbRgbRgbRgRsRsmmbLsbRibLgbLgbRiLsbRgbLsbRgb
LobLcbLcbLibLibLibRebRsRcRsmbLhLsbLsbLgbLibLgbRcbLjbRobRhbLhLsbLibLjbL
sLsmbLibLsbLgbRsbRjbLiLsbLsbLiLsRsbLsbLgRsLgbLgbLgbRjbRcLsbLjbRcbLjbLc
bLibRjbRibRibRibRjbLjbLjbLibLsbRsbLgbRibRibRiLsLsmbLjbRgbLgbRibLibRsbL
gLsbLgLsbLgLsbRsbRiRsmbRibLsbRibLjbRgRsmbRgRsmbLsbRjbLhbRibLsbLsbRgbRi
RsmbLsbLhbLibLibLgRsbLibLgbLgbLjRsbLiRsRsmbLcLsmbLcLsmbLebLibRgLsbRgbL
ibLgbLibRjbLiLsbLsLsRsLsmbLsbLgLsbRsLsbLgLsbLgbLgLsbLsbLgbLibRcbLibLgL
sbLsLsLsmmbRjbLsbLgbLgbRibRibLcbRgLsbLibLsbLibRibRjRobRobRjbLiRsbLibLi
bLsLsmbLgbLsbLgbRibLjbRgbLsbLgbRebLibLhRsbLhbLibRsbLcbLgbRgbRgbRhbLsbL
jbLibLsLsmbLgbLsbLibLsRsbLgbLgbLsLsmbLgbLsbLoRsbLhbLhbLhbLgbRgbLiRsRsL
smbLibLgbLgbLgbLgbLsbLgbLiLsbRibLgbRobRcLsLsLsmmbLgbRgbLjbRibRgbRibLsb
RgbRsbRebRcbRcbRcbRibLsbRjbRobLibRcbRcbRibRcbRibRsbReRsmbRsbLsbRgRsmbR
sbRsbRgbRiLsbLsbRsbRgbRsbRgbRsbRibRibLgLsbRebLgbLsbLibLibLgbRgbLibLsRs
bRjbRibLgbRgbRibLcbLcbRebLcbRebLgbLibRcbRcbLibRoRsmbRobLhLsbLgbLibLsbL
gRsLsbRgbLibRgRsmbRcbRcbRhbRhbRibRcRsmbLgbRgbRsbRgbRsRibLsbRibRsRsmbRg
bRgbRgbRgbLgbRiLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 22; Drug: NDMC 10 µM
bRobRsbRgbRgbRcbRgbRsbRgbLsbRgbLjbLgbLgbLibRgRsmbLgbLsbLsbRsLsbLiRsbLg
bLoRsRsmbRgbLcLsmbLgLsbLgbLgbRgbLgbLiRsbLgbLiRsbRibLhbLibLibRgbLgbLgbR
ibRibRgRsmbRgbRgRsmbRsRsmbRsRsmbRgbRgbLsbRgLsbRsbRsbRsRsmbRsLsbRsbRgRs
LsmbRsRsmbRsbRgbLsbRgbLsbRgbRgLsbRsLsbRsRsmbRgbRsbRsbLsbLjbLoRsbRgbLgb
LgbRsbLgbRsLsbRsbLsbLsRsbLsLsmbLsbLobLibLcbRsbLgLsbLgbRsbLibLgbLgbLgbR
sRsmbRsbLgbLibRsbLiLsbLgRsbLsbLgRsbLgLgbRsbRsbLibLsbLsLsmbLibLgbLgbLgL
sbRsbLsbLgbLsbLiLsbLsLiLsbLsbLgbRgRsmbLibLsbLgRsbLgbRsbLgbLsLsRsmbLgLs
bLgbLgbLgbLgbLgbLgbRsRsmbLgbLsLsLsmmbLgLgLsLsmbLhbRgbRibRibLobLobRgbLh
bLcRsbLgbLibLsRsbLibLgbLsbsbLsbRsLsbLsRsLsLsmbLsbLgbRsbLsLgbLgbLibLsbL
gbLsbLgbLgbRsbLsRsLsbLgLsbLgLsLsRsmbLiLsbRsbLiLsbLgbLsbLgbLgRsbRsbLgLs
bLsbLsbLgbLsbsbLgbLsbRsLsbLsLgRsbLsbLgLsbLgbLsRsbLibLgbLgLsbLsbLibRgLs
bLibRjbRibLobLibLibLsRsbRibLiRsRsmbLgbLgbLgbLgbLgbLgbLsbRsbLsbLsLsmbLi
LsLsLimbLgbLgbLsbLgbLgbLgbRsbLgLsbLsLsmbLiLgbLiLsbLgbLgLsLsmbLgbLgbLgb
RsLsbLgLsbLgbLsLsLiLsLsmmbLgLibLgLsbLgbLsbLsbLsRsbRsRsmbLiLsbLiLsRsRsL
smbLiLsbLsbLiLsbLgbLgbLibLsRsbLsLsmbLgLsbRsbLibLsbLiLsbLsbLibLgbLgbLgb
LgLsbLgbLgLsLiLiLsLsLiLsmbLgbLgbLgbLgbLgbLibLibLiLgbRcRsmbRhbLhLsbLebL
gbLibRsbLibRsbLiLsLsmbLgLsbLiLsLsLgLsmbRjbLibLgbLgbLgbLgRsbsbRsRsmbRsb
RsLiLgLsbLgLsbLgLsbLiLsbLsbLgbLgbLsRsbLgLsbRcbRhbLibRobLcbLibLgbLiLsbL
sbLsLsmbLiLsbLsbLgbLsbLgLsbLgbLgbLgbLgbLsLsmbLgbLsLsmbLsLsLsmmbLibLcbL
cbLibLgbLgLsbLcbLcbLgLsbRcbRobLgbLibLgRsbLibLgbLsbLgbLsbsbLsbLsLsmbLib
LgbLgLsLsmbRsLgLsbLsbLgbLsbLgLsbLsbLgLsbLsbRsbsbLiLsLsLsmmbLgLsLsLsmmb
LgLsbLiLsLgbRsbLgLsbLgLsbRsbLgLsbLsbsbLgbLgLsbLsRsLsbLgRjbLiLsbLgLsbLg
bLsbLibLiLsbRsbLibRsbLsRsLsLibLgbLsLsRsmbRgbRcbRoRsmbRiRsRsmmbLgbRhbLg
bsbRiRsmbRsbRgbRsbRgbRgbRsbRgbRgRsmbRsRsmbLsRsbRsRsmbRibLsLsmbLjRsbLhL
sbLiLsbRsLsbLiLsbLsbLsbLiLsLsmbLsbLiLsbLgbRsbLgbsbRibRsbRsbLiLsbLibRgb
LibLsbLhbRsbLiLsLsmbLsbLgLsLsLsmmbLgLsbRsbRsbLsLsRsmbLsbLgbLgLsbLgbLgL
sLiLsbLgbLgLsRsbLsbLsLsmbLgLsbLgLsbRsLsbLgbLgLsLsmbLgbLgLsbLsbLgbLgbRs
LsbRsLsbLgLsbRebLiLsbLiLsbLhRhbRcbLgLsbRcbRcbLhLsbRibRcbLhbRjbRsRcbLgb
LcbRjbLgbLibRgbLsLgbLsbLsbLgbLgLsbRsRsmbLiLsRsbLsbLibLsbLiLsbLgbLgbLsb
LsbRsbLibRsbLibRsRgbLcbRcbLibLiLsLsmbLsbLiLsbLsbLibLgLsRsbLgbLgbRsbLsL
smbLgLsbLsbLgLsbLgLiLsbLgbLgbLsbLgLsbRsLsbLsbLiLsbRcLsbLhbRcbRiRsmbReb
LhbRhbRgbLjbLoLsmbRcbLhbLiLsbLibLiLsbLibLgbRsbLsbLsbLgLsLsmbLsbLsLsmbL
ibLgbLiLgbLgLsbLgbLsLsmbLsbRsbLgLsbRsbLiLsbRsbLiLsbRgbLhbRsbLiLsbLgLsb
LibLsLsmbsbLibLsbLiLsbLibLsRsbLgbRoRsmbRgbLsbRsRsmbRgRsmbRsRsmbRgbRsRg
LsbRgRgbRsbRgbRgbLsbRiRsmbRsbLcbLibRsbLiRjLsbLibLgbRsbLiRgbLiLsbRsbLiL
sRsbRsLsbLiLsbLsbLibLsbLgbLsbLgbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 23; Drug: NDMC 10 µM
bLobLsbLcbLgbLgbLiRsbLiRsLsLsmbRsbLibRgbLcbLibLsbRsbRgbRibRgRsmbRsbRgb
RibRiRsmbRsbRgbRgLsbRsbRgRsmbRibLgRsbRgbRsbRgbRgbRsbLsbRgbRsbsbRsbRsbL
gbRgbRgRsmbRjbLsbLgbRsbRgbRsbRsLsbRsLsbRgRsmbRgRsmbLgbRgRsmbRgbRsLsbRg
bRgLsbRgbLgLsbRjbRgbRgbRibLjbRibLjbLcbRjbLgbLibLsbLsbLsLsmbRsbLibLgbLg
bsbRsbRsbRcRsmbRibLgbRibLgLsbRibRsRsmbRgbRsbRgbRgbLsbLibLgbRsbLsLsmbLg
bRsbLsbLgbLgbLsbRsLsbLsLsmbLgbLgbRsLsbLjbLcRsbRgbRsRsRsmmbRsLsbRjbRcbL
gLsbLgbLcRsbLibLsbLgbLsbLsLsRcmbRhbRibsbRsRsmbLjbLgbLsLsRsmbRjbLjbLgLs
bLsbLsLsmbLibLibLgLsbLsbLsbLibRsbLsLsLsmmbLsLsmbLgbLgbRsbRsLsbLsbLjbLj
bLgLsbLibLgbLsbRibRsbLgbRcbRiRsmbLsRsbLiLsbRjbLjbRjbRgRsmbLsbRgbRsbRgb
LsRsRsRgLsmbRgbLsRiRsmbRsbRgRsmbRgLsbLsbLsbRgbRibRibLjbLibRjbRgbRgbRgb
RgbRgbRsbRsbRsRsmbLsbRsbRgbRsRsmbRgRgRsmbLsRsbRgbRsRsLsmbRsRgbLsbRsRsm
bRibRgbRsRsmbRsRsmbLsRsbRgRsmbRsbRjbLobLibRgbRsbLiLsbRgbRjbRibRsbLcLsm
bLgbRsbLsbLgbLsbLsbLgbRsbLgbRsbLgbLsbLsbLiLsbLgbLsLsmbLgbLgbLgLsbLsbLs
bLsbLgbLgbLsbLgLsbLsbLgLsRsLgbLgLsLgbLgbLsbLgbRgbLibLsbLgLsbLsLgbLgLgb
LsRsbLgbLsbLgbLsbLgbLsbLgbLjRsbRgbLcbLhbLgbRiRsRsmmbRgRsmbRsLsbRsRsmbR
gRsmbRsRsmbRsbRgbLsRsLsbRgLsbRsbRsbRgbLsbRgbRgbRsRgbRgbRgRgRsRsmmbRsbR
gbRsbLsbRgbRiLsbRibRsbRsbRgbRsLsbRgbRiLsLsmbRgRsRgmbRsRsmbRgbRgbRsRgbL
sRsRgbRsRsmbRgbRgbRgbRsLsbRsbRsbRsRsmbRsRsRsmmbRsRsRsmmbRgRsmbRgRsmbRg
bRsRgRgRsRgmbRsLsbRgRsmbRsbRgbRgRsRsmmbRgbLgbRgbRcbRcbRibRgbLcbRjbRiRs
mbRgRsmbLgRsRgbReRsRsmmbRiRsmbRebRgRgRsRsmmbRgbRsRsmbRgRsmbRsRsmbRgRsL
smbRgbRgRsmbRsRsRsmmbRgbRgbRgRsRsmmbRgbRsRsmbRgbRgLsbRgbLsRsbRsbRgLsbR
gbLjbLibLsRsbLiRgbLgbLgbLsbLsRsbLgbLsbLgbLsbLsRsbLiRsLsbLgbRsbLgbRsbLg
LsRsbLgbLsbLsLsmbLibRgLsbLgLsbRsbLibLgbLsbLgbLsbLgbLsbLgbLgbLgLsLsmbLg
LsbLgbLgbLgbLsbLgLsbLsbLgbLsbLgbLsbLgbRsbLiLgLsbLgLsbLsLsmbLibLgLsbLgb
LgLsbLibLgbLgLsbLgRsbLgbLgbLgLsLgLsbLgbRsLsbLgbLgLsLgLgLsbLgbLgbLsbLgb
LsLgbLiRsRsmbLgLsbLsLsmbLgLsbLgLsLsmbLgLsLsmbLgbLgbLsLsLsLsmmmbLgbLsRs
LsbLgbLsLsmbLsbLgbLgLsLgbLgbLgbLsLsmbLgLsbLgbLsbLibLgbLgbLibLgbLgbLgRj
bLgbLibLgbLgLsbLsbLgbRgbLsbLibsbLsLsmbLgLsLsLgmbLgbLgbLsLsmbLsbLibLsbL
gLgbLgLsbLgbLgbLgbLsLsLsmmbLibLgbLgbLgbLibLgbLgRsRsLsLiLsmbLgbLgLsbLsL
smbLsbLibRhbRcbRsbRgRgbLjRgbRgbRibLgbRgbRibRgRsLgmbRsbRgbRiLsbRgbRgbLs
bRgRsmbLsRsbRgRsmbRibLsbRibRsLgbRgbRiRsLsRsLsmbRcbRsRsmbRgRsLsLsmmbRgL
sRsbRsRsmbRgLsRsbRgbsbLjLsmbRebRgRsmbRsRsmbRiRsmbLsbRgbRgbLsLsmbRgRgbR
ibRibLjLibLjLsmbLibLsbLgLsbLsLsmbLgbLgLsRsbLgbLgbLgLsbLsRsLsbLgbRsbLib
LsbLgLgLgLgbLgLsbLgLsbLgLsbLgbLsLsmbLgLsbLsbLsbLiRsbLgbLsLsmbLibLgbLgL
sbLsbLiLsbLsbLgbLsbLgRsbLsLsmbLgbLibLibLsbLgLsbLgLiLsbLgLgLsbLgLgbLgLs
bLsbLgLiLsbLgbLgbLgbLgbLgbLgbLsLsmbRgLsRsbLibRcbRsbRiRsmbRiLsbLiRsbRsb
RcbLibRcRsRimbLsRsLsbsbRibLgRsbRgRsmbRibLgLsbRibLgbRhLgRsbRgbRiLsLsmbR
gbRgbLgbRibRsRibRgbLsbRgRsmbRsRsmbsbLgRsbRsRgRsmbRgbRgbRgbRgRsLsmbRgRs
mbRgbRibLgbRsRibRsbRgRsmbRgbRsbRgbRibRgbLjbRibRibRgbLsRsRiLgbRgRsRimbL
gbRgRsmbRsbLsRibRsbRgRsmbLsbRgbRsbLsRgbRgRsmbLgbRsbRibRsbRgbRiLsbLjbRi
bRsbRcLsbLgbLjbRhRsmbLjbRibRibRgRsmbRgLgbRgRsmbRgRsmbRsRsLsmbRgRsRgRsm
mbRsLsRjbRgRsRsRsRgmmmbLsRgbRsbRgRsmbRgbRsLsbRgbLsRsbRgRsmbRgbsbLgLsbR
gbRgRsmbRgbRsbLcbLiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 24; Drug: NDMC 10 µM
bLcbLgbRgbLsbLsbLsbLgbLgbLgbLgbRsLsLsmbLsbLsbLgbLgbRsbLgbLsLsmbLgLsbLs
bLjRsbRgbRsbLoRsbLhbLsbLhLsbRibRiRsmbRibLgbLgbLsbLgbLsbRgRsmbRsbRgbLgb
RsbLibLgLsbLsbLsbLsbLsLsmbLsbLsbLgbRsRsmbLsbRgbRsbRsbRsbRsbRgbRsRsmbRs
bRgRgbRgbLsbLsbRjbRibRobRhbRjbRgbRgbRsRsLsmbRsLsbRgbRgRsmbLgbLjbLsbLiL
gLsLsmbLibLgbLsbLgbLsbLgbLsbLsbLibRibLsLsmbRjbRgbRsbRibRgbRgbRgRsmbLsb
RsbRgbRsbRsbRgbRgbRsbRsbRsbRgbRsbRgLsbRgbRsbRgRsmbRsbRgbRsRsmbRsRsmbRg
RsmbRgRsmbRsbRsbRgbRibRgbRibRibRibRgbRibRgbRsbRgbRgbRgbRgbLgLsbLsLsmbL
sbRibLjLgbRgbRgbRsRsRsmmbRgbRgRsRsRsmmmbRgbRsbRgbRgbLsbRgbRgbRgbRgbLsb
RgbLsbRgbLgbRgRsmbRgbRgbRiRgbRsbRsbRsbRgbRsbRsbRgLsbLsbRgLsbRibRgbRgRs
mbRgbRgbRgbRgRsmbRgRsmbRgbRgbRsbRsbRgLsbLsLsmbRgbRsbRsbRgbRsbRibRgbRgL
gbRibRgbRgLsRsLsRsbRgbRsbRgbRgbRgbRsbRgRsmbRgLsbRsRgbRgbRgbRgbLsbRgbRg
bLiRsbLcbRgbLcLsmbRcbRobLibRibRsLsbLjbRibRgLsbRibLgbRgbRgbLsLsmbRibRgb
RsbRgbRsRsmbLsLsmbLgbRgbRgbRgbRgbRgbLgbRgbLsbRgbRgbRgRiRibRsRsRiRsRiRs
mmmbRgbRsbRgbRsbRsLgbRgRsRiRsRsmmmbRgbRgbRgbRsbRsbRgRsmbRgbRsbRsbRgbRs
RsmbRgbRgbLsLsmbRgbRgbRsbRgbRgbRsRsmbRgbRsbRgRsmbRsbRsbRgbRgbRibLiLsbR
sRsRsmmbRibsbRiRsmbLibRibLsbRgRsmbLsbRgRsLsmbRgbRgRsmbRgbRgbRgbRgbRgRs
mbRgbRgRsmbRgRsmbLsbRgbRsRsRsmmbRgRsRgmbRgbRgbRgbRgbRsbRgRsmbRgbRgbRgb
RsRsmbRibRibRibRibRibRgbRgbRiRsRsLsmmbRibRgRsmbRgRsRgRsRsmmmbRgbRgbRgb
RgbRgbRsRsmbRgbRsbRibRgbRgRsRsRimmbRsbRgRsmbRgbRgbRgRsmbRsbRgbRgRsmbRg
bRgbRgRsmbRgbRgRsmbRgbRgbRgbRgbRsbRsRsmbRsbRsbRgbRsbLgRsbRgbRgbLsbRiRs
mbRgbRgbRgRsmbRgbRgbRgbRgbRsbRsRsmbRgbsbLjbRgbLjRsRsLcmbLhbLsLgRsbRgbR
oRsmbRsLsRsbRgbRsbRgLsbRgbRsRsmbRgbRgbRgbRgbRiRgbRgRsmbRgbRgbRsbRsbRgL
sbRgbRgbRsbLsLsmbRgRsmbRgbRgbRgbRgbRsbRgRsmbRgbRgLsRsbRgbRgbRgbRgbRgbR
gbRgLsbRgLsbRibRsbRgRsmbRgbRgRiRgbRsbRgRsmbRsbRibRgbRgRsmbRgbRibRgLsbR
gbRsbLibLiRgbLgRsbLiLsbLsLgbsbRgLsbLsLibRsLsbLgbLgRsRsmbLibLgbLgbLgbLs
bLsbLgbLsbLibLsbLgbLsLsmbLsbLgbLsLgLsbLsbLsbLiLsbLgLsbLgbLgbRsRsmbLgbL
ibLgbLsbLcbLibRgbLsbRgbLsRgbRgbLibLiLsbLgRsLsbLgRsRsmbRsLsbLiLsbRsLsbL
gbRsbLjbLsbRsbLsLgbLgLsLgLsbLgLsLsmbLgLsLsLhmbLgLsLsmbLsLsmbLgbRebRibR
ibRgRsmbRiLsbRgRsmbRgbLjbLcbLibRgbRebRgbRgbRgbRgbRgbRsbLibRibRibRhbRgL
sbRsbRgbLsbLgbRjbRgbRgbLsLsmbRsRgRsmbRgbRsbRgbRsRsmbRgbRsbRgbRgbRgbRgb
LsRsbRsbRgbRibRsbRgbRsbRgbLsLsmbRibRgbRsbRgbRgbLgRsbRgRsmbRsbRsRsmbRgb
RgRsLsmbRsbRgbRgRsmbRgbRgbRgbRgbLsbLsbRgbRgbLsbRibLsbRibRgbRgbLgbRsbRg
bRgbRgbRgbLsbRsLsbRgbRsbRgbRgLsbRsRsmbRsbRsRsmbRgbRgbLsbRgRsLsmbRgbRgb
RsLsbRgRsmbRgbRgbRsRsmbLsbRgbLgLsbRibRgbRibRibRgLsbRgbLgbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 25; Drug: Control
bRobRjbRjbRhbRcbRhbLibLjbRjbRsbLgbRsbRgRsmbRgbRsRsmbRsbRgRsmbRsRsmbRgb
LsbRgbLobRiLsLsmbRcbRhbRcbRjbLjbLjbRjbRsbRgbRibRgRsmbRgRsmbRsbRgLsbRgb
RgLsbRgbLsbLgbRjbRgbRsbRgbLgbRgbLjbLsbLgbLgbLgRsbRsbLgLsbLgLsbLsbLsbsb
LsbLgLsbLsbLibLiRsbLcLsmbLcbLjLsmbLjbLjLsmbLibLgbLgbRgbRibRgbRgRsRgRiR
iRiRsmmbRsbLsRgbRsbRgbRsRsmbRgbRsRsmbRgRsmbRgbLsbRgbRgbRsRjbRobLjbRibR
ibRgbRibRgRsmbLgbRgRgRgRgRiRgbRsbRgRsRiRgmbRgbRsbRsbRgbRjbRcLgbRsLsRsb
LibRjbLibRiRgbLgbRsbLsRsLgLgbLgLgbLsbLgLsbLgLsbRsbLibLgbRgbRsbLgbLgLsb
LsbLgbLgRgbLgbLgLeLiRsbLsbRsbLgbLjLsmbRjbLibLibRibLjLsmbLibLgLsbLgbLib
LibLiLsbLgbRsRsRsRgmmbLibLsbLibRsbLiLsbLgbLsbLgbLcbRgRiLsRgbLhbLsbLiRs
bLsLsmbLgbLgRsbRgLsbLiRgbLgbLsbLgbLiRgbLiLsbLsbLgLsbLiLgLsLibLgRsbLgbL
gbLgbLgbLgRsbLhRsbRjbRjRsmbLibLgbRsbRgbRibLgbRibLgbRgRsmbRgRsRgRsmmbRs
RgRsmbRebRebRiRsmbRgbRsbRgLsbLsbRibRcbLibLgbLgbRhbRibRibRibRgbLsbRgRsm
bLsbRiRsRembRgRsRiRgReRgRiRimbRibRebRgbRgRsmbLgbRibRobRhbRcbRcbRibRiLs
bLsbLsLsmbLsbRibLjbLcbLsRgbLibLibRgbLiRgRsmbLibRsRgbLiLsLsmbLgbLgbLibL
gLgbLgRsbLgbLgRsbRjRsmbLhbLcbRibLjbLcbLjbLibLibLgbRgRsmbLsLiLsbLibLsLs
mbLgbLgbLgbLgbLgbLgbLsbLgRsbRsbLgRgbLiLsbLgLgLsbLgLsLsmbLgLsRsLsbLgbLg
LsbLsbLiRsbLgbLcbLebLibLibLsbLsbLsbLgLsLsmbLgbsbLgLsRsbLjbRjbLgbLsLsmb
LsLgbLgLsbLgbLgLsbLgbLgbLjRsRsmbRcbRcbLjbRcbLgbRibLgLsRsbRgRsmbRgbRgbR
gRsLsLgmbRiRsmbRgRsRgRsRiRiRgRsRgmmmbRgbRibRgbRgbRgbRgbRobRibRhbRhbLib
RhbRiLsRiRsRgmbLhbLibRjbLibLgbLsbLgLsbLgbLgbLgbLgbLgLsLgbLsbLgLsbLibRg
bLjLsmbLibRiRsRimbLibLjRsRsmbRiRibLibRsbLgbLsbLgbLgRgbLgRsbLgRsbRgbLgb
LgbLgLsLsLsmmbLgLsbLgbLgLsbLgbLgbLsRsbLgRsbRgbLibLgbLibLibLibRibRsbRib
LebLgLsbLibRibLibRgbLgbLsRsbLsbLgbLsbLgRgbLiLsRsLsbLgbLgRsbRgLsbLgLsLs
mbLgbLgLsLgLgbLgbLsLsmbLgbLsbLibRsbLibLiRsbRgbLgRgbRibLjbRcbRibLgbLgbR
ibRgLsbLgbRibRcbRhbRibRgbLibRcbRibRsbRiLsbLgLjbRibRsbRsbRsbRgRgRiRsReR
smmbRgRsmbRgbLsbRgRibRgRsRgRiRiRsRiRiRgmmbRsRsmbRibRgLsbRgbRgbRsbRgbLs
bLhbLcbRiRiRsmbRiRsRgLsmbRgbRcbRjLsbLibLcbRibRgbLibLibRgbRibsbRsRiRsmb
LhLsbLibRjbLiLsbLsbLgbLgRsbLgRsLsbLgbLcbRibRcbRcbRcbRcRibRiRsmbRgRsLsm
bRibRsbRgRiReRgbRsRsRiRiRsmmbRgRsmbRgbRgbRgbLgbRibLgbRgbRibReLsRsbLhbR
ibLcbRibLsbRsbLcbRgbLiLsbLibLsbRsbLgbLsbLsbLibLgbLgbLgbLgbLsbLiLsbLgbL
sbRebRhbLibRhbRobLibLcbLibLibLjbLgRsbRibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 26; Drug: Control
bRobRgbRgbRjbRcbRhbRebRibRjbLjbLibLsbLgbLsLsmbLgLsbRsbLibLsbLgbLsbLgbL
gbLgbRsbLgbLgbLsbLoRsbLcbLsbLgbLgbLgbLgLsbLsbLgbLgbRibRgbRgbRibRjbRsbL
ibLsLsmbLgbLgLsbLsbRsbRsbLgbLsbLgbLsbLsbLgbLsbLsbLgbRsbLsbLsbRebRibLsb
LsbRsbLsLsmbRgbRgbRsbRsbRgbRsbRgbLobLsLsmbLsbLhbRsRgbLcbLsbRgbLgbLgbLg
bRcbLibLgbRgbRgbLgbRgbRgbRgbRgLsbRsbRgbRsbRsbRgbRgbRsbLsLsmbRgbRsbRjLs
bRcRiLsbLgbLsbLgbRsbLgbLsbsbLeLsLsmbRibLsbRsRsmbRsbRsbRsbLsbRgbRiRsmbR
sbRsbRgRsLsmbRgbLsbRsbRgbRsbRgbRsRsRsmmbRibRsRsRsmmbRsbRsbRsbRgbLsbRgb
LsbRgbRsbRgbRsbRgbRhLsbRibRiLsbRiLsbLjbLsbRgbLiLsbLgbRsLsbRsbLsbRibRgb
RsbRgbRsbRsbRsbRgbRjLsbRsbRsbRibRhbRibRsbRsbLgLsbLgbLgLsbLsbLgbRsbLgbL
gRsbRgbLobRsbLcbLcbLibLjRsbLgbLgbRsbLgbLgLsbLgbLibLgbLgLsbLgbLgbLsbLgb
LsbLgbLsbLgbLgRsbLsbLgbLsbRsbLiRsbRcbLobRcLsbRgbRsbLjLsmbLgbRsbLgbLsbR
sbLgLsbLgbLgbLgbLgbLsbLsbLgbLgbLgbLgbRgbRsbLobLobLibLsbLibRsbRebRibRgL
sRsbRsbRsbRsbRgbRsbRsbRgbRgbRsRsmbRgbRsLsbRgbRsbRsbRgbRgbRsbRgbRgbRsbR
gbLsbLsbRgbRsbRsbRsbRgbRsbRgbLsbRgbRsbRsbRsbRsbRsLsbRjbRsbRgbRgRsmbRgb
RgbRgRsmbRsbRsbRgbRgbRsbRgbRgbRsbRgbRsbRibLsbRsbRgbRsbRgRsmbLsbRjbRgbR
jbRsbRgbRsbRsbRiRsmbRsbRgbRsRsmbRgbLcbRjbLibLibLcbRhbRjbLjbLhbRgbRcbRe
bRgbRgbRsbRsbRgbLsbRgbRgbRsbLsbRsbRsbLjbLibLjbRebRcbRibRjbLgbLjbLsbLgb
RgbRebRibLsbLcLsmbRgbRibLibLsbRsbRsbLibLsLsmbRgbLgbRsbRebLsbLgLsLsmbLs
bLgbLsbLsLsLsmmbLsbRsbLgLsbLsbLgbLgbRcbRibRgbRgbLsRsbRgbRgbRgbLsbRgLsb
RsRsmbRgbRgbRgbRsbRgbLsbRgbLsbRgbRsbRobRgbLgbLsRsbLsbRibRiLsbRsbRibRsb
RsbLsbRsRsmbRgbRgbRgbRgbRsLsbRgbRgbRgbRsbLsLsmbRgbLsbRsbRsRsmbRsbRgbRg
bRibRsbRgbRgbRsbRgbRgbRsbRsbRgbRgbRgbRsbRgRsmbRsbRgbRsbRgRsmbRsbRgbLsR
sbRibRsbRgbRgbRgLsbRsbRgLsbRgRgbRiRsmbRgbRgRsmbRsbRgbRgRsmbRsbRgbRgRsm
bRsbRsbRgbRsbRgbRgbRsbRgbRgbLgbLcbRebRiRsmbRgbRibRgbLibLgbLgRsbRiLsbRi
bLsbRibLibRsbRgbLsbRgbRgbLsbRgbRsRsRsmmbRgbRgbRsRsmbRsbRgRsmbRgbRsbRiR
smbRsbRsbRgbRgbRsbRgbRgLsLsRsmbRgbRgbRsbRgbRgbRsbRgbRgbRsbRsLsbRiRsmbR
gbRgbRgbRsbRgbRsbRgbRsbRgbRgbRsbRgbLsbRgbRgLsbRsbLsbRibRsbRgbRgbRgbRgb
RsbRgbLsbRibLsbRgbRgRsmbLsbRgbLsbLebLibRgbRjRsmbRibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 27; Drug: Control
bRoRsRsRsmmmbRgbRcbRibRgbRsRsmbRibRgbRgbRgbRgbRgbRgRsmbRgbRgbRsbRgbRsb
RsbRgbRsbRsbRgbRgbRgbLgbRgRsmbRsbRgbRsbRsbRsbRsbRgbRsRsmbRgbRsbRgbRsbR
sRsmbLsRsbLsbRgbRgbRjbLgbLobRjRsmbLcbLibLibLgbRgbRibRibRgbRgbRgbRgbRsb
RsbRsRsmbRsbRgbRgbRgRsmbRgRsRgmbRsRsmbRgbRsbRsbRgbLsRgbRgbLsbRsbRsbRgb
RgbLgbRsbLsRsbRgbRsbRgbRgbRgLsbLsbLobRgbLjbLcbLibLiRsbRibLibLgbRsRsmbL
gbLsbLgLsbRsbLgLsbLsbLsbLsbLsbLgbRgRsmbLgbRjbRcbLgbLsbRibRgbRgbRgbRsRs
RsmmbRsbRgbRsbRgbLsRsbRsbRsbRsRsmbRsbRsbRsbRsbRhLsbRhRsmbRebRibRgRsmbR
gRsmbRsbRgbRsLsbRiRsmbRsbRgbRsbRgbRgbRgbRgbRsbLsbRsbRsbRgbRgbRgbRsbRsb
RgbRgbLsbRgbRgbRsbLsbRgbRgbRsbRgbRsbRgbRgbRgbRgbRgbRgLsbLgbRgbRgbLsbRg
bRsbRsbRsbRsbRsbRsbRsbRgbRgbRsbRgbRgRsmbRgbRgbRgbRgbRgbRsbRgbRgbRgbLgb
RibRsbRsbLsbRgbRibLibRgbLsbRhbRcLsbLibRibRsbRgbLgbLsbLgbLjbLiLsbLgbLib
LgbLibRgbLibLsbRgbLiRsbLsbLibLibLgbRgbLibRsLsbLgbLgLsbRsbLgRsbLgRsbLsL
smbLgbLsbLsbLgbLgRsbRsRsmbLibRibLiLsbLibLgbLibRibRgbLsLsmbLiLsbLibLibR
gbRgbLgbRjbRibLsbRgbRjbRsbLsRgbRgRsmbLsbLcbLobRibLcbLcbLibRjbLibRjbLib
LgRsRsmbLgbLsbLgbLsbRsbLgbLgbRsbLgLsLsmbLgLsLsmbLsbLsRsbLgbLgbRsbLgbLs
bLgRsbLgbLsbLgLsbLsbLgLsbLgLsbLgbLgbLgbRibLgbLgLsbLsbLsLsmbLsbLgbLsbLg
bLsbLgbLgbRsbLsLsmbLsLsmbLsbLgLsbRsbLgbLgbRsbLsLsmbLgbLsRsbLgbLsbLgbLs
bLgbLgbLgbRgbLibLibRsbRgbLibRsbLgbRsRsmbLgbLsbLgbLgbRsbLiLsbLgLsRsbLsb
LgbLgbRsbLgbLgbRsRsmbRgbLgbLgbLsbLsbLgbLsLsLsmmbLsbLgRsbLsbLgbLsLsmbLs
bLgbLsLsmbLibLsbLgLsbLsbLsbLgbLgbLgbLgbLgbLgbRgbRjbRibLjbRgbLsbRsbLcRs
bLibLibLibLibRsbLgbLsbRsbLgbLgbLsLsmbLgbLiRgbLgbLsbLibLsbLgLsLsLsmmbLs
bLgbLsbLsbLgbLsLsmbLgbLgRsLsbLgLsbLsLsmbLgbLsbLibLgbLgbLsbLsRsbLsbLsbR
sbLgRsbLgbLgbRgbLibLsbLsbLgbLgbRsbLgbLgbLibRibLgbLgbLgbRsbLgRsbRsbLibR
sbLgRsbLgbLgbLibRibRibRibLgbRgbRgbRsRsmbRgbRsbRgbLsbLgbRibLsbRgbLsLsmb
RhbRgbRibRibRibLibLgbLgbLgbLgbLsLsmbLsbLgLgLgLsbLsLsmbLgbsbLoRsbRsbLiL
obLcRsbLibRhbRsbRibLjbRibLcLsmbRjbLibLgLsbRsbLibLgbLibLgbLgbLgbLgbLsbL
gbRibRibRibRgRsmbLsbRsbRsRsmbRgRsmbRgbRgbRgbLgbRibRiLsbRgbLibLsbRibRsb
RgRsmbLsbRiRsmbLsbRgbRgRsmbRgbRsbRsRibRgbRgbRsRgbRsbRsbRgbRgbLsbRsbRsb
RgbLsRsbRgbRsbRsLsbRsRsmbRgbLsbRgbRgbRsbRgbRgbRgbLgbLjbRcbLsbRibRgRsmb
LsbRgRsmbLsbRgRsmbLsbRsLsbRsbLobLcbRcLsbLibRsbRibLgbRibLsbRibRsbRgbRib
LgbRgbLsbRibRibRgbRgbLgbRgbLcbLibLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 28; Drug: Control
bLoLsmbLobRjbRhbRcbRibRgbLgLsbLsRsbRgbLgbLibRcbRhbLgbRcbLgbRsbRcbRsRsm
bRsbRcbLsbLsbRhbRgbLsbLibRibRibRhbLgbRcbLgbLsbLsbLibLibRsbRgbRsLsLsmbL
ebRebRgbRibRcbReRsmbRgbLsbRibLobLgbLsRsbLibLgbLsbLsbLsbLsbLsbLgbLgbLiR
sbLibLhbLobLcbLjbRebLcbLcbRsbLsRsbLgRgbLsbLgbLgbLgbLgbRsbLhRsbLibLsbRj
RsmbLsbLsLsmbLsbLgbLcbRebRcRsLsmbRcbRsbLsbRiRsmbRiRsmbRsbLsbLsbRgbRibR
sbRgbRsbRsbRsbRgRgbRgbLsbLjbRcbRobRcbLcbLcbRgbRsbRgbRgbLsbRgbRsbRsbLsb
RgbLcbLhbLsbRsbLsLhbLebLcbRgbLgbRsRsmbRsbRsRsmbRgbRgbLsbLgbRgbRgbRsbLg
bRsbLcbLiLsbRjbRhbLsRsbLcbLcbRiRsRsmmbLgbLgbLgLsbLsLsmbLgLgLsbLgLsbLsb
RsbLsbRibLjbLhbRjbLhRsbLcbLgbRgbRgbRgRsRgRsmmbRsbRsbLjbLiRsbLsbLgRsbLg
bLsbLsbLjbRcbLsbLibsbLgLsbLgbRsbLgLsLsmbRsbRjbRgbRgbRsbLjbLibLibRsbRib
RgRsmbRgbRgbRgbRgbRgbRsRsmbRsbLsbsbLsbsbLsbRsbLgbLgLsbLsbLgbLgbLsbLgLs
bLsbLsRsbLsbLgbLgbLgbLsbLgLsRsRsmbLgbLsbLgbLsbLgbLsbLgbLgbLsRsbLgLsbLg
bLsbLgLsLgbLgbsbLgbLsbLgbLgbLgbLgLsbLsbLgbLgbLgLgbLgLsbLgbLgbLgbLibLgb
LgbLgbLgbLsbLgbLsbLgbLsbLsbLsbRsLgbRgbRibLjbLjRsbLiRsbLsbLsLsRsmbRsbLj
bRgbLjLsmbLeLsbRcRsmbRibRgbLgbLsbLibLgLsLsmbRsbLgbLgLsbLsbLgLsRsbLsbLg
bRsbRibRhRsmbLgbLsLsmbRhRsmbRgRsmbRsbRiRsmbRibRibLibLgbRsbRgbLibLsbRsb
LibLsbRsbLsbLgbLgLsbLgLsbLsbLsbLgLsbLsbLgbLsbLsbLsLsmbLsbLsLsmbLgLsbLs
bRsbLgbLsbLgbLsLsmbLsbLibLgbRcbRibRsbLsbRsbRebRgbLsbLobLcbLcLsmbRibRib
LsLsmbLjbsbLsLsRsmbLsbLibLibLcbLibLgbLjbLibRsbLgbLsbRsbLgbLcbLhbRcbLiL
sbRsLsRsbLiRsbLsbLgRsbLgbLgbRsbLsbRsbLgbLgLsbLgbLgbLgbLiRsbRgRsmbLibLs
bLibRsbRgbRsbLhbLhbLiRsbLibLibLgbLsbRjbRibRgbRsbLsbLhbLibRsbRibLibRjbL
obLibLibLibRsbLcbLcbLjbLhbRebLgbLiRsbLibLsbLgbRgbLoRsbLcbLiRsbLibLibLg
bLsbLsbLgbLgbLsbLgbLsbRjbRcbLsbRgbLcbLcRsbLibLibLibLcbLjLsmbLgbRgbRgbL
cbLgbLibLgLsbLsbLsbLsRsbLsbLibLhRsLsbRsbLgbLgbLgbLibLsbLgLsbRsbLsbLgbL
gLsbLgLsbLsbLgbLgbLsbRsbLgbLsbLgbLsbLgRsbLgbLsbLgbLgbLsLsmbLgbLsbLgbLg
bLgLsbLgbLgbLgLsbLgbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgLsbLsbLibLsbLgLsbLg
bLgbLgbLgbLsbLgbLgbLgbLgbLsbLgbLgLsbLgLsbLgbLgLsbLgLsbRsbLgbLgLsLsmbLg
bLgbLgbLibLgbLgbLsbLibLsbLibLgRsbLgRgbLgbLsRsbRhbRcbLgbLcbLcbRcbRcbRcR
sRsmmbRcbLgbRjbRobRcbLibLgbLsbRcbRgbLibLibLibRgbRgbLiLsbLibRsbRjbRcLsb
RcRsmbLhbLgbLjbLibLsLsmbLgbLsbLgLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 29; Drug: Control
bRobRibRibRsbRsbRsbRgbRsbRcbRsRsmbLsLsmbRsRsmbsbLgbLgbLgLsbLgbLiRsbLsL
smbLsLsmbLsbLgbLgbLsLsLsmmbLgbLsbLsbLgbLsbLgbLsbLgbLgbLsbLsbLgbLsbLgbL
sbLgLsbLgbLgbLgbLsbLsRsbLsbLsbLsbLgbLsbLsLsmbLsbLgbLsbLgbRsbLgbLsbLgRs
bRsbLsbLgbLgbLsbLsbLsbLgbLgbRgbLgbLgLsbLgbLsbLgbLgbLsbLsLsmbLgLsbLgbLs
bLgbLsbLibRgbLgLgbRsbLgbRebLibRibRibRibRgbRgbRobRcbRhbLjbLibLsbLsLsmbL
gbLgbLsLsmbLgbLsbLsbLsLgbLgbLgLsbLgbLsLsmbLsbLsbLgbLsbLsbLgbLgLsbLgbRs
bLgbLgLsbLsbLsbLsbLsbLgLsbLsbLgbLsbLgbLgLsbLgbLsbLgbLgRsbLgbLgbRsbLibR
sbRjbRibLobRcbRhbRcbRiRsmbRibRgLsbRibLibRhbRsbRgbRsbRcRsmbRcbRcbRibRib
RsbRgbRcbRibLgbRhbRibLsbRibLgbRobLgbRhbRhbLsbLsbRcbRcbLsbLgbLhbLgbLsLs
mbLsbRjLsbRibLsbRibLcbRibLcbLibLibLibRsbLgbLgbLsbLgLsbLsbLgRgbLgbLgbLg
bLgbLgbRgRsmbLgbLibLgbLgLsbLsbLgbLsbLgbLgbRsLsbLiRsbRgbRjbRibRgbLgbRsb
LjbRjbLcLsmbLgbLgbLhbRsLsbLgbLsLsmbLsbLgbLsRjbRsbLebRibLsbLgLsLgbLibLs
bLgbLgbLgbLgLsbLgbLgbLsbLgbLgRsbLgbLsbLgbRsbLgLsbLgLsbLsbLiLsLsLsLsmmm
bLgbLgbLgbLsbLgbRsbLibLsbLgbLsRsbLgLsbLgbRgbLibRsbLgbLiLsbLsbLibLsbLgb
LgbLsbLgbLsLsmbLgbLibLgbLgbLsbLsbLibLsbLgbLgbLgbLibRsbLiRsLgLsbLgRsbLi
bLsLsmbLgbLsbLgLsbLgbLgbLgbRsbLibLgbLgbLgbLgbLsbLgbLsLsRgRsmmbRjbRjbRi
RcbRiLsbRibRjRsRgmbRgbRsRiRsmbRgbRgbLhbLibRgbRjbRjbRcRebLhbRjbLhbLibLg
bRsbRjbRebLgbRsRsmbRgbRgbRgbRgLsbRgbRgbRjbRcbRcbRsbRsbRibRgbRgbRgbRgbR
sbRjbRgbRgbRgbRgbRgRsLsmbRibRjbRsbLhRjbLibLgbLgbRgbLhbRjbLibLsbLgbLgbL
gbLgbLgbLsbLibLsLsmbLsbLgRsbLsLebLgbLsbLgbLgbRsbLiLsLgbLgbLibLgbLiRsbR
ibRebLcLibRibRjbLjbLhLsbLibLsLsmbRsbLibRgbLibRsLhLsLsmbLcbLibLgbLgbLsb
LgLgLsbLgbLgbLibLsbLsbLiLgLsbLibLibRjbLgLsbLgbLgbLgRjbRjbRjbLibLhLgbLs
LsLjmbLibRjbLgbLibRgbLgbLibLsbLiLgbLgbRsbRibLiLibRcbRcbRjbRhbLcbLibLgb
LibRcbRibRhbLebLjbLcbRibRcbRibLcLcbLibLgbLibRgbRibLhbLgLsbLgbLiRibRjbL
obLjbLoLsLcmbLibLibLsbLibLgRsbLgLsbLgbLgbLgLsbLgLsbRgbLibRsLibLgLsbLgb
LgLsbLsbLibLgbLgbLgbLsbRsbLgbLgLiLsbRsbLgbLibLgbLsbLgbLsbLsLibLgLsbLgb
LgLsbLgbLgbLsbLgbLsbLgbLgbRsbLiRsLsbLgLsbRsRsLhmbRsLsbLgbLgbLgLsLsLsmm
bRsbLgbLibLsbRibRgLsbRgbRgbRhbRiRsRimbRhbLgbLibLiRsRgbLgLsbLibLiLsbLiR
sbLiLsRsbLibLgLsbLgbRjbLibLgbRgbLgLsbRsbRibRhbLjbLhbLhRjRsmbLibLibRsLg
bRgLsbLibLgbRsLsbLhbLibLibRibRgbRsbRgbLcbLibRgbRjbRibRgbLsbRgbRgbRsbLs
bLibRsbLeLgLsbRsLsbRsbLibLiRsLsRsLsbLgbLsbLibLsLsmbLcRsRgbLibRsLibLsbL
gLgbLgbLgLsbLsRsLsLibLgbLsbLibLgbLsbLiLsbLsbLiLsLsmbLsbLgbLgbLgbLgbLib
RgbRibLhbRjbRcbLcbLibRcbRcRiRsmbRhbRibLhbLsbLiLsRsbLgbRsbLibLsbLgbRsbR
gbRjbLibRjbRibRibRhbLgbLibRgbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 30; Drug: Control
bLobLgbLjbLgbLgbLgbLgbLibLibLsbLgbRgbRgbRgbLsbRsbRebRgbLcbLgLsbLgLsLsm
bRsbLgbRsbRsbLgbRsbLibRgbLgbLsbLgbLgbRsbLgbLsLsmbRsRsRsmmbLsRsbLgbLjbL
gbLgbLgbRsLsbLsbLgLsbLgbRgbRgbRibLgbRcbLsbRcRcbRibRgbRsbRibLgbRgRsmbRg
bRgbRsbLgbRsLsbRgbLhbRhbRcbRgbLgbLsbLibLsbLsbLgbLgLsLsmbLgbLsbLgbLsbRg
bLgbLsbLsbLgLgbLibLsLsmbLgbLgbLsbLgLsbLgbLgbLgbRgbLsbRsbLibRsLsbLsbLib
LsbLgbLsbLgbRsbLsLsmbLgbLgbLsbLgbRsbLsbLgbLgLsbRsLsLsmbLgbLsbLgRsbLobL
cbLjbLibLibLibLsbLibLgbLibLsLsmbLibRgRsmbLibRsbLgbRjbLibLsbLsbLgbLgbRg
bRsbLsbLgLsbLibLgbLgbLgbRsLgbLgbLibRsbLobLhbLjbLibLibLgbLgLsbLsLsRsmbL
gbLgbLgbRsbLgbLgbLsbLgbLgbLgbRsbLgbRsbLgbLgbLgbLgbLgbLsLsmbLgbLgbRsbLg
bLgbLgbRsLgLsbLibLgbLgbLgbLgbLgbRcbRobLgLsbLgbRcbRcbRibRibRibRibLhbRsb
RibLjbRcbRjbRgbLibLiLiLgbLibLgbLibLgRjbLibLiRsbRsbLibLibLgLsbLsRsbLcbR
sRsmbLibLgbLsbLgLsbLgbLgRsbRgbRjbLsbLiRsRsRsmmbRgbLgbLgbRsLhbRibRibRib
RsbRibLgbRgbLsbLibRebRibLjbRcRsmbRibRjbLsRsbLgbRebLibRibLhbLgbLsLsmbLg
bLcbLgbLsbLgbLgLsbRgbLgbLsLsmbLsbLibLsbLgbLgbLibRgbLiLgLsbLsbRsLgbLgLs
LsmbLsRsbLjbLgbLgbLcbRgRsmbLsbRsbLcbRgbRjbLoRsbRcbRibRebLsbRsbLcbLhLsb
LcbLcRsRsmbRgbRgLsbLibRjbsbLgLsLsLiRsRsRsmmmbLjbLgbLgbRgbLiLsLsmbLsLgb
LibLgbRsbLgbRjbRjbRibRiRsmbLgbRibRgRsmbLsbLibLsLsmbRjLcbRibLibLcbRibRc
bRsbRsbRgbRsbLjbRibLjbLibRcLsbLjbLcRsbLgbLsbLgLsbLsbLgbLsbLgbLgLgLsbLg
LsbLgbLsbLiLsbLsbLgbLsbLgbLsbLgbLsbLgbLgbRgLsbRebRcLsbLibRibRiLsbLsbLs
bRcbRcbLibRgbLgbLibLibLsbLsbLgbRhbRiRsmbLsbLebRhbLcLsmbLiRsbLiRsbRgbLi
bLibLgbRibRhbLjLsmbLibLsbLgLsbLgbLsbLgbRgbLibLsLsLgmbLgbLsbLsbLgLsbLgb
LgbLgLsbLgbLsbLgbRsbLgbLiLsLgbLgLsbLgbRgbLibLgbLsbLgbLgbLgLsbLgbRsbLgb
LgbLsLsmbLibRcbRcbRibLgbRhbLgbRobRcbRsbLibRgbLgbLsbLgbLsbRsLibLgbLsbLg
bLgLsbLgLsbLgLsbLgbLsbLgLiLgbLgbLgbLgbLsbLgbLgbLsbRsLsbLibLsbLsbLgbLgb
RgbLibLsbLgbRsLibRhbRcbRibRiRsmbRhbLgbRibRgLsbLibLibRjbLibLiLsbLgLgbLs
bLgbLgbLiLsbRgbLibRgbRgbRgbRcbRgbLhbLjLsmbRhbLebLgbLgbRsbLibLsbLibLgLs
bRsbLgbLsbLgLsbLgbLgbLgbLsbLsbLgbRsLsbLgbLsbLgbLgbLgbLgbLgbLgbLsbLgbLg
bLsLsmbLgbLsbLgbLgbLgbLgLsbLgbLgbLgbLgLsbLgbLgbLsbLgbRsbLgLsbLibLibRgL
sbLgbLoLsRsmbRsbRjbLobLibLgbRgbLibRgbRjRibRibRsbRsRcbLiLjbLibLibRjLsbL
cbRgLsbRsbLibLgLsbLgbLsbLsbLgbLgbLsbRsbLgbLsbLgLsbRgbRgbLibLibRsbRcbRi
bLgbRgbLcLsmbLhbLsLsmbLiLsbRsbLcbLcbLsRsbRhbLibLjbLcbLibLiRsLgbRgbLibL
ibRgbLibRgbLgbLgRsbLgbLsbLibRgbLibLgbLibLgbLsbRsbLsbLgbLgLsbLsbLgLsLsL
smmbLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbRjbRibRcRsmbLibRhbRhbLibRcbRcbRibRiL
gbLibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 31; Drug: NDMC 1 µM
bRobRsbRsbRcbRgbRibRgbLgLsbLhbLhbLhbLsbRgbLibLgbLsbRjbLcbRibLcLsmbLsbR
sbLgbLgRsbLgbLgbLgbLgbLgbLsbLgbLgbRsbLgbRsbLgbLsbLgbLsbLcbRgbLibRgRsmb
LsbRsbRibRgbRgbLobLibLsbLgbLgbLsbLsLsmbLsbLgbLgbLsbLsbLsbLgbLgbLsbLgbL
sbLgbLibLsbLsbRsbLsbLgbLibLgbLgbLgLsbLgbLgLsbLgbLgbLgbLgbLsbLgbLgbRgbL
sbRhbRgbRhLsbRibRgbLgbLsbLsbLsbLsbRjbRibRibRgbLgbRgbRgbRgbRibLibLsbRib
RgbRsbRsbRsbRgbRgbRsbRgbRsbRgLsbRsbLsbRsbRgbRsbRgbRgbRsbRgbRsbRsbRgbRg
bRsRsLsmbRjLsbRibRhLsbRsbRgbLsbLsbRsbLsbLgbRobLsbRsbRibRibLgbRgbRgbLsb
RsRsmbRgRsmbRgbRsRsmbRgbRgbRsbRsbRsbRgbRgbRgbRsbRgbLsLsmbRsbRibRsbRsbR
sbRsbRgRsmbRgbRsbRsbRsbRgbRgbRsbRgbLgbRibRgbRsbRsbRgbRsbRsbRgbRgbLgbRh
bLgbLsbRgbRgbRgbRgbRgbRgbRsbRgbRsbRgbRgbRsLsbRsbRgbRsbRsbRsbRgbRgbRgbR
sbRgbRgbRgbRgLsbRsbRgbLgbRsbLsbLsbRjbRjbLibLibLgbLsLsmbLsLsmbLgbLgLsbL
gbLsbLgbLgbLgbLgbRsLsLsmbLsLsmbLgbLsbLgbLgbLgbLsbLsbLibRjRsmbRgbRgbRsb
RsbLsbRgbLibLibLsbLgbLsLsLsmmbLsLsmbLgbLsLsmbLgbLgbLgLsbLgbLgLsbLgbLgb
LgbLgLsbLsbLgbLgbLgLsbLsbLgbLgbLgbLibRobRibLsbRibRgLsbLgbRhbLgbLsbRgbR
sbRgbRsbRibLoRsbRjbLcbRibLgbLgLsbLsbRgLsbRcbRibRibLibRibRgbRgbRsbRobLi
bLgbLsbRsbLgbRibRgbRibLgbRibLsbRibLsbRibLsbRibRgRsmbLgRsbRibRgbRibLgbR
gbRcLsbRibRibRsbLibLgbRsbRjbRsbRhbLjbLcbLgbLgbRsbRjbRcbRibLhbLgbRjbRib
RibLobLgbLgbLgbLgbLgRsbLgbLsbLgbLsbLgLsbLsbLsbRibLgbRsbRgbRgbLsbRgbRgb
LsbRgbRsbRgbRsbRgbRsbRgbRsbRgbRgbRgbLgbLsbRjLsbRgbRibRgRsmbRgbRsLgbLsb
LhbLibLsbLgbLgRsbLsbLgbLgbLgbLgLsbLsbLsbLgLsbLgbLgbLgbLgLsbLgbLgbLsbLs
RsbLsbLgbLsbLibRobLjbLsLsmbLibLgbLsbLgbLgbLgbLgbLgLsbLgLsbLgbLgbLgbLgR
sbLgbLgbLgbLgbRebRibLibRjbRibLgbLibRsbLibLsLsmbLsLgbLgbLgLsbLgbLgbLsbL
sbLsbLgLsbRcbRhLsbLgbRibRsbLibLibLgbLgbLgbLgLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 32; Drug: NDMC 1 µM
bRobLsbRsLsbLibLiRsbLsbLsbRibLsbLsbLibLhbLhbRgbLhbLibLsbRsbLibLgbLgRsb
RsRsmbRsbLgbLgbLgbRsbLgbLgbRsbLsbLsbRsbLgbLgbLibLhbLcbLibLgbRgbRgbRgbL
sbRgbRsbRsRsmbRgbRsbRgbRgbRsbRgbRgbLgbLjbLcbRgbLsbLjbLibRgbLsbLsbRjbLj
bLgbLgbLsbLsbLsbLsbLsbLsbLgbRhbLsbLgbRgbRibLsbLsRsbLsRsbRgbRgbRsbRsbRg
bLsbRgRsmbRsbRsbRgbLsbLcbLibRsbLgbRsbLgbRgLsbLgbLsLgbLsbRsbLgbLgbRgbLg
bLgbLgbRsbLgbLsbLgbLgbLgbLsbLsbLsRsbLsbLgbLgbLgbLsbLsbLsbRsbLgbLsbLgbL
gbRsRsmbRibRibRsbRsRsmbRgbRsbRsRsmbRsbRgRsmbRgRsmbRsbRsRiRsmbLsbLcLsmb
RjbRgbLibLibLsbLgbRsbLgbLgbLsbLgbLgbRjbRibLsRsbRsbRibLgbRsbRgbRgbRgbRs
bLcbLgbLsbLgbRsLsbLsbLgbLsbLgLsRsRsmbLgbRsbLgbRsbLiLsbLgbRsbLgbLgbLgbR
sbLgLsbRsbLgbLsbRsbLibLsRsbRgbLsLgbRsbLgbLgbRgbLgbLgbRsbLsbLgbRsbLgbLg
LsbRsbLgbLsbLgbLgbLsbRgLsbLsLsmbLsbRsbLgbLgbRsbLgbLgbRsbLgbRsbLgbRjbRi
bRibRibRibRgbRgbRsbLgbLgbLgbRgbLgbLsRsbLgbRcbsbRobLgbRibRibRsbRsbRsbLs
bRsbRgbRgbRgbRgbRgbLgbRgbRgbRsbRgbRgbLgbRgbRgRsmbRsbRsLsbRgbRsbRgbRgbR
sbRgbLgbRibLsbRgbRgbRsbRsbLgbRgbRgbRsbRgbRgbRiRsmbLsRsbRjbRibRibRhbRcb
RgbLgbRgbLsLsmbLgbRibRgbRsbRsbRgRsmbRgbRgbRgbRgbRgRsRgmbRgbRsbRsbRsbRs
bRsRsRsmmbRsRsmbRgbLgbRgbRsbRgbRgbLsbRgRsmbRsbRgRsmbRgLsbRgbRgbRgLsbRg
bRgbLsbLsbRibRgbRsbRgRsmbRgRsmbRsbRgbLsbRibRgbRsbLsbRgbRsbRgbRgbRsbRsR
smbRgbRsbRsRsmbRgbRgbRsbRgRsmbRsbRsbLcbLcbRgbRibRcbLibRgbLsLsmbRgbRsbR
sLsbRgbRsbRsbRgbRsRsmbRsbRsbRsbRsbRgbRsbsbRsbRgRsmbRsbRgbLsbRsRsmbRgbR
gbRsbRsbRgRsRsmmbRgbRsbRiLsbLsbRsbRgbRsbRgbRsbRsbRsbRgbRsbRgRsmbRsbRgb
RgbRsbRgbRgbLsbRgbLsbRgbRgRsmbRgbRgbRgbRsbRgRsmbRsbRsbRgRsmbRgbRsbRgbR
sbRgbRgbRgbRgRsmbRgbRsRsmbRgbRgbRgbLsbLsbRgbRsbRgbRsbRgbRsbLjbLibLibRs
bLibLgbLiRgRsRsmmbRibRgbRsbLgbRgRsmbLsbRgbRsbRgbRgbRsbRsbRsbRgbRgbRsbR
gbRgbRgbRsbRsRsmbRgbRgRsmbRgbRgbLgbLibLgLsbLsbLibRgbLgbLjbLobRibRgbLsb
RsRgbLjbLibLgbLsbLsbLsbLgbLgLsbRgbLgbRjbRibLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 33; Drug: NDMC 1 µM
bLcRsbRsRsmbRsbLgbLsbLibLgbLibRgRsmbRsRsmbLibsbLgbLgbRgbLhbRjbLibLibRs
bRsbRgbLgbRgbRhbLgbRgbLebLiRsbLgbLgbRgRsmbRjbLibLiRsbRsbLsbLibLgRsbLsb
LgbRsRsmbLibRsbLsbLgbLgbRsRsmbLsbLsbLsbLgbLsbLsbLgbRsRsmbLgRsbRsRgbRcL
sbsbRiRsmbRibRibRgbRsbRgbLcbLsbRcbRcbLgbLsbRhbLgbRgbRsRsmbRgbRgbLgbLjb
LcbRjbLibLgbLcbLibRibLcbRibLsbLsbRsbRibRgbRgbLsRsbRsbRgbRgbRsbRgbRsRsm
bLsLsRsmbRgbLsbRgbRgRsmbRgbRgbRsbRgbRgRgbRgbRgbRgbRsbLsbRsbRgbRgbRsbRh
bRibRcbRgbLgbRibRgRsmbLsbRgbLgbRgbRgbRgbLsbLsbRgbRgbRsbRsbRgbRgbRsbRgb
RgRsmbRgRsmbLgbLgbRgbLcbRibLibRjbLcbRibRjbRibLgbRibLibRibRsbLsbRiRsmbL
gbRgbLgbRibRgbRgLsbRsbRsbRgbRsRsmbRsRsRsmmbRsRsmbRgRsmbRsbRsbRsbRgbRgb
LgbRgbRgbRgbRgbRsbRgbLgbRgbRgbRsbRcbLibRgbLgbLgbLgbRsbRgbRgbLjbRgbLhbR
jbLhbLibRcbLjbLgRsbsbLgbLsbLsbLsbLibLgbsbLsbLsbLsLsmbLsbRsbLsbLgbLgbLg
LsbLsbLgbsbRsbLsbLgbLsbLsbLsbLsLgbLsRsbLsRsbLgbLgbRjbRoLsRsbRiRsmbRibR
sbRibRcbLgRsbRebRibRgbRgbRsbRgbRibLjbLcbRiRsmbLcbLibRjbLcbLhLsbRibRgbL
jbLibLsLcbLibRibRgbRsbLhbLibLibLibRgRsmbLibLibLgbRgbRiRsmbRibLibRgbRsR
smbRgbsbRsbRgbLgbRgbRgRsmbRsbLsbRgbRsbRsbRgbRibRsbLgbRsbRibRgbLjbRibRg
bRsbRsbRgbLgbRgbLsbRibRsbRgbRsRsmbRibRgRsmbRsbRgbRgbLgbLgbRjbRgbLsbLjL
hbLibRibRjbLibLibLibLhbLibLibLibRibLgbRhbRiRsmbLsbRibLsRsbRsbRgbRgbRgb
LsbRgbRsRsRsmmbRgbRgLgbRgbRgbLsRsbRsbRsbRgRsmbRsbRsRsmbRgbRibRsbRsbRsb
RsRsmbRgbRgbLsbsbRgbRsRsmbRsbRsbRsbRgbRsbRgbRsbRgbLsbRgRsRsLsmmbRgRsmb
RsbRgbRsRsmbLsbRgRsmbRgbRgRsmbLsbRgRsmbRgbRsbRgbRgRsmbRgbRsbRgbRsbRgbR
ibRgbRgbRgRsmbLsbRgbLsRsbRgbRsbRiRsmbLgbRibRsRsmbRgLsbRsbLsRsbRiRsmbRg
bLsbRsbRgbRgbRibRgbRgbRgbRgbRgbLgbRgbRgbRgbRgbRgbRsRsmbRgRsmbLgRsbLcbL
ibRibRibRsbRgbRgbLgbRgRsmbLsbRgbRsLgRsbRibRgbRgRsmbRibRibRgbRsbLibLgbR
jbRibRsbRgLsbRgbRsRsRsmmbRgbRgRsmbRgLsbRibRgbRibRgRsmbRgbLibLgbLgbLgbR
jbLibLgRsLsbLgbRobRiLsbRibRsbRgbRsbLibLhbLibRgbLcLsmbRibLgbLgbRgLsbLcR
sbRgbRibRcbRhbRgbRgbRgbRhRsmbLgbRcbRibLgbRibRsbRgbRsbRibRgbRgRsRsRgmmb
RsRsmbRgbLsLsmbRgbRsRsmbRgRsmbsbRgbRgbRgbRsRsRsmmbRsRsRsRsRsmmmmbRsbRg
bRsbRsRsmbRgRsmbRsRsmbLsRsRsmbRgbRgbRsbRgRsmbRgbRgbRgRsmbRgbLsbLsbRibR
gbLjbLibRibRgbRsRsRsmmbRgbLgbRgbRsRsRsmmbRsRsmbLsbRgbRsbRgbLsbRgbLjLcb
LibLgbLibLiRsbLibLgLsbLgbRgbLgbLsbLsbLiRsbRgbLsLsmbLiRsbLsbLsLsmbLibLg
b

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 34; Drug: NDMC 1 µM
bLobLsbRsbLobLgbLjbLibRsbRsLgbLibRsbRgRsmbRgRsRsmmbLhbLgbLgbLsbLsbLsLs
mbLgbLsbLgLsbLgbLsbLgbLsbLsbRsbRgbRgbLoRcbLjbLgbLgbLibLibLgbLgbLsbLsbR
jbRibRibRibRgbRsbLhbLgbLibRsbRgbRgRsmbRgbRgbRgbRgbLcbLgbLgbLgbRjRsmbRi
bRgRsmbRgbRsbRsRsmbRgbRsbLgbLgRsbRgbLsbLgbRgRsmbLgbLgbLgbLsbLsbRsbRsRs
LgmbRsLgbLgbRsbRsbLgbLgbRsbLgbLgbLgbRsbLsLsLsmmbLgbLsbLsbLgLsbRsLsbLsb
LgbLgbLgbRsbLgLsbLgbLsbLgbLsbLgbLsbLgbLgbLsbLsbLgbLgbLgbLgbLgLsbLgbLsb
LsbLgbLgRsbLgLsbRsbLgbLsbLsRsLgLsLgbLsRsbLsbLsbLgbLgbLgbLgbLgbLgbLsbLs
bLsbLgbRsbLsbLgLsbLsRsbLgbLgRsLsLgLibLgRsbLsbLsbLgLsbLgLsbLgLsbLsbLgRs
bLgRsbLsbRsbLgLgLsbLsRsbRjbLhbLgbRsbLiRsbLhLsbRibRgLsbLgbLsbLgbLibLibL
gbLgbLibLgRsbRhbLgbLebRsbLgbRsbLgbRsbLiLsbLgbLgLsLsmbLsbLgLsbLgLsbLgbL
sbLgbRsbLgbLgLsLgbLgbLgLsbLgbLgbLgbLsbLgbLgLsbLgbLgbLsbRsbLgLsbLsbLgbL
sbRsRsLgmbLsRsbLiLiLsbLsLsmbLgbLgbLgbLsRsbLgLsbLgLsbLgLsbLgbLgbLgLsbLg
bLsbLsbRsbLgbLgbLgbLgbLgbLgbLgbLsbLgbLsLsmbLiLsbLsbLsbLgbLgbLgbLgbLsbL
sLsmbLsbLibLgbLgLsbLgbRgbLgRsbLgLsbRsbLibLsLsmbLsLsLgLsLimbLgLsbLgbLsb
LgbLsbLsLsLsmmbRgLsbLgbLsbLgLsLsLsLsmmmbLgLsbLsLsmbLgbLgbLiLsLsmbLgbLg
LsbLgRsbLgbLgbLgRsbRgbLibLibRibRcbRhbRhbLiLsLsmbRgbRcbRibRgbLibLgbRjbR
cLsbRhRsRsmmbRibRgbRibRgbRgbLjbLcbLiLsLsmbRgbLgbLgbRsbLibRsbLgLsbLgbRs
bLgLsbLgbRgbLgbLsbLgRsLibRsbLgLgRsbLgbLsLsmbLgbLiLsbLsbLgbLgLsbLgbRsbL
gbRsbLhbRhbLibRsLsLsmbLgbLgbLgbLgRsbLsbLgLsLibRsRsmbLgbLgbLgLsbLgbLsbL
sbLsbLsRsbLibLsbLgLsLsLsLsmmmbLgLsbLsLsmbLgbLgbRgbLgbLibRsbRjbRibLcbLi
bRgbLgbLibLsbRgRsmbLgbRsRsmbLgbLgLibLsRsbLgbRsbLgbLsLiLgLgLgbLsbLgLsbR
sbLibRsbLgbLsbLgbLgbLgbLgbLsbLgRsbRgbLgbLgLsbLsbLgbLgLgbLsbLsbLgRsLsLi
LgbLgbLgbLgbLsbLgLsbLsbLgbLgLsbLgbLgbLgRsbLgLsRsbLsbLgbLgbLsbLgbLgLgbL
sbLgbLgbLgbLsRsLsbLibLsbRgbRjbRibRibRcRsLsRsmbRibRibRgbLcbRcbRibLgRsbR
gbRiLsLsmbLgbRgbLsbRcbRhbRibRibLcbRjbLibRjbLgbRjbRibLebLibRsbLhLsbRsbL
gLsLsmbLgbLsLsmbRsbLgLsbLgbLgbRsLsLsmbLgbLiRsbLgbLgbLsLsmbLgbLgbLsbLgL
sbLsbLgbLiRsbLgbRhbLgbRjbRibLgbRcRsmbRhbRibRgbLibLcbLibRcbRiLsbRgbLsbR
oLsbRcbRibRgbRcbRcbLgLsbLibRcbRcLsbLgbLgbRgbRcbRsLiLsbRgbsbsbRgbLgbRsL
sbRgLsRsbRgbLsbRgbRsbRibRgbLsRsbRgbLgbLcbLhbRjbLcRsbRgbLibLibLgbRjbLcb
LsbsbLsbLgbLgLsbRgbLgbLiLgbLsbLgbLgbLsbLsLsmbLsbLgLsbLgLsbRsbLgbLgbLsL
smbLsbLgLsbLsbLsbLsbLgLsbLgLsbLsRsbLsbRsbLsbRsbLgbLgbRsbLgLsbRsLgLsbLg
LgRsbLgbRsbLgLsbRsbLgRsbLsbLgLsbLsbLgbsbLsLsmbLgLsbRsbLgbLgbLsRsLgLsbL
gbLgbLgbLgbLsbLgbLsbLsRsbLibRsLsbLgbLgbRgbLibLsbLgbLsLiLgbLgbLgRsbLgbL
sbRgbLibRhbRibRgbLjLcbLibLibRjbLibLibRjbRcbLsLsmbRgbRgbRibRsLibLibRsbL
ibRjbLgbRjbLibRjbRibLsbLcbLcbRebRgbLsbLcbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 35; Drug: NDMC 1 µM
bRsbRobRcbRcbLgRsbRibRsbRgbRgbRgbRsbRgbRsbRsRsmbRgbRsbRiLsbRcLsbRibRsR
smbLgbRibRsbRibRgRsmbRsbRgbRgbRgbRgLsbReRsmbLsbLsbLgbLsbRibRgLsbLsbRsb
RsLsbRibRgbRsLsbRgbRgRsmbLsRsbRgbRsbRsRsmbRgRsRgmbRgRsRgRsmmbRgbRsbRgb
LsbRsbRgbRgbRgbRgbLgbRsbRiRsmbLgbRgbRibRcbLsbRsbRsbRcRsmbLsbRiRsmbRgbR
gRsLsmbRgbRgbRgbRiLsbRcbLiLsbLsLibLsRsbRjbLebRgbLcRsbRjbLhbLiRsbLhbRib
RhRsmbRibRgRsmbRibLcbLjbLgbRgbLibLgLsbLgbRgbLgbRobRjbRcbReRsmbRiRsmbRi
bRsbRsbRgRsmbLjbLcbRibRibRgbRsbLsRsbRibRsbRgbRgbRgRsmbRgbLcbLcbRhbRiRs
mbRsbLsbRcbRcbRhbRcRsmbRsbRgbRsbRgbRsbRsbRsbRibLsbRibRgRsmbRsRsmbLebLi
RsbLgRsbLsRsbLgbLgbLsbLgbRsbLgRsbLgbLgLsbLgLsbLsbLsLsmbLgLsbLsbLsbLgbL
gbLgRsLsbLsbLgbLgbLgLsbRsbLgbRsbLgbLgbLibRgbRsRsmbLibLibLgbLgLsbLgbLgb
LibLgLsbRgbLgbLibLsbLgbLsbLgbRsbLgRsbRsbLsbLiLsbLgbLgLsbRsbLgbLgbRsRsm
bLgbLgbRsbLgbLgbLgLsLsmbLsbLsbLgLsbLgbLgbLgbRgbLgbLgbLgbLsbRibLibLibLs
bRsbLgbLgLsbRsLgbLgbRsbLgbLsbRjbRibRgLsbRibRsbRsbRibRgLsbLgbRjbRibRgbR
gRsmbRsRsmbLgbRsRsmbLsbRibLgbRibRsbRibRgbRsbRgbRgbRgbRsbRsbRiLsbRsbRsR
gbRsbRgbRgRsmbRsbRgbRsbRsbRibRgbLgbRsbRsbRibRcbLiLsbLgbRsbRibRibLgbRib
RgRsmbLgbRibRsbLgRsbRcbRiRgbRibRgbLgbLgbLibLibLgLsbLsbLsLsmbLsbLgbLgbL
gbRgbLibLgbRsbLibLiRsbRebRhbRgRsmbRgRsmbLsbRgbRsbRibRsbRsbRgbRgbRgbRgb
RgbRgLsbRgbRsbRsbRgRsRsmmbRiRgbRiRsmbRsbRsbRibRsbLsRsbRgbLsbRgbRgbRgbL
sbRibRgRgbRibRiRsmbRgbRgbRgbRgbRibLgbRgbRgbRibRgRsRsmmbRsbRsbRgbRibRsR
smbLsbRibRibRibLsbRsbRgbLgbLcbRjbRcLsbLibRgbRgbLsbRiLsbRcbRibRcbRiRsmb
RsbRgbRgbRsbRgbRgbRgbRgbLsbRgRgbRgbRgRiRiRiRsmbRibRiRsmbRgbRiRsmbRgbRg
RgbRgbLsbRibRgbRsRgRsmbRgRgbRiRsmbRgRsmbRgRsRsmmbRsbRiRsRiRgRsRsmmmbRi
LsbRsbRgbRgbRgRgRsRgRsRsmmmbRgbRgLsbRibRgRsRsmmbRibRgRsRsmmbRibRiLsbLh
bRgbLibRjRsmbLjbRibRibRsbRgbRiRibRiRsRsRgmmbRgbRgbRgRgbRgbRgbLjbRiRsmb
RiRgRsLsmbRgbRgbLjbRhbReRsmbRcRsmbRhbRiLsbRibRebRebLhLsbRhbRibLjbRhbLg
RsbLsbRibRsbRgRsmbRsbRgbLgRsbRgRsRsLsmmbRgbRgRgRgbRgbRsbRsbRibRgbRgbRg
bRgbRgbRsbRgbLgbLcbRjbLcbRebRiRsmbRgRgLsbRgbRgRsRgRgmbRsbRibRgbRsbRgbR
sbRgbRsbRgbRgbLgbRsbRgbRgRsmbRgbRgbRibLsbRgRsmbRgbRgRgRsmbRgbRsbRgRgbR
gbRsbRiRsRgRsRsRiRimmmbRiRsRgmbRiRgRsRgRsmmbRgRsmbRgbRiRsmbRgbRgbLgbLh
bRjbRgbRibRgbRgbLhbRgbLjbLhRgbLcbRebRibLgbRibLsRsLsRsbRibRgRsmbRgLsRsb
RgbRsbRiLsbRibLgbRsbRgbRibLjbLjRsbLcbRgbRjRsmbRgRsmbRgbLsbRsLsbLcbLibL
iLsbRgbLhRsbLcbLhbLcbLibRibLebLgbLibLibRibLhLsbLibLgbLgbLgRsbRhbRiRsmb
RgbLsbRgbRsRsmbRgbRsbRsbRgbRgbRsbRsbRgbLjbLcLsRsmbRjbRhbRibLcbLcbRibLi
bRjbRcRsmbRgbLgbLsbRibRgbRgbRsbRgbRgRsRgmbRiLsbRgLsbRsbRgbRgbRgRsmbLsb
RgbLsRsRsmbRgbRibRgbLcbLobLcbLgbLhbRibLcLsmbLibLibLgbRgbRcbRjLsbRibLib
LgbLgbRibRcbLibLgbLgbLibLibLiLsbRibLgbLibLgLsbLibLcbLgbRibRiRsmbLsbRiL
sRsbRgbLsbRjbLcbLcbRibRibRgbRgLsbRgbRiLsbRsRcbRgbRcLsbLibLibLgbLgbLgbL
ibRhbRiRsmbLgbLhbLgRsbReRsmbLcbRibRgbLsbRibLsbRgbLsbLcbLibRgbLibLgbRib
LiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 36; Drug: NDMC 1 µM
bLsLsmbLobRgbLcbLcbRibRibRcLsbRebRcbRcRsmbRgbRcbRcbRcbRgRsmbRsbRibRgbR
sbLsbLsbLsbRcbRobRgbLsbRcbRibLgbRiRsmbRgbRcbRjbRcRsmbRcbRsRsmbRgbRgbLs
bRobRgLsRsbLgbLgbRcRsmbRsbRibRibLebLibLgbLgbLgbLgbLgbRjbLibLgRsbRibRsb
LsbLhbLsbRsbLgbLibLcRsbLcbLibLsbLgLsbLgbLibLcbRibRsbRibLgRsbRgbRsbRgbL
gbLibLgbLgbLgbLgbRcbRgbRgbRsbRsbRibRobRcbRibRgbRsRsRsmmbRobRjbLhbLsbLg
bLcbRobLgbLibLsbLsbLgbLsbLgbRcbRjbRsbLgbRjRsmbLjbRgbLgbRibLsRsbRsRsmbR
gbRgbRsbLibLcbsbRhbRcbsbRibLjbRhbRgLsbRgRsmbRsbRsbRsRsmbRsbRgbRsRsmbRs
bLsbRgbRsbRibRsbRgbRsbRsRsLcmbRjbLgbLibLgbRcbLgRsbRhbLgbLgbLgbRebLibRh
bRibLjbLgbRgbRgRibRsbReRsmbRgRgRsRsmmbRiRsmbRgbRebLhbLgbRgbLsbRibLcbRc
bLjbLcbRsbLsbLgbLsbLgbRsbLgbLsbLibRibLibLgbLibRsbLibRibLiLsbRsbLgbLgbL
sLsmbLibLgbLibLgLsbLgbRgbLibLibRjbRcRsLsmbLsbRibRibLcbLgbLsbRibLibLiLs
bLsbRjbRoRsmbLebLebLibLgbRsRsmbLsbLjbRgbLibRgbLsbsbLsbLgbLgbLsLgbLibLg
bLibLcbLhbLgbRcbLibLjbLcRsbLcbLcbLibLibRcbLjbLcbRjbRcbLjbLcbRgbLibRjLs
bRobLcbLcbRsbLgbLgLsbLgbLgbRgbLiRsbRsbLibRcbRoRsmbLcbLibRsbLgbLcbRhbLs
bLsbLgbLibLjbRjbLcbLibLobRhbLibRiLsbRibRibRibLibLibLgbRgbRiRsmbRobLeLs
bLibLibRcLsRsbLjbRhLsbRiRsRsmmbRsbLjbRhbLgbRgbRibLjbRgbLibRebRibLgRsbR
ibLsbRgRsmbRibLgRsbRibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 37; Drug: NDMC 3 µM
bRobRibRibRgbRsbLgbRgRsmbRsbRibRjbLjbRgbLjbLibRgbLsLibLsLsmbLgbLsRsbLs
bLgbLgbLsbLsbLgbLsLsmbLsLsmbLgbLgLsbLsRsbLgbRgbLibLgbLsbLiLsbRsbLibRsb
LgbLibRsbRsbLjLsmbLgbLibRgbLgbRsbRgbLsbLibLibLibLibLibLgbRjRsmbRgbRgbR
gbRcbRsbLgbRhbRcbRgLsbRgbLhbLibRgbLgLsbLgbLgRgbRjbRgbRsRsmbRsRsmbRgbRs
RsmbRgbRsbRgbRsbRsbRgRsmbRgbRsbRsbRgbRibRgbRgbRsbRgRsmbLsbRsbRjRsmbRgb
RgbRibRgbRsbRgbRgLsbRsbRgbRiLsbRgbRibRgbLsbRibRjbLjbLhbLibRibRibRjbLiL
sbLgbLibLgLsRsbRebRcbLibLsbRgbRgbLjbRiRsRgmbRsbRgbsbRgbRsRsmbRgRsmbRgb
RsbRsbRgbRibRgbLsbRgbRsbRgbRsbRgbRgbRsRsmbRgbRgbRgbRgbLsbRsbRibRgbRgbR
gbRgbLgbRibRsbRgbRsbRgbRsbRgbRsbRgRsmbRgbRgbLsbRgbRgbRgRsmbRgbRsbLcbLi
bRgbRgbLgbLgbLgbLsbLsbLgRjLsbLibRgbLcbLibLibRibRsbLiLsbRgbLcbLibRgbLib
RgbLgbRgbRebRibLjbRcbRcbLibRsbLsbLcbRcbRhbLgLsbRiRsmbRsbRgbRgRsmbRsbRg
bLsbRibRsRsmbRgRsmbRsbRgbRsbRsbRgbRiLsbRsLsbRgbLibRibRsRsLsmbRsbRgbLsb
RgbRsbRgLsRsbRsbRgbRgbRgbRgbRgbRibRgbRiRsmbRsRsmbRhRsmbRsbLsbRibRsRsmb
RgbRsbRsbRgRsmbRsbRgbRgbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRibRsbRgbRgbLjbR
ibLjbLhbRgbLcbRgRsRgmbLcbLcRsbLibRibLcbLcbRgbLibRgRsmbLgbLgbRjbLibRsRs
mbLgbRsbRibRcbRibRgbRsbRcbRibLgbRibRibRiRsmbLjbRiLsbLsbRgRsmbRgbRgbRgb
RgbRsbRsbRsRsmbRibRsbLgbRibRiLgLsbRgRsmbRgRsmbRgbRgbRsbRgbRsbRsRsmbRgR
smbRsbRgbRgbRsbRgbRgbRgbRgbRgbRgLsbRgbRsbLsbRibRibRgbRsRsmbRgbRsbRgbRg
bRsbRgbRgRsmbRgRsmbRgbRgLsbRgbRgLsbLcbRibLjbLcbRibRjRibLeLsbLhLsbRjbLh
bLibLebLcbLibRiLsbRibRibRsbRsbRsRsmbRgbRsRsmbRgRsRgRsmmbRgbRgbRgbRsbRg
bRgbRgRsRgmbRgbRsbRgbRgbRgRsmbRgbRgRsmbRgRsmbRgbRgbLgbRibLgbRgRsmbRgbR
gbRgRsmbRsbRgbRgbRgbRgbRsbRgRsmbRsRsmbRgbRgbRgRsmbRgbRsbRgbRsbRgbRsbRg
bRsbRgbRgbRgbRgbRgbRgbRgbRgbRsbRgbRsRsmbRibRsbRgbRgbRgbRgRgRgbRgbRgbRg
bRgbRgbRgbLgbRiRsRsRgmmbRgbRgbRgbLsbRsbRgbLsbRgRsmbRgRsmbRgbRgbRgRsmbR
gbRgbRgbRibLibRsbRcbLhbLhbRjRcbRgbRgbRgbLsbRibLibRibRibRgbLgbLjbRjbRgR
smbRibRsbRgbRsRgbRgRsmbRgbRsRsmbRgbRgbRgbRsRsmbRgbRgbRgRsmbLjbLhbLcbLe
LsbLcbRjbLcbLibLiLsbLgLsbRsbLiRsRsmbLiLsbLgbLgLsbLgbLgbLsbLsbLgLsbLgbR
jbLiRsbLgbLgbLgbLgbRibLibRjbLcbLibLibLibLgbRibRibLsbRgRgRsmbRsLsbRgbRg
bRgRgRsmbRgLsRsbRgbRsbRibLsbLhbLcbRjbsbLcLsmbRgbLcbRjbLhbRgbLibRsbLibL
sbLhbRgbLiLsLsmbLgbLgbLgbRsbLiLsRsbRsbLiLsbLibLsbLgbLgbLgbRgbLiRgbLhbR
iRsmbLhLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 38; Drug: NDMC 3 µM
bRoRsmbRibRibRgbRgbRgbRgbRibRgbLsbRibRgLsLsmbLsbRgbRibLsbRsbRibRibLsbR
gbLsbLgbLibRhbRsbRgbRgbLsbRsbRsRgbRsbRsRsmbRsLsbRsbRgbRsLsRsbLsRsbRgbR
hbRsbLgbRibRibRgbRsbRgbRsbRsbRgbRsbRgbRgbRgbRsRgRsmbRsbRsbRgbRgLsRsbRs
RsmbRgRsmbRgbRgbLsLsmbRsbRgbRgRsmbLsRsbRgbRsbRsbRgLsbRsRsLsmbRgRsmbRsb
RgbRgbRgbRgbRsbRgbRgbRgbLsbLjbRibRibLsLsLsLsRsmmmbRsbRibRibRgbRgbRgbRs
bLsbRgbRibRgRsmbRgbLsbRsRsmbRsbRsbRsbRsRsmbRgbRsbRsbRsRsmbRgbRsbRgbRgb
RgbRsbRgbRsbRgbLsbRgbRsbRgbRgbRgbRgbRgbRgRsmbRgbRgbLsbRgbLsbRgLsbRgbLs
bRgbRgRsmbRgLsbLsRsbRgbRgRsmbRsRsmbRsRsmbRgbRsbRgbRgbRsRsmbRgbRsbRsRsR
smmbRgbRgbRsbRsbRgbRsRsmbRsbRgbRgbRgbRgRsmbRsRsRsmmbRgbLsbRgbRsbRgbRsb
RsbRgbRgbRgRsmbLsbRgbRgbRsbRibRgbRsbRgbRgbRsbRgbRgbRsbLsbRgbRgbRsbRsbR
sbRgbRgbRgbRgbRsbRsbRgbLsbRsbRgbRsbLsLsmbRgbRsbRgbRgbLsbRgbRgbRsbRgbLs
bLsbRibRgbRsbRsRsmbRgbRgbRgbRsbRsbRgbRsbLsbRgbRgLsbLgbRibRgLsbLibLibLc
bRgLsbLsLgLsbLgbRsbLsbLgbLsbLsbLgLsRsbLgLsbRjbRibLcbLibLibLgbLibLibLib
LibRgbRcRgbRsbRibLgLsbRibLgbRgbLsbLcbLibRgbLcbRgbLibRsbLiRsbRsbLibLsbL
ibLgbLsbLsLsmbLgLsbRsbLgbLsbLgbLsbLgbLsbLgbLgRsbRsbLgbLsbLsLsmbLgLsRgR
smbLgbLgbLgbLgRsbLsLsmbLgbLsbLsLsmbLiLsRsbLsbLsbsbLsbLgbLgLsbLgLsLgbLs
bLgbRsLsbLgLsbLsLsmbLgbLsLsmbLsLsmbLgbLsbLgbRsLsbLibLebRgRsmbRsRsmbRgb
LcbLibRsbLibRgbLibRgbLhbRsbLiLsRsbLgLsbLsLsmbLgbLgbRsbLgbRsLsbLibRgLsb
LsbLibRgbLibLsbRsbLsbRsbLibLsbLsbLgbLsbLgbLsbLsbLsLsmbLsbLgbLsbLgbLgbR
sLsbLibLsbLsbLgbLiLsRsbLsbLgbLsLsmbLgLsbLsbLgbLsbLsLsmbLgLsbLsbLgbRsbL
ibRsbLsLsmbLibLsbLgLsbLsbLgbRsbLgbLsbLsbLgbLsbLgbLsbLgbRsLsbLiRsLsbRgL
sLsmbLgLsLgbLsLsRsmbLgRsLsbLsLsmbLsLsmbLgbLgbLsLsmbLgbLsbLgbRsRsmbLibL
sbLsbLgLsbLgbRsbLgbLsbLiLsbLsbLgbLsbLsLsmbLgbLsbRsRsLgLsmbLsLsmbLgbLsR
sbLgLsbRsbLgbLsRsbLiLsbLsbLgLsLsmbLgbLgbLsbLgbLgbLgbLgLsbLsLsmbLgLgbLs
bLgbLsbLgLsbLgRsbsbLgLsbLgbLgLsbLgbLgLsLgbLgLgLsLgLsbLgbLgbLgbLgbLgbLs
LsmbLgbLgLsbLsbLgbLgbLgLgLsbRsRsmbLgLsbLgbLsLsRsmbLgbLgLsbLsLsmbLgbLsb
LgbLgbLgbLsLsmbLgbLsbLgbLsbLgLsLgbLsbLgLsbLgbLsLsmbLgbLsLsmbLsbLgLsbLg
bLhRsRsmbLibLibLhLsbLibLgbRibRhbRibRgbRgbRibLgbRcbLgbRibsbLsbRgbRibRsb
LibRhbRiLsLsRsmbLsbRgRsRsmmbRgRsmbRgbLsLsRsmbRibRsLsbRiLsbRsbRgbLsbRhb
RgbLsbRhbRibRsbRgbRgbRsbRgbRsRgbLsbRibRsbRibRibRgbLgRsbRhbRgbLgbRibRgR
smbRsRsRgLsmbRibRgbRsbRgbRsRsmbRgbRsLsbRgbRgRsmbLsRsLsbRgbRgRsmbRsbRgb
LsbRibRgbRgRsmbRgRgRsmbRgbRgbRibLsbRibRgbRgbLgLsbRibRibLsbRibRsRsmbRib
RibLgbRgbLsbRcbLsbRgbRgbRsbRgbRgbRsbRibLsbRgbRsbRsLsbRibRgbRgbRsbRibLs
bRgbRgLsbRsbRiLsbRiRsmbRgbLsbRgbRgbLsbRgbRgRsmbRsRgbRsbRgRsmbRgRsmbRgb
RsbRgLsbLsbRgbRgbRibRgbRgRsmbRibRibRgLsbRgbRibRgRsmbLsbRgbsbRgbLsLsmbR
ibRsbRibRsRsmbRgbLsLsmbRibRgbRgbLsLsmbRgbRgbRsbRgbRgRsmbRgRsmbRgbRsRsm
bLsbRiRsmbRsRsmbRgbRgbLsbRibRgRsmbRgbRgRsmbLsRsbRgbRgRsmbLgRsbRgbRgbRg
bRgbLgbLsRibLsbRgRsmbLsbRgbRgbRgbLgbRgbRgbRsbRgbRsRsmbRgbRsRsmbRsRsmbR
sbRgRsRsmmbRgbRsRsmbRgRsmbRsbRgbRgbRsbRgbRsRsmbRgbLsLsmbRibRsbRgRsRsmm
bRgbRsbRgbRsbRgbRsbLsRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 39; Drug: NDMC 3 µM
bRobRibLsbLgbRcbLgbLjbRhbRsbRgbRiLsbRsbLgbRgbRsbRgbRgbRsLsbLsRsbRgbRgb
RgRsmbRsbLsbRgbRiLsbLgbLgbLjbLobLcbLibLsbRjbRiRsmbLjRsbRgbRgbRsbRgbRhb
LgbLibRjRsmbRcbRcbLgbRsbRgbRsbRjbRgbRsbRgbLsbRsbRgbRgbRgbRsbRsRsmbRsbR
sbRgbRsRsmbRgbRsbRsRsmbRsbRgbRsbRgbRsbRgbRsbRsbRgbRgbRgbRgbRgbRgbRgbRi
bRgbLgbRgbRsbLgbLsbLgbRsbLsLsmbLgbRsbRsbLsbLsbRcbRibLgbRgbLsbRgbRsbLsb
RibRsbRsRsmbRsRgRsRgmbRgbRgRsRsmmbLsbRgbRgbRsbRgbLsbRgbRgbLsbRgbLsbRsR
smbRgbRgRsmbRgbLsbLsRsRsmbRgbRsbRgbRgbRgbRgbLgbRgbLsbRgRsmbRsbRgbRgbRg
bRsbLsbRsbLsbRsbRsRgbLsbRibLgbRhbLjbLjbLjbRcbLcbLcbLcbLibLibLsbRsbLgRs
bLsLsmbLsLsmbLsbLgbRsbLsbRsLgbLsLsmbLsLsmbLsbLgLsbLsbLgLsbLgLsbLsbLsbL
sbLsLsmbLsbLgbRgbLsbLgbLsbLgbLgbLgbRsbLsbLgbRjbRgbRgRsmbRsbRsRsmbRsbRs
RsRsmmbLsbRgbRgbRgRgbRgRsmbRsbRgRsmbLgbRsbRgbRgbRgbRgbRgbLgbRgbRsbRsbR
gbRgbRsRsmbRsLsRsbLsbRgbRsRsmbRgbRgbRsbLgRsbRgLsbRgbRgbLsbsbRsLsbRgRsR
smmbLsbRsbRgbLsbRsbRgbRgbLsbRgbRgbLsbRgbRiLsbRgbRgRsmbLsbLgbRgbLsbRgbL
sRsbRgbLgbLsbRgbRsbRgbRgbRsRsmbRgbRgbLsbRgbRgbLgbRgbRiLsbLsbLcbLiLsbRi
bLgLsbLgbLsbLsbRobRibRibLgbLsbRgbLsbLgbRgbRsbRsbLsRsbRgbRgbRgbRgbRsbRs
bRgbLsbRgbRsbRsLsbRsRsLsmbRgbRsbRsRsmbRsbRgbLsbRsbRgbRsLsbRgbRsbLsbRsb
RgLsbRsbRgbRgbRgbRsbRsbRgbRgbRsbRsRsmbRgbRsbRsRsmbRgbRsbRsbRgbRgLsbLgb
RgbRgbRsbLsbRgLsbRgbRgbRsbRgbRsbLsbRsbRgRsmbRsbRsbRgbRgbRgbRsRsmbRsbRs
bRsbRgbRgbLsbRsbRgbLsbRgbRibRhbLgbRibLibLgbRgbRgbRgRsLsmbRgbRgbLsbRgbR
sbLjbRcbRcbLibLgbRsbLsbRhbLgbRhRsLsmbLibRibRgbRcbLibLgbLgLsbRcbRhbLibR
ibLibRsbRgbRgbRgbRgbRsbRhbRibRgbLsbLgbRsbLsbLiLsbRgbRcbRhbLibRgbRgbLsR
sbRgRsmbLgbRgbRgbRsbRgbRsbRgbLsbRsbRgbLsbRgbRgRsmbRgbLsbLsbRhbRsLsbRgb
RgRsRsmmbRsRsmbRgbLsbRgbRsbRsRsmbRgbRgbRsbRsbRgbRcLsbLgbLibRcbLjbRcLsb
RsbRibRibLgbLgbRsbRsbRibRgbRgbLsbRsbRgbRsbRgbRiLsbRiLsLsLgmbLiLsbLgbLi
bLibLgbLsbLgbRsbLsLsmbLgbRgbLgbLgbLgLsbRgbLsbLgbRsbLgbLsLsLgmbLgbLsbLg
bLsbLgbRsbLgbLsbLsbLgbRsbRebLebLgbRibLsbRsbRcbLibLjLsmbLibLsLsmbLgLsbL
gbLsbLsbLcbLcbLibLjLsmbLgbLgbLsbLgbLgbLsbLsLsmbLgLsbRgbLgbLsLsmbLsLsmb
LgLsbRsbLgbLsbLibLcbLebLgbRjbRgbRsbRsbRgbRgbRsRsmbRgbRgbLsLsmbRgLsbRcb
LibLibLsbRibRibRsbRgbRgbLsbRibLjLsmbRgRsRsmmbLsbRsbRgbLsbRsbRgbRsbRgbR
gbLgbRgbLgbRgLsbRibRibRgbRgbRgbLgbLsbLsbLsbRcbRjbRsbRgbRiLsbLgbRgbRsbR
gb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 40; Drug: NDMC 3 µM
bRobRsbLibRsbLiLsLsmbLgbLsbLsbLgbLsbLgLgLgbLgLsbLsbLgbRsbLibRcbRibRgRs
RsRiRsRimmmbRsbRsbRibLjRsbLjbLcbRgbLibLibRiRgbLibLibRgbLibLcRsbRibLgbL
gbRiRsmbRiRsmbRgbRgRsmbRgbRsRsmbRgbRsRsmbRsRsmbRsbRgbRgbRsRsmbRgbRsbRg
bRgRsmbLsbRgRsmbLsbRgbRgRsmbRgRgRsmbRgbRgRgRiRsRiRsRsmmmbRsbRgbRgRsmbR
gbRgbRsbRgRgRgRsmbRgRiRsRgRgmbRsbLsbRjbLgbRgbLcbLibLsbRgbLibRjbLjbRiRs
mbRibLjbRgbRgbLcbLhLsbLhRsbRgRibRibRgbRgbLsbRgbLsbRgbRgbLgbRsLsbLsbRsb
RgRsmbRsRsmbRgbRibRgRsRiRgRgRsRgmmbRgRgRgRsRiRsRiRgRsmmmbRgRgRsmbRgbRg
bRsbRgbRgbRsRgRibRgbRgRsmbRgbRgbRgbRsbRgbRibRibLhbLcbLcbRgRsmbLiRgbLsb
RsbLibLsbLsLgLsRsbLibLiLsbLgLsbLgbLsbLibLgRgbLgLsbLsLsLsmmbLibRsLsbLeb
LiLsbRsbLgbLsbLiRsbRgbLibLibLcbRhbLibLibRgRsmbRiRsmbRibRhbRibRibRibRhb
RiLsbRgbRgbRsbRgLsbLobLhbRgRsRsmmbRgbLcRsbRgbLibRgbLhRsbRsLsbLibRgbLib
RibLibLhbRcbRcbRibLjbLjbLibRsbsbLgbLgbLgbLibRhbRcRsmbLsRsbRgbRgbLsRgbR
gbRgbRsbRsRsmbRsRsmbRsbRgbRsbRgbRsbRgLsbLcbLgbLhbRsbRgbLgLsbLibLsbLgbL
gLsbLgbLsLsmbLgRsbLgRsbRibRjbLibLibRibReLsbRiRsmbLsbLsbRibRibRgbRgbRib
RhRsmbLsbLcbLcRsbRibRibRhbLgbRiRsmbRsbRgbRsRsmbRgRsmbRgbRsRsmbRgbRgRsm
bRsbRgbRibRebRsbRjbsbRsRsmbLjLsmbLjbLcbLhbLcRiRsmbRibLcbRjbLiRgbLgbRsR
sRhRsmmbRsbRgbRgRsmbRsbRsbRgbRgbRgbRsLsbRsRgbRgbLsRsRsmbRiRgbRgbLsbRgR
sRgmbRgbRgbRsRgbRgRsmbRgRsmbRgbRgbRgRsRgmbRgbRgbRgbRgbRibLjbRsbRhbLcbL
cbRgRsmbLcbRgbLibRjbLjRsbRsbLsLhbRsLsLsmbLgbLsLsmbLgLsbLgbLibRgbLgbRsb
LgbLsbLsbLiLsLsLgmbLgbLsbLgbLgbLgLsLgbLsbLgbRsbLsLsmbLgbLgRsbRgbsbLgbL
ibLsbLgbLgbLgbLgbLsbLgbLgLsbLgbRjbLgbLibLsbLibLgbRgbLiLsbRgbLibLgLsbLs
bLgLsbLgbRsbLgbLgbLsbLgbLgbLgbLsbLgbLsbLgRsLgLgbLsbLgbLsLsmbLgbLsbRsLs
bLibLhbLiRsbLcbRibRgbRibLibRibRibLsbRiRsmbRibRhbLibRhbRcRibRibRibLhbLi
bLhbsbLibLsbLgbLsbRsbLibLgLsbLibRgbLgbLgbLsbLgLsbLgLgLiLsbRsbLgbLgbRsb
LibLsbLgbRsbLgLiLsbLgbLeLgLiLibLgbLgLeLeLgbRjbRibRibRibLjbRibRgbRgLsbs
bRibLcbLcbRibLcbLgbRgbLebLcLsmbLgbLibLibLhbRjbLsbRhbRibRsbLcRsbLibRsbL
ibRsRsmbLibLsbLibLsbLgRsbLgbLsLgbLgLsbLibLsbLgbLgbLgLsbLsbLiLsbRsLgLgL
sLgbLgbLgbLgbLsbLgLsbLgbLgbRsbLgbLsbLsbLgbLgbLgLsbLgbLgRsbLgbLgLsbLibL
gLsbLsLsmbLgLsbLgbLgRsbLibLgbLgbLgbRgbLhbLibLibRgbRgbRgbLibLiLsbRibRgR
sRsmmbRgbRgbRgbRgbRgbRgbRsbRsLsbRgRgbRgRsmbLjbRgLsbLgbRgbRgRsmbLsbRgbR
gbRsbRsbRgbLsbRsbLcLsmbLiRsbRgbRsLgbLgbRsbLgLsLsRsmbLibLiLgLsRsbLgLgLe
LibLgbLsbLgbLgbRsbLibLibLibRiRsRsmmbRgbLibLsLibLgLsbRsLsbLgbLsLsLsLimm
bLibLgbLgbLgLgbLgbLgLsbLibLgbLgbLgbLgbLgbLsLsLsmmbLgbLgbLgLsbLgbLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 41; Drug: NDMC 3 µM
bLjbLibLibLsbLgbLibLiRsbRibLibRsbLgbLgbLibLibLsbLibLgbLgbRgRsmbRgRsmbL
sbLhbRsbLcbRibLcbRibLhbRibRjbLcbLsbLibLgbRhbRhbRcbRhbRhbRibRibRjRsmbRi
bRgbRgbRgbLibLgbLibRgbLibLgbLgbLgbRsbLibRsbRgbLcRsbRibLcbRebLhbLgbRjbR
cbRcbLgbLgbRibRsbRgbLgbRcbLgbLgbRhLsbLgbLebLibLsbLiLsbLiLgbLibLgbLgbLg
bLgbLgbLsbLgbRsbLibLgbRgbLgbRjLsbLiRsbLgbLjbRhbRhbRsbLgbLgbLsbLsbLiRsb
LcbLcbLcbRcbRibRgbLgbLsbRsbRibRibLsLsmbRiRsmbRsbRgbRsbRgbRibRgRiRsmbRg
LsbRgbRgbRgbRgbRsbRgRgRsmbRgbRgRsmbRgbLsRsbRiRibRgbRsbRebRgbRgbRgbRiRs
RsRgRsmmmbRibRgRgbRgbRgbLjbRsbRgbRsbRibRsbRibRgbRsRsmbRgbRgbRsbRgbLsbL
sbRibRsbRgbRgRsRsmmbRgRsmbRibRibRibRiRhbRgbRibRibRgbRibRsbRgbLsbRibRgR
smbRiRsmbRgbRgbRsbRgbRsbLgbRgbRiRebRgbRgbRgRsRimbRgRhbRgbRgbRsbRibLsbR
ibRgbLsbRgbRgbLsbRiRibRgbRgbRgbLsbRgbRgbRgbLsbLgbRibRgLsRgbRebRsbRgbRg
bRsbRgbRgbRgbRgbRgbLsbRibRgRgbRibRgbRgbRgbLsRibRgbRgbRgbLsbRgbRibRgRsm
bLsbRibRgRsmbRgbLsbRibRgbRgbRgbRgbRgbRgbRgbRibRgbRgLsbRgbRgbRsbRibRgbR
gRiRibRibRibRgbRgbRgbRgbRgbRgbRgbRgbLsbRgLsbLgRsbRibRgbRgRsmbRgbRgbRgb
RibRibRhbRgbRgbRgbRgbRgRsmbRsRsmbRgbRgbRgbRsbRgRsmbRiRibRebRiRiRsLsmbR
ebRibRibRgbRgRsmbRibRibRgRebRibRgLsRsbLjbRhbLcbRjbRiRsmbRibRgbRgRsmbRi
RebRgRsmbRgRgbRibRgLsbRgbRgRsRsmmbRgbRibRgRsmbRebRgbRibRgbRibLiLsbRgbR
hbLibRhbRgbLgbRiRsmbRgbRgbRgRsmbReRgbRgbRibRibRgbLsbRhbRgbRgbRiLsbRgbR
gbRgbRgbRibRgbRsRsmbRibRgbRgbRiRsmbRgbRgRgbRgbRgbRgbRgbRiRsmbRsbRibRsb
LsbRsbRsbRgbRibRgbRiRsmbRgbRgbRgbRsbRibRgbRibRhRsmbRiRibRgbRebRgbRgbRi
RsRsmmbRgbRgbRgbRsbRgbRcbLcRsbLcLsmbLcbLsRibRebRiRsmbRsbRibRsbRgbRgbRg
bRgRsLsRsmbLsbRibRsbLgbRcbRcbRcbRibRiRsmbRgbRgbRgbRgbRsbRgbRgRsLsmbRsR
gbLjbRjbLcbRjbRibRgRsmbRgbRgbRgRsLsmbRgbRgbRgbLsRsRibRiRsmbRgbRibRgbRg
bRgbRgRsmbRgbRibRibRibReRsmbRibRebRibLsbRibRsbRibLjbRibRgbRibRibRgRsmb
RgbRgbRibRibRgbRgbRibRgbRgbRgRsmbRsbRgRsRsmmbLsRsbRibRgbRgbRgbRibRiRsm
bRgbRgbRebRgRiLsbRgbRgRsmbRsbRiRsmbLsRgbRibRiRsmbRgRsRsmmbRibRgbRgbRiR
iRibRibRsRsmbRgRsmbRibRiRgbRgRsmbReRgRsmbRibRgbRiRsmbRibLsbRiRsmbRibRg
bRgbRgbRibRgbRgRsRgmbRgbRibRgbRgbRgRsmbRibRibRsRgbRgRsRsmmbRgbRsbRibLs
RsbLjbRgbRiRsRsRsmmmbRhbRgRsmbRgRsmbRgLsRgbRibRibRgbRsbRgRsRgmbRebRgbR
gbRibRgbRgbRgbRgbRgbRgbRgbRgbRsRgbRgbRgbRgbRgbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 42; Drug: NDMC 3 µM
bRsbLoRsbLgbLgbRgbRgbRgbRgbRgbRgRsmbRgbLsbLsbRgbRsbRsRsmbRgRsmbRsbRsbR
sbRsRsmbRgbRsbRebRgbRjbRhbRgbRsbRgbRsbLsbLgbRgbRsbRsRsmbRsbRibLsbRsRsR
smmbRsRsmbLsRsbRibRsRsRsRsmmmbLebLcbRsbRjbLibLgLsbRsRgbLgbLsbRibRgRsmb
RgbRgbRgbRgbRgbLsbRibRoRsmbRoLsbRibRsbRgbLgbLgbRgbLjbLjbRibRsbRgRsmbRs
RsmbRgbRsbRsRsmbRsbRsRgRsmbRsbRgbRsbLgbRsbRgbRgLsbRsbRsbRsbRgRgbLsRsbR
gbRgbRsbRgbRgbRgbRgbLsbRsbRgbRgRsmbLsbRsbLsbRjbLjbsbLcbRsbLhbRgbLjbLgb
RjbLsbRebRiRsmbRsRsmbRgbRsRsmbRjbLgRsbRsbRgbRsbRgbRgbRsbLsbRgbRsbRsbRg
RsmbLsRsbRjbRgbLjbLhbRjbRebRgRsmbRgbRgbRsbLsbRsbRsbRsbRgbRgbRgbRsbRgbR
sbRjbLsbLsbLsbRgbRsbRibLgLsbLsbRibLgbLsbRsbRgLsbRgRsmbLsRsbRgRsRsmmbRg
bRgbRsbRgbRsbRgbRsbRsLsbRgRsmbRgRsLsRsmbLsRsbRgRsmbRsRsmbRsRsmbRjbLsRs
RsmbRgbRgRsmbRgbRgbLsLsmbRsRsmbRgbRjbRibRsbRibRcbRibRjbLjbLibRhbRsbReR
smbLsbLgbRsRsmbRibRgbRcLsLsmbRibRsbRgbRibRiRsmbRebRsbRgbRgRsmbRiRsRsmm
bRgRgRsmbRsRsmbRsbRsRsmbRsRsRsmmbRsRsRsmmbRgRsmbRsbRsbRsbRgbRgRsmbLsbR
gbRsbRgbRgRsmbLsRsbRsRsmbRsbRsbRsbRgbRgbRgRsmbRsbRgbRgbRgRsmbRsbRgbRgb
RgbRsRsmbRgRsmbRsRgbRgRsRsmmbRgbRgbRgbRgbRgRsRsRimmbRgbRgbRgbRsbRgLsbR
gbRgbRgbRsRsmbRgbRgbRiLsbRibRsbLgbRsbLgbLsbLjbLgbLsbLgbRjbLsbRcbLgRsLs
bRsRsmbRgRsmbRsbRsbRsRsmbRsbRgbRsbRgbRsbRgRsmbRsbRgLsbRsbRgLsbRsbRgLsb
LsbRgbRgRsmbRgbRgRsmbRsRsmbRsbRgbRsbRsbRsRsRsmmbRgbRsbRgRsmbLsbRgbLsbR
gbRsRsmbLgbLgbRsbRgbRgbRgbRsbRgbRgbRgRsmbRgbRgbRgbRgRsRsmmbRsbRgRsRiLs
mbRgRsmbRsRsmbRsbRgRsmbRgbRgRsmbRgRsmbRsbRgbRgbRsRsRsRgmmbRgRsRgRsRsmm
mbRgRsmbRgbRgRsmbRgRsmbLsbRgbRsbRgRsmbLsRsRsmbRsRgbRgbRgbRsRsRsmmbRsRs
mbRgbRsRsLsmbRgRgRgbRsRgRsRgmbRsbRgbRsRsmbRgRsmbRgRsmbRsbRgbRsbRgRsmbR
gbRgbRgRsmbRgbRgbRgbLsbRgbLsRsRsmbRgbRsRsmbRgbRgbLsbRgbRsRsmbRsRsRsmmb
RgbRsbRgLsRsbRgbRgbsbRsRsmbRsbLsRsLsbLsRsRsmbLsbRjRsmbRebRebRebRhbRgRs
mbsbRgbRgRsmbRsRsmbRgRsRsRsRsRsmmmmmbRsbRgbLsRsbRibRgRsRsmmbLsbRibRgbR
sRsLsmbRsbRgLsbRgbRibRcbRebRibRebRgRsLsmbRgbRibRgbRebLsbLgbLsbLgbLsLgb
LsLsmbLsRsbRsbLiLsbRibLcbLcLsmbLgbLibLgbRiRsmbRhRsmbLsbLgRsbLgbLgbRebR
cbRsbRgbRcRsmbRibRgbRsRsmbRobRhbLgbLgbRiRsLsmbLjLsmbLcbLibRhbRiRsmbLhR
sbRsbLgLsbRgbLgbLhLsbLcLsmbRiRsmbRgRsmbRibRgbsbLeLsbLibLiLsbRgbRgbLcbL
ibLgbRsbLgLsbRsbLsbLsbLgbLgLsbLsbLiLsRsbLgLsbLgLsLsLsLsmmmbLsRsbLsbLgb
LgbLgbLgbLgbLgLsRsbLsbLgbRebRiRsmbLsbRibRgbRgbRsbRgbLsbRgbLsbRcbRibLgb
RibLgbRibRgbRiRsmbRgbRsbRgbRsRsmbLsRsbRsbRgbRgbRsbRgbRsRsmbLsbRgbRgbRi
RsmbRsRsmbRsLsbLsRsbRgLsbRsbRgbRsbsbRsRsLsRgRsRsmmmbRsRsRsmmbRsRsmbRsb
RgRsRsmmbRsbRsbRgRsmbRgbRsLsbRsbRsbRgRsmbRsRsLsmbRgRsmbLsbRgRsRsRsRgmm
mbRgbRgbLsbRgRsmbRgbRgbRibLgbLgbLgRsbReLsbLhbLcbRiRsmbRiLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 43; Drug: NDMC 10 µM
bRobRcbRhbRibLibLgbLsbRgbRebRibRibRiRsmbRsbLjLsLgmbLgLsbRsbLgbLcbLcbLj
bLgbLgbLgbRsbRjbRgRsmbRgRsRgRgRsmmbRsbRgLsbRgbRsRsmbRiLsLsmbRoLsbRibRi
bRsbRiRsmbRgbLjbLoRsbLgbRgbRgbLobLibLcbLgbRgbLibLgbLsbLobRsbRsbLibLsbL
gbLsbRsbLsRsbLgbLsRsbLgLibLsbLsLibLsbLsbLgbRgbRjbLjbRsRhbRibLsbRgbLsbR
ebLgbRobRcbRgbRibRgbLsbRibLsLsRsmbRhLsbRsbRcLsbRgbRsbLiLsbRsbRjbRibLgb
RgbRgbLsbRibRsbLsbRibRcbLibLgRsbLsbLhbRjbLcRibLcLsmbLsRgbLoRsbRibRjbRg
LsbLgbRgbRiRsmbRsRsmbRsRgbRsbRsbRgRgbRgRsmbRgRgbRgbRgbRgbLjbLobLsbRjbR
sbLhbRgbLcbRjbLgbLsbLgbRoRsmbRibLsbRcbLsbRobLhLsbLobRgRsmbLcbRgbLgbLib
sbRsbLgbLgbLgbLibLsbRjbLgbLgbLsbLgLsbLgbLsLsLsLsmmmbLgbRsLcbRgRsmbRiRi
LsbLiRsbRjbRcbLgbLibLcLsmbRgbLsbLgbLgRsbLgbRgbLibRjRsmbRibRibLsbRibLjb
RgbRgbLsbRiLsRcRsmbRhRsmbRibRibRsbRgbLsbRcRsmbLgRiRsmbRgbRgbRhbLiLsbLi
bRsbRjbRibRgbRgbRsbRgbRsbRgbRgbRgbLsbRiRsRsmmbRsbRgbRgbRgLsbRsbRgbRsbR
gRsmbRgbRsbRsbRgbLsRsbRibLibLcbRsbLgbLgbLibLgbRgbRhbRgbRgbRsbLebRibRgR
sRsmmbRsbRgbRgbRibLsbRiRsRsRsmmmbRgRgbRgbRgbRgRibRgbRgbRgRsmbRsbRibLcb
LcRgbRsbLgbLgbLsbLebLoRsbLcbRjbRibRgbRsbReRcRsmbRgbRsRiRsmbRsRsmbLsRsb
RsbRibRsbRsbRgbRsbRgRsmbRgLsbRsbRgbRgbRsbRsbRiRsRsRsmmmbRgbRsbLgRibRsR
smbRsRiLsbRgRsRiRgmbRgbRgbRgRsmbLsLsmbRibLsbRhbLibRsbLobRhbLcLcbRiRsmb
RjbRibRsRgbRgbRsRiRsRsmmbRsbRgbRsbRgbRsRsmbRgRsmbRsbRiLsbRcbRoRsmbRiRs
mbRsbRiRgRsLsmbRgRsmbRgRsmbRgRsmbRgbRgbRsbRgbRsbRgRsmbLsbRibLibLcbLgbL
ibRsLsbLgbLsbLiRsbRgbLsbLgRsbRgbLgbLgbRibRcbRcRsmbRsbLgbRibRsbRibRsbLs
RibRsbRgbRgLsbRgRsmbRsLsbRgRsmbRgLsbRsbRgRsmbRgbRgRsmbLcbLibRsRsmbLgbR
sbLgbRjRhbLibLcRsbRgbLhbRjbRibRhbLgRsbRgbRsbRibRcbLgbLsbRcbRcRsRimbRib
RiRsRsmmbRiRsRsmmbRgbLgbLsbLsbRsRsmbRiRsmbRgRgRiRsmbRgbRgbRgbRgbRgRsRs
mmbRsRgRgRsRsmmbRgRiRiRsmbRgLsbRibRgbLgbRibRcRsmbLibLibLobRgbLcRsRhRsm
bLjbsbRiRsmbRgRsmbRsbRiRsmbRsRgbReLsbLcbLgbRjbRgbLcbRjbLgbLgbLgLsbLsLs
mbRhbRibRgbRgbRgbRgRgRgRgbRgbRsbRgbRgbRgbRsbRiRgbRgbRgRiRgbRibRgbRsbRg
bRebRcRcbLsRsbRibLsRsbRhbLgbRcbLsRsbRgbRgbRibLcbRhbRsbRgbRgbRsbRgbRgRs
RsRgRimmbRsbRgbRgbRsRiRgRiRsmbRgRgbRgRsRgRgRsmmbRgRsmbRgRsRgmbRgbLgbRc
LsbRcbLcbLobRgbRebRcRsmbRjLsbRjbRibLsbRgbRsRsmbRsbRsbRgRsmbRgbRiRsmbLc
bRcRsmbLsRsbRiLsbRgbRgbRsbRiRsmbRsLsbRgbRsbRgbRsRsmbRgRsRsmmbLsbRebLiR
sbRsbLcbRgbLcRsbLibRgbLiLsbRsbRsbRsbLcbRgbLgbLgbRjbRcbRgbRgbRsbRsRsmbR
sRgRsmbRsbLsbLcbLsLibRsbLgbLsRsLsbLgbRcbRgbRhbLgbLsbRgRsmbRgbLsbRgbRib
RgbRsRgRsmbRgRsmbRgbRsRsRimbRsRsmbRsbRoRsmbLcbRiRsmbLsRsbLjbLibRgbRsbL
ibLgLsbLcbLsRiRsRsRsRgRsRsmmmmmbRgRsRsmmbRiRsmbLibLibRjbLjLsmbRgbLibLs
LgbLsbLsbLgbLoRibLoRsRsmbLhbLgRsbLhRgRsLsmbLhRgbLiLsbLgbRsbLiLsbLgLsbL
gbLibLgbLgLsbLgbLsLsmbRsbLgbRgbLgbLsbLgbRsLcRsRsmbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 44; Drug: NDMC 10 µM
bRoLsLsLsmmbRsbLsbRgbRcbLgbLgbRgbRgbRiLsbRhbRibRgbLgbLgbLsbRsbLsbRiLsb
RhbRhbRibRgbLgbRibRibRgbRiLsbLibRgbLibLgbLsbLjRsbRgRsmbRgbLgLsbRsbLgbL
sbLgbLgRsbRgLsbRsbLgbsbLsbLgbLgbLsRsbLsbLsbLsRsbLsbLsbLgbLgLsbLsbLsbLs
RsbLgbRsLsbLgbRsbLgLsbLgbRsbLsbLsRsbLsbLgbLgbLsLsmbRsbLgbLgbLsbLgbLgbL
sbRsLsbLsbLgbRcbRibRibRgbRgbRgbLibLgbLgbLsbLgLsbRsbLsLsmbLgbLsbLsbLgbL
gbLsbLgbLcLsmbRgbRgbRsbRsbLsbLsLsmbLibRjbRcbRhbRibRiLsRsbLibLgbLgLsbLs
bLsRsbLgbLsbLibLcbRiRsmbRgbLsbLsbLgbRgbLjbLibLgbRsLsbLgbRsbLgLsbLgbRsR
smbRsbLgbLgbLgbRsbLibLsLsmbRsbRsbLibLibLgbLgbLgbRsLsbLgbLsbLibLgbRibLi
bRgbLibLcbRibRgbRsbLcbRibRgbRgbRgbLcbLcbRsbLibLgRsbLgbLibLiRsbRibLgbRs
bLgbLsbLsbLsbLsbLgbLsbLgbRsbLgRsbRgbLgbRsbLgbLgbRjbLgbLgbRsbLsbLsbLgbL
gbLgbLsbLgbRsbLgbLsLsmbLsLsmbLgbLsbLsLsmbLgbLgbLgbLgbLgbRsbLgbLgbLgbLg
RsbRsbLgbRsbLsbLibLcbLcbLibLiLsbLibRgbRibLcLsmbRsbLibRgRsmbLgbLibRgbLg
bLgbLgbRsbLsbLsbLsLsmbLgbLgbLgbLgbRsbLgbLgbLsbRjRcbRibRgbLibRibRgLsRsb
RgLsbRsbRgbLoLsmbRibRsbRgbRgbRgbRjbRsbRgRsmbLsbRgbRgbLsbRgbLgbRgbLsLsm
bRgbRgbLcbRhbRibLibRiLsbLgbRcbLiRsbRibLsLsmbRgbLsbRsbLcbLibRjbRhbRibLs
bRgbLsbRsRgbLsbRgbLcbRjbLibLgLsbRsbLgbLiLsbLsbRsRsmbLsLsmbLgbLgLsbRsbL
sbLgbLsLsmbLgbRsbLgLsRsLgbLgbLsbLgbLgLsLsmbLgbLgbLgLsbLgbLgbLgbLgbLgbL
sbLgbRhbLiLsbRsbLgbLsbLsLsmbLgbLgbLsLsmbLsbLgbLgbLgbLgbLsbLsbLsbLibLib
LibLcbRgbLcbRsbLgbLgbLsbLgbRgbLsRsLsbLibRgbLiLsbLgLsbLgLsLsLsmmbLgLsbL
gbLgbLgLsbLgbLsLsmbLgbLgbLgbLgbRgRsmbLgbLsLsmbLgbLsLsLgmbLgbLgbLsbLgLs
bLgbLgbLsbLgbLcbLibLibLibLibLgRsLsbRsbLgRsbLgLsLsmbLgLsbLgbLsRsbLgbLsb
LgbLgbLgbLgRsbLsLsmbLsbRgbsbLibLibLgbLsbLsRsbLgbLsbLsLibLgbLgbLgbLgbLg
bLsbLgbLsbLgbLgLsLgbLgbLgbLgbLgLsbLgbLgbLgLsbLgbRsbLiLsbLibRsLsbLgbLib
LcbLgbLhbLibRibRgbLsbLebLsbLiLsbLsbLsbLgbLgbRsbLgLsbLibLgLsbLgLsbLgRsb
LgbLgbLgLsLsmbLgbLgbLcbLibLcbRjbLibLibLsbLsbLgLsbLsbLgbLsbLgLsbLibLgbL
gLsbLgbLgbLsRsbRgbLgbLsbLgbLgbLsLhbLcbLgbRibRsbRiRgbRibRgbLsbRgbRibLgb
RgbLhbLgLsbLsbLgbLsbLsbRsRsmbLgLsbLgbLgbLgbLgbLiLsbLcbLhbLibRjRsmbRcLs
bLgbRibLsbsbRgbRsbRgbRgbRgbLgRsbRgbRhbRhbRibRibLgbLibRsbRsbLibLsbLiLsb
LibLhbLsbLjbLibLgbLgbLgbLgbRsLsbLiRsbRsRsmbLgbLgLsbRsbLsbLgbLgLsbLibLs
bLsLsmbLgRsbLgbLgbLgRsbLgbLsbLgbLiRsbLcbLcbLibLibLgbRsbLgbRsbLiLsbLgbL
gbLsbLgbLsbRsbLgbLibLsbLgbLgLsbRgbLibLcbLiLsbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 45; Drug: NDMC 10 µM
bRobRebLibLgbRsbLjbLibLjRsbLibLgbLibLjbLsbRjbRibRgbRibRgRsmbRgbLsbLsRs
bRgbRcbLsbLsbLsbRcbRcbRhbLgbLgbLsbLsbLsbLsbLsbRsLsbRsbLhbLiRsbLgbLsbLi
bLjbLibLgbRgRsmbLsbLgbLjbLsbLgRsbLgbLgbRoRsmbRjbRjbRgbRsbRsbLsbRsbRgbR
sRsmbRsbRgbRgRsmbLsbRsbRsbRcbRgbRibRibRsbLsbLjbLibLibRibLgbLgbLsbLiLgb
LsRsbLsLsLsmmbLsbLsRsbRsbLgbRcbRhbRgbRgbLgbLgbLsbRjbLsLsmbLsbLjLsmbLgb
LsbLgbLgRsbLsbLgLsbLgbRgbRjbRjRjbRgbRibRcRsmbRibRibRgbRsbRsbRgLsbRsbRg
bRsbRgbRgRsmbRsbRsbRsbRgLsbRsbRgbLibLcbRibLhbLgbLgbLgbLgbLsbLgLsLsmbLs
LsmbLsbLibLgbRgRsmbLjbLibLgbLgLsRsbRsLsbRsbLjbLiRsbRsbRsbLibLibLgbRgbR
ibRsbLsbLgbLgRsbLsbLgbLgbRsbLgbLgbRiRsmbRgbRsbLsbRsbLgbRjbRcbRcbRibRgb
RgRsmbRgbRsbRsbRsbRsbRsbRgbRsRsRsmmbRgLsbRgLsbRsbRebRjbRhbRibRgbRgbRib
LgbRgbRgbLsbRsRsmbRgRsmbRsbRgbLsbRibRcbRcbRibRgbRgbRsbRgRsmbLjbLjbRgbL
gbLgLsbLsRsbLgbLsbLgbLgbLgbLgbLgLsbLgRsbLibLgbLsbRgbRgbLjbLgbLsbLgbLsb
LsbLsbLgbLgbLgLgLsbRsbLsbLibLgbLsbLibLgRsbRsbLsbRgbLsbRsbRsLsbLgbRgbRg
bLsbRgbRgbLsRsbRgbRgbRgbRgbRsbRgbRgRsRgmbRsbRgbRsbLsbRgbRsbRjbRibRcbRc
bRgbRgbRsbRsbRgbLsbRsbRgbLgbRgRsmbRsbRgbRsbRgbRsbRgbRgbRgRsmbRsRsmbRsR
gbRsbRgbRsbRsbRgbRibRgbLsbRsbRgbRsbRcRsmbRcbRiRsmbRibRibLsbRsbRibLgbRg
bRiLsbRhbRiLsbRibLgbLgbLgbRsLjLsmbLcLsmbRjRgbRcbRgRsmbRsbRgbRsbRsRsmbR
gbRgbRgbRgbRibLgbLsRsbRibLgbLcbLgbLsbLgbLsRsbLgbLsbLsbLiRsbRgbLgbRsbLg
bLiRsRibLibLgLgbLgbLgLiRsLsbLgLsbLgbLgbLgRsbRsRsmbLibRsbRgRsmbLsbLibRg
bRjbLjbLibLibLsbLsLsmbLgbLgbRsbLgbLsbLiRsbRgbLibRgbRsbLibLiLsbRgbRibRj
bRsbRhRsmbRsRsLsmbLsbLibRgbRsbLgbLgbLgbRsLsbLsbLgbLgLsLgbLsbLgbLsbLgbL
sbLgbLgbLsRgbLgLsbLgbLgbLsbLgbLgbLgbLgbLsbLsbLebLsbLsbRsbLgbLcbLhbRgRs
mbRgbLgbLjbLhbLibRgbRjbLsbLibLgLsbLgLsbLgLgbLgRsbLsbLsbLgbLsbLgbLgbLsb
LgbLgbLjbRjRgbLcbRhbRcRsmbLjbRcbRcLsRsbRibRhbLjbLibLgbLgbRgbLsbLgbLgRs
LsbLgRsbLibLsbLsbLgbLgbLsbLgbRhbRcRsmbRjbRhbLgbLsbLsbRibRsbLsbLsRcbLgb
LgbRibLsbRsbRsbLsbRgbLsbRsbRgbRsbRsRsmbRgbRgbRgbRgbRgbRiRsmbRgbRsbRgLs
RsbRsbRsbRsRgbRgbRgbRgbRsbRsbRgbLgbLjbLjbLgbRgbLibLgbLgbLgbLsbLgbLsbRg
bLgbLibRcbRjbRibLgLsbRibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 46; Drug: NDMC 10 µM
bRsbLcbLhbLhbLibLiLsbRgbRgRsRsRsmmmbRgbRsbRgbRgbRhbRcRsmbRibRcbRhbRibR
hbRcbLgbLhbLhLsbLgLsbLcbLcbLibRgbRjbRcbRoRsmbRsLsbRgLsbRibRjbRiLgbLsLs
mbRhbLgbRcRsmbRcbLsbLsbRgbLsbLgbLsbLsbLsbLsRsbLsbRjbRgbLibLgbLgbLsbRsb
LsbLsLsmbLsbLsLsmbLgbLiLsbLgbLgbLgbLgbLsLsmbRsbLgLsbLsbLgLsbRsbLgLsbLg
bLgbLgbLsbLsbLgbLgbLgbLibLsLsmbRsbLgbLgLgRsLhLsbLgRsbRjbLgbRsbLgbRgbRj
RsmbRcRsmbRcbRibRhbRibRibRgbLsbLiLsbLibLsbLsLsLsmmbLgbLsbLgbLgLsbLsbLg
bRsLsbLgRsbLhbLsLsmbLibLibLgLsbLsLjbLiRsbLjbLcbLcbLiLsbLsbLsbLibLgbRsb
RjbLibLgbsbLibLgRsRsmbLibRsbLgbLgLsLsmbRsbLgbRsbLgbLgRsbLibLsLsmbLgbLg
bLgbLgbRgbLiLsbLgbLhbLiLsbLibLjLsmbLibLibLibLgLsbRsbLgbRgbRibLjLsmbLcb
RjRsmbLsbLsbLibRsLsRsRsmbLsbLibLsbLgbRsbLgLsbLsLsLgmbLgLsbLgbRsLsbLsbL
sbLgLsbLsbLgLsbLsLsmbLsLsmbLgLsbLgLsbLgbLgbLgLsbLsbRcbRcbRibLjbLibLcbL
jbRjRsmbLgbLhbLibRibLibLgbLibLsbLgbRsbLgbLsbLgbRgbLgbLgbRgbRsbLgLsbRsL
sbLgLsbLgbLgbLsLsmbLgbLgbLsbLgbRcLsbRgbRibLiLsbLgbLjbRibRibRiLsbRibLgb
LgbRibRhbRibRiLsbRgbRhRsmbRibRibRgbLgbLgbRhbLjbRibRsRsmbRsRsRsLsmmbRgR
gbRgbRgRgRsmbRgbRgbRgRsmbRiRgRsRgmbRiLsRsRgRsLsmbRgbRgbRgRsmbRgbRcbRhR
smbRibLsbLibRsbLgLsbRsbLibLgLsbRsbLsbLsbLgbLsLgbLgbLsbLgbLeRsbLcbLhbRh
bRgbRgbRgbRgRsmbRgbLsbRgbRsRsmbRgRsmbRsbRgbLjbRjbRhbRcbRibRibLgbRhbRib
RibRcbRibRsbLibRcbRcbRibRibRgLsbLgbLgbRibLgbRhbRcbLjbRcbRibRibLgbRcbLg
bRcbLsbRgbRsbRgbRgbRgRgRibRsbRgRsmbRsRsmbRgbRsbRgbRsbRgRsmbRgbRgbRgbRs
bRgbRgLsbRiRsmbRsbRgbLgbRsbRgbLsbRgRsmbRsbRsbRgbRsbRsRsmbRgRsmbRgbRgbR
sRsmbRgbRsbRgbRgbLsbRgbRsRsmbRgbRsbRgbRsbRsRsmbRgRsmbRsbRgRsmbRgbRgRsm
bRsRsRsRgmmbRgbRgbRgbRcbRiRsmbRgbLibLgLsbLgLsLsmbRsLsbLgbLsbLsLsLsmmbL
gbLebLgbRsRsmbLjbLcLsmbLcbLiLsbLjLsmbLgbRcbRcbRibRibRsbLibRibLsbsbRibR
sbRsRgbRgbRgbRgbRgbLgbRibRcRsmbRgbLsbLibLsLsmbLsLsmbLgbLsLsmbLgbRsbLgL
sbLgLsLsmbLsLsmbLgRsbLsbReLsLsLsmmbLcbLhbLgbLgRsbLgbLgbLjbLibLgbRjbLib
LgbRibLibLgbLsbRcbRibRhbLibLsbLgRsbLgbLibLgbLgbLgbLsLsmbLgbLgbLsbRsbLg
LsbLsbLgbRcbLebLhbLgRsRsmbLjbLibLgbLgbLsLsmbRgbLgbLgbRsbLgbLsLgbLsLsLs
mmbLibLiRsbLcbLibLibRjbLcbLebLcbLgbLibLgbLgbRhbRcbRibRjbsbRsRsmbRgbRgR
sRsLsmmbRsbRgbRgbRgRsmbRibLgRsbRcbLgLsbRgbRsbRgRsmbRgRibRiRibRsRsmbRgb
RibLgbLgbLsbRcRsmbRibRcLsbRibRgbRibRgbRgbRsbRgbRgbRgRsRimbRgbRsRsmbRgb
RibRcbRhRsmbLgbLiLsbRhbRgRsmbLgbRgbRsbRgRsRsLsmmbRgbRsbRgRsLsmbRsLsbRg
bRsbRgbRgbRgbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 47; Drug: NDMC 10 µM
bRobLsbLibLcbLhbLgbLibRibRgbRsRsmbRsRsmbLjbLjLsLsmmbLgbRsbLgLsbLsLsmbL
sbLsLgLgLgbLgLsbLgLgbRsbRjbLibLcLsmbRsbRgbLcbRjbLcRsbLgbLgLgbLgbLsbLgb
LsbLgbLibLiRsbLgbLgbLsbRsbLhbLgRsbLgRsLgLsLgbLgbLgbLgbLhLsbRgbLgbLibRg
bRgbRsbRgRgbRsRsmbRsbRsbRgbRsRiRgbRsRsmbRsRsmbRgbLsbRgLsbRgbRgbLsbRsbL
sbRgbRgbRgRsRsmmbRsRsRsmmbRgRsmbRgbRsbRsbRgbRgbRsbRsbRsRsmbRsbRgbRsbRg
LsRsbRgRgbRgRsmbRgbRgbRjbLcbRjbLcbLoRsbLcbLcbRgbRibLjbRibLjbLcLsmbLebR
iRiRsRimbLiLsbRsbLgbLsbLsbLsbLsbsbLgbLgRsbLsbLgbLsbLsLsmbRsbLsbLsLsmbL
jbLcbRibLcbLhbLhbLgbRgbLibLsbLsbLsbLgbLibLsLsmbLgLgbLgbRsbRsbRebLgbRib
RibLgbLsbRsbLsbRjbRsbLibLgLsbLgLgbLsLsmbLsLsmbLsLsmbLiLsbLibLgbLebLsLs
mbRsbLsbLibLibLsRsbLobRcbLcbLobLjbLibRsbLsbLgbLiLgbLgbRsbLgbLgbLiLibLi
bLgbLcbLibRsbRjbLibLjbLgbRsbLgbLgbLgbLgbLgbLsbLsLsmbLsLsmbLgbLgbLiLsbL
gbLsbLibRebRcbRiLsbRibRsbRsbRgbRibLsbRgbLsbRiRsmbLsbRgbRsbLsbRgRiRsRgR
iLsmbRsbRsbRsbRgbLsRsbRgbLsRgRsmbRgbRgbRsRsRiRgmbRsbRsbRsbRgRgbRgRsmbR
sbRsRsmbRsbRgbRgbRsRgbRgbRsRsmbRgbRgLsbRgbRgRsmbRgbRgRsRgmbRsbRgRsRgmb
RgbRgbLgbRgRsmbRgRsmbRiRiRgRsmbRgRsRiRgRsRiRgmmbRsRgRsRgRsReRsRgRgRsRg
RsRgRgmmmmmbRgRsmbRgRhRgRsRgReRgmbRgbRgbRibRibLibRibRhRsmbLcbRibsbLcLs
mbLibRgbLibLibRibRgbLobLcbRgbLibLgbLgbRjbReRsmbRgRsmbRgbRsbRgRgRgbRgLs
bLsRsbRgRhRsmbLsRsbLsRsbRgReRiRiRsmbReRgbRgLsbRgbRsRsmbRgRsmbRgbRgbRsR
sRsmmbRgRgRebReRsmbRgbRgbRsRgRgbRgbRcbRcbRcbRiRsmbRgbLjbRibRgbRgLsbRsR
sRsRsmmmbRibRgbRjbRsbRsbRgLsRgRsRsRimmbRhbRsRiRsmbRibRgRsRcmbRibRgbRsb
RibRcRsmbRcbRsRsLsmbRobRibRibRibRgbLsbLibRjbLcbLibLcbLhbLgbRibLhbLhbRg
LsbRjbLiRsbLsLgbLibRjbLjRsbLjbLiRiRsRsRimmbLibLgbLiRjbLgbLjbLgbRjbLsbL
hbRibRgbLhbLibLcbRhbRibLcbLibRsLsRsbLibLgbLgbLsbLgbRgbRjbRiRsmbRsRsmbR
sbRiLsbRibRibLhbLcbRgbLcbLibLgbLibRjbLibRgbLsbLgbLsLsRsmbLgLsbLiLsbLgb
LgLsbLgbLsLsmbLsbLsLsmbLsbRcbRgbLjbRhbRibRcbRhbRcbLibLibLsbRibRhbRibLj
bRibRcLsbLhbLcLsmbLcbLcbLhLsbRgRibRibRsbRibRibRgbRgbRsRsLsmbRgRgRgRsmb
RsbRgbRsbRgRsmbRgRgRgRsRgRgmbRgRsmbRgRiRsmbRgbRgbLsbRgbLcbLcbRcLsbRibs
bRibRsbRgbRgbRgbLsbRiRsRgRgmbRgbLgbRhbRgRsmbRiRsmbRsRhbLebLcbLsbLiLsbR
iRsmbLcbRibLcRsbLhbRibLcbRibRobRgLsRsRsmbRgbRgRsmbRgRsmbLsbRgRsmbLsbRg
RgRiRsRgRgReRgRgmbRgRgbRsbRgRgbRgRsRiRgRiRsmmbRsbRebRgbRgbRgRsmbRiLsRs
bRgbRgbRgRsmbRibLobLoRibLgbLcRsbLcbRibRibRibRibRibLjbLcbLhbLcRsbLcbRib
RcbRibRibRibRgRsmbRiRsmbsbsbRibLiRsbRcbLgbLjbLobLgbLcbLgbLibLgbRibRibR
gbRibRibLjbRgbRgRsmbRgbLsLsmbRgRiRsRsmmbRgLsbRgRgRebRgbRsRsmbRgRsRsmmb
RsbRgRsmbRgbRgRgRgRsRsRgRimmbRgbLjbLcRsbRjbLcbRibRibsbRcbRobRibRcbRibR
gbRgRgRsmbRgbLsbRiRsmbRsbRcbLhbLcbLhbLibRibRgbLibLiLsbRsbRgbRiLsbLgRsb
LjbLhbLhRsbRibLibLgRsbLgbLsbLgbLsLsmbLgLsbLgLsbLsbRsbLsbRibLebRjbRcbLh
bRcbRcbLgbRcbLibRibRsbRcLsbLebLjbLgLsbRjbLibLibRjbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 111227; End: 111727;
Recording: 3-1; Individual: 48; Drug: NDMC 10 µM
bRobLgbLgbLcbLhLsbLcbLibLobLsbLgbLobsbLgbLcLsmbsbRgbRsbLjbRibRjbLibRjb
LcbLgbLibLcRsbLibLgbLibRsbRgRsmbRibRgbRgbRcLsbsbLgbRobLibLibLiLsbLsRsb
LgbRgbLsbRobRcRsmbRgbLsbLgbRhbRcbLibRcbLibRobLsbLgbRgRsmbLibLgbLgbLgLg
LsLgLgLsLgbLcRsRsRsmmbRsLcRsbLhbLcbLiLsbLhbLhbLibLibLcRsLsRsbLsLsmbLhL
sbRgbLsbRgbRsbLsbRgRsRgmbRsbRsbRgbRsbLsRgbLsRebRebRibLjbLiLsRsbLobRsbL
ibRjbRgRsmbRsRiRgRsRsmmbRjbLsbLcbRgbRsbRgbRsbLibLgbRsbLgLsbRsbLibLsbLg
bLsbLsbLgbLiRsRsmbLcbLibLcbLhbLibLgbLsbLgbLgbRgbLibRsbLsRsbLgbLgLsbLgb
LsbLgbLgbLgLsbLgbRobRobLsbLgbLibLgbRgbLibLsbLgbLsbLgbLgbRsbLgbLgbRsbLg
bLgLsbRsbLgbLgLiLgLsLgLibLgLsbLsbLgbLgbRsLsbLsbLibLgLsRsLibLsbLiLsRsbL
gLgLgbLgbLcbLsLsmbLibLcLsmbLiLsbLcbLibLgbLgbLibRobRcbLgbRiRsmbRgbRgLsb
RgbsbLsbRsbRiRsRiRsRgRsmmmbRgRiRiRsmbRsRsRiRsRsmmmbRibRgbRibRcLsbLeLsb
LcbLcbLcbRcbRcbRsbRsbRobRcLsbRibLibRibLhLsbRgbLgbLgbLsbLgLsbLgLsLsmbLs
bLgRsbLgLsbLsbLgbLsbLgbLgLsbLgbRsLsbLsbLgbLgbLgLgbLsbLibLsbLgbLgLsbLgb
LgbRsbLibLjbRebLibLgbLsbLgbLsLgLsLgLsbLgbLgbLgbLsbLgLsbLgLsbLibLsbLiLs
bRgbLgbLgbLgbLgbRsbLiLgLsLgbLgLsbLibLgLsbLsbRsbLiLsLsLiLgmbLgLgbLibLib
LcbLibLcbLiRsbLhbLibLsLsmbLibLcbLcbLibLiLsbLibRsbLibLgbLgbRgbLcbRgbLcb
LsbLibLibRsbLcRgbRsbLibLibLgLsbLgbLgRsbLobLsLibLibLibLibLiRsLsbLgLsbLg
bLgbLgbLhbLoRsbLcRsbLibLgbRsbLgbLsbLiLsbLsbLgbLgbLsLsmbLgLsLgLgLgLsbLg
LsLgbLgbLsbLsbRsLsLiLsLsmbLgLgLsLgbLgRsLsbLgLsLibLsLgLsbLgbLsLsmbLsLsm
bLgLgbLibLsbLsRsbLiLsbLsLiLgLsbLgLsLgbLgLsbLgLsbLgLsbLgLsbLgLsbLsLsmbL
gLsbLgLsLsLsLgmmbLgbLgbLgbLsbLsbLibLsLiLsLsLgmbLgbLgbLibLibRhbLibRhbLh
bLcbLcLsmbLibLcLsmbLibLibLibRebLcbRgbLcRsbLcLsmbLiLsbLibLjbLcbLcbRsbRi
RsmbLgLsbRgbRgbRsbRgRibRgRgRgRgbRgRsmbLsbRiRsmbRgLsbRibRgbRgbRibLgbRib
LjLsmbRiRsmbRgLsbRibRsbRsbRgbRgbRcbRhbRcbRgbRsbLcbLibLobLhbRibRgbRsbRg
LgbRibRsLsbLsbRgbRgbRiRsRgRgRiRsRgRsmmmbRgRsmbRibRgRsmbRgLsLsmbRibRcbL
hLsbRebRcRsmbRebLiLsbLcbLgbRcbLhbLcRsbRhbLoRsbLcbRebLobLibRgbLhbRjbLib
LsbLgLsbRsbLibLgbLiLsbLgbLsbLhbLcLsmbLibRibRgLsbRsbLiLsbLibRibRebRgbRi
bLgbRgbRibLsbLsbRgRsmbLsLsmbRgRsmbRsRgbLibLobLibRgbLibLcbLcbLjbLcbLcbL
ibRgRsmbRsbsbLcbLcLsRsLsmbLibLiLsbLgLsLsmbLcbLsbRsbLibRgbLibLsbRsRsmbL
ibRsbLgbLsbLgbLsbLgbLgbLgbLgLsLsmbLsbLgLsbLgLsbLgLsbLgbLgbLcbRibLhbRiL
sbLgbLcbLcbLgbLhbRhbLgbRobRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 1; Drug: Control
bRibRgbRhbLgbLgbLhbRibLiLsbRibLhbRoRsmbLgRsbLgbLibRgRsmbLibRibLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 2; Drug: Control
bRsbLcbLibRgbLibLgbRsbLgLsbLibRjbLgbLibLsbLibLgbLgbLgbRsbLibLiLibLgbLg
bLgbLgbLgbLgLgbLgLsbLgLsbLgbLgbLgbLgLsbLgbLgbLgbLibLgbLsbLgbRjbRhbRhbR
ibRcbLebLibLgbLsbLibLgbLsbLgLsbLgbLgbLhbLibLgbLgbLgbLgbLsLsmbLgbLgbLgb
LgbLgbLgbLibLgbLgbLgbLgbLgbLgbLgbLgLiLgbLgRsbLgbLgbLgbLgbLgbLgLsbRgbLi
bRgbLgbLgLsLsmbLgbLgbLgbLgbLgLsbLgbLgbLgLsRsbLsLsRsmbLibLgLsbLgLsbLgbL
gbLgbLgbLsbRsbLgbRsbLibLgbLgbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbLgbLgbLgbLgb
LgbLgLsbLgbLgLsbLgbLgRsbLiLsbLgbLgbLgbRjbRcRsmbRgbRiRsmbRgbLsRebRcRsRs
mmbRibRibRsbRgbRgbLibLcLsmbLiLsbLsbLibLsLsmbLibLgbLgbLsRsLsbRsbLiLsbLg
RsbLgbLgbLgLsbLgbLgbLgbLgbLgbRsbLiLsbLgbLibLiLsbLsbLibLibLibLcbLibLibL
iLsbLhbLibRsbLgLsLsmbLgbRgbLibLgbLgbRsbLibLsbLsbLgbLsbLiLsbRsRsmbLsbLi
bLsLsmbLgbLgbLgbLsbLibLsbLibRgbLibLgbLsbLgbLsLsmbLiLgbLgbLsbLibLgbLiLs
bLsbLgbLgbLgbLgbLgbLsbLgbRjbRcbLcbRgbRhbRibRgbLebLcbRsbLsbLiLsbLsbLgbR
sLgbLgLsLsmbRsbLsRsbLsLsmbLgbLsbLibLgbLgbLgbLibLsbLgbLsLsmbLgLsbLgLsbL
sbLgbLgbLsbLgLsbLgbRgRsmbLibLgbLgbLgbLgLsbLgbLgbLgbLsbLgbLgbLsbLgLsbLg
bLsbLgLsbRebRoLsbLsbRibRhbRiLsbLgLsbRibLsbRibRsbRgbRibRsbRgRsmbLjbLcbL
sbLgbRsbLgbLgbLgLsbLgbLgbLsLsmbRsbLibLsbLibLgLsbLgbLgLsbLgLsbLgbLgbLgb
LgbLgLsbRsbLibLgbLibLgbLgbLhbLgbLgbLibRsbLibLsbLiLsbLgbLsbLiLsbLgbLgbL
gbRsLsbLsbRcbRiRsmbLebLcbLgbLsLsmbLgbLgLsbLsLsmbLibLgbLgbLgbLgbLgbLgbL
gbLgLsbLgbLgLsbLsbLsLibLgbLgbLgbRsbLgbRcbRibLebLibLgbLgbLgbLgbLgbLgbLs
RsbLgLsbLgbLgLsbLgbLgbLgbLgRsbLsbLgRsbLgbRjbLsRsbRcbRgbRibRsbLcbLibLib
RsLsbLsLsmbLgbLgbsbRsbLgbLgbLgbLibLgbLgbLsbLgLsbLgbLgbLgbRgbLibLgbLibL
gLsbLsLsmbLibLgbLgLsbLsbLgbLgRsbLgbLgLsbLgbLgLsbLgbLgLsbLsbLibLgbLgLsb
LgbLgbLgbLgbLsbLgLsbLgLsbLgbLgLsbLgbLgLsbLgbLgbLgbLgbLgbLgbRsbLibLgbLg
LsbLgbLgbLgbLgLsbLibLgLsbLgbLgbLgLsbLsLsmbLgbLgbLgbLgbLgbLgbLgbLgLsbLg
bLgbLgLsbLgLsbLgbLgbLibLgLsbLgbLgbLibLsbLgbRgbRebRibRgbRcRsmbRgbRgbLiL
sbLgbLiLsbLgbLibLgbLgbLsbLgLsLsmbLsbLgbLibRibLibLsbLibLgbLgbLgbRgbRcbR
ibRhbRjbRiRsmbLjbLcbLsbRgbLgbLiLsbLgbLgbLsLsmbLsbLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 3; Drug: Control
bRibRgRsmbLoRsbRgbRjbLobRibLibLiLsbRsbLibLgbLcbLibRgbLcbLibLgbLgbRgbLi
bRgbLibLcbLobLhLsbLgbRsRsmbLibRgbLiLsLibLgbLgbLibLsbLsbLgbLgLsLsmbLgLs
LsmbLiLgLsLibLgbLsRsbLgbLsLsmbLgbLgRsbLgLibLgbRsbLibLgbRsLsLgLsLgLsLgb
LgbLgbLgLsbLgbLgLsbLgLsbLgLsbLgLsLibLgbLsLsmbLibLgbLgbRgLsbLiRsbLgLsLg
bLcbRiLsbRgbLhLgLsbLgbLgLgLgLsLgLgLsbLgbLsLsmbLgbLgbLgLsLibLgbLgbLgRsb
LgbLgRsbLgLsbLibLsbLibRsLsbLiLgbLgLsbLgbLsbLgLsbLgLgbLgLsLsLgmbLgbLgLg
LgbLgLgbLsLgbLgLsbLiLgLsbLgbLgLsbLibLgbLsLsLsmmbLgLgbLgLsbLgbLgbLibLgb
LibLcbLcbLobLcbRibRhbLobLsbLibLgbLcbLcbLcbRibLcbLibRgbLibLhbRgLgLsbLiL
sbLsbLibLgbRgbLiLsbRjbLiLsLsmbLgbLiLsbLobLjbRibLobRjbLcLsmbLcbLsbRgbLi
RsbRcbLiLjbLibRcbRibRhbRibLgbLsbRobLibRoLhbRhRsmbRcLsbRcbsbLibLcbLibLi
bRgLsbLiLsbLgbLgLsbLgRsbLsbLgLsLsmbLgbLgLsbLsLgbRsbLgLsLsmbLgLsbRgbLhR
sbRgbLhLsbLoRsRiRgbLhbLibLibLsbLiLsbLibLibLibLibLgLsbLgbLgbLiLsbRgbLib
RsbLgbRsLsbLgbLsLsmbLgLsbLgbRsRsmbLibLgbLibLiLgbLgbLgbLsLsmbLgLsbLsRsb
LiLsbLgbLsbsbLgLsLsRsmbLgbLgbLgbLgbRjbLibLibLsLsmbLgbRgbLiLgbLgbLsbLgb
LgbLsbLgbRsbLibLsbLsLiLgbLgLsbLgLsLsLsLsmmmbLgbLgbLsbLgLsLsmbLgLsbLgbL
gLsbLgLsbLgbLgbLgbLgLsbLgLsbLgbLgbLgbLsbLgbLsLsmbLgbLgbLsLsmbLgbLgLsRs
bLibLgbLgbLgbLgbLsbLiLsbLsbLgbLgbLgbRgLsbLgbLsbLgbLsbLgLgLsLgbLgLsbLgb
LgbLgbLgbLgbLgbLgbLgbLgbLsbLgLsLsmbLibLgLsbLgbLgLsbRsbLiLsbLsbLgbLgbLg
LsbLgbLgbLgLsLgbLgLgLsbLgLsbLsLsmbLgbLgLsLsmbLibLsLsLsmmbLgLsLgLsLgbLs
bLibLgbLiLgLibLsbLgLgLsLsLsmmbLgLsbLgLsLsLsmmbLibRgbLiLgbLibLgbLgbLgbL
gLiLsbLgbLgbRgbLiLsbLgLibLgbLgLgLiLgLsbLgbLgLgLsLibLgLsbLsbLibLgbLgLgb
LibLgLsbLgLgbRobRoLhbLcLsmbRjbLcbRgbLobLibRgbRibLibLibLibRsLsLsmbLibRj
bLcRsbRiLsbLcbRgbRjbLcLsmbLhLsbLiRsbLhLsRsbRibLgbLobLcbRhbLibRgbLcLsmb
LgLsbRgbLibRgbLiRsbRjbRibRcbLgbRibRcbLcbRcbRibRibRgbRcbLiLsbLcLsmbRibR
obLibRobRibLgbRcLsbRcbRibLiLsLsmbRiLsbLjbLobLhRsbRibLcbRjbRcbLebLgLsLs
mbRgbRibRibLgbRibLjbRobRcbRibRhLsbRgbLobLsbLobLhbRcbLhbLsbLibLgbLcbRgb
RgbLcbRiRsmbLcbRibLiLsbLobRibRcbLibLobRiLsbRjbLcbLibRgbLibLcRibLsbLobR
ibLgbLibRjbRcbRcbLsbLgbLibRjbRibLcLsmbLhbRsRsmbLibRsbLibRibLhbLiLsbRsR
sLsmbLibLsLsmbLibLibLcbRebRibLiLsLsmbLibRibLjbLcbRibLcbRsbLiLsbLsbLsbL
gbLgbRsbLibLsbLgLsbRsbLgbRsbLibLgbLgbLsbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 4; Drug: Control
bLibLcbRobRcbLgbRiRsmbLgbLsLsmbRiLsbRibLsbRsbRgbRsLsbRgbLsbRgbRsbRgLsb
RsbRgbRsbRgbRgbLsbRsbLsRsbRgbRsbRgbRgRsmbRgbRgbRgRsmbRgbRgRsmbRgbRsRsm
bRgbRsbLsbRsbRgRsmbRgbLgbLcbRhbLsbRsbLcbLgbLgbLibLibRgbRsbLibLgLsLsRsm
bLsbLhRsbRibRibRibLgbRcbLgbLgbRgbLebLgbLibRibLiLsbLgLsbLgbLsbLsbLsbLgL
sLsLsmmbLgLsbLgbLsbLsbLgbLgbRsbLgbLgbLibRgbRibLhbLgbLsLsRsmbLgLsbRsbLg
bRcbRcLsbLebLjbRebRhbRibRgbLibLhbLhbLsbLiLsbRsbLgbRcbRiLsbLgbRibRgbRgb
LgbRibLsbRgRsmbRsRsmbRgbRiLsbRgbRgbRsbRiRsmbLgbRibRsbRgbRgbRsbRgbRgbRg
bRgbRgbLcbLsbRgbLcbRibLcbRhbLibLibLgbRcbRcbLgbRibRgbLgbRgbRsbRgbRgLsbR
sbRibRsbRgbLsRsbRsLsbRgRsmbLsbLsRgbLgbRgbRsRsmbRgbRgRsmbRgLsbRgbRgbRsb
RgbRsbRsbLsbRgbRsRsmbRiRsmbRsbRgbRibRgbLibRibLjLibRcbLobLcbRibLobRibRc
bRcbRcbRgbLcbRibLibLgbRsbLgbLgbLgbLgbLibRibLiLsbLgbLsbLgRsbRsbLibLibLs
bLgRsbLsbLgbLgRsbLgbLgbLgbLsbRgbLibLibRsbLgbRcbRibLgLsbRgbLsbRibRgbRgb
RgLsbRgbLobLibLsRjLsbLsbRjbRibLcbLiRsbLgbRcbLcLsmbRsbLiLsbLjbRibLhbReb
RiRsmbLjRsbRgbRgbRgbRsbRgbLsbRsbLcLsLimbLcbLibLibLgbRibLgbLiLsbLibLibR
gbLibRgRsmbLgbRsbLibRgbLibRiLsbRcbLobLobRibRgbLgbRgbLcbLgbLsLsmbLgbRgb
LibRgbRsbRcbLgbLcbLibLcRsbLcbLibRgbLjbLibRcbLcbRhbRjRsmbLcbRibRgbLcbLs
bRcbRibLgbRsLsbRibLgbRsRibLobRjbLobRibRiRsmbRgbRibRgbLgbRgRsmbLgbRibLs
bRgbRgbLsbRgbRgbLsRsbRgRsmbLgbRgbRgbLcbRsbLgbRsbLiLsbRsbLibLibLgbLgbLg
bLibLgbLcbRibLgbLiRsbLgbLgbLgbRgbLgbLgbRgLsbLiLsbRibLcbRgbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 5; Drug: Control
bLcbLcbRjLsbLiLsbLcbRiRsmbRibRiRsLsmbRibLsbRsbRiLsbRcbRcbRjRsmbRibLgbR
cbLibLjbRibRiRsmbRibLsRsbRsbRibLsRsbRgbRsRsmbRgRsmbRsRgRsmbRgbRgRsmbRg
bRgbRsbRgbLsbRibRgbLcbLsbLibRibLiRsbRgbLibLhRsRsmbRhRsmbRiRsmbRgbRgLsb
RgbRsRsmbRgbRgbRgbRgbRsbRsbRgRsmbRgbRgbRgbRgbRgRsmbRsbRgbRgbRgbRgbRgbR
gbRsbRgbRgbRsLsbRsbRgbLsLsmbLcbLcbRhRsmbRjRsmbRgRsmbRgbRgLsbRgbRgbRgbR
gbRgbRgbRgbLsRsbRibRgbRsbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbRgRsmb
RsbRgbRgbRsbRsbRsbRgRsmbRgbRgbRgbRsbRgbRgbRgbLsbLobLsbLibRjbLibLibLcRs
bLsRsLsRsbLiLsbLsbLsbRgbLgbLgbLsbLgLsbLsbLgLsbLsLsmbLgRsRsmbLgLsbRgbLi
bRsbLsbLgbLibLibRibRibLibLgbLgbRibRibRgbRcbRoRsmbRcbRgbLgbRjRsmbLgbRob
LgbRsRsmbRcbLibRcbRhbRibLibRiRobRgbRsbLibRcbLcbLcbRibLobLhbRhbRibRgbLi
bLibLibLcbRibLibLsbLsbLibReLsLsmbLsbRgbRgbRgbLsbRibLsbRsbRibRsbRgbLsbR
ibRgbRgbRgRsmbRgbRsbRgbRgbRgbRgbRsbRgbRgbRgbLgLsbRiRsmbLsbRiRsmbRsRsmb
RgbRgbRgbRgbRsbRgbRsbRibRgLsbLjbRibLsbRibRsbRsbRsRsRsmmbRgbRgbLsRsbRsb
RibRiLsbLcbRibRsbRgbRsbRibLsbRgbRsbRgbRsLsbRsRsmbRibRsbRibRsRsmbRgbRgb
LsLsmbRiRsRsmmbLsbRiLsbRcbLibRsbRgbRibLjbLcbLcbRibLcRsbLibLhbReRsmbRgR
smbRgbLeLsbLsbLiRsbRjbLcbLcbRiRsmbRibRibRibRgRsmbLgbRgbRgbRsRsmbRgRsmb
LgbRibRsbRgRsmbLsbRibRgbLsbRgbRibRsbRgbRgbLsbRibRiRsmbLsbRibRsbRiRsmbR
sLsRsbRiRsmbLsbRibLgbRibRgbRgbLibRibRgbLsbRgbRgbRsRsmbRsbRibRsbRgbRgbR
gbRsbRgRsmbRsbRgbRgbLgbRgLsbLsbRibLsbRgbRsbRgbRgbRibLsRsbRibRcbLibLibL
iLsbRibRiRsmbRibRgLsbRgbLsLsmbRcbsbLhbLcLsmbRgRsmbRgbRoRsLsmbRhbLsbRhb
RibRibLjbLcbLcbRebLcLsmbLibLsLsmbLibRjbLgbLgbRjbLgLsbLgbRsbLgbRsbLibRi
bLibRibLjbLhbLcbRiRsmbLhbRsRsmbRjbLcLsmbLsRsbLcbRgbLiLsbLibLibLgbRcbRi
bLgbRiRsLsmbLgbRiRsmbLsbRibRgRsmbLsbRibRgLsRsbLsbLsbRiRsmbLjbLcbLibLiL
sbLibRibLibRebLgRsbLjbLhbLgbRgbLibLibLgbRsbLgbLsbLgbRibRebRiRsmbLgbRcb
LgbRibRibLsbLcbLibLibRhbLjbRcbLsbRhbLiLsbLibLgbRsRsmbRsLiLsbRgLsbLiLsb
LsRsbLgLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 6; Drug: Control
bRjbRjbLjbLibLcLsmbRibRgRsmbLcbLhLsbLgbLgbRjbRhbRcbRcbRibLibLibRsLsbLg
bRjbRcbLjbRiRsmbLsbRibLsRsbRgbRiLsRsbLjbLcbLsbLibLsbLiLsbLsLsLsmmbLsbL
gLsLsmbLgLsLsmbLgbLsLsLsmmbLgLsbLgLibLgbLgbLgbLgLsbLgLsbLgbLgbLsLsRsLs
mbLgLsLgLsbLsbLgbLgLsbLiLsbLgLsLgbLiLsbLgbLgRsbLgbLgbLgbLgbLgLsbLgbLgb
LgbRgLsbRcbRibRhRsmbLgbLhbRcbLsbLsbRoRsmbRibRgbRcRsmbLibRibRgRsRsmmbRg
bRgRsmbRgbRgRsRsmmbRsbRgbRgLsbRgbRsbRgLgbsbRgbLjbLcbRjbLcRsbLsRibLcbLi
bLiLsbLiLsbLibLgLsbLiLsbRsbLibLgbLgbLibRibLibLsLsmbLgbLsbLgbLgbRjbLibL
hbRibReLsRsbLjbLcbLcbRsbLibLgbLiLsLsmbLgbLsLsmbLgLsbLsbLgbLgLsbLgLsbLs
bLgLsbLgbLgbLgRsbLgbLgbLsLsmbLgbLgLsbLgbLgLsbLgbRsRsmbLgbLsLsmbLgbLgbL
gbLgbLgbLgbLgbLgLsbLgbLsbLgLsbLgLsbLgbLgbLgbLgLsbLgbLgbLgLsLsRsLsmbLgb
LgbLiRsbRcbRcbRcbRhbRebRibLibLibLiRsLsbLgbLgLsbLgbLibRgbLgbRcbRcbLibRc
bLgbRcbLsbRcRsmbRibLibLcbLcbRibLgbLibLgbLgbRibLibRgbLgbLsLsmbLgbRsbLib
LibLgLsbsbLsbLsLsmbLsLsmbLsLsmbLgLsbLgLsbLgbLgbLgbLgbLibRiRsmbRcbsbRib
RebLjbRhbLgbRcbLhLsbLcLsmbLhbRgbRgbLibRsbLiLsRsbLhbRgbRgbRsLibLiLsbRgb
LiLsbLgbLgRsbLgLsbLgbLgRsbLgbLsbLgLsLsmbLgbLgbLgLsbLgbLgbLgRsLsbLgLsbL
sbLgbLgbLgLsbLsbLgbLsLsmbLgbLsLsLsmmbLgLsRsbLgLsbLgRsbLgLsbLgbsbLibRjb
RcLsRsbRsRibRcRsmbRibRibLjbLcbLobLibLhbLgbRcRsmbRcRsmbLhLsbRobRibLsbLi
bRcbRhbRibRjbLibLsbLgbLibLhbLibLgRsbLjbRcbRcbRcbRcRsmbLgbLsbLibLgRsbRg
LsbLgLsbLsbLgbRsbLiLsbLsLsmbLgLsbLsbLibLsRsbLgLsbLsLsmbLgbLgRsbLgbLgLs
bLsLsmbLgbLsRsbLgLsbRjRhbRhbRcRsmbLibLiRsbRcbRibLibLjLsmbLibLibRibLibL
gbRsbLgbLgbRsbLsLgLsbLsbLgbLiLsbRsLsbLgLsbLgbLsLsmbLgbLsbLgbLgLsLgbLgL
iLsLgbLgbLgLsbLgbLgLsbLgLsbLgLsLsmbLgLsbLsLsLsmmbLgbLgLsLsmbLgLsLibLgL
sbLgbLgbLgbLgLsbLgbLsbLgbLsbLgbLgLsbLsLsmbLgbLgLsbLgbLgbLsLgbLsbLgbRsb
RcbRcbRcbRhbLebLibRibRcbLibRcbRibRgbRgbLjbLhLsbRjbLcbRibLobLcbRhbRibLi
bLsbRcRsmbLiRsbRcbRhbLjbRcbRhbLibRcbLjbRcbLgbLsbRcbRebRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 7; Drug: NDMC 1 µM
bLgbLibRsLiLsbLgbRsRsmbLeLsLsmbLgbLsbLgLgLgbLsbLgbRgLsRsbLiRsbRgbLgLsL
ibRsbLiLiLgLsbLsbLsbLsLgLsLsmbLgLsLgbLgbLsLsmbLgLsLsmbRsbLibRsbLgLsbLg
RsbLiLsLsmbLgbRsbLiLsbRsbLibRjbLcbLcLcbLcbLibRjRcbRibRibLsLsmbLibRhbLh
bRiLsLsmbLsbRhbsbLsRgbRhbLgbRibRgbRibLsbRiLsbRgRsmbLsbRiLsbRgRsmbRsRsm
bLsbRsbRgbLgRsbRgbRiRsmbRsRsmbRsRsmbRhbRgbRgbLsbRgRsmbRgRsmbRsbRsbRgRs
mbRgbRgbRjLibRibRhbLsbRhLsLsmbRsLsbRoRsmbRsRsmbRibLsLsmbRibLsbRsbRiRsL
sRsRsmmbRgRsmbRgRsmbRgRsRsmmbRsbRgRsRsRgRsmmmbRgbRsbRiRsRgmbRgLsbRgbRi
RsmbLsRsbRgRsmbRgbRgRsmbRgbRsRsRgmbRgRsmbLsbRgRsRsmmbRsbRgbRgRiRsRsmmb
RgRiRsmbRsRsRsmmbRibRgRsRsmmbRgRsRgRsRgRiRgmmbRgbLgbRibRgbRgRsRsRsmmmb
RgRsmbRsbRiRsmbRgbLsbRhbLibRobRcbRcbRgbRgbLjLjbLcbRcbRcRsmbRibLgbRibRi
bRgbRgbRibRgbRibRibLsbRibRhbRiLsLsmbRhbRsbRgRsRsmmbRgRsmbRsRsmbRgbRgRg
RibRgbRgRsRgRsRgRsmmmbRgRsRiRsmmbRgLsRsbRgbRgbRgRsRgRsmmbRiRsRgmbRgRsm
bRgbRgRsmbRibRgRgbRgbRgbRgbRgRsRsmmbRibRsbRibRgbLsbRgbRibLgRsbRsbRibRg
bLsbRibRgbLsbRgbRgRsRsRgmmbRgbRgLcbLhbLgbLhbRhbRibLcbLoRgRsmbLobLiLsbL
gbLgbRibRhbRibLsbRibLjbRhbRcbLibRhRsmbLjbLibRjRsmbRibRibLgRsbRibRsbRcR
smbLsbRsRiRsmbLcbLiLsbLcRsRibLibLgLhbLcbLiRsbRsbRcRsmbRgbsbRgRsmbRiRsm
bLsbRgbLjbRibLcbRcbLsbRgbRcRsmbRibLgbRiRsmbLsbRiLsbRgRsRsmmbLsbRiRsRsm
mbRsRsmbRgbRgRsmbRgbRgbRgRgRgRgbRgbRsbRibLsbRgbLsbLibLhLsbRibLiRsbRsRs
mbRsLibRebRcbRibRibLibRibRcRsRsmmbRgbRgRsLsmbRibRsbRibRgbRgbRsbRgbRgRs
mbRgbRgbLsbRgbRgRsmbRgLsbRgbLgbRiLsRgbRgbRgRsmbRibRgLsbRiRsRsmmbRcbLjb
RcbLcbLibRjbRcLsbLsbLcbLcbRibRibRibRgRsmbLsbRgbLsbLcbRcbRgRsLsmbRgbRsb
RsbRiRsmbLgbRibRgbLsbRjbLibRibLsbRiRsmbRgbLsbRgbRgbRsbRgRsRsmmbRgRsmbR
gbLgbRiRsmbRgbRgbRgbRsbRgbLsLsmbRibRgLsbRibLjbRibRgbRgbLsbRgRsmbRgbRgb
RsbRsbRiLsbRgbRgbRsLsbRgbRgRsmbRsLsbRiLsbLsRgbRsbRsRsmbLjbRcbRiRsLsmbR
sLsLsmbLjLsmbLibLgbLgRgbLhbRibRcRsmbRhbRgbRibRsRiLsbRibLgbRhbLsRsbRiLs
bLjbRgbRgbLsLsmbRgbRiLsbLgbRgbRgLsbRsLjbLhbRcbRhbRibLibRiLsbRiLsbLgLsb
RcbRgbLgbRcbRsbRcbRsbRgRgLsbRgLsbRgbRsbRsRsmbRgbLsbRgLsbRgRsRgmbRsbRgR
smbRsbRgbRgbRgRsRsmmbLgbRiRibRgbLsbRiRsRsRgRgmmbRsRsmbRgbRgRiRiRgRsmbR
gRiRsmbRgbRgbRgbLsbRgbRsRsmbLjbLibRjbLjLsmbRcbLjbRcbRjLsbRcbRcbLgbLgbR
ibRgRibRgLsRsLsbRibRibRgRsmbsbLsbRgLsbRgbRgbRsbRsRsmbRgbRgbRsbRgbRsRsm
bRgRgRsmbRiRgLsbRsbRsbLhbLibRjbRibLebLcbRibLhRsbRjbLiLsbLibRibLhbRgbRs
LoLcRsRsmbLhbLcRsbLsbLgLsbLibRjbRcbLibLhbLsLcLsRsmbLsLibRgRsmbRibRsbLh
LcRsRsRimbLibLgbLgbRcbLcbLsLobRgRgbLhRsbLsbRcbLsRgbRibRibRcbRcbRcbRgRs
mbRgbRsbRgRsmbRgRsmbRgbRgRsmbRsbRibRgbRsbRgRsmbRgRsmbRgbRgRsRsmmbLgbRg
bRgRsmbLgbRebRjbRibLjbLcRsLsbRsRgRsmbLibRjbLgbLgLsbRcbRibRsRsmbRgbRsbR
gbRgbRsLgbRibLsRsbRgbLsbRibRsbRgbLgbRgbRsbRgRsmbRgbRgbLsLsmbLgbRiLsRsb
LgbRibRcRsRsmmbRcbRcRsmbRibRsbRsLsbRgbLjbLcbLcbLobRibRiRsmbRibRsRsmbRe
RsmbRgRsmbLsbRgbRgbRgbRibRgbRjbRgLsbLsbRgbRgbRgbLgRgbRsbRiRsmbRgRsmbRg
LsbRgbRgRsmbRgRsmbRgbLjbRiRsmbRgbRgbRgbRsbRgLsRsLsbRgbRgbRsbRgbLsbRiRs
mbRgbLsbRiRsmbRsRsmbRgbRibRgbRibRgRsmbRiRsmbRhbRcbRibRibRgbLjbLcbRibRh
bRibRgRsmbRibRgRsmbLsbRgbRsbLsbRibLjbLibRjbRibLjbLcbRjbLcLsmbRibLjbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 8; Drug: NDMC 1 µM
bLsbLgLsbLsbLsbLgbLgbLgbRsLsbLsLsmbLgbLgbLjbLsbLgLsbRgLsbLibLcbLcbLgbL
jbLibRgbRcRhLsbLgRsbRcLsbLgLsbLsRhLsbRiLsbLsbRiRsmbRcbRgbLgbLgLsbRhbRi
bLsbRgbRibRsbLsbRibLgRsbLebLhbRobRhbRibLgLsbLgbRcbRibLgbRibLsbRiRsmbRi
bLgbRibRobLibRebRgbLibRcbRibRibRsbRgbLsbRibLjbRiRsmbLsbRcbLgLsbLiRsbRh
LsbLcbLibRjbRcbLhbLsbLibRjbLcbRibLibLgbLgbRsLsbLgRsbLsbLgRsbRgbLgbLgbL
gbLsbRsbLgbRsbLsbLgbLgbLsbLgbRsRsmbLgbLgLsbLsbLsbLgbRjbRoRsmbRsLsbRhLs
bLsLsRsmbRcbLsbRibRcbLgbLgbRibRobLgbRgbLgbRobLgbRibLjbRibRgbRgLsbLsbRh
LsRsbLsbRiLsbLsbRibLgbRiRsmbRibRibLgbLibLgbLcbRgbLgRsbRiRibLjbLibLsbLs
bLgbLsbRsbLgbLgbLsLsmbLsbLgbLsbLgLsbRsbLgbLgbLsbLsbLgbLgLsbRsbLsbsbLsb
LgbLgLsbRsbLgbLgbLgbRgLsbRibRibRibLgbRsbRibLsbRsbRibRgLsLjbRibLsRsbRsR
ibLsbRiRsRsmmbLsbRibRgbRiRsmbLobLgLsbLsRsbLgbLsLsmbLgbLsbLsbLgbLsbLsLs
mbLgbLsbLsRsbLsbLgbRsbRsRsmbLgbLgLsbRsbLgLsbLgbLgbRsbLgbLgbLsbLgLsbRgb
LgbLsLsmbLgbLgbLgbRgbsbLgLsbLgbRsLsbLgbLsbLgbLgbRsbLsbLgLsbLsbLsbLgbLg
LsLsmbRsLsbLgbRsbLsbLgbRhbRcLsLsmbRhbLgbRibRibLsbLebRhbRiLsbRiRsmbLcbL
sbLgbLsbLgbLgRsbLgbLgLsLsmbLsbLgbLsbLgbRsbLgbLgbLgLsbLsLsmbLgbLgbLsbLi
bRsbLsLsLsmmbLibLgLsbLgbLgRsbRjbRibRiRsmbLsbRibLsbRgLsbRgLsbLsbRgbRcbL
ibLgbRcRsmbLjbRibLsbRiLsbRibRcbRcbRibRgbRibRibLsbRgbRgRsmbLsbRgbLcbRgb
LebLgbLgbRiRsmbLgbRoLsbRsLsbLsbRibRsbRcLsbRibRibLgbRgbRcbLjbLcbRsbLhbR
gbLgbLgRsLsbLgbLibLgbRgbLgbRgbRhbRhbLhbRcbLgbRcbLgbRiLsbRsLsLsRsmbRibL
ibLobLgbRsbLibLhbLcLsmbLsbRgbLobLiRsbRjbLcRsbLibLibRibRsbLiLsbLsbLibRc
bLgbLibRgbLibRsLsbLiRsbRgbRjbRgbRiRsmbRgbLsbRgLsbLsbRiLsbLsbRgbRsbRibL
gbRcbLgbLsbRiLsbLgbRiRsmbLsLsRsmbRibLsbRiRsmbRibLgbLjbLobLgLsbLsbLgbLg
bLgbLsbLsbLgRsbRsbLgLsLsmbLgbLgbLgbLgLsbLiLsbRcbRcLsbRibRiLsbLibRcLsbL
jbRhbLgbRibLsbRibRibRibLcLsmbLiLsbRgbLibRsbLsbLsbLjbRobRsbRiRsmbRgbRgb
RobRobRibLibRgbLgbLgLsbLsbLgbLsbLsbLgbLsbRsbLgbRsbLgbLiLsbLgbLsbLsbLsb
LibRjRcbRibRgbLgbRibLsbRcLsbLgbRibLjbLhRsbLcbRgbRobRsbRibLcbLcRsbLgbLi
RsbRjbLibLibRibLgbLiLsbRcbRsLsbRibLsbRibRibRibRibRgLsbRibLiLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 9; Drug: NDMC 1 µM
bLibRsLsbLiRsbRsbRsbLgLsbLgbLsLsmbLsbLgbLsbsbLgbRjbLgbLgbLgbRjbLibRibL
hbRsbLobRibRsLsbLoLsmbRibRcbLsbRibRibRcbLjLsmbLiLsbRgRsmbLibRgbLsbLjbR
jbRgbRgbLsbRiLsbRiLsLsmbLsRsbLsbRgbRgbLsRsbLsRsbRgbsbRsRsRsLsRsmmbRgbR
sRsmbRgLsbRcLsbRibLgbRcbRcbLsbRibLgbRibLjbLcbRibRhbRcLsbLgbRcbLgbRhLgb
RcbLgbRibRiLsLsmbRgbRgRsmbRgbLibRibRibLibRcbLgbRcbLgbLgLsbLgbLibRsbLgb
RsbLgbLsLsmbRoLsbLsRsbsbLsbLgbLsbLsLsmbLsLsmbLgbLsLsLsmmbRjbLibRjbRcbR
ibRibLibRhbLgbRsbRgbRgLsbRcbLgbRcbLgLgbRcbLgbRcbLibRcbLgLsbRibRcbLgbRc
bLsbRsbLgbRcbRcbRsbLsLsmbRsbRcbRibLibRibRgLsLsmbRgRsmbRgLsbsbRiLsbRhbL
gbRsbRgbRibRgbLgLsbRgbRgbLgRsbLsRgbRiLsbLsLsmbRibRiLgLsbLsbRcbLjbRiRsm
bRsRsmbRgbRibRgbLgbLjbRgbRjRsLimbRibRibLjbLcbRcRsmbRiLsbLgbRcbLibRibRi
bLgbRgbLgbLsbRsbLsRsRsRsmmbRsbRgbRgbRsRsmbRsbRgRsmbRgbRgbRsbRsRsmbRsbR
sRsRsmmbRgbRgRsmbLeRsbRjRsmbRibLcbRibRibRsbLsLsmbRibRiRsmbRibLgbRibLsb
RsbRgbRsbRgbLsbRgbLsbRgbRsLsbRgRsmbRsbRiLsbLsbRsRsmbRsbRgbRibLsRsbRsRs
mbRgRsmbLhbLibLsbLgbLgLsbLsbLsLsmbRsbLgLgbRsbLgLsLsmbLsbRsbLsbLgbRsbLs
bLsbLsbLsRsbLsbLgbsbLgLsLsmbLgLsbRsbLsbLgbLibRsbLgbRsbLhRsbRibLibLsbLg
bRsLsbLgLsRsbRsLsbLibLsRsbLgbLsbLsLsmbLgbLgbLgbLsbLgbLgbLsbLgbLgLsbLib
LibRibRjLsbLibLiLsbLibRjbLibLsbLcRgbLhbLsLsmbLcRsbLgbLgbLsLsmbLgbLgLsb
RsbLsbLsLsmbLsbLgLsLsmbLsLsmbLgbLgLsbLgbLsbLsbLgLsbRsbLgbLgbLsbLgbLsbL
gLsbLsbLsbLgbRgbLsRsbLiLsLsLgmbLsLsmbLgbRsLsbLsLsmbLsbLgbLsbLsbLsbLgbL
gbLgbRoLsbRcbRsRsmbRiLsbRibLgbRhbLjbLjbLiLsbLgbLsbsbLgbLsbLsLsmbLgbLgb
LsbLgbLsbLsbLgbLsbLgLsbLsLiLsbLsLsmbLgbLsLsRsmbLgbLgbLgbLsbLgbLsLsmbLg
bLsbLsRsbLsbLgLsLsmbLsbLgbLgbRgbLgLsbLsbLgbLgbRjbRobRhbRibLibLibRcbRgb
LsbRibRgbLsbRsbRsbRibLgbRhLsLgbRibLsLsRsmbRhLsLsmbLgbRhbRibLgbRhLsbLgb
RcbRcbLibLsbLsbLhbRjbLhbLsbLcbLibLgLgbLiLsbRjbLibLgbLgbLsLsmbLgbRsLsbL
gbRsbLgLsbLgbRgbLgLsbLsbLgLsbLgbLsbLsbLgLsbRsLsbLsLsLsmmbLsbLgLsbLsbLs
bLgbLgbLsLsmbLgbLgbLsbRsbLgbRsLsbLsbLibLsbRjbRiRsmbRgbLjbLibRsbLibRjbL
sbRibRgRsmbsbRsbLjbLhbLcbLibRibLiLsbLgbLsbLgbLgbLsbLsbLgLsbRsbsbRsLgLs
bLsLsmbLsbLsbLsbLgbRsLsbsbLsLgLsbRsbLgbRsLsbLibLsRsbLgRsbLgLsbRgbLgbLs
bLsbLgbLsbLsbLsbLsbLgbRsbRsRsmbLgbLibLsbLsbLibRjbRcbLcbLobLibRibLsLibL
gbLibRsbRhbRhbLhbRcbRhRsmbLiLgbLibLgLsbLsLsmbLgbRgbLgbLgbLibLibRsbLsbL
sbLiLsbLgbLsbLsbLsbLsbLsbLsLgLsbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 10; Drug: NDMC 1 µM
bRgLsbRgbRibRsbRgbRgLsbLgRsbRibLgbLsbLsbRibRgbRgbLsbRibLgbRibRhbRjbRib
LgLsbRgbRgbLgbRgbRjLsLsmbLsLsmbRgbRgbLgbRgbLgbRibLsbRgRsmbLsbRgbLsbRib
LjbRjbRibRgbRgbRgbRsbLcbRcbRgRsmbRsbRgRsmbRibRsbRibLsbRgbRsbRsbRgLsbRg
bLsLsmbRgbRgbRsbRgbRsbRgbRgbLsbLjbLcbRcbLjLsmbRhbLjbRiRsmbRgbRibLgbRgR
smbLsbRgbRgRsmbRsbRsbRibLcbLcbRjbRibLsbRgbRsbRgbRgbRgbLsbRgbRgbRgbRgbL
gbRcbRsbLcbLcbLibRjbRcbLgbLsbLsbLsbLcLsmbRhbRgbRgbRsbRsbRgbLcLgbRobLsb
LcbRibLgbLgbLebRgbRibLibLibLsbLgbLibLibRsLsbLhLsbRibLibLcbRibLebRobLgb
RibLgbRibRibLgbRgbRgRsmbRgbLgbRibLebReRsmbRcbLjbRgLsRsbRgbRgbRgbLgbRgb
RgbRsbRgRsmbLgbLhbRjbRjbRgbLibRcbLjbRcRsmbLjbRiRsRsmmbRgbRibRibLibLgbR
ibRgbRgbRsbRgbLgbRiRsmbLgbRibRibLsbRgbRgbLgbRgRsmbLsRsbLsbRgbRibRgbLcb
LhbRibLsbLibLibRcbRibLgbRibLjbRobRgbRcLsbLgbLibRhbRgbRibRibRgRsmbRsbRs
bRgbRgLsbRsRgbLgbRibLsbRgbLgbRibLgbRiRsmbLsRsbRibRgLsLgbRjbRgbLcbLgbLs
bLgbLsbLgLsbLgbRsbLsbLsbLsLgbLgbLgLsbLgbRjbRibRsRsmbLgbRibLjbRibRgbLeL
sbLibRgbLiLsbLgbLsbLgbLgbLhbRhbLcbRibLgbRjbRobLgbRiLsbLjbLhbRcRsmbLjbR
iLsbLebLjbRsbRsbLgbLcLsRsmbLibRgRsmbRibLjbRcbLgRsbRgbLgbRsbRebLsbLgbRc
bLsbRcbLjbRiRsmbLebLgbLsRsbLsLgbLibLiLsbRsbLgbLsLsmbLgbLgbLibRsbLgLsbL
gbRgbLibRjbRcbRobLjbLsLcbRcbLibLcbRjbLgbRebRhRsmbLibRoLsbLgbRgbLobRibR
gbLjbRgbLibLibRjbLibLhbRjbLibRcLsbRibLjRsbRhbLibLcbRibLgbLobRhbLsbRibR
gbLibLibRjbLjbRhbRibLcLsmbLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 11; Drug: NDMC 1 µM
bRiLsbRgbRibLjbLhbLibLgbLsLsmbLsbRjLsbLibLcRsbRgbLibLibLgbLsLsmbLgLsLs
mbLgbLsLgLsbLsbLgbLsLiLsbLgbLsbLgLsLsLsmmbLsLsRsmbLgbLsbLgbLsbLsbRsbRs
bLsLsmbLsLsmbLsLsLsmmbLgbLgbLgbLgLsbLsbLgRsbLsLsmbLsbLgLsbLsbLgbLgbLgL
sLsmbRsbLsbLgbLgbLgbRsLsbLgbLgLsbRgbLibRsbLgbRjbLibLgLsbRsLsbLgLsbLgLs
bLibLgbRjbRcbRgLsbLjLsmbLibLiLsbLibLibRgbLhbRhbRhbRibLgbRgbLjbLcbLcbRi
bRibRibLjbRibRgLsbRhbLgbRibLgbLjbLiRsbLsbLgLsLsmbLgLsbLsLsmbLibLsbLsLs
mbLsbLgbLsbLsbLgbLgbLgLsbLsLsmbLgLsbRsLsLsmbLsLsmbRsbLgLsbLgLsbLgLsLsm
bRjbLibLsbLgbRsLsbsbLgbLgbLgbLgLsbLsbLgRsbLgLsLsmbLsbLgLsbLsbLsLsmbLsb
LgbLsbLgLsbLsLsmbsbRsbRsLibRsbsbLsLsLsmmbLsLsmbLsLsRsLgmbLgbLsbLsLsmbL
gLsLsmbLsbLgbRsLsbLgLsbLsbLgbLgbLgLsLsmbLiRsLsbRibLibLgbLsLsLsRsmmbRsb
LiLsbLsbLgbRjLsbLhLsbRgbRobLjbRcbLcbLcbRibLcbLibRiRsmbLhbRjbRcbLsbRhLs
bLgbRibLgbRibRgbRgbLsRsbRgbRibRgbLjbRiLsbRibRibRibRibRsbRgLsbRgbLjLsmb
RgLsbRgRsLsmbRgbLgbLsRsbRgbRebRibLgbRgbRibRgbRhbLiLsbRsbRibRhbLsbRgbRg
bRgLsbRgbRgbRgLsbRibRgbRgbRibRiLsbRgbRgbLsbRgLsRsbRgRgbLibLhbRjRsmbRjb
RibLsbRgbLsbRgRsmbLsbRgRsLsmbRgRsmbRgbLsbRgbRgbRgbLsRgbRsRgLsbRgRgbLsR
sRiRsmbRgRsRsRgRsmmmbRsbRgRsRgmbRsbRgbLsbRgRsmbRsRsmbRsbRgRsRsmmbRsbRg
bRsbRsRsmbRgLsbRsbRgRsmbLsbRgRsmbRgRsmbRgRsmbRgLsbRsRgbRiRsmbRgbRiLsLs
mbLcbLoLsmbRgbLhbLgbRsLgbRsbRsbLibRsbLgLsLsmbLsLsLiLsRsmbRsLsbLgLsLsmb
LsbLgbLsbLgbRsbLsRsbLsLgbRsbLibLgRjbsbLiLsLsmbRjbLsRibRibRgbLgbRiRsLsm
bLjRsbRgbRgbRiLsLsmbLgbRgbLhLsbRsLsbRjbLibLibRgbLgbRsbLgbRsbRsbLgRsbLs
RsbRibRgbRgbLibLibRjbRibRibLcLsmbLsbLhbsbLsbLgLsbLsLsLgLsmbRsLsbLgRsLs
bLsbLgbLgLgbLgbLgLgbLgLgLsbLgbLgLsbLgbLsbLgLsbLsbLsLsmbLgLsbLsLsmbLgbL
gbsbLgLsLsmbLsLgbLsbLgLsLsmbRsLsbLgLsbLsRsbLgLsbLgbLgbLgLgLsbLgbsbRsbL
iRsLsbLgbLsbLsbLsbLgLsLsmbLsbLgLsbRsLsbLgLsLsmbLgbLsLgbLgLsbLsLsmbLgLs
bLgLsLsmbLgbLgLsLsmbLsbLgLsbLsbLgbLsbLgLsbLsLsLgLsmbLsbLgLsbLgbRsLsbLg
bLsLsmbLgLsbRsbRsLsbRibRgbLcbRjbRibRiRsmbLjbLcbRjbRcbLiLsLibLcbRgbRsRe
LsbRibLibRibLgbRibLjbRibLcbLibRibLibRiLsbRgbRibRgLsbLgRsbRgRsmbRgbRgbR
gRsmbRgbRgbRibRcbRiLsbRcbRibRgbLgbLjbLibRhbRibLgbRibLsbLhbLibRjbRgbRgb
RgbRgbRgbLsbRgbLsbRgbRgLsRsbLsbRsbRsbRgbRsLsbRsbRgbLsbRsLsbRgbLsRsbRgb
RgRsmbRsbRgbRgbRsbRgRsmbLsRsbRgbRgbRgbRgbRgbRgbRgbRibRgbRgbRgRsmbsbRsb
RgRsmbRgbRsbRgbRgbRsRsmbRgRsmbRgbRsbRsbRsbRgbRgbRsbRgbRsLsbRsRgbRgbRgb
RgbLsRsbRgRsmbRgbRgbRsRsmbRgbRgbRgRsmbRgbRiLsbLibRiRsmbRgbLjbLcLsmbsbL
gbLcbRibLibLsbLiRsbRgbLibRiRsmbRgbLjbRjLsbRgbRgRsmbRsRsmbRgLsbRgRsmbRs
LsbRsbLsRgbRsbRgbLsRsbRgbRgbRsLsbRsbRgbRsRsLsmbRsbRsbRgRsmbRsbRgbRgRsm
bRsbRgbRgLsLsmbRsLsRsbRsbRgbRsbRgbRgbLsbsbRsbRgRsmbRgbRsbRsLsbLjbRgbRg
bRgbLibRgbRibLjLgbLibRiRibLjLhbRjbRhbLcbRiLsbRhbsbRgbRgbLgbRibLsbRibRi
LsbRgbRhLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 12; Drug: NDMC 1 µM
bRgbLgbLibRsbLibRgbLgbRsLgbLsRsLsbLgbLiLsLsmbLsbLjbRsbLgbLsLsmbLsbLsLg
RsLsbLibRsLsbLsbLgbRsbLibLgbLgbRsbLgLsbLgLsbLgLgbLgbLgbLsbLgbLsbLgLsbL
sbLgRsbLgbRsLibLsbLgLsRsbLiRsbLgbLgbLgRsbLgbLsbLgbLsbLgbLsbLgbLgbLsbLi
LsbRgbLibLgbLsbRibLjbLibLgbRgRsmbLgbLgLsbLgbLgbRjbLgLsbLiLsbLgbLgbLgLs
RjRsmbLgbLibLsbLgbLgbLgbLgRsbLsbLgRjbRjbRibLsbRcbLgbLjbLcbRsLsbRcbRibL
jbLjbLibLhRsbLcbLgbRhRsmbRsRsmbLcbLgRebLibLibLsbLsLgbRsbLsbLgbLsLsmbRs
bLgLsbRsbRsbLgbLgbsbLibRjbLsRjbRiLsbLsbRibRcbLgbRcbLibRcLsbLgbRsRsmbRo
bRibLgbLibRgRsRsRsmmmbLhbRcbLjbLcbLhbLibLibRsLibLiLsbLibLgbLsLsmbRsLsb
LibLibRsbLgbLgbRgbLibRsbLgbLsbRsbRsLiLsbLgLsbLgbLsbLgbLsbLgbLsLgLsRsLs
bLgLsbLgLsbLsbLsbLgbLsbLgRsRsLsmbLgLsbLgbLgRsbLiLsbRsbLgbLsbLgbLgRsbLs
LsmbLgRgbLgLsbLsbLgLsbRsbLiLsLsmbLgbLsbLgbLsLsmbLgLsbRsbLibLsbLgbLsbLg
bLgbLsbLgRsbLsbLgLsbRsbLgbRsbLgRsbLibLsbLgbLsbLsLibRibLibLibLiRsbRgRsm
bRgbLiLsbLibLcRsbRibRgbRgbLhLsbLibLibLgbLibLgbRsbLgbLiLsbLgbRsbLiRsbsb
LsbLgbLsbLsLsRsmbRsbLiLsLsLsmmbLgbLsbLgLsLsLsmmbLgRsbsbRsRsmbLjbRgLsLs
LsmmbRsbLgbsbRgbLgbsbLgbLsbLgLsbLsbLgLsLsmbLgLsbLsLsmbLgRsbLsLsmbLiLgb
LgbLgLsbLgbRsbLgbLgbRsbLgbRjbLibRsRsmbLgbLsbLsbLgLsbLsbLibRsbLsLsmbRsb
RsbLjbLsLsmbsbLsbLgbLsbLgbLgbRgbRsLgRsbLgRsbLgbLgbLgbRsbLgbLgbRgbLgbLi
bLgLsbRsbLgbLgbLgbRgbLgbLsbLgbLsbLgbLgbLgbLsbLibRgbLgbLsbLgbRsbLibLsbL
ibLgLsbRsbLiRsLsLsmbRsbLibLcbRsRibRgbLeLsbRcbLcbLcbRsbLcLsLsmmbLhLsbRs
RsmbRsRsmbRibLgbRiRsmbRgbRiRiRgbRgRgbRgRgRsmbRsbRgbRgbRgbRgRsmbRibLsLs
mbRgbLsbRibRcbRcbRcbRibRsbRibRcLiLsLsRombRiLsbRgbRsbRgLsbRobRgbRgbRgbL
ibRcbRibLgbLjbLcbLibRsbRsbLibLgRsbLibRsLsbRcbRhLsbRcbLibRhLsbRiRsmbRib
LjbLjbLsbLibRjbRcbLsbsbRhbRibRcbLibLgRsbRibLgbRibLsLsmbRgRsmbRiRsRsmmb
RgLsLsmbRgbLhbLjbRsRiRsmbRhbLgbLsbRiRsmbLsbRgbRgbLsbRgRsLsmbRibRsRsRsm
mbLsbRsbLjbsbRsbRjbRibLjbRcbLhbRibRibRibLsbRgbRgbRibRibLcbLcbRibLsbLhb
RjbRsbLsbLgbRcRsLsmbLeRsLsbRebLsRhbRibLgbRgbRsbRibLjbLibRjbLgLsbRjbRcb
RhLsbRhbRsbRgLsbRibRgbRgLsbLgbRcbLgbRgbLebLcbRibRgbRiRsmbRsbRgbRgbRsbR
gLsbLgbRgRsmbRgbRgRsmbRgLsbLsbRgRsmbRgRsmbRgbRsbRgbRibRsbRgRsmbRgbRgbR
sRsmbRgRsRgmbRiRsmbRgbRgbRsbRgbRsbRgbRgbRsRsRsmmbRgbRsbRsbRgbRgbLsRsbR
ibRgRsRgmbRibRgRsmbRsbRgRsRsmmbRiRsmbRsbRgbRiRsmbRsRsmbRgbLsbRgLsbLsLs
mbRhbRibRibRibLiLsbLsLibRgRsmbRcbRibRgbRiLsbLibLcbRhbLjbRjbLhbRjbLiLsb
RjbLiRsbLibRebRebLjbLcbRiRsmbRcbLibLibLibLibRsbLiRgLibLgRsbRgRsmbLgbLs
bLgbLjRsbLibLibRibLhbLibRgRsmbLcbRsbRsLibLgbLgbLibLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 13; Drug: NDMC 3 µM
bRsbRsbLsbLgbLibRgbLcRsbRgbLibLgLsbRsbLgbLgLsbRsbLgbLgbLcbRibLobRiRsmb
LibLgLsbLiLsbLsbLsbLgbLsbLgLsbLgLsbRsbRoLsRsbRcRsRsmmbRcbLibRhbLgbRcbL
ibLjbRcbRcLsbLiRsLjLsmbLiLsbRobLsbRsRiLsbRiLsLsmbRgLgbRcLsbRibRcbLgbRs
bLgbLobRibLcRibRcbsbRibRiRsmbLgbLjbRcbLjbLcbLibLgbLibRgbLgbLiRgRsLsmbL
gbLgbLgLgLsbRsLsbLgbLgbLgbLsbLgbLgRsRsLgRsmbLiLsRsRsmbLgbLgbLsbLgLsRsb
LgbLibLgRsRgbLgbRcbLhLsRsbLgLsbLibRgbLgbLgbRgLsbRcbRhbLsLsmbRibRgbRibR
gbLibRibRsbRibLsbRibLgbRgbRcbLhbRcbLcbLibRjbRobRcbLsLsmbLibRhRsmbLjbLi
LsbLcRsbRiRgbLgbLsbLhbRgbLgbLgbLcRsbRibRgRsmbLibLsRsbLgbLibRsbLgbRgbLi
bRsbLsLgbLsbLsbLgLsbLgbLsbLsbLsbLibRcbRibLhbLibLiRjbLibLsbLsbLgbLgbLsb
RsbLibLgLsbLgbLsbLgLsbLibRsRsmbLgbLgbRsbLiRsbLgRsbLsRsbLgbLgbRsbLgbLgL
sbRsbLibLgbLgbLgLsbRgbLgbLhRsbRsbLibLsbLgbLibLgbRgbLiLsbLsbLgLsbLgbLsb
LsbRsbLiLsbRsLsbLgbLgLsbLgbLgbLgLsbLsbLgbLgLsbLgbLsbRsbLibLsLsmbLsbLgL
sbLibRgbLgbLsLsmbLgbLgbLgbLsbLgLsbLgLsbLgRsbLsbLsbRsbLsLsmbLgLsbLgLsbR
obRcbRhbRibRibLibLiLsbRibLhbLiLsbLsLsmbLsbLgbLgbRgbRjRgbRibsbRgbLcbRjb
RoLsbLibRcbLgbLjbLibLibLgRsbRgLsbLibLsbLgbLobLcbLcbRibLibLibRcbLcbLhLs
RsbRsbLsbLsbLibRjbLiLsbLsbLiLsRsbLgLsbLsbLsRsbLibRsbLiLsbLgLsbRsbLcbLh
bRgbLgLsbRgbLcbRibRcbLjbLiLsbRcbRcbLgbRhbRsbRgbRgbLgbRiRsmbRgRsmbLibRg
bRibRgRsLsmbRgbRsRsmbRsbLcbRcbLjbLhbRgbLibLgbsbLibRjbLoRsbRcbLjbLcbLcb
RibLibLgLsbLcbRibRibRjbLcbLcbRsbRgbRgbLhbLibRibLgbLgbRsbLgbRgbLgbLgLsb
LsbLgbLjbLcbRibRgbLsbLgbLgbLsLibLibLsbLgLsbLgbRgbLibLsRcbRibRibLgbRhbR
cRsmbRibLgRsbLhbRgLsbLgbLiLsbRiLsbLibLsLsRsmbLgbLgLsLsmbRgbLgbLsbLgbLs
bLgLsbRsbLiLsbRsbLibRsLsbLgbRsRsmbLiLsbRsbLibRsbLgbLibRgbLhbLsRgLsbLgb
LhbRibLgbRcRsmbRibLjbLibLibRsbLiLsRjbLiRsbLsbLgbLhbRgbRcbRhbLibRsbRjLs
bLibLcbRcbRcLsbLgbRcbLcbRibRibRgbRsbRgbLgbRibRibLiLsbRgRsmbRiRsmbLsbRg
RsmbLsbRgbRgbRsbRsbRgRsmbLsbRgbRgbRgbLsbRgbRsbRsRsmbLsLsmbRibRibLsbRgR
smbRgbRsLjRsbRibLsbRgRsmbLsbRiRsmbRgbLsbRgbLsbRibLsRsbRgLsbRsLsbRiRsmb
RsRsmbRsbRgbRgbRgbLoRsRsmbLcbLobRcbRcbRibRgbLgbRibRgRsmbLgbRgbRoRsmbLi
bLibRcbLcbLiLsbRibRhbLcbLcRibLhbLgbLibLsbLiRsbLibLcbRjbLibLjRsbLcRsLsL
smbRibRibRcbLibLgRsbLcbRhbRcbLjbRiRsmbRgbRiRsmbLsbRiLsbLgRsbRibLsbRgRs
mbLsbRibLsbRgbLsbLsbLjbLibRjbRobRgbRobLebRibRcbRcRsmbRibRibLibLcbRibRh
bRhLsbLsRsbRgbRgbLsbRibRhbLgbRsbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 14; Drug: NDMC 3 µM
bRsbRgbRgbRgbLsbRgbRgbRgbLsbRgLsbRgbRgbRgbRgbRgbRsLsbRgbRgbRgbRgLsbRgb
LgbRgRiRsmbRgbRgbRgbRgbRgbRgbLsbRgbLgbRsbRiRsmbRsbRiRsmbRgbRsbRgbRgbLs
bRgbRgbRsRibLjbRgRsmbRgbRgbRibRgbRgbRsbLsRsbRibRgbRgLsbLgbRibLjbLcbLhb
RhbRcbRsbRsbRgRsRgRsmmbRgbRsbRiRsRgRsmmbRibRsRgbRgbRgbRgbRsbRgRsmbRsRs
mbRgbRgbRgbRgbLsbRgbRgRsmbRsbRgbRgbRgbRgbRgbRgbRsbRibRgRsmbRgbRgbRgbRg
RsmbRgLsbRgbRgbRgbLgbRgRsmbRsbRsbRibRgbRgbRgbRgbRsbRgbRgLsbLsRsbRiRsmb
RgbRgbLsbRgbRgbRgbRgbRgbLsbRiRsmbRibRgbRgRsmbRsbRgbRgbRgbRgbRgbRgbLsbR
sRibLjbLcbLcReLsbLhRsRsmbLobLibLibLibRcbRibLcbLsLhbRibLibLsbLgLsbLsbLg
LsbLgbLgbRsbLibLsbLgbLiRsbLgLiLsbLiLgLsbLiRsLsbLoRsRsmbRhbRcbRibLsbLjb
LhbRibRcbLebLsbRsbLcbRcbRobLibRcbLgbRhbRibLibLibRcbRcbRgbLibLsbRcbRibR
hbRibRgbRibRgbRibRibRgLsRsbRgbRgbRgbLsbRgbRsbRgRsmbRgbRgbRgbRgbRibRgRs
mbRgbRibRgbRgbLsLsmbRgbLsbRibLgbRibLgbRgRsmbLsbRibRgRsmbRsRsmbRsbRiRsm
bRgbRgbRgbRgbRsbRgbLcbLcbLcbRgbLhbLcbLibLiLsbLcbRibRcbRibLgbLjbRhRsmbR
sbLsRsbRibLgbRiRsmbRsbRibRibRcbRcbRebRgbRgbRgbRgbRsbRsRsRsmmbRgRsmbRsb
RibRgbRgbRgbRsbRsbRgbRgbRgbRgbRgbRsbRgbLsbRibLgLsbLjbLcRsbRhbRibRgRsmb
RgRsmbRgRsmbRgLsbRgbRgbRsRsmbLsRsbRgbRgbLgbRgbRibRgRsmbRgbRgbLgbRjLsbR
ibLgbRsbLjbRcbRsbRibRsbRgRsmbRgbRgbLsbRibRgbRgbRgbRsbRsbRsbRgbRsRsmbRg
bRgbRibRiRsmbLcRsLsbRibLjbRhbRgbLsRsLsbRgbRibRsbRibRcRsmbRcbRibRibLibR
sLsbRcbRiRsmbRhbRhRsmbRgRsmbRibRsbRgbRibRsRsRsRimmbRgbRgbRgbRgbRsbRgbR
gLsbRjbRebLhbLsbRhbLjbLcRsRsmbLgbLgbRcbRiRsmbLsbRgbRgbRgbRgbRibRsbLcbL
hRsbLhbRcbLcbLcbLcbLgbRcbRgbLjbLcbRjbRcbRhbLibLgbLgbLcbRibLibLsLsmbLiR
sbLibRsLsbLibRgbLgbLsbLgbRsLsbLgbLgbLiLsbLsLsmbLgLibLgbLgbRsbLcbRcRgbR
obRibLgbLsbRobLsbRiLsbLsbRgbRiLsbRgbRsRgRsmbRsbRgbRiRsmbRgbRgbLsbRgbLs
bRgbRsbRsbRibLgbRcbLhbRibRibLgbLibRibRibRsbRgbRsbRgbRsbRgbRgRsmbRgbRgb
RgbRgbRgbRgbLsbRiRsmbRgbRibRgbRgbLgbRgRsmbRgRsRsmmbRsRsmbRibRsbRgbLsbR
gbRgbRibLibRsRsmbRibLsbRibRgbRgbRsbRgbRgbLcbRjbRibLjRsbRcbLsbRsbRgbRgR
smbRsbRgbRgbRgbRsbRgbRgRsmbRsbLsLsmbRgbRgbRsbLsbRibLgbRsbRibLsbRgbRgbR
gbRgLsRsbRsbRgbRgbRgbLgbRibRgRsmbRsbRgbRgbRgLsbRsbRgbLsbRgbLjbRiRsmbRg
bRsbRgRsmbRgRsmbRgRsmbRgbRgbRgbLsbRgbRibRgbRgRsmbRgbRgbRgbRsRsmbRgbRsb
RibRiRsmbRsbRgbRgLsbRsbRgbRibLsbRgRsmbRgbRibLsbRibRgRsmbRgRsmbRsbRgbRg
bRsbRsLsbRgbRgRsmbLhRsbLibRcbRcbLsbRibRgbRsbRibLcbLhbRibLcbRcRsmbRcbLs
bRgbRiRsmbRgRsmbRgbRibRgbRgbRgbRgbRiLsbRsbLibRiRsmbRgRsmbRsbRgbRgRsmbR
gbRgbRgbRibLgbRibRgbLibLjbLgbLhRsRsmbLiLsbLgbLibRcbRgRsmbRgbRsLsbRgbRg
RsmbRgbRgbRgbRgbRgbRiLibLgbRhbLhbLcRsRsmbRibLcbRobRibLsbRgbRibRhbLibLi
bLgbLibLcbRcbLobRibRoRsLsRsmbRibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 15; Drug: NDMC 3 µM
bRsbRsbRgRsRsmmbRsbRgRsmbRgbLsbRibRgbRgbRsLsRgbRsRsmbRgbRgRsmbRgRsmbLs
bLgLsbRgbRgbRgRsRsmmbRsbRgbRgbLsbRgRsmbRgbRgbRgbLsbRgbRgbRgRsmbRgbRsRs
mbRgRsmbRgbRgbRgbRgbLsbRgbRgbRgbLgbRiRsRgmbLsbRgbRsbRibRgbRsbRgbRgbRsb
RsbRgRsmbRibRgbRsRsRsmmbRgLsbRsLsbRgbRgbRgbLgbRiRgbRsbLsRsbRgbRsbRgbLs
bRgbRgbLsbRgbLsbRibRgbRsbRgbRgbRgRsmbRgbRgbRgbLsbRgbLsbRibRjbRsbRgLsbL
jbLibLibLgbRhbRibRsbRgbLsbRgRsmbRgbRgRsLsRimbRgbRgbRsLsbRsbRgbRgbLsbRi
bRsbRgbRsbRgbRgRsmbLsRsbRgbRgLsbRgbLsbRiRsmbRsbLjbLgbLgRsbLsbLgbRsbLiR
sbLgbLiLsbLsLcbLibLgbRgbLiLsRsbRsbLibRjbLgLsbRsbLsbRhbRgbRgbRibRgbLiLs
bLgbLibLsRsbLgbRjbLiLsbRjbLhbRjbRhbLhbLhbRgRsmbLgbLhbLibLibLgLsRsbLgbL
ibRcRsmbRgRsRsmmbRsbRgbLsbRgbRsRsmbRsbRgbRsbRgbRibRgbRsbRhbRibRcbRibLg
bLgLsbLgbLgbRsbLibLgbLibRgLsbRgbLibLibLgbLgbRjbLsbLiLsbRsRsmbLgLsbRgbL
gLsbLgLsbRsbLgbLgbLgLsbRsLsbLgLsbLgbLgbLgbRsbLgbLsbLgbRsLgbLsbLgbLgLsb
RsbLsLgbLsbLsbLgbRsbLgbLgbRsbLgbLgbLsbLgLsbLsbLsLgLsLsmbLgbLgbLgbLgLsb
RsLsbLgLsbLsbLgbLsbLgbLsbLgbLgbLgLsbLsbLsLsmbLsLsmbLgbLgbLgbLsbLgbRsbL
gbLgbLgbLgLsbLsbLgLsbLsLsLsmmbLsbsbLgbRsLsbLibsbLgLsLsmbRsbLgLsbLgbLgR
sbRgbLgLsbLsbLibLsbsbLgbLsbLsLsmbLgbLgLsbLgLsbLsbLgbRsbLgbLgbRsbLgbLib
LgbLgbRgbLibLibLibLgbLgbRgLoRsbRibLcLsmbLibRjbLibLsLgbLsbLsbLgLsbLgbRs
LsbLgbLsbLgLsbLgbLgbRsbRebRgbRgbRsbRgbLsbRibLsbRgRsmbRsLsbsbLsbLjbLiLs
bLgbLgLsbLsbLgLsbRsbLsbLiLsbLsbLgbLsbLgbLsbLsLsmbLgbLsbLgbLgbLsbLgLsLs
mbLgLsbLsbLsbLgLsLsmbRsbLgbLsRsbLgRsbLibLgbLsbRsRsmbLiLsbLsLsLsmmbLgbL
gbRsRsmbLgbLsbLgLsbLgbLsbLgLsbLsbLgbRsbLgbLsbLsbsbLsLsLgmbLsbLgbLsbLgR
sLsbLsLsmbLgbLsbLibLgbLsbLgbLgbRsbLibLgbLsbLsbLibLsLsmbLgbLsLsmbLgbLgb
RsLgbLsbLgbLgbLsLsmbLgbLgbLgbLgLsbLibLgLsbLgbLsbLibLgbLgbRgbLgRsbLgbRs
RsmbLibRsRsmbLsbLgRsbLgbLsbsbLgbLsbLgLsbLgbLgbLgbLsbLsbLgLsbLsbLibLgbL
gbLsbLgbLsLsmbLgbLgbLgLsbLgbLsLsmbLgbLsLsmbLgLsbLgbLsbLgbLsLsmbLgLsbLg
bLgbLgLsbLgLsbLgbRsbLgbLgbLgLsbLgbRsbLiLsbLgbLsbLgbLgbRsbLgbLibRcRhRiR
smbLsbRibLsbRgRsLsmbLsbRgbLsLsmbRibRiLsbRgbRsbRgbRgRsmbLsbRibLsbRiRsmb
RsbRibLsbRgbRibLgLsbRiLsbLgbRgbRsbRsbRgbRgbRgbRgbRgbRsbRgbRgbRibRhLsbR
ibRgbRibRibRsbRibLgRibRsbRgbRgbRsbLsRibRgbRgbRsRsmbRgbRibRibLjbRibRsRs
mbRgbRgLsbRgbRgbLsbRgbRgbLsRsbRgbRgbRibLsbRibLgLsbRgbRsbRgbRibLgbRgbRi
bLsLsmbRgRsmbRgbRibLsbRgbRgbLsbRibRhbRibLibLibLsbLgbLsbLgbLsLsmbLgbLsL
smbLgbLsbLgbLsbLgbLgbRsbLgbLgLsbLgLsLsmbLgbRsbLgbLsbLgbLsbLgbLgLsbLgbR
iRjbRibRsbRgbRgbRgbLsbRgbRgbRgRsmbRibLgbRiLsbRibLibLibLgbLsbLgLsRsbLgb
LgbLsbLsbLibRsbLgbRsbLgbLsLsmbLsLsmbLsLsmbLiRsbLsbLsbLgbLgbLsbLsRsbLgb
LgbRsbLiRsbRgbLgLsbLgLsbLgbRsbLgbRjbRibRgbRgbRsbRgbLsbRgbLjbRibRgbRgbR
gbRgbRgbRgRsmbRsbLsbRibRibLgbRgbRsbRgLsbLgbRgRsmbLsbRibLsLibLibLibRsLs
RsbLgbLgbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 16; Drug: NDMC 3 µM
bLibRcbLsLsmbRcbLjbLgbsbRobLgbRiRsRgRsmmbRsbRsbRsRgbRsbRgbRgRsRgmbRgRs
mbRgbRgbRsbRsbRgRsmbRgbRsbRgbRsRsmbRgbRgRsmbRsbRsbRgRsmbRgbRsbRgRsmbLs
bRgbLsRsbRgRsmbRgRsmbRgRsmbRgbRgRsmbRsRsmbRsbRgbRgRsmbRsRsmbRibRgbRsbR
gbRgRsmbRgbRgbRgbRgbRgRsRgmbRgbRgbRgbLsbRibLsbRgbRgbRgbRgRsmbRsbLsbRib
RsbRgbRgRsmbRsbRgbRgbRgbRgbRgbRgbRgbLsbsbsbRgbRgRsRsmmbRgbRgbRgRsmbRgb
RgbRgRsmbRsRsmbRgbRsRsmbRgbRgbRsbRgbRgRsmbRgbRgbRgbRsbRgRsmbRgbRgRsmbL
gbReRsmbRsbRiLsRsbLsbRibLebLhbLgbLcbRjbLcbRgbLgbLcbLcbLcbRjbLcbLibRgbL
sbLsbLibLibRgLsbLcbRjbRobRgbRgbRibLjLsmbLcbRcbRibRsbLhbLibLcbLcbRibRib
LhbLcbLcbRgbLhRsbLibRsbLgbLgLsRgbLibRjbLiLsLsmbRsbLgLsLsmbRsLsbLgLsRgL
sbLibLsbLibLsLgbLgbLsLsmbLgLsbLsbLgLsbLgbLeLsbRebRoLsbLjbLcbRobsbRcbLj
bRcbRsbLjbRsRcbRibRsbRgbRsbLsbRibRsbRsbRgbRgbRgbRsbRsbRsbRgRsmbRgbRgbR
gRsRsmmbRsbRgbRgLsbRsbRgbRgbRgbRsbRgbRsRsmbRsbRgbRgRiRsmbRgbRsbRgRsmbR
gRsRsmmbRgbLsbRgbRgRsmbRgbRgbRibRgbRgRsmbRgbRgRgRgLsbRgbRgbRsbLgbRibRg
bRsRgbRgbRgbLjbLcbLibLgRsbRgbLgbLsbRjbRcbLcbLcbRibRsbRgbRgRsmbRsbRiRgb
RsRsmbRibRsbRgRsmbRgbRgbRsLsbRgbRgbRgbRgbRgbLgbRgRsmbRgbRgbRgbRsbRgbRs
bRgRsRimbRgRgbRibRgbRgbRgbRgbRibRsRsmbRibLsbRibRgRsmbRsRsmbRgbRibLjRsb
RibRgbLcbLibLcbRjbLibLibRgbLgLsbRgbRcbLebLgbLibRgbLcbLhbLcRsbRibRgbRgR
smbLsRsbRgbRgbRgbRgbRgRsmbRsRsmbRgbRgRsmbRgRsmbRsRsmbRgbRsRsRsmmbLsRgb
RgbRgRgRsmbRgbRgRsmbRgbRgbRsbRsbLcbLibRjbLibRcbRcbRsLsbLjbLibRhRsmbRcb
RiRsLsmbLsbRgbRgbRgbRgbRgbRsRsmbRgbLsbRibRgbRgRsmbRgbRgbRgRsRsmmbRgRsm
bLsbRibRgbRsbRgbLsbRibLjbRiRgbRgLsbRgbRgbRgbRgbRgbRsbRgbRgbRsbRgbRgbRg
bRgLsbRsbRsbRgbRgRsRsmmbRobRsbLcbRgbLibRcbRgbRgRsmbLjbLobLibLhRsbRiLsb
LobRibRcbRgbRgbRgbLsbRgbRsbRgbRibRsbRgbLsbRgbRgLsbRgRsmbRsbRgbRsRsmbRg
bRgRsmbRgbRgbLsbRgbRsbRgbRgRsRgmbRgRsmbRgbRgbRgbRgbLsRsbRgbRgbRsLibLcR
sbRjbLibRcbRibRibLibRhbLgbLcbLibRgbLhbRibRcRsmbRibLibRcbLgbRibLsbRiRsm
bRibRibLibRiRsmbRsbRgbRsbRgbRgbLsbRiLsbLsbRibRgbLcbLcbLibLiRsbRibLibLi
bRgbRcbRibRsbRsbRsRsmbRgbRsbRiRsmbRibRgLsbRgbLgRsbRibRsbLcRsbRhLsbRiRs
mbRsbRiRsmbLsbRibRsRsmbRsbRgbRgbRsbRibRsbRiRsmbLsbRibRsbRgbRsRsmbRgbRg
bRsRsmbRgbRgbLgbRiRsmbRgbRgbRgbLsRgRsmbRsbRgRsmbRgbLgRsbRibRgbRgbRsbRi
bRgbRgbRsRsmbRgbRibRgbRgRsmbRsbRgbRgbRsbRsRsmbRgbRgbRgbRgbLjbLcbLgRsbR
gRsmbLcRsbRjbLibLgbLibRcbLsbRcbLibRcbLjbRiRsmbRgbRgbRgbRgRsmbRgbRibLsb
RibRgbRgbRgbRgbRgbRgbLgbRsbRgLsRsbRgbLcLsmbLibLiRjbLibRcbLobLibRgbLibR
sRsmbRcbLjbRiRsmbLgLsbLgbLgbLgbRgbLibRgbLhRsbRibLibLibLgbRjbRjbLebLiRs
bLsLsmbLgbLibRsRsmbLgbLcRsbLobLhbLhbLiRjbRhRsmbLcbLibRsbLcbRgbLcbRgbLi
bLgbLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 17; Drug: NDMC 3 µM
bLibLgbLjLsmbRhbRjbLcbRcbRiRsRsmmbRgbLsLsmbLgbLjbLibLibLibLgbRhbLcbLib
LjbLibRhbRibLgbRibRgbLsbRibLgbRiRsmbLgbRgbLsbRibRgbRgRsmbRsbRgbRsbRsbR
sLsbRsbRgRsmbRsRsmbRsRsmbRgbRibRsbRgbLsbRgRsmbRgRsmbRsRsmbRgbRgbRsbRgR
smbRsbRgRsmbRgbRgbRgRsmbRgbRgbLsbRiRsmbRgbRgbRsLsbRgRsmbRgbRgbRgLsbRsb
RsbRsLsbRgbRsbRgbRgRsRsmmbRgbRgbRgbRgbRsbRgbRgRsmbRgRsmbLsRiRsmbRgbRgb
RgbRgRsmbRgbRgbRgbRgRsmbRsRsmbRgbLjbRiRsmbRgLsbRgRsmbRgbRsbRgRsmbLsbRi
bRgbRgbRsbRsbRibRgbRsbRgRsRsmmbRgRsmbRgbRgbRgbRgbRsbRgbRgbRgRsmbRgbRsb
RgbRsbRgbRgbRgRsmbRgbRgRsmbRgRsmbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbRsbRsbR
gRsmbRgbRgLsbLsLsmbRgbRibRgbRgbRgRsmbRsbRsbRsRsmbRgbRgbRsbRsRsmbRgRsmb
RsbRgRsmbRsbRsbRibRgRsmbRsbRgbRgbRgbRsbRgbRsbRsLsbRibRibRgbRgRsmbRgRsm
bRgbRsRsmbRgRsmbRgRsmbLsbLhbRibRgbRgbRgbRgbRgbRgbLgbRiRsmbRgbLsbRiRgbR
gbRgRsmbRgbRgbRsbRsbRgRsmbRgbRgbRgbRgbRgRsmbRsbRsbRibRsbRgbRgRsmbRsbRg
bRsbRgbRsRsmbRsLsbRibRgbRsRsmbRgbRgbRgbRgbRsbRgbRsbRsbRsRsmbRgbLsbLjbR
ibRibRsRsmbRgbRgRsRsmmbLsbRgbRibRsbRgbLsLsmbRibRgbRsbRsbRgbRsbRsbRgbRg
RsmbRsbRsbRsRsmbRgRsmbRgbRgRsmbRsRsmbRgbRgRsmbRgbLsbRibRgbLsbRibRgbRgb
RsbRibRgbRgLsbRgRsmbRgbLgbRiRsmbRgbRsRsmbRgbRsRsmbRgbRsbRsbRsRsmbRgRsm
bRsRsmbRgbRgLsbRgbRsbLsbRgbRsbRgRsmbRsRsRsmmbRgRsmbRgbRsbRgbRsRsmbRgRs
mbRgbRgbRgbRsbRgbLsbRgbRsRsmbRgRsmbRsRsmbRgRsmbRsbRgbRsbRgbRgbRgbRgbRg
bLsRsbRgbLsbRgbRsbRgbRgbRgbRsbRgbRsbRsbRgbRgbRgbRgbRgbRgbRgbRgbRibRgRs
mbRibRgbRsRsLsmbRgbRgbRsbRgbRgRgbRgbRsRsRsmmbRgbRsbRgbRgRsmbRgRsmbRgRs
RsmmbRgRsRsmmbRgbRgbRgbRgbRgbRgbRgbRsbRgbRgbLsbRibRsRsmbRgRsRsRsRsmmmm
bRgbRsRsmbRgRsmbRgbRgbRgbRgRsmbReRsLjRsRsmmbRibRiRsmbRgbRgbLsbRibRsRsm
bRsbRgbRgbRgRsmbRsRsmbRgRsmbRsbRgbRsbRgbRsRsmbRsLsbRgbRgbRgbRsbRsRsRsm
mbRgbRgbRsbRgbRgbRgbRsbRgbRgbRsbRsbLsRgbRgbRsbRgRsmbRgbRgbRgLsbRgbRgbR
gbLgbRibRibRgbRgRsRsmmbLjLsmbLibLibRsbReRsmbRibRsbRgRsmbRsbRsbRgRsmbRs
bRgbRsbRsbRgbRsbRsbRsbRgbRsbRgRsLsmbLsRsbRgRsmbRsbRgRsmbRibRsbRgRsRsmm
bRsbRgbRsbRgbRgbRibRgbRgbRibRgbRcbRcbRsbLhbRsbLibRgbLhbRsbLcbRibRgbRib
RibLsRsbRsbRibRgbLsRsbRgbRgbRibLibRibRgbRgbLgbLsbRibLsbRgbRsbRgbLsbRgb
RgbRsbRgbRgbRsbRibLcbRhbRibRibRcbRibRcbLgbLsRibLjbRibLgbRibRgbRgLsbRgb
LgbRiRsmbLsbRgbRsbLsbRgbRgRsmbLsLsmbRgbLsbRgbLsbRgbLsLsmbRgbRsbLsbRibL
sLsmbRibRsRsmbRgbLgbLjbRjbRibRibRgbLibRibRgbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 18; Drug: NDMC 3 µM
bRibLsbRibRsbRsbLsbRgRsmbLsbRibRgbLsbRibLgbLcbRsRsmbRgRsmbRgbRgLsbRsbR
gbRgbRsRsRsmmbRibRsbRgRsmbRgbRsbRgbRibRsRibRgbRgbRsRsmbRgbRgbLjbRgRsmb
RiLsbRibRiLgbRcbRcbRhbRhbLjbRiRsLsmbRiRsmbRsbRgbRgbLsbRgbRgbRibLgLsLsm
bLgbLhRsbRjbRhbRgbRgbLobLibLhLsbRgLsbLibLiRsRsmbLiLsLsmbRsbLoLsmbRgbLc
bRiLsbLcbRgbLcbLsbLgbLgbLsbRsbLibRjRsmbLibRsbLgbRsbLgLsbLgLsRsLsbRsbLi
LsbLsbRsbLgbLsLsmbLsbLgbLgbRgbLibRgRsmbLiLsbLsRsbLsbLgRsbLgbLsbLgLgLsb
LgbRsbLgbRsLsbLibLsbLgbLsbLsbLgbLsbLibLsbLibLsbLgbRsbLgLsRsbLiRgbLibLs
LsmbLibRgbLiLsLgLsbLgbLsbLgbLsbLgLsLsLsmmbLgLsbLgbLgLsLsmbLgbRsbLjbLsL
smbLsLsRsmbLgbLgbLsbLgbLgbLgLsRsbLgbLgbLgbLgbRsbLgbRsLsbLiLsbRsbLgLsbR
sbLiLsbLgbLgLsbLgLsbLsbLsbLgbLgbLiRsbLibLgbLibLgbRibLgbLhbRsbLibLobLiL
sLsmbLibRibRsbRibRjLsbRebLiLsbLjbLgRsbLibLgbLgLsbLsbLgbLgLsbLiLsbRsbLg
bLsLsmbLsRsbLjbLsLsmbLsbLgbLgLsRsbLgLsbLgbLsbLgLsbLsLgbLsLsmbLgLsbLgLs
bRsbLgbLsbLgbsbRsbLsLibRsbLiLsbLgbLsLsmbLibRsbLibLgLsRsbLgbLsbLgbRgLsb
LibsbLgbLgbLgbLgbLibLgbLsbLgLgLsLgLgbLgLsLsmbLsbLsbRsbLibLgLsLsmbLgLsb
LgLsbRsbLiLsbLgbLgbLgbRsRsmbLsLsmbLgbRjbsbRcbRcLsbLibRiRsmbRibRgLsbRgb
RibRgbLsbRgbRhbRibLibLhbLgbLgbLgLsRsbLcbRgbLiLsbLcbRcbRcbRcbRibLiLsbRc
bRiLsbLibRibRibRsbRgbRibRsbRibsbLgbRgRsmbRgLsbRiLsbLcRsbLhLsbLgbRsbLcb
LibLsLsmbLiLsRsbRgbRjbRibLcbLibRsRsmbLgLsLsmbLsbLsbLiRsbRjbLibLsbLgbLg
LsbLsbLgLsbLgbLsRsbLiLsbRsbLgbLgbLsbLgbLgLsbLgLsbLgbLsbLsLsmbLibLgbLsb
LgLsbLgbRsLsbLgbRsbRsbLibLgLsbLiRsbRgbLibRsRsmbLiLsbLgbLgbLgbLsbLsbLiR
sbRjbLiLsLsLsmmbLgbRjbLiLsbRsLsbLgbRsbLgLsbLsbLsbLgbLsbLgLsbLgbRsbLibL
gbRsbLgbRsbLgbLgLsbLgbLsbRsRsmbLgbLsbLgbLsLsmbLibLsbLgbLsbLsbLgLsbRsbL
ibLgLsbRsRsmbLgbLibRsLsbLsLsmbLiLsbLgbLsbLgbRsbLgLsLsmbLgbLsLsmbLgbLgb
LgRsbRgbLiLsbRsbLibRgbLiRsbLgLsbLgLsbLgbLsbLgbRgbRsbLiLsbLsbLibLgbRcbR
ibRhbLsbRobRibLhbLcbRjbRibRibLgbRibRsLhbRjbRibRebRsbRobRibRibLcbLgbLob
LgbLiLsbRgbLhbLgbRjRsmbRgbLcLsmbLhbRebLebRjbLcbRgbRjbRibRhLsbLibLjbLsR
jbRcbRgbRibRhbLgbRibRoRsRsmmbRibRiRsmbRibRibLsbRgbRgbRsLsbRiLsbRgbRgbL
cbRjbRgbLcbLibLibLgbRgbLibRcLsbRibLgbRgbRibRibRibLgbRgbRibLgbRgbRgbsbL
gbRibRgbRsRsmbRgbLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 19; Drug: NDMC 10 µM
bLiLsbLhbRjbLgbLgLsbLsLsRsmbLibRcbRhbRsLsbRiRsLsmbRibRsLsbRgbRgbRgbRib
LgbRiRsmbRsbRsLsbRgRibRgRsRsmmbRibRiRsmbRgRgbRgbRgbRgbRgbRgbRgbRgbRsbR
gbRgbRgbRgbRgbRgbRsbRgbLsLsRgmbReRsmbRsRsmbRiRsmbRgRsmbLsbRgbRibRgbRgb
RgLsbRsLsbRsRibRibLibLcbLcbLsbRgbLjbLibLgbLibRgLsbLsbLgRsLiRsbLsLsmbLg
bLgLgLsLsmbLgbLgLsbLgbLgbLgLsbLgLsbLgLgLsbLgLsbLjbRjbLcbRgbLsbRsbLgbRc
bRibRgRsmbRsRsmbRgRgRgRiRibRsRsRimbRgbRgbRgbRsRgbRiLsbRgRsmbRjbLibRhbR
cbRcbRibRsbRibLsbRgbRgbRsbRgbRgbRibRgRsmbRgbRgRgRsmbRgRibRgRgbRgbRgbRg
bRgbRibRsbRgbRibRgRgRibRgbRgbLsbRgbRgbRgRsmbRibLcbLcbRgbRhbRiLsbRsbRgR
sLsmbRibRsLsbRsbRgRsmbRjLsbLhbRibRibRgbRgbRgRgRgRiRsmbRgRsmbRiRsmbRiRs
mbRsbRgbRgRiRsmbRgRiRsmbRgbRsbRiLsRsbRibRsbRgbRgLsbRsbRsbRiReRgRiRgRsm
bRgRsmbRgbRgbRsRsmbRgRsmbRgbRsLsbRsbRiLsbLgbRiRsmbRgbRgbLsbRgbRiRsmbRs
RsmbRgbRsbRhLsLsmbRsbRsbRcbRcbRibRhbRibLgRsbRiRsRsmmbRibRgbRgbRgRsRsmm
bRgbRgRsmbLsRgRsRsRimmbRgbRiRgRsmbRgbRgbRiRsmbRsbRiRgRsRimbRiRsmbRgbRg
bRgRsRiRimbRgRgbRgLsbRgRsmbRgRsRiRsmmbRgbRibRgRsmbRgRsmbRgbRgLsRiRibRi
bRibRgbRgbRgLsbRcLsbLibRgbRsbRibLcLsmbRhRsmbRgbRgbLgbRibRsbRgbRgbRsRgR
smbRgbRgRhbRgbRgbRgbRgbRsbRgbRgbRgbRgbRsbRiLsbLebLcbRibLhbRgbLibLibLcb
RibLibRjbLibLsbLcLsRsmbLhbLcbRgbRibLjbRcbLsLsmbRibRgbLcbLiRjbLgbRhbRib
RsbRibRgbRibRgbRiRsmbRsRsmbRgbRgRsmbRgbRgRsmbRgbRgbRgRsmbRgbRgRsmbRgbR
gbRgbRibLiLsbRgbRcbRibRiRsmbRibLsbRcbLsbRiRsmbRsbRgbRgbRgbRgbRgbRgbRsR
smbRgRiRsmbRgLsRsbRgbRsbRibRgbRgbRgbRgbRgRsmbRgRsmbRgbRgbRgbRgRsmbRgbR
gbRgbRiLsbLgbRcbRgbRgLsRsbLcbLcbRiLsbRiRsmbLcbLcbRibLcbRibLibRjbRcbLcb
LibLibRgbLibLsbLibRsbLgRsbLobRibRcbRcbRiLsbLibRgbRcbLjbRobLhLsbLcbRibR
ibRiRsmbLsRsbLsRsRsLsRimbRibRsbRsRsmbRgbRsbRgbRgbRsRgRsmbRgbRgbRgbRgRs
mbLsRgRibRgbRgRsmbRsbRsbRgbRhbLibLsLsmbRibRgbRsRsmbRgbRgbRsRsRgmbRgbRg
bRgLsbRgbRgbRsbRibRgRsRsmmbRsRsRsRhmmbRiRsmbRgbRgbLsbRgLsRsbLjbLcbRjbL
ibLibRgbLibLcbLcbLgLibLiLsbRsRsmbLgbLsLsmbLgbRsLsbLgbReRsmbRiRsRsmmbsb
RsRsmbRibRgbRgRsmbRgbRgbRgRsmbRgLsRsRiRgbRsbRsRibRgRsRembRibRgbRgbRsRs
mbRgRsRsmmbRibRsbRiRsmbRibRgLsLsmbRgRsmbRcbLiLsbRgbRibRiLsbLibRcLsbLib
RobRcbRhbRibRibLcbLiRsbRcbRgRsmbLcbLobLcbLcRsbRhbRibRsbRgRsLsmbRgRsmbR
gRsmbRibRgRsmbRgRsRgRgRiRgRgRiRsmmbRgRgRsmbRgRsRsmmbRgbRgbRgbRgRgbRgRi
RsmbRgRsmbRgRsmbRsbRgRsRsmmbRgbRibRgbLoLibLcLsmbRjbLiLsbLgbLcbLhbLgRsb
RcbRcRsRsmmbLcbLcbRsbLobLsbLcbRgLsbLobRhbLobRibRcRsmbLiLsbRcbRhbLcbLhb
RjLsbLiLsbLcbRibRcbLibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 20; Drug: NDMC 10 µM
bRsbRgbRgbRgLsbRibRsbRhbRgbRgbRcbLsbRibLsbLsRibLsbRgbRibRiLjbRgbRgbLsb
RibRsbRgRsmbRgbRsbRgbRsbRsbRjbRjRsmbLibRiLsbRgLgbRibRgbRsbRgbRgRsmbRsL
sbRibRibRgbRgLsbLibRibRibRibRgbLcbLhbLibLsbLgbLsbRiLsbLibLgbLsRsbLgbRs
RsmbLgbLibLgLobLgbLgbLsbLgbRsbLgLsbLgbRsRsmbLgbLgbLgbLibLgbRcbRhLsbRgR
smbRgbLsLsmbRgbRgbRcbRobRiRsmbRibRibLsRsbRiRsmbRsRsmbLsbRiLsbRgbRgbLsb
RjbLibRibLgbRiRsmbRibRgbRgbLgRsbRibRsbRgbRsbRgLsLgbRibLsbRibRgbRgbRgbR
gLsbLsbRibRgRsmbLsbRgRsmbLsbRibRsbRgLsbRcbLibRibRibRibRibRcbLcbRibLgbR
gbLibRjRsmbRibRsbLsbRibRsRsmbRgbLsbRibLgbRjRsmbLibLgbLhbRjbLcbLhbLibLi
LsbLiRsbLgbRgbLhbLjbLibLiLsbLibRibLhbRgbLibRgbLibLsbLibRhbLibLsbLgbLgb
LgbRjbLiRsbLgRgbLgbRjbRoLsbLcbRhbRcbRibRcbRhRsmbRiLsbRibLgbRgbRsbLsbRi
RsLsmbRgbLsbRoLgRsbRsbLjbLiRsbLsLgbLgbLgbRjbLgbRhbLjRsbLibLgbLgbLgbRsL
sbLgbLgbLiLsbLsbLgLgbLsLgbRsbLgbLgbLgbLgRsbLgbLsbRgbLiLsbLgbRgbLgbLgbL
gbLsbLgbLsbLgbLibRjbRcLsbLibLibLgRsLsbLsbLgLsbLsbLgbRsbLibRsbLibLgLsbR
sLsbLiLsbLsbLgbLibRgbLibRsbLgbLgLsLsmbLsbLsbLibLgbLgbLibRiLsbRsbRcbRgb
LcbRcbRcbRhbRgbLebLsLsRsmbLgbRsbRibRibRibRcRsmbRcbRhbRhbRibRgbRgRsmbRs
bRgbLsbRgbRsbRgLgbRsbRgbLhbRsbLgbRjbRhbLsbRgbLsbRgbRoLgbRgbLjbRjbRhLsb
RiLsbLebRcbRoLsbRcbRhbRoLsbLebRibRgbRsbRibRgbLsbRibLgbRgbRibRgbRsbRgbR
ibLsbRgbRgbLsbRgbRgbRiLsbLcbRibRgLsRsbRsLsbRsbRgRsmbLsbRiLsbRsbRgbLsbR
gbRgbLsbRgbLgbRibRgbLgbRgbRiLsbRgbRgLsbLjbRiLsbLsbRibRcbLhbRibRgRsmbLs
bLjbRhbLjbRoLsLgbRgLsbRgbRgbRgbRgbRsbRiRsRsmmbRgLsbRiLsbRgRsmbLsbRibRg
LsbRgbLoRsbRiLsbRgLsbLsbRgbRgbRgbRgbLibLhbLibRgbLgbLiLsbRsRsmbLhRsbRgb
LibRsbLgbRgLsbLgbLgLsbLgLsbRsbLgbLgRsbLgLsbRsLsLsLsmmbLgbLgLsbLiLsbRib
LibLgbLgbRjbLibRsbLgbLiRsbLsbLgbLibLsbLgbLibRgbLiLsRsbLibLsbLhbRgLsbLh
bLiLsbRibRgbRibLjbRcLsbLibRibRibRgRsmbRgbRgbLgLsbRiLjbRibRgbRibRibRcLs
bRhbLcLsmbRoLsbLibLsbRgbLibLsbLgbLgLsbLibRsbLgRsbRsbLgbLgbLgbRjLsbLiLs
bRsbLgLsbRsbLgbRsbLibLgbLgbLgRsbLgbLgbLgRsbLibRsbLgbLibLibRgbLibRsbLib
RsbRjbLibLibLgbLibLcbRibLibLcbRgbLibRsbRibLhLsbLhLsbLsbLibLsLsRsLsmbLi
bRgbRgbLgbRibLgbRibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 21; Drug: NDMC 10 µM
bRsRsRsRimmbRgbRsbRgRsmbRgbRgbRgbLcRsbRiLsbRibLjbRibRgRsmbLgbRcbLsbLib
LhbLcbRhbLibLcRsbLcbRcbLibRibLsbRibRgbRgbRgbLsbRibLsbRsRgbRgbRiRibRgLs
bRibRgbRgbLsbRibRiRsmbRgbLgbRgbRgbRsRsmbRibRiLsbLibRgbRjbRobRobRcbRcbR
cbRcbRibRibRsbRiRsmbRgbRgbLgbRgLsbRgRsmbRsbRiRsmbRgRsmbRibRsbRgbRsbRgb
RibLjbRibRsbLgRsbRibLsbRhbLsbRgbRgbLsbRibRgbLgbRiRsmbRsbRjbRcbRcbLiLsb
RsbRjbRcbLeRsbRjbLhbLibLgbRobLhLsbLibLiLsbRsbLiRsbsbLsbRobRobRibRgbLsL
smbRgbLsbLsbRibLsbRibLibLjbRcbLobRcbRobLjbRobRhbLibLibLsbLgRsLsbRgbLib
LgLsbLsRsbLgbLgLsbLsbLgbLgbLgbLgLsLsmbLsRsbLibLsRsbLgLsbLgbLsbLgbLjbLc
bLcbLebLhLsbRibLibLgbLiLsbRjbLcbRsbLgbLgbRsbLgbRjbRobLhbRgbLebRsRsmbRj
bRcbRcbLgbLibRsRsmbRjbLhbRjbRobRobRcbRcbRcbLhbLgbRgbRhbRibRsLsbLibRcbR
ibLsLibRgbRiLsRsbRsRsmbLibLhbLibRgbRobRebLibLcRsbLibLobLcbLibRibLcLsmb
RgRsmbRebRcbRobLjLcbLcbRibRsbRgbLjbLcbLsbRoRsmbLibLjbRobLjbLhbLcRsbLeb
RhbLsbRobLiRsbRebLsbRsbRgLsbRhbRcbLibRhbLibRibRjbRsbRobRebRebRhbLibRib
RibLibRjbRibRibLibRgbRibLebLobLobRcbLjbRhRsmbLjbLjbRsbLibRibLibRjbLibR
jbLsRibLibLebRhbRcbLgbRibRibLjbLobRcbRibLcbRibRibLgbRibRsbRibLsbRjbLcb
LobLcbLcbRcbLjbRobLjbRibLjLsmbLobRcbRibLjbLcbLiLsbRgbLibRsbLiLsbRsbLob
LibRibRgbLibLgbLsbRebRsbRibRhbRobRoRsmbLhbLobRibRobLcbRjbLjbLibLibLgbR
jbRcbLibRiRsmbRsbLsbRgbRgbRsbLibRsbLgbRsbRsbLibLgbLsbLsbLgbLgbRibRcbLc
bLibLgbRjbLcbRhbRjRsmbRibLibLhbRsbLibLsbRcbRhbLibRjbRibRsbLhRsbLgbRjbR
sbLhbRjbRcbRsbRiRsmbRsLsbRibRgbRgbRgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 22; Drug: NDMC 10 µM
bLjbLsLsLsmmbLsbLiLsbLgbLgbRsbLibLsbLsbLjbLgLsbLsbLgLsbRcbLcRsbLibRobL
ibLibLgbLibRgLsbLgbLgbLsbLgLsRsLsbLgbLjbLsbLgLsLsmbRgbLiRgRsmbLsLibReb
RhbLcbRcbRibLjbLsRsbRoRsLjmbRibRibRgbRgbRsbRgRsmbLsRsRsLsmbLsbRibRgLsb
RiRsLsmbRsbRgRsmbRibRgbRgbRgbRsbRiLsbRsRsmbRiRsmbRsRsmbRgbRibRgbRgbRcb
LhbLhbLcbRibLoLsmbRgbLjbLsRsbLgbLoLsLsmmbLibLcRsLsbLcbRibRgbRibLjbLcbL
cbLsbLibRsbLiLsbLsLsmbsbLsLsLsmmbLsbsbRgbLiLsbRgbLiLsbsbLcbLibRgbLiLsb
LgLsRsbRsbRibLhbLjbLsLsmbLibRsRsmbLsLgLsbRgbLibRsLsbLibLgbLsbLgbLsbLsb
LsbLgLgLsbLgbRsRsmbLiLsLsmbRsLsLsmbLsbLiLsbLgbRsbLiLsbLsbLiLsLibLsLgbL
sbLibLgbLhbLgbLsRsbLgbsbLgRsbRgbLiLsbRhbLiLsbLibLsbLibLsbLgbLsbLsbLgbL
gbsbLsbLiLsbLgLsbLgbLiLiLibLgbLcRibRgbRibLcRsRsmbLiLsbLibLsRcbRoLsLsmb
LjbLhbLibLibLsbLibLgbRsbLibRsbLgLsLgLsRsbLsbLgLibLgbLsbLgLsLsmbLsbLgbL
gbRsbLibLgRsbRjbLsbLibRsbLiLsbRsLsbLibLgLsbRsbLgbLsbLsbLgbLsbRsbLsRsbL
gLsbLsLsmbRsbLibRgRsmbLibLsLsmbLgLsbLsbLgLsbLsLsmbRsbLibLsbRsbRsLsbLiL
sLsmbRsbLgLsbRsbLibLgbLgbRsRsmbLgbLgLsbRsbLgLsbRsbLibLgbLgLsbRsLsbLibL
sbLgLsLsmbLgbLsbLgbLgLsLsmbLsLsmbLgbLsLsmbLsbLgLsLsmbLgLsLsmbLgLsbLgLs
bLsLsmbRsbLgbsbLsRsbRsLsRsbLibLibRgLsbLsbRcbRgRsmbRibRhbLebRjbLcbRgbLi
LsbRsLsLsLsmmbLibLgbLsLsmbLibLgbRgbLibRsbLgLsbLsbLsRsbLsLsmbLgLsbLgLsb
LsbLibLgbLgbLgLsbLsbLiLsbLgbRsLsLsmbLgbLsbLiLsbLgLsbLgbLgbLgbLgbLgbLgL
sbLsLsmbLgLsbRsbLibLsLsmbLgLsbLgbLgLsbRsbLgbLsLsmbLgbLsbRsRcbRsbLibLib
LgbRsbLgbRsLsbLibLiLsLsmbRobRibRoLsRsbLibLsbRiLsbRiRsmbsbLsRsbRiRsmbRg
bLobLcLsLsmmbRjbLiLsbLsbLibLsLsmbLgLsbLsbLgbLgbLsbLobLibLibLibRgbLiRsb
RsbLiLsbLgLsbRgbLiLsLsmbRsbLgLsbLgLsbLgbLgbLibLgbLsbsbLsbLsbRsLibRjbLs
bLibRgbLibLiLsbRsRsmbLgLsbLgbLsbLsLsLsmmbLibLsLsmbRsbsbLgbLsLsmbLgRsbL
ibLgLsbLiLsLsmbLsbLibLibLgbRsbLgbsbLsLsmbLsLsLsmmbLgbLsLsLsmmbLsbLiLsb
LgbLsbLgbLsLsmbLgbLgbsbRjbLsLibLgbLsbLibLgbLgbLibRsRsmbLgLsbLgbLgbRsbL
ibRsbLibLsRsbRcRsmbLcbLiLsbLhLsbRgbRjbRcLsbRibLibLoLsmbRibLcbRibLcLsmb
RsLsbLcbRgbRjbLhRsRsLsmbRsLiLsbRsLsbLibRsbLibLiLsbRsLsbLibRsbLibRgbLib
RsLsbLgLsbLgbLgbLgbLsLsmbLiLsbRjbLhLsbLgLsbRsLsbLgLsbLsbLgbLgLsbRgbRsb
RjbsbLgLsbRebRsbLjLsmbLibLgbRcLsbRobLsLibRcbLsbRcLsbLgbRibRob

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 23; Drug: NDMC 10 µM
bRiRibLibLgbRsLsbLgbLsLsmbLibRgbLgbLgbLsbLgbRsLsbLiLsbLibRsLsLibsbLsLs
mbLgLsbLgbRgbLibLsbLgbLgbRsLiLsbLgbLgbLsLsmbLsbLjbRgbLiLgbLiLgLsbLgLgL
sLsmbLgbLsbLgbLsbLgLsLsLsmmbLgbsbLgbLsLsRsLiLsLgLsmbLsLsmbLgRsbRsbLgbR
sbLgLsbLgbRsbLibLsLsmbLibLhLsbLibLgLsbLgbLgbLsLsmbLsLsmbLgbLgLsbsbRsbs
bLgbLgLsLsRsmbLsbLibLgbLgbLgbLgbLgbLgbRsbLgLsbLgbRgRsmbLgbLgLsLibsbLgb
LsbLgbLsLsmbLsRsbLgbLsbLgLsbLsLsmbLgbLgLsbLgLsbLsLsLgLsmbLgbLgbLsbLgbL
gbLgLsLgbLibLsLsmbLgbLcbRebLgbLibLgbLgRsbLgbLgbLgbLgbLgbLgLsRsbLgbLsbL
gLsbLsbLsbsbLgbLibLgbLsbLgLsbLsbLgbLibLgLsLsmbLgbLgbLsLsmbLsbLgLsbLgLs
bLgbLgbLgLsbLgbLsbLgLsLsRsmbLgbLgbLsbsbRsbLgbLsbLgbLsbLgbLgbRsbLgLsbLs
LsmbLgbLgbLcRsLsbLhbLsbLibLhbLgbLgLsbLgLsbLibRsbRibLcLsmbRgbLhbLsbLgbR
sLsbLgbLgbLgRsbLgbLgbLgRsbLsbLjbRsRgbLjbLsLibLgLsRsLgbsbRsbLgbLgLsbLsb
LgbLgbLgbRsLsbLiLsbLgbLsbLsbLgbLsbLgLsLgbRsbLiLsLsmbLsbLgbsbLgLsbLsLsm
bLgRsbRsbLjbLsLsmbLgLgbLgbLgbLgLsbLsbLgbRsLsbRsbLhbRgbLsbLibLsbLgLsLiR
sbRsLgbLgbLibLibLibLgbLgLsbLibRgbLibLsLsmbLibRsbLgbLgbLgbLsbLgbRjbLiLs
bLibLsbLsbLgbLsbLiLsbLgbLgLsbLgLsbLgLsbLsbLgbLgLsbLibLsbLgLsbLibLibRgR
smbRjbLcbLibRsLsbLibLsbLiLsbLsRsbRsbLsbLgbLjbRgbRibLiLsbLcbLsbLsbRsbLi
bRsLsbLgLsLsmbLsLsmbLgbLsbLgbLsbsbLsbRsLsbLgLsLsmbLgLsbLsLsmbLgbLgbLsL
smbLgLsLsLsRsmmbLgLsbLsbRsLsRsLsLiLsbLsbLgbLgbLgbLgLsLsmbLgbLsbLsbLjbR
sbLjbLsbLsbLsLsmbLiLsbLgbLibLgbLsbLgbLibRjLsbLiRsbLjbLsLsmbRsbsbLgbLsb
LgbLgbLsbLgbLgbLgbRsRsmbLgLsbRsbLgLsLsRsRsLsLsmmmbLgLsbRsbRjbRibLcbRsL
sLsRsRsmmbLiLsbLsbLgbLgbLsbLibLsLsLsmmbLgbLsLsmbLjbLsLsmbLgbLsbLgbLsbR
sLsbLgLsbLsbLgbLgbLgbLgLsLsmbLsbLsbRgbLibLgbLsbLsLibLsbRsbLiLsbLibLsbL
ibLgLsbLgLgbRcbRiLsbLcbLibLgbLsbLibRsbRjbRibRibLjbRibRiRsmbLcbLcLsmbLs
bLsRsbLgbLiLsRgbLgbLiLsbRsbLiRsbLibRgbLcbLgbLgLsbLgLgLsLsmbLhbLgbLsbLi
bLgbLibLibRibLjbRibLhbLgbLgLsLsmbLgbsbRsbLibRgbLgLsbLgLsbLsbLsbLsbLgLs
LsmbLgLsbLgbLgbLsLsmbLgbLgbLibLsbLibRgLsbLiLsbLgbRgbLhLsbRgLsbLibLibRg
bRsLsbLiRsbLgbLsbLjbLsbLgbLsLsRsmbLgbsbLsbLsbLsLsmbLgbLsLsmbLgbLsbLgbL
gbLsbLsbLsbLjbLsLsLsmmbLgLsbLsbLgbLsbLgRsbLiLsRsbLsbLsRsbLsLsmbLgbLgbL
sbLgbLsbLsbLgbLsLsmbLibLiRgbRsRjbLcLsmbRgbLgbLsbLgbLgLsLsmbLsbLibLsbLs
bLjbLsbLgLsbLjbRsbsbLibLsbLsbLsLsmbLgbLgbLsLsmbLgRsbRsbLgLgbLgLsbLibLs
LsmbLgLsbLiLgbLgbLgbLsRsLsbLibLibLsbLibLgbRgbLibLgbRcbLcbRcbRibLjLsmbR
sLibLiLsbLsLsmbLgLsLsmbRsLsbsbLibLsbLsbLsbLsLsmbLgbLsLsmbLgLsbLgbLsbLg
bRsbLgLsbLsbLgbLgbLsbLibLsbLgLsbsbLibLgbLsbLgLsbLgbLsLsLsLsmmmbLsLsmbL
gbLsbLsbRjbLibLiLsbsbLgbLgbLsbLgbLsLsmbLgbLsbLgbLsLsLsmmbLgbsbsbLsLsmb
LgLsbLgbLgbLgLsbLgbLgLsbLgbLgbLgbLgbLsLsmbLgbLgbLgLsbLsLibRsbLgbLgLsbL
sbLjbLsLsmbLsbLibLsbRsbLgbLgLsbLsLsmbLgbLgLsbLsLsLsmmbLgbLgLsLsmbLgLgb
LibLgLsbLsbLibLgLsbLgLsbLgLsbLgbLgLsbLgbLgbsbRsbLgbLgLsbLsbLsbLgbLgLsb
LsbLgRsbLgLsbLgLsLgbLiLsLsmbLgLsbLsLsmbLgbLsbLibRgbLcbRgbLgbLibRcbRgbR
ibLgbRcbLibRibRibLjbRhbRibLiLsbLibLsbLcbRiRsmbRgbRcbRcbRcbLibRibLcbRsb
LibLhbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 24; Drug: NDMC 10 µM
bLsLibRsbLibLsbLsbLsbLhRsRsRgmbRoLsbLsbRgbRsRsmbRgbLsbRgbLsbRgbRsRsLsm
bRgbRgRsmbRgbRgbRgbRgbRgbRsbLgbRibRgbLebLibLibRibLibRsbRsbLhRsbRgbLiLs
bRsbLiRsbLsbLgbLsbLgRsbLsRsbLsRsbLsbLgbRobRiRsmbLsbRgbRsbLsRibRsbRgbRg
bRgRsmbRsbRgbRsbRgbsbRsbRsbRibRgbRgRsmbRgRsmbRgbRgRsmbRgbRgbRgbRgbLsRs
bRgbRsRibRgLsbRsbRgLsbRibRibLiLsbLjbLgbRobLibRsLsbLgbLsbLiRgbLgbLgbLgb
LgLsbLgRsbsbLgbLsLgLgLsbLgbLgbLgLsbRsbLibLgLsLsmbLgbLobLoRsbLgLsbLiLsb
LgbLsbLgbLgbRsbLgbLsbLgLsbLsbLgLsbLgLsbLgbLgRsbsbLsbLgbLobRsbRgbRsbRib
RsRsmbRgbRgbRsbRsbRgRsmbLgbRgbRibLgLsbRgRsmbRcbRgbRibLsLsmbRsbRgbRgbRg
bLsbRgbRgbRsbRgRsmbRgbRgRsmbRsLsbRgbRsbRgRsmbRgbRgbRgbRsbRgbRgbLsRsbRg
bRibLsbRsbRgRsmbRibLsbRgLsbLsbRgbRsbRgbRgbRgbLsbRgRsmbRgbRgbLsbRibLgbR
gbRgbRgbRgbRgbRgbRgbLsbRgbRsbRsRsmbRsbRgbRgbRgbRsbRgbRgbRgbRsbRgbLgbRg
bRgbLsLsmbRgRsmbRgbRsbRgRsmbRgRsmbRgRsmbRgRsmbRgbRsbRgbRgbRsbRsbRgRsRs
mmbRsbRgbRgbRsbRibRgRsmbRgbRgbRgbRgRsmbRgbRgbRgRsRsmmbRsbRgbRgbLsbRgbR
gbLsbRgRsmbRgRsmbRsbRgbRgbLsRsbRgbRgbRsbRgbRgbRsbRgbRgbRgbRgRsmbRsbLsb
RgbLsbRgbRiLsbLgbRibRsbRibRgLsbRgbRsbLjbRibRgRsmbLsbRgbRgbRsbRgbRgbRgb
RgbRgbRgbRgbRsRsmbLsbRgbRgRsmbRgbRsLsbRgbRgbRsbRgbRgbRgRsmbLsbRgbLsbRg
bRgbLsRsbRgbRgRsmbRgbRgbRsbRgbRgRsmbRsRsmbRsbRgbRgRsmbRsRsmbRgbRgRsmbR
sbRgbRsRsmbRgLsbRgRsmbLsbRgbRgbRgbRgbLsbRgbLsbRgbRgbLsbRgbRgbRgbLgbRib
RgRsmbRsRgbRsbRgbRgbRsbRgbRsbRsbRgRsmbRgbRgbRsbLsbRgRsmbRsRsmbRgRsmbRs
RgbRsRgbRsbRgbRgRsmbRgbRgbRsbLsbRgbRiLsbRgbRgbRgbRibRiLsbRgRsmbLgbRibR
gRsmbRgRsmbRsbRgRsmbLjbLibLgbLgbLsbLgbLsLsmbLgbLgbLsbLsLsLsmmbLgLgLsLs
mbLgLsbsbLsbLsRsbLgRsLsbLsbLgbLgbLsbLgbLgbLgbRsbRobRibRgbRgbRgbRsRsmbR
gRsmbRgbRgRsmbRibLgRsbRgbRgbLsbRsbRibRiLsbRibRgbLsbLibLibRsbLgLsbLibLs
bLgLsbLgLsbLgLsbRebLiLsbRjbRsbRibRsbLsbRiRsmbLsbRgbRsbRibRgbLsbRgbRsbR
gbLgRsbRgbRgbRsbRgbRsbRgbRgbRgRsmbRgbRgRsRsmmbRgbRsRsmbRsbRgbRgLsbRgbR
gbRgLsbRgbRsbRgRsmbRgLsbRgbRgbRsRsRsmmbRsRsmbRgbRsbRgbRgbsbLsbRgRsmbRg
bRgRsmbRgbRsbRsbRgbRgRsmbRgbRgbRgbRsbRgbRsbRsRsmbRsbLsRsbRgbRgRsmbLsbR
gbRgbRgbRibRgbRgRsmbRsbRgbRgbRgbRsLsbRsbRsbRibRibRgbRgbLgbLsbRibRibRgb
RgbLsbRsbRibRgbRsbLoLsmbLibRjbLcbRgbLgbLibLsbLhbRsbRjbRibRgbRgbRsLsbRs
bRgbRgbRgRsmbRgbsbRsbRgbsbRgRsmbRsbRsbRsbRsbLsLsmbRsbRgRsmbRsbRgbRsbRg
bRgbRgbRgbLgbRcLsbRibRsbLsbRiRsRsmmbRsbRsbsbLsbRibRsbRsLsbRsbRgRsmbRsb
RiLsbRsbRibLsbRgbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 25; Drug: Control
bLjbLhbRcbRcbLgLsbLibLibLibRjbLgLsbLsLsmbLgbLgRsbLgbLgbLhbLhbRgbLcbLib
LgbLgLsbRjbLgbsbLibLibLsbLsbLgbLgbLgbLsbLgLsbLgbLibLoRsRsmbRibRgbLcbRs
bLibLiRsbRgbLiLsRsbRgbLiRsbRsbLibLsbLibLibRibLjRsbLhbLhbRgbLibRibRibLc
bLsbLibLsbRgbLibLgbLsbLsbsbRsbLgbLsbLgbRsbLgLsbLgbLgbLgbLsbLgbLsbLjbLo
LsmbRiRgRsRgmbRibLjbLcbLsRjbLgbLibLgbRsLsRsbLgbLibLgbLsbLgbLjbLiRgLsRs
bRgbLibLsbLibLgbLibRibRibLgbLibLibLsbLgbLgbLgbLibRsbLgbLgLgbLgbLibLgRg
RsmbLibLibLgbLsLsmbLsbLgLsLsmbLsbLgbLgLsbsbLgRsLsbRsLsbLsLsmbLgbLsbLgL
sbLsbLgbLsbLgbLibLibLcbLibLibLibLibLgbLsLgbLgbLsLsLsmmbLsbLsLgbLiLsLiL
sbLsLsmbLgRsbLgbLsbLgbLsLsmbLgLsbLgbRsbLhbRibRjbsbLobRiRsmbLibLgbLsbLi
LsbLgbLgLsbLgbLgbLgbLgLsbLibLgbLgbLgbLgLsbLgbLgbLsLiRsbLgRsbRjbRcbRibL
ibRobLiLsbLgbLibLiLgLsbLgbLsbLgbRsbLgLsbLgbLsLsmbLsRsbLgbLsLsmbLgLsbLi
bLgbLgLsbLgbLgbLgbLsbLgbRjbRcbRibRgbRiLsbRibLsbRgRsmbsbLsbRsbRsRsmbRsb
RgRsmbRgbRiRgbRiRibRiRsmbRgRsmbRibRgbRgRsmbRgbRgbRibLibRhLsbRiLsbLgbRo
bLibRjbLibRcbLhbLibRcbLibLsbLiLsRgLsbLsbLgLsbLgbLgbLsbLgbLsbLgbLsbsbLg
bLsRsbLgbLgbLgLsLsmbLgbLsbRsLgbLgbLgbLsbLsLibRhbRobRobRibLibLgbRibRcbR
sbLgbRibLgbRcbRiLsbLibLgbLjbLsLibRiRsmbRjbRcbLsbLgbRgLsbRibLsbRgRsLsmb
LsbRgbsbRgRsmbRsbRgRsmbRsbRgbRgbRgbRiRsmbRgbRgbRgRgbRgbRibLjbRcbRcbRgb
RcRsmbLibLcbLcbRcbRibLobRgRgbLobLibRibRgbRcRcRsmbRgbLhLsbRsbLibLsLsLsm
mbLgbLgLsLgbLsbsbLsbLibLibRgbLibRgbRcbRcbLiLsbRobLibRibRsRsLsmbRiRsRsR
smmmbRgRsmbRgbRgRsRsmmbRgRgbRgbRgLsbRgbRgbLsbRibLjbRhbRcbLhbLibRgbRgbR
gbRgbRibRcbLiRsbLibRsbRcbLjbRcbLibRhbRgbRgbRsbLjbLebLgbLiLsbLgbLgbRsbR
sbLgbLsbLgbLsbRgbLhbRcbRiRsmbRcbRibLjbRiRsmbRsbRgbLgbRgbLsbRgbRgbRgbRg
bRgRsmbRgbLsRsbRibRjbRsbRgbRiRsRgmbRgbRgRsmbRsRsmbRgRsmbRgLsbRgbRhLsbR
gbLgbLjbRobRcbLhbLibLibLibRhbRcbRibLibLibLibLhbRibRjbRibLgbRibLsRsRsmb
RgbRgbRsRsmbRgbRibRiRibRgbRgRibRhbRgbRgRsmbRgRgRsmbRgbRibRgbRgbRgbRsbR
gbsbLjbRibRgbRibRgbLsbRibRibRgbRgbRgbRgbRsbRiLsbRhbLcbRgbRibLobRcbRibR
gbRgbRgRsmbLsbRsbRgbRgbRsbRibRsbRgbRgRgbRgbRsbRgbRgbRgbRiLsbLgbRibRsbR
iRsmbLhbRcbLhbLcbLobLibRjbLhRjbLsbRibRiRsmbRgbRgbRgbRsRsmbRgbRgbRgbRgb
RgbRgbRgRsmbRsbRgbRsbRibRgbLobRjbLcbRhbRibRibLibRgbRgbRgRgLsbRgLsRsbRg
bRiLsbRcbLhbLgbRgbRhbLjbRobRcbLebRgbRgbRoLsLsmbLhbRibRgbRhbLjbRibLsbLj
bRcbRibRgbRgRsRsmmbRgRsRsmmbRgbRiLsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 26; Drug: Control
bLobLcLibRgbLcbLhLsbRsbLcbRgbLibRgbLgbLsbLgLsbLgLsbLgbLgbLgbLgbRibLgbL
ibRibLiRsRsmbLibRsbRjbLibRgbLgbLobLcbRsbLcbLgbRsbLgbLibRiLsbLgbLgbLsLs
LsmmbLgbLsbLgLsLsmbLsLsmbLsbLgbLsbLgRsbLgbLgbRjbLgbRsbLgbLhbRibRjbRiRs
LsmbLjbRjbLibRibLsbRsbRgbRsbRibRibLsbRgbRgbRgbRgbRsbRsbRsbLsRgbRgbRgbL
gbRgbRgbRsbRgbRgbRgbRgbRgRsmbRgbRgRsmbRsLsbRgbRgbRgbRsbRgbRsbRsbRgRsmb
RsbRiRsmbRgbRgRsmbRsRgbRgbRgbRgbRgbLsLsmbRgbRsbRgRsmbRgbRsbRgbRgbRgbRg
LsbRgbRsbRgbRsbRgbRsbRgbRgbRgRsmbRgbRgbLsbRibRsRsmbRiRsmbLsbRgbRgbRsbR
ibRgbRgbRsbRgbRgRsmbRgbRgbRiLsLsmbRgbRgbRgbLjbLibRcLsbRgbLjbLobRgbLobR
gbLcbRgbLibRsbRgbLiLsLsmbRsbLsbLgbLgbLsbLgRsbLgbRsbLobRibRgbRibRjbRgbR
sRsmbRsbRibRgbRsbRgbRsbLsRibRgbRsRsmbRgRgbRgbRgbRibRsbRgbRgbRgbRsbRgbR
sbRgbLsbRgbRgbRgbRgbRsbRsbLgbRgbRsbRibRibRgbRgbRgbRgbRgRsmbLsRsbRgbRgR
sLsmbRsbRgbRgbRgRsmbLsbRgbRsbRgbRgbRgbRsbRgbRsbRgbLjbLhLsbRcbRgRsmbLsb
RgRsmbRgbRgbRsLsbRgRsmbRsbRgbRgbRgbRgbRsbRgbRgbRsbRibLsbRgbLsbRibRgbRg
bLibRibLcbLsbRibRgbRgbRgbRgbRgbRgbRsLsbRgLsbLcLsmbLobRgbLibRsbLiLsbLib
LgbRgbRgRsmbLjbLibLgbLibRgbRcbRgbRiLsbRgbLsRsbRibLsbRgbRgbRgLsbLjbRiLs
RsbLsbRgbRsbRgbRsbRsLsbsbLjbRibRsbRgLsbRsbRsRsmbRsbRgRsmbRsbRgbRgbRsbR
gbRgbLgbRibLjbRgbRgbRgbRgbRgbLsbRcbLcbLcbRjbLcbRgLsbRebLsbRgbRsbRsbRgb
RsbRibRsbRsRsmbRgbRsbRgbRsbRsbRgbRgbRgbRgbRgbRgbRgbRgLsbLgbLsbsbLhbRiL
sbLoLsmbRsLsbLhbRgbLcbLcbLibRibRgRsmbLobLcLsmbRibLgbLgLsbLiLsbRgbLgbLg
bLibLibRgbRibLibRhbLibLcbRibRibRcLsLsmbLgbLjbRiRsmbRgbRgRsmbLsbRsRgbRg
bLsbRgbRgbRgbRgbRgbLgbRgRsmbLgbRgbRgbRgbLsbRgbRsbRgbRsRsmbRgbRgLsbRgbR
gbRgbRgbRgbRsbLsbRsbRgbRibRgbRgbLsbLcbLibRsbRebRibRsbLcbRgRsmbRobRibRi
bLgbLsbRgbRibRgRsmbRgbLgbRibRsbRibLgbLobLsbLhbLsbRibRibRgbRsbRgRsmbRgb
RgRsmbRsbRsbRgbRsbRsbRsRsmbRsbRgbLsbRgRsmbRgbRsbRsbRgRsmbRsbRgbRgbLgbR
gbRgbLsbRibRsbRgbRsbRgRsLsmbRgbRgbRgbRgbRgRsmbRsbRgbRgbRgbRgbRsbRsbRgb
RsRsmbLsbRgRsRsmmbRsbLebRobRsbRibRsbRgbRgbRgbRgLsbRgbRgbLsbRgbLsbRibLi
bRgbRibRsLsRsbRsbRsbRsbRgbLgbRgbRgbRgbLsRsbRgLsbRgbRgbRgbRgRsmbRsbRsbR
gbLsbRgbRgbRsRsmbRsbRsbRgbRgbRgbRgbRsbRgbRsbRgbRgbRgbRsbRgbRgbRsbRibLj
bLibLcbRcbRhbRhLsbLgbRibRgbRgbLgbRibLsRsbLobLibRgbLoLsmbRibRjbLhbLibRs
bLsbLibRsbRgbLibRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 27; Drug: Control
bLsbRhbRibLibRsLjbLibLhbRebRgbRibLibLibLibRsbLcbRhRsmbRibRibRgbLsbLibL
jbLibRcbRhbLjbRibRhbRsbRgbRgbLgbRgbRsbRgbRgbRgbLgbRgbLcbLjbLgRsbRjbLib
LibLgbLgbLgbLgbLsbLsbRgbLsbLibRibRgbLhbRhbRibLibLhbRjbRcbRibLsbRsbLsbR
ibRgbLibRibRgbLsbRgbLsRsbRgbRsbRgbRgbLgbRgbLsbRgbRsbRgRsmbRsbRgbRgbRsb
LgbLcbRjbLibLibRjbLibLgbLibLgbLgbLgbLsbLibLgbRsbRsLsbLgbLgbLgbRjbRhbLc
bLgbLibLcbRjbRibRgbRgbLjbLibLhbRjbRhbLcbLibRjbRebLibRcbLcbLibRhRsmbRib
LgbLcbRcbRibLsbRibRsbRsRsmbRsbRsbRgbRsbRsbRgbRsbLsbRjbRgbLsLsmbLgbRibR
gbRsRsmbRsbRsRsmbRsbRsbRsbRiLsbLiLsbLgbRsbLjbLjbLiRsbRjbLibLibRjbLiRsb
RsbLgbLibRsbLgLsLsRsmbRsbLgbLsbLgbRsbLibRsRsmbLhbRgbLgbLgbRsbLgbLsbLgb
LgRsbRjbRcbRgbLjbLibLibRjbLibRcbRibLgLsbRgbLgLsbRgbRsbLcbRgbRgbRgbLsRs
RsmbRgbLgRsbRsRsmbLjbLibRcbRibLsLsmbRsbRibRsbRjbLsbRgbLgbLsbLgbLgbRgbL
gRsbLgbRsLsbLibRsbLibLsbLsLsmbLibRgbLgbLgbLibRibLsbLgbRsbLibRsbLgbRsLs
bLsbLsLsmbRsRsmbLgbRgbRgbLiLsLsmbLiLsbLsbLgbRcRsmbRiRsLsmbRsbLibRibLcb
LobRjbRiLsbRgbLsbRsbRgbRgbRgbLsbRgbRsbRsbRgbLsRsbLibLibRcbRcbLhbLibRgb
RjbLhbLgbRgbLgbRjbLgbRsbLgbRsbLibRcbRjbLjbRjbLcbLjbRhbLgbRjLsbLgRsbLcb
LibRibRgbLcRsbLobRibRjbLcbLibRhbRgbLobLibRjbRhbRiLsbRgbLjbLibLibRjbLib
LibLsbLgbLgbLgbRibRhbRiRsmbLsLsmbRgRsmbRsbLsbRgbRgbRgRsmbRsbLsbRsbRgbR
sbRsRsmbRgbRgbRgbRsRsmbRgbLsRsbRgbRsbRsbLsbRsbRgbRsbRsbRgRsmbRgbRgbLsb
RsbRgbLsbLcbLibRjbLgbLibLoRsbRibLcbRgbLibRsbLibLibRcbRgbLibRibLgbLibRc
bRibRibRibLsbRgbRgbRsRsmbRgbLsbRsLsbRgLsbLgbRgbRsbLsRsbLcbLibLibLgbRib
LibLgbLgbLgbLibLibLsbLiLsbLsLsRsmbLsbRsRsmbLgLsLsmbRsbRsbLiLsbLgbRsbLi
LsbLsbLgbRgLsbLsbRsbLgLsbLsbLgbRsbLsbLsLsmbLgbLgbLsbLgLsbLgbRsbLgbLsLs
LsmmbLsbLgbRgbLgbRgLsbLgbRibRiLsLsmbLibLjbLobRhbRjbLjbLhbRjbRcbLgbRcbL
ibLjbRcbLsLsmbRgbRibLsLsmbRibRgbRsbRsbRsbLjbLcbRibLibLibLibRgbLhRsbRib
LgbLibLgRsLsbRibLhbRjbLibRjbLiLsbRcbLibLjLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 28; Drug: Control
bLgbRsLsbLsbRsbLgbLgbLsLsmbLgbLsbLgbLsbLgbLgbLsbLsLsmbLgbLgbLsbLgbLgbL
gbLsbLgbLgbLsbLgbLsLsmbLgbLgbLgLsbLgLsbLsbLgLsbLsRsRgbRhbRibRgbRgbRgbL
sbRgbLsbRibLgbRibRibLiLsbLsbRiLsbLcbLgbLgbLsbLgbLgRsbLsbLsbLgLsbLsbLgb
RsbLgbLsbLgLsbLsLsmbLgbLgLsbLgbLgbLsbLsbLgbLgRsbLgLsbLgbLgLsbLgbLsbLgL
gbLibLgRsbLgbLgLsbLgLsbLsbLibRsbLiLsbRgLsbLgLsbLsbLhbLoLsmbLebLcLsmbRi
bLobLibLibRgbRsbLgbLhbLsRsbLcbLsbLgbLiLsbRebRcbRibRsbLgbRibRgbRibRsLsb
RgbRsbRcbLibLibRsbRiRsmbRibRcLibLgbLobRsLiRsbRibLsbRibRhbRcbRcLsbRibRj
RsmbRgbLibLibRsbLgbLgbLgbLsbLgbLgLsbLsbLgbRsLsbRsbLsbRebRibRgbRsRsmbLs
bRibLsRsRsmbRcbRhbRgbRsbLibRjRcbLsbRgbLibLoRsbLcbLgbLjbRhbRobRibRgbRgb
RiRsmbRgbRgRsRimbRgbRgbLsRsbRgbRgbRgRibRgbRiRsmbRsRsmbRgbRgbRgRsmbRsbR
ibLsbLgbRibLgbLgbLcbLibLgRsbLiRsRiRiRsmbRsbRcbRgRsmbLsbRcbRcbLhbLibRiR
smbLgbLibLgbRgbLhbRibLcbLibLsRsbLcbLibLibLgbLgbLgbLsbLgRsbLgbLsbLgbLgb
LgbLgbLgbLgbLsRsbLgbLgLsbLgbLibRjbLhbLobRcRsmbRgbRjbRgRsmbRgbRsRsmbRgR
smbLsbRhbLgbRoRsmbRibLibLgbRsbLibLgLsbLsLsmbLgbLgbLgbRsbLgLsbLsbLgbLsb
LgbLsbRgbLsbLgbLgbLgbLgbLgbLsbLgRsbLgbRgRsmbLcbRsbLobLhbLobRgbRgbRjbRi
bRgbRiRsmbLibLgbRcbLsbRgLsbRgRsmbRsbRsbRsRsmbRsbRgRsmbRgbRsbRsRgRgbRgR
gRsLsLsmmbRsRibRgbRibRsbRgRebRgRsmbRsbRgbRgbRgbRgbRibRgbLsbRibLibLgbRe
bRcbRibRjbRhbRibRcbLibRsbLiLsLsmbLgbLsbLgbLgbRibRcLsbRgbRgbRsRgRsRgRgR
smmbRgbRhRsmbRgbRgbRsRsRsmmbRgRgbRgLsRsbRibRsbLjbRgbRhRsRiRsmmbRsRsmbR
gbRgRsmbRgRsmbRsbRgRgRsmbRgbRgbRgbRgbRgbLjbLjbLjLsmbLcbLcbLcLsmbRsLcbL
ibLhbLgbLcRsbRhRsmbRhLsbRcRsmbLgbRibLibRhbRjbRibLgbRibRibLhbRcRsmbRhbR
gbRgbRgRsmbLjbLhbLgbLgLsbLibLiRsbLhbLibLibLsbLcbLcbRhRsRsmmbRcbLjbRebR
cbLgbLibLibRsbRibRcbLgbRibRcLsbRgRsmbLibRsbRibLiLibLibLgbLcbLcbLibsbRs
bLcbRgLsbLcbRsbLobLibRgbLcbRibRibLcbRsbRibRebLiRsbLjbRibRibRsbRsbRgbRg
bRgbRsbRgRsRsmmbRsbRgbRsbRgbRsbLsLsmbLsRsbRgbRsRsmbRgRsmbRsRsRsmmbRgbR
gRsLsmbRgRsmbRsbRgbRgbRgbRgbRsbRgRsRsLsmmbRgbRgbRgRsmbRsLsbRgRsmbLgbRg
RsmbRgbRsRsmbRgbRgbRgRgbRgLsbRsbRsbRsbRobRebRcRsRcRsmmbLcLsmbRjbLiRgbL
gRsbLgRsbLcbRsbRsbRgRsmbRebLibLjbLcbLcbLibLsbRgbRgbLsbLjbLobRibLsbRibR
cRsmbLgbLsbRjbLhbsbRibRsRsmbRsbRsbRgbLsbRgbRsbRgbLjbRgLsbRgbLibLcbLibL
ibRcbLibLcbLiLsbLibLsbRgbLgbLgbLgbLgbLsbRjbLcRsbLibLcbLgbRcbRsbRgbLcLs
mbRgbsbLibRsbsbsbLgbLibLhRsbLcRsRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 29; Drug: Control
bLsbLiLsbLsbLsbLgLsbLgbLsbLgLsbLgLsbLgbLgbLsLsmbLibLgbLibLsbLgbLgRjbLi
bLgbLgbLgLsbLsbLgLsbLgbLsLgLiLsbRsbLgbLsbLgbLgbRsbLgbLgbLgbRibRibLcbLh
bRsRsmbLibLsLsmbLhRsbLibLcbRgbRiLsbRgbRcbLgbRiRsmbRgbLsbRiLsbRsbRibRgb
LsbRibLsRsbRiLsRsbLgbRibRhbRcRhbRgbRibRgbRsbRgbRsRsmbRibRgRiRiRgRsRgLs
mbRgLsRsbRgbRiLsbLhLsbRebLcbRcbRiLsLsmbRcLsbRibRiRibRcbLsbRiLsbRgbRiRs
mbRibRsbLgbLgbRiRsmbRgbRgbLgRibRgRibLsLsmbRibLcbRjRsRsmmbRcbRcbRhbRibL
gbLhbLgbLgbLgbLsbLsbLsbLgRjbLiLsbLsbLgLsbLibRsLsRsbLgLgbLibLgbLsbLgbRs
bLibRsbLgbLgbLgbLgRjbRjbRgRibRgbRgbRgRgRsRgmbLsLsmbRgbRiLgbRsRgbLobRcb
RibLsbLibRhbRibLibLoLsmbRsbLgLibLibRgbLibLgbLgbLibRsbLgRjbLibLgRsbLgbL
cRsRsLsmbLgbLsLsmbLiLsbLsbLibLgbRsbLgbLsbLgbLgbLgbLgbRjbRjRsmbLhbLcRsb
RjbRibRsbRgRsRgmbRsRibRgRgbRgRsRgRgRsmmbRgbRgbRsRsmbRgRsmbRgbRsbRiRsmb
RiRebRgbRgRsmbRibLgbRiRsmbRgbRsbRiRgbRsLsbRgRsmbRibLsLcbLibLibRjbLibLi
bLoLsmbLibLibLgbLgRsbRsbLgbLgbLibLgLsbLgbLgbLgbLgbLgbLgbLgbLsLsmbLgLsb
LsbLgbRsbLibLsLsmbLibLgbLgbLgbLibLgLsLsmbLgbLgbLgbLibLgbLgbLgbLsLsmbLg
bLgbLgbLgbLgbLibLgbLgbLibLsbLibRjbLibLgbLgbLsbRjbLhbLgbLibRgbLibLgbLsL
iLgLsLgLsbLsbLgbLgbLgbLgbLsLsmbLiLsbLgbLgLsbLgbLsLsmbLgbLsbLgbLgLsbLgb
LgbRsbLgbRsLsbLgbLgbLgbLgRsbLgbLibLibLgbLgbLsbLgbLsbLibRgbLibLgbLgbLiL
sbLsRsbLibLsbLgLsbLibLgbLgbLgbLgbLsLsmbLgbLgLgLsbLgbLgbLibLgbLibLgbLgR
sbLgbLsbRsbLgRsbLibLgbLiLsbLsbLibRgbLiRsLsbLgbLibLiRsbLgRsbLiLsbLibLsb
LgLgRjbRiRsmbRibRhbRsRibRibRibRhbRiRsmbLcbLcbLsLsmbRjbLiLibLsLsmbLiRgL
sbLgLhLgLsbLgbLiRsRsLoLgmbsbLibLibLiLsbRjbRcbRgbRsbRgbRiRsmbRiRsmbRsLs
bRsLjbLsLsmbLiLsbLiLsLsmbRsbLgbLibRcbRgbRgRsRgmbLjbRcRsRsRsmmmbLebRhbR
ibLoLsmbLcbLsLsLombLgbLibLibLgbRgbLgbLgbLgbLgbRsLsbLibLgLsbLsbLgLsbRsb
LibLgbLsbLgbRsbLibLgbLgbLgLsbLgbRjbRsRjbRgLsRsbRcbRcbRibLjLibLsLiLsLsm
bLibRgLsbLibRgbLhLsRsbRsbLsbLibLibLsbLibRibLibLsbLgbLgbLibLgbLgbLgbLgb
LsbLgbLsbLgbLgbLsbLgbLsbLgbLsbLgbLgbLgLsbLsLsmbLgbLgbRsbLibLgbLibLsbLg
bLsbLgbLgbLgbLsbLgbLgbLsbLgLsbLgbLgbLsbLgbLgbRsRsLsmbLgbLsbLgbLgbRsbLg
bLgbLgbLgbLsbLgRsbLgbLsbLgLsbLgbLgbLgbLsbRjbLibLibLgbLiRsbLgLsbLibLgbR
ibRgbRgbRibLjbLoRsbRjbLsLsmbRobLsLsmbRhRsmbRcbRcbRibLjLiLiLsbRsbLgLsbL
gbLgbLgLsLsLsmmbLibLsbLgbRsbLgbRsbLgLiLsbLgbLgLsbLsbLiLsbLsLsmbLibLsbL
ibLgbLsRsbLgLgbLgbLgRsbLibLgbLgbLsbLgbLgbLsbLgbLgbLgbLgbLgbLsbLjRsbLgb
RibLiLsbLgLsLsmbRsbRjbRcbLjbLcbRsbLiLhbLiLgLsbLcbRgbLiRgbRjbLsbRobRgbL
gbLibRjbRibLjbRiRibLcbLsLibRjbLjbLhbRgbRebLjbLibLcbRhbLcRgLsLibLsLsmbL
gbLgbRsbLibLgbLgbRgbLibLgbLgbLgbLgbLgbRiRcbLibLibLgbLsbLgbLgbLgbLgbLsb
LgbLgbLgRsbLgbLsLsmbLgbRsLsRsbLiLsbLsbLgbLgbLsbLhLsbLibRhbRcRsmbRgbLsb
RibRibRgLsbLgbLjbLcbRjbRcRsmbLgRsbRibRiLgbRgbLebLhRjbLhbRibRibRibLcLsm
bLhbLibRsbLiLsLsmbRjbRjbLsbRibLsbRibLjbRhbLgbRiRsmbRgbRgbRgbRcbRgbRebL
gbLsbLjbRjbRiLsRsbRgRsmbRgbRgbLiLsbLsbLgLsbRsbLgbLsbLgLsbLsRsbLsbLgbLs
LsmbLibLsbLgbLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 30; Drug: Control
bLibLgbLgbLsbLgbLsbLsbLibLsbLgbLsbRsbLgbLsbLgLsLgbLgbLgbLibLgbRsbLsbLg
bLgLsbLgbLsbLsbLgbRsRsmbLgLsbRsbLgLsbLgLsbLgLsbLsbLsbLsbLgbLgbLgbLgbRi
LsbRcRsmbRibLgLsRsbRgbRcbLhbLcLsmbLiRsRsmbLibLsbLiLsbLibLgbLgbLgbRsbLi
bLgLsLsmbRsbLibLsbLgbLsbLibRsbLsbRcbRgbRiLgbRibRobLibLibRibRgbRibRibLg
bRoLibLjbRjbLibLsLibLgbLgbsbLgLsbLgbLgRsbLsbLgbLsbLsbLgbLgbLsbLgbLsbRg
bLgbLgbLgbLsbLgbLiLsLsLsLsmmmbLgbLgbRsbLibRsbRcbRibRhLibLobLsbLgbRsbRe
LsbRibRcbLibRcLsLsLimbRcbLibRhbRcLsbRibRibLhbRibLiRsbRibRiLsbLgbLcbLib
RgLsbLsbLibRsbRgbLhbLcbLhbLjbRjbRgbRiRsmbsbRiLsLsLgmbRhbLjbLobRsbLcRib
LsbLgbLgbLgLsLgLsbLgLsbLsbLgLsbLsLsmbLgbLsbLgLsbLgbLgLsbLgbLgbRgRsmbLi
LsbLsbLgLsbRgbLgbRebRhbLgLsbRibLjRoRsmbLgbLcbLgbLgbLgbRsRsmbRebLcLiLsb
LsbRobRjbRcbRibRgbLjbLoRsbLgbLgRsbLsbLgRsbLsbLsLsmbLgbLsbLibRsLsbLgbLg
bLgbLsbRgbRobRibLcbLibLsLsLsLsmmmbLsbLgLsbLsbLsbLgbLgbRgbLibRibLibLgLs
bLiLsbLgbRsbLgLsbLsbLgbLgbLgbLgbLgLgbLgbLgbRgbLibLgbLgbLgbLgbLsbRhbLeb
LiLsRsLsLsRsLsmbLgLsRsbLgbLgbLgbLgbLsbLgLsRsRsmbLibRsbRcbLibLibRsbLiLs
bLiLsbLsbLibLgLsbLgbLgbLgbLsbLsLsmbLgbRhbRiLgbRibRobRhbLgRsbRgbRibRcbL
iLibLibLgRsbLiLgbLgbLgbLgLsbLgbLgLsbLgbLgbLsbLgLsbLsbLgLsbRgbLibRsLsbL
sRsbLsbLgLsbLjbLsbLsLibLsbLgbLgbLgLsLsmbLsbLgbLgbLsLgbLsLsmbLgbLsbRsLs
LgRsLgbLgbLsbLgbLgLsbLiRsbLobRibRcRsmbRibLgbLibRjbRibRcRsmbLsLiLsbRcbR
ibLgbRibRgbRibLjbLobLsbLhbLsbLiLsbRgbLgLsbLsbLiRsbLcRsbRibRiRsmbRgbRgb
RgbLobLhRsbLsRsbRsbLcbLsbLgbLibRibRjbRgbLcbRgbLgbLgRsbLgLsbLgbLsbLgbLg
bLgbLgbLsbRjbLibLsbLiLsbLsbLgbLgLsbLgbLgbLsbLiLsbLsbLgbLgbRsbLibLgbLgb
LsbRobRibRsLcbLgbRsbLgbLgbLgbRsbLgbLsbLibLsbLobRsbLoLsmbRgbRibLobLiLsb
LgbLgbLsbLibLsbLsbLgbRgbLcRsbRsLsbLhbRiLsbRcbRcbLibRibLibRhbLgbLcbLibR
gbLgbLgbRsbLibLibLgbRgLsbRjbRcbLgbRgRsmbRsbRgbLsbRoLibRibRgbRgbRcbLsLs
LimbLobLcLsmbLibLgbLobLgbLsbLgbLgLsbLsbLgLsbLgbLgbLsbLgbLgbLgLsbLsbLgb
LsbLgbLsbLibRsbLjbsbLgbLgbLsLsmbLsbLsbLgbLgbRgbLsbLibLgbLgbLgbLsLsmbLs
bLsbLgbLgbRsbLgbLgbLgbLibLgbRjbLgLgLiLsLsLsmmbLgbLsbLsbLibLgbLsbLibLsb
RjbRcbRsbRoLsLibRobRibRibLgLsbRgbRiRsmbRgbRgbLgRoLibRsbRhbLjbRhbRobLgb
LibLibLibLsbLibLsbLgbLgbRsbLgbLsbLgbLgbLgbRsbRsbLibLgbLsbLgbLsbLgLsbLs
bLgbLgLsbLgbLgbLgbLgbRsbLgLsbLgbLgbLgbLsLsmbLgbLgbRsbLibLgbLgLsbLgbLgb
LgbLgbLsbLgbLgbLgbLgbLgbLgLsbRsLsbLiLsbLsbLsbLgLsbLgbLgbLgbLgbLgbRsbLi
bLiLsbRsbLgbLsLsmbLgbLsbLgLsbLgbLgbLgbLsbLgbLsbLgbLgbRsbLibLiRsbLgbLib
RgbRcbLcLcbLibRcbRgbLobLsbLsbLhbLsbLsbLsbLibRsRsmbLiLsbLgbLsLsRsmbLgbL
gbLgbLgbLgbLgLsbLsbLgLsbLiLsbLgbsbLgLsbLgLsbLsbLgbLgbRsLsbLgbLsLsmbLgb
LgbLsbLgLgbLgbLgbLgbLgbLgbLgbLgbLsbLgbLgbLgbLgbLibLgbLgbLsbLgbLgLsbLgb
LgbLgbLgbLgbLgLsbLsbLibRobRoLsbLibRhbRcLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 31; Drug: NDMC 1 µM
bLsbLsbLsbLsRsbLsbRhbLgLsbRiLsbRsbRgbRgbLsbRgbRsbRgbRsRgbRgRsmbRgbRgbL
gbRgRsmbRsbRibRgbLsbRibRgbRibLgbLgbRiRsmbRgbLsbRgbRgbRsbRgbRgLsbRgLsbR
gRsmbRgbRsbRibRibRibLiLsbLgbRsbLibLgbRsLsbLgbLgbLgbLgbLgbLgLsbLgLsbLsL
smbLgbLsRsbLsLsmbLsbLsbLiLsbLgbLgLsbLgbLgbLgbLgRsbLgbLgbLgbLgLsbLgLiRs
bLgLgbLsbLgRsLsbLsbRsbRjbRibRibRgbLibRiRsmbRsbRgbRsbRibLebLibLsbLsbLgL
sbLgbLgbLgbRsLgbLgbLgbLgbLgLsbLgbLgbRgbLibLgbLgLsbLgLsbLgbLgbLgbLgLsbL
gLsbLsbLsbLsbLgbRhbRcbLsbRibRibRgLsbLsbsbLgbRhbLgRsbRibRgbRgbRsbRgbRsb
RgbLgbRgbRcLsbLibLjbLibLgbLgLsbLgbLgLsbLgbLgLgbLgbLgLsbLsbLgbLgbLgbLgb
LgbRoLsbRcRsmbLjbLibLgbLgbLgbLgRsbRsbRcbRibRibRibRibRsbRgbRsRsRsmmbRsb
RsbRgbRgRgbRgRgbRgRsmbRsLsbRgbRgbRsbLsbRhLsbRiLsbLibRiRsmbRsbRibLgbRib
LgbRhbLgbRibRibRgbRsbLgbRibRibRsbRgbRibLsbRgbLsbRgLsbRhbRsbRgbRgbRgbRi
bLsLsmbLibLhbLsbLgbRsbLgbLgbLgbLsLsLsmmbLsLsmbLgLsbLsbLgbLsLsmbLgLsLgb
LgLsbLgbLgbLsbLgbLgLsbLsbLgLsbLgbLgbLsbLgbRsbRcbRibLgbRibLsbRibLgbRhLs
bLibRibLgbRibRibLsbLcLsmbLgbLgbLgbLgLsbLgRsbLgbLgbLgbLsbLgLsbRhbRcbLjb
RibRgbRgbLsRsRsLsmbRgbRgbsbRgbRgbRsbRgbRsRsmbRgbLsbRgbRgRsmbRsLsbRgRsm
bRsbLsLjbLcbRjbLcbRgbLibRsbLgLsbLgbLgbRsbRjbRhbRobLibRjbRibRsbLibLsLsm
bLgLsbLsbLgbLgbLgbLgbLgbLsbRcLsbRibRibRcbRibLcbLcbRsbLibLgbLgbLgbLsbLg
bLgbLsbLgbRsbRjbRcbRibRsbRibRibRgbRsbLibRgbRjbRgbRsbRsbRibLsbRgRsmbRgL
sbRgbRgLsbRgbRsbRgbRgbRgbRgbRgbRsbRibRsbLcbRibRgbRsLsbRsRsmbRgbRgbRibR
gLsbRgbRgRsmbRsbRgbRsbRibRgbRgbRgbLgbRgbRsRibRibLgbLcbLcbLibRsbRibRgbR
gbLjbLhbRcbRcbRibLhbRibRsbRsbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgbLs
bRjbRgbLjbLobLcbRcbLcLsmbLcRsbLhbRibLsLsmbLebLsbLgLsbLcbRibRjbRibLsbRg
bLebLcbRiLsbLibLcLsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 32; Drug: NDMC 1 µM
bLoRsbRibLgbLgbLgbLsbRsbLjbsbRgRsmbLibRgbRibRgbLjLhbLibLgRsbRsbLibRsbL
gbLgbRsbLgLsbRsbLgbRsbLgbLsbLibRgbLibLgLsbRgbLgbLsLgbRsbLgbRsbLsbLsRsb
LgbLgbLgbRsbLgbLgLsbLgLsbLgbLsRsbRjbLgbRsbLsbRjbRgbRgbRibRgbRgbRsbRsbR
gbRgbRgbRsbRsbRsbRsRsmbRgbRsbRsbRgbLsbRsbRgbLsbRgRsmbLsbRsbLsbRgbRsRsm
bRsbRsbRsbLsbRgbRgbRsbRsbRsbRsbRgbRgbRgbRgbRsbRsbRgbRgbLsbRibLsbRgbRgb
RgbLsbRsbRgbRgRsmbRgbLsbLsRsbLjbRibRsbsbRgRsmbLsbRgbRgbRsbLsbRgbRsbRgb
RsbRsbLsbRgbRjRsLsmbLsbRsbRgbLsbRsbRgRsRsmmbRsbRgbRsbRgbRgbRgbRgbRsbLs
bRgbRgbRjbRibLsbLsbLjbLgbLsbRjbRibRgbRgbLsbRgbRsbRgbRsbRgbRsbRsbRsbRgb
RgbRsbLsbRgbRsbRgbRgbRgbLjbRgbRgRsmbRgbLjbLcbRsbLibLibRjbLgbLgbRjRsmbL
gLsbLiRsbRgbLgbRsbLibLhRsbRcbRgbRgRsmbLsbLsRsbRgRsmbRsbRgbRsbRsbRgbRgb
LgbRgbRsbRgbRgRsmbRsbRgbRgbRgbRsbRsbRsbRgbLsbRgbRgbRgbRsbLsbRsbRgbLjbL
ibLibLibRgRsmbLgLsbLibRibLcbLibLibRsbRibLgbRgbLibLgbLgbLgbLgRsbRsbLgbL
sbRsbLgbLsbLibRsbLgbRgbRhbLjbLibRsbLibLibLibRiRsRsmmbRgRsmbLsbRibRgLsb
RiRsmbLgbRsbRsbRgbRgbLgbLibRsLgbRsbLhLsbRjbLgbLsbLibLgbLgbRsbLgRsbLgbR
gbLsbLibLcbRjbLibLibRsbRgbLobRgbLibLgbLhbRjbLibLgbLibRobRcRsLsmbLgbRib
RgLsbRgbRgbRgbLsbLjbLhbRjbRsbRgbLgLsbRibRgbRgbRsbRgbRgbRsbRgbRgbRgbLsb
RgRsmbRgbLsbRsbRsLsbLsbRgbRgbRsbLsbLjbRhRsmbRgbLsbLsbRgbRibLsbRgbRsbRs
bRsbRsRsmbRgRsmbRsbRsbRgbLsLsmbRgbRgbRsbRsbRsbRsbRgbLsbLsbRgbRibRgRsmb
LgLsbRsbRgbRsbRgbRsLsbRgbRsbRgbRsLsbRgLsRsbRsLsbRgbRgbLsbRgRsmbLsbRsbR
sbRgbLjbRjbRibRsbRsbRibLsbRhRsmbLibRgbRsbRgbRgbRsbLgbLsRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 33; Drug: NDMC 1 µM
bRibLgbRibRsbRsbRgRsRsmmbRgbRcLsbLgLsbLsbLgbRibRibRibLjbRiRsmbLcbLibLg
bLibLgbLgbLgRsbLgbLgbLgbLsbLsbLsbRsRsmbLgbRsbLgbLsbRsbLsbRsbLgbLgbLsbL
gLsLsmbLgbRsbLsbLibRcbLibLibLgbRsbLibLcbLhbLibRhbRhbLsbRibLibLiLsbLibL
hbLgRsbRgbRgRsmbLsbRibRgbLgRsbRibLjbRgbRibRsbRgRsmbRsbRgbLsbRgbRsRsmbR
sbRsRsmbRsbRsbRgbLsbRgbLjbLeLsbLibLgbRsRsmbLgbRgbRibLjLsmbRjbRibRibLgb
RibLsRsbRsRsmbRgRsmbRsbRsRsmbRgbRgRsmbLsbRgRsmbLsbRgbRgbLgbRgRsmbLsbRg
RsRsmmbLsRsbRsbRgbRibRsbRgbLgbRibRibRhbLgbLgbRibRsbRgbRcbLgbRsbRsRsmbR
gbRgbLgbRgRsmbRsbRgbRgbRgbLgbLsbRibLsbRibRiRsmbLjbRgbRgLsbLgRsbRgRsmbL
sLsmbRsRsmbRsbRgLsbRgbRgbRgbRsRgRsLsmbRgRsmbRsbRgRsmbRibRgbRgRsRsmmbRi
bRgRsmbRgbRsRsmbRsbRhbLsbRibLsbRgbRsbRibLgbRibRsbLsbRgbRgbLsRsbRsbRgbL
sRsbRgbLsbRgbLsbsbRgbLsbRgbRsRsmbRsRsmbRgbRgRsmbRsRsmbRsbRsRsRsmmbRsbR
gRsmbRgbRgbRgbLjbLjbRibRgRsmbLjbLibRcbRgbRgbRgbRsRsmbRsbLsbRgbRgbLgbRg
LsbRsRsRsmmbRsbRgRsLsmbLsbRgRsmbRgRsmbRgbRgbRsRsmbRsbRgbRgLsbRsbRsbRgb
LsbRgbLsbRgbRsRsmbRsRsmbRsbRsRsmbRgbRgbRgbRgbRsRsRsmmbLsbRibLsbRgRsmbR
gbRgbLsbRgbLsbRsbRgbRgbRgRsRsmmbRgRsmbRgbRgbLsbRibLsbRgbLsbRgRsmbLsbRs
bRgbRsRsmbRsRsmbRibRsRsmbRsbRgRgbRgbRgbRgbRsRsmbRgbRgbLsbLibRgbLgbRiRs
mbLibLhbLibRcRsmbRcbLgbRsbRoLsbLsbRiRsmbLgbRhbLgbRhbLgbRibRgbLsRsbLsbR
ibRiRsmbRgRsmbRgRiRsmbRgbRsbRgbRgbRiRsmbLgbRibRhbLgRsbRiRsmbLgbRcbLsbR
gRsmbRgbLgbRgbRsbRgbLjbLcbLhRsbLibLsbLibRgbLgbRsbRgbRhRsRsmmbLgbRsbRib
RiRsmbLsbRibLgRsRsmbRiLsbLgbRibRibRibRgbRgbRsbRgRsmbRcbRiRsmbLibLgbRcb
LibLcbLibRhRsRsmmbLgLsbLibLibLsbLcbLcbRibLcbLgbLhbLhbRibRgbRcbLgRsbLsR
sbRibLibRibRsRsmbLsbRsbRgbLsbRiRsmbRsbsbLsbRgbRgbLgRsbRsbRgbRgbRgbLgbR
gRsmbLsbRibLsbRgRsmbRsbRsRsmbRgbLsbLsbRiRsmbRsRsRsmmbRsbRgbRsbRibRgbRg
RsRsRsmmmbRsbRgbRcbLgbRibLjLcbLiRsbRjbLcRsbRjbLhbRjbLhbRcbLjbLcRsbRjbL
hRsbRsbRibRcbRsbRgRgbRgRsmbRsbRgbRgbRgRsmbLgbRibRgbRibLgbLsbRgbLeRsbLg
bLgRsbLgbLgbLgRsRsmbLsbLgbLgbLibRjRgbRoLsRsbRibLgRsbLsbRibRibLsbRibRsL
cbLibRgbRibRgRsmbRgbLgbsbRibLiRsbRibRhbRcbRsbRibRibLsbRibRsbRgbRsRsmbL
sbRgRsmbRgbRsbLsbRgbRgbRgbRgbRsbLibRgbRibLgRsbRgbLsbRsbRsbRiRsmbLsRsbR
sRsLsmbRgRsRsRsLsmmmbRgRsmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 34; Drug: NDMC 1 µM
bLgLsbRsLsbLgLsLgLsLsLsmmbLgLsbLgRsbLgbLsbRsbLgbLsbLgbLgbRsRsmbLgbLgbL
gbLgbLgLgLsbLsbLgbLsLiLsbLsbLgbLgLsbLgRsLsbLgbLsbLgbLgbLgRsLsbLgLsbLgb
LgbLgbLgbRgbLgbLiRsRsmbRebLgbLgRsbRsLsbLibLgbRgbLgbLgRsbRsbLgbLgLsbLib
LcbLibRibLibLcLsmbLibLgbLgbLgbLibLsbLgbRgbLgbLibRsbLgLsbLibLiLsRsbRhbL
sbLibRjbLgbLgbLgbLgLsLsmbLsLsmbLgLsLsmbLsbLgbLgLsbLsbLgbLgbLgbRsLgbLgb
LgLsbLgbLsbLgbLgbLsbLibLibRhbRibLcbLiLsbRgbLgbLiRsbLibRhbRibLsbLcbLibR
jbLsbRibRibLcbLcbRjbLiLsbLgbLhbRgbLibLibLsbLibLibRgbLgbRgbLibLgRsbRgbL
ibRsbLgbRsLibLsLsmbLgbLgbLgbRsLsbLiRsRsmbLgbLgbRsbRsLjbRcLsbRhbRcbLcbL
hbLibLgbRsbLibLsbLgbLgbRsbRsRsmbLibLsbLgLgRsbLgbLsLsLgmbRsLgLibLgbLgbL
gLsbLgbLiLsLsmbLgbLgbRjbLgbLgLsbRgbLgbLgbLgbLgbRsbLgbLgbRsbLibRsbLgLsb
LsbLgbLgLgbRsLgbRsbLgbLsbLgLsbLgbRsRsmbLgbLgbLgbLgbLsbLgbLsbLgbLsbLgbL
sLsmbLgbLsRsbLgLsLsmbLgLsbLsLsmbLgbLsbRsRsmbLibLgbLsbLsRsbLgbLgLsbLsRg
bLgbLiLsbLgbLgbLgbLibLibLibLibLibRjbRcbLcbRcbRgbLcLsmbRcRsmbRibLgbLgbR
cbRcbLebRibLibLgLsbLhbLhbRibRsbLibLibLgbLgbLgbRgbLhbRibLibLibRsbLsLsmb
LgbRsbLgLsbLsbLsbLgLsbRgbLgbLgbLsbLgbLsbRsbLgbLgbLgbLsLsRsmbLsRsbLgbLg
bRsbLgbLgLsbRcbLjLsLcLsmmbLiRsbLgRsbRsbLgbRjbRibRgbRhbLibLcbLiLsbLibRh
bLibRsRsmbLgbRsbLgbRcbLcbRgbLibLsbLgbLibLgbRjbLibRsbLibLibLcbLibRibRgb
RgLsbLgbLibLhLsLsmbLibRibLgbLgbRjbRsbLcbRgbRcRsmbLsbLibLibLiRsbRjbLibL
jbRjRsmbRibLsbLsbRgbLsRsbRsRgRsmbRsbRsbLsbRgLsbRgRsmbLsbRgbRgbLsbRgbRs
bLibLgbLibRsLsbRgbLgbLsbLsLibsbLsbLgbLsbsbRsbLgRcbLsbRibLsLsmbRsRsmbRs
bRgbRsbLsbLjbRhbRgbLsbLibRjbLgbLibLgbRjbLsbLgbLgbRsRsmbLsRsbLgbRsbRsbL
gLsLgbLsbLsbLsbLgbLgbLsbLgbLsbLgLsbLsbLgbLsbLgbLibRjbLibLgbLsbRhbRcRsm
bRcRsmbRcRsmbLcbRcRsmbLgbRibRsbLsbLcbRebLibLjbLibRibRcbRcbRiRsmbRsbLsb
LhbRgbRgbLcbLibLibLsbLgbLgbRsbRsbLibRsbLgbRgbLsbLgbsbRsLgbLjLiRsbLsbRs
bLsbLgbLibRjbRhbRgbLjbLcbLhbRjbRsbLibLibRibRibLsbRiRsmbLeLsbLgbLgbLibL
gbRsbLgbLsbRsbLgbLsbLgbRsbLibRsbRsbRjbLsbLjbLgbLsbLsbLgbLgbRgbLgbLsbLs
bLgbLgbLgbRsbLibLiRsbLsbLibRsLgbLgbRjbRcbRibLobLhbRgRsmbLgbRsbRsbsbLgb
LiLsRsbRgbLgbLgbLsbLgbLgbLsRsbLsbLgLsbLsRsbLsbLgbLgbLgbRjLsLcbLibRcbLg
bRsbRibRibLjbLcbRsbLibLgbRjLsbLgRsbRjbRibRgbRibLjbRibLcbLibRibLcbLsLcL
smbRsbRjbRibRgbRgbRibLibRgbRsbRibRsbRibRsbRgbRibLibRibRibRsbRibLsbRgbL
sbRgbRsbRgbRsLsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 35; Drug: NDMC 1 µM
bRgbRsbRibLsbRhbLhbLcLsmbLiLsRsbLsLsmbRebLjbLiLsbLgbLsLsLsmmbLiLsbLiLs
bRsLsbLibRsbLiLsbRgLsbLibRjbsbLibRgbLiLsbRcRsmbRibLgbLjbLcbRiRsmbRgbRs
bRgbLgbRibRcbRibLibLiLsbLsbLibReLsbRibRiRsLsmbLgbRibLgbRhbRgbLibLjbLsL
ibLgLsbLgRsLsbLgbLibLgLsbRsLsbLiLsbLibLibLgRsbLibLiLsbLsbLiRsbLiRsRsLs
mbLibLibRsbRgbLiLsbLgbLsbLibLgbLsbRgbRcbLibLibLibLibLibRgbRibLsbLgbLhb
RcbRcbRcbLhbLhbRsbLsbLgbLhbLibRibLhLsbRgbLibLgbRsbLgbRsLsbLgbLgbLgLsbL
gbLsLsmbLgbLgbLsbLgRsbLgLsbLgbRhbRibRgbRgbRgbRgbRgbLgbLcbLibLibRjbRibR
ibLgbLsLsmbRgbRsbRgLsbRsRsmbRsbRibLsbRgbRgbRgbLjbRhbLjbRjbRsbRgRsmbRsb
RibRgbRiLsbRgbLjbLcbRjRsmbRcRsmbLcbLcbLibRcbRcRsmbRgbLsbRcbRcbRgbLibLg
bLibLibLibLhbLgbLhbLibLsbLibLibRgbRhbRiRsmbRgbRsbLsbRgbRgbRgbRgbRgbLjb
RhbLsRsbRsbRibLsbRhRsmbRiRsmbRgRsmbRiRsmbLgbLcbLsLiRsbLibRiLsbLibLgLsL
smbRsbLibLoLsLsmmbLjbLibLobRibRobRhLsbRcLsbLcLsmbLcbRiLsbRhLsbLibLjbLg
bLgbLibLiLsbRsbLgbLsbLgbLsLsmbRsbLsbLgbLibRgbLibLibLsbLgbLgbRgbLgbLiLs
bLsbLgbRsbLgbLsbLgbLgLsLgLsbLgLgLiLsLgLsLgLsLibLgbLsbLsLsmbLgbLgLsbLiL
sbLsbLgbLgbLibLsbLibRibLibLiLsRsbLgLsbLsbRcbRhLsbLsbLjbRhLsbLjbRcbLibL
jbLibLibLsRsbLgbLsbRobRgRsmbLsbLgbRibLsbLsbRhbRgbLjbRibRgbRcLsLsmbRibR
gbLgbLjbLjbsbLsbLibLiRsLsbLibLibLibLgbLgbLgbLibRsRsmbLibRcbLibRcbRcbRs
bLjbLsbLibRobLcLsmbRjRsmbLhbLgbLibRgRsmbRgbLibLhbRjbLibLiRsbRibLgbLibR
sbLgbLgbRgbLgbRjbRibRibRgbRibLjbLcbRsRsmbRgbRibLcbLibLhbRsbLsbLibLgbLi
bLgbLgbRsLsbLibRgbLsbLibLibRsRsmbLgbLgbLgbRgbLibLgbLgbRsRsmbLgbLgbLsbR
sbLibLgbLibLiRsbLgbLgbRibLgbRhbRgbLcbLibLsbLibLgbLsLsmbLgbRsbLgLsbLsbL
sbLiLsbLgbLsbLsbLgbRgbLibLsbLsbLsbLiRsbLgbRsbLibLsbLibLgbRgbRgbLibRibL
iLsLibLgLsbLgLsbLgbLibLgbRsRsmbLibLsbLsbLgbLibLibRgRsmbRibLibLibRsRsmb
LibRsbLgbLgbLsbRsbLsbLibLgbLgRsbLsbLsRsbLibRsbLibLibRsbLgRsbLibLsbLgbR
sbLibRgbLhbLhRsbRibLibRjbRcbLgbRgbRibLjbLcbLibRjbRsbRcbRiLsbRgbRgbLsbR
gbRgbRgbRgRsRgmbRgRsmbRsbRsbRibLsbRgbLgLobLcbRibLibLibRsbLgbLgbLgbLgbR
ibRgbLoLsmbLibLsbRjbRhbLcLsmbLcbRibLoRsbRcbRcRsmbLgbRibLsbRsRsmbRibLsb
RibLgbLjbLhbRcbRcbLgbLjbLgbRcbRibRsbLgbRcRsmbRsbLsRsbRiRsmbRiRsmbLjLcR
sLsbLcRsbRjbLibLgbRsbLjbLibRiRsmbRjLsbLhbLibRjbLibLsbLsbLibLibLsbLgLgL
gbLiLsLgbLgbLgLsbLsLsLsmmbLgLsbLgbLsbLgbLgbLiLsLsmbLgbLgbLsbLgbLgbLgbL
gLsbLgbRsLsbLgbLsbLgbLsbLgRsbLibLgbLsLsmbLgLsbLgbLgLsbLgLsLgLsLiLibLgb
LsLibLgbLiLsbLiLsLsmbLsbLsRibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 36; Drug: NDMC 1 µM
bLjbLcbLcbRiRsmbRhbRcbRcbRsbRibRgbLhbLgbRcbRcbLsbRcbRsbLsbRibRgbRhbRgb
RibRgbRgbLebLcbLeLsbRibLhbLsbsbLjbLcLsmbLibLsbLcbRcbRcRsmbRcbLhbLgbLgb
LibLsbLsbLsbRcbRibRibLjbLhbLibRcbRcbRibRibRibRibRsbRsbRgbRgbLhbRebRcLs
bLibRibRhbLibLjbLhbLgbRhbLibLgbLebLcbRcbRibRcbLebLcbLibRcbLcbLcLsmbRiL
sbLhLsbLiLsbLibLsbLgRsbRjbLcbLcbReRsmbRgbLsbLobRcbRhLsbLgbRjbLcbLcbLsb
RibLibLcbRibLcbRibRcbRobLibLibLcLsmbRibLgbLibLcbLibRiRsmbLhbLebLgbRibL
sbLcbLsbRibRobRcbRcbRibLcLsmbLsbRcbLcbRobRgbLibLgLsbLgRsbLibLgbLjbRjbL
sRcbRgbRcLsbLibLhbLgbLgbRobLjbLjbLgbRibLgbLoLebRcbLsbLgRsbLgbLhbLgbRcb
RcbRiRsRsmmbLibRibLsbRibRgbRiRsmbLiLsbLsLsmbRobLsbRibRibRgbRgRsmbRgLgb
LjbLcbLgbLgbRcbLibLgLsbLsbRjbRcbLgbRgRsmbRgbRhbRcbRibLibLgbRobRibRgbLg
bRsbRibRgbRcbRibLgbLgbRgbRibRibRibLjbLjbLibLcbLcbRobLsbRhLsbLibLhLsbLs
bLgbRcbRsbRiLsbRcbRhbRibRjbRhbRibRcbRibLibLsbLibLgbLibLcbLgbLibLebLcRs
LsbRgRsmbRcbLibLibLibLsbRoRsmbRebLebRcbLebRcbLjbRhRsmbRsbRsbRgRsmbRsbR
gbRgbLjbRiLsbLsbRhbLibLoLsmbLibLsRsbLibLibRcbLsbRcbLibRibRibRcbRcbRcbR
gbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 37; Drug: NDMC 3 µM
bsbLhLsbLgbRibRibRgbLiRsbRsbRibRibLgbRiRsmbLgbRiLgbRebRibLibRgbRsLcLsm
bRibRibLcbLcbRgRsmbLcRibLcLsmbLobRgbRibLhbRgbRibLhbLibLcbRgbRiRsRsmmbR
gLsbLcbLhbLhbRgbRiRsmbRjbLcbLibLiLsLsLsmmbLsLsmbLiLgbLsRsbLgLsbLsbLgbL
sbRsLsbLsLcRgbLgLhbRgbLibRsLsbLcRsbRgLsbRcRsmbRibLgbLibRhbRjRsmbLgbRcb
LgLsLsRsmbLjbRibRcbLgLsbRcbLgbRibRgbLcRsRsmbRgbLibRsbLgbLsbRsLsbLgLsbR
sbLiLsbLsbLibLgbLgbLgbRsbLgbLibLgbRjbLibLcbLsbRgbLcbLibRiRsmbRibLebLcb
RgbRibLhbLcbRsbLhbLsbRgbLgbRgbRibRsbLsbRibRsRsmbRgbRsbRibRcbRibRibRjbR
cbRibRibLsbRgLsbLgbRgbRgbRibRsRsmbRiRsmbLsRsbRgbRsbRgbRgRsmbRsbRgbRgRs
mbRsRsmbRsbRgRsmbRsRsLsmbRibRgbLgbLjbRiRsmbRsbRgbRgbRsbRgbRgRsmbRgbRsR
smbRgbRgRsmbRsbRsbRibRgbLgbRibRgbLsbRibRsbRgbLsbRibRibRhbLibLsbRgbLjbR
cbRibRsbRgbRgbRsbRgRsmbRsRsmbRgbRgbRgbRgbRgbRgRsmbRgRsmbRgRsmbRgbRsbRg
bRsbRgbRibRsbRgbLebLcRsbLcbLgbRgbLjbLcbLcbRgbLibLsbRibRiRsmbLsbRibRsbR
gbRgbRibLgbRibRsbRgRsRsmmbLsbRibRsbRsbRibRsbLsbRgbRsbRgbRiRsmbRgbRgbRg
bRsbRibRsLsbRgbLebLhRsLsbRgbLhbRgbRjbRiRsmbRibLebLhbRiLsbLhLsbRgbLibLi
bLcbRgbLgbLcbRjbRjbRibLcbLcbRjbLibRjbLcbRjbRhbRibRgbLgbRgbLgbRiRsmbRsb
RgbRiRsRsRsmmmbRsbRibLgbRiLsbRsbRsbRibLgbRibRsbRgbRgbLsbRibLsbRibLsbRg
bLsbRibRgbLgbRibRgbLsbLgbRcbRcbRgbLgbRgbRiRsmbLcbRebRcLsbRcbRsbRsbRibR
cbLgbRibRibRibLibLibRgLsbRobRibRibLibRgbRcbRiLsbLgbRjbLgbLgbLcbRcbRibR
gbRibRibRibRibRgbLcbLsbRhbRgbRibRsbRibRsLsRsbRibRsbRgbLgbRibLsbRibRibL
sbRgbRgbRsbRgbLgbRgbLsRsbRgbRsbRgbRgbRibRibRibRgbLiLsbLibRhbRibRsRsmbL
gbRibRgbLgbRgRsLsmbLsbRsbRgbRiRsmbRsRsmbRsRgLsbRsbRsbRgRsmbRgbRgbRgbLi
bRgRsRsmmbRgRsmbRsbRgRsmbRgbRgbRgRsmbRsRsmbRgbRgbRibRsRsmbRgbRgbRgbRgb
RgbRgbRgRsmbRgRsmbRgbRgbRiLsbRibLebLcbRjbRcRsLsmbRibRsbRgbRsbLcbRjbRib
RsLsbRibRsbsbRgbRgbRgbRsbLsbRiRsmbRgbLsbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgb
RgbLsbLhbLcRsbRjbLcbLcbRgbLibRsbLibRgbLibLcRsbRibRhbRibRgbLsbRibRgbRgb
RgbRgbRibRiLsLibLsRsbRibLjbLcRsbRiLsbRcbRgbLibRsbRgbRgbRgbRgbRsbRgbRsb
RsbRgbRgbRgLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 38; Drug: NDMC 3 µM
bRsbRsbRgbRgRsmbRsbRgbLsbRgRsmbRsbRgbLsbRibRsRsmbRgbRsbRgRsmbRgbRgbRgb
RgbRgbLsbRgbRsRsmbRgRsmbLsbRgbRsbRgbRgbRgbRgbRiLsRsbRibRsbRgbRgbRgbRgb
RgbRgbLgbRibRgRsmbRsbRgbRsbRgbRsbRgbRgbLsLsmbRgRsmbRiRsmbRgbRgbRgRsmbR
gbRgbRsbRgbRgbRgbRgRsmbRgbLsbRgbLsbRgRsmbRgbRibRibRgbLgbRcbLgbRibLsbRi
bRsLsbRibRsbRgbRgbLsLgbRibRgbRgbRsbRiLsbRsbRgbRgbRgbRgbRgbLsbRibRsbRsb
RgRsmbRgRsmbRgbRsLsbRgbLsLsmbRgbRgbRgRsmbRgbRgbLsbRgRsmbRgbRgbRgbRgRsm
bRgLsbLgRsbRibRsbLsLsmbRgbRgLsbRgbRsbRgbLsbRgbRsRsmbRgbRsbRgRsmbRgbRsb
RgbRsbRsbRgbRsbRgbRsRsRsmmbRgbRsbRgRsmbRgRsmbRsbRgbRgbRgbRgbsbRsRsmbRs
LsbRgbRgbRgbRgbLsRsbRgbRgbRgbRgbLsbRgbRsRsmbRgbRsbRgbRgbRgRsmbRgbRsRsm
bRgbRgRsmbRgbRgbRibRgbRgbRiRiRsmbRsbLcbLcbRgbLiRsbLibRgbLibRsbLibRsRsm
bLiLsbLsbRsRsmbLhLsRsbRsbRsLiLsbsbLgbLsbsbLgLsbRsRsmbRibLeLsbLcbRgbRgb
RcbLjbRibRcbRhbRgbRibLgbRiRsmbLjbRcbRgbRsbsbRgbRsbRsbRgbRsbRgbRsbRgbRg
bRgbRgbRgbLsLsmbRibRgRsmbRgbRgbRgbRgbRgLsbLgbRgbRgRsmbLsbRgRsmbRsbRgRs
mbRgbRgbLsbRiRsmbRgbLsbRgbRgbRgbLgbRibRgRsmbRgbRsRsmbLsbRgbRsRsmbRgbRs
RsmbRgbLsbRgbRgRsmbRsbRgbRgbLsbRgRsmbRgLsbLsLsmbRiLsRsbRgbRsbRgbRgbRgb
RgbRgbRsbRgbRsRsmbLsLsmbRsRibRgbRsRsmbRgbLsbRgbRsbRsRsmbRgbLsRsbRgRsmb
RsbRgbLcbRhbRiRsmbRsbRgbRsbRgRsmbRgbRgbRgRsmbRgbRgRsmbLgbRjRsRsmmbRcbR
ibLsbLibLibRjbLhRsRsmbLhRsLsbRgbLibLsbLiLsbRsbLibRsbLcRsbRgbLcbLcRsbRi
bRjRsmbLcbRibLcbRgbLiLsbLibRgbLibRjbLibLcbRgRsmbRhbLhLsbLiLsbRsRsmbLjL
sRsmbLibRsbRsRsmbLibRgbLgbLgbLsbLsRsbLgLsbRsbLgbLgbLgRsbRsbLibRiLsbLib
LsbLhbRjbLcbLcbLsLsmbLhbLibRsbLcbsbRgbLcbRsbLiLsbLsbLibLibLgbRsbReLsbL
cbLiLsbLiLsbRsbLiLsbRsLsbLgbLgLsLsLsmmbRsbRibLcbRsLsbLhbRgLsbLhbRgbLhb
RjbLiLsbLgbLiRgRsmbLgLsbLgbLgLsLsmbRgbLcbRgLsbLhbRibLiLsbLibLibLibRibR
sRjbRcbLibRcbLgbRcbRiLsbLjbRiRsmbRgbLsbRsbRibRcbRibRcbLiLsbRibRgRsmbLs
RsbRibLgbRibRgRsmbRgbRsbRsbRgbRsRsmbRgbRsRsmbRgbRsLsRsbLjbLhbLibLibRsb
LiLsbLsbLgbRsbLsbLgbRsbLgLsbLgbRgbLgbLsbLgbRgbLgbLgbRgbRjbRibLcbLibRjb
LibRsbsbsbsbLcbRgbLsbLcbLcbRibRsbLibLhLsbLibLsbLibRgbLsbLobRibLibLibRg
bLibLgbLiLsbRgRsmbRsLibRsbLibRjRsmbLiLsbLgbRsRsmbLgbRsLsbLgLsbRsbLgbRs
bLgLsLsmbLsbLgbLsbLsbLsbLsLsmbLgbLgbRsLsbLiLsbLsLsmbLsbLsbLgbLsbLibRgb
RcRsmbRiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 39; Drug: NDMC 3 µM
bRsbRsRsmbRsbRsLsbRgbRgbRgbRsRsmbRgbRgbRsbRgbRsbRsbRgbRsbRsbRsbLsLsmbR
gRsmbRsbRsRgbRgRsmbRgbRsbRgbRgbRgbRgbLgbRsRibLibRgbRgbRsLsbRibRgbLsLsm
bRsbRgbRgbLsbRgbRgRsmbLsbLibLibRsRsmbLgbLsbLgbLcLibRibLcbLcLsmbLibLsLs
mbLgbLibLcbLibLgLsbRgLsbLsbLjbLsbLibRgbLgbLiRsbLgLsbRsbLgbLsLsmbLsbLsb
LsbLgbLgbLsLsmbLgbLsbRjbRcbRibRsbRgbRibRibLsbLibRhbRsbRibLgbRibRsbRsbR
gbLgbRgbRiRsmbRsbRsbRgbRibRgbLsbLsbLjbLibRsbLgbLibLcbLgbRsbRgbRsbRgbRg
bRgbRgbLgLsbLjbLibRjbRibLsbRgbRsbRgbLsbRgRsmbRibRgbLgbLobLibLibRiRsmbR
gbRgbRgbRgbRsbRsLsbLcbLgbLgbLsbLgLsbLsbLgLsbLsbLgbLsLsmbLgbLgbLgbLgbRg
bLsbLgbLgbLsbLiLcbLibRgbRgRsmbRgbRsbRgbRsbRgbRsbRsbRgbRgbLjbLjbLcLsmbL
ibLsbRsRgRsmbLibLgbLgbLsbLgbLsbLsbLgLsbLgbRgbRjRiRsmbRgbRsbRsRgbRgbRsR
smbRgbRsbRsbRsbRsbRsRsmbRgbRgbRsLsbLebLiRsbLsbLibLibLsbLgbRibRgbLhbRjb
RhbRgbRgbRgbRibLibLgbLibLgLsbLsbLsbLgbLgbLgbLsbLsbLsLsLsmmbLgbLsbLgbLg
LsbLsbLsbLgLsbLgbLsbLsbLsbLibLcbRiRsmbRgbLsbRjbRibRgbRibRsbRgbRsbLgbLi
bLgbLgLsbLsbLsbLsbLsLsmbLgbLsbLibRgbRgbRibRibLcbLibRgbLsLsmbLsbLsbRibR
ibRgbLcbLcbLgbLibLsbLsbLgbLgbRgbRjbLibLsbLibRgbLobLcbLgbRibRgbLjbRgbRi
bRgbLsbRsbRsbLsbRsbRgbRgbLsbRgbRsbRsbRsbRsRsmbRgbLsbRgbRgbRgbRgbLsbRsb
RgbRgRsmbRgbRsbRsbRgbRgbLsbRsbRjbRgbLsbRgbRsbRgbRgbRsLsbRgLsbRgbRsRsmb
RsbRgbRgbRsbRsbRsRsmbLsRsbRgbRsbRgbRgbRgbLsbRgbLsbRgRsmbRsbRgbRsbRsLsb
RsRsmbRsbRsbRgbRgbRgbRsbRgbLsRsbRsbRgbRsbRgbRgbRsbRgbRgbRgbRgbRsbRgbRg
RsmbRsbRsbRsbRsbRgbRgbRsbLsbRgbRsbRsbRgbRsbLsRsbRgRsmbRsbRgbLgbRsbRgbR
gbLsbRsbRsbRsbRgbRgbRsbRgbRgbRgbRgbLgbRsbLjbRibLsRsbRgbRsbRgRsmbRibLgb
LsbRhbLcbRcbLcLsmbRcbRcbLibRgbRibLgbLgbRgbLjbLgbRjbRibRgbRgbLjbLiLsbRs
bLgbLsbLgbLgbLsLsmbLgbLcbLgbLiLsbRgbLsbLgbLiLsbLgbLsbRsbLgbRsbLgbLgbLg
bLgLsbRjbLgbRsbRsbLgbLgbLsbLgbLgbLhbLibRgbRibRibLiLsbLgLsbRsbRibLsLsRs
LsmbLjbLjLsLsmmbRjbRibLjLsmbLibRsbLibRsbRsbLibLibLibRgbRgbRgRsmbLgbRjb
RgbRhLsbLibRsbRgbLjbLobLobLgbLgbLibLgbLgbRsbLgbRsbRsbLgbLgbLgbLsbRgbLg
bLsLsmbLgbLsbLibLhbLibRgRsmbRgbRsbRsbRhbLjbRgbRibLsbLcbLcbLibLibRibRgb
LgbRgRsmbLibLibLsbLgLsLsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 40; Drug: NDMC 3 µM
bLgbLgLsLsLgmbLgbRsLsbLgbLgLsbLsbLgbRsbLibRgbLgbRsbLibsbLsbLgbLibRgbLj
bLcLsmbLcbLhLsbLibRibLibLibRsRsmbLibLgLgLgLgLsbLgbLgbLgbRjbRcbRjRsmbRj
bLjbRcbRhbLibLhbRgbLgRsbLgLsLsLsmmbLgLsbLsbLgbLsRsLgbLsbLgbLgbLgbLgbLs
RsbLgbLgLsbRsbLgbLgbLgbLsbLgbLsbLsbLgbLgbLgbLgbLsLsRsmbLgLsbLgbLgbLsbL
sLsmbLgLsbLsLsmbLibLsLsmbLgbLsbLgRsbLgbRsLsbLibLgbLgbLgbLgbLsLsmbLgLsb
LsbLgLsbLsbLibLgbLgLsbLgbLgbLiRsbLgLsRsbLiLsbRsbLiRsbLibLsbRibRgbRibRh
bRibLhbRcbRcbRobRibRcRsmbRsLjbLsbRgbRgbRgbRgbRgbRsbRsbRgbRgRsmbRsbRibR
sbRgbRsRsmbRgbRgbRgRsmbLsbRgbRgbRgbRgRsmbRsRsmbRgbRgbRgbRsbRsbRgbRsbRg
bRsbRgbRgLsbLjbRhbRcbRgbRibRhbRibRgRsRsRgRgmmbRgbRsbRgbLsbRgRsmbRgbRgR
smbRibRgbRgRsmbLsRsbRgRsmbRgbLsbRgbRgRsmbRgbRgbRgbRsbRsbRsbRgbRsbRsbRg
bRsRsmbRgbRsbRsbRgbRsbRsRsRsmmbRsbRgRsmbRsbRgbRsbRgRsmbRsbRsbRsRsmbRsb
RgbRgbRgbRsbRgRsmbRsRsmbRgbRibRsbRgbLsbRgbLcbLiLsbRjbLgbLsbRsLgbLgLsbR
sbRebRgRsmbLsbRgRsmbRgbRgbRsbRgbRsRsmbRsRsRsmmbRgbRgbRgbRsbRsbRgbRsbLs
bRgRgbRgbRgRsmbRsbRgbRgRsRsRsmmmbRsbRsbRsbRgbRgbRsbRgRsmbRsRsRsRsmmmbR
gbRsRsmbRsRsRsmmbRsRsRsmmbRgbRsbRgbRgbRgbRgLsbRsRsRsmmbRsbRgRsmbRsRsmb
RsbRgbRgbRgbRsbRsRsmbLsRgbRgbLsbRgbLjbLcbLhLsbRibRiLsbRgbRgRsRgmbRsbRg
bRgbRgRsRsmmbRgRsmbRgRsmbRgbRgbRsbRsRsmbRgRsmbRsbRsbRsbRgbLjbLsbRgbLjb
LcbLibRsLsbLiRsbLcbRhbRcbRibRcbRibRgbRgbRgRsmbRiRsmbLcbLhbRgbLgbRjbRjb
RsRsRimbRgRsmbRgbRgRgRsRsmmbRsLsbRgbLsbRibRibRiLsbLibRiRsLsmbRibRcbRib
LiRsbLobRcbRcbLhbRsbRibLgbRibRgbLsbRgRsmbLsbRsbRgRsRsmmbRsLsbRgRsRsmmb
RgbRsbRgRsmbRgbRsbRsbRgbRgRsRsmmbRsbRgbRsbRsRsmbRgbLsRsbRgbLjbLsbRgbRi
bRibRgbRgbRgbRsRsmbRgRsmbRsbRgbRgbRgbRgbRgbRgbRsbRgbRsRsmbRgbRsbRgbRsb
RgbRsbLgbLjbRhbRhbRibRibLebRcbLjbLibLibRjbRcbRibLgbRibRgRsRsmmbRsRsmbR
gRsLsmbRibRsRsmbRgbRgbRsbRgRsmbRgbRsbRgbRgbRsRsmbRgbRgRsmbRgbLsbRsbRgb
RgbRsRsmbRgbRgbRsbRsbRgbLsbRgbRgbLebRjbRibRibLcbRhRsmbRsRsmbRgbRgRsmbR
hbRhbRibRcbLsbRibRsbRgbRsRsmbRgRsmbRgbRgRsmbRsbRibRgbRsbRsbRgbRgbRgRsm
bRgbRsRsmbRsbRsRsmbRsbLsbRgbRgRsmbRsbRgRsmbRsbRgRsmbRgRsmbRsRsmbRgbRgb
LjbRibLibRgbRgRsmbRgRsmbRsbRgRsmbRsRsmbRsRsmbRgbRsRsmbRgbRgbRsbRsRsRsm
mbRgbRgbRsbRgRsmbRsbRgRsmbRgbRsbLcbLgbRcbRibRgRsmbRsRsmbRsbRgbLjbRibLg
bRibRgbRsbRsbRgbLsbRgbRsbRsLsbRsRsmbRsbRgbLsbRgbLsbRgbRgbRgbRsbRgbRsRs
mbLsbRgbLsbRgbRgbLgbRgbRsbRgbRgbLibLobLcbRgbLiLsbRsLsbLiRgbLgbLhbRibRc
bLjbRibRgRsmbRgbLsbRgbRsbRgbRsbRgRsmbRgbRsRsmbRsbRsRsmbRgbRsbRgbRsbRsb
RgRsmbLsbRgbRsbRgbRgbRgRsmbRgRsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 41; Drug: NDMC 3 µM
bRgRsmbRiRgbRgRsmbRgbRsbRibRgbRiRsmbRebRibLgRsbRiRsmbRibRiRsmbRibRgbRg
bRiRsRsLsmmbRiRgbRgbRgRsmbRibRgRsRsRsmmmbRebRibRsRsRsmmbRgRgbRgbRgbLgb
LoRsbRiRsmbLsbRibLgbRiRiRsmbRgRsmbRiRsmbRgbRgbLgbRgbRsbRgbLsbRibRgbRiR
smbRhRsmbLibRsbRibLcbLibRgbLibLgbLobRiRsmbLoLsmbLhbLgbRgbLcbRgbLibLsbL
gLsbLgbLgbLgLsbLgbLibLgbLeLgLsbsbLgbLsLibRgbLibLcbRibLibLhbRcRsRsmmbRi
bRebRcbLcbRibRgRgbRibLjbLcbRsbLibLgbLsbRsbLgbLgbLgbRsbLgbRgLsbLgbLgbRs
bLsbLgbLsLsmbLgbLgbLebLgRsbLgLsbLgbLgbLibLibLsbRibRhbRgbRibLgRsbRgLsbR
ibRcbRjbRibRibRgbLgbRsbRgRsRsmmbRgRsmbLobLibLiLsbLibRibRjbRhRsmbRgbRsb
RgbLsbRgbRibRgbRgbRsbRgbLgbRibRsbRgRsmbRgbRibRibLgLsbRgbRgbRgbRgbRgbRg
bLjRsbRibRsbRsbLsLjbLgbLgbLgbLgbLsbLgbsbLgbRsbLibRjRsmbLibLiRsbLgbLsLe
bLgbLsbRsbLgbLgbLgbLsbLgbRgbLibLsbLgbLgRgbLibLgbLgbRjbLibLibRjRsmbLibL
gbRsbLibLsLsLsmmbLiLgLsbLgbLgbLgbLgbLgLsLeLsbLgbLgbLiLsbLgbLgbLibLiLsL
eLsbLgbLibLiLgbRsbLjbRjbLhbRhbLibRebLibLcbRcbLebRcbRiRsmbRibRsRsmbRsLs
bLeRsbRsbLibLgbRjbLibLibRibLibRibRebRiRsmbLsbRgbRgbLgLsbRsRgbRsbRgbRgb
RsbRgRsmbLsbRsbRgbLebRibRibRgbLsLsmbRiRsLsmbRibRsbRsbRgLsRsbRsRsmbRgRs
mbRgbRsRsmbRgRsmbRgbRsbRgbLsbRibRsbLsLsmbRibRsRsmbRgLsbRiRgbRgbRsbRibR
gbRgbRiRsmbRsbRiRsmbRgbRgbRsbRibRgbRgbRgLsbRgbRgRsmbRsbRgbRgRsmbRgbLsb
RibRgbRgbRgbRgRsmbRsbRsbRgbRgbRsbRibRibRibRsbLcbLibRsRjbsbRibLsbRibRgb
LjbRjbRibRsbLsbRibRgbLebLibRsbLgLsbLgbLgRsbLgbLiLsbRjbLgbLgRgRsmbLiLsb
LgbLgbLgbLgbRsbLgLsbLgbLgLiLeLebLgbRibLjbLhbRibRibLibRcbLebLhbRebLcLsm
bRibRibRibRibLjbLcbRjbLebRjRsmbRcRsmbLibRhbLsLsmbLjbLhbRjbRcbLiRsbRibL
ebLibLgbRjbLibsbsbLcbRibLibLgbRgbLgbLsbLibLcbRibRgbRhbLgbLibLcbRjbLhbL
ibLibRsbRibLibLibLibLgLsbLiLsbLgbLgbLgbLgbLsbLgRsbLcbRibRebRgbLobRiLsb
LibLgbRgbLibLgbRgbLiLsbLgbRsLsLsmbLgLsbRsbLgbLgbLibLgbLgbLgbLgbRsbLgLs
bLgbRsbLgLsbLgbLgbLgbLgLsbLsLsLembLgbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 42; Drug: NDMC 3 µM
bLsbRibRsbRsbLsbRgbRsRsmbRsbRgbRsRsmbRsbRgbRsbRgbRsbRsbRgRsRgRsmmbRsbR
gbRgRsmbRgbRgRsRsmmbRgbRgbLsRsbRgbRgbRgbRgbLgRsbRsLsbRgbRgbRgbRgbRibRs
bRgbRsbRsRsmbRsbRgbLsbRjbLsbRgbRsRsRiRsRiRsRgmmmbRgRsmbRgbRgRgRsmbRgRs
mbRgbRsbRsbRgbRgRsmbRgbRgRsRsRsRsmmmmbRsbRgRsRgRgmbRgbRsbRgbRgbRgLsbRe
bLibLiRsbLsRsbRsbLjbRjbRjRsmbLibRjRjbRgRsmbLsLsmbRgRsmbRsRsmbRgRsRsmmb
RsbRsbRsbRgRsmbRsbRsbRgbRsbRgbRibRgRsmbRsbLsbLcbLiLsbLsbLibLibLgbRgbRh
bRibRsRsRsmmbLcbLhbRibRjbLcLsmbRgbLhbRsRsRsLsmmbLjbLibRgbLibLsbLgbLiRs
bRibLsbLgbLgbRgbLgRsbLgbLsbLgRsbLsbLgbLgbLsRsLsbLgbLgLsRsbLsLsLsmmbLgR
sbLsbLgLsbLgbLgbLgRsRsmbRsbLgLsbRgbLsbLibLsLsmbRsbLgLsbLgRsbLsbLibLgbL
gbLgbLsbLgbLgbRsbLgbLjRsbLsbLgbLgbLibRgLsbLgLsbLgbLsLsmbLsLsmbLgbLgbLs
LsLsmmbLgbLgbRsbLgLsbLgbLsbLgbLgbLgbRsbLiLgLibLgbLgbRsRgbLsbLgbLibLsLs
mbLgbLgbLsLgbLsLsmbLgLsbLgLsbRsbLgbLgbLgbLgbRjRjbRcRjbLgbLgLsbLgLsLsmb
LsbLhbLgbRsbLgbLgLsbLgbRsbLgbLiRsbRsbRjbLibRjbRcbRibLgbRsbRibLgbLsbLjb
LhLsbRjbLcLsmbLsbRsbLgbLsbLgbLsbLgLsLgLsRsLgbLsbLsbLgbLsbRsLgbLgbLgbLs
bLsbLgbRjbLsLsmbLibRgbLgbLgbLsLibLiLsRsbLibLgLsLsmbLsRsbLibLgbLgbLgbLg
bLgbLgLsbLsbLsbLgbLgbLgbLsbLgLsLsmbLsLsmbLsbLgbLgbLgbLsbLgLsLsmbLgbLgL
sbLgLsbLsLsmbLsLibLsbLgLiLsLibLgLgLiLgLiLsbLgbLgLsbRsbLgLsbLgbLgbLgRsb
LgbLsbLgbLsLsmbLsLsmbLgbLsbRsRsmbLgbRsbLgbLgbLgbLgLsLsmbLgbLgLsbLgLsbL
gLsbLgbLsbLgbLsbLgbRjbLgbLgbLibLibLsbLgbLsbsbLsbLgLsbLgLsbLsbLgbLsbRib
LgbLgbLsbLgRsLsbLiLjbLgbLgbLgbLgbLsLsmbLgbLgLsbLgLsbLsLgLgLsbLsLsmbLgb
LgLsLsLiLimbLgbLsLsmbLgbLgLsLsmbLsLsLiLsLsmmbLhbRebLoRsbLhbRibRibRibLi
bRebLibRgbRibRcbRcbRsbLibsbLgbLgbLsbLgbRgbLgbLibRgLsRsbLsbLgLgbRsLiLsR
sbRsLgbLibRsLsbLsbLgbLsLgbRsbLgLgbLsLsmbLgLsRsbLgRebRsLgLsbLgbLsbLgbLs
RsbLgbRgbLgbRgbLhLsbLhLsbLibLgbLsbLibLjLsmbRjbLiLsbsbLibRsbRsbLgbLsLsm
bLgbLgbLsbLgbLgLsLsLsmmbLgLsbLsLibLgbLgLsbLsbLgbLgbLgbLsbLsbLgbLsbLgLs
bLgLiLsLiLsLsLgLsmbsbLgLsbLgbLsbRjbRjbRibLjbLcbLsRsbLcRsbRiRsmbRhbRcbR
cbLsbLgbLgbRsbLibRsbLgbLgbLgbLsbLgbLsLgLsbLgbLgbLgLsbLsLsmbLibLsbLsbLg
bLsbLgbLibRhbRsbRcbLibRobLgbRcbRibRibRibRgbRhRsmbLsbLsbRgbRgRsRsLsmmbR
gLsbRgLsLsmbRgbRgbLsRsbRsRgbRsbRsbRgbRgRsmbRgRsRsRsRgmmmbRibRsbLsbRgbL
gbRgRsmbLsbRgbRgbRgbRgbLgLsbRcbRibRcbRibRgbLgbLgbLsbRebRgbReLsbLebLiLs
bLsbRsbLgRsbLibLsLsmbLsbLhbLiLsLsmbLgbLgbRsbLibRsbLgbLibRibLgbLibRsLsb
RsbLiLsbLsbLibLgbLibLgbLsbLibRsLsLgLsLsmbRsLsbLgRsLsbLgLsbLgRsbLsLsmbL
ibLgbLsLsmbRsbLgbRsbLsbLgbLgbLgbLgbLsbRibLsbLiLsbRcbRibRsbLsbRibRibLib
LcbReRsmbRibLjbRjbLibRibRsbLsRsbRibRgbLsbRgRsmbLsbRgbRgbRsbRgbRsRsmbRs
bRsbRgRsRsmmbRgRsmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 43; Drug: NDMC 10 µM
bRsbLsbLibLsbLgLsbRgbLsbLgbLsLsRsRsmmbLgbLgbLsbLgLsRsLsbsbLgbRsbLgbLgb
LibRgbLgbLgLsbLsLsmbLgLsbLgLsbLgbLsbRsLsbLibLgbLsLsmbLgbRsbLgbLsbLgLsb
RsbLibLsbLgLibLsbLsbLgLgLsbRsbLiLsbLgbRsbLgbLgbLgRsbRsRsmbLibRgbLgbLib
RgbLgLsbRsbLibLibRsLsbLgRsbLibRsbLgbLgLsbLgLsbLsbLiLsbLibLcRsRsRgmbRjb
LobRsbLibLgbRsbLibLgbRsbLgbLibRgbLsbLgbLsRsLsbLsbLgbLsLsmbLgbLgbLgbLsb
LgbRsbLgbLgbLgLsbLsbLsbLgbLgRsbLgbLsLsmbLgLsLsmbLsbLsLsLsmmbLgbLsLsmbL
gbLgbLgLsbLgbLgbLgRsbRsRsmbLsRsbLgbLgbRsbLoRsRgbRiRsLsmbRhLsbLibRibRib
LhbRibRiRsmbLsbRgbRgbRgRsRsmmbLgbRcbRcbRcbRgbRibLsRsLsbRgRsmbLjRibRsbL
sRsbLcbLiRsbLgbLgbRsbLibRsbLibLibLgbRsbLgLsbLgbLgbLgLsbLgLsRsRsmbLgLsb
LgRsbLgbLsbsbLgbsbLgLsbLsLgbLgbLsLsmbLgbLsLsmbLgLsLsmbLsbLgbLsRsbLiRsR
ibLobLcRsbRiLsbLibLibLsbLiLsbRsRsmbLgLsLsmbLgLsbLgbLgbLsbLsbLgbLgLsbLg
bLsbLgbLgLsbLsbLiRsbRsbLgbLgLsbLsbLgLsLsmbRsbLgbLhbRgRsmbLobLhbLibLsbL
ibRsbLiLsbLsbLgbRsbLgbLgbLsbLgbLsbLsLsmbLgbRsbLgLsRsLgbRsRsmbLgbLgbLsb
LibLgbRjRsmbLgbLgbLgLsbLsbLsbLgLsbLsLsmbLsbLgbLgLsbLgRsbsbRgLsbLibRibL
gbRsRsmbLiLsbLsbLcbRsRsRsLsmmbRibLobRgbLgbLgbLcLsRgmbRhbLobLibRsbLgbLs
bLgLsbLgbLgbLsbLgLsbLsRsbLsRsbLgbRgbLsbLgbLgbLsbLgbRgbLgbLgbLgbLcRsbRg
bLgbLgbLoLsmbRsbLibRgbRcbLibLsRsbRcbLiRsLsbLiLsbRjbRiRsmbRgbRobLhbRgbR
hbRcbLgbRibRsbRgbRgbRsbRgbLgbRgbRsRsmbRibRoRsmbRcRsmbRsRcbRcbLsbLjbRoL
sbLgbLcbRcbRibRgRsmbRsbRiRsmbLsbsbRgLsbRsLsbRgRsmbRsbLgbRiRsmbRebRcbRi
bRhRsmbRsbLjRsbRibRgbRsbRibLsbRcbRsbLgbRcbRiLsbLibRcbRhLsbLibLcLsmbRjb
LibLsLsLsmmbLgbLsLsmbLsbLgbRsLsbLgbLsbLgbRsbLsbLsLsmbLgbRsbLsbLgbLgLsb
LsbLgbLgbRgLsbLgbLgbLgbRjRsmbLgbLgLsLsmbLgbLgbLgbLgLsbLgbRgbLgbLgbRgbR
ebRibRcbLobRgbRcbLgbRibLgbRcbLiLsbLgbRhbRsbRgbRiRsRsmmbRcbRhRsmbLsRgbL
ibRjRsmbRcbLsbLcbLsbRcbRibsbRgbLgbRsbRsLsbRgbLsbRgbRsbRgbLsbRgRsRsmmbR
gbLsbLsRibRgRsLsmbRgbLsbRgRsmbRsbRgbRsbRgbLgbRibLgbRgbRibLgbRibLgbRgbR
gbLgRsRibLcbLibRsbRhbRibLsRsbRgbRiRsmbRsRsmbRgbRgRsmbRsLsbRsbRgLsbRgRs
RsmmbRgbLgbRiLsbRsbLcRsbRjbRibRsbRibRgRsRsmmbRiLsbsbRgLsRsbLsbRibLsbLs
bRsbRgRsmbLsLsmbRgbRgRsmbLsbRgRsmbRsbLgbLcbLgLsbLsbRjbLjbLgbLgbRsbLgLs
bLgbLgRsbRsRsmbRcbLcbRjbRibRgbRgbLjbLcbLgbLgRsLsbLsbRsbLgbLgbLibRjbLgb
LsbLgbLsbLgbLsLsmbRsbLgbRsbLgbLsbRsbLibLsbLgbRsLsbLgbLsRsbLsbLgRsbRsbL
gbRcbRsbRibRibLibLgbRcbLcRsbRgbLcbRgbLcbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 44; Drug: NDMC 10 µM
bRsbRsLsbRgbRsRsmbLjbLcbRhbLibLgbLibRgbLiRsbLgbLgbLibRsbLgbLsLsmbLgbLg
LibLsbLgbLsbLgbLgbLgbRcbRcbLjLgbLgbLgbLgbLgRsbLsLsmbLgLsbLsbLibLcLsmbL
cbLibLibRsbLgbLgLsbLgbLgbLgbLsbLgbLibLsbLgLsbLgbLsbLgLsLsmbLibLgbLgLsb
LgbLgbLgbLgbLgbLgbRsbLgbLgbLgRsbLgbLsbLgbLgbLgbLgbLgbLgLsbLibLgLsbLgbL
gbRsRsmbLgLsbLgbLgLsbLgbLgbLgbLgbLgbLgLsbLsRsbLiLsbRsLsbLibLgbLgbLsbLi
bLgbLgbLsbLgRsbLibRgbLgLsbLgLsbLibLgbLsRsbLgLsLgbLgbLgbLgLsbLgRsbLgLsb
LgbLgbLgLsbLsbLibLgLsbLcbRgRsmbLgbLhbRsbLsLibLiLsbLiLsbRibRibRobRibRhb
RsRsmbRiRsmbLsbRibLjbRiRsLsRiRsmmbRibLsbRibRgLsbRgRsmbLsbRgbRjbLjRsbLc
bRcbLjbLhbLhbRsbLibRsbLhbRgRsmbLibLoLsRimbRsRsmbRgRsmbLsbRgbRgbLgbRgbR
sLsbRibRgRsmbRsbRgbRsbRgbRsbRiLsbRgbRgbLgbRgbRsbRibRgbRgLsbRgRsmbRsLsb
RgbLcbLibRgbLgbRsRsmbLgRsbLgbLsLsmbLsbLgbLgbLgbLgLsbLgbLibLgbLgbRsLsbL
gbRsbLibRsRsmbLgLsbLgbLsbLgbLgRsbLgbRjbRhbRcbLgbRibRgbLcbLcbLibLiLsbRi
bLcbRgbLgLsbLibLcbRibLcbRsbLsLsmbLhbRgbLibRsbLibRsbLsbLgLsbLsbLgbLgbRs
LsbLiLsbLsbLsbLgbLiRsbLhbLsbRibLgbLcbRgbLibLsRsbLiLsbRhbRcbLsbLsRiLsbR
sbRgbRgLsbRgRsLsmbRibRcRsLsmbRibRsbLhbLgbRcbRiRsmbLjbRibLjbLcbLsbLibLs
bRibLobRgbLsbLiLsbLsbLgLsbRgLsbLibLsbLsbRgbLiLsbRsbLibLibRgbRibLcbRsLs
bLiLsLsmbLsbLcbLibLibLgbRjRibLgbRgbLjbRiRsmbRgLsbRhbRcbRhbLibLibLgLsbL
gbLsbRsbLgRsbLsLsmbLgbLsbLgLsbLsLsmbLsbLsbLgbLgLsbLgbLgbRsLsbLsLsmbLgL
sbLgLsbRsbLgLsbRsbLibRsbLsLsRsmbLgLsbLgbLgbLgbLgbLgLsbLgbLgbLgbLgbLgLs
bRsbLgbLgbLgbLgbLsbLgbLsbLgbLgbLsbLgbLgbLibLcbLcbLiLsbRjbRcbLgbRibRsLs
bRgbRgLsbLgbRiRsRsmmbRgLsRsRibRsbRibRcbLhbLsLsmbLsbLibLibLcbLibLeLsLsm
bRjbRcLsbRsRibRibRiLsbRhbRibLibRibRiLsLsmbRgbRsbRiRsmbRcLsbRgLsbLgbRcb
RgbRgRsmbRgbLgbRiRsmbRsbRibRgbLgbRibRsbRsbRibRcLsbRiLsbRgLsbRsbRcbLsbR
gbLebLhbRsbRsbLgbLsLsmbLhbRcbRcbRibLsLsmbRibRhbLibLcbLsRsbLibLsbLgbRsb
LgLsbLsbLgbLgLsbLsLsmbLibLsbLsLsmbLgbLgRsLsbLgbRsRsLgmbLsRsbLgbLgbRgbL
ibLgLsbLgbRsbLhLsbLgbRgbLsbLcRsLsbLcbRibRibRcLsbLgbRcbLgbRibRgbLsbRiLs
LgRsbRgbRgbLsbRibLsLsmbRgbRsbRgbRgRsmbRsbLgbRibRsbRgbLgbRibLsLsmbRgRsm
bRsbRgbRsLsbRgbLsbRgbRgbRgbRibRgbRiRgbRiLsbRibLibRiLsbRcbRibRibRibLibL
ibRcbRhLsbRgRsmbLgRsbRibLgbRiLsbLsbRsbRibLibLhbLsbRsbLibLsLsmbLsbLiRsb
LhbLsbRcbRcLsbLgbRiRsmbRibRgbRsbLsbRiRsmbLsLsmbRibLgbRibRgbLgbRiLsbRib
RcbRibRibRibLsLsmbRiRsmbLsbRibLsLsmbRibLsbRgbRibLjbRiLsbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 45; Drug: NDMC 10 µM
bRgbRibLsbLgbLsbRgRsmbLsbRgbRsbRiLsLsmbsbRgRsmbRgbLsbRibRgLsbLibLibLgb
RjbLibLgbLgRsLsbLgLsbLsLsmbRsbLgbLgRgLsbLgbLgbLsLsmbLibLsbLgbLiLibLgLg
bLsbLjbLgRsbLsbLgbLgbLgbLgbLgbLgbRsbLgbLgbLgbLgLsbLgbLgbLjbLgbRjbRgbRg
bRcbReLsRgbRsbRsbRjbRcbRcRsmbRcbRcbRiRsmbRcbRcbRhbRgbRcbRgbRgLsbLsbRhb
RgbLsbRsbRgLsbRgbRsRsmbRgbRgbRibRibRsbLgbLsbLjbLgLsbLibLgRsbLsbLsbLibL
sbRsLsbLgbLgbLgbLgbLsbLgbLibLsbLgRsbLsbLgRsbLsbLgbLgbLsbLiRsbRgLsbLsbL
gbLgRsbLgbLgbRsbLgbLgbLgbLgbLsbRsbLgbRsLgbLgbLgbLgRsRgbLibLgLsbLsbLgbL
sLsmbLsbLsLsmbLgbLsLsmbLsbLgLsbLgbLsLgbLsbLsbLgLsbLgbLsbLsbLsbLjbLiRsb
RgbLgbLgbRsbLgbLgbLgbLgbLgbRsLsLsmbLgbRsbLgbLgbLgbRsRsmbLgbLgbLsLsmbLg
bLgbLsbLgbLsRsbLjbRjbLgbLsbLhbLhbLsbLhbLibRgbRibRibLgbRsLsbRsbLgbLgbRc
bRhRsmbRgbRgbRsRsmbRsbRibRcLsLsmbLgbLgbLsbRhbLgbRgbLsbRgLsbRsbRjbLibLh
LsbLgLgbRgbRibRsbRgbRsbLjbLibLgbLgbLgbLibLgbLsbLsbLgbLsbLgbsbLsbLibLsb
LgbLsbLgbLgbLgbLgbRsbLgbLgbLsbLgbLgbLgbRsbLsbLgbLgbRcbsbLhbLibRjbRcRsm
bRsbRgbRgbRsbRibLsbLsbRgbRsbRibRjbRcbRebLjLsmbLgbRiLsbRcbRhbRibRibRgRs
mbRiRsmbRsbRgbLjbLgbRjbLcbLgbRibRiRsmbRibRibRcbRibRcbLgbRsbLcbLibLsbLi
bLgbLgLsbLgRsbLiLsRsbLgLsbLgLsbLsbLgbLgLsLsmbLgLsbLsbLgbLgbLgLsbLgbLgb
LgLsbLibLgbLgbRsRsmbRcbRcbRgbRsbRibLgbLjbLgbLgbLsbLgbLgbLsbLgbLgbLgRsb
RsbLgbLgRsbLsbLgbLgbLgbLgLsbLsbLgbLgbLsbLsbLsbLgbLgbLsbLgbRsbLgbLsbLsb
LgbLgbLsbRgbLgbLsbLsLgbLsbLgbLgbLgbRgbLgbLgbLgbLsbLsbLgbLgbRsRsLsmbLgb
LgbLibRsbLsbLgbLsbLsbLgbLgbLgbLgbLsbLgbLibLgbLsbLsLsmbLgRsbLgbLgbLsbLs
bLgbLsbLgbLjbRsbLgbLsbLgbRjbLsbLsbRebRibRgLsbRibLsbLgbRibRsbRhbRcbRgbR
gRsmbLgbLsbLibLsbRsLjbRjbLhLsLsmbRibRiRsmbRsbRgbRibLgbLsbRgbRiLsbLgbRg
bRibRcbRgbLjbLgbLgbLgbLgbRsbLgbRsbLsbRjbRibRgbLsbRgbLsbRgbLgbLgbLsbLsb
RsbLsbRgbRgbRgbRcbLsbRibRibRsbRgbRgbRsbRiLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 46; Drug: NDMC 10 µM
bRcbRcbRibLsbRjbRibRiRsmbRgReRibRibsbLsRsLsbRgbRgRsmbRibRhLsRcbRcbRgbR
ibLsLsmbRhbRcbRibRhbRgbLibRhbRcbRcbRibRiRsmbLgbRgbRgbRsRsLsmbRgRsmbRgL
sbRgRgbRibRiRsmbRgbRgbLjbLcbLhbRibLsLsmbLsLebLibRibRjbRibRibRgRsmbRgbR
sbRgbRgRsLsmbLgbRgRsmbLsbRibRiRgRgRsmbRgbRgRsmbLhbLibLcbRhbLgbRcbRiRsm
bLgbRibRsbRgRsRsRsmmmbRgbRsRsRsmmbRsRsmbRiRgbRgbRgbRsRibRgbRgbLsLjbLob
RibLibLgbRjbLibRcbRibLjbRibRhbLiRsbLeLsbLibRibRjbRibRgbRsbRgbRsbRgbRgb
RsbLsbRiRsmbLgbRibLgLsbRibRcbRiRsLsmbRjbsbLibRgbRgbRgbRgbRgbRibRgRsmbR
sRsRgmbRgRsRsmmbLhbLibLhbLhLcbLgbRibRsRgbRgRsmbRgRsmbRsRsmbRiRgRgRiRiR
sRgmbRgRsRsmmbRgRsmbLhbRjbRcbRcbLgLsbLiLsLsmbRsbLgLibLcbRjbLhRsbRoLsbR
iRsmbRibLibRcbRiLsbRgbRgLsbRgbRgbRsbRibRsbRgRsmbRgbRgbLgbLcbRhbRibRsRs
mbRgbRsRsRimbRgbRgbRgLsLsmbLsbLebLibRjbLgbLgbLsbRcbRgbsbLjbRibLsbRsbRg
RsRsmmbRgRsmbRsbRgbRsRsmbRgRgRgRsmbRgbRgbRibRsbRgRsRsmmbRgbRgbRgRsmbRg
bLgbLibLibLibRebLcbRcbRobRcbRibRiLsbLibRhbLebLhbLgbLebLcbLibRhbRibLsbR
ibRibRgRgRsmbRgRgLsbRgbRsbRsbRgLsbLgbRgRsmbRsbRibLhbRibLebRgRsmbsbRgbL
jbLcbLcbLhbLibRiRsRsmmbRcbRibLgbLcbLcLsmbLibLcbRgbLsbLibLgbRjbLsRgbRsb
RgbRgbRgbRgRgbRsbRsbRgbRgRsmbRsbRgRsmbLsbLjbLeLsbLhbRhbRibLjbRibRibLjb
RsbRibRgRsRsmmbRgbLsRgbRsbRgRsmbRgRsRgmbRgRsmbRiRsmbRibRgRsmbRgRsmbRsb
RgRsmbRgbRgRsmbRgRsmbRiRgRsmbRgRsmbRibRgbRgRsRsmmbRsRsmbRgbRsbRgRgRsRg
RgmbRgRsRimbRgbRsRsmbLgbLibRjbRibRsbRsbRiRgbRgbRibRgRsmbRgbRgbRgRsmbRg
bRgRsRsmmbRiRgbLjbLsbRibRgbRiRsRgRsmmbRsbRiRsmbRgbRgRsmbRgRiRsmbRgbRsR
gbRgRsmbRgRsRsmmbRibRgbRsbRjbLsRsbLjbLsbRiRsmbRgbLgbRgRsmbRgbRgRsmbRgb
RiRibRgbRgRsmbRgRsmbRibLebLcbLgbLibRgbRjbRcbLcbLcLsmbLgRsbRibsbRcRsmbR
iRsLsmbLcbLcbRgbLhbLgRsbRebRsRsmbRiRsmbRgbLibLjbLcbLibRsbLhbLcbLgbLibL
ibRgbLsbLibLsbLsLgbLsLsmbRcbRgbLiLsbRjbRsRcRsmbRcbRcbRjbRibRsbRgbRsbRg
RsmbRgRgbLjbLjbLibLgbRcbRibRgLsbLgbRhRsmbRsbRgbRgbRgbRgRgbRgbRgRsmbRgb
RgbLsbLcLhRsbLsRjbLhbRjbLiLsbLhRsbRgbLcbLiLsbLhbRsbRgRsmbRibRsbRsRiRib
RgRsmbRgbRgbRgRsRsmmbRgbRibRgbRebRgbRgbRsbLeRsbLiRjbLibLgbLgbLsbLgbLgb
LsbRibRebLsbLjLsmbRobRcbRebRgbRiRsmbLibLcbLcbLibRiLsbRgbRjbRiRsmbRgbRg
bRgbRsbRgRsmbRgLsRsbRgbRgRsmbRsbRsRsmbLebRibRsbRgRsmbRgbRgRgRsRgmbRgbR
sbRgLsbLibLcbLgbLgbLsbLgbLcLsmbLcbLibLgbLgLsLsmbRsLsbLgbLgbLibLgbLgbLs
bLibLoLsmbLcLsLsmmbLhbRsbLiLsbLgbLibLcbLibRibRibLsbLgbRhbLjbLjbRcbRgRs
mbLsbLjRibRoRcRsmbLsbsbRibLjbRgbRiRgRsmbRgRsmbRsRiRsmbRsRgbRgbRgRgLsRs
bRebRcRsLsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 47; Drug: NDMC 10 µM
bLgbLgLsbRsLsbLcbRibLsLsmbRgLsbRgRhbRgbRgbsbRgbLsbRgbRobRgbRibLibRcbRi
bRgLsbLhbLebRjbRcRsmbRiRsmbRiLsbRibLsbRgRsRiRgRsmmbRgbRsbRgbRsRsmbRgRs
mbRgbRsRsLsmbRsRsmbRgbLjbRibRgbRsRsRgRiRgRiRsmmbRsRsmbRgbRgRsmbRgbRgbR
gbRibRcbLcbRsbRsbRcbRcbRebRcbLibLcbLhbLibRiRsmbLsbRibRibRgbRiRsRsRsmmm
bRgbRgbRgbRgbRgbRibRgbLgbRsbRhbLsbRgbRibRgbLsRsRgbRgRsmbRsbRgbRgRsmbRg
RsmbRgRsmbRgbRgbRgbRsbRsRsLsmbRsRsmbRgbRsbRgbRsRsRsmmbLgRsbRibLsbLcbLh
bLgRsbRgbLibRjbLibLgbLgbLgbRsbLgbLgbRsbLibRjbRcbRibLibLsbRcbRibLgbLgbL
jbRebRhbLgbRiRsmbRsbRgRsmbRgbRsbRgbRsRsmbRgbRgbRgbRgRsRgmbRsbRgbRsbRgR
smbRsbRsRsmbLsRsbRgLsbRsbRgbRsbRgbRsRsmbRsbRgbRgbRgbRsbRgRsmbRsbRgRsmb
RsbRgRsmbRibRgbLobLibLibRgbLhbLhbLiRsbLgbLgbRcbLjLibRcbLjbRibRiLsbLjbL
cbRsbRcbRgbRiRsmbRgbRiRsmbRgbRgbRgbRgRibRgRsmbRgbRgbRgbRgRsmbLsRsbRgbR
gbRsbRsbRhbRgRsRgmbRgbRgRsmbLcLsmbLcbRjbLiLsbLgRsbRjbRcbRiRsmbLcbLcbRj
bLibLsbLgbRsbRjbRcbLcbLcbRgbRsbRibRgbsbRgbRsRibLgRsbRgbLsRgbRsbRgbRiRs
mbRsbRgRsmbRsRsRsmmbRsRsRsLsmmbRgbRgbRgbRgbRgbRsbRgbRgbRgbRiLsbRhbRhbR
ibRjbLjbLhRsRsmbRhbRcbLgbLgbRiRsmbLsbRiRsmbRibLgbRibLgbLebRcbRcLsbLibL
ibLhRsLsbRsbLgbRgbRibRgbRsbLsbRgRsmbRgbRgbRgbRsbRsbRgbRsbRgbLsbRibRgbL
gbRgbRsbLcbLhbRibLibRjbRobLibLgbLcbLhRsbRibRibLcbLibRjbRhbRibRcbLgbRgR
smbRgbLsbRgbRgbRsRsmbRiRgbRsbRgbLsbRsbRibLsbLsbRibRgbRsbRgbRgbRgRgbRgb
RsbRgbRgbRgbRsbRgbRgbLsbRgbRsbRgbRgRgRsmbRgRsRgLsmbRibRgbRibRibLibRsbL
ibRibRibLjbRibsbLjbRibRiRsRsmmbLsbRgbRsbRsbRgRsmbRsbRsbRgRsmbRgLsbRsRg
RsmbRgbRgbRgRgbRsRsRsmmbRgbRgbRgbRgRsmbRgbRgbRgbRgbRgRiRsRsmmbRgbRgbRs
bRgbRgbLsbRgbRgbRgbRsbRgbRsRsmbLjbRibRgbRgbRgbRsbRibLgLsbRsbRibRsbRgRs
RsmmbRibLibRcbLsbRiRsmbRgbRsbRgRsmbLsRsbLeLsbRibRgbRgbRgRsRsmmbsbRgRsm
bRgbLjbLoLsmbRjbRiRsmbLebLcbLcbLcbRhbRcRsmbRhbRibLsbLibRcbRcbRibRibLib
LjbRibRibRgbRsbRgLsbRgLsbRsRsRsmmbRgRsmbRsbRgRsmbRgRsmbRsRsmbRsbRibRgb
RgRsmbRgbRsbRgRsmbRsbRgRsmbRgbRgRsmbRsbRgRsmbRgbRgbRgRsmbRsbRsbRibRgbL
gbLcbRcbLebLibRhbRobRibLcbRiRsmbLiRsbRiLsbLgbRcbLjbLiLsbRjbLgbLgbRjbRi
bLsbRibLsbRibRgRsmbLgbRibRsbRibLgbRsRibRsbRibRgbRgbLsbRgbRsbRibLgbLsbR
ibRsbRsRibRibRibLgbRhbLsbLsbRhbRibLgbRibLsbRiRsmbRsbRgRsmbRsbRsbRgbRib
RgRsmbRgbRgRsmbRgbRgbRgbRgbRgbRsRsRgmbRsbRgbRgbRgbRgbRgbRsbRgbRgbRgbRs
RsmbRgbRgbRgbRgbRgbRsbRgbRsbRsLsbRgRsmbRgbLjbRibRibLgbLcLsmbLhbRiRsRem
bRgRsmbLsLsmbRgRsmbRgLsbRsbRsRsmbRgbRgbRsLsbRgRsRsRsmmmbRgRsmbRgbRsbRg
bRgRsmbRgbRsbRgbRgbRsbRgRsmbRsRsmbRgRsmbRsbRsbRgbRgbRsbLsbRgbRgbRgbRgR
smbRsbRgRsmbRgbRgbRgRsRgmbRgRsmbRgRsmbRgRsmbRsRsmbLjbLobLsbLibLhbLibRi
bRgRsRgmbRsRsmbRsRsmbRibRsRsRiRsRsmmmbRgRsmbRsbLsRgbRgbRsbRiRiRgbRsbRg
bLsbRiRsmbRiRsRgmbLgbRgRgRibRgRgRsRgmbRgbRgbRgbRgbRgbRgbRgbRgbRgRsRsRg
mmbRgRsmbRgbRgbRgRsmbRgbRgRgbRgRsmbRgbRhbLobLcbLibRjbRibRibRgbRsbRgbRi
bLcbLibLhbRibsbRjbRgRsmbRhbRibLcbLhbRjbLiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 111728; End: 112228;
Recording: 4-1; Individual: 48; Drug: NDMC 10 µM
bLsbRgbLibLsLsmbLgLsLsRsmbLsbLsbLgbLgbLgbLgLgbLsbLgbLgLgLsbLibLgLsLsmb
LsRsbLibLibLsLsmbLgbRsbLibLsbLgbLgbLsbLgbLgbLsbLgLsbLsLsLiLsmbLiLsbLsb
LgbLgbLgbLsbLgbLgLsbLgbLoLiRsbRhbRcbLibRoRsLsmbLibRhbLgRsbRiLsbRsRsLsR
smbRiLsbRgRsmbRsbRgbRsbRibRgRsmbRgbRgbLsbRgRsmbRgRsRsmmbRgbRgRgRiRgbRg
LsbRsRiRsRgRsmmbRgRsLsmbRgRsmbLsbRgbRibRhbRgbRcbRhbLcbRebRcbLcbRhbLjbR
cbRgbRibLibLcbRsbLgbLsbLgbRsbLibRsLsbLgbRsbLsLcLsmbLcbLcbLcbLibLibLgLs
bLgbLcbLgRsbLibRcbLgbRcbLjbRobLiLsbLiLsbLhbLibRgbLiLsbLibLibRibLoLsmbR
gbLibRibRsbLcLsmbLibLgLsbLgLsbRsbLiLgbLgbLgLsRsbLgLgLiRsbLgbLsLsLimbLg
bLgbLgLsbLgbLhbRibLibRjbLcbRcbLcbLeLsbLibLsbLsbRsbLibLgbLgbLibRibLibLc
bRgRsRgmbLibLsbLiLsbLsLsRsmbLsbLgRsbLsbRsbLgLsbRgbLiLsbLsbLsLsmbRsbLiL
sbLgRsbRsLsbLiLsbLibLsbLgLsbRsbLiLsbLsbLgbLsbLsbLibLibLsbLhbLibLcbLcbL
hRsbLibLibLibRgbLgbLsLsRsmbLgbLgbLiRsbLcRsbRsRsmbLibLcLsmbLcbLibLibLjb
LibRgbLgbLsbLgbLgbLgbRgbLhbRibLiLsbRgbLgbLsLsmbLgLgbLgLsLgLsLsmbLgbLsb
LgbLgbLgbLgbLgbLgbLgbLgbLgbLibRgbLibRsbLibRjbRoRsmbLcbRoLsRsbLhLsbLibL
hLsbLibLsbLibLibLcLsLsmmbLibLibLjbLcRsbLcbLcLsmbRcbLhbRcRsmbRsbRsbRsbR
ibLgbRiRsLjmbRsRsmbRiLsbRsbRgbRsbRibRsbRibRsRsmbRgbRsbRsbLsbRsbRibLgbR
ibLjbLcbLcRsbLibRibLhbLcbRebLgbLobLcbLgbRibLcbLcbRgbLibLobRgbLhbRsRsmb
LsbLcbLsbLebLsbLcbLibRiRsmbLhbLibLsRsLsbRjbLibLgbLgbRsbLiLsLsLsmmbLgLs
LgLsbLgbLgbLgLsLgLgLgLsbLgLsbLgbLgbLgbRsbLibLhRsRsmbLcLsmbLhLsbLhbLhbL
iLsbLibLgLsbLhbLcLsmbRcbLibLhbRgbLhbRsbLibRjbLibLsbRsbLibLsbLgLsbRsRsm
bLgbLsbLiRsbLibRgbRgbLhbLsbLgbLsbLsbLibRgbLibRgbRgbLjbLoRsbRiRsmbLgbLg
bLibLiLsbRjbLibRsbLgbRsbLibLsLsmbLsbLgbLgbLgLsLsmbLgbLgbLsbLiRsbLibLsb
RgbLibLgbRsbLiLsbLsbLsbLsRsbLgLsbLibLebLcbLhbLhbRibLhbRgLsbLibLgbLgLsb
LsbLgLsbLsbLgbLsLsmbLsbLsLsmbLgbLgLsbLgLsbLgbLsbLgLsbRsbLibRsbLgbLsbLg
bLsbLgbLsbLgbLsbLgLsLsmbLgbLiRsbLibRgbLgbLgbLibRjbRobLgbRoRsLsmbRibRsb
RebRcLsbLjbRiRsmbRsbRibRsbRgbRsbRgRsmbLsbRiLsLsmbLgbLjbLcbLibLibLsbLhb
RjbRobLiLsbRhbLgbRgbRgbLsbRgbRsLsbRgRsmbLjRsLsbRjLsbLcbRibRgbLgbRiRsmb
LgbRibLjbRibLjbRibRsbRgRsmbRsRsmbRgbRsLsbRgbRgbRsbRgbRiRhbRibRebRcbLcb
LcbLcbLibLsbLcbRgbLobLcbLcbLcbLoRsbReRsmbRhbRcbLibLjbLcbRhbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 1; Drug: Control
bLgbLibRibLsbRgbLibRibLsLhRsbRibLgbRobLcbLibRgbRsbLibRgbRcbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 2; Drug: Control
bLgbLgbLgbLcbRsbRibLebRjbLhbLcLsmbLcbRibRibRhbLsbLgbLgbLibRgbLgbLiLsLs
mbLsbLhbLgbLsbLgLsbLsbLsbLcbLsbLiLsbRsbLsbRjbLcLsmbLiLsbRsLsbRsLsbLhbL
ibRjbLcbLsbLebLsbLhbLsbRhbLcbLiLsbLiRsbRgLsbLiLsbLibRgbLhbRcbRcbRgbLjb
RibRibLjbRhbLcbLcbRiLsbLibRsbLibRgLsbLiLsbRgLsbLibRgbLibLibRcbRhbRibRc
LsbLjbLcbLgbRgbLhbLjLsmbRgbRsbLibRgbLibRgbLibRsbRcbRibLcbRgbLcbRibRgbL
hbLsbLibRgbLcbRgbLibRgLsbLcLsmbRibLiLsbLgbLsbRgbLhLsbLibRsRsmbLsbLcLsm
bRibLibLibRgbLgLsbLibRsbLibRgRsLsmbRjbLsbLcbLhbRiRsmbRgbRgbLobLgbRibLe
bRiLsbLibLgbRibLebLiLsbRgbLibRibLcbRhbLcbLiLsbRgbLebLsbRgbLhbLibRgbLib
LsbRsbRjbRcbRibRhRsmbRibRibLgbLsbLibLsbLibLsbLibRibRsbLibLibRsLsbLibRs
bLgbLsbLgbLibRsbRgbRjbLgbLcbLibRiRsmbLibRgbLcbRjbLcbLibRibRsbLhbLsbLib
RgbLibRsbLgbLsLsmbLsbRgbLibRsbRsbLibRgLsbLsbLiLsbRsbLibLsbLsbLgbRsbRsb
RgbLibRsLsbLgbLsLsmbLsbLgbLsbLsLsmbLgbRsbLgLsbRsbLgbLgbLgLsbLgbLgbRsbL
ibRgLsbLsbLsbLibLgbLsbLgbLgbLsbLgbLsbLsbRsbLgbLsbLgLsbLsbLgbLsbLgbsbRg
bRcbRibRsLsbRgbRgbRgbRsbRgbRsbLcbLgbLgLsbLsbLgbRgbLibLsbLgbLsbLsbLgbLs
LsmbLsbLsbLsbLsLsmbLgbLsbLsbLgbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgLsbLsbLsLi
LsbLgbLsRsbLgbLgbLgbLgbLsLsmbLibRsLsbRcbRibRgbLcbLcbRsLsbRgbLiLsbLgLsb
RsbRgbLiLsbLibRibLibLgLsbRsbLibRgbLiLsbRgLsbLibLsbLibRgbLibLsbRsbLibLi
bRgbLibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 3; Drug: Control
bRibRcbRcbRgbRibLibRhbLjbRibLgbRcbRgbLgbRhbLibLhbRsLsbRibRibLibRcbLgbR
ibRhRsLsmbRiLsbLgLsbRcbLcbRcbLibLgbLibLibLobLcbRcbRobLgLsbLibLibRibRcb
RsbLgbLgbRibRcbRibRibLgbRsbLiLsbRsLsbLgLsbRsbLibRsbLiLsbLsLsmbLcbRcbRi
bLhbRgbLgLsbRsbRjbLgLsbLoLsmbRibLoRsbLoLsmbRjRsmbLibRibRgbLcbLgbLobLcb
LobRgbRibRcLsbLjbRobLibLgbLsRsbLcbRsbRgbLobRgbLobLsbLgLsbLsbRgbLibLgbR
sbLcRsRsmbRgbLsbRsLsbLiLsbLgbLgbRjbLcbRibRgbLibRsbLibRsbLgbLgbRjbRcbLc
RsbLibLgbLgRsbRgbLgbLgbRsLsbLsbRgbLgbRsbLhbLgbRhbLcbRhbRobRgbRgbRibRib
RibLcbRcbLibLgRsbRcbLsLsmbLjbsbLgbRsbLsbLgbLibRjbRebRibLjbRibRgbLgbRib
RibLgLsbLgLsbLjbRsbRibRibLsbRsbLsbRgLsbLcbRsbLgbsbRcbRsbLjbRibRsbRiLsb
LjbLjbRhbRhbLcLsmbLibLgRgbRebLgbRsbLsbLgbLsLsmbLsbLibRgbLibRsRsmbLgbLs
LsmbLgbLgbLgbLsbRsRsmbLsLsmbLgbLhbRgbLgbLgRsbLgbLgLsbRibRebRoRsmbRibLh
bRcLsbRcbLgbLsbRsbRgbRgbRgRsmbRgbLgLsbRgbLcbLobRgbRgbLgbLibRibRhbRobLe
LsbRsbRsbLobRjRsmbLgbLgbLgbLgRsbLgbLgbRsLsbLsbRsbLjbRcbRibRgbRiLsbRibR
ibRgbRgbRgbRibLibLjbLhLsbRibLiLsbLibLsbRsbLgLsbRjRsmbLibLsbLgbLsbLgbRg
bLibLgbLibRgbLgbRjbRcbLjbLibLiRsbRsbLgbRsbLiLsbRjbRjbLiLsbLgLsbRsbLgbL
gbLgbRgLsbLgbLsbLsbLgbLgbLgbRsbLibRjbLibLgbRsRsmbLgbLsbLgbLoLsmbRcbLgb
LobLhLsbLhLsbRibRsbLhbLibRgbRjbLibLsbLgbLgbRsbLgLsbLsLsmbLgbLgRsbLgbLc
bRiLsbRibLiLsbLiRsbLiLsbRjLsbLgbLgLsbLgbLgbRcbLjbLibRgLsbLgbLgbLgbRgbL
gbLsLsmbLsbRsLsLsmbLgbLgLsbLsbLgbLsLsmbLgbLgLsbRjbRhbRcLsbLsbLcbLhbRib
LgbLgbLsbLsbLgbLgbLsbLgbRjbLgbLgbRsbLsbLibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 4; Drug: Control
bLgLsbRsbLgbLgbLsbLibLgbLibLibLgbRhbLibLcbRcbLcbRcbRgbLcbLcbLjbLibRibL
cbRcbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 5; Drug: Control
bLibLibRgbLibRgbLibRibLsbRhbLjbRcbLibRcbLjbRhbLcbLibLibLjbRjRsmbLebRhb
RebLiLsbRhbLjbLsLsmbLgLsbRebReRsmbRsbRcbLibLgbLibRjRsmbRibRcRsmbLhbLob
LhLsbLgbLibRjRsmbLhbRgbRcbLgbRcLsbRsbLibRcbRibReRsmbLibLsbRsbLsLsmbLjb
RgbLhLsLsmbRsbLibLibLcLsmbLjbRsbLcbLiLsbLhbRibLcbLjbRjbLhbLiLsbRjbLibL
sbLsLsmbLsbLgbLsbLibLibReRsmbLibLgLsbsbsbRjbRgbRcbReRsmbLcbLobLgbLcbRi
bLiLsbLsbLgbRgbLoRsbRsbLibLgbLibRibLsLsmbsbLebRgbLgbLcbRhbLoLsLsmmbLib
RibLcbLgLsbLgbRiLsbLibRebRsLsbRsRsmbLcbLiLsbLsbRgRsmbLobRcbRobLgbRibLg
LsbRibLjbLcRsbLsbRibRiLsbRsbRsbLsbRgbRgRsmbRsRsmbRsRsmbRgbRgbLjbLcbLib
LibRsLsbLgbRcRsmbRibRgLsbRibRjRsmbLibRibRcbRhbLibRsbLibLgbLibLhbRibLcb
RiRsmbRibLobRsbLsbLibRgbLibLsbLsbLgLsbLhbLsbLgbsbRgbLibRgbLsbLgbLibRgb
LibRsbLsbRcbLsLsmbRibRibRibLibRhbLibRcbLiLsbRibRibRsbLsRsbRibRgbLgbRiL
sbLgbRibRibRcbLibLiLsbLsbLgbRibRcbLibRcbRsbRsbRgRsmbRgbLgbRibLgbRibRiR
smbLgbLgbRibRibLsbRgbRibLhbRhbLhbRibRibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 6; Drug: Control
bLcbRcbRcbLcbLcbRjLsbLjbRcbRjbRcRsmbRcbLhbLobRobRiLsbLgbRcbLhbRcbRhbRc
LsbRcbLiRsbLcbRsbsbsbRjbRhRsmbRjbRgbRibRjbRsbLgLsLibLobRibRjbRsbLcbRcR
smbLiLsbLcbLhLsbLsbRsRsmbLsLcbRibRsbRcbRhbReRsmbRcbLibRjbRcbRcbRgbLjbL
jbRjbRibRgbRibsbLsbLjLsmbLcLsmbRsbRgRsmbRsbRgbLsLsLsmmbLgbRgbRgbRgbLsR
sbLsbRgbRgbLsLcbRjbLjbRjbReRsmbLjLsmbLjLsRsmbRibRhbRsRsmbLgbLcRsbRcbRj
RsmbRebLiLsbLsLsLsmmbRgbLjbLgLsLsmbLgbLeLsbLsLsmbsbLibLhLsbsbLgbLsLsLs
mmbRgLsbLsbLsLsmbLsbRgbRobLibLebRcbLjbsbLsbLjbLsbRgbLsLsmbLsbRsbLjbRhR
smbLibsbLjLsmbLgbLgbLsbLjLsmbLsLsmbLgbsbLsbLjLsmbLiLsbLgbLsbLhbLjLsmbL
sbsbLibRibLibLcbLcbLhbLjbLobRgRsmbLsbLsbsbRhbLhbRcbRcRsmbLsbsbLsLsmbsb
sbLsbLsbLibLibRgbLibRsbRgbLibsbRsbLgLsRsbLsbLsLsmbLgbRgbLcbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 7; Drug: NDMC 1 µM
bLsbLibRjRsmbLgbLiRsbRjbLhbRiRsmbRjbRgbLgRsbRibLsbRgbRgbRgbRgbRgbRgRsm
bLgbRgbLsbRgbLsbRibRgbLgbRcbRgbRsLoLsmbLgbLgbsbRgbLsbLiLsbRsbLgbRgbLib
LhbRibLibLjRsbRsbLsRsbRjbRcbRsLhbLjbRjbLcbLobRibRiRebRgbRgLsbRgbLgbRib
LjbRhbRgbRsbRgRsmbRsbRgbRgbRiLsbLjbLobRibLjbRgbLibRgbLcbLobRgbLgRsRsmb
LsRcRsmbRcLsbLjbLcRsRibRhLsRibLeLsLiLsbLibLsLsLsmmbLibLjLsmbLibRsbLgbL
gbRsbRsbLsLhbLcLiRsRcbRgbRoRsLsmbLsbRsLsbRgbLcbRcbLhLsbRjbRobRsbRibLsb
RgbRgbRgbRgbRsbRgbRsbRgbRgbRibLgbLjbRhbRcbRgbLibRcbLjbRibLjRsbLjbLibRj
RsmbRhbRgRsmbRsRibLgbRgbRgbRsRsmbRgRsmbRgLsRsbLsbRgRsmbRsbRsbRsRsmbRsb
RgbRsbRgbRiRsmbLjbLcbRjbRibRibLjbLcbRgbLjbLgRsbLcbRibRsbRsbRibRcbLibRg
RsmbRgbRgbRsRsmbRsbLgbRibLsLsmbRibLjLsmbLibLibLibRgbRgbLcbRgbLsLsmbLiR
sbRgbLibLgbLgbRgbRibRgbRibRibRibLcbLhbRgbRibRgbRgbRsRsmbRsbRsbLgbRgRsm
bRgLsbRibRgRsmbRibLsbLcbLcbLcbRiRsmbRibLgbLiRsbRibRcbLjbRibLgLsbRsbRsb
RgbRsbRsbRgRsmbRgbLjLsRsmbRgbRgbRgRsmbRgbRsbRsbRgLsbRibLjbRhbRgbRgbRsb
RgbRgbRgbLcbRjbRibLibRibLsRsbRsbRgbLgRsbRgbRsbRgbRsbRsbRgbRgLsbRgbRiRs
mbRibRgbLgLsbRgLsbLsbRgbLsbRgbLjbRgbRgRsmbRsbRgLsbLjbLjbLibLoRsLcLsmbL
ibRsbLibRibLgbLcbRibRibRhbRobRibRhbRibLcbLobRibLcbLibLgbLcbRibLjbLgbLg
bRsbLgbRhbRibLjbRhRsmbRibRgbRsbRsbRgRsmbRsRsmbRibLjbRgbRsbRsRsmbRsRsmb
RsbLsbRsbRgbRgbLsbRgbRsbLibRiLsbLjbLibLibLiRibRcbLjbLgbLibLgbRjbLcbRcb
RcbLibRsRibLjbRgbRgbRgbRgbRgbRiRsmbRgbLibRhbLjbRobLibLobRsbRgbRjRsmbRh
bLibRhbLjbRgbRsbRgRsmbRsRsmbRgLsbRgLsbRgbLsLsmbRgbRgbsbRgbRgbLsbLcbRcb
LjbLibRcbRcLsLsRsLgmbRsbRsRgbRgbLsRsbRgLsbRsbRgbRsbRsbRgbRgRsmbsbLsRsb
RgRsmbRgbLsbRibLjRsbLcbLibRcbLiRsbRebRibLgbRibLhbRcbLhbLjLgLsbLiRgbRjR
smbRiLsbRibRsbRgbRsRsmbRsbLsbRgbRgbRsbLsbLsbRgRsmbRgbRsRsmbLsbRgbRgbRg
bLjbRiLsbRibRibLcbRjbRhbLgbRgbRsRsmbLgbRsLsbLsbRibRgLsbRsbRibLsbRgbRgb
RsbRgbRsRsmbRgbRgRsmbRgbRgbRgbRgbRibLiLsbRibRgbLobLobLgbRsRsmbLgbRjbRc
bRgbRsLsbRibLcbLiLsbLgbLgbLiRsbRibRjbRcRsmbRgbLgbRgbRgbRsbRgbRsbRgbRsL
sbLsbRsRsmbRsRgRsmbRsbRsRsRgmbRgbRsbRsbRgbRgRsmbLsbRgbRgRsmbLsRsbRibRg
bRgbLsRsbRgRsmbLobRsLgLsLsmbRjbRhbLjRsbRibRgbLjbRjbRcbRhbLibRhbRhbRgbR
gRsmbRsbRgbRgbRsbRsLsbRsbRgLsbRsbRsRgbRgbRgRsmbRgbRsbRsbRibLgbLhbLibLi
bRcbRcbLgbRsbRgbRgbRgbRgbRgbLsbLgbRhbLjRsbRibRgbRgRsmbLsRsbRsRsmbRgbRs
bRgRsmbRsLsbRgRsmbRsbRsRsmbRgbRgbLsbRsbRiRsmbLjbLhRsbRhbRiRsmbLgbRibRs
RsmbRsbRgbRgbLjbLibLibRebRcbLsLsmbRibRgbRsRsmbRgbLsbRibLjRsRsmbRibRgRs
mbRgLsbRcbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 8; Drug: NDMC 1 µM
bLeRsbRjbRibRjbLjbRibLgbRibRibLgbRgbRgbRgLsbLsLsmbRiRsmbLsbRgbRibLsbRg
bLgbRgbRsRsmbRgbLsbRgbRsbLjbLhLsbLgbRjbLgbLibRjbLibLiRsbRibLsbLhbRhbRg
bLiLsbRgbLibRgbLhbRibLibRgbLibRjbLiLsbLibRibRibLsbRjbLcbLcLsmbRjRsmbRc
bRibRibRhbLibRibRgRsmbRsbRsbRsRsmbRcbLhbLibRgbLibLibLibLcbLibLhbLsbLsL
smbLsbLsbLibLibLsbLgLsbsbLsbLsbLibLibRjbLibLgbRgRsmbRsbLgbLgbLsbRgbLsb
LcbLhbRibLiLsbRsbRsbLgbRsbLjbRjbRobRgbRsbLjbLsLsmbRibRcbLgbRgbLsbLgbLi
LsbLoLsmbRgbLgbLgbRgbsbLgLsbLsbLgLsbLgbLgbRsbRsbLsbRsbRsbLsbLibLsbRibR
sRsmbLgbLibLgbLsbLgLsbLibLibLgbLgbLibRgRsmbLcbLcbLgbRgRsmbRgbLgbsbRgbR
ibRsRsmbRsRsmbRhbRsbLsLsmbLsbRiLsbLsbLsbsbLsbLsbRgbsbRjbRsRsmbsbRsbRsL
sbRsbRgbRgbRibRibsbRsRsmbRjbRgbRibsbRsbRgbRsbRgbRsbRsLsbRibRsbRsRsmbRj
bRgRsLsmbLsbRgRsmbRsbRsbRiRsmbLsbLsLsmbLsbsbRsRibRsbLsbRhbRibRgbRsRsmb
RsbRsbRsbLhbLebRsbsbLgLsbLgRsbLgbLsbRgRsmbRcbRgbsbLgbRcbRgbRsbRhLsbRsL
sbRibRsbLgLsbLsbRcRsmbRjRsRsmmbLgLsbRibRsbRsbsbRgRsmbRsRsmbRjbRsbRsbLs
bsbLsbsbLgbRsbRjbsbLhLsbLcbLibRsLsbLjbsbRibRibRsbLgbRoRsmbRsbLsLsRsmbR
gbLsbRibLsbLsbRibRibLsbRibRibRgLsbRgbLjLsmbLibRsbLgLsbRsbLsbLsbLgbLgLs
bLsbLsbLgbLgbRjbRobRoLsbRibLsbRibRgbsbLgbRcbRibLjLsmbRibLsbLsbRsbRoLsb
RcbLibRsbRiRsmbLsbLgbRoLsbLsbLgLsbLibLcbRgbRibRibsbRgbLgbLsbLsbLgbLibR
ibLibRgbLibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 9; Drug: NDMC 1 µM
bLibLgbLgbLjbRjRsmbLjbLjbRhbLjbLcLsLsmmbLibLjbRjbRibLjbLjbRhbRjRsmbLjb
LibLibLcbRibRhbRibsbLsbsbLgbLjbLjbRebRcRsmbLjbRcbLjbRcbLsbLibLjbRjRsmb
RibLjbRhRsmbRgRsmbRibRjbLjbRhbRsbLsbsbRibRibRibsbRsbLgLsLsmbLjbLjbRjbL
jbRjbRjRsmbLibLgbsbRsRsmbLibLjbsbsbRibsbRsbLgbLhbRibRgbRhbRibRsbRjRsmb
RgbRsbLsbLgbLibLjbLiLsbRiLsRsbLgbRsRsLsmbLibLgbLsbLsbLgbRjRsmbLgbRcbRi
bRsbRsbRgbRibRjbRjRsmbRsbRsbRjRsmbLgbRsLsbRcRsmbRibLsbLsbRiRsmbRjRsmbR
hRsmbRcbRsbRibLjbRibRhbLgbLibLiLsbLibLjLsmbRcbLsbLjbsbLibRcbLibLibRibR
jRsmbRhbRsLsbLibLjbRhRsmbLjbRcbRcbRiRsmbLsbLsbLsbLibLhbRsbLhbLsbLsbLiL
sbsbLibsbsbLibLgbLibLibsbLgbRcbRhbRgRsmbRjRsmbLiLsbRcRsmbRsbRibRcbRsbR
gbRsbLgbRoLsbRgbRibRsRsmbLgbRibLsbLsbRhbRibLsbLsbLsbRsbRcbRibRibRgbRsL
sbLgbsbLgbLgLsbLsbLsbLibRjbRcRsmbRibLjLsmbRhbRibRiRsmbRsbsbRiRsmbRibRg
bRcbRibRsbRsbLgLsbLgbLjbRjbRibLjbRhbLgLsbLibRibRcRsmbRcbLsbRjRsmbLjbLi
bLgbLcbLjbRibLcLsmbRjbRcbLjbRjbRgbLibLsbLcbLcLsmbRibRibLibRsbsbLiLsbRj
RsmbRjbRcbRibLsLsmbsbRsbLsbLgbLsbLibRgRsmbRibRcbRhbRhRsmbRcbRsbLgLsbRc
bRib

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 10; Drug: NDMC 1 µM
bLhbLibLibLgbRcbRgbRgRsmbRgbRibRibRgbLibRsbLgbRsbRgbLgbLsLsmbRibLgbLsb
RibRibLjbRgbRibRibRgbRgbRibRgbRsbLgbRgbLsbLgbLsLsmbRjbLcbRgbRibRgbRgbR
sRgbLjbRsbLcbsbLgbLsLsmbRjbLibLsbLsbRcRsmbLcbLsbLibRjLsbRsbLgLsbLsbLgb
RjbLibLsbLgbLgbLibLibLgbRgbLsbLsbLgbLsbLibLgLsbLibLsbLiLsbLsbLibLsbLgb
LsbLsLsmbLsbLsbLibLsbLjbRsbLsbLsbLgLsbLsbRsbLgbLgbLsbLsbLgbLsLsRsmbLsb
LgbLsbRsbLgbLgbLgRsbLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 11; Drug: NDMC 1 µM
bRgbRgbRgbRjbRiRsmbRgbRibRgbRgbRgLsbRgbRgbRsbLsbRsRsmbRjRsmbRgbRgbRsRs
mbRjRsmbRibRsbRgbRgbRgbRgbLibLcbLobLcbRgbLibLibLibLjLsmbRjbLibRibRjbRs
bLjLsmbRjRsmbLiLsbLibLibLsbRjbRibLjbRibLhbRibRjbRsbLgbLjbRibRibRgbLsbL
ibLoRsbsbRsbLibLgbRjbLibRjbRjbRsbRcbsbRjbRjbRsbLsbRjbLgbLjbRgRsmbRjRsm
bRjbLsbLjbLgbLsbRjbRcbsbRhbLgbLjbLjbLibLibsbRgbsbRsbRcbRjbRsbRjbLgbLjb
LjbRgbRjRsmbLjbLsbLsbLcbRjbRhbLjLsmbLjbLgbRsbLcRsbLcbRjbRjRsmbLibLjbLi
bRsRsmbLeRsbLsbRibRjbRcbRcbLsbRjRsmbRibRsLsbRgbRjbRcbRibLjLsmbLgbLibLj
bLsbLgbLibRsRsmbRibLhbRhbRcbRjRsmbRgbLjbRgbLjbRjbLjbRibRjbLjLsmbRjbRjL
sbRcRsmbRhbRgbRhRsmbLjbRhbRgbRgbLjLsmbRjbRsbRjbLsRsbRibLsbLsbRibRgbLgb
LgbRcbLgbRjbRjRsmbLgbRgbRsRsmbLjbRebLgbLgbRgbLsbLgbLgbRibRibRcbRgbsbRs
bLsbLsbsbLcbRjbLibLjLsmbRjbRjbLgLsbsbLiLsbsbLhbRgbsbRjbLjbLjbsbsbLibLj
LsmbRibLhbRiRsmbLsRhbLsbsbRsRsmbsbRibLsbsbRcLsbRsbsbLsbRgLsbRhbLebLgbL
gbLcbRsbRgRsmbLgbLsLsmbLibRibLoRsbLgbRgbRsbRsbRgbRibsbRoLsbLgbLgbsbRib
RsRgbRibLsbRgbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 12; Drug: NDMC 1 µM
bRsbLgbRsbLiLsLsmbLsbLgLsLsmbLiRsbLibLsLsmbLsLibLsbLgLsLsmbLgbLsbLgRsb
LgbLgbLsbLgbLsbLgRsbLgbLgbRsbLgRsbRsbRjbLibLgbRcbLebRobRsbRsbRgRsmbRgb
RgbLsbLcbRsbRgbRcLsbRgbLiRsbRibRiLsbLgbRibLsbRibLibRibRibLjbLcbLibRsbL
ibRcbLcbReRsmbRcbRebRgbRgbLibRibRiLsbRiRsmbLgbLgbRibRibLgbRibLgbRgbRgL
sbRgbLgbRibRsRsmbLcbLgbRjbRjbRhRsRsmmbRgbRibRcbRgbRibRsRcRsmbLibLsbRcb
LgbRsbRgbRgbRgbRhRsmbLhRsbRiRsmbRiRsmbLiLsbRgbRgbRsbRibLjbRcbRibRhbReb
RcbLibLsbRcRsmbRhbRsRsmbLjbLcLsmbLcbLcbRcbRcbRcbRiRsmbRcbRibLhbRjbRhbR
sbLsbRsbRibRgbRsbRibLibRiRsmbRiRsmbLgbRiLsbRgbLibRibRgbLcLsmbRcbLibRcb
RhbLibLhbRjbRibRibLhbRgbLibLcbLsbRjbLcLsmbLgbRibRcbRibLjbLjLibRjbRgbLc
bLcbRibLjbRibLsLsmbLibLsbRsLsbLibLgbRjbRjbLjbRjbLibRjRsmbLibLhbRibRjbR
jRsmbLjbLjbLcbLgbRjbLjbLibRjbLebRcbLcbRjbRibRgbRibRgLsbLibRibLcbLgbRsb
LgbLsbLibLsbLgbLgbLibRobLhbRjbRhbLebRcbLcbRcbRibRgbRgbLobLcLsmbRibLgbL
gbRsbRjbRibRcbLibLhbRibRgbRgLsbRgbRsbRsRsmbRsbRgRsmbRsbLsbRsbRgRsmbRgb
RsbRsbRibRgbRgbRibRsbRibLibRibLhbLcbRibRcbLcbRibRgbRsbRgRsmbRsRsmbRsbR
gbRsRsmbRsbRgbRgbRgbRibLjbLcbLjbRcbLcbLgbRcbRiRsmbRcbRibRibRcbLibRibRg
bRsbRgbRgbRgbRgbRgbLibRsbLsbRibRsbRiRsmbRsbRgbRgbRgRsmbRgbRgbRsbRsbRgb
RibLjLsmbRibRibRgbLsbRcbRibLhbRsbLiLsbRhbRcbLjbLjbLcbRibLgbLibRibRibRs
bRsbRgbRgbRgbRgbRgbLsRsbLsRsbRgRsmbRgbRgLsbRibLhLsbRibRsbRgRsmbRsbRsRs
mbRsbRebRgbRgbRgRsmbRgRsmbRgbRgLsbLjbRibLibRjbRgLsRsbRgLsbRgbRgbLsbRgb
RjbLibRjbLibRiRsmbRgbLsbRgbRsRsmbRsbRgRsmbRgRsmbRiRgRsRsmmbRgRsmbRgbRi
bRiRsmbLgRsbLebLibLgbLiRsRsmbRjbRcbLjbRsRebLebRcbLibLhbRjbRibRcLsbRibL
hbRhbLgLsbRhbRcLsbRcLsbLibRhLsbLgbLjbRoRsRsmmbLjRsbRcbLiLsbLibLcbRjbLg
bLgbLjLsmbRcbRibLcbRjLsbRcbLibLhbRhbLjbLgbRjbLjbRcbLsRibRgbRibRsRsmbRs
RgbRgbLsRsbRgbRgRsmbRgLsbLgbRgLsbLsLsmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 13; Drug: NDMC 3 µM
bLsbLgbLsbRsbLgbLsLsmbLgbLgbRsbsbsbLgbLsbLibRgbRjRsmbLcLsmbLcbLhRsbRib
RjRsmbRibRebLsbRjbLhbRsbRsRsmbRgbRsbRiRsmbRibRsbRgbRsbRcbLcbLgbLcbRibL
iLsbLcbLgbLiLsbLcbRibLibRgbLoRgRsmbRgRsmbRhbLgbRhbLgbRgRsmbRjbRcbRgRsm
bRgbRcbLsbRcbRsbRsRsmbLsbRsbLcbRhbRcbRsRibRgbRgbRcbRgbLgLsbLgRsbRoLsbR
cLsbRsbLsbLgbRsRsmbRibRgbLibRibRsbRgbLcbRsbLobLgRsbRgbLsbLiLsbLgbRsbLg
bLgbLsbLgbLcbRgbRhbLcbLcbRibLibLibLcbRcbLcbRgbLgbRgbLhbRibLsbLibRiRsmb
LiLsbRsbLsbLgbLibRcbRcRsmbRibRhbRcbLibLcbRsbRgbLsbRsbLibLgbRsbRsbLiRsb
RibRibRiLsbLsbRgbRsRsmbRibLcbLsbRjbRibLjbRhLsbLibRibLsbRsbRsRsmbLsbRsL
sbRgbLsbRgRsmbRgRsmbRsbRsbRgbRgbLgbRibLibLgbRcbRcbLsLsmbRgbLibRiRsmbRs
bRsbRsRsmbLgbRobRcbLcLsmbLgbRsbLcbRcbRobLgbLsbRgbRcbLcbRgbRiRsmbRgbRgb
RsbRsbLsbRgbRsbRibRsbRsbRgbRgbRgbRsbRsLsbRgbLhbRcbRcbRibRibRcbLibRsbLi
bLibRjbRcbLjbLcbLibRjbLobLsLsmbRibRsbLjbLibLsbLgbRsbLibRsbRsbLhbRibLib
RjbLibLcbRibsbLibLibRjbLcbRgbLgbLhbRibLgbLgbLgbLiRsbRsbRjbLhbRibLobRgR
smbRibRsRsmbRgbRgbRgbLobLsbLibsbRgbLibLsbLgLsbLgbLgbLgbRjbLibRibLsbLib
RsbLibRsLsbLgbsbRcRsmbRcbLibRcbLsLgbRcbLgbRgbRsbRgbRhbLsbLgbLibLgbLsLs
mbLgbLgbLgLsbRjbLebRhRsmbRcLsbLjbRcbLgbRgbRgbRgbRsbsbRgbRgbRgbRsbRsbRg
bRsbRsRsmbLjbRcRsLgRsmbRgRsRgRsRsmmmbRsbLsbRiRsRsRsmmmbRsbRsbRgbRgRsmb
RsbLibRcbRgbRsRsmbRgbRgbRgRsLsLsmmbLjRsbRgbRgbRgbsbLsbRibLsbRgbRgbRgbL
cbLhbRhbRcbRsbRgbLsRsbRsLjbRibRiRsRsmmbLsbRgLsbRgbRgbRsbRgbRgbLsRsbRsb
RgbRgbRgRsRsmmbRgbRsbRgbRgbRgbLhbLcbRcbLibLcbRcbLjbLibRgbLcbRcbRiLsbLs
bLsbRgbRgbRgbRgbRgbRgbRsbLgbLsbRsbLhRsbRcbLcbLibsbLcbLcLsmbLgbLsLgLsLi
LsbLsbRiRsmbRhbLgbLsRgbLsbLibLibLibRcbRgbRgbRsbLsbRsRsmbRgbRcbLcbRiRsm
bRibRgbLsbRgRsmbRsRsmbLsbRsbRgbLsbRgbLsRsbRsbRibLgbRiRsmbLsbLgRsbRsbRg
bRgbRgbRgLsRsbLjbLcbLgbRsRsmbLibLcbRgbRsbLcbLcbRhbLcbRgbRcRsmbRibRsbLs
bRibRgbLsbRgbRsbRgbRgLsbLsbRgbRgbRsbRsbLsRsbRgbRgbRgbLsRsbRgbRgbRsbRsb
RsbRsbRsRsmbRsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 14; Drug: NDMC 3 µM
bRgbRsbRgbRgbRsRsmbRgbRgbRsRsmbRgbLsbLcbsbLibRcbRgbRiRsRsmmbLsbLsbRebL
cbLibLibRsbLibRsbLibRgbLibRebRiLsbLsbRgRsmbRibLsbRgbRgbLgbRcRsmbLibLsb
RibLsbLgbLsRhbLjbRhbLgbRibRgbLjRsbRgbRgbRsbRhbLgbRcbLgbLsbRibRgbRsbRgb
RgRsmbLjbLcLsRsLhmbLgLsbRsbRsbLibRgbLibRsbRjbRcbLjbRcbLiLsbRgRsmbRsbLs
bRgbRibLcbLhLsbRcRsRimbLsRsbRsbRibLsbLsbRhbLgbRobLsRsbLibLibLcbRebRhbL
sRsbRcbLgbRgbLsbRgRsmbLsRsbRsbRgbLsbRgbRgbLsbRibLgbRiRsmbRibLibLcbRsbL
ibRcbLobLibRibLcbLsbLsbRgbLgbLcbRgbRcbLcbLhbRgbRgbLgLsbLibLibLsbRibRcb
RgbRsbRsbLjbLcbRcbLcbLibRjbRcbLsbLibRsbRobRobLgbRgbLsRsbLsbRhbLjLcbLib
RcbLcbRgbLhbRibLibRsbLgbLgbLgRsbRjbLcbRiLsbLcbLsbRgRsmbLgbLgbLcbRgLsbR
ibRgbLsbRibLsbLsbRhbRibLhbLcbLsRcbRibLjbLibLibRsLsbLgbLsbLgbLsbRsRsmbL
cbRiRsmbRcbLjbLhbLibRcRsmbRcRsmbRibLcbLgbLibRcbRibRsbLsbRgbRgbRgRsmbRs
RsmbRsbRgbRsbRgLsbRgRsmbLsRsbRgbRgbRgbRgbRgbRsbRgbRsLsbLgbRgRsmbLsbRgb
LsbRgRgbRgbRgbRgRsmbRsLsbRgbRgbLgbRibLgLsbLhLibRhbRiLsbRibLhbLhbRjbLcR
sbRcbRsbRibLjbLibLibRjbLibLsLcbRcbLcbLcbRgbLgbLgbLgbLibLgbLsLsmbLgbLsb
RsRsmbRiRsmbRcbLibRobRsRsmbRibLsRsbLsbRibRsbRgbRgbRgbLgbRibLjbLcbRhbRc
bLgbRgRsmbRgbRsbRgRgbRgRsmbRsbRgRsmbRsbRgbRgbLsbRsbRgbRgbRgbRgLsbRgbLj
LcLsmbLcRsbRsRhbRsRcbLgLsbRhbLgbRsbRgbRgbRgbRsbRgbRsbLgbRiRsmbLjbLhbLi
bLgbRjbRcbLibLeLgbRcbRhbRgbLsbRgbLsbRgbRgbRsbRgbRgLsbLjbRjbRibLhbRsbRi
bLsbRibLgbRhbLgbLgbRiLsbRgbLibRcRsmbLibLjbRcbRcbLgRsLsbRcbLgbRgbRgbRgb
RgRsmbRsbRgbRsbRsbRgbRsbRsbRgRsmbRgRsmbRgbRgLsbLjbLcbRiRsmbRcbLsbLgbLc
bRebRcbLibLibLobLgbLsbRsRsmbLgbLgRsbLsbLsLsmbLgbRcbLcbRcbRiRsmbLsRsbRi
bRgLsbLobRjRcbLjbRcbLgLsbRibRsbRsbRgLsRsbRgRsmbRsbRsbRgRsmbRgbRgbRsbRg
RsmbRibLjbLcbRhbRcbRsbRsbRgbRgbLjRsbRibLjbLcbLcRsbRhbLcbRcbRcbLjbLcbLc
bRebRcLsbLsRsbLcbLgbRcRobLsbLgbRcbLgbRibLjbRibLgbRiRsmbRsbRgRsmbRibLsb
RgbRgbRgbRgbLsbRgbRgbRgRsmbRgRsmbRsbRsbRgbRgRsmbRgbLsbRgbLsbRgbLsbRgLs
bLgbRibRgbLjLsmbLcbLgbLsLsmbLgbRjbRcRsmbRgbRsLsbLsRsRsmbRiRsmbRiRsmbRg
RsmbLgbRibLsbRibRsbRgLsbRgbRgbRgbLibRsRsmbRibRgbRgbRgbLjbLibLibLsbLgbL
gbLgLsbRjRobRgRsmbLsbLsRsRsRsmmbRibLsRsbRgbRsbRgRsmbRsbLsbRgRsmbRsbRsR
smbRsbRgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 15; Drug: NDMC 3 µM
bLgbRgbLibLgLsbLgLsbRgbRsLsbLgbLibRsbLibRsbLsbLibRjbLiLsbsbLgbRsbRsbLi
LsbRgbLibRgbLibRgbLgbRsLsbLgLsbLibLgbLjbRsbRgbLjbRsbRgbLibLgbRgbRsbLib
LsbRsbLgLsbRsbRsLjbRsbsbLibRsbsbLsbLibLgbLsbRgbLiLsbLsRsbRgbLhbRgbLgLs
bLgbLsLsmbLgbRgLsbLibRjbRsRsmbLjLsmbRsbLsbLgbRgbLibLcbRjRgbRgbRsbLjLsL
smmbRsbRsbLhbRjbLcbRibLcbRgbRsbLgbLibLiRsbLsbsbLibLgbLgLsbRsbLibLgbLgb
RcbRibRgbLsbLsbRgRsmbLgbRibLgbRibLgbRcbLibLjbLiLsbLiLsbRgbRibLibRsbLib
RjbRcbRibLibRiLsRsbRiRsmbRgbRgbRsbRgbLhbLgbLgbLgbLibRgbRgRsmbLsbLhLsLs
mbLsbRsbLgbRsbLgbLgbLsbLsbLgbRsbLsbLgLsbLgLsbLgbLgbRsbLgbLgLsbLsbLgbRs
bLgLiLsLsmbLgLsbRcRsmbRibsbLjbRcbRibRiLsbRsbRgbRgbLgbLibLgLiLsbRjbLibL
sbLsbLsbLsbLsbsbLsRsbLgbLsbRsLsbLgbLibRjbRcbLcLsmbRibLgLsbLibLgbLgRsbL
sbRsbLgbLsbLsbLgLsbLsbLsbLsRsbLgRsbRcbRgbRibRcbLibRibRsRsmbLsbRgbsbLiL
sbLibLsLgbRsbLgLsbRgbLgLsbLsbRsbLgLsbRsbLgbRgbLgLsbRsbLsbLgbLsbRsLsbLg
bLgbLhbRibLsRjbRsbLhLsbLibRhbRcbLsbRgLsbRgbRibLgbLebLibRgbRsLsRsLgbLgb
LgLsbRgbLsLsLsmmbLibRjbRiRibRgbRgRsmbRgbRsbRsbLsLsmbLjLsmbRgbLgbRhbRiR
smbLgbRgbRgbRsbRsRsmbRgRgbLsbRgbRgbLsbRgbLjRsbRgbRgRsmbRsbRgLsLsmbRsbR
sbLjbLibLgbRsbLgbRjbLgbLgLsbLsbRsbRsbLgbLgbLsbLgbLgbLsbLsbLsLsmbLgbLgb
RsbLgLsbRsbsbLgbLsbLgbLsbRjbRjbRhLsbLjLsmbLgbLgbLsbLgLsbLgRsbLgbLgbLsb
LgbLgbRgbLgbLgbRsbLgbRsbLgbLgLsbLgbLsbLsbLgbLgbLgbRjbLgbLgLsbRsbLgbLgb
LgbLgbLsbLgbLgbLsbLiRsbRjbRcRsmbRgLsbRgbRgbLgbLibLgLsbRgbLgbLgbLgbRgbL
gLsbLsbLgbRsbLgbRsbLgLsbLibLgbRgbRgbRjbLsbRcbRsbRgbRgbRsbRsRsmbRcbLgbL
jbLibLgbLgbLgbLsLsmbLgLsbLgbLsbLsbRsbLsbLgLsbLgRsbLgbLsbLsbLgbLgbLgbLg
bRsbLgbLgbLsbLgbLgbLgbRjbRcbRgbRgbRgbRsbRsbLsbLhbLgLsbRsLsbLgbLsLgLsbR
sLgbLgbLsbLgLsbLgbRsbLgbRjbLibRgbLgbLgbLgbLgbLgLsbLsbLsbLgbLibRibLiLsb
LgbLsbLsbLgbLgbRjRcRibRsRgbRsbRgbLjbRibLjbLibLgbLgbLgbLsbLgLsbRjbRcbLj
bLibLibRiRsmbRgLhLsbRsbLgbLsbLgRsbLsLsmbRsLsbLgLsbLgbLgbLgbRgbLgbLgbLg
bLgbRsbLgbLgLsbRsRsmbLsLsmbLgbRsbLgLsbLgbLsbLgbLsLsmbLgbLgLsbsbLsbLgbL
sbLsbLsbLsbLgbLgLsbRsbLibRjbRcLsLsRimbLjbLiLsbLibRsbLsbRsbRsbRsLiLsbRs
bLgLsbRgbLsbLgLsbLgLsbRsLsLsmbLgbLsbLgbLgbLsLsmbLsbLgLsbLsbLgbLgbLgbRj
bRcbLsRibRibLsbRibRiRsmbRobRibLibLjbLgbLsbLgbLsLsLsmmbLgRsbLgRsbRsLsbL
sLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 16; Drug: NDMC 3 µM
bRcbRcLsRsbLibRibRhLsbLsbsbsbRibLgLsbRsbRcbLgLsLsmbRcbLibRgbLjbRhbLibL
jLsmbRcRsmbRgbRibLgbRibLgbRhbLibRibLgRsbRibLgbRibLgbRiLsbRgbLsbRiLsbRi
bLgbLibRcbRibRgbLgbRcbLiRsbRcbLsLsmbRibRibLgbLibRgbRibLsbRsbRgbRsbRgbL
sbLcbLiRsbRgLsbLibRgbLibRgbRcbRgRsLsmbRgbLgbRibLgbRiRsmbRgRsmbLsbRsbRi
RsmbLsbRgbLjbLcbRsLsbLibLgbLgbRibLcbRiLsbRjbRhbRgRsLsmbRgbLsbLibLibLib
RhbRcbRsbLsbRcbLgbRibLiRsbLcbLibRsbLgbLibRcRsmbLobRebRibLjbLhbRibLhbRs
bLibLoRsbRiRsmbLibRgbRcbLgbRibRgbLsbLhRsbLibRsbRcLsbLcbLcbRcbRobLhbRgR
smbRoLsbLhbRobLibLcRsbLgbLibLsbLsbRsbLgLsbLgbRgRsmbsbsbLibRgbRjbRcbLsL
ibLibLsbLsbLcbRcbLsbLibLsbLhRsbLsRiLsbRcbRibLgbRibRsbLsbRsbRgbRsbRiRsm
bRgLsbRgbRgbRsbRsbRgRsmbLsbRgbRgbRgbRgRsmbRsRsmbRgbLsbRsbRibLjbLjRebRo
LsbRsbLgbLibRibLgLsbLibRgbLgbLibRcbRibRsLjbRibRsbRgbRibLsbRibLjbRcbRib
LjbLjbLibLibLgbLgbLsbRcbRcbLcbRcLsbLibRgRsmbRsbRsbRsbRibRgbRgbRgbLjLsm
bLjbLhbRjbLibLibRcLsbRibLgbRhLsbLibRiRsmbLsbRgRsmbRsRsRgmbRgRgbRsLsbRg
RsLsmbRsbRgbRgbRsbRgbRsbRgbRsbRsbRgLsbLcbLhRsbRcbLcbRjbLcbRgRsmbLhbReb
RgbRgbRsbRsbRgRsmbRgbRgbRgbRgbRsRsmbRgRsmbRgRgbRgbRgbRiLsbLcbRcbLjbRib
RgbRgbRsRsmbRgRsmbRsbRgbRgRsRgLsRsRgmbRgRgRsLsmbRgbRgbLjbRiRsmbRgbLgRs
bRcbLebLhbLhbRibLcRsbRjbLhLsbRibLiLsbLgbLgbLoRsLsbLcbRibLsbRibLsbLsbRi
bRsbRgbLjbLcbLgbLgbLsbLgbRobLsRsbRgbRsbRgRgRgRiRgbRgbRgbRsbRibRgbRgbLj
bRibLsbRibRhbLcbRobRobRibRcLjbLhbLgbLsbLsbLgbLgbLgbLsbLgbLgbRcbLjbRibR
gbRgbRgbRsbRgbRgbRibRibLcbLcbRjbRsLcRsbRcbRhbLsRsLsbRgbRsbLsLsmbRgbRgb
RgbRsbRsbRsbRsbRgbRgbRgRsmbRgRsRgmbRgbRibRgRsmbRgbRgbRhbLgbRgbRsbRiRsm
bRgbRgbLsbRsbRgbRsbRgRgbRibRiRsmbRgbRgbRsRsmbRgbRgRsmbRgbRgbLcbRcbLcLs
LimbLsbLsbLibLgbRjbLobLcbRcbRibRgRsmbRsbRsbRgbRsRsmbRgbRgRsmbRsLsbRgbR
gbRgbRsbRgbRgRsmbRgbLhLibLcbLoLsmbLcbLibLgbLsbRjbLhbRcbLsRcRsmbLgbRibR
iRsmbLgbRibLsbRgbRgRsmbRgbLjLsmbLhRsbLiRjbLibLgbLgbLsLsmbLgbRsbLoRsbRc
bRcbLgbRibLjbLhbLhbRjbLibLibRjbLgbLibLibRcbLcbRibsbsbLsbLsRsbLibRsRsmb
LjbRcbRcbLjbRibsbRgbRsbRsbRgbRsbLsbRgbRsbRgbRsbRsbLsbRgbLsRgbRgbRgbRgR
smbRsRsmbRgbRgRsLsmbRgLsRsRgbRgRsmbRgbRsbRibLjbLcbLibLibRjbLhbRgLsbLgb
LsbLgRsbRjbLgbLibRcbRcbLibLgbLgbRjbRcbRsRsmbRgbRsLsbRsbRgRsmbRsRsmbLsb
RgRsmbRgbRgRsmbLsbLcbLsbLgbLgbLgbLsbLgbRcbRcbLibRibLjbRhbLjbRibRsbRiRs
mbRgbRsbRsbRgRsLsmbRgbRsbRsRsmbRgLsbRgRsRgmbRiRsmbLcbRhLsbLjbLcbLibRsb
RsbLsbLgbLsLsmbRcbLibLjLibLgbLgLsbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 17; Drug: NDMC 3 µM
bLibLibLibLsbLibLgbLsbRibLsRsbLsbLjLsmbRcbLibLiLsbLibLiRsbRhbRhbRibRib
LsbLsbRhbRibLgbLsbRibRjRgbRibRhbLsbRsbLgbRibRcbLgbLjbRcbRebLgbRsbRgLsb
LibLibLibRsbLsbLgbRgbLcbRgbLsbLcbLibRibLsbLgLsbLgbRcbRebRhbRhbRhbRhbLj
bRgbLsbLgbLebLjbLibRhbRebRhbLgLsbLsbLgbLcbLhbsbLcbRcRsmbRcbRcbLibLibLe
bLjLsmbLgbLibLgbLibRgbLcbLibRibRgbLebLibRsbLjLsmbRcbRcLsbLibRhbRcbRgbR
sLsbLsbLgbRgbRibRiRsRsmmbRgbLgbLgbRcRsmbLibLjLsmbLcbLibRsbRibRgbLsbLcb
LcbLgbRsbRcLsbLgbLjRsbRcbRgbRibRsbLsbLgbRibLgbRcbRgbLgbRsbRcbLgbLgbRcb
LsbRsbRsbRibRsbReRsmbLgRsbRsbLsbLgbLgbLibLgbLibRiRsmbLgbRcbRgbLsRsbRib
RsbRsbRgbsbRibRsbRsbRsbRsbRgbRsRsmbRibRsbRsbLsbLsbRebRsbRgRsmbRsbRsbLs
bRsbRgbRgbRsbRibsbRsRsmbLgbRsbRibRibRgbRgbRsbLsbLsbLcbLibLsbLgbLsbRjRj
bLibLgbLsbLcbLsbLibRsbLgbRsbLsbLhLsbLhbLsbLgbLgLsbRgbRcbLgbRgbRsbRibRg
bLgbRsbRcbLgbLsbRhbLgbLsbLsRcbsbLgbLsbLsbRcLsbRgLgbLcbLcbLgbRsbLgbLsbL
hbLsbRibLibRsbRgbLjbRjbLcbLibRsbRsLsbRibRgRsmbRcRsmbRgbLgbRgbRgbRsbRsb
RsRsmbRsbRsbLsRibRgbLsbLgbRcLsbRjbLibLgbLsbLsRsbRgbRcbLgbRsbRsbRhbLsbL
sbRibLsbRgbRgbRsbRgRsmbRsbLsbRibLgbLgbRcbRsbLibRcbLgbRcbLgbLsbRiRsmbRg
RsmbLsbLsRsRsmbRsbRgbLsRsbRgbRgbLgbRsbRibRsbLsbLsbRibRsbLsbRsbRgbRsbLs
bRgRsmbRsRsmbLjbRcbLgbLjbLcbsbRibLcbLibLgbRgbLsbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 18; Drug: NDMC 3 µM
bRgbRgbRgbRgbLsbRjbLjbLjbLibRhbLibLhbRsRsmbLibRcbLsbRgbRibLsbLgbRgbRib
LjbRhbLjbLiLsbLibRgbLibLsLsmbRgLsbLibRsRsLsmbLgLsbsbLibRgbLiRsbRgbLhbR
iLsbLibLiLsbRsRsmbLsbRgbLgbLgbLhbRibLhLsbLsbRsLsbLgbRoLsbRgbLgbRibRgbR
iLsbLsbRgbRgRsmbLcLsmbLibRgbLibRjbRcbRcbLhbLhbLibRibRsRjRsmbRjbLsbRgbR
iLsbLgbLjbLcbRibLiRsbLgbRibRibLebRcbRibRiRsRsmmbLiLsbLsbRgbRgLsbRgbRib
RgbRgbLsLsmbLsLsLsmmbRgRsmbRgbLjbLcbLibRgbLibLsLsmbLsbLsbLgbLgbLgLsbRj
bLibLsbRsbLgbLiLsbLgLsLsmbLsRsbLgbLsbLgbLsbLgbLsbLgbLcbLiLsbRgbLgbLibR
ibLibLibRcbRsbRibRgLsbRibLjbRhLsbLibRcbRgbLibRgbRgbRgRsmbRgRsmbLcbLibL
iLsbRcbLsbRcbLsLsLsmmbRiRsmbLjbRsbRgbLibLibLsbLsbRjbRgRsmbLjbRgbRgbRiL
sbLcbLibRsbLgbsbLibLgbRjbLibLibRsLsbLgRsbLgbRsbLgbLgRsbRsbLgLsbLgbLsbR
sbLgbLsLsmbLsLsmbLgbRsbLgLsbLsLsLsmmbLgbLsbLgbLsbLsbRsbsbLgbLgbLgLsbLs
bLgbLgLsLsmbLsLgbLsLsmbLgbLgbLgbLiLsRsbLgbLgLsbLgbLgLsbLgLsbLsbLgbLsbL
sRsbLgLsbLgbLgLsbLgLgLsLibLiLsbLgLsbLsLsmbLgbLgbLgbLebRgbRcLsbRgbLjbLc
bRjbRhbRgbRhbLhbLobLgbLgbRebRcbLeLsbRibLebLebRibLibLgLsbLsbLiLsbLgbLib
RibRjbRgbRgbLjbLebLsbLsbLgbLgbRgbLgbRsbLgbLsbRgbLsbLgbLsbLsbLsbLgbLgbL
sLsmbLgbLgLsbRgbLgbLgbLgLsbLgbLsbRgbLibRsbLjLsLsmmbRjbRjbRibRgbLebLhbR
sbLibRgbRjbRibRgbLebLhbRiRsmbLiLsbRgbLibLsbLsbLgbLgbLsbLgbLgbRgbLibLgb
RjbLhLsbRibLibRjbLgbLsLsmbRsbLsbRgbRgRsmbLebLcRsbRibLgbLibsbLjLsmbRjbR
cbRgbRibLhbLcbLgbLibRjbLgbLsbLgbRsbLgbLgLsbLsbLgbLgbLibRgbRcbRibRiRsmb
RsLsbRibLsbRibRgbLebLebRgbRjbRibLcbLcbRsbRsbLsbLibLiLsbRgRsmbLibRgLsbL
jLsmbRgRsmbRgbRjbRgRsmbLhLsbLhbRgbLcbRiLsbLgbLjbLsbRgbLsbLsbLgbLsbLgLs
bLgbLgbLgLsbLsbLgbLgbLgbLgbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 19; Drug: NDMC 10 µM
bLsbLiLsbLgLsbLibLgbRebLcbRcbRiLsbLsbLjbRibRibRibLibLjbRcLsRsbRibLhbLh
bRibLibRcbRiLsbLcbLcbRjbLgbLibRcbLibRoRsmbRgbRibLcbLcbLhbRcbLcbLgbRgbL
ibRjbRjRibRibRjLsbLsRsbLibRhbRsbLgbRibRgbRhLsbRibRhbRsbRibRgbRgbRibRib
LcbLoRsbLcbRsbRibRiRsmbRcLsbLcbRcbRoRsmbRcLsbRiRsmbLcbLgbLgLsbLsbLiLsb
LcRsLsbRibRsbLcbLcbRsbRgbLsbRsRcbRgbRgbLsLsmbRobRsLsbRibRibLcbRibRcbRc
bRobRhLsbRcLsbLgbRgbRgbRgbRgbLsbRsbRgbRibLcbLcbRibRiLsbRiLsbRibLcbLcbR
jbRibRgRsmbRgbRsbRgbRgbRgbRsLsbLsRiRsmbRsbRgRsLsmbRsbRiRsmbRsbRgbRgbLc
bLibLgRsbLibLibLibRibLibLsbLibLsbLiLsbRgbLhbRgbLiLsbLsbLsbLibLibRibLsL
smbLibLibLgbLibRiRsmbRhbRibLjLibLhbRibRhbRgbRgbRgbRsRsmbRgbLgbRgLsbRsb
RgRsmbRsbRgbRgbRsRsmbRgbRgbRsbRgRsmbRgbRgbRgbRgbRgbRgbRibRibLcbLcLsmbR
ibRobLhbLibRibRcbRobLcbLcbLgbRjbRobLjbRibRgRsmbRgbRsbRsbLhbLibRhbRcLsb
LgRsbRhbLibRibLgbLsbRhbLiLsRsbLebLibRgbLsbLiLsbLsLsmbLgbLgbLgRsLgLsLib
LibLgLsbLsRcbRsbRibRobLibRgbLcLsmbLibRsbLiLsRsbLsbLibLibRgbLhLsRsbLibR
ibLibLsbLgbLsbLgbLgLsbLsLsmbLgbLsbLsLsmbLibLgbRgbRcbRobLiLsbRcRsmbLhbL
obRebRibLsbRgRsRsmmbRgbRibRgbLgbRhbLgbRibLjbRcbRibLeRsRsmbRcbRgbRsbRgL
sbLsbLcbLhRsRsmbRibLiLsbLibLgbRhRobRcbLcbRjbLhbLibLgbRsbLgLsLsLimbLsbL
gLsLsmbLgLgbLgLsLgLsbLgbLibLgRsLsbLgbLgbLsLgLsbLgbLgbLgLsLgbLibLgbRcLs
bRcbLgbLcbLiRsbLsRsbLgbLgbLsbRsLiLsbLgbLgLgLgLsLiLhLgLsLsLeLiLsLsmmbLg
bLibRobRobLgbLhbLibRcbRcLsbLcbLcbRcbLsRoRsmbLcLsmbLcRsbRcbRobRgbLjbRcb
LcbRoRsmbRgbLcLsmbLcbRgbLibLgbLgbLsLsmbLgLsLiLgLgbLibRsbLiRsLsbLsbLiLs
LgLsLiLsbLgbLgLsbLgLsbLibRhRsmbRhLsLsmbLgbLibLibLgLsLsmbLibRsbRobRgbRg
bLsbRiRsmbLhbLcbRcbRcbRibLiLsLsmbLcbRobLcbLcRsbRhbRcbLjbRcbLibRsLhbLsL
gLgbLsLsmbLgLsLgLgLsbLgLsLgbLgLsLiLiLgLibLsLibLgbRcLsbRobLhLsbLobRcbRc
LsbRibLibLibLibLibRjbRibRiRsmbRgbRibRcbLcbLibLhbRjbLcbRibRgbRgbLsLsmbL
cbRjbsbLcbRibLcRsbRobRcbLcLsmbLobLhbLsRsbRsLsbLiLsbLibLsbLsbLgLsLgLiLe
LhLsRsLsbLibLibLgbLgbLgbLgbLgbRgRsmbLibRcbRibRiRsmbLsbLcbLibRsbLiLsbRs
bLibLsbLibLobLsLcbLhbRcbRibRsbRgRsmbRsbLjbLhLsbRcbRcLsbLebLcRsbRjbLiLs
bRobLibRcbLhbRcbRgbLsbRgbRgbLsLsRsmbRgLsbRgbRgRsmbRgRgRsmbRgbRgbRgbRgb
RgbRgbRgbRsbRgbRgRsmbRobLcLsmbLibLhbRjbRcbLjbsbLcbRibRiRsmbRiRgRsRgRsR
iRgRsmmmbRgRsmbRgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 20; Drug: NDMC 10 µM
bLcLsmbLcbLibRsbRgbLhbLhbRjbLgLsbLgbRsbRibLjbRjbLibRibLsbLibLsbRgbRsbL
iRsbRgbLgbRgbRsbRibLjbRsLsbLjLsmbRibRibLcbRgbRibRjbLcbLjbRibLcbLsbLsbR
sbLsLhbRobRibRsbRgbLgbRjRsmbRoLeLsbLobLibLsbLibLgbLibLsbRobRibRhbLhbRi
bLibRjbRibLjbRjbLiRsbLhLsbRjbRjbRcbLcbRcbRcRsmbRcbRjRsmbLgbRgbLhbLibRg
bLgbLsbLibRobRibLibRhbRgbLibRoLsbLhbLibLhbRobRibRibLibRibLibLjbLiLsbLi
bLgbRibLibRoRsmbRibRhbLhLsbRhbLibRibRgbLsbRgbLjbRiRsmbLjbLcbRhbRibLibR
ibRgbLgRsLsbRibLsbRgbLjbRibRgRsmbLsbLjbLiRsRsmbLgbLibRjbLhbLsbLgLsbLgb
LgbLsLsmbLibRhbRcLsbRibLgbRibLsbRgbLjbRiRsmbRibLibRcbRgbLgbLibLgbLibRi
bRhbLjbLhbRhbLcbRgbLibRgbLibRgbLgbRsLsbLsbRjbRgbRibLjbRgbRgbLsbRgbRgbR
jLsbLjbRibRibLjbRibLgbLjbLjRsbLgbLgbLgLsbLgbLgbRgbLibLibRgRsmbLgbLsbLg
LsbLsRsbLgLsRsbLsbRgbLgbLgbLgbLsbLgLsbLgbLibLsLiRsbRgbRgLsbLibLgbRgbLi
bLgbLibRhbRcbRgbLsbRibLjbLcbRjbRgbLjbLibRibRcbLjbLcbLsbLgbRsbLgLsbLgbR
gbLibLgbRibLibLgbLgbRgbLibRcbLiLsbRhbLhbLiRsbRibLsLsmbLhbRgbLgLsbLgLsb
LsRsbLsbLibLgRsbRcLsbRobLcbLiLsbLgbLsbRsbLgbLsbLgbLsbLsLsmbLsLsmbLgbLg
bLibLgLsRsbLgLsbLgbLgbRjbLiRsbLibRgbLiLsbsbRsLsLgbLiLsbLgbRibRcLsbRibL
jbRcbLiLsbLhbLiLsbLsRsLsbRjbRjbRibRsbRsbRgbRsLsRsbRsbRoLsbLibLhbLibLib
LgRsbLgLsRsbLsLsmbLsbLsbLgbLsbRsbLibLibLibLibLhbLibRsbRsbLhRsbRibLhbRg
bLibRjbLgbLgbRsLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 21; Drug: NDMC 10 µM
bsbRsRsRsmmbRsbRgbLsbRgLsbRsbLsbRgbsbsbRsbRgbRgbRibLhbRcRsmbLjLgbRcbLj
LsLsmmbRhRsRsmmbRcRsmbRibLoLsmbRibsbRcRsmbLjbRgRsmbRibLjbRibLjLsmbsbsb
LjbRhbRhbLgbLsbLsbLjbLgbRcbsbRgbLgbRsbRsRsmbRsbRsbRsbRiLsbLobLibRcbRcR
smbLgbRgbRsbRgbLsbRsRsmbLsLsmbLsRsbRgbLibRgRsmbRsbLgRsLsbLsRsbRsbRsbRs
bRcRsRsmmbRsbRsbRsRsmbsbLsRsbLebLsbLsbLhRsbRgbRjbRcRsmbLjbLsbRgbRibRgb
RhbsbRibLgbRsLsbLgbLibLgbLsbLgLsbLcbLsbLgbRgbLibLcRsbLjbRsbLibRsbRgbRs
bRibRgbReRsmbLcbLibLsbLcbLsbRgbRiRsmbLgbRibLsbLsbRiRsmbLsRsbRsbLjbRjRs
mbLibLgbLgbLibLsRsbRsbLibLgbLjbLsbRsRsmbRibRsRsmbRsbRiRsmbRsbRgbsbLsbR
sLsbRsRsmbRibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 22; Drug: NDMC 10 µM
bRcRsmbRibRibRibLsbLgbLsbLsRsbsbsbLhLsbRiRsmbLcbRsRsLsmbLgbLcbLcbLibRj
bLcbRcbLoLsmbRsbLibRjbLcLsmbRgbRgbRcbLibLjbLjbLibLjLsmbLcbLcbLibRjRsmb
LobRibRibLibLibRibLgbLgbLgbLsbLsbLsbLgbLsbLcRsbRgbRgbRgbRibRibLgbRoRsm
bRcbRcbLibRibLsbRgbRgRsmbLcLsmbLcbLhbRcbLgbRibRgbLobLgbRhbLibLibLgbLgb
LsbLibLhbLgLsbLjLsmbLibLibLgbLgLsbLobRgbRjbLibLcLsmbRgbRibRgRsmbLsbRhb
RgbRgbsbLgbLsLsmbLcbRcRsmbLjbRoLsLsmbLgbRibRibRiRsmbRiLsbRsbLgbLibLgLs
bLgbRgbRgbRobLcbRcbLjbRgbRibLsbRibRgRsmbLibRgRsmbLsbLibLibLgbRsbLsRobR
sRibRgbLgLsbLsLsLjmbsbLibRcRsmbRibRibLcbLiLgbRiRsmbRibRsbLobLibRsbRgbL
ibLoRsbLgbLibLgbRibLibLsLsmbLgbLgbRsbLgLsbLiLsbRsbLhbRcbLibLibLsLsRsmb
RjbLjLsmbLibLgbLgbLgbRjbLjbLibLgLsbLsbLibLsbRcbRcLsbLjbRcbRibLgbRjbLib
LibLibLsLsmbLsbLsLsmbLsLsmbLsbLgbRsbLsbRsbLsbLcbLcbLibLgbLsbRsbLgLsbLs
bLsbRcbLhbRcbLjbLhbRjbRhbLibRcbLibRcbLjbsbRcbLibsbLcbRgbLibRsbLsbRsbsb
RcbRibRsbRhbRgbRgbRgbLsRsbLsbRgbRsbRsbRgbLsRsbRsbLhbLibRcbLibLibRoRsmb
LsbRibLgbRsLsbRsbRgRibRsbLsbRsbRgbRgbRgRsmbRsbRsRsmbRgbRgbRsbRsbRgbRgb
RgRsmbLsbLsLsmbRgRsRsmmbRsbRsbRgRsmbRgbRgbRgbRgRsmbRcLsbLibRibRibLibRs
RsmbRgbRgbLjbRibRsRgRsmbRiRsmbLsLsmbLsbRjbsbRsbRsbRibRsbRgbRgbRgbLsbRg
bLsbLjbRgbRgbRgbRgRsmbRsRsmbRgRsRsRsmmmbRibRsRsmbRsbRgRsmbRgbRgbRgbRgb
RsbRgbRgbRgRsLsRsmbRibLjbLhbRsbLibLibRcbRibLgbRibLgRsbRcRsmbRiRsmbRcbL
sbRibLjLsmbLibRhbRcbLgLsbRcbLsbRsRsmbRsRsmbRsRsmbRgbRgbRgbRgbLsbRsbRsR
smbRgbRsbRsbRgRsmbRsbLsbLibRsbRcbRibLibLebLobRiRsmbRsbRibRibRibRibLibL
ibRgbRiRsmbRgbRsRsRsmmbRgbRsbRsRsmbRsbRgRsmbRsRsmbRgRsmbRgRsRsmmbLgRsb
RgbRsRsmbRsbLsRsbRibLibRibLgbRibRgbRgRsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 23; Drug: NDMC 10 µM
bRjRsmbLjbRjRsmbRjRsmbRiRsmbLjLsmbRcbRibLcbLhLsbRibRsbLiLsLsmbRebRgRsm
bLsbRjRsmbRgbRgbsbRibLjLsmbLibLiLsbLibLgbLgbLjLsmbLsbLibLsbLsbRjRsmbRi
bRiRsmbLibLgbLibLibLibLgbRibRjbRjRsmbLsbLibLiLsbLibLsbRgbLgbLibLhbRsbR
gbLibRsbRsLsbRgbLgbLiLibRsbRsbLibLgRsbRsbLgbLibLgbRibLibLiLsbLjbLhbLsb
LibLgbLibLgbLgbLibLsLsmbRsbLgbLgbLiLsbRibLgbLgbLibLgLsbRgRsmbLgbRgbLgb
LibLibRjRsmbLgbLibLibLibLibLibLgbLgLsbLsbLibLibLibRsbRgbLibLibLibLgbRg
bRsbLjLsmbLcbLsLsmbLgbLsbLibLibRgbLibLsbLibLgbLcbLgbLsbRhbRcbLcbRgbRsb
RibLibLibLibLsbRsLsRsbLgbLsRsbLsbLgbLgbRsRsmbLgbLgbRjbRcbRobRgbsbRgbLi
bLhbLhbRgbRsbLibLsbLsbRsLsLsmbLgbLsbsbsbsbRsLsbLgbLgbRgbLibLsRgbsbLsbR
sbLgbLsbLsbLsbLgRsbLgbRibLibLsLsmbLibLgbRgRsmbsbLibRsbLsbLibLsbRgbRsLc
bLsbLsbsbLiLsbLgbsbLgbLgbLgbLsLsmbLgbRsbRgbRsbRsbRsbLgbRiRsmbLibLibReb
LgbLhbLibLiRsbLgbLsRsbLcbLibLgbLsbRsbRibLibLibRgbLjbLgbLgbRsbRgbRsbLsL
gLsbLibRjbLcbLsbLibRsbLsLsmbLgbRsbLsbsbLsLsmbLsLsmbLgbLsLsmbLeRsbLibRg
bsbLgbLgLsbLgbRgbLiLsbLsbRsLsbRsRsmbRsbLibLgbLibRibLgbRsLsRsbLgbLsbLgR
sbLgbRjbRgbLjbLibLiLsbRjbLibRjbLsbLibLgLsbRgbLsbLgbRsbLgbRgbLsbLgLsbLs
bLgbRsRsLsmbLgbLsRsbLsLgbRgbLibLgbLibRibLsbLgbLsbLsLsmbLgbsbRgbLibsbRc
bRsbRibRcbLibLcbRcbRibRsbLsbRibRibsbRgbRsRibLsbRgLsbLgbRiRibLcbRibLebL
gbLgLsbRsbLgbLibRgbLibRsbLsbLgbsbLgLsbsbLsbsbsbsbLsRsbLsbRsLsRsbLsbLgb
LsbLsLsmbLgbLhbRibLgbLibLsLsLsmmbLsbLsbLsbLibLsbRjbRhRsmbRcbRcbRgbLgbL
gRsRsmbRibRcbLjbLcbRibRsLsbsbLgbLibLsLsmbLsbLsbLsLgbLgLsbRsbLiRsbLiRsb
LsbRgbLibLsbLsbRsbLibRgLsbLibLibRhbRjRsmbRsbLcbLhbLcbLibLgbLibLgbLgbLs
bLgbRgLsbLibLibLgbLsbRgbLsbLgbLibLgbRibLibLgbRjbLsbRsbLibRsbRsbRjbLibR
sLsbRsbRsRsmbLibLgbRibLgbLgbRsbLjbRgbLibLgbRibLsbLibLsbLsbLsbLsRsbLsbL
sbLsbLgbRhbRibLcLsLsmmbLibRgbLiRgRsmbLibRgbLibRgLsbLgbLsbLsbLsLjbRsbLs
bLsLsRsLimbRibLcbLhbLsLsmbLsbLsbLgbsbRgbLibRsbLibLgbRibLibLibRibLibLib
LibLibLgbRhbLcLsmbRcLsRibRgbRgbRibLjbLcbRsLsbLgbLgbRsLsbLibRgbsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 24; Drug: NDMC 10 µM
bRibLjbRibLsRiRsmbRgbLsbRiRsmbLjbRibLjbRgbLjbRibRsbLibRcbLgLsbLobLsbLi
bLgbLsbLgbRsbRgbRibRsbRibRibLgbRsbRsbLsbRibRgbRgbRgbRcbRgbLibRjbRcbRib
RgbLobLcbLibRobLhbRibLibLsbLibRjbRoRsmbRhbsbLsbLibLibRoRsmbRsbRjbRiLsb
RgbLgLsbRibRgbRhbRgbRgRsmbRgbRgbRsbRsbRgbRsbRgRsmbLcbLcRsbLgbLsbLiRsbL
gbLgbLibRiRsmbRgbLgLsbLibRsbLsbLjbLhbLcbRsbLsbLgbRgbRgbRgRsmbRgRsmbRgb
LebRsLsRsbLsbLgbLsRsbLgLsbLsbLgbLgbLgbLsbLsbLsbLgRsbRsbLcbRcbRiRsLsmbR
jbsbRiLsbLsRsbLsbRibRibLcbLcbRjbRcbRibRgbLgbRgbRiRsmbRsbRgbRsbRsbLcbRi
bRhRsmbRibRibRgbLsbRgbRiRsmbRgbsbRgLsbRgbLsbLgbLobRsbRibLobLgbLgbRgbLi
bLgbRjbLgbRsbLcLsRsmbLgbLsbLsLsmbRsLsbLgbRjbRoLsbRobLibLsbLhbRsbLgbLib
LgbLgbRsbLgRsbRsLsbLgRsLsbLgbsbRjbLebRgbsbRgbLgbLgbLsbLgbLsLsmbLsbLsbL
gbRsbLiRsbRjbLhbLibRgbRiRsmbRcRsmbRgbLsbLsbRjbRsbRgbRgbsbsbRgbRibRsRsm
bRsRsmbLsbRgbRgbLsbRsbRgRsmbRgRsmbRsbLebLsbRgbLgbRsbRobLibLsbLgbLgbLgb
RsbRobRibRgRsmbRibLjbLobLsbLsbLgbLsbLsbLsLsmbLsRsbLgbLsbRjbRibRsbRgbRi
LsbLjbRhbLgLsbRgbRgbRgbRsbRgLsbRibRsbLgbRgbRgRsmbRibLcbLibLibRiRsmbLiR
sbRsbLsbLgbLgLsbLgRsRsmbRoRsmbRibLsbLgbLibLibRobRgbRgRsmbRsbLsbRgRsmbL
sbRgbRgbRsbLsbRgbLsbRgbRsbRgLsbRsbRgbsbRsbRsbsbRsRsmbLgRsbLibLobsbLibL
sbLgbLgbLgbRibRgbRsbRgbRgbsbLcbLobRhbRibRibLcbRcbRcbLcbRibRibLibRgbRgb
LobLibLsbLsbLsbLgbsbLsLsmbLsbLsbsbRsbLsbLgbLsbLsbLgbLsbLsbLgbLsbLgbLgb
sbRsbLgbRibLibRcRibRsRsmbRsbLsbRgbRsbRgbRsbRsbRsbLsLsmbRgbRgbRgbLgRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 25; Drug: Control
bLsbRgbLjbRcbLhbLgbLcbRibLcbRsbRibLhbLcbRcbRjbLhbLhbLcbLibLcbLibLibRhb
LgbLjbLibRibRgbLibLjbRcbsbRcbLgRsbLcbLcbLiRsbRsbRgbLcbLcbLhbLibLibRhbR
ibLsbRiRsmbLgRsbRhbLibRobLgLsbLibRcbLibLiLsbLsbLiLsbRgbLobLsbLibLiRsLs
bLibRibLibLcRsbRibRcbLhbLsbLgLsbLsLsmbLgbLjbLobRiRsmbRgbLgbLjbLcbLcbLh
bRiRsmbLsRsRgbRiRsmbRibRcbRobLiLsbLgbLcbRibLcbRgbLoRsbRibLjbLibLgbRjbL
hbRiRsmbLsbRjbRhbLibRcLsbLibLcbLibLsbLcRsbLjbLhbLibRhRsmbLgbRhbLibRiRs
mbLsbRgRsmbLsbRgRsmbRsbRsbRgbRsbRsbLjLibRcbRiLsbLgRsbLcbLibLcbRgbLjRsb
RibLhbRhbLcbRibLibRsbLsbLsbLgbRsLsbLgLsbLgbRgLsbRcbRcbLibLjbLibLgLsbLg
bRgbLsLsmbLsbLgbLsbLsbLgbRsbLgbLsbLgLsbLgbLgbLsLsRsmbLgLgbLgRsbRsbLjbR
gbLibRjRobLjbLcRsbRibRjbRobLibLibRjbRcbRibLhbLiLsbRjbLcbRibLhRsbLgbsbR
gbRgbLgbLgbLsbLgbLgbLsbLgLsbLgbLgbRsbLsbRgbLibRiLsbLiLsbRgbLsLibRsbLsb
RsbRsbLgbLiRsbRibRcRsmbRgbRgbLhbLcbRhbLhbRibLibLiRsLsbRgbsbLibRjbLibLs
LsRsmbLgbLsbLgbLsbLgLsbRsLsbLibRgbLibLhbRiRsmbRsbRcbLjbLoRsRsRimbRsRib
RibLebLcbRsbRgbRgbLhbRgbLibLgbLsbLsbLsLsmbLgbLgLsbLgbLgbLsbLibRsbRsbLg
bLgbRjbLoRsLsbRibLibLibRsbLibRjbRibLobRjbLibLgLsbLsbLsbLsbRibLjbRgLsbL
cRsbRjbLobRjbLcbRgbLibLjbRsRsmbRjbLcbRibLjbLcRiRjbRibLobLsbRoLsbLgRsbL
hbLibRibLhLsbRjbRcLgRsbRiLsbRhLsbRibLjbRiRsmbRcRsRiLsmbLhbLhbRcbLibRcb
LgbRhbLgbRibLjbRibLcLcbRibLiLsbRgbLibRsbLibRsLsbLgbLibRjbsbLibRgbRsbLi
bRibLibRsbLsRsLsbLibRsRsmbLibRgbLhbRibRjbRiRsmbRibRgRsmbLjbRiRsmbLjbLo
LsmbRjbLcbRibLibRgbLibRsbLgbLsbLsbLsbLgbRgbLibRgbRjbRhbLsLsmbRgRsRsmmb
RgbRgbLcbLgbLgbLgbRgRsmbLgbRjbRhLsbLibRibLeLsbLibRsLsbLgbLsbLgbRgbLibR
gbRjRibLjbLcbRgRsLsLsmmbLgbLgRsbLsbRjbRcbLjbLhbRibRibLcbRibRgbLsbRgbRs
bRsbRsbLsRsbRibRibLcbLsbLgbLgbLibRjbRibLibRibRsbRgbRgbRsbRsbLsRsRsmbsb
RsRsmbRsbRgRgRsRsmmbsbRsbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 26; Drug: Control
bRgLsbRgbLcbLiLsbLgbRsbLsbLiLsbLibRgbLibRibLgbRsbLgbRcRsmbRgbLsbRibRsb
RiLsbLibLibRjbRibLgLsbRibRgbLobLiRsbLiLsbLibLsbRsLsbRgbRibRibLsRsbRibL
sRsbLjbRhbLgbRibRsbRibLsbLjbRhRsmbRgLsbRibRsbRgbRsbRgLsbRiLsbRsbRsRsmb
RhbLgbLgbRhbRgbRcbLgbLsLsmbLiLsbLhbLsbLibRgbRcbRsbRhbLjbRhbLsbLjbRcbRi
bLgbLibLobRsbRgbLgbLsbLgbLgbRibRibRoLsbLcbRibRiLsbRsbLsbRgbRhbLibRgbLi
bLcbLibLcbRiLsRiRsmbRibLjbRhbLgRsbRcbRibLiLsbLgbRibRhLsbLiLsbRibRibLsb
RgbLobLgbLsbLgbLsbRsbLibLgbRgbRgbLcbLcbRgbRcbLebLibRjRsmbRibLibLgbLgbL
gbLsbRgLsLsmbLgbLhbRgLsbLgbLsLsmbLsbLsbLibRsLsbLgbLsbRsbLibRsLsbRjbLib
LgbLsbLsbLgbLsLsmbLsbLsbLsbLgLsbLsbLsbLgbLibLsbRsbLsbRsbLsbLibLjbLeLsb
LcbLcbRibRgbRcbLjbRcLsbLjbRhbRsbLibRhbRgbLibRhbLgbRhbLibRhRsmbRsbLgbRi
bLsbLsbRhbRcbLsLsmbLgbRgbLhbRiLsbLhbRsbLgbLsbLgbLsbLsRsbLsbLgbLsLsmbRs
bLgbLhLsbRgbRsbLsRsbRoRsmbLiLsbLibLibRgbLibLsbRsbRsbLibRjbLibLsbRsbLiR
sbLgbRgbLgbLibRiLsbRcbRibLibRcbLgbRjbRibLgbRcbLgbRhbLjbRhbLgbRibRgbRib
RibRsbRgbRgbRsbRsbLsbRibRcbLibLcbRibRsLsbRibLibLhLsbLgbLsbLgbLibRsbLsL
smbLgbLgbRsbLibLibRgbRibLgbLgbLgRsbRgbLibLibRgbRibLcLsmbRibLcLsLsmmbLg
LsbLsbLsbLgbLsbLsbLsbLsbLgRsbRjbRjbRcbRjbLsbLgbRsbRebLhLsLsmbLiLsbRibR
ibLgLsbRibRsbRsbLsbRsbRsbRgbRsbRsbRgbRgRsmbRgbRsLsbRsbRsbRsLsbRgbRgbLs
bRgRsmbRgbRgbLsbRgLsbRgbRgLsbLjbRhbRibLgbRgbRsbRgbRgRsmbRsbRgbLsbRgbLc
bLiLsbRebRibRsbRibRgbRgbRsLsbRgbRgbRgbRsRsmbRsbRgbRibRgRsmbRgbRsRsmbRs
bRgbRsbRgbRgRsmbsbRgbRsbLsLsmbRsbRgbLjbRgRsmbRsbLjbRhbLibRhbRgbRsbRsbR
gRsmbRsbRsbRgbRgbLgbLoLsmbLgbLgLsbLgLsbLsbLgRsbLcLsmbLcRsbRgbRgbRgbRsb
RgbLsbRgbLgbRsbRsbRgbRgbRgbRsbRgbRsbRsbRsbLobRibRcbRhbLgbRhbLgRsbRibRs
LsbRcbLgbRibRgbRgbRsbRgbRgLsbLgbLjbLibLibRsLsbLgLsbLsLsmbLsLsmbLsbLsbL
sbLsbLsbRsbLgbLsbLgbLsbLgbLobLoRsRsmbLjbLibLgbLgLsbLsLsmbLobLobRgbRgbR
sbRgbLsLsmbRgbLgbRgLsbLsbRsbRgbRgRsmbLsbRgbRsbRgbRsbRgbLgRsbRgRsmbRiRs
mbRsLsbRgbRgbRgbRgbRsbRsbRsbRsbRgbLsbRsbRsbRsbRgbRgbRsbLsbRgbRsRsmbRsb
LsbRgbRsRsmbRgbRgRsmbRgbLcbLgbRsbLgbLibRibRcbRsbLsbRgRsmbRgbRsbRgRsRsm
mbRsbRsbRsbRgbRsbRsbRsbRsbRgbLsbRibLcbLgbLgLsbLgbLiRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 27; Drug: Control
bLsbLgbLgLsbLibLhbLibLgLsbRsbRgbLibLgbLibLibRibLgbRsbLgbLgbLgbLibLibRi
bLgbRsbLgbRibRibRiLsbRibRsbRgbRiRsmbLibRibLibLibLibRjbLjbRibRcbLjbRibL
jbLibRcbRcLsbLgbRibLsbRgbLibLebLhbLgbRsLsbRsbLgLsbLibRgbRibRiRsmbRibRi
bRgbLgbRibLgRsbRhLsbLgbLjbRobRcbLibLsbRgbRsRsmbRibLhbRcbLhbRcbRgbLgLsb
RibLibRhbLgbRiRsmbLjbRibLgbRcbLgLsbRcbLgbLibRibRcbRibLibRiRsmbLgbLhbRc
bRcbRhRsmbLibRcbLjLsmbRhLsbLgbRsRsmbRiRsmbLsbRsbRiLsbRsbRiRsmbRsRsmbRs
RsmbLibRibLibRjRsmbRgbLsbRgbLsbRgbRibLjRsbRiRsmbsbLjbLibLibRsbLgbRibLc
bRibLgLsbLiRsbLsbLibLsbRsbLsbLibRjRsmbLibLgbLcbLibLibLibRgbLibRjbLibRi
bLibLcLsmbRsRsmbLibLibRibRgbRibRsbRibLgbRsbLsbRgbLsbRsRsmbRgbRsbLsbRsL
sbRgbRsbRsbRgbLsLsmbLjbRcbRgbRsbRgbLgbRibRsbRgRsmbRgbRgbLsbLsRsbRgRsmb
RgLsbLsbRgbRgbLgbRsbRiRsmbLhbLiRsbRcbLjbLibRcbLibRcbRibRsLsbRsbRgbLsbR
gbRgbRsbRgbLjbLcbLibRjRsmbLibRjbLgRsLsbRjbRoRsLsmbLjbRcbLgbRibRibLgbRg
bRgbRsbRsbRsbLsRsbRibLjbRibLibRhbLgbRgLsbRiRsmbLgbRibLjbRiRsmbLjbRibLs
LsmbRgbRibLsbRsRsRsmmbRgbRgbRsbLsbRgbLsbRsbRsbRsbRibRgRsmbLsbRibLsbRgb
LsbRiRsmbLgbRgbRgbRgRsmbRiLsLsmbLibRgbRibRgbLcbLiLsbRibLibRsRsmbRsLsbL
gbLiRsbLcbLibRsbRibRibRibLgbRgbRsRsmbRgbLjbRgbsbRgbLgbRgRsmbRibLsbRsbR
sbRibLsbRgbRsbRibRibLhLsbRibRgRsmbRgbRsbRsbRgbRgbLjbRhbLiRsbLcbLibRjbL
ibRsbLibLgbRsbLibRjbLgbRhbRhbLibRhbRibRibRiLsbLjbRgbRsbLsbRgbRsbRgbRsL
sbRgbLsbRgbRgbRgbRgbRgbLgbRiRsmbLjbRibRibRgbRibLsbRgRsmbLsbRgbLobLgLsL
smbRcbLsbRgRsmbRsbRibLsbRgbRsbRsbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 28; Drug: Control
bRibRibRgbRsRsRsmmbRgbRgbLsbRsbLgbRsbRsbRgbRgbRsbRgbRsbsbRsbLsbRgbLgbR
jbLcRsbLgbRibRgRsRsmmbRgbLgbLgbsbRibLjbLcRsbLgbLiRsbRsbRcRsmbRgbRiRsmb
RibLibLgbRsbLhbRhbRcbLobRibRobRibRsbRibLgbRhbRiRsmbRgbLibRhbRiRsRsmmbR
gbLjbRcbLiLsbLhbLcbRibRjbRobRcbRsbRibRibRiRsmbRhRsRsmmbLibLcbLoLsmbLsb
RsbRsbLcbLgbLsbLibRgbLibRsbRsbLhbRgbRoLsbRcbRsbRibRsbRiRsmbLjbLcbRsbLg
bRsbRjbRhRsmbRibRsbLsbLsbRgbRibRibLibLcbRcbRcLsbLibRcbLsbRgbRiRsmbRsRs
mbLgRsbRcbRgbLsbRgbRibLebRcbLibRcbRgbLjbRcbRgRsmbLsLsmbRgbRibLgbRcbLsb
LgbRibRsbRiRsmbLgbLsbRsbRgbRiRibRsbLibLsLibRgbRcbRibLgbRcRsmbLsbLsbRib
RgbLsbRgbRgRsmbRsbRgbRgbRgbRgbLsbRibRsbRsbRgbRgRsmbLsRsbRsbRgbRsRsmbRs
bLsbRibLgbRiRsmbLsRsbLgbRibLgbRcbLgbRibLsbRibRgbRgbRsbRjbRsbLibRsbRgbL
gbLibLiLsbRsbRcbRibLsbLcbRcbRhbRsbRsbLhbLcbRibRcbRsbRsbRsbRsLsbLibLcbL
jbRsRsmbRibRsbLjbRcbRibLgbRgbRgbRsbLiRsbLibLsbLgbLgbLgbRhbRibRsbRjbRgR
sRiLsmbLibLcbRobLjbRgbRgbRsbRsbRgbRjbLcbRhbRgbRsbLibRibRgbRsbRibLsRsbR
gbRgRsmbLgbRiRsmbRgbLjbLcbRhbRibLjbRibLebLsbLsbRjbRhbRjbLcbLgbLsbLgbRc
bRgbRibLjbLsbRibLjRsbLcbLibsbRcbRgRsmbLibRjbRibRsbRgbRsbRgbRgbLsbRgbLs
bRjbRibLjbRiRsmbRgRsmbLgbLhbRibRiRsmbRgbLhbRsbLibLsbLgbLgbRjbRcbRgbRsR
smbRgbRibLgRsbRibLgbRibRgbLjbRibRsbRsbRgbLcRsbLcbRgbRgbLobRsbRsRsmbRjb
RcbRsbRsbRibRgbLsbRgbRgLsbLsbRibLjLsmbRcRsmbLibLobRgRsLsmbLibLgbRsbLgb
LgbLsbLgbLgLsbLgbRgbLgLsbRsbLgbRsbLgbLgLsbLsbLibLsbLibLgbRcbsbLsbRjbRg
bRgbRgLsbRgbLsbRgbReRsmbLibRgbLibRjbLcLsmbLgLsbLsbLibRgbLiRsbRgbLgbLib
RjbLibRsbLiRsbRibLgRsbLibRjbLgbLibRibRcRsmbRiRsRsLsRsLsmmbRgbRgbLibRhb
LgbRgbRibLgbRhbLsbRsLjbLjbLsbRibRhbLgbLsbRibRsbRgbRgbLgbRhbLibRiRsmbRs
bRgbRsRsmbRsbRsbRgbRsbRsbRgbRgbRsbLsbRsbRgbRgRsLsmbRsbRgRsmbRgbRgbRsRs
mbRgRsmbRgbRsbRgbRgbRsRsmbLsbRgbRgbRgbRsbRgbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 29; Drug: Control
bLjbLibLgbLgbLgLsbLgbRcbRebRhbRibLibLjbRjbRebRibLjbLiLsbLcbRhbRibRibLj
bLjbRiRsmbRibLsbLsLsmbLibLjbRibLibRibLibRibRibLibRhbLjbLgbRcbsbLgbRcbR
cbRibLibLibRcbRibLsbLibLibRibRibLiLsbLjbRibRcbLcbRjbLibLibLjbLibRhbLib
RibLgbLhbRibRibRcLsRsbRibLjbRjbLibLibRhbLjbRibLjLsmbLibLjbRhbLgbLibRoR
smbRcbRhRsmbRjbLibLibLibLibRjbRcbRjbRgbLibRhbLgbLjbLcbLcLsmbLcbRibLibL
gbRjRcRsRiLsRimbLsbRgbRsbLibRhbLcbLibLcbRjRsmbLibLibRcbRcbLgbLibLibLsR
cbLsbLibLhbRjbLibLibLibLibLibLhLsbLibLgbRgLsbLibRibLibLgbLiRsbLcbLibRg
bLibLgbLibLgbRjbLiRsbLibRjbRhbRibRgbRibRiRsmbLsRsbLgbRibRgbRgbLsbRgbLj
bRsRgbRsRsmbRsRhLsbLiLsbRcbLibLcbRcRsmbRhLgbRcbLgRsbRhLsbRsbRjbLjbRibR
ibLjbLiRsbLgLsbLgbRcbRjbRgbRsbRgbRsRsRgLsmbRgRsmbRsRsRgRsRsmmmbRsRsmbR
sRgbRsbLsbRgRsmbRgbRsbLjbLhLsbLibRsLsbLgbRjbRhRsmbLgbRgRsmbRgbLsbRgRsm
bRhbLibRibRgbRgbRhbLibRgRsmbRgRsmbRgRsmbRsRgbLhLsbLcLiRgbLgLsbLibRgbLi
bsbLgbRgbLgbRjbRcbRgbLgbRgbRgbRgbLjbRiRsmbRsRiRsmbLibRgbLjbLibRcbRibLi
LsbLjLsLsmmbLibRhbRiLsbRibLjbLsbRiRsmbRgbRgbLgbRgbRgbRgbLsbRibRibLsbLs
bRgbRgRsRgmbLsbRsbRgRsmbRgbRsbRgRsmbRsbRiLsLsRsmbRgRgRsRgRgRsmmbRsbRsR
smbRgRsmbRsRsmbLsRsbRibRsbRgbLsbRsbRibLjbRibLjLcbLhRcbRjbLebLibLcRsbRh
bLiRsbLgbLgbLsLsmbLgbLibRjbLgbRhbRcbLsbLgbRibRibRiLsbLgbLjbLcbLhbRibLg
bLibLgbRjLsRsbLgLsbLsbRcbRcbRgbLgbLibLibLgbRgbLgbLsbLgbLgbLsbLsbLsbLsb
RsbLgLsbLsbLibRjbRibLhLsbLibRcbRibLjbLebRcbRcbLibLjbRcbRiRsmbLgbRsbLjb
LibLsbLgLsbLsbLgbLgbLsbLgbRsbLgRsLsbLgbRcbLjLsmbLibRcbLcbRcbRobLhbRhbL
cbLgbLibRjbLibLgbLsbLgbLsbLsbLsRsbLgbLsbLsbLgbLsbLgbLibLgbLibRibRibRjb
RibLebLhRsbRgbLibLgbRjbLibRcbLcLsmbLcbLibRcbLibLiRsbLhbRibLgbLgLsbLgbR
sRsmbLgbLgbRgbLgbLibRjbLsbLebRibRjbRibLjbLibRibLibLibLibRgbLibLibRibRi
bLiLibLibLgbRgbLhbRibLiLsbLgbRsbRjbRgRsmbLcbLibRsbRsbLsbLibRgLsbLgbLiR
sbRsbsbLsbLibLsLsmbRibLibRjbRibLhbLibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 30; Drug: Control
bLsbRibRgbRgbRiRsmbLibRgRsmbLhbLcbRcbLcbRjbLhbLibRgbLgbLgbLgbRcbLgbRhL
jbRgbRobRsLsbLibRjbRcbRgbLsbLibLjbLsLsmbLcLsmbRjbRcbRgRsmbLsbLoLsmbRjR
smbLhbRibLibLhLgRsRsmbRobLsbLgbRibLcbRobRcbRsRsmbRgbLibLsbLsbRibRgbLsb
RgbLjbLobLibRsbLhLsbLsbLcbLcbLcLsmbRgbRcbLcbRgbLcbLibRiLsbLibRsbLiLsbL
sbRobRobLgbRgbLgbRhbRiLsbLibRhRsmbLcbRcLiRsLsbRcLsbLibRcbRibRgbLgbRgbL
ibRcbLhbLiRsbLibRsLsbLibLhbRcbRcbRgbRgRsmbLsLsmbLcbRgbLibRjbRjbRhRsmbR
sbRcbLgbRgbLgbRcRsmbLhbRobLibLgbRgbRibLjbRibLibRcbRgbLgbRsbRgRsmbRsbLg
bRgbRgbsbRsbLsLcbRgbLgbRsbRsbLibRsbLibRjLsbLibLgbRsbLgbLsRsbRsRsmbLibR
gbLibLiRsbRibLibRsbLgbLgbRgbLgLsbLgbLsbLsbLgbLgbLgLsbLgbLsbRsbLgbRsLsb
LgbLiRsLsbRgbLgbLsRsbLgLsbLsbLjbLobRcbRobLgbLibRibLibLgbRsbRsbLgbRgbRj
bLsbRhbRgbLjbLjRsbLiRsbRgbLibRgbLgbLibRgbRiRsRgmbRsbLjbRibLgbLcbLibRcb
LcbRjRoLsLsLsmmbRobLiLibRsLsbLgbLibLsbLgbLsbRsbLjbRjbRibLjbLobRhbLibLg
bLgbLsbLsbLsLsmbLgbLgbLgbLgbRsbRgbRsbLgbLsbLjbRjbRjbLjbRcbLhbRcbLcbLiL
sbLgbLsbLsbLsbLsbLgbLsRsbLsbLgbRjbRcbRgbRsRgbLsLsmbRgbLcbLsbRsbLgbLsbL
sbRsbLgbLibLcRsbRcbRhbRcbLibLibLsbLgbLiRsbRcbRobLibRhbLibRcbLhbLcbLsRs
bLgbLsbLsbLgbLsbRcbRgbLjbRcbLhbRobLibLgbLsbLibRjbRjbLjbLibRsLsbLiRsbRg
bsbLjbLgbRcbRgbRsbLsbRcbLcbRgbRgbRgbRgbRobLibLibRibLjbLibLgbLgRsbLsbLs
bLgbLsbLsbLgLsbLgbLsbLsLsmbLgbLgLsbLsbLgbLsbLgbLsbLgbLgLsbRsbLgbLsbLsb
LgbLgbLgbRobLjbLcbRjbLibRgbLgbLgbLsbLgLsbLgbLsLsmbRsLsbLgbLsbRsbLgbLgb
LgbLsLsmbLgbRcbLcbRgbLibRsbRsbLgbRsLsbLgLsbLsLsmbLgLsbLsbLgbLsbLgbLgbL
gbLsbLgLsbLsLsmbLgbLgbLsbLgbLgLsbLgbLsbLgbRsbRjbRibLjbRcbLoLsmbLoRsbRi
bRjbRibLcbLcbRiLsbLgRsbLsRsbLsbLibLgLsLsmbLsLsmbLgbLsbLgbLgbRsbLgbLsbR
sbLgbLgbLsbRsbRgbRobLibLibLibRgLsbRsbRsbRsLsbRgbLobLibRsbLsbLsbLsLsmbL
gbLsLsLsLsmmmbLgbLsLsmbLgbLibRjbLgbLsbLgLsbLgLsbRjbLiLsbRjbLgLsbRibLib
LgbRsbRibLibRhbRgbRgbRsLsbRgbRgRsmbRgLsbLjbRsRoLsbLibLibLgbLsbLgbLgbLs
bLibRsbLsLsmbLgbLgbLgbLgbLgbRsLsbLsbLgbLsbLgbLibLgRsbRgbLgLsbLsbRsbLgb
LsLsmbLgbRcbLgbRcbLibRibLsbRgbLgbLibLhbRsRgbLgbRsbLsbRsbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 31; Drug: NDMC 1 µM
bRgRsmbLsbLgbLhLsbRgRsmbLgLsbLibLsRsbLgbLgbLgbLsbLebRibLibLiLsbRgbRjbL
hbLibLsbRibLibLgbLgbLsbRibLgbLsbLgbLibLibRibLibRhbLhbRgbRgbRgbLebRibLi
bRcbLcbLcRsLsbRibLibLsbLibRibRgbLibRgbLibLibLgbRsbRcbLibLhbRebRcbRibLi
bLgbLsLsLsmmbRgbRgbLhbLsbLibRgbLibRgbLgbLsbLcbLeLsbLibRibLhbRgbLiLsbLi
LsbLgbLibsbRcbLsbLibLibRibRsbLgbLgbRsbLibLiLsbRiRsmbRibRgbLsbRcbRibLcL
sLsmmbLcLsmbLibLiLsbLsbLgbLsLsmbLsbLsLsmbRebRibLsLsmbRgbRiRsmbLcbRsbRe
bLcbLeLsbRhRsRhmbRiLsbLhbRjbLeLsbLgbLsbLibLgbRsbLcbLsbLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 32; Drug: NDMC 1 µM
bLgbRjbRsbRgbLebRjbRhbLjLsmbRgbRiLsbLiLsbLcbLcbRjRsmbRibRgRsmbLjbRcbRi
bLibLsbLsbRsbRibRcRsmbRjbRjbRoRsRsmmbRoRsmbLjbRoLsbLobLgbRcbRobLjbLsRc
RsmbRobRobRjbRcbLgRsbRcbRjbRjRsmbLjbRobRcbRcbRcbRhbLiLsbLjLsmbRcbLgbRo
bRcbLsbRhbsbRibRcRsmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 33; Drug: NDMC 1 µM
bRgbRgbLibLhLsbRcRsmbLibLgbLgbLgbLgbRjbLgbRjbRgbRibRibRgbRibLgbRgbLjbR
gbRgbRgbRgLsbLjbRibRgbLjLsmbLibRibRibRsbLsbRsbRgbRgbRgbLjbRibRgbRgbLgb
RgbRibLsbRgbRcbLgbRiRsmbLjbLcbLibLcbLibLgbRibLsbLjbLibRgbLhbRjbLcbLhbL
cRsbRcbRcbLhbRcbLcbRibLhbLibLiLsbLhbRibLgbRgbRhRsmbLibLcbLhbLibRibLcbL
cbLhbRgbRibRibLjbLhLsbRcRsmbRgbLjbRsLsLjbsbRcbLjLsmbLhbLgbRibLsRsbLibL
jbsbsbRsbLgbLsbLgbLgbRjbRjbRsbRibLjbRibLgbRibLgbRibsbsbLjbLibRcRsmbLjb
LjRsbLibLsbLgbLgbLgRsbLgbLsLsmbLibRjRsmbRsbRjRsmbRgbRgbLsbRsRsmbRsbRgb
LgbRgbRgRsmbLibRgbLgbRiRsmbRsbLjbLgbRjbLhbRibLgbRgRsmbLsbRgRsmbRsbLsRs
bRibLcbLhRsbRibRibRibRgbRsbLsLsmbRgbRgLsbLgbRgbRgbLsbRsRsmbRsLsbLsRsbR
sbRgbRsbRsbRsRsmbRsRsmbRsbRgbLjRsbRibRgbLsbRgbRgbRgbRsRsmbRsbLsRsbRsbR
gbRgRsmbRsbRsbRgbRsbRsbRsbRgLsbRgbLjbLcbLibLcbRoRsmbRibLibRibLgbRgbRsb
RgbRgbRgbRgbLgRsbLjbLhbLgbLgbRjbRoRsmbRibLgbRibRgbLibRibLgbRjRsmbLgbRg
RsmbRgbLcbLibLgbLgbLibRcbRibRsLsbRgRsmbRsbRgbLjbLgbLibLcRsbLibRsRsmbRg
bLjLsmbRjbLgbLjLjbLgbLgRsbRobRsbRgbRsbRgbRgbLsbRgRsmbLgRgbLsbRgbRsRsmb
RsRsmbRsbRsbRsbLsbLsbRgbRibLjbLsRibLgbRgbLjbLcRsbLibRjbRcbsbLhbLgbRiRs
mbRibLgbRibLsbRsRsmbRsRsmbRsbRsbRsbRsbRsbRgbRgbRsbRsRsmbRsbRsbRsRsmbRs
RsmbRsbRsbRsbRsbLsbRsRsmbLsbLgbLjLsmbLgbLgbRebLcbRcRsmbRibRsbLsbRsbRgb
RgbLjbRibLgbRiRsmbRgbRsbLgbRgbLgbRsbRgbRsbRgRsmbLgRsbRgbLjRsbRgRsmbLsR
sbRsRsmbLsbRgbLsRsbRsbRgbRgRsmbRgbRgbLgbRgRsmbRsbRiRsmbLjbRibRsbLsbLsb
RsbRgbRgbLsbLgbLjbLgbRibRgRsmbRibRsbLjbLjLsmbLgbRcbLjbLhLsbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 34; Drug: NDMC 1 µM
bLibLibLjbRhRsmbLsbLsRsbRibRsbRsbRsRsmbRsRsmbRsbRsbRgbRgbLsbRibLsbRibR
gbLgbRgbRgbRibRsbRgbRibRgbLgbRsRgbRgLsbLsbRibRgbRsbLcbLcbRebRobRsbRgbR
sbLgbRsbRhbRsbLsbLjbRibLjbRibRgbRgbRibRhbRibRgbLgbRgbRibRgbLcbLsbLhRsR
smbRgbLhbLcbRsLsbRjbLhbRgbLibRsbLibRsbLsbLibLcbRibLibLgbRgbLcbRibLoRsb
RibRibRgbRibRcbLebRibRgLsbRsbLgbLibLcbRibRiRsmbRcbRibRhbRsbLgbRgbLgLsb
LgbRcbRobLgbRsLsbLsbRjLsbLsbRhbRcbLgbRibLgLsbLgbRiRsmbLsbRgbsbRibRiLsb
RobRjbRgbRibRcbLjbLcbRgbRsbRgbLsbLjbLsbRsRsmbRiLsbRibLsbRsbRsRobRjbRgb
RgbLcbLcbRibLjbLcbLobRsbRsbRgbRsbLsbLsbRgbLjbLcbRgLsLibRcbRcbLhbRsbLhb
RgbRsRsmbLjbLibLsbRjbLgbRibRsbRgbRgbRsLsbLgbRgRsRsmmbRgbLcbRjbRgbLobRi
bLcbRhbLjbLsRsLsbLgbRsbRjbLgLsbRgbLibLgbLsbRhbLibLgbRgbLsLsmbLgbLgbLgL
sbRsbLsbRsbLsbRsbRsRibsbRgbLsbRgbLhbLgbRsbLgbsbLjbRibLjbRgRsmbLsbRgbLg
bRgbLgbLibLgbLsbRsbLsbRsbLibRjbLhLsbRgRsmbLgLsbLsRsbLgbLgbRjbLibLsbRsb
LgbRsbRsbLgbLsbLgLsbLsLgRsbRjbLsbLgbLsbLgbLsbLgbRjbRibRgbLjLsmbRjbLjbL
gbRsbRjbLibLgbLgbLgbLibLgbLsbLsbRsbLgbLhRsbRjbLsbLgbRgbRcbLgbLgLsbRsbL
cbRsbRsbLgRsbLgLsLsmbRjbRibRsbLjbLgbLgLsRsbLsbLgbRjLsbLjbRjbLibRsbsbRs
bLgbLsbLsbRjbLibLgRsbRsbLgbLjbLcRsbRcbRgbLiLsbRibRibRgbLsbLsbRsbRgbRgb
RgbLobsbRjbRcbLcbLgbLgbRsLsbLsbLgbLgbLsbLsbRsbLgbRsbLgbLgbLgbLgbLsbLgb
RsbLsbRjbLcbRhbLhbLsbRhbLibLsLcbRgbsbRibLebLibRcbRgbLcbLgbLsbRcbLibLgb
LsbLsbLgbLgbRsbLsRsbLgbLgRsbRgbLcbLgbRsbLsbRjbRgbRsbLsbLsbLsbRsLsbLibL
ibLgbLgbLgbRsbLgbLgbRsRsmbLgbRsbLgLsbLsbLsLsmbRsbLgbRoRsmbLjbRibLibLgb
LgLsbLsbRsbLsbRsbsbRjbRsbLhbLsbLibLgbRibLgbLgbLsbRjbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 35; Drug: NDMC 1 µM
bRjbRibRhbLgbRgbRgbLgbLgbRibRibRgbLjbRibRibRibLibRibRgbLibLibLibRebRsb
RcbLgbsbLjbLhLsbLhbLibLiLsbRibLibLibRjbRcbRiRsmbRsbRiRsmbRibLgbLjbRsbR
sbRibRsbRhRsmbRhbLgbLibRebLsbLsbRsbRiRsmbRsbRsbLjbRcbRebLibRibRgbRiRsm
bLgLsbRobReRsmbLibRgRsmbRsbRibRgbLibLcbsbRibRobRsbRjRsmbLibRibLibRcbLi
bLhbLjLsmbLgbLgbLgbRsbRgbRcRsmbLgbRobRiRsmbLsbLgbRcbRhbLgbRoRsmbRsbLgb
RcbRibLiRsbRobLsbRsbRcbRgbRgRsLsmbRsbRibLjbLcLsmbRsbRsbLgbRcRsmbRcRsmb
LiLsbRsbRibLibLjLsmbLiLsbRjbLibLsbRsbLgbRcbLgbRcbLibLcLsmbRsbLsbLsLsmb
LsbLgbLibRobRcbRsbLsRsbRcbLiLsbLibLhbRgbLgbLsbLcLsmbRibRcbLgbRcbLibRib
RgRsmbRgRsmbRsbRsbRgRsRsmmbLsbRhLsbLhbLcLsmbRjbRibRsbRcbRhRsmbRibLibLi
bRibLcbLsbRsbLsbLsbRsbLibLibRsbRgbLibRsbLsbLsLsmbRgLsbLgbLgbRsbLsbLobR
cbLobLhLsbLibLiLsbRibRibLjbRibRsLgbRiLsbLibRoLsbLgbLibRcbRjRsmbLibRcRs
mbLiRsbRsbRcbLgRsbRebRgbLgLsbRsbLibLgbRsLibRsbLiLsbRiRsmbLibRcbRsbLsbR
sbRgRsmbRsbRsRsmbRgRsmbRgbRgbRsRsmbRsbRgbRsbRgLsbRsbRgbRgRsmbLoLsmbLiL
sbRjbRhbRebRibLibRoLsbLgbLgbRsbRhbLgbRibLgbRibLsbRsRsLsmbRgbRsbRsbRgbR
gbRgbRhbLibRibLgbRiRsmbRsbRiRsmbLjbRcbLibRibRgbRgbLjbRibRsbLgbRibRsbRg
bLsbRibRgbLgbRhbLsbLgbRsRibRgbLgbRiRsmbLgbRhbRsbRsbRgRsmbRgbRgbRgbLgbR
ibRibLiLsbRjbLibRibsbRcbLibRhbRibLiLsbLibRsLhbLibRjbLibLiLsbRsbsbLhRsb
LibLibLibRgbRhbLibLcLsmbLgbLsbLiLsRsbLgLsRgbLibLsbLgbLgbRsLibLgbRsbLgR
sbLgbLgbLgLsbRsbLibRgbLcbLhbLcbRiRsmbRibRibLgbRhbLibRibLjbLcbRjbLibRsb
RhbRibLsbRibLgbRibLjbRibLjbLcLsmbRsbLgLsbLgbLgbLgbLgbLsbLgbRgbLibRjbLg
bLgbLgbRsbLgRsbLsbLgbLgbLsbsbLgbLgbRsbLgbLsbLgRsbLgbLgbLibLibRsbLibLib
RiLsbLgbLgbLgbLgbLgLsbRgbLgLsbLsRsbLsbLgbLsLsmbLsRsbLgbLgRsbLgbRsbLiLs
bLsLsmbLsLsmbLgLsbRsbLgbLgbLsbLsbLgbLgbLgbLibRsbLgbLgLsbLgRsbLsbLgbLgL
sbLgbLsbLsbLsLsmbLsbLgLsbLsbLsbRsbLgLsbRsbLgbLgbRsRjbRobRgbRgbRhbLibLj
bRcRsmbLcbLcbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 36; Drug: NDMC 1 µM
bRibsbsbsbLobRjbLsLsmbLsbLsbRsbLcbLjbLcLsmbsbLsLsLsmmbLsLsmbLobLsbLgbL
sbLsRsbRsRsmbRhbsbsbsbLgbLgbLcbLcbLebLsbLcbLiLsbRcRsmbLibsbLsbLcbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 37; Drug: NDMC 3 µM
bLcbsbRsLsbLiLsbRhbRibLiLsbRsRsmbLibRgbRjbRibRibLibRjbRgbLcLsmbRcbLcbR
hbRiRsmbRiRsmbRcbRcbLibRhbRcbLjbLjbRjbRhbRsRsmbLibRiRsmbRgbLgbLcbRjbLc
bRjbRibRsbRsRsmbRibRobRoRsmbRcbRibLebLcLsmbRibRsbLjbRcbRcbRcbRgbRibRsb
LebLcbRibLcbRgLsbRcbRibLcbLhbLgLsbRsbLibRgbLibLibRibRsbLcbLibRiLsbLsbR
gbRgbRibLobLhLsbRibRibRjRsmbRjbRiRsmbRhbRibLcbRibLobLoRsbRiRsmbRibLibR
ibLgbRsbLoLsmbLiLsbRibLjbLibLgLsRsbRgbLibRibLcbLcbRibRiRsmbLsbsbRsbLob
RiRsmbRgbRibRgbRsRsmbRsbRsbRsbRsbRgRsmbsbLcbLibRibLsLjbLcbRibRcRsmbRsb
RibRjRsmbRibLgLsbRibRibRsbRcbLsbRgbRibLgbRibLiLsbRiRsRsmmbRsbRsRebRobR
sbRgbRgbRsbLsbRiRsmbRibRgLsbRgRsmbRgbLcbLibLsbLgbLhLsbRhbLcbRhbLibLeLs
bRgRsmbLibRhRsmbLsbLsRsbRgbRibLsbRibLgbRiRsmbLsRsRsmbRgbRsbRsbRgbRsbRs
bRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 38; Drug: NDMC 3 µM
bRsRsmbRsRsmbRgbRsbRgbRgbRsRsmbRgbRsLsbLsbRgRsmbRsRsmbRsbRsbLsbLsbRgbR
gbRgbRgbLjbRgbRgRsmbLgLsbRgLsbRgbLsbLsbRibRgbLiLsbRgbRhbLjRsbLibLgbLiR
sbRjbsbRhbLsbRhbLgbRsLcbLibLjLsmbLsbRgLsbRibRiRsmbRibLsRsbRibRsbRsbRib
RsbRgbRgbRgbLsRsbLgbRgbRhRsmbRsbRibRgbLibRsbRgbRgbRibRiRsmbRsRsmbLsbRg
bLgLsbLsbLsLsmbLsLsmbRobRgbRgbLibRgbRgbLibLibLgLsbLsLsmbRgbRsRsmbRgbRi
bRsRsmbsbLjbLgbLsLsmbsbLsbsbRgbLsbsbLjLsmbLsbLgbRjRsmbRhbRsbRibRsRsmbR
sbLsbRsbRibRgbRsbRsbRsbLjLsmbLibLibLiLsbLiLsbsbLsLsRsmbRgRsmbRsLsbLjLs
mbLsbRgRsmbRsbRcRsmbLsbLgbsbRgbsbRgRsmbRgbRsbLibRhbRgbsbLsbLsLsmbLgbLi
LsbLsLsmbLsLsLsmmbLsbRibRebRsbRibLsRsbRsbRgbRgbRgbRsbRsbRiRsmbRsbRgbLs
bsbRgRibRibRsbRsbRgbRsRsLsmbRibRsbRgbLsbRgbRsbRgbRsbRgbRiRsmbRgRsmbRib
RgbRsbRsbRsbRsRgRsmbRsbRsRsmbRgbLsbRsbRsRsmbRsbRsbRgRsmbRsbRgbRsRsmbRg
bRsbRsbRsbRsbRgRsmbRsbRsRsmbRgRsmbRsbRibLgbRibRgbLsbRgbRgbRsbLsbRgbRgR
smbRsbRgbRsbRgbRgbRgbLsbRgbRsRsmbRgbRgbRgbRibRibLibRhbLsbRgRibsbRgRsmb
RgbRgRsRsmmbRsRsLsmbRgbRsbRsbRsbRsbLsbRgbRgbRibRgbRsbRiRsmbRgbRibLsbRg
bRsbRibRsbRgbRgbRsbRgbRsRsmbRgbRgbRgbRgRsmbLsbRgbRgbsbRgbRgRsRsRsmmmbR
gbRsRsmbRgRsmbRsbRsbRsRsmbRgbRgbRgbRgbRsbRgbRsbRsRsmbRgbLgLsbLcRsbLibL
gbLsbLsbLsLsmbLgbRjbLibsbLgbLibRsRsmbLgbLsLsRsmbLsbLsbLgRsbRjbRsbLibRs
bLhbLcRsbLgbRibLsbRsbRgbRgbRibRsbRgbRgRsmbRsbLsRsbRsbRsbRgLsbRsbRgbRib
LsbRgbRgbLgbRgbRsbRsRsRsmmbLsbRgbRgRsmbRgbRsbRgbRsbRgbLjbLcRsRsmbLcbRg
bLsbLgLsbRsbLibRsbLgbLgbRsbLsbLgbLsbLsbLsbLsbLsbLsbLsbLsLsmbLsbLgbLsLs
mbLgLsbRsbsbLgbRsbLibLsbRsLcbRibLibLibRjbLcbRgbRcbRhRsmbLibRibRhbRgbLh
bRiRsmbRgLsbRhbLsLsmbRgbRgbRsbRsbRgbRgbRsRsmbRgbRgRsmbRsRsmbRsbRsbRgbR
gbLsbLsbRgbRgbLjbLjLsLsmmbLiLsbLcLsmbRibRibRibLsRsbRibLsbRgbRsbRsRsRsm
mbRsRsRsRsmmmbRsbRsbRgbRsbRsbRgbRgbRsbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 39; Drug: NDMC 3 µM
bLsbLgbLsbLsbLgLsbLsbLgbLsbLgbRsbRsbLgbRgbLjbRjbLjRsbRsbsbRjbRgbRiLsbR
ibRgbRiRsmbRjbRibRibRibLgLsbRsbRgbRibRsbRibLibRsbLgbLcbLibLjbRgbLiLsbR
gbLgbLibLcbLibLibLibLgbLsbRgbRgRsmbRhbRibRgbLsLsmbLhbLcbRgbLhLsbLibLgb
RsbRsbLibLsLsmbRsLsbLgbLgbLgbLgbRsbRsbRgbRsbLsbRobRhbLgbRsbLgbLgbRgbRg
bRibRhbRsbRgbLgbLsbRgbRcbRgbRsbLgbRcbRibRhbLiRsbLgbLhbRsbRsbLsbLiRsbLs
bLgLsbLsbLcbLhbLjLsmbRjbRhbLibLibsbLiLsbLgbLsbLgbLgbLsbLibLibLcbRgbLib
LoRsbLsbLsbRgbLsbLgbLgbRjbsbRhbRsbLjbRibRjbRibRgbLjLsmbLcLsmbLsbLsbRsb
LibRsbRsbsbLsbsbLgbLsbLgLsbsbLhRsbLcbLgbLsbLibLsbLgbLgbRsbLgbRsbRcbRib
RsbRibLsbLgbRgbLsbLhbLjLsmbRsbLjLsmbLsLsmbLgbLibLcbLgbLgbLibRjbLcbRhRs
mbRhRsmbLjbRgbRsbRibLjLsmbRgbRibLjbRcbRgbRgbRibLibsbLjLsmbLsbLibLobRgb
LgbLgbLgbsbLgbLgRsRsmbRcRsmbLjLsmbRhbRcbLjbRgbRibRibLcbLibRgbLibRgRsmb
LibLsbLgLsbRjRsmbLcbRibLgbLsLsmbLibRgbRibRibRsbRibRsbRgbLjLsmbRhbLjbRi
bLjbRhbLgbLjbLcLsmbRhbLiLsbLiLsLsmbRsbRgbLobLcbLgbLgbLgbLgbRsbLgbLsLsm
bLgbRsbLgbRjbRcRsmbLjbRgbRibRgbRgbRgbRgRsmbLjbLcbLsbLibRsbLgbRcbRcbLib
LgbLibLgbLgbLgRsbsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 40; Drug: NDMC 3 µM
bLsbLsbRgbLsbRgbRsbRgbLsbLsbRgRsmbRsRsmbRgLsbLcbLgbLibLsLsmbLibRgbLgbL
ibLibLsbLgbRibRgbLcbLgbLibRibRgbLibRjbRjbRsbLhbLibLgLsbRsLsbLgbLcbLhbL
ibLgbRgbRibLcbRjbRcbRibRgbLsbRibRhbLcLsmbRibRiRsmbRgbLcbLcbRibLcbRibRi
RsmbRcbRibRcbRsbLcbLcbLibLibLhbRhbLcbLcbRiRsmbLgbLcbLcRsbLibLsLsmbLcbL
cbLibLgbRgbLcRsbRibRgbRibLibLcbRibRibLhLsbRjbRhbRiRsmbRhbRibLibLibLibR
ibLibLjbLjLsmbRibLcbLcbLcbRiRsmbRebLibLiLsbRibRibLibLjLsmbRjbLsbRcbRcb
RobRibLsbRibLjbRsbLjLsmbLibRibRjbRjRsmbRgbRgbRhbRcbRhbRcbRjRsmbLibRjbL
gbLibRibLcbLcbLsbLgLsbRcbRhRsmbRibRiRsmbLsLsmbsbRsbLsLsLsmmbRhbLcbLcbL
ibLhbLhbLibRsbsbRibRibRibRgbLiLsbLcbLhRsbRgbLcbLsLsmbLhbRsbLibRibLcbLi
bRsbRcRsmbRibRsRsmbRiRsmbLibLcbLsLibRsLsbRsbRsRjbLhbRibRgbLgbRiRsmbLib
RjbLjbRebRibRcbRhbRibLgbLibLsbRcbLebLhbLgbRgLobRibRcbRhRsmbRgbRgRsmbLg
bRgbLgbLgbLibRcbRibLibRibRibLibLhbLgbLibRjbRcbRibLgRsRsmbRgbRgbRgbLgbR
gRsmbRsbLsbRgbRgbRsbRsbRsbRsbRsbRsbLsRgbRgbRsbRgLsbRgbRgbLjbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 41; Drug: NDMC 3 µM
bLibLsbLgbLgbLgbLgLsbLgbLgbLgbLgbLibLgbRsbLibRjbRjbRhbRsbRgbRiRsmbRsRs
mbRibRsbRibLsbRsbLhbLgbLsbLibLgbLibLgbLsbLgbRcbRibLibRibRsbRiLsbLgbRsb
RibLsbLsbRibRsbLsbRibRiLsbRhbRsbLhbLibLsLsmbLiRsbLgbRibLibLsbLibLsbLgb
RgLsbLibLsbRsbLibLsbLibRgbLibLiRsbRjRgbLhbLibRiLsRsbLgbLcbRibLibLgRsbR
sbLiRsbRgLsbLhbRjbRcbRgbLsRsbRhbLgbLebRgbLibLhRsbRibLhbRsbLibRgbLgbLgR
sbLgbLsbLsbLgbLsbLgLsbRgbLhbRibLiLsbLgRsbLsbLiLsbRgbLhLsbRsbRsbLibRsbL
ibLsbLgbLsbLgbLibLsbLiLsbRsbLibRgbRcbRibLgLsRsbRgbRsbRsbLcbLiLsbLsbLgL
sbRjbLiLsbLgbRgLsbLhbRgbLcbRibLibLgbRsbLcbRiRsmbRhLsbRibRibLgbRibLsbRg
bRsbRsbRibLibLjbLhbRjbLiLsbLiRsbRsbLiLsbLsbLgbRhbRibRiLsbRsbLsLsmbRibR
sbRgbRsbRsbLeLsbLibRgbLcbRhbRjbRibRhbLibLobRibLiRsbRjbRsLcbRgbLhbRibRj
RsmbLsbRibLsbRsbRsbRiRsmbLgbRibLhbLeLsbRgbLoRsbReRsmbLjRsbLibRgbLobRhb
RsbLgbLcbRhbLibLcbRsbRibLsbLibLgbRgbLiLsbRjbLhbRibLsLsmbLcbRgbLibLsLsm
bLgbLgbLgbLgLsbLgbLgbLsbLgbLsbLsbLgbLgbLgLsbLgbLgbLsbLgbLsbLibLgbLsbLg
bLgbLgbLgbLgLsbLgLsbLgbLgRsbLsRsbLgLsbLgLsbLgbLgbLgbLsbLibRsbLgRsbLibR
sbLibLsbLgbLsbLgLsbLgbLsLsLsmmbLgbLobRibLibLebRibLibRsbLibRsbLgbLsbLib
LsRsbLgbLgbLgbLgLsbLgLsbLgbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbLibLgbLgbLgLsb
RsbLgbLsLsmbLiLsbLsbLibLsbLgbLsbLgbLgLsbLgLsbLgbLgbLgbLibLibLgbLgbLgbL
gbRjbLgbLgbLibRjbRcbLsRsbRibLgbRsbRibLcbLcLsmbRgbLsbLibRgbLgRsbLsLsmbL
sbLgbLsbLgbLgbLgbLsbLgbRsbLgbLsbLgbLsbLgbLgLsbLgbLgRsbLgLsbLgbLgbLgLsb
LgbLgbLibLgbLgLsbLgbLgbLibRjbRcRsmbRibRibLcbRibLiLsbRsbLibRibLcbRgLsbL
ibRgbLhbRibLibLsbLgbLgbLsbLgbRsbLsLsmbLgbLgbLsRsbLgbLgLsbLsbLgLsbLgbLg
bLgbLgbLsbLibLsLsmbLgRsbLgbLsLsmbLgLsbLhRsbRibRhbRibRibLebLsLsmbLibRgb
LcbRibLcLsmbRibLibRsbLsbLhbRibLcbRebLcbRibLiLsbLgbLgbLgbRgbLibRjbLiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 42; Drug: NDMC 3 µM
bRgbLsbRgbRsbRgbRsbRsbRgLsRsbRgbRgbLsbRgbLsbLsbRgLsbRgRsmbLsbRgbLgbRib
RjbLgbsbRsRsmbRsbRgbRsbRgbRibLjbLhbRjbLiRsbLibsbLibLibRgRsmbRgbLibLibL
sbLgbLgbRjbLibRgbLiRsbRjbLibLibRgbLcLsmbLibRjRsmbRgbRgbLgbLcbRjbLibLhb
LgbLsbLgRgbRsLsbRibRibRgbLsLsmbLhbLsbLiRsbLgbLibLsbRgbRsRsmbRsbLjLsLsm
mbLibRgbRjbRcbRcbLibLsLsLsmmbRgbRgbLibLiLsRsbLibRibLebLhRsbLgLsbLgbLgb
RgbLibsbLgLsbLgLsbLjbLgbLibRgbRsbRibLgbRsRsmbRgbRgbRsbLcbLiLsbLhRgbLib
LiLsbRcRsmbLhbRjbRcbRsbRhbLibLcbRcbRgbRjRsmbLsbRibLibLjLsmbLibRjbRiRsm
bLjbLcbRjRsmbRcbLgbRsbRibRgbLsbRibRsbLgbLhbLgbLibLibLsbRhbLebLibRibsbL
ibLgbLcbRsbRibRibRgbRgbLsbRgbLjbRibRibRgbRibLgbLibLibLsbLjbLsbsbRsbLgb
RobRoLsbLsbLgbLjLsmbLgbLgbLgbLgbReLsbRhbLgbRgbRsbLsbRgRsmbRgbLsbRibLib
RiRsmbRgbRsbLgbRibRsbRgbRcbLibRgbRibRgbRsRsmbRsbRgLsbRsbRgbRibLibLcbLo
RsbRiLsbRhbRibLebLcbRjbRcbRgRsmbLgbLibRjbLhbRcbRibRsRsmbRsbRgRsmbRgbRg
bRgbRsbLsbRibRsbRgbsbRsbLsbRsbRjbRsbRsRsmbRgbRgLsbLsbRsRgRsmbRgbRsbRsb
RsbRsbRsbRgbLgbRibRibRgbLibLibRcbLibRcbRsRsmbLsRsRsLsLsmmbRhRsmbLjbRcb
LibRcbRobLgLsbLgbLgbLgbRsbRsRsmbLibLjbRcbRcLsbLibLcbLsbLgbLsbLoLsmbLib
LjbLgbLgRsbLgbLjbLsbLsbsbLsLsRsmbLsbRsbRgbLibLgbLibLgbRibRebLibRibRsRs
RsmmbRsbRgbRsbRgbRgbRgbRgbLjbRcbLibLsbRibsbLsRsbRibLgbRcLsbLibLjbLgbLg
bLiLsbLgbLsbLgLsbRsbRjbLibLgbLibLibLhRsbRibRcbLhbLcbRgbRcbsbRibLsbRibR
gbLsbRsbRsRsmbRsbLsbLgbLjbRjbRjbLsbRsbRgbRsbRgbRsbRsbLsbRibLjbRibLsRsL
sRsbRgbRgbRsbRgbRsbRjbRsbRgbLsbRibRsRsmbRsbLsRsbRsbRgbRgbRsbRsbRgbRgRs
mbRgbLibRcbRgbsbLsRsbRsLsbRgbRsbRjbRsRsmbRgRsRsmmbRiRsmbLjRsbRcbRgbRgb
RsbLsbRjbLibRgRsmbRgbRgbRgLsbLjbLibLgbLjbsbRcLsbRobLibLibLgRsbLsLsmbLs
bLgbLcbLibRibRgbLgbRibLcbLcbRebRcLsbLgbRibLsbRibLsbLsbRiRsmbLjbRcbRgbR
sRsmbRsbRsbRsbRsRsmbRgbRgRsmbRsRsmbRgbRsRsmbRsRsmbRgRsmbRgbRsbLsRsbLsb
RgbRgbRgbRsbRsbRgbRgbLjbRibRibLsbLsbRibLsbRgbLsbLibLgbRcbLjbLiLsbRebRg
bLsbsbRibLgbRgRsLsmbRjbRsRsLsRsmbRsbRsbRsbLsbRsRsmbRsbLhbLgbRcRsmbLibR
cbLgbRibLsbRsbRsbRsLsbRgbRsbLsbRgbLsbRgRsmbLgbRibLgbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 43; Drug: NDMC 10 µM
bLobRsbLibLsbLibLgbLcRsbRgbLgRsbLcbRgbRibLcbLcLsmbRgLsbLgbLiLsbsbRcLsb
RibLjbRibLibRgbRhbRhLsbLgbRibRsbLsLsmbRiRsRsmmbLgbRiLsbRibLibRhbRcbRib
RibRibRibLgbRcbRobLgbRcRsmbLsbRhbRsbRibLsbRgbLjbLsbRcbLcbRhbRibRibRsRg
bRsbLjbLcbLgbRhRsmbRibRcbRibLiLsbRibLibRhLsbLgbRgbLsbRhbLgbRsbLgbRibRs
bRibLgLsbLebRjbRibLjRsbLcbRibRibRibRcbLibRgbRibRcbRibRsbRibRiRsmbLjbLh
bRibRcbLcbLjbRhbRibRibRibRsRsmbRsbRsbLsbRgbRibLgRsbRibLgbRibRibLjbRiRs
mbLjbRhbLsbRgLsbRgbRibLsbRgbLjbRcbLobLcbRjbLgbLsLibRjbLgbLsbLibRjbRcbR
cbRsbRsbRcLsbRsbLsbLsLsmbRiRsmbRhbRgbRhbLsbLgbLgbLgbLgbRgbLgbLsbLsbLsb
LsbLsbRebRcbLhbLgbRcRsmbLsbLjbRjbRiRsmbLgbRhbLcbRhbLjbLhbRebLsbRsbLsRc
bLibRsbRibLjbRcbRhLsbLiRsbRiRsmbRsbRsbRgbLjbLcbRibLcbRibRcbLcbLjbRgbRc
bRibRibRsbRgRsmbRgbRgbLsbRiLsbLjbRiRsmbLcbRibLcbRcRsRsmmbLjbRibLibRibR
ibLsbLsbRibRibLiLsbRcbLcbRhbLjbLibLgRsbLgbLgbLgRsLsbsbLgRsbsbRsRcRsmbs
bRcbRibLsbRcbLgbLibRsbRibRgbRgbLgbRgbRsbLjLgLsbLcbRgbLcbRibLgbLgbLsbLs
bRsbsbLsbLgbLgbLgLsbLgLsLsmbLsbLgbRsbLibLsbLgbLsbLsbLgbLgbLgbRjbRcbLcb
RcbRibRibLibRgbLsbRcbRibRhRsmbLsRsbRgRsmbRsbRsRgbRsbRsbRgRsmbRgbRsbRsb
RgbRgbRgbLibRjbRcbRgbLsbRgbLsbRcbLgbLsbRiLsbRibLiRsbRibLsbRgbsbRgbRgLs
bRsbRsbRsbRibLcbLcbRgbLsbLibRjbRoLsbRcbLiLcbRcbRibLibRibLgbRibLgRsbRib
LgbRibLjbRsbRcbLgbRiRsmbLgbRsbRibLjbLhbLsbLgRsbLhbRhbRcbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 44; Drug: NDMC 10 µM
bLsLsmbRgbRibRsbRgRsmbLsLsmbRgRsmbRsLgbRibLjRsbRgbRgbRgbRgbRgbLsbRgbRg
bRgbRgbRiLsbRhbRibRgbRiRsmbRsbLsbRgbRgbRgbRgLsbRiLsbRibRibRgbRibRsbRib
RgbLgbRibRibRgbRgRsmbRsbRibLgbRibRibLibRibRibLgLsbRcbRcbLgbLsbLibLgbRg
bRobRcbLgbLjbRibRibRgbRhbRibRgbRiLsbRcbLiLsbLcbRsLsbLibLsRsbRgbRcbRcbR
cLsbRgbRiRsmbRcbLibRhbLibRibLjbRibRsLsbLcbLcRsbRibLibRjbRoLsbRgbLsbRsR
smbRsbRibRibRibLibRgRsmbLsbLoLsmbLsLhbRgRsmbLsbRcbLgbRibRhbRibRgbRibLs
bRgLsbRgRsmbLjbRobLgbRhbLibRibRsbLgbRhbRsbLgLsbLsbLoLsmbRibLsbRjbRcLsb
RcbRibRgRsmbRsbRhRsRsmmbRsbRgbLsbRgbLsbRsbRsbRgbRgbLsbRsbRiRsmbLobRhbR
ibRgbRsbRsbRgLsbRsbsbsbRgbRsbRsbRgbRsbRsbRsbRgbRgbLsbRgbRsbLcbLsRjbRcL
sbLcbLcbRcbRibLsLsmbRibRgbRibRgbRsLsbLsbRibRsbRibLgbRgbRgbRcbRhLsbRibR
ibRjbRhbLiLsbRiLsbRgbRgbLsbRsLsbRgbLsbLhbLibRcRsmbLgbRgbRibRsbLsbRibLg
bRgbsbRcLsbRgbLibRsbRibRcbLebRiRsmbRibLjbLobsbRgbLibLgbRsbLgLsbRgbLibR
jbLibRjbRcbLgbRgRsmbRsbRiRsmbRsLsbRsbRgbRgLsRsbRgbLsbRsbRgbLsbRsRsmbRi
bRgRsmbRsRsmbLsbRgRsmbRgbLgbRsbRgbRsbRsbRgbRibRgbLjbLcbLibRjbLcbRgbRjb
LibLiLsbLcRsbRcbRgbRhRsmbLsbRgbRsbRgLsbRgbLsbRsbRsRgbRgbRsbRgbRsbRgRsm
bRsRsmbRgbRiRsmbLsLsmbRibRsbRsbRgRsmbRgbRgbRgbLcLsmbLibRsbRsbLgbLgbRgb
LibLibRjbRcLsbLsLjbRibRgRsmbRgbRsbRsbRsbRiLsbRgRsRsmmbRgRsmbRgRsmbRsRs
mbRgbLjbRobRsbRsbRgLsbRgbRsLsbRgbLsbRibLcbLibRsRsmbLgbRgRsmbLibLibLsbL
hbRibLsbLibRjbRoRsmbRgbRsLsbRsLsbRgbRsbRgbRgbLsRsbRsbRgbLsbRgbRgbRsbRs
bRsRgbRsbRsRsmbRgbRgbRgbLcbRjbLhbRsRsmbLibLibLibRibLcbRjbLgbLibRgLsbLi
bRsbLgbRsbLgLsbRjbRobLgbRgbRgbRgbRsbRgbRgbRgbLsbRgbRgbRgRsmbLoLsLsmmbL
ibRsbRsbLibLsbLibRiLsbLgbLibRgbLibRgbLibRiLsbLiRsbRsbLsbLibRjbLhbLhbRi
bLiLsbRsbRjbRcbLibLobRsRsmbLgbLgbLsbLgbLsbLgbLgbLgbRjbRcbRgbRsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 45; Drug: NDMC 10 µM
bLgbLgbLgbLgbLsbLsLgbLsbLgLsbLgbLsbLgbLsbLsbLgLsbLgbLsbLgbLsbLsLsmbRsL
sbRibRibLjbRibLgbRibRgbRsbRsbRibRibRgbLsbRjbRsbRibRsbRgbRibLsbRgbRsbLs
bRibRgRsmbRcbLsbRgbLsbRsbRgbRsbRsbRhbRhRsLsmbRsbRjbLgbLsLsmbRebRibRibR
gbRiRsmbRibRiLsbRibRgRsmbRgbLsbLsbRgbRgbLgLsbLsbLjbLibLgRsbLgbRsbLsbLg
bLsbLsbsbRsbLgbLgbLgbLsbLsbRgbRebLsbRhbRibRsRibRgbRsbRsbRibRgRsmbRgbLs
bRsbLibLibLsLgbLgbRsbLgbLsbLgLsLsmbLgbLsbLsbRsbLibLsbRjbLibRsRsmbLgbLs
bLgLsbLgbRsbRsbLibRibLiRsbRjRsmbRsbLjbRhbRsbRgbLsRsbLsbRsRsmbLobsbLgbR
gbsbLgbLgbLgbLsbLsbLsbLsbLgbLsbLgbLibRsbLgbLsbLgbLsbLgbLgbRsbRjbRjbRcb
LibLsbRsbRsbLjbLhLsbLibRjbLgbRibRgbLgbRjbLgbRgRsmbRsbLsRsbRgbRgbLsbRgb
LgbRiRsmbRcbRibRgRsmbLsbLgbLgbLgbLgbRgbLiRsbLiLsbRibLgbLibLcbRsbLgbLsb
LsbRsbRjbLcbRjbLibRgLsbLgbLgbLsRsLsbLsbLsbLgbLsbLgbLgLsbLgbLgbLsbLsbLg
bLibLsbRgbLsbLgRsbLsbLsbRgbLibRjbRsRsRsmmbRsbRcRsmbRgbLsbRgbRsbRobRgbR
ibRsbLsbRgRsmbLsbRgRsmbRsRsmbRsbRgbRgbRibRibRibLsbRibRibLjbRibLsbRsbLe
bLobLsbRsRsmbLsbRgbRibRsbRgbRsbRibLibLsbRgbRsRsmbRsbRibRgRsLsmbLsbRibL
gbLsbRgbLsbRgbRsRsRsmmbRgRsmbRibRsLgbRgbRgRsmbRgbLsbRhbLsbLgbRibRibRib
LgLsbLgbRgRsmbRhbRsbLgbRibRsbRgbRgbLsbRjRsmbLgRsbRgbRsbRsbRsbRgbRibLib
LsbRgRsmbRibLgbRibRcRibRibLsbRgbRsbRgRsmbRsbRgbsbRhbLsbRgbRgbLsbLgbRib
RgbLgRsbRgbRsRsmbRsbRsbRsbLcbRjLsbLcRsbRgbLsbLsbLgbLgbLgbLgbLibRjbLiLs
bLgbLgbLgbRcbLjbLcbLsbLgbLgbLgbLgbLsbLgbLgbLsbRsbLgbLgbRsbLgbLgRsbLsbL
gbLsRsbLsbLgbLgbLsbLgbLgbLgbLgbRsbLgbLgbLgbLsbLgbLgbLgbLgbLgbLsbLsbLib
RhbRcbLsbRgbRsbLebRsbRjbRibRgbLsRjbLgRsbRgLsbLsbRgbRgLsbLgbRgbRgbRsbRg
bRibLsbRgbLsbRsbRgRsmbRsbRgbRsbRgbLsbRgbRsbRgbRsbRibLgbRgbRgbRiRsmbLgb
RgbRsbRgbRsbRsbRgbRsbRgbRsbRsbRgbRsRsmbRiRsmbRgbRsRsRsmmbRgbRgbRgbRgbR
sLsbLgRsbRibLsbRibLgbRsRsmbRgbRsbRobRhbRcbRiRsmbRgbRsbRgbRgRsmbRsbRgbR
sbLgbRibLsbRsbRsbRgbLsbLcRsbRjRsmbRiRsmbRsRsmbRgbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 46; Drug: NDMC 10 µM
bRibRgbRgbRsRsmbRsLsbRgRsmbRsbRgbRgbRgbRgbRgbRgbRgbLsbRgbRsbRgbRsbRgRs
mbLsbRgRsmbLsbsbLgbRgRsmbRgbRsbRsRsmbRcRgRsmbRibLiLsbLjbLcRsbRgbRgbRgR
smbLsbRiRsmbRsRsmbRgRsRsmmbLsbRgbLsbLsbLgbRibRhbRcbRhbRibRgbsbRsbRgLsb
RsbRsbRgRsmbLjbLobLibRjbLsbLibRjbLiLsbLgbLhbRhbRsRcbRibLjbRhRsmbLhbRib
LjLjbRhbLjbLcLsmbLgbRsbLiLsbRiRsmbsbRcbRibLhbLcbRgbLhbRjRsmbRcbRibLgbR
gbRibLgbLcbLibLsRsbLibRsbLiRsRsmbRjbLhbRhbRobRibRcbRcbLcbRcbRibRhbRibL
gbRhbRhbRsLcLsmbRcbRebRibLibLcbLobLcbLcbRibRhbRsbRgRsmbRgbRgbRgRgRsRgR
smmbRgbRhbLeLsLsmbLobLoLsmbRibRcbRcbRibRibRibRibRgbRsbRgbRsRsmbRgbRgbR
gbRgRsRsmmbRgbRibRgRsmbRibRgbRgRsLsmbRgRgLsbRsbRgRgbRobRsbLobLobRiRsmb
LobLobRibLcbRibRibRsbRgbRgRsmbRsRiRhRsRsmmbRsRibRgRgRsmbRgRsmbRsbRgbLo
bRhbRhbRcbLgbLcbLhbRjbLobLibLhbLgbRgbRibLsbRgbLsbRgRsmbRsRsmbRsRsRgRim
bRsbRgbRgRsmbRjbLibRsLsbLcbLsbLibRjbLcLsmbRhbRibLgbRgbLebLhbRgbRcRsmbL
gbRcRsmbLibRjbLcbRhbRgbRibLibRibLgbRgbRsRsmbRgRgRsmbRsbRsRiRsmbRgRsmbR
sbRgbRgbLsRsbRgbRgbRgbRgRsRsmmbRsLsbRgbRsbLibRobRcbLjbLcbRcbRhbLgbRcRs
mbRibRiRsmbLgbLgbRcbRhbLsbRgRsmbRsbRibLgbRiRsmbRsbRgRsRsmmbLsbRgbRsRsm
bRsbLsbRibLibsbLibLgbLsbLcbRcbsbRobLgbRsbRgbRgbLsbRgbRgRgRsmbRgRsmbRiR
smbRibLcbRobLibLjbLibLiRsbLcbReRsmbRcbLgbLibLibRebLcLsmbRebRhbLjLsmbLo
bRsRsmbLhbRjbLibRjRsmbRcRsmbLibsbLsRsbLjbLiLsbLsLsmbRsbLsbLsLibLsbLsLs
mbRsbLibLibLsbLibLhRsbLiRsbLobLcbLgbRcbRsLcbRgbLgbLgbLsLsLsLgmmbLsbLgb
LgbLcbRiRsmbRjbRibLjbRcbLibLjbLibLsbLgbLgRsbLgbLsLsmbLgbLgbLsRsbLgbLgb
LgbLjbRobRhbLebLibLibLjbRcRsmbLjbLibRibLcbLcLsmbLibRibLcbLcbRibRjbRjbL
jbLjbLiLsbLgbLgbLjbRjbRoRsmbRjbRhbLhbLcbLoLsLsmmbLcLsmbLibRjbLgbLsLsLs
mmbLsbRsLsLsmbLebLsLsmbLsbLsLsmbLibLgbLgbRhbRcbRibLibLjbRibLjLsmbLcbRi
bRibRcRsmbRcbRibRhbRhbRgbRibRibRgbLgRsbLibRhbLgbsbLjbLibLgLsbLiLsbLgbL
sLsmbLgbLgbLgLsbLsbLgLgLgbLsLsmbLgbLgbRcbRiLsbRibLgLsbLsbRcRsmbLjLsmbL
ibLjbRebLhbRjbsbRjbLibLibRgbLgbLgLhbLgbLsRsbRsbRobLibRibsbRcLsbLcbLcbL
cbRibLoLsmbLgbRgbLcbRjRgbRcbLsbRibLsbRsbRsbRgLsbLsRsbRgRsRgRgmbRgRsRsR
gmmbRgRibRsRsmbRsRgbRgbRsbRgbLjbRjbLcbLcbRibLcbLcbRebLcbRjRgbRcbLgbRib
RsbRgbRgbRgRsRgmbRgbRgbRgRsRsmmbRsRsmbRgRgRgRgRsRgRsRgRsmmmbRsLibRgbRs
LgbLobsbRobRsRsmbRgRsmbRgRgRgRsRgRgRiRiRgmbRgbLsRsbRsbRgRsRsmmbRgLsbLg
bRhbLcbLobLhbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 47; Drug: NDMC 10 µM
bLgbRgbLgbLibLibLgbLsbLgLsbLhbLibLgbLgLsbLgbLgbLibLibRibLgbRsbLibLgbLg
bLgbLibLgbLgbLibRgbRiRsmbLsbRibRgLsbRibLibLgbRiRsmbRibRsbRgRsRsmmbRsbL
ibLibLgbLiRsbRgbRcbRcbRibRsRsmbRibLgbRcbLibRibRibRibRgRsmbRiRsmbLibLib
LibLcbLhbRsbRibRhbRcbRibRsbRgRsmbRibRibRibRgbRcbLcbLibLsbLsbLobRsbRsbL
ibLibRibLcbRsbRsbRhbRcbLibLgbRsbRibRgbRsbRgbRsbRgbRcbRibRibRibRibRobLs
bLgRsbRgbRgbRgbLjbRibLsbRcbLiLsbLibLgbLhbRgbLcbRibRjbRcbLibLjLsmbRhRsm
bRcbLiRsbLhbRcbRiRsmbLgbRibRgbRgbRibRsbRgbLjbRhbsbRibLsbLgLsbLsbRibLjb
RibRjbsbRsbLgbLgbLgbRcbLjbRsRsLcmbRjbsbRsbRibsbLibLgbRcbLjbRgbRgbsbRgR
smbRgbRsRsmbRgbLjbLibLibRibLgbLgbRcbLjbLhbLsRsbLgbRsbLgbLgbLsbLibLgbRg
bRcbRhbLibRibRsRsmbRgbLjRsLhRsbsbLsbRsbLsRgbRgRsmbLcbLgbLsbLsbLsbLgbLi
bRibLibRjbLsbLcbLibRjbRsLsRsbLjbRgbLsRhbLibRcbRsRsmbRibRsRsmbRgbLsbRsb
RgbRgRsmbRgbRgbRibLibRibLebLgbLgbsbLhbRcbLhbRjbLibRjbRcbLibsbLibLgbLgb
LsbLgbLgbRcbRibRjRsmbRibLibRgbLsbRiRsmbRgbLjbRibRsbRibLgbRsLsbsbLsRgRs
mbRsbRgbRgbLgbRibRsbRgbLcbLgbLcbRibRjbRhbRsbLgbRibLgbRgbRgbRgbLjbRibRi
bRsbRgbRgbRgbRsbRgLsbRsbRgbLobLcbRjbRibLgbRgbRgLsbRgbLsbRgbRgbRsbRgbRi
RsmbLibRiRsmbLcbLibRjRsmbRibRgRsmbRsbRgbLgbLcbLgbRjbRibLcbsbLgRsbLgbLg
bRgbLgbLibLgbLgbLibRcbLibLibRjbRcbLgbLjbRcRsmbLjbRibRgRsmbRgbLjbLibLgb
LsbLgLsbLgbLibLgbRjbRcRsmbRsbRgbLgLjbLiRsbRgbRhbLjbRibRgbRibLibRgbRgbL
jbRibLgbLjbLcbRjbRiLsbRibRgbLobLcbRibLcbRgbLgbLgbLibLibLgbRibRjbLcbRjb
RibRgbRibLjbLoRsLsbRsbLjbRjbRjbLcbLgbLobLjbRgbRjbRsbLgbRjRsmbsbRibRhbL
sbRibRibRibRgbRiRsmbRgbLcbRjRcbRsbRibLjbRjbRsbRgbLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112230; End: 112730;
Recording: 5-1; Individual: 48; Drug: NDMC 10 µM
bLhbRgbLgbLsbLgbLgbLsbRjbRobRibRiLsbsbRiRsmbLhbLobLoLsmbRgLgLcLsmbLoLs
LsmmbRibLcLcLsLsLsmmmbRjbRcRsmbRgRsmbRgRibRhRsmbRiRsmbRjbRsRsmbRsbLsRs
RsmbRiLsbRobLiLsbLsLiLsbLhLsbLsbLgbRjbRcbRgbReRsmbLsLsmbRsbRjbRjbRibRs
bRsbRsbLjbRsLsbRhRsmbLsRsbRibLjLsmbRibRsbRsbLjbLjLsmbRsbRsbLjbLibRgbRs
LsbLsbRgbRsbRoRsmbRibLhbRibLibLsbRgRsmbRibRsLsbRjbLgLsbsbLsbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 1; Drug: Control
bLibLsbRgbRobRobLcbLjbRobLibRgbLgbRobLibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 2; Drug: Control
bRsbRhbRibRiLsbLibRhbRgRsmbRibLhbRcLsbRcbRibRsbLsbLcbRibLhbRjbLhbRibLi
bRjbLcbRcbRcRsmbRibLjLsmbLcbRgbLhbRibRhbRcbRiLsbRgbLibRibRibRgbLibLcbL
ibRibRcbRiLsbRgbRgbLjbRibRgbRcbRibLcLsmbLiLsbRgbLibRjbLsLhbLhLsLsmbLhb
RiLsbLhbRjbRhbLhbLcRsbRhLsbRiLsbLjLsmbLobRibLibLgbRgLsbLibRgbLiLsbRgbL
ibLgbLgbLsbLgbLsbLgbRsLsbLibLsbLgbLsLsmbLgbLsLsmbLgLsbLgbLgLsbLgbLgbLg
bLiLsbLgbLgbLgbLgLsbLgLsbLgbLsbLgbLgbLgbLibLgbLsbLgbRsbLsbLhLsbRgbLgbL
gbLgLsbLibLgLsbLgbLgbLgLsLsmbLgbLibRgbLibLibRgbLibRsbLgbLgbLgbLsbLgbLg
LsbLsRsbLgbLgbLgbLgRsLsbLgRsbLgLsbLsbLgbLgbLgbLgbLsbLsbLgbLgLsbLgbLgbL
gLsbLgbLgbRgbRhLsbRgbRibRibRhbLhbRcbRiRsmbLibRibRgbRibRgbLibRcbRibRibR
ibRibRgbRibRibLjbRcbLcbLobRibRsbRibRgbRiLsbLjbRcbLebLcLsmbRibLibRsLsbL
ibRgbLibRgLsbLibLiLsbRibLiLsbLgbLsbLsRsbLgLsbLsbLgbLsRsbLibLsbLsbLibLg
bLgbLibLgbLsbLgbLsbLgbLgbLsbLgbLgbLgbRsbLgLsRsbLsbLgbLgbLgbLsbLgbLgbRj
LsbLibRcRsmbRibRibLibRcbRhbLibRibLoLsmbRgbRibLhbRjbLcbRgbLsRjbLibLibLs
bLgbLgLsbRgbLibRjbLibRgbLibLgbRsbLgbLgbLgbRsbLgbRsbLgbLsbRsbLsbLgbLgbL
sLsmbLsbLsbLgLsbLgbLgbLgbLgbLsbLgLsbLgbRgbRcbRobRhbRibRibLibLcbRiLsbLi
bRgbLibLgbLsbLgbLgLsbLsbLgLsbLgLsbLgbLgbLgbRgbLiLsbLsbRibRgbRiRsmbRcbR
cbLibRibLhbLiLsbRgbLibLibRibLibLibRhbRiRsmbRgbRgRsmbRgbRibRcbLibLcRsbL
ibRiLsbLsLsmbLibLgLsbRgbLibLhLsbRcbRobRibRhbLhLsbRibLjbRcbRibLsbRibRib
LibRibRibLibRiLsbRgbRgbLsbRgLsLsmbLobRibLcLsmbRiRsmbLhbRgbRcbLcLsmbLib
RjbLcbLiLsbRgbRiRsmbLhbLgLsbLgbLgRsbRjbLibLibRibRhbRibRsbRsbRibRgbRgRs
mbRgbRsbRgbRsbRgbRsbLcLsmbLibRgbLsbRjbRibRiRsmbRgbLsbRgRsmbRhbLhbRjbRi
bLjbRibRgbRsbRgbLsbRgbRgbRgbLgbRgbRgbRgbRsbRgLsbLgbRgbRgbLcbRgbLiLsbRg
bLibRcbRgbRgbRgbRsbRgbRgbLjbLcLsmbLgLsbRsLsbRibRibLobLoRsLsbRgbRgbRgbR
gbRgbLjbRibRobLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 3; Drug: Control
bLhbRcbLibRgbRgbRgbLibLobRjbLcbLobsbRibLibRsbRibLsbRobLibLsbLcLsmbLgbR
ibLgbLibLgLsbRgbLsLsmbLgbLgLsbLgbLgRsbLgLsbRiLsbLgbLsbLgbRsbLgbLgbLsbL
gbLgbRjbLibRgbLibLgbRgbLgbLsbLsbLgRsbRsbRjbRcLsbLjbLibLibRgLsbLsRsbLsL
sRsmbRsLgbRsbLiLsbRgbLgLsbLgbLsbLsbLiLsbLgbLgbLgbRgbLibLsbRjbLjbRcbLhb
RjbRcbRobLgbLgbLgRsbLgbLsbLgbLgbLgLsbLibRcbLibRgbLobLibRibRoLsbLibLjbL
ebRgRsmbLiLsbLsbLgbLgLsbLgbRjbLibRjbRcbLjbRibRgbRgbRsRgbLcbLsRhbLcbRgb
RjbRgbRibRsbRsRgbLjbLcbRibLibLsbLsbLgbLsbLgbLsbLgbLsbRsbLiRsbRsLsbLsRg
bLgbLsbLsbLsbLsbLgbLgbRsbLgLsbLgbLsLsmbLsbLgbLsbLgLsbLgbLgRsbLibRhLsbL
gbLibRgbLibLgRsLsbLsLsmbLsLsmbLsbLgLsbLgRsbLgbLgbLgLsbLgbLgbRcbRibLibL
gbLjLsmbLibLsbLgbRsbLgLsbRsbLibLsbLgbLgLsbRsbRjbLibLibLgbRgbLibLgLsbLg
bLgLsRsbLsbLgLsbLibRsbRsbLgbLsbLgbLgbLgbLibRgbRcbRibLcbRcbLjbLibRibRcL
sbLcbLcbRibLgbLgbRsbLsbLibRsLsbLgbLsbLsbLgRsbLgbLgbRgbLiLsbRjbLhbRgbLs
bLibRgbLsLibRgbLibLgbRebRsLsbLibLgbRjbLiLsbLibRsbLsbLgbLsbLgbLibLsbLsb
RsbLsbLgLsbLsbLgRsbLgbLibRjbLcbLcbRibLgbLibRobLgbRcbLgbLibLhbRjbLhbRib
sbLibLgbLsLsmbLsbLgLsbLgbLgbLgbLibRcbLgbLiLsbLgbLsbLsLsmbLgbLgbLgbLhLs
bRsLsbLgbLgbRiLsRsbRcRsmbRgbRibLcbLoRsbRsRsmbLgLsbLgbLsbLibLsbRcbRjbRg
bLiLsbLsbLcbRgbLobRgbLgbLibLcbRibLibRjbLsbRsRsmbLsbsbLgbLcbLibRsbRibRs
bRcRsmbLgLsbRjbLgLsbRcbLsLsmbRibLgbsbLgbRobLibRoLsbLgbRibLgbLibLibLibL
sLsmbRjbLibLsbLgbLsbLiLsbRsbLgbLsbLsbLgRsbLsbLsbLgLsbRgbRgbLcbLhbRgbLi
bLibLibRgbLibLsbLgbLgbLsLsLsmmbLgLsbsbLsbLgRsbLgbRgRsmbLgbLgbRsLsRsbLs
bLgbsbLhbLcbLgbLsbLcbLebRhRsmbLgbLgLsbRgbLgbLgLsbLgbRgbLibLsLsmbRgbLgb
LsbLibLsLsmbLsbLgbLsLsmbRgbLhbLobLsbLiLsbLcbRibLgbLibLoLsmbLjbLcbLibRs
LsbRsLsbLsbLgbLsbLsLsmbLgbLsbLgbLgRsbRobRcLsbRibRcbLgbRsbRgbLgbRcbLibL
cbRjbLhbLgLsbRsbLsbLgbLsbLcLsmbLibLgbLhbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 4; Drug: Control
bRcbLjbLcbRcbRhRsmbRibLoRsbLibRjbLjbRcbRcbLcbLcbLcLsmbLcLsmbRibsbLoLsm
bRjbLcbRibRjbLhbRjbRcbRiLsbLjbRibsbLsLsmbRibRibLsbRibRgbLgbRsbLgbRoRsL
smbRcLsbRgbRsbLibLibLgLsbRsbRibRgRsLsmbLjbRsRiLsbLobLibLibRgbRsbReRsmb
RgRsmbRgbRcbLsbLcbLgbRcbRibRgbRibLsbLjbLoRsbRibLjbLcbRgbLgbRsbLgbRsbLi
bLgbLsbRsbLibLcLsmbRebRsRsLsmbRgbLobLobRibRgbLgbRcLsbRibRibRibRsbLgbLg
LsbLsbLobLsbLgbRsbLgbLgbLgbLgbRjbRjbRibRsbRibRibLsbRibLjbRibRcbRsLsbLc
bLcbRjbLcbLibRhbLobRgbLgbLsbRsLsbLiLsbLgLsbLibLiRsRsmbLgLsbRgbRjbLhbLi
bRjRsmbLibRjbLibRjbLcbLsbRibRgbLibLsbLgbLgbRsbLsbLsbLibRgbLiLsbRjbLibR
sLsLsmbRgbLiLsbLgbLgLsbLsbLsbLgbLgbRsLsbLgbLgbRsbLibRjbLiLsbRjbRibRgbR
gLsbLcbRibRibRibRsbRibLjbLcbRgbRjbRibRgRsmbRsbRsbLsRsbRgbRgbLobLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 5; Drug: Control
bRgbLsRsbRibRhbRsbRcbLibRcbLibLsbLibsbLgbLsbLsbLgbLsbLsbRsbLsbLgbLgbRc
bRibLgLsbRsbRibLjbRgbRsRsmbRgRsmbRsbRgbLsbRgbLjbLjbLcbRjbLcLsmbRgbLgbL
gbLsbLgRsbLgbLsbLsbRsbLibRjbRcbRibRsbRgbRsbRsbRgbLsLsmbRgbRgbRgLsbLgbL
cLibRgbLsbLgbRsLibRgbLsbLgbLsbLgbRsbLsbLgbLgbLgLsbLsbRibRibLgbRibLsRsb
RgbLsbRsbRgbLsbRsbRgbLgLsbRgbRsRsmbRgbLgbLjbLsLhbLgLsbLsLsmbLgbLsbLsbL
sbLsbLgbLsLsmbRsbLgbLsbLsLsLgLsLsmmbLsbLgbRsbLgLsbRsbLgbRsbRjbRoLsbLgb
LjLsmbLibRsbLsbRsLibRjbRcbRgbRgbRgbRgbLsRsbRsbRsbRgLsbLgbRiLsbLgbRibLj
bRibLjLsmbRibLsbRibLcbLibRjbLiLsbRjbLcbRjbLgbLibLsbLsRsbLgbLsbLsbLsbRc
bRibLgbRgLsRsbRsbRsbRsbRgbRsLsbRgLsbRgLsLsmbLjbLcbLhbRjbLhbRibLibLgbLs
LsmbRsbLgbLsbRsbLsRsbLgbLgbRjbRhbLjbRibLsbRgbRsLsbRsbRgbRgbRgbRgbRgbRs
bRsbRgbRsbLsbLhbRhbRibLjbRibRcLsRsRsmbRobRhbRcbLjbRibRsLsbRgbRsRsmbRgb
RgRsRsmmbRibRibLjbLcbLiLsbLgbLibRsbLgRsbRgbLgbLsbLsbRsbLiLsbRsbLgRsbLg
bLsbLsRsbLsbLgbLsbLgLsbLsbRsLsLsmbLsbLgLsbRsbLgbLgRsLsbRsbRjbRiRsmbRgb
LsLsmbRibLsbRsbRibRsLsbRgbRgbLsbLcbLibRibLibLiRsbRjRsmbLhbRjbLiLsbRjbL
iLsbLgbLgLsbLsbLsbLsbLibRgbLgbLgbRsbLibRsbRoRsRiLsmbLgbRibLgbRiLsbRgRs
mbLgbRgbLgbRgbLsbRgbLjbRibLjbRibRgbLhbLibRhLsbLobRibLibLsbLsbLsbLsbLsb
RsLsbLgbLgbLsbLgbRjbRjbRibLcbLgbRsbLibRjbRibRibRibRsbRsbRsbRgRgRsmbRgb
RgbRgbRgbRsbRgRsmbRsbRgbRgRsmbRgRsmbRgbRgbRgbRgbLsbRibLobRcbRibRibLjbR
gbRgbLsbLsbRgbLjbRibLcbLobRcRsmbRibRibLgbRibLjbRjRsmbLgbRiLsRsRsmbLgRs
bRibLibRibLcbLiLsbRjbLsbLibRsbLgLsbRgbRobRgRsmbRsbRgRsmbRgRsmbRgbRgbRs
bRgbRgbRgbLhbRibLgbRibLgbRibLjbLobRjLsRibLcbLhbRibRjbRibLsbRsbRgbRsRsm
bRgLsbRgbRsRsmbRsbLsbRgbRgbRgbRsbRgbRsbRgbRgbRgbRgRsmbRgRgbRgRsmbRsbRi
bLjbLcbLsbRcbLcbLibRibRibLgbRibLgbRibLgbRsbRgbRsbRsbRgbRgbLcbLibRibLib
RcbRibRiLsbLgRsLsbRgbRgRsmbRsbRgRsmbRsbRsLsbRsbRgbLsRgbLsbRsbRgbRsbRgb
RgbRsRsmbRsbRgbRsbRgbRsbRsbRibLjbRibRsbRiRsmbLjbLjbLgbLgbRsbLibRcbRcbL
ibRibLsbRibRsbRgbRsbLsbRoLsLsmbLibRibLibLcbRjbRcbLibRgRsmbRsbRgbLsbRiR
smbLsbRgRsmbRsbRgbRgbRsbRgRsmbLsbRibLjbLcbLibLiRsbRjbRibRiRsmbLgbRsbRi
RsmbLgLsbRibLsbRgbRsLsbRsbRgbRgbRsbRgbsbLsbRgRsmbRsbRsbRsLsbRsRsmbRgLs
bRgbRsbRsbRgbRsRsmbRgbRsLsbRgbRgbRgbRsbRsbRsbRgbRgRgbLjbRcbLibLcbLibRj
bRsRcbLiLobLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 6; Drug: Control
bRiRsmbLcbLibRibLibRgbLsLsmbsbRsbLibRcbRiLsbLcbRsbRjRsmbRebRcRsmbRcRsm
bLhbRhbRcbLjbRibRhRsmbLcbLgLsbLibLibRjbLgbLgbLsLsmbRgbLjbRhbLibRcbRcbL
jbRibLgbRhbLgbRibRgbLsbLgbRgbRhRsmbLjbRhRsmbLcbRgRsmbLeLibRcbRhbLibRib
RibLjLsmbsbLsLsmbRsRibLiRsbRgbRgbLiLsbRjbLjbRcbRcbRcbRcRsRsmmbRiRsmbLg
bRibLgbRibLibRgbRgRsmbRgbLsbRgbRiLsbLibRibLgbRibLibRgLsbRgRsmbRgbRgbRg
bLsbRgbRgLsbRsbLhLibRcbRgbRgbRibLsbRgbLhLsbRcbRibRcbLobLibRsbLjbLgbLjb
RhbRibLibRebLiLsbRjRsmbsbLibRgbLsLsmbLgbLibRjbRibRjRsmbLgbLsbLgbLhLsbL
cbRibRibLsbLgbLgbLibRjbRjbLebRcbRcbRibLjLsRsmbLcbRjbLibRgbLibRgbLibsbR
gRsmbLgLsbLgLsbLgRsbLsbLsbRsLsbLsLsmbLsbLgbRsLsbLsbLsbsbLgbLgbRibLibLs
bLiLsbRsLsbRsLibLhbLhLsbLhbLhbRjbRibLcbLibRiLsbLibLgbsbRgbLiLsbRsbLgbL
sbLsbLsbLsLsmbLgbLgbLsbLgLsbLsbLsbRjRsmbRcbLjLsmbRhRsmbLiLsbLhbRibLhbL
cbRcbLibRibLiLsbLcbRjbRcbLjbRobLjbLsbRhbLibLcbLcRsbRibRibLgbRjRsmbRsbL
cbLcbLibRgbRgbLcbLcbRibLhbLiLsbRgbLsbLibLgRsbLibRgbLibRibLibRgbLibRgbL
ibRjbLibRsbsbLibLgbLjRsbLsbLgbRgbLibRjbLjbLcbRibLgbRjbRobLgbLgbLhbRibL
cbLcbLsLgbLgbLgbLgLibLibRibLibLsbLibRgLcRsbRgbLsbLgbLibLsbLgbLsLsmbLib
RjbLibLsbLibLgbLgbLsLsmbLgbLsbRsbLgbLibRsbRjbLibLgbRibLhbLibRibLibRjbL
ibLgbRsRsmbLibLgbRgLsbLgLsbLgbLibRgLsbLgbLgbLsbLsLsRsLsmbLsbLgRsbLsLsm
bLsbLgbLgbLgRsbRcbRebLibRhbLhbLobRgbLibLibRibLibLjLsmbRibLibRsbLsbLibR
gbLibLsbRsLsbLgbRjbLgbLgbLsLsmbRsbLgbLgLsbRsbLoRsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 7; Drug: NDMC 1 µM
bRibRhbLibLibRibLgbRcbLjbRcbRhbLgbRibRgbRgbRibRgbRgbLgRsbLhbLgbLibRgbR
ibRibLibRcRsmbLibRhLgRsbRgbRgbRsbRsRsmbRgRsmbRgbRsbRsbLsbRgLsbLsbRibRc
bLgbLcbLibLjRsbLgbLsLgRsbLcRsbRibRibRibRsRsmbLsRsbRgbRgbRgbRgbLcbLhbLg
RsbLibRgRsmbRgbRgbRibRsRsLsmbRgbRsbLjbLcbLsbLgbLibRhbRibLobRjbLcbRgbLi
bRgbLhbRgRsmbLcLhbRibRgLsbRibLgbRgbRsbRgbLjbLjRsRibRsbLgbRibRgbRibLsbL
hbRcbRcbRibRiRsmbLibLgbRjbLibLgbRgbLgbLgbLsbLgbLiLsbRcbRcRsmbLjbLcbLib
RjbRcbRiLjLsmbRibRgbLsbRsbRgbRsRsRsmmbRsRgbRgbRgbLsbLsRgbRgbLjbRibRgbR
gbRsbRsbRsbRsbRgbLsbRgbLsbRjLsbLjbLhbRcbLcLsmbLhbRhbRgRsmbRgbLhLsbLibR
sbLsLibRsbRjbLcbRgbLibRgbLjbRsbLgLsbLgbRsbRsbRoRsRsmmbLcbLhbRibLibLsbL
iLibRgbLibRjbLgbLsbLiRsLsbLgbLibLibRsbLibRjbRibLjbLcLsmbRiLsbLhbRgbLgb
LsbLgRsbLgbLgbLsLsmbLsbRsbLibLgLsbLjbRhbLibLsLsmbRjbRjbRgRsmbRgbRsbRgb
LibRibLcLjbLibRhbLcLsmbRhbRhRsmbRgbRsLsbLsbRibRsRsmbRgbLcbLiRsbLsbRjbL
gbLiRsbRebRgLsbRgbRsbRsbRgLsbRsRsRsLsRgmmbRgRsmbRsbRgbRgRsmbLjbRhbLcbL
oRsRsmbRjbLhbRcbRibLcbLiLsbRgLsbRgbRgbRsbLsbRsRsmbLsRgbRibRgbsbLsbRgRs
mbRsbRgbLjbLcbLsbLgbRsbLsbLgbLsbLgbRsbLgbLgbRhbRiRsmbLjbRibLibRibsbRgR
smbLgbRibRsbRgbLsbRsbRgRsRsmmbRgbRsRiRsRimbRgRsmbRsbRsbRgbLsbRgbLjRsbR
ibLsRgbLjbLobRsbRsbLiRsbLibLsbRgbLibRgbLgbLgLsbLgbLgbLhbRibLgRsbRsbLgb
LsbLsbLobLiRsRibLibRjbLcbLgbRsbLsbLibLgbRibLibRjbLcbsbRcbRjbLgbRjbRjbR
sbLsbRgLsbRgbRibLcbRibLcbRhbLjbLibLibRjbLhbRcbLgbLgbLsLsLsmmbLsbLgbRsb
LgbRsbLgLsRsbLibRibRibLjLgbRibRibRsRsmbRhbLjbRibRgbLsbRjbLibLcLsmbRibL
cbRibRjbLcbLibLgbLsbLgbLgbRjbLibRjbLcbRibLgbLsbLjbRsbRhRsmbLjbLebRibRg
bLjbLcbRcbRiLsbRsLsbLcbRjbLjbRjbLgbRcbLjbLcbLibLsbLgbLiRsbRgbLcbLgRgbR
gLsbLiLsbRsbLibRgbLgLsbLhbRgLsbRsbLiLsbLsbLsLsLsmmbLsRsbLgLsbLgbLgbLgb
RjbLhbRjbsbRsRjRgbRsbRsbRjbRsbRgbLjbLcbLjbsbRgbLibRjbLhRgLsbLgbLsbLgbL
gbRjbLibRjbRcbLcbLhbRgbRhbRiRsmbRsbRsRsmbLsbRgRgbRsbRgbRsbRjbRibLjbLcb
RebRgbRsbLcbRsbLibLgRgbRsLsbLsLsmbLgbLsbLsbLgbRjbLhbRibLhbRgLsbLgbRsLs
bLgLsbLsbLsLibRibLgbLsRsLibLsLgLgLsbLsbLgbLsbLgbLgRsRsmbRjbLcbRibLcRsb
RgbLiLsbRjbLibLsLsmbLgbLibRgbLsbLgbLibRjbLgbLgLsbLsLsmbLgLsbLgbLgbLgbR
gbLibRjbLibRgbLgRsbLgbRsLsbLsbLsbRsbLcbRibLhbRgbLgbLgbRgbLiLsbRjbLsbRj
RsmbRibLjbLhLsbRgLsbLibLiRsLsbRhbRsbRhbRsbRgbRsbRsbRsbRsbRgbLsbRsbRgbR
iLsbLcbLcRsbLcbRibLhRgbLibRibLcbRgbLsbLibRjbRcbLhbLobRsbRjbLibLgbLibLj
bRibLcbRsbRgLgbLgbRsbLibRjbLibRgbRjbRiLsbRgRsRsmmbLsbRsbRgbLsbRgRsmbRg
bRgRsmbLsbRgRsmbRgbLsbRsRsRsmmbRsRsLsmbRsRsmbLcRsbLiLsbLibRjbRcRsmbRgb
LcbRjbLjRsbLoRsLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 8; Drug: NDMC 1 µM
bLsbLgbRsbLgbLgLsbLgbLgbLhbRibRsbRcbRiRsmbLjbRcRsmbRgbRjRsRsmmbsbLsbLs
bLsLsmbRcRsLsmbRcbLgRsbRgbLgbRcbLibRoLsbRsLsbRgLsbLibLjbRjbRoLsLsmbLsR
sbLgbRibRibLjbLcbRjbRiLsbRgbRgbLsbRsbRsRsmbRgbLgbRgbRgbRgRsmbLsbRgbLsb
RsbRsLsbRsRsmbRsbRsbRgbRgbLsbRgbLjbLsLsmbLobLgbRsbLsbLsLsmbsbLgbRjbLgb
LsbLgbLsLsmbLsbRsbLibLibLgbRiRsmbLiRsbLgbRsbLsLsmbLsbLgbLgbRgbLibLsbLg
bRjbLibLgLsbRsbLsbLgbRsbLgbLsbLgLsbLsbLsbLsbLgbLsbLsbLgbLsbLsbRoLsRibL
sbRgLsbLsbRgbLsRsbLjbLibLibLgbLsbLsbLsLsmbLsbLgbLsbRsbLgLsbRsLsbLiLsbR
sLsbLgbLsbLsbLsbLgbLgbRsbLibLgbLgbLgRsRsmbLsLgLsbRjbRhbRibRsbRgbLjbLib
LiRsbLgbRcbRhbRcbLibRibLsbRsbRgbLsLsmbsbRibRsbLsbRsbRsbRgLsbRsLsbRgRsm
bLjbRibRsbRgbRgbLjLsmbRcbLjbLcbLsbLiLsbLhRsbLsRcbRsRsmbRiRsmbRsbRibLsb
RibLjbLcLsmbLgLsbRsLsbsbLgbRsbLgLsbRsLsbRsLsbRsbLsLsmbLgbLsbLsbLgLsbLs
RsbRgLsbLgRsbLsbLgbLgbLgLsRsbLsbLgbRhbRcbRoLsbLgbRobLgbRibLjbRgbRiRsmb
RgbLsbRibRcLsbLgbLcbLibRgbRjRibRibLgbLoRsbRsbLiRsbLgbRgbLgbRgbRjRibRgb
RgbLsbRgbLsbLibLgbRsbLgRsbLgbLsbRsbLsbRsbLgbRsbLgbLgbLsLsmbLgbLgbLsbRs
bLgbLsbLsbRsLsbLiLsbLsbLsbLgbLsRsbLgbLgbLsLsmbLsbLsbLsbLgbLgbRgbLsRcbR
gbLsRsbRibLsbRibRsbLsbRgbRsLsbRgbLcbLibRjbRhbLobLgbLgbLsbLsbRsLsbRsLsb
LgbRsbLgbLgbRcbRsbRgbLsbRsbRgbLcbLgbLgbLsbLgbLgbLgbRjbRobRibLsbRibLsbR
ibRiRsmbRgbLsbRsbRgbRsRsmbLsbRibLjbRcbLsRsbRgRsRsmmbRsbRgbRsbRsbRgLsbR
gRsmbRgbLjLebLibLgbLibLsLsmbLgbLgbLsbRcbRiRsmbRsbLobRsbRibRibRgbLsLsmb
RibRsRsmbLsLsmbRgbRgbRgRsmbRsbRgbRgbRgbLobLibLgbLsbLsbLsbLsbLsbLsLgbLs
bLsbLgbsbLgLsbsbLgbRsbLgbRsbRsLsbLgbLsbLgbRsbRgbLgbLgbLsbLsbLsbLgbRsRs
mbLgbLgbRsbLsbRhbRsRibRgbLsbRgRsmbLsLsmbRgbLsbRgbRgbLgbRiLsLsmbLjbLoRs
RsmbRgLsbLgLsbLgbLsbRsbLsbLgbLgbRsbLibRgbLibLsLsmbRsLsbLsbLsbLgLsbLgbL
sbLgbLibRiLsbLiLsbLsbLibRjbLibLibRcbRiRsmbRibLsbLgLsbRgbRsLsbLgbLcLsmb
LgLsbRsbLgbRsbRsbLsbLgbLgbLsLsmbLgbLgbLsbLgRsbRsLsbLgLsbLsbLsbLgbLsbLs
bLgLsbLsbLgLsbRsbLgRsLsbLsbLsbLsbLgLsbLsbLgbLgbLsbLgLsbLsbLsbLgbLsbLgb
LsbLgbLsLsmbRhbRhLsRsbLsbRgbLsbRcbLibLcbLibRhbLibRgbLibLcbLibRiRsmbLsb
RjbLoLsmbLgbLgbLsbLgbLsbRsLsbLgbLgbLsbLgbLsbLgbRgbLibRgbLibRjLsbLgbLib
RsbLgLsbLgbLsbLsbLgRsbLgRsLsbLsLsmbLsbLgbLgbLsRsbLsbRsbLgbLsbLgbRsbLsR
sbLsLsmbLgbLsbLgbLsbLgbLsbLgbLgbRcbRibLjbRiLsbRiLsbLgbRibLjbLcbRjbLcbR
gRsmbLsbLgbLsbLsbLgbRebRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 9; Drug: NDMC 1 µM
bLsLsmbLsbRibLjbRcbRibRibRsbLsbLgbRgbRcbRcbLibRhbLsbLsLsmbLibLibLsbLsb
LsLgLsbRsbLgbRoLsbRibLsbRibRsLsbRibRsRsmbLgbRiRsmbRibLibRhbLsbLsbLgbRi
bRsRsmbLsbsbLjbLcbRjbLobLibLibRgLsbRsbRgbLibLcbRiLsbLcbRibLibLjLsmbLib
RibLgLsbLgbLiLsbRibLsbLgbLgbLiLsLsmbRibLibLgbRhbRcbRibRibLgLsbRiRsmbRi
bLsbLgLsbLgLsbRibLhbRebLsbRgbRibRsRsmbRhbLsLsmbLgLsbLiLsbRjbLibRjbRhLs
bRibLjbRibLsLsmbRhbLsbRibLsbLsbLjbLibRibRhbRgbLjbRibLjbRcbLgLsbRsbRibL
jbRhbLjbLcbRcbLcbRcbLcbRcbLcbLiLsbRjRsmbRhRsmbLcbLibRjbRcbRhbRibLjbLjb
LibRhbRsRsmbRcbRsbsbLgbRibRsbRibRibRsbLsbRgbRgbLjbLcbRhbLjbLibRibRibLg
bRgLsbRibLjbRgbRsbLcbLgLsbLibRjbLibRibRjbRibLjbLiLsbRsLgbRsRsmbLgbRsbR
sbRcbRibLibRjbRibRibLsbLjbLgLsbRcbRcbLgbRiRsmbLgLsbRibLgLsbRibRgLsbRgL
sbRibRsRsRsmmbRsbRgbRsbRgbLsbLebRhbRibLcbLibRhbRhbLjbLibRibLhbLiLsbRgb
LjbRgbLjbLibRjRsmbLsbRsLsLsmbLgLsbRsbLsbLsbLsbLsLsmbLsbRsLsbRjbLhbRibL
gLsbLibLjbLsbLsbRgbLsbLgbLsbLgbLgbLgbRjbLiLsLsmbRjbRhbLibLiLsLsmbLsbLg
LsbsbLgbLsLsmbLsLsmbLsbLcbLsbLsbLsbLgLsbLsbLgbLiRsbRibLgbLsbLgbLsLsmbs
bRcbRibLjbRhbLjbRibLjRsbRebLsLsmbRsLsbLibLgbLsbLsbLsRsbLsbLsbLsbRsbLjb
RcbRibRebLgbLjbRgbLjbRjbLcbLjbLsbRsbRcbLgRsbRibLsbRibLjbRebLsbLsLsmbLs
LsmbLsbRebRibRhbLgbRebLcbLgbLgLsbRebLcbRjbLsbLgbLsLsLsmmbLsbLsLsmbRsLs
bLsbLgbLgbLsbLsbLsbLsbLsbRgbRibLjbRhbLjbRibRiRsmbLjbLhbRcbRibRsbRgbLhb
LibRhbLibLcbRibRhRibLgbRjbLcbLobRgbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 10; Drug: NDMC 1 µM
bLibLsRsbLgbLibRgbRiRsmbLsLsmbLibLhRsLsbLgbLhbLsbRsbRsbLgbLgbRebRsbRsb
RsbRsbRibRsbLibLsbRcbRsbRiLsbRgRsmbRsbRiRsmbRsbLsbLibRcbRsbRsbRibLsbRs
LsbRsbRibLsbsbRibRsbLibRibRgbRsbLibRibRsbRhbRsbRgbRebRsRsmbRsbRibRsbRs
bRsbRsRsmbRgLsbRsbLgbLjbLibLgLsLsmbLsbLsbLibLgbLsbLgbLibRgbLsbLsLsmbLg
bLibLsLsmbLsLsmbLsbLsbLjbLgbLibLsLsmbLgbLcbLsbLiLsbLsbLgbRgbLgbRobRibL
sLsmbRsbRgbRsbRsRsmbRsRsmbRgbRsbRsbLjbRcbRsbRsbLsbRsbRgRsmbRsRsmbLgbRi
bLgbRgbRsbRsbRebRsbRsbLgbRcbRsbLsbLgbRsbRsRsmbRhbLsbLgbRcbRgbLibLsbLsb
LsbReRsmbLsbRgRsmbRgbRsbRsbRsRsmbRsRsmbRsbLgbRiRsmbRsbRsRsmbLgbRsbRsbR
sbRiLsbRsbRsLjbRcLsbLsbRgLsbLsRsbRsbLgLsbRcbRsbRsRsmbRsbRgbLgbLsbRobRs
b

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 11; Drug: NDMC 1 µM
bLjbLcbRibRcbLjbLhbLibLibLhbRibRibLibRgbsbLsLsmbLgbLgbLcLsmbRjbLiLsbLi
bsbRgbLgbLgbsbLiLsbRibRibLjbRcbLibRibLsLsLsLsmmmbRibRgbLsLsmbRgbLibLsL
smbRjbLjbRcRsReRsRsRsLsmmmmbRsbRibRsbRcbLhbLgRsbLhLsbLiLibLjLsmbRcbRhb
LibsbRjbRibRgbRgbLgRsRhLgLsbRibRsRsmbRgbRgRsmbRgbsbsbRgbRgLsbLjbRgRsmb
RgbRgbLgbRgbRgRsmbLsbRgRsmbRgbLcLsmbRgLsbLjLcLibLsbLibRjbRjbRgbRgRsmbR
gbRsbsbRgRsmbRsRsmbRsbRsbRsbLsRgbRebRsbLibRjRsmbLgbRgbLgbRiLsRsbRgbLsb
LsbRibRibLgbLibsbRibRgbRsRsmbRgLsbRgbLjbRgbRgbRgbRsbRsbRsbLsbRgbRsbRgb
RgLsbRgbLgbRgbRgRsmbLsbRsRsmbRsbsbRsbLcbRjbRibLjbLibLgbLsbLgbRebLibLgb
LsbLsbLgbLsRsbLgbRsbLibRjbRibLgbLgLsbLsbLsbRjbLibLgbLgbLsbLgbLgbLsRsbL
gbLibRhbLibLgbLsbLsLsmbLsLsmbRjbLibRibRiLsbRgbRgbLsbRsRsmbsbRgbRgRsmbL
jbLiRsbLiLsbLgbLsLgbLgbLgRsbRsbLibRjbRgbLcbRjbRgbLcbLiRsbLsbLgbRsbLgLs
bRsbLsbRsLsRsbLgbLsbLsbLgbLsLsmbLsbLsRsbLgbLgbLgbLgLsbRsbLgbRsRsmbRjbR
ibLibLgbRsbRhbLjbLibLgbLgbLgbRsbLiLsbRjbLibRjLsbLgbsbRcbRgbRgbRsLsbRsb
RgbRgbRgbRibLjbRgbRgbRsLsbLjbRjbRibRgRsmbLsLsmbRgbRgbLgbLjbRsbLebLcbRi
bLibLsbLiLsbLgbLgbLsbRsbLgbLsbLsbLsLsmbRsbLgbLgbLsLsmbLsbRsbLsbLgLsbLg
LsbLsLsmbRsLsbLgbLsbLsbLsbLsbLibRjbRhbRgbRgbRgbRgbRgbRgbRsbLsbRsLsbsbR
gbRgbRsbRsbRsRsmbRsRsRsmmbRgbRsbRsbLiRsbLgbsbRgbRgbRgRsmbLcbLiLsbLgbLg
bLsbRsbRsbLsRibLibLibLsbLgLsbRsbLgbLgbRsbLsbLgbRjbLgbLibRibRhbRgRsmbRg
bRgbRgRsmbRsbRsbRsbsbLsbRsbRsLsbRgbRsbRsbRgLsbRsbRgbRsbRsLsLsmbRgbRgLs
RsbRsbRibLsbRgRsLsmbLsbLibRiRsmbRgbLobRjbRgbRgbRgbRgbRsLibRiRsmbRgRsmb
LjbLcbRjbRjbRgLsbLhbRibLibLcbRjbRibRgbRgbRsbLcLsmbLgbLgbLsbLgbLgbsbLgb
RsbRsbLjbLgLgbLsLsmbLsbLsLsmbLgbLsLsmbLgbRsLsbRsbLsbLsLsmbLsLgbLsbLgLs
bLgbLgbLgLsbRjbLsbLgbRsbLgLsbsbsbsbRjbRjbRibRibRgLsbRibLibRgbRibLhbLib
LgbRjbLibRjbLjbLgbLsbLgLsbsbRsbLsLsmbLsbLsbLsbLgLsbLgbRgbLgLsbRsbLsbRs
bLiRsLsbLsbLsbLgbLsRsLsbLsbLgLsbLsbLsLsLsmmbLgLsbLgbRibLibLibLgbLsbRsb
LgbLsbLsbLsbLgbRcbRgbRsbRgbRgbLhRsbLibLgbLgbRsbRsbRhbRgbRgbRgbRgbLjbLs
bRgbRibLsbLsRsbRgbRgbLsbLcbLiLsbLgbLsbLgbLsRsbRibRgbRibRgbLsbLibLgLsbL
sbLgRsbLgbLgbLsbLgbLsbRgbRgbRibLsbRibRsLjbRgbRgbRgbRgbLjbLobRgbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 12; Drug: NDMC 1 µM
bRgRsmbRgbRgRsmbRgbRgRsmbRgbRgbRgbLjbRiLsbRcRsRsmmbLibRibRiLsbLibLhbLi
bRsLsbRcbLibRjbRibLsbRibRsbRgbRgbRgbRgLsbRsbRgbRgbRiLsbRcLsbLhbRcbLhbL
gbRhbLsbRjLsbRibLjbRcbLiLsbLibRcbLcbRjbRcLsbRibLiLsbRibRgbLhbRsRiLsLsm
bLsRibLgLsbRibLjRsLcLsmbLsbLjRsbRsbRcbLgbRgbRgbRsLsbRgbRsbLsbRgbRgRsmb
RgRsmbRsbRgbRgbRgbRiLsbLibRiLsbLibLgbRibRjbRsbRgbRsbRgbRsbRgbRgRsRsmmb
RgbRgbRgbRgRsmbRgRsmbRgbRgRsmbRgbRsbRibRgRsmbRiLsbLibRgbLsbRsLsbLjbLcL
smbRcbRgbLcbRjbRjbRibLsRsbLsbRsbRsbLjbLiLsbRjbLjLsLsmmbLgbLgbLgRsbRcbL
sbLibLgbLgbRsLgbRjbRsRhbLjbLjbRsbLibLgbLoLsLsmmbLsLgbLgbLibLgLsbRibLgb
LgLsbRjbRjRsmbLibLcbRibRsbLjbLibLgbLgbLgbLgbLgbLjbRsbLjbLsLjbLcbLgRsbR
hbRibRiRsmbRibLsbLgRsbRgbRibRgLsbLsRsbLsbLiLsbRhRsmbRgbRgbRgbRgbRgbRgb
RgRsmbRgbRgbRibRibLibLiLsbRibRcbLibRibLsbLsRibRgRsmbRgRsmbRgbRgbRgRsmb
RgbRgbLjbRibRgbRgbRibRgbLjLsLsmmbRibLgRsbRiRsmbRgRgbRgbRgbRsbRgbRgbRsb
RsbRsbRgbRgbLgbRgRsRgRiRsmmbRgbRgbRgbRgbRsRsmbRgbRgbRsbLjRcbRhbLhbRiLs
RsbLhbRcbLgbRjbLjbLcbRibRjRsmbRibRgbRgbRibLibRsbRgRsmbRiRsmbLjbRibLjLj
bRiLsbRiRsmbLcLsmbRcbLcbLjbRobRsLsbLiRsbLsLsmbRsLcbRobRsRobLgbRibRibLs
bRgRsmbRgbRgRsmbLsbRgRsmbRibRgbRsbRsbRiRsmbRibLsbRgbRgRsmbRgbRgbRsbRiR
smbRgbRibLsRgbRsbLibRibRgRsmbRsbRgbRibRgRsmbRgbRgbRsbRgRsmbRgbRibRcRsR
smmbRsbLibRiLsRsbLjbRcbLcbLgbLibRibLgbRcbLjbRibRsRsmbRgbRgbRsbRgbRsbRg
bRgbRgbRgbRgLsbRsRsmbRgbLsbRibRibRgbLgbRibLibRjRsmbRibRibLgbRibRgbRsbL
sbRgRsmbRgRsmbRsbRsbRsbLsbRgRsmbLsbRibLsbRsbRsbRgbRsRibRsbRgRsRgLsmbRi
RgbRiRsmbRsRgRsmbLsLsmbRiRsmbRibLibRgbRsbRgbRgbRgbRgbRgbRgbRsbRsRsmbLj
bRibRcLsRobRcbRibLsRsbsbLgLsbRibLgbRibRgbRgbRgRsmbRsbRsbRibRsbLibLsbLs
bRibRsbLjLsLsLsmmmbLgbLsbLgLsbLibRcbRcbLjbsbRcbLsbRibLibLjbRcLsbRhbRgb
LsbLgbLgLsbRhbLjLsmbLjbLibRcbRibRiRsmbRsLsRsbRibRgRsmbLgbRibLsLsLsRimm
bRgRsRsmmbRsbRsbRgbRsbRibRgbLsLiLsbRibRsbRgbRgbRgbRgbRgbRgRsmbLsRgRsLs
mbRgbLibLsLsmbRibRsbRsbRsbRgRsmbRgbRgbRgRsmbLsRgbRgbRgRsmbRsbRsRsmbRgb
RibRgbRiLsbRibLiLsbRibLgbLjLsmbRcRsRsLsmmbRiLsbRsRsmbRgbRsRsmbRsbRsbRg
bRgRsmbRsbRsbRgRsRsmmbRibLgbRibRgbRsRsmbRgbRgbRsRsRsmmbRgbRgbRgbRgbRiL
sbLhbRibRibRsbRibLibRibLgbRibRsLsbRgbRsbRgRsmbRsbRsbRobLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 13; Drug: NDMC 3 µM
bLibLcbLcbLhbLibLsbLgbLibRjbRoRsmbRgRsmbLjbsbLcbRcLsbLgbRiLsbRsbLsLsmb
RgbLsbRsbRibLsbRibRsbRgbRsLsbRgbRsbRsbRsbRsbRsbRgbRgbLgbRibRgbLgbRiRsm
bRsbLcbLcRjbRcbRgRsmbLsRsbLibLcbLhbRsbRsLsbLhbLibLgbLgbLgbLibLsbRsbRhb
RhbLgRsRsmbLsbRibRibRsbRgbLibLobLibLhbLibRsbLgbLsbLibRcRsmbRhbLgbRsLsb
RhbLibLcbRcbRobRsbLsbRgbLgbRgRsmbRsbRsRgbRgLsbRsRsmbRsbRgbRgbLgRsbLhbR
cRsmbLcbLibRjbRcbLsbRsLgbLjbRobLibRobRibLiLsbRgRsmbRiRsmbRcbLhbLhbLhbR
gbRsRsmbRiRsmbLcbLcLsRsmbLsbLgLsbLgbLsLsmbLsbRsbLiLibRjbRcbRibRsbRsRsm
bRsRsmbRsbRsbRsbRgRsRsmmbLsbRgbRibRgbLhbLhbLgbLsRsbLsbRcbRibLsbLhbRcRs
mbRgbRsbRsbRsbRiLsbRiRsRsmmbRsLsRsbRgbRgRsmbRgbLgbRgbRsbRgbRgbLcbLibRi
bLsbRsRsmbLcbLcRsbLibRibRiLsbLgbLjbLibLibRgRsmbLcRsbRibRjRsmbRhbLjbLib
LhbRibLhbRjbLibLibLcLsmbRgRsLsmbRibRgRsmbRibRibsbLsbRgLsbRsRgRsmbRsbLj
bLibLgbLibLcbLcRsLcbLibRhRsRcLsmbRsbRgbRiRsmbRsbLsbRsLsbLibLibRcbLgbLh
bRgbRibLjbLcbLcbRhbRjbRiLsRsbRcbLiLsbLgbLibLgbLsLsmbLgbLsbLsbLsbLgbRgb
RcbRhbLgbRibLibLibLgbLsLsmbLgbRobLsRsbRiLsbRsRsmbRsbRgbRsbRsbRhbLibRib
LgbRibRsbRsbLsbRhbLibRgbRgbRgbRgbRgbRgbLobLgbLsLsmbLgbLsbRsbLgbLsbLibL
ibRjbRcbRcbLgbLgbRibRgbLsbRgbLgbRibLjRsbLibLibLsLsmbLsbLgbLsbRsbLgLsbL
sbRsLsbLgbLsbLgbRsbRjLsbLcRibRcbRcbRgbLsLsmbLsbLiRsbLcbRhbRcbLgbRhRsmb
LgbRibLsbRgbRgbRgbRgbRgbLsbRsbRsbRsbRgbRsLsRsbRibLjbRiLsbLsRsbRsbRsRsm
bRgRsmbRsbRgbRsRsmbRgRsmbLsbRgbRgbLsbRgRsmbLsbRsLjbLgLsbRcbRgbRsbLgbRg
bRsbRsbLsbRibLibRcbLsbRiRsmbRgbRsbRsbRgbRgbRgbRgLsbRsbRsRsmbLgLsbLsbLi
bRcbRibLgRsbRgLsbRgRsmbLsLsmbRsbRgRsmbRsbRsbRsRsmbRibRcRsmbLibRibLibRh
bLgbRiLsbRgbLsRsbLgbRibLibRibLsbLsbLjbRjRsmbLcbRcbRcbLgLsLgRsbLibRcbLi
RsbRcbLgbRgbRgRsmbRcRsmbLibRsRsmbRsbRgRsmbRsbRgbRgLsbRgRsmbRgbLobLcRsb
RibLhbLsRsLsbLsbsbRcbRibRiRsmbLibRiRsmbRgbRsRsmbRcbLibRiLsbRsRsmbRgbLs
bRgLsbRgbRcbLgbLsbLibRcbRibRsbRgbRsbLjbRgbLsbRsbRgbRgbRjRsmbRgLsbRsbRs
bRsLsbRsbRgLsbRgbRcLsbLibLjbLibRcRsmbRcbLsbRsbRgbLjbLhbRjbLcbRjbLibLcb
LoLsmbLibLibLgbLgbLsbLsbLsbLsLsmbLsbLsLgbRcbRobRhbLgbLibLgbLgbLgbLgbLg
bRjbLebRibRsbLgbRcbLiRsbRibRsbLgbRgbRiLgRsbRibLgbRsbRsbRibRhbLibRgbRgb
RgLsbLcLsRsmbLgRsbLsbLsbLgbLgbRjbRcbRibRibRiRsLsmbRgbRgRsmbLsbRgbLsRsb
LsbLibLgLsbRobRgbRsRsmbRsbRgbRsbRsbRiRsmbLjRsbRibLibRsRibLgbsbRgbRsbRs
bRsbRgbRsRsmbRgRsmbRsbRgbRgbLjbLcbRjRcRsmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 14; Drug: NDMC 3 µM
bRcbRibLsbRgbRsRsmbRgbRgbRsbRgRsmbRgbRsbRsbRgbRgbRsbRgbRgbRiLsbLibLcbR
cbLhbLiRsbRjbLibLgbLgbRcbRcLsbRgbRgRsRsmmbLsbRhbLsbRgbRsbRgRsRsmmbRsbR
cbRgbLibLibRhbRsRoRsmbLhbLiLsbRoRoLsLibLjbRcbLjbRibLgbRhLsbRhbLibLibRc
bLgbRibLgbRiRsmbRgbRgbRgRsmbRsbRsRsmbRgbRgRsmbRgRsmbRgRsmbRgRsmbRsbRsb
RgbRsbRgbRgRsmbLcbLhRsbRebRibRgRsmbRsbRgRsmbRgRsmbRsRgbRsbRsbRgbRgRsmb
RgbLcbRebRcbLibLhbLcbRjbRibLcbLibRcRsmbRcbLcbLhbLibRcbLjbLoRsbRjbRcLsb
RjLsRsbRsbRsLsbRiRsmbRsbRgbRgbRsRsmbRsRgbRsbRgbRgbRsbRsbRgRsmbRsbRsRsm
bRgbRsbRiRsmbLcRsbLibRibLcbRcbRhRsmbLgbLjLibLibRcbRcbLibLjLhbLsbLibRiR
smbLhRsLsbLibRgbLsbRgbRibRibRsRsmbRgbLsbRsRsmbRgRsRsmmbRsbRgRsmbRsbRgR
smbRsbRibRgbRibLcbLcLsmbRjbRibLgbLjbLibRsLgbLgbLsLgbLgbRjbLcbRcbLcbRjb
LcbLibRgbRgbLhbLsbLgbLsLsmbLgLsbRjbRobLsbRibLsbRibRsbRsRsmbRgbRgbRgbRg
bRibRgbRsRsmbLsbRgRsmbRgbRgLsbLjbLcbRcbLsRcLsbLibLsbLjbLibRcbRcbLiRsbL
jbLhbRcbRibLibRcbLsbLgbRcbRgbLibRibRcbLcbLcbLgbLgbLgbLsbLgbLgbLgbLgbLs
RsbLgbLcbRcbRcRsmbRgbRgbRsRsmbRsbRsRsmbRgbRsbRgbRgbRgbRgbRsbRgbRgbRgbL
cLcbRibLibLiRsbRjbLcbRibLibRjbRhbRcLsbLiLsbRiRsmbLsbRgbLsbRiRsmbRgRsmb
RsbRgbRsRsmbRsbRsbRgbRsbRsbRgbRsbRgbLsbRgRsmbRgbRgbLsbRgbRsbRsbRgbRsRs
mbRgbRgbRsRsmbRgbRsbRgbRgRsRsRsmmmbRgbRgbLjbRiRsmbLiRsbRibLcbLcbLgbRjb
LcbRibLibLgbLgbLiLsbLiLsbRcbRobRiRsRsmmbLgbLiRsbLibLgbLgbLgbRjbRobLgbL
sbRiRsmbRgRsmbRgRsmbLsRsbRsbRgbRgbRgbRsRsmbRsbRcbLcbLjLsLimbRcbLibLhLs
bLibRibLobRiRsmbLiLsbLgbLiRsbRgLibRgbLibLibRibRcbLgbRibRsbRgRsmbRgRsmb
RsbRsbRgbRsRsmbRgbRgbRgLsbRsbRsbLsbRibRsRgRsRsmmbRgRsmbRgbRsbRsRsmbRsb
RsbRgRsmbRgbRsbRsbRsbRsbRgbRsbRgRsmbRsbRgRsmbRsbRcbLcbRhbRgbRiRsmbLsRs
bRgbRsbRgbLibLibRjbRcbLibRcbLhbLsbRhRsmbRgbRibLjbRhRsmbLgbRgbRgbRgbRgR
smbRsRsmbRsbRgbRgbRgbRgbRsbRgbRgbRgbRsbRsRsmbRgbLgbRgbRgRsmbRsbRgRsmbL
sbRgbRsbRgbRsbRgbRgbRgbRgbRgRsmbRsbRgbLsbRibRgbLibRibRgRsmbRsbRgRsmbLs
RgbRsbRgbRsRsmbRgRsmbRsbRgRsmbRsbRibRgbRgbRgRsmbRgRsmbLsbRgbRsbRgbLsbR
gbRgRsmbRgbRgRsmbRgRsmbRgbRsRsmbRsRsmbRgRsmbRjbLjbLcbRcbRgbRsbRgLsRsbR
sbRgbRgbRsbRsRsmbRgRsmbRsbRgRsmbLsbRgbRgbLsbRgRsmbLsbRibLjbLcbLibLgbRj
bRcbRgRsLsmbRgbRgRsmbRgbRgbRsbRgbRgbRgbRgbRibLcbLibLibRobRibLibLibRcRc
bRgbRiRsmbLgRsbLsbRcbLhbRcbRgRsmbLgbRcbLcbRibRgbLsbRgRsmbLsbRgbRsbRgbR
sRsmbRgbLsLsmbLsRsbLhbLibRjbRcbLibRibRgbLcbLcbRiRsmbLiLsbLgRsbLgbRjRcb
LibLjbLhbRcbRcbLcbRcbRibLsbRibLgbRcbLebRobLgbLibRobLjbRobLcbRgRsRcmbRo
bLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 15; Drug: NDMC 3 µM
bLcbLgbLgbLsbLsLsmbLsbLgbLgbRcbRibRgbLsRsbRgbRgbRgbLibLcbLgLibRjbLcLsm
bLgbRjbLibLsbLgbLgbLsLsmbLgbRsbLgbLgbRsbLgbLsLsmbRsLsbLsbLgbRsbLgbRsbL
gbLsbLgRsbLsbLgbLsbLgLsbLgLsbLsbLgbLgbLsbLgbLsLsLsmmbLgbLgbLgbLgbRjbRi
bRiRsmbLcLsmbLibLsbLsLgbLsbLgbLsbLsbLgbLsLgLsbLgbLgRsbLgbLgbRhbRibRgbR
gbLibLibRsbLgLsbLgLsbLsbLgbLsbLgbLgbLgbLgLsbLgbLsbLgLsbLgbLsLsmbLgRsbL
sbLgbLgbLsLsmbLsLsmbLgbLsbLgbLgLsbLgbLgLsbLgRsbLsbLgbRgbLgRsLsbLgbLgLs
bLgLsbLsbLgLsbLsbLgbRsbLgLsbLgbLsLsLsmmbLgbRsbLgLsbLgbLsbLsbRcLsbRgRgb
LebsbLcbRgRsmbLibLgbRsbLgRsbLsbLgbLsLsmbLgbLgbLgbLgbLgbLgbRjbRcbRibRsb
RgbRgRsmbRgbRsbRsLsbRgbRgbRsbRsbRgbRsLsbRgbRobRibRgbRiRsmbLcLsmbLgbLgb
LgLsbLgbLgbRjbLibRsbLgbLgbLsbLgbLgbLgbLgbLgbRsbLgLsbRsbLgbLsLsmbLgLsbL
gbLgLsbLsbLgLsbLgLsbRsbLgbLgbLsbLgbLgbLgbLsRsLsbLgbLsLsmbLgbLgLsbLsbLg
bRsbLgbLgbLhbRgbLibLibRsbLgbRsbLgLsbLsLsmbLgbLgLsbRsbLgbLgbLsbLgLsbLgb
LsbLgbRgbLgLsbLgbLgbLsLsLsmmbLsLsmbLgLsbRsbLgbLsbLsbLgbLsbLgbLgbLgbLgb
RsbLgbLgbLsbLgLsbRsbLcLsmbLgbLsbRsbLgRsbLgbLgLsbLsbLgbLgbLgbLsbLgbLgbL
gLsLsmbLgbLsbLgbLgbLgbRhbRiRsmbRsbLsbRsbRsRsmbRgbLobLhLgLsbLibLsbLgbLg
bLsLsmbLsbLgbLgbLgLsbLsbLgLsRsbRsbLgLsLsmbLgbLsbLgbLsLsmbLsLsmbLgbLgbL
sRgRsmbLibRsLsbLgbLsbLgLsbLgbLgLsLsmbLgbLiLsbLgLsbLgLsbRsbLgbLsLsmbLsL
sLsmmbLgbLsbLgLsbLgbLgbLgbLgbLgbLgbRjbLhbRgbLibRgbLibLgbRsbLgbLsbLsbLi
LsbLibRibLsLsmbRhLsbRsRgbRgbRsRsRgmbLjbLiLsbRsLgbLgbLgbLsRsbLgbLsbLgRs
bLsbLgbLsbLsbLsbLsbLgbLgbLsbRsLgLsbLgLsbRsbRjbRiRiRsmbLjbLibLgbLgbLsbL
sbLgLsbLsRsbLgLsbLgbLgLsbRsbLibRgbLgbLsbLsLgbLsbLgbLgbLsbLgbLgbLsLsmbL
gbLgbLgbLgbRjLsbRcbRgbRgbRgbRgbLcbLibRgbLibsbLgLsbLgbLgbLibLgbRibLibLg
bLgbLgbRsbLsLgRsbLgbLsbLgbLgbLsLsmbLgLsbLgbRsbLibRgbLgLsbLgbLsbLgLsbLg
bLsLsmbLgbLsLsmbLgbLgbLsbLgbLgbRgbLgbRgbLgbLgbLgLsbLsRsbLgLsbLgbLgbLgb
RsbLgbLgLsbLgbLgbLgbLsRsbLgLsbLgbLgbRgbLgbLgbLsLsLsmmbLsbLgbRsbLgbLgRs
LsbLsbLgbLsLsLsmmbLgbLgbLsbLgbsbLsbLgLsbLgLsbLsbLgLsbLgbLsbLgbLgbLgLsb
LsLsmbLgbLgbLgbLgbLgbLsbRsbLgbLgLsLsmbLgbRsbLgbLgLsbLgbLgbLgLsbLgbLsbL
gbLgbLsbLgbLgbLsLsmbLgLsbRgbLgLsbRsLsbLiLsLsmbRsbLgbLgbLsLsmbLsbLgbLgb
LgbLgbsbLgbLgbLgLsbLibRjLsbLgbLgLsbLgbLgbLgLsLsLsmmbLgLsbLibRhbRcRgbRg
LsbRsbRsbRgLsLsmbLhbLhLsbLsbLgbRsbLgLsbLgbLgbLgbLgbLgbLsbLgbLgLsbLgbLs
bLgbLgbLgLsbLgRsbLgbLgbLgbLgLsbRsbLgLsbLgbRsLsbLgbLgbLgbLgbRsLgRcbRcbR
ibRgbRgbRsbRgbLsbLcLsmbLiLsbLibLsbLgbLgbsbLgbLgRsbLsbLsLgbLgbLgLsbLgLs
bLgbLgbLgbRjbLgbLgbRsbLgbLsLsmbLgLsbLgbLgbLgbLsLsLsmmbLgbLgbLsbLgLsbRg
RsmbRcRibRgbLsbRgbLcbLgLsbLgbLgbLgbLsLsmbLsLsmbLsbLgLsbLsLsmbLsLsmbLgb
LsbLgLsbLsbLgbLgbRsbLgbLgbLsbLsLsmbLgbLgLsbLsLsmbLgbLibRjRsmbLgbLgbLgb
LgbLsbLgLsbLibLcbLcbLgbLibLgbLsbRsbLgRsbLgbLsLsmbLgRsbLgbRgbLibRobRsbR
sb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 16; Drug: NDMC 3 µM
bLsLsmbLgLsbRsbLgbRsbLsbLsbRsbLgbLsLsmbLgbLsbRhRsLsmbRibLjLsmbRgbsbRgb
RsbRgbLsbRgbRgbLgbLcbLibRibLcbRgbLgbLgbLgbLgbRsbLgbLibRsbLgLsbRibLsbRs
bRgRsmbRsLsbRgbRsbRsbRsbRgbRgbRsbRsbRsbRgbLgbRibRibRgbRgRsRgmbRsbRgRsm
bRgLsRsbRgbRsbRgbLgbRiRsmbRsbLsbRgRsmbRsbRgbLcbLhbRibLiLsRjbRsbLgbLgbR
sRsmbRcbRibRgRsmbRsbRgbLgbRiRsmbLiLsbRiRsmbLjbLcRsbLgbLgLsbLsRsbLsbLgb
LgbLsbRsbRjbRibRgbLsbRgbRsbRgbRsbRsbRgRsmbRibRgbRgLsbRgbRsRsmbRsRsmbRg
bRsRsmbRgbRgbLsbRgbRgbRgbLsbRibLjbRsbRibRsRsmbRsbRgbRsbRibLcbLhbRjbRob
LcbRibRibRibLcbLibLibRgbLgbRsbLibLsbRsRsmbLgbLgbLibRgbLgLsbLsbLsbLgbRs
bLibRcbRcLjbLibLibLgbLsbRsLgbLsbLgbLgbLgbLgbLiLsbRjbLibRjbLsbLibRjbRhL
sbLhbRibRiRsmbRsbLsbRgbRgRsmbRsbRgbRsbRgbRgRsmbRgbRsbsbLjbLiRsbLgbLsbL
gLsbLgbLsbLsbRsLsbLgbLgbRoRsmbRgbRgbRsRsRsmmbRgbRgbRsbRsbLsbLjLibLgLsL
smbLgbRsbLgbLgbRsbLsbLgbRsbLgbLgLsRsLgbRsbLibRjbLibLgLsbsbRebRsRsRiRsm
mbLgRsbRsRsmbRibLsbLsbRgbRiRsmbLibRcbLjbRgbRibLcbLcbRibLibLiRsbRgLsbLc
bRibRcbRgbRgbRgbRsbRgbRsbRgLsRsRgbLsbLebLgbRcbRibRiLgbRgbRgLsbRibLcbLc
bRjbLcbRibLibRgbLcbRgbLsLgbLgbLgbRcbRgRsmbLsbRgbRsbRgbLsbRsRiRsmbRgbLg
bRgbRsRsmbRgLsbRsbRsbRgRsmbRibRgbRsbRsbLgbLcbLiRsbRcbLjbRcbLgbRibRibRs
bRsbRsbRsbRgbRgbRsbRgbLcbLhbRgbLgbLibLibRcbRhbRibLjbLhbLcbRibRhbLjbLiR
sbLgbLsbRsbRjbRiRsRsmmbRibRsLsbLcbLibLgbLsbLgbLgbLgbLsbLsbRsbRjbRhbLcb
LsbLgbRobRgbRgbLsbRsbRgRsmbRsRsmbRgbRgbRsRsmbRsbRsRgRsmbRgRsmbRgRiRgbR
gbRgbLjbLhbLibRcRsmbRibLhbLgbRhbLibLgbRcbRibRgbRgbRgRsmbRsbLsbRgbRgbRs
bRgLsLsmbLjbLcRsbRjbLcbRjbLibRsLsbLgbLsRsbLsbLgbLibRjbLhbRjbLcbRhbRcbR
sbRsbRsRsmbRgbRsbRsbRgbRgbRsbRgbRsbRsbLcLsmbLgbRsbRcbRgbLsbRibRsbRsbRs
RgbRgbRgRsmbRgbRsbRsbRsbRgbRiRsLsmbRibRgbLibRiRsmbLgRsbRgbRgbRsbRhLhbL
jbLibLgRsRsLimbLsbLhRsbRibRcbLgbRibRgbRsbRgbLhbRcbLibLcbLgLsbLsbLgbLsb
RsbLgbLgLsbLsbRsbRcRsmbRgbRgbRsRsmbRsbRsbRsbRgLsRsbLjLibLsLsmbLgbLgbLs
bLsbLgbLgLsbLsRsLsbLgbLsbLgbRsbLgbLsbLgbLsRsbLsbRcRsmbRiRsmbLsRsbLsRsR
gRsmbRgbRgbRsbRgbRsbRgRsmbLjbRibRobLcLsmbLgbLgbRgbLgbLgbLsbRsbLgLsbLib
LsRibRcbRgbLsbRsRsmbRgRsmbLsRsbRgbRsbLcbRsbLiLsbRjbLibRgbLiLsbRsbLibRc
bLibLcbRjbRcbRgbRgbRsbRsbRsbRgbLcbLsbLgbLgbLsbLgLsbLsbRsbLibLibRhbRobL
jLsmbLibLibLibRjbRibRgbRsbLsbRgbRgLsbLjbLhbLibLibRjbLibLsbLgbLgbRsbLsb
LgLsbLgbRjbRcbLcbRcbLjbLcbRjbRcbLjbLibLibLsbLsbRsRsRsmmbLgbLgbLgbLsbLg
LsbLsbLsbLgbRsLsbLsRsbLgbLsRsbRjbRibRgLsbRgbLcRsbLcbRibRhbRgbLsbRsRgbR
gbRgRsmbRgbRsbLsRsbRibLjbLhbRsLsbLibRoRsmbLcbLibRhbRibLgbRibLjbRibRsbR
ibLibLcbLsbLgbLgbLgbRsbRcbRibRibLsbRgbRsbRsbRgbLsbRsbLsbRgRsmbRsbRsbRs
RsmbRsbRibRgbRsbRsbRsRsmbRsbRgRsmbRsRsmbRgbRibLjbRibRgbLsbRgbLsbLcbLgb
LgbLgbLsbLsbRsLsbLgLsbRsbLgbLsRsbLsbLsbLsbLgLgLsbRcbRibRgbLgbRiRsRsmmb
RsbRgbRgbRgbRgbRobRjLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 17; Drug: NDMC 3 µM
bRsbLsLhbLgbRsbRsRsmbRcbLjRsbRgbLgbRsbRsLsbLibRsbLibLsbLsbLgbLgbLgbRib
LibLebLibRsbRsbRebLgbRhbLgLsbLgRsbRcbRsbRsbRsbRgbRsbRgbRgbRsbLsbRibRgb
LgbRhbLgbRsbRibRsRsmbLjbRibLsbRsbRsRsRsmmbRsRsmbRsbRsRsmbRibRsbLgbRiRs
mbLgbRcbRsbRsbRsbRgbRgbRgbLsbRgbRsbRibLgLsbRsRsmbRgbRgbRgRsmbRsbRsRsmb
RsbLibLhLsbLgbLgbLgbRjbLsbLjLsmbLgbRibLcbLibLibRgbLgLsbRgbLgbRibRsbRcR
smbRgRsmbRsbRsbRibLsbRgLsbRsbRgbRsbLsbRiRsmbRgbRhbLjbRibRgbLgbLsbLgbLs
bsbLsbLgbLsbLgLsbLiLsbLsbLsbLgbLsbLjLsLsmmbLgbRgbRgbLhbLgbLgbLsbLsLsmb
LjbLibLiLsbLsbLsbLsbRebRsbRsbRgbRgbRsbRgbRsLsbRsRsmbRjbLibLibLgRsbLjbL
ebLsbRsbRsRsRsmmbRjRsmbLibLgbLsLibLibLsbLsbLgbLsbLgbLsLsRsmbLgbLgRsbLg
LsbLiLsbLsbsbRgbLgbLgbRsbRcbRibRibRibRcbLibLsbRcbLsRsbLsbRhRsmbLgbLsbR
jRsmbRsbRsbRsbRcbLgbLsbRobLibRsbRcbLgbLsbLgbLhbLcbLgbLibLibLgbRibLgbLg
LsbLcbRibLibLibLibRgbRsbLjbLsbLibLsbLiRsbRiRsmbLibRibRibRebRgbLgbRsbLc
bLibLibLibLsbRcbLgbLgbRobLsbRgbRsbRsbRgbsbRgRsmbRgbLsbRgbRsbRgRsmbLjbR
sbsbRcbRhbRsbRiLsbRhbRgbRgbLgbRiRsmbRgbLsRsbRgLsbRsLsRsbRgbRgbRgbLsbRg
bRsbRgbLjbLhbRhRsmbRcRsmbLiLsbLhLsbLgLsbRsbLibRjbLibRibRibRgbRgbRsbRgb
LsbRibLgbRcbLibRhLsbLgbRibLsbRgbLjbRibRgbRgbRgbRgbLsbRgbLjbRcbLiLsbRsb
RibRiRsmbLsLsmbRibRgbLsbRsbRgbRsbLsbRiRsmbRibLibRobRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 18; Drug: NDMC 3 µM
bRiLsbLiRsbRjbRgbRgbRibLjbLcbLgLsbLgbLgRsLsbRcbRiLsbRgbRgbLsbRibLibLgb
RgbLgLsbLgbRjbRibRgbRgbRgbLhbLiLsbLsLsmbLsbLsbLsbLgbLgLsbLsbRsbLgbLgLs
bLsbLgLsbLsbLsbRcRsmbLjbLgbLiRsbLgbLgbLsbLsbLsLgbLsbLgLsbLgbLgLsbLsbLg
bLgbLgLsLgbLhbRibRibLcbLibRibLibRcbRhbRgbRiLsbLcRsbRcbLcbLhbRgbLibsbLs
bRjbLiLsbRjLsbRjRgbRibLcbLibRibLgbLsLsmbsbLsbLsbLsbLgbLsbLgRsbLgbLgbRs
bLgbLibLsbLgbLsbRsbLgbLsbLsbRjbRibLebLhbRsbLgLsbLsbLjbsbLgbLsLsLgLhLsm
bLgLsbLgbRcbRgbRgRsmbLeLsbLiLsRsbLibLibRjbRsLibRgRsmbLibRgbLibLibRibLh
bRjbLibLgbLgbLiLsbRsbLibLgbLsbLgRsbRgbLibRgbRsbLgbsbLsLsmbLgbLgbLgbLiL
iLsLiLsLibLibLsLsmbRsbLiLsbLcbRebRsbLsbRebRiLsbRgbRibRgbRibRhbLibLsbLo
bLiLsbLgbRgbLgbLgLsbLsLsmbLsLsmbLsbLgbLgbLgbRsbLsbLgbLsbRsLsbLiLsbLsbL
cbRgbLgbLibRibLgbLgbRjbLibRjbLcLsmbLsbLgbLgLsbLsbLsbRsbLgRsbRsbLibRsbR
jLsbRcRibRgbsbLjLcLsmbLgbLgbRjbLibRjbLgLsbLgbLgbLgbLibRjLsbLiLsbRsbLgb
LgbRgbLgbLgbLgbRsRsmbLiRsbRibLibsbLsbLsbLgbLgLsLgbRcbRgRsmbRgbLjbLiLsb
LebLsbLibLgbRsbRgbLgbLiLsbRgRsLsRsLimbRsbLjbLsbsbLgbRgbRsRgbLgbLsbLgbR
sbLgbLgbLsbLsLsmbLgbLgbLgLsbLgbRgbLcbRjLsbRibRiLsbRsRsmbsbRjbsbRgbLjbL
cbLibRsbLibRsbLibRjLsbLiLsLsmbRsbLgLsbRjbLibRjbRhbLjbLcRsbRgbLibLsbLgL
gLgbLgbLgLsLsmbLsbLgLsbRsbRibRibLhbsbLibLsbLgbLgbLgbRsbLgbRsbLgLsbLgbR
gbLibRsLsbLgbRsbLgbLgbRjbRibRgbRsbLsbLjbLhbRgbLibRibLgbLsLsmbLgLiLgbLi
bLgbRsRsmbLibRgbLgbLsRsbLgbLsbLibLsbLsbLgbRjbLibLcLsmbRibRsbRjbRgbRgbL
sbRiLsbLsRsRsLsmbRsbRgRsmbLsRsbRgbLsbLsbRgbLjbLcbRsbLibRsbRsbLgLsbLgbR
sbLgbLgbRgbLibLgbRjbRcbLcbRsbLgbRsLgLsLsmbLgbLgLsbLgbLsbLgbLgbLgbLsbLs
bLgbRsbLhbRsbLsbRjbLibRsbLgLsbLibRgbLibRgbLcbRibLcRsbLcbRibRsbLgbLibLg
bRcbRobLibLhbLibRsbRgbLgbLgbLgbRcbRgbLsbLcbLcbLsbLgbLgbLhbRsRgbLsLsmbL
gbLsbRibLibRgbLibLibLsbLjbRibLcbRibLibLsbRsbLibLcbRiLsbRcbLsbLcbLsbLoL
smbRsbRgLsbRsbLcbLiLsbLibRsRsmbsbLgbRgbLiLsbRsbLgbLsbLgbLibLsRjbRjRsRi
mbRibRsbRgbLeRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 19; Drug: NDMC 10 µM
bRgbRgbLgbRsLobLsbLsRsbLgbLgbLsbLgbLgbRsbLgLsRsbRobRoLgbLgLsbRcLsbsbLi
bRoLsbLibLcLsmbLsbLgbLgbLgbLsbLgLsbLsbLgLsbLgRsLgLgLsbLgbLsLsLgLiLiLsL
sLgLiLsLsLgLgLiLiLsmmmbLgbLiLsbLgbRoLsLsRsmbRobLhLsbLcbLibRibRcbLcbLib
LiLsbLibLcbRcbLjbRoLsbRibRiLsbLcbRjbRibRgbLsbRibRsbRsbRiRsmbRiLsbRsbRg
bRhbRsRsLgmbLcbRcLsbLcbLcRsbRibRobRgLsbLibLhbLgbLsbRgbLibLibRjbRcbRsbR
ibRibRibRgbLibLcbRibRcLsRsbRsRsmbRcbLcbLibLsbLsbLgbLgLsLgLiLhLsLsLiLsL
iLiLiLgmbLgLsbLhbLsRsbRcbRibRibLibLcbRhbRcbLcbRibRibLgbRobLcbLcbRcbLcL
oRsbRibLibLibLgbLcbRhbLcLsmbRibLibLgbLgbLsbLgbLiLsbLgbLsLsLsmmbLgLsbLg
bLsLsmbLsbLgLsbLsbLgLgLgLsbLgbLibLgbLiLsLsmbLgbLsLsmbLgLsLgbLgbLgLgbLi
bLgbLibRgbLgbLgbLsbLgbRoRsRoLsmbRgLsbRibRcbLhLsbLcbRjbRcbLcbLcbRhbRhbL
jbLibLgbRsbLibRgbLsbLibRhRibLcbLcbRhbRcbLgbRobsbLibRibLjbLcbRgbRjbLcbL
gbLgbLsLsmbLgbLgbLgLsLgLgbLgLsbLgbLiLiLsLsLgmbLgbLgLsLsmbLgbLgLgLgLgLg
RsbLgbLibLgLsbLgbLsbLibLgbRcRcLsRsbRgbRsbRgbLsLsmbRiLsbLjbLcbLoRsbLiLs
bRiRsmbLcLsmbRcRsRsmmbRobRibLhbLiLsLcbRibLibLgbLgbLgLsbLgLsbLgbLgbRcLs
bRibRsRsmbRiLsbRgRsmbRobLcbRibLcbLsbLcRhRsmbRcbRgbRgbsbRgbRgRgRgRibRgb
RgbRgLgbRgbLcbLibLsbLgLsbRsbLgLsLsmbLgLsbLsLsmbLsLiLibLgLgLsbLgLsLgLib
LiLsLgLiLsLiLsLiLsLibLiLsbLgbLiLsbRcRsmbRhLsbLjbLcLsmbLcbRibLcbRsRgbLc
RsbRibRcLsbLsbLcbLsbRobLcbLoRsbRcbRcbLsRibLjbRsbLcbRgRcbLjbsbLcbRjbRcb
LjbLcbRiRsmbRiRsmbRgRsmbRsbRgbRgRsmbRgRsmbRsRsmbRgRiRsmbRgRsmbRgbRgbRg
bLcbLobRcbLgbRhbRibLoLsmbLhbRjbRibRgbRgbLgLsbRhbLhbLcbRcbRiLsbRgRsRsmm
bRiLsbLsRsbLcbLgbLgbLgbLgbLgLsbLibLiRhLsbRcbRgbRgbRsbRgbRsLsbsbRsRsmbR
sbRcbLcbLgbLsLsmbLsLsmbLgLiLiLiLsLiLiLebLgbLgbLgbLiRsbRoLsbRhRsmbRgbLg
bRiLsbsbRhbLibRcbLgbRcbLjbLcRsbRibRcLsbRibRgbLjbLoRsbRcRsmbLcbLgbRcbRg
LsRsbLjLhbLobRgbRgbRcbRgRsmbRsbRgbRsbRsRsmbRsbRgbRgbRsbLsbRgbRgbRsbRsb
RiRsRiRgRsmmbRgbRgbRsbRgbRibLcbLoLsmbRiRsmbRcbRgbLsRsbLcbLcRsbRcbLhbLo
bRgbLiLsbRsbLibLgbRgbLhbRibLibLgRgbRcbRsRgRgbRsbRsbRgRsmbRgbRsbRgbRgRs
mbRgbRsbRgRsmbRsbRgbRsbLjbLcbLgLsbLsbLsLiLgLiLgbLgLsLgLsLgLsLiLsLgLibL
iRsbLhbRibLhbRiRsmbLiLsbLibLsbLgbsbRgbLgbLgLsbLsLgLgRsbLgbRcRgbRgbRsRs
mbRgbsbLsbRgLsLsRsRsmmbRgRsmbRsRgbRsRgRiRgbRgbRgLsbLhbLhbRibRibRgLsLsm
bLsbRgbRgbLhbRsLibRjbRhbLcbLhbRgbRcbRiLsbLcLsmbLebLcbLhbLhbRibLebLhbRc
bRcbLibLhbLibRsRsmbLibRjbRcbRcLiLsbLiLsbLibRgbLibLsbLgLgLgLgLsRsbLgLgL
gLgLeLiLeLeLsbLgbLgbRcRiLsbLcbRsLobRcbLobRobRoLsbLcbLcRsbRcbLcbRgbLsbL
gbRsLsbLgbLgLsbLgLsLsmbLgbLgRsbRcbRcbLcbLcbRhbRobLcbLcbLcbRgbRgbLcbLcL
smbRibRiLsbRobLhLsbLobRibRiRcbLebLibLiLsbRjLsbLobLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 20; Drug: NDMC 10 µM
bLgbLsbRsbLibRjbLibRcbRcLsbLebRcbLsLjLsmbLiRsbLibRsbLsbLgbLsbLsLsmbLgb
sbLhbRgbLgbRsbLgbLgLsbRgbLsLsmbLsLsmbLibRgbLgLsbLsLsmbRjbRibRgLsbRibRh
bLcbLibRiRsLsmbLibRjbRibLhbRibLebLhRsRsmbLgbLgbLsbLgRsbLgbLsbLgbLgbLgR
sbLgbRcbRcbLgbRcLsbLebRhbRsbRgbLcbRsRjbLebRjbRibLjbRibRibRibLhbLhbLgbL
gRsbRcLsbRibLjbRhbLjbRibRjbLgLsbRibLhbRjbRgbLcbLgbLgbRsbLjbLibRebLsRsb
LgRsbRsbLgbLgbLgbRobRhRsmbLhbRibRsbRgbRgbLgbRcbLsbLibLcLsmbLhbRsLsbRcb
LjbRiLsbLjbRcbLjbRcbRibRjbLgLsbLsLsmbLgbLsbLgbLsbLgbLsbLsbLgbLgLsbRiLs
bRhRsmbLcbRcbLebLsbLsRsbLsLgbLsLsmbLgRsbLsRsbLgbLgbRgbRjbsbLsbLsbLjbsb
RgbRgRsmbRiLsbLhbRsLjbLgbLsbRibRibRgbRsbRgbLsbRhbLcbLcbRibRsbLsbRebRsb
RsbRsbRgbRsbRsbLgRsbRsRgRsmbLjbLjbLsbLsbLgbLgbLgbLsbRgbRhbRhbLhbLibLgb
LgbLgRsbRcRsmbRjRsmbRibLjbLgbLsLsmbRsbRibRgbLjbRiLsbRgbRsbRsbRsLsbRgRs
mbRgbLcbRcbRibLjbRhbRebLjbRhbRcbLcbRibRjbRhbRjRsmbRiRsmbRsLsbRgbRgbRsb
RgbLsLsmbRiRsmbLgbRgbRgbRsbRgRsmbRsRsmbRgRsmbLibRibRgbLgRsbRibsbRgbLsL
smbRiRsmbRsbRgbRgbLjbRibLsRsbRibRgbLgbRgbLjbRibRgbRsbRibRsbRsbRsbRgbRg
bRgbLibRiRsmbLcbRcbLjbRcbLsbRibRgRsmbRgbRsbRsbRsbRsbLjbRibRibLibRibRgb
RgbLsbRiLsbLjbLhbLgLsbLgbRsRsmbLgbRgbLgbLgLsbLibLgbRsbLibRhLsbRiRsRsmm
bLsRsbRgbRsbLsbRiRsmbLibLcbRcbLhbRhbRibRgbLgbRgbLsbRgLsbRgLsbRgbLsRsbR
gRsmbRsbRgbLsbRgbRgbLsbLsbRiLsbRibRsRsmbRiRsmbLjbLibLgbLsLsmbLiLsbRjbR
obRsbRsbRgRsmbRsRgRsmbRgbLsbLjbRibLibRcbRiLsbRgbLsbRgbRgLsbLjbLcbRcRsm
bRcRsmbLibLcbLiRsbRgbLibRgbLgbRsbRibRiRsmbRgbLjbLhbRcbRhbLjLsmbLibLibL
gbLgbRjbLgbLgbLibRebLhbLsbLgLsbLsbLgbLsLsmbLsbLsbLgbLsbLgbRcbLhLsbLibL
gRsbRgbRibRibRiRsmbRgbRiRsmbLhbRsbRibRgbRsbRibLgbRibLeRsbLjbRibLjbRhRs
mbLjbRhLsRsbLgbRibLsbLsbRgbRsbRgbRgbRsRsmbRsbLsbRgRsmbRgbLsLsmbRgbRsbR
sRsmbRsbRobRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 21; Drug: NDMC 10 µM
bLsRebRcbRgRsmbRibsbRhRsmbLsbLgbRibLsbLsbLsRsbRgbRsbRgbRebLjbRhbRhbRcb
LcbRsbRgbLsbRgRsmbLcbLcRsbRsbRsbRhRsmbRibRibLeLsbRsbRibRgbRsbLsbRsbRsb
RgbLjbRsbLebLibRjbLiLsLsmbLsbLibRsbLibLsbRgbLibRjbLcbLcbRsbsbLsRsbRhbL
sLgbRebRcRsmbLsbLsLsmbRsRsmbRjbRibLjLsmbLcbRibLibLibLgbsbLgbLsbLibLibR
ebRebLibRcRsmbLhbLibLcRsbRcRsmbLjbLibLgbRcbRibRgbRgbRgLsbLgLsbLsbRiRsm
bsbLgLsbRgbRgbRgbRsbRibLcbLcbLgbLsbLibRjbLgLsbLiLsbLsbLgbLgbLgbRcbRcbL
iLsbRsRhRsmbRsbRgbRgbRsbRsLsbLsRsbRiRsmbLjbLoLsmbRcbRgbRibRibRibLjLsmb
RibRsbRcbLcLsmbRcbLgLsbRiRsLsmbRsLsbRsRsmbRgRsmbRgbRgbLsbRsbRsRsmbRsbR
gbRgbRgbLjbRibRibLjbRhbLjbLhbLibRebRobLibRibLjbsbRhbLibRobLhRsbRibLsbR
gbLsbRgbRgbRsbRsbRgRsmbRibRgbRgRsmbLjbRsLsbRibsbRibLgbRibRsbRibRsbRgbR
gbRsbRgbRsbRgbRibRcRsmbLibLibRiRsmbRhRsmbLjbRibRibLsbRgbLjbRibRsbRgLsR
sbLobLobLibLhbRibRiRsmbRsbLsbRgLsbRibRsbRibLsbRgbRgbLsbRibRibLibLobReb
LibLiLsbLiRsbRgbRgbRhbLsbRsbRibLgRsbRgRsmbRgbRsbLsRgRsmbRgbRsbRibRgbRi
bRibLibRibRsRsmbRgbRiLsbRcbRebRiRsmbRibLibLebLgbLgbRsbLibLsbRcRsRsmmbR
ibRsbLsbRgbRsbRgRsmbLsbRibLhbLcbLibRibLcbRgbLhbRjbLgbRgbLgbRcbRgbRsbRg
bRsbLgbRsbRibLjbLsbRibLsbRhbLibRsbLhbLibRgbsbLgbLsLsmbRsbLgbRsbRjbRcbL
sbRibRgbRgbRgRsmbLgRsbRgbLibLibsbLgRsbLsLsmbLsbLgbLgbRobsbLsbRsbRgbsbs
bLibLibLsbLsbLsbLgbLgLsbLgbLsbRgbReRsmbRibLjRsbRibRsLsbRgLsbRgbLsbRgbL
obRibLhRsbLgbLsLsLsmmbLgLsbLcbRibLibRobLibLibRebRhbLgbRgbRgbRsbRsbRgbR
sbRsRsmbLcbLiLsbRjbLhLsbLcbLibRjbLibLgbRsbLgbRgbRcbRibRsbLsbRjbRobLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 22; Drug: NDMC 10 µM
bRsbRibLibRiRsmbLjbLcbLiLsLsmbLiLsbRibLoLsmbLiLsbLibLibLgLsbLcbLgLsbLi
bLhbRhRsmbLibLibsbsbsbRsbRcbRcbLjLgbRgbRoRsmbLibsbRsbLibLgbLibLcbLiLsb
LgbRgbRcbRsLiLsbRobLgbRebLibRgbRgRsmbRgbRsbRgbRsbRsbLsRsbRgLsbRsbRsRsR
smmbRgLsbRgbLsRsbRjbRsbRsbRsbRsbRsbRgbRgbRsRsmbRgbRgbRsbRgbRgLsbRgbLsb
RgRsmbRgbRgbsbRsRsmbRibRsbRgbRgbRgbLgbLcbRcbLhRsbRcbRibLgbRgbRgbRsbRsL
sbLsbRjbRsLsbRjbRsRsmbLsbLsbLsbRgbRgbRgbRgbLjbLhbRcbLjbRoLsbLibLibRsLc
LsmbRgRsmbLobLcbRcbLgbLibRibRgbRsbLjbRsRsmbLiRsbRcbRibLjbRiRsmbRsbRgbR
sbLsRgbRsRsmbRsbRgbRgRsmbRgRsmbRgbRgbLgRsbRibLjbRgbRgRsmbRgLsbRjbRsRsR
gmbRsbLsbRgbRgbRgRsmbRsbRgbLsbRgbRgLgRsbRsLoRsbsbLsbRsbLcLsmbLebLibLgL
sbRebRiRsmbRsbRgbRcbLiLsbRcbLibLcRsbRobRjRsmbLgbRgRsmbRgbRsbRsRsmbRsbR
sbRgbRsbRgbRsRsmbRgbLsbRgbRgbRgbRgRsmbRsbLsbRsRsRsmmbRsbRgbRgRsmbRgbRg
RsmbRgbRgbRgbRgLsbLsbRgLsbRsRsmbRsbsbRgbRgbRgbRgLsbRibLiLsLsmbLhbLgbRs
bLoRhRsmbRibRcbRjbsbRebRibRgbLgbRcbLibRcbLgbRcbLibRcbLgbLsbRibLsRsbRgR
smbRsRsmbRgbRsRsmbLsbRsbRsbLsRsbRgbRgbRsRsmbRgRsmbLcbRjbRcbLgRsbRhbRsR
sRsmmbRiRsmbRjRsmbRsRsmbLgbRibLgbRiRsmbRgbRgRsmbLgbRibLgbRgbRgRsmbRgRs
RsmmbLsLsmbRgbRsRsmbRsRsmbRjbRsRsmbRgbRsbRgRsmbRgbRgRsmbRgbLcbLibRjbRi
bRgRsmbRsbRsRsRsmmbRgRsmbRgbRsbRjbRsRsmbRjbLsbRgbLsbRiRsRsmmbLcbLibLiR
sbLhbRgLsbRcbRhbLibLhbRcbRhbLgbRgbRgbRsbLjbLobLgbLibLgbRibLiLsbLibRiRs
mbRiLsbRcLsbRibLgLsbLsbRgbRgbRgLsbRsbRgLsbRgRsmbRsbRgbLsbRsbRsbRgbRgbR
gRsmbRgbRgbRsbLjbLhbRcbLjbLibRcbRiLsbRgbRsRsmbRsbRgbLsRsbRsRsmbRsRsmbR
gbRgbRgbRgRsmbRsbRgRsmbRsbRgbLsRsRsmbsbRgLsbLsRsRsRsmmbRgRsmbRgbRsbsbR
sRsRsmmbRsRsmbRgbRgbRgbRgRsRsmmbRgbLjbLhbRcbRibRgbRsbRgRsmbRgRsmbRgRsm
bRsbRgRsRsmmbRsbRgbRgbRgbRgbRgbRgbRgRsmbLgRsbLcbLiLsbRebRcbLgbRiRsmbLg
bRsLsbRgRsmbRsbRgbRgbRgRsmbRgbRgbRgbRgRsRsmmbRgLsbRgbRsbRgLsbRgbLjbLcb
sbsbRebLhbLgbRhbLsbRcbLgbRiRsmbRgRsmbRsbRibRgRsmbRgbRsbRgbRgbRgbRsbRib
RsbRsbRgbRgbRgbRgbRgbRgLsbRgRsmbRgbLsRsbRjbRsRsRsmmbRsbRjbRsRsLsmbLsbR
ibRgRsmbRsbRgbRsbRgRsRsmmbRgbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 23; Drug: NDMC 10 µM
bLiLsbLibLcbLibRibRibLsbLibRcbLgbRgbRcbLhLsbLjbLhLsbLsbRsbLsLsmbLgbRsb
LibLsbRsLsbLgbLsbLgbRibLjLsmbRjbRcRsmbsbRhbLibsbRsRhbLsbLsbRgbRsbLjbRi
bRgbLibLhbLibRibLiLsbRgbLgbLsbLsLsmbLsbLsbLsLsRsmbLsLsmbLibRgbLibRgbLg
bLsbLsbsbsbLgbLsbLsbLgbLgbLsbLgbRsLsbLgbLsLsmbLgbRsbLsbLgbLgbLsbLgbLgL
sbRgbLgbRsbLibRcbRibRibRgbLibLcbLcbsbRibLhbLibLgbRsbLgbLgbLgbLgLsbLgbL
sbLsbLsbLsbRcbLjbLibRsbRsbsbLgbRgbLibRgbLsLibLsbRgbLibLsbRgLsbLibsbRsb
LgbLsRsbLgbLsbLsbLsbLsbLsLsmbLibLiLsbRibLibLgbLibRibLhbRibLhbRibLibRgb
LibRgbRsbLgbRgRsmbLiLsbLgbRgbRgbLibRsLsbLibLsRsLsbLgbLgbLsbLsbLsbLgbLs
bLsbLgbLsLsmbLgbLgbLgbRgLsLcbRibsbLsbLjbRjbRcbLjbLcbRjbLhLsbRgbRsLsbLh
bRsbRsbLgbLsbLsbLgbLgbLgbLsbLgbLgbLgbLsbLgbLgbLgRsbRjbLibLhRsbRcRsmbRc
RsRimbLjbRcbLjLsmbLcbLcbRibRcbLcLsmbLibRsbLgLsbLsLsmbLsbLgLsbLsbRsLgLs
bLgbLsbLgbLsbLsbLibRhbRcbRhbLibLhbLjbLsbLsbLsbLgLgbLgbLgbLsbLsbLgLsbRs
bLgbRsbRjbRhbLcbLibRgbLibRibLsbLjbRgbLibRjbsbLgRsLcbRibRsbRgbLiLsbLibL
ibLgbLsbLsbLgbLsbLsbLsbLgbLsbLsbLsLsmbLsbLgbsbLsbLgLgLgLsbLgbLgbLgLsRs
bLgbLgbLgLsbLgLsbLsbLgLsbLgbLibRhbLcbLibRibRgRsmbLhbRsbLibRsbLiLsbLgbR
sbLiRsbRibRsRcbRibLhbLhbLsLcbRibRhbRibLgbRibLgRibRgbRibLsLsmbLiLsLsmbL
sbLibLiLsbRsbLgbLsbRsbLsbRjbRibLcbLcbRiRsmbRiRibRibLibRibRgbRgLsbLhbLg
bLibRsbLgbLsbRsbLjbRibLgbLsbLsbLgbLgbLsbLgbLsbLsbLsbLgbRsLsbsbLgbsbLsL
sLgLiLsLsmmbLgbLsbLgbLgbLgbLgLsbLgbLsbLsLsRsmbLgbRhbRhLsbLeLsbLcbRgLsb
RebLsbRsRibsbLibLcRsbRjRhbLgbRcbRiRsmbRibLibRgbLibRibRibRgbLcbRjbRibLc
bLsbLgLsLsmbLsLsmbLgbLgLsbLgbLsLgLsbLsLsmbLsbLgbRsbRhbRiRsmbLibLibLsbR
sRsmbRcbRcbLcbLhbRcRsmbLhLsbLibLibRjbLsbLsbsbRsbLgbLgRsbLgLsbLsbLsLsmb
RsbLgbLsbLgbLsbsbLgbLsbLgbLgLsbLsLsmbLgbLiLsbLsbRibRgbRibRgbRgbLjbLhbL
iRsbRjbRhbRgRibLjbLsRiRsmbLhbRhbRgbLgbRsRsmbRsbLsbRsbRgbRgbLcbLsbLiLsL
smbLgbLgbRgbLsbLsbLsbLgbsbRgLsbLgLsbLsbLsRsbLsbLsLsmbLgbLgbLgbRsLsRsbL
sLsmbLgbLgbLsbLgLsLgLgLsbLsbRjbRibRibLcbLibLgbRsbLsbLgbLsbLgbLsbLgbLsb
LgbRjRsmbRcbRibLiLsbLibRcbLjbLhbRhbRsRibLsbLibRsLhbLibRgbLibRgbLsLsmbL
sLsmbLsbLsbLgbLgbLsbLgbLgbLsbLsbLjbLgbLsbLgbLsRsbLsbLsbLgbsbLgbLgbLgbL
sbLgbLiLsRsbLgbRjbLibRjRsmbLibLgbLsbLsbLsbLsbLsbLsbRsbLgbLsbLgLsbLsbLs
bLsRsbLgbLsLsmbLgbLsbLsbLgbLgbLgRsbRjbLjLsmbRcRsmbLhbRjbRhbLcbLgbLsLsm
bLsbLgbLsbLgLsbLgLsbLgLsbLsbLgLgbLgLsbLibLgbLgbRsbLgbLsbLgLsbLsbLgbLgb
LsbLgbLsbLgbsbLgbLsRjbLgbRsLsLsLiLsmbLgLsbLsbLsLsmbLsLsmbLsLsLgmbLsLgb
RsbLsbLsLsmbLgbLsLsmbRsbsbLsbLgbLgbLsbRsbLgbLsbLgLsbLsbLgbLgbLgbLsbLgb
LgLsLsmbLgbRsbLgbLsLsmbLgbLgLsbLgbRsbLgbLgbLgLsbLgbLcRgbLibRiLsbLhRsbR
ebLhbLhbLibLcbLibLibLgbRgbLsbLgbLsRsLibLsbLgbRgbLgbLsbLgLsLsmbLsbLsbLg
bLgLgbLgLsbLgbLgLsLsmbLgbLgRsbRjbLibRgbLgbLjbRsbLjbLsbLsRsbLibLgbLgbLs
LgLsRsbLgbRsbLgLsLsLsmmbLsbLsbLsbLgbLgbLsbLsbLgbsbLsLsmbsbLgbLgbLgLsbL
gbLgbLsbLgLsbLsLsmbLgLgbLgLsbLgbLgbLgbLgbLhRsbRibLiLsbRjbRhbLjbLhbRiRo
LsbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 24; Drug: NDMC 10 µM
bLgbLsbLsbLsbLsbRsbLibLsLsmbLsLsmbLsbLsbLsLjbLsbsbLsbLgbLgLsbLsLsmbLsb
LsbLgLsbLgbLgbLsbLgbLsbsbLgbRibRibLcbRobRgRsmbLcbLcbRibRhbRjbLsbsbRsRc
LsbLibLibLibLhbRibLsbLgbLsLsmbRsbRibRcbRgbLgbRgLsbLjbRhLsbLibLcbRgbLib
LsbLgbLsbLgbLsbRhbRgbRsRsmbRsbLgbRgbLsbLoLsLsmmbLsbsbLsbRsbLgLsbLgbLsb
LsbLgLsbLgLsbLsbLsLsmbLsbRsbLgRsbLgbRcLsbRgbRgbRgbRsRsmbRibRsbRgbLibRg
bLsbLgLsbRsbLsLsmbLgbLsbLgbRgLsbRcbRgbRgbLsbLgbLjbRsLsbRgRsmbRsbRsbLsb
RgRsmbLsbRsbLobLgbLsbLsRsbLsbRsRsmbRjbRgbRgbLsbRgbRgRsmbLjbRgbRsbRgbRg
bRgbLsbRgbLhbRgbLhbRcbRgLsbRsbRgRsmbRsbRsbRsLsbRgbRsbRsbRsbsbsbLsbRsRs
mbLsRsbRsRsmbRsbRsbRgRsmbsbLoLsmbLibLsLsmbLsLsmbLsbLgbLgbLsbLsbLgbLgLs
bRsRsmbRsbLsbRsbRsbLsbLsbLgRsbLgbLsbLgbLsbLgLsbRjbLibRjbRobLiLsbLgbLsb
LgbLsbLsbRsbLsbLsbsbLsbLgLgbLgbLsLsmbLgbLgbLgLsbLsbRgbRcbLsLsmbLibLcbL
sbRgbLsbsbLgbLsbLsbLsbLgbLgbLgbLgbLgbLgbLgbLsbLgbRsbLgbLsbLsbLgbLgbLgb
LgbLgLsbRsbRcbLcbRsbLibLibRgbRobRibRsbLsbRibRhbLcbLobRibLjbLibLsbLgbLs
bLgbLsbLgbLsbLsbLgbRcbRgbRgLsbRsbLsbRsbsbRgRsmbRibLjLsmbLeLsbLibRgbLsb
LgbLsbLgbLsbLgbLsbLsbLsbLibRibRcRsmbRjbRsbRsbsbsbRsbRsbLsbRibLsbLcbRib
RibRgbRgbLsbRgbRgbLsbRgLsbRgLsbLobLibRgLsbLibLsLsmbLgbLsbLsbLgbLgbRsbL
sbRsbLsbRjbsbRobRgbRgbRgbRgbRsbRibRgbRgbsbRgbRgbRgRsmbRsbRsbRgbLsbRgRs
mbLsbLcLsmbRgRsmbLibLgLsbLgbLgbLgbLiRsLsbRobRibLjbLhbRgbRibRgbRgbRgbRg
RsmbRgbRgbRsbRgbRsbRgbLjbLcbLgRsbLsbLgLsbLgbLsbLgbLgbLgbRobRhRsmbRgbRg
bLsbLsbRgRsmbLcbLhLsbRibRibRiRsmbLgbLjbLhbRjbRsLsLcbRsRsmbLsLgbLsbsbLg
bLsbLsbLgbLsbLgbLgbLsbLgbsbLgbRobRibRsbRgbRsRsmbRsbLsbRsRsmbRgRsmbRsRs
mbRsbRsbRsbRgbRgbRsbRgbsbsbRsRsmbLcbLiLsbRgbsbLgbLsbLsbLgbRjbRcLsLsmbL
cbLhbLgbRibLibLibLgLsbLgbRgRsmbLgLsbLgbLgbRhbRobLibRiRsmbRgbRsbRgRsmbL
sbLibLiLsbLgbLsbLgbsbLsbsbLsbLsbsbLsbLgLsbLsLsmbLgbRsbRobRgbsbRsbRsbRj
bLsbLjbLcbLgbRgRsmbLiRsbLsbLibLibRjbRcbRsbRsbRsbRsbRsbsbRjbRsbLjbLobRs
bLgbLibRsbLsbLgRsbLsbRsbLiLsbLgbLgbLibRgbLgbLgbLgbRgbLgbLgbLgLsbLgbRcb
RhbRgbsbRsbLsRsbRjRsmbRgbLebRibRsbRibLsbRgbRsbRgbLcbLibLgbLsbLgbLgLsbR
jbRjbRgbRiRsmbRsbRsbRgbRsRsmbRsbRgbLibLsbLsLsmbLsbLgLsbLsbLsbRsbLgbLgb
LsLsmbLgbRsbLgbLsbLgbLibRjbLcbLhLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 25; Drug: Control
bRibLgbRibRsbRgbLobRsbLsbLsbLiLsbLsbRsbLjbRsbLsbLsbLsbLgRsbLsbLsbLsLsm
bLgbLsbRjbLibRgbLibRsbsbRsbLsLsmbRjLsLsLimbRibRiLsRiLsLsmbRiRsmbRgbLjb
LibLjLsmbRjRsmbLcbLgbLibRsbLibRjbRsbLibLgbRibLibLibRgbLibRsbLsbLiRsbRg
bLiLsbRjbLhbLibLgbsbsbLsbLsbLibRsRsmbRgbLibLibRibRiRsmbRhbLsLjbLibLibL
gbLgbLsLsmbLsbRsbLibLgbRibLiLsbLsLsmbLsbLgbLgbLgbLsbLsbLsbLiRsbRsbLiRj
bRhbLcbLoRsRsRhmbRjbsbRiLsbRsbRiLsbRsbLobLhbRgbLhbRhbRibLjbLcbRsLibRjb
RcRsmbRgbLjbLcbLgbRjbRibLcbLhRsbRgbRsbLibRsbRjbRhbLjbLjLsmbLgbLsLsmbRs
RsmbLgbLgbLgLsbRobRibLgbLcbRibRjbRcbRebLhbLibRiRsmbRgbLgbRgbRsbRgbLgbL
cbLgbLibRgbLibRgbRcbLhbRibRgbRsLsLsmbRgbRgbLgbLcbLobRibRibLhbRjbRiRsmb
LjbLcbRjbLibLgbLsbLsbLsbLgbLgLsbRgbRjbRhbLjbRcbLjbLhLsbLgbLsLsRsmbRsLs
bLgRsbRgbLgbLibRjbRjbRgbLjbLcbLgbRjbLjbLsbLsbRgbLgbLsbLgbLgbRjbLibRsbL
gbLsbRsbLibRcbLcLsmbLhLsbRgbLibLsbLibRgbLibLgbLgbRsbLgRgbLgbLgbLsbLgbL
gLsbLgLgbLsRsbLgLsbRjbsbLibLjbRjbLibRjbLiLsbRibRcbRibRgbRgbLjRsbLcLsmb
RsbLcbRiLsbLsbLibRsbLibRibLiLsbLgbLsbRsbLibLgbLibRsbRsbLibLsbLibRgbLiL
sbRsbLgbLsbLibRgbsbLgbLsbLgbRsLsbLgbRgbLibLgbLsbLgbRsbLibRsbLibRcbRgRs
mbLsbRgbRsbRgbLjbLebRgRsmbLibLsbLgbLgbLsbLgLsbLsbLsbLibRibRibLjbLcbRgb
sbRjbRcbLibLiLsbLgbRibRsbRsbRsbRgbRsbRgbRsRsmbRsRsmbRsbRgbRgbLsRsbRgbL
sRsbRsbLsbRgbRibRcbLibLgbRibLcbRgbLcbLobLhbRibLsbRibLjbLcbRibRgbRgRsmb
RsbRsRsmbRgbRgbRsRsmbLsbLsbRibRgbLsbLjbRsbLcbLsLsmbLgbLsbLsbLsRsbLsbLi
bRibRjbRibLgbRibLgbRibRgbRsbRjbsbRsRsmbRgbRsbRgLsbRgbRibRgbLjbRibRibLi
bRibLjbRjbRibRibLgbLibLgbLhbRsbRsbRgbRibRibLsbLgbRgbRiLsbLjbRibLjbLibL
hbLgbRgbRsbRjbLcLobRibRjbRiRsmbRgbRsbRjbLsbLgbRjbLsRsbLgbRgRsLsmbRsbRg
bLsbsbRhbLhbRsbRgbRjbLibLcbLsbLsbLsbRibRiLgbsbRgbRsbLsbRsbRgRsmbRsbRgb
RsbRsbRgbRgbLsbLebLibRibLibLibRjbRcLsbLgbRibRgbLsRsbLebLgbLgbRgRsmbRcb
RibLjbRgbRgbLibLebLibRjbRcbLibLibLgbLgRsbRsbLsbLsbLsbLgbLgbLgbLgbLgbLg
RsRsLsRsmbRjbLobRgbRiLsbLibRcbLibRibLcLsmbRcRsmbRibRgRsmbRsbRibLhbLgbL
sRsbLgbLgbLsbRsbRsbRcbRibLebRcbLcbRcbLibRibLibLsbLibLsRsbLsbLgbLsbLgbL
sbRsbRcbLcbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 26; Drug: Control
bRcLsbRhbLibRibRsbRgbLsLsmbRgbRgbRgbRsLsbRgLsbLsbRgRsmbRsbRsbRgbRsbLsb
RsbRgbLsbRibLsbRgRsmbRsbRgbRgbRsbRsbLcbLibRgbLgbRjbRiRsmbRsbRgbLjbRgbR
ibLsbRibLjbRsLcbRgbLgbLsbRgbRcbRgRsmbRgbRsbRsbRgbRsbRsbRgbRgbRgbRgLsbL
jbLobRjRsmbRcbLgbLcbLibRjRgbLibLibRobRgbRsbRibLgbRgbRgbLsbRgbRgRsmbRgb
ReRsmbLjbRibRgbRsbRsbRgbRgbRgbRgbLgRsbRsbRgbRsbRsbRgbRsbRsbRibRsbRgbLg
bRgbRgbLcbLgbLgbLsbLsbLobLcbLcbRcRsmbRhbLgbRibLebLgLsbLgbLibRhLsbLhbRi
bLibRibRgRsmbLsbRibLgbRgLsbRgLsbRibLjbRibLgbLobsbLsbLsbsbLsbLgLsbLgbRs
bLgLsbLsRsbLgbLgLsbLgbLsLsmbLgbRsbRebRcbLgbRibLhbRhbLjbRcLsbRsLgRsbRib
RsbRgbRsbRsbRgbRsbRsbRsbLsLsmbRsbRsbRgbRgbRgbRsbRsbRgbRsbRsbRgbRgbRsbR
ibRibRibLsbRibLgbRibLsbRgbLsbRsbRgbLsbRsbRhbRsbLiRsbRibLgbRjbLgLsbRiLs
bLgbLcbLibRjbRibRibLsRsbRgbRgbRgbRgbRgbRgbRsbRsbRgbRsbRgbRsbLsbRgbRgbR
sbRsbRgbRgbRsbRgbRsLsbLsbRibLcbLgbLibRcbRhbLgLsbRgbRsbRsbRgbRibLsLsmbR
gbLhbLiLsbLibRcbRobLsbRibLgbRibRgbLgLsbRibLsbRgbLsbRgbRiLsbRcLsbLiLsbL
ibLsLsmbLibLgbLgRsbLgbLsbRjbRebRgbRgRsmbRgbRsbRsRsmbRgLsbRsbRsbLcbLibL
sbLgbLgbRjbRobRiLsRsbLhbLibLgbRsbLibRsbLgLsbLsbLsbLgbLsbLsbLsbLsbLgLsb
LgbLgRsbLgbLgbRibLgbLsbLibRgbLibRjbLibRjbLibRjbLobRobRcbRibLjbLobRhbRc
bRgbLjbRibLgbRgbRsRsLsmbRgbRsbRgbRgRsmbRsRsmbRsbRgbRibRsbRsbRsRsmbRsbR
sbRsRsmbRsbRsbRsbRsbRgbRsRsmbRsbRgbRgbRgbRsbRgLsbLcbLibLibRgbLibRibLob
RgbRcbLjbLibRsbLibLsbLibLgLsbLsbLsbLgbLgbLgLsbLsLsmbLgbLsbLgbRsbRjbLjb
LibLoLsmbRgbLibRsbRibRibLibRsbRiRsmbRgbRsbRsRsmbLsbRgbLgbRgRsmbRgbRsbR
sbLsbRgLsbRsbRgbRgLsbLcbLobRjbRcbLcbLcbRgbLcbRibLgbLcRsbRibRjbRsbLibLi
bLgbLsbLsbLgbRgbLcRsbRhbLibRsbLgbLsbLsbLgLsbLgbLsLsmbLsbLgbRjbRcbLjbRi
bRibLjLsmbRhbLibRcbLhbRibLjbRhbRiLsbLjbLcbLibLgbLsLsmbLsbLsbLsbLgbLgbR
sbLgbRsbLibRgbRcbRibRibLibRcbLjbRhbLsbRiLsRsbLjbRcbRibRsbLgbLibRibRgbR
sbRgLsbRsbRgbRsbLsbRgbRsbRsbLsbRgbRgbRsbRgbRgbRsRsmbRgbRgbRgbRgbLcbLcb
RibRjbRibRgbLgbRibRgbRibRgbRibLsbRgRsmbRgbRsbRsbRgbRgbRsbRgRsmbRgbRgbL
sbRgRsmbLjbLiLsbLgbLgbRjbRcbLgbRibRibRibLsbRgbRsbRsbRsbRgbRsbRsbRgbRsb
RsRsmbRgbRsbRsbRgbLjbRibLgbRiLsbLgbRgRsmbRsbRgbRgbRgbRsbRgbRsbRsLsbRgb
RgbRgRsmbRsbRsbRsbRgLsbRsbRsbRgbLjbRgbRsbLsbRsbRgbRibLsbRibLjbRibLjLsm
bLoRsLsbLsbLibLibRibLibLoRsbLiLsbLibLibLhLsbRiRsmbRsbLgbLcbLobRsbRibLg
bRgbLibRgbRcbLgbRibLsLsmbRgLsRsbRsbRgbRsbRgbRsRsmbRgbRsRsmbRsbLsbRsbRs
bRsbLibLibLibLhbLibLcbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 27; Drug: Control
bLjbRgbLgbLcbRhRsmbRiRsRsmmbRibRgbRibRgbLjbLsbRibRgbRsRsmbRgbRgbRsbLsL
smbRsLsbRsbRgbRsLsRsbLsRgbRgRsmbLsRiRsmbLsbLibRiRsmbRibLgLsbRgbRibLsbR
gbRsbRiRsmbLsbRgbRsRsmbLsbRsbLsbRgbLsRsbRgbLsbRgRsmbRsbRgbRgRsmbRgbLib
RibLsbRibLgbRibLgbRgbLsLsmbLcbLibLgbLibLcbRjbLibRobRsbRsbRgbRsbRsbRgLs
bLsRsbRsbLsbRgbLsbRibRsbRsbLsbRgbLsbRibRgbRsbRgbLgbRiRsmbLgbRiRsmbLsbR
gLsLsmbRsLsbRsbRgLsbLgLsbRsbRgbLsbLsbRgRsmbRgbRgbLjbRibRgbRsRsmbRsRsLs
mbRsRsmbRgbRgRsRsmmbRgbRibLgbLjbLcbLgbLgbLibRsbRcRsRsmmbRcbLgbRsbRgRsm
bRgbRsRsmbLsRsbRgbRsbLsbRsbRsbRsbRsbRgbRgRsmbLsbRgbLsRsLsbRgRsmbRsbRsb
RsbRgRsmbLsbRgbRgbRsbRgbRgbRgbLgbLebLibRgbLibRgLsbLsbLgLsRsbRsbLibLgbL
ibRsbLcbLibLibLgbRiRsmbRibRsRsmbRsRsmbRsbRgbLsbRgRsmbLgbRgRsmbLsbLjbsb
RcbLsbRjbRibLgbRibRgbLsbRgbRsbRsbRsbRsbRsbRgbRgbRiRsLsmbLibRibLiLsbLgb
LiRsbLibRgbLibRibRcbLcbRcRsmbRibRsbLjbRhbLjbLcbLibRsbLsbLgbLsbLgbRgRsm
bRcbRsbRgRsRsmmbLsbLsLsmbRsbRgbRgbRgRsmbRsbLgbRgbRsbRgbRsbLjLsmbLobLib
LgbLibLsLsmbRibRibRiRsmbRsRsmbLsbRsbLsbRsbRsbRgbRgbRsbRgbLsbRgRsLsmbLs
bRgRsmbLgbRgbRibRgbRgbLgRsbRgRsmbLsbRiRsmbRgbRgRsmbLsbRgbLgRsbRgbLsbRi
bLgbRgbRsbLsbRsbLsbRibRgbRgbLjbLcbLiLsbRsbLsbLgbLcbRgbLibLibLgbRsbLibL
ibRibLibLibRibRhbRgbLsbRibLsbRgbRsbRsbRsbRsbRgbRsbRgbRsRsmbRsbRsbRsbRs
bRgbLjRsbRgbLsbRgbRgbRsRsmbRsbLsbRiRsRsmmbLgbRibRibRgRsmbLhbLibRjbRcbR
sLsbLsbRgbLsbRibLsbRgbRsLsbRsbRgbRsbRsRsmbRgRsmbRsbRgbRsbLgbRiLsbLsRsb
RgRsmbLsbRibLgbRibRsbLsbRgbRsRsmbLsRsbRsbRgbRgbLsbRibLiRsbRhbLibRibRsb
RgbRsRsmbRsbRgbRgbLjbLcbLsbLibRsbLgbLhbLcbLiRsbLgbRhbRsbRibLgbRibLgbRi
bLsRsbRsbRgbRgbLsRsbRsbRsbRgbRgbLsbRgbRgbRibRgbLcbLcbRjbRjbRibLgbRibRi
bLsbRiRsmbRgbLsbRgbRsbRsbRsRsmbLsRsbRsbRsRsmbLsbRsRsmbRsLsRsbRsRsmbRsb
RgbRgbRgbLgbRiRsRsmmbRibLgbRiRsLsmbRgbLsbRibLsbRgRsmbRsbRgRsmbRsbRsbLc
LsmbLibLcbRebRcRsmbLsbRibRsbRibRgbLgbLgbLibLibRcbRobLibRhbRiRsmbLsRsbL
gbRibRibLgbRhbLgbRiRsmbRsbRsbRgbRibLgbRgbLsbRsbRgbRgbRsRsmbRsRsmbRgbRg
bRgbRibRiRsmbLsRsbRgbRsbLgbRibRgbRsbLsRsRsmbLsLsmbLcLsRsLgmbLgbLgRsbLo
RsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 28; Drug: Control
bRsbLgbLgLsbLsbLiRsbRjRoLsbLsRsbRibRsbRgbRsRsmbRgbRgRsmbRgbLsbLjbLobLg
bLgRsbLgbLhbRjbRhRsmbRgRsmbRgbLgbLcbLhbRcbRibRsbRgbRsbRsbRsbRgbRsbLsbR
gbRgbRsbRsRsmbRgbRgbRsRsmbRgbRgRsmbRgbRgbRgbRsbRsRsmbLsbRgbLsbRiRsmbLg
bRibRsRsmbRgbRsRsmbRgbRgRsmbRsbRgbRsbRgbRgLsbLgbRibLjbLcbLcbRgbRjbLibL
sbLibRjbRcbRibRsbLibLcbLhbRibRjbRcbLsbRibRsbRsbsbRsbRsbRsbRsbRsbLsbRgb
RgbRsbLibRcRsmbLibRibRgbRsRsmbRsbRgRsmbRgbRgbRgbRgRsmbRsRsLsmbLsbRgbRg
bRgbRgbLjbRibLjbRhbLjbRhbLsbLsbRibRgbRsbRgLsbLgbLcbRcbRsbRgbLgbLgLsbRs
bRobRsRsmbLjbRcbRsbRsRsmbRgRsmbRgbRgRgbRgbRgbRgbLsbLsbRiRsLsmbRibLsbRs
bLcbLsLsmbLgRsbRsRsmbLibRibRcbRibLsbRgbRgRsmbRsbRgbLgbRcbRsbLgbLjbLjbR
cbRcLsbLsbRgbRgbLjbLcbRgbLcbRiRsmbRobRsbRsRsmbRgbRsbRgbRgbRsbRgbRsbRgb
RgbRgRsmbRgRsmbRgRsmbRgbRgbRgbRgbRgbRgbRsbLgbLjbRcbLjbLsbLcbLsbsbRebRg
bLibRibLjbLsbLcbRcbRsbLgbRgbRsbRibRsbRsbRjbLjbLeLsbRcbRiLsRsbRgbLsRsbR
ibLgbRibLsRsbRgbLgbsbLcbLibRgbLibLgbLsbLjbRibRcbRgbRsbLgRsbRibLiRsbRsb
LibLeLsRsbRhbRcbRgbRsbLsRibRsRsmbLsbRgbRgbLgbRcRsmbLgbLsbRibRgbRsRsmbR
gbRgbRgbRgbRgbRsbRsRsmbRgbRgbLjbRibLgbRibLgbRgbRgbLgbLcLsmbLjbRhLsbLsb
RibLsRsbRgbLjbLibRsbRjbRcbRiRsLsmbLgbRibRiLsRsbLsbLibRcbLibRcbRhbLgbRg
bLsbRsbRcbLibRibRgbLsbRibRibLgbLibRcRsmbLibLcLsmbLibRjRsmbRcbRgRsmbRsb
RgbRgbRgbRsbRsbRgbRgbLibRhbLibRcRsmbLgbRhbLiRsbRhRsLsRsmbRcbRsRsmbRgbL
ibRsbLsbLgbLgbLhbRibRgbLhbLsbLgbLsbLibLcbRibRibLibRgbLcbRgbLhbRgbLibLg
bRcRsmbRgRsmbRsbRgLsbRsbRsbRsbRgbRsbRsRsmbRsRsmbRgbRsbRsRsmbRsbRsbRgbL
sbRgbRgbRgbLcbLiRsbRgbRibRibRsbRgbRsbLgRsRsLsmbRsbRsRsmbRgbRgbLsRgbRgb
RgLsbRgbLgbRgbRgbRgbRgbLsbRgbRgbRgbLgbRibRgbLibLcbLjLsRsmbRgbLsLgbRcbR
ibRsbRsbRgRsmbRsLsbRgbRsRsmbRgbRgbRsbRsbRsbRgRsmbLgbRgRsmbRsRsmbRgbLjb
LgbRsbRgbRgbRsbRgbRsbRgbRgbLgbRibLgbRiRsmbLsbLibRsbRgbRgRsmbRgbRgbRgbR
gbRsbRgbRgbLsbRgbRgRsmbRgbRgbLsRgbRsbLsRjbLcbRcbRobLibRcbLibRibRsbRsbR
gbRgbRgbRsbRgbRgbRgRsmbRgbRgbRsRsmbRgbRsbRjbLsbLgbRgbRgbRgRsmbRgRsmbRg
bRsbRsbRgbRgbRgbRgbLsbsbRgRsmbRgbRgbRgbRgbLjbRhbLibRiRsmbRsbRgbRgRibRs
bRsbRgbRgbRgRsmbRgbRgRsmbRgbRgbLgRsbRiLsbLgbRibLgbLeLsbLiLsbRcRsmbRhRs
mbRsbRibRsRsmbRgbRgbRgbRsLsbRgRsmbRsbRgbRgbRgRsmbRgLsRsRsmbRgRsmbLsLsR
smbRhbLibsbRsbRjbRcbRsbLsRibLsbRgbRgRsmbRgbLsbRibLgRsbRibRgbRgbRgbRgbR
sRsmbRgbRgbLjbLsbRgRsmbLjbLobRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 29; Drug: Control
bRiRsmbLhbLibRgbLgLsbLgbLgbLgbRgbRibLhbLiRsbRibLibRsbLgbRgbLgbLgRsLsbR
gbLgbLgbLhRsbRjbRsRsmbLiRsbLsbLibLsbLiLsbRjRsmbLcbRiLsbRcbsbRoLsbLibLc
bLhbRhbLcbRibLibLsbLgbLsbLgbLsLsmbLsbLgRsbRgbLibLgbLgbLgbRjbLgbLgbRiRs
mbRibLjbLsLhbRibLoRibLibLiRsbLibRibRhbLjLjbLibRsbLgbLgbLgbLsbLgRsbLsbL
sbLgbLgbLsbLgbRcbRcLsRsbLibRibLsbRhbLiLsbLhbRhbRhbRibLibLcbLibLiRsbRib
LiLsbRjbLibLgbRsbLibLsLsLsmmbLibRsbLgbLiRsbRjbRcbRibLsbRgbLsbRsbLjbLjb
LhbRcbRsRibLcbRhbRsRsmbRibLjbLcbLibRjbLjbLibLgbRsbLsbLgbLgbLgbLgbLsbLg
bLgRsbLgbLsbLsbLgbRgbLgbRgbRcRsmbRibLjbLcbRjRsmbRhbLjLsLcmbRibLibLgbRs
bLsLsmbLsbLgbLsbLsbLgbLsLsmbLgbLgbLgbLgbLgbLgbLgbRgbLgbLgLsbLgbLsLsmbL
gbLgbRsbLibRjbRibRiRsmbRgbLgbRgbRgbRgbLgLsbLjbLibRjbRibLhbRiRgLsRsbRiL
sbLiRsRsLombRhRsmbRhLsbLibLhLsRsLibLoRibLibRsbLibLgbLsbLgbLsbRsbLgbLgb
RsLsbLgbLgLsbLgbLgbLgbLgbLibLsbLgbLgbLsbLsbLgbLgbLgbRjbRcbRgbRibRibLsb
LibLhbLcbRgbLibLibRsbRibLcbRjbRcbRcbLgbRsbRgbLhbLibLibRhbLibLgbLgbLsbL
sbLgbLsbLibLgRsbLibRjbLsLibRgbLibRjbLibRgbLibLgbLsbLgRsbLgbLgbLgbLgLsb
RjbRjbLibLhbReRsRimbLcbLcbRcbLibLgbLgbLgLsbLgbLgbLsbLgbLgbLibLgbLgLsbL
sbRsbRjbRcLsbLibLibLhbRibLjbLiRsbLsbLgbLgLsbLibRibRsbLibLhbLibRibRcbLg
bLjbLibLgbLsbLgbLgLsbLgbLgbLsLsmbLgbLibLsbLhbRibLibRjbLhbLsLsmbLibLibL
gbLhbRibLhbRgLsbLhbRibRsbRcbRgbRgRsmbRgRsmbRiLsbLibLcbLibLgbRgbLgLsbLg
bLsbLibLgbLsbLsLsmbLgbLgbLgbRgbLibLgRsbLgLsLsmbLgLsbLgbRsbLsbLibRgbRjb
RibRhbRcbRibLibRcbLhLhbLiLsbRibLibLgbLsbLgbLsbLsbLsbLgbLsbLsbLsbLgbRcb
RibRcbRcbRcbLgbRcbLjbRibRjLsbLcbLcbRjbLhbLibLsbRibLgbLibLhbRiRsmbRibLg
bLibLgbRsbLgbLibLibRgbLgbLgbLgbRjbRcbRiLsbLjbLhbLcbRhRsmbLcbRjbLcbLobR
ibLgbLibLiRsbRgbLibLsbLgbLgbRsRsmbLgbLgbLgbLsbLsLsmbLsbLsbRsbLgbLgbRcb
LcLsmbRibRhbRgbRibLgbLjLsmbLibLiRsbRgbLibLibRsRsmbRibLcbRibRcbLhRsbRhb
RhbLibLgbRcbLjbLcbLcbRgbLsLsmbLgbRgbLgbLsbLsbLiLsbLsLsmbRsbRsbLgbLgbLg
LsbRsLsbLgbLgbLgbLgLsbLsbLgbLsbLibLsbLgbLgbLgbLgbLgbRibLibLgbLsbRsbLgb
LibRjLsbLibLgRsbLgbRsbLgbLgbRgbLgbLgbLgbRjbRibRibLgRgRibRsLoLsmbLobRgb
LgbLibLjRsbRgbLibLgbRgbLibLsbLgbRjbLibLgRsbRsRsmbLibLgbLibRjbRcbLcbLob
LsbRibLgbLibLsbLgbLsbLgbRjbLcbRibLcbLsLsLimbRgbLibLsbLgbLibRgbLibLgbRg
bLibRjbLiLsbRsbLibRjbRcbRibLgbLcbLibLgbLgbLgbRsbRjbRgbRgbLibLibRhbLibL
ibLibRjbRcbRcRsmbLibRcbRibLhbLgLsbRiRiLsRsbRibLjbLcbRjbLiLsbLsbLgLsbRs
bLgbLgbLhbRibLibRibLcRsbRgbLibLgbRsbLgbLsbLgbLgLsbRgLsbRjLsbRibRgbRgbR
gbRgRsmbRgbRsbRsbRsbRsbRsRsmbRgbLcbLibLgbLsbLibRibLibLgbLsbLibRiRsmbLi
bRjbRhRsRgRimbLjbRhbRcRcbLiLsLsLsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 30; Drug: Control
bLgbLsbLsbLsbLgbLsbLsbLgLsLsmbLgbLsbLgbLsbLgLsbLsbLsbLgbLgbLsbLgbRjbRi
bRsbLhbLibLgLsbRgbLcbRcbLcbRibLsbLhbRgbLgbLsbRsLsbLsbLsbLgRsbLiLsbLsbL
gbLgbLibLsbLgbLsbLsRsbLibRcbRcbLibLcbLibLibRibLcbRibLhbRgbLgbLgLsbLsbL
gbRsbLgLsbLgbRcbRcbLgbRgRsmbRgbRsbRsbRiLsbLibLcbLgbLgbRsbLgbLgbLsbLgbL
sbRjbRibLebRgbLhRibLibLsbLsbLgLsbLgbRsbLgbLgbLgbRjbLibLibRcbRcLibLibLi
LsbRgbLgbLsbLgbLgLsbLsbLsbLibLgbLgbLgbLsbLgbLsbLgbLgbLgbLiLsbLgbRjbRcb
LcbRobLcbRcbRsRsmbRgbRgbRsbRcbLiRsbRgbLjbLiRsbRsbLgbLsbLsbLibLgLsbLsbR
jbLcbRjbRcbLjbLcRsbLgbRjbLibLgbLsbLgbLgbLgbLgbRgbLgbLsbLgbRjbLibRgbLib
RsbLgbLgLsbLsLsmbLgLsbLsbRsbLgbLsbLgbLgbLgbRsbLibRsbLibRgbLibRgLsbLgbR
sLgbLgbLsbLsbLgRsbLsbLgbLsbLgbLgLsbLsbLgbLgbRjbRcbRsbLjbRjLsbLcbLibRib
LhLsbRjbRibRsbLobLgRsbLgbLgbRjbRhbLcbRebLobRibLibLsRgRsmbLsLgbLgbLsbRo
bRhbLjLsmbLhRsbLsLsmbLsRsbLsLgLsLgbLgbLiLsbRcbLobRibLgbLgbLsbLgbRgbLib
RsbLgbLsbLsbsbLgbLiRsbRebLcbRjbLcbRibLibLgbRsbLgbLgbRsbLgLsbLgbLsbLgbL
gLsLsmbLgbLgbLsLsmbLsLjbRcbRhRsmbLjbLcbRobRibRebLgbLgbRjbLgbLsLsmbLgbL
sLsLsRsmmbLgbLsbRsRsmbRhbLgbLjbRcbLgRsbLibRcbRcbLgbRobLsbRebLibLgbLgLs
bLgbRsbLgbRgbLgLsbLgLsbLgLsbLgLsbLgbLgbLsRsbLjbRsbRcbRibLgbRibLcbLgLsb
LibLgbRsRsmbLgbRsbLgLsbRgbLiLsbRsbLgLsLsmbLgbLsbLgbLgbRsbLibRsbLiLsbRs
bLgbRibLgbLgLsbLjbRcbLcbRobLcbLjbLgLsbLgLsLsmbLibLgbLsbLgLsLsmbRsbRibR
jbLjbRcbLjLsmbLibLsbLsbLgbLgbLgbRsRsmbLjbRoRsmbLcbLgLsbLgbLgbLgLsbLsbL
sbLgLsbLgbRcbRebLhbLcbRjbLibRgbLgbLgbRgbLibRhbRebLcbRjbLhLsbLgbLsbLgbL
gbLgRsbLgLsbLgLsRsbLgLsbLgbLsbRcbRibLgbLjbLgRsbLsbLgbLgRsbLgRsbLgbLgbL
jbLibRjbLibLgbRgbLgbLsbLjbLgbRjbLibRsbLgbLsbLgLsbRsRsLsmbLibLgbLsbRjbL
sbRjbRgbLobRsLsbLgLsLsmbLgbLsbLsLsmbLsLsmbRsLsbLsRsLsbLibLsLsmbRsbLibL
gbLgbLibRjbLiLsbRibLibLgbRgbLgbLsLsmbLgbLsbLgbLsbLgLsbLgbLgbRsbLgLsbLg
bRsbLjbLsbLsLsmbLsbRsbLsbRcbRgbRgbRobRsbLiLsbLibRgbLcbRgbLcbLhbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 31; Drug: NDMC 1 µM
bRhbRsbRibLjbRhbLjbRhRsmbRibRhbLibLsbLsbLsbLgbLsbLibRhbRcbRibRibRsbRsb
RsbRibRsbRibLibRcbRsbLgbRibRgbLsbRiLsbRibRgbLibRgbRiLsbRibLjbLobRsbLib
RsbLebLcbLcbLsRsbLsbLiLsbRsbLcbLjbLcbRhbRibLcbRebLcbLcLsmbRsbRibLhLsbR
jbRcbRhbRibRgbLhbRibLibLcLsmbRsbRgbRibLibRcbRiRsmbLjbRhbLibRibRibLgbRi
bRibRsLgbRiRsmbRgbLsbRsbRsbRsRsmbRsbRgLsbRibRsbLibLibRebRcbRiRsmbLibLj
bRibRgbRgbRgbRgLsbLsbRiRsmbLsbRibLjbsbRibLgbRiRsmbRgbRgbLgbRibRgbRgbLi
bLsbRjbRgbRgbLjbRibRgLsbLsbRibRibLsbRibLsbRibRsbRiRsmbRgLsRsbLsbRsRgLs
bRsbRgbRgbRgbLsbRibLgbRibLsbRibLjbLcbLgbRgbRjbRibLhbLobRiRsmbLgRsbLhLs
bLsLsmbLgLsbLsbLiLsbRebRgbRibRgbRibRgbLjbRgbLsbRiLsRsbLsbRibLgbRiLsbRg
bLsLsmbRibLgbRibLibLcbLgbLsbLgLsbLsbLibRibRibRibRibLsbLebLibRgbLcLsmbR
ibLibLiLsbRibLibRgbLibRgbLhbRibLibRgbLiLsbRgbLgbLgbRgbLibRgbLiLsbRsbLs
bLgbRgbLhbRibLeRsLsbRgbLibLsbLgbLgbLgbRjbLhLsbRibLiLsbRsbLibRgbLhbRgbL
iLsbLsbLsbLgbLibLibLibRjbLcbRjbLhLsbRgbLhbRgbLibRgbLibRsbLibRgbLiLsbRs
bLibRjbLibLsLsmbLsbLgbLgbLsbLgbRibLiLsbLibRjbLibRsbLibRgbLiLsbRsbLiLsb
LsbLibRgbLibRgRsmbLgLsbLgbLgbLgbRgbLibLibRgbLcbRgLsbRgbLiRsbRgbLhbRsbL
sbLiLsbRgbRjbRibRibLsLsmbLsLsmbRiRsmbLjbsbRibRgbLsbRgbLgbRgbRgbLsbRiLs
bLgbRjbRsbRgLsbRsbRgbRibRgbLibLhLsbLibRoRcRsmbLebRcbLgLsbRcbLsLibRhbRi
bRobLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 32; Drug: NDMC 1 µM
bLibRhbLiLsbLgbRiRsmbRcbRcRsmbLibRebLjbRjbRjRsmbRhbLgLsbRobRobsbRibLsb
RhbLjLsLsmmbLgLsbRhbRibLgLsbRcbLsbRibRhbRgbRsRsRsmmbRgbRibRcbRibRjbRjb
RjbLsLsmbRgbRobRob

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 33; Drug: NDMC 1 µM
bsbRsbRsbRsRsmbRgbRgLsbRgLsbRgbRsRsRsmmbRsbRgbRsbRsbRgbRsLsbRgRsmbRsbR
sbsbRgbRsbRsbRgbRgbRgbLsRsbRgRsmbLcbLgbsbRjbLgbLgbLibRcbRhbLgbRiRsmbLs
bLsbRgbRgbLjLsmbLcbLgbRjbLhbRgbRibLjbRibsbRiRsmbLsbLsbRgRsmbRsbRsbRgbR
gRsmbRgbLjbRgbRgbRsbRgbLgbLsbRgRsmbRgbLgRsbLgbLcbLgLsbLibRcbLjbLibRcbL
cbLcRsbRibRhbLjbLcbLibRcbLibRcbRjbsbRgRsmbRsbRsbRsRsmbRgbRsbRsbRgbRgbR
gbLhbRiRsmbRiRsmbRibLgbRibLjbLcbLgbRsbLibRjbRsLcbRibRiRsmbLjbLibRcbRib
LsbRibRsRsmbRibLgLsbLsLsRhmbRsbLgbRcbLgbRcLsbLibLcbRgRsmbLjbLibLibLibR
hbLibRcbRjRsmbLjbLibLcRsbRcbLcbLcbRiRsmbRsbRgRsmbLhbLhbRibLiRsbLgbLiRs
bLsRsbRibLibRsbRgRsmbRibRgbLsbRgRsLsmbLhbRjbRibLjbLiRsbLgRsbRjbLcbLibL
gbLgbLsbLgbLgbRjbRibRgbLgbRsbRibLibRibLsLsmbRgbLsbLsbLcRsbLgbRgbLsbRgb
RgbLgLsbLhLsbLgbRcRsRsmmbRgRsmbRgbRibRgbRgbRsRsmbLgbLibRibRibLhbLgbLgb
LgRsbRsbLsbLgbLgRsbRsbLgRsbRsbRibRgRsmbRsbRgbLsbRgbRsbRgbLsbRsbRsbLsbR
sbRgbRgRsmbRgbRsbRgbRgbLjbRgbLjbLcRsbRibRcbLgbLjbLjbRjbRhbLsbRgbRgbRgb
LjbLjLsmbLibLibLgbRibLgbRcbLjbLibLgbLgbLgbLsbLsbLsbRjbRgbRibLgRsbRgbLs
RsRsmbRsbRsbRsbRsbRsbRgbLsbRgRsmbRsbRsbRgbRgbRgbRgbLjbLibLgbsbLibRhbLj
bRcRsmbLjbRibRibRgRsmbLsRsbLsRsRsmbRsbRsbRsRsmbRsbRgRsmbRsRsRsmmbRsbRg
bLsbRgRsmbRsbRgbLsLsRsmbRsbRgRsmbRsbRgbRgbRsRsRgRsRgRsmmmbRsRgbRgRsmbR
sbRsRsmbRsbRgRsRsmmbRsRsmbRgbRgbRgbLsRsRsmbLsbRiRsmbLjbLsbRibLgbRsbRgb
LsbRsRsmbRgbRgRsLsmbRgbRsLsbRgbLcbLibLgbLsLsmbRcbLcbLibLgbRcbLjbLibRcR
smbRibLibRibRgbRsbLsbRgbRsbRgbRsRsmbRsbRsbRgbRsRsRsmmbRsbRgbRsbRsbRsbR
gRsmbRsRsRsmmbLsRsbRgbRgRsmbRgbRgRsLsmbRgRsLsRsmbRgRsmbRgRgbRsbRgLsbRs
bRgbRgLsLgbLjbLcbRcbLobLiRsbRcRsmbRibLcRsbLibLcRsbLibLhbRiRsmbLgbRibLj
bRibRibLibRsbRibLgbRhbLgbRsbRgbRsbRgbRsRsmbRgbRsbRgRsmbRsbLsRgbRgbRgbR
sbRgbRsLsbRsbRsbRsRsmbRsbRgRsmbRgbLjbsbRibLibLiRsRsmbsbRoRsmbRgbLgbRgb
RgbLsRsbRjRsmbLgbRibLjbLobLgbLgRsbRibLcbRcbRcLsbRibRgbRibLibRjRsmbLgbL
gbRibRcbLibLhbRcbRibLjbRcbRibLgRsbLgbRibLibLjbRibRiRsmbRibLsbRgbRsbRsb
RgbLsbLsRsbRgbRsbLsLsmbRgbLjbRibLgbRgbRgRsmbsbLsbRsRsmbRsRsmbRsbRsbRsR
gbRgbRgbRgbLjbRhbRsbRgbRgRsmbLsbRgRsmbLsbRsbRgLsbRibLjbRsLjbLibRobRgbL
jbRcbLiRsbRgRgRobRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 34; Drug: NDMC 1 µM
bLgRsRsmbRsbLibLibLgbLgbLgbLgbRjbRgbRibRibRcbRibLibLgbLsRsbLibLgbRhbRg
bLjLsmbRsbLsbLgbLsbLgbRsbRsRsmbLgbLsbLgbLsbLgLsbRgbRgbLhbRjbRibRsbRsbR
gbLcbLsbLgbLsRsbLsbLsbLsbLgbLgLgbRsbLgbLgLsbRsbLgbLgbLsLsmbLgbRsbRsbLg
bLibRjbRjbLibLgbLgbLsbRsRsmbRjbLibLgbLsbLsbLgbLgLsRsbLsbLsbLsbLgbRsbLg
bLgbRjbLgbLibLsbLsbLgbRjbLsRgbLcbLhbRibLhbLsbRsbLsbLgbLgbRsRsmbLgbLsbL
sbRsbLgbLsbLgbLgbLgbLsbLgbLgLsbLsbLgbLsbLgbRjbRjbLjbRjbLibLgbLgbLgbLsb
RgbLgbLsbLgbLibLgbLsbRsbLgbRsbLgbRsbLgbLsbRsbRsbRsLsbLibRjbRjbRgbLcbRj
bLibLsbLgbRsbLgbRsbLgbLgbLsbLgbLsbRsbLsLibRsbLsbLsbLsLsmbLibRiLsbLcbRj
bLgbLsLgbLgbLsbLsLsmbLgLsbLsbLgbLsbRiLsbRcbLcbRcbRibLebLibLibLsbRjbLib
LcbRgRsmbLgbLibRgbRgbRjbLcbLcbRhbsbLgbRcbLobLsbLsbLsbLsbLgbLgbRjLsbLgb
LsbLgbLgLsbRsbLgbLsbLgbRgbLiLsbRgbLsbRsbLgRsbLsbLgLsbLsbLsbLgbLsbLgbLg
bRsLsbLgbLjRsbRcbRiRsmbLcLsmbRjbRcbLiRibLibLgbLsbLoLsLsRsLsmmbRgbLgbRi
bLibLibRjbLcLsmbRibLhbRjbLgbRsbLgbRgbLjbRgbLgLsbRsRsmbLgLsbLgbLsbRsLgb
LgbRsbLjbRobRcbLcbLibLgbLgbRsbLgbRibRibRiRsmbLobLcbRgbLgLsbRgbLjbLcbRi
RsmbRsbRgbLsLiRsbLiLsbLjbRjbRebRibRcbLhbLcbRjbRhbRgbLcbLhbRjbLjbLgbRjb
RjRsmbRgbRsbLsbLjbRgbRjbRjbLjbLgbLgbLsLsmbLgbLsbLgbLsbRjbRjbLjLsmbRcbL
cLsmbLhbLgbLsbLgLsbRsbLsbLgbLsbLgbRsbLsbLgbLsLgbLsbRsbLgbRsbLgbRsbRgbR
jbLibLsbLsbLgbLibRhbRibLjLsmbLsRhbRjbLcbRjbRcbLobLsbLgbLsbLsbLgLsbLibR
obRcbLgbLcRsbLhbRhbRsLibsbsbRcbLcLsmbLcbRgbRjbRgbLsbLjbLgbLiLsbRsbLgLs
bLibLibLgbRsbLgbLgRsbLgbLsbLgbLgLsbLsbRsbLgbLsbLsbLgbLgLsbLsLsmbLgbLsb
LgLsbLgbLgbRjRsmbLgbLsbLgbRsbLgLsbRgbLsbRjbLcbRgbRsbLibLgbLgLsbRsbLsbL
gLsbRsLsbLgLsbRsbRgbLgbLgbLgbLgbRsbRsbLgbLgRsbRsbLgbLsbLgbLsbLsbLgbLjb
LgbLsLsmbRsbLibLgbLgbLgbLgbLgbLsbLgRsbLgbRsRsmbLgbRsbLgLsbRsbLsbLgbLgb
LgbRsbLibRgbLcLcbRcbRgRsmbLgbLgbRiRsmbRibRgLsbLcbRhbRgRsmbLgbLjbRsbLgb
LgbRjbRcbLjbRgbLjbLgbLgbLsbRsbLsbLiLsLgLsLgRsbRsbLgbLsbLibLsbLgbRsbLsb
RsbLsbLgbLsbLgLsbLsbLgbRsbLgRsbLsbLsbLgLsbLgbLsbLgLsbRgbLhbLgbLgbLsbLg
bRsbLgbRebLcbLibRhbLjbRjbLcbLibRsbLsbLgbRsbLsbLgRsbLsbRsbRgbRsLcbRiRsm
bRgbRgbLcbLjbLgLsbLsbLgbLibLgbLgLsbLsbLjRsbLhbLjbLibLgbLgbLgbLibRjbRsL
cLoRsbRsbLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 35; Drug: NDMC 1 µM
bRhbLcLsmbLcbLibRgRsmbLibRhbLibLibLgRsbLgRsbLgbRgRsmbRjRsmbLjbLcbRjbLh
bRibRcbRcbLibRibLhbLobLibRgbRibLoLsmbLibRgbLsbLibRibLiLsbLibLsbLibLgbR
obRjbRebRobRoLsbRcbRhbRcbLibRibLgbRibLjbLcRsbRjbRobLgbRiRsmbRgbRsbRgbR
gbRsbRibRibLgbRgbLibRcbRsbLibLibRobLibRibLibLcbRsbRiRsmbRibRgbLsbRsRsm
bRgRsmbRgbRgRsRgRsmmbRgbRsbRsbRsbRibRibLibRcbLibRibLjbLoRsbLibLgbRgbLg
LsbLibRobRcbRgbRgbRibLibLiLsbLhbRibLibLsbLgbLibLgbLgbRibRgbRiRsmbLgbRs
bRgbRgbRsRsmbRsbRsRsmbRgbRgbRgbRgbRgbRcbLcbLobRsLiRsLsbLcbLcbRsbLjbRcb
RhbLiRsbRhbLgbRhbRibLjbRibLibRibRgRsmbRsbRsbRsbRgbRgbRgbRibLibRhbRibLi
bRibLgbRibRgbRgbRsRsmbRgbRgLsbRgbRgbRgbRsbRiLsbLgbLibLiLsbLgRsbLgbLoRs
bLcLsmbLiLsbRsbRibRsbRgbLsbRibRgbLibLjbLjbLgbLsbLgbLsbRcRsmbRibLibRgbR
sbRsbRsRsmbRsRgbRgbRsbRibRgbRsbRgbRgRsmbRibLjbLcbRjRsmbRobLiLsbRgRsmbL
sbRgRsmbRgbRsbRgRgRgRibRgRsmbRgRsmbRgRsmbRibRgbLsRsbRgRsmbRgRsmbRgRgbR
gbRgbRibRibLgbRiRsmbLibRhbLibRibRsRsmbRgRsmbRgRsmbRsbRgbRgLsbRgbRiRsmb
RibRsbLjbRibRiRsmbLjbLcLsmbRjbRcbLgRsbRibRgRsmbLsbRibRgbRsbRgRgRgbRgbL
gbRibRiRsRsmmbLiRsbRibLjbRsRjbRoLsbRobRcbRgRsmbLsbLgbRcbLibRcbLjbRiRsm
bLsbRibRgbRgRsmbRsbRiRsRsmmbRsRgRsmbRgbRgbRgbRgbRibLcbLobRjbRcbLjbRcbR
sbLiRsbLcLsmbLiRsbRibLobLibLibLibRgRsmbRibRgbLsbRibRgRsmbLgbRsRsmbRsbR
gbRgbRgRsmbRgLsRsRgbRsbRibRgbLibRcbRhbLhbRibRgbRsRsmbRibLjbLcRsbLsRjbL
ibLsbLgbLibLibRibLibLibLcbRibRobRgbRgbLgLsbRjbRibLjbRibRsbLjbLobLsRsbR
gbLgbRhbLiLsbsbLibLobLcbLsLsmbLhLsbLgbLsbRsbLibRgbLibRibLjbLsbLsbLibRg
bLgbLgbRsbLibLgLsbRgbLjbRgbLsLibRcRsmbRgbLgbRibLcLsmbRgbLjbLgbLgbLgbRs
LsbLiLsbLsbRsbLgbsbLgbLsbLjbRgbRgbRiLsbLgbRibLgbRhbLibRibRgbRsbLjbLoRs
bRsbLiLsbLibLgLsbLgbRsbLgbLjbRibRcbLgbRibRsbRsbRsbRgbLgbRjbLgbLcLsmbRj
bRsbRebLsbLiRsbRjbLcbRibLcbRiRsmbRebRgLsbRjRsmbRgbRgLsbLgbRibRjbLsbLgb
RjbRsbLobLcbRgLsbRgbRibRsbRsbRsbRsbRsbRgbLsRsbsbLjRsLcbLibRsRsmbLgbLsb
LsbRsbLgbLgbRsbLgbRsbLsbLiLsbLsbLsbLgbLsbLgLsbLibRsbLgbLsbRhbLjLsmbLib
LgLsRsbLsbLgbLsbLgLsbRjbLiLsbRgbLibRjbLibLgbLsbLsbLsbLgRsbRgbRcbLjbRib
RgbRsbLsbRibLjbRhbLcbLcbLibRgRsmbRjbRibRhbLcbLcLsmbLobRgbRgbLibRjbRcbL
jbRcbLibRgRsmbRgbRgLsbLgbRibRgbRsbRsbLoLsRgmbLibRjbRcbRgbLjbRobRjbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 36; Drug: NDMC 1 µM
bLgbLibsbRiRsmbLibRobRcbLhbLsbsbsbLsRsbRcbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 37; Drug: NDMC 3 µM
bLjbRibRsRsmbRgRsmbRsLsRsbRibLgbRibLsbRibLjbLibLibLibRiLsbRjbRebRcbLib
RibRibRsbRsbRgbLjbRibLgLsbRibRsbRsbRibRgbLgbRiRsmbRibRibLgbRibRsbRiRsm
bRsRsmbRsbRsbRsRsmbRgbRgbRgbRsbLoRsbLgbLjLibRcbLobLibRibLcbLobRibRsRsL
smbRgbRsbRgbsbRhbRcbLsbLibRcbRibRgbRgbLibRhbLsbRibRgbRgbLibRgbRibRgLsb
LgbRibLsRgRsmbLsbRiRsmbLsLsmbRgbRsbRgbRgbLgRsbRibRgRsRsmmbLgbRibRgbRib
LibRibRibLgbLcbRgbLcbRibLcbRibLcbRgbLibRjbRcbRiRsmbRibLjLsmbLhLsbLhbRg
RsmbLibRsbRgbLhbLcLsmbRgbLgbRgLsbRgbRgbLjbLcbLhRsbRjRsmbLiLsbLibRjbRcb
RhbRiRsmbLibRibLsbLgbRibRgbRiLsbRiRsmbLgbRiRsmbLgbLsbRcRsmbRsbRsbLsbRg
bRgbRsbRibRgRsmbRgbRibLgbLgbLhbLgbLsbRcbRgRsmbRsbLsbRsbRgbRsbRgbRgbRsb
RgbLsbLsbRgRsmbRsRsmbRsbLsbRgRsmbRibLjbRcLsbLcbRibRgbRsRsmbRsbRsbRgbRg
RsmbLsbRgbRgbRsbRgbLgbRiRsmbRiRsmbLjbRcbLhbRcbRsRcbLibLhbLsbRibRcbRibL
hbRcLsbRsbRibLgbRibLsbRgbRsbRsbLsbRiRsmbLjbLobLcbLcbRibRsbRcbLibRsbRib
RsbRgRsmbRsbRsbRibLgbRibRsbRgbLgbRibLjRsbRgbRgRsRgmbRgbRgbLjbLcbRsbRcb
RgbRibRsRsmbRgbRsbRgRsmbLsbRibLgbRgbRsbLsbRibRsbRsRsmbRgbRgbRibLcbLiLc
RsbRhbRhbRgRsmbLsbRibRibLibRibRsbRgbRsbRsbRgRsmbRgbRgRsmbRsbRgbLgbRgRs
mbRsRsmbRgRsmbRsbRsbRibRgbLsbRsbRgbLsbRibLcbLibRibRhbRgbRiRsmbLgbRibRs
bRsbRsbRgbRsbRgbLsbRibLgbRiRsmbRsbRgbLsbRibLgbRiRsmbLcbRcbRhbLgbRgRsmb
LgLsbLiLsbLibRsbRgbRhbRibLgbRhbLibRhRsmbRiRsRsmmbLhbRibRsbRsbRgbRgbRsR
gbRgbLcbLhbRhbRcRsmbRibLibLgbRibRibLsRsbRibLgLsbRiRsmbLsbRiRsmbRsbRgbL
gbLsRibLjbRibRsbRgRsmbRgbLgbRiRsmbLgbRcbLhbRibLgbRibLgbRiRsmbLgbRibLsb
RibRsbLsbRgbRibRgbLsbRhbLsbRcbRsRsmbLibRibLibLcbRiLsbLcbRibLsRsbLibRgb
LgbLgbLsbRibRcbRibLibRcbLgbLgLsbRibLsRsbRsbRsbRsbRgRsmbRgbRgbRgbRgbLgb
RibLsLjbRcRsmbLgLsbLsbRcLsbLgbRibLgLsbRobRib

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 38; Drug: NDMC 3 µM
bRgbRgbRgRsmbRgbRsRsmbRsbRgbRsbRsbRgRsmbRgbRgbLcbLcbRsRsmbLiLsbLsRsbLg
bLsbLcbLcbRibRibRgbRgRsmbRgRsmbRsbRsbRgbRsRgRsmbRsRsRsmmbRsbLsbRsbRgbR
gbRsbRgbRgRsmbRsbRgbRsbRgbRgbRsbRsbRgbRsbRgbRgbRgbLcbRsLibLgbLsbRcbRib
RsbRgRsmbRsbRgbRsRsmbRgbRsRsmbRgRsRsmmbRgbRgRsmbRsRsmbRgbLgbRibRiRsmbL
sbRgbRgbRgbRibLhLsbRiRsmbLjbLcLsRsmbLgbLiRsbRgbLibRjbLibRibRcbLibRiRsm
bRgbRgRsmbRsbRsbRsbRsbRsbRgbRsbRgbRsRsmbRgbRgbRgRsmbLsRgbRsbRgbRgbRgbR
gbRsbRgRsmbRgbLsbLcbLgLsbLsbRsLsbLsLsmbLsbLsbRsLsbLgbLgbRjbLsbRcbRibRg
bRsLsbRsbRgRsmbRsbRgbRsbLgRsbRgLsbRgbRgbRsbRsbRgRsmbLcbLiLsbRjbRibRgbR
gRsmbRsbRsbRsbRgbRgbLsLsmbRgbRibRgRsmbRgbRsbRgbRsRsmbRgRsmbRsbLsbRgbRg
bRgRsmbRgbLgbLcbLgbLsbLgbRsLsbLhRsbRcbRibRgbRsbRsbRgbRgbRsbRgbLcbLibRg
bLgLsbLsbLgbLgbLgbLsbRsbsbLsbLgLsbLgLsbRsbLgbLgbRjbRibRiRsmbRibRsbRsbR
sbRsbRiLsbRibRibLsRsbRgRsRsmmbRgbRgRsmbRsRsmbRsbRsbRgbRgbLsRsbRgRsmbRs
RsmbRgRsmbRgbRsbRgRsRsmmbRsbRsbRgbRsbRgbRgLsbRgRsmbRgLsbRgbRgbLcRsbLib
RsbRjbRibRgbRgbRgRsmbRgbRsbRibLibLjbLibLsbLibLgbLgbRjRsmbRibRgbRgRsmbR
sLsbRgbRsbRsbRgRsmbRgRsmbRsRsmbRsbRsbRgRsmbRgbRsbRsbRgbRgbRgbRgbRsRsmb
RgRsmbLsbLjbLiLsbLgbRgbRcbLgRsbRgRsmbRgbRsRsmbRsbRgbRsbRgLsbRsbRgbRgbR
sbRsbRsbRsbRibRcRsmbLsbRsbRhbRcbRgbRgbRsbRgbRsbRgRsmbRsbRsbRgbRgbRgbRs
bRgbRsLsbRgRsRsmmbRgbRsbRsbRsbRgbRgRsmbRsbRgbRgbLibLjbLgbLgbLgbLsbsbRs
bLjbLgRsbRgRsmbRgbRsbRsbRgRsmbRsLsRsbRsbRgbRgbRsbRsbRgbRsbRiLsLsmbRibL
ibLibLgbLibLibRsbRebLjbLibLgbLsbRsLsbLgbLgbLsbLsbLsbLsLsmbLsLsLsmmbLgb
LsbRgbLobRgbRsbRsRsmbRgbLsbRibRibRibLgbRgbRgbRgbLsbRgbRsbRsbRsbRsbLjbL
ibLgbRsbLgLsbLgbLgbLsbLsbLsbLgLsbLsbRsRsmbLgbRjbRibRgbRsbRgbRgbRsRsmbR
gbRgbLjbLobLgbLsbLgbLsLsmbLgbRsRsLsmbLgbLgbLsLsLsmmbLsLsmbLsLsRsmbLgbL
gbLsLsmbLsbLsRsLsLsmbLgbLgbRsbRjbRhLsbLcbLsbLgLsbRgLsbLgbRgRsmbLgbLgbL
gRsbLgbRsbRsbLibLgbLgbLsLsmbLsLsmbLsbLgRsbLsbLgbLsLsmbLsbLgbLgLsbRjbRc
RibRgbLsbRgbRgRsLsmbLjLsmbRgbRhbLibRgbRgbRsRsmbLjLsmbRgbRgbRgbLcbRcRsm
bRsLsbRibRsbLjbLhbReRsmbRgbRsbRsbRgbRgRsmbRsbRiLsRcbLebLhbRibRibLibRjb
RiRibLgRsbRgRsmbRgbRsbRgbLgbRiLsbRgbRsRsRsmmbRgbRgbRsbRgbRgbRgbRsbRsbR
gbRsbRgbRgbRgRsmbRgbRgbLgbRgbRgbRgbRsbRgbRsbRsbRgRsmbRsRsmbRgbRgRsmbRg
bRsbRsbRgbRgbLgbRgbRgbRgRsmbLsLsmbRgRsmbRgbRsbRsbLsRsRgRsmbRgbRgbRsRsm
bRsbRgbRgbRgbRgbLgbRgbRgLsbRsbRgbRsbRsbRgbRsbRsbRsbRsbLcbLibLgbLibRcbL
sRibsbRsbRgbRsRsLsRsmbRsbRgRsmbRsbRgLsRsbRgbRsbRsbRgbRsbRgbRsRsmbRsRsm
bRgbRgbRsbRsbRsbRgRsmbRgbRgbRgRsmbLjbLhbLgbRebRibRgbRsbRgbRgbRsRsmbRgb
RsbRsLsbRgbRgbRgbRsbRgbRgbRgbRgbRgRsmbRsbRgbLsbRiRsmbLgbRgbRgbRgbRsbRg
bRibLjbRibLjbLibLgbLsbLcbRibRgbRibRgRsmbRsbRsRsLsmbRgbRsbRgbRsRsmbRgbR
oRsRsmmbRgbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 39; Drug: NDMC 3 µM
bRsLsLsmbLibRsbRgbLibRhbLsbLgbLibLgRsbLgbRgbRgbLibLibRiRsmbRsbLcbRgbRi
bRjbLibLgbLgLsbRsbRjbRhbLjLsmbRsRsmbRiLsbRibLjbsbLcbRjbRibRgRsmbRgbRgb
LsLobRsbLsLsmbRsbLsbLgbLsbLsbLsbLgbLibRjbRjbRhbRgbRibLjLsmbRibLjbRibRi
bLibRgbRjRsmbLibLibLgbLsbLsLgbLgbRgRsmbRcbRiRsmbLsbLhbRibRibRiLsbLiLsb
RgbRgRsmbLgbRjRsmbRgbLgLsbLcbRhbRhRsmbLsbLgbRcRsmbLibRcLsbRcLsbLibRcbL
jbLgbRgbRjRsmbLibLjLsmbLgbLsbRgbRjbLjLsmbLgbLgbLgbRgbLgbLsLsmbLsbLsLsm
bLgLsbLsbLsbLgbLsbLsbLgbRsbLgbLsbRsbsbLgbRsLsbLsLgbRsbLgbLgLsbLgbRgbLg
bLibRsbLgbLsbRgbRgbRibRibLgbRgRsmbRgbLjbRgbRibLgbLcbLcbRibRibRcbLhbLcb
LoRsbRibLgbLgbLsbLsbLsbLsbRibLoRsbLcbRsbRibLibLibRgbLiRsbLcbLcbLcbRjbL
iLsbRhbRcbRhbLebRibRgRsmbLsLsmbRhbLcbLcbRhbRibRsbRgbRgbLcbRibLgbRcbRcL
sbLgbRcbLgbRcbLgbRcRsmbLsbLsbRgbRgbRibRibLjbLcbLsLsmbLsbLgLsbLgbLsbLhb
RibLcbRibLgbLcbRsLsbLibRgRsmbLsbLgbLgbLgbLgbLsbRsbRgLsbRcbLjLsmbLhLsbR
iRsmbLcbRjRsmbLgbsbLsbLgLsbLgLsbRsbLgbLgbLgRsbRjbLiLsbRsbRsbLiLsbRjbLj
LsmbRobRibLibLibLsLsmbRgRsmbRibLcbLgbLibRgbLgbLgbLgbLgbLsbLgbLsbLsbRjb
RsbRjbRibLjbLcbRjbRibRgbRgbRgRsmbRgbRsbLsbRsRsmbRgbRsLsbRgbLcbLsLsmbLi
LsbRgbLgLsbRsbLsbRsbLgbRsRsmbLgbRjbRiRsmbLsbLjbRjbRgbRgbRgbRsbRsbLsRsb
LsLsmbLibLjLsmbRibLhbRibLibRibLibRsbLgbRsbLsLsmbLsRsbLgbLibRgbLgbLgbRs
bLsLsmbRsbLgbLibRiLsbLhbRibLhLsbRhbLcbLcLsmbLsbLgbLibLgbRjLsbRhRsRcmbL
jLsmbLibLibLgbRobRgRsmbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 40; Drug: NDMC 3 µM
bLsbRgbRjbLjRsbLcbLibLiRsbLibLhRsbRhbLcbLsLsmbLgbLgbLgbLiLsLsmbRibRebR
ibRgbRgbRsbRgbRsbRsbRsbRgbRgRsmbRsRsmbRsbRsbRsRsmbRsRsmbRsbRsbRgRsmbsb
RibLgbRibLjbRiRsmbRgbRsbRsbRsRsRsmmbRsLsbRgbRgbRgbRsbRsbRgLsbRsRsmbRiR
gRsRsRgmmbRsRsmbRsRsmbRgRsmbRgbRsbRgRsmbRgRsmbRsbRgRsmbRgRsmbRobRibLib
sbsbRibLcbLcbRgbsbRcbLsbRsbRgRsmbRsbRibLgbRgbRgbRgbRgbRgbRsbRsRsmbRgbR
gRsmbLjbRgbRgbRsbRgbLgbRgLsbRsbRsRgRsmbLsRsLsbRsbRgLsbRgbRgbRgRsmbRsRs
mbRgbRgRsRsmmbRsbRgbRgbRsbRsRsmbLsbRgbRsLsbRgbRsbRsRsmbRgRsmbRgLsbRsRs
mbRsRsmbRgbRsRsmbRgbRgRgRgRsRgRsRgmmbRgRsmbRsbRgRsmbRsbRgbRgbRgbLjbRib
LcLsmbRgbLibLgbLgRsbRebRhbLibRibLjbRiRsmbLgbRhbRibLibRibRhbRsbLibRcRsm
bRhbLiRsbRgbRibRsbRsbRgbRsbRibRgbLjbRibLjbRibLjbLcRsLibRsbLgbLgbRsbLgb
LgbRhbRcbLjbLjbLibRjbRcRsmbLgRsbRgbRgRsmbRsRsmbRsbRsbLsRsbsbRhbLhLsbRj
bRsRsLsmbsbRgbRsbRgbRgbLsRsbRsbRgbRgbLcbLoRsbLgbRsbLibRibRcbRiRsmbRsbR
sbRgbRsbRgbRgbRsbRsbRgRsmbRgbLibRsRsmbLoLsmbLiRsbRgLsbLibRjbLsbLibRjbR
cbRibLsbRsbRgRsRgmbRgbRgRsmbRgRgRsRsmmbRgRsRiRgmbRsbRgRsmbLjbLcbRhbRgR
smbRsRsmbRgbRgRsRsmmbRsRsmbRgRsmbRgbRgbRgbRgbRgRgRsmbRgbRsbLsbsbRgbRgb
RgRgRgRgRsRimbRgbRiRsmbRgbRgbRgbRsbRgbRgbRgRsLsmbRgbRgbRgbLcRsbLcbLiRs
bLibRgbLibRjbRcbRibLjRhbLiLsbRiRsmbRgbRsbRsbRsLsLsmbRsbRgRsmbLsRsbRsbR
sLsbRsbRgbRgRsmbRgRsmbRgbRsbRgbRgLjbRsbRgRsmbRgRsmbRgRgbRgbRgRsRsmmbRg
RsmbRsRsmbRsRgbRgbRgbRgLsbLibRibLcbLibLiRsbLibRiRsmbRibRibLjbRcbLgbRgb
RgbRibLgRsbRibLcLcbLgbLibLcbRgRsmbLhbLiLibRjbsbRcbRgLsbRgbRsbRsbRgRsRs
mmbRgRsRgmbRsbRgbRgbRsRsRsmmbRsbRsRgbRgRgRgRsmbRgbRgRgRibRgbRgbRgbRgbR
gbLcbRgRsmbRgbRgbRgbRgbRsbLcbLibRjbsbRjbRgRsmbRsbRgbRgbRgRsmbLjbRibLcb
RibRgbRsRsmbLsbRgRsmbRsbRgRsmbRgbRgbRsbRsbRsbRsbRsbRsbRgRsmbRgRsmbRgbR
sRsmbRsbRgbRsbRgbRgbRgbRgRsmbRibLibRhbLjbLobLsbLsRcbRgRsRsmmbRsRsLsmbR
gbRsbRgRsmbRgbRgRgRsmbRgRiRgbRgbRgRsmbRgRsmbRgRsRsmmbRibRgRsmbRgRgRsmb
RgRsLsmbRsbRgRgbRgbRgRsmbRibLjbRibLcbLibRsbRcRibLgbRgRsmbRsbRgbRsLsbRs
bRsRsRsmmbRgbRgRsRsmmbRgRgbRgRsmbRgbLjbRibLsbRgbRgbRgbLgbLcbLgbLgbLgbL
sbLgbLgbLgbRsbLibRcbRcbLsbRgbRgbRgbLjbRibRsbRgbRsbRsbRgbRgbRgbRgRsmbLc
bLibLgbLgRsbRsbRibRibRsRsRsmmbRgRgRsRgRsmmbRgbRsbRgbRsbRgRgRsmbRgRsmbR
gbRgRgRsRsRgRgRsRiRgRsmmmmbRgRsmbRgbRgbLsRsRgbRgRsmbRgbRgbRgRsRsmmbRsb
RsbRgbRgbRsbRsbRsRsmbRgbRgbRgRsmbLgbRgbRgRgRsRgRgRgReRiRiRiRgmbRgbRgbR
sRsRsmmbRgRsRgRiRsRgmmbRgbRsRjbLebRibLjbLibLgbRjbRcbRsRsLsLsmmbRibLsbR
gbRgbRgbRgRsRgRsRiRiRimmbRgRgbRgbLjbRibRhbLibRibLjbLobLsbLgbLibRjbRcbR
ibRsbRsRsmbRgbRgbRgbLjbRgbRibLjbLcbRjbRcbsbsbRsbRgbRgbRgRsmbRgbRgbRgbR
gRsRimbRsbRibRibRgbLcbRibRgbRsbRsLsRsbRgRsmbRgbRgRsmbRgRsRgRsRiRsRgRsR
gRsRgmmmmmbRgbRgbRgRsRgmbRgRsmbRgRsRsmmbRgRsmbRsRsmbRiRgRiRsRgRsRiRsRi
RgmmmbRgbRiLsbLjbLcbLibRjRoRsRsRgRgRimmb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 41; Drug: NDMC 3 µM
bRjbLebLgbRibLhbRibLibRgbLibRsbLgLsbLgbLsbLcbRibLibRgbLibRgLsbLiLsbLsb
LibRgbRjLsLsmbRcbLjbRgbLebLhbRgbLibRsbLgLsbLgbLibLsbLgbLgbLgbLgbLsLsLs
mmbLgLsbLgbLgbLgbLsbLsbLsbRsLhbRibLiLsbLcbRibLhbRgLsbLhbRibLebRgbLibRs
LsbLgLsLsmbLsLsmbLgbLsbLsbLsbLiLsbLsRsbLiLsbLsLsmbLgbLsbLgbRsbLgLsbLsR
sbLsLsmbLgbLgRsbLgbLsLsmbRgbLibRjbLibRsbLibLgbLgbLgbRhbLhbLgbRsbLgbLsL
smbLgbLhbRgLsbLhbRgLsbLibLsbLgbLgbLibRgbLhbRgbLiLsbRgbLiLsbLgbRsbRjbRi
RsmbRibLgbRgbLgbRcbLcbLcLsmbRjbLcbRibLcbRibLibLibLibLgbRsbLibLsbLsLsmb
LgbLgLsbLgbLsbLgbRgbLiLsbRjbLsbRibRgbRgbLsbLcbRgbLiLsbRsbLiLsbLgbLsLsm
bLgbLsbLgbLsbLsbLsbLgbLsbLsbLgbLgbLgbLsbRsbLgbLsbLgbLgbLgLgbLsLsmbLgbL
sbLgLsbLgbLgbLsLgbLgLsLsmbLgbLsbRgRsmbLsbLibLsbLsbLibRgbLhbRibLibRjbLc
bRibLsbLcbRjbLiLsbRsbLiLsbLcbRgbLhbRgbLibRibLiLsbLgbRsbLgbLgbLgbLgbLsL
sRsmbLgbRjbReLsbRgbRsbRibLebLibRsbLibLgbRsbLgbLgbLgbLsbLgbLsbLgbLgbLsb
LgbLgbLgbLgbLsbLgLsbRsbLiLsbLsRsbLibLgLsbLgLsbLsbLsbLgbLgbLgLsbLgbLgbL
sbLibLibLgbLgbLgLsbLgbLgLsbLgbLgbLibLgbLgbLgbLgbLgLsbLibLgbRgbLibLsLsm
bLgbLibRsLsbLibLgbLsLgbLgbLgLsbLgbLgbLgbLgbLgbLgLsbLgLsbLibRsLsbLibLgb
LgbLgbLsbLibLgbLsLsmbLgbLsbLibRsbLibLgLsLsmbLsLsmbLgbLgbLgbLgbLgbLgLsb
LgbLgbRoLsbRjbLibLsRsbLibLsbLgbLsbLibLsbLgLsbLgbLgbLgbLsbLgbLsbLibLsbL
gbLgbLgbLgLsbLgbLhbRgRsmbLibLgbLebLsbRgbLibLgRsbLsbLgbLgbLgbLgLsbLgbLg
bLgbLgbLgbLgLsbLsLsmbLibLgbLgbLgLsbLgLsbLgbLgbLgbLgbLibRhbRcbRibLjbRgb
RibLsbRiRsmbLjbRcbRsRsmbLjbLcbRibLcLsmbRibLcbRibLibRgbLibRsbLgLsbRsbLg
bLgbLgbLgLsbLgbLgLsbLgRsbLgbRsbLgbLgbLsbLgRsbRgbLhbRibLhbRiRsmbLcbRgbR
ebRibRibLjbRibLeLsbLoRsbRhbRgLsbRibRgbRgbRsbRgbLjRsbRibLibLcbRjbRibRgb
RsbLsRsbRibRsbRgLsbRgbLgbRgbLcbRsbLibLsbLibLsbLgbLgbLsLsmbLgbLsbLibLgb
LgbLgbLgbLgbLiLsbLgbLgLsbLsbLibLsLsmbLgbLgbLgbLgLsbLgbRgbLibRjLsbLhbLg
bLsLsmbLgLsbLoRsbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 42; Drug: NDMC 3 µM
bRjbRibLibLjLsmbLgbLsbRcRsmbRgbRsbsbRgbRsbRibLjbLibLgbRcbRcLsbLibRibLs
bRgbRsRsmbRsbRgbRsbRibLgbRsLsbLhbRhbRiRsmbLibLgbRjbLsRibRgbRgRsmbRsbRg
bLsbRgbLgbRiRsmbRgbRgbLgbRibRgbLgRsbRibLgbRjbRsRsmbsbLsbRibRgbRsbRsbRs
bRgbRgbRgbRgbLcbsbLhbRjbRcbRgbRgbLsRsbLgbLgbLibRcbRcRsmbLgbLhbLibRcRcb
RsbLgbLobLsbRebLhbLibLcbRibRgbLcbRgbRgbRgbLsbLjbRjbRiLsbRgbRsbRsbRsbRs
bRsbRsbRibLsbLsRsbRgbLsRsRsmbRsRsmbRsRsmbRgbRsbRgbRgbsbRsbsbsbRsbRgbRs
bRsRsmbRgbRsbRsbRsbRgbRsbRgbLsRsbRgRsmbLjbRsRjbRgbLgbLibRhbRgbRgbRgRsm
bRgbLsbRgbLcbLgbLgRsbLcLsmbLobRibRibLibRibRsbRgbRgbLjbLcbRjbRhbRgbRjbL
gRsRsmbRgbLgbRgRsRsmmbRsRsmbLsbRsbRsRgbRsLsbRsbRgbRgLsbRsLsbRibLgRsbLs
RibRsbRsRsRsmmbRgbRsbRsRsmbRgbRgbRgbRsbRsbRsRsmbRgbRsRgbLjLsLsmmbRgbLj
bRjbRgLsbLgRsbRsbsbRsbRgbLgbRcbLibRibLjbLcLsmbRobLcbLjbLibRsbRsbLgbRcR
smbsbReLjbRsbLjbRibRsbRsbRgRsmbRgbRsRsmbRgbRgLsbRjbLgbRgbRgbLsbRgbRgbR
gbRgbRgbRibsbLgbRjbRgRsmbRsbRsbRsbLsbRsbRsbLgLsbLibLcbsbRobRsbLsbRsRsm
bRsbRsRsmbRgbRibRgbRgbRsbRibRibLgbLsbRsLjbRsRsRgmbRsbRsbLsbRgbRsRsmbLs
bRgbRsbRgbLsbRsbLsRsbRgbRsbRsbRsbRsLsbRsbRgbLjbRibLsbRjbLsbRsbRsbRgbRs
bRgbRsbRgRsmbRgbRjbLgRsbLjbRhbRsbRgbRsbsbRsbRgRsmbRsbRgbRgbRgbRgbRsbLs
bRibLgbRibLjbRhbLgbLsbRgbRsbRsbRsbRsbRgbsbLsRsRsmbRsbLhbLibRjbLcbRhbRc
bRsbRsbRsbRgbRsbRsbRsbRgbRgbLsbRgbsbLjbRebLgbRsbLgbLgbRgbRiRsmbRcbLiLs
bLhbRcbRibLgbRiRsRsmmbLsRsbRsbRsRsmbRsbRgbRsbRsbRsbRsbRgRsmbRsbsbRgRgR
smbRgbRgbRgbRgRsmbRsbRgbRgbRgbRgbLgbRibRgRsmbRgbRgbRgbLjbRibLjbLcbRcbR
cbLgLsbRibLsbRsbRsbRsbRsbRsbRsbRgbRgbLjbRiLsbRsLsbLibLcbLhbLoLsmbLibLs
bLibLibLgbLhRsbLhbRibLibRgRsmbLgbLcbLhbLhbRsbLsbRebRsLsbLgRsbRsbLiLsbL
gbLgbLgbLgRsbLgbRiRsmbRibRsbLsRsbRibRiRsmbLsbLsbRibLgbsbRgbRgbRsbRsbRg
RsmbLgbRibRgbRsbRgbRsbRsbRsbRsbRsbRsbRsbRgRsmbRgbRgbLgbRibLgbLsLsmbRgR
smbRsRsmbRsbRgbRsbRsbRgbRgbRgbRsbRsbRgbRgRsmbRgRsmbRgbRgbRgbLjbLcbRjbR
hRsmbRgRsRsmmbRsbRgbRgbRgLsbRgbLsbRgbRsRsmbRgLsbLgbLjbRibLgbLibRcbLgRs
bLjbLibLgbLibLcbLibRibRgbRcbRiRsmbRgbRgRsmbLjbLcbRebRsbRiRsmbRibLcbRib
RgbRsbLsbRgRsmbRsbRgbRsbRsbRsbRgbRgbLsRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 43; Drug: NDMC 10 µM
bRsbLhLsbRibLibLibRcbLcbRcbRibLgbRsbRiRsmbLgbRibLsbRibLjbRibLjbRhbRibL
ibRiRsmbLsbRgbLjbRhbLsbRgRsRsmmbLgbRcbLgbLgbLcbLgbLsbLibLcbRhRsmbLgbLg
LsbLsbLgbLgbLgbLsbLgbRebRcbRibLgbLoLsmbLcbRgRgbRibRgbRsbRgbLebLibRcbLc
bLibRibLibRjbsbLhbRgbLgbRsbRsbLsbLgbRgbLcbLgbLgbLgbLgLsbRsbLgLsbLsLsmb
LsbLgbLgbLsbRsLsbRcLsbsbRgbRsbRgRsmbRgbRsRsmbRgbRgbRgbRgbRsbLsbRgbRgbL
jbsbRcbLcRsbRcbLsbLjbRcbLsRsRibLcbRjbLiRsbLibLsbLsbRsLsbLgbLgRsbRsLsbL
gRsbRhLsbRibRgbRgbLgbRiLsbRsRsmbRsbRgRsmbLcbLgbLgLsbLcRsRsRsmmbRcbLhbR
ibLgbLgbRsbLgbRsbLibRjbLibLiLsbRibsbLibRcbRgRsmbRgbRsbLsbRiRsmbRsbRsbR
iRsmbLjbLcbRjbRibLhbLgbRibRgbLgbRobLcbRcbRibLgbRgbRgRsmbLsbRibLgRsRgRs
mbRsbRgbRgbLjbRibRgbLgbRgRsRsmmbRiRsmbRhbLhbRiRsmbRsLsbRibLobLibLgbLsb
LsbLgbLibRibLsbLgbLsRsbLsbLsbRgbRcRsmbLcbLgbLgbLgbRsbLgLsbLsbsbRsbRibR
ibLsRsbRgbLjbLhbLgbRjbLibLgbLsbLibRjbLibLsbRjbRgbRsbRgRsmbRgbRibRgbRsb
RgbLsRsbRgRsmbLsbRgRsRsmmbLsRsbRgLsbLjbRsbLoRsRsRsmmbLsbLibRgbLsRsbLgR
sbLgbRsRsmbRjbRibRsbRgRsLsmbRsbLcbLcbRgLsbLgbRsbLgbRgbLgbRsbRjbRhbLjbR
cbLgbRibLsbRibLjbRsRsmbRibLiRsbRibRsbRgbRsbRsbLsRsbRsbRsbRsbRsbRgLsbRg
bRsbRgRsmbRgRsRsmmbLsbRgbLcbLcbRgbLgbLibRjbRcbRgbRgbRgbLjbLobRjbLhLsbR
ibRibRgRsmbRsbRgRsLsmbRgbRgRsmbRsbRsbRsbRsbRgRsmbRsbRsRsRsmmbRsbRsbRsb
RsbLcbLgbLsbRcbLhbLgLsbRcbLjbRcbLsbRgbRsRsmbRgbLjbRibLgbRiRsmbLsRsbRgb
RsRsmbRgRsmbLsbRsbRgLsbLjbLhbRcbRibRsbRgbRgbLjbRibRgRsmbLsbRiRsmbRgbRs
RsmbRgbLgbRgbLcbLibRsbLgbLsbLgbLsRcbRibRsbRgbLsbLgbRibLgbRsbRibRsbRgRs
mbLsbRgbLsbRibLjbRhbLgbRibRgbLobLibRsLgbLsbLiLsbRcbRhRsmbLsRibLgbRgbRs
bRsbLcbLgbRhbRcRsmbLibLsbRgLsbRgbRsbRgRsmbRgbRsbRsRsmbRgbRgbRgbLjLsmbR
ibLibRcbLcbLcRsbLibRcbLjbRibRsbRgbRsLsbRibLgbRgbRgbRgbLcbRsbLgbRjbRcbR
gRsmbRsbRgRsLsmbRsRsmbRsLsbRsbRsRsmbRsRsmbRsbRsRsRsmmbRsbRsbRgbRgRsmbR
gbRgbLcbRjbLobRcbRibLjbLibLibRibLgbLgbLibLgbLgbRcbRiRsmbLgRsbRibLjbRgb
LsbRibLjbRibLgbRibLjbLcbLjbRcbRgbRsRgLsbRgbRsbRsbRgRsmbRgbLobLcbRgReRs
mbLcbLsRsbRcbLsbRgbRsbRgRsmbRgbRsLsbRgRsmbRebRobRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 44; Drug: NDMC 10 µM
bLsbRgRsmbRsbRsbRgbRgbRsbLsbRgbLgbLjbLcbRsbLgbLgbLsbLsLsmbLsbLgbLgbLsb
LgbRgbLgLsbRsbLgbRsbLgbRsLsbLgbLgbLsLsmbLgLsbRsbLgbLsLsLsmmbLsbRgbLibL
gLsbRsbLibRgbLgLsbLsbLgbReRsmbRgRsmbRsbLgbRgbRgbLgbRibLjbRibLjbRcbRcbR
ibLgbLgbRcbRcbLibRcRsmbRibRsbRiLsbRsLsbRgbRsbRibLjbRcbLiLsbRibLjbRcLsb
LcRsbLobRhbLibLibRsbLgbLsbLsbLgRsLsbRsbLsbLgbLsbRsbLgbLgbLsbLgbLgbLgbL
gbRsLsbRcbRsbLjbRcbLsbRgbLgLsbRgbRgbRsbLobRsbLgbRsbLgbRjbLhbRjbLiLsbLi
bRjbLibRsbLgbLsbLsbLsLsmbLgbLsLsmbLsbLsbLgbLsbLsbLgbLgbRsbLibLgbRsbRcL
sbRibLsbRgbRsbLsbRibLcbLibLsbLgLsbLsbLgLsbLsbLsbLgbRsbLgbLsbLsbLsbLgLs
bLgLsbLsbLgbLgbLsbLgbLgbLgbLgbRobRsbRsbRgbLsbRibRsbRgbLjbLobLibRsbLibR
sLsbLgbRsbLgLsbRsRsmbLgbLsbLgbLsLsmbLgbRsLsbLgbLsbLsbLsbLgbLgbLgbLgbLs
bLgbsbLcbRibRcbRibLjbRcbLgbLjbLgbLgbLgbRsbLgbRgbLgbLgbLsbLgbLgbLsLsLsm
mbLgLsbLgbLgbLgbLgbLgbLgbLsbRsbLibRhbRcbRibLjbRgbRgbLgbRibLjbLsbRgbRsb
RibRsbRgbLcLsmbLibLsbLsbLgLsbLgbLsbLgbLsbLgLsbLgLsbLsbLgLsbLgbLsbLgbRj
bRcLsbRcbRibRibLibRibRhbLgbLjbLcbRsRsmbLgbLgbLgbLsbLsbLgbLibRibLhbRgbL
gbLsbRsbLsbLsbLibRsbLsbLsbLgRsbLgLsbRoRsmbRiLsbLjbRgbLjbLibLibLgbLsbLs
bLsLsmbLsbLsbLsbLsbLsRsbLgbLgLsbLsLsmbLsbRsbLibRjbRsRhbRiRsmbLsLsmbRsL
sLsRgLsmbRsbRgbRhbRiLsbRibRsbLsbRibRhbRibRgbRgbRsbRgbRibLjbRoLsLsmbLgb
RiLsbRiLsbLgLsbRibRibRibRsbLgbRcbRsbRgLsbRgbRgbRsbRgbRibRsbRiLsbRcbRib
LsbRgbRibRsbRgbLsRsbRgLsbRgbLgbRgLsbRgbRsbRsbRgbRsbRgbLsRsbRsbRsbRsbRg
bRsbRsbRibLgbRgbRgbRsbRgbRsRsmbRgRsmbRgbRgLsbRhbLiLsbLcbLobLhbRgbLiRsb
RsbLibLsbLibRibLgbLsLsLgmbRsRsmbLsbLgbLsbLsbLgbLgbLsbLsbLgbLgLsbRgbLcb
RebRhbRsRsmbRiLsbLgbRcbLsLgbRibRsbRgbRgbLibLgLsRsbRsRsmbLibLgbLsbLgbLs
bLsbLgbLsbRsbLhLsbRobRhRsmbLjbLjbLiLsbRibLibRgbLiLsbRgbLgbLsbLsbLsLsmb
LgbLsbLsbLgbLsbLgbLsbLsbLgLsbLgLsbRgbLibRjbRhbRgbRibLgRsbLgbRibRsbRibL
jbRibRsbLsRibLsLsmbRsbRibRcbLobLcbLsbLgLsbLsbLgbRgbRsRcbRiLsbLebLibRgb
LsLgbLsbLsLsmbLsbLobRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 45; Drug: NDMC 10 µM
bRgbRsbRsbRgRsmbRgbRgbRgRsmbRgbRgbRgbLsbLjbRgbRsRsmbRibLsRsLsbRsbRgLsb
LsbRgbRgRsmbRsbRsbRsbRgRsmbRsbRgbRsbRgbRgbLsbRgbLsbRiLsbLgRsbRgbLjbRcb
LsbRgbRgbLjbLibLsbLsbLsbRcbRobLsbRgbRgRsmbRibRsbRgbRibLgbRibLgbRgbRsbR
gbLsbRibLcbLibRjbLibRebRsbRgRsmbRsbRsbRgbLhbLgRsbRjbLibLgbLsbRsbRibLgb
LjbLibLgbLgLsbLgbRebLibRjbLhbLibRsbLsbLgbLsbLgbLsbLgbLgbLsbLsRsbLsbLsb
LgbLgLsbRjbLjbLgbRgbLgbLgbLgbLgLsbLgbLgbLsbLgbLgbLsbLgbRcbLjbLgbRjbRib
LjbLcbLsbsbLgbLsbLsbLgbLgbLgbLsbLgbLgbLsbLgbLgbLsRsbLgbLsbLsbLsbRsRsmb
RebRibLsRsbRgLsbRgRsmbRsRsmbRgbRgbRsbRgbLgbRgbLjbsbLcbLgbLsbLgbLsbLgbL
gbLsLsmbRsbLgLsbLgbLiRsbRebLsRcbLsbRsbRgbRsbRsbRsRsmbRsRsmbRsbRgbRgLsb
RgbRibLibLjbLibRibRgRsmbRibLgbsbRsbRgbRgbRsbLibLgbLgbRjbRibRsbRgbRsbRs
bRgbRgbRgbRobRcbRibRgbLsbRgbLsbRgbRgbRgbLsbRgbLsbRibLgbLjbRgbRsbRsbRgb
RsbRgbRgbRgbRgbRsbRsbRgbLsbRgRsmbRgbLsbRibLgbRgRsmbRgbLsbLcbLibLgbLsbL
gbLsRsbLsbLgbRcbLjbLgbLgbLsbLgbRjbLjbRjbRibLjbLjbLgRsbLgbRcbLcbLhbLsbR
ibRebRgbRsRsmbRgbRgbRsbRgbRsRsmbRsbRgbRgbRgbRsbRsbLsbRsbRsbRsbRgRsmbRg
bRgbRsbRsbRgRsmbRgbRgRsmbRsbRsbLcbRibLsbRsbRgbRsbRsbRgRsmbRsbRgbRgRsRs
mmbRgRsmbRgbRgbRsbRsbRsbRgRsmbRgbRgbLibRjbRcbRsbRgbRgbRgbLsbRgRsRgmbRg
LsRsbRsbRgbRgbLsbRsbRgRsmbRsbRsbLsbRgbRsbLsbRgbRsbRsbRgbRsbRsbRgbRgbRs
bRsbRsRsmbRsbRsbLsbLjbLhRsbLgbLgbLgbLgbRsbRsbLgbRcbLjbLcbRcbRcbRgbRgbR
gbRgRsmbRsbRsRsmbRgRsmbRsbRsbRgbRgbRgbRsbRsbRsbRgbRsbRsbRsbRsbLsbRgRsm
bRsbRsbRsbRgbRsRsmbRgbRgRsmbRgbRiLsbRobRibRibRibRibRsbRsRsmbRgbRsbRsbR
ibLgbRsbRgbRsbRsbRgbRgbRsbRgbRgRsmbRgbRgbRgbRgRsmbRgbRgbRgbLsbRsbRgbRg
bRgbRgbRsbRgbLsbRsbRgbRgbRgbLsbLsbRgbRgbRibRcbRgbRgbRgbRcbLsbRsbRgbRgb
LsRsbRgbRsbLsbRgbLsbRsbRgRsmbRsbRgbRgbRgbRsbRgRsmbRgbLsbRsbRsbRsRsmbRg
bRgbLgbLjLsmbLgbLgRsbLibRjRsmbLcbRcbLsbRcbRibLsbRgbRgbLsbRgbLjbRgbLjbR
sbRsRsmbRgRsmbRgRsRsmmbRsbRgRsmbRsbRsbRsbRgRsmbRsbRgRsmbRgbRgbRsRsmbRg
RsmbRsbRgbRsbRibLgbRgbRgbRsbRsbRgRsmbRsbRsLsbRiRsmbLgRsbRsRsmbRgbRgbRs
bRsbRgbRgbLhRsbRjbRgLsbRibRsLsbLsbRsbRsbRgbRgbRgbRsbRgbRgbRsbRgbLjbsbL
jbLgbLgRsbLgbLgbLsbLsbRhbRibLsRsbRsbRsbRgbRsbRsbRgRsmbRsbRgbRgRsmbRsbR
sbRgbRcLsbRibRsbRibRibRcbRcbRcbLjbLgbLibRjbLhLsbRibLcbRhbLhbRcbLibRcbR
ibLsbLsbRiLsbLsbLsbRsbRgbRsRsmbLsbLsbRsbRjbLgbRgbRsbRgbRgbRsbRgRsmbRsR
smbLgbRgbLjbRiRsmbRgbLsbRgbRsbRsbRsRsmbRgbRgbRsbRsRsmbRgbRsRsmbRgbRgbL
sbLsbRsbRgbRgbRsbRgbLobLobLsLsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 46; Drug: NDMC 10 µM
bLibRcbLiRsbLjbLibRjbRcbRibLjbLcbRjbLiLsbRibRsbRcbLebLibLgbLgbLsbLsbLg
bLsbRjbLgbRobLibsbLhLsbRcbRcbLibLhbLgbLgLsbRibLsRcbRsLsRgbRgbRiLsbLcbL
cbRhbRcbRgbRcRcbRiRsRsmmbRibRsbRsRgbRsbRgRebRsbRgbRgbLjbRhRsRsmmbRcbRi
bLibRsbLsbRcbLibLibLgbRebRsRsmbRgbRgbRebRsbLjbRsRsmbLjbRcbLjbRibLjbLgb
LgbLsbLgbRebLibRjbLcbRebLsbLibLgbLgbLgLgbLsRsbLsLsmbLgbLgbLsbLgbLiLsbR
obRebLibRibRobLobsbLjbLibLgbLgbLibRjbRebLibLgbLgLsbLsLsmbLgLsbLgLgbLgb
RebRgbRsRsmbRgbRsLsbRgbRsRsRsRgmmbLibLibRjbLibLcRjbsbRjbRsRsmbRgRgbRiR
gbRsbRgbLgbLibRjbLcbRjbsbLhbRgbLsLsLjmbLsbRcbLsbRcbLhbLjbLjbLeRsbLgbLc
bRcbLhbRcbLcbRobLiRsbLcbRibLibRcbRjbRsbRgbLgbLjbsbRcbLsLgbsbLjbLsbRjbL
gbRsRsmbRibRiLsbLcbRjbLcbRibLgbLgbRsbRjbLibLcLsmbRgbLgRsbLgRsbLsbLgbLg
bRgbLsbLgbLgbRjbRgbLibLibLsbRebLjbLibRsLsbLgbLsbLgLjbRcbRhbLjbRcbRobsb
LcLsmbLjbRcbRibRgbLjbLjbRsbLsbLgRsbLsbLsbLibLgbRsbLgbLsLsmbLgLsbRjbLhb
RjbLsbLgbLsbLsLsmbLgLsbLsbLsbLgbLsbLsbLjbLsLsmbRjbLsbLgbLgbRhbLcbRhbLs
bLsbLsLsmbLgLsbLsLsmbLgLgbLgLsbLjbLhbLobLcbLhLsbRibLgbLgbRsbRsLsbLgbLg
bLsbRhbRibLjbRsbLcbLgbRsLsbLgLgLsLgLsLsLgLiLiLsmbLhbLibLgRsbRjbLsLsmbR
cbLjbRsbLcbRibRjbLsbLcbLcbLcbLibLibLgbRjbLjLsmbLcLsmbRibRibLcbRibRjbRi
bRsbLsbRgbRgbLjbLhbLcLsmbRjLsbLgbRsbLsbRjbLibLgbLsbLsbLgLsLibLsbRsbRjb
LcbLcbLibRibRcLsbRhbLjbLibLiRsbLsbLsbLgLsbLgLgbLgLibLsLsmbLgbLsbLgbRcb
RcbLgbRgRsmbRibLjLcbLiLsbRjbLibLsbRjbLiLsbLibRibRjbRgbRgRsmbRsLsbLibLs
LsmbLsbLgbLsbLibLcbRhbRiRsmbRgbsbsbLjbLibRiLsbRjbRcbLcbLhbLjbRcbLhbLjb
RjbRcbLjbRsbRcbLcbLibLsLgbLsRsbLiLgbLgbLsRsbLsLibLsbLebLibRcbRoLsbLcLs
mbLobRcbRcbRibRgbRgRsmbRibLsLsmbLibLgbLjbRibRjbRibLjbRiLsbRsRsmbRgbRgR
smbRsbRgLsbRgbRgbRgLsbRgRsmbRsRsmbRsbRgbRsRsmbRgbLhbLobRsRsmbLibLgbRsb
LibLibRibLoLsmbRcbRcRsmbLjbRibLsLhLsbLibRibRsbRibLsLsmbRibRsbRsRsmbRgb
RgbRgbRgbLcbLjbRsRsmbRibRsRjRsmbRobRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 47; Drug: NDMC 10 µM
bRiRsRsmmbLhbLjbLibLibRjbRibLjbLiLsbLhbRcbRibLjLsmbsbLsbRibLibLibRjbRi
bRgbRsbRgbRgbRsbRgRsmbLsbRibLhbLhbLgbLgRsbLsLsmbLsbLsbLsbLsLsmbLsLsmbL
gLsLsmbLgbLsbLgbLgbLsbLsbLgbLsbLgbRgbLgbLgRsbLgbLsLsmbLsbLgbRsbRhbRhbL
jbLhbRcbRibRsbLsbRgbRsbLsbRsRsmbRgRsmbRgbLhbRibRgbRgbLcbLibLgbLsbLsbLg
bLsLsmbLgbLgRsbRgbRsbLcbLjbLibRibRobLcbLiRsbLgbLsbLgbLgbLsbLgbLcbRcRsm
bRhbLhbRebLsbRiLsbLsbLcbRibLsLsmbRibLjbLiLsbLhbRibLgbLgbLsbLgbLsbLgbsb
LhbLcRsbRibLgbLiLsbRcRsmbLgbsbRibRgbRgbRgbLjbRgbLgbRgbRgbRgbLgbRibRibL
hbLiLsbLhbRhbLgbLgbLgbLsbLgbLsbLsbLgbLgbLgbRgRsmbLcRsbRcbRiRsmbsbLjbLi
bRjRsmbRcbLjbLcbRibRgbRsbRgbLcbRjLsbRcLsbsbsbsbLebLibsbLgbLgbLgbLsRsbL
gRsbRibLcbRgbRjbRibsbsbsbsbLobRibRhbLjbLcbRcbLibLjbLibRjbRcbLcbLgbLsbL
gbRsLsbLsbLsLsmbLgbRsbLgbLgbLgLsbLsLsmbLsLsmbLsLsmbLsbLsbLsbLgbRsbRjbL
cbRibLsRsLcbRjbLsbRsbsbLsbRhbRobRiRsmbRhbRiRsmbLgbRgbRibRgbLsbRsbRgbLi
bLjbLibLgbRgbLgbLibRibRcRsmbRsbRibLibRgbRgbRsbRgbRsbRgbRibLibLgbLgbLgb
LgbRebRgbRsbRgbRgbRgbLjbRibLsbRibRsbRsbRgbRgbRsbRsRsLsmbRsLsbLsbRibRib
LjbLcRsbRjbRhbLjbRjbRibRgbRgRsmbLhbLibRibRjRsmbLcbRcRsmbRcbLsbLgbRibRi
bLsbRgbRsbRsbRgbRgbRgbLibLjLsmbRhbRibLebRcbRsbRcbLcbRjbRcbRsbRgLsbLsbR
gbRsbLsbRsRsmbRhRgbRibRibLcRsbRgLcLsmbLibRcbLibLiLsbRcbRoLsLsmbLhbRgbR
gbRgbRsbLsRsbRgbRgbRibLjbLgbRobRgbRgRsRsmmbLsLsmbRgbLsbRgbRsRsRsmmbRsb
RgbRsbRgbRgbRgbRsbRgbRgbRebLibRjbLcbRjbLibRjbLgbLsbLibLibLsbRsbRjbRgbR
jbLcbLibRibLiRsbLgRsbRibRgbLcbRcLsbRgbRgRsmbRgRsmbLsRsbRsbRgbRsbRgRsmb
LibLcLsmbRebLcbRgbLibRjbRgbRobRjbRsbRgbRsbRsbRgbRsbRgbLsbRgbRgbLjbLcbR
cbLhbLiRsbLgbRcLsbRgbRjbRsbLcbLgbRjbRebRsbRsbRsbRgbRgbLcbRibRgbRgbRgbR
gbLjbLiRsbRjbRhbLeRsbLsbLsbLsLsmbLsbLsRsbLgRsbLsbRjbRcbRsbLjbLibRjbReb
LjbLiLsbRobRibRjbRsbRgRsmbRibLjbLoLsRsmbLcbLgRsbLibRibLgbsbLsbLibRibLs
bLsbLgbLibRiRsmbRibRgbRsbRgbRsbRgRsmbRsRgRsmbRsbRgbRgLsbRgRsmbRsbRsbRi
bLcbRhbLcRsbRjbLsbLibRjRjLsRibRgbRgLsbRgbLibLcbLgbLsbLgbLsReRsLsmbRgbR
gb

>ZF Recording 2016-03-18; tW: 300s; Start: 112731; End: 113231;
Recording: 6-1; Individual: 48; Drug: NDMC 10 µM
bLhbLgbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 1; Drug: Control
bRebRobLjbLcRsbLsbLgbLsRsbLsbLgbRgbLibRcbLgbRsbLjbRibLcRsbLgbLibLibLsb
LsRsbLgbLgbLgbLgbLgbLsbLgRsbLgbLgbLgbLibLgbLsbLsbLgbRgbLsLsmbRiRsmbLjb
LibRcbRcbLsbLsbRsbRgbLgbLsbLsbRhbRgbRibLsbLgbRibRgbRgbRgbRgbLjbRobRibL
gbLsbRsbRibRgbRgbRsLsbLgbRcbLgbRibRibRhbRgbRsRsmbLsbRgbRjbLhLsbRebRibR
cLsbLcbLhbLibRibLsbLgbLgbRsbLgbLgbLsbLgbRobRcbLsbLibLjbLgbLgbRjbLibLsb
RjbRhbLibLibLsbLiRsRsmbRsRsmbLgRsbLsbLgbLsbLgbRsbRjbRcbLibLjbLibRjbRoR
smbLjbLibLcRsbRibRjRsmbRiRsmbRsbRcLsbLibRiRsmbLsbRiRsmbRgbRgbRgbRobLgb
LgbRibRgbLhLsbRcbRibLgbLgbLibRsRsmbRhbLjbRebRcbLjbRibRibLgbRiRsmbLjbLj
bLibLcbRhbLcbLgbRibLibLgbRibLcbLibRcbRcbLibRibRobRiLsbLebLgbLgbRcbRsbR
ibLsRsbLcbsbsbsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 2; Drug: Control
bLibRibRgbRsbRgbRsbRgbRgbRgbRgbRsbRgbRibRsbLsbRgbRgbRibRibsbRibRsbLsbR
gbRgbRgbRgbRgbRgbLgbLsbRgbRjbRsbRsbRgbRgbRsbRsbRsbRgbRgbRgbRibLcLsmbRh
bRgbRgbRsbRgbRgRsmbRsbRgbRgbRgbRgbRsbLgbLjbRibRsbRibRgbRgbLibLiLsbRjbR
ibRibLjbRjbLcbLcLsmbRibLgbRgbLgbLgbRgRsmbRibRsbLgbRhbLjbRibRgRsmbRsbRg
bRsbLgRsbRsbRsbRgbRgbRsbLsbRgbRgbRsbRgbRgbRsbRgbRgRsmbRsbRsbRgbRgbLsbR
gbRgbLiLsbRgbLsbRgbRibRsbRsbRgbRgbRgbLsbRsbRsbRsRsmbLsbRibRsLsbRgbRgbR
gbLgbRiLsbRgbLsRsbRgbRgbRgLsbRgbRsbRsLsbRgbRibRgbRgbRgbLgbRgbLgbLibLgL
sbLgbLsbLgbLgLsbLgLsbLsbLiRsbLgbLsLsmbLgbLgbLsbLsbLgbRsbLgbLsRsbLgbRsb
LgbLsbLgbLgbLsbLgbRibRibRgbRsbRgbRsbRgbRgbRgbRsbRsbRsbRgbLgbRibRsbRgbR
gRsmbRsbRsbRgbRsbRgbLsLsmbRgRsmbRgbRsbRgLsbLsRsRsmbRsbRsbRibLjbRibRgbL
sbRhbLibLhbLibRsbLsbLiLsLsmbLgLsbLsbLgbLibLgbLgbLsbRgbLibRjbRibRgRsRsm
mbRsbRgbRgbRgRsRsmmbRgRsLgmbLjbLibRsbLgbLgbRgbLiLsbLgbLgbLsbRsLsbLibLs
LsmbLgLsbRsLsbLgbLgbLsbRsbRobLsbLgLsbLgLsbLgbLsbLgbLgbLgLsbLsbLgLsbLgb
LgbLsbLsbLgLsbLgbLgbLsbRsbLibLsbLibLsbLsbLgbLgLsbLgRsbLgbLgbLgLsbLgbRs
bLiLsbLgbLsbLibRsbLibRsbLgRsbLgbLgbLgbLibLgbRgbLgbLgLsLgbLgLsbLgbLsbLg
bLgLsbLgbRsLsbLgbRsbLibLgbLgbLgbLgbLgbLsbLgbLibLibLsbLgbRsbLsbLiLsbLib
LsLsmbLibLsbLgbLsbLibLgbLgbLsbLsbLgbLgbLgLsbLgbRibRjbRjbLsLsmbRgbRcbLe
bLgbLgLsbRsbLhRsbLgbLgbRsbLibLibLgbLibRgbRebRibLsbLibRsbLcbLcbRibLibRg
bLcbLgbLsLsmbLsbLibRsbLibLgbLgLsbLsbLiLsbLsbLgLsbLibRsLsbLgLsbLgbLgbLg
bLsbLgLsbLsLsRsmbLgbLgbLsbLgbLsbLgbLgbLsbLgLsbLgbLsLsmbLgLsbLgLsbLgbLg
bLgbLsLsmbLibLsbLgbLgbLgbLgLsbRsbLsbLsbLibRsRsmbLhbLgbLgbLgbRsbLibLgbL
ibLsbLsbLgLsbLibLgbLibLibRgbLgLsbLibLibsbRgbRsbLibLsbLgbLibLibLgbRgbLg
bLibLsbLsbLgLsbLsbLsbLsbLgbLgbLgLsbLsLsmbLgLsbLgbLsbRsLgbLgbLgbRsbLgbL
gbRsbLgbLgLsbRsbLibLgRsbLgbLgbLgbLgbRsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 3; Drug: Control
bLiLsbLgbLsbLgLsbRgbLsbLibRgbRgbLiRsbLsbLjbLgbRgbLsLsmbRsbLhbRgbLcbLhb
LgbLibLcbLsbRgbLobLibLgbLibLgbRibLcbLcbLcbLgbLgLsbLsbRsbLgbLgbLgbLgbLg
bRsbLgbLgLsbLgbLgbLgbLsbLgbRsbRsbRjbLjbLgLsbLgbLsbLgbLsLsmbLgbRgRsmbRs
bLgbRsbLgbLibLibLibLsbRgbRgRsmbLgbLibLgbLgbLgbLgbLgbLgbRsbLgbLgbLobLob
LibLgbLsbLgLsbRgbLsbLgLsRgbRibLcbLgbLibLibLgbLgbRsbLsbRgbRsbRsbLhbLhbR
gbLgbRsbLibRgbLibLgbLgLsbLgbRsRsLsmbLgbLgLsbLgbLsbLgLsbLsbLsbLgLsbLgbL
ibRgbLibRsLsbLsbLgLsbLsLsmbLgbLgbLgbLsbLgbLsbRgbLgbLsLsmbRsbLgLsbLsbLg
LsbLibLsbLsbLgbLsLsmbLgbLsbLsbLgbLgbRsbLgbLgbLgbLgbLgbRsLsbLgbLgbLsbLg
bLsbLsbLgLsbLsLsmbLgbLsLsmbLgbLgbLsbLgbLibLgbLgLsbLsbLsbLgbLsbLgbLgbLs
bRsLsbLgbLgbLsLsmbLgbLsLsmbLgbLsLsmbLgbLgbLsLsmbLgbLgbLgRsbLgLsbLgbLgL
sbLgbLgbLgbLgbLgbLgbLgbLgbLgbRsbLgbRsbLiRsbLgLsbLgLsLsLgmbLsLsmbLibRgb
LgbLgbRsbLgbLsbLgLsbRsbLsLsmbLgbLgbLgbLgbLgbLsLsmbLgLsbLgLsbLgbLgLsbLg
LsbLgbLgLsbLgbLsLsmbLsbLgLsLsmbLgLsbLibLsLsLsmmbLibLgbLgbLgbLsbLiRsbRs
bLgbRgbLgbLgbLgbLsbRgbLibLgbLgbLsbLsLsmbLgLsbLgLsbLsbLgLgLsbLgbLgLsLsm
bLgbLsbLgbLgbRgbLgLsbLgbLgLsbLgLsLsmbLgbLgbLgLsbLsLsmbLgLiLgbLgbLgbLib
RsLsbLgbLgLsRsbLgLsLsmbLgbLgbLgbLgbLsbLgbRsLsbLgLsbLgbLgbLgbLgbLsbLgLs
bLsbLiLsbLgLsbLgbLsbLgbLsLsLsLsmmmbLgLsbLgbRsLsbLgLsbLsbLsbLgbLgLsbLgb
LgbLgbLgbLgbLgbLsLsmbLgbLgbLgbLgbLsLsmbRsLsbLibLgbLgbLsLsmbLibLgLsbLib
LgbLgbLsbLgbLgbLsLsmbLibRjbLhbLibLibLgLsbLsbLibsbLgbLibRgLsbLibLgbLgbL
gbLgLgLsbLgLsbLgbLgbLgbLgbLgbLgbLsbLgLsbLgbRsbLibLgLsbLgLsbLgbLgbLibLg
bLgLsbLibLgbLhbLgbLibLgLsbLibRgbLcbLibLibLgbLgbLibLibLcRsbRgbLiLsbLibL
gbLgbLgbLibLgbRsbLibLibLgbLgbLgLsbLgbLsLsmbRgbLibLgbLgbRjbLiLsbLgLsbLg
bRsbLibLsbLgbLgbLsLsmbLsbLgbLgbLgbLsbLgLsbLsLsmbLgLsLgbLgbLgbLgLsbLiLs
bLgbLgLsRsbLgRsbRsbLgbLsbLgbLgLsbLgLsbRgbLgbLgbLgbLgbLsbLgbRsbLgbLsbLg
LsbRsbLgLsbLgbLgbLgbLgbRsbLibRgbLibRsbLiLsbLgbLsbLgbLgbLsLsmbLgbLgLsbR
sRsmbLgLsbLgbLgbLsbLgbLgLsRsbLibLsbLgbLgbLgLsbLgbLgbLgbLgbLgbLsLsmbLgb
LiLsbLiLsbLgbLsLsmbLgbLgbLsbLgRsbLgbRjbLibLiLgbLgLsbLgbLsLgbLgRsbRgbLg
LsbLsbLibLgbRsbLgbLgbLgbLgbLgbLgbLgbRsRsmbLibLgbLgLsbLgbLgbLgLsbLsbLib
LibLgLsbLgbLibLibsbLiLsbLgbLibLsbLibRsLsbLgbLgLsbRsbLibLsbLgbLiRsLgLsb
LgLsLsmbLgbLgLsbRgbLibLsbLsLsmbLgbLgLsRsbLgLsLsmbLgbLgbLgbLgRsLgbLibLg
LsbRgbLiLsbLsLsmbLsbLgbLgRsbLgbLgLsbRsbLiRsLsbLiLsbLsbLgLsLsLsmmbLiLsL
sLsmmbLsbLgLsbLgbLgbLsbLgLsbLgbLibLibLibLgbRgbRobLcbLcbRgLsbLibLsLsmbR
sLsbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 4; Drug: Control
bLgbLgbLgbLsbLgbLgRsbLgbLgbLgbLsbLsbRgbLibLgbRsbLgbLsbLsbLgbRgbLgRsbLi
bRsbLibLoLsmbRgbRgbLgbRsbLgbLsbLsbRibLcbLgbRsRsmbLibRgbLsRoLsbRjRsmbRi
LsbLibLgbRjbRsbRgbLobRsbRjbLcbLobLcbRibRjbLjbRiLsbLibRibRcbLibLcLsmbRs
bLsbRjbLibLgbLsbLsbLsbLgbLsbLsbLsbRcbRobLibLjLsmbLibLibRsbLgbRsbLgbRsb
LsbLsbLgbLsbLgbRsLsbLgLsbLgbRsbLsbLgbLgbRsbLsbLgbLgbLgbRsbRsLsbLgbLgbL
gbLgbLgbLgbLsbLsbLgbLgbLgbLgRsbLgbLsbLgbLgbRgbRsbLibLsbLgbLgbLgbLsbLsb
LjbLgbRsbLibLgbLgbLsbLgbRgbLgbRsbLibLgbRsbLgbLsbLgbLgbRsbLgbLgbLgbRsbL
gbLgbLsRsbLgbLsbLiLsbLgbLgbLsbLgbLgbLsbLgbRsbLgbLgbLgbLibLgbLsbLibRgbL
gbLgbLibRgbRgbLibRsbLgbRcbRobRgbLibLjbLgbLibLgbLsbLibLibLibLsbLsbLgbRs
bRibLibLoRsbRibRhbRgbRgbRibLjbLcbRibLibLsLsmbLibRsbLibLsbLsbLibRgbLgbL
sRsbLsLibRsbLiLsbLsRsbLgLsbLsbLgbLgbRgbLgbLsbLjbRhbLibLiLsbLibRgLsbLgb
RgbLibLsbLgbRsbLsLsmbLiLsLsmbRgbLibRgLsbLgLsbLgbRsbLgbLibRgbRjbLjbLiLs
bRsbRjbRcbRjbLcbLhbRgbRsbLgbLibRsLsbLsbLgbLgbLgbLsLsmbRebRebRsRsmbLgbL
sbLgLsbLgbLgRsbLibLgbLsbLgbRsbLgLsbLsbLgbLgbLgbLgbLgbLgbRsLsbLgbLgbRjb
LibLgbRsbLgRsbRsbLibLgbLgbLgbRsbLibLgbLsbLgbLsbLgbLgRsbRsLsbRcbLibRobR
cbLiLsbRsbRjRsmbRcbRcRsmbLibRgRsmbRibLibRibLcbLsRsbLcbRibRcbRibRibRibL
sbLsbRgbLgbRgbLjbRibLjbLcbRibRibLhbRibRibLgbRgbLhbLhbLsbLsbLgbLibRsRsm
bRsbLibRsLsbLgbLgbRcbRebRgbLsbRjbRgbLiLsbRibRgbRsbRgbRgRsmbLjLobRsbRsb
sbsbLhbRgbLhbRsRsLsmbLsbLgbLsbLhbRgbLsbLgbRsLsbLgbLsbLgbLgbLgLsLsmbLsb
LgLsbRsbLgbLgLsLsmbLsLsmbLgbLsbLgbRsbLsbLibRsbRsbLibLsRsbLgbLsLsmbLgLs
bLsLsmbLgbLibRsbRsbLibLgbRsbLiRsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 5; Drug: Control
bLgbLgbRiRsmbRgbLhbLsbRsbLcbRgbLsbRgbLobLgbLibLibLgbRgbRgbLobLgbLibRjb
RoLsbLsbRibRgbRobRibRibRhbLiLsbRjbRibRsbRsbRgbRsbRgbRsbRsbLoRsRsmbRjbL
obRsbLgbLsbLgbRcbLsbLsbRibRcbRibRsLsbRsbRibRgRsmbRgbLgbRgbRgbRgLsRsbLs
bLsbRgbRsbRgbLibLcbLhbRgbLcbLgbRgbRgbRibRgbRsbRgbLsbRsbRgbRsbRgRsmbLsb
RsbRgRsmbRsbRgbRgbRsRsmbRgbLobRsbLsRsbRgbLsRsRgbRgRsmbLgbRgbRgbRsbRgRs
mbRsbRgbLhbLhbLhbRiRsmbLibLibLibLsbLgbLgbLsRsbLgbRgRsmbLiRsbRgbLibLibL
sbLibRgbRibRsbRiRsmbLjbLcbLibLibRgbRgbLgbRsbLgbLgbLiLsbLgbLgbLgLsbLsbL
gbRsLsbLgbRsbLgLsbRgbLgRsbLgbRgbLgLsbLgbRgbLgbRsbLgLsbRsbLgbLgbRsbLgLs
bLgbLgbLsbRsbLgLsbRsbLgbRobRiLsbRcbLibLiLsbRiRsmbRgbRgbLsbRibLgRsbRibL
gbRgbLgLsbRibLgRsbRiRsmbLsbRgbRgLsbLgbRgbLsRsbRgbRsbRgbRsLsbRsbRgbRsRs
mbRsbRsbRgbRgbRgRsLsmbRgbLgLsbRgbRgbLgbRgbRgbRgbLcbLibRibLiRsbLibLgbRj
bRsbRjbRibLhbLibLsbLibRgbLibLsbLgbRgbLibLgbLgbLgbLgbLgbRsbLgbRsLsbLgbL
sbLsLsmbLgbLsbLgbLgRsLsbRsbLsbLjbLgRsbLgbRibRcbLgbRhbRibLibRibLebLibRs
bLcbRsbLgbLsLsmbLcbRiLsbRsLgbRsbLgbRsLgbRgbLibLsbLibRjbRcbLcbLcLsmbRib
LsbRoLsbRcbRibLgRsbRgbRibLjbRjbRgbRibLgbRsbRsRsmbRgbRgbLsbRgbRsbRgbRgb
RsbRsbRgbRsbRsbRsbLsRsbRgbRsbRsbRsbRgbRsbRgbRgbRsbRgbRsbRgbRsbRgLsRsbL
sbRibLsbRgRsmbLsLsmbRibLiRsbRgbRgbRgbRgbRgLsbRsbRgbRgbLsbRgbLgbRgbRsbL
sbRgLsbLsbRibRsbRiRsmbRgRsmbRsbRsbRsbRgbRgbRgbRgbRsbRgbRsRsmbRgbRgbLsb
RsbRgbRibLsbRgbRsbRsbRgbRsbRsRsmbRgRsmbRgbRgbRsbRgbRsbRgbRsbRgbRsRsmbR
gbRsbRgbRgbRgbRgRgbRgbRgbRgbRgbRgRsmbRsbRgbLsbRgbLsRsbRiRsmbRgRsmbRgbR
sRsmbRgbRsRsmbRsbRgbRgLsbRgRsmbRsbRgbRsRsmbRgbRgbRgbLgbRiRsmbRsbRsbRgR
smbRgbRgbRgbRgbLsbRgbRsbRgbRgbRsbRsbRgbRsRsmbLsbRgbLsbRibRgbRsRsmbRgRs
mbRgRsmbRsbRgbRgbRsbRgbRgbRgbRgbRgbRgLsbLgLsbRibRsbRgbRsbRsRsmbRgRsmbR
sbRsbRgbRgbRgbRgbRgbRgbLsbRgbRgLsbLsbRibRsRsmbRsbRgbRgbRgbLsbRibRgbRib
RobRcbRibRgbRiLsbRiRsmbRgbRgbRgbRibRsLsbLjRsbRjbRcbRgbRibRsbsbRgRsmbLc
bLcbLsLsmbRibRiRsmbRhbLgbRhbRiRsmbRsbLsbRibRsbRgRsmbLgbLsRhbsbRibLhbRg
bRgbLcbLibLgbLcbRjbRcbRebRsbLgbRgbRsbLcbLcRsRsmbRibLhbLcbLibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 6; Drug: Control
bLibLgbLsbLsbRcbRibLcbLibLhRsbLsbRgbLcbLcbLjbRibLgbLibLgbLgbLibLhbRgbL
cbRgRsmbLhbLsLsmbLiLsbLsbLsLsmbLsbLgbLgLsbLsbRsbLsbLsLsmbLgLsbRgbLjRsb
LibRjbRhbRcbLgbRibRgbLgLsbsbRgbRgbRgbLsbRgbRsbRgbLsbRgbLcbLhbLcbLhbLjb
RgbLjbLibLibRgbLgbRgbLgbLgbLibRsbLgbLgbLsbLsbLsbLgbLgbLgbRsbLgbLsbLibR
sbLgbLiRsbRjbRgbRgbRjbRgbLjbLcbLcbLcbLgbLgbRjbRcbLgbLsLgbRgLsbRgRsmbRs
bRsbRgLsRsbRgRsmbLjRsbRgbLjbRibRsLsbRsLsbLsbRibRsLsbLsbRibLjbLiLsbRjbL
jbLibLibRjbLcbLcbLhbRgbLgbRibRsbRgRsmbRsbRgLsbLsbRgRsmbLsbLsRsbRgRgbLs
bRgbLjbRiRsRsmmbRibsbLsbLgbLsbRgbRibRgbRgbLsLsmbRgbLgbLhbsbLhbRiRsmbRc
bLgbRibLibLibRgbLgbRsbLiLsbLsbLgbLgbRsLsLsmbLgLsbLgbLsbLsLsLsmmbLsRsbL
sbLgbLgbLgbLgLsbRsLsbLgbLsbLgLsbLgLsbLgbLgLgbLgLsbLgbLgLsbLsLsRsmbRsbL
iLsbLgbLsbLgbLgbLsLsmbLgbLsbLgbRsbLgRsbLgbLgbRsbLgbLibRgbLibLibLgbLsbL
gbRcbRibLgbRibLsbRgRsRsmmbRgbRgbLgbRgbRgbLcbLcbLcbLhbLgbLibLiLsbRibRjb
LcRsbLsRgbRsbLgbLgbLgbLgbLgLsbLgLsbLgbRsLsLgbLgbLgLsbLgLsbLgLsRsbLsLsm
bLsLsmbLgLsbLgbLgLsbLgLsbsbsbLgbRsLsbLgbRsbLgLsbLgLsLsmbLsbLgbLgbLiLsb
LsbRgbLgbLjbRjbLgbLibLgLsbLgbLcbRgbRsbLobLibLhbRjRsmbLibLsbLibRhbRhbLi
bRcLsbLhbRgRsmbLjbLcbLcbLibLibRgbRibRgbRsLsbRiLsbRgbLiLsbLjbLibLgbRcbR
iRsmbLgbRibRiLsbRjRsmbLibLibLsbRhRsmbRiRsmbRibLibLjbLibRsbRebRibRibLib
RiRsmbRsRsmbLsbRgbRhbRcbRgbRibRgbLcbLcbRgbLhbLcbLibLibRibRhbRibLsLsmbR
cbLsbRsRsmbRibLiLsLsmbLcLsmbLcRsbRibLibLsbLgbRsbLibLgbLsbLgbLibLsbLgbL
sbLgbLgLsbLsbLgbLsLsmbLsLsmbLgLsLsLsLsmmmbLgbLgbLgbLgLsLsmbLgbLgRsbLgL
sbRsbLgbLgbRsbLgLsLsLgmbLgbRsbLgbLgLsRsbLsLsmbLgLsbLsRsbLgLsLsmbLgbLgb
RsbLgLsbLgRsbLgLsbLgLsRgRsmbLgRsbLsLiLsbLgRsbLiLsbLsbLgRsbLsbLgbLgbLgL
sLsmbLibsbLibLibLibRibLcbLiLsbLsbLibLibRgbLcbRibLibLgbLsbLgbLgLsLsmbLs
bRjbRibRhbRcbLiLsbRibLiLsbLhbRgbLgbLgLsbLiLsbRsLsbLgLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 7; Drug: NDMC 1 µM
bLjbRjbRsbLsbRgbLgbLcbRiRsmbRibLhbLibLjbLcRsbRjRsmbRcbRcRsmbRgbRibRgbR
ibRgbRgbLsbRgbRgbRsbRsRsmbRsRsmbRgbRsRsmbRsRsmbRsRiLsbRhbRibRibLjbLcbL
hbRgbRibLsbRgbRcbLgRsRsmbLjbRcLsbRhbRsbRibRsbLsbRgbRibRgbRsbRsbRgbLsRs
bRsbRsbRsbRsbRsbRgLsbRgbRgbLjbLibLobRsbRgbRsbLsbLibLsLsmbRibLibLgbRgbL
gbLgLsbLibLsbLsbLsbLgbLgbLibRsbRsbLsLsmbLibRsbLsbLgbLsbLsRsbLgLsbLsbLg
LsbLgbRsLsRsbLgLsbLgbLiRsbRgbLiLsbRsRsmbLgbRsbLibLhbLgbLgbLgbLcbRiRsmb
LibLsbLiLsbRsbLcbRsbLcRsbLgbRsbLgbRgbRcLsbRobRgbLiLsbRsbLgbLgRjbLsbLgR
sbLibRsbLgLsbLgLsbLgbRjbRcbRgbLsRsbRibRsbRibRsbLsRsbLgbRjbRibRsbRsRsRs
mmbRgRsmbRgbRgbRsRsmbRiLsbLgRsbRibRibLsRsbRgbRgRsmbRgbRsbRsLsbRgbRgRsL
smbRgLsLsmbLsbRgRsmbRgbRibLgLsbLjbRcbLjbRhbRsbLhbRjbRjbRibLgbRhbRibRgb
LsRsbRgbRgbRgbRgbRgRsmbRgbRgRsmbRgbRgbRsbRsbRgbRsbRsRsmbRsbRgRsmbRsbRg
bRgbRgbRgRiRsRsmmbRgbRgbRgbRsbRgbRsRsmbRsRsRiRsRgRsmmmbRgRsmbRsRibRgbR
gRsmbRsbRgbLjbLibRjbRhbLjbLibLsbLibRjbLobLibLibRibRibRibRgbRsbRibRsRsm
bRgbRgbRgbRsbRibLjbRoLsbLgbRhbLibLgbRcbLsbRiLgLsbRgLsbRibLsbRgbLsbRgRs
mbRsbRgbRsbRgRsmbRsbRsRsmbRsRsmbRgRgRsLsRgmbRsRsmbRgbRgRsmbRsbRgRsmbRs
bRgbRgbRgbLgbRibRgbRgbLgbRgbRsbRgbRgbRgbLgbRibRgRsRsmmbRgRsmbRgRsmbRgb
RgbLsbRgRsRgmbRgRgbRgbLebRcLsbRgbRsbRgbRibRgbLibRcbLgbRibRsbRgbRsRsmbR
gbRsRsmbRgbRgRgRsmbRgRibRgRgbRgbRiRsmbRgRsLsmbRgbRgRsmbRgbLsbRgbLjLsLc
mbLibRebRjbRibRgbRgLgbRibRsbRgbRgbLgbRgRsmbRsbRgbRgbLjbRiLsbRgbRgbRsbR
gbRibLgbRsbRgbRgRsmbRgRgRsRsmmbRgbRgRsmbRgbRgRsmbLsRsbRgbRgbLjbLcbRcbR
gbLgbRgbRebRsRsmbRcRgRgRsmbRsRsmbRgRsRiRimbRsRsmbRsLsRgRsmbRsbRgRsmbRg
RgRibRgbRsbRgRsmbRsRsmbRgRiRsRsRgRsRsRgmmmmbRgRsmbRgRsmbRgbRibRgbRibRs
RsmbRibRiRsmbRcbRgbRiRsmbRsRsmbRgRsmbRsLjbRcRsRsRsmmmbLgbRjbRsRsRgRsmm
bRsbsbRgbLsRgbRsbRgRsmbRgRsRsmmbRgbRibRsbRibRsbRjbRjRgRsRsmmbRgRsRsmmb
RgbRgbRgLsbRsbRsbRgRsRsmmbRgbRgbRibRiRsmbRgRibRgbRjbRjbRgbRsbRgbRsbRgb
LsbRgbRiRgbRgbRgbLjbRibRebRsRcbRjbRsbRgRsRgRsmmbRgRsmbRsRsmbRgbRgbRiRi
RibRjbRsbRgbLjbLobLhbLibsbRcbRgRsmbRgbRgRsRsmmbRibLsLsmbRgRsmbRibRgbLg
bRiRsmbLsbRibRgRsRgRsmmbRgRsmbRgbRgRsmbRsbRsRsRsmmbLsRgRsmbRiRsmbRsbRj
bRgbRsbRgbLcbLhbRjbRcRsmbRgRsmbRibRgRsmbRgLsbRsRsmbLcbLebRgbLhbRgbLsLi
bRhbRgbRgRsmbsbRiRsmbLsbLsbRsbLjbLibLcbLibRibRsbRobRsLsLsLsmmbLcbLibLi
bRebLsLobLiLsRgbRgbLcbRsRsmbLhbRgbLibLibRgbRjRcbRcbRhbRgbRgbLsLibRsLiL
sLsRsmbLgbLsLgLsbLgLsbRsbLiLsRsbLgLsbLgbRgbLhbLhbRibLsbRgbRibRibRsRsmb
RgbRgRsmbRgbRgRsmbRgRsRsmmbRgRsRgRgRsmmbRgRsmbRgbLsbRgbLsbRibRgbRsbRgb
RgbLsRsbRgRsmbRsbRgbLjbLhbRjbRhbRibRgbRibLhbRcbRiRiLsRsbRcbLgbRibRgbLs
bRgbRgbLjbLjbLibRjbLebRiRsmbLhbLgbRibLcbRibRsbRebRibLjbRebLsbLjbLcbLhb
LobRibLsbRibLjbLjbLhRsbLgbRibRsRgbLjbLibRjbLibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 8; Drug: NDMC 1 µM
bRgbRibRiLsbLsRhbRsbRgbRsbRcbLsRsbRibLjbRiLsbRgbLgbRibLjbRjbRcbLgbRsbR
ibLsbLgbLsbLgbRjbRoLsbLgbRhbRibLibLobLgbRjbRcbRobLgbRhbRcLsbRibRhbLgRs
bRibRibLsbRgbRiLsbRibRsLsbLibLgbLcbLcbLgbLgbLgbRhbRcbLsbRhbLsbRgbRsbLs
bLsLsmbRibRgbLsLsmbRgbLgbRibLgbRoLsbLgbRiLsbRibLibRibLibLibLsbRjbRjbRc
bLgbRibRobRoLsbRibLibLiRsbLgbLgbLsbLsbLsbLsbLgbLsRgbLsbLgbLsbLsLsmbLgL
sbLgbLsbLsbLsbLgbRsbLgLsbRsbRsbLgbRsRsmbLgbLgbLgbLsLsmbLsbLsbRsbLgbRjb
LibLsbLsLsmbRsbRibRibLsLsmbRsbRgbRsbRgbLsbRibLjLcbLhRsRsmbRcbRgbRgbLjb
LobLibRgLsbLhbRsbRcLsbRsbRiRsmbRgbLsbRibLgbRgbRsbRgbLsbRibLsbRgbRibRib
RsbLgbRoLsRsbLgbRiLsbLjbLcbLsbLsbLgbLibRjbLhRsbLibLgbRsbRgbRiRsmbRgbRs
bRibLgbRiLsbLjbRibRiLsLsmbLgbRibLsbRibLsbRiLsRsbLsbRibLsbRibLgbRibLsbR
gbRsbRibLsbRibLsbRgbRsRsmbRgbRgbRsLsbsbRgbRsbRgRsmbLsbRgbRgbRsbRgbRgbR
sbRgRsmbRsbRgbRsbRgbRgbRsbRgbRsRsmbRgbRsRsmbRsRsmbRgbRgbRgbRgbRibLjbRh
bRibRgbRgbRgbLcbLibLsbLobRibRgbLsLsmbLsbLibRjbRhRsmbLjbLgbRsLsbRsbLsLg
bLsbLsbLsLsmbRhbRsLgRsRibRgbLobsbRsbLibRgLsbRibRiRsmbLsbRiRsmbRsbRgRsR
smmbRsLsbRgbRgbRgbRgbLsbLgbRibRgRsmbRsRsmbLobLsRsbLhbRiLsbLibRhbRgbLsb
LsbRgbRgbRgLsbLoRsbLcRsbRgbLibLobRgbRibLhLsbRgbLibRjbLibLsbLgbLsbRsRsL
smbLgLsbLgbRsRsmbLgbLsLgbRsbLsbLsRcbLjLsmbLibLgbLiRsbRsRsmbLgbRsbLgbRs
LsbLgbLgbLsbLgbLgbRsbLgLsbLsbLgLsRsRsmbLsbLgbLsLsmbLgLsbRsbRsbLgbRsLsb
LgbLgbLsLsmbLgbLgbLgbLsbRsbLgbLgLsbLgLsbLsbLgbLgbLsbLsbLgbLsbLgRsbLgbR
sbLgbLgLsbLgRsbLgbRsbLgbLgbsbLgLsbLgbRsbLsbLgbLsbLsbLsbLgbLsLsmbLgLsbL
gbLgbLgbLgbLgbLsbLgbLgRsbLgbLgLsbRsbLgLsbLsRsbLsbRjbRiRebLcbRibRibLgbR
cLsLsmbRcbRibRsbLobLibRgLsbLgbRgbRjbRgbRgbLsbLsbLsRgbRgbRsbRgbRhbLibLj
bLcbRgbLobLibLgbLgbRgbLgLsbRobRhbLgbRgbRibLsLsmbRgbRoLsLsmbLgbLcbLcbRs
bLgbLgbLgbLgbLsbLgbLgbLgbLsbLsbLsbLgbLsbLgbLsLsmbLsbLibRgLsbLibRsbLibL
gbRgbLgRsbLsLsmbLgbLsbLgbLsbLsbLsbLgbLgLsbRsbRsbLgbLgbLsbReLsbRibLsbRi
LsbRiLsbLsbRibLgbRibLsbRibLsbRibLgbRgbLsbRiLsbLsbRibLsbRgLsbLsLsmbRgRs
mbRgbRibLgbLgbRiRsmbRgbLsbRgbRsLsLsmbRibRgRsmbRgbRsbRgbLgLsbRgbLsbRibL
gbsbRgbLsbRibLsbRgbRsbRgbRgbLgbRibRibLgbRiLsbRiLsbLgbRiLsbRibRibRsbLgb
RobLsbRgbRhbRgbLgbLgLsbLjbLibRgLsbLiLsbLgbLsbLgbLgbRsLsbLgbRsbLgbLgbLg
bLgbLsbLgbLsbLgLsbRsbLgbLsbLsbLgLsbLsbLgbsbLsRsbLgbLsbLgLsbLgLsbLgbLgb
RgRsmbLgbLgbLgbLgbRsbLgLsbLsLsmbLgbLgbLgbLsbLgbLgbRsbLsbRcbRibLsbRibLs
LsmbRibRhbLgbRgbRibLsRgLsbLjbRobLgRsbRcbRgLsbLjbLiLsbLgbRgLsbLgbRsbLcb
Rib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 9; Drug: NDMC 1 µM
bRibRcRsmbRgbRgbRibLcbRjbLcbLobLsbLgbLsLibLsbLgbLgbRebLcbLibLsbLsLsmbL
sbLsbLsbLsbLgLsbLibLsbLgbRibLgbLgLsbLsbLobRcbRcLsbRibLgbRibLgbRgbLsbRs
bRsbRsbRibRsbRsbLgbLjbRhRsmbLgbLsbRibLsbRsbLsLsmbRgbLsLsRsmbLjbRibLjbL
ibLibLhbRgbLgbLgbLgbRjbLsLibRgbLgbLgbRhbLibLgbLgbLgbLgbLibLibRgLsbLgbR
cbLibLiLsbLgbLjRsbLcRsbRibLgbLgbLgbLjbLgbLibRibLibLsbRsbLsbRsLgbRsbRsL
ibLsbRsbRsbLsLsmbLgbLsbLsbLsbLsbRjbLcbRjbLcLsmbRgbRhbRcbLibLhbRhbRibLs
bRibLgLsbsbRibLsbRsbRgLsbRgbRgbRsbRgbRsbLsRsRsmbRsRsmbRgbRgbRsLsbRsRsm
bRsbRsbRsbRsbRgbRsRsmbRgLsbLcbLcbRgbLcbLsbLibRsbRibRhbLhbLibRjLsbLibLs
bLgbLibRjbLibLibRjbsbLibLiLsbLsbLsbLsLsmbLsLsmbLgbLsbLsbLibLgbLibRgbLs
bLgbLgbRgbLiLsbLgbRsLsbLgbRsbLgbLibRgbLibLsbLsLsmbLgbRgbLgbLibLgbLgbLg
bLibLibLiLsbRsbRsbLibLgbLsbLgbRjLsbLibRjbLibLibLgbLsbRsbRgbLgbLibLsLsm
bLsbLgbLgLsbLgbLsbRsLgLsbLsLsmbLsLsmbLsbLsbLgbRsbLgbLsLsmbLgbLgbRjbLgb
LgLsbLsbLgbLsbLgbRsbLgbLgbLgbRsbLgbLgbLgbRsbRhbRiRsmbLsbRgbRsbRcLsbLgb
RcLsbLgLsbRcbLibLibLgbLgbRsbLiLsbLjbLobLsbLcbLibLibRjbLibLibLsLsmbLgbL
sLsLsLsLsmmmmbLsLsRsmbLsbLgLsbLsLgbLgbRjbLgbLgRjbLsbLsLsmbLsbLsLsmbLgb
LgbRgRsmbLgbLgbRsbLgLsbRsbRjLsbLibLibLsbLsbLsbLibRsRsmbRsbLgLsbLsbLgbL
sbLsbLgbLsbLsbLsbLgbRgbLsbLibRsbLgbLgbLgbLgbRibLibLsLsmbLgbLgbRsLsbLiL
sbRsbLgLsbLsbLgbRsbLiLsbLgbLgbLgbLgbRgbLiLsRsLsRsbLsLgLsbLsbLsbLgLsbRs
bLgbLgLsLsmbRsbLibLsbLgRsbLsbLgLsbLgLsbRjbLibRgbLgLsbLgLsRsbLgbRjLiRsb
RhbLiLsbLibRjbLgbLgbLsbLgbLsbLsbLsbLsbLibRsbLiRsbRjbRcbRcbRibLgbLgbLib
LibLgLsbRgbRhbRgRsmbRiLsbLgbRhbLgbRibRibLjbRibLgRgRsmbLsRsbRgRsLsmbRgb
RsRgRsmbRgbLjbLibLgbLsLsmbLsbLsLsmbLgbRsLsbLgLsbLsbRgLsbLgLsbRgbRsLsbL
gLsLsmbLsbLgbLgbLgLsbLsbRgbLgLsbLgbLsLsmbReLsbRibLibLiLsbLhbLgLsbLsbLs
bLsLsmbLhbLgbRgbLobRibLhbLcbLibLsbRgbLibLibLgbRsbLiLsbRsbRjbRibLcbLibR
ibLibRjbLgRsbLhRsbLsRsbLibRsLsbRsbRsLgbLsbLgLsbRjbRcbLjbLibLgLsLsmbRgL
sbLgbRsbLgLsLsmbRsbLsLsmbLsLsmbLgLsbRsbLsbLgbLiRsLsbLibLgbRgbRiRsmbRib
LgLsLsmbRsbRcbLibRhbRibLsbLgbRcbLgbRiLsbRiLgLsbRgbRcbLgbLibLibLibLsbRg
bLjbRhbsbRjbRhRsmbRgbRibRsbLsLsmbRsLsbLibLibRsbLsbLsbLgLsLsmbRsbLsbLgR
sbLsbLsLsLsmmbLsbLgbLsbLgbRgbLsbLibRjbLibRsLsbRsbLsLsmbLgLibRsLsLgLsbL
gbLsRsbLsLsmbLsLsmbLsbLsLsmbLsbLgbLsbLgLsbLsbLgbRsRsmbLiLsbLsLsmbLgbLs
bRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 10; Drug: NDMC 1 µM
bRgRsmbRsbLsbLgbRibRgbRgbLsbRsbRsbRgbRgbRobRgbRobLjbLsbRsbLobRcbRcbRgb
RjbRcbRhbRsbRgbLgbRibRgRsmbRsbRgbRgRsmbRsbRgbRsbRsbRgbLjbRhbLobLsbRcbR
ibLobLibRgbRsbRsbRibRibRgbRgbRsbRgbRgLsbRsbRgbRgbRgbLibRibRibLjbRcbLsb
RibLjbRgbRibRibRcbRcbRibRgbRgbRsbLcbRjbRibRgbRjbRebRebRsbRcLsbLgbRsbRg
bLibLsbLsbLjbRjbRobLsbLgbRgbLjbLgbLibRobRjbRjbRebLgbLibRibRgRsmbRgbLgb
RgbLgbRgbRgbRgbRsbRgbLsbLjbRibLsbsbRgRsmbRiRsmbLsbRgbLgbRgbRsbRjbRgbRs
bRgbLjbRibRgRsLsmbRgbLsbRgbRgbRgbLsbRgbRgLsbLgLsbRsbRgbLsbRgbLjbLibLgb
RgRsmbRgLsLsmbLobLgbRjbLibLobRsRgbLsbRgbRgbRsbRgbRsbRgbRsbRsbRgbRgbRgb
RsbRgRsmbRgbRgbRsbRgbRgbRgbLjbRgbRgbLjbLgbRsbLibLibRibRibRcRsmbLibRibL
eLsbRjbLjbLsbLibRibRhbRgbRsbRgbRgbRgbRgRsmbLsbRgbLgbRgLsbRgbRgRsmbLgbR
gbLgbLgbLhbRjbLibLgbLgbRgRsmbRobRsbRgRsmbLgbRgbRgbRgbLjbLibLgRsbRjbRsb
LgbLgbLgLsLsmbRgbLgbRgbRibLsbRibRgbRgbLgRsbRgLsbRgbLgbRibLhbRgbLhbRjbL
ebRibLibRgbLgbLgRgbLgbRjbRcbLgRsbLjbLcbRibLgLsbLgbRsbLiLsbLibLgbLsbRob
RsbRgRsmbRhbLjbRibRibRsbRgbLjbLobLibLsbRcbRibLjbLiLsbLebLsbRebRgbLiLsb
LgLsbsbLsLsmbLhRsLsbRibRjbRgbRgbRgbLsbRgbLgbRhbRgbRgbLgbLgbRibRgRsmbLs
bLobRib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 11; Drug: NDMC 1 µM
bLsLgRsbLsbLibRjbLhbRibRgbRgRsmbRsbRsbLsbRgbLcRsbRgbLcbRgRsmbLibRsbLib
RgbRsbLgbRjbLiRsbLgbRjbRibRibRgbRgbLjbRgbRgbRcRibLibRsbRsbLsbLibRsbRsb
RgbRgbLiRsbLcbLgbLibLsbRsbLsbLsbLibRsbLgbLsbRjbLhbRgbRsbLibRjbLibRjbRg
bLjbLcRsbRgbLgbLgbLsbRsLsbLgbRsbLsLsmbLsbLsbLsbLsbLgbLsbLgbLsbLgbLsbLs
bLgbLgRsLsbLgbLsbLgbLgbLsLsLsmmbLgbLsbLsbLgbLsbLgRsLsbLgLsbLsbLsbLgbRs
bLgbLgLsbLgbLgbLgLsbLsLsmbLgbLgLgLsbLgLsLgbLgbLsbLsLsmbLsbLgbLsLsmbLsb
LsLsLsmmbLgbLgLsbLgbLsLgbLgbLgbLgbLgbLgbLsbLsbLgbLgbLsbLgbLsLsmbLgbLgb
LsbLgbLsbLsLsLsmmbLgbLsbLsbLgbLsLsmbLgRsbLsbLgbLsbLgRsLsbLsbLsbLsbLgbL
gRsbLobLsRsbLsLsmbLgLsLsmbLsLsmbLsbLgLsbLgbLgbLsbLsLsmbLsbLsbLsbLsLsLs
mmbLsRsbLsLsLsmmbLsLsmbLgbLgbLsbLgbLgbLgLsbLgLsbLsLsmbLsbLgLsLsmbLgbLg
bLgLsbLsbRsLsbLsLsmbLsLsmbLgLsLsmbLgLsbLsLgbLsLsLsmmbLgbLgLsRsbLgbLsLg
bLsRsLsLsLsLsmmmbLgbLsbLgbLgLsbLgbLgbLibRgbLibLgbRsbLibLobLibLgbRgbLjL
ibRgbRibRgbLebRcbLjbRibRibLjbRgLsbLsRgbRsbRsbRsbRgbRgbRgLsbRgbRsbRgRsL
smbRsbRgRsLsmbRgbRsbRsRsmbRsLsbRsbRgbRgbRgbRsbRsbLgRsbRgbRgbRgbLsLsmbL
sRgRsmbRgbLgbRgbRgLsbRgbRgRsmbRsbRsbLsbRgRsmbRgbRsbRgbLsbRgbRsLsbRgLsb
RsbRgbRsbRgbLsbRgbRgbRsbRgbRsRsmbRgLsbRsRsmbRgRgbRgLsbRgLsbRgbRsbRsbRg
bRgbLsRsbRgbRsbRgRsmbLsbRgbRsLsbRgbRsbRsbRgbRsbRgbRgLsbLgbRgLsbLsbRgLs
bRgbRgbRgLsbLsbRgbRsbRsbRsRsmbRgRsmbRsbRsbRsbLsRsbRgLsbRgLsbRsbRgLsbRg
bRgbRgbRgbRsRsRgRsmmbRsRsmbRgRsmbRgRsmbRsRgRsRsRgmmbRgRsmbRgbRgbRsbRgL
sbRgbRgLsbRsLsRsbRgbRgbRgbLsbRgbRgbLgbRgbsbRgRsmbRsbRgRsmbRsRsmbRgbRsR
sLsmbRsbRgbRgbRgRsmbRsbRsbRgbRsbRgbRsbRgbRsbRgbLibLhbLibRjbLhbRjbLibLi
LsbRjbRjRgbLebRsbLibRsbLgbRsbLibRsLsbLgbLsbLgbLgRsLgbLsbLgbLgRsbLgLsbR
sbLibLgRsbLsLsmbLsLsmbLgbRsRsLsLgmbRsRsmbLgbLibRgbLibRjbRjRibRibLsbRib
RgbLhbLibRjbRgbRibRibLsbRgbRgbLgRgbRgbRgbLgbRgbRgbLgbRgbRgbRsbRgbRsbRs
bRgbRgbRsbRgbRsbRsbRsbRsLsbRgLsbRsLsbRsbRsbRsbRgRsmbRgbLgbRgRsmbRsRsmb
RgbRsbRgbLsLsmbRgbRsbRsbRgbRsLsLsmbRsRsmbRgbRsbRgLsbRsbRgRsmbRsLsRsbRg
bRgRsmbRgbLsbRgLsbRgbLsbRgbRgbRsbRgbRgbRgbRgbLsbRsbRgbRsRsmbRgRsmbRsRs
mbRsLsbRgRsmbLsbRgbRgRsmbRsbRgbRsRsmbRgbRgbRgbRgbRgbLgbRgbRgbRgRsmbLsb
RgbRgbRgLsbRgbRsbLsbRgbRsbRibLgbRibRgbLsbRsRibLjbRjbRibRgRsmbLsbLhbRib
RibRgbRgRsmbRgbLsbLgbRiRsmbRgRsmbLsRsRgbRsbRgbRgbLjbRgbRsbRgbRgRsmbLgb
RgbRsbRgbRsbRsRsmbRsbRsLsbRgbRgbRgbLsbRgRsmbRgbLsLsmbRgbRgbLsbsbRgbRgL
sbsbRsRsmbRsRsmbRgbLsbRgbLgbRgbRgLsbRsbRsRsmbRgRsmbLsRsbRgbRsbRgbRsbRg
LsbRgbRsRsmbRgbRsbRgbLsRsbRgLsbRgbRsbRgbRgbLsbRgbRgbRsbRgbRsbRgbRsbRgb
RgbRsRsmbRsRsmbRsRsmbRsRsmbRgRsmbRgRsmbRgbRgbRsbRsbRgRsmbRsRsmbRgbLsbR
gbRsRsmbRgbRgLsRsLsbRgRsmbRsRsmbRsLsbRgbRgRsmbRgbRsbRgLgRsbRgRsmbLsbsb
RgbLsbRgbRgbLgLsbRgbRsbRsbRgbRsRsmbRsbRgbLsbRgRsmbsbRgRsmbRsRsmbRgbRsR
smbRsRsmbRgRsmbRgRsmbRgRsmbLgbRgbRsbRgbsbRgbRgLsbRgbRgbRsbRgRsRsmmbRsb
RsRsmbRgbRgbRsbRsbRgRsmbRgLsRsbRgRsmbLsbRgRsmbRsbRgRsLsLsmmbRgLsRsbRgb
sbRsbRgbRgbLsbRgbRgbLsLsmbRgRsmbRgRsmbRsbRsbRgRsmbLsRsbRgRsmbRsbRgbsbR
sbRgbRsRsmbRsbRgRsmbRgLsbRgbRsbRgbRgRsmbRgRsmbRgbLgbRsbRibRgbLgbRibRgb
LjLiLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 12; Drug: NDMC 1 µM
bRibLoLsmbRsLibRcbRoLsbRgbRiLsbLjbLhbLcbLhbLgbLgbRcbRcbRcbRiLsbRibRoLs
bRgbLoRsRsmbLjbLgbLhbRibLobLibLibRibLcbRgbLibRcbRsbLjbLcbLibLgbLsbLgbR
sbRibLibLibLcbRgbLhbLibLgRsbLibLgLsbLiRsbLgbLhbRjbRjbRibLjbLcbLjbLcRib
LiRsbLsRsbLgbRhbRibRsbRsbRsbLebLibLgLsbRjbLibRsbLgbLgbLgRgbLibRibLhRsb
RibsbRsbLgbLgbRjbLgbLgbLgbLgbLsLsmbLgRsbLgbLgRsbRgbLgRsbLsLsmbLgbLsLib
LgbLgbLsbLgbLjbRibLibLjLsmbLcbRibLibRibLcbRibLjbLibLgbLgbLgbLsbLgbLsLs
mbLsLsmbLgbLgbRsbLgLsbLgbLgbRsbLibRgRsmbLibRjbLibLibRibRjbLibLsLsmbsbR
gbLjbRsRsmbLjbsbLgLsbLsLsmbLgRsbLgRsbLgbLsbLsLsmbLgLsbLgbLsbLsRsLsLsmb
RsRsmbLgbLsbLsbLgRsbLgbLsbLgbLsbLgLsLsRsLsmbLgbLgbLsbLsLsmbLsRsbLgLsbR
sbLsLgbRsbLgbLsbLgbLsbLgbLsbRsbLgbLsLsmbLsbLsbLgbLsbLsbLsbLgbRsbLgbLgb
LgbLgLsbLgbLgbLgbLgbLgLsbLibRgbLibLibRjbLgLsLsmbLgbRsRsmbLibRsbRsbLibL
sbRgRsmbRgRsmbLjbRsbRgbLiLsRsbLsbLgLsbLsLsmbLsLgbLsbLsLsmbLsbLgbLsLsmb
LsbLgLsbLsLsmbLgbLgbLsbLgbLsbLgbLsbLgbLsLsmbLgbLsLsmbLsRsbLgbLgLgbLsbL
gbLgLsbRsbLgbLgbLgbLgbLibLebLgLsbLgbLgLgbLibRjbLgLsbLsbLsLsmbLgbLgbRgb
sbsbLgbLgLsbLgLsbRsRsmbLgbRsLsbLgbRsbLibLsbLsbLiRsbRsbRsRsLsRsmbLgbLsL
smbLgbLsbLgRsbLsbLgbRgbLgLsbLgbLgbRsRsmbLiLsbLgbLsbLgLsbLgbLgbLgRsbLsL
smbRcbRcbRiRsmbLibLgLsbLsbLsbRibLcbLgbRibLebRjbRebLcbLhbLgLsbLjbRebRgb
RcbLjLsmbRibRsbLgbRgbLibLgbLsbLjbLgbLgbLgbLsbLiLsbLgbRsbLjbLibLsbLsbLg
LsbLgbRgbLibLsbLjbLibRsRsmbLsbLgbLiLsbLsbLibLsbLgLsbRsbLjbRcbLjbRhbRsb
RibRsbRsbRgRsmbRsbRsbRcbLgbRgbLebLcbLcbRjbRibRsLsbRebRcbRcbReLsbRgbLgR
sbRibLgbRibLsLsmbLsbRsRgbLsbLgbRgRsmbRgRsmbRgRsmbRsbRgRsmbRgbRgRgRsmbR
sRsmbRgRsmbRsbRgbRiRibRsbRiRsmbRgRibRiRibRgbRgbRgRsmbRsbRgbRgRsmbRibRg
LsRsRsmbRsbRgRsmbLgbRiRsLsRsmbRgbRgbLsbRsRsmbRiRsmbRgbRibRgRsmbRgbRibR
sbRibRsbRgbRgRsRgmbRgRgRsRgmbRgRsRgRsmmbLsRibRsbRibRgbRgbRgRgbRgLsRsbR
ibRiLsbRiRsmbLiLsbRibRiRsmbLsLsmbRcbRibRcbRiRsmbRsbLhbLhRsbLcbLiRsLsbL
ebLjbRjbRibLjbsbRhbRcbRibLibLgbRsbLgLsbLsbRgbLibRsbLiLsbRsbLgbLgbRjbLi
bRjbLhbRjbLhbReLsbLibRcbLiLsbRsbRhbRcbRobLibLgbLibLgbLgbRibRibLgRcbRib
Lsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 13; Drug: NDMC 3 µM
bRgbRsbLsbRhbLgbLsbLgbLcbLobRsbRgbLiRsbLibRjbLcbLgbLhRsbLiLsbLibLibLgb
LgbRjbLcbRgbLgLsbLgbLgbLsRsbLsbLgbLsbLgbLgLsbRsbRjbRcbLibLjbRjLsbRibLc
bLjbRcbLgbRcbLibRjbRoLsLsmbRcbRibRibLsbRgbRgbLsbRsbRgLsbRgbLsbLgbRgbLi
bLgbLgbLgbLjbLsRcbRhbLgbRgbRgRsmbRgbRjbLjbRjbRjbLibLobLcRsbLibRibRsbRs
bRcbLsbRsbLgLsbRcbRcbRjbRcbLibRjbLcLsmbLcbLcbLgLsbLibLsbRgbLibLgLsbLgb
LibRibLgbLgRsbLsbLsbLgLsbLsRsbLsbLgLsbLgbLibRgbLibLgbLibRsbRjRcbRjbRcb
RibLibLgbRgbLgbLsbLgbLsbLsbLgbLsLsmbLibLgbLgbRsbLgbRsbLgLsRsbRgbLgbLgR
sLsbLgbLgbRcbRibLjbLiLsbLsbLgbRsbLiRsbLsbLibRsbLsRsRsmbLgbLgbLgbRhRsmb
RgbLcbLiRsbLcbLibRsbLjLsmbLibRjbLjbLgbLgbRcbRhbLibLibRcbRibLjbRibLsbRi
bLibRibRibLgbRsbRgbLsbRsbRibLgLsbRsbRgbRgbLjRgbRsbRsbRgbRgbRgbRsbRgbRg
bRgbRsbRsbRgbRgbLgbRgRsmbRsbRibRgbRsbLgbRgbRgbRgbRsbRgbRsbRsbRsRsRsmmb
RsbRgbRgbRsbRgbLcbRjbLcbLgbRcbRcRsLsmbLgbLibLibLiRsLsbLgbRsbLgbLgbLgbL
gLsbLsLsmbLsbLsLsmbLgbLgbRjRibLjbLibRcbLhbRcbRcbLgbRgbLibLibLgLsbLiLsb
LsRsbLsbLgbLgLiRsbLsbLgbLibLgRsbLgbLgbRsbLgbLsLsmbLsLsmbLgbLgbLgbLgbLg
bLsLsmbLgbLsbLgbLgbLgbLsbLgRsbRsbLibsbLibLsbLiLsbRcbLhbLiRsbRcLsbRsbLs
LcRsbLibLiRsRsmbRgbLhbRgbLhbLgLsbLgbLgLsRsbLgbLgRsbLgbLsbLgbLgLsLsLsmm
bLgbLibLsbLgbLgRgRsmbLgbLibRcbRhLsbRcLsbRibRibLhbLcbRgRsLsmbLoRgLsLiLs
bLgbRsRsmbLgbRsbLiLsbLsbRsLgbLgbLgbLsRsbLibRibLhbLibRsbLgbRsbLiRgbLgbL
iLsRsbLgbLsbLsbLgbLsbLgRsbLibLgLsbLgbLgRsbLiLsbLgbLibLgbLhbRibLgLsbRcb
RcbLgbRhbLhRsbLgbLibRjbRobRibLsbRgbLsbLiLsbRgbLibRsbLgbLsbLsbLiRsbLsbL
iRjbLiRsbLsRsbLgbLiRsRsRsmmbRibRjbLhbRcbRcbRgbLsbLsRobLibLibLsbLgbRsbL
gbLsbLgLiLsbRsLsRsbRsbRhbRibLibRjbRobRcbLibLibLgbLgbLiLsbRsLsbLsbLgbRe
bRibLibLibLgbLgbRcRibRgbLhbLgbLsbLgbLsbLgbLsbLgbLgbLgbLgbLgbLgLsLsmbLs
bLgbLiRsbLgRsbLgbRsbLiLsbRjbLibLibLgbRcbRcbRcbRgbRcbLiLsbLgbLiLsbRcbLj
bLcbRhbRhbRcbRibLsRgbLibLobRibLsbLiLsbLgbLsbLiRsbRgbLgbLsbLsbLibRibRjb
RcbLsbRibLsbRgbRgbLsbRgRsmbRsbLsbRgbLjbLiRsbLgbLgbLsbLgLsLsmbRsRsmbRib
RibLsbRibLgbRibLgbRgbRgbLsbRgbRgRsmbRsbRgbRgLsbLgbRgRsLsmbLsbRgbLsbRiL
sbRsbRgRsmbRsbRsbLibLgLsbLibRcbRcbLibLhbLibRsbLgbLibRcbRcbRgbRibsbLiRs
bRibRibRibLsbLjbRibRibLsbRibLsbRgRsmbLsRsbRiLgbLcbLibRgbLibLcLsLsmmbRi
bRgbLobRibLibLibLsbRsbLgbLsbLgbRsLsbLsLiLsLsmbLgbLgLsbLsbLgbLgbRgbLgRs
bLibLgRsbLgbRsLsbRsLgbLgLsbRsbLiLsLiLsLsmbLgbLgLsbLsbLgbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 14; Drug: NDMC 3 µM
bLibLsbRsbRgbLibRsbLcRsRsmbLgbRsbLgbRcbRgbRsbLsLsmbRibRsbLsRsLsbRgbRgb
RgRsmbLgbRsbRibRcbRibRiRsmbRibRibLgbRibLjbLcbLcbLcRsbLibLibLgbRiRibRgb
LsbRgbRsbRsbRgbLsRobLiLsbLgRsbRgbRgRsmbRibRgbLsRgbRgbRgbLgbLjLsmbRjbLj
bRibLiLsbRibLsbLsbRgbLsLsmbRgbRsbRgbRiLsbRsbLibRcLsRsbRgbRgbRibRibLsbL
hbLsbRhbLsbLgbRiRsmbRsRsmbLgRsbRgbRsbRgRsmbRsbRgRsmbRsLsbRgbRgbRgbLgbR
ibLgLsbRgbLsbRgbRgbRgRsmbRgbRsbRgbRgbLgbRgRsmbRgbRsbRgbRsbRgbRgbRgbLjb
RiRsmbRgbRgbRsbLsbRgLsRsbRsRsmbRgbRgbRgbLibRibRibRsbRsbRgbRsbRibLgbRib
LgbLsbsbsbRcbRcbRebRcbRhbRgbLsRsbLgRsbRcbLgbRsbRibRsbRibLgbRibLgbRibRg
LsLsmbRgbsbRgbLsbRibLsbRgbRsbRgbLgbRibRsbRibRibRibRcbRcRsmbLjbLhbLcLsm
bLibRibLgRsbRgbRsRsmbRibRhLsbLgbRgbRibRgbLsbRhbLgLsbRcbRibRgbRsbLgbRcb
RcLsbRsbLgbRibRibLgbRgRsmbRsbRgbRsbRgbRgbRgbRgbLgbRsRsmbRgRsRsmmbRgbRg
bRgRsmbRgbRgbRsRsmbRgbLgbRibRgbLgLsbRibRiRsmbRsbRgbRgbRgbRsbLibLsbLsbR
ibLebRhbRgbLsbRibRibLibLsbRsbRibRgbRgbRgbLgbRgRsmbRibLjbLcbRibLcbRibRe
RiRsmbRgbRgbRgLsRsbRiRsmbRsbRgLgbRgbRsbRgbRgbRgbLjbRhbLjbRcbLcbLcbRiRs
mbRhbLibRiRsmbRsbLsbRiRsLsRsmbRibRgbRgbRibLgbLsbRibLsbRibLsRsbLsRsbRgR
smbRsbRsbRibRsRsLsmbRgbRsbRgbRgbRcbLgbLsbRibLjbRhbRibRgbLgbRibLsbRhbRs
bRibRcbLibLiLsbLibRjbRhbRhbRibRibRsLsbLcbLibRhbLgbRjRibRiRsmbLsRsbRibR
gbRgbLgbRcbRhbRibLibLibRibLgbLibRsbLgbLibLhRsbRgbRjbRibRgbRsLsbRsbRiRs
mbRgbLgbRgRsRsmmbLsbRgRsmbRibLsbRibRgbRgbRibRibLibLcbRibRiRgRsmbRsRiRs
mbLsbRiLsRsbRsRsmbLgbRcbRjbRhbRibRgRsmbRgbLgbLcbLibRhbRibLsbRibLgbRibL
sbRsbRgRsmbRibRsbRgbRsRsmbRgbLsbRgbLsbRgbRgbLsbRgbRsbRgbRgbRsbRgbRsbRg
LsbRgbLcbRibRgbLsbRsRgbRgbLjbRibRgLgbRsRiRsmbRsbRiRsmbRsRsmbRibRsbLsbR
sbRgRsmbRsbRgRsmbRsRsmbRgLsbLgbRibRgbRcbLhLsbLcbLsbLcbRebLibLgbRjbRhbR
gbLsbRsbRgbRibLgbRibRgbLgbRibLjRsbRsbRibLsbRgRsmbRsbRsbRgbRsbRgRsmbRgb
RgbRgbRgLsLsmbRibRsbRgbRibRibRibLjbRibLhbRcRsmbRgbLgbRibRsbRgbRsRsmbRg
RsmbRgbRsbRgbRgbLsbRgbRgbLsbRiRsmbRsbLsbRgbRsbRgRsmbRsbRgbRgbLgbRibRsR
smbRgbRgbRgbRgbLsbRgbRsbRgbRgbRgbLjbRiRsmbRsbRgbLsbRsbRiLsbRgbRgbRgbRg
LsbRibRsbRgbRgbRsbRgRsmbRsbRgRsmbRgbRgbRgbRgbRgLgbRgbLsbRiRsRsRgmmbRgR
smbRgbRgRsmbRgRsmbRiRsmbRgbRgbRgRsmbRibLhbLhbLcbLcbLebLjbLhbRibRhbRibR
cRsmbLsbLsbRibLsbRibRgbLgbRiRgbRgbRgbRsRsmbRgbRgRsmbRsbRgbRgbRgbRgbRgL
sbLgbRibRgRsmbLgbRibRibRgbRgbLebRjbLcLhRsbRjbRhbRiRsmbRsbLsbRgbRsbRsbR
ibLsbRibRsLsbRgbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 15; Drug: NDMC 3 µM
bRsbRgbLjbLobRsRsmbLgbLcLibLgbLgbLsLsmbLsbLibLsbLsbLsbRgbRibLcbLgbRsbL
sbLgbLgbLibLibLsbRgbLsbRsbLgbLibRgbLibRsbLsbLiRgbRgbLhbRjbLcbRgRsmbLib
LibLhbRgbLibLgbLgbRgbLibLsbLibLgbLgbLgbRgbLgLsbLsbLgbLsbLgbLgbLgRsbLgb
LgbRsbLsLsmbLgbRsbRsbLibRsbLsbLsbLgLsbRsbRsbLgbLgbLsbLsbLsbLsbLgbLsbRs
bLibRsRsmbLsLsmbLibRsbLsbLsbLibLibLgbLgbLsbLgbLgbLgLsbRsbLgbLsLsmbRsLs
bLgbLsbLsbLibLgbLgLsLgLsbLgLgbLgbRsbLgbRgbLibLibRgbLiLsbLgbRgbLcbRsbRs
bLgLsbRjbLibRsbLgbLgbLsLsLsmmbRsbLgbLgbLgbLgbLsbLsbLsbLgbRsbLgRsbLsbLg
bLsLsmbLsLsmbLgbLsbLgbRsbLsLsLsmmbLsbLgLsbLsbLgbLgbLsbLibRsbLgLsbLsbLg
LsbRsLsLsmbLsbLsLsmbLsbLsbLibLsbLsbLgbLgbLsLsmbLgbLsbLsbLgbLgbRsLsbLgb
LgbLgLsbRsRsmbLiLgbLsbLgbLgbLsbLibRgbLiLsbRsbLsbRsbLsbLibRsLsbLgLsbLgL
sbLgbLsbLgLsLsmbLgbLsbRsbLgbRsbLgLsLsmbRsRsmbLgbLgbLsbLsRsLsbLgLsbLsbL
sbLgbLsbLgbLsbLgLsbRsLsbLgLsbLsLsmbLsbLgLsbLgbLgbRsRsmbLgbLgbLgbLsbRsb
RsRsmbLgLsbLsbLsbLgbRsbLgbLgLsbLgbRsbLgbLgLsbRsLsbLgbLgbLsbLgbRsLsbLgb
LsLsmbLsbLgbLsbLgLsbLsbLgLsLsmbLgbLsbLgLsbLsbLgLsbLsbLgLsbLgbLsLsmbLsb
LgbLgbRgbLibLsbRsbLibRgbLiRsbRjbLibRjbRhbRgbRibLsbRibLsbRibRgbRsbRgbRs
bRsbRgbRgbRiRsmbLsLsmbRgbRgRsmbLsbRibLjbsbLsbLjbLibLgRsbRjRsmbLgbRjbRh
bRibRibLibRcbRcbLgLsbRibLjbLgbRgbLgbRhbRibRhbLhbRhbLsbRibLsRibLcbLhbRs
bLsLsmbLgLsbLgbLsbLgbLgbLsbLsLsmbLsbLsbLgbLgbLsbLgRsbLgbLgbRsLsbLsRsbL
ibLsbLgLsbLgRsbLsbLgbLgbLgLsbLsLsLgmbLgbLgbLsbLgLsbLsbRsbLsLgbLgLsbRsb
RsLgbLibLgLsLsmbLsbLsbLsbLiLsbLsbLgbLsbLsbLibRsbLsbLgbLsRsbLgbLsLsLsmm
bLsbLiLsbLsbLgbLsbLgLsbLgbLgLsbRsbLgbLsbLsbLgLsbRsLsLsmbLgbLgbLsbLgbRs
bLibRsbLgLsbLgbLsbLgbLsbLsbLgbLsbLibLgRsbRsbRjbRcbRibRiLsbRgbRibRsbLgb
RcRsmbRhLsLsLsLsmmmbRgbRgbLgRibRsbRcbRibLibRgLsbLobLgLsLsmbLsLsmbLgbRs
bRhLsbRiLsbRibRgRsmbLgbRibRibLgbRgbRgbLsbRgbLsbRibLgbRgbRiRsmbRgRsmbRg
bLsLsmbRgRsmbLsRgbLsbRibRgbLsLsmbRgRsmbRsbRgbRgbRiLsbLgbRhbRhbRiRsmbLg
bLsbRsbRcbLjbRibRgbRgRsmbLsbRgbRgbRibLsbLjbLsRibRgRsmbRsbRgbLsbRgRsmbR
gbRgbRgbLgbRgbRgbRibRibLibRibRibRsbRibLibRibRgbLgbLjbRcbRibLsbRgbLgbRg
bRgLsbRgbRgbRgLsbLgRgbRgbRiLsbLjbRibRibRgLsbLgbRibRibRgLsbLibLsbRjRsmb
RibRgbLsLsmbRgbRibLsLsmbRgbRgRsmbLsLsmbRibRgbRsRsLsmbRgbLsLsmbRgRsmbRg
bRgbRgbRsLsRsbRgbRsbRgRsmbRsbRgbLsbRgRsmbLgLsbRibRgbRsbRsbRgRsmbRgbLsb
LgbRgbLjbLoLsmbLobRibRgbLsbRgbRgbRgbRgbRsbRgbLsbRgbRgbRgRsmbRgRsmbRsbR
gbRgbLsbRgRsmbRgbRibRibRgbLgbRgLsbLibRsLhbRgbLgbLgLsbLgbLibLgRsbLibLib
RgbLibRgbLibLgbRsbRsLsbRjbRibRsbRgbRsbLcbLgbLgLsbRcbLjbLiLsbRcbLcbLhbR
jRsmbLgRsbLgbLgbRgbLsbRsbLibRgLsbLsbLgbRsbLgbRsbLgLsbLsbLgLsbRsLsbLsbL
sbLgbLsbLgbRsLsLsLgLsmbLsLgbRsLsbLsbLgbLsLsmbLgLsRsbRsRsmbRsbLsbLgLsbL
gbLsbLgRsLsbRgRsmbLjbRgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 16; Drug: NDMC 3 µM
bRjbLcbLibLcbLcRsbLcbLgbLsbLgbLcbLoLcbLcbRjbLobRgbRgbLgbLgRgbLibRcbRob
RgbRcbLsbLcbRgLsbLgbRsbRsbLgbLjbLgbLsbLsbRsbLgLgbLgbLsbLgRsbLgbLsbLgbR
sbLgbRsbLgbRsbLgbRgbLsbLgbLsbLobRobLibRhbRhbLgbLcLsmbRoLsbRcbLibLibLgb
RgbRgbRgbRgRsmbRgbRgLsbLsbRgRsmbRsRsmbRgbRsbRgbRsRsmbRgRsmbRsbRgbRgbRs
RsmbRsbLsbRgbRgbRsbLsbLhLhbLibRibRjbRibRgbLsbRgbRsbRgbRgbRsbRsbRsbRgbR
sbLjbLcbLibRcbRcbLibRiRsmbRgbRgbRibLjbRibRibRsbLsbRgbLsbRsbRsbRgbRsbRg
bRsbRsbRgbRsbRgbRsRsmbRsbRsbRsbRsbRsbRgbsbRgbRsbLsLsmbRibRgbRsRsmbRsbR
sbRgbRgbRgbLsbRgbLcLsmbLgbLibRgbLgbLgbLgbLgbLgbRjRcbRhbLsbRgbRgbLjbRib
RgbRibRgbRsbLgbRgbRgbRsbRgbRgbRgbRgbLsbRgbRsRsmbRsbRgbLgbRgbRibRgbLsbL
sbRgbRsbRgbRgbRgbRgbRgbRsLsbRgRsmbRsbRgbRsbRgbRsbRgbRsRsmbRsbRgbLsbRgb
RsbRgbRsbRgbRgbRgbLsRsbRgbRibRgbLsbLgbRiRsmbRgRsmbLsRibRgbRsbRsbRgbRgb
RiLsbLibRibRgRsRsmmbRgbRgbRsbRgbRgRsLsmbRgbRgbRsRsRimbRgbLsbRiRsmbRgbL
gbRiRsmbRgbRgbRsbRibRsRsmbRsbRgbRsbRgRsmbRgbRgbRiRgbRgbRgbRgbRgbRgbRsb
RgbRgRsmbRsRsmbRgRsRsmmbRgbRsbRgbRgRgRsmbRgbRgbRgRsmbRgbRsLsbRgbRsbRgb
LsbRgbRsbRsbRibLgRsbRgbRsRsmbRgRsmbRgbRgbRgRsRimbRsbRgRsRsmmbRgRsmbRgb
RgbRgbRgbRgRsmbRgbRgbRgLsbRgbLebLibRjLsbLhLsbRibLhbLcbRibRibLeLsbRsbLi
bLibRiRsmbLgbLibLibRobLsbRgRgRsRsmmbRgRsmbRgbRgbRgbRgbRgbRgbLsbRgRsmbR
gbRgbRgLsbRgLsRibRgRgbRgbRgbRsRsmbRgbRgbRsRibRgbRgRsRsmmbLsbRgbRsbRgRs
mbRibRibRgbRsbRgbRgbRgbLsRsbRgRsmbRsbRgbRgbRgbRgbRgbRsRsmbRgbRgRsRsmmb
RgbLsbRibLjbRibRgbLsRsbRgbRsRsmbRgRsmbRgRsmbRgLsbLsbRgbRsbRgRsmbRsbRgb
LcbLobRibLobRcbRoLgbRsRsmbRoRsmbLibLcbRjbLhbRjbRcbLibLgbLibRgbLibLgbLs
bLgbLibLibRibRjbRhbLcLsmbLcRsbRgbRjbRibLsbRgbRgbRgbRgLsbLgLsbRibRsRsLs
mbRgbRsRsmbRgRsmbRgbRsbRgbRsbRiRsmbRsbRgbRibLsbRgbRgbRsbRibRgbRgbRibRg
bRgbRgRsRsmmbLsbRgbRgbLsLsmbRibRsbRgbLibLcbRjbLcbRjbLcbRibLoReRgbRgbRg
bRiRsRsmmbRgbRsRsmbRgRsmbRsRsmbRgRsRsmmbRsRgRsmbRgbRgRsLsmbRgbRgbRgbRg
bRgbRgRsRsmmbLgbRibRsbLgbRibLjbLibLgbLcbLgbLibLgbLibRjRobLcbLcbLgbRibL
gbLcbRgRsmbLgRsbLgbLsbLibLiRsbRsbRcbRcLsbRhbLibLhbRibLhbRcbLcbLcRibLgb
LibLgbRsbLhRsLsbLgLsbLoRsbRgbLcbLhbRibRsLsbLsbRcbLjbRsbRibLjbRobLibLib
LiRsbLgbLgbLgbRsbLgbLsbRibRibLjbRibLgbRgbRgbRgbLcLsmbLcbRibRjbRiLsbRsb
RgbsbsbLsbRgbRgRsmbRgRsmbLsbRgbLsbRgbRsRsmbRgRsmbRsbRgbRgbRgRsmbRgbRsb
RiRsmbRibRsbLgbRgRsmbRgRsmbRgbRsbRgbRsbRsRsmbRgRsmbRgbRgRsmbRgRsmbRgbR
gbRsbRgRsmbRgbRsbRgbRgRsRsmmbRsbLsbRibsbRgRsmbLjbRibLhbLhbLcbRibLcbRjb
sbRcbLjbRhbRiRsmbRibRsLsbRgbRsbRgbLsbRgbRgbRhbsbRgRgbRgRsmbRgRsmbRsRsm
bRgbRiRsmbRsbRibRgRsRsmmbLsLsmbRibLsbRgbRibRgbLjRsbRibRgbRgbRsbRgbRgRs
mbLsbRiRsmbLsbRgLsbRsRsmbRgbRsbRgbRgbRgbRgbRibRsbLibLcbRgbLibLibRibRcb
LoRsbLcRsbRcbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 17; Drug: NDMC 3 µM
bRgLsbRgbRgbRgLsbLgbRgbRgbRgbRgbLobRgbRsbLsbRgRsmbLsbRsbRsRsRsmmbRgbLs
LsmbRgbLsbRgbRsbRibRsRsRsRsmmmbRsRsmbRgbRgRsmbRsbRgbRgbRsbRgbRibRsbRsb
RgbRgbRgbRgbLsbRsbRsLsbRsbRgRsmbRsbRgbRsbRsbRgbLsRsLsbRsbRgbRgbRgbRsbR
gRsmbRgLsbRsRsmbRgbRgbRgbRgbRgbRsbRsbRgbRgRsmbRgbRsbRsbRsbRsbRgbLsRsbR
sbRgRsmbRgbLsRiRsmbRgRsmbRgbRsbRsRsmbRsbRgbRgbRgbRgbRgbRsbRsbRgLsbRsRs
mbRgbRsbRgbRsbRsbRgbRgbRgbLsRsbRgbRsbRgRsmbRsRsmbRsbRgbRsbRgbRgbRgbRsb
RibLsbRgRsmbRgRsmbRgbRsRgbRgLsbRsbRgbRsbRgbRsbRsbRsbRgbRgbRgRsmbLsRsRs
mbRgbRgbLsbRsbRgbRgbLsbRgbRgRsmbRgbRsbRgbLsbRsbRgRsLsmbRsRsmbRgbRsbRgL
sbLsLsRsmbRgLsbRgRsRsRsRsmmmmbRsbRibRgRsmbRsLsbRsbRgbRgbRsbRsbRsbRsbRs
bRgbRsLsbRsbRgbRgbRsbRgbRsbRgbRsRsmbRgRsmbRsbRgRsmbRibRsbRsbRsbRebRjbR
gbRgRsmbLsbRibRsbRsbRsRsLsmbRgbRgLsbRgRsLsmbLsRsbLsbRiRsmbRsbRgbRgbRsb
LsbRgRsmbRsLsbRibRsRsRsmmbRsbRgbLsbRsbRgRgbRgbRgbRsbRjbRsbRgbRgbRsbRsR
smbRsbRsbLobLjbRibRsRsmbRgRsmbLsbRgbRibRsbRsbRgbRsRsmbRgbRsbRsRsmbRsbR
gRsmbRgRsRsmmbRsbRibLsbRgbRgbRgbRsbRgRsmbRgbRgbLsRgbRgbRgbRgRsmbRgbRsb
RgbRsbRgbRgbRgbRsbRgbRsbRgbLsRsRsmbRgbRsRsmbRgRsLsmbRsRsmbRgbRibRgbRsb
RgRsmbRgbRgbRsbRsRsmbRgbRsRsmbRsRsmbRibRsbRsbRgbRgLsbRgbRsLsbRgRsmbRsb
RgbRgbRgbRsbRgbRsbRgLsbRgbRsRgbRsRsmbRsbRsbRsbRgbRgbLgbRibRsbRgbRgbRsR
smbRgbLgbRiRsmbRgbRgbLsbRibRgbRgbRsbRgRsmbRgRsmbRgbRgbRgbRsRsmbRgbRsbR
gbRgbRgbRgbRsbRgbRgbRsbRiRsmbRgbLsbRgbRsbRsRsmbRgbRsbRgbRgbRgbRgRsmbRg
RsmbLsRsbRgbRsbRsbRiRsmbRsbRsbRsRibRsRsmbRiRsmbRgbLsbRibRsRsmbLsLsmbRg
RsmbRgbRsbRgRsmbLsbRgbRgbLsbRgbRsbRgbLsbLcbLgbLibLibRcbRcbLsbRsbRhbLgR
sbRibLsbRgRsmbRgRsmbRgbRsbRgbRgRsmbRsbLsbRgRsmbRsbRgbRgbRsbRgbRgbLsbRi
bLsbLgLsbRibRsbRsbRgbRgLsbRibRgbRgRsRsmmbRgLsbRibLsLsmbRgbRsbRsRsmbRgb
RgbRsRsmbRgRsmbRgbRgbRgbRsbRsRsmbLjbRcbRgbRgbRgbRgRsmbRsbRgbRgbLcbLibL
ibRjbRcbRsRsmbRibRsRsmbRgbRgRsLsmbRgbRsbRgbRgbLsLsmbRibRgbLgbRiRsRsmmb
RgbRgbLgbRgRgRsmbRgRsmbRsbRgbRibRsbLsbRgRsRgRsmmbRgRsmbLsbRibRsbRsbRgb
LgbRgLsbRsbRgbRsbRgRsmbRsbRgbRsbRibRsbRgRsmbRgRsmbRgRsmbRgbRsbRgRsmbRg
RsmbRsbRiRsmbRsbRiRgRsmbRsbRgRsmbRsbRgbRgbLgbLoRsbRgbRgbLsbRibRsbRgRsm
bRsRsmbRgRsmbRsRsRsmmbRgbRsbRgRsmbRsRsmbRsbRsbRgbRgbRgbRgbRgbRsLsbRsbR
sRsmbRibRsbRsbRibRsbRsbRiRsmbRgbRgLsRsRsRsLsmmbRgbRgbRsbRgRsmbRsbRgbRs
bRgbRsLsbRibRgbRgbRgbRgbRgbRgbRsbRsbRibRgbRgbRsbRgbRgLsbRsbRgRsmbRgRsm
bRgLsbRgbRgbRsbRgbRgbRgRsRsLsmmbRsbRgLsbRgbRsRsmbRsRsmbRgRsRsmmbRgbRgb
RgbRsbRgbRgbRsbRsbRgbRsRsRsmmbRgRsmbRgbRgbRgbRsRsmbRsRsmbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 18; Drug: NDMC 3 µM
bLhbLsbRibRhbRgbLgLsbLsbRgbRgbLgbRjbRgbLobLiRsbRjbLibLsLsmbLgbRsbLibRg
bRcbRhbRhRsmbRibLobRsbRgbRsRsmbLibRjbRgbRjbLcbLcbRjbLjbLgLsbLjbRgbLjbR
jbLjbRebRgRsmbRgbRgbRgbRsbLsbRibRibRsbRsbRgbRibLsLsmbRgbRgbRgbRgbRgbLs
bLgLsbLsbRgbRjRsmbLebRgbRiRsmbRsbRgbLcRsbRjbLjbLgbRsLsbLgbLgbLgbLsbLsb
LgbRsbLgLsbLibLsRgLsbLsbLibLsbLgbLsbLsbLgbLgbLgRsbLsbLgbLsbLsLsmbLgbRj
bRhRsmbRibLgLsbLjbRjbRgbRgbRgbLsbRibRsbRgbRgbLebRjLsbRibRsRibRgLgbLgbL
jbLgbLsbLgbLibLsbLgbLgbRsbLgbLgbLgbLgbLsbLsbLsLsmbLgbRsbLsbLjbRjbLiLsb
LsbLgLgbLgLgLgbLgbLsLsmbLibLsbLgbRsbLgLsbRsbLgLsLgLgbLiLgbLgbLgbLsbRsb
LgbLsbLibLgbRcbRibLgbRgRsmbRgbRgbLsbRgbRgbLgbRjbLgbRgbRsbLsbLsbRgRsmbR
ibLsRgRgRsmbRgbRsRsmbRsbRiRsmbRgbRgbRgbLsbLjLsmbRobRobLibLibRhbRcbLhLs
LsmbLgbLibLgbLgLgbLgbLgbLgbRsbLhLsbRgbLcbRsLsbLgbLgLsbLgLsbLsbLgLsbLsb
LgbLgbLsLsLgmbLsbLgbLgLsbLsRsbRsLsbLsbLgbLsbLgbLgbLsbLgLsbLgLsbLgLsbLg
LsbLsbLgbLgbLgbLgbLgbLgLsbLgbLiRsbRcbLcLgbLgbLgbLibLiLsbLsbRgbLiLsbLgL
sbLsbLgRsbLiLsLgbLgbLgbLsbLgbLgbRsbLgbLsLsmbLgbLgLsbLsLsmbLgbLsbLgbLsb
LgbLgbLsbLiLgbLgLgbLgLsLgLibLgbLgLsbLgRsbLibLgbLhbLibLgbLibLibLsbLsbLg
LsbLiRsRsmbLgRsbLgbLiLsbLgLsbLibRsbLgbLgRsbLgbLsRsbLsLgbLgLsLsmbLsbLgb
sbLgbLsbLgbLsbLiLsLsmbLhRibLsbRiLsbLgbRsbLcbLsbLibRjRsmbLgbRcbRibRcbRc
RsmbLgbRgbRgbLgbLjbLibRjbRcbLhbRcbRhbRgLsbLsLsmbLgbRcbRibLgLsbRsLsRsbR
obLgbLcbLcRsbLibRgLsbLgbLiRsbRjbLcbRgbLsbLgbLsLsmbLsbLgbLgLsbsbLsbLgRs
bLiLsLsmbRsbLgbLsbLsbLgbRsbLgLsLsmbLsbLibRsLsbLsbLgbLgRgbLibLgRgbLsbLs
bLsbLgLsbLsbLgbLsRsbLgLsbRgbLgLsbRsbLibLsLsmbLgLsbLgbLiRsbLsLsmbLgbRgb
LgLsbLsbLgbLgbLgbRgbLgbLsLsmbLgbLgRsbLgLsbLgbLgbLsbLsRsbLsbLgLsbLgbLgb
RsRsmbLgbLiLsLsmbLgLsbLgRsbLiLsbLsbLsbLiLsbLgbRibLibLsLsmbLgbLgRsRsmbL
iLsbRgLsbLibLsLsmbsbsbLsbLsbLsbLsRsbLgLsbLsbLgbLibLsbLgbLsbLsbLgLsRsbL
gbRsbLgbLsbLsbLsbLsbLibLsbLsbLiLsbLgbLgLsbLsLsmbLgbLgbLsbsbLgbLiLsbLsb
LiLsbLsbLsbLgLsbLgRsbLiLsbLgbLgbLsbLsbLsbsbRgLgbLsbLibLgLsLsmbLgbLgLsb
LsbLgbLgbLgLsRsbLsbLsbLsbLsbsbLgLsbLgbLgLsbLgbLgbLgbLgLsLsmbLgbLiLsRsb
LgbLsbRsbLgbLgbLibRhbRsRibRobLiLsbRcbLjbRibRgbLgbRibRgbLeLsbLibLcLsmbL
cbLhbLsbLhbLibLgbRgbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 19; Drug: NDMC 10 µM
bLibRsbRsbLcbLcbLhbLgbRsbRsbRgRsmbRsbRibRgRsRsmmbLgLsbRsbRsbLcbRjbRcbR
ibRcbLjLsmbLgLsbLsbLjLsmbLibLgLsbRsbRsbLcbLcbRibLibRsRsmbRcbLhbLjbRjbR
cbRcbRcLsbRibRibRgbRibRgbLgbRgLsbRgbLsLsmbRgbRgLsRgRsmbRgbRgLsRsbRsLsb
RsbRibRgbRsbRgRsmbLsbRgbRibRcbRibRcbLjLsLsmmbLhLsbLsLibLhbRhRsmbLjLsmb
LibRibRibRsRsmbRgbLsbRgbRgbRsRsmbRgRsmbRgbRgRsmbRgRiRgbRgbRgRsmbRgbRsR
gRsmbRgRiRiRiRsRiRsmmbRgbRgbRgbRsbRgLsbRgbLsbRgRgbRgbRsbRgRsmbRsbRgbRs
bRgLsbLsbRgbRsbRgbRgbRsbRgLsRsRgLsbRgbLsbRgRsmbRgbRgbRgRsmbRgRgRgRsmbR
gbRgLsbRgbRgRsmbRgRsmbRgbRgbRgRgbRgbRgRibRgbRgbRgRiRsRgmbRgbRgbRgbRgbL
sRgbRgRsmbRsRiRsRgRiRsRiRimmbRgbRgRgRibRgbRgRsmbRgbRgbRgbRgbRgbRgbRgbR
gLsbRgRsmbRgbRgbRgbRgbRgbRgbRsbRgLsbRiLsbLibRcbLcbRibRibRsbRgbRsbRgbRg
bRsbRibRgbRgbRsbRibLsbRgbRgRsmbRsbRgbRgbRsRsmbRgbRsbRgRsmbRgbRsRsmbRgR
smbLsRsRgRiRsRgRgmbRiRsmbRgbRiRsmbRgRsmbRgRsmbRgRsRsRimmbRgbRgRsmbRgbL
cbLcbLcbRgbRibLsbRibRgbRibRgbRgbRgbRgbLhbRhbRgbRcbRcbRibRibRhLsbRibRgb
LibRgbLibRcLsbLibRjbRcbLcbLibLgLsbLgLsbLsbLsbLsbLgRsLgbLgLgbLgbLgbLsLg
LsLgLgLsbLgbLsbLsLsmbLgbLgbLibLgbRhbRgbRibRgbRiLsbRgRibRgRiRsRgRiRsRgL
smmbRgbRsbRiLsLsLsmmbRiLsbRgbRgLsRsbRgRgbRgRsmbRsRsRgRgRsLsmmbRgRibRgb
RgRiRhRiRgbRgbRgLsbRgbRgbRgbRgbRgbRgRsmbRibRsbRiRsmbRgLsbRsLsbRiRsmbRg
bLjbLcLsmbLcbRgbRsRsmbLoLsmbLcLsmbLcbRcbLibRsRsmbRibLjbLcbRgbLhbRibLib
RsbLgLsbRsLsbLgbLsbLgbLgbLsbLgbRsbLsLsmbLsbLiLsbLgLgLiLsLiLsLibLiLibLg
bLiRsbLsbLjbLiRsbRgbLgRsLsbRhbRcbLgbRsRibRobRcbRiLsbRhbRiLsbLsbLibRgbR
iLsRgbRgRgbRsbRgbRgbRgbRgbRibRgRgbRibRibRgbRgbRgLsRsbRgbRgRsRgRsmmbRgR
smbRgbRgbLsbRibRsRiRsRimbRsbRgbRgRsmbRgRsmbRgbRsRiRiRsRiRsRimmbRgbRgRg
bRgbRgRgRsmbRgbRgbRsRsmbRiRiRgRgRsRimbRgbRibRgbRgbRgRgRgRsmbRgbRgbRgbR
gRsRgmbRsRgbRgbRsbRgbRgRgRiRsmbRgRgRsRiRgRsmmbRiRibRgbRgbRgbRgbRgbRgbL
obRgRsRsmmbRsbRgbLsbLcbRcbLebLgbLobRobRhRsmbRibLcRsbRiRsmbLcLsmbRgLsbR
cRsmbLcbLsbLibLhbRibLgbLsRsbLibRjRsmbRiRsmbRibRgRsmbRsbRsLsbRgbRgRsmbR
sbRgLsbRgbRgbRgbRgbLsbRgbRsbRsbRgbRsbRgbRgRsRsmmbRibRgbRgbRgbLgbRsRibR
iLsbRibRibLcbRgbRibRibLibLhLsbLcLsmbRibRgbLcbRjbRcbRgbRsLsbRgRsmbRibRs
bRgbRgRsmbLsbRiRsmbRgbRsRibRibRgbRgRsRgRsmmbRgRsRsmmbRgbRgRibRgbRgbRgb
RgbRsbRsRibRsRibRsRiRsRsRgmmbRgRsRsmmbRsRsRsmmbRgbRsRsRiRsRsmmmbRsbRgR
gbRiRsReRsmmbRgbRgbRgbRgbRgbRgbRgbLhbRibRgbLsLsmbRgbRibRsbLhbLcbLhRsRs
mbRsRibLhLsbLcbLcbRibRcLsbRibLibsbRebRobLgbLgRsbRjbLiRsLsbLgbLgRsRsmbR
sLsbLibLgbLsbLgbLsbLgbLsRsbLgbLibLibLgRsbLsbLgbLsLibRiRsmbLiLsbLibRjbR
hbRibRiLgbLsbRiLsbRsRsmbRibRsbRgbRibLgbRgbLsbRcLsbLsbRibRobLsbRcbLhbRg
bRsbLcbRibLibRjbsbLibRcbRibRgbLjbLhbLgRsbRgbLgbLsLsmbRsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 20; Drug: NDMC 10 µM
bLibLibRibRobLiLsbRgbLcbRjbRcbRhbRjLsbRobRcbRsbLibLebRobRobRcbRcbRgbLi
bRsbRsbLsbLgLsbLjbRjbRobRcbRjbLcbLibRgbLibLjbLgLsbLgbLcbRcbLcbLobLiRsb
RibLjbRjbLcbLgbRobLjbLjLsmbRiRsmbLgbRibLgbRibLgbLgbLibRibRsRsmbLjbLibL
ibLgbLgbRoLsbRobLjbRcbRobRgbLgLsbRgbRgRsmbLgbRibRgbRcbRhbRibRobRibLjbL
cbLiLsbLgbRoLsbLibRjbLgbRjbRgbRgbLjbLcbLhbRgRsmbLgbLgbRjbLibRsLsbLcbLc
bRjbRcbLjbLjbRjbLcbRjbRoLsbRcbLgLsbLgbLjbLgbLjbRjbLgbLgbLsbLhRsbLgLsbL
hbLhbLcbLhbRgbLjRsbRjbLhbLcbRgbLibLhbLgbLibLsRsbLgLsLsmbLiRsbRjbLibRoL
sbLjbRibRibLsLsmbRibRibRcLsbLiLsbRgbRcLsbLiLsLjbRobRsbRibRgRsmbRibRgbL
gbLibLgbLsbLgbRgbLgbRsbRsbLibLgbRsbLgLsbLibRsbLibLsbLgbLgbLgbLsbLgLsbL
gbLsRsbLibRgbLibLsbLgRsbLibRsbsbLibLgbLgbLgbLcbRgbRgRsmbLibLgbLjLsmbLi
bRibLibLgbRgbLibRsbLgbLgbLiRsbRsLibLcbLibRiRsmbRiLsLsmbRgbLcbLgRsbLsbL
gbLcLsRsmbRgbLgbLgbLibRhbRiLsbLgbRgbRsbRgbLsRsbRibRgbRibRiLsbLgbRsbRib
RgbLgbRibLsbRgbRgbRsbRgbLgbRibRibRsbRibRiLsbRjbLibRsbLgbRiLsbRgbLsbRiL
sbLjbRgbRgLgbRgbRsbRgbRgLsbRgbRiLgbLgbRgbRibLjbRibLsRsbRibRibRgbRgbLsb
RgbLsbRcbLibLjbRibLsbRibLjbRgbRibLjbRibLjbRhbLhbLcbLcLsmbLsbLsRsbLgbLh
bRhbLhbRjbLcRsbRgbRjbLibLsbLgbLgbRsLibLgbLgRsbLibLsbLibRsRiRsmbLgbRcbL
gbRibLgbRgbRsbRibRsbRiRsRsmmbRsLsbRgbRsRsLsmbRsbLjbRcRsmbLsbLsbRgbRsLs
bRgbRsbRjbLhbLhbLcbLcbRgbRibLgRsbLjbLibLgLsRsbLsLsmbLsbLsRsbLgbLgLsbLs
bLiRsbRsbLgbLibLsbLiRsbLsbLibLibRgbLsbLibRjbRhbLcbLibRcbRibRgbLgbRibLg
bRgbRsbRiRsmbLsbRgRsRsmmbRiRibRgRgbRgbRsbRgbRgLgbRibRgbRsbRsbLsRsLsbRi
LsbLgbRgbRgbRsbRiLsLsmbRgRsmbRgRsmbRgbRgRsmbLgbRibRgbLjbRibLcbLgbLjbRs
RsmbLibRgbLgbLiRgRsRsmmbLgbRjbRobLcbRoLjbRibRgbRgbRibLsbRoLsbLcLsmbRib
LhbRjbRcbRcbLibLsbLobLibRgbLibLgbLgbRgbRjbLcbLgbLsbRgbLiLsbRgRsmbLgbRs
bLibRgbLgbRgbLiLsbRsbLgbRsbLgbLgbRsbLgbLgbsbRcbLibLgbLibRibRoLsbLjbRob
RibRgbRibLsLsmbLsbRgRsmbRcbLibLjbLiLsbRjbsbLjbLibLiRsbLgbLibRsbLibLgbL
gbRibLcbRibLhbRjbLibLgbRibLiLsbLjbRobRcbRgLsbLhLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 21; Drug: NDMC 10 µM
bLibLiRsbLgbRgbRjbLobRobRcbLsbRobRjbLcbLibLobLcbLgbRibRibLcbRjbLcbLsbR
obRobLiLsbRobRcbLgLsbRcbLibLsbLgbLsbRcbRiRsRsmmbRsbLgbRibLgRsbRibLsbRg
bRgbRsbRgbRgbRgLsbRcbRgbRsbLgLsbRgbLjLsLsmmbRiLcbRjbRsbLgbLgLsbRobLjbR
ibRjbRjbRibRibLgbRgbRsbLjbRebRobLibLjbRibLjbLsbRibRcbLgbLsbRibRsLsLsmb
RjbRgbRgRsmbRgbRiLsbLgbRcbRjbLsbRjbLsbLgLsbLgbLgbLgbRjbRebRibLsbRhbLjb
RcbLjbRobRebLsbLgbRgLsbLgbLibRsbLgbLibLjbRsbLjbRobRcRsmbLjbRebLgbRgbLs
bLcbLsbLcLsmbRibRsbRgbRsbLsbLiLsbLhbLibRcRsmbLibLsbRhbLcbLibRebLhbLibR
jbLibRsbLiLsbRsbLjbLibLibLhbLibRoRsmbRebRjbLjbRgbRiLgLsbRiRsmbRgRsmbLs
bRjbRgbRgLgbRibRjbRsbLcbRcbLjbRhbRsLsbRiRsmbRsbRibRgbRsbRgRsmbRsbRgbRs
RgbRsbRgbRgLsbRibRebRhbLjbRibRsbRgbRibRsbRgbRibRibLjbRiLsbLsbRibRgbLsb
RibRibRgLsbRibLsbRgbRjbRibRjRsmbRiLsbRiRgbRsbRjbRgbRsbRibRsbRebLgLsbRs
bRgRsmbRgbRgbRgbRjbLgbRobLjbLsbRobLibRibLsbRgbRjbRhbLgbRibRgbRgbLsbRgb
RsbRsbRsLsbRgbRgbRiRsRsmmbRgRjbRgbLjbRhbLgRsbRiLsbRiRsmbLgbRebRsbLebLg
bRebLcbLobRsRsmbRoLsbRcRsmbsbRobLcbRobLebRgbRcRsmbLjbRhbRsbRibRsbRsbRg
bRgbRibRsbRgbRgLsbLjbRcLsbRibLcbRcbLcbLobLobLibLgLsbRjRibLobLcbRiRsmbL
sLcbRhRsmbLiLsbLsbLoLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 22; Drug: NDMC 10 µM
bLsRsbLibRcbLgbRgRsmbRsbRgbRgRsmbRoLsLgbLsbRgbRgbLcbLcRsRsmbRgbLoRsbLs
bLibLibRgbRcbLgbRgbRibRibLgbLjLsmbLgbLiLsbLsbLgbRsbLsbLsbLgLsbRsbLgRsb
RobsbLsbLhbLgbRsbLgLsbLsbLgbLsbLsbLgbLsLsmbLgbLgbRsbLibRobLgbRibRsbRcL
sLsRsLgRsLsmbRgbRcbRcbRsbRgbLgbLibLgbLgbRsbLgbLsbLgbLsbLgLsLsmbLsLsmbR
ibLhbRhbLgbRcbLjbLjbLcRsbRgbLibLsbRsbRjbLhbLibLgbLsRsbLhRsbLgbRgbLgbLg
bLgbLgLibLgbLgLsbLgbLsbLibLsbRsbLgbRsbLgRsbLgbRjbLgbLsLsmbLsbLibLgbLsb
LgbLgbLsLsmbLgLgbRjLsLsmbLcLsmbRobRcbRibRibLjbRcbLjbRhbLgbRcbRsbRsbRcb
RibRgbRiLsbLjbLhbRgbLgLsLsmbLsbLsLsmbLgLgbLgbLgLsLsmbLiLgbLgLsbLsbLgLs
bLsbLsbLsLsmbLgbRcbRsbLcbLibLcbLiLsbRsbRiRsmbRibLgbRibLsRsbRgRsmbLsbRg
bRobLgbLgbRcbLgbRiRsmbRsbRsRsmbRgbRsbRsbRibRgRgbRgbRsRsmbRiRsRgRsmmbRg
RsmbLsRsbRgRsmbRsbLsbRgbRsbRgbRgbRgbRgbRgbRsRsmbRgLsbRgRsmbLgbRsbsbRsR
smbRgbRgbRgbRsRsmbRgbRsbRgRsmbRgbRsRsRsmmbRgbRsbRsbRgbRibRgbRibRsRsRsm
mbRgLsbRgbRiRsRsLsmmbRgbRgRsmbRsRgbRgbRgRsmbLcbLibRjRcbLgbRcbRibRiRsmb
RibRiLsbRgbLcbLcRsbRibLibLibLibRibLiLsbsbLsbRcbRhLsbRibRibLsbRibLsbLsR
gbRsbRgbRgbRsRsmbRgRsLsmbRgRsmbLsbRgbRgRiRsmbRgRsmbLsbRibRgRsmbRgbRgRs
mbRgLsbRgRsmbRsRsmbRibLibRibLsbRibLgbRgbRsbRgRsmbRgbRebRsbRiRiRibRgbRg
RsmbRibRcRsmbLcbRsRsmbRjbRiRsmbRgbLsRsbRgbLsLsmbRibRsRsmbRgRsRgRsmmbRg
bRgbRebRibRibRgbRgRsRgRsmmbRgRsRsmmbLsbRjbRiRsmbRgbRgbRgbLjbLcbLhRgbLi
LsLsmbRsbLibLsbLgLsbRcbRsbLcbRoLsLgbRsRsmbRsbRgRsmbRgbRgbRsRsmbRsRsmbR
cRsmbRsbRcbLhLsbRiRsmbLjbLcbRibsbLibsbLsbLgbLiLsbLgbLsLsLiLgRsLsmbLiLs
bLgLsbRsbRibRiRsmbLgbRibRgbRobLiLsbLibRibLcbRibLcbRibLsbLiLsbLgbLsbLib
LsbLibLsbLiRsbLgLsbLibRjbLibLgbLsbLgLsRsbLgLgRsbLibLgbRsbRsbLgLsRsbLgL
sbLiLsbLsbRgbLibLibLsbLgbLgLsbRsLsRsbLibRgbLibLgbLiLsbLgLsLsRgmbLiLgLs
bLgRsbLgbLsbRsbsbRsbLgbRgbLhbRobRcRsLsmbRcbLibRibLhbLibLgbLibLibRibRgR
smbRibLhbRibRgbRibLsbRsbRsLsbRibRsbRgbRgbRsRsmbRsRiRsmbRgRsmbRibLsbRsR
sRsmmbLsbRsbRibRsbRgRgbRgbRsbLsbRiRsLsRgRsRsmmmbRgbsbRgbRibRgRsmbRibRs
RsmbRgRsRsmmbRiRsRsmmbRgbRsbRibRiRsmbRgbRgRsmbRsRibRgbLsbRsbLsRsbRgbRg
bRgRsmbLjbLobRoRsmbRobRhbLcbRobRcbRibLgRsbRibRibLgbRgbRgbRgbRgbRsbsbRe
RiRgbRgRsmbRsRsmbRibLgbRhLgbsbsbRibRgRibRgbRgbRsbRgRsmbRsRiRgRsmbLsbRs
bRsRsmbRgbRgbRgbRgRsmbRgbRiRsmbRgRsRsmmbRgRsRsRsRjmmmbRsbRsRsmbRibRgbR
ibRgbLsRgbLsLsmbRibLsbRiRsLsRsmbRgbRsbRgLsbRsbRgbRsbRibRgbRgbRibRgbRgb
RgbRibRgbRgbRgbRgRsmbRgRsmbRgRsRsLsmmbRgbRsbRibRibRiRsmbLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 23; Drug: NDMC 10 µM
bLhbRgRsmbLcbLgbRgbLibRibLibLgbRjbRcRsmbRibRcRcbLibRjLsbRjbRgbLjbLobRi
bLcbLcbRibRgbLibLcbLibRibRgbLgbRgbLcbLcbLcLsmbLgbLjbLgbRsbLsbLsbLsLsmb
LsbLsbLebLjbLgbRcbLcbLhbLgbRgbLsbLgLsbLgbRjbLibRsLsbLgbLsLgLsbLgbLgbLs
LgbLgRsbRsbLgbRsbLgRsLgbRsbLgbLsbLgbLsbLsRsbLsbLsbLsbLjRsLsbLibLiLsbLg
bLgLsbLibRhbRsbRgbRjbRgbRgbRgRsmbRgRsmbLsbRsbRgLsbLsRsbRsbLjbLjbLjbLgb
LsbRjLsbRibLcbRjRsmbLibLgbRsbLibRgbLgbLsRsbLgbRsLsbRsbLibRsbLgLsbLsbLg
LgLsbLsbLgbLgbLsbLsLsmbLgLsbLsbLsbLgbLsLsmbLgbLsbLgLsbRsbLsbLsRcbLcbLi
bRsLsbLgbLgbLsbLgbLgbRsbLsbLgbLgRsbLsRsbLgLsbLsLsmbLgbLsbLgbRsbLibRibL
iLsLsLgmbLgbLgbLgbLsbRsbLsbLgbLsLsmbRsbLgbLsLsmbLsbLgbLgLsbLsbLgbLgbRs
bLgbRsbLgbLgLsLgbLgbLgLsbLsbLgLsbLgLsbLsbLgLsbLsbLgLsbLsLsmbLsLsmbLsbL
gbLgbLsbLgbLgbLgbRsLsbLsbLgbLgbRsbLiRsbLsLsmbLsbLgLsbLsbLibLsbLgLsbLsb
LsbLgbRobLsbLsbLsLsmbLsbLgbLgbLgbLsLsmbLgbLgLsbLgbLsbLsbLgbLsLsLsmmbLg
bLsbLsbLgbLgLgbLgLsbLgLsbLgbLgLsbLiLsLgLgLgLgLgbLgLgbLgbLgbLgLsbLgLsbL
gbLibRsbLiLsbLgbLgLsLgbLgbLgLsbLgLsbLsbLgbLgbLgLgLgbLgLgbLgbLgbLsRsbLg
bRsbLibLgbLgbLgbLgbLgbLgLsLsmbLgbLgbLgLgbLgbLgbLgbLgbLsbLgbLgbLsbLsbLg
LsbLgbLsLgLsbLgbLgbLsLsmbLsbLgLsbLgbLgbLsbLgbLgbLgbLgRsbLgLsbLsbLgRsbL
gbRsbLsbLgLibLgbLgbLgbLgbLsbLsbLsbLgbRibRjbRibLcbLibLsbLsLsmbLgLsbLgLg
bLgbLsLsmbLsLgbLgLgLgbLgLsbLsbLgLsbLgbRgLsbLgLsbRsLsbLsbLgLsbRsbLsbLgL
sbLgbLgbLsbLgbRsRsmbLgbLgbLgbLsbLgbLsbLgbRsbLibLgbLgbLsbLgbLgbLgbLsbLs
bLgbLgbLsbLgLsLgbLgbLgbRsbLgLgbLgbLgLsbLgbLgLgLgLsbLgbRgbLibLsbLgLsbRg
RsmbLgLgbLibsbLgbLgLsLsRsmbLsbLgLsbLgLsbsbLsbLgbRsbLgbLsbLgbLgLsRsbLib
LsbLgbLgbLsbLgbLibLsbLgbLgbLsbLsbLgLsbLsbLgbLsLgbLgLsbLgbLgbRsbLibLgRs
bLibRhbRcbRcbLsbRibLjLsmbLsLcRsbLsLsmbRsbRsLgRsbLsbLgLsbLgLsbLsLsmbLsb
LgbLgbLgbLsbLgLsbLsbLsLgbLsLsmbLgbLgbRsbLiLgLsbLgbLgbRsbRiRgRsRsLsmmbR
gbLgbRgbRibLgbRhbLcbLhLsbLgLsLsLsmmbLsbLsbLgbRsbLgbLgbRsLgbLgbLgbLsbLc
RibRsLsbLjbLsbsbLgbLgLsLgbLsbLgbLsbLgbRsRsmbLgbRgbLiLsLgLsLgLsLsmbLgLg
LgbLgRsbLsLsmbLsbLsbLiLgLgLgLiLsbRgbLibRibRjbRhbLcbLibLsbLgbLsbsbLgLsb
LgbLgbLgbLgLsbLgbLgbLsbLgLsLgbRgbLibLsbRsbLgLsbLgbLgLsbLgLgbLgLsbLsLsm
bLgbLgRsbRgbsbRsbRsbLgLsbRsbLgbLgbLsbRjRsRimbRibLcbLcbLgbLgbReLsbRhbRi
bRibRiRsmbRgbRgbLcbLibLsLsmbLgbLgbLgRsbLjbLsLsmbLgbRjbLhbRcbLcbRcRsmbR
cRsmbLcbLcbLgbLgLsbRsLiLsbLgbLgbRjbRiLsbRgbsbLcbRhbRgbLsbRgRsmbLeRsLoR
sLsbLcbLibLgbLibLibRgbRhbRcbLcbLcLsmbLgbLgbLsbLobLibLgbLibLgbRibRibRib
LjbRgbRgbLhbLibLibRsbLgbLgRsRsmbRsLsbLibLgbLgbLsLsLgmbRgbLgbLsbLgLsbLg
LsbLsbLgLsbLibLgbLsbLgRsbRgbLibLsbLgLsbRsbLibRgbLibLsbLibLsLsLsLsmmmbL
gbRsbLibLgbLgbLgLsbLsbLgLsbLgbRgbLibLsbRjbRiLsbLjbLcbLgbRgbLhbLiRsbRcR
smbRsbRhRsmbRgbRibRgbLgbRibRgRgLgbRgLsbRgbLgLsbRgbRjbRsbLsbRsbLgRsRsmb
LjbRgbRgbRcbRjbLcbRsbLibLgLsbRjbRibLebLibLsbLibLsbLgLsbLgbLgbLsbLsLsmb
LgLsbLgRsbLgLsbLgbLsbLsbLgLibRgRsmbLsbLgbLgLsbRsbLibLgbRsbLiLsbLjbRgbL
ibRsbLgbLgbRsbLgbLgbLgLsbLgbLgbRsbLibRgRsmbLgbRsbsbLsbLgbLgbLsbLiLsLsm
bLsbLibRgbRsbLiLgbLgbLgbRsbLgbLgLsbLsbLgbLgbRsbLgLsbRjbRibRgbRsLcbLibL
iLgbLgbLgbLsLsLgLsLsmmbLgbRgbLibLgbLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 24; Drug: NDMC 10 µM
bRibRgRsmbLsbLsbRibRsbLibLsbLsbLsbLsbLsbLgbLsbRgbLibRsbLcbLsbLsbLgbLgb
LsbLsbLgbRsbLgbLsLsLsmmbLsLsmbLsbLjbRgbRobRibLsbRgbRgbRgbRgbRsbRsbRgRs
mbRibRjbLcbLobRgRsmbLgbRsbRibRgbRgbRgbLgbLsRsbLsbLiLsbLsLsmbLgbLgbLsbL
sbRsbRsbLibLibLgbRsbLsbLgbLsbLsLsmbLiLsbLsbRsbLsRsbLgbLgbLsbLgbRsbLgbL
sRsbLgLsLsmbLgbLgbRgbLibLsLsmbLsLsmbLgbLsbLsbLsbLcbRgLsRsbLgbLgbLsbLgb
LsbLiLsbLgbLgbLgbLgbLsbLgbLsbLgbLgbLsbLgbLibLgbLgbLsLsLsmmbLgbLgLsbLgb
LgbLgbLgLsbLsbLgbRsbLgRsbLgbLgbLgbLsbLsbRibRgbRgbsbLsbRgbRgbLsbRsbRgbR
ibRsbRibLgbLsbRgbRgbRgbLgbRibLsbRgbRsbRgbRgbRsbRibRobRibRgbRsbRgbRgRsm
bRgbRsRsmbRsbRsbLsbsbRsbLsbRsRsmbRsbRsbRgbRgbLsbRsbRgbRsbRgbRsbRgbRgbL
sbRgbRgbLsbRgbRgbLhbRibRibLsbRgbsbRsRsmbRgbRgbRsbRsRsmbRgbRsbRsbRsbRsb
RsbRgLsbRgbRgLsbRsbRsLsbRiRsmbRibRsbRgbRibLgbRgbRsbRgRsmbLsbRgbRgbRgbR
cbLgbLgLsbLgbLgbLsLsmbLiLsbLsbLgRsbLgbLgbLgbRsbLgLgRsbLgRsbLsLsmbLgbLs
bLgbLgbLgbLgbLgbLsbLgLsRsbsbLsbLsLsRsmbLgLsbLgbLgLsbsbLgbLsbLgRsLsbLgb
LsbLgbLgbRsbLibRsbLgbLsbLsbLgbsbLgbLgRsbLgbLgbLgbLgbLsbLgLsbLsRsbLgLsb
LsRsbLsbLsbsbLsbLsbLsbLgLsbLsbLgbLsbLgLsbLsbLgbLsbLgbLgLsbLgbLcRsbRiRs
mbRgbLsbLsRsLsbRjbRibRibRibRgbRsbLgbRhbRsbRsbRgbRgbRgbRsbRsbRgbRgbRibL
gbLgbRhbLsbRgbRibRgbRiLsbLsbLgbRibLsbLsbRgRsLsmbRsbRgbRsRsmbRgbRsbRsbR
sbRgbsbRsbRgRsmbRsbRgLsbRgbLgbRcbLibLjbRgbRgbRgLsbRgbRsbRsbRsbRgRsmbRg
bRgbRsbRgbsbRgbRgbRsbLsbRiLsRsbRgbRgbRibLgbLgbRobRibRgbRsRsmbRgbRjbRgb
RgbRsbRsbRsbRgbRsbRjbRsbRgbRsbRgbRsbRgbRgbRgbRsbLsbRgbRgbRgbRsbRgbRsbR
sbRgbRgbRgRsmbRgbRgbRsRsmbRgbsbRgbLsRsbRgbRsbRgbRibRibLiLsbLgbRsbRiRsm
bRibRgbRgbRgbRgbLsbRibsbLgbRcbLsbLsLgbLsbRibRsbLsLsmbRgbLsbRgbRgbRgbRs
RsmbRsbRgRsmbRgbRgbLsbRsbRgbRgbLsLsmbRgbRgbRibRgLsbRsbLsbRsLsbRgbRsbRg
bRgbRgbRgbRgbRsbLgbRgbRsbsbRgbRibRsbRsRsmbRgbRgbsbRsbRgbRsbRiRsmbRgbRg
bRgbRsbLgbRgbLsbRgbRsbRgbRjbRsRsmbRgbRgbsbRgRsmbRsRsmbRgbRgbRsbLsbRgbR
gbRsbLsbRgbRsbsbRgRsmbRsbRsbsbRgbRgRsmbRgbRgbRgbLsbRgbRgRsmbLsbRgbLeRs
bLcLsmbRgRsmbRsbLibLibLiLsbRjbLibLhLsbsbRgbRibRobRibLibLgbRgbRiLsbLsRs
bRgbRibRgbRibLgbRhbRibRgbLibRibRibRgRsmbLsbRibRsRsmbRgbLgbRgbsbLsbLsbR
sbRgbRsbRibRibRgbLsbRiLsbLibLjbLgbRsLsbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 25; Drug: Control
bRibRgbRgbLgbRgbLgbLgbLibLiLsbLgbRsbRjbLiLsbRgbLcbLjbRjbLhbRjbLhbLcbLi
bRibRjbLgbLsbLgbLgbLsbLhbLcbLhbLcbLjbRobRobLjLsmbLsbLsLsmbLibLjbLsRsbL
gLsbRobRibRgbRgRsmbRgRsmbLsLsmbLsLsRsmbLgbLiLsbRjbRibRibRibRgbLsbRsbLi
bLgbRcbRhbLsbRsbLsbLjbLsLsmbLsLsmbLgLsbLsbLgLsLsmbsbLgbLgbLsbLsLsmbsbL
sbRsbLgLsbLgRsbLsbLsbRsbRjbRsbRibRibRobRhbRibLgbLibLsbLgbLsbRsRsmbLgLs
bRsbLgbLsbLgRgbsbsbsbRsLsbLjbLgbRsLsbRgLsbLiLsbLsbRjbRcbRgbRcbLgbRgRsm
bLgbLgbRjbRcbLibRgbLsLjbLjLsmbLibLibLsbRsRsmbLsbLcbRibLjbLibRsLsbLgbRg
bLibLsbLgbLgbLgbLsbLgbLsLsmbLsbLsLsmbRsLsbsbLsbLsbLsLsRsmbRsbLgbLsRsbL
sbLsbLsbRebRcLsbRcLsbRibLjLsmbLsbLsbsbLibLgbLgLsbRibRhbLgbLibRgRsRsmmb
LibRibRgbRjbRsRsRgRsLsmmbRgbRgbRsbRcbRebLibRjbLibLjbLcbRibRibRsLsbLgbL
gbRgbRjbRcbLibRibRiRsmbLsbRobLgbRibLgbLgbRsRsmbRjbRcbRibRibRgRsmbLsbRc
bLgbRibLsbRgbRsbRsbRgbRsbRgbRgbRsbRjbLgbRebLibLcbLjbRibRjbLcbLsbRcbReb
RibRgbRibLiRsbRibRsRsRsRsRsRgmmmmbRgbRgRgRsmbRgbRsbRjbLsbRibLibLebLgbR
obRibRcbRibRibRibRgbRibLjbRgbRsbRsbRgbLsbRiLsRsbRgRsLjmbsbRsRsmbRgbRsb
RgRsmbRgbRgLsRiRiRgRsRimbLgbRsbLsbRgbRsRsmbRgbRgbRsbRsRsmbRjbRsbsbRgbL
sRsbLsbRsbRgRsRsmmbRsbRgRsmbRgbRgbRgbRgbRsbRgbRiLsbLeRsbLobRjbRiRsmbRi
bLgbRgbRgbRsRsRsmmbRsbRiLsbsbRsRsRimbRgbRgbRgRsmbRibRsbRsbRsRgbRgbLgbR
hRsmbRcbLhbRibRcbRibRibRibLgbLgRsbRoRsmbRiRsmbRsRsmbRsbRibRcLsbRgRsmbR
gbRgbLjbRibLjbLcbLibRibLcbLhLsbRibRibRgbLcbLebRgbRgbLobLjbRibRgbLobRsb
LgbLgbLsbLsbRsbLsLsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 26; Drug: Control
bRibRgbRgbRcbRibLgbLgbLgbLgbLibLgbLgbLgbLgbLgLsbRsbLsbRgbLgLsbLgLsbLgb
LgbLsbRcbRjbRhbRcbLhbRgbRhLsbRgbRgbRgbLjbLibRjbRebLeLsLsmbLgbRgbLgbLjb
RebRsbRjLsbRsbRgbRsbRsRsmbRsbLgbLgbLgbLsbLoRsbLjbRcbLgbLgbRgbRsbRgbRsb
RsbRsbRgbLgbRcbRsbRsbRgbRgbRgbRsbRgbRsbRsbRsbRsbRsbRsbRsbRsbRcbRhbRjbL
jbLibLgbLgbRsbLibRibLjbRibRibRibRibLgbLsbRsLsbRsbLibLiRsbLibLgbLibRsbL
gbRgbRgbRjbLjbLibLibRobRibRgbRsbLsbRsbRsbLsbLibLgbLgbLsbLgbRgbRobRsbRi
bLibRibRsbRiLsbLgbRibRgbRsbRgbRgbLsbRgRsmbRgbRgbRsbRsbRsbRgLsbLsbRgbLs
RsbRsbRsbLsbRgbRgbRsLsbRibRgbLsbRgLsbRgbRgbRsbRgbRsbRgbRgbRsbRsbRgbRgb
RsbRsbLsbRsbLjbLibLgbLgbLsbLsbLgbRjbLsLjbLibRibLsbRebLjbRebRibRsbRsbRg
bRsbRgRsmbRgbRgbRsbsbLsbLcbLcbRibRjbLcbRibLobRcbRjbLjbRsbRgbLgLsbRsbLg
LsbRebRiLsbLjbRsRsmbRsbRgbLsbRgbLsbRgRsLsmbRibRsbRsbRsbRsbRsbLsbLibReb
RsbRgbRgbRsbRgbRsbLsbRgbRsbRgbRgbRobLibLgbRsRsmbLcRsbRibRgbLibLgLsbRsb
LobRibRiRsmbRgbRsbRgbLsbLcbLgbRobRcLsbRibLgbRibLgbLsbRibRgbRsbRgbRgbRg
bLsbRsbRsbRgbRgbLsbRgbRsbLsbRibLsLsmbRsbRgRsmbRgbRgbRgbRgbRgRsmbRsbRgb
RsbRgbRgLsbRgbRsbRgbRgbRsbRgbRsbRsbRgbRgbRgbLsbRgbRgbRsbRgbRgbRgbRgbRs
bRgbRsbRgbRgbRgbRgbRsbRgbRgRsmbLsbLgRsbRgbLcbRcLiLsbRobLgbRgbRgRsLgmbR
gbRsbRgbRgbRsbRgRsmbRgRsmbRgRsmbLsbRibRsbRgLsbLsbRsbRgbRgbRsbRsbRgbRsb
RsbRsbRsbRiRsmbRgbRgLsbRgbRgbRsbRgbRsbRgbRsLsRsbRgbRsbRgRsRsmmbRgbRgLs
RsbLsbRibRgbRsbRibRgbRgbRgbRgbRsRsmbRsbRgbRgRsmbRsbRgbRgRsmbRgbRsbRgbR
sbRibRsbRibLsbRhbRgbRgRsmbRgbRgbRgLsbLibLobRjbLcLsmbRgbRibRgbRgbRgbRgb
RgbRgbRsbLgbRsbRgbRgRsmbRsbRgbRgbRsbRgbRibLsbRgbRgbRsbRgRsmbRgRsmbLsbR
gbRgbRgbRsbRsbRgbRsLsbRsbLsbRibRibLsbLgbRibRsLsbLsRsbRibRsbRsbRgbRsbRg
bLsbLcbLobRhbRibLobRobRgbLsbRgbRsbRsbRgbRgbRsbRsbRibRsbRiLsbRsbRsbRgbR
sbRgbRgbRsbRgbRgLsbLgbRsbRgRsmbRgRsmbLsbRsbRgbRgbRsbRsRsmbLgbRgbRsbRgb
RgbRobRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 27; Drug: Control
bRgbRgbLibRgbRgRsmbRgbRsbLjbLibLjbRibLjbRsbLgbLgbLgbLibLgbLibLgbLgbRsb
LgbLsbLgbRgbRgbRgbLjbLibRjbRibRgbLgbLjbRcbLibRcbLibRcbRjbRibRibLcbRsLi
bRhbRibRibLibRibRgbRgbLsbRgRsmbRsRsmbRgbRsbRgbRsbRsbLsRsbRsbRgbLjbLoRs
bLcbLiRsbRgbLgbLgRsbLgbLsbLgbLgbLgbRgRsmbRgbLgbLgbLgbLibLibRibLgbLsbLg
bLgbLsbLgbRgbLjLsmbLgbRgbLgbLgbLgbRsbLgbLsbRsbLsbLgbLsLsmbRsbLgbLgbRsb
LgbRgbLsLsmbLgbRsbLgbLgbLsbLgbRsbLsbLgLsbLibLgbLsbLsbRgbLgRsbLgbLsbLgb
LgbLgbRibLibLsbLgbLsbLsbLsbLgLsLsmbRsLsbLgLsbLgbLgbLsbLgbRibRgbLibLgbR
sbLsbLsbLgbLgRsbLgbRgbLsbLsbLgbLgbLgbRsbLgbLgbRsbLgbLgbLsbLgbLsbLsbLsb
LgbLgbRgbLgRsbRibLgbLibLsbLgbRsbLgbRsbLgbLsRsbLgLsbLgbLgbRgbLgbLgbRsbL
sLsmbLgbLgbLgbLgbLibRgRsmbLiLsbLsbLgLsbLgLsbLsbLsbLgbRsbLsbLsLsmbLgbLg
bRsbLgLsbLgLsbLsbLsLsmbLgbLsbLsbRjbLjbRcbRcbRibLjbRibRgRsmbLsbRsbRgRsm
bRgRsmbLgbRgbRsbRgbRgbRibRgbRgbsbRsbRgRsmbRgbLsbLhbRibRgRsmbRsbRgbRsRs
mbRsbRsbRgbRgbRsLsbRgbRgbRgbLgbLsbRgRsmbRsRsmbRgbRgRsmbRsbRsRsmbRcbRib
LibLgLsbLibLibRibLibLibLcbLgbRjbLhbLibLjbRiRsmbRibLcbRcbLcbLcbLiRsbLgR
sbRgbLsbLiRsRsRsmmbRibLjbLsbLgbsbLgbsbRgbRgbRcbRjbRibLgbLgbLibLgbLjbLi
bRibRgbLcbRjbRcbLjbRgbLjbLibRjbRhRsmbRibRhbLibLjbRibRcLsbLjbRgbLsbRgbR
hbLsbRgbRgbRsbLgbRgbLjbRibRgbRgRsmbLsbRgRsmbRgbRsRsmbRsbRsRsmbRsRsmbRg
bRsbRgbRgbRgbRgbRibRgbLsbLgbRibRgbRgbRsbLsbsbRgbRgbLsbRsbLcbRjbLcbRibR
gbLsbLsbRgbLsbRibRsbRgbRsbRsbRgbRsbLsbLsbRibLsbRgbRsbRgbLsbRgbRgbRgbRg
bRgbRgbRgbRgbRgbRsbRgRsmbRgRsmbLsbRgbRsbRgbLsbRgLsbRgbRgbRsRsmbLsbRsRs
mbRsbRgbRgbRsbRgbLsRibLibRgRsmbRgbRgbRgbRibLjbLcbRibRibLjbLobLiLsbLiRs
bRsbLibRsbLiLsbLibLibLgbRgbRgbRgbLgbLgbReRsLsmbLjbLhbLibRibLibLgbLsbLi
bLgRsbRsbLibRibLgbLgbLsbLibLibLgbLgbLgbRsbLgbRgbLjbRhbRibLjbRibRgbRibR
sbRgbRgRsmbRibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 28; Drug: Control
bLcbRcbLcbLcbLhbLcbRjbLhbLcbLibRcbLjbLjbRhbLibRcbLcbLoRsbLcbLcbLiRsbRs
bLjbLjLsmbRjbRsbRibLebLgbLibRjbLebRcRsmbRcbRgbLgbLibRebLsbLsbRsbRgbRcb
RibLibLgbLsbRgbsbRsbRibRcbLgbLjbRcbRsbRsbRibRgbRsbRiRsmbRjbLgbLgbRsRsm
bRibLhRsbRsbRjbRobRibRhbLgbLgbRibRobLsbLgbLjbRibRcLsbLiRsbLgbLcbLiRsbL
cbLcbLebLhbLibLsbRsbRibRgRsmbLhbLcRsbRgbLgbLcbLsbRgbLcRsbRebRjbLoRsbLg
bLgbLibRsbRsbLibLiLsbLsLsLsmmbLsbLsbLsbLsbLgbLsbRsbLsbLgbLgRsbLsbLgbLs
bLgRsbLsbLgRsbLgRsbLhbLoRsbLcRsLsbLgbRsbRhRsmbRiLsbLibRcbRhbLibLibLgbL
gbLsbLsLsmbLgRsbLgbLgbLsLsmbLsbLibLsRcbRjbRibLsbRjLsbRibRibRsbLgbLsbRg
bRsbRhbRibLgbLibLgbRsbRgRsmbRgbRgbRgbRgbRibLcbLhRsbLibRgRsmbLibLgbRjbL
jbLibLcRsbRibLibLiLsRsbLjbLsbRsbLgbLsbLgLsbLsbLgbLgbLgbRsRsmbLgbLgRsbL
sbRsbLhbRsbLibLgRsbRhbLcbRibLobRibLobLibRibRibRsbRgbRibRgLsbRgbRgbLgRs
bRgRsmbLsbRgLsbRsbRsbRgbRsbRgbRgLsbRgbRsbLsbRsbRgbRgbRsbRsRsmbRsbLebRi
bRgRsmbRsRsmbRgRsmbRsRsmbRgbRsbRgbRgbRgbRgbRgbRsbRgbRsbLsbRjbRgbRgbRgb
RsRsmbRgbRgLsbRgbRgbRgRsmbRgbRgbRsRsmbRsbRgbRgRgRgbRgbRgbRsbRgbRgbRgbR
gbRgbRsRsmbRsRsmbRgbRgLsbRgLsbRgLsbRgRsRsmmbRsbRgRsmbRgbRgbRgbRgbRsbsb
RsbRgbRsRsmbRgbLiRsbLeLsbLgLsbRsbLibLoRsbLcLsmbLcbLibRibRibLjbLcbLsRsb
RjbLcbRgRsmbLibLibRsbLibLsRsbLgbLcbLhbLgRsbLjbRhbRsbsbLibLsbRgbRsRsmbR
sbRsbRgbLsbRsbRsbRgRsmbLsbRgbRgbRgRsmbRgbRgbRsbRsbRsLsbRgbRsbRgbLsbRgR
smbRgRsmbRgRsmbRsbRgbRgbRsbRgRsmbRgbRsbRgbRsbRibRgbRsRsmbRgbRgbRgbRsbR
gbRsRsmbRgbRgbRgRgRsRsRgmmbRgbRibLcbLhbLobRibRgbLcbLibRibLhbLhbRgbLibR
jbLibRgRsmbLgbRsbLgbLiLsbRgbLeLsbRibLsRjbRcbRibRhbLibRgbRgbRibRiLsbRhb
sbLsbRibRgbLcbLiRsbLibRgbLsbLibLhbRgbRibLjbLcbRsbLibRgbLibRjbLibLgbLgb
LhbLcRsbRgbLibLgbRgRsmbRsLsbLcLsmbLibLiRsbLsbRgRsmbRibLcbLgbLsbLgbLgbR
gbLgbLibRgbLgLsbLsbLsbLgbLsLsmbLsRsbLgbLgbRsbLgbRsbLgbLgbRgbLgbLsbLgbR
sbLibRgbLibRsbLibLsbLgbRgbLcbRibLgbLgLsbLsbRcbRibRgbsbLsbLgbLsbRgbRgbL
gbLgLgRsbRsbRgbLgbLhbRebRebRsbRgbLsbRiRsmbLibRiRsmbRgRsmbRgbLsbRsLsRsb
RcbRsbLsbRgbRgRsmbRsbRgRsmbRsbRibRgRsRsmmbRgbRsbRgRsmbsbRsRsmbRsRsmbRs
RsmbLobReb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 29; Drug: Control
bRsbLgbLiRsbLsbLsbLsbLgbLgbLsbLgbLsbLsbLsbLsbLsbLgbLgbLgbRsRsmbLgbLgbL
gbLsbLgbRsbLsbLsbLsLsmbLgbLsbLsbLgbLgbLgLsbLsLsmbLsbLgbLgbLsLsRsmbLgbL
gbLgbLgbLsbLsbLsbLgbLgLsbRsbLgLsbLgbLgbLgbLgbLgbLsbLsbLsbLgbLsLsmbLgbL
gLsbLsbLgbLsbLgbLgbLsbLgbRsbLgbRsbLgbLsbLgbLgbRhbLgbLiLsbLsbLgbLsLsmbL
gbLsbLibRsbLibLibLibLsbLsbRibRhbLcbLcbRjRcbLhbRibRgbRcbRoRibRjbRiLsbLc
bRjbRibRibLgbRgbRgbRsbRgbRgbRgbRsbLsbRgbRgRsmbRgbLgbRgbRgRsmbRgbRgbLsb
RgbLsRgbRgbRgbRsbRsbRibRcbRhbRgbLjbLgLsbLgbRgbLgbLibRgbLibLsbLgbLgLsbL
gbLsLsmbLsLsmbLsbLgbLgLsbLgbLgLsbLsbLgbLsbLsbLgbLgRsbLsRsbLgbLgbLgLsbL
gbLgLsbLgbLgLgLsbLsbLgbLsbLgLsbRsbLibLgLsbRsbRsbLibLsbLsbLibLgbRgbLibL
sbLgbLsbLgbLsLgbLgbLsbRgbLgLsbLsbLgLsbLgbLibRjbRiLsbRgLsbRgbRgbRibLsbL
hbLcRsRjbLjbRobLiRsbLibLsbLgbRgbLoLsRjmbLibLsbLgbRgbLgbLibRibRjbLsbLcb
LibRebRgRsRgRgmbRgRsmbRgbRgbRsbLjbRjbLcLsmbLsLgbLsLsRsmbLibLgbLgbRsbLg
bLgRsbRsbLgbLgRsbLsLsmbLsbLsbLsbLsbLgLsbLsLsmbLsLibLgbLsLsmbRsbLsbLgbL
sbLsbLgbLgbLsLsmbLgLsbRjbRibRjbLgRsbLibRjbLcLsmbLcbLgbRjbRcbRjbRibRibR
ibRjbLhbRgbRjbLhbLgbRjbRebLcbLgbRjbLhbLibRgbRjbRgbLcbRibLcbLjbRiLsbRgR
ibRgRsmbLjbLjbLgLsbLibLibRsbRjbRsRsmbLibLgbLjbLgbRibRcbRebRjbRgRsmbRgR
smbRgbRgbRgRsmbRsbRsRsmbRgbRgRsmbRgbRibRgbRjbRsRsmbRsbLhbRjbLgbLcbRjbR
ebLobLhLsRsLsLsmbLjbLsbLgbLgRsbRjbRibLhbRjbLhbRsbLhbLgbLsbLsbLgRsbLgbL
gbLsLsmbLgbRsbLgLsLibLgbLgbLsbLgbLsbLgbLgbLsbLgbLgbLgbLsLsLsLsmmmbRsRs
LsmbLgbLsbLsbRsLsbLsLgbLcRgbLhbLibRhRsmbRcbRcLsbRibRcbRibLibLcLsmbRjbL
hbRibRjRiRsmbLcbLobLgbLgbLsbLiLsRsbLsLsmbLiLsRsbRibLcbLgbLibRibRiRsmbR
cbRcbLibLsbRgbLgbLibRjRhbRibLhbLibLgbRhRibRibLcbLoRibRebLobRebRsRsmbRg
bRsbRgRsmbRgbRgbLsbRjbLsbRobLgbLjbLiRjbRsbLgLsbLgRjbRjbRcbLgRsbRsbLibL
iLsbLgbLsRsbLgbLgbRsRsmbLgLsbLiRsbLcbRibRiRsmbLibLobLibLgbLgbRcbRcLsbR
sbRibRgRsmbRgRsmbRsbRhbRobRibLgbLibLsLibLgbLgRgbLsLsLgmbLsbLgbLsbLgbLs
bLgbLgbLgbLgRsbLgbLiRsbRibRjbLjLibLibLgbLgbLjRsbLsbLgbRsbRsbLibRjbLoRj
bLiLsbLsbLibLiLsbLgLsbLgbLgLsbLibLsbRsbLibLgLsbLsLsmbRgLsbLgbLgbLsbLgb
LiRgbLgLsbLgbRsbLibRsbLibLgLsbLsbLsbLibLgbRgbLgRsbLibRsbLibLgLsLsmbLsL
smbLgbLgbRsbLgLsbLgbLgbLsbLgbLgbLsbLgLsbRsbLiLsbLibLgLsbLgbRsbLibLsbLg
LsbLgbLgRsbLgbLsbLgbLgbLsbLibRsbLsbLgbLsbLgLsbLgbLgbLsbLgLsbLgbLgbLgbL
gbLgbRcbRebRhRsmbLibLgbLibRibLjbLiRsRsmbLgLsbLibLiLsbRgRsmbLgLsbLsbLgb
LsbLgbLgbLgLsbLgbLsbLsbLgbRebLgbLgbRjbRjbRibLgbRibLcbLcbRgbLiLsbLibLgb
LgbRsLsbLibLgbLiRsbLsLsmbLgbLgbLgRsbLsbLgRgbRjbRhbLcLibLgbRsbLiLsLsmbL
gbLiLsLsmbLsLsmbLiLsbLsLsmbLibRsLsbLiLsbLgbLgbLgbLgRsbLgbRibRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 30; Drug: Control
bRjbRgbRsbRsbRgbRobLsbLiLsbLgbRgbRgbRibLjbLibRgbRsbLobLebLcbRibRibRgbR
sbLsbLgbRsbLgbRjbRhbRjbRcLsbRgbRibRhbRiRsmbRsbLgbRgbRsbLsbRgbRgbRsbRcL
sbLsbLgbRsbRgbRgbRibLjLsmbLobLgbLgbRsbLgbLsbLsbLgbLgLsbLsbLsbLgbLsbRsb
LgLsbLsbLgbLsLsmbLgbLgbLgbLsLsmbLgbLsbLgbLgbLgbRsbLgbLsbLsbLsbLgbRgbLi
bRjbRobRoLsbRibRibRsbLsbRsbLibLiLsbRgbLgLsbLsbLsbLsbLgLsbLgbLsbLsLsmbL
sLgbLsbLgbRgbLgRsbLgRsbLgbRhbRjbRgbRgbLibLibRgRsRsmmbLgbLsLsmbLsLsmbLs
bLsLgbLgbLgbLsbLgbLgbLgbRsbRgbLgbRsLsbRgbRhbRibRsbRgbRsbRjLsRsbRcbLibL
jbRgbRgbRgRsmbLsRgbRgbLgbLjbLjbLobRgbLgbLgbLgbLsbLsbRgbLibLgbLgbRsbLgb
LgbLsbRsbLgbLsLsmbLgbLgbLgbLgbLsbLgbLgbLgbLgbLgbLgbRgbLgbLgbRgbLibLiLs
bLgbLsbLsLsLimbLgbLgbLsbLgbLgbLgRsbLgbLgbRgbLgbLgbRgbLibRgbRhbRibLgLsb
RgbLgbLjRsLibLjLsmbLgLsbLiRsbLsLsmbLgbLgbLgbLsbLgRsbLgbRsLsbLgbLgbLgbL
gbLgbLsbLgbLsbLgbLgbLgbLgbLgbLsbRsbLgbLgbRsbLiLsbLsLsmbLgbLgbLgbLgLsbL
gbLsbLgRsbLsbRobRcbLibLhbRjbRobRcbLibRibRgRsmbRibLgbRibLsbLjbRobLsbRob
RgbRjbRgbRgbLsLsmbRibLjLoRsbLsbLibLgbRcbRcbRibLjRsbLcbLgLsbLgbLgbLsbLs
LgbLgbLgbRsLgbLgbRsbLsbLgbLsbLsbLgbLgbLgbLgbLgbRsbLgbLsbLsbLgbLgLsRsbL
gbLgbLgLsbLgbRgbLgbLsbLgbLsbLgbRsbLibRsLsbLsLsmbLsbLibLgbLgbLgbRsbLsbL
gbLgbLsbLsLsmbLgbLgbLsbLsbLgbLgbLgbRsbLgbLgbLgbLgbLsbLgbLgbLgbLgbLgbRg
bLibLsbLiLsbRoLsbRibRebLsbLcbLcbLhbLcbRgbLoLsmbLibLgbLsbLibRgbLibRgbLg
bLgbLgbLgbLgbLgbLibLgbLsbLgLsbLgbLgbLibLgbLgbLibLgbRhbLiLsbLsbLgbLgbLg
LsbLgbLgbLsbLgLsbLgbLgbRsLgLsbLgbLibLgbRibLibLsbLgbLgbLgbRjbLibRsbLsbL
sbLgLsbLsbLgbRsbLgLsbLgbLgbLsbLgbLsbLgbLgbLgbLgbLgbRsbLgbLgbLgbRgbLibL
gbLgbLgbLgbLgbRsbLgbLibLgbRcbRcbRibLgLsbLjbRibRgLsbLgbRiLsbLjbLcbRgbLo
bLobLibRibLjbLebLcbRgbRgbLgbLibLsRsbLgbLgbLgbLsbLgbLsRsbLsbRjRhbRcbRhb
LsbLibRiRsmbLgbLgbLcbRhbRgbLcbLsbLgbRgbLibRsLsbLhbLibLgLsbLgLsbLibLgbR
jbLibRgbLgbRcbRibRsbLgbRibRibLsbRgbRsbRcbRibLibLibLibLgbLsbLgbLgLsbLgb
LgbLgbLgbLsbLgbLgbRgbLiLsbLsLsmbLsbLsbLgLsLsmbLsLsmbLsbLgRsbLsbLgbLgLs
bLgbLgRsbLsbLsbLgbLgbRsbLgLsbLgbLgbLibLgbLgLsbLgbLgbLgLsbLsbLsLsmbLgbL
gbLsbLgbRgbLgbRsLsbLibLsbLsbLgRsbLgRibRgLsbRoLsbLsbLibLibRhbRhLsbLcbLo
RsbLhbRsbLibRgLsbRgbLcbLibLgbLgbLsbLhbLhbRsLsRsbLibLgbLgbLsbLgbLsbLgLs
bLgLsbLgbLgbLsbRsbLsbLibLgbLgbLsbLgLsbLgbLgbLgbLgLsbLgLsbLsbLsbLgbLgbL
gbRsbLsbLgLsbLgbLgbLgbLgbLgLsbLgbLgbRgLsbLgbRjbLsLibLgbLgLsLsmbLgbLsbL
gbLgbLgbRjbLibLgLsbLsbLgbLibLgbLgLsbRsbRsbLgbLgbLgbLgbLgbLgbLgbLgbLgbL
gbLgbRsbLgbLsbLsbLgbLgLsbRsbLsbLgbLgbLgbLgLsbLgbLgbLgbLgbLgbRgbLgLsbLg
bLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 31; Drug: NDMC 1 µM
bRhbLjbLhbLsbRgbLsbLgbLibRibRgbRgbRsbLeLsbLgbLgbLcbRiRsmbRcRsmbLebRgbL
sbLjbLcbLibLhbRsbLibLcbRebRebLcbLcbRjbRibLjbLibRjRsmbRjbRibRiRsmbRibLg
bLcLsmbRibLcbRibRgbLhbLcbLibLibLibLgbRgbLgbLsbLibLsbRgbLgbLgbLsbLsbRjb
LjbRibLjbLibLobLjbRgbLgbLgbLsbLsbLsbRsbLgLsbLjbLjbRsbRibRiRsmbRsLsbRib
RgbLsbRgbRgbRgbLsbLebLibLgbLjbLsbLsbRibRibRibRgbRgbRjbRgbRgbRsbLjbLibR
ibRibRibRgbLsbRsbLgLsbLsbRgbLgbLgbLsbRobRobLjbRsbLgLsbRsbLsRsbLgbLibLg
bLgbLgLsLsmbLgbLibRsbLgbLgbLsLsRsmbLgbRsbLjbLsbLgbLgbLgbLsbLgbLsbLsbLc
bRgbRgbRgbLgbLsbRibLgbRgbRsbRgbRgbRsbRgLsbLibRsbLcLsLsmmbRgLsRsbLcbRsb
LibLhbLcbLiLsbLibLcRsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 32; Drug: NDMC 1 µM
bRsbLobRgbLsbLibLgbLsbLhbLibLgbRsbLibRibRsbRgbLcbLibRjbLgbLobRsbRgRsmb
LgbRsRsmbRgbRgbLhbLgbRgbLhbLibLgLsbLsbLsbLibLiRsbRgbRgbRgbRibRsbRgbRsb
RsbRgbRgbRsbRsbRsbRsbRgbLsbLsbLcRsbRjbRhbLsbRibLsbRsbRgbRsbRsbRsbRsbRs
bRgbRgRsmbRsbRsbRsbRgbRgbRgbLibRgbRibRgRsmbRsbRgbRsbRgbLsbLsbRgbRsbRsb
RsbRgbRsbRgbRsbRsbRsbLsbRgbRgbLsbRsbRsbLsbRgRsmbRsbLjbLibRjbRjbLibRjbR
hbLsbRgRsmbRgRsmbRsLsbRgLsbRgbRgbLsbRgbRgbRgbLsRsbRsbRgbRsbRgbRgbRgbLg
bLsbRgbRsbLsRsbRgbRgbLgbRgbLsbRgbRsbRsRsmbRsbRsbRsRsmbRgbRgbRgbRsbRgbR
gbRsbRgbLsbRgbRsbRgbRsbRgbRsbRgbRsbRgbRgbRibLgbRiRsmbLobRgbLgbLgbLgLsb
RsbLgbLsbLgbRjRsmbLgbRjRcbLsbRsbRsbRgbRsLsbRgRsmbRsbRgbRgRsmbRgbRgbRgb
LgbsbRgRsmbRsbLsbRibLsbRgbRsbRgbRgbRgbLsbRgbRsRsmbRgRsmbRsbRgbRgbRgRsm
bLsbRsRsmbLjbLgbLgbLhbRibLhbRhbLsbRcbRcbLgRsbLgbLgbLgbLgLsbRsRsmbLgbLg
bRsbLgbRsRsmbRjbRibRiRsmbLsbRsbRsbRsLsbRgbRsbLsbRiRsmbLsRsbRsbRgRsmbRg
bRgbRgbLsbRgbLsRsbRsbRsbRgbRgbRgbRgbRgbRgbRsbRsbLsbRgbRgbRsbRgbRgbRsbR
sbRgRsmbRgbRsbRsbRgbRgbRgbRsRsmbRsbRgbRgbRgbRsbRgbLsbRsbRgbLsLsmbRgbRs
RsmbRgbRsbLsbRiRsmbRgRsmbRsRsmbRsbRsbRgRsmbRgbRsbRgbRsbRgbRsbRgbLsbRgb
RsRsmbRsRsRsmmbRsbRibLsbLhbLcbRibLibLibRcbRgLsbLibRsRsmbLobRsbRsbRgbLi
bLgbRibRibLgbRsRsmbRgbRgbRsbLsbRsbRgRsmbRsbRgbRgbRsbRgbRgLsbLgbRsbRgbR
gbLgbRibRsbRgbRsbRsbRsbRsbRsbRgbRsbLsbRgbRgbLgbRgbLsLsmbRsbRgbRsbRsbRi
RsmbRsbRgbLsbRsRsLsmbRgbRsRsmbRgbRgbRsbRgbRsbRgbRgbRsbRgbRgbLsbRgRsmbR
sbRsRsmbRsbRgbRgbRgbLsbRgbLsbRgbRsbRsRsmbRibRsbRgbRsbRgbLsbRsRsRsmmbRs
bRsbRsbRgbRsbRgbLsbRgbRsLsLsmbRgbRsbRgbRgbRgbRsbRsRsmbRgbRsbRsbRsbRgbL
sbRgRsmbLsbLgbLgbRsbLgbLsbLgbLsbRcbRobLgbRsbRibRoRsLsmbLibRgbLibLgbLgb
sbLgbRsbLgbLgbRsbRgbLobRibLibLibLibRsbLcbRgbRibLjbLibRjbLgbRjRsmbLjbLg
bLgbLibRjbLobLibRsbRgbLgbRhRsmbLgbLcbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 33; Drug: NDMC 1 µM
bLjRsLcRsbLibLibRsbRsbLhbRgRsmbRgbLibLgbRsbRgbRobRibRgbRgbLsbLgbLsRsbR
sbLibRibLhbRibRjbRcbRibRsbRsbRsbLsbLgbLsbLsbRgbLgbRibLhbRjbLobLibLgbRi
bLgbRsbRgRsmbLibLhbLgbRgRsmbRgbLgbLgbLgbLgbRcbRgbRsbRsRsmbLsRsbRgRsmbR
gbLsbRsbRsbRgbLsRsbLgbRjbLsbRgRsmbRgRsmbRgbRgbRgbLgRsbRsbLsRsbRgbRgbLs
RsbRsRsmbRgRsmbLsbRgbRgbLsRsbRgRsmbRsbRsbRsRsmbLsbRsbRsbRsbRsRsmbRgbLs
RsRsmbRgbRsbRsRsmbRsbRsRsmbLsbRgbRsbRsRsRsmmbRsbRsbRsRsmbRsbRsbRsRsmbs
bLgbRibLjbLibLibRoRsmbRibLibRibLgbRgbRjbLgbLobLibLgbRjbLibLgbLjbLgbRsb
LgbLgbLgbLgbRsLsbLgLsbLgbLsLsmbLsRsbRsbLgbLsbLgbLgbLsbLsbLiRsbLgbLgbLs
bLsRsbLgRsbRgRsmbRibRibRsbRsbRgbRsbRsRsmbLsbLgbRgbLgbRibRgbRsRsmbRsbRs
bRgbRgbRgbRgbRgbLgbRgbRgbRsbRgbRgbRsRsmbRgbLsRsbRsbRibRsbLjRsbLcbLibLg
bRibLgbLgbLgbLgbRibLgbRibLgbLsbRibRgbRsRsmbRsbRsRsmbRgRsLsmbRgbRsbRsRs
mbRsbRsbRsbRgbRgbRgbRgRsRsLsmmbLgbLsbRibLsbRibLgRsbRgRsRsmmbRgbLjbRibR
sbLsbRgbLsbLcbLibRjbLiRsbRsRsmbLgbLgbLgbRgbRjbRibRibRibLibLgbRgbRibRib
LsRsbRsbRgbRibRhbRibRibLgbRgbLhbRcbRcRsmbLsbRibLgbRibRgbRibLgRsbLibRjb
RibRiRsmbRgbLgbRiRsmbLsRgbRhbRsbRgRsmbRgbLgbRgbLgbRgRsRsmmbRgRsmbLibRj
RsmbRsbsbLhbLibLibRjbLgRsbsbsbRcbRgbRgbRgbRgbLsbRgbRgbRgbRgbLsbRsbRsbR
gbLsbRgbLibLibLhbRibLibLibLgbLibLibRgbLgbLgbLgLsbRsbLgbRsbRhbRibRsbRgL
sbRgbRsbRcbLgbLgbRgbRsbLgbRgbRgbLsbRgRsmbRsbRsRsmbRsbRsbLsbRgRsmbLsbsb
RgbLgbRsbRgbRsLsbRgbRsRsmbRgbRgRsmbRgbRiRsmbRgbRsbRsRsmbRgbLsRsbRibRgb
LgbRibRgbRgbRgRsmbLsbRgbRsRsmbRgbRgbLsbRibLsbRibRsRsmbRgbRgRsmbRgbLsbR
sbRgbRjbLgbRsbRibRsRsmbRgRsmbRgLsbRgbLjLsmbRibRgbRsRsmbLsbLgbRibRibLgb
RibLsRsRsmbRibLgbRsbRiRsRsmmbLgRsbRibLgbRcRsmbRibRiRsmbRgbRgbLiRsbRibL
jbLibLgbRjbLibRcRsmbLjbRjbRcbLcbLeRsbRibLiRsbLgbLgbLgbLsbLgbRsbLibRsbL
gbLibLiRsbRjbLibRcbRibLibRibRibLgbRgRsmbLsbRsbLsLsmbRsbRgbRsRsmbRgLsbR
sbRgRsmbRgbLgLsbRgRsmbRgLsbRgbLsbRgbRgbRsbRsbLsbRjRsmbLjbRhbLsbLsRsbRg
bRgbLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 34; Drug: NDMC 1 µM
bRhbRibRibRibLgbLsbRgbLgbRibLcbLibLsbLcbRgbRsbRsbRgbLoRsbLcbLjbLibLcbL
iLsbLibLgbLsbLgbLgLsbLgbLsbRsbLgbRsbLsbLgbLsbLgLsbLgbRobLsbRgbLgbLibRg
bRsbLgbRsbLgbLsbRsbLibLgbRsbLsbLgLsbLgbLsbLsbLsbLgLsbLgbLgbRsbsbLgbLgb
LgbLsbLgbLgbLgbLgbRgbLgbLgbLsbLgLsbRsbLibRsbLsbLsbLsbLgbLgbLsbLgbRgbLg
bRsbRsbRgbLgbLgbLgbRsRsmbLgLsbLsbLsbLsLsmbLsRsbLsbLgbLgLsbRsbLgbLgLsRs
bLgbLgbLgbRgbLgbLgbRsbLgbLgbRjbLgbLgbLsbLgbLgbLsbLgbRgbLgbLgLsbLgbRsLs
bRibRgbRsRibLobLibLsbLsbLgbRibRgbRjbLjbLiLsbRgbRgbLsbLgbRibRgbRibLcbLg
bRsbRsbLgbRsbLgbRsbLjbLibLibRsbRsbLsbLgbsbLgbLgbLsLsmbLgLsbLsbLgbRsLsb
LgbLgbRsbRibLjbLhbRgbLjbLgbLsbLgbLgbLgbRgbLgLsLgbLsbLgbLgbLgbLgbRsRsmb
LgLsbRsRsLsmbLgLsbLsbRsbLsbRsbLsbLgbRgbLgbLgbLsbLgLsbLsbLsbLsLjbLibRjb
LgbRgbLsbLcbLsRsbRgbLibLibRjbLibLgbLjbLgbRjbLsbLibRsbRsbLgbRsLsRsRsmbL
sRsbLsbRcbRgbLjbLcbLsbLgbRgbLgbLsLsmbLgLsbLsbLgbLsbLsbLgbRsbLgbLsbLsbL
gLsbLgbLsLsmbLgbLgbLgbLgLsbRsbLgLsbLsRsbLgbLgLsbLsLsmbLgbLgbRsbRhLsbRi
bLjbRcRsmbLcLsmbRcbRebLibRjbLgbLgbLibRgbLibLsbLibLsbRsbLjbLgbRsbLsbLgb
LibRjbRhbRoRsmbRjbLibRjbRhLsbRiLsbRebLibLgbLibLibRiRsmbLiLsbLgbRgbRibL
obRibLibRgbLibLgbRgbRjbRsbRgbRibRgbRsbRgbLcbLgbLgLsbRgbRibLsRsLsbLsbsb
RjbLgbLgbRsbLgbLgRsbRsRsmbLsRsLsbLibLgbRsbLgbRsRsLsmbRsbLsbLibLjbLgbRg
bLibRjbRhbLcLsmbRcbRhbLiLsbLjbLcbLibRibRgbLsbLgbLgLsbLgbLgbRgbLgbLgbRs
bLsLsLgmbLgLgLsbLsLsLgmbLgbLsbLsbLgbLsbLgbLsbLgLsbRsbLgbLsbLgbLgbRsbRj
bLjLsmbRjbRobLgbRgbLgbLgLsbRsbLgbLsbLgbLgbLibLgbLgLsbLgbLgbRsbLsbLgbLg
bLgbLgLsbRgbLgbLsbLgbLgbLsbLsbLgLibLsRsbLgbRjbLsbRcbRcbRgbRsbRgbLiRsLs
bRsbLibRgLgRsbsbLgbLsbLgbLiRsbLiRsbLgRsbRiRsmbRgbLibRsLibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 35; Drug: NDMC 1 µM
bRibLsbRsRsmbRsbLsbRsbLibLibRsbLibLgbLgbRsbRjLsRobRcbRhbRhRsmbLgbRibRg
bRgbLcbLcbRcbRobLsbLibRjRsmbLjbRcbRcbLcbLcbRcbRibLhbRobRoLsbRibLjbRiRs
mbLjbLobLibRgbLibLgbLcLsmbRhbRibLibLhbRibRgbLjbLibLiRsbLibLjbRjbRibRiL
sbLgbRiLsbRgbRsbLsbLjLsmbLhbLgbLsbLgbLcRsbLibLibRsbLibLcbLgbLgbLibRsbL
sbLiLsbLgbLgbLsbLsbLgbLsbLsbLgbLsbRsbLibLgbLiRsbLibRgbRgbLsbLgbLjbLibL
hbRcbRhbRjbLjbLibLibRsbLgbLcbLgRsbRsLsRsbRgbLgbRibLjbLgbRjbLibLibLibLj
bRibLobLjbRebLgbLgbRgRsmbRgbRsbLsbLsbRgbLsbRgbRsbRjbRgbRgbRgRsRiRgmbRg
RsmbRgbRgbRsbRgbRsbRgbRgbRgbLgbRsbRibRsbRgbRgbLsbRibRibRsbRsbLsbLgbRgb
RgbRsbRiLsbLibLgbRjbLibLgbLibRgbLibRgbRjbLjbLibLcbRibLjbRgbLibLcLsmbLg
bLhbRcbLjbRobRibLjbRcbRjbRibLgbRsbRgbLsbRgbLsbRsbRgbLsbRgbLsbRsbRgbRiR
gRsmbRsbRgbRgbRgbRgbRgbRgbLgbRgbRgbRgRgbRgbRgbRgbRgbRsbRgbRgbRgRsmbLsb
RgbRgbLcbLiRsbLcbLgbLibLgbRebRibLibRgbLjbRhbRcbLibLgbLgbLhbRgbRjbLibLg
bLgbLcbRgbLobLibLgbLsbLsbLgbLsbLgbLgbRsbLibLgbLcbLgbRjbLiRsbLibRsbLobL
cbLhbLjbLibLgbRgbLgbRjbLjbRhbRiRsmbRibLgbRibRsbRgbRsbRgbLgbRibRsbLgbRi
bRsbRsbRibRsLsbLgbRhbLsbRgbRgbLsbRgbRgbRgbRibRgbRsbRgbRgbRibLgRgbRgbRs
bRgRsmbRgbLgbRibRgbLgbRiLsbLsbRibLjbRjbLcbLhbLibRjbLibLibRibLibLgbLgbL
gbLcRsbLhbLgbRibRgLsbRgbRsbRgRsmbLsbLhbRcbRibRsbLsbRibRgbRsbRgLsbRgbRi
bRgbLsbRiLsbRsbRsbRgbRgbRgLsbLsbRiRsmbRgbRgbRgLsbRsRsmbRsbRgbRsbRiLsbR
jbLgbRsbRhbLibRgbRgLsbLsbLhbLgbRsbRjbLhbRhbRcbLsLsmbRibLibRjbLsbRgbLjb
RibLcbLibLibRgbRibLibLhbRjbRgbRgbLsbLsbRibLsRsbRgbRgbRsbRsbRsbLsbRsRsR
smmbRgbRibRsbRibRsbRsbRjbLcbLiRsbRjLsbLsbLjbLsbRgbLsbRibRgbLibLobLibRj
bLibLgbLsbReRsLgmbRebLibLgbLgbRsRsmbLhbLgbRgbRcRsmbLgbLibLgLsLsmbLgbLg
RsbRgbLgbLibRhbLjbRsbLibLgbLibLibLibLibLgbLsRsbRibRibLsbRsbRsbLjbLibLg
bRgbLibLgbRsbLsbLsbRjbRcbRsbRibRsbRsbRibLibRhbRgRsmbRgbRgbRsbRibRgbLjb
RibLibRibRsbsbRibLgRsbRgbLsLsmbRibLgbRibLgbLjbRjbRcbRcLsbLibLgbLgbRhbR
oRsmbRcbRibLgbLibLibLsbLgbLibRgbLibLgRsbLgbRgRsmbLibLibRsbLibLibLgbLib
RsbLgbLgbLiLsbRsbRgbLibLgbLgbLgbRhbRibLiLsRsbRgbRibRibLiLsbRhbRgbLsbRi
RgbRsLsbLcbLiLsbLgbLsbLibRibRjbRcbRsLsbLgbRgbRgRsmbRibRgbRsbRibRgRsmbR
sbLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 36; Drug: NDMC 1 µM
bLsbLgbLsbLgbLobRsbRsbRsbRcbRcbRsbRcbRebRsbRibRibRgbRebRgbRgbRibRcRsRs
mmbRgbRgbRcRsmbRsbLhbLhLsbRsbLoLsmbLobLcbLsbLcbRebRsbRhRsmbLgbRibLsbRc
RsmbRhbRgbRsRsmbRgRsmbRcRsLsmbRsRsmbRibLibLebLcbRibLsbLgbLibLibLibRebR
oRsmbLibLibLhbLibLgbLgbLsLsmbLgbLibLgbLgbLibLgbLgbLibRhbLgbLhLsbLgbRcb
RsbLsbLcbRcbLcbLibRcRsmbLibLebLcbRibLsbLibLibLsbLibLgbLibLiRsbLgbLhbLi
bLibLgbLgbRjbRcbLebLibLgbLibLiLsbLgbRcbRibRcbRiLsbRhbLgbLeLsbRobLeLsbL
cbLhbLgbLgbLibLgbRgbRcbLibRcbLebLjbLebLsbRgbRgbRjbRcbLibLebLibLgbRcbRi
bLebLebLsbLcLsmbRsLsbLibLgbLgbLgbLsbLgbLgbLgbRcbLjbLibRsbLiRsbRsbLibRo
bRgbRcbLcLsmbLibLgLsbRsLsbRsbLjbLcbLoLsmbRjbLsLsLsmmbLcRsLsbLgLsbLsbLj
bRibLjbRsbRibLgbRgbRgbRebLgbLibLobLcbRebLcLsmbLgbLsbRjbLcbLgbRsbRibReb
LcbLobRjbLcbLgbLsbLsbLcbRcbLgLsbLjbLcbRcbLiRsbLhbLebLjbLsLsmbLsLsmbLsL
smbLibLsLsmbLsRsbLibLjbRcbLibRcRsRsRsmmmbRebLsbLcbLibRgbLcbLhbLibLsbLi
bRgbRjbLebLhbLjbRsbRgbRcbLgbRebLgbLcbRcRsmbLebLcbLcbLcRsRiLsbLgRsbLebR
ibRobLsLsmbLebLsbRsbLhRsbLcbLgbLsbLibLgbLgbLcRsbRebLgbRhbLgbLiRsLsbLhb
LjbRsRsmbRibLjbRcbRsbLjbRcbLjbLcLsmbLgbLiLsbRsLsbLgLsbLsbLgbLsbLsbLgbL
sbLgbLgLsRsbLcbLcLsRsmbsbLobRcRsmbRsLcbsbLcbLcbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 37; Drug: NDMC 3 µM
bRgbRgbRgbRgbRgbLsbRgbRgbRgbRgLsbRgbLsbLsbRibRgbRgbRgbRgbRgbRsbRgbRgbR
gbRgbRgbLebLcbLibLgbRsbRgbRgbRgbLsbRgbRsbRgbRgbRgbRgRsmbRgbRgbRgbRgbRg
bRgbLsRsbRsbRibRibRgbLsbLsbRibRgbRgbLcbLgbLcbRhbRgbRgbRgbRibRsbRsbRgbR
gbRgbRgbRgbRgbRgbRgbRsbRsbRibRsbRgbRgbRgbRsbRgbRgbRgbRiRgbRgbRgbRgbRib
RgbRiLsbRgbRgbLgbRibRibRsbRibRsbRgbRgbRgbLsbRibLgbRibRgbLsbRgbRsbRsbRg
bRsbRgbLsbRsbRgbRgbRgLsbRgbRsRiRibRgbRibRsbRgbRsbRgbRibRgbRsbRibRibRgR
smbLsbRiLsbLsbRibRgbRgbRgbRgbRgbLibRgbRgbRibRsbRgbLsbRgbRsbRgLsbRsbRib
RgbRgbRgbRgbRgbLibLsbLsbLibRjbRibRgbRsbRgbRgbRgbRsbRgbRgbRgbRgbRibRsbR
sbLgbRibRsbRgbRsbRgbRsbRgbRgbRibRgbRgbRgRsmbRgbLgbRgbRiRsmbRiRsmbRsLsb
RgbRgbRsbRgRsmbRsbRibRgLsbRgbRsRsmbRgbRgbRsbRibRgRgRsmbRgbRgbRgbRibRgb
LsbRiRsmbRgbRsRsmbRibRgLsbLibLhbLcLsmbRgbRiLsbRhRsmbRiRsmbRgRsmbLsLsmb
RibLsRsbLgbRibRgbLsbRgbLgbRibLsbRibRgbLsbRiLsbLsbRgRsmbRiRsmbRgbLsbRgb
RgRsmbLsLsmbRgbRsRsmbRgbRsbRibRgbRsbRgbRibRgbLgbRibLgbRibLsbRibRsbRgbR
gbRibRgbRsbRsbRgbRgbRiRsmbLsbLjbRcbLsbRibRiRsmbLsRsbRsbRgRsRsmmbRgbRgb
RgRgbRsbRiLsLsmbLgbRgbRsbRgbRgbRgbRibLgRsbRibRsbRgLsbRgbRgbRgbRgbLsbRg
bLsbRsbRgbRiLsbLgbRibLsbRibRcbLcbRibLiLsbRsbRgbRcbLibLgRsbRibRgbLsbRib
RsbRsbRgbRgLsbRgbRgbRgbRsbRibLgbRgbLgbRiRsmbRgbRsbRsbRgbRsRsmbRgbRgbRg
RsmbLsbRibRsbRiRsmbLsbRibRsbRgbRgbRgbRgRsmbRgbRgbRgbRsbRgRsmbRgbRgbRgb
RgbRgbRibRsbLgbRibRsbRgbRgbRgbRgbLsbRibLsbRiRsmbRsbRgbLsbRgbRgRsmbRsbR
gRsmbRgbRsbRibRgbRgbRgbRgbRgbLgbLgbRibRgRsmbRgbRgbRgbRgbRgRsmbRgRsmbRg
bRgbRgbRgbRgLsbLibRiRsmbRibLjbRibRiLsbLebLgRsLsbRsbLsbLgbLibRjbLgbLibR
jbLibLcbLcbLhbLibRgbRjbRibRiLsbRsbRgbRgbRgbRgRsmbRgRgbRgRsmbRgbRgbRgbR
gRsmbLsRsRgbRgbRgbRgbLgbRgbRgRsmbRgbRgbRsbRibRsbRgbRibRgRsmbRsbRgbRsbR
gbRgbRgbLgbRiRsRgRsmmbRgbRgRsRsmmbRsbRgbRgbRsbRibRgbRsbLjLhbLcbRcbRobR
cbLgbRibLgbLhbRjbLibLsLsmbLgLsbRsbLhRsbRgbLgLsbLsbRobRhLsbLcbLcbRjbLcR
sbRjbLhbLibRsbLcLsmbRibLhLsbRibLibLibRgbLiRsbRgRsmbLibRgLsbLibLibLgbLc
bLibLiRsbRibsbRhbRsRsmbRgRsmbRsbRgRsmbRsLsbRibRsRsmbRgRsmbRgRsmbRgbRgb
RsbRibLjbRibRsbRgbRgbRgbRgbRgbRgbRgbRsbLjbRibLsbRgLsbRgbRibRgbRsbLsRgR
smbRgbRgRsmbRibRgbRibRgRsRsmmbRgbRibRgbRgbRibRgbRgbRgbRgbRgbRibRgRsmbR
gbLgbRibsbRgRgbRibRgbRgbRgbRgbRgLsbRgbRgbRsLsbRgbRgbRgbRsbRgbRgbRgbRsb
RgbRgbRgbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 38; Drug: NDMC 3 µM
bLsbRsbRibRhbRgbRsbLsbLgbLsRsbRgRsmbLgbRhRsmbRhbLsbRgRsmbRhbRibRibRgbL
sbRsbLsbRsbRsbLibLibLgbLgbRsbLsbLgbRgbRsLsRsbLibRgbRjbLcRsbRjbLjbLibRj
bRibRcRsmbLsbRibLsbLsbLsbRsbLgbRgbRcRsmbRcLsRsbRjbRcLsbLgbLgbRgbRgbRib
RsbLgbLjbRibRibRsbRgbRgbRsRsmbRsbRsbRgbRsbRgbRsbLsbRsRsmbRgbRsbRsbRgbR
sbRgbLsbRgbRsbLsbRcbLibLgbRgbRgRsmbRgbLsbRgbLsbRibLsbLsbRgbRgRsmbRsRsm
bRgbRgbRgbRsbRsbRgbRsRsmbRgbRsRiLsbRgbRgbLgbRcLsbLgbLibRsbRibRcbRhbRgb
LibRibRgbLgbRibLhbLsbLiLsLsmbLsbLsLgRsbRibRibRibLsbLsLsmbRsRsmbRgbRgbR
gbLjbLcbRibRgbLcbLhbRgbLcbRgbLjbLgbRsbLibRsbLoRsbRiRibLgbLibRjbLibLgbR
sRsmbLiLsbRsbRjbRcbRibRgbLgbRhbLgbRjbRibRsbRgRsmbRgbRsbRsbRsbRgbRgbRgb
LsbRgbRgbRsRsmbRgbRgRsmbRgbLsbRgbRgRsmbLsbLsLsmbRibRgbRgbLsbRgbRgRsmbR
sbRgbRsbRsRsmbRgbRgLsbRsRsmbRgRgbRgbLsbRgRsmbRgbRgbRgRsmbLgLsbRgbRgbRg
bLsbLgbRgbRgbRgbRsbRgbRgbRsRsmbRsbRsRsmbRibRgbRgbLsRsbRgRsLsmbRgbRsRsm
bRgbRgbLgLsbRgbRgbRgbRgbRsRsmbRgbLsbRgbRgRsmbRsbRsbRgbRgbLsbRgbRsbRgbR
sbLibRjbRiRsRsmmbRsLsRsbRgbRsbRgbRgRsmbRgbLsbRgbRgbRsbRsRsmbRsbRgbRgRs
mbRgbLsbRgbRgbRgbRgbRgbLgbLiLsbLcRgRsmbLiLsbLibRjbLgLsbLsbLgbLsbLsRsbL
sLsmbLgbLsLsmbLsbLgbLibLgbRsLsbLgbLsRsbLgbLsbLgRsbLsbLgbLsbLgbRsbLgbLs
RsbLgbLsbLsbLgbRsbLgbLsLsmbLsbLgbRsbLgLsbLgRsbLsbLgbLgbLsbLsbLsbLgbLsb
LgbLsbLgbLsbLgbLgbLsRsbLgbLsbLgLsbLgLsbLsbLiRsbRsbLiLsbLsbLgbLsbLgLsbR
sLsRsbLibsbLsbLsbLgLsbRgbLgbLsbLgLsbLgLsLsmbLsbLgbRsRsmbLgLsbLgbLsbLgb
RsbLsLgbsbLsbLgLsbLsbLsbLgLsbLsbLgLsbLgbLsbLgbLgbLsbLibLsbLgbLsbLgbLgb
RsbLibLibLibRgbLsbRgbLibLibsbLhRsbRsbLgbLgbLgbRsRsmbLsbLgLsLsmbLsbLgLs
bLsRsbLgLsbLsbLgbLsRsbLibLsbLgbLsbLsbLiLsbLsbLsbLgbLgbLgbLgbLgbLgbLgbL
gbRgbLgbRcbLcbLibRsLsbLibLsbLgLsRsbLibLsbLgbRsbLgLsbLsbLgbRobRibLgbRsR
gbRgbRgbRgRsmbLgbRiRsmbRgbLjbRgbRibRgbLibRcbRhLsLsmbLgbRcbLgRsLsbLgbRi
bRgLsbRgbRgbRiRsmbRgbRibLsbRibRibRibRgbRsbLsbRgLsbLcbLcbsbRgbRhbRcLsbL
ibLhbRjbLoRgbLibLhbRgbLibLgbLgbRgbRgbRibRebRhRsmbRiRsmbLgLsbRibRcbLgbR
ibRibLgbRhLsLsmbRgbLgbLgbRibRgbRsbRgbRsRsmbRgbRgbLsbRgbRgbLsbRgbRgRsmb
RgbLsbRgbRsbRsbRgbLsbRgbRgRsmbLsbRibRgbLsbRgbRsRsmbRsbRgRsmbRsbRgbRsRs
mbRgbRsbRgbRgbLsLsmbRibRgbLsbRiRgRsmbRsbRgRsmbRsRsmbRgbRgLsbRsbRsbRgbL
sbRgRsmbRgRsmbLsbRgbRgRsmbRgbLjbRibsbRcbRhbRibRgbRgbRgbLjbLibRjbLhLsbR
sRjbLibLcbRgbLcbRgbLibsbRgbLcbRibLcRsbRiRsmbLobRgRsRsmmbLobRsbRjbLibLc
bRgbLhbLgbLibLgRsbLgbRibRgbRgbRgbLsbRgRsLsmbRgRsRsmmbLsbRgbLgLhbLibRjb
LibLsLsmbLibRjbRibLjbLibRcbLjbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 39; Drug: NDMC 3 µM
bLsbLgbLibLgbLsbLgbRgbRsbLgbLgbRcbRibLjbRibLhbRcbLobLjbLoLsmbLibRgbLgb
RgbLobLhbRsbRhbRgbRjbLjbLcbLoLcbLgbRgbRsbLsbRsbRobRcbRibRgbLgbRgbLsbRh
bRhbRgbRgbRsbLsbRcbRcbLjLgbLsbLgRsbLsbLsLsmbLsbLgbLsLsmbLsbLsLsLsmmbLs
bLsLsmbLsbLsbLgbLgbLsLsmbLsbLjbRjbRsbLibRgbLgbLsbLsbRsbRsLsbLsbLsbLsbL
sbLsbRjbLibRjbLebLgbRebRcbLgLsbRgRsmbRsRsmbRsbRgbRjbLobLobRcbRcbRgbLob
LibLgbLjbLgbLibLibLsbLsbRhbRsbRgbRsbLsRsbLsbRsbRiLsbRibLgbRhbRsbLgbLgb
RsbRgbRibRibLjbRgbRibRgbLgbLsbRsbRgbRsLsbRsbLsbRgbRsbRsbRgbRgRsmbRhbRi
bRsbRgbRibRsbRgbRgbLsbRgbLgRsbRgbRsbRsbRsbRgbRsbLsRsbRgbRgbRsbRgLsbRsL
sbRgbRsbRgbRgbRsbRsbRgbRsbRsbRgbRsbRsRsmbRsbRsbRgbRgbRjLsbRhbLjLsmbLib
LgbLgbRgbRgbRgbRgbRsRsmbRsLsbRgbLsRsbRgbRsbRgbRsbRgRsmbLsRsbRsRsmbRsbR
sRsmbLsbRibLcbLcLsmbRibRsbLgbLsbRsbLgbLsbLgbRsbRcbRibLjbRgbRgRsmbRgbRg
bLibLibLiLsbLgbRsbLsbLibLsbLgbRgbLibRsbLsbLgbLgbLsbLsbRsbLgbLsbLsbRgbL
gbRsRsmbLgbLgbRgbLsLsmbLgRsbLgbRsbLsLsmbLgbLsRsbLibLsbLsRsbRsbLgbLgbLs
bLgbLgbLgbLgLsbLsbLgbLgbLsbLgLsbRgbLgbRsbLsbLgbLgbLsbLgbLgbRgbRsbLgbLs
RsbLgbLibLgbLsbLcbRgbRsbRgbRgbRgbRgbRjLsbLjbRgLsbRsRsmbRsRsmbLsbRgbRib
LibLobLgbRgbRsbLgbLsbLgLsbLsbLgbLgbLgbLsbLgbLgbRsbLgbLsbLgLsbLgbLgbLgb
LibLibRgbRgbRgLsbLgbLgbRjbLcbLcbLhbLgLsbRiRsmbRgbLsbLebLobLibRgbLibLib
LgbLgbLgbLsbRgbLgbRgbLgbLgbLsbLgbRsbLgbLsRsbLsbLgLsbLsbLgbLsbLgbLgLsbL
sbLgbRsbRsbLgbLgbLgbLgbRgbRgbRsLsbLgbRsbLibLsbRsbLsLgbLgbLgbLsbLsbLgbL
sbRsbLgbLsbLibLgbLibLgbRsbRgbLsbRgbRgbRgRsmbRgbRgbLjbLhbLsbLgbRsbLgbLs
LsmbLgbLgbLsbLibLgbRsbLsbLgbRhbRobRibRgbLgbRibRiRsmbRgbRgbRgbsbRiLsbLj
bLoLsmbLhbLgbLgLsbLgbLsRsbLibLibLibRgbRibLibLsbLiLsbLibRgbLgLsbLsbLgbL
sLsmbLgbLsbLgbLsbLsLsmbLgbLgbLsbLgbLgbLgbRgbLsbLiLsbRsbLgLsbLsbLgbLsLs
mbLiRsbLgbRgbRhbRibRibLhbRcbRgbRsbRsRgbRgRsmbLibLcbLcRsbsbRcLsbRsbRhbR
cRsmbRsbRcbLibLgbLibLibRgbLcbRgbRsbLobLsbLibLcbLgbLgbLhLsbLhRsbRsbRsbL
sbLhbRgbLsbLgbLibLgbRjbRcbRgLsbRgbRgbRgbRsbLhLsbRsbLgbLsbLgbLsbLsLsmbL
gbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 40; Drug: NDMC 3 µM
bRsbLgbRgRsmbRgbRibRgbRgRsmbLsbLjbLhbRgbRjbRjRsmbRsRibLibRibRjbRsbRsRs
mbRsRsmbRsbRgbRgbLsbRgRsmbLsbRibRsbRsRsmbRsbRcbRhbRibRgbRgbRsbRibRgbRg
RsmbLsbRibRgRsmbRsbRgbRgbRsbRgbLgbRgbRsRsmbRgRsmbRgRsmbRgbRsRsmbRgbRsb
RgbRsRsmbLsRsbRgRgRsmbRgbRgbRsRsmbRsRsmbRgbRsbRgbRgbRcRcbRcbRgbRgLsbLg
RsbLsbRgbRgRsmbRgRsmbRsbRgRsmbRsRsmbRsbRsbRgRsmbLsbRgbRgRsmbRgRsmbRsRs
mbRsbRsRsmbRsbRgRsmbRgbRsbRgbRgbRgbRsbRsRsmbRgbRgbRgbLgbRgbRsbRgRsRimb
RgRsRgRsmmbRgRsmbRgRsmbRgRsmbRgRgbRsbRgbRsbRgRsmbRgbRgbRsbRgbRgbRgbLsb
RgRsRgRiRsmmbRgbRsbRgbRgbRgRgRsRsRgRsRgRsmmmmbRgbRgRsRsRgRsmmmbRgRsmbR
sRsmbRgbRsbRgbRgbRsbRibRgbRibRibRgRsmbRgbRibRibRsbLcbLhbRibLsbRhRsmbRi
bLibRgbRgbLcbRcRsmbRhbLsbRgRgbRgbRgbRgbRgbRsRsmbRgbLjbRibLgbRibRibLibR
sbRgRsmbRgRsmbLsbRsRsmbLsbRgRsRgRgRgRiRgRsRgmmbRgbRgRsmbLsRsbRsRgbRsbR
gbRgbRgbLsRsRsLsmbRgRsmbRgRsRsmmbRgRsRsmmbRgRsmbRgbRgbRgbLsbRsbRgbRgbR
gbRsbRgbRgbRgRsmbRgbRsRsmbRsbRgbRgRsmbRgbRgRsmbRsLgbRgbRgbLcRsbLiRsbRc
bRhbRgbRgRgbsbRgbsbRgbRsbRsRsmbRgbRgLsbRgbRgbRgbRsbRgRsmbRsbRgbRgRsmbR
gbRsbLsbRgbRgbRsbRgRgRsRgmbRgRsmbRgRsmbRgbRsbRgbLgbRibRgbRgbRgbRgbRgbR
gRsmbRgRsmbRgbRgbRgbLgRsbRsbLibLibRgbLibLsbLiRsbRjbRhbsbRibLsbRgbRgRsm
bLsRsbRgbRsbRgbRgbRgbsbLhbLoRgbLibLgbLgbLgbRjbRsbLhRsbRcRsmbRgLsbRibLg
bRsbRcbRiRsLsmbRibLibLsbRsbLhbRhbRcbRgbRibLjbRgbRgbLsbRgRsmbRcbRgbRgbR
ibLsbRgbRiLsbRhbRsbRiRgRsRgRsmmbRsRsmbRsRsRsmmbRgbRgbRsRsmbRibRsbRgbRs
bRgbLgbRgbRgbRsbRsRsmbRgbRsRsmbRgbLsbRgbRgRsmbRsbRgRsmbRgbRgbRgRsRsmmb
RsbRgbRgbRsRgbRgbRsbRsbRgRsmbRsbLsRgRsRsmmbRsbRgbRgRsmbRgbRgRsmbRsbRgb
RsbRgbRgbRsbRibRgRsLsRsmbRgbRsbRgbRgbRgbRgRsmbRsbRsbRsRsmbRgbRgRsmbRgb
RgbLsbRgbRgRsmbRgRiRgRgRsRsRsmmmbRgbRgbRgbRgbLsRsbRgbRiRsmbRsRsRsmmbRs
RgRsRsmmbRgbRgbLsbRgbLjbRiRsmbRgRsmbRsbRiLsbLgbRgbRgRsmbRgbRsRsmbRsbRs
RsRsmmbRsRsmbRsRsRsmmbLsRsbRsRsmbRgRsmbRsbRsbRsRsLsmbRsbRgbRgRsmbRsRsm
bRsbRsbRgRsmbRgbRgLsbLgbRiRsmbRibLgRsbRgRsmbLsRsbRibRgRsmbLsbRgRsmbRgb
RgRgbRibRibRgbRiRsmbRgbRibRgbRgbRgbRgbRibRgbLgRsbRgbRgRsmbRgbRsbRgbRgR
smbRgRsLsmbRgRsmbRgRsmbRgRgbRgbRgbRgbLsbRgbRsRsmbRsbRsRsmbRgbRsbRgbRsR
smbRgbRgbRgRsmbRgbRgbRsRsmbRgbRgbRgbRgbRgRsmbRgbRgRsmbRgRsmbRgbRgbRgRs
mbRgRsmbRsbRgLsbRgbRgRsmbRsRsRsLsRsmmbRsbRgbRsbRgRsmbLsRsbRgRsRsmmbRsb
RsbRgbRgRsRsmmbRsbRgbRjbLgbsbRiRsmbLcbRhbRsLsbRibLjbRgbLjbRibRgRsmbLsR
sbRgbRsRsmbRgbRsRsmbRgRsmbRgbRsRsmbRgbRsbRgRsmbRgbRsRsmbRgbRsbRsbRgRsR
sRsmmmbRgbRsRsmbRgRsmbRgbRgRsmbRgbLjbRibRgbRgbRgLsbRgbRgRsmbRgRsmbRgbR
gbLsbRgbRgbRsRsRsmmbRgbRgbRsbRgbRgRsmbRgbRgbRsbRgLsbRgbRgbLibRsbRgRsmb
RgRsmbRgbRgbRgRsmbRgRsmbRgbRgbRsRsmbRgbRgbRgRsmbRsRsmbRgbRgbRsRsmbRgRs
mbRgbRgbRsRsmbRsbRsbRgbRsbRgRsmbRgRsmbRgRsmbRsbRgbRgbRgRgbRgRgbRgbRgbR
gRsmbRgRsLsmbRgRgRsmbRgbRgbLjRsbsbLibLcbLsbLiLsLsmbLibLibLibRgbRgbRcbR
iRsmbLibRhbRsbsbRibLsbRhbRhLgbRsbRcRsmbsbRibRgbLhLsbLcbLiRsbLibLibRgbR
gRsmbRgbLjbRibRgbRgRsmbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 41; Drug: NDMC 3 µM
bRcbRibRibRgbRgbRibRibLobRsbLsbRibRibRibRjRsmbLobLsbRibLobRgbRcRsmbRgR
smbsbLcbRibRsbLibLgbLibLgbLsbLgbLsbLgbRgbLgbRgbLobRgbRjbLcbRgbLjbLhLsb
LsbRgbRgbLhbRgbLhbLgbLibLsbLgbRsbRgbLiLsbLsbLsbLibLhbLgbRibRsbLcbRgbLs
bLgbRjbLibLcbLsbLgbLsbLgbRsbRsbRgbRgbRibRgbRsbLgbRibLibRibRibLgbRhbRib
RgbRsbRgbRgbRgbRgbRsbLcRsbLcbLgbLibLgbRsbLsbLibLsbRsbRgbLibLhbRjbLsbLi
bRgbLibLgbLjLibRgbRsbRgbRgbLgbLhLsbRsbLgbLgbLsbLgbLibLgbLgLsbLsbLgbLgL
sRsbLsbLsbLgbLgbRjbRibRgbLsbRibRgbLcLsmbLgbLgbRgbLgbLgLsbLsLsmbLsbLsbL
gbLgbLsbLgbRsLgbLgLsbRsbLgbRcbLjbLhbLhbRsbLgbLgbLibRjbLibLsLsmbLgLsbLg
bRsbLgbLgbLsRsbLgbLgbLgbLibLgbLgbLgbLgbLibLgbLsbLibRgbLgbLsbLgbLsbLibL
sbLgbLgbLibLgbLgbLsbLgbLsbLibLgbLgbLgbLgbLgbLgbLgLsLsmbLgbLsbLgLsbLgbL
gbLgbLgbLgbLsbLgbLgLsbLgbLsbLgbLsbLcbRsbsbRgbLibLgbRsbLibLsbLgRsbLgbLs
LsmbLgLsbLgbLgbLgbLsbLgbLgbLsbLgbLgbLgLsbLgbLgbLgbLgbLsbLgLsbLibLgLgbL
gbLiRsbLoLsLsmmbLobLibRgbLibRgRsmbLgbLgbLgbLsbLibLgbLgLsbLgbLgLsbLibLg
bLgLsbLgLsbLgbRsbLgbLgbLgLsbLiLsbLgbLgbLgbLsLsmbRsbLgbLsbLgbLibLgbLgbL
ibLgbLgbLgbLgbLgbLgbLgbLgbLgbLgbLibLgbLgbLsbLgbRsbLibRsbLibRsbLibLsbLi
bLgbLgbLgbLsbLgLsbLgbLgLsbLgbLgbLgbLgLsbLgbLibLgbLgbRsbLgRsbRgbLiLsbLg
bLgbLsbLibLgbRgbRibLhbLebLsbRgbLiLsbLsLsmbLgbLsbLgbLgbLgbLsbLibLgbLibL
gbLgLsbLiLsbLibLgbLgbLgbRsbLhbLibRsbLgbLibLgbRgbLgbLgbLsbLgLsbLgbLgbLs
LsmbLgLsbLgbLgbLiLsbLgLsbLibLgbLgLsbLgbLgbLsbLgbLgbLgbLsbLgbLgbLsLsRsm
bLibLgbLgbLgLsbLibLsRsbLibRgbLibLiLsbRgbRjbLhbLgbLibRjbLibLcbLsbRjbLcb
RsbRibLibRsbLgbLgbRsbLsbLibLgLsbRsbLsLsmbLibLsbLgbLgbLgbLgbLgbLgLsbLgb
LgLsbLgbRsbLibLgbLgbLsbLgbLgbLgbLgbLgbLgbLsbLgLsbLgbLgbLgbLgbLgbLgbLgb
LgbLgLsbLgbLgbLgbLgbRsbLibLsbLiLsbLgbLgLsbLgLsbLgbLibLgbLgbLgbLiLsbLsb
LgbLgbLgbLgLsbLibLiRibRhbLsbRiRsmbLcbLibLcbLsbLgbLgbLgbRgLsbLibLgbRsLs
bLgLsbLgbLgbRgbLibRsbLiLsRsbRgbLhbLobRibRgbRsbRhbRgbLgRsbRibRgbRgbLgbR
gbRgbRgbLjbRibRiRsmbRgRsmbRgbLeLsbLibRgbRcbRiLsbRhLgbLebLibRgbLcLsmbRg
bLibLibRsbLiRebRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 42; Drug: NDMC 3 µM
bRgbRsRsmbRgbRsbRsbRgbRgbRibRibRgbLgbRgbRgbRcbRibRibRsbRgbRgbRsLsbRsRs
mbRgRgRsmbRgRsmbRsbRgbLsbRjbRcLsbRsbLsLsmbRobRcbRgbRibRibRgRsmbRsbRsbR
sbLjLsmbLiLsbLgLsbLgLsbLsbLcLsmbLgbLgbLsbRgbRgbRgbRibRjRsmbRgbRibLsbLs
bRgbRgRsLsmbLibsbLcbRgRsmbLgbLjbRsbLgLsLsmbLgLsbRsbLsbLsbLsbLsbRsbLgbL
sbLgbLsbLgbRsbLsbLsbLsLsmbLgLsbLgbLsLsmbLsbLsLsmbRsbLsbRgbLsbLgRsbLjbL
sLsmbRsbLjbsbRsbLibRsbLsbLgLsbLgLsbLiRsbRsbLibLibRsbLgLsbLsbLsbLgbLgbL
sRsLgLsbLgbLsbLgRsRsmbRsbLsbLgbRgbLgbsbRsbLibLobLgbLjbLgbLgbLgbLsbLsbL
sbLgRsbLgbLsbRsbLgbRsbLsbLgbLgRsbLgbLgbLgbLgRsbLsbLsbLgbLsbLsbLsbLsbLs
LsmbLgLsLsLsmmbLgbLsbRsbLgbLgbLgbLsLsmbRgRsmbLsbLgbLgbRjbRibRsRsmbRsbR
sRsmbLsbRibRsLsbRsbRgbRgLibRjbRgLgbRgbLsRsbRgbsbRsbRgRsmbLsbRgbRsbRgbR
sbRgRsmbLjLsmbLobRjbLgbLibLsbLgbsbRsbLsbLgLsbRsbLsbLsbLsbRsRsmbRobLcbR
ibRiLsbRibRcbRibRgbLsbRgbRgbRgbLjbRsbRsbRjbRibsbLjbLcbsbRgbLgbLgbLsRsb
LsbLsLsmbLsbLsRsbRjbRgRsmbRhbRibLsbRjbRsRsmbRsbLsLsmbRsbsbRsbRgbRsbRgb
RgLsbRsbRsbRgbRgbRgbRsbRgbRsbRgbRgbRgbRsbRsbRgbRsbRgbRibRjbsbRgbRsbRgR
smbRgbRsbRgbRsbRgbRsbRsbRsbRsRsRgmbRsbRsbRhbLgbRibRsbRgbRsbRgbLjbRjbLj
bRibRgbRjbRibRgbRsbRsbRsRsmbRgbLgbRobLcLsmbLgRsLsLsmbRsbLgbLsbLsLsmbLi
bLgLsbRebRhbLgbLhbLibsbRhRsmbRiRsRimbRgbLsRsRsmbReRsmbRcbRsRsmbRiRsmbR
ibRcbRebRibRhRsmbRibRsbRsbRibRgbRsRsRsmmbRgbRibLsbRgbRsbRgbRsbRgbLsbRs
RsmbRgRsmbRsbRgbLsbRgbRsbRgRsmbRgRsRsmmbRgbRgbLsbRgbRsbRgbRgRsmbRsRsRs
mmbRgbRgbRgbRgLsbLsbLsbRgbRgRsmbRsLsbLsRsbRgRsmbRsbRsbRsbRgbRsLsbRgbRg
bRsbRgbRgLsbsbRsbRgRsmbsbRgbRsbRsbRsbRgbRgbRsbRsbRsRsmbRgRsmbRibRgbRgb
RgbRsRsmbRsbRsbRsbRgbRgRsmbRgbRgbRgbRsbRgRgRsmbRgRsmbRsRsmbRgbRsbRgbRg
bRsbRgbRgbRgRsmbRibRgbLgbRgRsmbRgbRgbRsbRiRsmbRgLsbLsbRgbRsbRgRsmbRgbL
sRsbRgbRgRsmbLsbRsbRsRsmbRgRsRsmmbRgLsbRsRsRsmmbRgbLsbRgRsmbRjbRjbLobL
ebRcbRebRibLgbRsbLgbLcbLiRsbLsbLgbRibLibLgbLgbLsRsbLsbLjbLibRobLsbLsbR
gRsmbRsbRsbRsbRgbRgRsmbRgbsbRsbRsbRgbRgRsmbRsRsmbRgbRgbLsbRgRsRsmmbRsR
smbRgbsbRsbRgbRibRsbRgRsmbLsbLjbLcLsmbRebLcRsbLcbRebLhbRjRebRgbRibRibR
gRsLsmbRgbRgbRgbRjbRgbLobLibsbRibRebLsbRgRsRsmmbRgbRgbsbRsbRgbLsbRsRsm
bRgbRsbRgbRgbRsbRsbRgbsbRgbRgbRgRsRgmbRgRsRsmmbRsbRgRsmbRgbRsRsmbLsbRg
bRgRsmbsbsbRsbRgbRjbsbRgbRsbRsbLsbRgbRgbRsbRgbRgbRgRsmbRsbRgRgbRgbRsbL
sbRibRsbRsRgbRsRsRsRsmmmbRsbRsbRgRsmbRsRsmbRgbRgRsmbRsbRgLobRsbRsbRgbs
bRsbRsbRgRsmbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 43; Drug: NDMC 10 µM
bRsbLgbRgbRgRsmbRsbRsbRgbRgbRsbRgRsmbRgbRgbRcbRiRsmbLgbLjbLgbLgbRsbLgb
LsbLsbLgLsbRgbLibLobRcRsmbRhbRibRibRsbRgbLsbRgbRgbLcLsmbRcbRcbRsbRsbRh
bLsbRobLgbLsbRsbRgRsmbRgRsmbRgbRsbRsbRsbRgbLgbRiLsbLgRsbRgRsmbRsbRgbRi
bLsbRgbRsRsmbRgRsmbRgbRgRsmbRsbRgbRibLgbRjbLhbLobRjbLibRjbRibRibRgRsmb
RsbRgRsmbRsbRgbRgbRgbRsRsLsmbRsRsRsmmbRgbRgbRgbRgbLgLsbRibLibRsbRgRgbR
gbLsRsbRgbLcbLgbRjbRcbLsRsbRgbRgbLcbLgbLgbRgbLgRsbLgbLhbRcbRjRsmbRibRg
bRsbRsbRsbRsbRsbRgbLgbRjLsbLgbRsbRsbRgbRsRsmbRgbRsRsmbRgRsmbRsbRiRgbRg
bRgbLibRibRibLjbRcbRcbLgbLsbRsbRsbRcbRcbRsLsbRsRsRsmmbRiLsbLsRsbRgbRgb
RgRsmbRsbRsbRsbRgRsLsmbRgbRgbRgRsmbRgbLsbRsbRgRsmbRgbRgbRsbRgbRgRsmbRs
bRgbLsRsRsmbRgbRgRsmbRsbRgbRsLsbRgLsbRgRgbRgRsRgmbRgRsmbRgbRgbRgRsmbRc
bRiLsbRibRibLibRibRibRgbRgRsLsmbRcRsmbLobLibLibRgbLgbLgbRsbLiLsRsbRgbL
gbLgbLsbLiLsbRgbLsbLibRgLsbLgbLibRgbLsRsbRhbRibRgbLibLibRcbRiRsmbLsbRs
bRgbRgbRsbRsbLhbRibRgbLcbLiLsbRsbLcRsbRgbLgbLjbRcbRcbLsbLsbRiRsmbLsRsb
RgbRgbRsbRsbRibRcRsRsmmbLsbRgbLibRgbRibRsbRgbRsbRsbRgRsmbRsbRgbRsbRgbR
gLsbRgbRsLsbRgbRgbRgbRsbRgRsmbRsRsmbRgRsmbRsRsmbRgbLjbLcbRjbRcbLgbLjbL
obRsbRebRgbLsbRgbLcbLsbLgbLgbLsbLibLgbLsbLgLsbRsbRjbLgbLgRsbLsbLsRjbLg
bLsbsbRsbLgbLgbLgbLgRsbRgbLgbRsbLgbLoRsbRiRsmbRiRsmbRsbRgRsmbLcbLgbLgb
LgbRgbLsbLjRsbLgbLgbRgbLgbRobRsbRgbRsbRgbRsbRgbRsbRgLsbLsbRhbRsbLcbRgb
LoLsmbRjbLibRsbRibRgbRgbLsRsbLsbRgbRgRsmbRsRsRsmmbRgRsmbRgRiRgbRgbRgLs
bRgbRsLsbRgbLsRsbRgbRgbRgRsmbRgbLsbRgRsmbRgRsmbLsRsLsbRgRsmbRgRsmbRsbL
sbRgbLjbRiRsmbRgbRgbLgbRgbRibLgbRgRsmbRsbRgbRibLsbRiRsmbRgbRhbLhbRibRc
bLiLsbLsbRobRcbRibLsRgbRgRsmbLhbLiRsbRgbRjRibRcbRsbRsbRsbLcbLcbRsbLhRs
bRsbLgbLgbLsRsbLgRsbLsbLgbLgbRgbLgbLgbRsRsmbLsbRhbRsRsmbRgbRsbRgRsmbRs
bRgRgbRsbRsLsbRgbLsRsbRgRsRgRsRgRsmmmbRgRsRsRgmmbLjbRhbLiRsbRgbRsbRibR
hbLcLsmbRhbRgbRhbLsbLsbRibLsLsmbRibRgLsbLcbLgbRjbLhbRgbLjbLcbRibLgbLgb
LgbLsbLsLsmbLgbRgbLgbLgbLgLsbRsbLsbLsRsbRcRsmbRgbRsbRsbRgbRsRgbRsbLgbR
gbRgRsmbLgbRibLsbRgRsmbLcbLgbLsLsmbLhRsbRgLsbLibRjbLgbLgbLgbLsLsmbLgbL
sbLgLsbLsLsRsmbLsbLgbLgbRjbLsRsLsbLgbLsbLgbLgbLgLsbLiRsbRgbLsbLibLgbRs
bLgbLsbLgbLsbLgbLgbLgLsRsbLsbLsbLsLsmbLgbLgbLsbLgLsbLsbLsLgbLsbLgbLgbR
sbLgbLgbLsRsbLgRsbLgbLcbRgbLobRgRsmbLgbRcbLcbLibLsRsbRcbRcbLsbRibRcLsb
LibLjbRcbsbsbRgbRsbRgLsbRsRsmbRgbRgbRsbRgRsLsmbRgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 44; Drug: NDMC 10 µM
bLcbRgbRoRsmbRcLsbLgbRibRibRibRsbRgbLsbLgbRcLsbRhbRgbLgbLgbLgbLsbLgbRs
bRibLjbLobLcLsRsmbRibLibLgbLhbRsbRsbLhbLibLgbLgbRgbRibRibRsbLgbRgbRgbL
jbRgbRgbRhbRibLgLsbRgbRgbLsbRgbRibRiLsbLgLsbLgbLcbLhbLcbLcbLsbLgbLibLi
bRgbLgLsbLgbLsbRgRsmbLgbRsbRsbLgbLgLsbLsLsmbLsbLibRsbLiLsbRgbLiLsbLgbL
iRsbRibRsLsbRcbRibRgbRsLsbLsLsmbLhLsbRcbRcbLgbRgbRgbLsbRsbRgbRgbRgbRhb
RgbLsbLcLsmbRgbLobRsbRsbLibLgbLgbRsbLsbLgbLsbLsLsmbLgbLsbLsLsmbLgbLgbL
sbLsbLgbLhbRgbLgbRgbRsbLjbLibRgbLibLsRsbLgbLsbRsbLcLsmbRgbLsLsmbRsbLiL
sbLsLsmbLiRsbLibLsbLsbRgbLibLsbLgbRsbLibLibRgbLcbRgLsbRsbLcbRibRibRcbR
sbRibRsbLgbLgbRjbRgbRsbRsbRgbRgbRgbRsbRgbRgbLgbLhLsbLiRsbRgbLibRsbRsRs
mbLibLsbLgbLsbLsbLgbLgbLsLsmbLgLsbRsbLgbLsbLibLsLsLsmmbLsbLgbRsbLgbLgb
LsLsmbLgbLgbLsbLsbLibRsbLsbLibLsLsmbLgbLhbRgbLgbLsLsmbRsbLibLsbLgLsbRs
bLsbLsbLsbLgbLsbLgbRsbLsbLsbLsbLsbLgbLgbRsbLgLsbLsbLgbRsbLgRsLsbLgbLsb
LsbLsbLgbLgRsRsmbLgLsbLgbLsbLgLsbLgLsbLgbRsLgRsbLsbLgbLgbLsLsmbLgbLsbL
sbLgbRgRsmbLgbRsbLgbLsbLgLsbLsbLiRsbLsLsmbLgLsbLsbLsbLgbRgbLgbLgbRsbLi
bLsbLsbLgbRsbLgbRgbLgbLgRsbLgLsbLsbLgbRsbLgbLsbLgLsbRsbLgbLgbLsbRsLsbL
gbLgbLgLsbLgbLgbLgbLgbRgbLibRgbLibRibLcLsmbRgbLibLgbRgbLiLsbRsLsbLibLs
bLsbLgLsbLgbLsbLgbRcbRiLsbRcLsbLsLsmbRsLobLibLsbRgbLhbRgLsbLibRgbLiLsb
RsbLgLsbRsbLgbLsbLsbLsLsmbLgbLsbRsLsbLgbLsbRsbLsLsmbLgbLsbLsbLsbLgLsbR
sLsLsmbLsbLsbRsLsbLgLsbLsbLgbLgbLgbLgbLgbRsbLibLobLcRsbLibLgbLsbLsbLib
RsbLgbLsbRsbLsbLgbLsbLsbLgbLgLsbLsLsmbLgbRsLsbLgbLsLsmbLgbLgbLgbLgbLsb
LsbRgRsmbLibLsLsmbLgbLsbLgbLsbLgbLsbLsbLibLgbLsLsmbLsLsmbLsbLcRsbLibLg
bLcbRjbRgbLjbLibLiLsbLibLgLsbLgbLgbLgbLgbLgbLgbRibRgbLibLgbLgbLsRsbLgb
LgbRsbLgbRsbLgbLibRgbLsLsmbLgLsbLgbLsLsRsmbLgbLgbLgbLsbLsbRsbLgLsbLgLs
LsmbLgLsLsmbLiLsbLibLcbLcbLibLgbRsRsmbLibLibRsbLgbLsbLibLgbLgbRgLsbRcb
RgbLjLsmbLgLsbLgbLgLsbLgbLgbLsbLgbLgbRsbLgbLsbLgLgLsbLsbLsbRsbLgRsbLsb
LsbRsbLiLsbLsbLgbLgRsLsbLsbLgbLgbRgbLhbLibLgbLgLsbRibLcbRjbRibRgRsmbRi
LsbLiRsbLhLsbRhbRobsbRhbRibRibRibLjbRibLsbRgRsmbRgLsbRgbRgbLgbRsRibRcb
RibRibRibRgbRgbRiRsmbLsbRibLsbRgbRgbRgLsbRgbRgRsmbRsbRsbRgbRgbLsbRgbRg
bLgbRiLsbsbRgbLsRsbRgbRibRhbRiRsmbLgbRibRiRsmbRibRiLsbRgbRgbLsbRibRgbR
ibLsbRsLsbLjbRiRsmbRiRsmbLsbRiRsmbRsbRgbLsLobRgRsLsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 45; Drug: NDMC 10 µM
bRsbLibLsbLsbRsbRjbRhbRibRibLgbLgbLsbRsLsbLgbRsbLgbLgbLgbLgbLgbLsbLsbL
ibLibLgbLgbLsbLgbRsbLibLgbLgbRsbLgbLgbLsbLgbLgbRsbLgLsbLgbRjbRcbRhbRgb
LgbLgbLgbRsbRsbRhbLsbRsbLsbRcbRcbRgbRsbRibRgbLcbLibRjbLibLsbLibLsbLgbL
gbLsRsbRgbRjbRcbRgbRebRgRsmbRsRsmbRgbRiRsmbRsbRobRgLsbLsRsbRsbRgbRsbRs
bRjRsRsmmbRibLgbLsbLgbRsbRgbLgbLgLsbLsbLgbLgbLgbLsbLsbLsbRsbRcbRibRgbL
sbRgbRibRgbRibRcbLgbRsbLsLsmbRjLsbsbRgbRgbRsbRsbRgbRgbLsbRgbRgbRgbRsbL
sbRgbRsbRgbRgbRcbRhbRibLsRjbLgbLgbLgbLsbRsbLgbLsLgbRgbLgbLsbLgLsbLgbLg
RsbLsbLsbLsRsbLgbLgbRcbRgbLsbLsbRgbLgbRibLsbRjbLibLsbsbRgbRgbRgbLgbRgb
RsbRgbRsbRibRcbRcRsmbRibRibRgLsbRgbRiLgbLgbRibRibRgbRgbRsbRgbRsbLsbLgb
LsbLgbLgbLgbLgbLgbRgbLgLsLsmbLgbLgbLgLsbLsLsmbLgLsbLsbLsbLgbRsRsmbLgbL
gbLgbLgRsbLgbLsbLgbLgbLsbLgbLgbLgbRgRsmbLgbLgbLsbLgbLsbLgbLgbLgbRsbLib
LsbLgbRjbLgbLgbRibLibLgbLgLsbRsbLgbLgRsbLsbLgbLsbLgbRsLsbLgLsbRsbLgbLg
LsbLsbLgbLsbLgbLjbLcbRibRibLsbRibRibRgbLsLsmbRgbRibRsbRgbRsbLsbLgRsbLj
bLgbLgLsbLgbLgbLgbLgbRjbRibLsbRgbRgbRsbRgbRsbRgbLsbRsbRgbLsbLsbRgbsbLs
bLsbRgbRgbRsbRgRsmbRgLsbRgbRobLibLgbRgbLsbRsbRgbRgbLsbRsbRgbRgbLsbRibR
obRibLibRhbRibRgbRcbRiRsmbLibLgLsbLgRsbLsbLgbLgRsbLobRhbRsbRgbRgbRgbRg
bRsRsmbLobRibRjbLgbRsRsmbLibRgbRsbLsbLibLibRsbRhRsmbRcRsmbLibRsbRibLsb
RhbRcbRibRibLjbRjbRcbLsbLsbRiRsmbRgbRsbRibRgbRsbRgLsbRsbRgbRsbRsRsmbRg
bRsbRsbRgbRsbRgbRgbRibRibRcbRhbRibRgbRcbLsbLgbLsbLsbLgbLsbLgbLsbLgbLsb
LgbLgbRsbRjbRsbRibRibRhbRcbReRsmbRibRjbRgbRibRsbRgbRcbLgbRcbLgbLsbRgbR
sbRgRsmbRgbRsbRsbRgbRgbRsbRsbRgbRsbRsbRsRgRsRsmmbRsbRsbRsRsmbRgbRgbRgR
sRsmmbRgbRgbRgbRsbRgbRsbRsbRsbRsbLgbRgbRsbLjbLcbLgbRjbLgbLgLsbLibLgbRj
bRebLgbRcbLcbLcbLgbLgbLgbLsbLgRsbLsbLsbLsRsbRgbLgbLibRjbLgRsbLsLgbLjbL
ibRsbLgbLgbLgbLgbLgbLgbRsbLgbRsbLjbLgRsbLgbLgbLgbLsLgbRsRsmbLiRsbRsbLi
bLhbRibRgbRjbRibLsbRgbRibLsbRsbRgLsbRsbRsRgbRsbRgbRsbRgRsmbRsRsmbRgbRs
bRsbRsbRgbRsbRsRsmbLgbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 46; Drug: NDMC 10 µM
bRobRsbRhbRsbLcbLcbLjbLjbLibRjLsbLibLgbLsbLgbRcbRiRsmbRibRibLgbRsbLgbL
sbLsbRcbRibRgbRsbLgbLcbLgbLgbLsbRcbRibRibRgbLgLsbRsLsbRibRsbLjbLcbLcbL
gbRibRjRsmbLsLgbRibRebLsbLgRsbLsbRobRhbRsLsbLsbLgbLiLsbLibRgbRgbRgbLob
RjbLsbRsbRgbRgRsmbRgbLsbRsRsRsmmbRgbRgLsbRsbRgRibRgRsmbRgLsbRgbRsbRibR
gbRhbLibLhbLcbRgbLcbLcbLebLjbLjbRgbLgLsbRsbLibLibLoRsLsbRibRgRsmbLcbRg
RsmbLhLsbLibLibLsbLibLsRsbRsRsmbRgRsmbLsbLsbLibLgbLsLsmbLiLsbLgbLgLsLs
mbLsLsRsmbLiLsbLsbRsbLgbRsbLgbLgbRsbLgbLgbRsbLgbLhbLhbLibLibLiRsbLibLg
bLsRsbLibLgbLibLgLgbLsRsLsLibLgbRsbLgLsbLiRsbRsbLeRsbLcbLibLibLgRsbRsb
LibRsbLibLibLgbLsbLgLsbLgbLgbLgbRsbLgRsRsmbLibLsbLibLgLsbLsbRsbLiLgLgL
sbLgbLgbLsbLgLsbLjbRhbLjbLcbLcbLhLsbLgRsRsmbLiLsLgLsRsbLgbLgRsLgRsbLgb
LgbLsbLgbLgLsLgbLsbLgLsbLsLsmbLgLibLsRsbLgRsbLsbLgLgLibLgLgLsbLgbRgbLg
bLsLsmbLgbLebRcbRcbRcRsmbLeLjbLibLsbLgbLsbLsbLgbLsbLibLsbRsbLgLsLsLimb
LgbLgLgbLgRsbLsLsLsmmbLgbLsbLgbLgbRjbRjbRcbRcbLibLebLjLsmbLibLibLsLsmb
LgLsbLgLsbLgbLgbLgLsbLgLsbLgLsbLgbRsLsbRjbRcbLibRjbRibLjbRsbLiLsLgLsbL
ibLsLgLgbLgbLgLsbLgbLgLsbLgbLgbLgLsbLsLgbLgbRsRgbRsbLgbRsbLgbRgbLjbRgb
RgbLgbRsbLibLsbLgbRsLsRsbLibRibLiLgLsLsmbLiLsbLiLsbLgLsLsmbLgLsbLgbRcR
smbRcRsmbRhbLiLsLibRhbLjbLcbLgLsbRgbLgbLgbRsLsbLibLgLsbLgbLgbLgbLgLsbL
gbLsLsmbLgbRgbLgbLsbLgbLsbLgbLgbLsLgbLsbRsRsmbLgbLgbLgLsbLsLsmbLibLgbL
sbRsbLgbLsbLgbLsbLgRsbLsLsmbLgbLsbLgLsbLsLsmbLgbLgbLgLsLgbLgbLsbLgbLsb
LsbRjbRhbRjbLibLgLsLsmbLeLgbLgbLiLsLsmbLgLsbLgLsbLgbLiLsLgbLgbLgRsLsRs
LsbLibLsRsbLiLsbRgLsbLgbRsbRjbRhbLjbRjLsbsbRjbLcbLiRsbLsbLiLsLsLgLsmbL
iLgLsbLsbLgLgLebLsbLgLibLsbLgLsbLgbLgbRsbLgLsLsmbLiLsbLgbLgbLsbLgRsbLs
bLsbLgbLsbLgLsbRsLsbLgLsbLgbLgbRibLibLgLgbLibLgbLgLsLsRsmbLgbLgbLgbLsb
LsLsmbLsbLibLgbLgLsbLgbLgbLgbLgLsbLgbLsLsRsmbLsbLgbLgbLgbLhLgbLsbLgbLg
bLgbLgLsbLsLsmbLiLiLsLgLsbLsRsbLsbLsbLgbLiLgbLgbLgLsbLsbLgbLgLsbLsbLgb
LgbLgLsbLgRsLsbLgbLsLsmbLsLsRsmbRcRsLsmbRhbRibLibLjbLibRebRsbRcbLibRsb
LsbRsbRgbRgRsmbRgRsmbRgRsmbRgbRsbRsbRgbRgRsmbLcLsmbLiLsLsmbLibLgbLsRsb
LgbLibLgbLgLsbLsLsmbLiLsbLgLsbLsbLgLsbLgbLgRsLsbLsLsmbLgLsbLsbLiLsbRsR
sLsmbRsbLhbRibRobLgbRibRgbRsbRgLjbLebLgRsbRibLibLgLgLgLsLsmbLibLibLgLi
LsbLgLsbLsLsmbRibLjbLhRsbRobsbRhbRibRcLsbLhbRibRibLhbLeLsbLcbLsLibLibR
ibRcbsbRhbRiRsmbRsLsbLgLsbLgbLsbLsLgLgLgLgbLsbLgbLgbLebLiLsbLgbRsbRhbR
obLgbRsRiRsLsRsRgmbRgRgRgbRgRsmbRgbRgRiRsRgRsRsmmmbRiLsbLsRsLjbRcbRcbR
hbLgbsbRsRjbRcbRcLibLgRsbRobRgbRibRgbRibLgbLgbRjbRsbLsbLgbLgbLgRsbRsbL
ibLsbLsbRgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 47; Drug: NDMC 10 µM
bsbRsRsmbRgbLsbRibLsbLsbRibLsbRsRiLsbRiRsmbRgbRsRgRsmbRgbRsRgbRgbRhLsL
sRsLsLsmmbRsbRibRgbRgbRsRsmbRgbRsLsbRgbRgbRsRsmbRgbRgRiRgbRgbRibRhbRsb
RibRibRcbRibRgbRgRsmbRgbRgbRgbRsbRibLsLsmbRgbRibRgbRgRsmbRgRsRgmbRgRsm
bRgbRgbRsbRgbRgRsRgRiRimbRibRgbRsbRgRgRibRgbRgRsmbRsbRgRsRsmmbRgbRgbRs
bRgRsmbRgbRgRsmbRgbRibRgLsbRgbRsRsmbRsbRgbRsbRgbRsbRgbRgbRsRsmbRgRsmbR
gLsbLsRgRibRgbRgbRgbRgbRgbRgbRgbRgbRhbRibRibRibRibRibRibRibRsbRibLsbLi
RsLgbRjbRibRgbRibRgbRgRgbRgbRgbRgbRsbRgbRsbRgRgRiRgRsRgRgRgmbRiRsmbRgb
RgbRgbRgRsmbRgbRgRsmbRgbRgRgRsRgmbRgRgbRgRsmbRgRgbRgbRibRgbRgbRgbRgbRg
RsRimbRgRsmbRgRsRgRgmbRgRgbRgRsmbRgbRiRibRibRgbRgbRibRgbLobRibRcbLcbLc
bRjbLcbLcLsmbLcbLhbRgRjbsbsbLjbLibRibLibLgbLeRibRibLcbRibLhLsbLgbLgbRg
bLibRsbLiRibRobRcbLcbRgbLcbLcbRibRibRgbLgbRibRibLsbRibRgbRsRsmbRgbRsbR
gbRgbRgbRgbRsbRiRsmbRgbRgbRgbRgbRsbRgbRgbRsbRgbRgbRgRsRsmmbRgbRgbRgLsb
RgbRgbRgRsmbRgRsmbLhbLhbRiRhbRibRgRsmbRsbRgRsRgRsmmbRgbRgbRgbRgbRgRsmb
RgbRsRsRgLsmbRgRgReRsRsRgmmbRsbRgRsRimbRgbRgbRgRibRgbRgRsmbRgbRgbRgbRg
bRgbRgbRgbRgbRiLsbRgbRgbLsRsbRjLsbLsRgRsmbLcbRjbLibRjbRibRibRgRgRsmbRg
bRsbRsbRsbRgbRsbRsbRgRsRsRsRsmmmmbRgRsmbRsbLsRgRsmbRibRsbRgbRgbRgbRgbR
sbRgRibRgbRgRiRibRgRgRsmbRgbRgbRgbRgbRibRibRcRsmbRhRsmbRibRibRhRsmbRhb
RibLcbLcbLcbRibLjbLhRsbLibLgRsbLibRjbLgbLiRsbLsbLgLsRsbLgLsbRsLsRsbLgb
RsbLgLsbRsRsmbLibRgbLcbRhRsmbLgbRcbRsbRjbLsbRgbRiRsRgmbRjbRcbRcbRebRsb
RgRsRgRiRsmmbLsbRiRsRsmmbRgRgRgRsmbRgRsmbRgbRgbRsRgRiRsmbRgbRgRsRjmbLj
bLcLsmbRcbLcbLgbLsbLgbRsbRebRgbRsRgRsRgRsmmbRgbRgbRgbRgbRjbRsRsLsmbRib
LjbRiRgbRgRsmbLgbLsbLcbRhbRgbRiRgRjbRsRsRsmmbRgRsRiRgmbRsbRgbRsbRgbLcb
RsRsmbRgRgbRgbRgbRgRgRsmbRgbRgbRgRsmbRgbRsRibRiRgbRgbRgRgRsmbRibRgbRgb
RgbRgbRjbLcbLcbLhbLcbLjbRsbRibRhRsmbLhbLgbRcbRebLibLiRsbLibRgbLibLcbRg
bLcbRobLjbRobRibRsbRibRgbRgRgbRgbRgbRsbRsRsRgmbRiRsRiRsmmbRsbRgRibRgbR
gbRjbLcbLcbLjbRibRiRsmbRibRgbRsbLsbRgRsmbRiRgbRgbRgbRjbRgbRsbRgbRgbLsR
sbRgRgbRgbsbRgbRgbRibRgRsmbRgbRgRsmbRiRsmbLsbRiRsRgmbRgbRgRsLsmbRiRgRs
RgmbRibRiRgRsRsmmbRgRgbRsbRjbLhbLhRsbRgbRebRibRgbRgbRibRgRsRjmbRsRgRsm
bRgbRgRsmbRgRsRsmmbRibRsRsmbRgRsmbRjRsRiRiRsmmbRgRsmbRsRgRgbRgLsbLjLcb
RibRibRsbRsbRgRsRsmmbRgRsmbRibRgbRgbRibsbLgbLcbRibRjbRgbRibRgLsRsRgRgR
gbReRgRsmbRebLhbLibRebRobLcRjbLiRjbLibRcbLcbLibRcbRsbRsbLobRsRsmbRsRsm
bRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113232; End: 113732;
Recording: 7-1; Individual: 48; Drug: NDMC 10 µM
bRoRsmbRibRhbLsbLsbRsbRsbLsbLsbRebRoLsbRibLcLsmbLsLsmbLobRgbRsbLibLsbR
sbLjbLobLhbLiLsbLgbRgbLgLsbLsLsmbLsLsmbLsbLgLsbLibLoLsmbRsbRgbLsLsmbRg
bRgbRgbLsbRobLiLsbRgbRobLiLsbLsbRobLibRjbRibLsbRibLsbRibLgbRgbRgbRsbRg
bRsbRsLsbLgbLcLsmbLibLcbLibRhbRcbRebLgLsbLgLsbLsbLibRgbLcbLcbLhbLcbLib
RgbLhLsbRiRsmbRsRsmbLibRgLsbLibRiLsbLibLoRsbLcbLhbLibLibLgbLsbLgbLsLsm
bRsbLiRsLsbLcbRibRgbLsbLiLibLhbRjbLeLsbRgRsmbLibLgbLsbLgLsbLgbLsbLgbLg
bLgbLsbLgbLsbLgbLgbRjbLjbLcbRibLsbLgbLhbRjbLibLoLsmbLibLibLhbLgbLgLsbL
sLsmbLgbRsbLgbLsbLgLsbLgbLgbLgbLgbLgbRsbLibRsbLgbLgbRsbLgLsbLgRsbLgbLi
bRgbRsbRsbLibLibRsbLgbRsbLhbRgbLhbRgLsbLibRsbLgbLsLsmbRsLsbLgbLsLsmbLs
bLiLsbLgbLgRsbRsbLgbLgbLgbLiLsbRgbLgRsbLgbLibRjbLcbLiLsbRsbLsRsbLsbLib
LebLcbLiLsbLiLsbRjbLhbRsbLsLsmbLibRsbLgLsbLibLibLgbLgbRhbLgbRgbRiRsmbL
gbRibRsbRgRsmbRgbRgRsLsmbRgLsbLsbLhbLibRsbRsbLobRibLibRgbLcLsmbLcbLibL
jbLibLjbLgbRsbLsRsbRgbLibLsbLiLsbLsbLsbLgLsbLgbLibLiLsbLhbLgbLcLsmbLhL
sbLibLgLsbLsbLgbLibLcRsbLhLsbLibLgbLcbRcLsbLjLsLhRsLsmbLiLsbLibRgbLsbL
gbLibRsRsmbLgbLgbLgLsbRiRsmbRgbLhbLsbLibRgbLgbLsLsmbLsbLsbLsbLsbLsbLgL
sbLsbLgbLgbRsbLibLgLsbLgLsbLgbRcbLibLgbRsbLgbLsbLgbLgbRsbRsbLiLsbRgbLi
bRjbLiLsbLsbLgbLsbLgbLsbLgLsbLgbLsbLgLsbLgLsbLgbLibLibLsbLgbLgLsbLgbLi
bRcbLjbRiLsbLjLhbLcbLibRsLsbLibRjRsmbLgbLibLhbLcbRibRgbRgbLibRsbLibLsb
RsLgLsbLgLsRsbLgbLgLsRsbLgbLsLsLsmmbLgLsLiLiLsbLgbLiLsLsLsmmbLgbLgLgRs
bLgbLgLsbRsLsbLgLsbLsLsmbLgbLgbLgbLgRsbLgbLgRsLsLsmbLsbLgbRsbLiRsbLibL
ibLhbLebLebLiLsbLgLsbLibRjRobRhbLibRcbLhLsbRcbLibRcLsbLeRsbRiRsmbRibLc
bLcbLcLsRsmbLhbLhLsbLebRebLcbRgbLebRgbRsbLgbLgbRsbLgLsbLgbRsbLibRsLsbL
gbLibLsbLsbLgbLjbRgbLgbLsRsbLgbLsbRsbLgbRgbLgbLsbLgbLsbLsbLgbLgLgbLgLs
LsLsmmbLsbLibLgbLgbLgbLgbRiRsmbRgRsmbLsRsbLobLcLsmbLebRcbLibRcbLgbLgbR
obsbLgbLgbLgbLibRsbLjbLcbLeLsbRibRoRsmbLibLgLsbRibLeLsbLgRsbRjbRcbLgbR
oRsRsmmbLibLibRgbLsLsmbLibLcbRsLsLsmbRsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 1; Drug: Control
bRjbLibsbsbRibLibRsbLhbRhRsmbLsbLibLsbRobRibLcbLibsbsbRcbRsLsbsbsbsbLi
bLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 2; Drug: Control
bLgLsbLgbLgbRsbLgbLiRsbRjbLibLgbRjbLibLgbLgbLsbLgbRgbLgLsbLiLsLsmbLgbL
iLsbLsbLgbLgbLgbLgLsbLgLsbLsbLgbLgbLgbRsbLgbLhbRibRgbLhbLibLgbLsbLgbRs
bLgbLsLsmbLgLsbLgbLgbLgLsbLgbLgbLgbLgLsbLgbRsbLiLsbLsLsmbLgbLgbLsbLgbs
bRsbLgLsbLsbLgLsbLgbLgbLgbLgbLsbLibLsbLibLsbLgbLgbLgLsbLsbLibLibLgbLgb
LgbLgbLgbLgbLsLsmbLibLsbLgLsbLgbLgbLgbLgbLgbLsbLgLsbLsLsmbLgbLgLsbLgbL
gbLsLsmbLgbLgbLibLsbLgbLgbLsbLibLgbLsbLsLsmbLgbLgbLgbLgbLgbLgbLgbLgbLg
bLgbLsbLgbLgLsbLgbLgLsbRgbLibLsbLgbLgbLsRsbLgbLgbRsbLsRsbLibLsbLibLgLs
bLgbLgbLgbLgbLsbsbLiLsbRsbLgbLsbLgbLgbLgbLgbLgLsbLgbLsbLgbLgbLgbLgLsbL
sbLgbRsbLgbLgbLgbLgLsbLgLsbLgLsbLsRsLsLsmbsbLibLgbLgbLgbLgbLgbLgbRsLsb
LgbLsbLibLgbRsbLibLsbLgbLgLsbLgbLgLsbRsLsbLiLsbLgbsbLsbLiLsbLsbLgLsbLg
bLgLsbLgbLgLsbLgbLgLsbLgLsbLgbRgbLibLgbLgbLgLsbRsLsbLibRgRsLsmbLibLgbR
sLsbLibLsbLiRsbLgbLgbLgbLgbRgbLgbLsbLcbLibRhbLgbRjbRobRsbLibLgbRiLsbRh
bLgbRibRgRsmbLjbRhbRjbLcLsmbLsbLsbLiLgbLgbLgbLsbLgbLsbLibLsbLsbLsLiLsb
RsbLgLsbLsLsmbLgbLsbLgbRsLgbLsRsLsbLgbLgbLsbLsbRgbLiLsbLsbLgbLgbLgbLgb
LgbLsbLsbLgbLgbLgLsbRgbLibRsbLibLgLsbLgLsbLgbLgbLsbLsbLsLsmbLgbLgLsbLg
bLgbLsbLgLsbLgbLgbLgLsbLsbLgbLsbLsbLgLsbLgbLgbLibLibRsbLibLsbLgbLgbLgb
RsbLibLgLsbLsbLgbLgbRgbLibLgLsLsmbLsbLgbLgbLjLsmbLsLsmbLgLsbLsbLsbLgbL
gLsbLgbLgbLsbLibLsLsmbLgbLgbLgbLgbLgbLgbLsbLgbLgbLgbRgRsmbRjbRiLsbLsbR
iLsbRcbRsbRsbLcbLibLgbLgLsbRgbLibRsLsbLibRgbLibLgbLgbLgLsbRgbLibLibRgL
sbLibRsbLibLsbLibRgbRcbRiLsbRcbRibRhbLebLibRgbRobRhbLsbLcbRgbRibLcbLhb
RgbLsbLhbRgbLcbLhbLgbRibLgbLcbLgLsbLibRgRsmbRcbRibRcbRsLsbLhbLibLsLsmb
LsLsLsmmbRibRjbRcbLjbRibLebLhRsbLgRsbRibRibRgbRibLsbRibRobLsbLibLhbLgL
sbRsbLiLsLsmbLgbLgbLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 3; Drug: Control
bsbRsbRibLsbRjbRibLjbRcbRhbRibLibRcLsbLgbLsbLjbRjbRgbRiRsmbRcbLiLsbLjb
LhbLgLsbLgbLgbLgLsbLgbsbRgbLgbLsLsmbLibLcbRibRiLgLsbLsbLgbLgbLgLsbLgbL
gbRsbLiLsbLibRgbLiLsbLgbLibLgbLgLsbRgbLgbLsLsmbLgLsbRgbLibLsbRsbLibLgb
RgbRgbLibLibRgbLibLsbLsLsLsmmbLgbLsbLsbLgLsbLgbLsbLgLsbLgbRsbLgbLgbLgb
LgRsLsbLsbLiLsbLgLsbLsLsmbLgbLgbLsbLsbLgbLsLsmbLgLsbLgLsbLgbLgLsbLgLsb
LsbLgbLsbLgbRsbLgbLsbLibLgLsbLsLsmbLgLsbLgbLsbLgLsbLiLgLsbLsbLibLgbLgL
sLsmbLgbRsbLibLsLsmbLgbLgbLsbLibLgbLgbLgbLgbLsbLgLsLsLsmmbLsbLibLgLsbR
sbLgbLsbLiLsbLgbLgbsbLsLsmbLgbLgLsbLsbsbLgbLsbLibLgbLgLsbLgLsbRjbRhbRc
bLibRobLgLsbLibLcbRgbRhbRibRibLjbLobRgbLibLcbLgbRgbRgbLjbLhbRgbRgLsbLi
bRjRsmbLiLsbLgLsRsbLiLsbLsLsmbLgbLgbLgbLsbRjRjbRibRibRcbRibLgbRcbLcbRi
LsbRgbRgbRibRiLsbLibLobRsbLgbLibLgbLgbLobRsbLcbRibRibLhbLibRsbLgbLibLg
bRibLibLibRsbLgbRsbLibRsbLgLsbRsLiLsbLgbLsbLgLsbLgLsbsbRsbLibLgbRsLsbL
gbLsbLibLgbRgLsbLgbLsLsmbLibLsbLsLsmbLgbLsbLgbRsbLgLsbLibLibLgbRgbLibR
gbRibRibRiLsRsbRobLibRibRobRibsbRgbLgbRgbRgbRiLsbRgbLsbRibRibLgbLjbLhL
sbLhbRgbRibLcbRgbLiLsbRsLgbLibLgbLgbRsbRsRibRhbLgbRibRgbLsbLjbRcLsbRsb
RgbLhLsLsmbLgbLgbLsLsmbLgbLgbLibLsbRgbRibLibLsbLiLsLsmbLsLsmbLgbRgRsmb
LibRsbLibRsbLgLsbsbLgbRgLsbLgbLsbLsbLibLsbLgLsbLsbLibRsbLgLsLsmbLsbLgb
LgbLgLsbLgLsbLgbLgbLgLsbLgbRjbRiLsbRcLsbLibRcbRcbRhLsbLcbRibLcbRgLsbLo
LsmbLsLsmbLobRebLiLsbRsbLibLsbLsbLiLsbLgLsLgbRjbLibRsbLgbRsbRhbLcbRjbL
cbLgbLjLsmbLsbRibLgbLgbRgbLibRsbLibLibLgbRjLsbLgbLsLsmbLgbLgbLibLgLsbL
gbLgbLgbLsbLsbLgLsbLgLsbLgbLgRsbRibLibLgbRsLsbLibLgbLgbLgLsbLsLsLsmmbL
sbLgbLgbLgbLsbLiLsbRsbLibLgbLgbRsbLgbLibLgLsbLibLgbLsbRjbLjbLibLiLsbRs
LsbLsLsmbLgbLgbLsbLsbLgbRsLsbLgbRsbLgLsbLsbLsbLgbRsbLibRgbLibLgbRsbLgb
LgLsbLgbLgbLibRsLsbLibLgbLgbLgbRgbRsLsbLiLsbLgbLsbLiLsbLgbRsbLgRsbLibL
gbLsLsmbLsbLibLgbLsLgLsLsmbRsbLiLsbLgLsRsLsbLsbLgbLgLsbLgbLgbLgbLsLsRs
mbLgbLgbLgbLgbLgbLgLsLsmbLsbLgbLgLsLsmbLsLsmbLibLgbLgbLgLsbLgbRgbLgLsb
LgbLgbRjbLibRsbLhRsbLcbLsbRobLgbLgbLiLgbLgLsbsbLibLibLsLsmbLgbLgLsbRsb
LgbRsbLsbLgbLgbLgLsLsmbLsbLgbLsbLgbLsbLgbLgbLsbLgbLgbLgbLsLsmbLgbLgLsL
smbRsbLgbLgbLsbLgbLsbLibLsbLgbLgbLgLsbLgLsbLibRsLsbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 4; Drug: Control
bsbLgbRgbLiLsbLsbLgbRsRsmbLgbRsbLibLgbLgLsbLibLgbLgbRsbLgbLgbRsbRsLsbL
ibLgbLsLsmbLgbLgbLgbLsbLgbRgbLibLsRsbLgbRsbLgbRsLsbLsbRsbLgbLgbLgbLgbL
ibLgbLgbLibLgLsbLgbLgRsbLibLgbLgbLgbLibLibLgbLibLgLsbLiLsbLsbLgbRsLsbL
ibLgbLsbsbRsbLibRjbLibRjLsbRcLsbRhbLebRhbLcbRhbLcbRjbRibRibLibLobLibLi
bLgbRhbRcbLobLoLsmbRiLsRsbLgbLsbRibRibRgbRibLibLgLsbRibRibLcLsmbLebRgL
sbLibRsbLsbLibLsbLgbLgbRjRsmbLibLgbRgbRsbLsbLiRsbRjbLibRsbLgbRjbLhbRib
RhbRibsbRcbLebLibLgbRcbRhbRhbRiRsmbRgbLsbLeLsLsmbLsbLibLsLsmbRsbLgLsbL
cbRhbLsbLobRibRsbLibRsLhbLiRsbRgRsLsmbRsbRibLibLcbLcbRhRsmbLiLsbRgbRoL
sbLcbRebRibRgbLsbRcbLgbLhbRgbRgbLjbRebRiRsmbLjbRibLcLsmbLobRibRibRiRsm
bLsbRibRsbRgbLgbLobLsbRcbRcbRhbRgRsmbRibLcbRebRsbRhLsbRibRibLcbRibRibL
hbLsbLibLibRsbsbLhRsbLsbLibLgbRjbRobRcbRibLcRsbRsbRibRgbLibRibRsbLjbRi
RsmbRsbRibLjbLobRgbRjbRcbRcbRhbLibRobRjLsbsbLcbLcbRsbLgbLibRibRjRsmbLc
bRgbLcbRibLsLsmbRcbRibRebRsbRiLsbRhbRsbLibRibRibLgbRgbRgbLgbRiRsmbLjbR
ibRgbRibRibLcbRibRibLsbLibRgRsmbLibLsbRibRibRibRgRsmbRiLsbLgbRibLsRsbs
bLsbRsRibRhbRcbRcbLcbRcbLobsbLcbRobRgLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 5; Drug: Control
bRibLjbLjbLiRsLsbRjbRjbRibLsbRibRgRsmbLsbRgbLsLsRsmbRibRgRgRsRsmmbRgbR
gbRsbRgbRgbLsRgbRgbRsRsmbRgbRgRsmbRgbLgRsbLjRsbLhbLcbRibLcbRgbsbLgbLiL
sbLgbRiLsbLgbLibRibLgLsRsbLcbLibRebsbLibLgLsbRjbLoRsbLgbRibLobRibRjbRi
bLcbLibRjbLcbLsbLiRsbLsLsmbLcbRgbRhbRibRgLsbLgbRgbLgbRibRsRsmbRsbRibLs
LsmbRgRsmbRsRsmbRgbLsbRibRibLsbRgbLsbRgRsRsmmbRgbLsbLsRsRsmbRgRsRsmmbR
gbRgbRsLsbLsbLjbLhbLgbRjbLibRhbRsbRibLobLgbLsbLgbRgbLiLsbRgbLgbLgbLibR
sbLiLsbRibRjbLjbRsLibLibRgbLgbLibRsbLgLsLsmbRgbLgbRsRsmbLgRsbRsbLgbLiR
sbRgbLgbLgbLgLsbRsLsbLgLsLsmbLgbLsbLgbLgLsbRsbRgbLgbLgbRjbLibRjRcLsbLo
bLsbRgbRgLsbRgbRiRsmbRsRsmbRgbLsbRiRsmbLsbRgbRsbRsRsmbRsbRiRsmbLsRsbRg
bLsbRgbLsRsbRsbRibLsbRgbRgbRsRsmbRsbRgbLsbRibLsbRiRsmbRsbRiRsmbLjbRibL
sbRjbRsbRgbLsbRgbRiRsmbRgbRsbRjbLgbRcRebRebRsbRibLcbLibRjbLibLcbRcbRhb
LgbLcbLibLibLjbRgbRibLgbRgbRibRebLibLiLsbRgbLibLjbRgbsbLgbLgLsRsbLgRsb
LsbLgbRgbLgbRsbLibsbRgbRsbRibRibLgRsbLsbRgbRgbLcbRcbRibLjLcbRiRhbRebLi
LsbLibRjbRjbRhbLjbRjbRsbRjRsmbLjbRibRsRsmbRibLibRibLsbRjbLsLsmbRibLsbR
hbRjRgbsbRjbRjbLibRibRibLibRibLsLsmbRiRsRsmmbLsbLjLsmbRjbLcbLsbRjbRsbR
jbLjbRjRsmbLjbRgbRibLgbRiRsRsmmbRsbRsbsbsbRibLgbRibLsbRiRsmbLsbRgbRibR
ibLgLsbRibLcRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 6; Drug: Control
bsbLgLsRsbLgbLgbLhbLibRgbRgbRsbLcLsmbRsbLiLsbLibLibLsbRgbRiRsmbRcbRibL
sbRibRcbRcbRibRibLgLsRsbLsbLgbLiLsbRsbRibRgbLsbRjbLjbRiLsbLgbRgbRgbRsb
LoLgLsbRhbLhbRsbLcbRsbLiRsbLgbLibLsbLsbLibsbLgLsbLsbLgLsbLgbRgbLgbLibR
gbLgbLibRgbLgbLsLsmbLsRsbLgbLgbLgbLgRsbLgbLgLsLsmbLgbLgRsbLgLsLsmbRsLs
bLiLsbLiLsbRsLsbLibRgbLgbRsbLhLsbRsbLgbLgLsbRgbLgbLibLcbRgbRgbLgbLibLg
bRgRsmbLgLsbRsbLiLsbLgbLgbLgLsbLgLsbLgbRsRsmbLgLsLsmbLgLsRsLsLsmbLjbLs
LsmbLgbLsbRsbLiLsLsmbLsLsmbLgbLgbLgLsRsbLgbRibRcRsmbRhbLgLsbLibRcbRibR
gbLibRibRgRsmbLgbRibLjbLibLgbLgbRjbRcbRhbLgbRibRcbRiLsbRibLibLsRsbLgLs
bRjbRibLjbLhbLibRgLsbLsRsbLibLsbLgbLsbLgbLsbLsbLsbLgLsLsLsmmbRgbLibLsb
LgbLsbLgbLgRsRsmbLgLsbLgRsbLgbLgLsLsmbLsLsmbLsLsmbLgLsbLsLsmbLgbLgbLgL
sbLgbLgbLgLsbRgbLgLsLsmbLibRcbRcbRsbRhbLgbRcbLsbRibLgbLgbLcbRcbRebLibL
jbLibLibLsLsmbsbLgbRgbLibRsbLibLibsbRgbRsbLibLsbLibLibRibLibLhbRibLibL
iRsbLibRibRibLsbLhbLibLhbRgbLgbLcbRibLhbLgbLibLgbRgRsmbRcbRcbRhbLgLsLs
mbRsbRibLibLibRcbRibRibLjLsmbLibLibLgbRgRsmbLibLsLgbRgbLgbRsbLgbLgbLgR
sbLgbLgbRsLsbRsRsRsmmbLgbLsLsmbLsbLgbLsLsmbLgLsbLsbLgbRsRsmbLgbLgbLgbR
sbLiLsbLibLibRibRiRsmbRibRibLcbLcbRgbLibLsLsmbLsLsmbLibRsbLgbLgbLgRsLs
bLgbLgbRsbLgLsLsmbLsbLgRsbLgbLgLsbLgbLgLgbLsbLgbRsbLgbLgbsbRgbLiLsbLsL
smbLibRjRsRsmmbLiLsbRjbLhLsbRgbLsbLibLibLibRiRsmbRcRsmbRcbLibLibLhbLcb
LcbLhbLibLibRsbLgbLgbRsLsbLgbLsbLgbLgLsbLgRsbLgbRsLsbLgbLgRsbRsLsLsmbL
gbLsbLgLsbLgLsbLsbLgLsbLgLsbLgLsLsmbLsbRsbLgLsbLgLsbRsRsmbLibLsRsLsLsm
bLgLsbLgbLsbRsLsLsLsmmbLgbLgLsLgbLgbRsbLgbLgLsbRsLsbLsLsLsmmbLibRgbLsR
ibRcbsbsbsbRcbRjbLibRhbRsbLibRibLgbRibLsRsbRgbRibLsbRgbRcbRcbRebLcLsmb
LiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 7; Drug: NDMC 1 µM
bRsRsmbRgRgRsmbRsbLsRgRsmbRgbRgbRgRsRsLsmmbLsbRsbLhbLcRsbRcbLgbRobLibL
ibLjbRjbRhbRibLjbLobLibRhbRcbRgbLgbRsbRsLsbRgRsmbRsbLjLibLsbRsbRsbLhbR
jbLibLibRjbLgbLgbLsbLgbRjbLibRjLsbRcbRcbLibLhbLgLsbLgbRsRsLimbRsbLgbLc
bRibLgLgLsLsmbLgbLgbRsbLgbLgbLgLsRsbRgbLiRsbLgbLiLsLsLsmmbLgbLgbRgbLgb
RibLobRcbRhLsbRiLsbLjbRiLsbsbLcLsmbLebRibRiRsmbLcbLcbRsbLibLcbLgLsbLsb
LcLsLsRgmmbLsbRjRsmbRibLsbsbRgRsmbRgbRgRibLgbLsbLibLiRsbRgbLjbLibLsbRs
bLibLgbLgbRgbRhbRgbLsLcbLhRsbRsLgbRgbRjbRgbRibRgbRsbRgbRgbLsbRibLsbRgb
RgbLsRibRsbLsbRgbRgbRsbRgbRgbRibRgbLibRibRgbLsRsRsmbRsbRgbRgbRsRsmbRsL
sbRibRgbLgbRibRsRsmbRgRsmbRgRsRsmmbRgbRgbRsRsmbRgRsmbRgRsmbsbRgRsmbRgb
RgbRgbRgbLgbRgbRgbRsbRgRsLsmbRgbLsbRgbRgbRgRsmbLsbRgbRgbRibRgbRsbRgLjb
RgbLjbLhbLhRsbLgbRhbRcbLsbRgbRiRgLsbLhbsbRcbRgbRgbRiRiRsLgmbLiLsbRcbRi
bRsbRibLgbRgbRiRsmbLsRsbRgbRhbRiRgRsmbRibRiRsmbRsbRgRsmbRgbRgbRgbRsbRi
bRgbRgbLgbRgbRiRsmbRgbRhbRibRibRibRibRgbRgbRiRsmbRgbRsbRgbLsbRgbRgbRgL
sLsmbRibRibRsbRgbRgbRsRsmbLsRgbLsbLhbLibRgbLibRgbLiRsbRcbRibRibLgbLjbL
obLhbLobLibRibRibLcbLibRsbLgbLgbLgRsbLgbRgbRjbRibRsbRgbRgRsmbRgbRgRsmb
RgRsmbRgbRsRsmbRgbRgRsmbLgbRsbRgbRgbLsbRgRsLsRsmbRgbRgbRsbRgLsRsRsRsmm
bRgbRsbRgRsRgmbRgbRgRsmbRgbRgRsmbRsbRgbRgRsmbLsbRcbRgLsbLsbRsbRibLhRsb
LgbRcbRgbRibRiLsbLgLsbLsLgbRoRsmbRibRgbLjbLhbRibLhbRgbLibRsbLibRgbRcbR
gbRsbRsRsmbRibLsRsbRiRsmbLgbRibRsbRsbRgRsRsmmbRgRsmbRsRsLsmbRgbRgRsRsm
mbRgRsmbRgbRgRsmbRsRgbRsbRgbRgRsmbRgRsmbRgbRgbRsbRgbRsbRibRgbRgbRgbRib
sbRgLsbLibRgbRhbRibRobRgLsbRiRsmbLsRibRgbLjbLhbLibRibLcbRgLsbLibLibRsL
sbLibRjbRibRibRsbRibLjbRgbRcbLjbLcRsbLcRsbLhbRgbLcRsbLsRsbLjbLibRobRgR
sLsmbLsRsbRibRgbRsRsmbRsRsmbRgRsmbRsLsbRgbRgbRgRsmbRsbRjbLebRcbRibRgbR
sbRgbLebLcbLjbRsbRiRsmbRgbRibRjbLibLhbRjbLiLsbLjbLjbLjbRcbRjbLobRibLsL
smbRcbRibLgbLcbRsbLcbReRsmbLcRsbRgbLhbLgbLibRibRgLsRsbRibRibLsRsbRsbRg
bRgRsRsmmbRgRsmbRgbRgRsmbRsbRsbRsbRibRgbLjRsbRgbRgbRibRgbRibLgLsbLjbLi
LsbRsbLibRgbLgbRhbRsbReLibRsbRsbLibLsbLgbLibRiRsmbRibsbRibLsbRgbRgRsmb
RgbRgbRgbLsbRibLgbRiRsmbLgbRibRsRsmbRgLsbRgbRgLsbRgbRgbRgbRsbRgLsbRgRi
bRgbRgbRsbRiRsmbRgbLsbRgbRgbRgLsbRgbRsbRiRsmbRgbLsbRgRsmbRgRsmbRsbRgbR
gbRgbLgbRcbRcRsmbRibRibLsRsbRiRsmbRsbLsbRgbLibLsbLobLsLibLhbRiRsLsmbLh
bRjRcbRsLsbRibRgbRsRsmbRgbLsbRgbRsbRgbLgLsbRgbRsLsbRiRibRsRsmbRgbRgbRg
bRgRsmbRsLsbRsbLjbLiRsbRjbRcbLjRsbRibRiRsmbLsbRsRgRsRgRgRimbRgbRgRsmbR
gbRgbRgbRgRsRsmmbLsbRibRgbRgRsmbRgbRgbRgRsmbLsRsbRgRsRsmmbRgbRgbRgbRsb
RiRsmbLsbRhbLibRobRcbRibRibRcbLsbRibLgbRibRgbRsbRibLsbRibRgbRibLibRhbR
gRsRsmmbRsbRiRsRgmbRsRsmbRgbRgbRsbRiRsmbRgbRgbRsbRgbRgbRsRsmbRgbRgbRgR
smbLsRgRsmbRgbRiRsmbRgbRibRibRibLcbRhbRiRsmbRgbRsbRsRjbLsbLsbRibRgRsmb
RgbRsbRgRsmbRgRsRsmmbRgbRgbRgLsbRgbRgbRgbLgbRsbLsbLibLhbRibLcbRhbRcbLg
RsbRgbRgbRgbRibRgbRibLibLsbRobRiLsRsbRiRgbRiRsLsmbRgbRgRsmbRgbRgRsmbRg
RsmbRgbLsbRsbRgbRgRsmbRgbLgbRibRgRsmbLsbRsbRgbRiRsLsmbRgbRgbRgbRsbRgbR
gbLsbRibRsRsmbRgLsbRgRsmbRgbLgbRgRsmbRgLsbRgLsbRsRiRsRsmmbRgbRsbRgbLgb
RgbLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 8; Drug: NDMC 1 µM
bLgbLibLibRcRsmbRhbLgRsbRhbLgbRobRcbRhbRgbLibLibLibRsRsmbLgbLsbRsbLgbL
gbLsbLgbRsbRibRgbRgbLjbRibRsbRcLsbLgLsbRhbLibRibRoRsmbRibsbLjbLibRoLsb
LobRcbLgbRibLgbRibLgbRibLsbRgbRsbLsRsbRsRsmbsbRsbRoRsmbLgbRibRibLjbRcb
RsbRgbsbRsbRsbLsbRibRsbLsRgbRsbRiRsmbLgRsbRibLsbRibRgbRgbLjbRibRsbRibL
sbRgbRgRsmbRgbRsbLgRsbRibLsRibRsbRsRibRibLjbRibRgbRsRgbRgbLgLsbRibLgbR
ibLsLsmbRgbRibRibRgbRibLgbLsbLsbLcbRgbLibLiLsbLsbRgbLgbLgLsbLgRsbLgLsb
RsLsbLgbRjbLobRibLgLsbLgbLibLoRsbRiLsbRhbRibRobLgRsbLsbLgbLibRjbRibLsb
sbRibLsbRgbLsLsLsmmbRsbRibRiLsbLjbRhbLgbRibLsbRibRgbRgRsmbRgRsmbsbLsbR
sRgbLsbRgbRibLgbRhbRoLsbLibRgbLgbRgbLibLiRsLsbLgLsbLsbRsbLgbLsbRsbLgbR
sbLgLsbRsbLgLsbRgLsbLgbLgbLsbLgLsbLgbLgbRsbLgbLgLsRsbRgbLgbLgbLsLsmbLs
bLgLsbRsbLgLsbLgbLsbRsbLgbLsbLgbLgbLgLsbLgbLsbLsbLsbLgbLgbRsbLgLsbLgbR
sRsLsmbLgbRsbLgbLsbLsbRsbLibLgbRsbLgbLsbLgbLgbRsbLgLsbLgbRsbLgLsRsbRsb
LgLsbLgLsbLsbRsbLgbLsbLgbLsbLgbRsbLiLsbLsbLgbLgbRgbLgbRcLsbRiLsbRibRiL
sbRibRcbLsbRiLsbsbRgRsmbRgRsmbLgbRibLsbRibRsbRibRhbRgbLibLgbRgbRibLgbR
ibRibLgbRibLgbRsLsbLsRibLjbRibRcbRibLibLibLsRgbRobsbRibRgbLibsbLgbLiLs
bLjRsbRgbLgLsLsmbRsbLgbLsbLgbRgbLsbLgbLgLsbLgbRgbLgLsbLsbLgLsbRjRsLsRs
mbLgbLgRsbRgbLgLsbLsbLgLsbRsbLgbLibLgbLsLsmbLsbLsbRsbLgbRsLsLsmbLgLsbL
sLsLsmmbsbLsbRgLsbRsbLibRjLsbLgbLibsbRjbLgbLgLsbsbLibRsbLiRsbLgbLcLsmb
LsbRsbLjLsmbRcbRiLsbLjbLobLhbRibRcbLsRiLsLsmbsbRgLsbRibRsbRgbLibRcbRsb
LgbRcbRibRsRibLsbRgbLgbRcbRcbRibRsbLibLgbRgbRjbLiLsbRcbRgbLsRsbRhbLsbR
iRsmbRibLgbLgbRgbRcbRsLsbLjbRcbRibRsRsmbsbLsLsRsmbLgbRgRsmbRgRsmbRgbLs
bRgbRgbLsbRgbRgRsmbLibRcbRibLsbLsbLcbLsLsmbRsbLcbLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 9; Drug: NDMC 1 µM
bLgbRsbLibLgbRsbLgbLsbLsbLsbLgLsLgbRjbLiLsbLgLsbLsLsmbLibLgbLibRsbLgRs
bRibRibLsbRibLgbsbRgLsbLibRhbLgbRcbRcbRibRgRsmbRcbRibLgbRcbRsbLjbRhbRi
bRiLsbLsbRibLibLgbRcLibRibRsbRcbLsbLgbRcbLgbRcbsbLgbRcLgbRibRibLgbRsLs
RibLsLsmbRibLgLsbRibsbLsbRibRcLsbRsbLjLsmbRcbRibLjbRibRiLsbRgbLsRiLsbR
ibLibLjbRcbLjbLjRsbRoLsbLsRibLibRibLcbLibLgbLgbRgbLsbLibRsbLgbLgbRjRsm
bLsRsbLgLsbLgbLgbRjbLgRsbLiLsbRjbLsbLibLibLgLsLsmbLiRsbRgbLiLsbRsLsbRj
bRibLjbRgbRibRcLsbRcbLgbRibLgbLibRsLsLsmbLgLsbRsbLsRsRsmbLgbRgbLjLsmbL
gbLgbLsLsLsmmbLsbLgbLsLsmbLsbLgLsRsbRgRsmbLibLgLsRsbRgLsbLgbRgLsbLgbLg
bRjbLgbRgRsmbLgbLibRjbLsbLibLgLsLsmbLsbLibRsbLibLjbRjbRibRiRsmbLsbRibs
bRibRsbLibRcbLgbRcLsbLiLsbRobRibLibLgbRcbLgRsbRibRcbLibLsbRjbRibRcbLib
RibsbRjLsbLsLsmbRibRgbLibRcbLgbsbLjbLibRjbLhbRgbLibLibRebLhbLgLsbLibLg
bLsbLgLsbLgLsbLibRcLsbRibLjbLibLibRsbRcLsbRhbLibRcbLgLsbRobLsbRcbLibRg
bLgbLgbLgbLibRjbRibLjbLibLsbLibRjbLibRibLibLgbLibLgbRcbLibRcbRcLgbLgbL
cRsbRcbLjbLgbRgbLgbLgbRgbLibRjbLibLgbLgRsbLgbLgbLibLgbRsbRibLgbLgbRsbL
gbLsLsmbLgLsbLibRjbLgbLgLsbLsLsmbLgRsbRgLsbLsbLsbLsbLgbRsRsmbLsLsmbLgb
LsbLsbLsLsmbLgbLsbLgLsbLsLsmbLgbRsbRsbLgbLsLsmbLsbLgLsLsRsmbRsLsbsbLgb
LgbLgbLgbRgbLgbRsbLibLsbLgbRsbLsbRjbRibLjbRibLjbLcbRhbLibLiLsbLsbLgbRg
RsmbRebRcbLgRsbRcbRcbRibRsbRhbLjbLhbRibRcLsbLjbLiLsbLgLsbLgbRgbLibLsbL
gbLsbLsbLsbLibRjbRcbRcbRcbRhbLsbLgbRsRcbRhbLhbRibLhLsbLibLgbLgbLgbLgbL
sLsmbLsbLsbLgbLgRsbLibRgbLsLsmbLibsbLgLsbLibRjbLsbLgLsbLgLsbRjbLsbLgbL
gbRsbLgLsbRsLsRsbLgbLsbRgbLibRsbLgLsbRsbRsLsbLgLsbLgbLgbRjbLgbLibLgbLc
bLobLoLgbRsbLgbRsbLibLsbLgbRsbRjbRibRibRibLjbRibLiLsbLibLcbRibLibRjbLi
bsbsbLsbLgLsLsmbLsbLsbLgLsLsmbRsbRsLsbLsLgbLgbLgbLsbLsbLsLsmbRsbLgbRsb
LgLsLsmbLsbRsbLgbLgbLsLsmbLgLsbRgLsRsLgLsLsmbLsLsmbLsbLgbRsLsbLgLsbRsL
sbLgLsbLsbRiLsbLcbRcbRhbRiRsmbLibLibLiLsbLibRjbLibRjbLibLgLsbLsbLsbLjR
sbRgbLcbRsbLgbLibLiLsbLiLsbRsbRebRsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 10; Drug: NDMC 1 µM
bRibLgbRcbRgbLcbLgLgbLgbLcbRebRibLsLsmbRibLgRsbRgbRgLsbRgbLcbLobRibRhb
RibLjLsmbRjbRoLsbLgbRcbRcRsmbRgbRgbLibRibLjbLcbRhbLcbLibLsbRibLgLsbLgb
RibLibRsbLibRjbLibLibRsbLgbRsbLgbRebLcbLibLibLibLjbRibLibLsLsmbRibRibR
oRsmbRgbLhbRgLsbLgRsbRhbRiRsmbLgLsbRibLgbRsLsbRgbRgbRsRsmbLsLsmbRibLjb
LgbRhbRiRsRsmmbRcbRiRsmbRcRsRsmmbLhbRgbRibRibLsbRibLjbRibRcLsbLcbLobRg
RsmbRibRgbLibLjLsmbRcbLjbRobRhbLsbRibLibLgbRgLsbRgbRgbLibLgbLgbRgLsbLi
bRibRgbRgbRgbLibRibRibLjbRgRsmbRcbRiRsmbLgbLsbRibLgbRibRibLgbRibRgbLib
RsbRcbLgbRgbRgbRiRsLsmbLgbRibLgbLcbLibRjbLibRcbLjbRsbRgbRibRgbRsbsbLgL
sbRcbLcbLcbRibLgLsbLibRhRsmbRibLibLsbRhbRgRsmbRibLobRjbRiRsmbRiRsmbLjb
RgbRibRgbLgbLsbRiLsbRibsbRgRsmbRhbLibRgbsbRhbLibLjbRhbRibRsbRgbRsbRgbR
ibLsbLsbLjbRhbLgbRcbLsRgbRsbRoRsmbRcbLibRcbRhbLgLsbRibsbRgbRhbLgbRgbRg
bRgbLjbLibReRsmbRgbRgLsbRgbRgbLgbRsbRibLsbRgbRgbRgbRgbRsLsbRsbRgRsmbsb
sbRibRcbRobRcbRgbRibRibRcLsbRebRgLsbRgbLsbLiLsRsbRibRiRsmbRgLsbLgbLjbL
ibLjbRjbLiLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 11; Drug: NDMC 1 µM
bLcbLhbLibRjbRgbLjLcbLibLibRgbRgbLcbRibRiRgbLjbLibLgbLibRgLsbLibLsRsbL
ibRgbLibRsbLiRsbRsbLgbRjbRjbLhLsbLiLsLsmbRsLsbLgLsbRsLsbLibRgbLgbLibRg
bLsbLibRsLsbsbLibRgbLibRsRsmbLgbLsRgLsbLibLgbRgbLgLsbLsLsmbLsRsbLsbLsb
LgLsbRsbLgLsRsbLgLsbRjbLibRsLsbRcbLibLiLsbRibRgLsbRcbLjbLhbRjbLhbLsbLs
LsmbRsLsbLhRsRsmbRibLibRsbLiLsbsbRgbLiLsbLgbRjbLgLsbRcbLibRjbRgbRibLjb
LcbRjbRibLibRibRibLjbRiLsbRgbLjbLsLibLiRsbRjbRibRibRiLsLsmbLgbLgbLibLi
bRibRhbRgbLjLibRibRsRgbRgbRgRsmbRgbRgbLsbLebRibRgbRibLhbLcbRibRcbRgbRg
RsmbRgbRgbRsLsbRsbRgbRsbRgbRgRsmbRsRsmbRsRsmbLsbRsbRgbRgbLjLsmbRgbRgbR
sbRsbRsRsmbRgbRgbLsbRgLsbsbRgbRgbLgbsbRgRsmbRsbRgbLsbRgbRgRsmbRsbRsLsb
RgbRsbsbRgRsmbRsLsbRgbRsbRgbRibRsbRsbRgRsRsmmbLsRsbLsRsbRsbRgRsmbRsLsb
RgLsbRgbRsbRsRsmbRgbRgbRsbLsbRgRsmbLhbLiRsbsbLibRjbLiLsbLibsbRibsbsbLi
bRjbLibLibLibRibLibLibsbRjRsmbRcbRibLibLsRsbRibRgRsmbRgbLsbRgRsmbRgbLg
bRibRgbRsbRgbLibRiRsmbLsbRsbRgRsmbRgbLgbRsbRgRsmbRsbRsbRsRsRsmmbRsbsbs
bRgbLsbRgRsmbRgbRgRsmbLsLsmbRsRsLsmbRgbRgbLsLsmbRsbRibLsbLsbRgRsmbRsbR
sbRsbRsbRgbRsbRsRsmbRgLsbRsbRsbRsRsmbRsRsmbRsRsmbRsbRsbRsRsmbRgbRgbRgL
sbLsbRgbRgLsbsbRgbRsbRsbRgRsmbLsbRjRsmbRgbRsRsmbLgLsbRibRsbRgbRibRgbLi
bLjbLsLsLsmmbRsbRgbRcbRgbRsbRgbRgbLgbRibRiRsmbLibRhRsmbRibRibRibRgbRgb
sbRgbRgbRibLibsbLsbRcbLgbRgbRibRgbLsbRgbRgbsbRgLsbRgLsbLgbRibRibLgLsbL
cbRibRcbRibRgRsmbRgbRjRsmbRiLsbLibRibRgbRibLsbRibLibLhbLhRsbLsRsbLibsb
RsbRsbLibLhRsLsbLgbsbRgRsmbRibRjRsmbLibLibLibRibLcbRhbLcbLjbLhbRsbLibL
sRsbRjbLibsbRjRsmbLhbRhbRiRsmbRibRiLsbReRsmbLhbLcRsbRibLcbLgbLibRgbRsb
RjRsmbRebLibRhbsbRibRgbRgRsRsmmbLibLgLsLsmbRsLsbRcbRibLgRsbLsLsmbLsLsm
bRcLsbLgbRcRsRsLsmmbRibRgbRgbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 12; Drug: NDMC 1 µM
bRcRsmbLibLibLsbLibLsRjbLsbLibLsLsmbLsbsbLgbLgLsLsmbRsbRsbLsbLibRsRsmb
LgbLsbLiLsbLibLibRgbLgbRebLjbLibRcbRibLgbRsbRibLgLsbRgbLcbLgLsbLsbLgLs
bLsbLgbRsbRebRcbsbLjbRcbRcRsmbLibLsbLiLsbLgbRgRsmbLsLjbLgbsbLhbRsbLgbL
sbLjbLibRsRsmbLgbLobRjRsmbLjbRobLgbLjbRsLsRsbRiRsmbRsbRibRebLsbLibLsbL
gbLsbLsLsmbLsbLibRsRsmbLjbLsbRgbLjbRgRsmbLjbLsbRcbRebLsbLgbLgbLgbRebRc
LsRsbRibLjRsbLcbRhbRgbLsRsRsmbRibLsLsmbRgbRgLsbRsRsmbRgbRgRsmbLsRsbRgR
sRsmmbRgbRsbRjbRgRsmbRjbRgRsmbRgbRgbRsbRgbRsbRsRsmbRgbRsbRgLsbRgbRsbRg
bsbRsRsmbRgbRsbRgbRgRsRgmbRgRsmbRgRsmbRsbRgRgbRgbRgRgbRgRsmbRsRsmbLsRe
bLsbRsbLsbRibRiRsmbLgbRibLsLsmbRjbRgbRsbRgRsmbLsbRgbRsRsmbRgbLsbLgbRjb
RibLibRobLgbRcbLibRebLibRebLibRjbRcbLgbRsRsmbsbRgLsbRgRsmbRcbLgRsbRsLs
bLjbLibRjbLsbRibLjbRcbLibLcRsbLibRibRiRsmbLsbRjbRjbRgbLjbRibRsbRibRsRs
mbRgRgbRgbRsLsbRibRgbRgLsRsbRgRsmbLgbRsRsmbRsLsbRjbRsbRsRsmbRibLsbRcbL
gbLcbLcbRibLjbRsbsbRjbLibLibLibLcbLgLsbLgbLgRsbRsRsmbLibLibRobLjbRsbLi
bRebLibLibLgbRsbLiLsbRsLsbLgLsbRsbLibLsbLgbLsbRgbLgbRsbLsLgbRjbLhbRoLs
bLibLgbLgbRsbLgLsbLgRsbRsbLgbLibLsbRjbLibLgbLjbLsbRgbRoRsLsmbRibRgbRgb
LgbLcRsbRcbLcbLjRsbRcbRobRsbRobRcbLiLsbRiRsmbLebLsRjbLibLibLgbRcbRhbLs
RiRsmbLsRsLsbLibLibLgbRcbRsbRcbLjbLsbLjbLibLibRsbLibLsbLibLgbRsbLgRsbL
gRgbLebLsbLsbLgRsRgbLgbLgbLsbLgbLsLsmbLgbLibRgbRjbRibRsbRsLsbRobLibsbL
gbRgbLebReLsbRgRsmbLgbRobRcbRcLsbRibLibRiRsmbRibRibLjbRibRibLjRsbRibRs
bRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 13; Drug: NDMC 3 µM
bRibLjbRibLjbRibLsbRgbLsbRgRsmbRgbLgbRgbRgbRiRsmbRsbRgbRgRsmbRgbRsbRsb
RgbRsbRcLgbLhbLiRsbLibRibLjbLibRcbRoLsbsbLgbLibLgbLhbRgRsmbRcbRoLsbLgb
RobRibRibRibLibLibRibRibRibLgbRgbRsRsRsmmbRgbRsbLsbLcRsbLibRsRsmbRjbRi
bRibRgLsbLibRoRsmbRgLsbLibRgRsmbRcbRcbRgbLgbLcbRgbLibLsbLgbRsbLgbLiLsR
sbLgLsbLibRsbLibRjbLibRcbRcbRsLjbLibRgbRgbLjbRobLibRcbRhLsbLibRhbLjbRi
bsbLhbLhbRjbLibLibRsbLibRsRsmbLgbLiRgbLibRgbLibRgbLgbLgbLsbLgbLgbRjbLi
LsbLgLsbRsRsmbLgbLgbLgbLsbLsbLgbLgbRgbRcbRiLsbRiLsbLhbLiLsbLgRsbLibLgb
RgbRjbRhbLcbRhbLgbRcbLibRhRsmbLjbsbLcbRgbLhbRsbLsbLgbLiLsRgbLgbLgbRsbL
iRsLsbLgbLgRgbLgbRsbLgbLibRgbLgbLgbLgbLibLgRsLsbLgbLsLsmbLgbLsbLgLsLsm
bLsbRsbLiRsbLgbLsbLgLsbRgbLgbLsbLgbLgRgRsLsmbLgLsbRsbLiLsRsbLsbLgbLgRg
bRiRibRhbLebLcbRjbRcbLiRsbLibRjbRcbLibLjbRcbRcLsbRcbRibRcbLibRobRsbRib
LibLgbRcbRibLjbRhbLsbRibLsbRgLsRsbRiLsbLgbRibLjbRsbRhbLgbRgRsmbRgbLjbR
iRsmbRcbLibLiLsbLibLgbRsbLibLsbLgbLibRgRsmbLibRcbLibLibLcRsRsRiLsmbLgb
LsbLsbLibRebRhbLgbRiRsmbRiLsbLibLibLibLsbRhbRgbRgbRibRibLhbRibLoLsmbRg
bLcbLsbLcbLibLsbLibRcbRoLsbsbLcbLjbRibRgRsmbLgLsbLjbLibLiRsbRsbLgbLiRg
RsmbRcLsbLcbLibRjbLgbRcbLjbLhRsbRjbRcbLibLebLcLsmbRibLcbRibLibLiLsbLcR
sLsbRibRjbLhbLgbLsbRcbLcbLibRjbRcbLsbRgbRgbRsLsbRsbLjbRcbLgbRgbRgbRsRs
mbRgRsmbRsbRgbLhbLobRibLcbRsbLibLibLgbRsbLsRcLsbLibLibLibRsRsLsmbRsbLg
bLsLsmbLgbLsbLgbLsLsLgmbsbLgLsLsmbLgLsbLibLgbRgbLgLsbLgbLgbRgbLobLcbLc
bRsRsLsmbLibLibRjbLiLsbLgLsbRsbLibRsLsbLgbLsLsmbLsLsmbLgbLsbLsbLgbLgbR
sLsbLgbLsbLgbLgbLgbLgbLsbLgbRgRsmbLgbRcbRcbRiLsbLibRgRsmbLcbLcbRiLsbLc
bRgbLibLibLgbLiLsbLiRsbRibRiLsRsbLibLibsbLhbRibLoRgbLhRibLgbLibLibRjbL
ibLgbLsbLibRsbLibRjbLibRsbRcLsbRiRsmbLsLsmbRiLsbLoRsbLiLsbLsbLibLsbLcb
RiRsmbRcbRgbRsbRgbLsLsmbRgbRobLibLibRgbLcRsbRjbRibLcbLibLsbLcRsbRibRhb
RsbLjbRjbRiLjbRiRsmbRibLgbRsbRiRsmbRsbLibLgbRjbLcbRibLcbRgbLcbRiLsRsbR
gbRibRcbLhbRjbLhbRsbLgbLibRjbRcbLcbRcLsbRibLsbRgbLsbRgbRgbRsbRgbLsbLsb
RibRgbRsbRibLgbRgbRibLgbRibRibRibRibLibRgRsmbLibLibLsbLgbLgbRsbLgbLsbR
cbRjbLcLsLcmbRgbLiLsbRsbLgbRsbLgbLiLsbRsbLgbLsbLibLgbRsbLgbLgbLsbLgRsb
LgbLgbRsbLibLhRsRgLsbLgbLiRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 14; Drug: NDMC 3 µM
bRhbLjbRibRiRsmbLsbRsbRiRsmbLgbRsbRiRsmbRsLsbRgbRgbRgbRgbLgbRibRgbLcbR
ibRibLgLsbRibLsRsbRgRsmbRsbRiRsmbLsRsbRsbRiRsmbRsbRgbRgbRgbRgbLsbRgRsm
bRsbRsbRiRsmbRgbRgbRibRsbRibRgbRsbRgbRgbLgbRibRgRgbRgbRgbLgbLgbRibRibL
gbLcLsmbLibRjbLcbLibLiRsRsmbsbLibRibLibRhRsmbRibLgbRcbRgbLsbRhbLgbRibL
sLgbRiRsmbRsRibLcbLcbLgbLibLibRibRibLcRsbLiRsRsmbLgbLsbRcbLjLibLgbLsbR
cbRibRgRsRsmmbLsbRibLgbRgbRibLsbRgbLsRsbRsbRibLgbRibRsLsbRsRsmbRgRsmbL
sbRibRsbLgbLsbRibRgLsbLgbLsbRibLsLsmbRgbRiLsbLibRcLsbRcbsbsbLebRibLsbR
cLsbLcbLcbRjbLcbRjbLiLsbRjRhbRibRcLsbLiRsbRcbRhbRibLibLcbRibLjLsmbLibR
iLsbLibRgbLsbRsLhbRgbLhbLibRsRsmbLhbRhRibRhRsmbLibLjbRcbRcLgbLsbRcbLib
RcbRobRcbRibRibLcbLcbLcbLsbRcbRgbLibLiRsbRcRcLsbRibLibLcbLcbLibLibRiRs
mbLhbRhbRhLsbLgbRibLgbRibLsbRgRsmbRsbRgbRgRsmbRsbRgbRsbRgbRsbRgbLgbRib
RsRsmbRsbRgbRsbRgRsmbLsbRibLsRgbLsbRibRsRsmbRgbLsbRiRsmbRgbRgbRgbLgLsb
RsbRgbRgbLsbRgbRgbLsRsbRgRsmbRsbRgbRgbRgbLgbRgbLsbRibLsRsbRsbRgbRgbLgb
LjbRibRibLsbRgRsmbRgRsmbRgbRgbRgbRgbLsbLgbRibRgbLsbRgLsbRibRgLsLsmbRgR
smbRgbRibLsbRiRsmbRsbRgbRgbRgbRgbLsbRgbRgbRgbRgbRgbRgbLsbRibRsbRsbRgbR
gbRgbRjbLsLebLcbLgbRjbLibLibLcbLibRjbLcbRjbLcbRjbsbRjbRibLgbRgbRgbRsbR
gbRgbRgbRgbRgbRgRsmbRgRsmbRgRsmbRgbRgbRgbRgRsLsmbLgRsbRiRsmbRgRsmbRgRs
mbRgbLobLcbRgLsbLhbRibLgRsbLibRsbLoRsbRcbRibLgLsbLgbLgbLhbLiLsbLcbRgbL
gbRibRibRibRgbLjbRibRgRsRsmmbRsbRibRgbLsbRiRsmbRgbRgbLsLsmbRgbLgRsbRsb
RibRgbRgbRgbLgbRgbLsbRibRcbRhbLibLibRibLhbRibLhbRgbLibLgbLsbLibLsbLgbL
sbLgbRsRsmbLgbLsbLgLsbLgbRgbLibRsbLibRgRsmbLibLsbLibLgLsbLgbLsbLgbLsbL
ibLsbLgLsbLsbRsbRsbLiLsRsbLgbLgLsbLgLibLgbLgbLgbLsbLgLsLsmbRsbLibLgbLs
bRgbLibRcRcbRibLsbLhbRcbRoLsRsLibRsbLoLsmbRcbLjLcbLibRibLhbLibRibRgbRi
bRgLsbRgbRgLsRsbRibRgbRgLsbRgbRgbRiLsbLibRhbLibRibLgbRibLsbRgRsmbRhbRi
bRhLsbsbLhRsbLibRsbLcbRibLibLsbLibRsbLhbsbRsbLsbLsbReLsbRgbRgbRibLgbRi
bLsbRibRsbLjbLcbLcbRibsbLcbLiRsbRjbLcbLibLibLibLgLsbRsbLsbLgbLgbLsbLiR
sbLibLgbLsbLgbRibLjbRebRebRebLgbRcbRcbRjbLcbRgLsbLibRibLibLgbLibLsbLsL
gbLsbLgbLgbLgbLsbRsbLsLsmbRibLiLgbLgbLsbLjbLsLsmbLobLgLsbLgbRsbLgbLsRs
bLsbLibLsbLgLgbLibLsbLgbLgRsbRibRcbRcLsbLcbLhbLiLsbRjbLcbRibRcbRibRiLs
bLibLjbLibRsRsRsmmbLgLsbLsRsbLgbLiLsbLgbLgbLsbLibRjLsbLcbRibLcbRibLibL
iLsbLgbRsbLgbLsbLsbLgRsbLgbLgbLsLsLiLgmbLsbLsbLgbLgLob

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 15; Drug: NDMC 3 µM
bLgRsbRsbLgbLgLsbRsRsmbLsbLgbLsbLgLsbLgbLsbLgLsbLsbLgLsbLgbLsbLgbLsbRs
bLgbLsbRsbLsbLsRsbLgbLsbLsLsmbLsRsbsbRsbLgbLsbRgLsRsbLibLgbRsbLgbLgbLg
bRgbLibRgbLibRsbLgbLibLsbLgbLgbLsRsbLgLsbLgLsbRsbLgLsbLgLsbRsbLiRsbLsb
LsbLibLgRsbRsLsbLiLsLsmbLsRsbLgLsbLsbLgLsLsmbRsbsbLiRsbLsLsmbLgLsLsmbR
sbLsLsmbLgbLsbLgbLsLsmbLgbLsLsmbsbRsbLgbsbLsbLsLsmbRsbsbLgbLsRsLsbLgLs
bLgbLgbLgbLgbRsbRhRgbRgbLsRgbRibLgbRgRsmbRgbRgbRsbRgbRsbRgbsbRgbLsLsmb
RibRsbRgbRgbRgbRsbRgLsbLgRiLsbLjbRibRibLgbRgLsbRgbRibLgLsbRsbRgbRgbRib
RibLgbRgbRgbRibRiLsbRgbLgbRgbLibLsbLibLgbRgbLgbLgbLgbRsbRgbLiLsbRgbRsL
sbLibLgbRsbLiLsbRgLsbLsLsmbLgbLgbLsLsmbLsRsbLgLsbLsbLgbLgLsbRsLsbLgbLg
bRsbLsbLsbLibRsbLgbRjbLibLibRgbLibLgbLiLsbLibRsbLibLibRgbLgbsbLgLsbRsL
sLsmbRcbRibRibRibRgbRsbRgbRiRsmbRiLsbLgbLibLibRsbLibLibRsbLgRsbLiLsbLg
bLgbLsLsmbsbLgLsbLsbLsbLgLsbRsbRjbRibRibRgLsbLjbRgbRsbLsbRgbRgbRsbRgRs
mbRgbLjbRibRsbRgbLibLibLiRsbRjbLhbRjbRibRgbRsbRsbRgRsmbRsbRgbRgbRsLsbR
gbLsbRgbRsRsRsmmbRsLsbRgbRgbLsLsmbRgbRgRsRsmmbRsbRsbRgbLsLsmbRibLjbLib
LibLibLibRjRsmbLgbRsbLsbLsLiLsbRjbRiRsmbRgRsmbRgbLsbRgbRgbRgbLgbRgbRsb
RgRsmbRgbLsbRsbRgbRgbLsbRgbRsbRgbRiLsbRibRiLsbLiLsbLgbLsbRhbRibRibRibR
gbLibRgbLcbLibLgRsbRibRibRsbRsbRgbRgRsmbLsRgbRgbRsRsmbRsRsmbRsRsmbRgbL
gbRibRgRsmbRsRsmbRgbRgbRsbRgbLsRgRsmbRgRsmbRgbRsbRgRsmbRgLsRsbLsbRgbLi
bLibLhLsbLsbRgRsmbLgbLsbLibLibRgbLsbLibRsbLgbRsbLgbLgbRsbLibRsLsbLgbLg
LsbLsbLgbLsbRsLsLsmbLgLsbLgbLsLsmbLgbLibLgbLibLgbLgbLgLsbRibRgbRgbLjbR
gbRgbRgbLjbRibLsbRgbRgRsRsmmbLcbLibLgbLsbLgbLsbLgLsbLsRsbLgbLgbLsbLgLs
RsbLsbLgbLgbLgLsbLgbLibRgbLiLsbLgbRjbRibRgbRgbRgbRsbRgbLsbRgRsmbRcbLib
LgbRcLsbRibRibLsbRibLsbRgLsbRibRsbLsbRgbRgbRgbRibRsbRgbLsbRgbRsRsmbRsb
RgbLobLibLhLsbRgbLibRgRsmbsbLibLgbRgbRsbLibRsbLgbLgbRsbRjbRcbRcbRgbRib
LibLgbLibRsbLgbRjbRobRibLjLsmbRibRgbLsbRgbRgbLcbReRsRiLsmbLjbLhbLgbLgL
sbLsbRjRsRimbLhbRhbLhbLgbLgLsbLgbRjbRsbLsbLsbLgbLsRsbLgbLgbRsbLgbLgLsb
RsLsRsbLgbLgbLsbLgbRcbRibRibLgLsbRibRsbLgbRgbRgbRsbRsbRgbLgbRhLgbLgbRg
bRgbRgbLgbRgbLjbLibLibRgbLgbLgbLgbRsbLgbRsbLsLsLsRsmmbLgbRgbLgbLgbRsLs
LsmbLsLsmbLgbLsbLsLsmbLgbLsbLgbLsbLgbLgLsbLgbLgbsbRjbLsbLjbLgbLgbLsbRc
bLibRcbRibRhLsbRibRsbLgbLibLgbLsbLgbLsbsbLgbRsbLgLsbRjbLibRjbLsbLgbRsb
LgbRgRsmbLibLgRsLsbLgbRgbRsLgLsbRsLgLsbLgbRsbLgbLsbLgbLgbRsRsmbLgbLsLs
LsmmbRsLsbRsLsbRsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 16; Drug: NDMC 3 µM
bLhbLhbRobRgbRsbRsbRgRsmbRsbRgbRsbRgRsmbRsbRgbRsbRibRgbLgbRgRsmbRgbRgb
RgbRsbRgbRgbLjbLcbLibRibLibRibLgbLhbRibLcbRibRcbLjbRibRgbRibRsRsmbRsbR
sbRsbRgbRgbLjbLcbRcbRibLjbsbRibRsRsmbRgbRsbRsbRibLsbRibRsbRgRsmbRgbLsR
sbRgbRsbRgbRgbLsbRgRsRsmmbRgbRgbRgbRgbRgbRgRsRgmbRgbRgbRgbRgRsRgmbRsbR
gbRgRsmbRgbLjRsbRibLsbRibLjbLcbLibRgbLiRsbLibLhbLcbLibRibRiLsbRsbLsRib
LhbLgRsbLgbRhbLcbRibLibLcbRiRsmbLoRibRcbLjbRibLsbLjbRhbLgbRibRgbLsbRsR
smbRgbRsbRgbRgbRsbRgbRibRsRsmbRgbRsbRibRsbRgRsmbRgbRgbLsbRgbRsbRiRsRsR
gmmbRgbLsRsbRiRsmbLsRsbRsbRibRsLsbRgbRgbRsbRgbRsbRibLsbRgbRsbRsbLjbRcb
LhbLibLibReRsmbRhbRibRibLibRibRibRiRsmbRsbRibLebRcRsmbRibLsbRobRcbLsbR
obRsbLcbRcbRoLsbLsbRgbRibLcLibRsbLcbLhbRiRsmbRibLobLgbRsbRibRcbRgbLgbR
gRsmbRibRsbRgRgbRibLgbLjbLebRjbRhbRibRibLgbRibRgRsmbRsbRgbRgRsmbLjbRsb
RibRgbRsbRibLsbRgbLjbRiRsmbRgbRsbRsbRgbRsbRgRsmbRsbRgRsmbLsbRibRgbRgbR
gbRgRsmbRsRgRsmbRgbRgbRsbRgbRiRsmbRsbRgbLcbLiLsbRsbLibRibLhbLgbLcbRibR
ibRgbLcbRcbLsbRibLgRsRsmbRiRsmbLsbLsbRibLsbRibRsbRsbRibLsRsbRibRsbRgbR
gRsmbRgbLsbRgbRgRsmbRgbLsbRgbRgRsmbRgRsmbRsbRgbLsLsmbRiRsRsmmbRsRsmbRs
bRsbRgbRsbRgLsbRibLsRsbRgbLsbRibLcbLgbLibRjbLibRebLcbRjbLcbRgRsLgmbRcb
RsbLcbRcbRhbLgbLjbRibRgbRsbRgbRgbRgbRsbRgRsmbLsbRiLgRsbRcLsRsbRsbRibLi
bRhRsmbLgbRcbLgbRgbRgRsmbLsbRibRgbRsbRsRsmbRgbRgbRsbRiRsmbRgbLgbRibLgL
sbRibRsbRsbRgbRsbRgbRsbRgbRsbRgbRsbRsbRgbRgbLgbRgbRiRsmbRsbRgRsmbRgbRg
bRgbLgbRibRibLjbRibRiRsmbRibLcbLhbRcbLcbLibRcRsmbRobLebRiRsmbRcbLgbLsb
LibLhbRgbLibLgbLibRibLgbLgLsbLgRsbRcbRibLsbsbsbRhLsbLiLsbRsbLsbRhbRibR
sbLgbRgbRibRgbRibRiRsmbLcRgbLgbLgbLibLgbRsLsbLgbRgbLsbLibRcbLcbRjbRcbL
jbLibRcRsmbRiRsmbLcbLcbLcbRcLsbRhbRsbLcbRgbRiRsmbRhbRgbRgbRsRsmbRsbRsb
RgbRsRsmbRibRgbRgbRsbRsbRsbRsbRgbRsRsmbRgRsmbRsbLsRsbLsRgbRgbRsbRgbRgb
RgbLsbRgbRgbRsRsmbLjLcbLhRsbRjbRcbLibRcbRgbLsbRibRgbLsbRgRsmbRgbRhLsRs
bsbRsbLibLcbRibRibRgbRsbRsbRgRsRgmbRgbRgbRgbRgLsbLibLcbLcRsbLobLibRibR
ibRsRsLsmbRgbRgbRgRgbRsRsmbRgbLsbRibRiRsmbRsbLcbLhRsRsmbRibLibLgbLiRsR
smbRibRcbRibLgbRiRsmbLgbRiRsmbRsRsmbRsbRiRsLsRsmbRgRsmbRsbRgbLsRsbRgRs
mbRgbLsbRsbRgbLsbRibRsbRgRsmbRgbRsbRgbRgbRiRgbRsbRgRsmbRgbLgbRibRgbLgR
sbRiRgbLgbRgbRsLcbLibLhbRjbLcbRcbRcbsbRhbRsLsbRsLsbRgRsmbRsRsmbRgRsmbR
gbLsbRgRsmbRgRsRgmbRsRsmbRgRsmbRgbRsbRgbRgbLgbRgRsmbRgbLcLsmbRcbLsbRhb
RsbRgRsmbLcbLiRsbRibLcbRjbLsbLibLobRsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 17; Drug: NDMC 3 µM
bRgRsmbRgbRgRsRsmmbRgbRgRsmbLsRgbRsbRibRgRsmbRsLsRsbRibRgbRgbRsbRgbRgb
RgbLibLjbRcbLsbLjLjbLcbLhbLibLgbRgbRsLsbRcbLsbLgbRgRsmbRcbRsbLsbRibRgb
RibRibLsbRsbLcbLcbRgbLcRsbRsbLcbLhbLsbRiRsRsmmbRibsbRsbLibLibLgbLgbLgb
RjbLibLsbLibRgbLhbRgRsmbLgbLcbRsbLhLsbRhbLibLgbRjbRibRgbRsbRgRsmbLgLsb
RiLsbRgbLgbRgbLsRsbRibRsbRiRsmbRgRsmbRgbRsbRgRsmbRsbLsbRibRsbLsbRiRsmb
RibRsbRgbRgbRsbRibLgbRibRsbsbRgbRgLsbLsbRgbLsRsbLsbRiRgLsbRsbRsbLhbLiL
sbRibLcbRibRibRibRgbRsbRiRsmbLsbRgRsmbLsbRibRgbRsbRsRsmbRgbRsbRibLgbRi
bLsbLsbRibLsbRgbRsbRibLgbRhbRgbRgbLsbRgbRsRsmbRiRsRsmmbLgbRibRsbRibRsb
RgbLgbRibRgLsbRsbLsbRibRsbRsbRgbLsLsLsLsmmmbsbRgbRgbLsbRhbRgbLsbRibLjb
RcbLibLcLsmbLgbLgLsbLibRjbRjRsmbRibRgLsRsbLgLsbRibLsbLsbRgRsmbRgbLsbRi
bLsbLsbRiLsbRsbRibLsbRgRsmbRibLsbRibRgRsmbsbLgbRibLsbRibRsbLsbRgRsmbLs
bRgRsRsmmbLsbRibRsRsmbRgbLsbRgbRsbLsLsmbRibRsbRibRgbLgbRgbRsbRiRsmbLsR
sbRibRsbRgbRsbRiRsRsmmbRgbRgbRsbRgbRsbRgbRgbRsRsmbLsbRgRsLsmbRsbRibRsb
RibLsbRsbRiRsRsmmbLsbRgRsmbRgbRgbRgbRsbLsbRhLsbLsRsbRibLgLsLsmbRgbRgbR
sRibLsbRibRgbLibRibRiRsRsmmbRgbLsbRiRsmbRsbRsbRgbRgbLgLsbLgbLhbRjbRcbR
gbLgLsbRibRsbRgbLsbLibLgbRjbRcbRsbRgbLsbRgbLgbRiRsmbLsRsbRibLsbLgbRibL
jbRcbLiLsbLcbLgbLsLsmbRjbLibRjbRebLsbRibLgbRhbLsbRibRsbRsRsmbRgbRsbRsb
RsbRgbRsLsbRgbRsbLsbRibLsbRgbLgbRibRsbRsbLsLsmbRgbRsbRgbRsRsmbLsbRgbLs
bRsbRsRsmbRibLsbLgbRcLsRsbLgbRsbRibRgbRgRsmbLgbLcbLgbLibLibRsbLibLiRsb
LsbLgRsbLiRsbRjbRsbLhbRgbLcbRibLibLsbLibLsbRgLsbLiLsbRgbLgbLgbLgbRibLi
bRjbLgbLibRjbLgbLgLsbLgRsLsbRcRsmbRcbRsbRiRsmbLibLgbRobRcbLsLsmbLgLsbR
cbRhRsmbRcRsmbRibLibLhbLcLsmbLcbLsbReRsmbRiRsmbRjbRibLsbLebLcbLhbLibLg
bLgbLobLjLsLsmmbLgbRiRsmbLsRsbLsLsmbLcbRjbLsRebLsbsbsbLsbLsbRsRcbLcbLj
LsmbLgbLibRsbLebLgRsbRgbLibRibRjbLibRcbRcbLgbLsbsbRebLgRsbRhbLgbsbsbRc
bLsbLsRsbRobLibsbRibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 18; Drug: NDMC 3 µM
bLibRibLibRsbLgLsbLgbRsbsbsbRsLgbLsLsRsmbRsLsbLibLsRsbLsbLgbLgbRgbLibs
bLibRibLiLsbRsbLgbLsbLibLiLsbLsbLsRsbLgbsbRsRsmbLjbLsbLgbLgbLiLsbLgLsL
gLsbLsbLibLsbLgbLgLsbLsbLibLgLgbLiLsbLibLgbLgbRjRsRcmbRibLcbLcbLgLsbLi
LsbLsLsmbLgbLsLsmbLgRsbLsbLibLsbLgbLgbLhbRiLsbLiLsbRhRibRibLgbRiLsbLgb
RiRsmbRibRibRgbRibLiLsbLsbRibRgbLsbRgbLjbRibRibRgbLgbRibRgbRgbRibRgbRg
bLibRiLsbRgbLcbLobLgbRibRibRibRsbRiLsbRgbRgbsbLgbLsbRhLsLsmbRhbLibRibR
gbRhbLjbRibRgbRibRibRibRibRibLgLsbRgbLjbRcbRibLsbRsbRgbRiRsmbRgbRgbRsb
RgbRgbRgLsbLgbRibRibRgbRgRsmbRgbLsbRgbLsLsmbRgbRgbLjLsmbRgbRgbRgbRgbRi
bRgbRgbRgbRgbRgbLgbLjbRjbLebLhbRgbRjbRibRgbRgbRibRgbLsbRgbRsbRgbLsbRgL
sbRgLsbRgbLgLsbRgLsbLjbLiLsbLgLsbRgbLgbsbsbRsbLsbLgbRsbLiRsbLgbRgbLiLs
bLgbLsbLgLsbLgbRgbLgbLsLsmbLsLsmbLsbRsbLibLsbLsbLgbLgbLgbLgbLsbLsbLsbL
gbLsbLgbLgbLsbLgbLiRsbLsbLsbLgbLgbLiLgbLibLgbLgbLsbLsLsmbLsbLgLsbLgbLs
bLgbLgbLiLsbLgbLsLsmbLgbLgLsbRjbLiLsbLgbLiLsbLgLsLsmbLsbLgbLsbLsbLgbLi
bRsbLsbLsbLibLsLsmbLibLsLsmbLsbRsbLibLsbLgbLgbLgbLgbRgbRjLsbRiLsRsbRib
LcbLcRsbLcbLgbLgbRjbRibRiRsmbLgbRibLibRibRgbLjbLibRjbLibLiLsbLsbLsbLsb
LiLsbLsbLgbLjbLsbLgbLsbLgbLgbLgbLgbRgbRibRiRsLsmbRibRgbLjbRibLcbLiLsbR
gbRjbRibRhbLibRsbLhbLibLgbRibLsbLiLsbLsbRcbRhbLibLhbLibRibLiLsbLgbRsbL
sbLsbLiLsbLsLsmbLgbLsbLgbsbLsLsLsmmbLgLsbLgbRgbLiLsbLgLsbRsbLgbLgbLsbR
sbLgbLgbRsbLgLsLsmbLgbRsbLgbLsbLgbLibLgbRjLsbRobRiLsbLibRhbRhbRsbRibLj
bRcbLcbsbRsRsmbRgbRcbLjbRibLeLsbRjbLcbRgbLobRibRibRgbRcbLjbRhbLgbRibLg
bRgbRgbRibRgbLibRgRsmbRgbRgbLsbRibRibLgbRgbRsbLjbLibRsLsbLgbRsbsbLobRg
bRsbRjbRcbLjbRibRiRsmbRcbLiLsLsLsmmbLibLsbRibLgbRgbLjbLibRjbLiLsbLhbRg
bLcLsmbsbLgbLsbsbLgbLibRsbLgbLgbRsbLgRsbRsRsmbLiLsbRsbLsLsmbRjbRibsbLc
LsmbLcLsRsmbLgbLsLsmbRhLsbRhbLgbsbRgbRgbLsbRgbRibLcRsbLhLsbLibRibRjbLc
bRjbLibLsbLiLsbLsLsLsLsmmmbLgbLsbLgbLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 19; Drug: NDMC 10 µM
bLgbLgbLgbLgbLgbLgLsbLgbLgbLgbLgbRsLsLgbLgbRsbRcbRiLsbLsLsmbRiLjbRsLsb
RibRsbRgbLsbRibRgbLsbLhbLiLsRsbLgLsLsmbLsRsRsmbLgbLgbLiLsLgLgbLgbLsRsb
LibRjbLibLgLsbLsbLgLsbLgbLgbLgbLsbRsLsbRcbRsbRhLsbLgbRcbLhbRhbRcLsbLib
RibRhbLobLhbRibLibLgLsbRsbLibLgLsbLgbRjbRcbLsRiLsLsRsmbRgbRsRibLsbRgbR
gRsmbLsLsRiRiRgRgRsRsmmmbRgRsmbLibRhbLibRhLsbLgbRcbLsbRsbLcbLcRsbLgbLo
RsLsbLhbLhbRsbRcbRhLsbLhbLcbRsbRibRgRsLsLsmmbRibRgbRgbRibRsbRgbLsbRiRg
bRgRibRgbRgRiRgbRgRgRiRsRsmmbRsRsmbRgRsmbRsbsbRgRsRgRsRimmbRgRsmbRsRsm
bRgRsRsLsmmbRgRsmbRgRsmbRgbRsRgbRiRsmbRgbRiLsbLcbRibRcbLobRcbLobRebRoR
smbRhbLiLsbLjLsmbRhbRgbRgRsmbRsbRibRgRsmbRgbRgRsRiRsRgmmbRgRsmbRsRsmbR
gbsbRgbRgRsmbRgRsmbRsRsmbRibsbRsbRgRsRimbRgbRsRgbRgRsmbRiRsRgReRiRsRsm
mmbRibRibRiRgRsmbRibRsbRiRsRiRiRgRiRsRiRiRgmmbRgRsmbRgbRgbRgbRgbRsbRib
RibRibLibRgbRibLhLsbLcbLcbLcLsmbRibLgbRhbRhbLgbRcbLcbRcbRcbRibLibRgbRh
bLsbRgbRibLcLibLibRgbRjbRibRibLibLibLiLsbLiLsbRgbLibLgbLgLsbRcbRgbLgbR
ibLsRsbRibLibRiRsmbRsRibRsRcbLcbRhbLgRibRsRsmbRsbRgbRgRgbRgbRsbRgbRsbR
iLsbLsRsbLcbLcLsmbRgbLhbRgbRibLcbRcLsbLoRsbRcbRgbLsbRgbRsbRgbRsbRiLsbR
gRsmbLsLsLsmmbRsRiRsmbLsRsbLsbRibRibRgbLsbRsRsmbRgbRibLibLcLsmbLgReLhb
RgLsbRjbLiLsbLcbLoRsbRcbRibRsbRibLobLcbsbLgbRhbRhbLjbRibRibLiLsbRibRgR
sLsLsmmbRgbRgbRsbRgLsbLsbRgbRsbRgRsmbRgbsbRsRsRsmmbRgbRgbLsbRgbRsbRgbR
gbRsbRsLsbRgbRsbRsRiLsbRgbRgbRgbRgbRgLsbsbRiRsmbRibRgbLsbRiRsRsmmbRsLs
bRibRgbRgbRgbRgbRsbRgbRgbRgbRgLsbLjbsbRibRgbRgbRgbRiRsmbRsRgbRgbRgbLjb
LcbLiRsbRgbLibRgbLgbRjbRibRsRibRsbRgbLsbRibRibRgbRibRsbLjbLibRsRibRcbL
hbRibRsRhbRcLsbRobRcRsmbRhbLsbRibLjbRhRsmbRgbRsLsbRiRsmbRsbRgRsmbRibRs
bRgbRibLibRebRgRsmbRgbRsbRgRsmbRgbRiLsbRgRsmbRibRsbRiRsmbRgRsmbRgbRsbR
iRsmbRgbRgbRgbRgbRgbLjbRhbRiLjbRiRsmbRgbLsbRgbRgbLsbRgRsmbRsbRgRsLsmbR
sbRiRsmbRibRgRsRsRsmmmbRiRsmbRgRsmbRgRsmbRgbRgbRgbRibRibRgbLcbRjbLcbRs
bLgbLibRibLcbRibLibLibRhbRhbRsbLcbLcbRiRsmbLobRibRhbRibRsbRibLjbLiLsbL
ibRjbLibRcbLcbLobRgbRgbRjbRibRgbRibLjbLhRsbLibRjbRibLjbRcbRsbRgRsmbRgb
sbLjLsmbRibRgbLgbRgbRibRgbRgRsmbLsbRgRsmbRsbRibRsRsmbRgRsmbRgRsmbRgbRs
bRgbRgRsLsmbRsbRgRsmbRsLsbRgRiRsmbRgRgbRgbRgRsmbRgRsmbRgRsmbRsbRgbRsbR
gbRgLgLsbRiRsmbLsRgbRgbRsbLsbRiRsRgmbRsbRgRsmbRgbRgbRgbRgLsRsbRgbRgRsm
bRgLjbRgbRiLsbRiLsLsmbLhbLcbLsRjbLhbRibRibRibRoLsbLcbRibRibLsbRgbLjbLg
bLgbLgLsbsbLsbLsRsbLgbRgbRsbRcbRibRgbLsbRgLsbRsRsmbRgbsbLjbRibRsbRibLg
bRibRsLsbRsbRgbLgbRgbRgbLjbRiRsmbRsLsbRgbRgbRgbRgbRgbRibRgbRsbRgbRsbRg
RibRsbRgbRsLsbRgRsRsmmbLsbRiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 20; Drug: NDMC 10 µM
bLibRsLsbLgbRsbLgbRsLsbRsLgLsbRgbLgbLiRgbLibLsRsbLiRsbRgbLgbRsbLgbLgbR
gRsmbLibLiRsbLsbLgbLgbRjbRoLsbLcbLibLgbRsbRjbRjbLcbLjLsmbLgbLoRibLgbRi
bLibLiRsbLibRjbLibRjbRcbLjbLebLgRsbRiLsbLsLsmbLibLgLsbRgbLibLsbRjbRibR
hbLjbLhbRsbLgbsbLgbLgRsLsbLgbLgRsbLibLgbLgLsbLcbRibRsbRgbLsbRibLsbRgbL
jbRcbLcbRhRsmbRgRsmbRoRsmbRibRcbRgRsmbLgLsbRibLsbRibRgLsbLjbRibLcbLibL
sbLibLibRgbLgbLgRgbLibLgLsLsmbLgRjbLgbLsbLgbRgRsmbLgbLgRsbLiLsRsbLgbLs
bLgbRgbLibLibsbLibRjbLgbRsbLsbLibRjbLibLsbLgbLgbRjbLgbLgRgbLgbLiLsbLiR
sbLibRcbLiLsbLsbRgbRibRiLsLsmbRibLsbRgbRsbRgbRgbRgLsbLjbLibLgbLgbLsbLg
bRjbLgbLibRgbLibLsbLgLsbLsbLgbRsLsbRjbLobLibLibLsbRcbLsbLgbRcbLsbLgRsb
RgbRibLgbRibLgbRibLjLsmbLibLiLsbLgbLgRsbLgbLsbLsbLgLsbLsbLgbLsbLiLsbLg
bRjbLibRgbLibRjbLhbRhbLibLgbRsbRjbLjLsmbLebLibRsRsmbRsbRibRcLsLsmbLibL
jbRhRsLsmbRibRsbRgbRsbRibRgRsmbRobLjbLcbRgRsmbLhRsbRgbRibLcbRsbLcbRgbR
gbLibLgRsbLibRgbLiLsbRgbLgbRsbLibRjbLiLsbLsbLibRsbLgbLsbLiLsbLgLsbLsbL
gbLgLsLsmbRgbLgbLgbLsRsbLibLsbRsLsbLgbLgRsbLgLsbLgbLiRsbLgbRgbRjbRhbLc
bRjbLcbLcRsbLibRcLsbLibLgbRgbLsbRibRsbLcbRjRsmbRhbLgbLcLsmbLobLibLgbRs
RsmbLibRsbLgbRjRsmbLjLsRsmbLcRsbRgLsbLgLsLsmbLgbLsbLgbLibRsbLibRsbLsbL
gbRgbLgbLsbLsLsmbLsbLibRsbLibLsbLgLsbLgbLsbLgbLsbRsbLgbLibRjbLibLibRcb
LhLsbRsbLibLgbLgbRsbLsbLibRoLsbLhbLgLsbRsLsbLibRcbLcbRjbLobLgLsbLgbLib
LgbRibLiLsbLsRsLsbLibLibRsbLgLsbRgLsbLgLsRsLsbLgLsbLgbRgRsmbLibRsLsbLi
bRsbLgLsbLgbRgbLibLsRgbLgbRjbRibLcbLibLsbLsbRgbLgbLgbRjbRgbLobRgbLsbLh
bRjbRobLibLibRjLebRsbRhLsLsLimbRiRsmbLcbRcbRhbLjbRebRobLhbRiLsbLiRsbLi
bRsbLgbLgbRgbLiLsbRsbLsbLhbRibsbRgbRibLobRgbLibRgbLgLsbRsRgbLibLsbLibR
sbLibLsbLgLsbLgbLgbRgLsbLgbLsRsbRsbLjbRobLjbLibLcbRibLgbLiLsbRcLsbRebL
sbLgbLibLiLsbLsbLgbLjbRsbLsbLiRsRsmbRsbLjbLhbLsbLibLibLibRjbLibRjbLcbR
ibLjbRsbLibLibLgLsbLgbRsbLiLsbRsLsbLgbLibRgLsbLgbLsLsmbLgbLgbRgbLiRsLs
bLgbLjbRgbRgbRibLjbLhbLsLsmbRibLcbLibRgLsbRgbLjbLibRjbLhbRjbLcLsmbRibR
gbRibLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 21; Drug: NDMC 10 µM
bLobLibRjbLibLgbLsLsmbLgbLsbLibRjbRcbRcRsmbLjbRsbRhbRgbRibLgbRibLsbRib
LjbLoLsmbRcbLcbRcbRcbRobLcbLcbRgbLibRibLcbRebLobLhbLcbRhbLsRsbLibRoRsm
bRobLgbLsbRcbRcbRibLhbLgbRsbLiRsbRcbRibRibRibRibLgbLjbLibRcbLoLsmbRsbL
iRsbRcbRobLibLibLebRsbLiRsLsbRobRcbLibRcbLsbRhbRcbLsbRiRsmbRsLsRsbRiRs
mbRsbRgbRibLgRsbRiRsmbRsbRgbRgRsmbRgRsmbLsbRibRsbRibRibLgbRibRgbLsbRib
RsbRsbRibRgbLsbRibRsRsmbRhLsbLhbRebRobRjbRcbLhbRibLjRsbLobRibLcbRcbLhb
LibRibLibRjbLibLcbReRsmbLobRcbLjbLoRsbRcRsLsmbRcbRobLibLsbRibLjbRhbLcb
LcbRiRsmbLcbRebLebLgbsbRjbsbLibRcbLgbLibRcbsbRobRoRsmbRjbReRsmbLjbRcbL
gbLjbLobLcbRibLsbLobRcbRibRibRsbRgbRsbRgbRibRibLgbLobLobLibLgbRcbRibLj
LjbRcbLebLoLsmbRibRoRsmbLibLsbsbRibRibLsbRibRibLgbLsLhbLibLsbLgbRsbRob
RcbLcRsbRjbRobLebRcbLcbLhbRhbLibRobLjbLhLsbRcbRobRobLsbsbRibLcbLcbRibR
ebReLsRsbLcbLcLsmbLebsbLsbRgbRsbRibLobLiLsbRibLcLsmbLgbRiLsbRsbLcLsmbR
sbsbsbLcbRibRgbRgbLgbRcbsbRibRcRsmbLebRcbLsbRsbRsbLibLsbLjbLgbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 22; Drug: NDMC 10 µM
bRibRgbRgbRebRgRsmbRibRgbRsRsmbRgRiRsmbRgRsmbLsbRgRsmbRgbRgbRsbRiLsbLj
bLhbRjbRgbRgRsmbRgRiRsLsmbRsbRsbLgbLsRsbRibRgbRgbRgbReRgbRgbRsbRgbRsbR
ibRgRsRgmbsbRgbRgbRgRsmbRgRsmbRgbRsRsmbRibRgbsbLsbLjbLcbLcLsmbRcbLsbLc
RgbLgbLibLsbLiLsbLgbRjbLibLiLsbRsbLiLsRsbRgbLibLsbLgLsbRcbsbLhbLobRebL
cbRgbLhLsbRgbLiLsbLgbLgbRjbLibLhbRibLibLgLsLsmbLgbLiLsbLiLsbRsbLibLibR
jbLhbRsbLgbRsRsmbLibLgbLsLsmbLgbLobRcbLibLiLsLsmbLgbLgbLgLsbLsbLiRgbLg
LsLsmbLgLsRsbLgLsbLibLgbLgLsbLgbLgbLgbRsRsmbLsLsmbLgbRgbLgbLsLsLsmmbLg
LsbLibLhLsbLcbLgbRiRsmbRhbLhbRcRsmbLiRsbRcbLjRsbLjLsmbLcbRjbLibLibRibL
hbRgbRsLibLgbLsLibRsbLibLgbsbLiLsbsbRsbLibLiLsRsbLgbRsbLibLibRhbRobLiL
sbRibRgbRgbRsRsRsmmbRjbRsRsmbRsLsbRgbRsbLsbRgRsmbLsbRsbsbRibRgbRsRsmbR
gbLsRsbRgbRgRsmbRsbRgRsmbRsbRgRsmbsbRgbRgbRibLgbRgRsmbRgbLsbRgRsRsmmbR
gbLsbRgbRgRsmbRgbRsbRgbRgbRgbRgbRgbRgbRgbLsRgRsmbRgRsmbRiRsmbRgRsmbRgR
smbRsbRgLsbLgbLhbLhbRjbLiLsbRebRiRsmbLjLsmbLcbRgbLjbLgbRibRcbLgbLibLhb
RjbsbLsbLibLiLsbRgbLibLibLgbRgbLibRjbLibRjbLibRjbLsLibLsLsmbRsbLgLsbLg
LsLsmbRgbsbLgbLibLgbLgbLgLsbRgRsmbRjRsmbRcLsbRiRsLsmbRiRsRsRsmmmbLgbLo
bLhbLibRgbRjbLiLsbLgbsbRsbLgbLgbRsLsbLibLsLsmbLgbLsbLiRsbRsbLiLsbLsbsb
LsbRsbLsbRcbLcbRobRsLibLsbRcbRhbLjbRiRsmbRibRsbRgRsmbRibsbRsbRibRsRsmb
RsbRiLsbRgbRjbRgbRsbRsRsRsmmbRgbLjbRibLgbRibLcbLibLhLsbLgLsbRsbLgRsLsb
RsbsbRjRsLsmbLgbRsLsbRsbRsLibLgLsLsmbRgbLcbRebRsbLobRibLobLobLcbRjRsmb
RibLsbLhbLgbLgbRsbLgbRsbRsbRebLjbLobRiLsbsbLgbRcbRibRibRoRsmbLcbLibRcb
LibRcbRcRsmbRobLibLibRsLsbRibRjbsbRibRsbRibLibLjbLcbRibLibsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 23; Drug: NDMC 10 µM
bsbRibLgRsbLebLhbRcbRhbLebLibLsLsmbLsbLgbLsbLgbRsRsmbLsbLgbLsLsLsLsmmm
bLsLsmbLgLsbLsbLsbLgLsbLsbLgbRjbRjbRibRibLibRibRjbRsbLiRiRsRsRsLsmmmbR
ibRgRsmbLsbRibLgLsbRjbRsLsbRsbRsbRjbRsbRibRsbRsbLsbRsRsmbRsbRgbLsLsmbR
gbRsRsmbRgbRgRsmbsbRsbLibRibRgbRsRsmbRsbLsbLibRsbRhbLgRsLsbRhLsbLibLob
LiRsRsmbRibsbRsbsbLibRsbLibRgbLibRsbLgbRsLsLsmbLibRsbLiRsbRsRsmbLibLgb
LgbLsbLgbLgbRjbLibLsbLgRsbLibRgRsmbLibLcbRcbLgbLsbRcbRiRibLgLiLsbRcbRj
bRibsbLsbRgbRgRsmbRsRgbRsRgbLgbRjbRsbRsbRgbRsLsbLsRsbRsbRebRsbsbRsRsmb
RgbRgLsLsmbRgbRsRsRsmmbRgRsLsmbRgbsbRgbRsbRsRsmbRgbLsRsbRgbRsbRibLjbLc
bLiLsbLgbLibLgbRsbLibRgbLcbLiRgbLgbLgbLgbLsRsbLibRsbLiRsRsmbLgbLsbLiLg
bLgbRsbRjbLhRsbLgbRgbRcRgbLsRsbRgRsmbRgbLcbLibRsbRsbLhbRibLiLsLsmbLsbs
bLsLsmbLsbLsbLgbLsbLgbLgbLgbRsLsbLgbLgLsbLgbLgLsbRgbLibLgbRjbLsbLsbLsL
gbLsbLgbLsbLgbLsbLsbLgbLsbRgbLsbLsbLgbRsbLiLsbRgbLsbLgbLibLsbLgLsbLgbL
gbLgbRsbLgbLsbLgbLgbLsbLgbRgbLgbRcbLibLjbLsbLgLsbLgbLsbLsbLgbRsbLgbLsb
LgLsbLiLsbRsLsbLjbLsbsbLibLgLgbLsLsmbLgLsbLsbLgLsRsbLiRsbRsbRsRsLsLimb
LsbLsRsbLgbRgbLgbLsbRsLgLsbLgLsRsbRsbLiRsbLgbLgLgLsbLsLsmbLgbLsbLgbLgR
sRsmbLgLsbRhbLcbLiLsbRsbLsbRsLsbLsbLsbLsRsbLgbLgLsbLgLsLsLsmmbLgRsbLgb
LsbLsRsbRgbLsRsbLgLsbLjbRsbLsLsmbsbLsLsmbLsbLgLsbLgbLgbLsbLsbLgbRgbLiR
sbLibLsbLgbLibLibLsLsmbRgbLibLgbRsbsbLiLsbLsLsmbLgbRsbsbsbLsLsLsmmbLgb
LsbRgbLcLhLgLsbLsbLcLsRsmbLgbLgLsbLibLgbLgLsbRsbRhbLjbLhbLgbRsbLiLsbLg
RsbLgbRsbLgbLsbRsbLsbLsRsbLgbLgLsbLgbLsbLgbLsLsmbLgbLsbLsLiRsbLgbLgbRs
LsbLibLgbRgbLibRsbLiLsRgbRebLcbLgbLsbLgbLsbLsLsRsLsmbRsbLibRjbLibRsLib
LgLgbLibLgbRgbLgbLgbLgbLsRsbLsbLsRsLsbLsbLgLsbsbLgbLgbLgbLsbLgbRsbLgbL
ibLgbsbLgbRsbRhRibLjbRhbLhbLcbRibLcbLgLgRsbLgbLibRsbLibLsLsmbLsbLgLsbL
hLsbLgbLgbsbsbLsLsLsmmbRsLsRsLsLsmbLgbLgbLsbLgbLgbLgLsRsbLsLsRimbLhLsR
sbLibLibRsbLsbLsLsmbLgbLsLsmbLgbLgbLsLibRgbRjRgbLjbRcLjbLcbRgbLibRsbLi
bLgbRobRibRibRhLsbLibRsbRhbLjbLjbRcbLsbRibRjbRsbsbLsbRgbRgbsbLjbRgRsmb
RsRgbRsbRgLsbRgbLsRsbRgbRgbRgRsmbRgbRsbRgbRsbRsbsbLgbRiLibRibRgRsmbRib
RcbLiRsbRcbRgbLsbRhbLgbRibLgbRhLsbLgbRibRsbRgbRgbRgbLjbRibRgbLgRgRsmbR
gbRiRsmbLgbRcbLhbRibRiRgbLjbRgRsmbRibLsRgbLgbRgbRsRsmbLsbLhRsLsLcRsbRs
bLibsbRibRibLjLhbLgbRgbLsbLiRsbLgbLsbLgbLsbLgbLgRsbRgbLibLsbLgRsbLibRc
bRcbLgbRibRibLgbRiLsbLgLsbRibLgbRibLsbRgbLgbRibRgRsmbRibLgRsbsbRibLsbR
gbRgbRsbLjbRgRsmbRjbRsRsRsRsmmmbLiRsLjbLsbsbLsbLsLgbLsbLsbLsLsmbLgbLgL
sbLsbLgbLgbRsbRsbLgbLsbLsbLsLsmbRgbLgLgbLsbLsbLgbRgbRjLsbLcLsmbLibRhbL
sbLcbLiLsLgLsLgbLgbRjLsbLgbLsbLgbRjbLsLgbLsbLgLsLsmbRsLsbLsbLgbRcbRgRs
mbRsbRgbLgbRibRibLcbLibLgRsbLgbLsbLibRgbsbLjbsbLsbRsRsmbLibRsbLgbLsbLg
LsbLibLgbRgRsRsmmbLibRsbLibsbLsLsmbLgbLsbRsLsbLgLsbLgbLsbLibRsLsbLgbLg
LsbRsbLgLsbLsbLiRsbRgbLgLsbLgRsbLsbLiRsbLsbLgbRhbLcbLsbRsRsmbLibLsbLgL
sbLsbRgRsmbLgLgbLgbRgbLgLsbLgRsbRgbLsLsmbLgLsbRsbRebLsbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 24; Drug: NDMC 10 µM
bRsbLcbRhbLibLibRibLgbLibRjbLcbRsbRsbRjbRgbRgRsmbRsbRgLsbLsbRgRsmbRgbR
sRsmbRgbRgbRgbRgbRsbLsbRsbRgbRgbRgLsbLsbRgbRgbRsbRgbLsbRgbRgbRgRsmbRgR
smbRgbRgbRgLsbRibRiLsbRibRgbsbRgbRgRsmbRgbRgbRsRsmbsbRgRsmbRgbRsbLgRsb
sbLsRsbLsbsbRsRsmbRsbRgbRjbRsbRsbsbRgbRsbRgRsmbRgbRgbRgbRgRsmbLsbRgbRs
bRgLsbRiRsmbRgRsmbLgLsbRgbRgRsRsmmbRgbsbLsbRiRsmbRsbRgRsmbRgbRgbRgbRgb
RsRsmbLsbRibRobRiLsbRgbRibRgRsmbsbRgbLsbRibRjbRsbLsbRsbRsbRsRsmbRgbsbL
sbRgRsRsmmbRgbRsRsmbRgbRgbRgbRgbRgbRgbRsbLgbLsbRgbsbRsbLgbsbLsbLsbLgbL
sbsbRgbRgbRgbRgbRgbRgbRgbRgRsmbLgbRibRgbLgbRibRsbRgRsmbRjbRsRsmbLgRsbR
iRsmbLsRsbRibRgbRgbRgbRsbLsbRiRsmbRgbRibRiLsbRibRgbRsbLhbLiLsbLibRhbRo
LsbLgbRibRgRsmbRgbRsbRgRsRsmmbsbLjbsbRsbLsRsbRsbLjbRsRsmbRibLsbRibRsbR
gRsRsmmbRgbRgbRgRsLsmbRgbRsbRsbRsbLsRsbsbLsbRsbRgbRgbsbRsbRsbRgRsmbLsR
sbRgbRgbRgbLsbRgbRsbLsbLsLsRgRsmmbRsRsmbsbRibLsbLsbLcbRjbLibLibRgbLhbR
ibLobLibRibRgRsmbRsbRoLsbLibRibRibLgbRsbRiRsmbRibLgbRgbLjbRgbRibsbLsbR
ibRgbRgRsmbRgbRsbRgRsRsmmbLgbRgbRgbLsLsmbsbRgbsbsbRsbRsLsbRsbRgbRgbLsb
RgbRgbLgbRgbRsbRgbLsbRgbsbsbLsbsbRjbRsbRsbRgbRsbsbRsbsbRgbRsbRsRsmbRgb
RsbRgbLgbRgbRgRsmbRgbRgbRgbLsbLgbRibRgbLgbRgbRgbLsbRgbRsbRgbRibLsbRgbR
gbLsbRibLsbRibRgbRibLsbRibRsbRsLsbRgbRgbRgbRgbLgbRiRsmbsbsbRsbLsbRgbLs
bsbsbRjbRsbLsbLsbRsbRgRsmbLsRsbRgbRgbRgbRgbRgbLsbRibRsRsmbsbRgbsbsbRsb
LsbRgbRsbRgbRsbRsbRsbRgbRgbRgbLgbRgbLsbsbLgbRgRsmbLjbRcbRebRiRsmbRibRs
bRcbRgbsbLsbRiRsmbRgRsmbLsbLiRsbRibLsLsmbRiLsbLgbsbLsbRoLsbRibRsbLgbRc
bRcRsmbRgbRibRgbLsRsbRibRsbRsbLsbLsbRibsbLsbsbRgLsbRgRsmbRgbLobLibRibL
cbRibRoRsmbRsbRsbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 25; Drug: Control
bLgbLgbLgbLgbLsLsmbLsbLgbRcbRhbLhbRebLobLobRsRsLsmbLibRgbLcbRgbLcRsbRg
bRgbLjbLsRsbLcbRiRibLibLgbLsbLgbLgbLsbLgLsRsLsbLgbLsbsbLjbRjbRjbRcbRcb
RibRibRibRcbLibLgbRjbRibRsbRgbsbsbRgbLsbRsbRgRsmbLsRsbRsbLgbRjbRsbLobL
jLsmbRibRcbLiLcbLcbRibRibRcbLibLcbLhLsLsmbRibLibLsbLsbLibRsbRcRsmbRibL
hbRsbLgbRebLhbLcbLobLjbRgbLjRsbRibLibLsbRjbRiRsmbLgbRhbLibLobLsLibLhbR
ibLibLibLibLiRsbRsbLibRsbLsbLibRsbLsbRsbLjbLibRjbRibRgRsmbRgbLcbLsbLiR
sLsbRsbLgbLsbLgLsbRgbLibRiRsmbLibLsbLibLsbRsbLjbLsLsmbRgLsbRsbRsbsbLib
LgbLsbLsbLgbLsbLgbRsbLibRgbLibLjLsmbLhLsbRcbRcbRhbLjbLiLsbRgbRjRcRsmbL
gbRiRsmbsbsbsbsbsbsbLjbRibRibRibRsbRgbRsRsmbRsbLgbLsbRibLjbRobRcbLibRo
bRibRiLsbRiRsmbRibLibRgbRgbLsbRibLjbLcRsbRjbRcbLsLsLjmbLobRjbRibLibLcL
smbRjbRhbRsbRgbLcbLcbRjbsbLhbLhRsbRgRsmbLgbLsRsbLibRgbRsbLibRsRsmbLsbL
sbRsLsbLgbRsLjbLsbRsbRsbLgLsbLsbLsbRsbLgbRsbLgbRsLsbLibRjbRobRhbLhbLhb
RcRsmbRiLsbLcbRibLcbLsbLibLsbRsLgLsbLsbLgbRjbLibsbRjbsbsbsbLibRhbRcbLj
bLcbRjbLibLjbRsRsLsmbLsbLsLsLsLsmmmbLsLsmbLgbsbLgbLsbLibRgbLibRsbLiRsb
LjbRibLibLibRsbRsbLsbRsbLgbLgRgbsbLhbRibLgbLsbLsbLibLsbLgbLgLsbLsbLsbL
gbLsbLgbRgbLiLsbRibLsLsmbLgbRgbRsbLgbRsLsbLhbsbRgRsRsmmbLibRjRsmbLoRsb
RsRibLibLhbRgbRjbRebLcbLibRgbRgbRgbLjbLobLhbLhbLgbLgRsRgbLibLsbLibRgbL
obLcRsbLgbRibRibRgbLjbLhbLibLibLiLsbRiRsmbRsbRobLsbRoLsLsmbRcbLebRgbRi
bLiLsbRgbLgbRsbRjbRjbLebLcbRcbLibLjbLibRibLcbLcbRibLobLibLibRibLgbLgbR
sLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 26; Drug: Control
bLiRsbLiLsbLiLsbRjbRibRibRsbRsbRgbRsbLhbLibLibRjbLcbRsRjbRcbLgbRcLsbLg
bRobRsbRibLibLhbRsLsbRjbRibLgbRibRgRsmbRsbRgbRibLsbRgbRgbRgbLsbRgbRgbR
sbRsbRgbRgbRsbRgbLsbRiRsmbRsbRgbRgbRgLsbRsbRgbRsbsbRgLsbRgbRsbRgbRsbRg
RsmbRsbRsbRgbLjbRhbRsbRhbLgbRhbRibRsLsbLcbRgbLoRsbLibLsbLobLobLibLibLg
bLgbRgbRgbLgbLgbRsbLgbLgbRsbLgbLgbsbLgbRjbLibLsRsbLsbLgbLgbLibLgbLgbRg
LsbLgbRsbLibLsbLsbLgbLsbLgLsbLgbLsbLgbLibLibLgbLiRsbLibRcbRsbRibLgbRgb
RgRsmbsbLgbRibLsRsbRgbRsbRibLsbRsbRgRsmbLsRsbRgbRgbRsRsmbRsbRsbRibRgbR
gbRsbRsbRgbsbRsbRgbRsbRgbRsRsmbRgbRsRsmbRgbRsbLsbRgbRsbRgbRgbRgbRsbRgb
LsbRsbRgbRgbRsbRgbRgbRsbRgbRgbRgbRsbRgbsbRsRsmbRsbRgbRgRsmbRsbRsbRgbRg
bLsbRgbRgbRgbLsbLebLobRgbLgbLgLsbLsbLhbRsbRsbRgbRgbRsbRgbLsbRibRsbRgRs
mbRgLsbRsbLsbRgbRsbRibLsbRsbRgbRgbRsbRgbRgbRsbRgbRgbLsbRsbRgRsmbRgRsmb
RsbRgbRgbRgbLsRsbRgbLgbLsbRgRsmbRsbRgbRgbRgbRgLsbRsRsmbRsbRgbRsbRgbRgb
RsbRsRsmbRgRsLsmbRgbRibLcbLobRgbRcbRibRgRsmbLgbRjbRsbRgRsmbRgbRgRsmbRg
bRsbRgbRsbRsbRgbRsbRgbRgbRgbLsbsbRsbRgbRgbRsbRsbRjbRsbRsbLjbRibRibRsbR
gbRgbRgbRgbRgbRgbRgbRsbRsbRsLsbRsbRgRsmbRgbRgbRgRsmbRgbRjbRsbRsbRgbsbR
sbRgRsmbLsRsLsbRibLgRsbRgbLsbRiRsmbRsbRgbRgbRgRsmbRgbRgbRgbRgRsLsmbRiR
smbRgbRsbRgbRgbLsbRsbRgbLsRsbRgLsbRsbsbRgbRsbRjbRgLsbRgbRgRsmbRgbRgbLi
bRibRsbLcbRobRsbLobRcbLibRcbRibRgbRgbRsbRgLsbRhLsbLgbRibRgbRgRsmbRgbRs
bRgbRgbRsbRgbRsbRgbRsbRgbRgbRsbRsbRsbRsbRgbRsLsbRsbRgbRsbRgbRsbRibRsbR
gbRgbRgbRgbRgbRgbRgbLsbRgbLebLhbLobLoRsbRsbRhbRibRobRgLsbLibRibLibLsbL
sbLgbLibRibLobLgbLcbRcbRsbRgbRgbRgbLsbRgbLobsbRhbRsbRgbLsbRhRsmbRhbLib
LcbRhbRcbLsbLibRibRsLsbRibRsbRiRsmbRsbRibRsLsbLsbRiLsbRgbRsbRsbRgbRgRs
mbRsbRgbRgbRgbRgbRgbLsbRibRgbRgbRgbRgbRgbLsbRgbRsbRsbRgbRgbRsbRjLsbLob
RjbRibRgLsbRsbRgbRgbLsbRgbRgbRsbRgbRsbRgRgRsmbsbRsbsbRgLsRsbRgbRgRsmbR
gbRsLsbRsbRgbRgbLsbRsbRgRsmbLsbRgbRgbRgbRsbRgbRsRsmbRgRsmbRsbRsbRsRsmb
RsbRibLjbLhbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 27; Drug: Control
bRibLibLibLgbLgbRibLibRgbLgbLgbLsbLsLsLsmmbLsbLsbLgbLsbLgbRsbLibRgbLhb
RgbRoLsbLcRsRgbLibLgbRsbRsRsmbLgbRsbLgbLsbLgbLgbLgLsbLsbLsbLsbLsbLiLsb
LsbLsbLibLsbRsLsbsbsbLgLsbLsLsmbLgbLgbLgLsbLgbLsRsbLgLsbLsbLsbLgbLsbLg
bRsbLgbRsbLgLsbsbRsbLgbLgbLgbRgbLibRgbLibRsbLibRgbLgRsLsbRsbLgbLsbRcbL
cbRcbRgbRiLsbLgbLsbLgbRjbRiLsbLsbRibsbRgbRibLcbLhbLgLsbRibLiLsbLgbLgbL
gbLibLcbLibLibLgbLgbRibRgbLibLibLibRsRsmbLgLsbRgbLgLsbLsbLgbRsbLsbLgRs
LsbLgRsbLgbLsbLgLsbLsLsmbLgbLgLsbLgRsbLsbLgbLgbLsbLgbRgbLibLgbsbLgbLgb
RibRgLsbLibLhbRjbsbLibLsbLsbLgbLgbLgbRsbRibRjbRibRgbRgbRgbRgbRgbLoRsbL
cbRibRibLcRsbLgbLgLsbLibRjbLibLgbLobRsbRgRsmbRsRsmbRsbLsbRibRgRsmbRsbR
jbLsRsbRgbRgbLgbRiRsmbLsbRgbRsbRsbRgbRgbLsbRsbLobRjbLsbRcbLgbRibLjbRib
RjbLsbRsbRibLobRgbRgbRgbRsLsbLgbRibRibRgbLibRibRgbRibRibLsbRibRgbRgbRc
LsbLibLjbLcbRcbRibRgbRgbRsbRgbLsbRgbRgbLjbRgbRgbRgbLgbRgbRjbLsbLgbRhbL
gbLcbLjbRibLjbRgbRhbLjbLibLibRsbLibLibLgLsbLjbRiRsmbRgbRibRibLsbRsbRjb
LgbLibLibRjbRebRibLsRsbRiLsRsbRhbLjLjbLsbLhRsbLcbRjRsmbRcbRgbLgbRgbRgb
RgbRgbLibRgbRsbRgbRsRsLsmbRsbRgbRsbRgbRgbLsbRgRsmbRsbRsLsbRsbRibLcbLib
LcbRibLsbLcRsLsbRsbLibRjbLibLgbRebRibRsbRgbRsbRgbLgbRibLjbLcbLobRgbLib
LjbLhbRgbLhbLgbLsbRcbRjbLgbRibRsbRhbRcbLibLgbLsbLgbLgLsLsmbRebRibLjbRi
bLjbRibLgbRiRsmbRsbRibLsbRibLjbRsbRibLsbRibLsbRgbRsbRgbRsbRjLsbRobLgbs
bLgbRcRsmbLibRibRgbLgRsbRgbRiRsmbLjbRgbRgbRgbLgbRibLsbRgRsmbRgbRgbRgbR
gbLgbRibLgbRgbsbRsbRibRgbRgbRgbLsbRgbLsbRgbLsbRgbRsbRibLgbRgbRibRgbRsb
RgbLgbLgbRibRsbRgbRgRsRsmmbRgRsmbRsRsmbLsbRibLsbRgRsmbRgbRsbRgbLsbLsRs
LsbRgRsmbRsRsmbRgbsbRgRsmbRgbRgbLsbRgbRibLibRiRsmbRsbRgbRgbLsbLcbRjbRi
bRiLsbLsbLjbLcbLibRcbLjLsmbLibLhbRjbRhbRibLcbLcbLhbLibLgbRibLibLgLsbsb
Lsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 28; Drug: Control
bRgbRgbRcRsmbRibRsbRhbRibLibLibLibRgbLsRcbRibRgbRsbRsbRsbRsRibRsbLcbLi
bRjbsbRcLgLsbRibRgbRsbRsRgbLsRgRsmbRgbRsRsmbRgbsbLsbRgbRibLgbRibLsRsRs
LsmbsbRsbRgbRsRsmbRgbLsbRgRsmbRsRsmbRgbRgbRgbRgbRgbRgbRsbRgbLsbRsbRgbR
gbRgbLsbRsRsmbRsbRgLsbLsbRibLgbRgRgRsRgRsmmbRsRsmbRgbLebLcbRjbLhbRcbLc
bLcbRjbLibRgbLcbReRsmbRibRobRgbRgRsmbLsbLibLgbLgbRebRsbRibLgbRiRsmbRsb
LcbLibRjbLsRcbRsbRgRsmbLsLsmbRiLsbRgbRsbLsbRhbRgRsmbLsbRgRsmbLgbRjbRib
RibRibLibRcbRgLsbLsRsbLcbRebRcbLsbLcbLibRiLsbLcbLsbLibLgbLsbLibRsbRgRs
mbLgbLgbLebRibRibRjbLcbLhbRjbRgRsmbRgbRgbRgbRsRsmbLcbLibRjbLhbsbRjbsbR
ibRibRgRsmbRsbRsbRgRsmbRgbRgbRsbRgLsbLsbRgbRgbRgbLgbLjbLcbRsbLhbRhbRcb
RhbRsbLsbLsbRgbLsbRsbRiRsmbRgbRgbLibLgRsbLhLsbRsRsmbLobRsbRibLsbLcLsmb
LhbReRsmbLibRcbRgbRsbRgRsmbLsbRgRgbRgRsRsmmbRsRsmbRgRsmbRgbRgbRgbLgbRc
bRgRsmbLgbLsbRcbRhbLebLgbRhbLsbRhbLsbLibLhbLsbRibRhbRibLsbRgRsmbRgbRsb
RsRsmbRgRsmbRgbRgbRsbRsbRgRsmbRgRsmbLsRsbRgRsmbRsbRgbRsRsmbRgbRgRsRsRs
mmmbRsbRgbLjbLcbRcbRibLcbLhLsbLgbLgbLgbLgbRjbLibRcbRiRsmbLsRsbRgbRsbRg
bLsbRgbRsbRgbRgbRgLsbRsbRgbRgRsRsmmbRsRsmbLsRsbRsbRgbRgbRgRsmbRsRsmbRs
bRgRsmbsbLgbLjbLcbLibRobRsbRsbRgbRgLsbRgbRgbsbLjbLhbRebRcLsbRsbRgbRibR
gRsmbRsbRgbLgbRcbRgbLhbsbRsbRhbRsbLsbRcbRibRgbRibLsbLhbRcbRcbRsbRsRsmb
RiLsRsRsmbRgbLsbRgbRgbRgbRgLsbRsbRgbRgbLsbRgRsmbRgbRsbRgRsmbRgbRgRsmbR
gbRibRgRsmbRgbRgbLiLsbsbLjLcbRjbsbRcbLsbLcbLibRjbRcbRsbRgRsmbRibRsbLsb
RgRsmbRgbRgbRsRsmbRgbRsbRsRgbRgbLcbRibLsbRibLibRibLjbLobRcRsmbRgbLjbLc
bLgbLibRjbLgbRcbRibRgbRcbLgRsbLsbRsbRcbLgbRibRgbRgLsbLgbLsbRjbRibLhbLi
bLibRsbRcbRibLgbRsLsRibRgRsmbRgbLsbRibRsbRsbRsbRgbRsbLcbRebRibRsbRsRsL
smbRgbLsRsbLjbLcbLgbLgbRcbRgbRibRsbRsRsRsmmbRsbRsbRsLsbRgLsbRjbLsbRsRs
mbRsRsmbRgRsmbLcbLibRcbRcRsmbRsbRiRsmbLsbLcbLobRcbRgbRcbRgbRsbRgbsbRsb
RgbRhbRgLsbLhbLsbRcbRsbLjbRcbRcbRgbRibRibRgbRibRgbRgbRgbRgbRsbLsbLsbRi
bRiLsbLibLibLiRjLsbLgLsbLgLsbRebRibLgbRsbRibLgbRgbRsRsmbRgbRsbRgbLsbRg
bRgbRgbRsbRgbRsbLcbLibLgbLgbRgbLibRebRibLsbRsbRgbLgbRgbRsbRsbRgbLsRsbR
sbRgRsRsmmbRsbRgbRgbRgbRsbRsbRgbRgbRgbLsbRibRsRibRgbLgbLsbRjRsmbLcbLcb
RgbReRsmbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 29; Drug: Control
bLsbLgbLsbLibRsbLibRgbLibRsbLibRsbRjRcLsbRibRcRcbRibRibLgbRibRibLiLjbL
ibLsbLgRsLsbLgbLgLsbLgbRsbLibLgbLsbLibLgbRsbLgbLiRibRjbLjbLsLiLsRsbLgb
LgbLsbLiLsbLsbLsbLiLsbLiRsbLgLsbLgbLhbRsbRgbLhRsbRjbLcbRsbLcbRibRibRhb
LjLsmbLcbRsbRhRibsbRibLgbLjbLibRjbRhbRiRibRgLsLibRsbLsbRgLsbLgbLcRsbLh
bLsbRhbLgbLibLiRsbLgbLiRsRibLobLgbLibLsbLibRibRiRsmbRibLcbLhLsbLibRsbL
gbLgbLsbLibLgbRjbLibLsbLgbLgbRebRcbLibLibLgbLgbLsbRsLgRsLsbLibRsbLiLsb
LsbLiRsbLgbLgbRsbLgbLsbLgbLgbLgbLgbLsbLgbLgLsbLgbLgLsbLgLsbLgbRjbRibLc
bLgbLsbLiLsLsmbLgbLgbLgbLsbLgLsbLsLsmbLgbLgbRsbLiRsbRgbLiLsbLgbLgLsRgb
RhbRgbLsRgbLsbRgbRsbRgbLsbRibLsbLobLsRhRsmbLobLsbLibLsbRjbLiLsbLibLgbL
gbLgbLsbLgbLgbRsbLgbLgbLsLsLsmmbLgbRjbRjbLcbLsbLibRjRcbRgbRgbRgbRgbLjb
LoRibRibRibLsRsbRibRiRsmbRsRgbLsbRiRsRgmbRsRgRsRsmmbRsbRiLsbLsbRibLibR
iRsmbsbRhLsbLhbRiRibRgbLcbRjLsbLhbLibRcbRibRsRibLjbRibLjbLcRsbRjbLibRj
bRibRgbRsbRgbRgbRibRgbLsbRibLjbLobLibLibLibLibLgbRibLgbRsbRiRsRsmmbRib
RgRgbRibLibRibRgbRibRcbRhbRibLgbLcRsbRibLiLsbLcbRgbLjbLhbRjbLjbRhbRcbL
sRsbLcbRiRsmbRibLjbRibRsbRobLibLjbRiRgbLcLiRsbLhRjbRibRibRibRgbLgbLibR
hRsmbLcLsmbLiRsbLcbLgbRgbLoLsmbLibLcbRiRsmbRibLgbLibLibLgbLgbLsbLgbLsb
RsbLgbRsLgbLgbRgbLibRsbLibRcbRgbLsRibLjbLhbRsbLiLgLsbRsRsLsmbLgLsbLibR
gbRjLsbRgbRgbLobLibLgbRgbLgbLgbLgbRgRsmbLibRsbLiLsbLgbLgLsbLgbLgbLsLsm
bRsLsbLgbLgLsbLgbLgbLsbLgbRsbLgRsbLgbLgbRsbLgbLgbRgbLjbLgbLgbRgbLgLsbL
gbLiRsbLgbRsbRibLjbLibLgLsbLgbRsbLibLgbLgbLgbLgbRibRjbLhbLgbLsbLiLsbLg
bLgbLgbRsLsbLsLsmbLgbLsbLsbLgLsbLsbLsbLsbLgbLgbLgRsbRsbLibLsbLgbLgbLgb
RgRsmbLgbLgLsbLgLsbLsbLgbLgLsbRgbLgbLgbLgbLsbLibLgbLsbLsbLgLsbLibLgbLs
bLgbLgbLgbLsbLgbLgbLgLsbRsRsmbLgbsbLsbLgbLgbLgbLiRsbRgbLiRsbLgbLgbLibR
ibLibLgbRgbLibLgLsbLgLsbLsbLgbLgLsLsmbLgbLgbRsbLiLsbLiLsbRjbLiLsbLgbLg
bLgbLgbLgbLgbLgbRibLjbLobRgbRgLsbRgbRsLobLiLsbRgbLgRsbLgbLibRgbLiLsbLg
LsbRsLsRjbLcbLiLsbRsbLgbLgbRsbLiRsbRjbLibLibLgbLgLsbRsbLgbLgbLsLsmbLsb
LibLsbLgbRsRsmbLibLgbRsbLhRsbRsbLibLgbLgLsbRjbLibLhRsRsmbLibLcbLibRibR
hbRibLjbRobLjbLibLcbRhbRcbLjbLcRjRsmbLibLibRjbRiRgbRibLjbRcbRcbRcbRibR
ibRibLgbLcbLibLsbLsRjbRibLebLiRsRsmbLgbLibLibLhRsbRhbLebLcbLcbLsbRhbRi
bRibRjRsmbRobRebLibLjLsLsmmbLibRsbsbRhbRcbRhbRibLibLibRibRhbLgbRsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 30; Drug: Control
bRhbLibLibRgbLsbRibRgLsbRibRgbLcbRcbLobRgbLobRgbLgbLibsbLsbLibRsbRjbRi
bRhbLcbRcbLjbRobLsbLgbLibLibLibRgbLgbLiRsRsmbLgbRgbRiRsmbRibLgbLoLsmbs
bLcbLgbLgbLgbRcbRobLhbRibLgLsbLibLgbLsbLsLsmbLgbLgbLsbLgbLibLsLsmbLibL
gbLgLsbLgbRjbLibLgbLsbLsbLibLsbLgbLsbLgbLgbLgbLsbLgLsbRjbRhbLobRjbRhbL
cRsbLcLsmbRsbLgbLibLibRgbLcLsmbRgLsbLhbLibLibRgbLiLsbLsbLiLsbLsLsLsmmb
LgbLsbLsbLsbLsbLgbLgbLsbLgbLgbLgLsbLibLsbLsbLsbLgLsbLsbRsbLgbLsbLibLsb
LsbLgbsbRsbLjbRgbLgbLgbLgbLsbRsbLgbLgbLgLsbLsLgbLsLsmbLgbLgbLsbLgbLsbL
gbLgRsbLgbLgbLgbRsbLgbLsbLibRjbLibLibRhRsRcmbRibRhbRhbLsbRgbRibRibRsbR
gbLgbRibRgbsbLibLgRoLsbLgbRibRgbRgbLibRgbLibRgbLgbLgLsLsmbLsbLgbLsRsbR
jLsLibRsLsbLgbLibLsbLsbLgbLgRsbLsLsmbLgbLsLsmbLgRsbLgbLgbRsbRcbLoLsmbL
sLobRiRsmbLcbRgbRcbRgbRhbRcbRsbRgLsbRibLgbLhRsbRjbLibRsRjbRhbRgLsbRibL
sbRgbRoRsmbLcLsmbRsLsbRsLsbRsbLibRjbRcbLiLsbLobRgbLgbLhRsbLsbLsbLgbLcb
RsbLibRcbRcLsbRibLhLsbsbLsbRibRgbRibRiLsbLibLjbRcbRgbRhbRsbRsbRgLsbRsb
RgbRgbRgRsmbRgbRsbRgbRgbRsbRiLsLgbLsbRgbRgbRgbRsbLsbRibLgbRsbLobLoRsbL
ibRjbLcbRgRsmbLsbRjbRgbRibLcbLgbRsbLgbRsbLibLgbRgbLibLiRsbLsbLsbLgbLgb
LgLsbRsbLgLsbRsbRibLjbLcbRsRsmbLgLsbLgbLgbLgbLgRsbRsLsbLibLgbLsbLgbRgb
LgbLgbLsLsmbLgLsLsmbLgLsbLgbLgLsbLgbLibLsbLsbLsbLgLsbLsbLsbLgLsbLgbLgb
LgbLsbLgLsbRsbRobLibRibRgbRhbRhLsbRibLsbRsbLgbLgbLgLsbLibLgbLsbLsbLsbL
gbLgbLgbLsbRgbRcbLjbLgbLgLsbLgLsbLgbLsbsbLsbLsbLgbLsbLgLsbRsLsbLgbLsbL
sbLgLsbLgbLgbLgLsbLsbLgbLsLsRsmbLgbLgbLgLsbLgLsbLsbLgbLsbLsbLgbRsbLsbL
gLsbLjbLsbLjbLsLsRsmbLsbLsbLgbLgbLsbLsbLgbLsbLgbLgbLgbLgbLsbLgbRsbLibL
hbLobLobLibLibLgLsbLsbRsbLibLsbLgbLgbLgbLsbRsbLibLgLsbLgLsbLgLsbLsbLgb
LgbLgbLsbLgLsbLgbRsbLiLsbLgbLgLsbRsbLiLsbLgbsbLsbLgbLsbLgbLgbLgLsbRgLs
bRjbRobsbLgbRhbsbLibRobRobRgbLgbRgbLibLibLsbLgbsbRgLsbRjbLibLgbRsLsbLs
bLgbRoLsbRibLibRcbRibRsbLgbLcbLiRsbLhbRgbRsLsbLibLgbLsbLgbRsbRsbRsbLib
LibLsbLgbLgbRgbLibLsbLgbLgbRsbLgbLhbRgbRsLsbLgbLibRjbLhbRibRhbRhbRhbRh
bRibLgLsbRibLjLcbRcbLibLhbsbRibLcbRgbLhbRjbLibsbLsbLgbLibLiLsbRsLsbRgb
LsbRibLobRsbLobLgbLgbLgbRsbLibLiLsbRgbLhbRibRibRobLhbLgbsbLgLsbLgLsbLg
bLsbLgbLsRsbLgbLgbLgbLgbLsbRsLsbLsbLgbRjbRgLsbLcbRsbLjbLgbLjbLsbLgbLsb
LsbLibLsRsbLgLsbLsbLgbLsbLgbLsbLgbRgLsbLgbLgLsbLgbLsbLsbLgbLgbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 31; Drug: NDMC 1 µM
bRsbLgbLsLsmbLibRsbLcbRgbRgbRcbLcbRebLjbLibRcRsmbRhbRjbLibLhbRjRsmbRgb
RsbRgbRsbRsbRgbRgbLgbRgRsmbRsbRibLsbRgbRgbRgbRgbRgbLgbRibLsbRgbRsbRgbL
sbLibLcbRgRsmbsbLibLsbLgbLgbLsbRsbRjbRjbRcbLhbRibRgbRsbRgbRsbRibRgbRgb
RgbRgbRsbRgbRgbRgbRgbRgbLibLibRibRibLgbRgbRsRsmbRgRgbRgbRgbLsbRgbRsbRs
bRgRsmbRibRgbRgbLsbLiLsbLsbRibRibRgbLjbRibRgbRgbRsbRgbRgbRibRsbLsbRibR
sbRgbLjRhLsbRibRibLibLiLsbRgbRsbLibLgbRjbRhLsbLcbRcbLjbLibRobLjbLibLib
RhbRibRibRibLgbLhbLiLsbLgRsbLgbLsbLgbRsbLibRsbLsLsmbLgbRgbLhbRgbLibLsb
LgLsbLgbRjbRcbRcbLsLjbRiLsbLebLsbLhLsbRgbLsbLgbLgbRgbLibRebRibLjbLhLsb
LibLibLgbLibRgbLibsbLgbRgbRjbLcbRibRobsbRibRgbsbLiLsbLgbsbLgbRibRibRiR
smbLibLebLibLgbLsbLgbLsbRgbLhLsbRjbRcbLjbLhbRjbRgbLcbLcbLhbLcbRiRsmbsb
RgbLcbRibLobLobLgbLgbLcbLsLsLsmmbLgbRhbRiRsmbRiLsbRibRsbLibRjbLhLsbLib
LgbRibsbRjbRibRibLebRibRibRibRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 32; Drug: NDMC 1 µM
bLhRsbLgbRgbLgbLgbLgLsRsbLsbRgbRjbLibLgbLgbLsbLgbLsbLgbRsbLgbRsRsmbLgb
RgbLgLsbLgbRsLsbLibLgbLsbRsbLgbRcbRcRsmbLgbLgbLibLgbLgbLsbLsbLsLsmbLgb
RsbLgbLgbLgbLgbRsbRsbLibLibRjbRcbRiRsmbLsbLjbLjbLibLsbLhbRibLibLibRsbL
gbLibRgbLgbRsbLgRsbLgbRsLsbLgbRsbLibRgbRcRsmbRibsbLobLibLibLsbLgbLgbRg
bLgbRsRsmbLgbLgLsbRsbLibRgbLibRsbLobRibRgbLjbLiLsbsbLibRgbLibRjbLibRsb
LgbLgbLgbRsRsmbLgbLibLgbLibLsRsbRcbRgbLgbRgbLgbRibLsbRgbLgbRgbsbRgbRgb
LsbRgbLgbRsbRibRgbLsLsmbRgbLsRsbRgbLsRsbLsbRgbRsbRgbRsRsmbRsbRibLsbRgb
RsbRsbRgbRsbRsbRgbLsbRgbRgbRibRsbLibLibRjbLgbLhbLgLsbRibLibRsbLgbRsbLi
bRgbLgbsbLibRjbRcbRibLgbsbRsbLjbRjbLibRjbLiLsbRibRgRsmbLoRsbRibLibLgbR
sRsmbLgbRibLjbLibLibLgbRgbRjbRcbLgLsbRgRsmbRgbRibLcbRibLoLsmbLjbLibsbR
gbRibLhbRjbRcbRcbLibRibRibLcbRhbRgbsbLsbRhRsRsmmbLcbLibLgbLgbLsbRgRsmb
LgbsbRiRsmbRsbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 33; Drug: NDMC 1 µM
bRgbRsbRhbRibLibRcRsmbRhbRibRibLgbLgbLibLgbLgbLgRsRgbLgbLcRsLsbLcbLibL
jbRibRsbRiRsmbLiRsbLsbRhbLgLsbRibLsbRgRsmbLsRsLsbRgbLsbRgbRsbRgbRsbLgb
RiRsRsLsmmbLgbRibLsbRsbRibRsRsmbRgbRsbLsbRgbLsbsbRgbsbRcRsmbRibsbRgbLg
bRgbLibRgbRjbRibLjbRcbRhbRsbLsbLibLgbLgbLgRsbLibLcbRjbLibLibLibLibLgRs
RsmbRsbRsbLsbLibLibRjLsbLibLsbLgLsbLgLsbLgRsbRjbLgbLgbLgbLsbLgbRsbLgRs
bLgbLgbLsbLgLsbRsRsmbLsLsmbLgbLgbLgLsbRsbLgbLgbLgbsbRsbLsbLgbLgbLsLsmb
LsRsbLgbLsbRcbRibRcbsbRgbRgbRgbLcbLcbRgbsbRsbLgRsbRgRsLsLimbLgRsbLgLsb
RgbLgbLgbLgbRsbLgbLsbLgbLgbLsbLgbLgbRgbLibLgRsbRsbRsbLibLgbLgbLsbLsbRs
bRibRgbRsbRibLgbRsRibLgbRibLgbRibLgbsbRgbRcRsmbLgbLsbRibRibLsbRgbRgbRs
RsmbRsbRgbRgbLgbRibLsbRgRsmbLsbRgRsmbRgbRsRsRsmmbLsbRgbLsbRgbRgbRsbRgb
LsbRgRsmbLsbRgRsLsmbLsbRgbRsbRcbLgbRibRjRsmbLibRibRgbRsbLsbRiRsmbRgbRg
bLgbRibLgbRibLgbRibLgLsbsbRhbRiRsmbLsbLibRsbRjRsRsRsmmmbRgbLgbRsRsmbRg
RsRsmmbRgRsmbLgbRibLgbRiRsmbRgbLgbRibLsbRgbRgbRgbRsRsmbRsRsmbRgbRsRsLs
mbRgbRgbLibLjbRgRsmbLjbsbRibRibRibRibLgbRgbLgbRgbRiRsmbLibRgbRgbRgRsmb
RsbLjbRgRsmbRgbLsbRgbLsbRgbRgbRsbLgbRgbRsbLsRsbRsbRsbRgbLsbRsbRgbRgRsm
bRgbLsRsbRsRsRsmmbRsRsmbRgbRgbRgbRgbRcbRibLibLibLibRgbRgRsmbLibLgbLgbR
cbRhbRjbRsbsbRiRsmbLiRsbRiRsmbLgbLgbRcRsmbRiRsmbRsbsbLsbRibLgbRgRsmbRj
RsmbsbRsRsmbLjbLhbLibLgLsbRhbRjRsmbRgRsmbRjRgbRcbsbLjbLjbRcRsmbLsbLjLj
bLibLibLibRsRsmbLsbRibRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 34; Drug: NDMC 1 µM
bRgbLibRsbLsRsbLgbLgbRjbLgbRsLsbLsLgLsbLsbLsbLgbLsbLgbRsbLgbLsbLgLsbLg
LsbLsRgbLgbLgbLsbLgbLgRsbLgbLsbsbLgLsbLgbRjbRhbLcbRjLsLcbRgbLgbLgbLgbR
gbLgbRsbLibLgbLsbLsbLgbLgLsbRgbLgbRsbLgbRjbLibLsbLsbLgbLgbLsbLsbLsbLsb
LibLgbLsbLgbLgbRsbLgbLgbsbLsbLgbLsbLgbRgbLgbLgbLgRjLsbRibLcbLibLgbLiLs
bRjbRjbRibLgbLcbRsbLhbLgbLsRsLsbRsbLgbLgbLsbLsbRsbLiRsbLgbRgbLsbLgbRsR
smbLgLsbRsbLgbLsbRsbLibLsbLgbLgLsbLgLsbLsbLsLsmbLgbLgbLibRjbLgbLgRsLsb
RjbRibRgLsbLibLsLsmbLsbLsbLibLgbLsbLgbLsbLgbLsbLsLsmbLgbLsRsbLiLsbRsbL
gbLsbRgbLgbLgbRgRsmbLgLsbLgbRsbLgbLgbLgbRgbLgbRsbLgbLgbRgbLibLsbLgbLgb
LgbRsbLiLsLsmbLsRsbLgbLsbLgbLgbRgbLgbLsbLgbLgbLsbLgbRsbLgbLgLsbLgbLgbL
gbRibRhbRcbRcbRibLhbLibLgRsbLgbRgbLcbLibLgbLsbRjbRsbLibLiRsbLgLsbRgRsm
bLibLgbLsbLgbLsLsLsmmbLsbLgbRgbLibRjbRiRsmbLcbLibRjbLibRsbLgbLgbRsbLsb
LgbRsLsbLgbRsLsbLibRibLgbLgbRjbLibLgbRsbLgbsbLgbRsLsLgbsbLgbLgbRsbLgRs
bLgbLgbRsbLgbLgbLsbLgbLgLgbRcbRsbRgbLcbRsbLcbRgRsmbLgbLsbRsbRibLjbLiLs
bRcbLcbLgbLibLgbLsbLsbLsbLsLsmbLgbLebRcbLsRsbLiLsbLgbLsbLibRcbRgLsbLcb
LcbRcbRibLhbRobRebRgbRsLsbRsbRibRhbLjbLiRsbLgbRgbLgbLgRsbRsbLgbLibLgbR
sbLsRsbLibLgbRgbLsLgbLsbLiLsbRsbLgbLsbLgbLibLgLsbLibLgbRibLibLibRgbLib
LsLsmbLibLgbRjbLgbLsbLibRsbLgbLiRsbRjbLibLibLgbRsbLsbLgbLsbLgbLgRsbRjb
LgbLgbLgRsbRjbLgLibRsLsbLsLsmbLgbLsbLgbLsbLhbLgbLgbRsbLgbLgbLsbLgbLsbL
gLsbLcRsbRibLgbLgbRsbRjbRibRsbRgRsRsmmbsbRsRsmbLcbLibLgLsbRsbRsbLsbLib
LjbLibRhbRcRsLsmbRgbRgbRsbLcbLobRiRsmbRgbLjbLibRsbLsbLgbLiRsbRcRsmbLib
LgLsbLibRebLsbsbRibRibLjbLhRsRsmbRjbLhbLgLsbLgbLgbRgbLibRgbLhbRibRcbLe
bLibLsbLgbRibLgbLsbLsbLgbLgbLsRsbRsbLgbRsbLsbLsbLibRjbLsbLgbLhRsbRibLi
bLgbLsbLsbRjbLsRjbRgbLcbLsbRjbLgbRibLsbLjbLhbRjbsbLibLsRsbLgbLgbLgbRsb
LsRsbLgbLsbLsbLgbLsbRgbLgbLjbLgbRgbLibRgbLibLgbLgbRibLibLgbLgRsbRhRsmb
LgbRhbRgbRhbLsbRgbRsbRibLgbRgbRcbLhbRgbRhbLgbRibRibLsbRibRhbRibRibLibL
gbRsbLgbLgbLsbLgbLgbLsbRgbLiLsbRsbLgbLgLsbLgbRsbLsbLgbLgbLgbLgLsbLiLsb
LgbLgbRsbLgbLgbLgbLgbLsbLgbLsbLgbLgbLgbRsRsmbLgbLgbRsbLgbLsbLgbLgbLgbR
cbRhbLjLebRsbRhbRsLsbRibLcbRsbRebRgbRgbRgbLibLibLibRgLibLgbLsLsmbLsbLs
bLgbRsbLsbLgbRsbLgbRsbLgbLgbLgbLsbRsbLgbLsbLgbLgbRgbLgbLgLsbLsbRsbLsbL
gbRsbLibRgbRcbLcbLgbLsbLgbRsbLgbRsLgRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 35; Drug: NDMC 1 µM
bLjbLibRsRsmbRjbRibLibRibRgbRgbRibRsbRgLsbRgbRgRgbRibLsbRsbRgbRgbRgbRi
bRibRgRsmbRsbRibRibRgbRibLibRibRsbLjLsmbLibLibRjbLcbRcbRhbRgbRsbRsbRjb
RibRgbRiLsLsmbLjbRibLsbLcLsmbLibRgbLiRsbLsRsbLsbLibRgbLhbLibRgbRhbLibL
gbLgLsLsmbRsRsmbLibLibLgbLgbLsbLgbRibLiLsbLibRjbRobLjbRcbLgbRibLsbRibL
gbLsbRibRibLjRsbRibRgbLgbRiRsmbRsRsmbRiRsmbRsbRibRgbRgbRibRgbRgbLgbLjL
smbLcbRgRsmbRgbRcbRibLgLsbRibLgbRibLsbRibRgbRgbLcbLcbRhbLcLsmbLhbLgRsb
LgbLcLsmbLibLibRcRsmbRiLsbLsbRsbRsRsmbRgbRibRgbRibLsbRsbRgbRgbLjbRibLc
bLhbRjbRcbRgbRgbLjbRibLcbLobRhbLebLgbLcbRjbRcbLsbRgbRibLgbRhbLgbRibRgb
RibLgbLiLsbLgbLgbLsLgbLgbLsRsbLibRgbLgbLgbLgbLgLsbRibLhbLgbLgbLgLsLsLs
mmbLcLsmbLhbRibRhbRgbRibRgbLibRiRsmbLcbLibLgbRhbRibRibRiRsmbLgbRgRsmbL
sbRgbRibLgbRibRgbRgbRgbRgRsmbLgbRgbRsbRgLsbRgbRgbRgbRgbRgLsbRiRsmbRsbR
sbLjbLiRsbRjbRiRsmbRhbLibRsbLjbRcbRgbRgbLjbLcbLibLgLsbRcRsmbLcbRcbLcbL
ibLhRsbRibRjbRibRibLgbRibLsbRibRsRsmbRgbRsLsbRibLgbRibLhbLibLibRsbLibL
hbLhbLibRgbRibLjbLhbsbRsbLiLsbLsbLgbLsbRsbLibLsbLibLibsbLibRgbLsbLgbLs
bLibLsbLsLibRsbRsbLgbLibLgbRsbLibLibLsbLgbLgbLibLibRibLgbLsbLibLsbLibR
gbLibRibLibLgbRsRsmbLibLgbLibLibRsbRsbRsbLgbRhbRcLsbLhbRibRiRsRsmmbRib
LcbLibLibLgbLhRsbRebRgbLhbLibRsbLibLiRsbLgbLcbLiLsbLibLsbRjbRibRsbLjbL
ebLhbRgbRcbRsbRibRsbRibRibLjbLcbLibRebLibLsbLibLgbRsbRsRjbRsbRgbRibRgR
smbLgbRsbRsbLsRibLjbRibRgbRibRsbLjbRebLgbLgbLibRjbLibLjbRcbRobRibLcbRi
bRibLobRjbRibRsRsmbRgRsmbRsbRgbRgbLsbRiRsmbRgbRsbLgbRibLsRsbRgbRgbLgbR
ibLsbRibRsbLjbRhbLcbRibLhbLibLsbLiLsbRsbLgbLibRsbLibLgbLibLibLibRjbLib
LsbLibLhbRibRibLibLibLibRsRjbLibLsRsbLibLgbLgbLibRibRjbRiRsmbLjbRiLsbR
sbLjbRibLibLebLhbRgbLiRsbLibRgbLgbLgbLgbLibRsbLibLgbLsbRsbRsbLibRsRsmb
LsbLibRsbLgbLibRjbRhbRibRibLibLcbRhbRhbRgbRsbRgbLjbRibLcLsmbLiRgbLgbLi
bLjbLhbRibRgbLsbRjbRhbLcbRjbRibRgLsbLcbLoRsbLsbLiRsbRjbLhbRjbLcbRgbLib
LibLibRiRsmbRsbLibLgbRobLibRsbLgbLibRjbRhbRibLibRhbLjbRibRjbRcLsbRibLc
bRgbLgbLsbLibsbLibRgbLibLgbLgbRibLgbLgLsRsbLgbRjRcbRibLcbRjbLcbLibRjbR
sbRoLsbRibLgbLgbRsbLsbLebLsbLgbLgbLgbRgbRsbLibLgbLibLsbLcbRibRhbLsbLcb
LgbRsbLgbLibLgbLgbLibRsbRgbLsbLgbLgbRjbLibLibLgbRgbLsbLgbLsbLsbLgbLgLs
RsLsbLibLsbLsbLiLsbRsbLibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 36; Drug: NDMC 1 µM
bLebLebLsbLibLhLsbLgbLgbLsbLibLcbRcbRoLsbLcLsmbLibLgbLcbRcbLebLhbLsbLs
LsmbRebLhbRgRsmbRibLibLcbLibRcbRoLsbLcbLibLgbLgbRjbLibRgbLjbRcbRcbLibL
cbRcRsmbRcbsbLebLcbRgbRjbRhbLebLhLsbLiLsbLsbLibRcbRcLsbLgbLjLsmbLcbLob
RcbLiLsbLibLgbLsbLcbRgbRgbRjbRibRgLsbRhbRcbLhbLhbLibLgbLibLcbRcbRcbLjb
RcbRibRgRsmbLebLibRcbRcRsmbLebRcbRibRibLjbRibLebLcbsbRjbLebRsbRjbRcbLc
bLgRsbRsbRjRibLcbLgbLsbLiLsbLsLsmbRgbRobRsbRibLgbRgbRibRiLsbLcbLibLgbR
obLibLcbLibRsRsRsmmbRsbLibRcbRiRsmbRibRibRsLjbRiLsbLobRgbLebLobLjLgLsb
LcLsLsmmbLibRgbLgbRcbRibLjbRebRibsbRgLsbLibLibLobLgbLcbRsLgbLibRibLibL
ibRjbRcbRhRsmbLhbRsLcbLibLsbRsbRibRhbLgbRcbRibRibRibRiLsbRibRibLjbLcRs
bRibsbRcbRibLjbsbLcbsbsbRsLsbLibLibLibRibLcRsbsbRcbLhbLibLcbsbLcbRibRi
bLcLsmbRcbLoLsmbLgbRcbLcbLsbLibLgLsbRgbRsRsmbLibLsbLsbLjbLsbRoLsbRhbsb
LsbRcbRgbRcbRhbRgbLibLgLsbLcLsmbLobRibRebRsLsbRcbRiRsmbLiLsbLhLsbRgbLs
bLsLsmbLobLcbLibRcbRibLgbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 37; Drug: NDMC 3 µM
bRgbRibRgbLibLebLhbRsbLcbRcbRobRgLsRsbLgbLhbRhbLcLsmbLibRibRgbLhbLibRg
bLibLibLibRiRsmbRibRsbRibLjLjbLibLgbLibRsbRibRibLhbLibRgbLibLgbRiLsbRo
bLcLsmbLobLcbsbLhbRiRsmbLebRibLibLcbLebLiLsbRgbLgbRibRibsbLibRhbRgbsbR
ibLjbLhbLhbRhbLcbRiRsmbRiRsmbRcbLibRibLcbLcLsmbLiLsbRibLibLiLsbRcbRgbR
sbRgbLsbLsbLebRjRsmbRobRibLcLsmbLeRsbRjbRibRibRibLgLsbRibRibLibRibRiRs
mbRgbRgbRsbRiRsmbRgRsmbLibRibLcbRcbRhRsmbRibRgbLsbLgbRcbRibLhbLcbRibLc
bRjbLobRiRsmbLcbLibLibLebRibRcbRibLobLcbLsLsmbLhbLsLsmbLsbLgbRibLebLeb
RcRsmbRcbRcRsmbLiLsbRhbRiRsmbRsbRhLsbRibRibLsRgbRsbRsbRgbLeLsbLibRibRc
bRibRgbRibRibLhbLcbRibRgRsmbLibLcbLiLsLsmbRjbRjRjRsmbLcbRibRcbRhbRibLe
bRibRibRgbRibRcRsmbLibLhbRhbRobLibLibRjRsmbRjRsmbRibRiRsmbLiRsbRgbRcbR
gbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 38; Drug: NDMC 3 µM
bsbRgbLsbLgbLgbLibLsbLibLhbRibLibRgbRibRcbLjbRibRibLgbLhRsbLibRsbRjbLi
RsbLgbLsbLsbsbLgbLsbLgbLsbLgLsLsmbLgbRsbLgbsbRjbRibRibRhLsbRhbLgbLcbRi
bRgbLoRgbLhRsbRgbRjbRibRibLcbRjbLobRibRcRsmbRibRibRgbRsbRibRgbRgbRgbRs
bLjbLsLibLiLsLsmbRsbLgLsbsbLibsbLgLsRsbRsbLgbLgLsbRgLsbLgbLibRjbRibRsb
RgbRibLgbRgRsmbLsRsbRgRsmbRsbRsbLsbRgRsmbRgRsmbLsbRgbLsbRibRgbRsbRgRsm
bRibRgLsbRibLibRibRgLsbRgbRiRsmbRibRsRsmbRgbRgbRibRgbRgbRgbRibRgbRsRgR
smbLcbLiLsbRsRsmbLgbLsbRsbsbLibRsbRibRgbLjbLibRjbRibsbRhbLibRiRsmbRgbL
gbRibRibRgbRgbRgbRibRgbLibRgbRgRsmbLjLsmbLibRjbLcbRcRsmbRcbRibRgbRgbRi
bRibRibRgbLgRsbRgbRgbRgbLjbLiLsbLiRsbRcbRibRgbRibRibLibLgbLibLgLsbLsbL
ibRibLibRgbLiLsbRgbLibRsbLiLsbRsbLibRsbLibLgbLiLsbRgRsmbLibLsbLsLsmbRs
LsbLgbLsbLgbRsbRjbLibLgLsbRsbLgbRsbLgbLgLsbLsbLibLsbLgbRsbLgbLsbRsRsmb
LgbLsbLgbLgLsbLsbLsbRsbLgLsbLsLsmbLgbRsLsbLsLsmbLgbLsLsmbLsLsmbLgbRsbL
gbLsbLsbLgbRsLsbLibLsRsbLgbLgbLgbRsRsmbLgbRsbLgLsbRsLsbLsbLsbRsbLibLgL
sbLgbLsbRsbsbLgbLsLsLsmmbLibRsLsbLsbLgLsbLgLsbRsRsmbLgbRsbLibLsLsLsmmb
LgLsbLsbRsRsmbLibLgbLsbLgLsbLgLsRjbLsbLiLsbRsRsmbLibRsLsbLgLsbLgLsbLsb
LgLsbLgLsbLsbLsbLgRsbLgbRsbLgbRgbLibLgbRsbLgbLgLsbRgbLibLgbRjbLgbLsbLg
bRsbLgbLgRsbLgbRgbLiLsbRsbLgbRsRsmbLsbsbLiLsbLsbLgbRsRsmbLgLsbLsLsLsmm
bLgbRsRsmbsbLgbLgbLgbRgbLobLhLsbLgbLiLsbRibRcbRiLsbRsbRibRsRsmbRibLgbL
sbLgbRcRsmbLsbRibsbRgbRsbRibRgbLsLsmbRiRsmbLsbRgbRgLsbRgbLjLsmbRgbRgbR
ibLcbLibRibLibRgbLiRsbLibLgLsbLibLgbRcbRhRsmbLsRhbLiLsbRcbRibRibLibRcb
RibLgbsbRibRibRiRsmbRgbRgbRibRsRsmbLgbRibRgbLgRsbRgbRgbRgLsbLsbLsLsmbR
ibLcbLibLhbLibsbLgbRgbRgbRcRsmbLgRsbRiLsbRibLgbRibRibLiLsbRhbRibRhbRib
RibLibLcbRibRibRcbLsbLgbRibRgbLgbRibLsbRibRsbRgbRiRsmbLjbLobLibRjbLibR
gbLibRgRsmbLgbRsLsbLibRsbRcbRiLsbRgbLsbRgbRgbRgbRgbRgbRsbRgbRsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 39; Drug: NDMC 3 µM
bLibLibLgbLibLcbLibLibLgLsbRsbLgbLsbsbLgbLibLsbLgbLsLsmbRsLgLsbLgbLsbs
bLgbLsbLgbLgbLsbLgbLgbLgbLibLgbLgbLgbLgLsbRgbLjbLibRjbLibRsbLiLsbLsbRs
bLsbLgbLsbLgLsbLsbLgbLiLsLsmbLsbLgbLgbLsbLgbLibRsbLgbLgbLgbLsbLgRsbLgb
RsRsmbLibLgbLgbRsbLgbLgbLgbRsbLgbLibLiLsbRibLiLsbLgbLsbRjbRhbLcbLcbRib
LibLsbLibRsbLgbLibLgbRgbLsbLgbLgbLibLgbLsbLibLgbLgbLsLsmbLgLsbLsbLgbLg
bLgbLgbLsbLgbRgLsbRsbLibLibRibLhbRsbRsbLibRgLsRsbLobRibRsbLibRsbRibLcL
smbLibLibLcbLibLgbRgbLsbLibRsbLibLibRsbLjLcbLcbRibRcLsbRcbLcbRgbRgRsmb
LcbRgbRcbLhbRcbRcLsbRibLgbRcbLibRcLsbLjbRcbRibRibRgbRgbLsbRgbLsbRgbRgL
sRsbRiLsLsmbLiLsbRcbRobRgbLcbRibLibLsLsmbRsbRibLjbLibLgLsbRsLsbLibRgbL
sbRsLgbLgbLgbLgbLgbRsbRgbRgbRsbLjbLsbLibRsbLcbsbRcbRcbRgbLibRsbRgbRibR
gbRgbRgbRhbsbLibLibRcbRgbRibLibLibRibRgbRsbRgbRsbLsbRibLobRsbLobLhbLhR
sbLgbLgLsbLhbRibLibLgbLsRcbRibLhbRcbRgbRibRibLibRibRgRsmbRgbRgbRgRsmbR
sbRgbLsbRsbRgbLsbRibLibLcbLsbLgbLgbLiRsbLibRiRsmbRgbRgbLibLgbRsbLgbRsb
LsbLsbLibLsbLsLsLsmmbLgLsbLsbLsbLgbRsLsbLibLsbLgbLgbRsLgRsbLsLsmbRgbRs
bLgbLgbLsbRsbLgbLgLsbLsbLgLsbLsLsmbRsbLsbLibLgbLgbLgbLsbLgbRsbLibLsbRj
bLibRsbLsbLgbLsbLsbLgLsbLsLsmbLsbRsbLsbLgbRsbRsbLgbLgbLgbLgbLsbLsLsmbL
sbLibLgbLsbLgbRsLsbRsbRsbLibRgbLibLcLsmbRcLsbLsbLibLgLsbRibLibLiLsbLgb
LgbRgbLsbLibRgbLgbRsbLsbLgbLsbRsLibRgbLibLgbLgbRsbRgbRjbRibRgbLsbRgbRj
bLcbLcbRcRsmbRsbRobRcbRgbRgbLgbLgbLibLsbLgbLgbRgRsmbLibRsbRobRsbRgbRgb
RgbRgLsbRsbRsbRgbRgbRgbRgbLsbRgbRsbRsRsmbRgbRsLsbRsbRcbRcbLibRgbLsbLgb
RcbRgbLjLibLibRibLibLgbRsbLgbRsbLsbRsbLibRgLsbLgbLsbLsLsmbLgbLgRgbLgbL
gbLgbRsbLsbLgbLgbLgbsbLgbLgbRsRsmbRcbRibLsLsmbRiLsbLhbRiRsmbRibLcbLsbR
sbLgbLsbLgbLgbLiLcbLoLsmbLibLsbLsbLgbLsLsmbLgbLsbLiLsbLsbRsbsbLibLibRi
bsbLibLgbLsbLgLsbLgbLgbRsbLgbRgRsmbRgbLhbRgbLcbLgLsbLgbRibLibLgLsRsbLg
LsbLsbRgLob

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 40; Drug: NDMC 3 µM
bLsbLhbRsbLibLgbRgLsbLiLsbLgbLgbLgLsbRsbLgLsRsbRsbLgbLsbRgbRebRiLsbLsb
RibRgRsmbRsRsmbRsRsmbRgbRgbRgbRgbLsRsRsmbRsbRgbRsbRgRsmbRgRsmbRsbRgRsL
smbRsRsmbRgbRsbRgRsmbRsRsRgmbRgbRgRsmbRgRsmbRgbRsbRgbRsbRgRsmbLsbRgbRs
RsRsmmbRgbRgRsmbRgbRgRsmbRsRsmbRgbRgRsmbRsbRgbLjbsbRgbRgRsmbLsRsbRgbRs
bRgbLsbRgbRgbRsRsmbRsRsmbRgbRsbLsbRgRsmbRsbRsbRgbRsRsmbRgbLsbRibRhbRgb
RgLsbRjbRibRibLjRsbRgbRsbRsRgbRgbLgbRiLsbRgRsmbRibRsbRgbRgbRsbLcbLibRg
bLiLsbRjbsbLgbLgbLgbLibRibLiRsbLibRjbLgbRsLsbLsLgLsLsmbRsbLgLsbLgLsbLg
bRsbLsbLgLsbRsLsbLgbLgbLgbLhbLhbLibRiRsmbLcbRebRcbLcbLoRsbLiLsbLsbLibL
ibRgbLcbRiLsbLhbRgbLibLsbLgbRgbLhbRgbRibRhbLgbRgbRibRhRsLimbLibRjbRcbR
gbRgRsmbRgRgRsmbRgbLsbRsRsmbRgbRgLsbLgbsbRgbRgbRsbRgbLjbLhbLiRsbLibLib
RgbLibRgbLiRsbLgbRsbLgLsbRsRsmbLgbLsbLgLsbLgbLgLsbLgLsbRsRsmbLiLsbRsbL
sbLgbRsbLgbLgbLsbLsLsRsmbLgbLgbLgbLgLsLsmbLgbLgLsbLsbsbLgLsbRsbLgLsbRs
LsbLgbLgLsbLgbRjbLcbRgbRcbRibRgbLiLsbRiRsmbRibRibLsLsmbRhbLhbRibRgbLsb
RgbLsbRgbRgbRsRsmbRgbRsRsmbRgRsmbRsbRsRsmbRgRsLsLsmmbRgbRjLsbLjbRibLsb
RgRsmbRsbRgbRgbLsbRgbsbLjbLibLibRsbLgbLsRsbLgbLsbLgbLgbRsbLiLsbLgbLsbL
gRsbLgbLgbLgRsbRsRsmbLsbLsLgbLgbLsbLgbLgbRgbLgbLsRsbLgbRsbLibLgLsRsbLg
bLgRsbLsRsbLgbLgLsLsLsmmbLgbLgbLgbLgbLgLsbLgLsbLsLsmbLsbLibRibRgbRgbRg
LsbRgbLibRiRsmbRgbRgbsbRsbRgRsmbRgRsmbRgRsmbRsRsRsmmbRsbRgbRsbRsRsmbRg
LsbRgbRgbRsbRgRsmbRsbRgbLsbRgbRsbRsbRgRsRsmmbRgbRgbRgLsbRgRsmbRsRsmbRs
bRsRsmbRgbRgbRsbRsbLsbRgbRsRsmbRgbLcbLgbLcbRhbLhbRgbLcbLiLsbLgbLiLsLsm
bLsLsmbLgLsbLsbLgbLsbRsbLsRjbRcbRgbRgbRgRsmbRgRsRsmmbRsRsmbLsbRgRsRsmm
bRgbRsRsmbLgbRgbRgRsmbRsLsbRgbRgbRsRsmbRsbRsRsmbRsRsmbRgbRsbRgbRsRsRgm
bRgbRsRsmbRsRsmbRgbRgbRgbRgRsmbRgbRsRsRsmmbLsbRgbRgRsmbRsbRgRsmbRsbRgR
smbRsbLsbRibRgbLsbRgbLcbLibLiRsbLibRjbLibRjbRjbRgRsmbRsbRsbRsLsbRgbLoR
sbRsbRsRsmbRgRsmbRsLsbRgbRgbRgbRgbRgbRgbLcbLibRjbRcbRgbRgRsRsRsRsRsmmm
mmbRgbRsRsmbRsRsmbRgRsmbRsRsmbRgbRsbRgRsmbLgbRgbRibLjbLsRgbRsRsmbRgbRg
bLsRgbRibRgbRgbRgbLgbRgbRgbLsbRgRsmbRgbLsbRsRsmbRgRsmbRgbRsbRsRsmbRsRs
RsmmbRsbRsbRsRsmbRgRsRsmmbLsbRgbRsRsmbLsbRgbRgRsmbRgRsRsmmbRgbRsRsmbRs
bRsbRsbRgbRsbLsbsbRgRsmbRsbRgRsmbRgbRgRsmbRgRsmbRgbRsLsbLsRsbRgRsmbRsb
RgbRsRsmbRsRsmbRsbRsbRgbLsbRgbRgbsbLsRsbRgbRgbRsRsRsmmbRsbRsRsRsmmbRsb
RgbRgbRsRsmbRgRsmbRsbRgbRgbRsbRsbRgRsLsmbRsRsRsLsmmbRsRsmbRgRsmbRsbRsb
LsRgbLjbRsLcbLsbLibRibLcbLcbRgbLhbRgbRcLsbLsRsbRgbRgbLsRsbRgRsmbLsRsLo
bLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 41; Drug: NDMC 3 µM
bLjbLhbLibLsbLgbRgbLhbLibLsbLsbLsRsbLgbRgRsmbLibLgbRsbLgbLgLsbLgLsbRgb
LgLsbLsbRgbLgbLibRsbLibLgbLsbLgbLsLgbLgbLgbLgbRsbLibLgLsbLgbLgbLgbLgbL
gbLsRsbLibLgbLgbLgLsbLgbLgbLgLsLsmbLiRsbLgbLgbRsbLgbLgbLgbLgbLgbLgLsbR
sbLibLgLsbLsbLibLgbLgLsbLgLsbLsbLsLsmbLgLsbLgbLgLsLsmbLgbLgLsbLibLgLsb
LgbLgbLgbLgLsbLgbLsbLgbLgLsbLsbLgbLibLgbLgRsbRgbLgLsbLgbLsbLiLsbLgLsbR
sbLibLgbLgbLgbRsbLgLsbLgRsbLgbLsbLgbLsbLsLsmbLgbLgLsLsmbLgbLgLsbLgbLgb
RjLsbLgbRsbLgbLgbLgbRsLsbLgbLgLsbLsbLibLsbLibLgbLgbLgbLsLsmbLgbLgbLgLs
bLgbLgLsbLgbLgbRsLsbLibLgbLgbLgbLgbLgbLgbLsbLgbLgLsbLgbLgLsbLgbLgLsbLg
bLgbsbLgbLgbLgbLsLsmbLgbLgbLgbLgLsbLsRsbLgbLgbLgbLgbLgbRjbLibLgLsbLgbL
gbLsLsmbLibLgbLgbLgbLgbLsbLiLsbRcbRibRibLgbRibLjbRibRgRsmbRgRsmbLcbLgb
LgbLgbLsbLgLsbLgbLgbLgbRsbLgbLgbRsbLibLibLgbRjbLiLsbRjbLcbLsbLsbLgbLgL
sbRjbLibLsbLiLsbRgbLibLsbLsbLibLsbLibsbLsbLgbLgbLgbRsbLsbLgLsbRgbLiLsb
LsbLgbLgbLsbLgLsbLgbLiRsbLsbLibLsbLgbLsbLsbLgbLgLsbLgbLgbLsbLgbLgbLgbR
gbLgLsbLsbLibLgLsbRsbLgbLgbLgbLsbLgbLgbLgLsLsmbLgLsbRsbLiLsbLsbLgbLgLs
bLgLsbRsbLgLsbLgbRgbLibLsLsmbLgLsbLgbLgbsbRsbLgRsbLsbLibLgbLgbLgbLgbLi
bLsbLibRsbLgbLgLsLsLsmmbLsbLgRsbLsLsmbLsbLiLsbLgbLgbLgbLgLsbLgbRsbLgbL
gbsbLsbLibLsLsmbLgbLgLsbLgbLgbLgbLgbLsbLiRsbRsbLgbLgbLibLgbLgbLiRsbRjb
RcbRsbRgbLcbLcbLsbLibLsbLibRgbLiLsbsbRsLsbLiLsbLsbLibLgbRgbLiLsbRsbLib
LsbLibRsbLgbLgbRsbLgbLsbLgbLgbLgbLsLsmbLiLsbRjbLhbLsbLibLgbLsbLgbLsLsm
bLgLsbRsbLgbLgLsbLsLsmbLgbLsbLgbLsLsmbRgbLibLgbLgbLsbLgbLgLsbLsRsbLgbL
gLsbLsbLgLsbLgbLgbLgbRsbLibLgbLgbLgbRsbLibLsbRsLsbLibRgbLsbLibsbLsbLiL
sbRjbLsRsbLibLgLsLsmbLsbLibLgbRjbRhbLjLsmbLibLibRgbLgbLsbLgbRgbLibLcRs
bLgbLsLsmbLsbRibRebLibLibLibRgbLibRsbLibRsbLibLgbLgbRgbLgLsbLgbLiLsbRi
bLhbRsbLhbLibsbRgbRiRsmbLibLibRsbLiRsbLsbLsLsmbLgbRjbRcbRibLgbLcbLobRs
bRiRsmbRsbRibLgbRibLgLsbRgbRgbRsbLjbRhbLibRibRiLsbLjbRibRgbLjLobRjbLhb
LhLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 42; Drug: NDMC 3 µM
bRsbRsbRgRsmbRgbRgbLgbRgbRsbRgRsmbRgbRgbRibRsbRsbsbRsLsRsRibRsRsRgRsmm
bRsbsbRgbRgbRsbRgbRgRsLsRsRgmbRsbRgbRsRsRsRsRsRsmmmmmbLsbRgbRgbRcLsbsb
LiRsbLgbLgbLsbLgbLsbLgbLjbRsRsmbLjbRsbRibLcbLcbRhRsmbRibRgbRgRsmbRgbRi
bRgbRgbRsbLsbRgbRgRsmbRsbRgbRgbRgbRgRsmbRgbRgRsmbRsbsbRgbRsbLjbLibLgbL
gRsbLjbLsbRgbLsbLsbLgbRgbLgbsbRsbLjbLsbRgLsbLsbLgbLsLsmbLsbLgbLsbRgRsm
bRgbLibLibLsbRibRibRsbsbLobRgbLhbLgRsbRgbLiLsbLibLgbRsbLgLsbRjbRiRsmbR
sbRsbRiRsmbRsbRsRsmbLibLibRebRcbRiRsmbRgbRgbRsbRcbRgbRgbRsbRgbLgRsbLib
RjbLibLcLsLsmmbLgbLgbLibLhbRjbLobRibLgbRibLobLibLgbRibLgbLgbRcbRibLibL
ibRhbRiLsRsbLsRsbRsbRgRsmbLsbRgbLsbRsbRhbLibLsbLgRebLgbRgRsmbRjbLjbLib
LgbLsbRibLsbLjbLjbRgbLgbLgbLgLsbRsbLsbRsbLgbRsbLgbLgbLsbLsbLsbLgbLgbRg
bLsbLgbLsbLgLsbLsbLgbLgbRsbLgbRsLsbLgbLgbLsbLsbLsbLsbLsbLgLsbLgLsbRsbL
gbLsbLsbLsbLgLsbLsbLgbLgRsbLgbLgbLibLgbLgbRsbLibLgbRgRsmbRgbLgbLibLgLs
bLgbLgbLsbLgLsRsbsbLsbLgbLgbLgbsbLsbLsbLgbLsLsmbRsLsbLgbLsbRsbLsbLgbLg
bLsbLsbLgRsbLgbRgbLgbLgbLsRsbLibRgbLgbLgbRsLsbLgbLgbLgbRjRcLsbLibLjbLg
bRjRgRsRsmmbLsbRiLsbLsbLsbRoRsRsLsmmbRibLgbLsbRobRgbLgbLebRibLsRiRsmbR
gRsmbRgRsmbLsbRgbRsLsbLsbsbRsbRsbRgbRgbRsRsmbRsbRjbRsbRgRsmbLsRsbRgbRg
bRsbRsbRibRsbRsbRjbLgbLsbRgbRgLsbRgbRgRsmbRsbRgbRibRibRgbLgbRsbRcbLsbR
jbLsbRsbRcLsbLibRsLsbRcRsmbRibRgLsbRsbLgbLgbRjbRjbRgLsbLjbRibRibLgbRib
LsbRibLgbRgRibRhRiRsmbRibRibRgbsbRiRgbRgRsmbRibRgbRgbRgLsbRjbLcLsmbsbL
sbsbRsbRsbRsbRsLsbLibLsbLcbRiRsmbRgbLgbLjbLgbLgbRebRibRibLhRsbLsbRibRg
bLgbRibRgbsbRgbRgbLsbRgbRsbRsbLsRgbLebRjbLobRgbsbLgbLsbLsbsbRsbLgbLgbR
sbLjbRsLsbLsbLgLsbRsbRhRsmbLgRiRsmbRgbLsLsmbRgbRsRsmbRgbRsbRgbLsRsbRiR
smbRibRsbRgbRgbRgbLsbRgbRiRsmbRsbRsbRsbRsbRgRsmbRsbRgbRsbRsbRsbRsbsbRj
bsbRsbRgbRgbRsbRgbRgRsRsmmbRsbRgRsmbRsbLsLsmbRibLsbRsRsmbRjbLsbRsRsRsm
mbRsRsmbRsbLsRsRsmbRsbRsRsmbsbRsRgbRsbRgbRgbLsbRgbRiLsbRgbLsRsRsRgmbRg
bRgbLgRsbRgbRsbRgRsmbLsRsbRgbRsbRgRsmbRsbRsbRsRsRsmmbRsbRgbRsRsmbRgbLs
RsbRgbRgbRgbRgbRibRsbLgbLcRsbLsbLgbLgLsbRgbRcbRoRibRibRhbLsbLobLcbRjbL
ibLibLibRhbLhbRsbLibLiRsbRgbRgbLcLsmbRjbLibRjbRsRsRsmmbLgbsbLgbLsLsmbR
sbLgbRsLsLsmbLsLsLsmmbLgRsbLsbLsbLsbRsRsLsmbLgbLgbRsbLgbLgbRgbLibLsbLg
bLgbLsbLgbLsbRsbLsbLgRsbRgbLgbRsbLgLsbLgbsbLgbLgbLsbRsbLcbRsLsRsbRsLsb
LgbLgbLjbRsbLgbLibLibLibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 43; Drug: NDMC 10 µM
bLibLibRsbLhbRgbLibRsbLgRsbLgbLgLsbRjbLgbLsLsmbLgbRjbsbLiRsbRsbLgbRsbL
gbLsbLgbLsLsmbLgbLgbLgbLsbLgRsbRgRsmbLgbLsbLibRgbRibLibLobRibRgbRsRsmb
RibLcbRgLsbRsLsbLcRsRsmbRibLgbLsbLgbLgbRsbLsbLgbLgbLsbLgbLgLsbLsbLsbLo
bLsbRibRgbRgbLjbLobRibLgLsbLcRsbRgbRjbRcbLjbLobRgbRhbRgbRsbRgbLsLsmbRg
RsmbLcbRcbRsbRgbRsRsmbRibLsbLgbRhbLgbLsbRgRsmbRsbRgbLgbRcRsmbRhbRibLib
RgbRcbRcbLibLsbRgbRgbRsLhbLgbRhbRgbRgbLcbLgbLgbLhbRgbLibRgbLiLsbLsbLcR
gbRgbLoRsRsRimbLgbLhRsbRibLhbRhbLgbLgbLgbLgbRgbLgbLgbLsbRsbLibRsbLgbLs
bLgbLsbLibLsbLgbLsbLgbLsbLsbLgLsbLsbRgbLibLgbLgbLsbLgbLgbLsLsmbLgLsbLs
bLgbLgbRsRsmbLgbLibRgbLgLsbLgLsbLgbLsbLgLsbLsbLsbLgbLgRsLsbLsbLgLsbLgb
RsbLgbRcbRgbRiRsmbLjbLcbLsbLsbLcLsmbRibLsbLgbLgbLgbLgbRgRsmbLsbLsbLgLs
bLgbRgbLibRgbRibRsbLhbLcbLgbLsRsbLgbRgbRsbLibLibLcRgRsmbLcbRibLibRibLi
bLgbRcbLgbLobRgbRjbLibLgbLgbRgbLgRsbLgbLgbLcbsbRgbRsbLoRsRsmbLcbRsRsmb
RibLgRsbLjbRhbLjbRiRsmbLjLsmbLibLsbLhRsbRgRsmbLgbLgbLibRsbLgbLgbLgbRhb
RcbLcbRcbRcbRgRsmbLibRgbLgbLgbRsbLibLsbLgbLgbLgbLgbLgbLsbLsbLgbRsbRjbL
cbRjbLhbRgbLgbLgbLsbLobRgbLgbLjbLsRcbLjbRcbLgRsbRhbRgbRsbRgbLibsbsbsbL
cbLiRsbLgbRhbLcbRsbRjRsmbRibRcRsmbRobRjRsmbRgbRebLobLcbRsLsbRsbLcLsmbL
hbLgbLgLsbsbsbLibLcLsmbRibRsbRibLjRsbLsbLjLsmbLsbLcbRjRsmbLjLgbLsbsbLs
b

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 44; Drug: NDMC 10 µM
bRsbRibRgLsbLgbLjbLgbLsRsLsbLgbLgbRsbLsbLgbLsbLgbLsbLsbLiRsbRsbLgLsbLs
bLgbLgLsbLsbLsbLsbLgbRsbLgbLgLsbLgbLgbRsbLiLsbRsbLgbRsbLgbLgbLgbLgLsLs
mbLgbLsLsmbLgbRjbLcbLiRsbLgbRcbRsbLsbLjLsmbLgLsbLsbLibLsbLgLsbLgLsbLsb
LgbLgbRsbLsbLgbRsbLgbLsbLibLgbRibLiLsbLgbRsbLgbLsbLgbLgLsbLgbLgbRgbRjb
RsbLjbRgbLibLsbLgbLgbRsbLgbLgbRsbLgLsbLibRgbLibRsbLibLsbLsLsmbLgbLgbLg
LsbLgLsbLsLsmbLgbRsbLsLsmbLsbLiLgbLhbLsbLhbRibRibRobRcbLibLgbRcRsRiRsm
mbRgLsbRsbRgbRgbRsbRsbLsbRgLsbLsbRsbRsbRgbRsbRgbLsbRhbLgbRibLgbRiRsmbR
sRsmbRgbLgbRsbRgbRgbRgbLgbRgbLsbRibsbRgbLgbRgbRgbRgRsmbLjbRibRiRsmbRsL
sbRgbRsbRgbRgbLgbRiRsmbRsbRgbRgbRgRsmbRgbRsbRgbRiLsbRibRgbRsbRhbRiLsbR
gRsmbLsbLiLsbLsbLibRgbLiLsbRgbLibLsRsbLgbLgbLiRsRsmbLsRgbRiRsmbRgbRgLs
bLcbLiLsbRgbLgbLiRsbRjLsbLgbRsRsmbLgLsbLgbLsLgbRsbLgbLsbLsbLgbLgLsbRsb
LsbLgLsbRsRsmbLibLsLsmbLgRsbLsbLgbRsLsbLgbLgbLgbLsbLsbLgbLgLsbLsRsbLgb
RsbLiLsbRsbLsbLibLgbLsLsmbLgbRgbLibLsbLgbRsRsmbLgbLgbLgbRhbRcbRgbRhbLg
bRibLsbRibRgbLgbRgbRibLgLsbRibRsLsbRgbRgbRgbRsLsbRgbLgbLcLsmbLgbRgbLgR
sLsbLibsbRibLibLibRgbLgbLgLsbRgbLgbLsbLibRsRsmbLgbLgbLsbLgLsbLsLsmbLib
LgbLibLibRsbRibLjbLhbLibsbRiRsRsmmbLhbRgbLibRsbLibLgbLsLsmbRsbLgbLgbRs
bLiLsbRsbLiLsbRsbLgLsbRsbLibRsbLsbLibLgLsbLsbLgbRgbRsbRgbRibRgRsmbRcbL
gbLibRgbRcbRgbLsbRibRsbRibLgbRibLgbRgbRgbRgbLsLsmbRgbRgbLsbRsbRiLsRsbL
iLsbLsbLibLgbRgbLibRgRsmbLiRsbRjRsmbLgbRcbRiRsmbsbRgbLsbsbLjbRhbRgbRib
RgLsbRsbRibRgRsmbLgbRibRgbRgbLgbRibLsbRgbRsbRgbRgbRsbRgRibRsRsmbRgbRsb
RgbLsbRgbRsbRgbRgbRgbLsbRsbRgbLsbRgbRgbLsbRhbLcbRibLhbLobRibRibRibLsbL
sbRiRsmbsbLsbRgbRgbRgRsmbLsbRgbRsRsmbRibLsbRgbRsLsbRgbRsRgbLsbRgRsmbLs
bRgbRgLsbRcbRgbRgLsbRgbRibRibLgbRobRibLgbLgbLibsbRjbLiRsRsmbRsbLgbRcbR
iRsmbLsbRhbLibRibRgbRgbRgbLsbRgbRsbRibLjbRiRsmbLsbRibLjbLcbRsbLibLibLs
LsmbLsbLibRgbLgbLcbRibLgbRibRiLsbRgRsmbRgbLsLsmbRiLsbRsbRgbRibRsbLsLsm
bRgbRgbRsbRgLsbRgbRgbRgbRsRsmbRgRsmbRsbRibLjbLjbLhbLsbLgLsbRgbLibLsbLg
bLgbLibRsbRjbRoLsbRsbRsbRiRsLsmbRiRsmbRsbRsbRsRsmbRgbLjbRibRgbLsbRgbLj
bRsbRgbRsLsbRgbRgRsmbRsbRgbRgRsmbRiRsmbRgbRsbRgbLgbRibLsbRgbRgbRgbLjbL
sbRgbRsbRgbRsbRgbRsbRgbRgbRibLgbRibRsbRgRsmbRgbRgbRsbRgbRgbRgbLgbRgbLs
bRiRsRsmmbRgbRsbRgbLgbRiLsbLibLgbLgLsbRgbLgbLgbLgLsbLibLhbRgbRcbLsbRiL
sbRgbLjbLibLiRsbRsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 45; Drug: NDMC 10 µM
bRgRsmbRjLsbRsbLsbRibLjbLcbLibLsRsbLsLcbLhbRcbRibLcbLibRsbRjbLibLgbRsb
LgbRsbLgbLsbLgbLsbLgbRgRsmbRsbLgbLibRsLsbLgLsbLgbRjbLhbLhbRgbRibRgbRgb
LjbLsLjbRiRsmbLjbLgbRsRsmbLsbRsbRsbRsbsbsbsbLsRobLsbRsLsbRgbRsRsmbLsRs
bRgbRsbRgbRgRsLsmbRgRsmbRsbRgbRgbRgbLsbRgbLsbRgbRsbLsbRgbRsbRsRsmbRgbR
gbRgbRgRsmbRgbRsbLsbRibRiLsbRibRcbRhbsbRibRgbRsbRsbRgbRsRsmbLgbRgbRgbR
sbRsbRsRsmbRgbRsbRgbLgRsbLgbRgbRgRsmbRgbLsbRgbRgbRgbLsRsLsbRsbRgbRgLsb
RsbRgbRcbLgbRsbRibLcbLibRgbLgbLgbLgbRsbLibLgbLgbRsbLgbLsbLgbLsbLjbRsbL
gbLibLibLibLgbLsLsmbRsbRgbRgRsmbRgbRsbRjLsbRsbRcbLgRsbLgbRcRsmbRcbRhbR
ibRhbRgbRsbsbLjbRiLsbLsbRibRgbRgbRgLsbRsbLsLsmbRgbRgbRgRsmbLsbRgbRsLsR
sbRgbRsbRsbRjbLibLcbLibRcbRoRsmbRgbLgbRsbLgRsbLibLgbLgbRsRsmbLgLsbLsbL
gbRjRsRsmmbLhbLibRsbRiRsmbLibRsbLgbLgbLsbLgbLgbLsbLgbRsLsbLsbLgbLgbLsb
LgRsbLgbRcbRcbRcbRsbRibLjbRhbLsbRsbRhbLibRcbLgbRcbLsLgbLsbRjbRcbLsLsmb
LgbRgbRibLsbRgbLsRsbRsRsmbRgRsRsmmbRsbRsbRgbRiLsbRgbLjbRgbRgbRibRsbLgb
LibLsbLgbLgbLgbLsbLgbRsbLgbRsbLgLsRsbLgbRgbLcbRhbRsbLiLsbLgbLgbLgbRjbL
ibLhbLgbRgbLgbLgLsbLgbLgLsbLgbLsbLsLsmbLsbLgbRibLgbLgbLibLgbLibRgbRgbR
gbRsbLsbLjbRcbLsRsbLsRsbRgbsbRgbRgbRgbLcbLhRsbLgbLgRsbLsbLsbLsbLibLsbR
gbLgbLgRsbLgbLsbLgRsbLgbLgbLsbLgbLgbLgbLibLgbRhbRjbLcbLhbRcbRcbRcbRcbR
gRsmbLjbLibLgbLgLsbRsbLsbLgbLgbLsLsmbLsbLgbLsLsmbLgbLgLsbLsLsmbLsRsbLs
bRjbLgbLgbRsbLsbRcbRhbLgLsbLgbRibLsbRsbRsbRsRsmbRgbRsbRsbRsbRgbRsbLsbR
gbRsbRgbRgRsmbLsbLsRgRsmbRsbRgbRsbRgbRsbRsbRgbRsbLgbRgbRsRsmbRsbRgbRsb
RgbLsbRsbRgRsmbRsbRgbRgRsmbRgbLsbRobRcbRhbRibRgbRgbsbRgbLgbRsbRgbRgbRg
bLsbRsbLsbsbsbRsbRgbRsbRsbLsbRgbRsbRgbRgbRsbRsRsmbRsbRgbRibRcbRhbRhbRi
bRgRsmbRibLsbLgbLsbRgbRgbRsbRgbRgbRsbRgbLsbRgLsbRsRibLgbRgbLebRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 46; Drug: NDMC 10 µM
bLebLjbLjbLibRibRiRsmbRibRiRsmbRgRsmbRgbRibRgbReRgbRgRsLsmbRgRsmbRsbRi
bRsbRgbRgbRgRsmbLgbRgbLsbRibLhRsbLebRcRsmbLgbLgLsbLgbLhbLsbLibRjbRjRsm
bLsbLjbRibRibRibLjbLhbRjbLsbLhbRsLsbLgRsLsbLibLgbLgLsbLsbLsbLgbRgLsbLg
bLgbLsbLgbLsLsmbLgbLgLsbLsbLgbLsbLgLsbLgLsbLsbRjbsbRcbRgbRgbRgbRgbLcbR
sLsbLibRgbLibLcLsLsLsmmmbRiRsmbRibRibLgRsbRsLsbRcbLgLgbRibRibRgbLibLgb
LibLebLgLsLsmbLgbLgRsbLgLsLsmbLsLsmbLeLsLsmbLgLsRsbLgLsLsmbLgLsbLibLgL
sbLsLsmbLiRsbLgbLgbLgbLgLsbLhbLgbLsRsbLhLsbRjbLibLgLsLsmbRcbLgbRibLgbR
gRsmbLsbRcLsLsmbLibLjbRcbRhRsmbRcbRhbLibRcbLgbRiRsmbRgbLjbRsbLebLibRiR
smbsbLsLcLsmbRgbRsbLsbLiLsbRgbLibLsRsbLsbLgLsbLsLgLsLsmbRsbLiRsbsbRsbL
gLsbLgLsLsmbLsbLiRsbLgLsbLsLibLgRsbLgbLgbLgRsRsmbLgbLsbLgLsLsmbLsbLgbL
gbRjbLjbRhbRibsbRgbRgbRgbLsbLjLsmbRibLibRibLjbRibLhbLcbRhbRcbLjbRcRsmb
LibRibLsbRsbRgbRgRsmbRgbRgbRgbLgbRiRsmbRgRiRsmbRiRsmbLsbRgLsbRgbRgRsmb
RgbRgbRgRgRsmbRgbRibRsbRibLsbRgbRsbRsbRsRsmbRgLsbsbRhbLibLjbRibRgRsmbR
gRsmbRsbRsRgbRgbRgbRgRsmbRgbRgRsRsmmbRsRsmbRgRsmbRgRsmbLsbRgRsmbRgbRgL
sbRsbRsbRgbRgbRsbRibLibLobLcbRhbLcbRebRibLjbRcRsmbLibLgbLsLiLsLiRgbLgb
LgbLgbLgLsbRjbLgbLsbLgbLgLgbLgbLgbLsbLgLsbLgbLgbLgbLgbRjbRjbRcbLgRsbRi
bLgbRgbRsLsbRgbRsbRgbRsRsmbRgbRgbRsbRgRsmbRgbRgbRgbRibRgRsmbRgbRgbRibR
gbRibLibRcbRcbRibRibRgRsmbRibRhbLgbLgbLibLsbLgbLgbLibLhbRsLsbLgbLsbLsb
RsbRibLgLeLsbLhbLjbLibsbRsbLgbLsbLgbLsbRsbLibLsLgbLgLsbRsbRibRcLsbRhbR
ibRhbRiRsmbRgbRcbsbRgbRcbLibRcbLgbRcbRhbRhbRibRsRsmbRhbRsLsbRobLgbLibL
eLsbRibLjbRhbRibRgbRsbRgRsmbRibRgRgRhRsmbRgRibRgRgRsmbRgbRgRsmbRsRsmbR
gRsmbRiRgRgRgRsRsmmbRgRsRgLsmbRibRcbLcbLebRgbLhbRcbRibRgRsmbRhbRcbRcbR
gbRiRsmbRsbRgbRibRgbRgbRgbRgRsmbRgRsmbRgbLsbRgRsRsmmbRibRgbRgRsmbRgbRg
bRgRsmbRgbRgbLgbLsbLcbRebRcRsmbLcLsmbRhRsmbRgbRgbRsbRgbRgbRgRsLsmbRiRs
RsmmbLgRsbRibLgbRiLsbRgRsmbRgbRgbRsRsmbRiRsmbRsbsbRsbRgbRsRsmbRgRsRsmm
bRgbRsbRgRsRgmbRgbRgRsmbRgbRgbLgbLibLsbLcbRhbReRsmbRcbRcLsbRsbsbLjbLjb
LjLsmbLcLsLsmmbLcbsbRjbLibLsbLsLgbLiLsbLsLibLsbLgbRsbRgbLsbRcbRgbLgbLc
bsbLibLgbRibRgbRsbRgbRgbRgbRgbRibLsbRgLjbRibRoLsbLibRgbsbRsbRgbRgRsmbL
sbRgLsbRsbRgbRgRsmbRgRsmbLsbRjRsRsmmbRcRsmbRcbRiRsLsRsmbRibLgbRsLsbsbR
ibLsRsbRgbLsbRgRibRgbRgbRsbLjbLgbLibLcLsRsmbRiRsmbLibRibLsbLsbRhbRgbLe
LsbLcbRhbRobRibRgLsbRcbRgbReRsRsmmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 47; Drug: NDMC 10 µM
bRgRgRgbRgRsmbRgbRgbRgRsmbRgRgRsmbRiRsmbRgbRgbRgbRgRsmbRgRsmbRsbRgbRgL
sbLsbLcbLibRjbLibRsbRjbRhbLjbLhbRhbRcbLcbLcbRhbLcRsbRjbLhbRsbsbLibRjbL
cbRhbRiLsbRgbRgbLsbLcbLibLibRjbLsRibRgbRibRsbRgbRsbRgRiRgbRgbRgRgbRgbR
gRsmbRiRsmbRgbRgbRsbRiRgbRgRsRsRsmmmbRgbLgRsRiRgRsmbRsbRgbRgbLsbRibRsb
RgbRgRsmbRsRgbRgbRgbRgRgbRibRgRsmbRsbRgbRgRsmbRgbLjbRibLjbLcRsbRjbLibR
cbLcbRhbRgbRgRsRiRsmmbRgRsmbRgbLhbLobRjbLcbRibLibLibLsbLibLsRjbLhbLcbR
cbRibLibLibLiRsbLhbRibLebRhbRhbRgbRibLsbRgRsmbRgbRgbRgbRgbRgRsmbRsbRsb
RgbRgbLjRsbRsLjbRibRgbRgbLgbRsbRgbRgbRsbRsbRgbRgbRgRsmbRgbRgRgbRgbRgbR
gbRgbRgbRgbRsbRgbRsbRgbLsLsmbRibLsbRebsbRgbRsRgbRgbRgRsRgRgmbsbRgRsmbR
sbRgRsmbRgbRgRsmbRgbLhbLcbRiRsmbLjbLsLsmbLcLsmbRiLsbRebsbRgbRsbRsbRiRi
RsmbRgbRsRsRimbRgRsmbRgbRgbLjbLhRsbRgbRhbRsbRgbRgbRgbRgRgbRgbRibRibRib
RjbLibLcbLibRiRsmbRibLgLeRsbRjbLgbLgbLjbLiRsbRjbLgRsbLgbRsbLgbRsbLsbLi
bLgLsbRsbLcbRibLjbLjbRcbRcbLsbRibRgbRsRsmbRgbRsbRgRsRgmbRgbRsbRgbRsbRi
bRsbRgbRjbRsRgRgRsmbRgbRgRgRibRgbLjbRsRsmbRsLsbRiLsLgRiRsmbRgbRgbLibRj
bRgbLsRgRgRsRsmmbRiRgbRhbLjbRjbRsbRgbRgbRgbLsbRebLcbLcRsbRjbLcbRibLcbR
cbRobLcRsbRcbLibRjbRsbRgbRgbRgbRgbRiRgbRsbRgbRgRsmbRgRsRsmmbRiRsRsRgmm
bRgbLjRsRsLhmbRebRgbRibsbRgbLsbRgRsmbRgbRibRsbRsbsbRjbRsbRgbLgbRhbLsbR
gRgbRgbRjbRsbLsRsbLsbRgLsRibRgbRgRsmbRjbRoLsbRobRjbRibRgbRgRsmbRgbRgbL
gbRgbRiLsbLgbRgbRibRsbRgbRgRsRgRgRimbRgbRgRsRgmbRgRgbRgRgRsmbRgRgRgbRg
bRsbRgbLibRiRgRgbRiLsbRsbRsRsmbRgRsmbRgbRgRsmbRibLgbRibRsbLjbLcbLebLcb
RibRibLobLgbLjbLibRgbLibLiRsbRgbRjbLibLibLsbLibLhbRgbRcbRibLibRhbLcbRs
RjbLobRgRsmbLgbLgbRsRsmbLiRsbLgbLiRsbLgbLiRjbLibLiRjbLibLgbLibLgbLibLh
bRibRobRibRgRsmbLgRsbRibRgbRgRsmbRgbRgRsmbRgRgRsmbRibRgbRgbRgLsbRgbLhb
LcbLsLsmbRsbLibRcRoLsbLobRjbRobLhbLcbLgbRobRobRibRiRsmbLcbLcbLcbRibRcb
LjbRoLsbLibLibLibLgbRobRhbLcbRcbRibLgbLcbLibRgbRjbLgbLgbLgRsbLibLgbLiR
sbRgbLibLgbRsbLgbLgbLgRjbLibLibLibLibLiRsbRgRsmbLibLibRjbRcRsmbLjbsbLc
bRcbRiRsmbRgbRgRsmbRsbRgbRgRsmbRgbRsbRgbRgbRsbsbsbsbLjLsmbLcbRjbLcbRsb
LibLibRjbRsLsbLibRgbLgbLgRgbLgbLgLsbRsbLgbLgbRgLsbLgRsbLsbLibRgbsbLgbR
hRsmbRiLsbRoLsbLgbLgLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 113734; End: 114234;
Recording: 8-1; Individual: 48; Drug: NDMC 10 µM
bLibLsbLsbLoRsbRjRsmbRcbRiRsmbRibLhbLcbRgbLsbLibRsbLibLsbRsbLgbLgbRsbL
sLsmbLgbLgbLgbRsbRsbRsLsbLibRsbLibLiLcLsmbLcbLiRsbRibLhbRgbLibRsbLgLsb
LgbLibRsLsbLibRsLsbRgbLgLsbLgbLsbLsbLgbRsbLgbLsbLgbLgRsbLgbsbLsbLsbLgL
sLsmbRsbLibLgbLcbLcbLhLsbLhLsbLibRgbLiLsLsmbLsbLgbLgbLgbLsbLgLsbLsLsLs
mmbLgbLgbRjbRcbLibLjbLhbRcbRcbLgLsbLjLsmbLibLsbLgbLgbLsbLsbLiLsRsbLgbL
gbLsbLgbLgbLsbLibRsLsbLibLsbLibLsbLibLibRcbRibLibLcbRhbLibsbLgLsbRsbLi
LsbRsLsbLgbLgLsbLgbLsbLgbRgbLiLsbRsLsbLgbLgLsbLgbLsLsmbRsbLgbRgbLibLcb
RibLsbLibLsbLsbLsbLsbLsbLgbLgbLgLsbLsbLjRsRsmbRebRcbLcbRobLsbLibLibLgb
RsbLibRjbLibRsbLibLsbLsbLibRsbLgbLsRsbLgbRjbLcbLgbRibLgbLsbLibRsbLgbLg
bLgbRsbLgRsbLsbLgRsbLsLgbLgbLsRsRsmbLgbLgbRsbLgLsbLsLsRsmbLgbLgLsbRsbL
gbLgbLsbLgbRgbLiLsbRsbLsRsbLgLsbLsbLgbLgbLibLibLsbRibLibLhbRibLcbRibLi
bRibLjbRsbRsbLsLsmbLibRsbLgbLgbLgbRgbLgbLsLsmbLgLsbLsbLgbLgLsLsLsmmbLs
bLgbRsbLsbLibLsLsmbLgbLsbLiRsbLgbLgbLibLgbRgbLiLsbLsRjbLcbLcbLcbLebLib
LiRsbLcbLibLjLsmbLibRjbLcbLcbLebRcbRcbLibLebRsbRgbRhbLgbRsbLeLsbLcbLgL
sbLibLibLibRhRsmbRcbLsbRiLsbRgbLsbLsRibRibRgRsmbRgbRsbRiLsbLsbRgbLgRsR
ibLsbLcbRsRebRiLsbRibRhbLgbRobReRsmbRhbRoLsbLibRgbLhbLcbRsbLcbLhLsbLhb
LibLibLhRsLsbRgbLiLsbRibLcbLcbRibLsbLgbLoLsmbLcbRiLsbLibLiLsbLgbLibLsL
smbRibRcRsmbRgRsmbLcbLcbLcLsLsmmbLibLhbRgbLiLibRgbLibLsRsRsRsmmbLgbRsb
LgbLgbLgbRsbRsbLibsbLsbLsbLsbLgbLgbRsLsbLgbLgLsbLsbLgLsbLgLsbLgbRgbLiL
sLsmbRgbLsLibLgbRsbRsbLiLsbLsLsmbLgbLgLsbLsLsmbLsLsmbLsbLgbLsbLjbLcRsb
RibLgbLsbLobLsbLcbLebRibRoLsbsbLibLibRsbRsLcbRjbLcbRgbsbLibRgbLiLsbRsb
LgbRsbLsbLiLsbRsbLsbLsbLibLiRsbLsbLcLsmbLibLgLsbLibLgbLgbRgLsbLgbsbLsb
LgbLsbLsLsmbLsLsLsmmbLgbLgLgLsbLsbLsbLsLsmbLgLsbLsbLsbLgbRsbLibLgbLgbL
gbLsbLibsbRibRjbRiLsbRgbRsbRsbRgbLsLgbRcbLibRibLsRsbRibLsbRsbRibRsbRsb
RsbRgbRgRsmbRgLgbRgRsmbRgRsmbRsLsLsmbRibLjbRiLsbLgbRgbLjbLcbLsbLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 1; Drug: Control
bRibLsbLgbRcbLibLsbLsLsmbLgRsbsbLibRcbLsbLcbLsbLsLsmbRhbRjbLhbsbRcbRsb
LhbRsLsbLcLsmbsbRibLsbLsbRsbRibLgbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 2; Drug: Control
bLibLsbRsbLibsbRgbLibRsbLiLsbLgbLibLcbLebLhbLgbLsbLsbLcbLhbLiLsbRsbLib
LsLsmbLibRsbLsbLsbLsbRsLsbLibRsbLibLsbRsbRcLsbRibLibRjbRibLsbLibLibLiL
sbLsbRsbLibLgbRibLsbLibLibRhbRjRsmbLibLiLsbRibLiLsbRhbRibRsbRibLcbLcbL
ibLsbLibRiRsmbRsRsmbRgbLhbRsbRsRsmbRsLsbRsRsmbRebRsRsmbRibRgbLiRsbLcbL
ibRsbRgbRgRsmbRgbRsbLjbRcbLcbLcbRsbLsRsbRjRsmbRhbLcLsmbLibRjbLibLibRib
RgbLibLcbRhbRcRsmbRiRsmbLhbLcbRsbLhbLsbRhbRcRsmbRsbRibLjLsmbRibRgbsbRc
bLcbsbLiLsbRjRsmbRcbRibLjbRobRhbLiLsbLiLsbLeLsbRsLsbRsbRsbRgbLcLsmbLib
RgbsbLibRgbLibRjbRobRibRgbLsbRsbRgbRibLgbRgbLsbRgRsmbRibRcbLhbLibRgLsb
LcbLibLibRsbRgbRibRibLgbRibLjbRgbRgbRgbRsbRsbLgbLcbLibLgbRgRsmbRibLjbL
ibLcbLhbLgLsbRgbRsbRhbRgbLibRiRsmbLcLsmbRjbLibLsbLgbLsbLgbLgbLsbRsbLib
RgbLiLsbRjbRcRsmbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 3; Drug: Control
bRcbLgbLibRgRsmbLcbLobRgbLhbLgbRcbLibLibLibRsbLibRgLsbLibLgbLibLibLsbL
gRsRsmbRgbRcbRgbLibRhbRcbLgbLibRcRsmbRsbLeLsbLibLgbLgbLgbLgbRgbLiLsbRi
LsbLibLibLgbRgbLgbRibRgbLjbLcbLsbsbRgbRsbRibRcbLsLsmbRcbLiLsbRgbRibRib
LibLgbLobLcbRhbRsLsbRgRsmbRobRoLsbRcbLhbLibLcbLobLobRcbRcbRgLsbRibLibL
ibLgbRgbRcbRcbLhbRobLgbLsbLibLibLsLsmbRsbLgbLgbLsbLsbLibLsbRcbRcRsmbLi
LsLsLsmmbLhLsbLcbLcbLhbRjbRhbLjbLhbLiRsbLoLsmbRibRgbLgLsbLibLgbLsbLgbL
gbRgbLibLgbLibRibLsbLiLsLsmbLibLgbLgRsbLsbLsLsmbLgbRgbLgbRsbRjbLgLsbRg
bLgbLgLsbLsbLgbLsbRsbLgLsbRjbLibLgbRgbLhbRsbRsbLgbLgbLibRhbLhbRsbLgbLg
LsbLgbLsLsmbLgbRsLsbLsLsmbLsLsmbLgbLsbLsbLgLsbRsbRsbLgbLibLsLsmbRsbLsb
LgbLsbRgbLgbLgbsbLibLsbLgLsbRgbLibLiRsLsLsmbRsbsbLsbLsbLsbLgbLgbLgbsbR
sbRsbLgbsbLsbLgbLgbLsLsmbLgLsbRjbLiLsbLgbLgbLsbLgbLsbLsbRsbLgLsbRsbLgb
LgbLsLsmbLsLsmbLgbLsbLsbLsbLsbLgbLsbLgbLgLsLsmbRsbRhbRgLsbLhbRobLjbLhb
RsLoRsbLiLsbLiLsbLsbLibLsbLibLgLsbLgLsbRgbRibLgbLcbRibLibLgLsbLiRsRsRs
mmbRibLibLsbLsbLibRsbLgbLsbLsbLsbsbRsbLgbLsbLibLgbRsbLgbLgbLgLsbLgbLsb
LgLsbLsbLgbRgbLibLgbLgbLibRibLibLsbLgbLibLgbLgLsbLgbLgbLibLhbsbLibRsbR
sbLsbRsbLsLcbLiLsbRgbLgbRibLibLsLsmbLgbLsbLsbLgbLgbRgbLibLibsbLsbLsLsm
bLgbLoLsmbLcbRsbRgbRsbRibRsbRgbLgRsbRobLiLsbLibLibLcbLiLsbRgbLsbLibLcb
LsbRsbLibRgbLiLsbLsbLibLhbRgbLgbLgbRsbLgbLsbRsbLgbLsbLsbLjbLoLsmbLsbRc
bLiLsbRsbRcbLgbLcbLibRjRsmbLibLgLsbLsbLgbLiLsbLibRsRsmbRgLsbLsbLgbLsbL
gbLiLsLsmbLgbLgbRsbRibLcbRibLibLgLsbRgbLibRgbLibLibLsbLcbRhbLibLgbLsbL
sbLiLsbRsLsbLiLsLsmbRsLsbRsbLgbLsbLsbLgbRjbLibLsbLgbLgLsbRsLsRsbLsbLsL
smbLsbLgLsbRsbLibLsLsmbRsbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 4; Drug: Control
bRibLhbLcbLibLibLsLsmbsbLhbLibLibLibLiLsbLibLsbLgbLsbLsbLsLsmbLibsbRjR
smbRsbLgbRhbLibsbLjbLsbLjbLcLsmbsbLgbLibLcbRgbLjLsmbsbLgbsbLgbRgbLsbRj
RsRsmmbsbLibLiLsbLhbRgbRsbLhbLsbLibLcLsmbLjLsmbsbLgbLgbLsbsbLjLsmbLeLs
bRhbLhbsbLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 5; Drug: Control
bLibsbRjbLibRjRsmbLibRibLiLsbLibLsbRgbLibRibsbLibRjRsRsmmbRjRgbLjbRhbL
gbLjbRibLsbLjbRibRgbLjbLjbRhbsbRhbsbLsLsmbLibLgbLjLsmbRebReRsmbLibRsbL
jbLibRjbRcbLibRjRsmbRcbsbLhbLsRsbRsbLcbLsbRsRsmbRibRsbRibLgbLgbRibRsbs
bLgbLjbRjbLcbLcRsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 6; Drug: Control
bLjbRjRsmbLjbLjbRgbLhRsbRjbLcbLjRsRsmbRjbRjbsbRcbLjLsmbLjbLsbLsRcbLhbL
jbLjbRibLjbRjbRcbLhbLgbRhbRjRsmbLcbRcbsbRcbRjRsmbLsLsmbLsbRhbLjbLhbsbR
iLcbLcLsmbLsbLsbLgbLgbLjLsmbLsbLibRsbRjbsbLiLsbLiLsLsmbLsbLgbLsbLgbLsb
LsbLjLsmbLsbLibLsbLcbRibLgbLsbsbRjbRjbRjbRsRsmbLhRsbRjRsLsmbLjLsmbRgbL
ibLjLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 7; Drug: NDMC 1 µM
bRsRsmbRibRibLsbRibLibRhbLgbLhbLgLsbLjLsmbRhbRebRjbLcbLcbLcRsbLibRhbLi
bRgbLgbRibLobLibLgbRibLsbLibLoRgRsmbLsRsbRjbRcbLgLsbLcbLcbLibRjbRjRsmb
LibRcRsRsmmbLjbLgbRhbLjLsmbLsbRjbRhbRcbRgbLsbLgbLsbLibLcbLsbRgbLibRcbR
sbLsbRibRiLsbRcRsmbRgRsmbRibLsLsmbLgbLibRgbLibRgbRsbLjbLoLhbRhbLgbLsbR
sbRhLsbLjbRhbLsbLjbRibRibLiRsbRiLsbLsbLsbRibRibRiLsbLsbRgbRibRgRgRsmbR
gbLhbRibRiRsRsmmbRibLjbRsbRsbRgbRgRsmbLobLcbLibRgbRgbRsbRibRgRsmbLsbLs
bRgbRsbRgbLgRsbRgbLsbRibLhbRibRsbLsbRibLjbRjbRibLcbLobRjbLhbLibLcRsRsR
smmbRgbRgbRsbRibRibRgbLgbRhbLjbsbLsRgbRgbLjbRsbRibRhLsbLgRsbLjbRgbRibL
gbRiRsmbLsbRgbRsbRsbRgRsRsmmbRibLgbLjbRibRgbRgbLsLsmbLsLsmbRgbRibLcbLh
bLgLsbRjbLibLhbLgbRjbRibRgbRcbLibRgbRsbRibRibLjbRgbRiLsRsbRgLsbRgbRsbR
sbLsbRgRsLsmbLsbRsbRsbLibRjbLibLgbLgRsRsmbLjLsmbRgbRibLsRsbRibLgLsbRgb
sbRgbRgbRibRsLsbLgbRibRgbLgbRgbRsbRgbRgRsmbRsbRgbRgbRgbLgbRgbRsbLgbRgb
RiRsmbLjbRsbRibRibLibLibRjbRjbLibLsLibLgbLsbLgbLgbLgbLibRjbLgbLibRiLsb
LibRgbLoLsmbRsbRibRiRsmbLjbLibLgbRjbLibRjRsmbRibRgbLjbLcbRibRibRsbRsbR
gbRsbRsbLgbRibRsbRsRsmbRsRsLsmbRsbRgbLibRibLibRibRgLsbRobRgbRsRcLsbLob
LhbLgRsbLibRjRsmbLcbRgbLgLsbLgbLgbLgbLgbLiLsbRgbRsbLibRgbLibRjbLibLgbR
gbLgbRsbLgbLgbRsbRiRsLoRsLsmbRibRcbRibLgbRgbLsbLhbLhbRjbLcbRcbLhbRibLh
bRgbLibLsLsmbLgRsbRsbLibRgRsmbRsbLibLgbLgbLgbLgRsbLsbRgbLiRsbRgbLibRsL
sbLgRsbRgbLgbLgbRibLibRjbLhbLibRgbLgbRgbRibLcbLibRsbLcbLsbLsbLgbLgbRgb
RgbLiLsbLibLgbRgbLibRjbRcbLcbRjbLcbRhbRibRgbRgbRcbLiLsbRibRhbLibLsbRsR
ibLsbRgbRgbLjbRgbRibRsbLgbRibLgLsbRgbRibRgbLhbLsbRcbRcbLibRgbRsbRsbRib
LgbRibRgLsbLgbLsbRibLgbRgbRgbRgLsbLibRibRibLcbLibRjbLgbLibLgbRgLsbLgbR
sbLgbLgbLgbLsbRjbLgbLgbRsbLibRjbRcbRsLsbRgbRgbRgbRgbLgbRgbRgLsbLjbLjbL
ibLibLibRsbRjbLgLsbLgbLgbLgbRgLsRsbLibLsbLiRsbRgbRgbRjbLcbLibRjbLibRcR
smbRobRcbRibLsLsmbLgbLgbLgbLsbLgLsbLsLgbRjbRibRgRsmbRibLibRibRibLibRib
RibRcbLhbRibLsbRgbRgbRhbRgbLjbLcbLibRsLsbLsLiLsbLgbLgLsbLgbLiLsbRgbLib
RsbLgbLgbLgbLgbRsbLgbRgbLibRsRgbLgbLgbLsbLsbLgbLgRsbRjRsmbRibRgbLjbLhL
sbRibLobRjbLcbRgbLibRsbLsbLgbLsbLgLsLsmbRsbLsbLgLsbLibRgbLibLsbRgbLibR
jbLibLgbRibRgbRgbRgbLcbLcRsbRibLibRjbRcbRsLcbLibLgLsbLsbLgLsbLgbRsbLgb
RsRsmbLgbLgbRgLsbLgbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 8; Drug: NDMC 1 µM
bLjLsmbLgbRjRsmbsbRjbLibLgbLgbRjbLgbLhRsbRjbRsbRobRsbRgbRgbRsbLsbLsbRo
bsbRhbRgRsmbsbRgbRsbRiLsbRsLsRsbRgbLgbRcbsbLgbRcbRsbRibLgbsbLgbRcRsmbL
sLsmbRsbRobRsbRsRsmbRcbRibLsbRcbLgLsbLgbLcbRibRsbRcbRcbLgbRsbsbLgLsbLs
bRcbRsRsmbRsRsRsmmbRibLsLsmbsbLgbsbsbLcbLiLsbLsbRsbLibLsbLsbLebLeLebLe
RoRsRsmmbRgbLsbRsRsmbsbsbsbsbRsRsmbRibReRiLoLhLhLsbsbsbsbRgbRcRsmbLhbR
jbRhbLhbRhbRcbRsbRsbLoLsmbsbLsLsmbsbLibLgbLhbLgbLsbLsbLsbLsbLgbsbLsbLg
bLibLgbRsRsmbsbLsbLibLsbRsbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 9; Drug: NDMC 1 µM
bLjbLjbRcbRcbRjbsbRjbRhRsmbLjLsmbRjbRjbLjbRcLsbRcbLjbRebRjRsmbRibRjRsm
bLjLsmbRibLjLsmbLhbRcbsbLjbLjbRibRgbLjbLjLsmbRjRsmbLibsbLgbRgbLjbRcbRh
RsmbRgRsmbsbLjLsmbRjRsmbLjbLsLsmbRjbLjbLcbLobLjbRgbRgbRjRsmbLibRcbLibL
hbRjbRhbRjRsmbLgLsbLhbRjbLibLjbRibLibRjbRcbRcbRibLibRhbLjbLjbLibLjLsmb
LsbRibRibLjbLjbLsbLibRjRsmbRjRsmbRsbRgRsmbRhRsmbRibRsbRibRibsbLgbLsLsm
bsbLibRjbRcLsbRibRjRsmbLgbLsbRibsbRsbRsRsmbsbRibRgbRibRibRgbLgbRhbRibL
sbLsRjbRcbRhbRjRsRsmmbRiRsmbLgbRcbLjbsbsbRibLibLsbRcbRsbRsbRsbRjbLsbRj
RsmbRsbLibLgbLhbRhbLjbRhbRcbRsbRsbRibsbLgbLsbRsbRgbRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 10; Drug: NDMC 1 µM
bLgbRsbLibLsbRsbRsRsmbRgbLsLsmbsbRsbsbsbsbsbLsbLsbRsbRsbsbRsLsbRsLsRsb
RsbRsRsmbsbLsbRsLsLsRsmbsbsbRsbRsbLsRsbRsbRsRsmbsbsbRsLsbRsbRsbLsbLsbR
sbLgbLsLsmbLsbRsbRsLsbsbLhbLsLsmbLsbLgbLebLsbLsbLgbLiLsbLgLsbLgbLgbLhb
LsbRsbRibLgbLsbRgbRsbRsbLsLsmbRsbRgbRebRsbRgbRiRsmbRsbRgbsbLcbRgbsbRcR
smbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 11; Drug: NDMC 1 µM
bRgbRgbLgbLsbRsbRjRsmbRgbRjbLjbLsbLsbLjbRiRsmbLsbLiLsbLgbRsbLjbLiLsbLg
LsbLgbsbLjLsmbLsbRcLsLsmbRjbRjRsmbRsbRibsbLsbRjbRibRgbRibRjbLibLgbLgbL
jbsbLsRsbLjbsbLgbLjLsmbLsbLgbRsbRsRsmbRjRsmbRibRgbLgbRjbLgbRjRsmbRjRsm
bLjbRsbsbRgbRjRsmbRsbsbRsbRhbRibsbsbRjbRgbLgbRibsbRjbRjbRjRsmbLjbLjbLi
bsbLgbRibRcbLsbsbsbRibRhbRjbLjbRsRsmbRjRsmbRjbRiRsmbRsbRibRibRibLibRjb
sbRgbLgbRjbRibLsbsbRsbRcbRsbRcbLgbLjbRjRsmbRsbRibsbRjRsmbRjRsmbLibLibR
hbRjbRibRiLsbRibRgbRhbRjbRsbRjbsbRjRsmbsbsbsbRsRsmbRsbRibsbLgbsbLsbRgb
RhbLgbLiLsbLgbLcbLgbLgLsbRjRsmbRgbsbRjRsmbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 12; Drug: NDMC 1 µM
bRibRiRsmbRsRgbsbsbRiRsmbRibRibLibRjbLcbLjbLibRgbRsbRhbLsbLsbLibLgbRsb
LgbLibLibRgbRjbRibRsbLjbLibRjbLjbLibLibLgbLsbRjbRsRsLimbRjbRsbRobLgbRs
bRiRsmbRgbRgLsbLjbRibLgRsLsbRibRgbRsbLsbLsbRibRsRsmbRsbRgbRgbLsbRgbLsR
sbRjbRsbRhbLjbRcbLcbRjbLjbRcbRibRjbLibRsbLibLcbRhbLjbRibRcbLcbLcbRibLc
bRcbLcbRgbRsbRgRsmbRsbRiLsbLsbLsbRsbRgbLsbRsbRgLsbLsbLjbLcbLcbLobLgbLg
bRsRsmbLibLgbLcbRcbRsbLobRjRsRsmmbLibRhbLiLsbLgbLibLgbRhbRibLhbRcbLjbL
ibRjbLgLsbLgbLsbLgbLsLsmbLgRsLsLsmbLsRsbLsLsLsmmbLgbsbLsLsmbLsbLsbLsbL
sbLsbRsbLgbLgbLgLsRsbRsbLgbLgLsbRsbLgbLgbRgbLibLgbLibLgRsbLsLgRsbLhbLo
bLibRebRibLibLjbRcbRibRgRsmbLsbRsbLsbLsbLjRjbRobRjbRhbLjLsmbLcbRjRsmbs
bLibLgbLgRgbRibRibLibRjbLhbLibRcbLcbLjbLibRsbRsbLsLsLsmmbLsbRsbLsbLgbR
sbRsbLgbRsbRsRsmbRsLgbRgbLgbLiLsbRcbRiRsmbLhbRcbLjbLjbLiRsbRibRgbLgbRg
bRgRsmbLsLsmbLjLibRjbRcbLgRsbLhbLgbLsbRibsbLjbRcbLjLsmbRobLcbLgbRibRiR
smbRgbRgbRgbRgbRgbLgbLsbRjbLsbLibRebLhLsbRjbRcLsbLibRibRjbRjbLgLsbRibL
cbLcRsbRhbLgbLgbRjbLibRebRsbRcbRebRibRgbLsbLiRsbRibRsbRsRsmbRgbRgbRsbR
gbRgbLiLsbRgbRgRsLsRsmbRgLsbRgbRgbRgbRgbRgbRgbRgbRsbRgRsmbRsbRgbRibLob
RcbRiRsmbLsbRsbRgbRsbRgbRgRsmbRgbRsbRgbRgbRgLsbRgbRgbRibLhbRiRsmbsbLgb
RiRsmbRsbRsLsRsbRsbRgbRsbRgbRibRgbLsRibRjRsmbLjLsmbLgLsbRibRiRsmbLsLsm
bRiRsmbRsRsmbRsbRsRsmbRgRsmbRgbRgbRgbRsbRgbRsRsmbRgbRsbRgbRgLsbRibRiRs
mbLibRibLcbRibRgbLjbLgbRhbLcbRcbLibLsbLgbLibRcbRcbRgbLsbRsbRgbLsbRsbRg
bRsbRgbLjLsmbRhbLibLjbRcbRgbRibLsbLibRibRibRsbRsbRsbRgbRgbRgRsmbRsbRgb
sbRgbRsbLsbRsbRsbRsRsmbRsLsbRsbRgbRsRsmbRgbRgbRgRsmbRgLsbRibRgbLcbRibR
iLsbsbRgbRgbsbsbLgLsbRgbRsRsmbLsbRibReb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 13; Drug: NDMC 3 µM
bLgbRjbsbLcbLcbLibsbRsbRgRsmbLcbRjbRjbLcbsbRgbRsRsmbRjbLjLsmbsbRibsbLc
bLjbRgRsmbRebRiRsmbRjbLcbLcLsmbLcLsmbLgbLgLsLsmbLcbLibRibLcbLibLgbLsbL
sRsbLsbRgbRcbRcbRcbLcbRsRsmbLsbLibRjbRcbRibsbsbLsLsLsmmbLcbLibRsRsmbLi
bLsbRsbLgbLjRsbLibLcbLsbLgbLgbLcbRiLsbLcbLsRsbLsLsmbLsbLcbRcbLobRgbLob
RibLiRsbRsLsbLibRsLsbRsLsLsRsmbLoRsbRcbLgbRsbRgbRcbLjbRobRcbRcbRcbLibR
cbsbRgbRsbRgbRhbLgbLgbRcbLibRobRgbLsbLgbRhbLgbRibRgbRsbLsbRsbRsbLcbRcb
LobRhbLhLsbRjbLiLsbLibRgbLgbsbLsbLsLsmbLgbLgbLgRsbRgRsmbLibRgbLgbRjbLs
RcRsmbRgbRcLsbRcbRcbLgRsbLcbRjbLibRjbRcbRcRsmbRsbLsbRsRsmbRibsbLibLgbL
gbLgbRjbRcbRgbRsbRsRsmbRgRsmbRgbRgbRgbRsbRsbRgbLgbLsbRgbRgbLcbLcLsmbRc
bLgbLcLsmbRhbLhbRibLgbLgLsbRsbLgbLgLsbLiRsbLsbRhbLgbLibRgLsbLibLibRjbL
cbRibRjbRcbLibRcRsmbRgbLjLsmbLhbLibLibRibLibRgbRcbRgbRgbRgbRsbLcbLhbRg
bRjbLhbRgbLgbLgbLsbRsRsmbLhbRebRcRsmbLjbLcbRjbLibLgbLiLsbRsLsbRsbLibRs
bLibRjbLibRsbLgbRsbLgbLgbRgLsbLgbLgLsbRgbLgbLsbLsbLiLsbRjbRcbRobLgbRib
LgbRibRibLjbRcRsmbLibRgbRgbLgbRibLgRsbRgbLsbLsbRgbLsbsbLhbRcbRgbRgbLgb
RsbRiRsmbRgbLgbRgbLsbRgbRsbRsbRgbRsbRsbRgbRgbRibLgbRsbLsbRgbLsbRibLsbR
ibLibsbRcbLibLhbRhbRibRgRsRsmmbRgbRgbRgbLgbRibLjbRsbRoLsbLsbLgbRcbLgbR
gLsbLoRsbRibLcbRcbLibLsbLsbLgLsbRsbLgbRcbLhbRcbLjbRoLsbLcbRcbsbLcbRcbL
sbRibLgbRibRgbLsbLgLsbLcbRibRcbLibRsbRibRgbRsbRsbRsbRgbRgbLgLsbRgbRiLs
bLgRsbRgbRsRsmbRgbLhRsbLcbRhbLibRibLobsbRcbLcbLgbRibLobRgbRhbRibLibLcb
LibRcbRobLgbLjbLibLibLsLsmbLsbRsbLibRjbRobLsbLgbRcLsbLgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 14; Drug: NDMC 3 µM
bRgbLgbRjbRcRsmbLebRsRcbRhRsLsmbLobRhbRibLibRiLsbRsbRgbLgbRsbRsbRibRob
RcbRgbLsbRibRsbRibLhbLgbRjbRcbRgbLgbRibLsbLgbRhbLjLsmbLjbLcbRhbRgbRibR
ibRcbLhbRgbRhbRiLsbLsbRgbRhRsmbLsbRgbLsbRjbRsbLibRibRsbLsbLgbRcbLcbLob
LgbRgbLsLsmbLcbRibLcbRibLgbLhbRebLcbLobRgbRsbLsbLsbLsbRhbLcbLibRsbLiRs
bRgbRgbRcbRsbsbRibRgbRibLgRsbLcbLobRhRsmbRobLgbRgbLjbLcbRebLhLsbRjbRcb
LjLjbLiLsbRjbRjbLibLcbRcRsmbLsLobLibRibRcRsmbRsLjbLibLsLibLgbRsRgbRgbR
gRsmbRibLsLsRsmbRgRsmbLgbRibLsbLgbRibRgLsbRsbLgRsbRibLsbLsbRibRsRsmbLs
bRgbLjbLcbRcbLiLsbLgbLsbRgLsbRcbRibLjbRibRsRsmbRibLsbRibsbLgbLiRsbLibL
gLsbRjbLgbLibRibLgbLibLgbRhbLibLibRgbsbRibRibRgbLsbLsbRgbRgRsmbRsbRsbR
gbRgbRgRsmbRsbRsbRsbRsRgbRsbLsRsbRgRsmbRgRsmbRgbLsbRgbLgbRiRsmbLcbLibR
jbLsbLcbRibLgbLibRoRsmbLjbLcbRibRiRsmbRgbsbRgRsmbRsbLhbLiLsRsbRcbLibLc
bRibLiLsbLgbLgbLsbRjbLibLsbLgbLsbLgRsbRsRsLsmbLgLsbLsbLsbLgbLgbLgLsbLg
bsbLgbRsbLsbLsLsmbLsbLgbLsbLsbLgbRgbsbRcbLsLsmbRgbLsbLsRgRsmbRsbRibsbR
iLsbLhbRjbRcRsmbLhbRgbRgRsmbRsbLcbLibRjbRcbLcRsbRjRsmbLibLgLsbLsLgbRsb
LgbRjbLibRsRjbRcbLcbsbsbRgLsbRsbRgbRsRsmbRsRsmbRsbRibLjbRhbLeLsbRjbRib
RsRsmbRsbRgbLgbRiRsmbRsRsmbRgLsbLsbRgbRgRsmbRgLsbLcLsmbRcbRoLsbLgbLsbL
ibRjbRhbLjbLibRcbRibRgbLjbRibLibRiLsbRsbRsbRsRsmbRgRsmbRsbRgLsbRgRsmbR
gRsmbRsbRsRsmbRsRsmbRgbRsbRgbRgbRgbLcRsbRcbRibLjbRibRsRsmbLsbRgbRsbRgb
RsRsmbRgbRsbRgbLsbRgRsmbRsbRgbRgRsmbRgbLjbLcbRjbRibLjbRcbLjbRsbRibLjbL
cLibLsbRjbRhbLcbLoRsRsmbRcbRcLsbLgbRibRcbLgbRgbLsbRsbRgRsmbRsbRgbRsRsm
bRsbRsRsmbRsRsmbRgRsmbRgbRgbRgbLjbRiRsRsmmbRgbRibLibRgbLgbLsbLhbLibRjb
RobLgbRcRsmbLgRsbRgbLgbRgRsmbRgbRsbRgbLsbRgbRgbRibLcbLiLsbLiLsbRjbRhbL
jbRjbLibLhbLgLsbLgbLsbLibLgbRjbRcbRiLsLsmbLsbRsbRgbRibLsRsbRibLjbRiLsb
LgbRibRsbRsbRgRsmbRsbRsLsbRsRsmbRsRsmbRgLsRsbRsbRiRsmbRgbRgRsmbRsRsmbR
gbLsbRgbLsRsbRsRgbRgbRsRsmbRgbRsbRsbRsbRsbRgbLsbRgbRgbLjbLibRcbRibLsbR
ibLhbRibRgRsmbLgbRiRsmbRgbRsbRgbRgbRsbRgbRsbRsbLsbRgRsmbRsRsmbLsbRgbRg
RsmbLsbRgbRgbLsbRgbRgLsbLsbRibLjbLhbLgLsbLgbRcbRibLgbRsbRgbRgbRsbRsbRs
bRsbRgbRsLsbRgbRsRsmbRgRsmbRgRsmbRsbRgbRgbRsLsbRgbRgbLcbLcbRhbRhbLjbRc
RsmbLjbLcRsbLibRibRcbLobRsRjbRsbLjbsbLcbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 15; Drug: NDMC 3 µM
bLsLsmbLgbLgbLsbLsbLgbLjbsbLjbLsbLjbRjRsmbRgbRgbRibRibRsRsmbRsRsmbRjbR
gbRsRsmbRjbRsbRgbRsbRgbRsbLibLgLsbRibRsRsmbLjLsmbLjLsmbRsbRgbRgbRsLsbL
sbLjLsmbLgLsbsbLiLibLgbRgRsmbRjbLibsbLgbRgbRjbLcbRgbRjbLcbLcbLjbLgLsbL
ibLhbLsbLgbLgLsbRibLsbLibRsbLgbRibLsbLgbRgbsbsbLsbLsbLgbRgbLgRsbLsbLgL
sbRsLsbLgbRsRsmbLgbLgbRgbLoLibRiRsmbLgLsbRjbLjbRjbRgbLsbLgbLsbLsLsmbLg
bLgbLgbLgbsbRjbLibLsbRsbRsbLgRsbLsbLibRsbLsbRsbLgLsbLjLsmbRsbLgbRsbRsb
LgbLsbLsbLsbRsbLsbsbsbLgbLgbLgbLsbLibRgbLgbLibRgbLibLiLsbRgbRgRsmbLgbL
ibLsLsLsmmbLsbLgLsbsbLibRibRgbLgbLibLiLsbLgbRgRsmbLsbRjbLgLsbRsLsbLsbL
gLsLsmbLgbLsLsmbLsLsmbLgLsbLsbLgbsbLsbLsbLobRsRibRiRsmbLsbRgLsbLobLgbL
sLsmbLsLsmbLgRsLsLsmbRsbLgbLgbRgbLgbRsbRsbLibRgbRsRsmbLibLsLsmbLsbLsLs
mbLgLsbLgLsbLgbLsbLgbRsLsbLgbRjRsmbLibRjbLiLsLsmbLsbRiRsmbLhbRgbLibRsb
LsbLgbLsbLgRsbLgbLgbLgbLgbRibLibRgLsbLgLsbLgbRgbLgbLgbRjbLgbRjbRcbRibR
ibRgbRgbLjLcbRjbLibRsbRsbLgbLgLsbLgLsbLsbLsbLgbLsLsmbLsbLgbLsLsmbLgLsb
RgbLiLsbLibLgbLgbLsbLsLsmbLsLgbRsLsbLsbLgbLgbLgbRsLsbLsbLgbLsLsLsmmbLg
LsbRsbLibLhbLiLsbLibRgbLgLsbLgbLjbRjbLhbRibLibLgbLsbLgbLgbLgbRibRibRgb
LcLsmbLgbLsbLsbRjbRsbLjLsmbRjbLhbRibLiLsbLgbLsbLgLsbLsbLgLsbLsLsmbLsbL
gbLgbRgbLgbLgbLibLgbRibLgbLgbsbLsbLgbRcRiLsLsmbLcbLibLgLsbRgbLgbLgbLgb
LgbLsbLsbLsLsmbLgbLgbRsbLgbLsbLgbLsbLsbLsbLgbLsLsmbLsbLgbsbLsLsmbLgbLg
LsbLgbsbLgbRgbsbLgbLgbLhbRgbLgbLgbLsRsbLibLgbLgLsbRjbRsLgLsbRgbLgbLgLs
bLsbLsLgRsbLgbRjbLgLsbRsLibLsbRcRsmbRgbRgRsmbRsbRgbRgbsbRibLiLsbLiRsbL
gbLsbRsbLgbLsbLgbLgLsbLsbLgbLgbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 16; Drug: NDMC 3 µM
bLhbLgbLcbRibLibRhbLsbRibLibLjLsmbRhRsmbLgRsbLibsbLiLsbLcRsbRgbRgbLcbL
ibLibLsbLibLsbRibLhbRoLsbLibRgbRhbRgbLsbLsbRgbLgbRhbRcbLcbRibLcbLcbRsb
LcRsbRibRgbRobLhbRgbRcbLibRsbRibLjbRebRhbLhLsbRibLsbLsLsmbLsbRsbRobLgb
RiRsmbRibRibRcbLhbLibRhbLibRgbRcbLgbRobsbRcRsmbsbRibLibRsbRibRibLibLcb
RhRsmbLcbRcbRcbLjbLibLsbRhbRsbRgbRsRsmbRgbLsbRiLsbLhbRcbLjbRibRsLsbRgb
RsbLgbRsbRibRgbLcbRcbRibLibRgbRsbRibLjbRcbLgbLgbRcbLgbRibRjRsmbRsLsbRg
bLjbRhbRhbLibRgbLgbRsbRibLsbRcbLcbLibLhbRjbRibLibLibRsbLgbLibRcbRcbLib
LjbRcbLgbRgbRjbRiRsmbLjbRibLjbLebLibRjbRibLgbRcbLcbLcbRcbLcLsmbRjbLgbL
gbLsbLgbLsLsmbLgbRjbLibRjbLiLsbRjbRcbLibRcbLibRibLsbRibLjbRgbRcbLcbRgb
RebLebLibRcbLjbLhbLibRibRjbRhbLsbLjbRjRsmbRsbRgbRgbRgbLjbRibLjbRcbLibR
gbRgbRsbRgbLjbLjbLhbRhbLibRjbRoLsbLhLsbRjbRsbRibRibLibRgbRibLsbRibRgbR
sbRsbLsbRgbLgLsbLhbRcbRiRsmbLjbRibLcbLibLsRsbRgbLiRsbRgbRebRgbLgbRibLg
LsbRibLgbLsbRhbLibsbsbLsbRibLgbRsbRgbRgbLsbRsbRsbRsbRsbRsbRgbLsbRgbRgb
RsbRsbRgbRgbRgbRgbLjbLcbRjbLibRgbLibRgbLhbRsbRibsbLibLgbRjbLibRsbLibLg
bLsLhRsbReRsmbLgbLibRcbRjLsbRibsbLsbRsbRsbLsLsmbRgRsmbRsbRiRsmbLgbRibR
gRsmbRgbRgbRgbRsbLjbRibLcbLcLsmbRjbLhbRgbLhbRhbLcbRsbLgbLgRsbRsRsmbLsb
LsbLgbLgLsbLsbLsbRsbLgbLgLsbRsbLibRjbRcbLcbLsbLgbLgbRsbLsbRibRhbLgbRjb
LebLibRjbLibLsbLgLsbLgbLsbLhbRjbLhbRgbLibRgbLgbLsRsbLsLsmbLgbLgbLgRsbR
cbLjbLhbRcbRebLsbRibLgbRsbRgbRsbRgbRsbRsRsmbRgbRsbRsbRibLjbLhbLcbRgbLg
bRsbRsbLgbRsLsbRcRsmbLjbLhbLsbLsbLibLhbRgbLibRgbLgbLsbLgbLiLsbRjbLcbRi
bLcRsbRibLibRgRsmbLgbLgbLsbLsbRsbLgbLsbLgbRsbLgRsLsbRsbLgbRsbRjbLibRcb
RibLgLsbRibLsbRgbRsbRsbRsbLsbRgbRgbLgbLjLsmbRibLcbLsbLiLsbLgbRcbLjbRcb
RibLibLhbRhbRcbLhbRgbLhbLcbRibRibRibLjbLcbRibLcbRsbLgbRsbLsbLgbLsRsbLs
bLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 17; Drug: NDMC 3 µM
bRjRsmbsbRjbRibLsLgbRgbRjbLgbRsRsRsmmbsbsbLsbLsRsbLiLsbRhbsbLjLsmbRjRs
mbRcbRibRibRibRgRsmbsbsbRhbReRsmbRgbRsbRibRibRsbRibLjLsmbLibLsbLsbRibL
jLsmbLsbLgLsbLsbLgbLsbLcbLcbLsbLibLsbLcbRibRobRiLsbRhbRibLsbRsbRibRcbL
sLsmbLgLsbLgbRhbRibRiRsmbLsbsbLgbLsLsmbRibLsbRcbRcbLsbRiRsmbRsbRibRhbR
gbLsRsbLsRsbRcRsmbRhbRibRsbRibRsbRcbRgRsRsmmbRgbRsbLsbLgbsbLsLsmbRibRc
LsbsbLibRsbRibRcbRgbLsbRgbRcbRcbRgbLgbLjLsmbRsbRibRcbLjLsmbLhLsbLibLhb
RsRsmbRibRsRsmbRebRibLgbRiRsmbRgRsmbRsbRsbRgbRsbRgbRsbLgLsbRiRsmbRsbRi
RsmbRibRibRsbLsbLcLsmbLcbLeLsbLcLsmbRhbRcbLsbLgbRhbLsRsbRsbRsRsmbLsbsb
RibLsbLjbRibLsbRgRsmbRgbRgbLsbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 18; Drug: NDMC 3 µM
bRsbLsbLjbLibRgbLibLgbRiLsbRsLiLsbRsbLcbLsbsbLibLgbRsbLsbRsbLibRjbRebR
sbRsbRhRsmbRsbLsbRibRibLgbLgbRibRibRgbRjbRsbsbRsbLgLsbRibLsRsbRibRgbRs
LsbLibRibRsbRgbRcbLgLsbRcbsbRhbRsbRjbRhbRgbLsLsmbLsbLsLsmbsbRgbRgbRcbR
iRsmbLsbRgbLjLsmbRhbRgbLgbLsbLibLsbRsLsbLibLgbRibRgbRibLsLsmbRsbLebLcb
LgbRsbLsbLgbLsbLhbRsbLibRgbLsbLiLsbLsbLgbLsLsmbRsRsmbLiLsbRgbLgbLsbRgb
LibRgRsmbLibLsbsbRsbLibLgbLibLsbLgbLsbRgbLsbLibRsLsbRgLsbLcbLibLsbLsbL
gbRsbLgLsbLibLgbLsRsbsbLsbLibLsbLsbRsbLgbLsbLiLsbLsbLsbRsbLgbLsbRsbLsb
LsbLgbLibLsbRgbLjbLsbRibRsbRsbRcRsmbsbLcbRsLsbLgbRgbRsbLcbLsbsbsbLhbLs
bRsRsmbRsbRgbLcbLsbLgbLsbRgbLgLsLsmbLsbLgbRsLhbRsbLsbsbRsbsbLsbLcRsRsm
bLhbLsbRsbLjLsLsmmbLsbLsbRibRcbRjbLsbRsbLsbLjbLsbRhLsbRsRsmbRhbLgLsbLg
bLcbRgRsmbLhbRsbsbRgbLsbLhLsbLcbRsbLibRsRsmbRiRsmbRiRsmbLjbLcbLibLsbRs
RsmbLgbRsbsbLoRsbLsbLgbLsbRsbLsbLibLsbLgLsbLjbLgLsbLsbLsbRsbLsbRgbRgbR
cbRibLsbLsLsLsmmbRibRibRibRgbLsbLsbLjbLjLsmbLsbLcbLgRsbRsbRsbLgbRgbLsb
LgLsbsbsbLsbLsLsmbLsbLsbLgLsbLsbRcbRibRsbsbLsLsmbRhbRgRsmbLibsbRsbRgbR
ibLgbRhbLjbRobsbLsbRsbLsbRiLsbRsLsbRibRsRsmbsbRgbRsbRgLsbLcbLsbLgbsbRh
bsbsbRgbRsbRsbsbLsbRgbLsRsbRibLcRsLsLibRsbRsRsRsmmbLiLsbRjbLjbRsbLsLsm
bLsLsmbLsbLgbRsRsmbLiLsbRjbLibLsbLsbLsbLsbLgLgLsbLiLsLgbLgLsbLsbLgbRsb
LgbRobLcbLcbRiLsbLsLcbRsbRsLsbLsbLsbLgbLgbRsbLgbRjbLgbLsbLgbLsbLibsbLs
bLgRsbLsLsmbLgbLsLsmbLgbRsbLibLibRibLhbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 19; Drug: NDMC 10 µM
bLhbLiRsbsbRcRsmbRgbRhbRgbLsbLcbRhbLobRjbRcbLibLibsbRcbLcbLjbRcbRcbLcb
RjbLjLsmbRhbLcbLcRsLsbLsbRsLsbLjbRcbLibLjbLibLgbLjLsLsmmbRibRjbRcbsbRc
bLobLcbLibRjbLjbRcbRcbRcbRcbLgbRcbLjbLibLhbLsbLobRhbRsbRcbRcbLgbRibLjb
LcbRcbRiRsLsmbRsbRcbLibLsbRjbRgbRibLjbLcbLibRjbRjbRibRiRsmbLjbRsbRibLi
RsbRcLsbLjbRibLibRhRsRsmmbRobLibRibLjbLgbLibRobLsbsbLsRiRsRsmmbRsbRibL
cbRobLjbRgbRibRgbRgbRgbLhLsbLobsbRibRjRibLhbLgbLsLgLsbLsLsmbLsbLgbLgLs
bLsbRebRibRibLcbLcLsmbRcbLcbRobRobRsbRgbRsbsbLibLgbRcbRcbRobLhbRibRiRs
mbLsbRgbRsbsbRgbLjbRhbLibRibRgbLgbRibRsbLsbRgbRgbRsRsmbRgbRgRsRgmbRgbR
gbRgbLjbRibRibLcbRibRibLcbLobLcbRibRsbRcbsbRibLjbRcbLobRobLobLobLibLsb
LhbLgbLsbLsbLsbLgbLgbLhRsbRibRgbRibRiLsbLobRobLsRsbRgbRsbRsbLhbLgbLibR
hbLcbRibRobLgbRibRsbLsbRibLgbRibLgbRiRsRsmmbRsLsRsbRgRsRgRsmmbRsbRgbRg
RgRsRgRgRsmmbRgbRgbRgbRgbRsLsRgbLcLsmbLcRsbRibRhbRiLsbLhbLcbLibLcbRiRs
mbLgLsbLibLgLsbRgbLibLsLibRhbLhbLgbRgbLibLsLsmbLgbRsbLiRsbRcbRibLsbRiR
smbRibLsbRgbRsbRibRsbLsbRsbRgbRsbRiRsRgmbRgbRgRsLsmbRsbRgbRsbLibLibRcb
RcbLcbRiRsmbRibRgRsmbRgbRgLsbLcbLhbRibLcbRjbLibLsbLsbLsbLgbLsbLsbLgLsb
LgbLsbLgbLgbLgbsbLgbLsRsbLsbRsbLibRsLsbLsbLgbLgbLgLsbRcbRgbRsbRibLibRo
bLcbLibLibLibLhLsbLgbRcbLjbRibRibRiLsbLsbRsbRcbLcbLoLsmbLibRhRiRsmbRib
LsbRgbRgbLsbRgbRibRsbRibRsbRsbRgbRgRsmbRoRsLsmbLcbRcbLobLhbRsLsbRobLcL
sRsmbLgbRgbLiLsbRgRsmbRcbRibRsbLsRsbRsbRgRsmbRgLsbLcLibLsbLiLsLsmbLgbL
sbRsbLoLsRiRsmmbRibRcLsbLcbRcbRgbLsbRibRgbRgbRsbRiRsmbLcLibLgbRjbRcLsb
LcbLhbRgLsbLgbLgLsbLsbLgbRibRcbLibRibRiRsmbLsbRgbRgbRsbRsbRsRgbRsbRgbR
gbRgbRgbRgbRgbRgRsmbRgbRsbRsbLcbLcRsbRiLsbLgbLgLsbLsbLsbLsbLgbLgRsbRcb
LsbRibRgbRobLcbLhbLgLsbLibLibRcbRiRsmbRgRsLsmbsbRgbLsbRgbRsLsbRibRsbRg
bRibRgbRgRsmbRgbRgbRsbRgbRsRgbRgbLjbLobRcbRcLsbLcbRcbLcbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 20; Drug: NDMC 10 µM
bLgLsbRiLsbLsbLebRjbLjbsbRsbLibRsbLsbLsLsmbRjbLgLsbsbLsbLsbLsbLgbLibLi
bRibRjbLgbLcLsmbsbsbsbRibRjbLibRsRibLsbLgLsbRgbRsRsLsLsmmbRibLcbLcbRgb
LjLsmbLsbsbLgbRsbRjbLhRsbRsbLgbRsRgbRcRsmbLgbRsbRibRgbRsbLsbRjRsmbLjbL
sbLibRcbLsbRgbLibLibRgbRcbRibLjbLjLsmbRjbRsbRsRsmbLjbRgbRsbRsbLjbRsbRj
bLjbLhbLgbRobLcbRibRjRsmbRcbLgbsbRibsbLjbLibRjRsmbRjbRjbLcbLhbRcbRgbRc
bLiLsbRibRgbRcbLjbRibRibRhRsmbsbLcbLibRhRsmbLgbRsbRibLibRibRcbLsbLgbLj
bRcbRhbRcbRhbsbRibRsbRsbLjLcLsmbLgbLgLsbLsbLsbLiLsbRibLibLibLgbRsbRgbR
ibRcbRibRgRsRsmmbLsbRsbLcbLibRjbLebLgbLcbLibLsbLiLsbRgbRibRibLibRibLgb
RgbRibRibRibLibRibRgbLjbRibRsbRiLsbRsRsmbRiRsmbLgbRibLjbsbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 21; Drug: NDMC 10 µM
bRsLsbsbsbRsbLsRsbLsLsmbLsbLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 22; Drug: NDMC 10 µM
bLsLsmbLgbLjRsbLcLsmbRsRsmbLjLsmbLgbLsLsLsmmbLgbRobLgbLgbRsbsbLsbRibRg
bsbLsLsmbLhbLiRsbRjbRcbLjbRcbRjRsmbLgbRsbRsbLhbsbRsbRsbRebRgbRsbRgRsmb
LjbRcbRgRsmbRsbsbRgRsmbRsRsmbsbRsbRsbRsbLibLibLgbRsbRsRsmbRsRsmbLobsbL
ibRsbLgbLgbRibLgbLibRjbLcbLobRsbRsbLsLsmbRgbRibRgbRgbLgbRgRsmbRsRsmbLg
LsbLgbRibRibRsLsRsbLsbRibRsbRsbRsbRsbRsbRgbRgLsbRgbRgbRgbRibRgRsmbLgbR
gRsmbRgRsmbRgbRsbRsRsmbRsRsmbRsbRoRsRsRsmmmbLhbRsLsbLcbLibRgbRjbLhbLhb
RgLsbLibLibRgbRibRcbLgbRgbRcbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 23; Drug: NDMC 10 µM
bLgbLibRjRsmbRjbRibLjbRibLjbLjbLiLsbLibLhbRiRsRsmmbLsbLsbLgbLcbLgbLebL
ibLcRsbRibLcbLcLsmbLibLsbRjbsbRibRgbRsbLgbLibRgbRibRsRsmbLgbLcbLsbRjbL
cbLcLsmbRgbLcLsmbLcbLhbRgbRibRsRcbRgRsmbsbsbRjRsmbLibLibLhLsbLibRsbLhR
sbLsRsbLsbLcbLhbLcbLgLsbLsbLgbLgbLsbRjbRibRibRhbLsbLsbRibLsbLsLsmbRsbL
sbRcRsmbRgbRibsbLsbLgLsbLsbLsLsmbLgbLsLsmbLgLsbLgbLgbLsLsmbLsbLibsbLgb
LsbRgbRsbRgbRsRsmbLgbLcbLsbLsLsmbLgRsbsbLsbLsbsbLgbLsLsmbLsbLsbsbLgbLs
LsmbLsbRsbsbRsbLhbLiLsbLsLsmbRgbsbLgbLgbLiLsbLsbLibLsbRjbLiRsbLgbLhbRs
bRgbsbRsRsmbLibLiLsbLgbLgbLsbLsbLibLjbRiRsmbLhbLgbRhbRiRsmbRgbLjbLibRs
bLsbLsLsmbLsbRsbLibRcbRhbRsLsRcbLgbLsbRcRsLsmbRibLgbLsbsbLsbLjLsmbLgbR
gbsbLgbLsbLsbLgbLhbLibLsbLsbLsbRjbRsRsmbRsbRsbLsbLgbLcbRjbRcbsbRcRsmbL
sbLsbLsbLgbLsbLsbRgRsmbLjbLsLsmbLsbLsbLsbLsLsmbLgbRgbLgbsbLsbLgbLsbsbL
gRsbLiRsbLibLgbLsbLgbLsbLibLibLgLsbRgRsmbRgbLcbLsbRsbLibLsbLsbRsbLsbLg
LsbLsbLibLgbRjbLgbsbLsbLsbLsbLsbRgbLibLgbRsbLgbLgbLgbLibLibRgbLibLgbLj
LsmbLibLsbLgbLsLsmbLsLsmbsbRsbLgbRgbRsbLgbLibLgbRsbLsLsLsmmbLsbLgbLiLs
bLgbLsbLibLibLhbLibRsbRgRsmbLgLcbLibLibLibLsbRsbRgbRibRgbLsbLsbLjbLcbR
hbLcLsmbLsbLsbLsLsmbLgbLsbLsbLsbRsbLibLgbLsbLsbLiLsLsmbRsbLgbLgbLgbRib
LsbLiLsbLgbRsbLjLsmbRgbLibLgbRcbRiRsmbRhbLgbLcbRgbLibLgLsLsmbRcRsmbLib
RgbLsbLsbLsbRsbRsbLsLibLsbLsbLsLsmbRsbLsbRsbLibLibRhRsmbLsbLsbLibRsbLg
bLsbRsbLgbLgbLiLhLsbRsbLsbRsLsbLibLgbRsbLjbRcbRcbLhbRsbLcbLgbLsbLsbRgb
LibRjbLibLiRsbRsRsmbRgbLhbLsbLgbLsbsbLgbRsbLsRsbLsRsbLsbLibLgbRsbLibRs
bLsbLibsbRsbLibLgbRjbLibRsbRgbLibLsbLgbRsLsbLgbLgLsbLgbLiLsbRhbLgbLgLs
bLibRgbsbRcbRcbRcbRgbLgbLibRsbRcbRhbRsbLjbLcbRgRsmbRsLibRsbLsbLiLsbLgL
sbRgbLibLsbRsbLibLibRgbRsLsbLgbLsLsmbLsbLsbLsbLgbLgRsbLibLgbLgbLibLsbL
sbRsbLgbRsbLiRsbRgRsmbLjbLsbLsbRsbLsbLgbLgbRgbRsbLcbLsbRgbLibLibRgbLgb
LsbLsbLibLgbLiLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 24; Drug: NDMC 10 µM
bRiLsbRgRsmbRgbRsbLgbRiRsmbLjbsbLjbLjbLiRsbRsRsmbLsbLibRsbRgbRgbRgbLgb
LgbsbLsbsbRgbRibRsbRgRsmbRsbRgbLsbLjbRcbRsbRsbLibRiRsmbLsbLsbRgbLsbRgb
RiLsbRgbLibRgbRibLcbLhbRcbRsbRjbsbLiLsbLibRsLsbRjbLibLgbRsbLgbLsLsmbLs
bRsbLiRsbLibLsbRgRsmbLgbLgbRsbLibRsbRebRibLgbRiLsbRhLsbLgbRibRgbLsbRcb
LcbLobLsLsmbLsbLsbLgbLgbLgbLsbLgbRjbRebRgRsmbRgbLgbRgRsRsmmbRgRsmbLgbR
ibRgbRsRsmbRgbRsbRgbLjbRibLcbLiLsbLgbLgbLgbLgbLgbLibLsbLgbRgbLibRjbLsb
LhbRibsbLjbRjbLibsbLhbLiLsbRgbRibRhbLsbRsbLsbLibRjbLcbLcbLsbLibRsbRgbR
ibRibLoLsmbLgbLsbLgbRcbRiRsmbRsRgbRibLsLsmbRgbRsRsmbRsLsbRgRsmbRsbLsbR
jbRsRsmbRsRsmbRsLsbLgbRibLjbRibRsRsmbRsbRgbRgRsmbRsbsbLcbRobRsbLgbRibR
gbLgbRiRsmbLsbRibRibRibRibRsbRgbRgbsbRibRsRsmbRsbRsbLsbLsbsbLsbRibLjbR
hbLgbRibsbLjbRgbRgbRsRsmbLsbRgLsbRgbRcbLibLjLsmbRsbRiRsmbRgbRsbLsbRjbL
sbRsbLsbsbRgRsmbRgbLgbLcbLibRsbLsbLgbLsbLsbLsLsmbsbRsLsbLsbRgRsmbLsbRi
bRjbRibRgLsbRsbRgbRsbRgbLgbRsbRjbLsbRsbRgbRibLgbRgRsmbRsbRgbRgbLsbRgbR
sbRsLsbLsbRibLgbRibsbLgbLgbLcLsmbRsbsbRsbLgbRjbRibRjbRsbsbsbRjbRsbRgbs
bRgbLsbRsbRgbRgRsmbLsRsbRgbRgbLgbRibRgRsmbRsbRsbLcLsLsmmbLiLsbRjbLsbLi
bLsbLgbLgbRjbRobRsbRgbLsbRsbsbRgbsbRjbsbLsbsbRibLcbLgbRgbLibLsLiLsbRib
LibRsbsbRsbRobRsbRsbsbRsbLsRsbRsbLsLsmbRgbRgRsmbRsbRgbLsbRgbLsbRgbRsbR
gbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 25; Drug: Control
bRgbLgbLsbLjRsbLiRsbLgbLsbLiLsbLjbRibRjbLibRgbRgbLsbLgbLcbLoLsmbLhRsbL
sbRgbRibLebLsLibLsbRsbRjbRhLsbLibLgbRibRsLsbRgbLhbLiLsbLsbLgbLgRsbsbsb
sbRcRhbLjbRebRsbLcLsmbLiLsbRjbLibLibLibRcRcRsmbLjbLhbRgbRcRsmbRibLjbRi
LsbLjbRibRgbsbRgRsmbRsRsmbRgbRsbLsbLsbsbRibLcRsbRibRhbRibLgLsbLgbRhbLg
bRibRgbRgbsbRsbRgRsmbRsbRgbRobLhbLjLsmbRhbRcbRibLjLsmbRibLhbRsbRibLjbR
hLsbRibRsbRsbRgbLjbRgbLcbRiRsmbRibLjLcRsbLgbLgbRsbRsLsbLibLibLibRgbLib
RgLibLsbRgbRjbLhbRibLibLibLsbLsbLgbLgbLgRsbLgbRsLsbLibLibLgbLgbsbLibRc
bLjbRibRibRgbRibRibLjbRibLcLsLsmmbLibRjRsmbLibRjRsmbLsbLibsbLibRsbLgbR
sbRjbLiLsbRjbLibRgbLsbLiRsbLiLsbRsbLgbLsbLsbLsLsmbRsbLibRsRsmbLsbLgRsb
LgbLsbLgbRgRsmbLiLsbsbLibLibLibRgbRsbRgbRjbsbRsbLjbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 26; Drug: Control
bRiRsmbRibRgbLibLcbLobLcbLsbLibLhbRibLoLsmbLibLibLibLibRibLiLsbLcbLibL
sbLibLiLsbRsbsbLgbRhLsbLobRsbLcbRsbLcbRebRjbRsbLibLsbRcbRgbLcbLcLsmbLo
bLibLcbRibLibLcbLgbLcbLsbRgbLhbRsbLcbLgbRsbLibRsbLgbLoLsmbRiRsmbsbRgbR
sbRgbRsbRgbRsbLsbRgbRibLgbLjbLcbLsbLibRsLsbLiLibLibLgbRiRsmbRcbLibLhbR
jbLiLsbLibLibRsLsbRgbRibLjbLebRibRobLsRsbRsbLobLsRsbLobLsLsmbRibRsLsbR
sbRhbRsbRgbRsbRibRiLsbLcbRcRsmbLgbRibLsLsmbRgbRgbLsLsmbRgRsmbRgbRgLsbL
sbRibRsbLsbRsbRsbRgbRgbLcbRibRibRgbRsLsbRgbLsLsmbRgbRsbRgbRsbRgbRgbRhb
LjbLsRhbRsRsmbRgbLsbRibRsbRgbRsbRjbLjbRhbLgbRgbRgbRiRsmbRgbLibLeLsbLgb
LiRsbLsbLgbLiRsbLsbLibLiLsbRgbLgbLgbRibRgbRgbLjbRcbLsbRibRgbRgbRsbRsbR
gbRsbRgbRgbRsbRgbLcbLcbRcRsmbLhbLsbLgbRgbLgbLsLsmbLsbLsbLgbLgbLibRjbRi
bLiLsbLibRsbLibRgbLibRsbRsbLgbLgLsbLgbRsbLibRhbRhbRsbRibRsbRsbLsbRgbRg
bRgbRsbRgbRsLsbRgLsbRsRsmbRsLsbLsbRgbLcbLgbLgbLibLgbRsbLibRjbLhRsbRibL
gbLibLgbRgbRibLiLsbLgbLgbLgbLsbLsbLsbLibRgbLibLsbLgbLsbLsbLsbLsbLgbRgb
LcbRibLgLsbLiLsLsmbRsbsbLiLsbRsbsbLsbLsbLgbLsbLsbLgbLgLibLsRjbLiRsbRsb
LibRgbLgbLgbLsbLsbLgLsbLgbLsbLsbLgbRjbRcbRibLjbRhbRsbRgbRsRsmbRsbRsbRs
bRgbLsbRgbRgbRgbRsbRsbLoRsbLcbRibLhLsbLgbRibLibsbRgbLgbLsbLgLsbLsbLsbL
gbLsLsmbLgbLgbLgbLgbLibLsbLgbLgLsbLibLgLsRsbRcbLgbLiLsbRgbLgbLsbLgbLgb
LsRsbLhbRibRibLibLgbRsbLibLibRgbLgbRsbLibLgbRiRsmbRobRcbLgbLibLgbLgLsb
LgbLgbLsbLgLsbLgbLgbLgbRsbLgbLgbLsbLsbLgbLgbRgbLgbLgbLsbLsbLgbRsbRsbLi
bLsbLgbLgLsbLgbLgbLgbLsbLsLsmbLgbRjbLhbRcbRibRsRsmbLsbLobLibRibLgbLsbL
gLsbRsRsmbLibLsbLgbLgbLsRsbLsbLsbLsLsmbLgbLcRsbRhbsbRcbLibLhbRibLcbRgb
LibLsbLsLsmbLsbLsLsmbRsbLgbLsbLgbLsbLsbLhLsbLibRcbRcbRgbRgLsbRgbRgLsbL
oRsbRjbRsRhbRgbLcbLiLsbRsbLibLsbLgbLgbRsLsbLsLsmbRsLgbLsbLsRibRsbRgbLs
bRsbRgbLobLibLhbRsbLiLsbRjbLgbLibRgbLgbLsRsbLgbLgbLsbLsbLgbLsbLgbLgbLg
bLcbRiRsLsmbLibRgRsmbLibLsbLibLgbLsbLsbLgbLsRsbLsbLsbLgbLiRsbRibRsbRhb
RsbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 27; Drug: Control
bLgbLgRsbLgbLgLsbRibRjbRibLhbRhbRibsbLgbRibRgbLsbLgbRhbLibRiLsRsbRsbsb
RibLjbLjbRjbRibRibRibLibLgbRibRibRsbRiRsmbLibLsbRsbRibRgRsmbRhbRibLgbL
ibLhbLgbLhRsbLibLgbLgbLsbLibRsbLcLoRsbRgbRsbLsbRibRcbLgbRsbRibRiRsmbsb
LsbRsbRibRibLgbRgbLgbRibRgbLsbRibLjLsmbRcbLibRsbRibRsbRgLsbRgRsmbLibRg
bLsbRibLibRibRsbLsbRgbRsRgbRsbRgLsbRgbsbLgbRsRsmbRsbRhbRhbRibLibRibLgL
sbLsbRsbRsLsbLibRibLibLsbLsbLgbLgbRsbRoLsbRsbRibRsbRgbLsbRsbRgbLgbRsRs
mbRgbRsbLsbRsbLjLsmbLibRjbRibLgbRibLgbRgbRsRsmbRgbRsbLsRsbRsbRsbRsbRib
LgbRsbRibRgLsbRibLibRgRsmbLgLsbLjLsmbRibRsbLsRibLsbRgRsmbRgbRibLgbRsbR
sbLjbLcbLibRgbLibLsbLsbLgbRsbLgbLjRsbLhbLgbLsbRibLibRibRsbRsbRgLsbRgLs
bRiLsbRgbsbLiLsbLsbLjbRhLsbRibLjbRgbRsRiRsmbLjbRcbLiRsbRiRsmbRsbLsbRgb
LsbRgRsmbRsRsmbRgbLsbRgbsbRgbRsRsmbLsbRgbLsLsmbRhbRcbRibLgbRibLibLgbsb
LibLgbLsbLgbLsbLgbLgRsbRgLsbLgbRsbLgbLiRsbLibRjRsmbLiLsbRsbLgbLgbRsLsb
LgbLibLgLsbRgbLibLiLsLsRsmbLsbLgbLgbRcbLibRobLgbRjbLibLgbLgbLsbLgbLsbL
sLsmbRsbLgbRsbLsbLgbLsbLsbLgbLgbLsbLgbsbLgbLibLgLcRsbRgbRibRgbRgbRgbRs
bRgbRgbLsbRsLsbLsbRgbRsbRsbRsRsmbsbRsbRgbRgbRibLsbRgbRgRsmbRsbLgbRibRs
bRgRsmbRsbRibRibRibLhbLgbLgbRiLsbLibLeLsbLgbRsbRsbLgbLsbRcbRiRsmbLgbRh
bLjbLhbRobRcbRsbLjbRhbLjbRhbLibRibRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 28; Drug: Control
bRibRgRsmbRiRsmbRsRsmbRsbRgbRsbRgRsmbRgbRgRsmbLgbRgbRhbRgbRsbLgbRsbRib
RgbRgbRgRsmbLibsbsbLgbLibRgbsbRjbRhbRsbLgbRgbRgRsmbRcRsmbLsbLibLobLcbs
bLsLsmbLcbLibLsbLgbLiRsbRsbRgbsbsbLibRsbLhbRgbRibRhRsmbRsbRibRibRsbRiR
smbRiRsmbsbRsbRgRsRsmmbRsLsbRjbsbRsbRgbRgbLsbRibRibLsbLibRjRsmbRibLsbR
gbRgbLgRsbRibRgbLibRcbLiRsbRcRsmbLgbRiRsmbRsbRsbRgbRsbRgbLsbLcLsmbLsbL
ibRgbRebLcbLobRibRebRgbRgbRsRsmbRsRsmbRgbRgbLsbLgRsbRgbRibLsbRgbRsbRib
RcLsbLsbLibLsbLibLsbLcbRibRgbLibLgbLiRsbLgbRsbRibLcbLcbRgbRhbsbRsbRgbs
bRjbRsbRsbRgbRsLsbRsRsmbRiRsmbRgbRsbRsbRibLsRsbRibLibRhbRgbRgbRgbRgbRg
bRgbRsbLhbRjbRibLgbRhbRgbLgbRsbRibRgbRsbRibLgbLobLhbRgbRsbLobRgbRgbRjb
RobRsbLibLsLsmbLgbLgbLsbLoLsmbRsbRgLsbLsbLcbLibRgbLibLgbRgLsbLhbRgRsmb
LcbLgbLgbRsbRsbRgbRgbRibLjbLcbLgLsbsbRhLsbRgbRibRgbRgbLgbRgRsRsmmbRgbL
sRsbRgRsmbRsRsmbRgRsmbRibRgbRgRsmbLgbRiRsmbLiRsbRibLgRsbRgbRgbRgbRsbRg
bRgbRgbRsRsRsmmbRgbRgRsmbRgbRgbRgbLgbRibLgbRsbRgRsLsmbLsRsbRibLgRsbRgb
RgbRgRsmbRgRsmbRgbRgRsmbRgbRgbRgbRgbRgbLsbRgbRsbRgbLgbRgbRgbRgbRgbRgbR
gbRsbRgRsmbRgbLgbRibRsbLgbLsbLibLcbLgbLsLsmbLgbRebRobRgbLsbRhbLgRsbLgb
RhbRsbRibRgbRsbRgLsbRsbRibRibLsbLsbRibLsbRibLibRcbLgbLcbLhbRibRjbRgbRg
bRgbRsbRgRsRsmmbRsbRgbRsbRsbRsbRsbRibRgRsmbRgbRgbRgbRsbRibRsbRgbRgLsbR
sRsmbRgbRgbRsbRgbRgbRgbRgbRgRgbLibLhbRcbRibLgbRgRsmbRgbRsbLsbRgbRsbRgb
LgbRibRgbRgRsmbRsbRgbRsbRgRsmbLgbRgbRgbRgbRsRsmbRgbRsRsmbRgbRsbRsbRgbR
sbRgbRgbRsRsmbLjbRiRsmbRsbLgbRibLjbLcbLcbRhbsbRiRsmbRibRsbsbRgRsRsmmbR
gbRgbRgRgbRgbRgbRgbRgbRgLsbRgbRgRsmbRsbRiRjbRgLsLsmbRgLsbRsRgbRgbRgbRg
bRgbLibRibLjbLgLjbRcLsbRgbLsbLsbRibLsRsbRsbRgbRibRiRsmbLgbRsRsmbRgRsmb
RgbRgbRgbRsbRgRsmbLjbLsbRcRsmbRcRsmbLgRsbsbLcbsbRgbLgbRgbRgbLgbRibLsRs
bRgLsbRgbRgbRsbRgbRsbRgbRgbLsbLsbRgRsRsmmbRsbRgbLsbRibLgbRhbLgbRgRsmbR
gbRgbRgbRsRsmbRgbRgbRgRsmbRgbRsbRgbRgRsmbLgbRgbRsbRgbRsbRsbRgbRsbRgbLs
bRgbRgbRgbRgbRsbRgbRgbRgbRgbRgbLgbRgRsRsmmbLjbLcbLgbLiRsbRobRibRgbRgbR
gbRgbRiRsmbLgbRhRsmbRsRsmbLgbRhbRsbRgbRsRsmbRgbLgbRgRsmbRgbRgbRgbRibLi
RsRsmbRsRcbLibRcbLgRsbRsRsmbRiRsmbRsbRibLsRsbRsbRsbRibLgbRhbLibRibRsbR
gbRjbRgRsLsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 29; Drug: Control
bRcbLjbRhRsmbRgbLsbLcbRjbLibLibRhbLsbRjbRebLiLsbLjbRiRsmbLhbRjbLgbRgbL
jLsmbRibLsbsbLgbLgbRcbRsRsmbLibsbLibRgbLibLsbRiRsmbRsbLsbLjbRibRjRsmbL
jbLibLsbRjbRgbLjbRsbLgbLgbLsbRsbLgLsbLibRibRibRibLsbLgbRsbLgbLsRsbRcbR
ibRibRibRsbRsbLibLibLibLgbLsbRibLgbLiRsbRibLibRcbRcbRibLsbRiRsmbRibRib
LgLsbLgbLibRibLsLhbLhbsbLibLibLhbLgbLgbRibLibLgbLiLsbRcLsbRcbRibLsbRib
LsbLgbRcbRibRibLibRibRibRiLsRsbRcbLgbRgbLsRsRsmbRgbLibLjbRcbRcbLibLgbL
sbLoLsmbRsbRibLcRsbLibRibLcRsbLibLgbRsLsbLgbLibLgbRibLibLcbRibLibLibLg
bLgbRjbLhbRiLsbLibRgbLhbRsbLibLgbLgbLgbLhbLgbLibRsbRjRibLiRsbRhRsmbLgb
RibRibRgbLjLsmbLgbLibLgbRgbLibRibLibLgbRsbLgbLsLsmbLgbLgbLgLsbLgLsbLsL
smbLgbLgbLgbLgLsbLgbLibLhbsbLcLsmbRjbLcbLibRhbLhLsLiLsbLsbLgbLsbRsbLsb
LibRjbLhbRsRhbRcRsmbRsbRcbRcbLhbLibLiRsbLgbRhbLgLibLsbLsbLgbLsLsmbLsbL
sbLsLgbLsbLobRcbRhbLjbRcbRibLhbLiLsbLiRsbLgbRibRibRcRsmbRibRsbRhbRsbRg
bRgbRgbRsbLcbLsbLgbLibLgRsbLgbRsbLibRcbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 30; Drug: Control
bLgbLgRsbRjbLgbLgbLsbsbLjbRcRsmbRibLjbRhbLjbLibRhbLjbRcbLgbLjbLcLsmbRi
bLibRhbRhRsmbLibRcbLsRsbsbLjbRcbRibLsbLcbLcbRobLibRsbLhRsbLibRgLsbLsRs
bLibRjbRcRsmbRcbLibsbRsbLhLsbLhbRgbLibLibLobLcbRhbRhbRobRjbLibLjbLjbsb
RjbRobLcbLibRsLgRsbLjbsbsbLgbRcbRsbRcbLsRsbRjbLjRsLjbLiRsbLgbLgbRcbRjb
LjbLcbRcbLhLsbLjbLgRsbLhbLgbLgLsbLjbLibRsbLjbRibLibRcbRibRcbLibRcbLgbL
ibLsbLibRjbLibLsLsmbLsbRsbLibRsbLgbLibRibLjbLjbLibLgLsbLsbLgbLgbRgbRcb
RebLhbLjbRibLgRsbLgbLsbRsbLgbLgbLsbLsbRgbLibRcLsbLhbRgbLgbLjbRibRhbRgb
LsRebLibRsbLebRibRebLjLobLsbLgbLibLgbLgbLgbLsbRgbLibLjRsbRhbLibLgLsbLg
bRibLgbLgbRjbRobLibLhbLgLsbRibLibRsbRsLsbLgbLgbLsbLsbRjbRcbLhbRcbLgbRg
bLjbRcbRjbLgbsbLjbLgLsbRsbLgLsbRsbLgbLgRsbLgbRiRsmbLjbLiLsbLgbLgbLsLsm
bLgbLsRsbRsbLgbRsbLgbLsbLsbLgbRibRcbLcbLgbLgbLsbLsbLsbLgbsbLgbLsbLgbLg
bLgbLsRsbRibRcbLibRgbRgbLcbsbLgbLgRsbRsbLsLsmbLgbLgLsbLsbLsbLgbRsbLgbL
sbRhbRcbLibRcbRibsbRibRsbRsbLsbLgbLgLsbLsbLsbRsbLgbRgbLgLsbLgbRsbRsLsb
LgbsbLgbRsbLibRgbLgLsbLsbLsbLgbLsbLjbRibLibLgbRjbRgbLsbLcLsmbLgbLgbLib
LgbRibRgbLibRjbLgbRsbLsbLsbLsbLsbLgbRsbLgbLsbRsbLgLsbRsbLgbLibRjbRsRsm
bRhbRsbRgbLjbRgLsbLobRgbRibRgbRsbLibRsbRsbLsLsLgmbLhbRjbLgbLgbLgbLgbLg
bLsbLsbLsbLsbLgRsbLgbLsbLgbLgLsbRsbLgbRsbLgbRsbLgbLsbRsbRobRibLhLsbLgb
LsbLgbLsbLgbLsbRsbLgbLgbLibRjbLibRiLsbLgbLsbLgbRsbLsbLgLsbLsbLgbRhbsbR
hbLibRhbLibRgbRibLcbLibRsbLiLsbLsbLsbLsbRsLsbLgbLgbLgbLgbRsbLgbRgLibRs
bLgRsLsbLsbLsbLsbLsbLgbLgbLgLsbLgbRcbRsLsbRgbsbRhbLjbLibLgRsbLsbLgbRib
LsbRebLcbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 31; Drug: NDMC 1 µM
bRgbLsbRiLsRsbRgbRgRsmbRsRsmbRgRsmbLgbRgbRgbRsbRgbRsbRsRsmbRgLsbRsbRgb
RsbRgbRjbRsbRgbRibRgbLibLgbLsRsbRjbLiLsbLiLsbLgLsbLgLsbLgbRsbLiLsbLgbR
jbLibLsbLgbLsbLibRibLsbLibLsbLibRgbLibLsbsbLiLsbLsbsbLibRsbLibRgbLibLs
bRibRgbRsbLgbLjbRhbLjLibLiLsbRsbLsbLibRsbLsbRibLibLsbLibRsbRsRsmbRjRsm
bRcRsmbRsbRibRibLsbLibLibRcbRibLsbLsbsbRiRsmbsbLsRsbLsbsbLsbRibRibRgLs
bLsbLhbLibLibLibRsbRsbRibLiLsbLgbLsbLebRsbsbLibLgbLibLibLsbRgbLgbLibRs
bLhbLsbRgbLsbLsbLibRsbLgbLsbLhbRgbRsbRgbRsbLobLsbLsbLibLsbRgLsbLibLsbL
iLsbLebLsbRsbLsbLiLsbLibLsbRsbRsbLsbRgbRcbRsbRiRsmbLibRgbRibRsbRibRsbL
sbLibRibRibLsbRibRgRsRsmmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 32; Drug: NDMC 1 µM
bRibLgLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 33; Drug: NDMC 1 µM
bRgRsmbLjbLibRjbLibRgbLcRsbRjbRhbRsRsmbLibLcbLibLjbLibLiLsbLhLsbRhbLhb
LobLibLjbLibLibLcbLibLhRsbLcbRcbLhbLsbRibRobLsRsbLjbLcbLibLjbRjRsmbLib
LiLsbRhRsmbRibLibLibRsbRiRsmbRsbRgRsmbLjbRibLgbsbRsRsRsmmbLjLsmbLjbRjb
LjbLjLsmbLgbRjbRsbLiLsbsbLgbRjbLjbLjbLhbRcRsmbRgRsRsmmbLjbRjRsmbLibLib
LibLibRcbLjbsbRjRsmbLjbRjbRjbLiRsbRjRsmbLibLibLhbRcbsbLsbLjLsmbRibRibL
jLsmbLjbLjbLiLsbLcbRjRsmbLcbLibRsbLgbRjRsRsmmbRjRsmbRjRsRsmmbsbLjbLjbR
sRsmbRjRsmbLhbLjbLjRsbLibRibLjbLsbLjbLgbRjRsmbRgbLcbLibRjRsmbsbRsbRjRs
mbLibLhbLibRsRsmbRjRsmbLibLcRsbLcbRjbLibsbRjRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 34; Drug: NDMC 1 µM
bLibLsbRiLsbLgbLibRjbLsRjbRgbRibRibLgbRibRiLsbLsbRibRgbRsbLcLsmbRhbLcb
LhbRibLgbLibLgbRiRsmbLcbLcRsbLcbLibLgbRcbRibLibRcbRcRsmbLhbRcbLibRcbRi
bRgbLsLsmbRhbLgbLcLsmbRibLhbLgbRgbRgRsmbLibLgRsbLcbRiRsmbRgbLobRibLgbL
gbLsbLgbsbRsbLiRsbLsbLibRsbLsbLgbLsbRobLgRsbLgbRjRsmbLobRjbRsbRsbLobLc
bRgbRsbLsbLsbRibLsRsbRgbRgbRgbLsbRobLhbLibLibLsbRsRsmbRcbRibRsbLsbRcbR
ibRsbRgbRgbRhbRiRibRgbRiRsmbRsbRgbLgbLibLgbLsRsbLsbLsbLsLsmbLgbLgbLgbL
gRsbRcbLobRhbRjLsbLjbLgbRjbLgbLgbLsbRgbLgbLgbRjLsbLgbRsbLgbRsLsbLibRsb
RsbLgbLgbRsbRsbLgbLiRsbRcbRcbLhbRhbLjbLcbLgbLsbLgbLibRgbRsbRgbLgbLgLsb
RgbLsRsbLibRsbLsbLsbLgbRsbLgLsbLsbLsbLiLsbLsbLgLsbLgbRsRsmbLgLsbLsLsmb
LsbLgbRsbLgbRjbLibRsbLgbLsbLsbRsbLsbLgbRsbLjbRcbLibRgbLgbLsbLgbLgbLhbR
hbRsLsbLgLsbLgbRgbLgbRhbRcbLcbLcbLsbRsbRgbLgbLibRgbLgRsbLsbLgRsbRgbLgb
LsbLsbLsbLsLsmbLsbRsRsmbLgbRjbLhbsbLgbRjbLgbLibLhbRiLsbLgbLibRsbLibLgb
LgbRgbLgLsbLgbRjbLgbRjbLgbLgRsbRgbRjbLsbLiLsbLibRsbLibRjbLibRcbRibLhbL
ibRjbLgRsbLibLgbRsbLgbLgLsbRsbLsbLgLsbRsbLibRsbRsbRsbLgbLgbLiLsbRgLsbL
sbRhbRjbLgLsbLjbRebRgbLsbLibRjbLsbLiRsbRsbLgbRsbLebLsbLgbRibRsbRgbRibL
cbLcbLsbLgbRjLsbLsRsbLgbsbLibRgbLgbLsbLsbLgLsbLsbRsbRjbRebLcbLibLhbRgb
RgbRibRgbLjbRcbLcbRcbRcRsmbLcbRcbLjbRjbLobRibRibLgbLgbRjbLgbRibLgLsbLg
bLgbRsbLsbLsbLgbLgbRsbsbRsLgbLibRibLibLgbRsbLgbRsbLgbLgLsLsmbLgbLgbLsL
smbLgbRsbLjbLsbRebRgLsbRgbLsbRsRgbLobRhbLobRjbLibLgbRsRsmbLgbsbRjbLgbR
sRsmbLgbLgbLgbLgbRjbLibRcbRcbLhbLibRibLcbRsbLgbRibLhLsbRsLcbRibRsbLgbL
sbLsbLgbLsbLsbRgRsmbLibRsbLgbLsbLgRsbRsbRjbRibLjbLibLiLsbLsLsmbLsbLgbR
sbLgbLsbLibRsbLgbLibLsbLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 35; Drug: NDMC 1 µM
bLsbLibLgbLgbRsbLsbLibRsbLgLsbLsbRsbLobLibRjbRhbRcbRcbLjbRjbLcbRcbsbRi
bRcbRcbRhbLjbRsbRsbRibRsRsmbRibRjRsmbReRsmbLibRcbLgbLgbRibRebRgbLgbRjb
RsRsmbLibRcbRhbRgbRibRjbRibRgbLsbLgbRobRsbLjbLjbLibLibLiLsbRiRsmbRjbRi
bRgbRibLsRsbLjbRjbLjbRebRsRsmbLibLgbRhbLgbRjbRgbLsbLsLsmbLjbRcbRsbRsRs
mbRjbLjbRgbRibRgbReRsmbRibRsbRibRjRsRsmmbLsbRsbLibRebRsbRgRsmbLibLgbRg
bLjbLibLsbRcbLjbRhbsbRsbLsbLsbLsRibLjLsmbRsbLsbRgbLjLsmbsbLibLibRgbRob
sbRibLgbsbLsbRibLjbLhbLebLhbLsbLsbRibLhbRsbRjRsmbRibRibRgbLgbLjbRsbRgb
sbRsbRjRsmbRgbLjbLibLsRsbLgbRibLsbRcRsmbRcbRhbRjRsmbsbsbRibLsbRsbRjbRh
bsbRibLcbRsbLsbRcbRhbRhRsmbRsbLgLsbRjbRjbLeLsbRsbLgbLcbLebLibRiRsmbLib
RgbRibLjbRebRsbLgbRsbsbRjbLoLsmbLibLibLsbLjLsmbRibRsbRgbLgbRibsbRiLsbR
cbRsbLgbRjbRsbRibRibLsbRibRibRgbRsLsbRgbRgbLibRibRsbRsbLibRjbLibLsbRgR
smbRsbRgbRebLgbRiRsmbLsbRgbRsbRobRhRsmbRsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 36; Drug: NDMC 1 µM
bsbRsLsbLcbRibLjbRhRsmbLjbRibsbLsbLsbLjbRgbRgbRsbRsbRibLsbLsbRibRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 37; Drug: NDMC 3 µM
bLibLgbRibRibRibLgbLcbsbLibLgbRibRgbLgbRcbRsbsbRsbLcbRibRiRsmbRsbsbsbR
ibLjLsmbsbsbLjbRsLsbLsbLgbRjbRjbLcbsbsbRgbRsRsmbRjRsmbLgbLgbRibsbRjRsm
bRcRsmbRibLhbLobRibRjbRebRsbLjLsmbLcbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 38; Drug: NDMC 3 µM
bRjLsbRibLsbRsbLsbRibRsRsmbRgbRgbRgbRsbRsRsmbRgbRsbRgbLsbLsbRsbRgbRgbL
sbLsbRgbRibRgbRgbRsbRgbRsbLgbRsbRibRsbRgbRgbRgbLsbLsbLsLsmbLgbLibLsbLs
bLsbLsbLgbLgbLgLsbsbRsbLgbLgbLsLsmbLgbLsbLgbLjRsbLiLsbLsbLgbRgRsmbsbLg
bLsLsmbRiRsmbRiRsmbLsbLsbLsbLgbLsbLhbLgbsbLibRsRsmbLgbLsLsmbLgLsbLgbLs
bLgLsbLsLsmbLgbsbLgRsbLsbRsbLsbLsLsmbsbRsbsbRcbRgbRsbLsbRgbLsbRibRsbRi
bRsbsbLsbRgbRgbRsbRibRgbRgbRgRsmbRgbRsbRibRgbRibLsbLgLsbLgbLsbLiLsbLib
RsLsbRgbRgbLcbLsbLgbLsbLsbLsbLsLsLsmmbLjLsmbsbLgLsbRsbLsbLcbLgbLsbLsbL
sbLjLsmbsbsbRgbsbLsbLgbLsLsmbRjbLsbLsbLsbLsbLsbLgbsbRsbLsbLgbLgbLiLsbL
gLsbsbRsbLsLsLsmmbRsbLibRsbLsbLgLsbLgbsbRgbLcbLibLsbLsLsmbLsbRsbLsbLib
LgbsbLsLsLsmmbLgbLsbsbRjbLsbLsLsmbLsRsbLsbLgbLsRsbLgbLgbLsbRsLsbLsbLgb
sbLsbLgbsbLsbRsLsbRgRsmbRcRsmbRibRsbRjRsmbRsbLsbLsbLsRsbRsbLgbLibLibLs
bsbRgbRgbLcbLibLsbLsLsmbLsbsbRsbLsbLibLsbsbsbLibLjRsbLgbLsLsmbRgbRgRsm
bRsbRibRhRsmbRsRsmbRsbRgbRgbLsbLsRsLsbRgbRgbRsbRsbRibRibRsbRiRsmbLsbLs
bRsRsmbsbLsbRsbRcRsmbLsbRsbLgbLsbRibRibLsbRibRjRsmbRsbRgbLsbLsbLsbLgbL
ibLsbLiLsbsbLibRsbsbRsbLsbRsbRgRsmbLcbLgbLgLsbsbLsbRsbLsLsLsmmbLibLgbL
sbLsLsmbLibLsbRsbRsbRgbRsbRibRiRsmbLsbLsbLsbRgbRsRsmbRgbsbRsbRgbLsbRiR
smbRibRgbRsbRibRibRsbsbLsbRgRsmbRhRsmbRgbsbLgLsLsLsmmbLjbLibLsbRsbLibR
sbRgbLgbLibLsbLiLsbsbLsbsbLsbsbRjRsmbLjLsmbLgbLsbLsbLgbRgRsmbRiLsbRibR
ibRjbLgbRgbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 39; Drug: NDMC 3 µM
bLgbRgbLjbLiRsbLcbLiLsbLsbRcbsbsbLjLsmbRibRjbRjbRjbRibRcbRsbLhbRhRsmbR
ibRjbRgbRcRsmbRhbsbLibRjbRjbLibLiLsbLibRjRsmbRsbLibRjRsmbRjbLjbLgbLsRs
bLsbRibRibRibRsbsbLjLsmbsbRibRjbRiRsmbLgbLjbLgbLjbRoRsmbLsLsmbLjLsmbLj
LgbLjbRjbLsbLibLjLsLsmmbLgbLgbLsbRiLsLsmbLcbsbLiLsbRsbLjbLsbRibRibLjLs
mbLsbLsbsbRgRsmbRibRsbRgRsmbsbRsbRsbLjLsmbLibLsLsmbLoLsmbLhLsbLcbLsbLg
bLsLsmbLgLgbLsbLsbLsbLgbRjbRsLsRsbsbLiRsbRjbRsRsmbRcLsRsbsbRjRsmbRsbRg
bsbRibRsbRsRsmbRgbRgbRsbRjRsmbRsRsmbRsRsmbRgRsmbsbLsLsmbLcbLjLsmbLeLsb
Rjb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 40; Drug: NDMC 3 µM
bLjbLgbLgbLibLsbLhbRibRibRgbLjbRjRsmbRjbLibLgbLsbsbRibRsbLcbLibRgRsmbR
gRsmbRgbLcbLhbLibLibRcbLgbRcbRcRsmbRibLsbLgbLoLsmbLsLsmbLibLcbLcbRgbLi
bLibsbRibRhbLcbRcbLjbLibRjbRcbLjbRibLgbLibRjbRhRsmbLiLsbRjbLjbRibsbsbL
jbLcbRjRsmbsbRibRgbLgbLcbRhbLcbLiLsbLcbLhbLsbRsbLibsbRgbRsbRhbLgbRhbRs
bLsbRsbLgbRhbLcbLcLsRsmbRjbRjRsRsmmbRsbRjbRsRsmbRcbRcbRhRsmbsbRsLsbRgb
RjbRgbLjbLcbLibRibRcRsmbLjbsbsbRhbLcbLibRjRsmbRjbLsRsbRgbRsbsbRgRsmbRs
bRgbRgRsmbRjbLjbRjbRibLhbRgbRibLsbRsLsRsbLsbRgRsmbLsbRsbRsbRjbLjbRgbLj
bsbRibLibsbLsbsbLsRgbsbRsRsmbRgbLibRgbRsbLsbRsRsmbRgbRibLjbLcbRsRsmbLs
bRhbsbRgbRiRsmbRcbLibRcbRhbRibRsbRgbRibLcbLcbsbRjbLsbRhbRibRibLibRibLs
bLcbRgbRhbLcRsbLcbRiRsmbRjbRhbLsbLsRsLsbRgbsbLsbRgbRsbRgRsRsmmbRsbRsbR
gbRsbRgRsmbRsbRsbRsRsmbRgbRsRsmbRgLsbRsbRgRsRsmmbLsbRgbRgbRsRsmbRgRsmb
LobLibLcLsmbLcbRgRsmbRjbRgRsLsmbLsRgbLcbLibLgbLsLsmbLgbRjRsmbRoRsRsRim
mbLsbRsRsmbRgbLsbRsbRgRsmbRsRsmbRsRsmbRgbRgRsmbRgLsbRsRsmbRsbRgbLsbRgb
LgbRgbRgbRsbRgbRgbLsRgRsmbRgbRgbRgbRsRsmbRgRsmbRsRsmbRgRsmbRgbRsbRsRsR
smmbRgbRgRgbRgbRgbRgRsmbRgRsLsmbRgbRgRsmbRgRsmbRgbRgbRgRsRsmmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 41; Drug: NDMC 3 µM
bLibLibLsbLgLsbLsbLgbLsbLgLsbLgbLgbLsbLsLsmbLsLsmbLibRjbLibLhbRcbRsbRi
bRibRibLsbRibRgbLibLebLibLsbRgbLibLsbLsLsmbLgbLsbLgbLgLsbLiLsbLsLsmbLi
bLsbLiLsbLgbLibLsbLibLsLsmbLibLsLsmbLgbLgbLsRsbRgbRgbRcbRgbRgbRiLsbLsb
LibRjbLibLgLsbLhbLsLsmbLgLsbRibLiLsbLsbLgbsbLibLgbLgbLsLsmbRsbRsbLebLs
bLibsbLibRgbRsbLgbLsbLibLsbLhbLsbLsbLibLsbLgbLgbLibLgbLsRsbRsbLgLsbLsb
LebLsLsmbRsbLgbLgbLibLsbLebRsbLgbLibLibLsbLibLgbLiLsbLsbLiLsbLsbLgbLsb
LibLibLgbLibLibRsbLibRsbRibLsbLsbRcbLsbLsbLibLeLsbLibLsbLsbsbRsbLibRib
RibRgbRibLsbRgbLsbLsbRebRsbLsbLcbRgbRsbRsbLebLsbRsbRsbRibRsbsbRibRsbRg
bLgbRsbRcbRsbRgbLgbRhRsmbRsRsRsmmbRsbRsbLiLsbLsLsmbLibLsRsbLibLsbLibLs
bLsbLgbLsbLibLsbRibRhbRsbRibsbLgbLobRgbLibLgbLsbLsbLiLsbLsbRgbLibLsbLs
bsbLiLsbLsbLgbLgLsbLibLsbLibLgbLhbLsbLibRsbLhbRsbLsbRsbRsbLibLebLsLsmb
LibLsRsbLiLsbLgbLibLgbRibLhbLsbLgLsbLsbLgbLsbsbLgLsbLsbLgbLsbLgLsbLgbL
sbLsbRjbLibLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 42; Drug: NDMC 3 µM
bRibRibRgRsmbRsbRsbRsbRgRsmbRgbRgbRsbRgbRsbRibsbRiRsmbRsRsmbRsbRgbRsRs
mbRibRgbsbRgbLibsbRiRsmbRgbRibLsbLiLsLsRgRombLgRsbLsbRgbLobRibLsRgbRiL
sLsmbRcRsmbLsbLcLgbRobLcbLibRobRcbLhbLjbLsbLsLsmbLjbRhbRibLjbRjbRsRsmb
RibsbRsRsmbLgbRsbRsRgbRiRsmbLgbRibRsRsmbLgbRgbRsbRsbRgRsmbLgRsbRjbLibL
obLgbRjbLgbLgRsbRjbRcbLsbLjbRibLsbRjbLgbLcbLibLjbRjbRjbLgLsbLjbRjbLsbs
bLjbLibRcRobLgbLsbRgbLgbRjbLjbRjbLjbLjbRibRhRsmbLgbLgbLgbRgbLgbRhbLsbR
jbRibLibLibRjbLgbRsbRgbsbLgbRibRgbLsbRsbLgbRibRsbLsbRgRsmbLsRsbRjLsbLh
bLibLgbRgbLiLsbLsbRjbLjbLobRcbRsbLjbLibLgbLsbLsLsmbLsLsmbLibRibRsbRoLs
bRsbRsRsmbRjRsmbLsRsbRibRsRsmbRsRsmbLsLsmbLgbRsRsmbRibLgbLsbRibRsRsmbL
sbsbRgRsmbLsbLgbLsbRgbRhbRibsbRibLgbLjbLsbLgbLgbLgbLgbLgbLsbRsbLsbLgbL
gLsbLcbLhbRgbRgbRhbLibLcbLibLsbLgbLsbRsLsbLsbRgbLibsbLibLsLibLgbLsbLib
RgbRgbLjbLibLgbLgbLjbsbRgbLgLsLsRsmbRsRsmbLgbRcbRiLsbRgbLgbLsbRhLsbLjb
RobRgbRsbRgbRsbRgbRibRgbRibRibRgbLgbLgbLibRiRsRsRsmmmbRjbRcLsReb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 43; Drug: NDMC 10 µM
bLcbRgRsmbLhLsbLcbLsbRjbRobRgbLgbRhLsbRhbRibLgRsbLiLsbLsbLgbRsbRsbsbLs
RsbRcRsmbRcbRgbRsbLgbLjLsLsmmbsbRebRsRsRsmmbRgbRsbLgbRjRsmbRibLobLsbLg
bLgbRcbRgbLcbLgLsbLgbLgLsbRsbLgbLsbLcRebLobRsbRcbsbRiRsmbLjbLcbLibLgbR
sbLsbRjbLgbRjbLsLsmbRsbLsbLsbRsbRjbLibLsbRgbsbLsLsmbRibLsbLgbLiLsbRsbL
gbsbRsbLibLsbRjbRjbLsbRgbRjbRcbRsbRcbRcbRsbLgbLcbLsbLgbRcbRoRsmbRjRsmb
RiLsbLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 44; Drug: NDMC 10 µM
bRiRsmbRibsbRjbRibRibLibLjbRibRjbLjbLsLsmbLgLsbRjbRgbRhbLjbLhbRjbRsLsb
LiLsbLibRgbLsbLcLsmbLibsbRgRsmbRibRgbLhbLjbLgLsbRibRibRcbLgbRhbRsbRibR
gbRgbRibRgbRibRsbRiRsmbLcbRgbLgbRsbRgRsmbRobRibRgbRiRsmbRibRsbRobLgbRi
bRsbRsbRiRsmbLibLjbLhLsbRgbLcbLcbRgbLibLsbRiRsmbRcbRgbRsbLsbRibRsbLibR
hRsmbLjbLcbRsbLebRgbRgbLcbLgLsbLsbLgbRgbRgbRobsbRgbLsbRsbRsbRibLiLsbRo
bLibRsbRoLsbLgLsbLsbRhbRgbLgbLgbRcbRiRsmbRibRhbRibRsbRcbLgbRhbRibRcbRs
RsmbsbRiRsmbLibLjbLibRibLibRgbLcbRibLgbLsLsRsmbLcbLibRsbLsbRibRgbRibRc
bRibRibRgbRibLgbRibLgbRgbRibLsbRsbRgRsmbRsRsmbRsbRsRsmbLsbRibRgbRsRsmb
RgbLsbRgbRgbLsLsmbRsbsbsbsbRgbLcbRibRibRgbLsbLsbLcbRjbRjbRibRgbRsbRcbR
sbRibRibLsbRsLsbRcbLsbLsbLibRsbRcbRibLgbRsbRgbLsbRgbRcbLgbsbLjbRibsbRg
bRgbRgbRsbLgbRgbRgRsmbLgbRgRsmbLsbRsbRsLsbRsbRsbRsbRgbRgbRgbRsRsmbRibR
ibRsbRgbRgbRsbRcbRgRsmbRsLhbRibRcbLsbRibRiLsbLsbLsbRsLsbLibRgbRcbRibLg
bLsbRibLsLsmbRgbRoLsbRibRibRgbLgbRibRiRsmbRcbLgbRsbRhLsbRsbRsLsbLsbRgb
RgbLsbRsbRgbLsbRsbRgbRgbRsbRibLjbRibRcbRgbLsbRsbRibRgbLgbRgbRsbRsLsbRg
bRgbRsbRgbRibRhbRiRsmbRsbRsbRcbLibRhbRsbRgbRsRsmbRiRsmbLjbLcbLgbLgbLsb
LgbRgbLibRgLsbRcbRiRsmbLsbRsLsbRsbRgbLsRsbRgbLsbRiRsmbLjLobRibLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 45; Drug: NDMC 10 µM
bRibRcbLjLsmbRjbRibLgbRsbLibLgbLgbsbLjbLibRgbLgRsbLgbLgbRibRibLsbsbRjR
smbLgbRsLsbLibLjLsmbLgbLgbLsLsmbRgbLsbLsRsbRsbRsbRsbRsbRiLsbLsLcbRjbRs
bLsLsmbRgbLjbLjLsmbLibRjbRgbRgbsbRsbLjbRjbRibLhbRjbRcbRjbLjbLjbLjbRcbR
gbLsbRgbLsbRsbLsbRjbLgbLsbRsbsbRsbRsbRsbRsbRgRsRsmmbRiRsmbsbRsbRibRgRs
mbRsbLsLsmbLsbLgbLgbLjLsmbLsbRsbRgbRgbRgbRcbLgbLsbRcbRsRsmbLsbLjbRgbLs
bRibLjbRibRgRsmbRsbRgRsmbLsbRsRsmbLgLsbLgbLgbLibLsbLibLsbLgbLsbLgbRsbR
gbRgbRcbRgbLgbRsbRsbRsRsmbLgbLgbRibRsbRsRgbRsbLsbRsRsmbRcbRcbRibRcbLgL
sbRoRsmbRibRsbRgbRhRsmbRsbsbLsbRsbRobLgbLsbLgbLgbLcRsbRgRsmbLcRsbRsbRs
bLgbRsbsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 46; Drug: NDMC 10 µM
bLsbRgbLsLsmbRgbLsRsbRgbRsbRsbRsbRgbRcbRhbRgbsbLebLibRibRgbRsbRgbLebLc
bLibsbRjbLcbLcbLcLsmbLebLjbRjRsmbRiRsmbRhbRcbRcRsmbRibRsbLcbRgbLibLsbR
ibRhbRcbRibRebRgbRgbRgRsmbRsRsmbRsRsmbLsLsmbLgbsbLjLsmbLsbRjbLjbRjbLjb
sbRjbRjbLjbRcbRibRsRsmbRsbRjbLcLsmbLiLsbRgbRibRsbLibLcbLjbLgbRiRsmbRhb
RibRgbRsRsmbRibLcbLcbRsbRjbLsbRcbRcbRhbRgbRibLjbLsbRsRsmbRibLhbsbLibLc
bRibRjbLhbLcbLibLibRgbRgRsmbRgbLsbRgbLebLcbLiLsbRgbLgLsbRjbLsbRsbLsLhb
RhbRcbLsbRcbRebRibRiRsmbRsbRgbRgRsmbLjbRibRgRsmbLgbRiRsmbRibRcbRgbLjbL
gbRcbRebRibRiRsmbRsbLsbRsbRgbRiRsmbRgbLsbRebLcLsmbRibLjbLhbLsbLoLsmbLi
bLjLsmbRibRgbRcbRibRibRgbLibRhRsmbLibsbRcbLibsbRibLjbRjLsbLibLsRcbRobR
ibRgbRiRsmbRgbLsRsbRibLjbRibRgbLsbRsLsbRgbLjbLcbLobLibRibRgbRgbRgbLibL
cbRjbLhbLgbRjbLcbLcbRiRsmbLsbRgbRebLibLcLsmbLibRsbLsbLibLgbRgbLgLsbLsb
LgbLibLgLsbLsbLsbLsRsbLgbLsLsmbLgbLsLsLiRsLsRsmbLhbsbRcbLjbRsbRgbRgbRg
RsmbRsbRebLibLhbLibLibLhbLibRsbRgbRibRibRgRsmbLcbLcLsmbRgbRhbLobRjbRib
RjbLcbLebRcbRibRiLsbLjbRibRsLsbRgbRibLibLcbRsbLgbLsRsbLgLsbRsbLibLgbLi
bLgLsbLgbLsLsmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 47; Drug: NDMC 10 µM
bLsbsbLibLiLsbLgbLgbLsbLcbLsbLibLsbLibLsbLsbRsbLgbLsbLgbRgbLsbLibLsbLi
bLgbLiLsbLsLsmbLgbLgbLsLsmbLsLsmbLgbLgbLcbLiLsbLibRgbLibLsbLgbRgbRibLc
bLibLsLsmbLgbsbLibRsbRsbRjbRibLjbLcRsRsmbRiRsmbRsbRsbLsbLibLgbRjbRjbRs
bLgbLjbLhLsbRjbRcRsmbLibLjbLibLibLgbRcbLibLibLgbRcbRobLibRgbRgRsmbRibR
sbLjbLcbRibRibLsbLjbLjbRjbRjbRibLcbLibLjbRoRsmbRcLsbRiRsmbRsbRjbRibLjb
RibRibRsLsbRsLsRsbRibRiRsmbRsbRcbRgbRgbLsRsbRgbLjbLcbRjbRhbLjbRcbRsbRs
LsbLobRjbRsbRsbLibRgLsbLjbRcRsmbRibLibLsbRjbRjbRibRcbRibRgbRibRibRsRsm
bRsbLsbsbRjbRhRsmbRcRsmbRhbsbLsbsbLsbsbLibRsbRjRsmbRcbLcbRjbRsLsbRsLeb
sbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114236; End: 114736;
Recording: 9-1; Individual: 48; Drug: NDMC 10 µM
bLjLsmbLgLsbLgbRibLjbLgbRobLgRsbLibLsbLjbRhbRhbLsLsmbRsLsRsbRibRjRgbRs
bLgbLgLsbLgbLgbLibRjRsmbLgbRjbRjbRibLjbLibLjbLgLgbLjLgbLsbRgbLgbLsbRib
sbsbRsLgbRibLsbsbLgbLiLsbLsbsbRjbRobLhLsbRjbLjbLiLsbRsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 1; Drug: Control
bRsbsbLibRcLsbLibRsbsbLsbRcbLibRcbLcbRibLsbLhbLibRgbLsbRcbLibLgbLgLsbR
sRsmbRsbLcbRgbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 2; Drug: Control
bRsbRsbRgbRhbLiRsbRibLsbRgbRgbRsbRgbLsbRgbRgRsmbLgbRgRsmbRgbLjbRibRsbR
sbRsbRsbLgbRgRsmbLsbLsRsbRibRgbRsRsmbRgbLcLsmbLgbRsbLibRsbLibRsbRjbRob
LjbRibRgbRgbLjbLsbsbsbRibLsbRibLsbRsbRgbRsbRgbLsbRgbRsbRgRsmbLsbRibRsb
RibRgbLjbLcbLgbLsbRgbLibLibRjbRcbRibLsLsmbsbRibLsbRibRiRsmbRsbRiRsmbRg
bLsbLebLibLsbLgbLsbLsLsmbLgbLgLsbLgbLgbLsbLgLsbLsbLgbLsLsmbLgbLgbLsbLg
bLgLsbLgbLcbLibLibLibRgbLibLgbLsbLgbLsbLsLsLsmmbLgbLsbLgbLsbLsbLgbLsLs
mbLgbLgbLgbLgbLgLsbLgbLgbRsLgbLgbLgbLgbRgbRoRsmbRgbRsRsmbRgbRsbLobRgbL
ibLgLsbRgbLibRsbLgbLsLsmbLsbLgbLsbLgLsbLsbLgbLgLsbLgLsbLgRsbLsbLsLsmbL
gLsbLgbLibLgbLsbLiRsLsbLgbLsbLiLsbLgbRgbLgbLgLsLsmbRsbLibLsbLgLsbLgbLg
bLgbLgbLgbLiLsbLgbLgLsbLgbLgbLgbLgbLsLsmbRcbRibRiLsbRcbRsbLgLsbLibLsbL
iLsbLsbLgbLgbLsbLgLsbLgbLgLsbLgLsbLgbLsbLgbLsLsLsLsmmmbLibLgbLgbLgLsbL
gbLgbLsbLibLgbLsbLgbLgLsbLgbLgbLgbLgLsbLgLsbLsbLgbLgLsbLgbLgbLgbLgbLib
LeLiLsLibLgLsbLsbLgLsbLgbLgbLsLsmbLgbLgbLsbLgLsbRobRibRgbLsbLcbLgbRgbL
iLsbRgbLibLsbRsbRcbRiRsmbRibLibRhbLjbLcLsmbRibRibLcbLhbRiLsbLibLgbRsbL
gRsbLsLsmbLsLsmbLibLgbLgbLgLsbLibLgbRsbLibRjbRjbRibLcbLibRgbLgbLsbLsbL
ibLiLsbLgbLgbLibLgbLsbRjLsbRhbLjbLibRgbLibLgbLsbRsLsbLgLsbLibLgbLgbLgL
sbLgbLgRsbLgbLgbLgLsbLsLgLsLsmbLiRsbLgLsbLsbLgbLgbLgbLgbLgbLgbLgbLgLsb
LgLsbLgbLgbLgLsLsmbLiLsLgbLgLgbLiLsbLgbLgLsbLgLsbLgbLibLgbLibLsbLsbLgb
LgbLibLgbLgRsbLgbLibLgLsbLgbLgLsbLsbLgbLsbLgbLsbLgbLsLsmbLiLsbLibLgbLi
bLsbLsbLgLsbLgbLgbLsLsmbLgLsbLgbRgbRhRsmbRibRiLsbLjbRcbLjbRcbLjbLobRgb
RsbRjRsmbRgbLcLsmbLsbLibRgbLibLgLsLsmbRsbLgLsbLsbLgLsbLsbLsLsmbLgLsbLg
bLgbLgLsbLibLgbLgLsbLibLgbLgbLgbLsbLgLsbLgLsbLsbLgbLgLsbLgLsbLgbLsLsmb
LgbLgbLgLsbLsbLsbLgLsbLgbLgbLsbLgLsbLiLsbLgbLsbLiLsbLgbLgbLgLsbLgbLgbR
jbLibLibRgbLgbLsbLsLsmbLgbRgbRcbRgbRgbLgLsbRibRgbRgbRsbRgLsbLeRsbRjbLc
bRgbLcbRsbLibRgbLibRgbLiLsbLgbLsbLgbLsbLgbLsbLsbLgbLsbLsbLgbLgbLgLsbLs
bLgLsLsmbLgbLgbLgbLgbLgbLgbLgbLgbRoLsbRibLjbLcbRgRsmbRsbRsbLibLgbLgbLg
bLsbLsLsmbLsRsbLsbLgbLgbLgbLgbLgbRhbLcbLibLsbRgbLibLgLsbLsbLsbLgLsbLgb
LsbLgbLgLgLsbLgRsbRjbRibRgbLebLcbRgbLibRgbLibRsRsmbLgbLgbLsbLsLsmbRgbR
cbLgbRgRgbRgRsmbRgbRsbRsbRsbRsbRgbRoRsmbRsbRibRgbRibRgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 3; Drug: Control
bRgbLibLgbLgLsbRgbLibRsLsbLgbLgbLgbLibsbRibLibLibRibLjbLgbLsbRibLiLsbL
gbLgbLsbsbLibRgbLiLsbLsLsRsmbLsbLgbLsLsmbLgbLgbLgbLgbLsbLsRobRgLsbLcbL
iLsbLsbLgLsbLsbLgbLsbLsLsmbLgbRsLgbsbLsbLibRjbRjbRcbLibLjbLibRcbRcLsbL
jbLhbLibLgbLgbLsbLsbLgbLsbLsbLibRgbLsbLibLgbRsbLibRgbLiLsbRsbLgbLgRsRs
LsRsmbRcbLgbLcbLsbLibRgbLgLsbLgbRsbLgLsbLsbRsRsmbLgbLgbLgbLgbLsbRsbLib
RsbLgbLsbRjbLibRsLsbLsbLgbLsbLgbLiLsbLgbRjbLibRsbLgbLibRibLhbRiRsmbRsb
LhbRsbLgLsbLsbLgbLsbLjbRcbRcbLibLgbLiLsbLgLsbRsbLibLgbLgbRcbLiLsRsLsbL
iLsbRjbRsLibLsbRjbLibLsbLsLsmbRsbLibRsbLgRsbLsLsmbLsLsmbRsbLgbRgbLgbLg
bLgRsbRsLsLsmbLgRsbLgbsbLsbLgbLgbRsbLsbLgbLgbLsLsmbLsLsmbLsbRsbLsLsmbL
gbRgbsbLibLsbRsbLgbLgbLsbLsLsRsmbLgbLgbLsLsmbsbLibRibLibLibRsbLibLsbLs
bLgbLgbRsbLgbLsLgbLgbLsLsmbLibLjbRcbLgLsbRsLsbRcbLiLsbLsbLgbLgLsLsmbRg
RsmbLibLgbLgbRsRsmbLgbLsbLgbLgbsbLhLsbLgbRsbRsbsbsbLcbLsLsmbLsbLsbLgbR
gbLibLibLhLsbLsbLsLsmbLsLsLsmmbLgbsbLeLsbLsbLgbLsLsmbLgbLsbLgLsbLgbLsb
LiLsbLgbLsbLgbLsbLsLsmbLgbLsbLgbLiLsbLhbLsLsmbLsbLgLsbLsbLgbRsbLgbLgbL
sbLgbLsbLiLsbLsbLiLsbLsLsmbLsLsmbLiLsbLsLsmbLsLsmbRgRsLsmbLsbsbLgbRgLs
bLsLsmbLsbLsLsmbLsbLgbLsbLgbRsbLgLsbLgbLsLsLsmmbLgLsLsmbLsbLibLsbLsbLs
bLgbLsbLibLibRsbLgbLgbLgbLgbLsLsmbLgLsbLsbRsRsmbRcbLobLsbLiLsbLgbLsbLs
LsmbLsbsbRsbLibLibLsLsmbLsbLgbRsbLgLsbLsLsmbLibLgLsLsmbLsbLsbRsLsbLgbL
sbRgbRjRsmbLibLgLsbLgbLsbLibLsbLsbRsLsbLgbRgbLiLsbLsLsmbLibLgRsbLgbLsb
LgbLibLhbRibRibsbLsbLibLsbLgbLgbLsbLsbLgbLsbLibLsLsmbLgbsbLsbLsbRsbRsb
sbLhbLsLsmbLsbLsLsmbLsbLsbLsbLsbLsLsLsmmbLsLsmbLgbLsbLsbLgbLsbLsbLsbLs
bLgbLsLsmbLsLsmbLgbRgbLibLiLsbLsbLsbLsbLibLsLsmbRgbLobRsLsbRgbLibLsLsm
bLsLsmbLgRsbLibLsbLgLsbLgbLsLsmbLgbsbLgbRjbLiLsbRjbLgbLibLgbLsLsmbLgbL
sbLsbLgbLsbLgbLsbRgbLibLibLgbLgLsbLgbRgLsbRibRgbLjbLiLsbLoRsRsmbLobRgb
RobRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 4; Drug: Control
bRhbRibRcRsmbLeLsbLsbLcbRsLsbRsLsbLsbLsbLsbsbRhLsbRsbsbRcRsmbLibRibRgb
RcbLcbLebLsbLcbLebRibLcbLcbLsbLsbRjbRsbLiLsbLcbRgbLcLsLsmmbLgLsLsmbRcb
RcbLgLsLsmbsbRobLcbLibsbLibLgbLebLcLsmbRhbLjLsmbLcbLgbRgRsmbLhbLsLsmbL
ibRcRsmbRobLsbRsbLgbLcbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 5; Drug: Control
bLgbRibLibRibRcbLibRcbRsLsbRcbLibsbRiRsmbLsRsbLgbRjRsmbLsbRjRsmbLiLsbR
cbRgRsmbLgbLsbRsbRcbLgbRcbLgLsbRgbLsRsbRgRsmbRcRsRsRsmmmbRibRibRgbLcLs
mbLibRsbLgbsbLsbLsbRsbRsbLcbLibLibsbLgbLibRgbRsbRiRsmbRsbRibsbLsbLsbRh
bsbsbRibRsRsmbRibLsbLsLsmbRgbRsbRgbRsbLsbLsLsmbLcbLibRibLsRsbLobLibsbL
ibLsbRsbRsbLibLsbLsbLcbRgRsmbRgbRjbRibLsbRibLgbRibsbLsbLsbRibLjLsmbRib
LgRsbRsbRibRgRsmbRsbLsLsmbRibLgbLgbRhbLgbRibLgbRhLsbLgbLsbRcbRsLsbLgbR
hRsmbLgLsbRhbLsbRibLibRibLsRsbRgLsbRgbRsRsmbLsbRsbRsRsRsmmbRsLsbRgbRgR
smbLcbLobLibLcLsmbRgRsmbRsbLiLsbRcbRhbRsLsLsLsmmbLjbLjRsbRibLjbRibLgbR
ibRcbRsbRsbRibLibRsbRhbRiLsbRsbRsLsbRsRsmbRgbLsbRsbRgbRgbLgbRibLsbRhLs
bRcRsmbRsbLgRsbRibRibRgbRgbRgbRibLibLcbLibRjbLsbLibRsRsmbLgbLgRsbLibRg
bLgLsbLgbLibLibLgbRsbLibLsbLsbLgbRjbRcbRhRsmbRgLsbRgRsmbLibRgbRibLsbRs
bRgbRsbRsbRsbRsbRgbLcbLhbLgbRibRhbRibRsbRsLsbLsbRiLsbLsbRsbRibLsbRsbRg
LsbLgbRibLgbRibLsbRgRsmbRgbRgbRgbLibLjLsmbLgbLsbLgbLsbLgbLgbLsbLgbLgbR
jbRobRgbRsRsmbRsbRgRsmbRsbRsbRgbLjbRibLsbLsbRgbRgRsmbLsbRsbRsbLjLobRsR
smbLgLsbLiLsbLsbLgbLgbLsbLsLsmbLgbRjbRibRgbRgbRgbRgbLsbRibLjbLcbLhRsbR
gLsbLgbLgbLsbLsbLgbLsbLgbRsbRjbRiLsbRibLgbRibLgbRibLgbRibLgbRgRsmbRgbL
gRsbRibLsRsbRgRsmbRsbRsbRsbRgbRgbRgbRgbLibRibLjbLhbLibLgbRsbLgbRebRibR
sbRsbRsbRgbRsbRgLsbRgLsbLsRsbRgLsbLgbRibLjbLhbLgbLsbLgbRsLsbLgbLsbLgbR
cRsmbRsbLobLsbLsbLsbLsbLsRsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 6; Drug: Control
bLibLibLsLsLsmmbLibLsLsmbRibRsbLibRgbLibRibLgLsbLhbRjbRjbLgbLsbLsLsLsm
mbRibRsbRcbLcbLibLgbLjLsmbRjbRhbLcbLibLiLsbLhbsbLibLibRcRsmbRjRgbLgbLc
bLsLiLsbLgLsbLiLsbLibRsRsmbLgbLjLsmbLjbLsLsmbLsbLebRjbRiLsbLhbLibsbLjL
smbLsbLjLsmbsbRsbLibLsbLgbLcbLgbLibRsbsbRsbLibLebRsbLiLsLsmbLgbsbLjbRc
bRcbLjbRsbLibLsbLiLsbRgRsmbLibLibRiRsmbLibRibLgbLsbLibRgbLibsbRsRsmbLi
RsbLgbLsLsmbLgLsbLibRgbLibRgLsLibLibRjRsmbLgbLsbsbLgLsbRsbLibRsbRsbLgL
sbLsbLiLsbsbRgbLgbLsbLebLibRibLibLsbLgLsbLibLsbLibsbRibLibRiRsmbLibLib
LsbRgbLibLiLsbsbLibRgbLibRhbLcbRibLiLsbLiRsbRgbLibLibLsbRibLibLibLsbLg
bsbLsbLsLsmbLsLsmbLgbLibRibRsLibRgbLhLsbLibLibLcLsmbLsRsbLebLcbLibLibL
iLsbRgbLgbLsbLgbRsRsmbLibRgbLhbRhbLibLibRgbLibLgbLobLjbLibLsbRjbLsRjRc
LsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 7; Drug: NDMC 1 µM
bsbRcbRibLhbRsbRcbLcbRcLsbRcbRgLsLsmbRibRgbRgbLsbRhbLjbRibRibLobLcbLgL
sbRgbLibLsbLsbLhbLgbLgbLgLsbLgbLibLgbLgbLcLsmbRibLibLsbLsbLibRsbLgbLsb
RsbLsbLgbLibLsbRsbLibRjLsbLibRgbLibLgLsbLsbLgLsbLgRsLsbRjbLcbRcbLhbRcb
RobLcbRibRcbRgbsbRibLgbRibLsRgbRsbLcbLcbRibRhbLcbLgLsbRsbLgbLsLiRsRsRs
LsmmbRgbRcbRsbRgbLgbLgbLsbRcbLcbRjRsmbLgbLgbRsbLgbRsLgbLgbsbLgbLsbLgbR
jRsmbLsbLibLgbLjbLgbRsRsLsmbLgbLsbLgbLgRsbLgLsbRjbRcbRibLjbRibRgbRgbLg
bRgbRgbRiLsbRsbLjbLgbLgbRgbLibRgbLgbLgbLgbRjbLibsbRjbLcbRibLhbRsbRsbLg
bLibLsbLgLsbLsbLibLgbRjbLhbRibLibLsLsmbRsbLsbLgbLsbLgLsbLgRsRsLsmbRibR
iRsmbRhbLcbRcbRsbLgbRibLsbRsbRgLsbRsRibRgbLgRiRsmbRibLcbLcbRgLsbLibRsb
LgbLgbLgbLgbRjbLcbRgbLhbRgbRsbLibLgRsbRgbLcbRibRgbLobLibLsRsbRsbLibLsb
RibRcbRgbLcLsmbLcbRcbLgbLgbLiRgbLibsbRsbLgbLgLsbLsLsmbLsLsmbLgbLsbLgbL
sLsmbLgbLgbLsLsmbLgRsbRcbRcbRibRgbRsbRibRgbRsbRgbLjbRibLjbRibRibRgbsbR
ibRgbLibRcbLcbRhbLgbRgbRgbLjLsmbRhbLgRsbRhRsLsmbLgbLgbRhbLgbRgbRgbRgbR
gLsbRgbLjbLjbLgLgbLsbLibLsLsmbLsbLgRsbLsbRgbRcbRcbLgbRgbRibLsbLibLgbRc
bLjbRgbRsbLsbRibRgRsmbRgbLsbRibRgbLgbRibRsbRgbRgbRgLsbLcbLibRjbLibLhbR
jRsmbRibRgRsmbLsbRiLsbRgbRiRsmbRgbLgbRibLsbRgbRgbRsRsmbRsbRibLgbRgbRsb
RsbRgbRgbRgLsbRsRsmbRgbLsLsmbLhbLibLgLsbRjbLibRjbRhbRsbRibRibRgLgRibRs
bRsbRsbRsbRgbRgRsmbRsRsmbLjLsmbRhbLhLsbLhbRjbLgbLgbLgbRjbRhbRhbLcbLcLs
mbRjbRiRsLsmbRibLjbLhbLibLgLsbRsbLgbLibRjRsRsmmbRhbLibLgbLsbLgbLgbLsLs
mbLgLsbLsbLgbLsLsmbRjbRjRsmbLjbRcbRgbRsbRgbRgbRsRsmbRsbRgbRsRsmbRsRsmb
LsbRsbRiRsmbLsbRgLsbRsbRgbRsbRsbRsbRsLsbRibLcbLhbRcbLhbRcbRibRibLgbLcb
RcbRcLsbRgbRgbLsbRgbRiRsmbLsRsbRgbRgRsmbRgLsRsbLgbLjbLcRsbRjbRgbLjbLeb
RgbRgbRgbLgbRjLsLsmbLcbRobRibLsbLibRgbLcbRjbRhLsbRgbRibLgbRgbRgbRsbRib
LjbLgbLibLgbLgbRsbLgbLgbLgbRcbRgbRsLsbRsbRgbRgbRgbRgbLsbRgbRibRcbLsbRi
bRibLibRhbRgbLibLsLgbLgLsbLsbRsbLgbRsbLiRsbRgbLgLsbLgbLsbRsbLgbLgbLgbR
jbLhbRibLgbLgbLgbLgbLsLgbLgbRsbLsbLgbLgbRjbLcLsmbLcbRcbRibLcbLgbLibLgb
LibRsbLsLsRsmbLgLsbLsbLgRsbLsbLgbLsbLgbLgbRgRsmbLgbLgbLsbLgRsbLsbLsbLs
bLgbRcbRiRsmbLibLcbLgbLiLsbRcbLcbRjbLgbRgbLibLgbLgbLgbLgbRsbRsbLibLsbL
gbLgbLgbLgbRsbLgbRcbLcbRcbLibLibRjbLgbLibRsbLgbRsbLgbRsbLibLsLsmbLgbLs
bLgRsbRgbLgbLibRjbLibLgbLibLsLsmbRsLsLgLsbLgLsbLgbLsRsbLhbRcbRhbLcbLcb
RgbRsbLibRsbLgbLsRsbLgbRsbLiLsbRgbLgbLgbRgbLgbLgbLgRsbLgbLsbLsbLsLsmbL
gbsbLhLsbRcbLcbRhbRcLsbLjbLjbLgbLgbLgbLiLsbRsbRsbLgbRsLsbLgbRsbLgbLgbR
gLsbLgbLgbLsbLibLsLsmbRgbLibRgbLgbLgbLsLsmbLgbRgbRjbRibRibRgbLibLibRib
RibLobLhRsbRgbLcbRgbLsbLgbLsbLsbLibRsbLgLsbRsbLgbLiLoRsRsmbRgbRgbRcRsR
imbRibLibLjbLgLiRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 8; Drug: NDMC 1 µM
bRibRgbLibRobRsbLsbsbRibLobsbLgbLgbLgbRcbLsLsmbLibLcbLobRiRsmbLjbLhbRc
RsmbLcbRhLsbLcbLsbLsbLiLsbRgRsmbLgbLgbRjRsmbLibLsLsmbLibRibRsbRobLjbLs
bRcbRcbRsbLsbLgLsbLgbLibLeLsbLsbLgbRibLhbsbRgRiRsRsmmbLcbRebRibRsRsmbR
oLsRsbRibLjbRhbLibRibLgRsbRibLgbRibLjbRcbLiLsbRibLjbRhbLiLsbRobRibRibL
sbRsRsmbLibLhbRibLsRsbLibRsbsbLiLsbRgbRsbLsbLibRsbLgbLsLsmbLiLsbRibLib
LgbLgbLibRgbsbLibRgbLgbLsbLsbLgRsbLsbLgbLibsbRjbLibRjbLsbLibRsbsbLsbLs
bLgbLsbLgbLsbLsbLgLsbLibRjbRhbRibLsbRgbRsbRgbRgLsbLjbRoLsbLibLibRcbLjb
LibLiLsbLsbLsLsmbLgbLsbLsbLsbLgbLsbLgbLgbRgbLibRsbLsbLgbRgbLibLsRsbLiR
sbRjbLibLgbLsbLgbLgLsbLsbLsbLsbLsbLsbLgbLgbLsbLgLsbLgbLgbLgLsbRoLsbLjb
LiLsLsmbsbLgbLibRsbLgLsbLgbLsbLsbLsbLsLsmbRjbRcRgbLcbLsLgbRsbLsbRsbLgL
sbLsbLgRsbRsbLhbRgbLibLgLsbLsbLgbLsbRsLsRoRsmbLobRibRibLsbRgbLcbLjbLsb
LsLsLsmmbLgbRebLhbRibLhbRibLibRsbLgLsbLsRsLsbRobRjbsbLgbRjbRsbLjbRjbLc
bLsLcbRgbRcbRgbRjbLibLcbLjbRcbLcbLhbRgLsbLgLsbLgLsbLsLsmbLgbRsbLsbLibR
hbRibLibLcbRibLcbLsbLsbLgbLsbLsbLsbLgbLgbRcbRebLibRjbRjbLjbRgbLsLsmbLs
bsbRgbRgbRibLobLsbLgRsbLsRsbLgbLgbLcbRibLibLgbRgbLjbRibRgbRsbRgbLibLgb
RjbLibLibRhbLibLgbLsbLsbLsbRjbRgbLsbLsbRgbLsRsbRgbRsbLsRgbLsbLibLgbRhb
LgLsbRgbLsbRobRjLsbLob

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 9; Drug: NDMC 1 µM
bRsLsbLsLsmbLsbLsbRibRiRsmbLgbRhbRibRibRgbsbLibLiLsbLsbLsbLsbsbLcbLiRs
bRibLjLsmbLsbLsLsmbsbLgbRebRhbRcRsmbLgbRcLsLsmbLsbLsbLsbLsbRsbRsRsmbLs
bLsbRibsbRibRjbLibRjRsmbRsbsbLgbsbRsbRsbRibRibsbRsLsbRgRsRsmmbRsbRibRc
RsmbLsLsmbsbsbsbLsbLjbLibsbRiRsmbLsbLgbsbLgbLibLibLibLjLsmbLibLgbsbLib
RibLhbLiLsbLsbLsbLsLsmbLgbRhbLsbLobsbLiLsbLsbLsbRgbRjRsmbsbLjbLcbRjbRc
bLjbRcbRsbRibRsLsbLsbRcLsbLgbRiRsmbLsLsmbRibLibRcbRsbLgbRsbRsbRebRibRs
bRibLsbLsLsmbRibRsbsbRcbRcbRsbRibRsbLsbLibLibRjbRcLsRhbLsbRsLsLsmbRibR
sbsbRgbRgbRsbRsbLsbLsLsmbLcbLiRsbRjbLcLsmbLibLgbRiRsmbRsbRsbLgbLgbRcbR
cbsbLsbRcRsmbRsLsbRjbLiLsbRcbLgbRcbRsbLgbLsbsbRjRsmbLsLsmbRcbRcbsbLhbL
ibLsbLsbLibRjbRcbRsbRibRcbLibRhbLsbLgLsbsbsbRgbLibRjRsmbRgbsbLjLsmbRjb
LjbLjbRcbLjLsmbLcLsLsmmbLcLsmbLcbRhbRibLibRibsbRsbRibLibLcbRhbRcbRcLsb
sbRgbRibsbRsbsbRsRsmbLjbLgbLiLsbLiLsbLjLsLsmmbLhbLibLibRjbRcbRsRsmbRib
RiRsmbRgbRsbRsbRsbRsRsmbsbRsbRcbLgbLibLhbRhbLibsbLsLsLsmmbLsbLsbLiRsbR
ibLgbLibRjbRjbRibLjbLhbRcbRgbRibLjbLcLsmbsbRsbLibRcbRcbRibRsLsbRibLcbL
cbRjbRcbRsbRsbRibLjbRcbLibRcbRibRsbRibLgLsLsmbsbLsbRibRibLjbLcbRjbRcbL
ibRhbLsbRhbRobRsbRjbRjbRcbRgbRgbRgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 10; Drug: NDMC 1 µM
bLgLsbLsLsmbRgbLsbLgbLsbRsLsbRgbLobRsbRibsbLsbLsRsbRjRibLsbRiLsbRsbLsb
RhRsLsmbLsbLsbRsbsbLiRsbLgbLsbsbLgbLsbRiLsbLcLsmbLjbRsbLcbRsbLgbLibLib
RsbLgbLgbLgbLsbLsbLsbLsbLibLsbRsbLsbLsbLgRsbRsbLsbLgbLgLsbLgLsbLiLsbLg
bLsbLsLsmbLsbRcRsmbRsbLsbLgbLibLsbsbLsRsbLsbLgbLsbRsbRsRsRsmmbLsRsbRsb
sbLcLsmbLsbLsbRsbLgbLsbLsbLsbLgLsbRsbRsbRsbLgLsbsbRsbLgbLsbLsbLibLgbLs
bsbRsLsbLgLsbRgRsmbRsbLibLcLsmbRsbRsbRjbLgRsbRjbRiLsbRgRsmbRcbRsbLsbLs
bRebLhbRebRsbRgbRsbRsbRgbRsbRsbRgbLsRsbLsbLgbLibLgbRsbLibsbRsbRsbLgbsb
LsbLsbsbLcbLsbRsbRsbRsLsbLsbLsbLibLgbLsbLobRgbRgbRgbRgbRsbLgbLjbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 11; Drug: NDMC 1 µM
bRgbLsbRibRibRjRsmbRsbRgbRsbRgbLgLsbLibsbRjbLgLsbLgbsbLsbRsbsbLgbLibRg
bRsbLcbRsbLgbLsbRibRgbLgLsbLiLsbLibRgbLibsbRgRsmbLsLcbLsbLgbLibLibRibL
cbRibRiLsbRgbLibRibRibLsbRibsbRgbRgbRjbLibLjLsmbsbLibsbRgbRgbLsbRibRjb
sbRibLiLsbLgbLibLibsbRhbRiRsmbLsbLgbRcbLsbLgbsbRgbLjbLhbsbLgbLibLgbLib
RibRgbRsbRgbsbRgbRsbLsbLgbLobLgbLsbRgbLcbLgbLgLsbRsbRgbRgbRgbsbLjbLobR
gbLobRibRgLobLibLgbLgbRgbLiLsbRgbLsbRsbLiRsbLsLgbLgbRsbLgbRjbsbLibLsLs
mbLibRsLibLgbLgbRjbLhbRcbRibRgbRgbRgLsbRsbRsbRsRsLsmbRsbLsbRgbRsbRgLsb
RgbLsbRsbRsbRebLsbRgbLjbRgbRiRsmbRgLsbsbsbRgbRsbRsbRsRsmbRgbRsbRgRsmbR
sbRsbRgRsmbRsbRgLsbLsRsbRgLsbLsbRsbRgbLhbRgRsmbLhbRibRgbRgRsmbRgbRgRsm
bRsLsbRgbRsRsmbRsRsmbRgbRsbRgbRsbRsbRsbRgbLjbLsbLcbLibLibLgbLgbLgbLsLs
mbLsbLgbLgbLsbRcbLhbRibRibRgbLsbRgbRibRsRsmbRsbRsRsmbRsbRgbRgLsbLgbRib
LjbRibRgLjbsbRibRgRsmbRgRsmbRgLsRsbRsbRgbRsbRsbRsbRgbRsRsmbRgbLgbRibLg
bRgbRgbRgbRsbRgbRgbRgbLgbRgRsmbRgLsbRgRsmbRgRsmbRsbRgRsmbRsbRsRsmbRgbR
gbLjbRsbLoRsbLgbLsRsbLgbLgRsbLsLsmbRgbLgbLgRsbRgbLgbRibLsRsbRsbRgbRgbL
sbRgRsRgmbRgbRsbRsbRsbRsbRgbRgbRgRsmbRsbLsbRgbRgbRgbRgRsmbRsLsbRgbRsRs
mbRgbRsbLsLsmbRgRsmbLcbRibRibLsbRgbRgLsbRgbLgbRgbRsbRsRsmbRgRsmbRsbRgb
RgbsbRgRsmbRibRgbLibRibRgLsbRgbRsRsmbRsbRsRsmbRsbRsbRsbRgbRibLibLobLsb
LgbLsRsLsbRgLsbRjRsmbRiRsmbRiRgbRgbRgbRsRsmbRsbRsbRsbRgbRsbRsbRgbRgbLc
bRibRgbRgbLsbRgRsmbRgbRsbRgbRgRsmbRsbRgbLsbRgbRsRgRsmbLjRsLibLgbLgRsbL
gbsbLibRjbRsbRgbRsbRsbRsbRsbRgbRibRsRgbRgbLjbLhbRiRgbRgLsbRsbRsbLsbRgR
smbLsbRgRsmbRgbRgRsmbRgbRgbRsRsmbRgbLsbRgbRgbLjbRgRsmbRgbRgbRgbRgbRgbL
sLsmbRsbRgbRgbRgbRgbRgbLsbRgbRgbRgbRgLsLsmbRsRgbRgRsmbRgbLsbRgbRibLjbL
hbLgbLgbLgLsbLgbRcRsmbRgbRsbRibRgRsmbRsbRgbLgbRibLibRgRsLsmbRibRgbRsbR
gRgbRgRsmbRgbRsbRsbRgbRsbRibRsbLjLsmbRgbRgbRgRsmbRsRsmbRgbRibLjbLcbLib
LsbsbLsLsmbLgbLgLsbLgbRjbLgbRjbLibLsbLgRsbLgbRsbLgbLsbLgbLgbLsbLgbLsLg
bRhbRibRgbRgRsmbRsbRsbLsbRgRoLsbLhbLgLsbRsbLobLibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 12; Drug: NDMC 1 µM
bRgbRibsbRgbLibRsbRibLgbRsbRgLsbRsRsmbRsbRsbRgbLsRgbRgbRgRsmbRgbRgRsmb
RgbRgbRibLjbRibLgbLsbRiRsmbRiLsRsbRsbRgbRsRsRgmbRgRsmbRgRgRsmbRibRgLsb
RibLjbRibRibLgbLgbRhbLgLsbRhbRsbsbRgbLjbRjbLibRjbLjLsmbRjRsmbLjbRjLsbL
jbLjbRibsbLjbRgbLgbRjbLjLsmbRibLjbRgbsbLgbLhbRcbLgbRjbLhbRibLibRcbLjbL
ibRcbRcbLcbLjLsmbRcbLhbLjbRsbRcbLjbLhbLjbRjLsbLiLsbLsbLiLsbRjbLsbLibLs
LsmbRsbRcbLhbLgbLgbRibRsbLgbRobLjbLibRjbLcbRcbLjbLgbRhbLjLsLsmmbLgbRjb
RhbLsbRibLibRcbLhbRcbLiLsbLjbLgbRcbRcbLibRsRjbLjbLhbRgbRhbRjbLcbLgbRiR
smbRgbLsbsbsbLsbRgbRsRsLsmbLsbRgbRsbRsbRsbRsRsmbRsbRgbRsLibRgRsmbRsRsR
smmbRgbRgbRsRsmbLgbRibRibLgLsbRcbLcLsmbRibLsbLibLjLsmbRibRcbLhbLcRsbLj
LsmbRjbLgbLgbRjbRsbLsbsbRjLsbRcRsmbLcLsmbRjbLhbRjbRiRsmbLibLsRsRsmbsbR
sRsmbLjbRibRjbLsLsmbLibRjRsmbLibRjbLibLjLsmbRjbLjbLgbRobLjbRibLcbLiLsb
RebLjbLibRobLjbRjbRhbLibRsbRiLsbLjbRibLebRgbLjbRobLobLcLsmbLgbRjbLhLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 13; Drug: NDMC 3 µM
bLhbLibLgbLsbLsbRcbLhbRcbLjbRcbLgRsbRibLsbRgbLobLhbLgbLibsbRibRibLibLi
bRgbLgbLsbLgbLgbRjbLiLsbRibRcbLcbLobRcbLcbLibRjbLcbLgbLsbLgbRsLsbRsbLi
bRsbRcLsbRibLjLsmbRsbLcbLiLsbRgbRsbLhLsbRgbLgbLgbLsbLibRjbLcbRebLiLsbL
gbLsLsmbLsbLgbLsbLsbLgbLsbLgbLgLsbLsbRcbRcbRcRsRsLsmmbRcbRibLiLsbRibLc
LsmbLibLgbRgbLibRibLibLsbRsbLgbLgbLsbLgbLgRsbRjbLcbRibLhbRibLibsbLgbLg
RsbRgbLgbLgbLsbLsbLsLsmbRgbLgbLiRsLsbLgbLgbRjbLibLgRsbLsbLgbLgLsbLibRi
bRcbLcbLcbRiRsmbLibRgLsbLibRgLsbLgRsbLgLsbLsLsmbLsLsmbLsbLsbLcbRcbRcbR
sbRibLhLsbLjbLcbRibLcLsmbRgbRgbLcbRibLcbRibLiLsbRgbLcbRibLibRcbRcbsbLi
bLgLsbLibLgLsbRsbLsbLgbRsbLsbLsbLgbRsbLibRsbRibRgbLcbLibRgbLibRgbLgbLs
bLgbLsbLgLsbLsbLsbRsbLgbLgbRsbLgbRsbLibLsbLiLsbRgbLibRjRsmbRcbRibLjbLh
bLsbLiRsbRibRcbRcLsbLhLsbLjbLiLsbLgbRsbRjbRcbRibLgbRibLgbLcbLhbRcbLibR
sbRsbLibRsbLgbLsbLgbLgLsbLibLhLibRcbRibRhbLjbLibLgbLibLsbLsbRgLsbLibLs
bRsbLgbLsbRcbLcbRhbRcbLcbLhbRjbLhLsbRgbLgbLsbLsRsbRsbLgLsbLgLsbRsbLgbL
ibRjbRcbRgbLobLhbRibLgbLsbRsbLsbLgLsbLsbLsbLsRsbLgbLsbLgbLgbLgbRgbRcbR
gbRgRsmbLsbRibRcbLibLsbLgLsbRibLgbLibLcbRibLibLcbLcLsmbRgRsmbRcRsmbLgb
LgLsbLiRsbRgbRsbRcbRobsbLcbLgbLsbRibsbLibLiRsbRsbRcbRibLibRgRsmbRgbLsb
RgbRibLgbRibLgRsbRibLsbRibLibRiRsmbRgbLibRibRgbRsbRsRsmbRsbRgLsbRsLsbR
gbRsbRsRsRsmmbRgbRcbLibsbLibLgbRjbRibRgbLhbLcLsmbRcbLhbLgRsbRsbLgbLgLs
bLsLsmbLsbLsRsbLiRsLsbLgRsbLsbLsbLgbLsbLgbLibRcbRcbLsbRgbRibLgbRiRsmbL
jbRibLjbLibLibRsbLcbRgbRhbLsbRiRsmbRgbRgbLsLsmbRgbRsbLcRsbRgbLibRsLsbL
ibLsbLgbLsbLsbLgLsbLgLsbRsRsmbLgLsLsmbRgbLibLsbRcbRcbLgbRgbRgbRibRsbLc
RsbLhRsbLibRgbRgRsmbLcbLiRsbRgbLibRibLhbRgbLgbLsbRiRsmbRibLjbLcbLibRgb
LibLibRsbRgbLsbRgbLcLsmbRibLcbRibLcbRiLsbLiLsbLsbRsbLsbRjbRhbLcRsbRcbR
ibLhbLcbRjbLhbLgRsbLgLsbRsLsRsbLsLsmbRsbRsLsbLgbLsbLsbLsbLiRsbRjbLibRg
LsbLgbLsLsmbLsLsmbRsbLgbLsbRjbLibLsbLgbLsbRsbLibLibLibRgbLgLsbRsLsbLib
LibLsbLgbLsbLgbLsbRjbRjRsmbRibLjbLebLibRsbLgbLsbLsbLgbRcbRsbRibLjRsbLs
RsLcLsmbLiLsbRsbLsLgbLgbRjbLibLibLgbLsbRsbLgLsbLibRjbRcbLcLsmbLoRsbRiR
cbLoLsmbLibRsbRsbLgbRsbLibLsbLibRsbLgbLsbLgbRsLsbLgbLgbLgLsbLiRsbRjbLg
bLibRgLsbRibLcbRcbLcbRjbRhbLhbLiLsbLibLsbLsbLgbLgbLjbLobRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 14; Drug: NDMC 3 µM
bRsbRcbLjbLcbRhbRibRsLgbLjbLibLgbLgLsbRjbLobRcbLhbLsbLsbLgLsbRsLsbRibR
cbLjbRcLsbLiLsbLcbsbRsRcRibRgbRsbRgbRsbRsbRsbRsbRgbRsbRgRsmbRsRsmbRsbR
gbRsbRsbRgRsmbLgbLjLibLibRjbRcbLibRibLsbRiLsRsbRgRsmbLjbRhbLibRhbLjRsb
LeLsbLobRibRsLhbRjbRcbLibRhbLjbLcbLgbLsbLgbLsbLibRcbLcbRjbRcbLcbLibLgb
LibRjbRcbLibLcbRgbLgbLibRsbLiRsbRobRgbRsbRgRsmbLsbLsRgbRsbRgbRsbRsbRgb
LsbRibRgRsmbRsbRgbLsbRgbRsRsmbRgbRgbLsRsbRgRsmbRgRsmbLsbRgbRgbLjbRibRs
bRgbLgbRgbRsbRsbRsbRsbRiRsmbRsbLjbLjbLiRsbRjbRcbRgbRgbRgbLcbRcbLcRsbRc
bLibRobLibLibLibLibRjbLibRobLjbLcbRibRcbLibLjbLibLgbRgbLgbRsbLgbLgbLgR
gbRjbRgbRgbRsbRsbRsRsmbRibLgbRibLjbRibLsbRibLjLsmbRibLgbRibRsLsbRsbRib
LgbRiRsmbRibLjRsbRibLsbRiRsmbLgLsbRoLsbLibLsbLcbRsLibRjbRcbLsbRsRgbRgb
RsbRsbLsbRcbLcbRhRsmbRgRsmbRsbRsbLsbRibRiLsbLibRgRsmbRgbRsRsRsmmbRgbRg
bRsbRsbRsLsbRsRsmbRgbRgbRsLcbRjbLcbRcbLhbRcbLhLibRhbRcbLcbRibRiRsmbLgb
RibRcLsbLsbLsbRgbRgbRsbRgbRgRsmbRgbLgbRibRsbRsbRsRsmbRgRsmbLsLsmbLibRc
bLcbLhbRhbRcbLjbRcbLgLsbRsLsbRibRgbRgbRsRsmbLsbRgbRgbRsbRgbRgRsmbRsbRg
bRsbRibLcbRcbRibLhbRcbLgRsLsbRgRsmbRgbLsbRgbRibRgbLsbRgRsmbRgbRgbRsbRg
bRsbRgbLsbRibLcbLhbRhbLcRsbRcbRoRsmbLhbLhbLiRsbRcbRobRgRsmbLgbLsRsbRib
RibLgbRgbRsbRgbRsbRgbRgbRgbRgRsmbRgbLjbLcbRjbLcbRcbRcbLgLsbLjbLcbRhbRi
bLjbLcRsbRjRsmbLobRgbRgbRsRsmbRsbRsbRgbLjLsmbLgRsbLgLsbLgLsbRcbRoLsbLi
RsbLgbRcbRibLgLsbRiRsmbLgbRiRsmbsbRibRibLibRgRsmbRgbLjbLobRjbRsRibLsbR
hbRgRsRsmmbRgbRgRsmbRsbRgbLsbRgbRsbRgbRsbRibRsbLsbRgbRgbRgbRsbRgbRgbRg
bRgbRgbLgbRiRsmbLsbRiRsmbRsbRibLgbRiRsmbLobLgbLgbLgbLgbRcbRgbRsbLsbRgb
RgRsmbRsbRgbRsbRibLjLsmbLeLsbRhbRibRgbLjbLobLibLgRsbLgbLgbLgbLgRsbLgbR
hbRcRsLsmbLibRibRibLsbRgLsbLsbLsbRibRsbRgbLsbRiRsmbLsbRibRsbRgbRsbRgLs
bLsbRgbRgbRsbRsbLsRgbRgbRsRsmbRgRsmbRgbRgbRsbRibLjbLcbLibRjbRcbLibLhLs
bLibRcbLsbRibLgbRibLgbRiRsmbRsbsbRsbRsLsbLsbRgRsmbRgbRsbRsbRgLsRsbRgbR
sbRgbLsbRibRiLsLsmbLhbRibRibLgbRibLjbLcLsmbLibRcbLibLhbLiLsbRjbRsbRcbL
jLsmbRobLgbLibLiLsbLgbRsbLgbLsbLibLsbLsLgbLsLsmbLsbLsbRsLgbLiLsbRjbLsR
cbRsbRibRsbRsbRsbRgbRsbRgbRgbLgbRgbRsbRgRsmbRgbLsbRgbRsRsmbLsbRgbRgRsm
bRgbRsbRiLsbLgbRgbRgRsmbRsbRsbRgbRsRsmbRgRsmbRsbRgRsmbRsbRgbLgbLjLibRs
LibRgbLibRjbLebLsLsmbLibRjbLibRcbLjLgbRcbLhbLgbLgbLsbLgLsbRsRsmbLgLsbL
gbLsbLgRsbLgRjbLhbRebRiRsmbRgRsmbRsbRgRgbLsbRsRsmbRgbRsbRgRsmbLsbRgbRs
bRgbRgRsmbLsbRgbRsRobRgbRobRsbLjbReb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 15; Drug: NDMC 3 µM
bLsbRjbLibRjbRibRgRsmbRgbLcbLibLsbLgbLgbRjbLsbLgbLgbLgLsbLsLsmbLsbLgbL
gbLgbRgbLgRsLsbLgRsbLgbLgbLsbLsbLgLsbLsbLgLsbLgbLsbLsLsmbLibRjbRcRsRgR
sLsRsmmbRgRsmbRgbRgbLsbRibRhbRsbRibLibLsbLibRgbLgbLgbLsbLsbLsbLsbLgLsb
LgbRjbLiLsbLsbLgbLsbLsbLgbLgLsbLsbLgbLsbLsbLgbLsbRjbLgbLgbLsbLgLsbLgbL
sbLgLsbLgbLgbLsbLgbLsbLsbLgLsbLgbsbLgbLgbLgbRjLgbsbLgRsbLsbLgRsbLgbLsb
LgbLgbRsLgbLgbsbLsbLgLsbLgbLgbRsbLgbRgbLgbLsbLgRsbLgbLgbLgbLsLsmbLgLsb
LgbRjRhbRibLgbLhLsLsmbLibRgbLgLsLsmbLgLsbLgbRsLsbLgLsbLsbLsbLgLsLsmbLg
bLgLsbLgLsLsmbRsbLgbLgbLsbLgbLsLsmbLsbLgbLsbLsRsbLgbRsbLgbRsbLgbLsbLgb
LgbRsbLgbLgbRjLsbLgLsbRgLsbRsLgLsLsmbLgbLgbLsbLsbLsbLibLsbLgbLgbRgbLiL
sbRsbLgbLgbLgLsbLsbLgbRgbRsbLibLsbLgbLgLsbLgbLgbRgbLgLsbLgbLgbLsbLgbLs
bLgbLgbLgbLgLsbLibRhbRgbRgbLcbLibLsbLjbLsLsmbLgbLgbLsbLgbLgbRjbLhbRgbL
sLgbLgbLsbLsbLgbLsbLgbLsbLgbLgbLgbLgbLgbLgbLsLsmbRsLgbLsbLgbLgbLgbLgbL
gbLsbLgbLgbRsbLgbLsbLsbLgbLgbLgLsRsbLgRsbRsbLgbLsbLgbLgbLsbLgLsLsmbLgb
LsLsLsmmbLgLsbLgbLsbLgbLgLsbLgbLgLsbRsbLgbLgbLgbLsbLgLsbLsLsmbLgbRgbLg
bRsbLgbRsLsbLgbLsLsmbLsbsbLgbLgLsbLgLsbLgbRsLsbRsLgbLiLsbRgLsbLgbLgbLg
bLgbLsbLgbLsbLgbRsbLsbLsbLsbRsbLsbLsbLsbRsbLgbLgbLgbLgLsbLsRsbLgLsLsmb
LgbLsLsLsmmbLgbRobRibRibLsbRibRgbLiLsbLcbRsLgbLsLsmbLibLsbLgbLgLsbLgbL
gbLgbLgbLgbLgLsbLgbLibRsbLgbLsbLgbLgbRsLsbLsbLgbLsbLgLsbLgLsbLsbLsLsmb
LsbLgbLsbLgLsbLgbRsbLgbLsbLgLsbRsbLgbLsbLsLsmbLgbLgbLgbLgbRsLsbLgLsbLs
bLgbLgbRgbLgbsbRsbsbLgLsbRsbLgbLgbRgbLgLsbLgbLgLsbLsbLgbRsbLgLsbLgbRsb
LsbLsbLgbLgbLgRsbRsbRjbRibRgbRgRsLsmbRgbRsbLsbRgbRgbLcbLgbLgLsbLgbLsbL
gbRobLoRsbLgLsbRsLsbLgRsbLsbRsbLgRsbLsLsmbLgbLsbLsbLsbRsbLgLsbLgLsbLgb
LgLsbLsLsmbsbLgbLsLsLsmmbLgbLsLsmbLgbLsLsmbLsbLgbLsbLgbLgbRgbLibLgbLsb
LgbRsbLgbRsLsbLgLsbLgLsbLgLsbLgbLgbLgbLsbRsLgLsRsbLgbRsbLgbLgbsbLsbLgb
LgbRcbRsLsbRgRsmbRgbLjLsmbLcbLsbLgbLgbLgbLgLsbRgbLibRsbLgLsbLsbLgbLsbL
sLsmbLgbLgbLgbLgbLsbLgbLsLsmbLgbLgLsbLgLsbRjbRcRgLsbRgbRgRsmbRsbRgRsRs
mmbRgLsbLcbLgbLgLsbLsbLsbLgbRsbLsLsmbLgLsbLgRsbLgbLsbLgLsbLsbLgbLgLsbL
gbLgRsbLsbLgbLsbLgbRgbRcbRgLsbLibLibLgLsbRsLsbLgbRgbLsbRjbRibRgbRibLhb
LcbRjbLgbLibLsbLsbLgRsbRsRsmbLibRsbLibRsbLgbLgbLgbLgLsbLgbLsbLsbLgbLgb
LgRsbLsLsmbLgbLgLsbLgbLgbLgLsbRgbLsRcbRgRsRsRsmmmbRsbLcLsmbRibRibRgbRg
bRgbRsLsbRgRsmbLcbRsLgRsbLgbLgLsRsbLgbRsLsbLgbLgbLsbLsbLsbLsRsbLsbRsbs
bLgbLgbLsbLgbLgLsbRgbsbRcRsmbRgbRgRsmbLcbLibRjbRibRgLsbRgRsmbLjbLiRsbL
gbLsbRiLsRsbLsbRgLsbLjbLibRsbLsbLcRsRsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 16; Drug: NDMC 3 µM
bLgbLsRsbLgbRiRsmbLibLsbRgbLsbLgbLsbLgbLsLsmbLgbLsbLgbRjbRgRsmbRsbRsbL
sbRibLjbLsLsmbRibLobLibRibRhbRgbLcLsmbRjbRhbLjbLobRgbLiLsbLgbRgbLhbRsb
RgbLibRsLsbLhRsbRiRsRsmmbLgbLgLsbsbLgbRobRgbRsbRsbRsbRsbRsbRgRsmbRgbRi
bLibLcbRcbRgbLjbLcbRgbRsRhbLcbLibRcbLibRibRgbRsbRgRsLsmbLoLsmbLgbsbLib
RsbRsbLibRjbLcbRhbLibRcbRgRsmbRiRsmbRibLsbRsbRgRsmbRsbRsbRsbRgbLcLsmbL
ibRjbsbRcbRibLjbRcbLhbLobRjbLgbLgbLgbLgLsbLsbLgRgbRcbRibLjbRiLsbLcbRcL
sRsbRibLcLsmbLcbRhbRcbLibRjRsmbLsRsbLsbRgbLsRsbRgbRgbRgbLsbRgRsmbRgbRs
bRsbRgLsbRgbRsbRgbRgRgbRgRsmbRgbRsbRgbLobLcbRcbLcbLibRjbRcbLjbLibRcbRi
bRiRsmbLiRsbLibLibRobRgbRgbRsbRhbLibRiRgRsRsmmbLsbRgbRgbRsbRgRsmbRgRsm
bRsbRsbRsRsmbRgRsmbRgbRsbRgbRsRgbLhbLcLsmbRiRsmbLcbRhbRcbLgbRgbRibRgbR
sbRsbRsbRsbRsbRgLsbRsRsmbRsbRgRsmbLsRsbRgbRsbRgbRsRsmbRsbRsRsmbRgRsRsm
mbRgbRibLcbLcRsbLgbLgbLsbLgLsbRcbRibRibLibRibRgbRsRsmbRgbRsbRsbRiRsRsm
mbRgbRgbRsRsRsmmbRgbRgbRsbRgRsmbRsbRgbLgbRgbRsRsmbRgbLgbRibRsbLcbLgLib
LcbRcbLcbRgbLibRoLsbRgbRibRsbRsbLsLsmbRgRsRgRsmmbRgbRsbRsRsmbRgbRgRsmb
RsbRsbRgbRgRgbRgbRgbRsbRsbRgbRgRsmbLgbLsLcbLgbLgbLgbLibRjbRcbRgRsmbRgb
LgbRibLsLsmbRgbRgbRsbRsbRibLgbRibRsbRsbRsbRgbRgbLcbLcbRgbLhbRiLsbLibRs
bLibRjbRcbRibRhbLgbRiRsmbRsbLgbRgbRgbRsRsmbRgRsmbRgbRgbLsbRgLsRsbRibRg
bRsbRsbRibRgRsmbRsbRsbRiRsmbRsbRgbRgbRgRsmbRgRsmbRgbRgbRgbLjbLcbLhbRib
LhbLgbRjbLibRsbLibRjbLiRsbLibRibLgbLgbLgbRcbRhbLibLsRibLjbRgbRgbRsbRgR
smbRsbRsbRsbRgRsmbRsRsmbLsbRsbRgbRgbRgbRgbRgbLsRsbRibLcbLibRjbRcbRhbLi
RsbLjbLhbRjbRcbRcLibLgbLhbLgbLibRibLhbRibLcbRgbRsbLiRsbLgbRsbLsbLgbRgb
LgbLgLsbLgbLgbRsbLgbLgbRgbLgbLgLsbLsbLgbRibRobRibLjbsbLoLsmbRsbsbLgLsb
LgbLsbRsbLgbRsbRcbRhbLhbLibLibRibLiRsbLsbLsbLgbRsbLsbLgbLsRsbRcbRibLgb
RgbRsbRsbRsbRsbRsbLcbLibRsbLgbLsbRibRibRibLgbRgRsmbLsRsbRsbRgbRgbLsbRg
LsbRgbRgbRibRsRsmbRgbRgRsmbRsbRgbRgRsmbRsLsbLcbLgbLgLsbLsbLsbLibRjbRib
RiRsmbRibRibLibLhRsbLsLgbLsbLsLsmbRibRibRsbLsbRiRsmbRsbRsbRsbRgbRgRsmb
RsbRsbRgbRsRsmbLsbRibLcbLgbRhbRiRsmbRsbRgbRgbLcbRjLsbLoRsLsbRcbLiRsbLi
bRgbLgbRgbLhRsbRibRcbLsbRiLsbLgbRibRsbLsbRgbRgbRgbRgbRsbRgRsmbRsRsmbRi
bRsbRsbRgbRgRsmbRgbRgbRgbLsLjbLcLsmbRsRjbLibLgbRsbLgbLsbLgbLgbLsbRsbRj
bRhbLjbRibRsbRsbRsbRgbRsbRgbRgRsmbRsbRsbRsRsmbRsbRiRgbLgbRsLibLgbLgbRj
bLcLsmbRhbRoLsbLhbRjbRibRsRsLsmbLsbLibLibRcbLgbRibRsbRsRsmbRgRsmbRgbRs
bRsbRsbRgbRsRsmbRgbRibLjbRibLjbLibLgbLgRsbLgLsbLsLsmbRsbLgbLsLsmbRcbRc
LsbLgRsbRgbRgbLgbRiRsmbRgbRsbRsbRsRsmbRsbRhLsbLibLsbRibRgRsmbRsbLsbRgb
RgbRgLsbRgbLjLcbLgbLgbRjRcbLgbRibRgRsmbRibLjbRibRsRoRsmbRsbRobLibLsbRg
bRhbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 17; Drug: NDMC 3 µM
bRsbsbRgRsmbRsbLjLsmbLsbRjRsmbRjRsmbLhLsbLcbLcbLsbRibRibRcbRgbRsRsmbRs
LsbRgbLsbRsbRibLgLsbRoRsmbRsbLsbLiLsbLcbLsbRsbLcbLgbRibRsbRsbLebLebRiR
smbLsbLsbLibLibRibLibLsbLhbLsbLsbRsbLhbsbRjRsmbLibRgbLcbLhLsbLibRibRgR
smbLgbLsbRhbLgbLsbRibLsbRibRsbRgbsbLsbLebLhbLibRhbsbLsLsmbLcLsmbLgbLsb
RsbRhRsmbRcbLibLjbLsRsbLcbRibRjbLjbLibRcbLhbLibRgbLcbRcbLcbLgbRsbRjbLh
bLiLsbRibLiRsbLibRgbRjbRcbLibRcbLiRsbLsbLcbLibRiRsmbLiLsbRgbLibLibRgbL
gbLhbLhbRibLgbLsbLiLsbLgbLgLsbLsLsRsmbRibLgbLgbLibRibLhbRibRcbRiLsbLsb
RibLjbRcRsmbLibRgbLsbRcbLibLhbLibRgbLcbRgbRsbLgbLgLsbLgbRsRsmbLgbLsbLg
bLibRjbLibLsLsmbLgLsbLibLsbRgbLiLsbRgbLgLsbLgbLgbLsbLsbLgbLgbRgRsmbLib
RgbLgbLsLsmbsbLgRsbLgbRsbLibLgbLgbLsbLgLsbRobLibRsbRcbLibLcRsbLibRsbLg
bRgbRsLsbLsbLhbLgbRjRsmbRhbLhbRjbLcbRhbLiLsbLgbLgbLsbsbRgbLibRgRsmbLgL
sbLgbLgbRsbLgbRjbLhbLsbLjLsmbRiRsmbRsbLibRjbLcbRiLsbRsbLhbLibRibRsbLib
LgbLibLhLsbLibLgbRgbRcbLibLgbRhbLjbLcLsmbLgbRgbLibRjRsmbLjbLgbRjbLsbLi
LsbLgbRiRsmbRgRsmbRgbRcbRgbRsbRgbLjbLsLcbLgbLhbRjbLjbLcLsmbLhLsbLibRib
LsRsbRhbLcbRebLjLsmbRhbRgbsbRsbRgbLgbRibLsLsmbRgbLgbRibRoRsmbLhbRibLsR
iRsmbRgbRgbRsRsmbRsRsmbRgbRsbRgbRgbLsbRgbLsbRiLsbLjbRcbLcbRibRibLsbRib
RgbLgbRhbRgbLibRiRsmbRgbLgbRsbRgbRgbRgbRgLsbRgLsbRsbRsLsbRibRgRsmbLiLs
bRiRsmbLibRiRsmbRiRsmbRsRsmbRgbRgRsmbRgLsbRgbRgRoRsmbLsbRgRsmbLsbLjbLs
bRjbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 18; Drug: NDMC 3 µM
bRsbLgLsLsmbLibRgbLibLsbsbLgbLsbRsbLsbLsRsRsmbLsbLibLgbLsbLgbLgLsbLsbL
sLsmbLgbLgbRsbRjbRsbRsbLsbLgbLgbLsbLsbLgbRgbRcbRiLsbLjbsbLcbRgLsbLibLg
LsbRgbLiLsbLsbLgbLsbRgbLibRsLsbLgbLgbLibRibLsbLgLsLsmbLibRgbLiLsbRgbLi
LsbLsbLgbLsbLibLgbLsbLgbLsRsbLgbLgbRibLhbRgbLibRgbLibRgbLibLsbLibRgbLg
bLsbRsbLibLsbLgLsLgbLgLsbLgLsbLgbLsLsLsmmbLgbLgbLgbRjRsmbLiRsRsmbLsbsb
sbRsLsbLsbLiLsbRgbLibRgRsmbLibLiLsbLsbRsbRibRcLsRsbLobLcbRibLgbLsbLgbR
gRsmbsbLgLsbLgbLgbLgLsRsbLgLsbLgLsbLgbLgbRgbReRsmbRibLcbLibRhbRibRibLc
bLhbRiLsbLibRsbLgLsbLgRsLgbLgbLgbRgbLibRsbLgbLhbRibLiLsbRibLgbLgbRgLsb
LibLgbLsbLgbLgLgbLgbRgbLibRgLsRsbLibRgbLibLgRsbLgbRsbLgbLsLsmbLgLsbLgL
gbLgLsbLgbLgbLgbLgbRcbRibRgbLcLsmbLhbRgbLsbLgbLgbLsbLsLsLsmmbLgLsbLgbL
gbLgLsbLiRsbLgLsbRjbLhbRgbLhLsbRiRsmbLoRsbRibLcbsbRsbLgbLgbRsbLsLsLsmm
bLsbRsbLibRjbLsLgbLgbLsbLgbLsbLgbLgbRjbRcbRibRobLhbLcbRsbLiLsbRsLsbLib
RsbLsRsbLgbLsbLsbsbLsbLgLsLsmbLgLsbLgLsbLgbLgbRgbLgbLgbLgLsbLsbLiLsbRg
bLibLibLgLsbLgbLgbLsbLsbLgbRgbLhbRgbLsLiLsbLgbLgLsbLgbLiRsbLgRsbLsbLsb
LgLsbLgbLgbRjbRcbRgRsmbRgbLgbRgbRibLjbLcbRsbLhbsbLsbLsbLibLsbLgbLsLsmb
LsLsmbLgLsbLsbLsbLibRgbLibRsbLgbLgLsbLgbLgbRgbLiLsbLgbRsRsmbLiLsbRsbLg
bRgbLgbRgbsbLsLgbLsbLgRsbLgbLiLsbRsbLgLsbLsbLgLsbLgbLsbLgbLsbLgbRgbLhL
sbLhbRibLibRibRiRsRgmbRgbRsbRgbsbRobLcbRgbRhbRjbLiLsbLsbRibLgLsbRgbLgb
RibRsbLjbRgbRibRgbRgbRgbRgbLcbLibRgbLhbLibRibRsLsbLibLsbLgbRjbLibLgbLj
bRgbLibRibLiLsbLsbLsbLsbLgbLsRsbLgbLgbRsbLiLsbRgbLgbRgbLgbLsbLgbLgLgLs
bLgbLgbLgRsLsbRjbLibRsbLgbRgbRsbRsbRsLsRcRsmbLcLsmbLcbsbRibRgbLgLsbLib
RgbLibsbRsbLgLsLsmbRgRsmbLgLsbLgLsbLsbRsbRgbRgLsbRobLsRgbRibLjbLcbRjbR
hbRgbRibLjbLcbLgbLgbLsLsmbLsbLsbRsbLsbLsbRsLsbLgLgLgLsLsmbLgbLgbRcbLjb
LcbRiLsbLibLibRgbLsbLibLsbLgbLsbLgbRgbLgbRsbsbLgLsbLgbLgbRgbLibRcbLhLs
bLiLsbRsbLibRgbLibRsbLgbRsbsbLgLsbLsbLgbLgbLgbLgbLgbRjbRcbRibRgbLjbRib
LjbRibRjbLgbLcLcRsbLibLgbLsbLibLsbLsbLgbLgLsbLgbLgLsbLsLibLsbLgbLgbRgb
LibRjbRcbRiLsbLebLcbLsbLgbLgbsbLgLsbLsbLgbLsbLsbLsbLsLsmbLsLsmbLsRsbLg
bRobRibRgbRgbRsbLgbRsbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 19; Drug: NDMC 10 µM
bRsbRsbLsbRgbRgbRsbRibLjbRcbLgRsbRgRibRgRsmbRgbRgRgbRgRsmbRsbRgbRgRsmb
RgbRgRsRsmmbRsLsRsbsbRgRsRsRiRsmmmbRgRgLsRsRgbRgbRgbRgbLcbLgbLibRebRiR
smbRibRibRgbLjbRcRsmbLhbLjbLibRgbLibRibRibLsLsmbRoLsbLcbRgbRiRsmbRibRs
bRcRsmbLibRibLjbRibLcbLcRsbRibLcbRcbLcbLcbRibRsbLsLsmbLsbLobRcbRobRsLh
bRiRsmbRgbRsbRgbRgRsmbRsbRsbRgbRsbRsLsbLsbRgbRgLsbRgbRgbLcbLgRsLsbLgbL
gRsbRobLhbLhbRibLibLibRgbLibRjLsbLiLsbRsbLgbLgbLsLsmbLsLsmbLgbLjbLsbLs
bLgbLsbLsLsmbLgbLgbLgbLgbLgbLgLsbRoLsbRsbLsbRibLsbRgbRgRsmbLsbRgbLcbLc
bLcLsmbRibRibRgbLcbRcbRcbLjRsbRgbRsbRgbRgbRgLsbLsbRsbLjbLibRibRiRsRsmm
bRgbLsbRiRsLsmbLcbLcbRiRsLsmbRhbRibLobRobLcbRhbRibRsbLjbLobLgbRgbLibRg
bLibLsbLsbLgbRjbRcbRibRsbRgbRsbRsRsmbRgbRsbRsRgbRgbRsbLcbLcbRiRsmbLcbR
gbLibLgbLsbLgRsbLsRsbLsbLgbLsbLsbLgbLsbLsbRibLsbLsbLiLsbLsRsLsbRjbRhbL
jbLobRsLsbLibLibLgbRgbLiLsbLgbLsLsmbLsbLgLgbLgLsbLiLsbLgbLsbLgbLgbLibL
gbLgbLgLsbLgLsbLsbLgbLgLsbLgbLgbLibRcbRoRsmbLibRhbRiRsmbRgbRhbLobLcbLc
bRsbLhLsbLcbRibRhbRibLcbLgbRjbRcbRibLcbLoRsbRibRcbLsLsmbRiRgbLsLsmbRib
RsbRgbRgRsmbRgRsmbRgbRgbRsbRgbLsbRgLsbLcbLhbRgbLhbRgbLiLsbLsbLgLsRsbLg
bLsLsmbLgbLiRsLeLiLgLsLsLsmmbLgLsLsmbLsbLgbLibRcbRcbLibRibLjbRibLcbLhb
RgbLibLsbLsbLibRjbRobLsbRibRibLjbRobLcbRgbRibLjbRcLsbLhbRibRgRsmbLsbRg
bLhbLhbRiLsbLhbRsbLsbLgbLsLsmbLgbLgbLsbLsLsmbLsbLgbLgbLgLiLiLiLsLiLgLi
LiLgLsbRsLibRobRcbLcbRcbLibLcbRibRcLsbRhbLhbLcbRcbRhbLibLsRsRhbLcbRiRs
mbLcbRiRiRsmbRgbRgbRgbLibLcbsbRjbLsbLgRsbLsLgLsbLsbLgbLsbLgLsLiLgbLiLi
LsLgLsbLgRsbLgbLsLsmbRgLsbLgbLsbLibLgbLgbLgbRcbRgbLsbLsbRibLsLsmbRhbLh
bLcbRobLobLhbRgbLibLhbRibRhRibLsbsbLsRsbRibRsbRgbRsbRgLsRsbRsRsmbRsbRg
LsbRgbLjbLhLsbLibRjbRcbLcbRcbLobRhbRiLsbRsbRgbsbRsbRsbRibLcbLcRsbLcbRi
bLiLsLiRsbLsbLgLsbLgLgLgLsLsmbLibRcbRobLcbLhbLiLsbRcbRobLcbLhbRgbLhbRg
LsbLgbLgbLgLsbLsLsmbLsLiRsRsmbLgLsLgbLgLgbLgLsbLgbLgLsbLgbLgLsbLsLsmbL
sbLsbLgbLibLsbLgbRsRsmbLgRsLsLgLiLsLsmbLiLgLsbLibLgLsLgLgLsLiLiLiLsLsL
smmbLgbLgbRsLsLsmbLgbLgbLgbRgbLsbLsbLgLsLsmbLgLgbRsbRcbRgLsbLjbRcbLcbL
cbRibRibRiLsbRibLcRsLcbRibLsRcbLcbRcbLibLcbRjbRibRibRgbRsRsmbLsRsbLsLs
mbRsbRgLsbRgbRgbRsRsmbLsbRgbRgLsbRgbRiLsbLcLsmbRoRsmbLcbLobRgbRgbRibRh
bLobLcbRibRjbLcbLiLsbRgbLibLhbRgbLibRobLcLsmbLoRiRsmbRgbRiLsbRibRgbsbR
cLsbLhbLhbLibLsLgLgbLgLsbLgLiLsbLgbLgLsbLgLsLsmbLsbRsbLsLsmbLsLiLsLibL
gLsbLgLsLsmbLsbLgLgLsLgLgLsLsmbLibLsbLiLsbLgbLgLsLgLsLgLiLsLgLsLiLsLib
LibRcbRcbLobLjbRibLobLibRsRsmbLibLibRibLcbRibLibLgbRsbLgbLsLiLsLsmbLgb
LiLsbLgbLgbLgbLsbLgLgLiLebLibRiRsmbRcbRobRgbRiRsmbRibRibRjLobLibLsbLgb
LgLsLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 20; Drug: NDMC 10 µM
bLjLsmbLsbRjbRobsbsbRibLsbRgRsmbLsbLsbRiRsRsmmbRgbLibRcbLibRgbLgbLcLsm
bLibRibLibRsbRsbLgbRgbLibLgbRibRsLsLsmbRcbRiLsRsbRibLsbLsbRsbRgbRiLsbR
gbLibRibLgbRibRgRsRsmmbLibRibRiRsmbLibLsbLibLibLsbLgbsbLcbRibLgLsbLibR
jbLcbRgbLsbRsbRjRsRsmmbLjbRsbsbLjLsmbLcbsbLgbLgLsbRhbLgbsbLibRhbRoLsbL
cbLhbRjbLgbRjbLibLgLsbRjbLgLsbLjLsmbRibLibRgLsbLgRsbLiRsbLgbRjbLiLsbLi
bRibLhbLgbLsLsmbLsbLgLsbLsbLsbLgbRiLsbLibRobRibLsbRsbRgbRsLsbRgRsmbLjb
LcLsmbLiLsbRjbLibRjbLibLsbLgbRiRsmbLibLsbRgbLhLsbLcbRibLiRsbRsbLibRsbR
ibRibLgbRibRiLsbLibRobLhbRibRibLjLsmbsbRibLjbLibRsbRcbLibLcRsbRibsbRob
RsbRgRsmbRgRsmbRsRsmbRgbLhbLibLiRsbLgLsbLgbRcbRhbRibLjbRiRsmbLjbLsbRib
LibRhbLgbRiRsmbRibLsbLsbLsbRgbRgbLjbRibLjbLhbRjbRibRibLjbRibRsbRsRsmbR
gbRgbLsbRsRsRsmmbRgbRgLsbRsbRiLsbLibRcbLibRhbLjbRibLjbRgbRgbRgbRgLsbRi
bRibLibRiLsbLibLibLgbLgbLgbLgbRcRsmbLjbLibRcbRobRibLgbRgbLjbLjbLgbLgbL
sRsbRjbRcbLcbRibRibRiRsLsmbRibLgbRibRgRsmbRgbRsbRgLsbLjbRgbRibLjbRiRsm
bRiRsmbLibRibLgbRiRsmbRgbRgbLjbRibLibRhRsmbLibRibLgbRibLjbRcLsbLsbRgbL
gbRgbRgRsRsmmbRhLsbRcbLibRibLibRiLsbLsbRgbLibLibRiRsmbLgbLgbRgbLiLsbLi
bRjbLcbRibLgbLibRgbLiRsbLibRsbLibLibLsbRjbLhbLcLsmbRibRibLiRobRgbRobLg
b

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 21; Drug: NDMC 10 µM
bLjbLibRgbRjbLcLsLsmmbRsbRibsbLsbRibRcbRsbsbsbRsbRjbLgbLibRibLibRiRsmb
LgbRsLsRsLsLsRsmbRibLjbLcbLcbRibsbLgbLsbsbRgRsmbRsbRhbLsbRoRsmbRcbRsbR
ibLgbRibRsbLsbRibRsbLsbsbRibRsbLgbLsLsRsmbLgbLgbRibLsbLsbRibsbLsbRjLsb
LjbRhRsmbLgbRcbLsbLjLsmbRsbRsbRsbRgRsmbRsbLsRsbRsbRgbRibLsRsbLsbRsbRsR
smbRsbRsbLsbRsbRibLsbLgLsbLjLsmbRibLjLsmbLibLsbLsbLibRjbLgbRgbLsbLobLs
b

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 22; Drug: NDMC 10 µM
bLgbRsbRiRsRsmmbRgbLsbRsbRsLsbRsbLsLsmbRobLhbLhLsbRgbRjbLibLgbRgbLibLs
bLsRsbLsRsbRsbsbLsbsbLibRjbLsbsbsbLsbsbsbLsbLibRibLobLcbLcbLgLsbLgbRsb
RjbLhbLsLsmbRjRsmbRjbRibRgbLgbLsbLsLsmbRsbLhbRjbLgbLjbRcbRibRibRsRsmbR
gbLsbRgbRsbRgbLsbLsLsmbRgbRsbRgbLjbRibLgbLsbRgbLsRsbRgbRgbRsbRiLsLsmbL
ibRcbLgRsbRgbRgbRgbLsbRgbLobLobLcbLibLibRobLsbLjRsbRibLsRsbRgRsmbRsRsR
smmbRgRsmbRgbRgbRsbRsRsmbRgbRgbRsbRibLgbRibLsbRgRsRsmmbRgRsmbLjbRsbLcR
sbRcRsmbLjbRsbLsRhbLgbRgRsmbRsRsmbRsbRsbRsRsmbLsbRiLsbLsbLgbLcbLobRebL
hbLebRhbRgbRibRgLsbRhbLgbRibLjbRhbLsLsmbRibRgRsmbLgbRibLgLsbRiRsmbRsRs
LsmbRsRsmbRsbRgbRgRsmbRgRsmbLsbRgRsRsmmbRgbLgbRibLgbRgRsmbRsbRsLsbRsbR
gLsbRsbRgbRsbsbLsRsbRgbRgRsmbRgbRgbRgbRgbRgbLsRsbLsRgbRgbRgLsbRsbRsbLg
RsbLsbRgRsmbRgbsbRgbRsbRgbRsRgbRgbRsbRjbRsRsmbRgbLsbRiRsRsmmbLobLgbReb
LiRsbLcbRiRsRsmmbLibLcRsbLobRsbRsbLjbLcbRcbLhbLiLsbRsbRjbLsbsbLibLgbLg
RsbLcbLsbLcbRcbLibLjbLsbRjbLibRjbLgbLiLsbLcbRsbLhbLgbRgRsmbRjbRebLibRi
bLsbRibLsbRgbLsbRgbRsbRgRsmbRsbsbLgbRibLjbRibRsRsmbRgbRsbRgbRgbRsbRgLs
bLsRsbRsRjbRsRsmbLsRsbRjbRsbRsRsmbRgRsmbRgbRgbRsbRgbRibLsRsbRibRgbLgLs
bRsRibLgbRgLsbRsbLsRsRsmbRsbRsbsbRgbRgbRsbRgRsmbRgbLgRsbLjbRcbLgbLcbRc
RsmbRhbLgbLsbRibRgbRgbsbRsbRgbRgRsRsmmbLcbLsRcbRhRsmbLiRsbLobRobRibLsb
RiRsmbLjbRibRsbsbRgbRsbsbRsbRjbRsbLsRsbRsRsRsmmbLgRsbRsbRsbRgbRgbRgbRg
LsbRgRsmbLgbLhRsbRcbLgRsbRibLgbRiRsmbRgbLibRcRsmbLjbRsbRhbRgbLgbRibRgb
RsbRsbRiRsmbRgRsRsmmbLsbLsRjbRsbRsbRsbsbRsbRgRsmbRgbLjbLobRcbRibLgbRgb
RgbRgRsmbRgbRgbsbRgbRsRsmbRgLsbRsbRgbRsbLcbLibRcbLsbLsbRcbLhLsRsbLcLsm
bsbLobLhbRcbLsbLibLibRsbLiRsbRibLcbRgRsmbLcLsmbLibRsbLiLsbRsRsmbLhbsbL
gbRgbLobRsbRsbLcbLobRjbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 23; Drug: NDMC 10 µM
bLsbLiLsbLgbLgLsbLsbLsLsmbLsLsLsmmbLgbLsbsbLsbLgbLsbLsbLgbLsbRjbLibLib
LhbRgbLgbRgbLsbLcbLgbsbLsbLgbLgbRibLgbLsbRsbLgbLsbLsbLiLsbRsbLgbRsbLgb
LsLsLsmmbRsbLgbLsbLgLsbLsbRsbRsbLjLsmbRcbRcbLhLsbLibLsLiLsbRjbLsbRcbLj
bLibRsbLibRsbLiLsbRjbLibsbRcRibLjLsmbLcbRhbRibLjbLhbLgRsbRgbLhbRgbRgbL
cbRibRgbLsbLibLgbLsbRsbLgLsbLsRsbLsLsRsmbLibRjbRcRsmbRibLibRibLjbRiRsm
bRgbRsbRcLsbLgbLgbRsbRjbRgbLjbLibLgbLsbLsbLsbLsbLsbLgbLgbRjbLsbLgbLsLs
mbLsbLgbLgbLsbLsbLsLsmbLgbLsbLibLsbLibLgbLgLsbLsbLgLsbLgRsRsmbLibLgbLs
bLgbLsbLgLsbLgLsbLsbLgbLgbLiRsbRjbRcbLibLibLibLgbLgbLsbLsbRjbRcbRsRsmb
RibRgbLjbLcbLsbLibLgbLsbLgLgLsbLgbLgLsbLsLsmbLgbLgbLgLsLibLgbRhRibLcbR
iRsmbRibLcbLcLsmbLgbRsbLsbLsbLiRsbRgbLibLgbRibLhbLibRiRsmbLsbLibLgRsbR
ibLibRcbRhbLjLibRjbRcbLjbLibRjLibLsbLgbLsbLgbRsLsbLgLsbLgbRjbLgbsbLgbL
gbLgbLgbLgLsbLgLsbRsbRjbLcbRjbLiLsbLsLsRsmbLgbRsbLgLsbLsbLibRibLibLsLg
LsbLsbLgbLsbLgbLsLsmbLgbLgbLsbLgbLsbRsbLsbsbLsRsbLsbLsbRsbLsbLgbLsbLgb
LgLsbLsbLiLsbLsbLsbLsLsmbLsbRsLgbLgbRsbLgRsbLibRiLsbLibRsbLibLsRsLsbLi
bRsbLibRsbLgLsbLsbLsbLgbLibRhbLibRgbLcbLobLcbLibLiLsbLsLsmbLsbLsLsmbLs
LsmbLsbLgbLgRsbLsRsbLgbRjbRcbRibLcbLibLibRgbLiLsbLsbLsLsmbLgbLsLsmbLgb
LgbLsLsmbLgbLgbLsLgbLsbLgRsbRsLsbRjbRiRsmbLcbLibRgbLsbLsbLgLsbLgbLgLsL
gbLgLsbLgbLgbLsbLsbLgLsbRsbLsLibRgbRjbLhbLebLgbRibLibLibRibLiLgLsbRsbL
gbLsLgbLgbLgbLsbsbLgbLgLsbLgbRgbLibRsbLgbLsbLgbLsbLgbLgbLgLsRsLsbLgLsb
LgLgRsLibLgLsbLgLsbLgbLgbLgRsRsmbRcbRhbLibLcbLgbLgbRcbRhbLjbLcbLibRhbR
hbLcbLcbLgbRgbLhbRibLiLsbLgbRsbsbRsLsbLgRsbLsLsmbLgbLgbsbLgbLgbLgbLsbL
sLsmbLgbLgbLgbLsLiLsbLiLsbRgbLgbLsbLgbLgbLsbRsbRsbLsLsmbLibLsbLgbLgLsb
LsLsmbLgbLiRsbRjbRiRibLcbLcbRgbLgbsbLgbLsLsmbLsLsmbLsLsRsmbLsbLgLsbRjb
RcbLcbRhbRiRsmbLhbLcbRgbLgbsbsbLsRsbLsLsmbLibRjbLhLsbRjbLhbLgbRibLgbLg
bLgbLsbLgLsbLgLsbLgbLgbLsbLibRsLsbLibRgbLgLsbLsLsmbLgLsbRsbLgbLgbLsLsL
smmbLsbLgbLsbLgRsbLgbRsbRsbRibRibLebLhLsbRsbLibRgbRhbRsRcbLcbLibRiLsbR
cbRobLsRsbRibRhbLjbLibLgbLgLsRsbLgbLsLsmbLsbLsLsmbLgbLgLsbsbLsRsbLsbsb
LsbLsbLgbRgbLgbLgbRgbLibLsbLgbLgbLgbLgbLsbLsLsmbLgbLgLsRsbLsLsmbLgLsLg
bLgLsbLgbLgbRcRsmbRgbLjbLcbLgbRgbLibRibLibRibLiLsbLgbLibRjbLibRibRcbRc
bRsbLibLibRibRibLjbLcbLiRsLsbLsLsmbLgbLsbRsLgLsbLsbRsbLgbLgLsLsmbLgbRs
bLibRjbLibLgbRgLsbLsbLibLgRsbLgbLgbLibLsbLgbLsLsmbLgbLgbLgLsLsLsmmbLsb
LgLsRsbLgbLgbLsbRgbLibLsbLgbRsbLsbLgLgbLgbLgbLsbLgbLgLsbLgbLsbLgbLgbLg
bLsbLibLgbLgbLgbRgbRibRhbLcbLibRgbLiLsbLgbLgbLgbLgLsbLgbLgbLsbLgbLgbLg
bRgbLibLsLsmbLgbLgbLsLsmbRsLsbLgbLgLsbLgLgbLgbLgbLgbLgbLibRgLsbLgLsRsb
LgbLsbLsLsmbLgbLgLsbLgbLsbLgbLgLsLgbLgbLgbLgbRcRhbLjbRhbLhLsbLiLsbLgbs
bLgLsbLsbLgbLgbLsbLgbLgbLsbLsLsmbLgbLsbsbLsbLgbLibRhbLibLsbLgbLgbLsbLs
bLgLsbLgbLsbLgLsbLsbLgbLsLsmbLsbLgbLgbLgbLgLsbLgLsLgbLgbLgbRsRsmbLgbLg
RsbLsbsbsbLgbLsbLgbLgbRgbsbLsRibLhbLgbLgbLibRhRsmbLibLiLsbLgbRgbLsRsbR
jRhbRibLhbLhbLibLgbRjbLcbRibLgbLibRgLsLiLsbLgLsbLsbLgbLsbLgbLsbLgbRsLs
bLsbLhbRjbLoRsbRsLsRib

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 24; Drug: NDMC 10 µM
bLsLhbsbLsLsmbLgbLgbRgbRobRgbLsbRgbLebLibLsbsbLsbLgbLgbLsbLsbLgbLsbLgb
RhbRhbRsbsbRsbLsbsbRsbLgbRiLsbLgRsbRgLsbRgbRgbLsLsmbLcbLibLgbLgbLsLsLs
mmbRsbLsbLgbLsbRsbLibRsbRjbLjbLgLsbLsbLsbLsbLgbLgRsbRgLsbRobRgbRgbRgRs
RsmmbsbRibsbLsbRgbRgbRgbRsbLsbsbLobRgbRsbLsbLgbLgRsbRobRsbRsbRsbRsbsbR
gbRgbRsbRgbLsbRgbLobLcbsbRjbRsbRjbRgRsmbRgbRgbRgbRgbLhbLibLgbLsLsmbLsR
sbLsbLgbLgbLsbLsbRibsbRgbRgbRcbLsbsbLgbRgbRgbLgbRgbRgbLhbLgbLsbLgbLgbR
jbRobLibLgLsLsmbLgbRsbLibLibRsbLiRsLsbLgbRgbRhbLjbLjbLgbLibRjbRcbLgbRs
bRgRsmbRsbRsbRsRsmbRsRsmbRgbRsbLcbLgbLgbLgbRsbLgbRjRsmbRgbRsbRsbRgbRib
RibRgbRgbRgbLjRsbRibsbsbRsbLsbLsLsmbRsbsbsbsbLsbsbRgbLgbRibLcbLibLgbLg
RsbRsbLsbLgbLgbLsbLjbRsbRsRsRsmmbRgbRsbRhbLibRobsbRsbRgRsmbRgbRjbLgbRg
bLibLsLsmbLsbLgbsbLhbRebRgbLsbRgbRsRsmbLgbLgbLgbLgbLjbRsbRsbLsRsbRgbLg
bLsbLsbLsbRgbRgLsbsbRsbRsbRgbLgbRgRsmbRsbRsbsbsbRgbRsbRsRsmbLsbRibRgbR
gRsmbLsRsbRgbRgRsmbLsbRgbRsbRjbRsbRsRsmbRcbRiRsRsmmbLjbsbLgbLgbRgbRsbR
sRsmbRgbRsbLsbsbRgbRsbRibRsRsmbLobLobRibRgbRsbRsbRgbRsbRgbRgbLsbRgbLsb
LcbLgbLsbLgbLibLgLsbLgbRgbRoRsmbRsbRgbRgRsmbRsRsmbRsbRsRsmbRgbRgbRgbsb
RiLsbLsbRgbRgbLsRsRsRsmmbRgbRgbRsbLsLsmbLiLsbLgbLgbRgbLgbLgbRobRsbRibR
gRsmbRgRsmbRsbRsbRsbRgbRsbRsbRgbRgbRgbLgbRibRgLsbLcbRsbLsbLgbLobLjbRgb
RsRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 25; Drug: Control
bLibLsbLibRjbLibRjbLibRjbRcbRgbRgbLebRjRsRcmbLibLsbRibRjbRsbLjbLcbRjbs
bLoLsmbRgbLiLsbLsLsmbLsLsLsmmbRsbLsbLgbLibLgLsbLsbLsbLgbLgbLsbLsbLgRsb
RjbLeLsbLcbRjbLibRgbLibLibRjbLibRgbLgbLgbRsbLgbRsRsLsmbLgbRsbRjbLhbLsb
LgbLgbLsLsmbLsbLsbLgbLsbsbLibRjbLjbRibsbLjbRibLibRgbLibLgbLsbLgbRgbReb
LobRjbLobRgbLibLsbLgbLsbLsbLibRjbRjbRgbRgbRgbLsbLibRgbLibRgbLgLsbLsbLg
bLsbLgbLsbLsbLsbRsbRibRibLjbLjLjbLgbLibLibLibRgbLsbLiRsbRsbLibLsbLsbLj
bRjRcbLhbRjRsmbLsbRgbRsbLcbLibLsbLgbRibLhbRsLsbLgbLsbRjbLjbLhLsbRgbLgb
LgbRsbLiLsbRgbLgbRsbLsbsbRsbRjbRiRhbLiRsLcbLsbRsbRibRsbsbsbLhbRjbsbRib
LjbRibLobLhbLgbRhbRgbLsLsmbLebLcbRsbRgbLcbRgbLgbLsbLsbLibsbLgbLsbLgRsb
LgbLsbLgbLgbRsbLibRjbRsbLsbRcLsRsRibRgRsmbRgRsmbLjbLobLgbLsbLsLsmbLsLs
mbRsbLgbRsbLgbLsbRsbLgLsbLgbLgbLsbLsbLgbRgbLiLsbRsbLgbLibLgLsRsbRibLib
sbLgbRibRsbLhbLcbRibLsLsmbLibLgbLsbRgRsmbRjbRibRgbLjbLcbRgbLgRsbLgbLgb
LibRjbLiLsbLsLsmbLgLsRsLsbLgbRsbLsbLgbRsbLibRgbLsbLsbLsbLsLsmbsbLsbLsb
LsbLsbLsLsmbLjbLsbRgbLgbRsbLibRjRsmbLibLsbLsbLgbRsRsmbLsbRgLsbLjbRgbLj
bRgLsbLsbLsbLsbLiLsbLibRgbRibLibLsbLgbLsbLgbLsbRsbLgbLgRsbLgRsbRgbRebR
ibLjbLibLibRgbRjbRibRgbRsbLsbLcLsmbLibRibLibRibLibRsbLgbLgbLgbRgbLibLs
RsbLibLsbLgLsbLsLsmbsbLgbRjRsmbLiLsbRgbLibLsLsmbRsbLibLibRsbLjbsbLsbRs
bLgbsbLsbLgbLgbRsbLsbLgbLibLsbLsLsmbLiLsbRgbLibRgbLibRjbLibRgbRsbLsbRs
LsLsmbLsbLsRsbLsbLsbLgbLgbLsbLgbLgbLibRgbLiLsbLsbLibRgbLibRgbLiLsbLsbL
hRsbRibRibRjRsmbRgbLcbRgRsmbLibRsbLibRsRsmbLibRgbLibLgbLsLsmbLgbLsbLsb
LibRjbLcLsLsmmbLsbRgbLiRsbRgbLibRgRsmbLgbRgbLiLsbRgbLgbsbLgLsbLsbLsbLs
LsmbLibRgbLibRjbLibRgbLsLibRgbLgbRgbLibLsbLibRibLebRiRsRsRsmmmbLibRjbL
iLsbRsbLgbLsbLsbLsbLibLjbRjbLsbLibRsbLgbRsbsbLiRgRsmbRjbRoRsmbLhbRjbRh
bRgbRgbLsbRgbRgbLgLsbRsbLibRibRsbLiLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 26; Drug: Control
bLhbRgbLhLsbRgRsmbRjbLibLsbLibRjbLcbRgLsbLhbLibRibRibRgbRgbRgbRgbRgLsb
RsbsbLsbRsbRiLsbLobLhRsbRcbRgbRibLjbLobRjbsbRibRgbRgbLsbLsbRgbRsLsbRgR
smbRsbRgbRgbsbRsbLcbLcbRiLsbLgbLgbLgbLsbLgRsbRjbRhbRgbRsbRgbRgLsbLjbLo
bRibLhLsbLibRsRsmbLgbLsbLsbLgbsbLgbLsLsmbLgbLsbRsbLgbLgbRgbLgLsbLgbLsL
smbLgbLsLsmbLgbLgbLgbLsbLibLgLsbRgbRcbRibRibLobLgbLsbLsbLsbLgbRsRsmbLg
bRjbLibLsbLgbLsbLsLsmbLgbLiRsbLgLsbRsbRhbRcLsLsmbLjbRibRsbRgbRgbRibLcR
sbLcLsmbRiLsbLhbRcbRobLcbRgbRiLsbRiLsbRhbLgbRsbsbRgbLsbRgRsmbRsbRsbRgb
RgbRsbRgbRgbRsLsbRsbLsbRibRsLsbLcbLgbLgbLgbsbRjbRsRjbRsbRcbLgbRgbRgbRg
bRgbRgbRsRsmbLsbRgbRgbRsbRgbRsbRgLsbLsbRgbRgbRsbRgbLsbRgbLsbRibRsbRgRs
mbRgbRsbRsbLsbRcRsmbLgbRgRsmbRiRsmbRiRsmbLsbRibRsbRgbRsbRgbRsbRgbRsbRs
bRgbRsbRgbRgLsbLcLsmbLgbRsbRcbRibLsbRgbRibLsbRgRsRsmmbLgbRgbLsbRiLsbLi
bRhLsRsbLsbLjbLibLgbLgbLsbLsbLibLsbRjbsbRcbLibRhbLjbsbRibRgbRsbLsbRgbR
gLsbLjbRibRsRsmbRsRibRgbRgbRgbRsRsmbLsLsmbRgbRsbRgbLgbRhbLibRibRsbRgbR
sbRgbLsbRsbRgbRsbRsbRgLsbLibRhbLsbLsbRibLjLsmbRgbRgbRsRsmbRsbRsRsmbRgb
LcbLhbRibLibRsbRhbRgbRsLsbRgbLsbRsbRgRsmbRgbRsLsLsmbRsRsmbRgbLobRgbLib
LsbLsbLibRhbRcbLsbRiRsmbRgbRsbRsbRgRsmbRgbRgbLjbLcbLgbLgbLgbRcbRgbRgbR
gLsbRhbLibRhbLsLsmbLsbRgRsmbRsbRgbRgbRgbLsLsmbRsbRgbRgbRgbLcbLibRjbRhb
RsbLcbLgbLgLsbRsbLcbRcbRcbLsbRibLjbRibLjbRibLsbRibLsbRgbRsbRgbRgbRibLi
bLjLsmbLiLsbLgRsbRgbLgbLsbLgbRsbLgLsbRjbRcbLjbRcbRsbLjbRcbRsbRiLsbLgbL
ibRjbRibLsbLsbRsbRibLsLsmbRgbRgbRgbRsbRibLgbLjbLibLgbLgbLgbRcbRhbRsbLs
RsbRgbRsbRgRsmbRsbRgbRibRsbRgbRsbRsbRgbRgbLsbRgbRsbRsbRsbLsRsbRgbRgbLs
bRjbRgbLgbRgRsmbRsbRibLgbRsRsmbRibLgbRibLsbRibLjbRibRiLsbLjbRgRsmbRibR
sRgbRgbRsRsmbRgbRsbRsbRgbRsbRgLsbRsbRgbLsbRsbRgbRsbRibLgbRiLsbRsbRgbRg
RsmbRsbRsbRsbRgbRgbRibRsbRgbRsbRsbRgbLsLsmbLcbLibRhbRibRgbRgbLjbRcbLib
RibLgbRibLsbsbRgbRsbRsbRsbRgbRsbRgbRsbRsbRsbRsbRgbRsbRsbRgbLgbRgRsmbRs
bRhbLiRsbLjbLiLsbRhbLcbRgLsbsbRcLsbLgbRsbRsRsmbRgbsbLgbRgRsmbRibsbRsbR
sbRsbRibLgbRibRsbRgbLjbLibLgRsbLsbLgbRobLgbRiLsbRsbRsbLsbRgbRgbRsbRgbR
sbRsbLsRsbRsbRsbRsbRgbLgbRgbRsbLsbRibLgRsbRgbRgbRsbRsRsmbRsLsbRgbRgLsb
LjbLcbRgbsbRhbRibRgbRsbRgRsmbLsbRsbRgbLgLsbRibRgbRgbRgbRgbRsbRsbLsbRib
LjbLcbLcRsbRhbLibLgbRsbLgbLsLsmbLsbRsbLcbRhbLibRsbLsRsbLgbRibRibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 27; Drug: Control
bRhbRibLibRibLgbRibRiLsbLibRibLsLsmbLcbsbLgbLjbLobLsbLiLsRsbRsbLibsbRj
bLgbLsbLsbLgbLgbLsbLibRgbLsbLibRjbLgbLibLibRsbLgLsbLsbLsbLsbLsLsmbLsbL
gLsbLgbLibRibRibLhbRsLsbLsbLsbsbLgbLgbLgbLsbLgbRgbLgbLgbRgLsbLgbLsLsRs
LsmbLgbRsLsbLsbLsbLsbRobRgbRsbLjbRibRsbRibLgbRgbRsbLsbRibRgbRibRibRgbR
gbRhbRibRsbRsbLsbRgbRgbRsbRgbRsRsmbRsbRibRgLsbLsRsbRgbRsbRgbRsRsmbRgRs
RsmmbRsbRsbRgbRgbRsbRgbRsbRibRibLjbRibLobLgLsbRsbRebRgbLsbRgRsmbRsbRsb
LsbLoLsmbsbLsbLgLsbLsbLgbRjLsbRgbRsbRsbsbLjbRibRsbRgbLjbRgbLsbRgbRsbRs
bRibLgbRsbRgbLsbRibLgbRgbRgbRgbRgbRsbRgRsmbRgbRgbRsRsmbLsbRsbLsbLjbLgb
RiLsbRsbRgbLsRgLsbRsbRsbRsbRgRsmbRsRsmbRgbRsbRsbRgbRgbLjbRibRsbRgLsbLg
bRgbRsbRgbRsbRsbRsbLsbRgbRsbRsRsmbRsbLsbRsbLsbRiLsbRsRsmbRgbRsbRgbRsbR
gbRgbRsbLsbRibRgbRgbRsbLgbRibLjRsbRibRsLsbLcbLgbLgbLgLsbRsbRgbRibLsbRi
bsbRgbRsRsmbRsbRsbRsRsmbLsLsmbRgRsmbRgbRgbRgRsmbLjbRibRsRsmbRibRgbLgbR
iRsmbRsbRgbRgbRsbRsbLiLsbLgLsbLsbLjLsmbLgbLsbRobRhbRibRgRsmbLsRsbLibLi
bLgLsbLgbRsLsbLsbLsbLsbLibRsbLgLsLsmbRsbLgbLgbLgbRjbRjRsmbRjbRiRsRsmmb
LsbRsbRsbRgbRsbRgbRsbRsbRsbRsbRgbLsbLhbLgbRcbRgbRsbRsbRgbRsRsmbRsbRsLs
bLhbLsbRcbLgbLgbLgbLgRsbLibRibLibLibLsbRsbLgbLgbLgbLsRsLsbLgbLiRsbLcRs
bLcbLhbLibLibLsLsLsmmbLgbRhRsmbLjbLhbLibRsbRebLsbLhLsbLgLsbLsbLgLsbLsb
LsbLgbLsbLsbLgbLgbLgbRgbLgbLibLgbRsbLgbLgbLsbLgbRjbLibRgbLgbLgbRsRsmbL
gLsbLgbLsbLsbLsbLgbLgbRgbLgbLibLgLsbRgbLibLsbLsbLsbLsbLsbLgbLsLsmbLgbL
gbRsbRsbRcbRgbRibLsbRibLcbLibLsRsbLgbRsbLsbRjbRibRsLsbRgbRgRsmbRibLjbL
cLsmbRibRgbRsbRgbRsbRgbLcbLibRgRsmbLgLsbRsbLgbLjbLsbRiRsmbRibLsbRgbRgL
sbRgbLgbRgbRsbRgbRibRsRsmbLsbRsbRgbLjbLibLgbLsbLsLibRgbLibLsbRsbLgbLsb
LsbLgbLibRibLibLsLsmbLsbRsbLgLsbRsbRsRjbRgLsbRgbLsbRsbRgRsmbRgbLgbRgbR
gbRsbRgbRgbRgbRgbRsbRsbRgbRsbLsbLsbLhbLcRsbRjRgbRjbRjRsmbRgbLgLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 28; Drug: Control
bRibLsbRcbRhbRibRiRsmbRgbsbRiLsbRsbLsbLsbRgbRsbRgbRgbRgbRsbRgLsbLsRsRs
mbRgbRgbsbRgRsmbLgbLjbLcbRebRsbRhbLsRsbsbRibRgbRsRsmbRsRsmbRgbRgbRgbRg
bLjbLcbLsLsLiRsmbRebRcRsmbRibLgRsbRiRsmbLgbRibLgbLgbRgbRgbRgbRgbRgbRgb
RgbRgbRgbRsbRibLgbRibRsbRgbLsLcbRjbRibRiRsmbRsbRgRsmbRgbRgbRibLibRibRi
bRsbRsbRgbRsbRgbLsbRibLgbRcRsmbLsLibRibRgRsmbRsbRgbLgRsbRiRsRsmmbRsbRg
bRibLjbRhbRsbLsbRiRsmbRsbRgbRsRsmbLcbLhbRibLgbRjbLjbRibRgbRsbRgbRgbLiR
sbRibLsbLgbRgbRsbRsbRgbRgLsbRsbRgbRsRsmbRjbLsbLgRsbRebRsRsRsmmbRgbRgbR
sbRgRsmbLgbRibLibRsbRgbRgbRgbLibRhbLgRsbRgRsRsmmbRsbRgbRsbRgbRsbRgRsRs
mmbLsbRibLjbRgbRgRsmbRsbRgbRsbLsbRibLsbLsRsbRgbLjbLibLiRsbRjbRebLibRib
RsbRgbRibRsbRiRsLsmbRsbRgRsmbLjbRibLsbRibLsbRibLsbRgbRjbRgbLsRsbRgbLsb
RibLibRcbRibRgbRsbLsRsRsmbRsRsmbLjbRibLgbRiRsRsmmbRsbLgRsbLsbLhLsbLibL
sbRgbRobRgbRgbRgbRgRsRsmmbRgbRgbRsbRsbRibLgbLcbLhbRhbRsRsRcmbRgbRibLsR
sbRgbRsbRsRsmbRgbRgRsmbRgRsLsmbRiRsmbRgbRiRsmbRsbRibLgRsbRibLsRsbRgRsm
bRsbRgbRgbRiRsmbLgbLhbLhLsbRibRcbRibRsbRsbRgbRgbLgbLhRsbRcbRiRsmbLsbRg
bRsRsmbRgbRgbRgbRsbRsbLsbRsbRsRsmbRgLsbRgLsbRgbRgbRgRsmbRsbRgRsmbLsbRi
bLjbLcbRhbRgbRgbRgbRgbRsbLsRgLsbRgbRibRsbRgbRgRsmbRsbRgbLgbRibRsRsmbRg
bRgRsmbRsbRsbRsbRgbRgbRgbRgbRgbRgbRgbRgbRgbRgbLjbLcbLibRcbRobLgbRsbRib
LgbRhbLibLibLcbRibRhbRibLgbRgRsmbRgRsmbRsbRgRsmbRsbRgRsmbRsRsmbRgRsmbR
sbLsbLjbRgbRsbRiRsmbRsbRsbRgLsbRjbRsbRgbRsbRgbRgbRgbRgbLsbRgRsRsmmbRsb
RgbLsbRsRsmbRibRsbRgLsbRgRsmbRgRsmbRsbRgbRsRsmbRgbRgbRgRsmbRgbRsbRgbRs
bRgbRgbLsbRgbRgbRgbRgbRgbRgbLsbRgRsmbLgbRgbLjbsbLsbLjRsbLibRcbRgbRibLg
bRiRsmbLgbRibLgbRjbRsbRsbRsbRgbRsbRgbRsbRgbRsbRgbRsbRgbLsbsbRcbRsbRsbs
bRsRsmbRgbRgbRgLsbRgRsRsmmbRsRsmbRsbRgRsmbRsbRgbLjbLsbRsbLgRsbRiLsRsbL
sRsbRgbRgbRsbRgbRgbRgbRibLgbRibLibRcbLiRsbRiRsmbLibRibLibRibRgbRsbRgbR
sbRsbRsLsbRgbRsbRgbRgbRgbRsbLsRsbRibRgbRsbRgRsmbLjbLhbLibRgRsmbLgbRjbR
cbRgbRgbRgbLsRgbRgbRibRgbRsbLsbRiRsmbLsbRibLibLsRsbLgbRibLgbRgbRgbRgRs
mbRgbRgbRsRsRsmmbRgbRgbRgbRgbLgRsRsmbRgbRgRsmbRgbRsbRibRgLsbLibReRsmbL
gRsbRgbRgbRsbRibLobLibLibLgbRsbLcbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 29; Drug: Control
bRobLgRsbRibRhbRsbRibRgbLgbRiRsmbRibLibsbRebLgbLibLibLiRsbLhbRibLgbLsb
LibLgbLgbRgbLgLsbLsLsmbLgbLsRsbLibLsbRsLgbRsbLgbLgLsbRsbLibRgbLiLsbLsb
LsbLgbRsbLgbLgLsbLgRsbLsRsbRsLgbLgLsbLgLsRsbLgbLgbRsbsbsbLiLsbRiRsmbLi
bLgbLibLgbLgbRjbLibLgbLibLsbLibLgbRsbLsbLsbLsbRsbLibLgLsRsbLgbLsbLsbLi
bRsbLgbLgbRgbLgbLsbLgLgLgLsbLiLsbLgbLgbLgLsbLgbRhbRibRgRibLhbRcbRobRib
LgbLibRibLiLsbLsLsmbLibLgbRsbLgbLsbRsbLgbLsbLibLgbLgbLgbLgbLsbLsbRgbLi
bLgbRsbLibLgbRsbLibRgbLibRjbLsRcRcbRibRgLsbRibRibRibLibLcbLibRcRsmbRhR
smbRsLebLoRsbLsbRjbRhbLcLsmbLobLsbRgbLgbRcRibLibLhbLcbRibLhbRgbLgbLibR
sbLgbLsLsRsmbLgLsbLsbLgbLgLsbLsLsmbLgbLjbLhbRibRjbRibRgbLhbLcbLibLibRg
LsbLibLgbRgbLgbLsLiLgbLibRibLeLsbLcbRcRhbLibRcbRcRibRiRsRsmmbRibLgbLhb
LibRjbRibLhbLhbRcbRsbRcbLcbRobLsRsbRibLjbRcbLhRsbRibRgbRsLsbRgbLiLsbRg
RiRiLibRibRgbLjbRgRsRimbLibRcbLhRhRsRgmbRsRibLjbRhbLibRhbRibLgbRiLsbRi
bLgbRgRibLjbRibLibLiLsbLgbLsbLibRhbRcbLjbLibRcbRgbRibLgbRibRsbLsRsbLjb
LhbRjbLcbRjbRcbLhbRhbLsbRsRibLgRiRsmbLsbRibRgbRibLibRibLsbRibLgbRgbRsR
gbLgbRgbRsbRsRsmbRgRsmbRsRgbLgbLhLcbRibLibLgbLgbLsbLgbLsbLgbLsLgbLgbRj
bRcbLhLsbRcbLcbRhbLjbLibLsLsmbLsbLsbLgbLgbLiLsLgbRsbRsLsRsbLgbLgbLsbRg
bLibLgbRhRsmbRibRgbRibLjbLibRcbRibLibRcbLgRsRibRsbRgbRgbRgbRgLsbLgbRsb
RgbLcbLsLobLgbRcbsbLibLibRjbRhbRsbRgRsRgRsmmbLsbRgbLgbRibRibRgbRibRsbL
sRibLobLhbLibRcbRibLibRsRiRsmbRgbRsLsbLjbRhRsmbLsRibRgbRgbRsRgbRiLsbLe
bRoLsbLhbRhbLibLibLgbLgLsbLsbLsbLgbLsbLsbLgbLsLsmbLgbLgbLsbRsbLiLsbLgb
RsbLibRcbLsRhbLjbLhbRjbRibLjLsmbLibLibLsLgbLsbRgbLgbLgbLgbLgbLsbLsbLsb
LsbLgbRsbLgbLsbRsLgLsbLsLsmbLibLgbLgbLgbLgbLgbLgbLgLsbLsbLsbLgbLgbLsbL
gLsbLgLsbLsbLgLsbLgbRsbRhRiRsRiRsmmbLsbRibLibLiLibRjbLsLcbRiRibRhbLhLo
bLibRhRsmbRhbLcbRcbLjbLcbRibRcbRsLsbRibRibLcRsbRibRibLgbRgbRgbRsbRsbRs
bRsLsbRsRsmbRsbRgLsbLjbRibRgbLsbRgRsmbLjbLcRgLsbLsLibRjbRibLcbLibRhbRc
bLjbRcbLsbRgbRgbLsbLjbRibRibLcLsmbLcbRsRsmbRjbRibLsLjbRibRibLsRibLsbRg
RibLcbLcRgbLiLsbLgbRgbLgbLgbRsbLsbLgbLsbLgLsbLgbLsbLsbLgLsbLgLsbLsbLsb
LgLsRsbRsLsbLgbLgbLgLsRsbLsbLgbLgbRjbLibRsRcbRiRsmbLhbRcbLhbRcbLsbRgLs
bRiRsmbRgbLsbLjbLcbRiRsmbLiLsLsmbLgLsbLsbLgbLgbLgbLsbLgbRsLsbLgbLsbLsb
LgRsbRsLsbLgbLsbLgLsLsmbLibRjbsbLibRgbLhbLibRsbLgbLgbLgbRgbLgbLibRibRj
bRiRsmbRibLjbRibLjbLcbRibLhbRjbLibLsbLgbLsbLsbLibRsbLgLgLsRsbRsbLiRgbL
ibLibRjLsbLibLgbRgLsbLgbLsbLsbRjbRjbRgbRsbRsbRgbLjbLcbLibLsbLibLgbRsbL
gbLsbLgLsLsmbRjRiLsbRiRibLiLsbRhbLgbLcbLhLsLsRgmbLgbLgbLgbLsLsmbLsbLgb
LgRsbRjbRcbRibLibLcbRhRsmbRhbLibLjbRibLjbLiLsbLibRgbLcbRgbLcbRgbLibLib
LsbLgbRsbLhbLibLgbLsbLibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 30; Drug: Control
bLibLgbLsbsbLsbLsLsmbRsbLsLsmbLgbLibLgbRjbRjbLibLibLgbLsbLgbLsbLsbLsbL
sbLsbRsbsbRebLsLsRcmbLibsbLibLgbLgbLgbLsLsmbLgbLsbLgbRsbLgbLsbLgLsbLsb
LgLsbRgbRobLgbLgbLgbRgbLgbRjbLhbRiLsbLibLgbRjbLibRjbRsbLgbRcbRgbLhbLib
LgbLsbLgLsbRgRsmbLibLgbLgbLsbLgbLsbLsRsbLibLgbLgbRjbRjbLhbLibRgbLsbLgb
LsRsbLibLgbRsbLgbLsbLgLsbRsbLgLsbLgLsbLsbLsLsmbLgbLgbLgbLgbRcbLcbRcbsb
RhbLhbRsbRhbsbLjbRjbRgbLibLgbLgLsbRsbLgbRgbLibLsbLgbLgbLgLsbLgbLgRsbLg
LsbLsbLsbLibLgbRsbRgbRjbRibLjbLsLhbRgbRgbRgbRgbLjbRjbLgbLgLsbRjbLsbLgb
RsLsbLsbLgbLgbLgbLsbLsbLgbLibLgbLgbLgbLgbLsLsmbLgbLjbLsbRhbLcbRibRhbRs
bRsbLebLsbLgbLgLsbLgbLsbLgbLsbLsbLgbRgLsbLsbLsbLsbLgbRsbLgbLgbRebLsbLi
LsbLsbLsLsmbLsLsmbLgbLsbRsbRobRcbRsbRhbLjbRsbRibLsbLcbLgLsbLgbLsbLgbLg
bLgbLsbLgbRcbRjbLjbRsLjbRgbLobLjbRebLsbRibsbLsbRsbLgbLgbLgbLgbLgbLjbRj
bLcbRhbsbLibLiLsbRsbLgbLiRsbLibRibLiLsbLsRsbLgLsLsmbLsbLsbLgbLsbRsbLgb
LgLsRsbLgbLibRebRibLhbRibRgRsmbRjbLsbLjbLibLibLibLsbLgbLgbLgbRjbLibRjb
LibLibLsLsmbLgbLgbLsbLgbLgbRjbLgbRgbRjbRcLsbLcLsmbLibRgbLiLsbLsbLgbLgb
LsbLsRsbLsbLgbLsbLgRsbLibRjbLhbRsbRsbsbLgbLsLsmbLsbLibLgbLgRsbRobRjbRs
bRgbRiRsmbLibLjbLibLibRgbLibLsRsbLgbLsbLgRsbLsLsmbRsbLgbLgbRjLsbLibRjb
sbLgbLsbLgLsLsmbLgbLgbLgRsbLgbLgbLgbLgbLsbLgbLsbLsbLgbLsbLgbRgLsbLibLg
bLgbLsLsmbLgLsbRsbLgLsbLgbLgbRgbLgbRsbLibRcRsmbRhbLhbLcbRjbLiLsbRgbLib
LgbLsbLgLsbLgbLsbRsbLgLsbLgbLgbRsbLgLsbLsLsmbLgbLgbRsbLibLgbRjbLibRgbL
ibLgbLgbRhbLobRcbLibLgbLsbLsbRsbLgLsbLibRjbLibRjbsbLgLsbLsbLgbLgbLgbLs
bLgbLsbLgbsbRgbLiLsbRgLsbLibLjbLgbLibLsbLsbLgbLgbLgbLibRgbLibLibRibLib
RibLibRgbLgLsbLsbRsLsbRsbLgbLsbsbLgbLsLsmbLsbLgLsbLgbLgLsbLgbLsbLgbRsb
LgbRsRgbLibLibRsbLiLsLgLsbLgbLsbLibRgbLibRgbLgbLcbRcbLhbRibLibRsbLgbLs
bLsRsbLgbLgbLsbLsbLibRjbLiRsbLsbLiLsbLgbRjbLcbRobRhbLgbRhRsmbRsLibRiRs
mbLgbRcbLhbRibRhLibLibLjbRhbRobLibLibLgbLsbLsLsmbLgbLsbLgbLgRsRsmbLcbR
sRibRcbLgbRgbRcbRgLsbLgbRgbRgbRsbRgbLgbLgLsbLsbLgbLgLsbLgbLgbLcbLoRsbR
sbLjbRsbRjbLcbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 31; Drug: NDMC 1 µM
bRsLsbLgbLsLsmbRcRsmbRgRsmbRibRiRsmbRsLsbLsbRibRibLsbLgbLsbLhbLibLibRs
bsbRibRcbLsbRibRsbLcLsmbLhbLibLhLsbLhbLibLsbLibLsbRsbRebRcLsbRcbLgbRsb
RsRsmbLsbRcbRibLibRcRsmbRsbRgbsbRsbRsbRibRhbsbLcLsmbLibLsbLiLsbRjbRobR
iRsmbLibRhRsmbRgLsbLibRhbRgbRsbRgbRgbLjbLibLibLgbLhbRhbLgLsbRibsbRibLi
bLibLibRibLebRgbLibLgbRgbLibsbLibRgbLiLsbRgbLiLsbRgbLibRgbLsbLibRsbLgb
RjbLiLsbsbRgLsbLiLsbLgLsbRgbRebRgbLhbLibLsbLsbLsbRsbLiLsbRgLsbLibRgbLi
bRsbLgbLibLgLsbRgbLibLgbRsLsbLibRgbLibRgbLhbRsbLhbRsbLibLsbRgbRjbRibLi
bRcbLjbLcbRibLoLsmbRibLibLhRsLsbLhbRsbLiLsbLibRcRsmbRibRibLhLsbRibRibL
jbRibLebRibLcbLhLsbRgbLibLgbLiLsbRjbLcbRjbLcLsmbRebRgbLhbRcbLhbRibRibR
gbRibLsbRibRsRiLsbLibRibLjbRibRibRibLibRibRgRsmbLsbLsbRgbLsbRgbsbRgbLs
bRgbRibRgbLgbRgLsbRibLgLsbRiLsbRsbRibRibLibLjbLibLibLjbLibRibLibLiLsbs
bRibLcLsmbLhbRiLsbLibLibRibLibRjbLiLsLsmbRgbLibRgLsbLibRgbLibRsLsbRsbL
gbRsbLiLsbLibLsbLgLsbRsbLgLsbRjbLebLibRobRibLsbLgbRhbRibsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 32; Drug: NDMC 1 µM
bRgbRhbRcbRhbRcbRgbLsbsbsbRobRcbRjRsmbRsbRsbRcbRsbRibsbRibRsbRcbLsbLgb
RibRibLjbLobLiRsbRsbLgbLgLsbRsbLgbRjbRcbRgbRsbRibLobLibLgbLgbRibLibLib
RibLibRcbRoLsbRgbRibLibLgbRibRsbRgbLsbRgbLobLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 33; Drug: NDMC 1 µM
bRgbLjbRjRsmbLcbRgRsRsmmbRobRsbLsbRibLcLsmbLhbLhbRiRsmbRibRsRsmbRiRsmb
RibRhbRjbRjbRjRsmbLsbLgbLcbLibLibRibsbLjbRibRibRjRsmbRibRjRgbRibRjbLjb
RsbRibRjRsmbRibsbsbsbRibRibsbRgRsRsmmbRibRsbLsbRibLgbRcbRsbsbRjbRcbRjb
LgLsbRcbRcbRsbRibLgbRhbLgbLgbRcbLjbLibLcbLcbLgbLsRsbRcbRsbLsbRcRsmbRiR
smbLjbsbRhbLgbRibLgbRsRsmbRhRsmbRcbRgRsmbRsRsRsmmbLibLcbLsLsmbLjbLsbLh
bLjbLhbRsRsRsmmbLibLsRsbRhRsmbRsRsmbRcbRcbRsbRgbRibRibLsbLsbsbRsRsmbsb
LibLgbLsbLsbLobRgRsmbLgbRjRsmbRibRjbLcbLcbLhbRsbRgbsbsbRcbRgRsmbsbRsRs
mbLhbLcbLcRsbRsbLgLsbRibRcbRgbRsRsmbRgbRgbRsbLgbRibLgbRibLsbsbsbLsbLsR
sbLsbLsbRiRsmbRhbRibRsRsmbRsbLgbRjbsbRjbRgbLsRsbRsbLjbRcbLibLcbLibLcbR
sRsmbLgbLsbLsLsmbLhbRcbRsbRgbRsRsmbRibRsbLsbLsRsbRgbRgbLgLsbLjbLibLsRs
bsbsbLibLsbLgbRjRsmbLjbsbLhbRsbLsbsbsbRgbLsbRsbRcbRgbRcbRcRsmbsbRsRsmb
RsbLibLgLsbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 34; Drug: NDMC 1 µM
bLgbLgbLgbLgbRjbLibLgbRibLibLsbLgbRgbLibLgbRcbRcbLcbLobRsbRcbLsLsLgLsm
bLgLsbRgbLhbRgbLsRsbLgbLsbLsbLsbLgbLsbLsbLsbLgLsbRsbLgbRjbRibRgbLcLsmb
RjbRjbLibLsLsmbLgbLibRgbLgbRhRsmbLgbLiRsbLsLgbRsbLgLsbLsLsmbLsLsmbLsbL
gRsbLgbLsbLgbLgLsbRsbLgbLgbLgbLsbRebRibRgbLebLgbRsbLibLcbRibLibLsbLgbL
sLsmbLgbLsRsbLsbLgbRsbLgbLsbLgbLsRsLgbLsbLsbLgbRgbLsbLgbLgbRsbLibLsbLs
bLsbLsLsmbLgLsLsmbLsbLgbRjbLgbLsbLgbLsLsmbLgbLsbLsbLgbRsbLsbsbRjbRcbRi
bLcbLibLsbLibRcbLobLibRibLgbRgbLhbRgbLgbLgbLsbLsbRgbLsbLcbRibRibLhRsbL
gbLgLsbLsbLsLsmbLgRsbLsLsmbLsLsmbLsbLgbLgbRgbLgLsbRsbLsbLgbRgbLhbRcbRj
bRibLcbRobRcbRcbRibLibRgbRsbLcLsmbRjbLiLsbLgLsbLgbLgbLgbRjbsbRcbLjbLiL
sbLgbLibLgbLgbRsbRsbLgbLgbRsRsmbLibRgbLgLsbRsbLsbRsbLiRsbLsbLgbRgbLgbL
sbLgbLgbLgbRjbLjbRjbLiLsbLsbLgbLsbLgbLgbRgbLgbLgbRsbLgLsbLgbRjbLibRgbL
gbRsbRhbRiRsmbRgbRibRsbRgbRibRibLgbRiRsmbRgbLgbRhbRhbLiLsbLibLoLsmbRcR
smbLsbRibRgbRgRsmbRjLobRjbLibRsLibLsRsbLgbRsbLibLgbRgbLibLgbLgbRjbLgbL
gbRsbLsbLgbRgLsLsmbLgbLibRjbLgbLgLsbRsRsmbLgbRebRgbLibRsbLgbLgbRsbLgbR
sbLgbLgbRsbLgbRsbLgbRsbLgbLgbLsbLgbLsLsmbLgbRsbRsRjbRcbLcbRcbLoLsmbLib
RgLsbsbLgbLsbLgLsbLgbLsbLsbLgbLsbLgbRjbLgbLgLsbLgbLgbLgLsbRgbRsbsbRjbR
ibRgbLjbLibLgbLsbLsbLsbLgLsbLgbLgbLsLsmbLsbsbLgLsbLgbLgbRhbRgbLcbRibLc
bLgbLiRgLsRsbLhbRgRsLsmbLibLibLiRsbRiRsmbLcbLiLsbRgbLibRjbLibRsbLgbLsb
LsbLsbLgbLgbLibRsbRgbLgbLgbLsbLgRsbLsbLgRsbLsbLsLsmbLsbLsbLsbLgbLsbLgb
LgbRgbLibRebRcbRcbLcbLibLgbLgbLsbLcbRibLsbLsbRjbRgbLcbLibRgLsbLibRgbLs
bLgLsbRjbLobRgbLgbLsbLsbRcRsmbRgbLjbRgbRsbRobLsbLgbLgbLsbLcbRcbLoRsbLh
LsbRgbRgbLobRibLhLsbRgbLsbLgRsLsbLsbRsbLsbRsbLcbRibLgbRgbRsLsbLibLgbRs
bLgLsbRsbRjbRsbLibLgLsbLgbLsbLgbLhbRsbLgbRsRsmbLibLsbLsbRsLsbLgLsbLsbL
gbRcbRgbRgRsmbRsbRgbRgbRsbRsbLsbRgbRsLobRibLsbLgbRgbLibRibLobLsbRjbRiR
ibLcbLcRsbLsbRsLibRsRsmbLgbLgbLgLsbRjbsbRgbLibLsLsRsRsmmbLibRsbLgbLgLs
bLgbRjbLibRjbLibLgbRsbLibLgbLsLgbRjbLgbLgbLsbRsbLgLsbLgbLsbLsLsmbLgLsb
RsLsLsmbLsLsmbLsbLibRjbLcbRgbRsLsbLgbLibRgLsbLgLsbLsbLgbLsbLsbLsbRsbRj
bLibLsbLgbLsLsmbRsbLgbLgLsbLgLsbLsbLsbLgbLgbLiLsbLgbLsbLgLsbRsbLgRsLsb
RsLsbLgbLsRgbLibRsRsmbLgbLgbLsbRsbLibRsbLgLsbLsbLgbLsbLgbLsbRsbLgbLobR
jRsmbLobLibRgLsbLcbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 35; Drug: NDMC 1 µM
bLsbsbRsbRgbRjbRcRsmbsbRibLibRgbLsbLsbRsbRibLibRhbRsbRsbLgbRibsbRgbLsb
LsRsbRcbLgbRsbLgbRcbRgbRsbLgbRhRsmbLsbRgbLcRsbLsbRjbRiRsmbLgbRjRsmbRsR
smbRgbRsbRgbLgbLsbRibLjbRibLsbLjbRibLsRsbLsbRiLsbRgbRibRsbRjRgbRsbLgbR
gbLjbRsbRsbLjbLcbLgLsbLsbRsbRsbRibLsbRsbRgbRsbLsbRsbRgbLsbRsLsbRgbRsbR
gLsbRibRibLibRsbRsbRgbLjLsmbRgbRgRsmbRcRsmbLiLsbRsbRibRsbLsbRgLsbLcLsL
jmbLibLgbLibLsbLsbLibLgbRsbLsbLgbLsbRcbRsbLgbRhbLibRibRibLjbRcLsbLgbLs
bRsLsbRcRsmbRhbRsbRiRsmbRsbLiLsbRibRibsbRsbRcLsbLibRsRsmbRcbRhbLgbLjbR
ebRgbLibRsbRsbRibRsbLjLsmbLcbRibLcbRiRsmbLcLsmbLsbLsbLgbLsbRsbLsLsmbRg
bLibRsLsbRsbLibLgbRsbRgbLsbLsbLibLhRsbLgbsbRhbLsbLibLsbRgRsmbRgbLsbReR
smbRsLsbLibRhbLgbRibLibRibLibsbRiRsmbLibRgbRibLjbRcbLibLibLcbLsbRsbRib
LcLsmbRgbLobLsbRsbLsbLcbRgbRjbLobLibLhbLsbLgbLgbLhbLibsbLgbLsbLgbLgbLg
LsLsmbRsbLjLsmbRsLsbRjbLcbLibRibLibRsbRibLcbRgbLibRjbLibRsbLibRjbLibLs
LsmbLsbLsbLiRsbLibRgbLhbRiRsmbLcRsbLjLsmbLsbLgbLiLsbLibLsbLebRsbLhbRgR
smbRsbLibLgbRsbLibRgbLcbRcbLjbRgbLhbLiLsbRjbRcbLibLhbRhbLibLgLsbLibRgb
RgbLhbRjbLcbRgbsbLiRsbLibsbRsbLsLsmbLibLsbLgLsbRjRsmbLjLsmbLsLsmbLsbRs
LsbLsbLgbLsLsmbsbLsbLgbLsbLsbRsbLgRsbLgbLsbLgbRsbRsbLgbLibLibRibLibLsb
LgbLsbLgbLsbLgbLibLibLibLibLibLgbRjbLcbLibRibLiLsbRsbRibLcbRhbLcbLgbRs
bLsbLsbRsLsbRsLsLsmbLibRibLcbRgbLgbLgbRgbRsbLiLsbLgbLgRsbLsbLsbLibLiLs
bLgLsbRcbRcbLiRsbRgbLsRsbRibRibLibRibLibLgbLjbRebRsbRcRsRsmmbLibRgbRob
RsLsbsbsbRobRibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 36; Drug: NDMC 1 µM
bsbsbsbsbLobRcbRsbsbRsRsmbLcLsmbRcbRsRsmbLsLsmbLcbRobRsbLjbRcbsbRgbLib
RcbLcbLcbRsbRobRsRsmbRsLsbRsbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 37; Drug: NDMC 3 µM
bsbRjbRcbLhbsbLjbRcbRcRsmbLjbLebRibLcbRhbRcbsbRgbLsbLjbLcbLebRcbRcbRib
RibLibLebLcbLibRcbRcbLsbRibLsbRgRsRsmmbLjbLhbRjRsmbLcbLhbRebRibRhbLjbL
cbRibRebRibLhLsbRsbRibRsbRsbRgbLsbRcbLibRibRibRhbRsbRsbRibLgbRgbRcbRib
LibRibRibLsbLsbRibLsbRgbRsbRgbRsbLjbLibLiRsbRibLcbRibLsbLgbLgbLgbRcbRi
bRiRsmbRhbLgbRsbLsbRhbRibRgbRsbRgbLgbRgbRsbLgbLcbLibRibLibLibRjbLcbRib
LcbRsbRsbRgbLibLsbLibRibLibRgbLiLsbRibLcLsmbLcbLsRsbRiRsmbRsbLsbLgbRhb
RibRgbRsRsmbRsbRsbRgLsbRsRsmbRsRsmbRgbLjRsbRibLgbRibRsbRibLgbRibLsbRgR
smbLsLsmbRgbLsbRiRsmbLgbRiLsbLgbRibRsbRibLjbsbLobRjbRibRibLgRsbRiRsRsm
mbLsbLsRibLgbRibRgbRgRsmbLibRiRsmbRsbRgbRsbRgbRgRsmbRgbRsbRgbRsbRsbRgb
LjbLcbRiRsmbRgRsmbRsRsmbRgbRsbRsLsbRiLsbLibLcbRjRsmbLiLsbLgbLsbRobRsbR
ibLsbRgbLsbLsbRibLsbLobRgbLibRibLgbRibRsbRgRsmbLsbRgbRgbLgbRhbLibRhRsm
bLibRibRgbRibLgRsbRibLgbRibLgLsbRibRsbRjbRobLcbRjbRcbRibRgLsbLsRsbRibL
jbRibLjbLcLsmbsbRebLcbRjbRiRsmbRibRsRsmbLgRsbRcbLsbLsbRibRibRhbRsbLibR
ibRsbLibRhbLgbRibRsbRgbRcbLibRsbRsbRsbRsbRgLsbRgRsmbRsRsmbLjbRgbRgbLgb
RiRsmbLgbRibLgbRibLsbRgRsmbRgbLgbRibLgbRibLsRsbRibLsbLcbLcbRhbRobLhbLj
bLibRoRsmbRgbRsbRsbRsbRibRibLsbLibRcbLjbRiRsmbLgbRibLgbRibLsbRsbRibLgb
RiRoLsbRsbLsbLsLibLobLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 38; Drug: NDMC 3 µM
bRsRsLsmbRiLsRsbRgbRsbRsbRsRibsbLsbLgbRiRsmbRibRgbLsbRhbRibRgRsmbLsbRs
bRgbRgbsbRsRsmbRiRhbRhbRgbRsbLsbRgRsmbRibRsbRibRsbsbRibRgbRjRsmbRsbLiL
sbRsbRiRsmbRsbRsbRgbRgbRgbRgbLsbLsbLsLsmbRiRsmbRgRsmbRsbLsbRibRibRgbRs
bLgbRgbRgbRiRsmbRibsbLsbRibLsbLsbRgbsbRgRsmbRsbRibRibRsbLsbRsbRgbRjRsm
bLgbsbRibRgbsbLsbsbRibRgbRsRsmbRsRsmbRsbRgbRsbRgRsmbRsbRgRsmbLsbLsLsmb
RsbRsRiRsmbRgbRsbsbRsbLgbRibRsbRgbRsbRgRsmbRsbLjbRibsbRgbRgLsRsbRibRib
RsbLjLsmbRgbRibRibRsbsbRsRsmbLsbRgbRhbRgbRgbRsLsbLsbRgbRgbLsbLsLsmbRib
RgbRgRsmbRsbRgbsbLgbRsbRibRgbRgRsmbRgbRgbRgbRibRgbRsbLgLsbLsbRibRhbLsb
LgRsbRibRibLsbRgbLsbLsbRibLsbLgLsbRgbRibRgbRsbRgbRgLsbRgbRsbRsRsmbRgbR
ibLjbRibRibRsbLgbRiRsmbLiLsbRibRgbRgbRgbLgbsbRibRsbRibLjRsLsbRibLgbRib
RgbLgLsbLsbRibRibRsbRgbRgRsmbLsbRibLsbRibRsRsmbRgbLgbRibRgbRcbLibRgbRg
bRiRsmbRgbRgbLsbRsbRibRsbRibRibLibRibRgbRsRsRimbRibLsRsbRgRsRsmmbRgbRg
RsmbRgRsmbLjbRibRibRsbLgbRgbRgbRsbRsbRgbRsbRgbRgbRgbRsRsmbRgRsmbRgbLgb
RsRibLcbLiRsbLibRjbRjbRibRibRgbRsbRsRsLsmbRsRsmbRsbRsbRgbRgbLsbLjbRiRs
mbRsbRgbRgbRiRsmbLgRsbRibRgbRgbRgRibLibLiLibLgbLsbLgbRsbLgRsbRjbRcbRgR
ibLsbRgbRgbRibRgbRsbRsbLjbLhbLcbRibLibLgbsbRsLsbLgbLgbRgbLibRsLsbLibRs
bLibRgbLgbLgLsbRsbLgbRgbLsbLibRsbLibRgbLibLgbRsbLgRsbRsbLibRsbLgbLsbLg
RsbRgbLiRsLsbLibRsLsbLiLsbRgbLibLgRsbRgbLibRsLsbLibLsbLgbLgbRsbLibRgbL
iRsLsbLgbLsbLgbLsbLgLsbLsbLgbLgbLibLsbRgLsbLgbLgbLgbLgbLsbLgbLgbRgRsmb
LibLhbRhbRgbRsbRgbRibLibRcbLgLsbLcbRcLsbLsRsbRgbRgbLsbLobLibLcbRibRibR
gbRgRsmbRsbRsbRsbLsbLhbLgbLsbLgLsbLgbLgbLsbLibRjbRibRibLjbRhbLjbRobLib
RgRibRsRsmbRgbLsbRgbRsRsmbLsLsmbRgRsLsmbRsbRsRsmbRiLsLsmbLibRgbRgbRgbR
sbRgRsmbRsbRsbRgbLjbRgbRgbRgbRgbRgbRgbRgbRgbRgbRsbRgbRsbLcbLgbLgbLjbRc
bRgbRsbRgbRgbRsbRsbRsRsmbRgbRsbRgbRgLsbRgLsbRgbRsLsbRgbRgbLgbRgRgbRibR
sbRibRgbRsbLsbLjbLibLgLsbRsbRjbRibRgbRsbRsbRgbRgbRsRsmbRsbRsbRgbRiRsmb
RgbRgbRsbRgbRgbRgbRgbLjbLcbLgbLgbLsbLsbLsRsbLgbLgLsRsbLsLsmbLsbLgbLgbR
gRsmbLgLsbRsbLsRiRsmbRgRsmbLsbRgbRsRsmbRgbRsRsmbRsbRsbRsbRgbRsbRsbRsbR
obRhLsbRobRhbRsbLgRsbRsbRgbRsbRibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 39; Drug: NDMC 3 µM
bLhLsbLibLcLsmbLgbRgbsbRsbRibsbsbLjbLobLjbLsbLgbRhbRsbRsbRjbRgbRgbRibR
sbLsLsmbLsLsLsmmbRgbRgbRjRsmbRibsbsbLcbLobLjbLsLsmbRiRsmbRhbLsbLgbLsbL
hbLhbLibRgbLsbRhbRhbRsbLsbRsbRibsbsbRibRsbsbsbsbLgbLsLsmbLibLsbLcLsmbL
ibLsbLibLcLsmbRgbRsbLsbRgbRgbRgbLsbLsbLobLoLsRsLsLsmmbLsbsbRsbLebRhbRc
RsmbLsbLsbRcbLsbsbRjbRgbLsbsbLebLhLsbLsbLiLsbLibLibLibLiLsbRsbRjRsRsmm
bLgbRcbLsbLgLsbRcbRgbLibLibLibLsbLibLsbLibRobRcbRibRsbLsbLhbLibLgbLgbR
jbLcbLgbLebLsLsmbLsbLibLsLsmbLcbLcbLgbLsbLsLsmbLgLsbRsbLcRsbLhbRsbLsbR
jbRibLgbLcbsbLibRcbRibRsbRsbLgLsbLibLgbLjLsmbLsbLibLebLsLsmbLibLsLsmbL
gbRjbRsbRsbRcRsmbRibRibsbsbRsbRjbLsbRibLjLsmbRhbLobLcbRsbRsbRgbLgbRsbR
gb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 40; Drug: NDMC 3 µM
bRibRgRsmbRgbRsRgbRgbLcRsLcbRsbRhbsbRibLsLsmbsbRsbLsbsbRibLjbLcbLgbLiR
sbRhbRcRsmbRibRsRsmbRsRsmbRgbRgbRsRsmbRsRsmbRsbRsRsmbRgRsmbRsRsmbRsRsm
bRsbRgbRgbRgbLjbRibLibRgbRgbRsbRgbRgbRsLcbLibLgbLibRjbRcbRgbRgbRgRsmbR
sRsmbRsRsmbRgbRsbRgbLjbLcbLgbLgbLgRsbRjbRcbLiRsLcbRibsbRhbRsbLjbLibLsb
LgRsbLsbRjbRgbRgbRsbRsbRgbRsbRgRsmbRgbRsbRgbRgbLsRgbRgbRsbRgRsmbRsbRsb
RgLsRsbRsRgRsmbRgbRsRsmbRsRsRimbLsbRgbRgbRsRsRgRsRgRgRsmmmbRgbRgbRgRsm
bRgRiRgbRsbRgbRgbRgbRsRsmbRgbLjbLcbLibRjbRjbRjbLjbLoRsbRsbsbRcbRiRsmbL
gLsbRibLibRibRsbLjbLcbLsbLgRsbRsbLobRcbRibRiLsbLjbRhRsmbLgLsbRcbLgRsbR
ibRibLiLsbRhbRsbLsbRgbRgRsmbRgbRsbRgbRgLsbRsbRgRsmbRsLsbRsRsmbRgRsRsmm
bRgbRgbRsbRsbRsbRgRsRsmmbRgbRgRsmbRsbRgRsmbRgRsmbRgbRsRsRsmmbRsbRsRsmb
RgbRsLsbLgbRibRgbRibRibLibLjbRcbsbRibLcbRjbRibLsbRibLjbRjbLhbRgbRgbRgb
LjbLsbRgbRsbRgLsbRgbRibLgbRgbRgbRsbRsbRgbLjbsbRgbRgRsmbRgRgRsRgRgmbRgb
RgbRgbRgbRgbRsbRsbRgLsbRgRsRsmmbRgbRgbRgbRsLcbRgbRiRsmbLjRiRsmbRgRsmbR
sRsRsmmbRsbRgbLjbRjRsLsmbRibRgbRsbRgbRgbLjbRibRsbRgRsmbRgRgRgbRgRgRgRi
RsRgRiRsRiRgRsRsRgRsRgRsmmmmmmbRgRsmbRgbRiLibRibRgbRgbRgbRgRsmbRgbRsRs
RgRsRiRgmmbRgbRgbRsRgbRsLsbRsbLcbLibLgbRsbRjbRcLjbRibRgRsmbRgbRsbRgbRg
RgRsRgmbRgbRgbRibLgbRgbLjbLibLgbLgbLgbsbRjbLobRhbLcbRcbsbRobLjbRibRgRs
mbRgbRsbRsbRgbLjbsbLhbLsbLgLsbLgLsLsmbLgbLsRsbLgbLgbLsbRcbRibRsbRsbRsR
smbRgLsbRsbRibLgLsbRibLibRgbRgbRsRsmbRibLjbLcbRhbRgbRsRgRsmbRgbRgbRgRs
mbLsRsbRgbRgbLsbRgbRgRsmbRgbLsbRgRsmbRgbRsbRgbLebRgbRgRsmbRgRsRgRgmbRg
RgbRgbLgbRibRgbRgbRgRsRimbRgbRgbRgRsmbRgRgRsRiRsRsmmmbRgRsmbRiRsmbRgbL
hbLcRsbRcbsbLgbRibLsbRgRsmbRgRsmbRgRgRsRsRsRemmmbRsbRiRsLsmbRgRsmbRgbR
gLsbRiRsReRsRiRgmmbRibLcbLiLsbRjbLibLgbLgbRjbRiRsmbRgRsmbRgbRgRsmbRgRg
RgRsmbRgRsmbRgRsRgRsmmbRgRgbRgbRibRgbRgbRgbRgbRgRsmbRgbRsbRsbRsLsbLsRs
bRgRsRgmbRgbRsbRgRsmbRsRebRgbRgbRgRsRiRsRgRsRgRgmmmbRgbRgbLjbLjbLibRjb
RcbLgbRcbLgbRiRsmbRiLsbLgbRibRgRsmbRgbRgbRgbRsbRgbRgRsmbRgbRsbRgRsRsmm
bRibLjLsmbRibRgRsmbRsbRibLgbRiRsmbRgbRgbLibRibRgbLibRibLsbRgbRsbRsbRsb
RgbRgbRgRsmbRgbRgbLgbRgbRgRsmbRsbRsbRsRsmbRgbRgbRgRsRsmmbRsbRgRsmbRgbR
gbRgRsRgRsmmbRgbRsbRgbRsbRsbRgRsmbRgbRgbRgRsmbLcLsLimbLgbLgbRsbLibLobR
ibRcbRibRibRsbLibRgbRibLjbRibRsbLjbRibLgbsbRgbRgbLjbRibRibLibLibRebsbR
gbLsbRgbRgbRsbRgbRgbRsRsmbRgbRsRsmbRsbRgbRsRsmbRgRsmbRgbRsRiRgRsRgmbRg
bRgRgRiRsRgRsmmbRgRgRsRiRsRgmmbRgbRgbRsbRgbRgRgRsRsmmbRgRsmbRgbRgRgRsR
iRgmbRgbRgbRsbRgbRgRsmbRgbLjRsbRibLjbRgbRgRsmbRgbLjbRgbRiRsRsmmbLjbsbR
ibLibRibsbRgbsbRibLsbRgRsmbRsbRsbRgRsmbRsbRsbRgbLjbLjbRhbRebLsbLhbLcbR
ibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 41; Drug: NDMC 3 µM
bRsbLsbRibLibLsbLcbRgbRsLsbLgbLgLsbLgLsbLgbLsbsbRsbLhbLgbRsbLhLsbRgRsm
bLsbLsbRhbLiLsbLebLgbLsbLibLsbLsbLibLsbLibLsbLgbRsLsbLibLgbsbLibRibLib
LsbRsbLebLsbLibLsbRsbLibLsbLsbLiLsbLibLsbLibLgbLeLsbLsLsmbLibLsLsmbLsL
ibLsbLsRibLiLsbLhbRsbRsbLhbRgbLhbLsbLibLsbLsbRsbLiLsbLsbLibLibLsbLibLs
bLibLsbLgbLsbLhbLsLsmbLgbRgbLebLsRsbLibLgbLibLsbLgbLgbLibLhbLsbLsbLibL
sbLsbLibLsbLibLsbLsbLhbLsbLibLsbLsLsmbLibLhbLsbRsbLibLsbLsbRsbRsbLibRj
bRcbRcbsbLsLsmbRibLsbLjbRgbRsbLgRsbRibRsbsbRebRcbRsLsbLibRsbLsbRgRsmbL
cbRsbLhbLsbLgLsbLibLsbLcbRibLhbRsbLhbLsbLgbLsbRgbRcbLsbRsbRiRsmbLgbRjR
smbRsbLjbRsbRibRgbLsLsLsmmbRgbLobRsbLhbRibLibLibRsbLibRsbLibLsbLgbRgbL
ibRsbRsbLibLgRsbRgbLibRjbLibLgbLgbLgbLsLsmbLgbLsbLgbLsRsbLgbRgbLgbLibR
jbLibLsLsmbLibLsbLgRsbsbRgbLibLgbLsLsmbLsbLsLsmbLsbLgbLgbLsbLsbLgbLsbL
ibRgbLibRsbLibRsbLibLiLsbLhbRibRibLsbLgbLibLcbRiRsmbLibRjbLhbRgbLibRsb
LgbRgbLhbRgbLgbLibsbRsbRsbLgLsbRgbLhbRgbLcbRgbLiLsbRgbLibRsbLibRgbLibR
gbLibLsbLsbLibLgbRgRsmbLibRjbLiRsbLsbLsbLgbRgbLobLsbRgbLobLib

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 42; Drug: NDMC 3 µM
bLgbRgbRgbLgbRibLgbRsbLgbRjbsbLsbLsbRsbRsbRgbLsbRsbRgbRgbLgbRibLsbRibL
ibRcbRcbLgLsbLsbLgbRsbLgbLgRsbLgbLgbsbLsbLsbLsbLibRjbLcRsbRhbRobLsRsbR
ibLsbLgbRibRjLsbLgbRhLsbLibLcRsbRcbRoRgbLcbRibsbRcbRgbLgbRibLiRsbsbRgb
RsbRgbLsbRgLsbRgbLibRcLsbLgbLsbRibLsbRgbRgbLgbRgbRiLsbLibLjLsRcmbLsbsb
RsbRgbLsbRgbRgbLjbRibLjLsmbLjbRcbLgRsLsRibLgbRibRgbLgbLsbRiLsbRgbLsbRg
bLsbRibLiRsbRhbLgbRibRgbLsbRibLibLsbRgbRibLgbRiLsbLibRibRgbLsbsbRsbRsb
RsbRsLsbsbRgbRsbLsbsbRsRsmbLsbRiRsmbLsbRgbRsRsmbRsbRgbLsbRibLgRsbRhbLs
bsbLsLsmbRsbRhbRibLibLhbsbRsbRiRsRsmmbLgRsbRibRsbLsbRgbRsbRgbRgbRibRsR
smbRgbRgbRsbLgbRgbLgbRsRsRsmmbRgbRsbRsbRsRsmbRibRgRsmbLgbRibRiRsmbLgbR
ibLgbRibLsbsbRsRsmbLgbRgbLsbLjbLgbLjbRhbRebLibLcbLjbRibRsbLgbLjbRcRsmb
LibRhbRibLsRsbLsRsbRiLsbRsbLgbRjbLibRibLsLsmbRsLsbRsRsmbLiLsbRjbLibRsb
LgbLgbLsbRsbLgbLgbLjbRsRsmbRgbLjbRsbRgRsmbLjbRobLgbRhRsmbLgbLjbLcbRcbL
cbRgbRsRsmbRsbRgbRgbRgRsmbRgbRgbRjbLgbRjbRsRsmbLcbRjbRsbRgbRjbLsRsbLib
RgbLibLgbLgbLgbRsLsbRsbRsbsbRsRsmbLsbRhbLjbLcbLgbLgbRsbLgbLgbLgLsbRgbL
jbRobRgbRsbLsLsmbRsRsmbLsbLibRjbRsbRgbLsRsbRsRsmbRsbRsbRgbRsbRgbRgbLcb
RjbRcbRjbRgbLgbRsbsbsbLsLsmbRsbRgbRsbRsbRgbRsbRsbRgRsmbRsRsmbRsbRgbRgL
sbRibRgbRibRgRsmbLgbRgbLgbLibLiRsbRjbRibLsRsbRcRsmbRobLgRsLgbLsbLjbLgb
RgbRcbRhbLibLcbLsbRsbLobRebRcbRsbLjbLibLgLsbLgbRgbLsRsbRsbLsbLgRsbsbRs
bLsbRsbLgbLsLsmbLsbRgLsbRjbLjbLgbReRsmbRcbLibLhbRobRibLjbLsbRiRsmbRsLs
RsbRsbLsbRgbRsbRsRsmbRsbLsbsbLsbLgbRsRsmbRsbRsbRgbRgbRgbRsbRsbRsbRsbRg
bLgbRibRsbLcbRcbRhbRgbLibRibRgbRsbRgbRgbRibRgbRgbRgbRgbLibRibRgbLibRjb
RhbRibLibLgbLibLsbRgbLgbsbLgbsbsbLhbLoRsRsRsmmbRgbRgbLsbRsbRsbRsbRsbRg
bRsRsmbRsbRiLsbLibLebLjbLjbLsLsmbRsbLgbsbLgbRsbLobRhbRcbRsLsbLgbLhRsbL
gbRcbRgbRibRgbLjbRsbLgbLsbLsbLsLsLsmmbLgbLgbLgbLgbLgbLgbLgbLsbLgbLgbLg
bLgbReRsmbLiLsbLiLsbLcLsmbLgbLgbLsbLobRsRsmbLgbLibRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 43; Drug: NDMC 10 µM
bLgbLjLsmbRibLhRsbRsbLgbRjbRhbRiRsmbLsbsbRibRsbRhbRcRsmbRcbRiRsmbRgbLg
bRsbRiRsmbLjLsmbLgbRibLgbRgbRcbRsbRcbLgbLsbRjbsbRsLsbRgbRibLgbLgbLibRj
RgbRsRsmbLibLgbLhLsbRibLcbRcbLibLgbRsbLgbRsbLgbRjbRcbLjbRibRibRgbLibRs
bRibRsbLgbRsbRibLgbRibRsbRgbLjbLoRsbLcbRgbLgbLibLsLsmbRcRsmbLsbRsbRhbL
gbRibLgbRhbLibRibRsbRibLsbRgbLsbRgbLjbLobLibRsbRibLibLgLsbLgbLibLgbLgb
LgbRsbLgbLibRgRsmbRcRsmbRibLsbRibLsRsbRibLsbLjLibLcbLgbRgbLibLsbRibRhR
sLsmbLsbRibLsbRgRsmbRibRcbRsRsmbRcbRsbRibRgbLgbLgbRcbLjbRsbRiRsmbLibRi
bLgbLcbLsbLibRibLjbLgbsbRgbLsbLsbLibRjbLcbRiRsmbLgbLgbLgbLsLsmbRibLhbR
iRsmbLsbLgbLgbLgRsbLsbLgbLsbLsbLsLsmbLsbLgLsbRsbLcbRgRsmbRjbRcbLhbLibR
jbLibLsbLsbLsLgbLsRsbRsLgbLsbLgbLsbLgbRhbRcbRsLsbRibRgbLgLsbRibRsRsRsm
mbLsbRsbRgbLsbRiLsbLibRhbLibLcbLgbLcbRgbRsRsmbLgbRjbLhLsbLgRsbRibLibLg
bRsbsbLgbRsLsbLgLsbLgbsbLgRsbLsbLgbLgbLsbLsbLsbRgLsbLoRsbRiRsmbRsbRhbR
hbsbRcbLibRsRgbRcbLgbLjLsmbRcLsbRibLsRsbRibRsbLsbRgbRiRsmbRsbRibLsbRgb
LjbRibRsbRsbRibRgbLsLsmbRgbLcbLibRgRsmbRgbRibRgbLgbRcbLsbLsbRgbRgbLgbR
ibLgbRgbRsbLsbRibLjbRcbLhbRibLiLsLsmbRibLgRsbLsbRgRsmbRgbRgbRgbLibRsbR
ibLcbRsbLgRsbLhbRcbRcbRibRsbRgbLsbRgbRsbRgbLcbRcRsmbRsbRgbLsRsbRgbLsbR
gbRgbLhbLcbRibRiRsmbRibLjbRibRobLgbLgbLsbRsbRsbLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 44; Drug: NDMC 10 µM
bRgbRgbRsLsLsmbRgbRgbLsbRgbRgbLsRsbRgbRsbRgbLgbRgbRsbRsbRsbRsbRsbRgbRs
bRgbLsRsRjbLebLobRsbRsbRibRibRjRsmbLsbRhbRibRsbRgbRgbRiRsmbLjLsmbRibLs
LsLsmmbLsRsbRibRiRsmbRgbRibRgbLsbLsbRjbLcbLibRgbLhbLibLsbRgbRsbRgbRgbR
cbRjbRibRhbRsbRsLsbLsbLibRsbLibLsbRgLsbRsbLhbLcbLibLibRibRibRsbLsbRhbL
gbRsbRibRgRsmbRgbLsbRgRsmbRgbRgbRsbRgbRgbRgbRsRsmbRgbRgbLibRhbRgbLjLsm
bLibLibRsbLgLsbRgbLgLsbRgbLgbLgbRsbRsbLgbLibRgbRsbLsRsbLgbRsLsbLgbRjbR
cbRgbRsbRsRsmbRgbLsbRsbLsbRgbRgRsmbRgbRgbRsRsmbRsRsmbRsRgbRgbRsbRsbRsL
sbRgbRgbRgbLsbRgbRgbRgbLjbRhLsbLjbRibRsbRsRsmbRsbRsRsmbRgbRsbRsRsmbRgR
smbRsbRsRgbRgbRgbRsRsmbRgbRibRsRsmbRgbRsbRgRsmbRgbRgbRgbRgbRsbLsbRgbLs
bRgbLobLibRcbRhRsmbRgbLsbRsbRgRsmbRsbRsbRsbRgbRsLsbRsbRgbRgbRgbRgbRgRs
mbRgbRgbRsbRgbRgbRgLsbRcRsmbRcbRiRsmbRjbRiRsmbsbRgbRsbRsbRsbLsbRsbRsbR
gbRsbRsbRgRsmbRgRsmbRgbRgRsmbRibLjbRobRcbRibRgbRcbLibLcbLiRsbLcbLobRsb
RhbRgbsbLsLsmbRsbRhbLiRsbRgbRhbLcbLjbLgbLgbLgLsbRsbLgRsbRsbLgbRoRsmbLs
bLsLsmbsbRgbRgbRsRsmbRgbRgbRsbRiLsbRibLibRgbRibsbRibRsbLgLsbRiRsmbLsLs
mbRiRsmbLsbRgRsmbRgbRgbLsLsmbRibLsbRibLgbRiRsmbLsbRgbRsbRsbRgbRgbRsbRg
bRgbLsbRgbRsbRsbRgbRsRsLsmbRgLsbLsbRgbRgbRsbRgbRsbRsbRgbRgbLgbRibLgbRg
bRgbRsRsmbRgbRsbRgbRibLjbLobRjbLhbRjbLiRsLsbRebRcbLibRibRgLsbRgbRgbLsL
smbRgbRsbRsbRgbRgbRsRsRsmmbRgbRsLsbRgbRsbRgRsmbRsbRsbRgRsmbRgLsbRgbLjb
LcLsmbLsbLgbRhRsmbRibRsbRsbRgbRsbRgbsbRibRiRsmbLsbLibLhLsbRgbLibLsbRjb
RobLjbRcbRhbRsbRsRsmbRsLsRsbRhbLibRsbRibLsbRcbRiRsmbsbRibRsbLsbRobLjbR
cbLcbLcbRsbLsbLhbRhbsbRcbLsbRsbRgbRsRsmbRgbRsbRgbRgbRgRsmbRsbLsbRibRgR
smbRsbRgbRsLsbRgbLsbRgbRgbLjbRgbRsLsbRsbRsbRsbRsbRsbRgbRgbRjbLobLsbRsb
LgbLsbLibLobLhb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 45; Drug: NDMC 10 µM
bLgbLsbLcbLgLsbLsbLgbRsRsmbRcbRjRsmbLsbRgbLsbLjbRgbRsbRsbRsRsmbRgbRgbR
gRsmbLsbLgbRsbRibRsbRgRsmbRjRsmbLgbLsRsbLsbRcbRsbRsbRgRsmbLsbRsLsbRsbL
gbRcbsbRsbRibRsbLsbLgbLsbLsbRgbRcbLgbRcbLsbsbRsbLsbRgbRsLsbRibRsbLgbLs
bRgbRgbLgbRgbRgRsmbLsbRsbRsbRsbRgbRgbLsLsmbRhbRhbRgbRgRsmbLsbRgbRhbLsb
RjRsmbRsbLgbLsbRsRsmbRibLgbRcbRcbRhbRsbRgRsmbLsRsbLsbRhbRgbLsbRsbRsRsm
bRgbLgLsbLsbLgbLsLsmbLgLsbLcbRsbLibRsbLsbLgbLsbLsbLgbRsbLsbLsbRgbRcbRi
bRsRsmbLsbRjRsmbLsbLsbLgbLgbRcbRsbLgLsbRsbRgbLsbsbRibLgbRsbRibLsbRibLg
bRcbLjbLgbLcbLgbLgbLgbLgbLibRsRsmbRsbRcbLgbRgRsmbRgbRcbRcbRsbRhbLsRsbR
ibLsRsbRgbLsbRgbLsbLsbRgbLhbLcbRibLiRsbLsbLgbLsbLgbLhbRsbLsRsbLibLsbRs
bLsbRsLsbLgbRjbRhbLsbRgbRibLsbLsbLgRsbLgbLgbLibRjbRcRibRsbRgRsmbRsbRgb
RgbRgbRgbLsbsbLsbLgbRsbLsbRiRsmbRsbRsbLgbRgbRibRsbLgbRiRsmbLgbLgbLjbRi
bRibRibLgbRgbLsbRiRsmbRsbRhbLsbsbLgbLsbRiRsmbRcbLibRsbLsbRgRsmbRibLsbL
gbLsbRibRibLgbLsbRibLgbRjbRgbLgbRsbRgbLsbRgbLgbRhbLcbLcbLhbRgbLsbLgbLg
bLgbLgRsbLsRsbLsbRsbRibRgbRcbRgbLsbRsbLsRgbRgbRgbRsbRsRsmbRgbRsLsbRibL
sbRgbRgbLsbRgbRsbRgRsmbLsbRgbRsRsmbRgbsbLgbRhbLgbRsbRgbRibLgbRsbRgbRgR
smbLsbRgbLsRsbRgbRgbRgbLgRsbRcbRcbRibLiRsbLibRgbLhRsbRibRcbRgbRiRsmbRc
bRibRibRibLgbRibLgbLsLsmbRibRsbRgbRsbLsbRsbRgbLgbLsbRiRsmbRgbLgbRibLgb
RgbRsRsmbRgbRgbRsLsbLgbRsbRibLsbRgbLsbRgbLsbRsRsmbRibRsbRgRsmbRgbLgbRi
bLsbLsbLsbLcbLjbLsbRsbLgbLsbLsbRcbRcbLgbsbRsbRsbRgbRsbRgbLsbRibRgbLgbR
gbRsbRgbRgbLgbLsbRgbRibLsbLgbRibRsbRsbLsbRgbRgbLsRsbRgbsbLsbRhbLjbLgbR
sLcbRjbRsRcbRsbLsbRibRsRsmbLgbLsbRgbRgbRgbRgRsmbRsRsmbRsbRgbLsbRgRsmbL
ibRsbRgbRgbRsbRgbRgbRsbRgbRsbRgbLgbRibLsbRcbLgbLjbLebLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 46; Drug: NDMC 10 µM
bsbLjbRcbLhbLobRjbLcbRibRobsbRibRibRgbLgLsbLgbRgRsmbRiRsmbRgbRgbRsRsmb
LgbRibLcbLhbLibLibRsbLgbRsLsbLsbLsbLgbLsbLgbLsLsmbLsbRobLebsbRobRsLjLh
bLcbRibLcLsmbRibRhbLsbRcbRcRsmbLsbRibLibRcRsmbLjbRibLjbLhbRjbRibRiLsRs
bRjbLcbLcbRgbLibLgbLsLgbLgLgbLgbLgLsLsmbLibRcbRibRsRsmbRgLsbRsbRgLsbRg
RsRsmmbRgRsmbLsRcbLcbLibLgbLgRsbRobLjbLsLhbLcLsmbRibsbRjbRsbRcbLjbRcbR
cbRiRsmbRsbLgbLgbRsbLcbRiRsmbLgbLgbLsLsmbLgbLgLsbRebRgbRibLjbRjbLjbRcb
RcbLgbLsbLsLsmbLsbLibLgLsbRsbLjbRsRsmbsbRcbRobLgbRgbRebLhbRjbRiLsbRcLs
bRjbLgbLgbLgbLgbLsLsmbLjLsmbRcbRebLibLhbRsRjbRjLjbLgbRsbRcbRcbRgbLgbLi
bRjbRebLibLcbRgbLgLiLsRsbLgLsbLgLibLgbRcbLjbRobRebRibLsRsbRgbRsRsmbRgL
sbsbRgbRsbRgRsmbRjbLebLcbRibLcbLiLsbRgbRcbRibRsbRsbLhLsbRcbLibLibLgbLg
bLgbLgbLgbLgbLgLsbRsRsmbRiRsmbRibRgbRiLsbRcbLgbRgbRibLgbRgRsmbRsbRibLj
bRebLgbRibRcbLcbLibLgbRgbRjbLgbLgLsbLgLsbLgLsbLgbLgbLsbLgbLgbLhbRcbRgb
LcLsmbRjbLebRibLcbRjbLibLsbLiLsbRgbLcbRibRsbRibRjbLjbLcbRgbRcLsbLjbRsb
LiRebRcRebsbLsRibLcbLgbLcbRsbRibLgbRjbLcbLsbLgbLgbLgbLgbRhbRiRsmbRhRsL
smbLjbLhbLcRsbRibRsLiLsbRsbLibLgbLgbRsbLgLsRsbLsbLgbLsLsmbLsbLgbLsbRcR
smbLsbRgbLsbRgbLsbRgbLobsbLcRsbRiLsbRjbRibRebRobRibRsbLgbRiRsmbRgLsbLi
bLebRsbLibRgRsmbLgbLsbLiRsbRibRjbLjbLgbLgLsbLgbLgbLgbLgLsbLsLsmbLgbLgb
LgbLgbLsbLgRsbRjbRcbLcbLcbRibRcbRjbRibLhLsbLcbRgbLibLiLsRsbLgbLgLgbLgb
LsLsmbLgRsbLiLgbLiLgLsbLgLsLsmbLibRiLsbLgbLgLsbLsbLgbLgLsbLsLsmbLgLsbL
gRsRsmbRcbRhbRgbLsbRgbLgbRgRsRsmmbLsLsRsmbRgLsbLsbRgbLjbLcbLgLsRsbLhbL
sRsbLgbLgbLsLsLsmmbLgbsbRgbLsLsmbRcbLcbLiLgLsLsmbRsbLgLsbLsbLgbLgbLgRs
bLgbLgRsbRobRibLjbRibLjbsbRcbLhbLhbsbRsbLiLsLsLsmmbLgbLgLibLgLsbLsbRgb
RcbRgRsmbRiRgbLsbLcbLhbRgbLiLsbLibRsbLgbLgLsbLsbLsbLgbLsbLsLsLsmmbRcbR
gbRgbRibRsRsLsmbRsRgRsRgLsmbRsbLgRsbLjbLcbRibRiLsbRgbLcbRgbLgbLgbLobRc
bRibRibLibRibRgbRsbLjbLebLgbLibLsLsmbLgLsbLsbLsbLgbLgLgLsbLgbLgbLsbLgL
sLsmbLsbRcbLhbLiLsLgbLgbLgRsbRsLsbLgbLgLsRsbRsbRobRgbRsbRsRsmbRgRsmbLs
RsbLeLiRsbLibLgLsbRsLiLsbLsRsbLgLsLsLsmmbRjbRebLsRsbLjbLjbLibLsbRcbRcR
smbRibRgLsbRcbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 47; Drug: NDMC 10 µM
bRjbRebsbRcbsbRjbRjbRobRcbRsRsmbLsbsbsbLsbRsRsRsLsmmbRjbsbLcLsmbLhbLsb
LsbLsbRcbRcbRibLhbLsbRjbRsbLsbLibLobRhRsmbLsbLjbsbLjbRjbRsbRjbsbLsbLib
LiLsbRibLsbsbRibsbRsbLsRsbLsbLcbLcbRibRsbLgLsbLibRcbRgbRgbRgLsbRibRsbL
gbRibRibRebRgbLgbLhbRsbLhbRgbRhbRobLcbLibRjbRcbLibsbLsbsbRibRjRsmbLibL
jbsbLcbRibRsbRhRsmbLsbLsbLibLibRhbLgbLobRibRsbRsbRhRsmbRsbRcbRibRcbRhb
sbLcbLcbLibRgbLsbsbRsbLibLsLsmbRgbRjbLhbRjbLhbRsbRsbLsbsbRobLsbRsbRibL
ibLsbLcbLsbLgLsbsbLibRibRjbRcbLibRgbRibLjbRcLsbLsbLgbLoLsLsmmbLcbRsRsm
bRgbRgbRibLibRibLgbRgbRgbLjbRgbRsbRgbsbRgbLgbRgbLsRsbRgRsmbRgbLsbRgbLs
bRgbRibLjbRhbLhbLjbLhbRgRsmbRobRoLsRsLsbLibLcLsmbLgbLgbRgbLibRgbLcbRib
RibRgRsmbRsbRgbRjbLsbRgbLibRhbLhbRgbRgbLgbRibRgRsmbLsRsbRgbRibLjbRgbRi
bsbLsRsbLsbRsbRsRsmbRgbRsbRsRsmbRgbRgbRsRgbRsbRiLsbLjbsbRgRsmbRhLsbLib
LhbsbRhRsRsRgmmbLgLsbRiRsmbRsbRgbLsbLobLobRsbRibRsbLibRgbLibLibRgbRibL
gbLsbLibLgbLgbLsbLsbLsLsmbLgbLibRcbRgRsmbRsbRibRobLsbRsbLsbLgbLsbLibLs
bRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 114738; End: 115238;
Recording: 10-1; Individual: 48; Drug: NDMC 10 µM
bRsbLjLsmbLsbsbsbsbRsRsRsmmbLgbLsbLsbLsLsmbLibLcLsRsmbLjLsmbLibLsbRsbL
sLsmbLgLsbLgLsbRsbLsbLsbLsbLiRsbRibRoLsbRhbsbLjLsmbLhbsbLibLcLsLsmmbRs
RsmbLsbRsLsbRcbRcRsmbLsbRjRsmbLibLgbLeLsbRsbRgbRgbRjbLgbRibLgRsLsbRibL
sLsLsmmbRibLsbRiLsbRhbLibRibRgbRobLibsbRgRsmbRibRhbLsRsbLibRibLsLsmbRg
bRiLsbLsLsmbRibReRsmbLibLsRsbsbLibRibRiLsbRsbRjRsmbLgbRiRsmbRoRsmbRibL
iLsLsmbLsbLgLsbLgLsLsmbLsbRgbLgLsLsLsmmbRgbLiLsbsbLibLsbLsLsmbRsRsmbRi
bLjLsmbRsbLgLsbLsbLsLsmbRjbLhbRgbLgbLgbLgbRgbRhbLgbsbRebsbRiRsmbLiLsbR
hbLgbRibLgbRibLsbRcLsbRobLhbRgbLhbRgLsbLibRgbLcbRgbLsbLiLsbRibLcbRsbLh
bLsbLibLcbsbsbLgbsbRcbRcbLhbRsbRhbLgLsbLsRiRsmbRsbRgbsbRibsbRibLjbRibL
jbLcbLgbLsbLgLsbLsbLcbRibRibRibRgbRibLgbRibLgbRcLsbLgLsbLgbRibLsLsmbRg
RsmbRsRsmbRgRsmbLsbLjLcbRhbRibRgRsLsmbRibLhbLibRebRibLsLsmbRgbRsbLsbsb
RgbRgbLsbRsRsmbLsLsmbRgLsbRgbRsLsbRsLsbRgbRgbRibLibLcbLiLsbRjbLhbRjRsm
bLhbRcbRgbRsbRiRsmbsbRgbRsbLjbRiRsmbRgbRgbRsbLcbLcbsbLgbLjbLhbLebLebLs
bLgbLsbLsbLibRibLibRibLhLsbRjbLhbRsRsmbRjRgbRsbRibRsbRibLsRsbRsRsmbRgb
RhbLibRiRsmbRsbRsbRibLgbRibRsbRgbRgLsbLgbLcbLgbRobRobLibLsbLgbRsbLhLsb
RjbLiLsbReRsmbLobLgbLobLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 1; Drug: Control
bLibRibLsbLsbLibLsbLgbRobLhbRsbLibLibLobLhbLgbLgbLgbRsbLibLgbLibLcbLib
LgbLgLsbLjbLibRsbLgbLsbLsbLgbLgbLsbLgbLsLsmbRgbLibRsbLibLsbLgbRsbLsbLi
bRsbLgbLgbLsbLsbLgbLgbLcbRcbLibLsbLgbLgbRsbRjbRibRcbLibLgbLiLsLsmbRoLs
bLsbRcbRhbRsbLsbRgRsmbLsbLgbLibRsbLsbLibLiRsbLibLgLsbLgbLgbLsbRhbRibRo
bRibRsbLsbLsbsbRcbRgbLgbLhbRsbLgbRsbLibLgbRgRsmbLibLibRjRsmbRcbRsbRibR
gRsmbLgbLjbRjbLjbRibsbRgbLsbLibLibRsbLsbLibRhbLibLgbLgbRsbLibLsbRjbLsR
cRsmbLjbLjbLgbLsbLsbLibLgbRsbLibRcRsmbRoLsbLibRiRsmbRcbLgbLhbLhbRgbRib
RiLsbLibRgbLgbLcLsmbLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 2; Drug: Control
bsbLgbRgbRsbRgbRibRgbRsbRgbRgbRgbRibLhbLjbRjbLibRjbLiLsbLiLsbLsbLgbLgb
LgbRjbLgbRibLjbRhbRiLsbRsbRgbRibRsbRgbRgbRgbLsRsbRgbLgbRibRsbRsbRibRib
LjbRcbLgbRibLgbRgbRgbRgbRgbLgbRsbRsbRibRibRgbLgbRgbRgbRgbRgbRsbLgbRhbL
gbRgbRgbRibLgbRhbLgbRsbRibRsbRgbRsbRgbRgbRsbRgbRgbRgLsbRsLsbRgbRsbLsbR
ibRgbRsLsbRgbRsbRibRgbRgbRgbLibRgbRibLsLsmbRibLsRgbRgbRgLsbRgbLsbRgRsm
bRgbRgbRgbRsRsmbRgRsmbRsRsmbRgbRsbRgbRgbLsbRgRsLsmbRgRsmbRsbRsbRgLsbLs
bRgbRsbRgbRgbRgbRgbRgbLibLgLsbRibRgbRibRsbRsbRgbRgbRgbRgbRgbRibRiLsbLi
bRibLibLsbRjbLibLsbLsbRjbRcbRcLsbRhbRibRibRgbLsbLsRsbRgbRgbRsbRgbRgbRg
LsbRgbLgbRjbRgbRibRibLhbRsLsbLgbRibRibRsbRgbRgbLgbRibRsbRsbRiRsmbRgbRg
bRgbRhbLibRsbRibRibLibRibRgLsbRibRgbRgRsmbRsbRibLgbRgbLsbRgRsmbLgRsbRg
bRgbLgbRsbRibLsbRibRibLiRsbLjbRjbRibRsbRibLsbRgbLjbLcbRsbLhLsbLibLhbRi
bLgbLibRhbRgbLsbRibLsbRibLgLsbRibRsbRibRsbRgbRgbRsbLsbRgbRsbRgbRsbRsbR
gbRgbLgbRgbRgbRsbRgbRgbRgRsmbRgbRibLsbLgbRibRiRsmbRgbLsbRgbLjbLibLcbRg
bRsbLgbRsbLcbLibLiRsbRgbRibRibRibRiRsRsmmbLsbRibRgLsbLjbRibRibRgRsmbRs
bLgbRibLsbRibRgbRgRsmbRsRsmbRibRgbRgLsbRgbLsbRgRsmbLsRsRsmbRgRsmbRsRsm
bLsbRibRsbRgRsmbRgbLsbRgbRgbRsbRgbRgRsmbRgbRgbRgbRgbLsRgLsbRsbRgbLgbRi
bRgbRsLsbRgbLsbRiLsbRsbRgbRgbRgRsmbLgRsbLgbRibLsbRibRgbRsbRsbRgbRsbRgb
RgRsmbLsbRgLsbRgbRgbRgbLsbRsbRgbLjbLibRsLsbLibRsRsmbLibRsbLibLsbLibRjb
LibRjbLiLsbLcbRibRibLcbRjbLiLsbRsbLiLsbLsRsLhbsbLiLsbRibRjbLcLsLsmmbLh
RsbLiLsbLibRgbLibLibRgbLibLgbRsLsbLibRjbRjbRhbLibRibRcbLibRhbsbRibRibR
sbLsbLibRsLsbRibLcbLibRjbLhLsbLsbLcbLibLibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 3; Drug: Control
bLgLsbLsbLgbRcbRibRgbRsbLgLsbLibLibLgbLsbLibLsbRsbLsbLgbLgbLgbLgbLgbLo
bLhRsbLobLgbRgbLgbLgbLsLsmbLsbLgLsbLsbLgbLgbLgbLsbRsbRsLsbLibLsbLgbLsb
LsbLgbRjbLiLsbLsbLsbLsLsLsmmbLgbLgbLsLsmbLsbLgbLgbLgbRsbLgbLsbLgbRgLsb
LiLsbLsbLgbLsbLibRsbLsLsLsmmbLgLsRsbRsbLgbLsLsLsmmbLgRsbLgbLsbLsRsbLgb
LgbLsbLsbLgbLgbLgbLsbLsLsRsmbLgbLgbLsbLsLsLsmmbLsbLgbLgbRgRsmbLsbLsbRs
LgbLsRsbLibLsLsmbLsbLgbLsbLsLsmbLgbLsLsmbLgbRsbLgLsbLsbLgLsbRgbLgbLsLs
mbLgbRsLsbLibLgbLgbLgbLgbLgbLgbLgbLsbRjbRgbLjbRgbRibLcbLhRsbLibLgbLgbL
ibRgbLibLgbLgbLiLsbLgbRsbRjbLiLsbLgbLgLsbRgbLgbLgbLgbLgbLgbLsbLsbLsbLg
LsbLsbLgLsbLgLsbRgLsbLgbLgLsbLgbLgbLgbRgbRsbLsbLgLsbLgbLgbLsbLsbLgbLgb
LgbLsbLgbLgbLsbLgLsbLgbLgLsbLsbLibLgbLsLsmbLgLsbRjbLibLsbLsbLibLgbLgbL
gbLgbLibLgbLgbLhbLibLgbRibLcbLgbLsbLgbLsLsmbLgbLsLsmbLsLsmbLgbLgbLgLsL
smbLgbLsbLgbLgbRsLsbLibLgbLgbLibLibRgbRibLgbLgbLhbLgbLsLsmbLgbLiLsbLgb
RsbLgbLgLsbLsbLsbLgLsbLgbLgbLsbLgLsbLgbLsbRsbLibLsbLgbLgbLgbLsbLgbLgbL
iLsbLgbLibLgbLgbLibRsbLgbRsbLgbLibLgbRsLsLsmbLsbLgbLsLsmbLgRsRsmbLibLs
LsmbLgbLgbLgbLgbLsbLgbLgLsbRsbLgLsbLgbLgLsRsbLsbLgLsbLsbLgLsbLsbLgbLgb
LgbRgLsbLiLsbLsLsmbLsLsmbLgbLsLsmbLsbLsbLgbLsLsmbLgbLsbRgbLibLsbLsLsLs
mmbLibLsbLgbLgbLsbLsbLgbLsbLgLsLsmbLgbLsbLgbLgRsbLgbLsbLgLsbLsbLgbLsbL
gbLsbLsbLgbRjbLibLgbLgbLibLibRgbLsbLibRgbLibRibLgbLiLsbLsbLgbLgbLgbRjb
LibLgbLgbLgbLgbLgbRgbLiLsRsbLgbLsbLgbLsLsmbLsLsmbLsbLgbLsbLgbLgbLsbLsL
smbLgbLsLsmbLgbRsbLiLsbRsbLsbLgbLgbLsLsmbLgbLsbLsbLgbLgbLibLibLhbRcbRi
bRgbLgLsbLgbLgbRgLsLibLiLsbLgbLsbLgbLsbLsbLsLsmbLgbLgbLgLsLsmbLgLsbLgb
sbLgRsbLgRsbLgbLgLsbLgbLsLsmbLgLsbLgLsbLgbLsbLgbLsbLgbLgbLsRsbLsbLsbLg
bLsbLgbLgbLsRsLsbLibLsbLibLgbRsbLgbLsbLsbLgbLgbLgbLgLsbLgbLgbLsLsmbRsb
LgbLgLsbRgbLibLsbLgLsbLgbLsbLgbLgLsbLgLsbLgbLgbLgbLsbLibRsLsbLgLsbLgRg
bLibLsbLgbLgbLgbLsbLgbLgLsbLgbLgbLgLsLsmbLibLgLsbLsLsmbLgLsbLsRsbLgbLg
LgbLgbLsbLgbLgbLsLsmbLgbLgbLgbLgbLgbLgbLgLsbLsbLgbLgbLgbLgLgRsbLgbRhbR
cbLjbRoLsbRoLsbRgbRsLsbLcbLcbLsbLgbRgbLgbRcbLiLsbLhbLibLgLsLgbLsbLgbRs
bLgbLibLgLgbRgbLsLsmbLibRsbLibLsbLgbLgbRsLsbLgLsbLgbLgLsRsbLsbLgbLsLsm
bLgbRsLsbLsbLgbLsbLsbLsbLgLsbLgLsbRsbLibLsbLgLsbLgLsbLgLgbLgbRsbLgLsbL
sbLgbLgbLsbLsbLsbLsbLobRsbLcbLcbLibLgLsbLgbLibLgbLibLgbLiLsbRibRobRiLs
bRgbRibLiLsbRhbLjbLcbLsbLgbRebRibLsRoRsmbRobLiLsbLgbLobLgLsbLgbLibRgRs
mbLiLsbLsbLgLsbLgLsbRsLsbRjbLhbLibLsbLgbRhbLiLsbLgbLgbRsbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 4; Drug: Control
bRsbLgbRobRsbRgbRgLsbLsbLsbRjbRgRsmbRsbRgbRgbRcLsbRibLibLgbLgbRsbLsbLi
bRsbRjbLibRsbLgbLobLobsbRgbLobRjbLjbLibLsbLgbLsLsmbRgbRgbRgbLsLsmbLgbL
gbLgbLgbRsbLgbLgbLgbLgbLsLsmbLgbLgbLgbLgbLsbLgbLgbLgRsbLgLsbLsbLsbLgLs
bRsbLgbLgbLsbLgbLsLsmbLgbLgbLsbLibRgLsbLsRgbRjbRgbRsbLcbRjbRhbRibRibRg
bLiLsRsbLgbRjbRgbRibRsbRgbLobLgbRhbRgbRibLcbLobRsbRibRibRgbRgRsmbLsbRg
bRgbRgbRgRsmbRsRsmbLobLiRsbRjbRgbRgbRibRsbRiLsbRhbRgRsLsmbLsbLgbLgbLgb
LgbRgbRibLhbLgbLsbLgbLgLsLsmbRsbLibLiLsbLibLibRjbRibLjbRsbRibLsbRgRsmb
RgbLsRsbRsbRgRsmbRgbRsbRgbRgbRsbLgLsbRgbRgRsmbRsbRgbLgbRibRgbLsbRgbRgb
RgLsbLsLsmbRibRgRsmbLsbRgbLsRsbRgbRibRibLibRgbLgbRgbRgbRibLgbRhbLcbRcb
LjbLebLgbLgbRsbLcbRibRjbRgbRgbRgbLsbRjbLsbRobRoRsmbRgbLobRgbsbRiLsbLib
RgRsmbLgbLoLsmbRibRcRsmbRgbLsbLibRcRsmbRcbRcbRgbsbLibLgbRiRsmbLibLgbLi
LsbRgLsbLiLsRsbsbLibRsbLsRjbRibLjbLhbLobLobLgLsbLsbLiLsbRgbLibLgbRsbLg
bRjbLgbLgRsRsmbLobRibRsbLibLsbRobRibLjbLhbLibLsbLsbRsbLgLsbRjLsbLibLib
LgbLgbLsbLgbRgbLgLsLsmbLsbLgbLsbLibLgbLgbRibLibRsbLibLsLgbLgbRgbLsbRhb
RibRibLgbRibLsbRibRgLsbRsbLgbRgbRgRsmbLgbRgbRgbRgbLobLsLsLsmmbRsbLgLsb
LibLgLsbRsbLsbRjbLeLsbRsbLibLsbLsbLibLsbLgbLsbRsbLiRsbLsbLgbLgRsbRgbLg
bLgbLgbRibLiLsbLsLsmbLgbRsLsbLgbLgLsbRjbLiLsbLsbLgbLgbLsbRobLhbRjbRibL
jbLibRjRsmbRsbRcbLcbRibLobRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 5; Drug: Control
bLcbLsbRsbLgbLgLsbLgbLsbRsLsbLgbLsbLsbRhbLjbLgbLsbLsbLgbLsbLgbRgbLgbLi
bRgbLcbRsbLgbLsLsmbRgbLgbRibRgbRgbLsbRsRsmbRgbRgbRsRsmbRsbRgRsmbRgbRsb
RgbRgLsbRgLsbsbLsbRgbRsbRgbRgbRgbRgbRgLsbLsbRgbLsbRgbRgbRsbRsbRsbRgbRs
bRibLiLsbRcbLsbLgbRcbRjbsbLgLsbRibLgbRsbRgbRibLsbRgLsbRgbRsRsmbRgbRgbL
gbRsRsmbRgbRsbRibLsRsbRgbRsbRsLsbRgbRsbRsbRgbLsbRgbLsbRsbLsbRgbRibRcbs
bRgbRibLgbRhbsbRibLsbRsbRsbRibLsbRsbRibLgbRgbRsbLsbRgbRgRsmbRsbRgRsmbR
gbRgLsbRsbRibRgbLsbRsbRibRsbRgbRsbRsRsmbRgbRgbRgbRgbRiLsbRgbRsbLiRsbLc
bRibLibLsbLgbLsbLgbRsbLibLibRgbLibRsbLiRsLsbLsbRibRibRgbRgbLgLsbRibLgb
RgbRsbRsbRsRsRsmmbLsbRibRsbRsbRgRsmbRgbRsbRgbRsbRsbRgRsmbLsbRgbLsbRgLs
bRgbLsbRgbLsbRgbRsbRgbRsRsmbRsbRgLsRsbRsbRibRgbRibLgbRibsbRgLsbRsbLgbR
jbRibLsLsmbRgbRsLsbRgbRsbRsbRibLsRsbRsRsmbRgbRgbLsbRgbRsbRgbLgbRgbRgbR
sbRibRsbLsbRobLcLsmbRiRsmbRibRsbRsRsLsmbRsbRibRgRsmbRgbLibRgbLsbLjbRjb
RibRiRsmbRsRsmbLsbRsbRgLsRsLsbLgbRiLsbRsbRgbRsRsmbRgbRgLsbLsbRgbRsbLsb
RgLsbRsbRsRsmbRgbRsbRsbRsbRgbLsbRgbRgbLgbRgbRgRsmbLgbRgbRgbLsbRsbRgbLs
bRgRsmbRibRgbLjbRibRsbRibRiRsmbLgbRsbLsbRhbLjbRibLgbRiRsmbLsRsbRgbLsbR
ibRsbRibLgbRsbRgbRgLsbRgbRgbRibLsbLsbRibLsLsmbRgbRsbRsLsbRsbRiLsbLsbRs
bRgbLsLsmbRgRsmbRsbRgbRgbRsbLsbRibRsbLsbRgbLsbRgbRgbLsbRgbRsbRsbRgRsmb
RsbRgbLsbRibRiRsmbRgbRibLhbRiRsmbRgbLjbLhbRjbRebRsbRibLgLsbRgbRsbRgbLg
bRgbRgbRgbRgbLibRcbLsbRgbRgbRsbRgbRgbRsRsRgLsmbRsbLjbRibRsbRibLsRsbRgb
RgLsbRibRgbLjLsmbRibRsbRibRsbRgbRgbRgbRsbLsbRiRsmbLsbRibLsRsbRibLsRsbR
gRsmbRgbRsbLsbRsbRgbRsbRgbRgbLsbRgbRgbLsbRgbRsbRibRibLgbsbRgbRsbRibRcb
RibRsbRhbRcbRibRibLsRsbRgLsbRcbLgbRibRibLsbRiRsmbRsLsbRsRsmbRiRsmbRsbR
gLsbRgbLsbRgbRgbLgRsbRibRsbRibLsbRibRsRsmbRsbRgbRgRsmbLsbRibRgbRgLsbLs
LsmbRgbRsbRgbLsbRsbLsRgRsmbRsRsmbRgbRgbLgRsbRibRsbLgbRibRgbLgRsbRibRsb
RgbLsLsmbRgbRgbLsbRsLsbRiRsmbLsbRgbRgbRsbLsbRgbRgbLgbRhbLgbRibRsbLibRc
bRgLsbRibRibRgLsRsbRibLjbLhbLiLsbRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 6; Drug: Control
bLsLsmbLgbLoLcbRgbLibRgbRibLcbLibRgbRjbLcbLcbLsbLibLsbRsLsbLsLjbRjbLib
LibLsbLsbRsRsmbRgbLgbLibLgbLhbLcbLibLgbRiLsbRibLsbLhbLibRsbLjLsRsmbLcR
sRsLsmbLcbLcbLibLsbLsbLgbLsLsmbLibRgbLgbLsbLsbLsbLgbRsbRgbLibLgLsRsbRs
bLsLsmbLiLsLsmbLsLsmbRsRsmbLgbLgbRsLsRsbRsLsbLgbLsbLgbLgbRsbsbLgbLgbLg
bRsbLibsbLcbLcbLibRjbRgRsmbLsbRgbRgbRjLsbRsbsbRsRgbRibLgLsbRgbRsLsbRgb
LsbRgbRhbLjbLcbLcbLhbRgRsmbRsLgbLgLsbLgbLsLgLsLsmbRgbLiLsLsmbLgbLsbLgL
sbRsLsbLgLsbRsLsbLsbLgbLgbLgbLgbLgbLsRsbLsbLsbLsbLgbLsbRsbLsbLgbRjRsmb
RcLsRsbLjbRcRsmbLcLsmbLibRsbLcRsbLobLcbLiLsbLibRsbLhbRsbLgbLgLsRsbRsbL
gbLsLsmbLgbLsbLsLsmbLgbLgbLsbLsbLgLsbLsRsLsbLsbLgLsRsbLsbLgbLsbLsbRsbL
sbLjbRgbLibRsbLibLsLsmbLsbLsbLibLgbLgRsbLsbLgbLgbRsbLsbLsbLiLsbLgbLgLs
bRjbLgbLiRsbLgLsbRsLsLsLsmmbLgbLgLsLsLsmmbLgbLgbLgLsLsmbLsbLgbLgbLgbLs
bLgbLsbRgbLibRsbLgLsbLsbLsbLgbLibLgbRsbLsbLsbLgbLibRgbLibRgLsbLgLsLsmb
LsbLibLiLsbLibLgbRgbLgbLsLsmbLibLsbLgbLgLsbLgbLgLsRsRsmbLsbLgbLgbLibLc
LsmbLibLsLsmbLsRibRgbLjbLcbsbLsLsmbLiLsbLsbLgLsbRjRsmbLgLsbRsbLibLgbLs
LsmbLsLsmbLgbLgRsbLgLsLsmbRsLsbLgbRsbLgLsbLgbLgLsbRsbLsbLsRsbLgLsLsmbL
sLsmbLgbLgbLgbLgbLsbLgLsbLgLsbLsbLgbLgbLsbLibLgbLgLsbLgbLgbLgbLgbLgRsb
RgbLgLsbLsbLsLsmbLibRjbRcbRcbLibLsbRoLsbRcbRibRibLsLsmbLgbLgbLibLgbLsb
LsbLgLsbLsbLsbLgbsbRsLsbLgbLsbLsLsmbLgLsbLsbLgRsbLgRsbLsLsmbLgLsLgbsbL
gbLgbLgRsbLgRsLsbLgLsbLsRsbLgLsbLsbLgLsLsmbLsLsmbLgbLgLsLsmbLsLsmbLgLs
RsbLgbRsRsRsLgmmbLgbLgbRsbLgbLgbLsbLibRjbRobLibLgbRgbLgbLgbLgbLgbLgLsb
LgLsbLgLsbLsbLgbLgbLgLsbLgbLgLsRsbLgLsRsbsbLsLsmbLgbLgbLsbLgbLgLsbLsbL
gbLgLsbRhbRcRsmbRebReRsmbRsRsmbRhbRcbRcLsbLgbLibLgRsbLsbLibLgbsbLgRsbR
sbLgbLgRsRsmbLgLsbLgbLsbLgLsLsmbsbsbLgbLibLsbLgbRsLsbLgLsbLgbRsbLibLgb
LiLsbLibRiRsmbLibLgbLhbRgbLsLsmbLiLsbRsbLgLsLsRsmbRsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 7; Drug: NDMC 1 µM
bLjbLjbLjbLcbRgbRcbLibLgbRsbsbRgbLsbLgbLjbRjbLsRobRibRcbRhbRjbLjbLhRsL
ibRjbLgbRcbRsbRgbRgbRgbLobLcbLcRsbLjbRcbLjbLcbLcbLibRjbLgbRsbRgbRsbRsb
RgbRgbRgRsRsmmbRsbRsbRgbRgbRsRgRgbRgbRsbRibLibRgbRgRsmbRgbLsbRgbRgbRsb
RibRcbRibLibRcRsmbRgbLsRgbLgRsbRsRgbRgbLebLcbRsbLcbRgbLibLibLibLsbRgRs
mbRgbRsbRibRsRsmbRgbRgRsmbRgbRsbRsLsbRsRsmbLsRsbRgbRgbRgbLsbRgbRsbRsbR
sbRgbRcbLcbLhRsbLgRsbRgLsbRsbRsbRibLsLsmbRsRgRsmbRgbRgbRibRibLgbLgbLsb
RgbRibRsbLgbRgRsmbRgbRsbRgRsmbRgbRsbRgRsmbRgbRgbRgRsmbRgRgRsmbLsbRgbRg
RsmbRgRsmbRgRsmbRgbRsbRgbRgbLsbRgbRsbRgbRgbRgbLsbRgbRgbLsLsmbRgbRgbRgb
LsbRgbRgbRsRsmbRsRsmbRgRsRgmbLsbRgbLsbRibRgbRgbRgLsbLgbLsbRibRgbRsbRgb
LgbRiRsmbLsbRgbLsbRsbRiLsbRgbRiLsbLhbRjbRcbRsbRsRgLsbRgbLsbRgbRgbRgRsR
sLsmmbRsRsmbRgbRgRsmbRsbRgRsmbRgbRgRsmbRgbRgLsbRgLsRgbRgbRgRsmbRgRsmbL
sLsmbRgbRgbRsbRsbRgbLcbRjbLcRsbRgbRjbRiLsRsbLhLsbLcbLibRsbLcRsbRibRgbR
gbRibRgbRgbRgLsbRgbRgbLsLsmbRgbRgbLsRsbLjbLebsbLibRjbRjbRgRsmbLjbRhbLi
bsbRibRsbRgbRgRsRsmmbLgbRgbRgRsmbRgbRsLsbRgRsmbRgbRgbRgbRsbRgbRgbRsbsb
RgRsmbRgbRgbRgbRgbsbRibRibLgbRsbRgbRsLsbLcbRcbRgbRgbLibLcbRgbLsLiRsbRj
bLjbRjbRibRibRgLsLgbLsbRgbRsbRibLgbLcbRjbLibLjbRjbsbLibLibRebRgbRibRcb
LibRgRsmbLsbRsbLgbLibLsbLsbLsLsmbRsbLibRsRsmbLibRsbLgbLgbRsbLgbRjbReLs
bLjbRgbRsbRibRibRgbLgbRhbLcbLcLsmbRibLoRsRsLsmbLcRsbRsbLcbRgbLibLsbLhb
LcRsbRibLgbLgbLgbLgbLgbRgbLgLsbLsbLgbLgLsbLsbRsbLibLsbRsbLibRsbLibLibR
sbRjbLcbRgbLibRjbLhbLcbLibRibLsbLsbLsbRcbRsLsbLgbLgbLjbLibLsbLsbLgbLsb
LgbRsbLgbRjbRibLcbLhbRgbRjbRgbLoLsmbLcRsbRgbLsbRgbLgbRgbRgbLjbLibLsbLi
bRgbLcbLobLibRcbLgbRgbRgbRsbRsbRgbRgLsbRgbRsRsmbRiLsbLgbRhbRgbLsbRibRi
RsmbLsbLgbRcbRibLgbRibRsbRsbRgbRsbRibRibRiRsmbRgbRjbRgbRgbLjbLhbLibRsb
RsbLgbRsbLibRgbLgbLhbRcbLjbLjbLcbLcbLsbRgRsmbRgbRgbLjbRgbRsbRgbRsbRgbR
gRsmbRgbRsbRsbRgbRgbRgbRgbRsbRsbRgbRgbRgbRsbRgbRgbRsbRsbsbRsRsmbRsRsmb
RgbRsbRgbRgbRsRsmbRgRsRgmbRsRsmbRgRsmbRsbRgbRgbLsbRgRsmbRgbRsRsmbRgbRj
LsbRhbLjbLcbLibRiLsbRibRgbRibRgbRsbRsbLobRsRsmbRgbLhbRgRsmbRjbRcbLjbRi
bRgbRgbRgbRgbLsbRsbRibRsbRcLsbLsbRgbLibRcbRgRsRsmmbLsbRibRsbRsbRibRsbR
gLsbRgbLsbRgbRgbRsbLsRsbRgbRgRsmbRgbRsbLsbRgbRgRsmbRgbRgbRsbRgRsmbRgbR
sbRgbRgbRsbRgbRgbRgbLsbRjRsmbRibRhRsmbRsbLgRsbRsbLeLsbRiLsbRjbLsbLcLsm
bLhbLoRsbLcLsmbRcbRcbLibRhbLgbRgbRgRsRsmmbLsbRsbRibLsbRgbRsRsmbRsRsmbR
gbRsbRibRsbRgbRgbLsbRgRsmbRsRsRsmmbRgbRgRsmbLsbRgRsLsmbLsRsbRiRsLsmbRs
bRgRsmbRgbRgRsmbRsbRgbRgRsmbRgbRgbRgbRgbRsbLsbRgbLsbRgRsmbRgbRsbRgbRsb
RgbLsbRgbRgbRhbRcbRibRibRibLsbRgbRsRsmbRgbRsbRsbRgRsmbRgRsmbRgbRgLsbRg
bRgRsmbRsbRgbRsRsmbRgRsmbRsbRgbRgLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 8; Drug: NDMC 1 µM
bRgbRgbLobRcbLsbRgbRgbRsbRsbLsbLsbRibRcLsbLgbRgbLibRgbLibRjRsRimbRibLs
bRoLsbRhbRgbRcbLgbRcbRsLsbRibLsbRibLgLsbLgbLgLsbRibRibLsbRsbRgbRgbRgbR
gbRgbRgLsbRgbLsbRgbLjLsmbRibLobLhRsbRsbRibLibLgbRsbLsbLgbLsLsmbLsbLsbL
gbLsbLsbRsLgbLgbLsRsLsbLsbLgbLgbLgbLgbLsLsmbLsbLsbRsbLsbLgbLgLsbLgbRsb
RcLsbLgbLgbLsbLgbLgbRsbLgbLsbLsbLgbLgRsbLgbLsbRsbLgLsbLgbLcbRsbRgbRjbR
ibRsbRsbRsbRgbRgbRsbRgRsmbRgbRgbLsbRibRiLsbLgbLsRibRibRibLgbLgbLgbRgbR
cbRhbRhbRgbRsbRgbRgbRgbRsbRsRsmbLsbRgbRgbRgbRsRsLsmbRsbRsbRgbRgRsLsmbR
gbRgbLsbRgbRibRsbRgbLibRibRibRibLjbRcbRobLibRgbLgLsbRsbLsbRjbRibLsbRgb
RsbRgRsmbRsbRsRsmbRsbRgbRgbRgbRsRsmbRgbRgbLsbRgbRgbLsbRibLgbRgRsmbRgLs
LsmbRgbRebsbLgLsbRsLsbRsLsbLgbLgbLsLgLsbLgbRsbLgRsbLiRsbRsbRoLsRobLsbR
ibRgbRgbRgbRsbRgbRsbRibLgbRgbLobLibRjbLibRjbRhbLibRgbRgLsbRgbLjbRgbLsb
RgbLsbRsbRibRgbLsbRsbRibRibLgbRgbRhLsbLgbRcbLgLsbRibLjbRibLgbRgbRsbRgb
RoRsmbLibLgbLsbLcbLibRgRsmbRgbLcbLgbLgLsbLsbLgLsbRgbLiRsLsbRjbLgbLsbLg
bLgbLgRsbRsbLsbLgLsbLgbRsbLgbLgbLgbRgRsmbLgLsbRgLsbLibLsbLgbLgbLgbRsbL
gLsbLgbLsRsbLsbLsRsbRsLgbsbLgbRgbLibLsLsRsmbRgbLibRgbLgLsbLgbLgbRjbRob
RibLgbRibLgbRibLsbRgLsbRgbLsRsbRsLsbRibRsbRibLgbRgbRgbRsbRgbLsbRibLjbR
sLsbRibLjbRibRibRgbRsbRgLsbRiLsbLsRsbRgbRgbLsLsmbRsbRgbRgbLsbRgbLsbRib
LgRsbRibLoLsmbLibRgbLgLsbLibRsbLgbLgbRgbLgbLgbLsbLgbLsRsbLsbLgbLgbRsbL
sLsmbRsLsbLgbLgbLgLsbLsLsmbLgLsbRsbLibRgbLgLsbLgbLgbRgbLibRjbRhbLsbRib
LsbRibRibRgLsbLsLsmbRsbRibRgbRsbRgbLsbRibLgbRgbRiLsbLgbLobLgbLgbRcbRib
RibLgbLgbRhbLsbRibLsbRhbLgbRibLgbRcbLgbRgbRgbLcbRsbLibLgLsbRgRsmbRsLib
LsbLsbLgLsbRsbLibRsLsbLibRsbLibLsbLgbsbLgbRsbLibLgbLgLsbRjbLibLgLsbRsb
LiRsbLcRsbRgbsbLobLgbRibLgRsbLibLgbLgbLgbRsbLsbLsbLgbLsbLsbLgbLgLsbLgb
LgbLgRsbLgbLgLsbRgbLgbRsbLgbLgbLsLsmbLsRsbLgbLsLsmbLgbLgLsbRsLsLsmbLsb
LgbLgbLgbLgRsbRsbLibLsbLgbLgbLgRsbRgLsbLgbLgbRgbLgbLgbLgbRsbLgbLgLsbLs
bLgbLgbLsbLgbLsbLgbLgbRsbLgLsbRsbLgbLgbLgbLgbLibLiLsbRgbRgbRobLibRcbLg
bRibLsbLcbLiLsbRibLhbRjbLiLsbLsbRoLsbLgLsbRibLgbRgbRcbLgbRibRhLsbLgbLi
bRjbRcbRhLsbRibLibLibLibLgLsbLgbRgbLibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 9; Drug: NDMC 1 µM
bRsbRgbLsbLibRsbRsbLgbLobRibRgbLgbLgbRgbLgbLibRsbLsbRsLsbLgbLibLgbRsbL
iRsLsbRsbRcLsbRibLgbLcLsmbLibRibLibLgbLibLsbRsbLgbLibLgbRgbLgbLsbLsbLg
bRsbLibLgbLgbLsbLsbRgbLgbLibRsLsbLgbLsbLsbLgbLgbLgbRgbLgbLgbLgbLgbLsbL
gbRsbLibLibRsbLsbRsbLgbLsbLsbLgLsbLsbLgbLgbLsbLgbLgbRgbLgbRgbLgbLibRsb
LibLgbLgbRibRgbLiRsbLibLgbRcbRgbRibLsLsmbRgbRsbRgRsmbLcbLhbRgbLibLibLg
bLsLsmbLsLsmbLgbLgbLgRsbRibLibLibRsLsbLsbRsbLibLsLsLsmmbLgbLgbRgbLgbRs
bRebRgbRsRsmbRibLcbLcbLgbLgbLsbLibRjRsmbLibRsbLgbLgbRgbLsbLibLibLgbLiR
sbRsbLibRgbLibRibRjbRibLjLsmbLibLibLibLsbRgbLgbLgbRgbLgbLsbRibLgbLgbLs
bLibRsbLibLgbRgbLgbLsbLsbLgbRgbLibRsbLgbRsbLibLgbRgLsbRsLsbLibLsbLsbLg
LsbLgLsbLsbLgLsbLgbLibRjbRcLsbLcbLiLsbLgbRsbLgLsbLsbLgbRjbLgbLgbLsLsmb
LgbLsLsmbRsLsbRjbLibLjLsLsmmbLibLgbRsbLgbRibRcbRsbRsbRsbLjbRibLjbLcbRs
bLiLsbLsbLsbLgRgLsbRjbRibLibLibRgLsbLibRgbLibRgbLgbLibLgbRgbLibRsbLsbL
gbLgbLgbLsbLgbRgbRcbRgLsbRobRibRgbLsbRgbRgbLhbRibRibRsbRgbLsbRibRiLsbR
sbLgbLcbRjbRibRhbRobRcLsbRhLsbRibLjbRibLsbRgbRsbRibsbRsbLsbRgbRgbRsRsm
bRsbRsRsmbRgbRgbsbRgLsbRsbRgbLsRsbRgLsbLsLsmbLsbRgbRsbRgbRsbRsbRsRsmbR
sbRgRsRsmmbRoLsLsmbLibLibsbLsbLibRgbLibLsbLcbLibRgbRgRsmbLjbLcbRibLcbL
gLsbLgbRgLsbLgbLsbLcbLibRibLsbLibRsbLibRgbLcbRibLcbRibLjRsbLcbRibLgbRj
bLhRsbLiLsbLsbsbRsLsbRsbLibRsLsbLsbRoRsmbRsbLibRsbLsbLgLsbLsbLgLsbRsLs
bLgbRsbLgbRjRsmbLgbLjRsbRjbLibRsbLsbLgbRgbsbLsbLgbLgLsLgbLgLsbRsbLgRsL
sbLsbLgbLibLgbRsbRhbRcLsbLjbRcbLgbLsbsbRibRsbRibLsbLsbRsbRgLsbRsbRsbRg
bRgbLsbRobLiLsbRiLsbRibRhbLgbRcbLgbRgRsmbRgbRgbLsbRsRibRsbLsbRsRsRimbs
bRsbRgbRsbRgbRgbRibLjbLsLsmbRhLsbLjLsmbRhbLiLsbRcbLjbRibRibRsbRgbRoLsb
LgbRobRibLgRsbLgbRobLjbRibRibRibLjbRcRsmbLsbLgbRhbLsbRcLjbLibLibRhbRjR
smbRiLsLsmbRsbRibRcLsbRsbLsbLgbRcbRhbLibLgbRhbRobLgLsLsmbRsLgbRiLsbRib
RibLgbRcbsbRgbRsbLsLsmbRgbRsRsmbRgbLgbRiRsmbRgLsbLsbRgRsmbRsbRsRsmbRgL
sRsbLsbLsbRiRsmbLsbsbRgbLsbRgRsRsmmbRsbRsbRsbRsbRsbLgbLsbRhLsbLgbRibLg
bLsRsRcbRcLsRsbLibRsbRibRibRibRibRibRgbLibRibLibLiLsbRgRsmbLgbLcbRgbRj
bRiLsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 10; Drug: NDMC 1 µM
bsbRgbLsbRgbRsbRsbRsbRgRsmbRsbRgLsbLgbRgLsbRgbRgbRgbRgbLebRcbRcbRibLgb
RibLsbRgbLsbRgbRgbRsbRgbRgbRsRsmbRsbLsbRobRibLgbRgbLgbLobRgbLsRsRsmbRj
bRgbLsbRgbRsbRgRsmbRgbRgbRcbsbRhbRibsbLsbRhLsbRcLsbRibRibRgbRsbLobRibR
ibRgbLgbRhbLsbRgbLibRibRhRsmbRgbRgbLgbRgbLsLsmbRgRsmbRgbLgbRgbRgbRgLsb
LgbRibRgbRgRsLsRsmbRsLsbLgbLsbRsbLjbRibRgLsbRibRgbLsbsbLcLsmbLcbRjbRhb
RgbRsbRsRsRsmmbLsbRgbLgbRgbRgbLsbRgbLsbLobsbRjbRgbsbRsLsbsbRibRgbRibRj
bsbLsbRjbLcbLsLsmbLibRebRjbRgRsmbRsbLsbRgbRibRobRjbRebLgbLgbRsbLjbRibR
gbRibLsbLgbLgbRobRcbRsbRsbRibRgbLsbRjbLibLibLibLibLibLibRgbLibLibRcbLg
bLibRjbRibRgbRsbRgbRsbLobLsbLgLsbRjbLibLhRsbRibRjbRgbLjbRsbRsbRibLsLsm
bRgLsbRgLsbRsbRsbRgbRjbLsbLgLgbRsbLgLsbLgbLibLgbRebLobRjbLibLgbLebRcbR
gbRsbRibRibLibLgbRibRibLsbRgbRgbRsbRibRgbRgbRcbRebRgbRhRsmbLgbRcbsbLjb
RibRibRgbRgbRgbRsbRgbRgRsLsmbRibRgbRgbLjbLsRhbRgLsbLgbLsRgRsmbRgbRibRg
bRsLsbsbRsRsLsmbRibLhLsbRgbRgbLcbLibLsbRebRibRgbLibLsbLiLsbRjbRcbRgbRg
bRgRsmbLjbRibLhbLgbsbLiLsbRebLcbRjbLgbRcbRgbRgbRgRsmbLjbRibRibRibRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 11; Drug: NDMC 1 µM
bRgRsmbLsRsbRsbRsbRsRsRsmmbRsbRgbLsbRgRsmbRgbLsbRgbRgbRgbRsbRsbsbRgbRi
LsLibRibRgbRibLgbLsbRgbRibLcbLcRsbRjbRjbLjbRgbRsRgbRgbRsbRgbRsbRsRsmbR
sbRsRsmbRgbRgbRgbRgbRsbRsbRsRsmbRsbRsRsmbRsRsmbRsRsmbRgbRgbRgbRsRsmbRs
RgRsmbRgbRsbRgbLsbRgRsmbRsRsmbRsbRgLsbRgRsmbRsRsmbRsbRgbRgbRgbRgbRgbRs
bRgbRgRsmbRgbRsbLsbRgbRsRsmbRgRsmbRgbRsbRsbRgRsmbRgbRsbRsRsmbRsbRgbRsL
sRsbRgbRgbRsbRgbLsbRsbRgRsmbRsbRgbRgbLsbRsRsmbRgbRgbRgbRgLsbRsRsRsmmbR
sRsmbRgbRgbRsRsmbRgbRgRsRgRsLsmmbLoRsbRsbRgRsmbRsbRgbRsbRgbRgRsmbRgbRs
bLsbRgRsmbRsRsmbRgRsmbRgbRgbRgbRsRsmbRgLsbLsbRgbLobRjbRibRgbRgbRsbLsbL
jLibLgbLibRgbRjLsRgbLcbLhbLgbLibLsbRgbRgbRjbRibRgbLjbLibLibLibLibRjbLi
bLsbRsbLgbLgbLibRgbLcRcbLebLibRebRibLsbLgbLjLibLgbLgLsbLgRsbRsRsmbLgLs
LgLsLsmbRsbLsLsmbLgRsbLgLsbRsbLgbRsLsbLgLsbRsLsbLgbLgbLsbLsRsbLgbRsbLg
bLgbLgLsbRsbRsLsbLgbLgbLsbLsLsmbRsLsbLsbLgbLsLsmbLsbLsbLgLsbLgbLgbLsRo
bLsbLsbLgbLsbLsLsRsmbLsbLgLsLsLsmmbRgbLgbRsbLgbLsbLgbRsLsLgbLsLsmbLsLs
RsmbLsLsmbLsbLgbLsbLgLsbLsLsmbLsbLgbLsbRsbLgbRsLsbLgbRsLjbLsLsLsmmbLgb
LsLsLsmmbLgbLsbLgbLsLsmbLgbLsbLsbLgbLsbLsbLsbLgLsbLsLsmbLgLsbLsLsmbsbL
gLsbLgbRgLsRsbLgbLsRsbRsbLgbLgbLsbLgbLgbLgbRsRsmbLgbRsbLgbLsLsmbLgbLgL
sbRgLsbLgbRsbLgLsbLgbLsRsbLgbLgbRsbLgbLsLsmbRgbLgLsbRjbLsbLgbLsRsLsbLg
LsbLgLsbLsRsbLsLsmbLsbLiLsbRsLsLsmbLsbLgbLsbLgbLsRobRsbLsbLgbLgbLcbLgb
LgRsLsbLsLsmbLgLsbRsLsbLgbLgbRsLsbLgbLsbLgLsbLgLsbLsbLgbLsLsmbLgLsLsmb
LgLsbLgbLgbLsbLgbLsbLgRsbLsLsmbLsbLgbLgbLgRsbLsRsbLgLibLibRibLcbLhbLhb
RsbRgbRsbLhbLcLsmbRgbLibLibLibLibLgbLsRsRsmbRcbRibLsbRgbsbRgbRgbLjbRib
RsbRibLsbRibLjLsLimbLiLsbRgbLgbLsbLgbRsLsbLgbLgRsLsbRsbLsbLgbLgbRgbLgL
sbLsbLsbLsLsmbLgbLsbLgbLsLsmbsbLsLsLsmmbLsLsmbLsLsmbLgbRsLsbLgLsRsbLgL
sbLsbLgLsbLsbRsLsbLgbLgbLgLsbLgbRsbLgbLgbRsbsbLgbLgRsbRsbLgbLiLsbRgbLs
LsLsmmbLgbRsRsmbLgbLgbRsbLgLsbLsLsmbLgLsbLsbLsbLsRsbLsLsmbLgbRsbLgbLsb
LgLsLsmbLsbLgbLgbLsLsRsmbLsbLgLsLsmbLsbRsLsLgbLgbRjbRibRibRibLjbRibRib
LjbRgbRjbRibLsbRhbRibRcbRgbLhbLgLsbLgbLgbRibLobRgbRjbLiLsbLgbRsbLsbRsb
LgbLsLsmbLgbLsbLgbRsbLsLsmbLgLsbLgbLsLsmbLgLsRsbRsbLgLsLsmbLsLsmbLsLsm
bLgLsbLgLsbLsbLgbLsbLsLsmbLsbLgbRsLsbLsbLgLsbLgbLsLsRsmbLsLsmbLsLsmbLs
bLsRsbLsLsmbLsbLsLsmbLsbLgLsbLsbLgbLsbLsLsmbRsLsbRsLibLsbLgLsbLgRsbRsb
LgLsbLgbRsbLgbLsbLsbLgRsbRsbLgLsbLgLsLsmbLsLsmbLgbRsLsbLgLsbLgLsbLsbLg
LsLsmbLsLsmbsbLsbLgbLgbLsLsLsmmbLgLsbLgLsRsbRgbLibLgbRsLsLsmbLiLsbRsRs
mbLgbLgbRsbsbLsLgbLgLsbRsbLsLgbRsbLsbLgLsbLgbLsbLsbLgbLsbLgbLsRsbLgLsb
LsLsmbLsbLgbLgLsLsmbLsRsbLgRsbRsbLgbRsbLgLsbLgbLsLsLsmmbLgRsbLsbLsRsbL
sLsmbLsLsLsmmbLgLsLsmbLgRsbRsbLgbLgbRsbLgLsbLgbLsbLgbLsbLsbLgbRsbLgbLg
b

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 12; Drug: NDMC 1 µM
bLcbLhbLgbRiRsmbLcbLibRgbLibRjbLhLsbLobRgbLcbRibRgbLcbLibLgLsbRjbRobRc
bRcLsbLjbRsbRgbLjbLibLgbLsbLgbLibLcLsmbRibLsbRgbRibRsRsmbRsRsmbRsRhbRs
bRobRgbLibRsbLgbLgbRsbLgbLgbRgbLgbLsbRsbLgbRobRcLsbLgbRcbLgbRibRiRsmbR
gbRibLgbLsbLsRsbRsbRcLsLsmbLgbRgbRgbRgbRsRsmbRgbRsbRgbRsbRsbLsbRibRgbR
gLsbLgbRgbRgbRibRcbRibLibRcbRibRibLgLsbRsbLsRsbRoRsmbRobLibLgbRoLsbRib
LgbLgbLibLibRcbRhbLgbsbRsbRsbLcbRjRsmbLobLhbLgbLgRsbLsRsbLgbLibRsLsbRg
bLcbRibLcbLgbLsbLsbLiLsbRgbLgbLgbLibRgbLgbRsbLibLsbLgbRjLsbLsRcLsLsmbL
ibLibLibRgbLgRsbLibsbLibLcRsbRgbLibLjbRebRgLsbRibLgbLjbRibLsLhLsbLibLg
bLgbRjbLsbLgbRjbRibRibLsRsbLjbRcbLibLgRsbRjbLibLcbRiRsmbLgbRibRgbLjbRe
bRiLsbLjbLebRjbLcbLjbRcbRgbRsLcbsbRgbLcbRsbRsLsbLiRsbRgbLcRsbRgbLgbLgb
RgbLgbLsbRsbRsbLsbRsLsLsmbsbLsbLgLsbsbRsRsmbLgbRsbLsLgbLsbLsbRsbLgRsbL
gbLsbLsbLgbLsbLsbLibLgbRsbLgbLsbLgbLsbLgbLsLsmbLgRsbLgbRgbLgbLsRsbRsbL
gbLgLsbLgbRjbLgbRsbLgbLjbRjRcbLibLiLsbLgbRhRsmbRibRiRsmbRsLsbLsbRgbLsb
RcbRhLsbLibLiLsbLsRsRsLsmbLgbRibLcbRibRibRsbRibRjbsbLgbRjbRgbRsRsmbRgR
smbLsRsbRibRsbRsbRsbRsbRsbRgRsmbLgbRgRgbRsbLgbLgbLsRsbRsLsbRibRgbRsbLs
bRsRsmbRgbRsbRgRsmbRsbLsbLiRsbRgbLibLgbLiLsbLibLibRhbLjRsbLibLgbLgbLsL
smbLgLsbLsbLsbLgLsbRgbLgbLgbLsbLgbRgbLiLsbRjbLibLgbLgbRsbLgLsbLsbLibRg
bLjbRsbRcRsmbRibRgbRsbRgbRsbRsbRsbRsbRgRsmbRgbRgbRsRsmbRgbRsRsmbRsbRgb
RgbRgbLsRsLsbRgbRsRsmbLsbRsRjbRsbRgRsmbRgbRgbRgbRgbRgbLsbRgRsmbRgbRgbR
gbLgbRgbLsbLsbRsRgbRsbRgLsbRibLjRsbLhbRcbLcbLibLobLcbRibLcLsmbLibLgbRs
RsLsmbLgbRjbLcRsbLibRhRsmbRgbRibLjbLhbLibLgbLibRsLsbRsRsmbRsbLibLgLsbR
sRsmbLgbLsbLsRsbLsbLgbRsbLgbLsbLgbLsbLsLsmbLsbLibRgLsbLgLsbRsLgbRsbRsR
cbRiLsbLgbRibLsbLsbLcbLsLsmbLibLiRsbLgbRsbRibRibLjbRsRhLsbLibLoLsmbRjb
LibLibLgbLsbLibLsbLhbRibLgbLsbLsbLgRsbRgRsmbLgbLgbLgRsbLgbLgbRgbLgLsbL
gbRsRsmbRsbRcbRebLibRjbRsRoLsbLjbRibLhLsbRobLcLsmbLhbLgbRjbLibLgbLgRgb
LgbRsbLgbLgbRsRsmbLibLsbLgLsRsbLgRsbLgbLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 13; Drug: NDMC 3 µM
bLcbRcbRcRsmbRcLsbRcbLjbRgbRgbLgbRgbRgbRgbLsbRsbLibLibRibLibRjbRobRcbR
sbRibRibLsLsmbLjbLibLgbRjbLgbLsbLsbLsbLgbRsbLgRsbLsbLgbRsbLgbLsbLgbLsb
RgLsbRsbLgbLsRsbLgbLibRcbRcbLgbLibRibRgbLibRcbLjbLebLjbLhbRgbLcbLibRsb
RgbRgbLibLibLgbLgbLgbLsLsmbLsbLgbRgbLgbLgbLsbRgbLibRcLsbRibRsbRsRgbRgR
smbRsbRgLsbLcbLibLjbLcbRgbLcRsbRgbLibLsbLiLsbLgbLsbLgbLgRsLsbLgLsbLsbL
sbLgbLgbLgbLsbRsLsbLibLgLgLgbLgbLsbLgbLibRgbRgbLibLgbLcRsbLcbRibLiLsbR
gbLibLsbLiLsbLsbLgbLgRsbLgLsbLsLsmbLgLsbLgLsRgbLibLsbLgbLgbRjbLiRsbRsR
smbLgbLgbLgLsbLgLsbRsLsLibLgbLsRsbLgbLsbLsbLsbLsbLgbLgbRjLsbLiLsRsbRgb
LibLgbLgbLibRcbRcbLibRibLibRjbRibRibLoRjbRibLcbLcbRgbLibLsbLgbLgRgbLsb
LgRsbLgbRgbLibLsLsmbLgLsbLgbLgLsLsmbRsbLiLsRsRsmbLgLsbLsbLgbLgbRsbLgbL
gLsbLsbLgLsbLsbLsbLgbRsRcbRcbLhbRcbLjbRibLcbLcbRsbLsbRjbLibLibRjbLibLi
bRjbLjbLibRgRsmbRjbLibLiLsbLibLgbLsbLsbLgbRsbLibLsbLsbLiLsbLgbRgbLgRsb
LgRsRgRsmbLgRsbRjLsRsbRcbRibRhRsmbLjbLcbLsRjbRjbRsLibLibLgbRsbLiRsbLgb
LibLsbLgbRsbLgbLgbRjbLibRcbRhbRcbLgbLcbRjbLcbLibRsLsbLibLgbLgbLgLsbLib
LibRibLsbRobRobRibRcbRiRsmbRgbLibRibLgbLcbLibRsbLiLsbRgbLsbLiLsbLgLsbL
sbLgbLgLsRsbLgbLhRiRsmbLibRsbRsbRibRibRjbLcbRjbLhbLsbRcbLsbRiRsmbRcbLg
bRhbRibRsbLgbLsRsRsLsmbRcLsbLjbRibRgbLcbRjbLcbRibLjbLgbLgRgLsbLgbLgbRj
bRsbLgRsbLsLsmbLsRsbLsbLsbLgbLsRsbLgbLgbLsbLgLsLsmbLgRsbLgLsbRsbLibLsb
LsbLgbLgbLgbRibLhbRjbLcLsmbLsLsmbLiLsbRsRgRsmbRibRibLsbRiRgbRsbRgbRsLs
bRgRsmbLsLsmbRsbRgRsmbRibRgbRsbRgbLibLibRjbRibRibLibRibLgbRiLsbRsRsmbR
gbRsbRsbRsbRibLsbRibLsbRgbRgbRgbLgbRibRsbRgbLgbRiRsmbLsRsbRgbRsbRsLsbR
gbRsbRsbRgbLjbLibLibRjbLhbRsbLiRsbLgbLgLsbRsbLgbLgLsbRsLsbLsbLsbLsbLgL
sbLsbLgLsbLsbLgbLgRsLsbRsbLgRsbLgbRjbLibLgbRgbLgbRcbRibRibRgbRoLsbLibR
obRcLsRsbRibLgbLgbRibLcbRjbLibLgbLgLsbLsbLsbLgRsbLsLsmbLsbLgbLsbLgbLgb
LsbLiRsbRgbRcLsbRcbLiLsbRhbRcLsbRsbRiLsbLibRjbRgbRgbLcbLcbRibLoRsRsmbR
gRsmbLgRsbRibLcbLibLgbLgbRgbLcbsbLiLsbLsLsRsmbRsbsbLgbRcRsmbRobRhbLibR
cRsmbRcbLgbLgbRiRsmbLobLibLibLgbRsbRjbRibRgbRgbLcbLibLgbLcbLsbLcbRibLj
bLibLibRgbLibRsbLgbLsLsmbLiRsbRsbRsbLgLsbLsbLgbLsRsbLgbLgbLsLsLgmbLsbL
gbLgbLgbRgbLgbRgbLibLgRgbLgLsbLgLsbRgLsRsbLibLsbLgbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 14; Drug: NDMC 3 µM
bLibLgbLgbRibRgbRgbLsRsbRgbRgbRgbRgbRgbRgbLsRsbRibLsbLsbRhbLgbLsbRgbRg
bRgbRsbLgbRgbLebRebLhbLsLsmbLcRsbRgRsmbRgbRibRibRsLsbRgbRgbRgbRsLsbRgb
RsbLgbRibLjbRgbLibLcbRjbRcRsmbLjbRgbRiLsbRcbLibRcbRibRibLibRibRiLsbLjb
RgbRcbLobRcbRcbRiRsmbRibLsbLsbRibLgbLobLibLsbLsbRjbLcbRgbLibLhLsbRiRsm
bRcRsmbsbLjbRibRsbRgRsmbRgbRsbRsRsmbRsbRgbLsRsbRsbRgRsmbLgbRgbRgbRgbRi
bLgbRsRsmbLgRsbRsbRibLgbRhbRgbRgbRsbLgbLjbLhLsbRibLsLhbRgLsbRjbRcbLsbR
sbRsbRgRsmbLsbRsbLsbRgLsbRgbRsbRsRsmbRsbRgbRsbRgbRsbRsbRgbRgbRsbLsbRib
RsbRgbRgRsmbRgbLsbRgbLgbRibLsbRibRgbRibLibRsRsRsmmbRibRgbRsbRgbRsRsmbR
gRsmbRsbRgbRgLsbLgbRgbLsbRgbRgbRgbRgbLsbRibRibLibRibRgbLgbRiRsmbRgbRsb
RsRsmbRsbRhbRhbRibLiRsbRibRgbRgRsmbRiRsmbLsbRgbRiLsbLibRsRibRgbLgbRgbR
gbRsRsmbLsRgbRgbRgbRgbRgbRgbRgbLgbRgLsbRiRsmbLsbRsbRgbRsbRsRsmbRgbLsbR
ibRsbRgbRgbRgbRgbLgbLjbRgRsmbRibLgbRgbRgbLsbRiLsbRibRgbRsRsmbLsbRiRsmb
RgbRsLsbRgbRgbRgbRgbRgbLibRgbRibLjbRibRgbLcbLcbRgbLibRsbLgbRgbLgbLsbLg
bRgLsRsLibLsbLgRsbRsbLgbRjbRcbRhbRobRcbRcbRgbRsRsmbRsbLsLsmbLjbRhRsmbR
gbRgbRsRsmbRgbRsbRgbLsbRgLsbLsbRgRsLsmbRgbRsRsmbRgRsmbLsbRgbRgbRgbRibR
gbRgbLgRsbRibLjbRgbLsbLsRsbRibRgbRibRgbLibRibLgbRcbRcbRsbRhbLiLsbRibRc
bRibRgbLgbRsbRcbLgbRibRsLsbRgbRgbRgbRgbRgbLibRibRgbRibRibRgbLsbRgbRiLs
bRibRgbLsbRgbRgbRsRsmbRiLsbLgbRibRsbRsbRgbRgbRgbLsbRibLgbRgbRibRsbRsbR
ibLsbRsbRibLibRgLsbRsbRiRsmbRgbRgbRgRsmbRgbRgRsmbRgbRgRsmbRibLsbRgbRsb
RsbRgbRsbRgRsmbRsbRgbLsbRsRsmbRgRsmbRgRsRsmmbRgRsmbRsRgRsmbRsRsmbRsbRi
LsbLjbRcRsmbLibRgbLgbRiRsmbRgbRsbRibRgbRsbLgbRiRsRsmmbRgbRgbLgbRgbRsbL
sbRsbRgbRgbRsbRgbRsbRgbRsRsmbRgbRgbLsbRgbLsbRibRgbRgbRsRsmbRibRgbRsbRg
bsbRsbRgbRgRsmbLsLsmbRgbRgRsmbRgbRsRsmbRgbRgbRsbRgRsmbRsbRgbRgLsbRgRsR
sLsmmbRsbRgbRibLgRsbRibLsbLsRiRsmbRgbRsbRgbRgRsmbRgbRsbRgRsmbRgbLsRibR
gbRgbRiLsbsbRiRsmbLgbLgbRobLiRsbRiRsmbRibRibRsbLeRsbRcLsbLcbLcLsmbRgRs
mbRcbRcbLgbRhLsLsmbRibLgbLibRcbRhbLibLhbRcbLhbLibRgbRebLcbRgbLsLibRgbL
cbRiLsbLibRjbLgbLhRsbRgbLibLcbLgbRsbRibRcbRibLsbRgRsmbRsbRgbRgbRgRsmbR
gbRgbRsbRsbRgbRsLsbRgbRgLsRsLsbRgbRgLgRsbRibRsLsbRgbRsbRsbRiRsmbRibRgb
RsRgbRsbRgRsmbRsRsLsmbRsbRiLsbRgbLibRcbRsbRgRsmbLsbRebLcbRgLsbRiLsbLcb
LobRhbLobRgbLibLsbLibRgbLibRjbLibLibLsbLgRjbLhRibRibLsbLeRsRsmbRiRsmbR
hbRobRibLibLgbRibRcbLjbRibRgbRibLhbLsLcbRibRhbRibLjbRcbLibRobLsRsLgLsb
Lhb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 15; Drug: NDMC 3 µM
bRgbRhbRobRgbRobRsbRgbRgbRibLsbLgbRsbRgbLibLgbRsbLgbLgbLsLsmbLsbLgLsbL
sbLgbLgbLgbLsbLgbRsbLibRsbRgbLjbLhbLhbLgbLsbRibRgbLsRsRgbRgLsbRsbLjbLo
bRjbLcbRgbLgbRjbLiLsbRsbRsbLibLcbRgbLsbLgbLgbRjbRgbRibRhbLibLgbLgbLcbL
gbLhbLibLsbLsbLgbRjbRgbRibRiRibRgbLsbLhbRgbLsRsbRsLsLiLsbRgbRsRsmbLgbL
sbLgbLgLsbLjLsLsmmbLjLsmbLgbRsbLsbLgbRsbLhbRgbLiLsbRgbLsbLgbLgLsbLgbLg
bLsbLgbLsbLgbRgbLsbLsLsmbLsbLhbRgbLibRsLsbLgbLgbRsRsmbLgbLsLsmbLsbLgbL
sbLsbRsbLibRgbLgbLibLsLsmbLibLgbRgbLsbLgbLgbLgbLgbRgbLsbLgLsbLsbLgbLsL
smbLsRsbLsbLgbRjbLibLsbLgbLgbLgbRsbLgbLgbLgbLgLsbLsbLgRsbLgbLgLsbRsbLg
LsbLsbLsbLgbLsbLgbLgbLgbLgbLgLsbLgbLgbRgbLgbLibLgbLgbRgbLsbLsbLgbRsLsR
sbLgbLgLsbRsbLgbLsbLibLgbLibLgLsbLgbLsbLgbRgbRiRibLsbRgbRsRsmbRgbLsbsb
RgRgbLgbRgbRgLsbRgRsmbLsLsmbRiRsmbRgRsLsmbRsbRgRsmbRsbRgbRcbLgLsbRcRsm
bRibLgbLjLsmbRibRhbRsbRgbLsLsmbRgbRgbLsbRsbRgbRgbRgbRsbRgRsmbRgbLsbRgb
RsbRgbRgbRgbRsbLsbRgRsmbRibLibRibLcbLcbRgLsbLibRgbLiLsbRsLsbLsbLgbLgbR
sbLiLsbRsbLsbLsbLibLsLsmbRsLsbLgbLsbLibRgbLibLsbLgRsbRgbLgbLgLsRsbLsbL
sbLgbLgbRsbLgbLgbRsbLgbRsLsbLgLsbLsbLgLsbLgbLgRgbRsLsLsmbLgbLsbLgLsbLs
bLgbLsbLgRsbLgRsRsmbLgbLjbLsbRjbRjbRgbRgbRibRgbRibLsLsmbRgbRsLsLsmbRsb
RgbRgbLsbRgbRiRsmbLsRibRgbLsbRibRgbRsbRgbRiLsbRibRibRsbRgbRgbRsbLsRiRs
mbRgbRsbRsbLsRgbRgbRsbRsbRgbRgRsmbRsLsbRsRsmbRibRgbLsbRgLsbRgbRgbLsRgb
RgbRgRsmbRgbRsLsbRgbRsbRgRsmbRgbRgRsmbRgbRsbRgbRsbRgbRgLsbLjbRibRibRib
RibLibLgbRsbLibLsLsmbLgLsbRobRiRsmbRgbRgbRgbRgbLsbLgbRiLsbRgbRsbRgbsbR
sbRgbLsRibLsLsRgRsmmbRgbRgbLsLsmbRsbRgbLjbRibRsbRibRcLsLsLsmmbRiLsbRib
LgLsbRgbRjbRgbRgbLsbRgbLsbRgRsmbRsbRgbRsRsmbRgbLsbRsbRgLsbRgbLhbLibRjb
RjbRibRgbLsbLsRibRgbRsbRgbRsbRgLsbLjbLcbLsbLibLgbLgLsbLiRsbRgbLgbLgbLi
bLgbRcbRsLsLsmbRgbRibRgbRgRsmbLjbRgbRgbRgRsRsmmbLsLsmbRsbRgbLsbRsRgRsm
bRsbRgbRgbLsLsmbRgbRgbRgbRgbLsRsbRgbRsbRgbLsRsbRsbRgbRgbLsbRgbRgbRgbLs
bRgbRgRsmbRsbRgbLsbRgLsbRgLsbRsbRgbRgbRgbLsLsmbRgbRsbRgbRsLsbRgbRgbRsb
RsbRgbRsbRgbRgRsmbRgbRgRsmbRgbRsbRsbRgbRgbRibLsbRibRgbRgbRgbRgbRibRgbR
ibLsbRgbLsRsbRgLsbRsRgbRgRsmbLsRsbRgbRgbRgLsbLgLsbRgbRgbRsbRgbLsLsmbRg
bRsbRiLsLsmbLgbRgbRgbRgbRgbRsbRgRsmbRgbLsbRsbRgbRgbRgbRgbLsbRibLgbRibR
gbRgbRgbLsbRsRgRsRsmmbRsRgRgbRgbRsbRgbRsbRgbRsbRgbRgbRgbRgbRgRsmbRsRsm
bRgbLsbRgbRgbRsRsmbLsLsmbRgbLgbRibRsbLsbRgRsRgRsmmbRsbRgbRgbRgbRgbLsbR
gbRgLsbLjbRgbRsbRgLsbRgbRgbLsbRgbRgbRsbRgLsRsbRgbRgbRsbRgbLsbRibRsbRgb
RgbRsbRgbRgbRgbRgbLsLsmbRgbRgbRgbRgbLsbRgRsmbLsRsbRgRsmbRgbRgbRgbRgRsm
bLsbRgbLibRsbRgRsmbRgbRgbLsbRgbRsRsmbRiLsRsbRsLsbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 16; Drug: NDMC 3 µM
bRsbRobLibLgbLobLobLibRsbRsRsmbLjbLgbLgbLgbRsbLobLcbLjRsbLgbLsbLgbLsbL
gbLsbLhRsbLobLhbLcbRcbRcbLgbLjbLjbLcbLibRcbLibLgbRsbRsbLsbRibRgbRsbRgR
smbRgbRgbRgbRiRsmbRsRsmbRsbRsRsmbRgbRsbLsbRgbRgbRsbRsbRsbLsbRsbRgbRgLs
bRsRsmbRsbRsbRsbRsbRsbRgbLsbLsRsbRgbRsLsbLsbRgbRsbLsbRgbRsbRgbRsbRgbLs
RsbLibRiLsbLcbLhLsbRebRsbRibRgbRsbRsbRgbRgbRgbRsbRsbRsbRsbRgRsmbRgbRsb
RsbRgbRgbRgbRsbRgbLsRsbRgRsmbRgbRgbRsbRgbRgbRgbRsbRsbRsbRsbLsbRiRsmbRs
bRibRobRhbRjbLhbLibLgbRibLgbLibRgbLgbRsbLibLgbLgbRgbLsbRibLibRgRibRibR
sbRgbRsbRgbRsLsbRsbRsbRsbRsbRsbRsbRsbRsbLebRibRibsbRgbRsLsbRsRsmbRsRsm
bRgbRsbRgRsLsmbRgbLsbRgbRgRsmbRsbRgbRsbRsbRsbRsbRgbLsRsLsbRgbRsRsmbRsb
RgbRsbRgbRgbRsbRgbRgbLsRsbRgRsmbRsbLgbLjbRibRobLhbRhbLgbRibRgbLgbRibRs
RsmbLsRsbRgbRsRsmbRsbRgbRgbLjbRgRgbRsRsmbRgbRgbRgbRgbLgbRgRsmbRsbRgRsm
bRsbRgbRgbRsbRgbRsbRgRsmbRgbRsbRsRsmbRgbRsbRgbRgbRgbLgbRgbRgbRgbRgbRsR
smbRsbRgbRsbRgbRsRsmbRgbRgbRsbRgbLgbRgbRgbRibRgbRsbRsRsmbRgbRgbRgbRsbR
sbRsbRgbRgbLcbLcbRjbLebRjbLcbRibLgbLcbRibLjRsbLgLsbRgbLobLobRgbRsbLgbR
ibRgbLsbRgbRsRsmbRgbRsbRgbRsbRgbRgbRsbRgRsmbLsbRibRsbRgbRgRsmbRsbRsRsm
bRgbRgbRgbLsbRgRsmbRgbRgRsmbRgRsRsmmbRgRsmbRgRsmbLsbRgbRgbRibRgbRiRsmb
RgRsmbRgbRgbLsbRgRsmbRgbRsbRgRsmbRsbRgRsmbRgbRgRsmbRsbRgbRgbRgbLsbRgLs
bRgRsmbRgbRibRsbRsbRgbRsbRiRsmbRsRsmbRgbRsbRgbRsbRibLgbRibRgRsRgRsmmbR
gbRgbRgbLsbRiRsmbLibRgbRiRsmbRgbLgbRgbRgbRgbRgbRgbRgbRgbLeRsbLgbRsbLgb
LibRsLsbLiRsbRgbLiLsbLcbRgbLibRjbRcbLibLibRhbRhLsbLcbLcbRsbLibLsRsRgbL
sLibRsLgbRjLsRhbLhbRcbRibRgbRcbLibRsbRgbRgRsmbRsbRgRsmbRgbRgbLgbRiRsmb
LsbRibRsbRgRsmbLgbRiRsmbRsbRsbRsbRgRsmbRgRsmbRgRsRsmmbRgbRibLgbRgbRgRs
RsmmbRsbRgRsmbRgRsmbRsRsRsmmbRgbRgbRsbRgbRgbLsbRibRgbRgRsmbRgbRgbLsbRg
bRcbLibLcbRgRsmbRgbRgbRiRsmbRsRibRgbRgbRsbRgRsmbRgbRsRsmbRgbRiRsmbRgbR
gRsRsmmbLibRiRsmbRgbRgLsbRgbRgbRgbRsbRgbRsbRgbRgRsmbRgbLsbRgRsmbRgbRsb
RgbRgRsmbRgRsmbRgbRgRsmbRgbRgbLcbLcbLgbLibLsbRjbRcbLsRsbRibLgbRiRsmbRg
bRgbRgbRgbRiLsbRgRsmbRsbRgbRgRsmbRsRsmbRsbRsbRgbRgbRgbRsbRgRsRgmbRgRsm
bRsRsmbRibRgbRgbRgbLcbRcbRgbRgbRgbLcRsbLibRibLcbRibLhLsbRhRsmbLcbRgbLg
bRobLsRgbRgbRgbLsbRibRsbRgbRgRsmbLjbLcRsbRcbRibLsbRgRsmbRsbRgRsmbRgbRs
bRgRsmbRgbLsLsmbRgbRgbRsbRgbRgbRgbRgbRsbRgbLgbRgRsmbRgbRsbRgbRgLsbRgbR
gbRsbRiRsmbRgbLgbRgbRsbRibLjbRibRsLsbRsLsbLgbRibRgbRgbLgbRibRgbLsbRgRs
mbRsbRgbRgRsmbLsbRgbRgRsmbRgRsmbLsbRsbRgbRgRsmbLhbRhbRgbLjbRibRsbRsbRg
bRgRsmbRgbLsbRgRsmbLsLsmbRiRsmbLsbRsbRgbRgbRgbRgbLsbRibRsbRgbLsbRgRsmb
LjbRhbRibRibRcbLgLsbRgbRibRhbLgbRibRsbRgbRsbRsRsmbRgbRgbRibLgbRibLsRsb
RibLsbLsbRiRsmbRsRsmbRsbRgRsmbRgbRgbRgbRgbRgbRgbRgbRgRsmbRgbLcbLcbRgbR
jbRcbLcbLcbRibRjbRhLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 17; Drug: NDMC 3 µM
bLcbLobLgbLsbLsbLjbRcbRhbLcRsbRhbRsbLsLsmbLsRgbLjbRcbRgbRibLibRibRsbRs
bRjbRcbRjbLgbRjbRcbLjbRgbRgbRsLsbRsbLjbLhbLibRjbRsbLgbLgbRjbRibRsLsbRs
bRjbLgRsbRgbLgbRibLsbRgbRsbLsbRgbRgbLsbRsbRsbRibRibLgbRgbLsbRgbRgbLsbR
gbRgbRsbLsbRgRsmbLsRsRsmbRiLsbLgbRibLsbRsbLobRgbLsbLsbRsbRiRsmbLgLsbRg
bRibRgbRgbRsbRgbRgRsRsmmbRsbRibRgbLsbRsbRgbRgbRsRsmbLgbRhbLgbRgbLgbRgb
LsbRgbRgbLsbRgbLsbRgbRsbRgbLsbRsRsmbRsRsLsmbRgbRsbRsbRgbRgbRsbRsbRgbLs
bRgbLsbRgbRsbRgRsmbRsbRsRsmbRsbRgbRsbRgLsRsbLsbRgRsmbRgbRgRsmbRgbRgbRg
bLsbRsbRgbRsbRgRsmbLsbRgbRsbRgbLsbRiRsmbRiRsmbRgbRsbRsbRgbRgbLsbRgbRgR
smbLsbRgRsmbRsRsRsmmbRibRsbRsbRgbRgbRsbLgbRibRsbRsbRgbRgRsmbRgbRgbRgbR
sbLsbRgbRgRsRsLsmmbRsbRgRsmbRsbRjbLjLgbLibRjbRibRsbRgbLsLsmbRgbRsbRsbR
gbRsbRsLsbRgbRiLsbRsbRgbRibLgbRgbRgRsmbRsbLgbRgbRsbRsbRsbRgbLsbRgRsmbR
sbRsRsmbRgLsbRsbRsbRsbRgRsmbRsbRgbLsbRsbRgRsmbRgRsmbRgbRsRsmbLsRgRsmbL
gbRibRsbRsbRgRsmbRsbRgbRgLsbRgbRsbRsbRgbRgbRgbLgbRgRsmbRgbLsbsbRgRsRsm
mbRgLsbRgLsbRsbRgRsmbRgbRgLsbLsbRgRsmbRsbRsbRiRgbsbRgbRgbRsbRsbRibRgRs
mbRibRsbRgbRsRsmbRgRsmbRgbRgbRsbRsbRgRsmbRsbRsRsmbRgbRibRsbRibRsbRgbRs
bRgRsmbRgbRsbRsbRsRsRsmmbRsRsmbRgRsRsmmbRgRsmbRsRsmbRsbRgRsRsmmbRsbRgR
smbRgbRsbRgRsRsmmbRgbRgbRgbRsbRsbRsRsmbRgRsmbRgRsmbRsbRgbLsRsbRgbLsbRg
bRgbRsbRgbRsbRsRsLsmbRsbRgbRgbRsRsmbRsbRgbRgbRgbLsbRgbRgbLsbRgbRgbRsbR
gbRgbRsRsmbRgbRgbRgbRjbLhbLhLsbRebRgbRgbRsbRgbRibRsbRsRsmbRgbRsbRsbRgL
sbRsbRsbRgbRgbRgLsbRgRsmbRsbRgbLgbRiRsmbRgbLgbRgbRgRsmbLgbRgbRgRsmbLsb
RgbRsbLgbRgbRgbRsbRsbRgbRgbRgbRgbRgbLsbRgRsmbRsbRgbRsbRibRsbRgRsmbRgbR
sbRgbRgbLgbRiLsbRgbRsbLsRsbRgRsmbRgRsLsmbRsbRgRsmbRgbRgbRgRsmbRgbRsbRg
bLsbRibRsbRgbRsbsbRibLgbsbRiRsmbRsbRsbRgbRgbRgbRgbLibRibRgbRgbRibRgbRg
bLhbRibRibRgbLjLsmbRibRsbRibRsbRgbRgbRsRsmbRgbLsbRgbRgbLgbRibRgbRgbLsb
RgbLgbRgbLsbRgbRgbRgLsbLsbRgRsmbRgbRgbRgRsmbRgRsmbRgRsmbRsRsmbRiRsmbRg
bRgbRgbLhbLibRjbLhbLcbRiRsmbRgbRibLjbLcbRibLibLgbLibRjbLibRjbRibRsbRib
LgbLcbLhbLibRibRsbRgbRibLcbLiLsbLibLgbRjbRibRgbRgbsbRibLsbRiLsbRsRsmbR
gbLsbRsbRgLsbLsbRibLsbRibLsbRgbRsbRgbRgbRsbRgbRsLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 18; Drug: NDMC 3 µM
bLgbRiLsbRibRiLsbRgbLgbRibLobsbLibRibLibRjbRibRgbLgLsbLcbRjbLcbRjbRobR
hbRcbRibRgbLibLibRibRibRibRgbRgbLibRgbLsbRibLibRibLhbLcbRibLibLcbLoLsm
bLgbLjbLjbRjbRiLsbRsbRgbRgRsmbRsbRgbRibRgbRibRgbRgbRiLsbLgbLibLsbRsRsm
bLibRsbLsbsbRibRiRsmbRgbLgbRibLjbRgbRgbLcbRjbLcbLibLcbLcLsmbLibRsbLibL
ibRgbLgbRsbLsbRsbLibRjbRhLsbLjbRibRgbRsbRgbLgbRgbRgRsmbRsbLjbLcbLgbRib
LibRsLsbsbLsbRsbLibLgbRsbLibRsbLibsbRgbLjbLcRsbRjbLibRgbLiLsbLsbRibRsR
gRsmbRgbLobRibLcbLcbLibLcbLibRibLibLsbLibLibRsbRgRsmbLgbLsbLsbLsbRgbLi
bLgbLsbLibRgbLibLgbLgbRgbLjbLgbLgbLgbRsbLgbLsbLsLsmbLsbLsbLsbLsLsmbLgb
RsbLibLhbRgbRsbRsLsbLgbLiRsbLsbLgbRsbLgLsbLsbLsbLgbRgLsbLibRgbLsbLsbRs
bLiLsbLgbLgbRsbLgbsbRsbLhbRibLsLsmbLibLsbLsLsmbLgLsLsmbLsbLgbLsbLsLsLs
mmbLibRsbLsbLibRsLsbLgbLsRsbLsRsbLgbLsbLgbLgbLsbLsbLsbLsbLibRsLsbLiLsb
RjbLsbLsbRsbLsLsmbLgLsbLsbLgLsbLsbRsbLibLsbLgLsbLgbLgLsbLgbRsbLiLsbLsb
LgbLsbLsRsbRgbLgbLgbLsbLgLsbRsLsbLgLsbLsbLsLsmbLgLsbRsbLgLsbLsLsmbRsLs
bLiRsbLsbsbLsbsbLibLsbLgLsbLgLsbLgRsbLgbLgLsbLsbLgbLgbRgbLgbLsbLiLsLsL
smmbLsbsbLsbLibLibsbLgLsLsRsmbLgbLgbRsbLibLgRsbLsbLgbLsbRjLsbLcbLibLgL
sbLgLsbLgbRgbLgbRsbLibLsbLiLsbRsRsmbLgbRsbLgbLgbLsbLjbLgbRgbLgbLgbLgbR
gbLibLgbRgbLgbLgbRsbLsbLibLgbLgbRjbLibLsLsmbLsbLgbLsbRsbLgLsbLsbLibLgb
RgLsbLgbLibLsbLgbRgbLibLgbLgbLgbLgbLgRsLsbRcbRcbRgbRibRgbLjbRibRibLjbR
ibRibLjbRcbLiLsbRgbRibRgbRibLiLsbLjbRibRgbRiLsbLiLsbLjbLibRjbRibRgLsbL
cLsmbLcbLhbRgbRibLsLsmbLcbRibRjbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 19; Drug: NDMC 10 µM
bLoRsbLcbRgbRjbRcbRgbRgbRsbRsbRcLsbRoLsbsbRcbRhbRhbRhbRgbRgbRgbRibRgLs
RsbRgbRgbLgLsbRgbRsbRsRsmbRsLgbRgbRsbRsRsmbLsLsmbLsbLsRsLsbRgbRsRsmbRg
bRgbLsLsmbRgRsmbRgbRgbLjbRcbLcbRjbLcLsLsmmbLjbLobRibRgbRgLsbRibLibRoLs
bLjbRcbLsRibLhbLjbLhbLibRjbRcRsmbRhbRibRibRibRgbRgbRgbRsbRsbRgRsmbRsRs
mbRgbRsRgbRsbRibLsRsbRgbRgbRsLsRsRgRiRsmbRgRgRsmbRgbRsbRgbRsbRgRsmbRcL
sbLsbRsbRobRiRsmbRibRibRhbRgbLsbRgbRsRsmbRgbRsbRgRsmbRgRibRgbRsLsbRgbR
gRsRsRgRgmmbRgbRsRgRsRgRsRsRiRsmmmmbRgbRsbRiRsmbLsRsLsRsRiRsRgRsmmbRgR
gbRgRsmbRgRsmbRgbRgRgRiRgbRgbRgRsRgRsRimmbRgbRgRiRsRhmbRgRgRgbRgRgbRgL
sbRsbRgbRgbRgbRgbRsbRgbRgbRgbRgbRgRsmbRsbRgLsbRibLsbLiLsbRhbRgbRgbRsbR
gRsmbRsbLcbLibRjbLiRsbRsbLibLsbLsbRsLibLgLsLsmbLsRsLgbLgbLgLgLsbLgbLsb
LsbRjbLcbRgbLgbLiLgbLgLgLsbLsLsLgmbLgLsLsLsLsLgmmmbLgbLgLsLsmbLgbLjRsb
LgbRcbRhbRibRgbLgbRgbRgbRgbRgbRgbRgbRgbRgbsbRsbRgbRsbRgbRsRsmbRgRsmbRs
bRgRsmbRgbRgbRgRsmbRgRgbsbRgbRsRibRsRgRsmbRibRgbRgRsmbRgbRgRsRimbRgRib
RgRsRsmmbRgbRgbRgbRgLsbRgRsmbRgbRgbRsbRsbRgbRgbLsRibRsbRiRsmbRsbRgbRsb
RibRgbRgRsmbLsbRgLsbRgLsbRsbRibRsbRgLsbRsbRiLsbRsbRgRsmbRgbRsRsmbRgbRo
bRcbRibRibLjbLcbRhbRibRsbLjLhbRhRsmbRiRsmbRsbRiRgRsmbLjbRibRgbLiLhbRhb
RhbRiLsbRgRsmbRsLsbLibRsbLgbLsLsmbLgbRsbLsbLgRsbLsbLibRgLsbLsbLgbRgbRo
bRibRibLcbLcbLcbLsRsbLjLibRcbRiRsmbRgbLsRsbRsbLcbRjbRiRsmbRgbRiRsmbLib
RhbLsLsmbLgbRgRsmbRgbRsbRgbLsRgRgbRgbRsbRgbRgbRsbRgbRgRsRsmmbRgbRiRgRi
bRgbRgRsRgRsRgmmbRgbRibRgbRsRgbRsRgbsbRiRsmbRgbRgbRgbRsbRgbRgRsmbRibRs
bRgbRsRsmbRgbRgbRgLsbLsRsbRsbRgbRsbRibRgbRgbRsbRsbLsbRcbLibLcbRjbLcbRg
bLiLsbLsbLsbLgLsLsmbLgbLgbLgbLgbLsLsmbLgbLgbLsbsbLgLiLsLsmbRjbLhRsbRsb
LibRsbLgLsbLibRsbRcbRsbLjbReLsLsRgmbLsbRibRibLcbRcbRjbLcbLibLcbRibLsbL
hLsbRjbRibLjbRcbRgbRgbRcbRgbLebLobRhbLgbLjbLhbLsbRjbLibLgLsRsbLgLsbLsb
LgbLgLsLsmbLsbRsbRsLsbLgbLsbLibLsbsbLsbLgbLsRsbLsbLgbLiRsbRsLsLsmbLgbL
gbLsbLgbLgbLgbRsLsbLsLgbLgLsLiLsbLgbRsbLgbRcbLiLsbLibLgRsRsmbLgbLgbLiR
sbRjbLcbRcbRobLibRibLsbRibRsbRhbLcbLcbLsbRgLsbLibLsbLibRgbRjbRibRsRsLs
mbLsRibLobLhbRibRgbRibRibLcbRcbRgbLgLsbLgbRiRsmbRgbRgLgbRibLsRsbRgbRgL
sbRgRsmbRsbRgbRsbLsRibRgbRsbRiLsLsRsRsmmbRgbRgbRsRsmbRgbRsbRgbRsbRgbRg
LsLsRsRgmbRgbRgRsmbRsbRgRsmbRgRsmbRgbRgRsmbRgLsRgbRgbRsbsbRgRgRsmbRgRs
RsmmbRibRsbRgbRsbRgbRgbLsRsbRiRsRsmmbRgbRsRgRsmbRgbRgbRgbRgbRgbRgbRiRs
mbRgRgRsmbLcbLibRgbLibLsbLsbLibLgbLgLgLsbLibLgbLgbLgLsLibLgLsbLgbLgLsL
sRsmbLibLsbLgbLiLsLgLiRsbLgbLsbLgLsbLgLsRsLsbLgbLibLgbLgbLgLsbLgbLgbLg
LsLgLsLsmbLibRcbRcbLcbsbRobLcbRobLcbRsbLcbRsLsbRibRoLsbLgbRibRoLsLsRsL
smbLsbRgbRiRsmbLjbRcLgLsLsmbRsRsmbRibLsRgbRsbRiRsLsmbRiRsmbRgbRsbRgbRs
RsmbRgbLsbRgbRsbRibLsLsmbRgbRibLsbRgbRgLsbLgbRgbRsbLsbRibRibRgbRsLsbRi
bRsbRibRgbLsbRibRsbRgbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 20; Drug: NDMC 10 µM
bRoLsbLibRgbLgbLgbRsbRgbLsbLgbRcbRsbLcbLibLibLcbLcbLibLjbLhbLobRgRsmbL
sbRgbRgbRsRgbLsbLgbRsLsRsbRhbRgbRgbLgbLgbRibRibRgbRgbLgbRgbRgbRsbRgbLc
bLcbLgbLgbRgbRobRibRibRgbLgbRjbRsLcbLcbLibRgbRibLgRsbRjbLibLgbLsbLgLsb
RsbLgbLibRjbRhbRoLsbRjbLibLgbRhbLgbRibLsbRiLsbLgbRibLibRgbRgbLcbLhbRjR
smbRjbLjbLibRsbLgbLgRsbsbLgbLgbLgbLgbRcbRhbRhbLjbRibRibLgLsbRibRibRgLs
bRgLsbLgLsbRgRsmbRgbLsRsbRsRsmbRgbLsbRgRsmbLcbRjbLibRobRjbRcLgbRgbRgLs
bLgbLsbLibRobRobLcbLgbRobRsbLgbRibLjbLiLsbLsbLsLsmbLgLsbLgbRgbLgRsbRob
LgbLjRsbRjbLibRhbRobRiLsbLgbRgRsmbRgLsbRibRgbLgbLcbsbLiRsbLgbLgbLgbRgb
LibLibRgbRjbLgbLgbLibRjbLibRobRibRiLsbLgbLgbRhbRgbLgbLibLgbRcbRhLsbLib
RgbRjbLibLjbRobRcbLcbsbLibRgbLsbLjbLgbLgbLiLsbRgbLjbRsbLibLgbLsbRjbLib
LsRsbLgLsbRsRsmbLgLsbLgbRsbRebLsLsmbLjbLibRsbLibRsbRsbRjbRobRjbRsbLibR
ebRsbRibRsbRsLsbRobLgbRibLgbRibRsbRjbRgbRgbLgbRgbRgbRgbLsbRibRibsbRhbR
ibRgbRsbRjbLibLibLsbLgLsLsRsmbLgbLibsbLiRsbRgbRjbLgbLibLibRgLsbLibRgbL
ibRsbRsbLibLibRsbRsbLgbLsbLsLsmbRsbLgbLsbLgbLgbRgbLgbLjbRsbLjbLgbLgbLg
bLgbRibLibLiRsRsmbLgbLibRjLsbRoRsmbLjbRcbLhbLobRsbLgbLibRjbRibRgbRibRs
RgbLcbLsbRjbRibsbLsbRibLsbRgbRgbRsbRgbLsbRgLsbRsbRgbRsbRibRsbRgbLsbRgL
sbRsbRiRsmbRsbRgbLjbLibLgbLibLobLhbRibRsRsmbLjbRibLcbLcbRgbLsLcbRibRsb
RjbRgbRgRsmbRibLjbRgbLgbRoLsbLibLsbRibRhbLibRgbRgbLgbRibRgbLsbLjbLibRg
RsmbLibRgbLiLsLsmbRjbLibLsbLgRsbLgLsbLibRsbLgbLiRsbLiRgLsbLgbLibLibLiR
sbRgbRibRgbLibLgbRjbLcbLsbLgbRgbLsbLgRsbRgbLjLsmbLibLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 21; Drug: NDMC 10 µM
bLibLhbRsbLibLibLgbRgbLibLcbLsbLobLibRibRsbRjbLobRebsbLobRhbLcRsbRobRg
RsmbRibRsbLebRjbLiLsbRgbLgbRobLgbRobRsbLsbRibRgbLsRsbRobLibLgbLsbRibRi
bRhbLgbRsbRsbLjbRcbRgbLobRcbRhbLibRiRsmbRgbLsbRibLgbLsRsbLjbLobLcRsRsm
bRiRsmbLgbRgRsmbLsbRibRiRgbRgbRsbRibRcbRcbLibLsbRsbLjbRjbRobLgbRgRsmbL
sbRsbsbLsbRsbRibLgRsbRgbRcbLgbLgbRgbLcbLibLibRgbLgbLibLsRsbLgbRcbRgbLj
bRcbRiRsmbLsbRgbLsbRibLcbLcbRjbLibRcLsbRobLibLsbLgbReLsbRgbRobRibRgbLs
bRsbLsbRibLjbRibRiRsmbRsbRgbRsbRiRsmbLjbRcbRibLgbRgbRgbRsbRgbRgLsRsbRg
bRgbRgbRgbRgLsbRibRgbRsbRcbLobRiRsRsmmbRsbRibRgbRsbLcbRjbRhbRobLibRibL
gbLiLsbLhbRcbLibRebsbRjbRobLgbLsbLsbLibRjbsbRgRsmbLgLsbLsRgRsmbRsRsmbR
iRsmbRgbRhbLjbRcbRcbLjLsmbRcbRjbLibLibRjRsmbLhbRobRobLhbLibRsbLhbRgLsb
RobRgRsmbRgbRgbRgbRibRgbRjbLsbRjbLsbRibRgbRgbRsbRjbRsRsmbRgbRsbRgbRgbL
sbRibRiRsmbRsbRibRsLsbRibRsbRsbRjbRsbRgbRgbRgRsmbRsbRgRsmbRsbRgbLsbRib
RgRsmbRsRibRibLjbRjbRiRgbLibRibRhbRsRsmbRsbLsbRebLsbRsbRsbRobLcbLsbLib
RgbRjbRcbLjbRgRsmbRsbLsbRibRgbRibLgbRibRsbRebLibRebLcLsmbRsbLgbRjbLobR
cbRebLibRgbLcLsmbLhbRibRjbLgbRsbRgbRgLsLgbRibRsbRiLsbLsbRgbRibRgbRiLsb
LgRsbRibRibRgbRsRsmbRgRsRsmmbLsbRiRgbRsbLgbRgbRibRgRsmbRgbRiLsbRjbRgbR
gbRgRsmbRgbRibRjbRsRsmbLiRsbRsbRibLsbLhbLobLobLcRsbRiRsmbLibLcbRibRhbR
gbRsRsmbRgRsmbLibRibRibLjbRibLsbRcbLgbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 22; Drug: NDMC 10 µM
bRgbRibRsbRgbLobLibLobRibRiRsmbLgbLiLsbLgbRcbLcbLibRobRhbLibRgbRgbRsbR
gbRgbRsbLsbRgbRcLibRsRsmbRiRsmbRibRcbLgbLsbRsbRibRcRsmbLibRsbRgRsmbRgb
LgbRibLjbLiLibRsbLgbRjbLibLsLsmbLgLsbLjbLgLiLsbLgRsLsbLgLsbLsRsbLsbLsb
RsRsmbLgbLsbRsbLcbRcbRcbRgbRiLsbLjbRcbLgbLjbRibRsRsmbRgbRgbRsRsmbRsbRg
bRsbRsbRgRsmbLsbRibRgbRsbRgbLsbRibLsbRgbsbRsbRibRgbRsbRgbLsbRgRsRsRsmm
mbRgbRgLsbRsbRgbLgRsbLsbRgRsmbRsRsmbLgbLhbLsbRcbRibLsbLsbsbRcLsbRgRsmb
RsRsmbRgbRibRsLjbRibLjbLibLiRsbRgbLgbLgbLiLsbRsbLiRsbRgbLiLsbLgRsbLsbL
sbRsbRebRsLsbRibRcbLibRcLsbLsbRgbRibRsbRsbsbRsbRibRsbRgbLsRsbRsRsmbRgb
LsbRsbRjbRiRsmbLibRsRsmbRiRsRsmmbRibRsbRiLsbRgbRgbRibRgbRsbLsLsmbRgRsm
bRsRsmbRibRsRsmbRhbLgbRobRibRibRibLcRsbRcbRibLhRsbLcbRjbRsRsmbRibLsbRi
bLjRsbLcbLibsbRjbLibLibRsLsRsbLgbsbLgbRsbLgbRgbLiLsLsLsmmbLgbRsbLgbRgb
LjbLsbLjbRsRsLsmbLhbsbRibLibRsbLibRjbLiLsbLsbLsbLgbLsRsbLgbRsbLsbLibRs
LjbRsRsmbRgbLgbLsLsmbLsLsmbLsLsmbLgLsbLibRsbLhbLibRiRsmbRgbRibRibRibLo
bLcRsRsmbLhLsbRhbRjbLcbRjbLibRjbLsRsLsbRsLibLgbLgLsLsmbRgbLiLsLsmbLsbL
ibLgbLgLsLsmbRsRsmbsbLgbLsbRsbLgbLsbRsbLgbLsLsmbLibRjbLiLsbRsbLibRsbLg
bLsLsLsmmbRgbLsbRsbLsLsmbLgbRiRsmbLiLsbRsRsmbLibLsbLiLsbRsLsbLgbRsbLgL
sLsmbLgLsbRsbsbRgbLsLsmbRgRsmbLsLsmbLgLsLsmbLsLsmbLsbLsbLgbLgLsbLsLsmb
LgLsbLgbRsbsbLgbLsbRsbLibRsbLibLgbLgLsbRsbLgbLsbLgLsLsmbLsbLgbLsbLgbLs
bRsbRsLsLsmbLjbRsbLsLsmbLgLsbRsbRsbLibLsbLsbLgLsbLsbLibLsbLibRsLsbsbLg
bLjbLsbLsbLgLsbRsbLobLgbRsbLibLgbLgbRibsbLibLsbLibRgbLibsbLgbLgbLibRiL
sbLibLsbRcbRibLibRhbRgRsRsmmbLibLjbLibLgbLsbLsbLgbRsbRgbLgbLgbLsbLgbLs
bRsLsbLcbLgbLgbLibRcbRibRibRgbLibLibLebLiLsbLgbRibRhRsmbLiLsbRhbRsRsmb
LjbReRsmbLgbRibLgbRiRsmbLibRobRibLsbLhLsLsmbRsRsmbLsLhbLgbLgbLsbLsbLib
LgbRjbsbLibLgbLgbLibRcbsbLsLsRsRcmbRebRibLiLsbLibRsbLjb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 23; Drug: NDMC 10 µM
bLjbRibLgbRibLgbLsbLsLcbLsbRjbLhbRcbLgbRhbRibLjbLcbLibRjbRcbLjbLobRibL
ibRjbRcbLibLjbRhbLjbLcbRgbLgbLibRgbLjbLibRibRjbRcbLjbLobRibRsbLcbLoLsm
bLibLebLibRsbLsLiLgLsbRgLsLsmbLgbLgbLgLsbLgLsbLgbLsbLgbLebLgLsbLsbLgbL
sbLgbLgbLgbLgLsbLgbLgbLsLsmbLgbLgbLsbLgbLgbLsbLgbLgbLsbLgbLgbLgbLgRsbL
gLsbLsbLibLgbLiLgLsbLsbLgLsLsLsLsLhmmmbLgLsbLsbLgLsbRsbLsbLgLgbLibLibL
iLeLsbLiLibLgbLgbRsbLibLsbLhRsbRgRsmbLsbRcbLjbLibLsbRsbRcbLjbLcLsmbRsb
LhbLsbRsbRjbRhRsmbLjbLhbLibRsbRsbLgbLgbLsLsmbLgbRsbLibLsLsmbLgbLgbLgbL
gLsbLsbLiLsLgRsbLgbLgbLgLsbLsbLgbRsbLgbRgbLibRsbRgbLibLibRgbLhRsbRgLsb
LgbLgbLiRsbLsbLsbLsbLgbLgLgbLgLsLibLgbLgbLsbLgLsbLgbLgLsLsmbLsLsmbLgLs
bLgbLgbLgRsbLgbLgLsbRsbLsbLjRsbRsbLgRsbLgbLgLsbLgbLgbLgbLgbLsbLgLsbLsb
LgbLsbLgRsbLsbLsbLgbLsRsbLsbLgbLibLsbLgLsLgRsbLgbLgbLgbLsbLgbLsbLgLsLs
mbLgbLgLgLibLgLsbLgLsbRsRsmbLgbLgbRsbLgbLsbLsLsmbLgRsbLsRsRsmbLgbLgLsL
smbLgbLgbLsbLgRsLgLgbLsbLgbLsbLgbLgbLgbLsbLsbLibLgLgLgbLsbLgLsLsmbLgbL
gbLsRsbLibRsbLsbLibLsRsbLibRsbLibRgbLibRsbLibRjbLibRsbLsbLsLsmbLsLgbLi
bLsbLsbLiLsbLsRsLsbLgbLgbLgbRsLsbLiRsbRsbLgLsbLgLsbLgLsbLsbLgbLgbLsLsL
smmbLgbLgbLgbRsbLgbLgbLgLsbLgbLgbLgbLgLgbLgbLgLsbLgbLibLsbLgbLsbLibLsb
LgbRgbLgbLgLsbLgbLgbLgbRsLsbLgLsLgLgbLgbLgbLsbLiLsLgbLgbLgbLgbLsbLibLs
RsLsLsmbLibLsbLgbRsbLiLsRsbRsbLibRsRsmbLgLsLsmbLgbLsbLgLsLgbLgbLgLsbLg
bLgbLgbRsbLsbLibLsbLgbLgLsbLgbLgLsbLsbLsbLgbLgbLsbLsbLsbsbLsbLgbLgbRsb
LibLgbRsLsbLgbLgbRjRsmbRibLhbLhbLiLsLsmbLsbLsbRcLsbRhbLibRibLibLcbRhbR
cbRcRsmbRhRsmbLibLibLhLsbLgLsbLsbLgbLgbLsbLiLsbLsLsmbLgbLgbLibLsbLiLsR
sLsbRhLsbRibLjLcbLibLsbLsbLibRibLibRsLsRsbRhRgbRibRgbRgRsmbLcbLsLcbRgb
LibLsbLgbRsbLsbRgLsbLgbRsbLgbRsbLibLsbRsbLibRsbLgbLgbRgbLgLsbLgbRsbRcb
RibLsbRgbRgbLcbLhbLgbLsbRsbRgbLcbLibRhbLgbLiLsbLsbLgLsLsmbLiRsbRibLiLs
bLsbLiLsbLgbRjbLibRsbLsbLibLgLsbRgbLibLsbLgbLgbLsbLgLsbLgLsLsmbLgLsbLg
bRsbLgLsbLgbLgLsbLgbLsbLibLsbRsbLibLgbLgbLgbLsbLgLsLgbLgbLsbLibLgbLgbL
gbLgLsLsmbLgbLsbLgbLgbRsbLgLsLgbLiRsbLibRibLgbLibLiLibLsbLgbLgLsbLsbLi
LsbLgbLsbLgbsbLiLsbLgbLgbLgbRsbLiLsbLsbLgLgbLgbLsbLibRibRjbRibRgbRiLsb
LcbLgbLgLsRgbLiLsbLsLsmbLgLsLsmbLgbRsbRsLsbLibRsbLsbLhbRibRibRgbLjbLcb
RsbRcbRgbLcbLibRgbRjRsmbRibRcbRgbLgbRcbLgbRibLsbRibRsLsLjbRibRibRgRsmb
RsLsRsbsbLebLjbLsLsmbLgLsbLgLgbLsRsbLgLsbLsbRsbLsbLsbLgbLiRsbRsbLgLsbL
gLsbRgLsbLiLsbLsbLgbLgbLgLsbRsbLgbLsbLgLsLgbLsbLsbLgLsbLgRsbLiLgbLgLsb
LsbLsbLgLsbLsLsmbLgbLgbLgbLiRsLsLsmbLgbLgLsLibLgbLgLsbLgbLgbLibLgbRsbL
gbLgLsbLgLsbLgLsbLgbLiLsbLgLsbRsbLibRsbLgLsbLgbLgbLgbLsbRobLsbLiRsbLib
LibLsRgbRsbLiRgbLibRsbLsLibLgbLgbLsLsmbLgbLgLsbLgbLgLsLsLsmmbLgLsbLsbL
ibLsbLgbLgLgbLgbLgbLgbLgbLgbLgbLgbLiLgbLgbLgbLsRsLsbLgbLgbLgLsbLsLsmbL
gLsbLgbLgLsLgLsLiLiLeLebLgbLibLibLgbRsbLiRsbRcbRibLcLsmbLibLgbLsLsmbRj
RhbLjbRibRgbRgbRgRsmbRibLgLsbRsRgbRgbLhbLibLsLsmbLgbLgbLsbLsLsmbLgLgLs
bLsbLgbLgbLgRsbLgbLsLsmbLgbLsbLgbLgbLgbLgbLgbLgbLsbLgbLgbRsbLgLsbRsbLi
bLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 24; Drug: NDMC 10 µM
bRsbLibLsbLsbLgbRsRsmbLgbLobLgLsRsbLgbRgbRgbLsbRgbRsbRsbRsbLsLsmbRgbsb
RgbRsbLjbRibLgbLobRcbRobLgbLsbRibRsbRibRgbRsbRsbRsbRgbRsRsmbRsLsbsbRjb
RobRgLsbRjbRibRibLjbLjLgbLgbLsbLgbLgbLsLsmbLgbLsbLsbLsLsRsmbLsbLsbsbLs
bLsbRsbLsbLibRgbLibLibRgbRsbRjbRibRgbRgbRgbLsRgbRsbRgbRsbLsbRibRsbRgbR
gbRgbLsRsbRgbRgbRgbLsbRgbRgbRgbRsbRibLgbLsbRibRgbRgbRsbRgbRsRsmbRsRsRs
mmbRgbLsRsRsmbRgRsmbRsbRgRsmbLsbRsbRgRsmbRgLsbsbRibRgbRgbRgbRgbRgbRsbR
sbRgRsmbRgbRsbRgbLsbsbRsbsbRgbRsbRsbRgbLgbRsbRgRsmbRgbRgbRgbRsbRgRsLsm
bRsbRsbRsRsmbRgbRsbRgbRsbRsbRgbRgbLsbLgRsbRgbsbRsbLsbRsRsmbRsbsbRsRsmb
RsLsbRsbRsRsmbRgRsmbRgbRgbRgbRsbRgRsmbRibRsbRgbRgLsbLsLsmbRgbRgbsbRsRs
mbRsbLgbRsbRgbRgbRgbRsRsmbRgbRgbRgbRgbRsbRgbLsbLobLibRsbLgbRsbLibRsRsm
bLiLsbRsbLgbLgbsbLsbLgbLsbLsbLjbLsbRsRsmbLjbRsbRsRsmbsbLibLsbLgbLsbLgL
sbLgbLsbLgbLsLsmbLgbLsbLgbRgbLhbRsbRgbLibRsbLsRsbsbLgbLgbLsLsmbLsbLsbL
gbLgRsbLgbLsbLsbRsRsmbLjbsbLgLsbsbLgbLsbRsLsbRgbLgLsRsLsbLsbLgLsbLgbLg
bLgbLgLsbRsbRcLsbRibRibRgbRgbRsRsmbRgbLsbRgbLsbRgbRgbLsbRgbRcLsbLgRsbR
ibRibRgbRiLsbLibLsbRibRiRsmbRgbRsbRgbRsbsbRsbRsbRsbRsbRsbsbRsbRsbRsbRs
bRgbRsbRgbRsbRjbRgbLsbRsbRgbRgbLsbRgbRsRsmbRsbRsLsbLsbRsRsmbLsbRsbRsRs
mbRsbRsbRsbRgbLsbRgLsbRgbRcLsbLgLsbLsbRsbLibLjbsbLsbLoLsmbsbLibLgbLgbR
gbLgbLgbLgbLgbLgbsbRgbsbLjbLsbsbLsbLsbLsbLgLsbLgbLgbLsbRsbLsLsmbsbsbRs
bRjbLobRgRsmbRibRibRibLsbRgbRsbsbLsbLsbLsbRsbRsbRsbRgRsmbLsbLsRsbRgbRs
bRgbLsbRsbRsRsmbRgbRsbRiRsmbRgbRgbLsbLgbRgbRsbLsbLsbsbRgbLsbRgRsmbRgbR
gbRgbRgbRgLsbLgbRgbRgbLjLsmbRibsbRsbRsbRsRsmbRjbsbRgRsmbRgbRsRsmbRgbRs
bRgbRgbRgbRsbRsbRsbLsbRsRsmbRgbRsRsmbRgbRgbRgbRsbRgbRsbRgbRgLsbLsbRsbs
bLsRsbRhbLsbLsbRiRsmbRsbRgbRgbRgbRgLsbRsRsmbRgbRgbLsbLsbRibLsbRgbLsbRs
bsbsbsbRgbRsbRgbsbRgbRgbRsbRsbLsbRgbsbRgLsbRsbLsbLgbsbLjbRgbLibLcbLsbR
gbRibRgbRsbRgbRgbsbRsbRgbRgbRgbRsbsbRgbRsbRsbsbRsbsbRgbRsbRsbRgbRsbRgb
RsbLeb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 25; Drug: Control
bLjbLibLsbLcbRgbLgbLibRgbRgbLiRsbLjbLibRjbLibLcbRebRcbLcbLibRjbLcbLobL
jbLibLgbLjbRjbLjbRcLsbRobRibLjLsmbRgbRsbLsbLgbLsbLgbRgbLcbLgbLcbLgbRgb
RsbRgbRgbRsLsbRjbRsbLibLobLibLcbRsRsmbLcbLcbLgbLsbLsbRibsbRgbLjbLcbRsb
RsbLgbLiRgbLibLsbLgbRsbRsbLsbLgbRsbLjbLsbLgRsbLsbLgbLgbLgbLgbLsbLjbLgb
LibLhbRgbLsbLsRsbLgbLibLibRsbLcLsmbRgbLhbLjbRibLjbLhbLsbLgbRgbRsbLgbLi
bLgbLibRibLgbLjbRcbRibLgbRsbRjbLgbLjbRibRsRjbLibLibRsbLibRgbLiRsbLgbLg
bRsLsbLiRsRsmbRgbLibRjbLibLsbRsbLgbLsbLibRgbLsRsbLgbLsbLgbLsbRsbRsbLib
LsbLgbLsbLsbLgLsbLsLiRsbLsbLiLsbsbLgbLgbLgbLibLsLsmbLibLgbLgbLgbLibRgb
LgbRsbLsbLgbRsbRjbRibLsbRibRsbLjbLjbLibRjbLgbLsbsbLsbLgbLsLsmbLgLsbLsb
LgbLsbLgLsLibLgbLsLsmbLgbLgbLsbLgbLgbLsbRjbLjLsmbRgbLibLgRsLsbLgbLgbLs
bLgbLgbRsbLsRsbLsbLgbLsbLgRsRsmbLibLgbLgbLsbLgbLibRgbRsRjbLibLibLgbRgb
LibRjLsbLgbLsLsmbLgbLsbLjbRebRcLsbRjbRhbRhbRibRibLjbLibLibLcLsmbRibLib
LcbRgbLcbRgbRjRsmbRoLsbRibRjRsmbRcbRibRgbRsbLibsbLgbLsbRsbLgLsRsbLgbRs
bLgbRgbLgbRsbLgbLsbsbsbsbRjbRiRsmbRcbRibLibRsbRcbLgbLjbRhbLjbRcbLgbLiL
sbRebRibRgbRcRsmbRibRibLhbLibRgRsmbLgbRsLsbRoRsLsmbRobRibRsbRibRgbRgbL
jbLibRjbsbRsbRgRsmbLsLgRsbLsRsbRibRgbRsbRgbRgbLgbRgbRgRsmbLsbLsbRgbLsb
RsbLgbLsbRibLjLsmbRhbLgbRibLsbLibRcbRcbRibLibLibLibRgbRsbRgbRobRsbLjbR
hbRcbLibRjbRibRgbLibLsbLgbLgbRjbRcbRibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 26; Drug: Control
bRgbRjbLibLgbRobRgbRgbRjbRjbLjbLcbRhbRibRsRsmbRsbRgbLsbRjbLgLsbLsbLgbL
sbRjbRcbRhbRobRibRjLsbLgbLgRsbLjbLgLsbLoRsbRgbRsbRgbRgbRsbLgbLsRsbRsbR
gbLjbLgbLgRsbLibLjbRhbRsbLgbLjbLiLsbRibLibRgbRhbLsbLgbRgbRgbRibRsbLgbR
sbRgbRsbRsbRsbRsbLjbLsbLsbLjRsbRobRcbRsbLibLsbLgbRsbLjbRibLsbLgbRjbRib
RhbLibRjbLjbRjbsbRsbRsbRgRsmbRsbRgbLsbRsbRsbRsbRgbRgbRibRgbLcbRgbRsbLg
bLgbLsbLgbLjbRebRcbLsbLsLgbRsbLiLsbRsbLobRsbRgbRsbRgbRsbRibRgbRsbRsbRs
bRebLibRsbRgbLjbLiRsbRgbLibLgbRcbLgbLgLsbRcbRibLgbRibRsbRgRsmbRgbRsbRi
LsbRsbRebLibLsbLsbRjbRcbRiRsmbRgbRjbLibRgbLiLsbLibRgbLgLsbRjbRcbsbLsbR
cbLgbRgbRsbRsbRcbRobRibRjbLibLgbRsbLgbLgbLsbLsbLsbsbLgbRsbLsbLsLsmbLsL
smbRgbLsbLgLsbLcbRgbLsbLgbLgbLsbRhbRoLsbRhbRgbLgbRsLsRsbRgbRgbRgRsmbRs
RsmbRgLsbRsbRsbLsbRgbRsbRibLsbLobLobRsbRhbRibRgbLsbLhbLoRsbRgbRiLsbRgb
RjbRsbRgbRgbRsbRsRsmbRgbRgRsmbRgRsmbRsbRsbRgRsmbLjbRiLsbRcbRcbRgbRsbLs
LsmbLsbLsbRibRgRsmbRsbRsbRgbRsbRsbRgbRsbRjbLgbRsbRibRsbRgbRsRsmbRgLsRs
bRgbRgbRgbRsbRgbRgbLsbRgbRsbRgbRgbRgbRsbRsbRgbRsbLobLsRsbRjbLobsbRgbRi
bRiRsmbRsbRgbRgbRsRsmbRgbRibLgbRgbLibLgbLgbRebRgbRgRsmbRgbRgbRsRsRsmmb
RsbLjbRjbLjbLibLibLgbsbRebRiRsmbRsbRgbRsbRsbRsRsmbRgbRsbRgbRgbRgbRsbRg
bRgLsbLsbRgRsRsmmbsbRcLsbRibLibLgbLgbRebRsLsRsbRsbRsbRgbRgbRgbLsbRgbRg
bRgbRsbRgbLsLsmbLsbRgbRgbRsbRsbRgbRiLsbRgLsLsmbLsbLgbRsRsmbRibLsbRibLg
bRgbRgbRsbRsbRibRsbRgbRsbRgbRgbRsbRgbRgbRgRsmbRsbRgbRsbRgbRgbRgbRsbRgb
RgbLobRjbRibRgbRsbsbRsbRgRsmbLgbRgRsmbRgRsmbRgbLsbRsbRgbLsRsbsbRsbRsbR
gbRgbLsRgbRgbRsbLsbLsLsmbRgbRsbRsbRgbLgbRgbRgRsmbRgbRgbRgbRgbRgbRsbRgb
RgbRgRsmbRgbLsbRibLsRsbRgbLsLsmbLobLsbLiLsbRjbRobLiRsbRobRibLsbRiLsbLg
bLcbRcbRiLsbRsbLgbLgbRgbRsbRsbRgbRsbRgRsmbRsbRibRgbRsbLjbRibLjbRiRsmbL
sRsbRgRsmbRgbRsbsbRgbRgbRgbRgbRgbLsbsbsbRsbRsbLgbRgbRhbLgbLgbLibLcbRib
LibLibLsbLsbsbLoRsbRibsbRibRibRsbRgbLgbRhbLgLsbRibLjbRhbRsbRsbRgbLsbRg
bRgbRsLsbRgbRgbRgbRgbRgbRsbLsbRgbRgbRgbLsbRsbRgbRsbRgbRgbLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 27; Drug: Control
bLjbLcRsRsmbLibRiLsbRsbRgbLgbRsbRgbLgbRgbRjbLjbLgbRcbRibLjbRhbRibRsbLg
bLibLhbLibRibRgbRibLgbRsbRgbLsbRgbRgbRgbRgRsmbLibLcbLgbRgbRibLjRsbLcbL
jbRibsbLsLcbLibRsbLsbRsbRgbLgbRgbRgbLgbRjbRibRibRsRsmbRgbRgbRsbRgbLsbR
gbRgbRgbLsbRgbRsbRgbRsbRgbLobLhbLibLgbRgbRgbLgbLsbRgbRgbLibRibLjbsbLib
LgbLsbLgbLgbRsbLgLsbRgbLibRgbLsbLgbLsbRjbLgbLgbLgbLsbRsbLgbLgbLsbLgbLs
LsmbLgbLgbLgRsbRibLjbRibRjbRcbRibLgbRsbLgbRibRgbRgbRgbLsbRiLsbRgbRgbLc
bRibRibLjbRibLjRsRsmbLiLsbLgRsbRiRsmbRgbLgRsbRsbLgbLgbLgbLgbLibRgbLibR
gbRsbLoRsbRibRgbLgbLibLibLibLgbRgLsbLgbLgbLgbLgbRgbLgbRsbLgbLibRgbLsbL
sLsmbLsRsbLsbLsbLsbRibRcLsbLibLgbLgbLibRgbLgbLgbLgbLsbRgRsmbRsbRgbLibL
gbLgbLsbLgbLsbLgbLgbRsbLsbLgRsbLibRgbLibLgbLgbRcbRibRibRgbLsbLgbRgbRgb
RgbRgbLsbRsRsRsmmbLsbLsbRgbRebLsLsmbLcbLcbRibRjbRibLjbLcbLibRjbRcbLibR
ebLjbRjbLsbLcbLjRsbRcbRhbsbRebLibRibRgbRsbLgbRsRsmbRgbRsbRgbRgbRgbRsbL
sbRsbRsRsmbLsbRsbLebRebsbRgbRgbLgbRgbLsbRibRgbRgbRsbRgbRibLgbRsbRibRgb
LsLsmbRgRsmbRgbRgbRjbsbRsbLeRsbLibLjbRcbRgbRibLibRgbRibLgbRibLjbRibRsb
RjbRsbRgbRhbRgbLjLjbRibRibLjbRebLibRjbLobLcbLgbRsbLgbRsbLibLgbLgbRgbLg
bLjbRgbLjbLgbRgbLgbLsbLgbLibLibRibRgbLibLibLsbLgbRgbLgbLgbLgbLgLsbRjbL
ibLgbLgbLgbLgRsbLgLsbRsbLgLsbRsbLgbLsbRsbRjbRibRibRibLibLgbRibRsRhbLsL
smbRibRsbRsbRgLsbRsbLgbRsbRsRsmbRgbRsbRgRsLsmbLsbRgbRgbRsRsmbRgLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 28; Drug: Control
bLgbRibRgbRhbRcbLgbRsRsmbRhbRibLibRgbRsRsmbRibLjbLcbLibLibRibLibRjbRcb
LgLsbLjLsmbRsbRibLcbLcbLeLsbLsbRibRgbRgRsmbLibLcRsbLebRhbLcbRjbLhbLgbL
obLhbRiRsmbRsRsmbRgbRibLebLgbRgbLibLsbLcbRsbLgLsbLgbLsbLobLhbLibRsbRiR
smbRiRsmbRgbRibRgbRgbRgbRsbRsbRgbLsbLsRibRsRsmbRsRsmbRsbRgbRgbRibRsbLs
bRibLgbLgbLgbRcbRibLgbLgbLjbLcbLobLjbLcbLibRsbRsbRsbLcbLsbRibRgbLcbLib
RebRjbLjbLjbLgbLgbRjbRhbRsbRgbRsbRsbRgbRhbRsbRiRsmbRsRsmbRhRsmbLibRgbR
sbRibRibLsbRsbRgbRgbRsbRgbRsRsmbRibRgbRgbRgbLsRsbRibRhbRsbRibRsbRsRsRs
mmbRiRsmbRgRsmbRsbRgbRgbLsbRsbLcbLoRsbLgbLsbLjLsmbLcbRgbRjbRibRgRsmbRg
bRsbRgbLsbRgbRsbRgbRsbRsbRgLsbRsbRgbRsRsmbRsbRsbRsbRsbRgRsmbRsbRgbRsbR
gbRsbRgbRsbRgbRsbRgbLsbLgbsbRsbRgbRsbRsbRgLsbRsRsmbRsRsmbRgbRsbRgbRsbR
gbRsbRgRsmbRsbRgbRsbRgbRsbRsRsmbRgbRsbRgbRsbRgRsmbRgbRgbRgbRgbRgbRgRsm
bRsbRgbLgbRgbRsbRgbRsbLsbRgbRsbRgRsmbLsbRgLsbRibRgbRibLsbRgbRsbRgbRgRg
RgbLjbLjbLiRsbRjbLcbRibRjbRibLgbRgbRgLsbLsbRsbRgbRsbRsbRgbRgRgbRgLsbRg
bRsLsbRgbRsRsmbRgRsmbRgbRgbRgbRsRsmbRgbLsLsmbLcbLhbRibLjLsmbLibLgbRobR
iRsmbRsbRhRsmbLgbRebLibRibLiLsbLgbRibRgbLjbRsbLhbLgbLgbLjbLsbRgbRjbLib
LsbRjbRebRibRgRsmbRibRgbRgRsmbLsbLgbRibRsbRsbsbLcbRcbLsbLsbsbsbRsbsbLs
bsbRhbRsbRgbRibRgRsRgRgmbRgRsRsmmbRgbRsRsmbRsbRgRsmbRgbLgbRsbLjbRibRgb
sbsbLhbLcbLsbRsbRibRgbRgbRsbLcbLcbLsbLcbLcbLgbLjbLjbLibLibLibRsbRcbRcb
RsRsLsmbRsbRsbRibLgRsbRgbRgbRgbRgbRsbRgbLsbRgbRgRsmbRgbRgbRsbRsRsmbRgb
RgbRgbRgLsRsbRsbRgbLjbLhbLibRsbLgbLibRjbLebLcbLibLcbLiRsbLgbRsbRibRgbL
ebLibLgbLibLcbLibRsLsbLebLgRsbLgLsbRjbRsbLiLsbRsbLiLsbLgLsbLibLgbLoRsb
RsbLgbLhbRibRhbLsbLgbsbLhbLibLibRibLibsbLcbRgbLcbRebRibRjbRsbLibLobLiL
sbLsRsbRsbsbLibRibLcbRsbLibRjbLhbLgbLcbRsRsmbRgbRibRgRsmbRgbLjbLcbLgbR
sbLgbLgbLibLgbRhRsmbLcLsmbLgbLsbLsbLgbRjbLiLsbLsbRiRsmbRcbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 29; Drug: Control
bRjbLhbRjbRjbLoLhbRgbRjbRcbLebLhRsbLibLibLsRibRsbLgbLgbLgbRsbLsbLgbLgb
LsRsbLgbLgbLsbLgbLgbLgbLgbLgLsLsmbLgbRsbLgbLgbLgRsbLsbLgbLsbLgbLgbLgbL
gRsbLsRsbLsLsmbLgbLgRsLsbLgbLgbLgbLsbLgbLsbLgbLsbLsLsmbLgbLgbLgLsLsmbL
gbLgbLsbLgbLgbLsbLgbLgbLgbLsbLgbLgLsbLgbLsbLgbLgRgLsbLsLsmbLiRsbLgbRsb
LgbLgbLsbLgbLsbLgbLsbLgbLsbLgbRsbLgbLgLgbLsbRjbLibRcbRibRibRobRhbLgbRc
bRgbRgbLgbRibLgbRoLgLibLgbLjLsmbLgbLsbLibLsbLgbLgbLsbLsbLsbLgbLgbLgbLg
bLsbLsbLibLgbLsbLgLsbLgbLgbLgbRsbLibLgbLsbRsRsmbLiLsbLgbLsbLgbLgbLsbLg
bLsLgbLgbLgbLsbLibLgLsbLibLgbLsLsmbLgbLsbLgbLgbLgbLgRsbLgbLsbRibLcbLib
LibLibRibRjbRjbRibLibLjbRhRgbRgbLjbLhbLgbLgRjLsbRjbRcLsbLhbLcbRjbRibRc
bRoRhbRjbRibRgbLibLhbRhbRibRgbRgbRgbRgbRsRsmbRsbRgbRgbRsbRcbLgbRcbRhbR
ibRsbRgbRgbRgbLgbRibRibRibRsRgRsmbRgbRgbLjbRibRgbRsbLjbRibRibRibRsbLgb
RibRgbRsLsbLjbLsbRgLsbsbRjbRcRcbRebRgLsbRgRsmbRgbLgbLebRcbRcbRjbRgbRgR
smbLgbRgbLcbLgbLiRsbRjbLibLibLgbLiRsbLibLiLgbRhbLjbRibRibLibRgbRibLgbL
jbLiLsbLgbLgbLgbRgbRsbRjbRjbLcbLjbLcbLhbLgLsLibRjbLjbLgbLgbRjbRhLsbLgL
sbRjbLhbLibLibLgLgLgbRsbLgbLgbLgbRgbLgLsbLgLgbLgbLgbLgbLgbLgbLsbLgLsRs
bRebLgbRibLjbRibLgbLjbLjbLibRgbLgLsLsmbLgRsbLsLsmbLibLsbLgLsbLgbLsbLgL
sbLgLsLsmbLgLgbLgbLgRsbLibLsbLgbLsLsmbLgbRsbLibLgbLgbLgbLgbLsbLgbRsbLi
bLgbLgbLgbLgbLsRsbLgLsbLgbLsbLgbLgLsbLsbRjbRibRgLsbRebRebRibRibLsbLibR
hbRibLjbRhbLsLsmbRgbRiRsmbLjbRiRsmbRibLjbRibRibRgbRgbRhbRibLibReRsmbLs
bLjbLibLgbLgbRgbLgbLgbLgRsbRsRsmbLgRsbLgbLgbLgLsbLgbLgLsbLgLsLsLgmbLsb
LgRsbLgbLsbLgbLsbLsLsmbLiLsbLibLsLsmbLgLsbLibLsbLiLsbLgbLgbLgbRgbLibRj
bLibRgRsmbLibRsbLgbLgbLsbRjbRsRsmbRsbRibLibRcRoLgbRcbRgLsbLsbRgbRsbRsR
hLsbLsRsbRcRsmbLsRebRibRgbRibRibLibRgbRsbLjbRibRibLjbRibLibLhbRcbRcbRc
RsmbRcbLgbLibRjbRcbLsbRibRsRiLsbRgbRgbRgbRgbRgbLsbRgbRsbRsbRgbRibLgbLs
RgbRibLhbRsbRcLsbLgbLhbLcbRgbLibRsbLibsbLsbsbLgbLgbLgLsbLsbLgbLibRgRsm
bLibsbLibLgbRsbLgbLgbLgLsbLgLsbRsbLgLsbLsbLsbLgbLsLsmbLgbLgbLgbLgbLgbR
ibLgbLgLsbLgbRgRsmbRjRsmbRibRibLgbRgbRiLsbRibRiRsmbRiLsbLibRibLsbLcbLc
bRgbLibLiRsbLcRsLsbLiLobLibLsbLsbLibRgbLgbLgbLgbLgbLsbLgbLsbRsRsmbRibL
hbRsbLibRjbRcbRgLsbLgbRhbLgbRoLsbRgbRgbRcbRgbLgbRibRcbRibRgbRhbRibLjbR
jbRibRsbRiLsbRgbLsbRgRsmbRgbRibRsbRibRibRcbLibLibRgbRgbRgbLibRibRibRib
LsbRgbRgbRgbRgbRsbRgbRgbRsbRgbRgbLsbRibLjbLibRiRsRsmmbRgbRiRgbRgbRgbRs
bRibLibRsbRiRsmbRgRsmbRgbRgbRgbRgbRsbRsbRsRsmbRgRgbLibLcbLsLoLsmbRcbLo
LsmbRjRcbRhRsmbLibLhbLcbRibLiRsbLiRsbRjbsbRjbRsbRgbsbRibLjRsbRgbRibLib
RiRsLsmbRhLsbLgbRcLsbLibLjbRhbRiRsLsmbRsbRibRiLgbLibLibLgRsbRibRcbLjbR
iRiLsRsLsbRsbRgbRgbLgbRgbRgbRsbLjbRibRgLsbRibRgbRgbRsbRgbRgLsbLsRsbRgR
sLsmbLgbRgbRsbLjbLhbRibRhLsbRgbRibLiRsbLobRsLgbLibRsbRcbRjRsmbLgbRiRsm
bRgbLjRsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 30; Drug: Control
bLgbLiRsbRsbLsbLibRsbRsbLsbLgbLgbLgbLgbLgbLgLsbRsLsbLgbLsbLgLsbRsbRsbL
sbRsbLibLgbLgbLsbLsbLsbLgbLgbRgbLibRsbRcbLiRsbLgRsbLgbLgbRsbLiRsbLgbLs
bLsbLgbLgbLgbRsbLgbRsbLgbLgbLgbLgbLgbRhbRiRsmbLjLsmbRebRebLgLsbLsLsmbL
sbLsbLgbLgbLgbLgbLgbLgbLgbRjbLgbRsbLsbLgbLgbLgbLgbLsbLgbLsbLgbLibRjbRj
bRjbRcbRgbRibLsbLibLibLgbLgLsbLgLsbLsbLsbLsLsmbLgbLgLsbRgbLgbLsbLgbLgb
LgbLgbRsbLsbLgbLgbLgbRgbLgbLgbLgbLsbLibRebLsbLiLsLsmbLcbLsbsbLsbLsbLgb
LgbLgbLgbLgbRsbLjbLsbLsbLgbLgbLsbLgbLgbLgbLgbRsLsbLibLgbRsbLibLgbLgLsb
LsLsmbLgbLgbLsbLsbLgbLgRsbRjRsmbLibRebLoRsbRhbRebRobRoLsbRgbRgbRjbLsbR
ebLobLgbLgbLsLsmbLgRsbRhbRcbLgLsbRibLiLsLsmbRobRsbLgbLsbLibLgbLgbLsbRs
bLgbRjbRcbRgbsbRgbRiRsmbLgLsRsbLgbRibRgbLsbRgbRgLsbsbRgbLcbLibLgbRibLg
bsbLibLgbLgbLgbLgbRsbLgbLsbRgbLibLsbLcRsbRibLsbLgbLgLsbLibLgRsbLgLsbLg
bLgbLsbLgbLgbLgLsbLsbLgbLsbLsbLgbLsbLgRsbRsbLgbLgLsbLgLsbLgbLgRsbLgLsb
LsbLgbLgbLgbLgbLgbLgbRsLsbRgbLibRibRcbRibRjbLjbRibRgbRhLsLgbRgbRibRcbs
bRgbRcbLiLsbLsbRgbRgbRibRgbLsLsmbRgbRgbRibRcLsbLgLsLsmbLibRcbRibRibRsb
RgbRsbRsbRiLsbLcbLobLgbRhbRgbLjbRibRgbRsbRgbLsbRiLsbLibLcbLgbLsbLgbLgb
LsbRgbLgLgbLsbLgbLsLsmbLgbLsbLgbLsbLsbLibLgbLsbLsbLsRsbLgbLsbLgbLsbRsb
LibRibRjbRjLsbRiLsbLibRgLsbLobRiLsbLoLsmbLgbLsbLgbLibLgbLgbLsbLsbLgbRs
bLgbsbLsLsmbLsbLgbLsbLsbLgbLgbLgbLsbLgbLgbRsLsbLgbRsbLibRgbLibLgLsbLsb
LgbLgLsLsmbLgLsRsbLgbRsbLgbLgbLgbRsbLgbLsbLgbLsbLgbLgLsbLsbLgbLgbLgbLg
bLgbRgbLibLgbLgbLgbLgbRsbLibLsbLsbLsbLgbLsbLsbLsbLgbLgbLgbLgbLgbLgLsLs
mbLsbLgbLgbLsbLgbLsbLsbLgbLsbLgbLgbRcbRibLcbLobRibRobLibLhbRgbLibLsbLg
bLgLsbLgLsbLgbLgbLgbLgbRsbLibRsbLsbLgLsbLgbLgbLsbLsbLsbLgbLgLsbRsbLgbL
gLsbLsbLgbLgbLgbLgLsbLsbLgbLgLsbLsbLsbLgLsbLsLsmbLgbRgbRcbRgbRcLsbRibR
ibLibLgbLibLibLsLsmbLibLibRsbLgbLgbLsbLgbLsbLgbLsLsmbLgRsbLsbsbsbLgbLs
bLgbLgbLsbLsbLgbLgbLgbLgbRgLsbLgbLsbLgbLsbLibLgbLgbLgLsbLiLsbLgbLsbLsb
LgbRsbLgLsbLgLsbLibLsLsmbLgbLgLsbLsbLgbLgLsbLgbLgbLsbLgbLsbLgLsbRsbLgb
LgbRsbLgLsbLgbRjLsbRhbRcbLjLsmbLcLsmbLgbRgbRcbLjbLiLsbLcRsbRsbLgbRcbLi
LsbLcbRgbLgbLgbRgbLibRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 31; Drug: NDMC 1 µM
bLgRsbRgLsbRgbLoRsLhbLgbLgbLgLsbRsbLgbRjbLjLsmbLiLsbLgbLgbRsbLgbLgbLsb
LgbLsbLsRsbLsbLgbRhbRhLsbRibRgbLgbRgbRsbLsbRgbRgbRgbRsRsmbRgbLsbRgbRgb
RgbRgbRgbRsRsmbRsbRiLsbRgbRgbLsbLsbRsbRsbRsbLsbRsbRsbRgbRgbRgbRjbRibRs
bRgbRgbRgbRsbRsbRgbRgbLsbRsbLsRsbRgbRsbRgbRsbRsbRjbsbLgLsbRgbRjbRgbRgR
smbRgbRgbLsbRgbRgbRsbRsbRsbRsbRsbRgbRsbRgbRsbRgbLsbRgbLiLsbLsbLgbLgbLs
bLgRsbLgLsbLsbLgbLgbRsLsbLsbLgLsbLgbsbLgbLgbLgbRgbRebRgbRgbLsbLsbRgbLs
bLsbRgRsmbRgbRsbRsRsmbRsbRjbRjbLcbRiLsbRibRgbLsbRsLsbRibRsbRgbLgbRiRsm
bRgbRsbRgbLsbRgbRgbRgbRsLsbRgbRgbRgbLcLsmbLjbRibRcbRjbLsbRgbLebRjbLibR
jbLgbRjbRsbRsbRgbRgbLsbRgbLsbRgbLsbRgRsmbLcbRjbsbRibRsbRsbRgbRsbRgbRgb
RgbRsbRgbRsbRjbLgbLjbRebLobLjbRgbRibLebRhbRibLsbRibLcbRhbLcbLjbLsbLcbR
gbRiLsbRsbRebLcbLibRgbRgbRibLcbLjbRsbRgbLjbRgbRjbLjbLsbLsbLiLsbRibRgbR
jbLoLsmbLsLsmbLsbLgbLgRsbRgLsbLhbLcbLibRibLgbLhbLiLsbLcLsmbLgbRjbLibLi
bLcbLcbLebRibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 32; Drug: NDMC 1 µM
bLgbRgbLjbLibRsbRsbLgbRsbRsbRsbRgbRgbRgbRsbRsRsmbRsRsmbRgbRgRsmbLsbLgb
RibRibLsbRgbRgbLsbRgbRgbRgbLsbRsbRgbRsbRgbRgbRsbLsbRgbRsRsmbLsbRsbRsbR
gbRsbRgbRsbRgbRsbRgbLsRsbRsbLsbRibRsbLsbRibRsbRsbRsbRgbRsbRsbLsbRsRsRs
mmbLsRsRsRsmmbRsbRsbRgbRgbRsbRgbRgbLsRsbRgbRgbLsbRsRsmbRsbRsbRsbLsbRgb
RsRsmbRsRsmbRgRsmbRgbsbLsbRsbRsbRsbRsbRsRsmbLsbRsbRgbRgRsmbRsLsbRsbRsb
RgbRsbRsbRgbRsbLsbRsRsmbRsbRsbRgbLsbsbRsbRgRsmbRsbRgbRgbRgbRsbRsbRgbRs
bRsbRsbRsbLgbRgRsmbRgRsmbRgRsmbLsbRgbRgbRsbRsLsbRgbRsbRsbRsbRgRsmbRgbL
sbRgbRsbRgbLsbRgbRgbRsbRgbRsRsmbRgbRsbRsbRgbLsbRsbRsbRgbLsbRgbRgbRgbLs
bRgbRibLsbLobLibLibLgbLgbLgbLgbLgRsbRgbLibRsbLibRjbRsbRjbRibLsbRsbLjbR
ibRsbRgbRgbRsRsRsmmbRgbRsbRgbRgRsmbLgRsbRgbLgbLsbRgbLsbRgbRgRsmbLsbRgb
RsbLsRsbRgbRsRsmbRsRsmbRgbRgbRgbRgbRgbRsbRsbRgbRgbRgbLsbRsbRsbRgbRsRsm
bRgbLsbRibRgbLgRsLsbRgRsmbRsbRgbRgLsbRgbRsbRgbLsbRsbRsbRgbRgbRgbRgbRsb
LsbRgbRgbLjbRibLsbRsbRsbRibLsRsbRgRsmbRgbRgbRsbRgbRsbRgbLsbRibLgbRgRsm
bRsbLsbRsbRgbRgbLsbRgRsmbRgbRgbLgbRgbRsbRgbRsbRgbRgbRsbRgbLgRsbRgbRsbR
gRsmbRgbLgRsbRsRsmbRgbRgbRsbsbRgRsmbRsbRsbRgLsbRsRsmbRsbRsbRgbLsbRgRsm
bLsbRiRsmbLsbRibLgbRsbRsbRgRsmbRsbRgbRsbRgbRgbRgbLjbRgRsmbRsbRsbRgRsmb
RgbRgbRsbRsbRgbRgbRsbRgbLsRsbRgbRsbRgbLsbRgbRgbRgbRgRsmbLsbLsbsbRgbRgb
RsbRsbRsbRsbRsbRgbRgbRgbRgbRgLsbRiRsmbLsbRibRibRsbRgRsmbRsbRsbRsbRibRg
bRibLsbRibLgbRibsbRgbLjbRibRsbRgbRibLgbRgbRgbRgbLsbRgbLsbRgbRgbRgRsmbR
sbRsbLsbLjbRibRsbRibRsbRgbRgbLsbRiRsmbLgbRgbRgbRibRgRsmbRgRsmbLsbLhbRj
bLhbRjbLibLgLsbRsbLgLsbRgbRjRsmbRcbRiRsmbLibLjbLibLgbLobRjbsbLibLcbRgb
RjbLhRsbRjbLibLgbLgbLibRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 33; Drug: NDMC 1 µM
bLgbLsbRgbLsbLsbLsbRsbLcRsbLcbLobRgRsmbLsbRgbRsbLsbRsbLsbRsbRjbRobLsRs
bLsRsbRsbLgbRsbLsbRibLobRjbRhbLsbRobRgbLsbLgbRsbLsbRgbRgRsmbRsbLsRsbRo
bLgbLsbLsbLsbLsbLsbRjbRgbRsbRobRiRsmbRgRsmbRsbsbLsbRibRgbRgbRsRsRsRsmm
mbRsbRsbRgbLsbRgbRhRsmbRsbLsbRgbRsbRsbLsbRgbRgbLsRsbRiLsbRsbLsbRsRsmbR
gRsmbRgbRgRsRgRsmmbRgbRgbRsbRgbRsbLsbLsbRsbRgbRgbRsbLjbLobLiRsbRgbLgbL
gbLsbLgbLiRsbRsbLibRgbLgbsbLgbRgbLgbLgbLgbRsbLgbRhbRiRsmbRsbRsbRgbRsbR
sbRgbsbRgbRgbLsbRobLgbLgbLsbLsbRsbRgbRsbRsbRgRsmbRgbRibLgbRsbLsbRcbRib
LjLsmbRibLgbRibRiRsmbRibRsbRsbRgbLsbRgbLsbRsRsmbRsbsbRgbRgRsLsmbLsbRsb
RgbRgbLjbLgbLgbLibRsbLgbLgbLgbLsbLsRsbLgbRsRsmbLgbLibLcbLibRgbRgRsmbRg
RsmbRsbLgbRgbRiRsmbLsbRhbLgbRibRgbRibRgbLsRsbRsRsmbRgbLsbRibLhbRjbRibR
sRsmbRgbRsLsbRgbLsbRsbRgbLsbRibLsbLsRsbRsRsLsmbRgbRgbRsRsmbRsLsbRsLsbR
gbLsRsbRgRsmbLsbRgbLsbRgbsbRgbLsbRsbRgbLsbRgbLsbRgbLsbRgbRgRsmbLsRsbRs
bRgbLsRsbRgRsmbRgbRgbRsbRsRsmbRgRsmbRgbLhbRibLibRiRsmbRgbLsbRsRsmbRgbL
sRsbRsbRgbRsbRsbRgbRgbLgbRgbRgRsmbRsbRsRsmbLsbRgRsmbRsbLsRgRsmbRsRsmbR
gRsRsLsmmbRsbRgLsbRgRsmbRsRsRsmmbRgbRgbRsbRgRsmbRsbRsbLsbRgRsmbRgbRgbR
gRsmbRsbRcbLgbRgbRgbRibRgbLsbRcbRsRsmbRibRhbsbRgRsmbRgbRgbRgbRgbRgbLgb
RibRgbRsRsmbLsbRsbLsbRgbRgbRgRsmbRsbRsRsmbRsRsRsmmbRgbRgbLsbRgbRgbLhbR
iRsmbLcbsbLcbLibLgRsbLgbRgbRiRsmbRibRsLibRibLsbRgbRgbLsbRsRsmbRgRsmbRg
bLsbRibLsbRsRsmbRsbRgbLjLibLibLibLhbRjRsmbLibLhRsbRjbLobRjbLgbRjbRibRi
bRcbLgRsbsbRgbRgbRiRsmbLsbRgRsmbLsbRgbRsbRsbRgbLsbRgRsRsRsmmmbRsbRgbLs
LsmbRgRsmbRgbRsbRgRsmbRsLsbRgbLsbRgbRsbRsRsmbRgRsmbRsRsmbRsRsmbRgRsmbR
gRsmbRsbRgLsbRsRsmbRsbRgbLsbRgRsmbLsbRibLgbRsbRhbRibsbRgbLgbLibRgbLcRs
LsbRjbLibLhbRcbRcbRiRsmbRibRcbLgbRgbRcbLgbRibRibRsbRgbRsRsmbRsRsmbRgbL
sbRiLsRsbsbRgbRsbRgbRgbRgbLibRibRgbLsbRgbRsbRsRsmbRgbRgbRgRsmbRgbRsbRg
bLsbRibLsRsbRgbRgbRgRsmbRgbLgbLibRibRsRsmbRgRsmbLgbRgRsmbLsbRgbLsbRiRs
mbLsRsbRgbRsbLsbRsRsmbRgbRgbRgbRiRsmbRsbLgRsbLgbRiRsmbRgbRsbRgbRsbRibL
gbRgbLsbRgbRgRsRsmmbLsbRgRsmbRgbLsbsbRgbLsbRiLsbRgbLsbRsbLsbRcbLgbRiRs
mbLjbLibRjbRhbLgbRibRgRsmbRgbRgbRgbRiRsRsmmbRgbRgRsmbLsLsmbRsbLjbLibLi
RsbRjbLibLjRsbRibLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 34; Drug: NDMC 1 µM
bRsbLgbRgbLgbRjbRobRiRsmbRsbLgbRgRsmbRsbLibLhbLhRsbLsbLgbLsbRsbLcRsLsb
RsbLsbRsbLibRgbLjRsbLoRsbLibLcbRsLiLsbLibRsbLibLgbLgbLgbLsbLsbLgbLgbRg
bLibLgbLgbRgbLgbLgbLsbLgbLgbLsLsmbLsbLgLsbLsbLgbLsbLgbLsbLgLsbLgRgbLgb
LgbRsbLsbLibLsbLgbLsbLsbLsbLsbLsLsmbLgbLsLsmbLgLsbLsbLsbLgbLsbLjbLhbRs
bRhbRsbLgbLgbLgbLgbRsbLgLsbLgLsbLsbLgbLgbLsbLgLsbLgRsbLgbLibLgLsbRsbLo
bRgbLsbRsbRibRibRcRcbRgRsmbLgbRsbLgbRsRsmbLibLgbRjbLgbLgbLsbLsLsmbLgbL
gLsbLsbLgbLgbRcbLebLibLiRsbLsRsbRgbLgbRobLgRsbLsbLsbLgbLsbLgbRsbLsbLgb
LgbLgbLsbLsLsmbLgbRgbLsbLgbLgLsbLsbLgbLgbLsLsmbLsbLgbRsbLsbLgbLgbLsbLs
bLgbRgbLibLgbLgRsbLibRibRgbLcbLibRsbLsLgbLsbLgbLsbLgbRsbLgbRgbLsbLgLsb
LgbLgbRsbLgbLgbRjbLgbRsLsbLgLsbLgbRsbLibLgbLsbLgbLsbLgbLsbLgbLgbRgbLib
LgbRjbLibLiRsbRibLgbLibRjbRjbRgbLeLiLsbLsbLgbRgbLgLsbLsbLgbLsbLgbLsbLg
bLgbRgbLibRsbLiLsbLsbLgbLgbRsbLiRsbRibLgbRsbLiLsbLsbLgbLgbLsbLgbLgLsbR
sbLgbLgbLibLsbLgRsbRsbLiLsbLgbRsbLgbLgLsbRsbLgbLgbRjbRcbRgbLjbRibRgbRg
LsbRgbRsbLeLsbLibLsbLgbRsbRjbLeLsbRgbRjbLibLgbLsbLibLgbLsbRebRcbLjbRib
RgbLgbLjbLcRsbRjbLiRsbLgbLibRibRcRsmbRsbLsbRibLsbRgbLsbRsbRgbRsRsmbRsb
RsbRgbRsbRgbLsbRgbRsbRgbRgbRsbLsbRcbRoRsmbRibLgbLiLsbRsbLgbLgbLsRsLsbL
sLsmbLgbLgbLgbRsRsmbLsbLibLsLsmbLsbLgbLgLsbLgbRgbLgbLgbRsbLsLsmbLsbLgb
LgbLgbRsbLgbLgbRgRsmbLsbRiLsbRobRibRjbRibLcbRgbRjbLgbRsLsbLsbLgbRgbReb
LibLgbRsbLgbLgbLsbLgbLsbLgbLgbLgbLgbLgbRgbRebsbRgLsbRgbLgbRhbRiLsbRgbL
sbLcbLsbRsbRhbLcbLobRibLsLsmbRjbLibLgbLsbLjbRgRsmbLgbLcbRibLsbLgbLgbLs
bLgbLsbLgbLsbRgbLibLsbLgbLsbLgbLsbLgbRsbLsbLsbLgbLsbLgbLgbLibRibRsLgbL
sbLgbRsbLgbLsLsmbLsbLgbLsbLgbLgbLsbRgbRibRgLsRsbLjbLjbLibLcbRibLgbLgbL
gbLgLsbLgbLgbLgbLgbLsbRsbLgRsbLsLsLsmmbLgLsbLgLsbRsbLibLgbLgbLgbLgbRsb
LgbLgbLsbLgbLgbLgbRgbLgRsbLgbLgLsbLgRsbLsbRjbLibRsbLgbLibLibRiRsmbLhbL
cbRgbLgbLsbLgbRgbLsbLsbLgbLgbRgbLgbLsbLgRsbLgLsbLsbLgbLgLsbLsbLsbLsbLg
bLgbRjbLgbLgbLgbLgbRgbLgbLgbLgbLgbRsbRebLhbLibLgRsbLibLgbLsbLsbLgbLsbL
gbLgbRsbLgLsbLgbRsbLgbLgbLsbLgbLgbRsbLgbLsbLgbRjbRibRgbRibRiRibLgbLgbL
ibRjbLiLsbLgbLgbRgbLibLgbRsbLgbRsRsmbLibLsLsmbLgRsbLsbLsbLsbLgbLgbRgbL
sbLibLsbLgbLsbLgbRsbLsbLgLsbLgbRsbLgbLibRibLhbRjbRibRgbLcbLsbLjbLobLcb
LibRsLsbLgbLgbRgbLibLgbLsbLgbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 35; Drug: NDMC 1 µM
bRcbRcbRcbRjbLibLibRcbRsRsmbRsbRibLibLjbLibLibLgbLgbRobRobLgbLsbRgbLjR
sbLibLibLgbLibRjRsmbRcbLgbLibLibRsbLibLgbRgbLibRsbLibRgbLibLgbLibRibRg
bRibRibRsbRsbRibRiLsbLsbRiRsmbRgbLsbRgbRsbLgbRgbRgbRibLgbLjbLcbRjbLsbL
ibLgbRsbRsbLjbLobLhbLhbRsbRebLjbLgbRibRsbLjbLibRcbRgbLjbRcbLjbLjbLibRs
bLgRsbLibLsbRgbLsbLgbLgbLgbLgbLsbLgbRsbLgbLgbLsbLibRsbsbLgbLgbLgbLgbLg
bRgbRgbRgbRgbRgbRgbLebLibRibLibLgbRjbLibLibLibRibLiLsbLiRsbLgbLgbLgbLi
bLgbRsbLgbRgbLibLgbRobRiRsmbLhbLgbRcbRibLjbLgbRsRcbRgbLjbLibRcbRgbLibL
gbLgbLgbLsbRcbRibsbLibLgbLibLhRsbRgRsRsmmbLibRgbLgbRsbLsbLibLibLgbLgbL
gLsbLsbRsbLsbLsbLsbLibLjbLgbRjbRhbRibLsbLjbLhbRibRhbLsbRhbLjbLjbRhbLjb
LibLsbLgbLjbLcbRibRcbLgbLgbLibRgbLibLgbLsbLgbLgbLibLgbRgbLgbRsbLsbRibL
jbRjbLhbLgbLibLhbLcbRibRibRsbRgbRsbRsbRgbLgbRgbRgRsmbRsRsmbRgRsmbRgbRg
RsmbRgbRgbLjbLcbRhbRsbLcbLcbRhbRgbRgbLsbRhLsbLibRsbRsbRgbLebLiLsbLibLh
bLibRcRsmbRgbLgbLibLgbRsbRgbRgbRibLsbRgbRsbRobLibLgbLgbLsbRgRsmbLsbLgb
RhbRibRibRgbLjRsbLobLgbRsbLibRgbLgbLibLgbLibLibRibRiRsmbRgbRibLhLsbLsb
LiLsbLibRgbRsbLgbLgbLsbRsbLgbLgbLsbLibLsbLgbLgbRgbLibLgbLgbRgbRsbLsbLg
bLhRsbRibRhbRhbLgbRgbRsbRsRsmbRgbRsbRibRsLsbRgbRgbRsbRgbRsbLsbLjbRibLg
bRibLgbRibLgbRibRgbLsbRsbRiLsbRsbRibRgbRgbLgRsbLibsbLibRsbLibLsbRsbLgL
sbLsbLgbLibLgbLsbLsbLgbLgbLsbLibLgbLgbRgbLsbLibRgbLibLibRgbLgbLibRgbLs
bLiLsbLgbRgbLgbLjbLsbLibRsbsbLgbRsbLgbLibRsbLiRsbLsRgbRgbRibRibLhbRibR
jbLoLsmbRibRjbLibLgbRsbLiLsbLsbLsbLsbLgbRsbRgbLsLsmbLsbRsbRgbLgbLibLsb
RjbLiLsLsmbLsbLgbLgbRsbLjbLibRjbRsRsmbRsbRgbLsLsmbRiRsmbLsbRgbRibLsbRg
bLsbRgbRsbRibRiRsmbRgbRgbLibLgbRgbLgbLgRsbRjbLibLgLsbRgbRobRcbRhbRibRs
bRibRsLsLsmbRgbLjbLcbLibRsbLhbRibLobLcbLibLgbLibLibLgRsbLgRsbRsbRjbLib
LibLoLsmbLobLgLcbRcbRibRgLsbRibRsbRibLcbLibLibLibRsbLiLsbRgbLgbLibLibR
gbLibRcLsbLibLiLsbLsbLgbLgbRsbLibRsbLibRsbLsLsmbLgbRsbLgbLgbLgbLgbLgbL
gbRsbRjbLibLibRsbLibLgbRsbLibRgbLibRsbLibRsbRjbRhbRsLjbRibRibRgbLhbRib
RsLsbRibRsbLjbLcRsbLibLsbRsbLgbLiRsbLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 36; Drug: NDMC 1 µM
bRsbRibRibRibLsbRobLgbRobLibLebLcRsbLobRjbRcbLibRsbRoRsmbLsbRcbRcbRsRs
LsmbLibLgbRgbRsbRcbRcbRibRibLsbRgbRobLgbLebLibLibLsbLsRsbRsbRcbRgbRibR
sbRobLgbRgbRgbLgLsbLcbLgbRcbLjbLebLibLcbRjbLcbRibLibLibRoRsmbLjbLcbLgL
sbLibLgbLgbLiRsbLsbRgbRibRibLobLsbLibLsbLgbRgbRobRibLcbLcbRsbLibLsLsmb
LgbRcbRsbRiLsbRsLsbRibRsbRibRhbLobLhbRhbLgLsbLgbLsLsmbRjbLcbRsbLsbLsbL
gbLsbLibRgbLibLhbRibRsbLibRsbLgbLgbLgbRoRsmbRhbLcbLibRjbLhLsLgbRjbLhLs
bRsbRsbLsbLgLsbRjbLhbRsbLgbRsbLsbLibLgbLiRsbLhRsRsRsmmbRibLgbLibLgbLiL
sbRibLibRsbLibLsbLgbLiRsbRgbLsbLgbLibRcbRcLsLsmbLebLebRsbLsLsmbLibLibL
gbRgbLibRjbRebRoRsmbLcbLobLibRgbLibRiRsmbLsLsmbRibRsbRibRibRgbRebRibLg
bLiLsbLgbLsbLibLgbLsbRgbLhRsRsmbRgbLiRsbRsbLgbLsbLobRcbLsbLcbLgLsbRsbL
gbLgbLgbRgbLgbLgbRgbLiRsbLgbLibLibLgbRgbLhbLgbLgbLjbRjbLibRgbLibRgLsbL
iLsbLsbLiLsbLibRobRsRcbLobRsbLsbLcRsbRebLcbLcbLgbRgbLcbLibRjbLiLsbLgbL
gLsbLgLsbLsbLsbLibRibRsRsmbLibLgbLcbsbRgLsbLcbLcbLcbRjbLoLsmbRiLsbRsbR
sLhbRjbLobsbLcbLcbLsbRjbLcbRgbLhbLibLgbRibLibRgbLgbLibLhRibLgbLibLibRh
bLgLsbLcbRibLcbRibLgRsbLibLgbLibRsbLsbLhRsbRgbLhbRibLcLsmbRgbRobRibLcb
RcbRsbLjbLcbRibLibLibRgbLhbLgbRibLgbRiRibRibRibLcbLsbLibLibRibRibRjbLc
RsbLjbLibLibLibLibRibLcLsmbLgLsbLibsbRcbLobRibLibLgbLgbRsbLibLgbRjbRcb
RgbLobLibLsbLgbLgLsbLiRsbRsbRjbLsLhbLibRcbRhbLebLsbLobLoRsbRcbLjbLsbRc
bLebLcLsmbLgbRsbLibLsbLsbLhRsbRsbLgLsbLibLgbRhbLgbLibLgbLiLsbRgbLibLcb
Rib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 37; Drug: NDMC 3 µM
bRgbRsbRsbRebLeRsbRsbRobRcbLgbRibRgbLsbRibLcbRcbLcbLibLgbLsbLgbRsbLsbL
sbLgbLsbLsbLjRsbRgbLgbLsbLibRsbRsbLiRsbLgRsbRgbLibLsbLgbRgbLibLsbLsbLg
LsbLgbLgRsbLgbLgbLibLsbRgbLibLgbRgbLiRsbRgbLgbRsbLgbRsbLsbLibLgbLgLsbR
sbLgbLsbLibRibLibLgRsRsmbRjbLsbRsbLsLgbLibLgbLsbLsbLsbRsbLibLsRsbLgbRs
LsRsbLgLsbLgbLgbLgbLgbLgbLgbLgbRgbLsbLgbRibRibRibRgbRgbLsbRgbRgRsmbRgb
RsbRgbRsbRgbRgbRgbRsbRcbLcbRgbRsbRgbRibRgbRgbRibRsbRibRibRgRsmbLgbRibR
sbRgbRibRgbRgbRgbRsLgRsbLibRgLsbLsLsmbLibRgbRjbRjbRhLsbLiRsbLcbRjbRgbR
ibRsbRgbRsbRgbRgbRsbRsbRgbRgbRgbRibRgbLibRiRsmbRgbRibRgRsmbLsbRibRsbRs
bRibRsRobRhbRobRobRibRiLsbRgLsbLsbRjbLiLsbLgbLsbLsLsmbLgLsbLsbRjbLcLsm
bLgbLgRsbLsbLgRsbLjbLsbRsbLhRsbRibLsbRjbLibRhbRibLcbLcbRibRgbLhbLgbRgb
RjbRibRsLsRsbRgbLjbLibRebRsbRgbRsbRgbRgbRgbRgbLgbRgRsmbRgbLsRsbRgbLsbR
gbRsbRgbRgRsmbRsLsbRsbRgbRgRsmbRgbLsbRsbRgbLsbLjLibLcbRgbLibRgbLiLsbLs
bLgbLgbLgLsbRgbLibLibRsbLibRjbLiLsbLsbLgLsbLgbLgbRsbLgbLgbRsbLgRsbLgbR
gbLibRgbRsLgLsbLgLsbLsbLgbRjbRjbLibLhbRibRjbLcbLobRgbLibLibLgbRgbLcbLc
bRsbRcbRibRgbLsbRjRsmbRibRsbRgbRsRsmbRgbRsbLcbLibLibRsbLibRjbRobRobLgb
RobRoLsbLhbRsbLcbLcbRjRsmbLibRibRgRsmbLgbRibRibLsRsbRgbRsbRgbRgbRgRsmb
RgbRgbRgbRsbRgbLjbRibRgLsbLsbLsbRibRgbRgbRsbRgRsmbLsbRsbRgbRgRsmbRgLsb
LsbRibRibRgbRgLsbRgbRsbRgbRgbRgbRsbRgbRsbRgbRgbRgbRgRsmbRgbRgbRgbRibRg
bRgbRgbLgbRibRsbRibLcbRibRsbRgbRgLsbRsbRgRsmbLsRgbRgbRgRsmbsbRgbRsbRgb
RgbRsbRgbRgbRsbRgbRibRgbRibLhbRibLhbLhbRgbLcbRjbLcbRgbLobLcbLiLsbRsRsm
bLebRobLgbRgbLiLsbRgbRibRibRgRsmbRsRsmbRgbLsRsbRgbRsbRgbLsbRibLsbRgbRi
bLsbRgbRgbRgbRsbRgRsmbRgRgbRgbRgRsRsmmbRsRsmbRibRsbRgbRsbRsbRgbRgbRsRs
mbRgbRibRsbRgbRgLsbLibRibLjbsbRhRsmbLibRibRsbRgbLgbRibLgbLsbRgbRibLsbR
gbRsbLobRhbLsbRgbRsbRibRsbRgbRsbRgbLgbRibRgRsmbLgbRgbRsbRsbRgRsmbRsbLc
bRjbRcbLcbLgbLcbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 38; Drug: NDMC 3 µM
bLgbLsbRgbRibRibRibRibLibRsbRgRsmbRsbLsbRjRsRimbLcbLhbRhbRgbRibRsbRgbR
sRsmbRgbRsbRgRsmbRsbRgLsbRibRsbLsbRgbRsbRgbRhbLibRgbRgbRibRgRsmbRibLgb
LsbRibRgbRgbRgbRgbRgbRgbRsbRsbRsbRgbRgbLsbRgRsmbRgbRgbRgbLgbRsbRibRgbR
sbRgRsmbRsbLobLobLcbRcbRhbRobLgbLhbRhbRgbRibRsbRgbRsbRgbRsbRgRsmbRgbRg
bRsbRgbRgbRgbRsbLsbRgbRgbRsRsmbRgbRgbRsbRgRsmbRsbRgbRsbRsRsmbRgbRgbRsb
RsbRgRsmbRgbRgbRgbLjbRibRgbRsRsmbRgbRgbRgbRsbRgRsmbRsbRgbLsbRgbRgbRgbL
sbRgbRgbRgbLgbRgbRgbRsbRgbRgRsmbRgbRgbRsbRsbRgbLjbLhbLgbLgbLibLibRgbLi
bLoRsLsbRibRibRgRsmbRibRgbRgbRsbRsbLsbRgbRgbLsbRsbRgbRgbRsbRgbRgbRsbRg
bRgbRgbRibLibRibRibLsbRsbRgRsmbRgbRsbRsbRgbRsbLsbRsbRgbRibRgbRgbLsbRgR
sLsmbRgRsmbRgbRibLgbRibRsRsmbRsbRgbLgbRiRsmbRsRsmbLsRgbLsbLsbLobLgRsbR
hbRgbRgbRsbLsRsbRibRgbLsbRgbRgLsbLgbRiRsmbRibRoLibLgbLsbRibRgbRgRsmbRg
RsmbLjbRgRsmbRgbLsLsmbRgbRsbRsRsmbLsbRsbRibRgLsbRgbRgbRgbRgbRsbRsbRgbR
gbLjbLcRjbLibRjbLhbLhbRgbRjbLhbLgbLsbLsLsmbRsbLiRsbLgbRsbLgbLiRgbsbRjb
RibRgbRibLgbRibLsbRibLjbLcbRcbRibsbRibRibRgbRsbRgRiRsmbRsbRgbRgLsbRsbR
gbLsRsbRgbLibLgbRgbLgbRsbLibRgbLibLgbRsRsmbLgbLibRgbLibLibLcbRibRgbRgb
LobLgbLibRsbRibRgbLibRcbLhbRcbRibRgbRsbLgbRcbRobLgbRcbRibRibRgbRgRsmbR
cRsmbLgRsbRhbRgbRgbRgbRhbLgbLgbRgbRgbRgbRsbRibRsbRgbRgbRsbRgbRgRsmbLsR
sbRgbRgbRsRsmbRgbLsbRgbRsbRgRsmbLsbRgbRgbRsbRgbLsbRgRsmbRgbRsRibRsbRgL
sbRgbRgRsmbsbRgbRgbLgbRgbRgbRsbRgbRgbRsbRgbRsbRgRsmbRsbRgRsmbRsRsmbRgb
RgbRsbRgbRgbRgbRsbLsbRgbRgbRsbRgbRgbLgLsbRgbRgbRgbLsLsmbRgRsmbRgbRsbRg
bLsbRibRsRsmbRsbRgLsbRgbRsbRgbRgbRsRsmbRgbRgRsRsmmbRgbRgbLsbRgbRsbRgbR
sbRgbRgbRsbRgbRgbRgbRsbRgbLsbRgbRgbLsLsmbRgRsmbRgRsmbRgRsmbRgbRiRsmbRi
bRgbRgbRiRsmbRibRgbRgbRgbRgbRibRibLgbRibRhbRibRgbRibRgbRgbRibRhbRibLgb
LsbRibRgbRibRhLsbLgbRsRsmbRibRibLgbRiRsmbRsbRsbRgbRsbRgRsmbLsbRgbRgbRg
bLjbLcbLhRsRsmbRgbLiLsbLgbLiRsbRibLibLsbLhbRgbLsbLiLsbLgbLibRsbLgLsLsm
bRsbLibRsbLgbRsRsmbLibLgbRsbLgLsbLsLsmbLsbLgbLgRsbRhbRibRiRcbLsbRibRib
RgbRibRsLsbLgbRibRibLgbRgbRsLsbRgbRgbRsRsmbRgbLsbRgRsmbLsLsmbRgRsmbRgb
RgRsmbRsbRgbRgbRgbRgbRgbRsbLsbRgbRsRsmbRgbRgRsmbRgbLsRsbRgbRsbRgbRibRg
bRgbLsbRgbRgbRgbRgbRgbRgbRgbLgbRgLsbRgRsmbRibRsbRibLsbRgbRgbRgRsmbRsbR
gbRsRsmbRgRsmbRsbRgbRgbRgRsmbRsRsmbRgbRgbLgbRiRsmbRgbRgbRgbRgbLgbRibLs
bRgRsmbRgbRgbRiRsmbRgLsbLsRsbRgbLgbRgbRgbRgbRgbRgRsmbRiLsRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 39; Drug: NDMC 3 µM
bLsbLsbRsbLoLsmbLoLsmbRsbLgbRsbLsbLjbLibLsbLgbLgbLgbLcbRsbLobLgbLgbRgb
LsbLibLgbRcRcbRsbRibRgbRcbRhbRsbRsbLibLsbLgbLgbLsbLsbRsbRibRgbRgbLhbLh
bRgbRjbLcbLoRsbLsbLibLsbRgbRgbRgbRsbRsbRgbLsbRsbRsbRsRgbRsRsmbRsLsbRgb
RsbRsbLcbRcbRibRjLsbRhbLgbLgbLgbRsbRgbLcbLcbLsbRgbLoLsLsmmbLhbLibLsbRh
bRgbRsLsbRsbRgbRsbRgbRgbRgRsmbLsbRgbRgbRgbRsbRgbRsbRgRsmbRsRsmbRgbRsbR
gRsmbRgLsbRgbRsbRsbRsbRgbRibRgbRibLhbLgLsbRsbLjbLgbLgLsbLgbLsbLsRsbLgb
LsbLsbLgbLibLibRobLibLibRgbRsLsbLgbLgbRjbLebRibRobRhbLgbRsbsbRgbRsbRib
LgLsbRgbRiRsLsmbLsbLjbRcbLibRibLibLjbLgLsbLibRgbLhbRgbRgbRiRibLgbLsbLg
bLibRsbLsbLibLgbRsRsmbLhbRibRsbLgbLgbLsbLsbsbLsbLgbLsbLsbLgRsbLibLgbLg
bRhbLibLgbLibLgbLgbLibLsbLibLibLgbRsbLgbLsbLjLsmbRobRobLibRgbRibRgbRgb
RgbRgLsbLgbRibLjbRgbRgbLsbRgbRgbRgbLsLsmbLsbLcbLhRsbRibLibRjbLiLsbRgRs
mbLgbRjbLgLsbLgbRsbRsbLiLsbLgbLgbRgbRsbLgLsbLsRsbLsLsmbLiRsbLgLsbRsLsb
LgbRgLsbLgbRjbRcbLebLibRsbLsbLgLsbLgbLgbRgbLsbLibRsbRsbLgbLsbLgbRsbLib
LgbLgbRsbLgbLgLsbLgbRsbLgLsbRgbLsbLibLgbLgbLsbRsbLgbLgbRgbLsbLhbLibLib
LibLsbLibLibsbRgbRsRsmbLibLsbRsbLgbRsbsbLgbLgbLgbLgbLgbLsbLjbLibLgbLgb
RgbLsbRgbRibLiLsbLibRsbLgbLsbLibRsbLgbLgLsbLsLsmbLgbRsbRsbLgbLsLsmbLib
LgbLgbLgbRgLsbRgbRsbLsbLgbLsbLibRsbLsbRsLsbRjbRibLcbLcbLgLsbRsbRgbRgbL
sbLibLgRsbLgbRhbRcLsbRibLcbRcbRibLibLibRsbRgbRcbLiLsbRcbRhRsmbLibRcbRc
bRibLsbsbRibsbRcbLjbRibRsbLgbRibRibRgbRgbRcbRsLsbRgbLgbLsbLobRsLhbLjbL
ibRgbLiLgRsbLsbLgbLibRsbsbLsbLsbLgbLsRgbLgLsbLiRsbRgbRgbLibLcbLsbLibLg
bRgbRgbRgbLibRhbLjbLcbRibLibRsbLgLsbLsbLsbLsbLsLsmbLgbLsbLsbLgbLgbLsbL
ibLgbLsbRgLsbRsLsLsmbRsbLsLiLsbLgbLsbLgbLgbLgbLgbRcbRoLsbLibLibLgbLgbR
gbLibLsbRsRsmbLibLsbLgbLgLsbLgbLgbLsbLgLsbRsbLgLsbLgbLgbLgbLsbLgLsbRsb
LgbLgbLsbLgbLsLsmbLsLgbLgbLgbRibLcbRsbLibLsbLgbLsbLsbLsbRobRcbLhbLcbRg
bLibLgbLsbRsbLgbLgLsbRsbLgbLgbRsbLgLsbLgbLsbLgbLsbLsbLgbLgLsbLsbLgbLgb
RjbLibLsbLgLsbLgbLgbLsbLiRsbsbsbLibLgbRjbLibRsbLgbLgLsbLgbRgbRgbLibRob
RcbLjbRiRsmbsbRgbRibLibLjbLibRsbLsbLcbRibRsRcbRcbLjbRhbLjbRjbRibLcbLcb
LcbRibRgbRcbLgbRibLibRsbLibLgbRsbRgbLhbRsbRsbRgbLgLsbLsbLibRgbLibLgbLg
bLsbRsbRgbRcbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 40; Drug: NDMC 3 µM
bRcbRcbLgbRgbRgbRsRsmbRibLibRsbLsbLibLsbLgbRsLsbLsbRsbLgbLgbLsbLsLsmbL
gbLgLsbRsbLgbLgbRjbLibRgbLgLsbRsbLibLobRibRibRibRhbLsbRsRsmbRibRjbLgbR
sbRgRsmbRsbRgbRgbRgbRsbRgbRsbRsbRgbRgbLsRsbRgRsmbLgbRibLsRsLsbLsRsbRgb
RsRsmbRgbRsbRsbRgbLgbRibRibLgbLjbRiRsmbRibLgbRibRsbRgbLgbRgbRibRiLsbRi
bLsbRiRsmbRgbRibRgRsmbRgRsmbRsbRibRsbRsRibRgbRsbRgbRgRsRsmmbRsbRsbRgbR
sbLgbRgRsmbRgLsbRsbRgLsbRsbRgRsmbRsbRgbRsbRgbLsbRgbRsbRsbRgbLgbRgbRibL
gbRibLgbRgbRsRsmbRgbRgLsbRsbRgRsmbRsRsmbRsbRgbRgbLgbRiRsmbRgbLsbLsbRgR
smbRgbRsbRsbRgRsmbRsRsmbRgRsmbLgbsbRiLsbRgbRgbRgbRsbRsbRgRsRsRsmmmbRgb
RsbRgbRgbLsbRgbRgRsmbRsRsmbRgbRgbRgbRgRsRsmmbRgRsmbRgRsRsmmbRgbLgbRgRs
mbRgbRgbRgRsmbRsbRgRsmbRsbRsRsmbRgRsRgRsRgRgmmbRgbRgbRsbRgbRsbRgbRsbRg
bRgLsbRgbRgbLsbRgbRgbRsbRgbLsRgRsmbRgRsmbRgbRsRsmbRgbRsbRgRsmbRsbRsbRg
bRgbRsRsRsmmbRgbRgbRgbRgbRgbRsbRgbRgRsRsmmbRsbRgbLsbRgbRsbRgRsmbLsbRgR
smbRsbRgbRsRsRsRsmmmbRgRsmbRgRsRsmmbRgbRgbLsRsbRiRsLsmbRibRgbRgbRgbRgb
RgRsRgmbRgbRiRsmbRgbRgbRgbRgbRgbRgbLjbRsRgRsmbRgRsmbRsLsbRgbRgRsRsmmbR
sRsmbRsbRgRsmbRgbRsRsmbRsRsRsmmbRgLsbRgbRsRsmbRgbRsbRgRgRsmbRgbRsbRgbR
gbRsRsmbRsRsmbLsRgRsmbRgbRgLsbRgbRsRsmbRsRsmbRsbRgRsmbRgbRgRsmbRsbRgLs
bLsRsbRgbRgRsRsmmbRsRsRsmmbRgbRsbRgbRgRsRsRsRgRsmmmmbRgRsRsmmbRsbRgLsb
RgRsmbRsRsmbRgbRgbRsbRgbLjbLcbLibLiRsbRjbLsbLibLibRibRibRgbRgRgRsmbRgR
sRsmmbRgRsRsLsmmbRgbRgbLsbRgbRgbRgRsmbRsRsmbRgbRgRgRsmbRgbRsbRgRsRsmmb
RsRsRgmbRgbRsbRgRsLsmbRsbRgbRsLsRsbRgRsmbRgRsmbRgRsRsmmbRgbLsRsbRgbRgR
smbRcbRcbLcbRjLsbLcbRjbLibRcbsbsbRibRiRsRsmmbRgbRgbRgRsmbLobLibRjbLhbR
jbLibLiLsbLiRsbRibRhRsmbRibRgRsmbRgbRgbRsbRibLgbRgRsmbRgRgbRgRsmbRsbRg
bRgbLsLjbRsbRibRcbLiLsbLobRgbRhbRibLsbRibRgbRgbRibRgRsRsRsRgRsmmmmbRsb
RcbLibRgbRibLjbsbLobRgbLibRsbLibRgbLibRsbLgLsbRsbsbLsbLibsbRsbLgbLiLsb
RjbsbLgbRsbLibLsbLiRsLsbRsbLibRhbRiRsRsmmbLsbRgbRsbRgbLsbRiRsmbLsRsbRg
bRgRsmbRsbRgRsRsmmbRsbRgRsmbRsbRsbRgbRgbLsbRgbRgLsbRgRsmbRibLgbRgbRcbR
cbRibRibRibRgbRibRgbRgbRgbRgbLsbRsbRgbRibRsbRgRsmbRibRsRsmbLjbRibRgbRg
bRgRsmbRsRsmbLsbRgbLsbRsbRsbRgLsbRgRsmbRsbRgbRsbRgLsbRsbRgbRsbRgbLsRsR
smbRgbRgbRsRsmbRgRsmbRgRsmbRgbLsbRgRsLsmbRgRsmbRgbRgbRsbRsRsmbRgbRgbLs
RgLsbRgLsbRgbRsbRibRsRsRsmmbRibRibRgRsmbRgRsmbRgbRibRgbRgbRgLsbRgRsRsm
mbRsbRgRsmbRsbRgRsmbRgRsmbRsbRsbRsbRsbRsRsmbRsLsbRgRsRsmmbRsbRgbRsRsmb
RgRsmbRsbRgbRgRsmbRsbRgbRgbRsbRgbRgRsmbRsbRgRsmbRgRsmbRsbRgbRgRsmbLsRs
bRgbRgbRgbRgbRibLibLhbLsbsbLsLcbRjbLhbRgbLgbLgLsbLgRsbLsRsbLiRsbRjbLhb
RjbLcbRjbLibLibLgRsbRgRsmbRjbLibLiRsbLibRsbLgbLsbLibRjbsbLibLobLibRgbR
hbRsbRgbRgbRgbRgbRgbRgbRgbRsbLcbLhRsbLiLsbLiRsbRgbLhbRibRsbLibRgbLiLsb
RsbLgRsRsmbLcRsbLsbRebRiRsmbsbRgbRgbRsbRgRsmbRsRsmbRgbRsbRgRsmbLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 41; Drug: NDMC 3 µM
bRobRobRsLsbRgbLiLsbRgbLgbLibRsbRsbLgbLsbLsLsmbLoRsbRgbRsbRgbLhbLibLsb
LibLsbRgbRgbLibLsbRjbLhLsbLgbLibLgLsbLgbLsbRsbRsbLgLsbLsbLgbRsbLsbLgbL
gbLgbLgbLgbLgLsbLgbLgLsbLgbLgbLsbLhbRgbLsbLibLsbLibLgbLgbLsbLibLsbLsbL
gbLgbLsbLgbLsbLgbLgbLgbLgbLgbLsbLgbLgbLgbLgbLgLsbRsRsmbRsbLgbLibRsbLgb
LibRgRsmbLsbLgbLgRsbLsbLgbLgLsbLgRsbLsbLgbLsbLibLsbLsbLgbLgLsbLgbLgbLg
LsbRgbLgbLibRsbLgbLgbLgLsbLgbLgLsbLgbLgbLgbLgLsbLgbLgLsbLgbLsbLiLsbLgb
LgLsbLgbLgbLgbLsLsLsmmbLgbLgLsbLgbLgbRsbLibLsbLibLgLsbLgbLibLgbLgLsbLg
bLgbRsbLibRsbLsbLgbLibLcLsmbRhbRgbRgRsmbLibLgbLibRjbLibRgbLibLibRgbRsb
LhbRgbLcbRibLibRsbLgbLsLsmbLsLsmbLgbLgbLgbLsbRsbLgbLibLibLsbLgbRcbLibR
hbRiRsmbLcbLibsbRsbLgbLhbRgbLibRsbLsbLgLsbLiLsbRgbLsbLibLsbRsbLgbLsbLs
bLgLsbLgbLgbLgbLgbLgLsbLgbLsbLgLsbLsbLgbLgbLgbLgbRsbLibRgbLibLgbLgbLsb
LgRsbLgbLgLsbLsLsmbLsbLgbLsbLiLsbLgbLgbLgLsbRsbLgbLsbLgLsbLgbLgbLgbLgb
LsbLgLsbLgLsbLgbLgbLsbLgbLgLsLsmbLgbLsbLgbLsbLgLsbLgbLsLsmbLgbLibLgbLg
bLgbLsbLgbLgbLgbLgLsbLgbLgbLgbLgLsbLgbLgLsbLgRsbLgbLgbLsLsmbLgbLgbLgbL
gbLgbRgbLibLsbLgLsbLgbLgbLgbLgbRsbLgbRgbLibLsbLgbLgbLsLsmbLgLsbLgbLsLs
mbLgbLgbLgLsRsbLsbLgbLgbLsbLsbLgbLgbLsbLgbLsbLibLsbLsLsmbLgbLgbLgbLgbL
gbLsbLsbLgbLgbLgbLgbLgLsbLsbLgbLgLsbLgbLgLsbLgLsbLgLsbLgbLgbLsbLibLgbL
ibRgbLibLsbLibLsLsmbLgbLgbRsbLibLgbRsbLgbLgbLsLsmbLgbLgbLgbRgbLibRsbLi
LsbRsbLgLsbLsLsmbLgbRsbLsbLgbLsbLgbLgbLgbLgbRsbLgbLsbLibLgLsbLgLsbLgLs
bLsbLgbLiRsRgLsbRsbLibRsbLibLgbRgbLgbLgbLsbLgbLsbLgbLibLsbLgLsbLgbLibL
sRsbLgbLgbLgbLgbLgbRsbLsbLgbLgbLsbLgbLsLsmbLibLsbLgbLsbLsLsmbLgbLgbRsb
LibLgbLsbLgbLgbLgbLgLsbLgLsbLgbLgbLgbLgbLgbLgbLgbLgLsbLsbLibLgbLsbLgbL
gbLsbLibLsLsmbLibLsbLgLsbLgLsbLgbLgbRjRsmbRhbRcbLebLcbsbLsbLibLiLsbLsb
LibsbRsbLibLsbLgLgbLibRgbLsbLsbLhbLibLibRgLsbLibLcbRebLibLcbLiLsbRgbLg
bLcLsmbRgbLhbLibRibLgbLibRjbLibLiLsbRgbLibRgbLibLgbLsbLgbLgRsLsbRgbLiL
sbLsbLgbLsbLgLsbRsbLgbLgLsLsmbLsbLgbLsbLgbRgbLibLsbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 42; Drug: NDMC 3 µM
bRgbLibLgbLgbRgRsmbLgbLsbLgbLgLsbRsbLsbLgbLsLgbLsbsbLsbLgbLsbLsbLgbLgR
sbRsLgbLhbRgbRsbLobRibRgbLsbLgbLgbLgbLgLsbLgbLgRsLsLsmbLgbLsbLgRsbRsbL
gbLgbLsbLgbRsLsbLgbRsbLgLsRsbRsbLsLsmbLgbLsbLgbLjRsbLgbRgRsLsmbRjbLgbL
gbLgbLsbLsLsmbLgbLgbLgbRsbLgbLgbLgbLgbRjLjbRgbLgbRsRsmbLsbRsbRgbRgbLsb
RsbRgbLsbRibRsbLsbLgbRgbRsbRgbRsbRibRsbRsbRgRsRgmbRgbLoRsbRsbRsbLsLsmb
RgbRsbRgbRsbRgbLgbRgRsmbRiRsmbsbRsbRsbRgRsmbRjbRsbRsLsbRgbLsbRgLsbLsbR
sbRgRsmbLsbRgbRgbRsbRgbRgLsbLibRjbRgbRibLibRibLjbLsLsmbLibRjbLgbRjbRcb
LjbRsbRibRsbRiRsRsmmbLgbRgbRgbLsbRgbRgLsbLgRsbRgRsmbLjbRsRsmbRgbsbRgbs
bRsbRgRsmbLgLsbRjbsbLsLsmbRjbLsRsbRgbRgbLgbRibRsbRjbRebRsbRgbRsbRsbRsb
LebLibRsLsbLsLgbLiRsbRsLsLobRiRsmbRebLcbLgbRgbLgbLgbLgbLhbRibRjbLibRjR
smbRiRsmbLsbRgbLsbRiLsbRgbRsbRsbRgbRgRsmbRsRsmbRjbRsbRsbRgbRsbRsRsmbRs
RsmbRsbRgbRgbRsbRgbLsbRgbRsbRsbRgbLsbRgbRsbRgbRgbRgbLsbLgbLibRibLsbRgR
smbRgbRgbLsbRgRsmbRgbLsbLsbRgbRgLsbRgbLsbRgRsRsmmbRsRsmbRgLsbLsRsbRgbL
sbRgbRibRiRsLsmbRjbRiLsbRgbRgRgRsmbRgbRsLsbRibLsbRsbRsRsmbLsbRgbRsbRgb
LsbRgbRsbRjbRsRsmbRsbsbRgbLsbRsbLsbLsbRgbLgbRgbRgbLsbRjbRsLsbsbLsbRibR
sbRhLsbRibRjbRsRsmbRgbRsbsbRsLsbRgLsbRjbRsLsbLsbRobLibRgbLibLgbLcbRibs
bRhbRibRjbLgbLcbLibRgbLgbLcbsbLgbLibRibRcbRiRsmbRibRgbLcbLcbRjbRsbRsRs
RsmmbRgbRsRsmbLsbRsbRjbRsbLsbRgbLsbRjbRgbRsRsmbRsbRsbRgbRsRsmbLsbRgLsb
RsRsmbRsbLsbLsbLsbRjbLsRsbRgbRsbRsbRsRsmbRsRsmbRgLsbRsbRgbRgbRgbRgbRjb
LibRsbRsbLcbLcbReRsmbRibLcbLjbLibLgbRgbLgbLgbLgRsbLibLibLjbRibRobLibLi
bLibLgbLgbRsbLsRibRgbLjbLgbLgbLgLsbLgRsbLgbLsbLsbRgbRsbLgbLgbLsbLibLhb
LhbRebRibLgbRibLibLgbLgbLgbLsbLgbRsbRsbLsbLgbLibLgbRsbLsbLsbsbLsLsLgmb
LsLsLsRsmmbRsbLsbLsbLgbLgbLgbRsLsbLgLsbLsbLgbLibLibRebRibRiRsmbLsbRiLs
bLsbLgRsbRcbLibRsbRibLjbsbRibRsbsbRsbLsbRibLgbLobLsbRsbLsbLsLsmbsbLsbL
sbsbLgLsbRsbRsbLcbLgbLgbLsbLgbLgbRibRsbLcbRibLibLsbLgbRgLsRsbLsRsbLibL
ibRsbRgbLibRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 43; Drug: NDMC 10 µM
bLobLibRjRsmbLsbRobRobRhbRsbRjbRgbRgbRgbRgbRsbRsbRsRsmbRgbRgbLgLsbRibL
gbRiLsbRcbRsbRsbLgbRsbLgbLgbLgbLgbLsbLgbRoLsbRcbRibRcbLsbRhbLgbLgbsbLi
bLgbLgbLsbLsbLhbRgbLsbLsbLgLsbRsLsbLgRsbLgbRsbLsbLgbLhRsRgbRsbRgbLcbLs
bRibRgbRsbRsbRcbRibLgbRgbRsbLsbRsbRibRgbLsbRsbRsbRgbRsbRsRsmbRgbRsRsmb
RgLsbRsbRgRsmbLgbRgbLjbLobRjbLibRjbLibRgbRjbRibLsbLsbRgbRgbRsbLsbRgbRg
RsmbLsbLjbLcbRjbLjbLibRjbLibRsRsmbLgbLgbRsbLsbLgbLgbRgbLgLsbLsbLgbLsbL
sbLiRsbLsRsbLgbRgbLsLgbLsbLgbLibLiRsbRgbRibRsbLobRgbLgbLgbRsbLibRsbLgb
RsbLgbLgbLgbLgbRgbLibRsbLibLgbLsbLsLsmbLgRgbLgbRjbRjbLgbLjbLcbRgbLsRib
LobRibRsbRjbLcbRjbRcbLgLsbRhbLgRsbRgbRiLjbsbRgbRsbRsbRgbRsLsbRgbRgRsmb
LsbRsbRgbRibRgRsmbRsRsmbLsRibRsbRgbRsRsmbLobLibLibRgbLoRiLsRsbLibLgbRs
bRcbLsbRsbRibLgbRgbRsbRsbRsbRgLsRsbRgbRgbRgRsmbRgbLsRsbRgbRgRsRsmmbRgb
RgbRgRsRsRsmmmbRgbLgRsbRibLibLobLgbLibLgbLsbRgbLgbLgbRgbLgbLsbLsbLsbLg
bLsbLgbLgbRsbLgbLgRsbLsbLgbLgbRsLsbLgLsbRsbRjbRcbRsbRcbLsbLjbRcLsbLgbR
ibRsbRsbRiRsmbLgbRgbRgbRgbRgbLsbRsRsmbRgbLsbRgbLsbRgbRgbLsRsbRibLjbLoL
smbLgbRjbLobRgbRsbRebRcbLgRsbRsbRsbLsbRcbRhbLgbLibRibRibRgbRgbRsbRgbRg
bRsbLsbRgbRgLsRsbRsbRibLgbRibRsbRsbRiRsmbLsRsbRsLsbRgbLsbRibRsbLjbRcbL
sLsRsmbRhbRsbLcbLgbsbRjbRhbLcbLgbRgbLibLsbRsbLgbRsbLgbLsbLgbRgbLgRsbLg
bRsLsLsmbLgLsbLsbLsbLgbLgbsbLgRsbLsbLgbLgbLcbRibLhbRgbRsbLcbRibLgbLgRs
bLsbLgbLsbLgbLsbLgbLsbLgbLsbLgbLsbLsbLsbRsbLgbLsbLgbLgLsLsmbLgbRsbLsbL
gLsbLsLsmbLgbLsLsmbLsbLgLsLsmbLgLsbLgbLsbLgbLgbLsRsRsmbLsbLsbLgbLgLsbR
sbLiRsbRgRsmbLsLibRhbLibRsbLibRsbLgbLhRsRibLsbLgbLibLsbLgLsbsbLgbLsLsm
bLgRsbLsbLsLsmbLgbLsbLsLsmbLsbLibRsbRsbLibLsLsmbLgLsbLibRcbRcbLsbLsbRi
RsmbRcbLibLsbRcbRcbRibRsLsbRjbRgbLsRsbRgbRsbRsbRsbRibLgbRgLsbRsbRgbLsb
RgbLsbRgRsmbRgbRsbRgbRsbRgbRibLgLsbLgbRibLgbRsRgbLjbRsbRcbLsRsbsbRhbLg
bsbRhbRsbRgbRhbLsbLjbLibLibRibLhbLsLsmbLgbLibRsLsbRsRsRsmmbLgbLgbLgbRs
bLgRsbLgLsbRsbLsbLgbRsbLgbRsbLgbRjbRibRiLsbRibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 44; Drug: NDMC 10 µM
bRgbRgbRsbRgbRgbRgbRgRsmbLsbRgbLcbLgbLgbLibLsbLibRsbRgbRgbRibRibLibLhb
LgbLgbLsLsmbLgbRhbRibRgbRsbRgbRsbRgbLsbRgbRgbRjbRgbLsbRsbRgbRsbRiLsbLg
bLsbRgbRgbRgRsmbRsbRsbRsbRsbRgbRgbLsbRgbRgRsmbRsbRgbRsbRgbRgbRgbLsbRgb
RgbRsbRsbRgbRsRsmbRgbLsbRsbRiRsmbRgbRgbRgbLsbLsbRgbRsbRgbRgbRgRsmbRsbR
gRsRsmmbRsbRgbRsbRgbRgbRsbRgbRgbLsbRgbRgbRsbRgbRgbRgbLgbRgbRsbRsbRgbRs
bRcbLgRsbLsbRgbRsbRiLsbLsRsbRsbRibRsbLsbRsbRgLsbLsbRgbRgbRgbRgbRgbRgbR
gRsmbRgbRsbLsbRgbRsbRgbRgRsmbRsRsmbRsbRgbRgbRgbLsbRsbRsRsRsRsmmmbRgbLs
bRgbRsRsmbRgbRgbRgbRsbRhLsLsmbLgbRgbRgbLjbLoRsbLcbRgbRgbLibRsbLgbRsbLi
bLgbRsRsmbLibRgbLgbLsbLgbLsbRgbLibLsbRsRsmbLgbLsbsbLgbRsbLgbRjbRsbLibL
sbLiRsbLibLhbLibRibRibLiLsbLsbLibRsbRibRgbRgbRsLsbRgbRgbLgbLsLsmbLhbLc
bRibRjbLsbLiLsbLhbRibLibLsbLsbLibLgbRhbRhbRobRcbRhbRgbRibRgbLsbRiLsbRg
bLsbRgRsmbRgbRsbLsbRgbRsbRgbRsbRgbRgbRsbRgbLsbRgbRgbRgbRgbRsbRgbRgbLsR
sbLhbRebRhbLgLsbRgbRsbRsbRgbRgbRgbLsbRsbRgbRsbRgbRibRgbLsLsmbRgbRgbLsb
RibLgbRibRsbRsbRibRsRsmbRgbRgLsRsLsbRgbLsRsbRgbRgbRgbRibRgbRsbRgbRgRsm
bLjRsbRibLsbRgLsbRgRsmbRsbRsbRibRgRsmbRgbRgbRgbLsbRgRsmbRsbRibRgbLsbRs
LsbRgbRgbRgLsbRsbRgbRsbRsbRsbRgbLsbRgbRsRsmbRgbRsbRgbRgbLgbRgbRibRgLsb
RsbRgRsmbLsbRgbRgbRsbRgRsmbRgbRgbRgbRgbRsbRgRsmbRsbLcbLebLobRibRibLsbR
gbLgbRibRgbRsbRgRsmbRsLsbRgbRibLsbRgRsmbRgbLsbLsbRgbRsbRgbLsbRsbRibRgR
smbRgbLjbLhRsbRcbRibRgRsmbRsbRsbRgbRgbRsbRsbRgRsLsRsmbRsbRgbRgbRsLsbRg
bRgLsbLgbRgbLsLsmbRgRsmbRsbRgLsbRsbRgbRgbLgbRiRsmbLsRsbRsbRsbRgbLsbRgb
RibLibRhbRsbRgbLsbRgbRgbRgbRsbRgbRgbRsbRsRsmbRgbRsbRibRgbLgbRgLsbRsRsL
smbRgbLsbRgbRsbRsbRiRsmbRgbRsbRgbRsbRgbRgbRgbRgbRsbRgLsbRgRsmbRgbRsbRg
bRsbRgbLsRsbRgbRgbRsbRsbRgbRgbLsbRgbRgbLsbRgbRsbRibRsbLsRgbRsRsmbRgRsm
bRgbLgbRgbRgbLsRsbRgbRgbLsRsbRgbRsbRsbRgbRsbRgRsLsmbRsbRgbRsbRgbRsbRgb
RsLsbRgbRgbRsbRgbRgbLsbRibRgRsLsmbRgbRsbRgbRgbRgbRsbRgbRsbRsbRgbRsbRgb
RibRibLobRibLhbLibLibRgbLibRjbLiLsbLgbLgbRgbLibRjbRcbLgbRiRsmbRgbRsRsm
bRgbRgbLsbRcbLibLjbRibRgbRsbRibRsbRgbRgbRsRsmbRgbRsbRgbRibRsbRsbRsbRib
LgbRgRsmbRgbRsRsmbRgbRgbLsbRgbRsbRgRsmbRsRsmbRgbRsLsbRgRsmbRsbRgbRgbRi
bLgLsbsbRgRsmbRsbRsbRgbRgbRgbLgbRibRsbRgbRsbRgbLsbRibRsRsmbRgbRgRsmbLs
bRgbRiLgbRibLsbRhLsbLsbRhLsbLibRibsbLsbRgbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 45; Drug: NDMC 10 µM
bRgbLibLgbLsbLsbRjbRsRjbLcbRsbLgbLgbLsbLsbLgbLibRibRjbLibLibLsbLibLsbL
gbLsbRsbLsbLibRgbRjbRcbRhbLsbRcLsbLgbLgbLsbLsbRsbLgbLiRsbRjbRcbRibLsbL
sbRgbRsbRsbLsbRgbLsbRsbRsbRjbRcbRcbLgLsbLgbRjbRcRsmbRiRsmbRibRibRgRsmb
RgbLgbLsbLgbLsbLibRjbRgbRjbRibRsbRgbRgbRsRsmbLsbRsbRgRsmbRsbRgLsbRjbRc
bRibRgbRgbRgbRgbRsRsmbLibLhbRgbLgbLgbLgbLsbLgbLgbLsbLibRibRcbRsbRgbRsb
RsbRgbRsbRgbRsbLgRsLjbLhbRcbLgbRgbRsbRgbLgRsbRgbLgbRgbRsbRibRsbLsbLsbR
ibRgbRsbLgbLsbLsbLgbLgRsbLgbLsbLgbLibRgbLgbsbLgbRsbLibRjbLgbLibLibLibL
gbLiLsbLsbLgRsbRsbLiRsbRgbLibLgbLgbLgbLgbRibLibLsbLgbLsbLgRsbRgRsmbRsb
LgbLgbRcLgbRsbRgbRgRsmbLsRsbRgbRibLsbRsRsmbRsbRsbRgbRgbLsbRgbRgRsmbLsb
LsbRgbRsbRhbRoRsmbRcbRgRsmbRgbRgbRgRsmbRgbRsbRgbRgbRgRsmbRsbLibLsbRsLh
bLibLibLcbLgbRgLsbLgbRgbRsbRgbLgbRcbsbRcbRgbRgbRcbRsbRcbsbRiRsmbLsbLsb
RibRcbRsbLsbLgbLcbLibRsbLiRsbRsbLgbLgbLgbLgbLsbLsbLgbRsLsbRsbLsbLgLsbL
gbRsbLgbLsbLgLsbRsbLgbLgbLsbLsbRgbLgbLgRibRibLjbLcbLibRsbLsbRsbLibLsbL
gLsbLsbLsbLgbLsbLgRsLsbLgbLgbsbsbLibRgbRsbRjRsmbRcbRsbRsbRsbsbRgbLgbRg
bRsbRgbLsbRgbRsbRsbRgbRsbRgbRgbRgbRsbLsbRsbRgbLsbRgRsmbRsbRgbRgbLjbLjb
LgbLjbLgbLibRjbLsRsLsbLibLgbLgbLgLsbLgbLsbRgbRsbLgLsbLibRjbsbLgbLjbRgb
LgRsbLsbLsbLibRcbRcbLsbRgbRgbLsbRsbLsbRgbLsbLhbRsbLgbLgbLsbLsbLsbLsbLs
bLsbLiRsbsbRgbLgbLsbLibLibRgbLhbLibLgbRgbRgRsmbRsbRsbLsbRgbRgbLsbRgbRs
RsmbLsRsbRgbRgRsmbRsbRgbRgRsmbRsbRgbRoRsmbRibRgbRcbRsbRgbLsRsbRsbRgbRg
bRsbRgbRsbRgRsmbLsbRsbLsbRgbRgRsmbLsbRgbLsbLcbLibLibLsbRgbRibLjbRgbLgb
LibRgbLgbLsLsmbLiRsLsbRibLgbLgbLgbLibRgLsbLgbLsbLgbLsbLgbLgLsbRsbLibRs
bLsbLsbLgbLgbLibLsbLibLgRsbLsRsbLgbRsbLgbLgbLsbLgbLgbLsbLgbLsbLgbLsbLg
bLgRsbRjbRoRsmbRgbLgLsbLsbLjbLcbLhRsbRgbRgbLsbRgbLgbRgbRgbLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 46; Drug: NDMC 10 µM
bRibRibRibLgbLgbRobRhbRgbRibLsbRobRibRibRsbLgbRjbRsbRcbLgbLsbRobRibRcb
RsbRhbRibLgbRibLgLjbLibLsLsRsmbLgbLgbLibLhbLsbLjbRjbLcbLsbRgLsbRsbLibL
eRsLsbRhRsmbLgbRsbRsbRebRibLgbLgbRobRibRibLsbLgbLgbLsbLibLgbRgbLgLsbLs
bLgbLsbLibRgRsmbLgbLobLobLibLibRgbLgbLgLsbLsbLgbLsRsbLgbRgbLibRebLibLg
bLjbRobLibLjbLcbRjRsmbRobRcbsbRjbRcbRgbLjbLiLsLgbLgbLgbLgbRsbLgLsbLsLs
mbLgbLgbLgbLsbLgLsbLgbRsRsmbLibRcbRibLgbLibLibLgbRhbRoLsbLgbLjbLsbLiRs
bRsLsbLgLsbLgbLibRsLgbRgbLsbLibLgbLibLgbRsbLgbLgLsbRsbRjbRobLhLsLsmbRj
bRibRjRgLiLsbRiRsmbRcbLebLibLgbLsbLsbRsbLsbLsLsmbLsbLibLgbLgbLsLsmbRgb
LsbLgLsbRsLsbLgbRgbLjbRjRsmbRjRsmbLebLibLgbLsRsbLibRjRsmbRgbRsbLibLsLi
LsbLgbLgbLebLsRsbLsLgLibRsbLgbRobRibLibLoRsbRjbLcbRjRsmbRcbLjbLibLsbLg
bLgbLsbLibLsbLgbRsbLibLgbRcbRcbLibLgbLgbRibRgbLhbLcbRgbRsbLgbLibLsbLgb
LgLsbLgbLgbLsbLgLsbLsbLgbRsbLibLgbLgbLsLsmbLiLsLgRsbLgbRjbLsbLjLsmbLgb
LhLsLsLsmmbRibRibLjbRgbRsLsbRgLsbRgRgRgbRsbRgbRsbRgRebRsbRgbRgRsmbLjbL
ibLsbRjbLcLsmbLsbLsLgbLsbLgLsbLsbLgLsLsmbLgRsbLsbLgLsbRsbLgRsbsbRcbRiR
smbRhbLjbRibRgbRibRgbRgRibRgbRsLsbRgLsRsbRgRsLsmbRsbRgRgbRgRgbRgbRgRsm
bRibLsbRgbRhRsmbLiRsbLebLgbLibRibLcLsmbLibLsbLgbLsbRjRsmbRcbLgbLgbLsbs
bRibRsRsmbRgbLgbLjbLcbRgbRiRsmbLhbLgbLgLsbLgbLgLgLsbLobLcbLcbLeLsLibRs
RsLsmbRgbRiRsmbLsbRgbRsbLsbLebLjbLgbLhbLgRsbLsbLiLsbLcbLgbLebLibLibLib
LgLsbLsbLgbLgLgLgLsbLgLsLsmbLsbRsbLgbLgbLibRibLsLibRgbLsLsmbLiLsbRgRsm
bLsbLjbLobLobLjbRibLeLsbLiLgbLjbRjbRsbRhbRsbRjbLsRsLsbRsbRgRgbRgbRgRsL
smbRgRsmbRgLsbRgbLsbRibLibRgbLsbRiRgbRsbRgRsmbRhbRsbRgbRibLjbRibRgbLgb
RsRibLsbRgbLgRsbLsbRjbRgbRsbRibLsbRiRsRsmmbRgbLibRjbRsRsRsmmbRsbRgRsmb
RhbRgbRsbRgbLjbLibRjbRgbLgbRgbRsbRgbRgbRgbRibRgRsmbRgRsmbRgbRsbRsRsmbR
gRsmbRsbRgbRiRobLgbRobRebRcbRibRibLjbRiRsmbRgLsbLhLsLsmbLibsbRcbRibRgb
LgbRgbRgRsLsmbLsRgbRgbRgRibRgRiRsmbRgbRgbRibRsbRgbRgbRiLsbLjLsmbLhbLsb
LcbRhLsbLsbRibLsbRgbsbRgbLsbRgRsRsmmbRsRsmbRgRsRsmmbRgRsmbRsRsmbRgbRgb
RgRsmbRsbRgRsmbRgRsRsmmbRsbRgRsRsRsRsmmmmbRgRsmbRgbRibRsRsmbRgbRsbRsbR
gbRgRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 47; Drug: NDMC 10 µM
bLebRcbLibRgbLgbRgbRibRgbRgbRsbLsbRgbRgRgRgRgRsmbRgRgbsbRgbRibLgbRibRs
bRgRgbRgRgbRgbRgbRgbRgbRgbRgbRgRsmbLibRobRibRgbRobLgbLsbRgbRebLibRjbRi
bLsRsbRsRsmbRgRgbRgRsmbRgbRgbRgLsLsmbRgbRgbRgLsbRgRgRgbRgbRgbRgRgbRgRs
RsmmbRgbLhbRgbLgRsbRgbRsbRgRsRgmbRsbRgLsRsbRibRjbLgbRjbRgRgRsmbRgRsRgR
gmbRgbRibLcbRgbLjbRhbRgbRsRsmbRgRgRgRsmbRsbRgRsRsRgRimmbRgRgbRsRgRiRsm
bRgRsmbsbRjbLsbLsRsbLsLsmbRgLsbRgRsmbLsbLsbRiLgRsbRjbLjbRiLsbRibLhbLjb
RgbRjbRgbRibLhbLgbLcbRgbLcbLcbLoRsbLhbLcbRcbRibRgbRibLgbRgbRgbLgbRgbLg
bRsbRibLgbRgbRgRsmbLsbRgbRsbRgbRsRiRsmbRgRsmbRsbRgRgbRsbRgbRgbLsRiRgbR
gRsmbRgbRgbRiRsmbRiRgbRgLsRiRsmbRgRsRsmmbRgbRgbRsbLhbLcRsbRjbLhRsRsmbR
gbLibLgbLgbRgbLibRibLhbRibLibRgbRgRoLgbLsbLsbRibRiRsmbRgRsmbRgbLgbLjLo
bRibRhbRcbRgbRcbLibLibRibLcbRjbRjbLibLiRgRsmbLgLsbRsbLgbLibLgbLiRgbLgb
LsLsmbLgbLgLsbRsbLiRsRibLsbLgbLsbLsLsmbRsLsLsmbRsbLgbRjbLcbRgbRibRhbRe
bRobRibLibRibLsbRsbLcbRgbLcbsbRibLjbRgbRgRsmbRgbRsbRibRgRsmbRsbRjbRgbR
gbRgLsLsRgmbLjbRibRsbRgbRibLhbLibRgbRibLjbRoRsmbRibRcbLibRibLcbRiLsbRg
bRgbRgbRibRsbRsbRgbRgRgRsRgRsRgRgmmbRgRsmbRgbLgRhRgbRsbRgRsRgRiRsmmbRg
bRgLsbRiLsbLsbRgRsmbRgRsmbRgbRgbRsRgbRgRsmbRsbRibRgRsmbLsRgbLsbRiRsmbR
gRsmbRgbRgRsmbRgbRsbRgbRgbRgbRgbRibLhbLcRsLsbRgbLcbRgbLcLsRimbLibRgbLi
RjRsmbLibLgbLgbRjbLsbLcbRgRsmbRsRsRgmbRgLsRsRgbRiLsbLcbLjbRibRibRibLcb
RhbLibsbLebRibRjbLibLcbRibLsLjbLgbLsLsmbLgbRsbLsbRsbLgbLibRebLhbLgbLib
RjbLibLibLibRsbLibLsbLhRibLsbRjbRobRgbRgbRibRsbRgbLgbLibLibRgRsmbLibLg
bLgbLsbLsLgbLgRsbLgbLgRsbLibLiRsbRgbLibLiRsRgbLibLjbLhRiRsmbRjbsbRsRsm
bLgbLibRcbLgRsLsbRgbRgbRgbRgbRsbRsRsmbRsbRgRsmbRibRsbRgbLsRsbRgbRgbRsb
RgbRgbRgbRgbRgbRgbRsbRgRsmbRibRsbRgbRgRsmbRgbLsbRgbRsbRgRsmbRsbRgLsbRs
bRgRebLgbRgRsmbRsbRgbRgRgbRgbRsbRgLsRsbRsbRibRgbRsbRgRsmbRgbRgbRibRsRg
bRgRsmbLsbRibRgRsmbRsbRgbRsbRiRgRibRsbRgbRgLsbRgbsbRibRgbRgbLsbRgRsmbR
gRsLsmbRgRsmbRiRgbRgbRsRsmbRsbRsRgRsmbRgLsbRsbRgRsmbRgbRsRsmbRgRsRgRsm
mbRibRgRsRsmmbRiRsmbRsbRgbRsbRgbRgRgbRgRsmbRsbRgbRgbLsbRibRgbRgRsRsRsR
gRsRsRiRgmmmmmbRsRiRsRgRsRgRsRsmmmmbRgRsmbRsRgbRgbRgbLgLsbRiRgRsRgRgRg
mbRsbRgRgRibRiRebRsbRibRgbRsbLeRsbRibRibRibRcRsmbsbRcbLcbLhbLcLsmbLcbR
sbLoRsbLiLsbLcbRiRsRimbRgbRgRsmbLsbRiRsRsmmbRgRsmbRibRsRsRgRsmmbLsRiLs
LgbRibRsRgRgbRgbRgbRgbLsLsmbRiRgRiRgRiRsmbRgbRgRgRsRgRsRgRsRgRgmmmbRgR
gRgbRgRsRsRsRgRsRimmmmbLsbLebLsLhbLcLsmbsbLcbLhbRjbLibRsbLjbReRsmbRobL
cbLcbLcbLsbLiLgLgbLibRgbRcbRiLsbRgbRibRgbLgbLsbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 115239; End: 115739;
Recording: 11-1; Individual: 48; Drug: NDMC 10 µM
bLsbLsbLgbRgbRsbRibRsbRjbRoRcbLibLgLsbRebRobLhbRibRibRibRgbLgbLsRsbRgL
sbLsbRgbRgbLjLobLcbRgbRsbRsbRjRsmbRjRsRsmmbRgbRsLsbLjLsRsmbLgbRsbLgbLs
bLgbLsbLiRsbRgbRsbLibLsbLgbLobRiRsmbLsbLsRsLsbLsbRjbLjbLjbLcbLcbLcbLib
LibLsbLsbRjbLibLsLsmbLsbLsbRsLsbLsbLgbRsbLsRsbLsRsbLgbLgbRsbRsbLibRgbL
gbLibLsLsmbLgLsbLgbLsbLgbLibLibRcbLcbRibRobLiLsbLsbLgbRsbLibRsbLiLsbLs
bRsLsbLgbLsbLgbLgbLgLeLgbLgLgLibLsbLgbLgbLsbLgbLgbLgbLgbLgbLgbLjbLibRi
bLgbLsLsmbLgLsbRsbLibLibsbLcRsbRibLgbRgbRsbLsbLjLsmbLgbLsRsbLgbLsLsLsm
mbLgbLsbLsbLgbLgbLgRsbLgbLibLhLsbLibLibLhbLibLhbLcLsmbLibLebLiLsbLgbLi
bLsbLsbRgRsmbLgbLiLsbLsbLsbLiLsLsmbLiLgLgbLsbLgbRsbLiLsbRgbLiLsLsRsmbL
sbLgLgLsLiLgLsLsLgLsRsmbLgbLgbLsbLgLsbLgbLgLsbLgbLsbLgbLgLibLgbLgbLgbL
iRsRsmbLgbLgbRibLhbLcbLcbLibLhbRgbLibLgbLgbRgbLgbLsLgLsLgLgLsLgLgbLgbL
gLsbLgLsbLsbLgLsbLgbLgLgLiLgbLgLsbLgLgbLjRsbLiRsbLibRsRsLsmbLgbRsbLcbL
sRjbLibLibLcbLibLcLsmbRgRsmbLibLgRsbLgLgLsbLsLsLsmmbLiLgbLjbLsRsbLgbRs
LsbLsLsmbLgLgLsbLgLgbLsbLjbLsbLjbLibRjbLiLsbLgbRgbLiLsbRsbRsLsbLgLsbLg
LsbLgLsbLsbLgLsbLgbLsbLsLsmbLgLsLsmbLsbLcbLgbLhbRjbLcbsbLibLjbLgbLgbRs
bLibLiRsbRgbLcbLibLgbLsbRsbLibRsLsbLsbLiRsbRsLjbLibLibLiLsbRgbLjbRsbLs
bLjbLgbLgbRjbLibRsbLsbLibRgbLibRgbRsLsbLibRsbLgLsbLsbLgLsLsRsmbLgbLgRs
bLibLcLsmbLcLsmbLibRjbLibLgbLgbLsbLsLsmbLgbLiRsbRjbLiLsbLsbLgbLsbLgbRs
bLibRgbLsLsLimbLsbLgbRsbLibRgbLgbLgLsbRsbLgbLsbLgbLjbLgbRgbLibLgRsbLiL
sbLsbLgLsbLsLsmbLgLsLgLsbLgbLsbLgLsbLsbLgbLgbLgbLiRsbRsbLibRgbLgbRsbLg
LsbLiRsbLibLgLsbLgbLgbRsbLibLhbLhbLibLebLibLgbRsbLcbRgbLibRgbLjbLiRsLs
bLgbLiRgbLibLcbLcbLjbLiLsbLiRsbRibLibRgbLibLsLsLsmmbLgbLgLsbLgbRsbLgbL
gLsbLibLsbLgbRsbLgbLjbRsbRsbLiRsbRibLcbLcLsmbLcLsmbLcLsmbLibLgbLgLsbLg
bLgbLgbLgbLibRgbLibRsbLgbLibRsbLgLsbLgbRsLsbLibRsbLsbLgLsbRsbLgLsbLgbL
gLsbLgbLgLsbLgLsbLgbRgbLgLsbLgbLsLsmbLgbLgLsbLgbLsLsLgLgmbRsLgbLibLhbL
sbLibLcLsmbLhLsbLhbLibRibLgbRibLjLibLgLsbRgRsmbLiLsLsmbRsbLgLsLsmbLiLs
LgLsLgLiLgbLgLsbLgLsbLsbReLobLebLhLsbLcbRcbRebRcRsRsmmbLcbRobLibRcbLgb
RoRsLsmbLibRsbRiRsmbRgbRgbRibLibLibLgLsbLibLcLsmbsbLibLgbsbRgbLobLobRg
bsbLibRsRsmbRgRsmbRibRsRsmbRgbLjbLcbLiLsbRgbLiRsbRsbLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 1; Drug: Control
bRcLsbLgbLhbRsbsbRsbsbRhbLgbLcbRibLjbsbRcbLibRhbLsbLoLsmbRiLsbLibLgbRi
bRcbRgbRcbLcbLjLsRsmbLibRhbLibRiLgbLgbLgbRsbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 2; Drug: Control
bLibLgbRibLibLibRjbLibRgbRsbLiLsbLgLsbRgbLiLsbRgbLibLgbLgbLhbLhLsbRgbL
jbLibRjRgbRhRsmbLhbRibsbLjbLibRgbLibRgbsbLibRgRsRsmmbLibLibLiLsbRibRiR
smbRhbLhLsRsbRibLgbLsLsmbRgbsbRgbLjbRibLhbLhbRjbRsbLcLsmbRsbLibRibRgbR
ebRsbRgRsmbsbRibLsbRhbLjbRgRsmbLhbLjLsmbRibLgbRjbLibRcbRibLjLsmbLjbReb
RgbRibsbRibLiRsbRhbRjRsmbRgRsmbRibRsbLibLsbRsbRsbsbLibsbLibRibLhbRibRs
bLcLsmbRsbLcLsmbLebLcbLcbRhbLibLibRgbLibRsbLibLcbLibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 3; Drug: Control
bsbLgbLgbLibRgbRsbRjbRiLsbRobRhbRibLibLibRsbLibRsbLgbLsbLgbRsbLiLsbsbL
ibRsbLsLsmbLibLibLsbLgbRsbLgbRsLsbLibLgbRgbLgRsbLsbLgLsbRsbLiLsbLsbLsb
LgbRsLgbLgbRsbLgLsLsmbLsLsmbLgbLibLgLgbRjbLibLgbLsRsbLiLsbLgbLgbLgbRgb
LgbRsbLibRjbLhbLgbLgbLgbLgbLsbLgbRjbLiLsbLsbLibLsbLsbLgbLgbLsbLibRsLsb
LgbLsbLgLsLsmbLgLsbLsbLgbLgbLgbLgLsbLsLsmbLibLsLsmbLiLsLsmbLgbLibLgbLg
LsbRsbLibLgbLsbLsbLgLsbLsLsmbLgbLsbLsLsmbLibLsbLgbLgbLgbLgLsbLgbLsbLgb
LgbLgbLgRsbLgbLsbLgLsbRsbLgLsLsmbLgbLgLsLsmbLsbLgLsbLgbLgbLgbLsbLgbRob
RobRcbLgbRibRcbLibLcbRgbLiLsbLgbLsbRsbLibLsbLiLsbRsbLgbsbLgbRgbLibLsbL
gbRsbLgLsbLgRsbLgbLgbLgbLsRsbLiLsbLibLgLsbLgbLibsbRibRcRsmbRhbRibRhbLs
bLsbLibLcbRibRibRcLsbLibRcLsbLsbRcbRibLsbLgbRibRobLhbRgbRoLsbLhbLcbLgb
LgLsLgbRebLjbLcbLsbLgLsbRjbLcLsmbRgRsmbLcbRsbLibLsbRsRsmbLibLgbLgbLsbR
gbRcbRgbLjbLcbRgbsbLibRsbLibLgbLsbRsLsbLgbLgLsbRjbLgbLgLsLsmbRsLsbLiLs
bRsbLgbRsLsbLsbRsbLibRsRsmbLibLgbLsbLgbRsRsmbLgbLgbRsLsbLgbLsRsbLgLsbR
sbLgbLsbLsbRsRsmbLibLgbLgLsbLgbRsbLgbLsbLsbLsbLgbLsLsmbLgLsbLsbLgLsbRs
bLgbRsbLibLgbLgLsbRsRsLsmbLiLsbLgbLgbLgbLgbRgbLgLsbLgbRsbLgbLgRsbLgbLs
bRibRcbRgbLjbRiLsbsbRgRsmbRgbRiLsbRibLgbRsbLhRsbLsbRibRgLsbRibRgbLjbRc
LsbLgbRibLsbRibRgRsmbRibRgbLhbRcbRsRsLsmbRgbRgRsRsmmbRibRibRsLsbRcbRsb
RsbRibRgbRibRibLgbRibRgbLgbRgbLeLsbLoRsbLgbLibLsbRiLsbLcbLibLgbLsbRsLs
bLgbLgbLgbLibLgbsbLsbLsbLsbLibRsbLgbRgbLibLsbLgbLgLsbLgbRsLsbRsbLgbLsb
LgbRsbLiLsbLsbRjbLibLibLgbLsbRgbRhbRiLsbRgbRgbLjLsmbRgRsmbRibRcbLgbLjb
LcbRgbLgbLhbLsbRibLhbRgbLibRsbLibLibLsLsmbLibRgbLgbLibLibLgLsbLgbRjbLi
bLgbLgbRsbLsLibLsbLsbLgbLsbLsbLsbLibLgbRibRibRibRibLsLsmbRgbRibRgbRcbL
ibRibRhbRcbLiLsbRhbRibLcbRjbLsbRhbLhbLcLsmbRsbLgbLsbLiLsbRjbLhbRsbLiLs
bLgbRsbLsbLgbLsbLgbRgRsmbLibRsbLibRjLsbLgbRsbLibRsbLibLgLsbLsRsbLgbLgb
LgbRgbLibLsLsmbLgLsbLibLibRgLsbLgbLgbLsLsmbLgbLgbLgbLsbLgbRgRsmbLibLgb
RgbLibLgLsbRsbLgbLgRsbLgLsbRgbLiLsbLgLsbRsLsLsmbLgbRsbLsbLibLibLibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 4; Drug: Control
bRgbRibsbRgbLcLsmbRsbLhRsbRsRsmbRsbLibRsbLgLsbRgbLiLsbRsLsbLgbRsbLgbLi
bLsbLgbLgbRsbLibRsbLsbLibLsbLgbRgbLibLsLsmbLgbLsbLgbLgbRsbLgbLibRsbLgb
LsbLgbRgbLsbLgLsbLsbLgbLgbLsbLgbRsRsmbLgbRgRsmbLgbLgbLgRsbLgbLgbLgbLib
RibLiLsbLgLsbLsbLgbRsRsmbLibRgLsbLgbLsbLgbLgLsbLsbLgbLgbLgbLgbLgbRsbLg
bLibRjbLibLsLsmbLibsbLgbRgbLiLsbRsbLgbRjbRibLjbLjbRhbLjbRhbRibRiLsbRsL
sbLgbLsbRobRgbLhLsbLiLsbLiRsbLgbRcbLcLsmbRjbRcbLcbRjbRcbLcbLcbRsbLgbLg
LsbRsbLgbLiRsbRgbRibLjbRibRibRsbRgbRibRgRsmbLcRsbRjbLcbRjbRhbLoLsLsmmb
LsbRiRsmbRibRsbRebLcLsmbRibLgbRibRgLsbLobLobRibRsbRibRibRgbLibRibLsRsb
RgbRsbRsbRobRiRsmbLhbRgbLibRjbRibRgbLjbRibRiLsbRibLgbsbRgbRgRsmbLgbRgb
RgbLcbLsbLgbRcRsmbRibRcbLsLibRjbRcbRcbRibLgbLibRsbRibRibLobRjbLhbRjbRi
RsmbRgbRsRsmbRsbLjbRibLjbRhbLobRjbRcbRgbLcbRsRsmbLjLsmbRsRsLsmbRjbRcbR
ibRsbLeLsbRcbRibRhbLibLiLsbRcRsmbRibLibRibRsbRgbLibRsLsbLibRcbRibLcbLh
LsbRsLsRsbLgbRjRjbLjbLibLsbLibLgbLgLsbRjbRjRibLcbRjbRcbRoLsbLjbLcLsmbL
cLsRsmbLgbRgbLsbLjbRibRib

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 5; Drug: Control
bRcbLcbReRsmbRibsbLgbRibLgbRgbRgbLgbRiRsmbLsLsmbRgRsmbLjbLsbRhbRsLsbRi
bLsbRiRsmbLsRsbLsbRcRsRsmmbRsbRiRsmbRgbRsLjbLibRcbRiRsmbLgRsbRibLgbLib
RjbRoRsRsmmbRcRsmbRgbLibRgbLcbLgbRgLsRsbLgbLgbRjRjRsmbRgbRibRibLgbRibL
sbRiRsmbLsbLgbRibLsbRgbLsbRgbLsbRibLgbRsbsbRsRsRsmmbRsbRsbRibsbRgbRibL
gbRiLsbLgLsbLsbLibRcbRiRsmbRibRgbLjLcbLibRsbLgLsbLibRjbLibLsbLgbRsbLgL
sbLgbRibLiLsbRcbRsRcbLibRcbLgbsbRibRgbRibsbLsbRibLibRibLibRibLsbRsbsbR
gbLibRibLgLsbRiLsbLjLsmbLjLobsbRjbLhbRibLibLgLsbRjbLibLibLgbLsbsbLsLsm
bLsbLsbRjbsbLcbLgbRjbLgbLgbRsRsmbLibLibsbRhbRhbRsbLibRibLibRjRsmbLibRj
bRcbLcbLiLsbLiLsbRibsbRjbRhbLibRjRsRsmmbLjLsmbLsLsLsmmbLhbRhbRhbLgbRhb
RgRsmbRhRsmbRhbLgbRhbRibRgbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 6; Drug: Control
bLgLsbLiLsbLsbRgbLcbLcLsmbLibLgLsbLibRjbRibRibRhbLibLsRsRibLjbRibLjbRi
RsmbRibRiLsbRibLebLibLcbLibLsbLgbLcbRgbLibLsbLibRgbLgbLgbRgbLjbLsbRsLs
bLgbLsbLiLsbLgbLgLsbLgbLgbRgLsbLgbRgbRjbRhbLcbRcRgbRibRgbLgbsbLgbRiRsm
bRgbRgbLsbRgbRgbsbLcbsbsbLiLsbRgbLgLsbRsbRjbRcbLcbLcbRhbLcLsmbLibRsbLg
bLgRsbRgbLjLsmbLibRgbRsbLiLsbLgbRsLsbLgbLgLsLsmbsbLgbLgLsbLsLsmbLsbLgL
sbLgbLgbLsbLgbLgLsbsbLgbRgbLiLsbRsbRsLgbRsLsbLgLsbLgbRsbLiRsbLcLsmbLhR
sbLhbLiLsbLgLsbRsbLibLsbLsbLgbLgbLsbLgbLgbLgbLsbRsLsbLgbRsbLgLsbRgbLgb
LgbLsbLgbRsbLgbRsbLgbLgRgbLibLgbRsbLsbLsbLgbRgbLibsbRsRsmbLgbLgbLsbLib
LcbLibLhbLibRjbLgbLgbLsLsmbLgLsbLsbLgbRsbLibRsLsbLgbLgbRsbRibRhbRibRcb
LgbLibLibLibLhLsbLcbRibLibLibRsbLibRcbRibLibRcbLjLsmbLsbRcbRhbRgLsbLib
LibLgbLsbLibLibRiRsmbLibRgRsmbLibLgbLsbLgbLsbLgLsbRsbLiLsbLgLsbLsbLibR
sRsmbLgbLgbLgLsbRsbLgbLgbLgbLibLsbLsbLgbRgbLibRsbLibRcbRcbRhbRgbLiLsbL
ibLiLsLsmbLgbLgbRsbLgbRsbLgLsbLgLsbRsLsbLgbLsRsbLsLsmbLsbLgLsbLsbLsbLg
bLgbRsLsbLgLsbLsLgbsbRsbLgbLgbRsbLgbRcbRibLiLsbLibLibsbRsbLsLsmbLgbRsb
LsbLibLsbLgLsRsbLsbLgbLgbLsbRsLsLsmbLgbRsLsbLgbLgbRjbLgbLgLsbRgbLsLsmb
LibRsbLjbLsbRsLsbLgbLgLsbLsbsbLgbLsbLgLsbRsLsRsbLgLsbLgbRjbRcbRcbRibRg
RsLsmbRgbLgLebLsbRsLsbLiLsbLgRsbLsbLgbLsLsmbLsbLgbLgbLgbLgbRgRsmbLiLsb
sbRsbLgbLiRsbLgbRiLsbLibLsbRjbRcbRhbLibLjbRcbRhbRhbLgbLsLsmbLibRcbRhbR
ibLibLibLcLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 7; Drug: NDMC 1 µM
bRsbRgbLsbRgRsRsmmbLsbRgbRgbLsbRgbRgbLsbRibRgLsbLsbRgbRgbRgRsmbLsRsbRs
bRgbRgbRgRsmbRsLsbLgbRibRgRsmbRgRsmbRsbRsbRsRsmbRgbLsbRgbRgbRgbLjbLjbL
ibLgbRsbRobRcbRibRiLsLsmbRibRgRsmbRiRsmbRgbLsbRgRsmbRsLsbRsbRgRsmbRgbR
gbRgRsRsmmbRgbRgRsmbRgbRgRsmbRgbRgbRgbRsbRgbRibRgbRsbRibLsbRibRgbRgRsm
bRsRsLsLsRsmmbRgRsmbRgbRsLsbRgbRgRsmbRgbRibLgbRiRsmbRgRsmbRgbRiLsbRgbL
sbRgRsmbLjbLhbRjbRiRsmbRibRgbRsbRgbRgLsbRsbRgbRiRsmbRgRgRsmbRsRsmbRgbR
gbRgbRgLsbRgRsmbRgbRgRsmbRgbRsLsbRgbRgbRgbLgbRibRgbRgbRsbLcbLibRgbLibL
sbLgbLibLiLsbLsLsmbLiRsRgbLgLgbRsbLibRjbLibRjbLobRiRsmbLcRibLcbRibLibR
sbLjLsmbRjbLibRgbLibRjbLibLgbLibRibRhbRibLcbRjbRcbRgbRcbRibRgbRcRsmbRs
LsbLsbRibRsbLsRsbRgRsmbRsbRsRgbRsRsRsmmbRgbRgLsbRgbRsbRgbRgbLsbRgbRgbR
sbLsbRgbRgbRsbRgbLjbRibRgLsbRiRsmbRsRsmbRgRsmbRgbRgbRgLsRsbRsRsmbRgbRg
RsmbLsbRgRsmbRsLsbRgbLebLibLgbRcbRibRgbRsbRgbRobLgbLjbRibRgLsbLjbLibLi
bRgbLhbRgbLgbLibLcbRibRgbRcbLjbRcbLgbRgbRgbRgbRsbLsRsbRgLsbRgRsLsmbRgR
smbRsbRgbRgbRsbRgRsmbLsbRgbRgbRgbLsbRgbRgRsmbLsRsbRgbRgbRsbRgbRgbRgbLs
RsbRgbRsbRgbRgbRiRsmbLsRsbRibRsbRsbRgbRgRsmbRgbLsbRibRibLiLsbLgbLibRcb
RhLsbsbRcbRsbRgbRibRibRsbRibRsLsRsbRgRsmbRsbRgRsmbRsRgRsmbRsbRgLsbRsRs
mbRibLsbRgbRsRsmbLcbLibRcbRebRibLgbLgRsbLjbLibRcbRibRibRgRsmbRgbRgRsmb
RibLsbRgRsmbRgRsRgmbsbLsRsRiRsmbRgbRgRsmbRgbRgbRgRsmbRgRsmbRsRsmbRgbRs
bRsbLsbLjbRcbRgLsbLhbRiLsbLgbLiLsbLobLcbLhbLgbLcbLsRgRsLsmbRjRsmbRgbRs
RibRsbRgbLsbLcbRiLsbRgbRibRgbRsbRibRsbRgbRgRsLsmbRsbRsbRgbRsbRgLsbRgRs
RsRsmmmbRgRsRgRsmmbRsRsmbRgbRgbRsbRgbRsbRgbRgRsmbRgbRgbRsbRgbRsbRgbRsb
RsLsbRiLsbRgbRgbRsbLobLibLibLgLsbLgbRjbLibLgbLsLibsbRjbRobLgbRibRsbRgb
RgbLgbRgbRgRsmbRsRsmbRgbRgbRgRsmbLibLibLgbRgbLhbRcbRcbRgbLjbLibLsLsmbL
ibRsbLibLsbLgbRobLsbRibRgbRgbRsbRgRsRsmmbRgbRsbRgbRgbRsRsRsmmbRsRsmbRg
bRgRsmbRgbRgbRgRsmbRsLsbRgbRsbRgRsmbRgbRgRsmbRsbRiLsRsbRgbRgbRgbRgbLsb
RgbRgbRibRsLsbRgRsmbLsbRiRsLsRsmbRgLsRsbLsbRgRsmbRsbRgRsRsmmbRgbRgRsmb
RsbRgbRgbLsbRgRsmbRgbRgbLsbRiLsbRsbLjbLibRcRsLsmbRibLgbRgLsbRsbRgbRgbL
sbRibRsbRsbRgbLsLsmbLsRibRgbRgRsRgRsRsmmmbRgbRgbRsbRgbRgbRsbRibRsbRgbL
hRsbLiRsbRcbRgLsbRgRsRsmmbRgbRgRsmbRsbRgbRgbRgbRgLsbRgbRgRsmbRgbRsbLsb
RgbRgbRgbLebLibRjbLcbRjbRcbLsbRgbRgbRsbLhbLibRiRsmbLgbLibRcbRgLsbRgRsm
bRiLsLsmbRgRsmbRsRsmbLjbLhbLcRsbLcbRjbsbLiRsbRhbLgRsbLcbLcbLsbRjbLcbRj
bLibLsRsbLgbLsbRibLjbRobRhRsmbsbRjbRsRsmbRgbRgRsmbRsbRgRsmbRgbRsbRsbRj
bRcbRebRjbRgbRiRsmbRsbRgbLjbRgbLibsbRcbRjbLibLibLobLjbRibLibRcRsmbRcRs
mbRibLgbLgbRibRibLsbRgbRgbRgbRsbLjbRcbRhLsbLibRsRsmbRiRsmbRgbRgRsmbLsb
LcbLibRjbRcRsmbRibLjbLobLibLibLgbLgLsLsmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 8; Drug: NDMC 1 µM
bLgbLsbLgbLobLsbRhbLgbLcbLgbLgbRgbLgLsbRsbLgbLgbLgbLsbLgbRsLsbLgbLsbLs
bLgbLgbLsbLgbLsbRsRsmbLgbLgbRsbLsbLgLsbLgbLsLsmbLgbLgbRsbLgbLsbLsbLgLs
bLgbLsLsmbLgbLgbLsbLsbLgLsbsbRjbRcbRgbRsbRibRibLsbRgRsmbRsbRgLsbLgbRib
sbLsbLsLibLibRibLcbRsbLibLgbLibRsLsbLgLsbRsbLsLsmbLgLsbLgLsLsmbRsbLgbL
sbLsbLsbLsLsmbLsRsbLgbLgRsbLsbLsbLsbLsbLsbLgbLgbLsbLgbLgbRgbRsbLgbLsbL
sbLgbLgLsbLgbLsbRjLsbLibLsbRsbLgbLgbRobRgbRiLsLsmbLjbRcLsbLgbRhbLjbRhb
LgbRibRibRibLibRobsbRiRsmbLibLgbRhRsmbRibsbRhbLgbLcbLgbLgbLsbLgRsbRjbR
iLsbRsbRgbRgbLgRsbRibLgRsbRibLsbRgRsmbRibLgbRibRibLhLsbRcbLibLcbLgbLsb
LgbLgbRsRsmbLsbLgbLsbLgbLgLsbLsLsmbLsbLsLsmbLgbLgLsbRsbLgbLsbLgbRsbLgL
sbLgbLsbRsbLgbLsbLgbRsbLsbRjbRibsbRiLsbLjbRibLobLgbLgbLgbLgRsbLgbRjbLc
bRgbRjbLcbRobRcLsLsmbRibRgbLgbLgLsLsmbLcbLgbLibLibLgbLgbRsbLcLsmbRgRsm
bRgRsmbRibRhLsbLibRsbRibLgbRgbLsbRibRhbRgbRgbRgbLibRsbLgbLgbRgbLiLsbLi
bLgbLsbRsbLgbLgbRsbLgbLgbLgLsbRsbLsbLgRsbRsbLgbLgRsbRoLsbLgLsbLgbRsbRs
bLsLsmbLgbLsbLgbLsbLsbRgbLgbRsbLgLsbRsbLgbLsbLsbLsbLibLibsbLgbLgbRibLg
bLgbRgbLibRsLsbLsbLsbRsbLibLgbRsbRgbLibRsRsmbsbLsbLsLsmbRsbLgbLsRsbRgb
LibLsbLsLsLsmmbRibLibLsbsbLgbLsLsmbLibLsLsLsmmbLgLsbLgbLsbRgbLsbLcbsbs
bLsLsLsLsmmmbLsLsmbLgbsbLibLsLsmbRsbRjbLsLsmbLgbLsbLoLsmbLibLsbRsLsbRg
bRsbRsbRcbRibLsbRjbRsbRsbLsbLsbRjbRsbsbRsRsRsmmbRsRsmbRgRsmbRibRgbLgLs
bLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 9; Drug: NDMC 1 µM
bLcbRjbRgbRiLjbRgbRcbRgbLibLibRjbLibLgbLgbLgLsbLgbRjbLsbRsLsbLgLsbRsLi
bRgbRjbRibRibLjbRhbLgbRoRsmbLgbRcLsbLsbRibLgLsbLsbRcbRobLgbRcLsbRgbLib
LibLgLsbLsbLsbLibRgLsbLibLgbLgbRgbLgbLsbLgbRjLsbLibRsbLgLsbLsbLgbLgbLi
bLgbLsbLgbLgbRsbLsbLiLsbRcbLhbLibRjbRcbRcbRsbLsLsmbRsbLsRibRibRgLsbRsb
RiLjbRgbRibLgbLibLibRsbLibsbLgbLsbLcbLsbRsbLgLsbLsbLgbLgbLgbLsbLgRsbLg
LsbRjbLgLsbLgbLsbLgLsRsbLgbRgbLiRsbRhbLgbRsbsbLsbLsLsmbLgbLgbLgLsbRsbL
gRsRsmbLgLsLsRsmbLsbLsLsLsmmbLsbLgbRgLgbLibLgbLsbLgbRsbLgLsLsmbRsRsLsL
smmbLibLgbLgbLsRsbLsbLgbLsbLsbLgbLsLsmbLgLsbLgbLgLsbLgbLgbRsbLgbLgbLgL
sbLgbRgbLiLsbLsLsmbLgLsbRsbLgLsbRsbLgLsbLgLsbLgbLsbLgLsbLgbLgLsbLsLsmb
LgbLgbRsLsbLgbLgbLgbLibRjbRsbLcbRcbLcbLcLsmbRibLsbLibLsbLibLibRobLcLsm
bRhbRcbLjbLibLibLibLibRcLsbRcbLjbsbRibRiLsbRhbRsbRcbLibLsbRhbLibRcbRib
LgbRsLsbRiLsbLsbRibsbRhbLgLsLsmbRiRsmbRcLsbLibLibLibLgbLsLsLsmmbRcbLjb
RcbLjbRcbLibRcbRcbLgLsbLibRsbLibLibLgbLsbLibLgLsbLsbLgLsRsbLgbRjbLjbRo
bLsbRgbRebLgbRjbRjbLjbRibRhbLibsbLsLsmbLibLsLsmbLgbLsbLgbLgLsbRgbLibLi
bRjbsbLiLsbLsbLsbLsLsmbRsLgLsbLsbLgbsbRgbLjbLgbLiRsbRsbRsLsbLgbLgbLsbL
sLsRsmbLgRsbLgbsbRjbLibRsRsmbLgbRjbRcbRhbLiLsLsmbRibRgRebRcbLgLsbRoLsb
LgLsbRcLsbRebLjbLibLgLsLsmbLjbRsbLjbRhRsmbLsRiLsbRsbRebLibRebRcbRsbLgb
LgbRgbLsLsmbLgbRjLsbLibLgbLsbLgbLsbLsLjbLgbLsLsmbLgbRebRsLibLsbRsbLgbL
iRsbRsRgbLiLsbRcbRcLsbLgbLjbRcbLsLgbRiLsbRsbRiLsbLgLsbRgbReRsmbRsRsmbR
sRsmbRgbRsRsmbRgbLsbRsLsbRgbRsRsmbRsRsmbLsRsRsmbRgRsmbRsRsmbRgLsRsbRsb
sbRgRsmbRibRcbRibLiLsbRobRsbLhbLibRcbLjbLhbRjbLcbRibLcbLgbRsbRibRcLsLs
mbLibRcLsLjbRibRcbRibLibLgLsbLsbRoRsmbRibLsRsbRhbLibRcbLsRsbsbRcLsbLgb
LjbLibLcbRiRsmbRibLobRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 10; Drug: NDMC 1 µM
bsbRgbLjbRgbRgbLjbRgbRibRibRibRgbLsbRgbRibLibRibRebLsbRebLcbRgbLibRjbR
jbLsLsmbRsbRebRgbRgbLgbRiRsmbLsLsmbRgRsmbLebLibRsRsmbRcbLsbRibLgbRibLs
bRibLsbRibRgbLjbLibLgLsbLgbLgRsbRgbRjbRhbRsbLjbLibLibLhbsbRiRsmbReLsbL
gbsbRibLjbLebLhbRibsbLhbRgbLibLgRsbRjRsmbLiLsbLibLsLsmbLgbRjbRibLjbsbR
cRsmbLgbLhbRsbLibRjbLibLibLsbRjbRebRiLsbLhbRibLjbLcbRgbRsRsmbLiLsbLgbL
gLsbRgbLibRjbLsbRsbLsbsbsbLiLsbLhbRibsbLibLgLsbRibRibLsbRgbRgbLgbRibLe
bRgbRjbRibLcbLibLibRiLsbRibLiRsbLibLsbLibLgbRgbLibRgbLibRgbRsbLiRsbRhb
RcbsbRgbRsbRgbRgbLsbRgbLsbRiLsbLibRibRgbRgbRsbRgLsbRgbRgbRsbRhbLgbLcbR
jbLsbRsRcRsmbRgbLebLibLgbRjbRjbRiLsbRgbLsbRgRsmbLsbRibRgLsbLjbRibLjbLi
bRgbLhbRibLibRgbLibLibLgbLgbLgbRebLibLhbLibLibRiRsmbRsbLibLgbRcbRcLsbL
jbLibRcLsbRibRhLsLsmbLgbRibLjLgbLiLsbRgbLibRsbLhbRibLsbLibLgbRsbRcbRib
RsbRibLjbLeLsbsbLibRjbLcLsmbRgbLibRjLsbsbLebLiLsbLsbLgbLibLibRibLcbLiL
sbLibRhbLiLsbRibRgbRibRibRcbLebRhbRoLsLsmbRhbRiRsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 11; Drug: NDMC 1 µM
bLsbLsRsbLgbLgbLsLsmbLgLsbLgbRsbLsbLgbRsbLgbsbLsbLgbLgLsbRsRsLsmbLsRsb
LgLsbLgLsLsmbRsLsbLgbLgbRsLsLsmbLiLsLsmbLibRjbLcbRibRjRsmbRibLgbRcLsbL
ibRibRibRgbLibRcbLjbRibLcbLibRgbLiLsbLibRjbRjbRibRgbRgbRgRsmbRsbRgbRgL
sbLsLsRsmbRgbsbLsbRsbRgbRgbLsbRsbRgbRgbRsbRsbLsbRgbRsbRsbRsbRgbRgbRsbR
gbRsbRsLsbRgRsmbRsRsmbRgbRsbRgLsLsRsmbRsRsmbRgbRgRsmbRgbLsLsmbRsbRsLsb
LebLsbRgLsbRibRgbRsRsmbRgbLsbRgbLsbLsbRgbLsbRsbRsRsmbRsRsmbRibLsLsmbRg
RsmbRsRsmbRgbRgbLsRsbRcbRjbLsbRgbLsLsmbRgbRsRsmbRsRsmbRgbRsbRgbRibRgbL
sLsmbRsbRgbLsbRgRsmbLsbsbRgbRgbLgRsbRgbRgbLgbRgbRsbRgbRsRsLsmbRgbLsRsb
RgbRjbLsbLibLgbLsbLiRsbRsbLibRsLcbRsbRcbRgbLsbRjbRibLjbLjbRibLcbRhbRib
RgbLsLsmbRgbRgbRsbRsbRgRsmbRsRsmbRgRsmbRgbRsbLsbRgRsmbLsbRsRgLsbRsbRsb
RsbRsbRjbRgbRgbLgbRsLsbRgRsmbRgbRsbRgRsmbLgbRgbRsbRgbRgbRsRsmbRgbLgRsb
RsbRsbRgbRgbRjbLgbRgbRsbRgRsmbLgbRiLsbLsRsbRsbRgbLsbRgbRsbRgbRsbRgRsRs
mmbsbRsbRgbRgbRsbRgbLjbRibRgbLjbLsLcbRibRgbRgbRgbRgbLsbRgbRsbRsbLobLgb
RgRsmbRgbLsbRibRibRgbLjRsbRsRgbRibRgRsmbLsLsmbRibRgbRgbLcbRcbLgbRibLsb
RgbRgbLsLsmbRgbRgbRsbRgbRgbRsbRgbRsRsmbRgbLgbRgLsbRgRsLsmbLsLsmbRsbRgb
RgbRsbRsbRgbLsbRibLsbRibRsbRgbsbRsbRgbRgbLjbsbLsRgRsmbRsbRsbRsbRgbLgbR
gbRgbRsbRsbsbRgbLsRsbRgbRsLsbRgbRgbRibLjbRibRgbLsRjbLibRibRsbRsbRibRgb
RgbRgbLibLgbLhbRjbRibLsRibLsbRibRgbRibRiLsRsbRsbRsbRgbRsRsmbRsRsmbRsbR
sbRsbRsRsmbRgbRgbRgRsmbRsbRgbLsbRgRsmbRgbRsbRgbRgbLsRsbRgbRgbLgLsbRibL
sRsbLsbRgbRsbRgbLsbRsbRsRsmbRibLsbRgbRgbLgRsbRibLgbLibLgbLgbRsbLgbLibR
gbLiRsLsbRgRsLsmbLgbLsbLibRsRcbsbRsbRgbRgRsmbRsbsbRgbLgbRgbRgbLsRsbRgb
RsbRsbRgRsRsmmbRiLsLsLsmmbLibRgbRibRibRgRsmbRibRibRcbRibRibLjbLcRsbLcb
LgbRibRgbRibLhbLibLibRsbLgRsbRgRsmbLibRsbLibRgbLgbLgbLgbLibsbLibLgbLgb
LgbLgbLsRsbLgRsRsmbRgbLsLsmbLibRsbLgbLgLsbRsbLsbLsLsmbRsbLgbLgbLsbLgbL
sbLsLsmbLsbLgbLsbLgRsbLsbRgRjbRcRsmbRgbRgbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 12; Drug: NDMC 1 µM
bLgbRsRsmbLgbLgbRsbLgbLsLsmbLsbLiLsLgbLsbLsbLsLgbRsLsbLgRsbLgbsbLsRsbL
sRsbLgbLsbLgLsLsmbLsRsbLgbLgbLsbLsbLibLgbRsbLgbLgbRgbLibLgbLiRsbLsLsmb
LsRsbLgbLgbLsbLgbLsLsmbLgbLsbLgbLgLsbLsbLgLsbLgbLgbLgLsbLgbLgbLsbLgbLg
RgbLgbRjbLgbRcbLhbLibLebLhbRibLibRjbLibLibLiRsbLcbsbLibRibLgbRibRsRsmb
RsbRibRibLsbLjbRibLjbLibLgbLsbLgbLgbRjbLgLsbLgbRgRsmbLgbLgbLsbRjbRgbRs
bRsLsbLibLibLcbLcbLcbLibRebRiRsmbLsRsbRcRsmbLsLcbLjbRhRsmbLebLgbLgbLsb
LibRjbRsLibRcRsLsRsRgmbRsbLibLgLsbRsbLgbLgbRsbLgbLsbLgbRsbLgbLsRsbLgbL
gLsbLgbLgbLgLsbLgbLsLsmbLsbLgbLsLsLsmmbLsbLgbLgbLsbLiLsbRibLibLgbLsbRs
LsbLgRsbLsbLgbRsbLgLsLsmbLgbLsbLgLsbLsbLgbLgbRgbLsLgbLibLgbLsbRsbLiLsb
LiRsbRhbLibLgbLibLgbLgbRjbLgbRsbLgLsbRsbLgbLsbRsbLgbLgbLsbLgRsbRjbLibL
hbRibRjbRcLsbLibLgbLiLsbLibRsbLsLsmbLgbRsRsmbLgRsbRgbRhbLjbLgbLibLgbRj
bLibLcbLiRsbLgbLibLibLgbRgbLibRgbRsLgbLgbLgbRsbLsbLgLsbRsbLgbLsbRebRgb
RsbLsbRgbRsbRsRsmbRsRsmbRsbLjbLcbLibLibLcbRcbRoLsbRcLsbLhbRsbLgRsRsmbL
sbLgbLibLibRjbLibLgbLsRsbLgbRsRsmbLibLgbLibRsbLibLgbLsbLgbLsbLsbLgbLsb
RsLibLgbLgbLgbLsbRjbLjbLibRjbRcbRcbRobLibLsLsmbLsbLsbLhbRjbLobRibLsbRs
RgbRcbLibLebLgbLcLsmbRiRsmbLobRgbRibLebRsLcbRibLhLsbLcLsLsmmbLibLibLib
LgbRsbLcbRgbRgbLcbRgbLibLiLsbLsbRsbLgLsbRgbLibRsbLibLsbLsLsmbLgLsbLsbL
sLsLsLsmmmbLsbLgLsbRsbLsbLgbLsbLgbLgbLsbLibLsbLgLsLsmbLsbLgbLgbLsbLsbL
ibRgbsbLibRjbLiLsbLgbRsRsmbLgLsbLsbLsRsLgLsbRjbRcbRhLsbRibRhbLiRsbLgbL
ibRcbLcbLcRsbLhbRgbLiLsLsmbRgRcbRibRibRsRsmbRsbRibRibRgRsmbRgRsRsmmbRs
bRgbRsbRgbLsbRibRgRsmbLsbLjRsbLibRcbRibLjbRhbRobRobRobRhbLjbLcbRgbRibR
ibLgbRgbRgRsmbLgbRgbRsbRiRsmbRiLsbLgbRiLsbRsbRgRsmbRgRsmbRgRsmbRsbRgLs
bRgbRsbRsRsmbRgbRgbRgbRgbRibRiLsbRgbLcbRhbRjbLobLcbRjbLhbRjbLjbLibRcRs
RsmmbRibRgbRsbLobRhbRobLsbLcbLgbRhbRibRcbRgbRibRibRgRsmbRsbRgbRgbRibLs
bRiRsmbRsbRgbLsbRhLsbRgbRgRsRsmmbRgbRibRsRsRsmmbRibRgbLsbLjbRiRsmbLjbR
hbLhbLsbRhbRcbLjLsmbRgbRgbRiRsmbLsbLsRsRcbRibLibRsRsmbRcbRcbRibRibLibR
ibLcbLibLibLgbLgLsRsbLsbLgbLsbRsRsmbLiLsLsmbRsbLgbRsbLibRsbLsbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 13; Drug: NDMC 3 µM
bsbLgLsbLgbLibLsLsRsmbLibLhbRibLibLgbRsLsbRgbLiLsbLsbLgLsbRsbLgbLsbLgR
sbLibLgbLibRjbRcbRcbLibRhbLibLgbRgbLhbRcbRcbLibLhbRsbRsbLhbRsbLgbLgbLg
bLgLsRgbLgbLgbRgbLgbLsbLgLsbLsRsbLsbLjbRhRsmbRhRhbRiLsbLiLsbLjbLhbRgbL
iLsbRgbLsbLibLibRgbLgbLgbLsbLgbLgbRsRsmbLgLsbRgRsmbLibRsbLgLsbRsbLgbLs
LsmbLsLsmbLibRgbLiRsbLsLsmbLgRgbLibLgbLsbLgbLgbRsbLgLsbLgLsRgRsLsmbRcL
sbRcbRcbRsRsmbReRsLsmbLcLsmbLobRgbLcbLgbLibLsbLcbRgbLobLibLibLsbLibLgb
RgbLibRcbRsLcLsLsmmbLibRebRcbLibRcLsLsmbLcbLibLibRsRsmbLgbLsLsmbLgRsRs
LsmbLgRsbLsbLsbLsbLibLsbLsbLibRgRsmbLibRjbLibRgbLiRsbLibLgbRgbLibRsbLg
bLsbLgbRsRsmbLibRjbLibRsbLiLsLsmbRsbRjbRcbRcbRiLsbLibLgLsRsbLgbRjbRibR
ibLhbRibLhbLibRcbRgbRcbLibRsbRhbLsRsbRoRsmbRibRsbLgbRcbRgbLcbsbLhbRsbR
cbLoLsmbLibRgbLibRgbLgLsbRgbLhbRcRsmbLiRsbLsbLibLsLsmbLgbLgRsbLgbLgLsb
LibLsLsmbRsbLiLsbLgLsbRsLsbLsbRjbRjbRibRgbLgbRiLsbLobLhbRibLhbRjbLhbRj
bLjbLibRgbRhbLjbLcbRcbLjbRobRsLcbRobRibLgbRgRsmbRgbRgbRgLsbLgLsbRiRsmb
LsbRgbLcbLhLsbRhbLcbLjbLcbRiRsLsmbRsLsbLcLsmbRsbLsLhLsbRgbLgbLgbRgbLib
RsRsmbLibRsbLgbRsbLgLsbLgbLjbRibLcRibLjbLiRsbRgbRgbLcbLcRsbRgbLhbRibRi
bLibLhbRcbLjbLcbLgbRsbLibLgLsbRsbRjbLcbRjRsmbRcLsbLibRcbLjbLibLiRsbRsR
smbLibRibLgbRsbLibLsbLgbLgbRgbLgbLgbRsLsbLgbLsbLgbLsbLibRsLsbLgLsbLsLs
mbLgbRsbRsbRcRsmbLjbLibLgRsbLsLsmbRsbLibLibLsbLibLgbLgRsRsmbLiLsbLsbLg
bRgbLgbRsLsbLibLjbRcbRcbLhRsbRcbRgbLebLhbRcbRobLcbLobRgbLgbRjbLibLgLsb
RsbLgbLibRgbLiRsbsbLsbLibRjbLibRgbRcbRoLsbRhbRcRsmbRibLibLibRsbLcbRgbL
ibLiRsbLgLsbLgbRibLibLibLsbRgbLibRsLsbLsbLgbRgbLibRsbLgbRcbRcbRcbRibLg
bLiLsbRobRhbLjbRiRsmbLcbLhbRiRsmbLsbLiLsbRgbLgbLsbRgbLibLsbLsbLgbLsbLg
bRsbLgbLsbLgbRsbLibRgbLgLsbLsbLiLsRsLsRgbLiLsbLiRsbLgbLsbLgbLsbLgRsbLg
bRsbLibLgLsbRibLiLsbLsbLgbLsbLiLsbRsbLgbLsRsbLiLsbRsbLibLgbLgbRsbLgbLg
bRgRsmbRjbRibLhbLjbRgRsmbLibRsbLoRsLsbRibRibLibLibRcbLjbLcbLhRsbLibLhb
RibRsbLjbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 14; Drug: NDMC 3 µM
bsbRebLiRsbRibRibLgbRiRsmbRsbRgbRgRsmbLsbRibRiLgbLsRsbRsRibRiRsmbRgRsR
smmbRgbRgLsbRgbRgbRsbRgbRgbRsbRgRsRsmmbRsbRibRsbRgbRgbRgRsmbRsbRgbRsbL
sRgbRgbLcbLibRcRsmbLhbLhbRibLhbRjbLhbLibRjLgbLgbLgRsbLsbLgbRsbLgbLsbLg
bRgbLiRgLibRsbLgLsbLgbLgbLsbLsbLsbLgbLgbRsbLgbLsbLgbLsbLgRsbLgbRsbLgbL
gbLgbLsbRsbLgLsbLgbLgbLgLsbRgbLgbRsbLgbLgbLgRsbLgLsbLsbLibLgbLgbLgbLgb
LsbRcRhbLcbLcRsRsmbLsbLibLibLcbRcbRibRhbLsbLibLibRjbLcbLibRibRcbRgbRiL
sbRgRsmbRgbLsbRgbRsRsmbRsbRgbRibLgbRgbRcbLibRgbLgbLiLhbRgbLibLibRjLsbL
iRsbLiRsbLsbLiRsLgbLgLsLgLsbLsbLsLsmbsbRsLsbLgbLgbRsbLgLsbRgLsbLiLsbLg
bRjbLibLgbLebRsbLibLsbLgbLsbLgbLibLgbLsbLsbLgbLgbLgbRsbLibLgbLgLsbLgbL
gLsbLgRsbLsLgbLgbLgbRcbLiLsbLibRcbRoRsmbRibLhbLhLsbLibLgbLsbRhbRibLebL
hbLgbRibLcbRibLcbRibRcbRcLsbRibRsRibRiLsbRibRiLsbLiLsbLibLgRsbRjbsbLcb
RgbRhbRobRobRcbRibLibRobLgbLsbLobLcbLsbRsbsbLiRsRsmbLhbLsbRgbRjbRibRsb
RgbLsbLiLsbRcRsmbRcbLsbLgbLsbRobRgLsbLjbRobLgbRiRsmbLjbRibRsbRhLsbLeRs
bRcbRcLsbRcbRobRibLibLcbRjbLcbRibLibLsbLgbLsbLgLsbRgLsLhbRgLsbLibRgbLi
bRjbLibLgbLgbLgbLgbLsbLsbLgLsbLgbLgbLsbLsbLgbRjbLsbLibLgLsLsmbLsbLgLsb
LibRsLsbLgbLsbLgLsbLgLsbLsLsmbLgbRsbLgbLjbRcbLibRjbLsRibLjbLcbRcbRebLj
bRcbLebLcbRsbLhbRgbLibLgbLsbLsLsmbLgbRsbLgbLsbLgLsbLgLsRsbLsLsLsmmbLgb
LgbLgbLgbLgbLsbLgbLgbLgbLgbLgbLsbLgLsbLgbLgbLsLsmbLgbLsbLsbLsbLgbLsLsm
bRsbLibRiLsbLsbLibRgLsLsmbLibLgLsbLgbLsLsmbLgLsbLgbRjbLsLibLgbLgLsbRgR
smbLiRsbLgbLgbLgLsbLsbLgbRsbLibLgbLgbLsbLsbLgLsbLsbLgbLgbLsbLgbLgbLgbL
sLsmbLgbLsbLgbLgbLgbLgbLgLsbRsLsbLgbLgLsbLgRsbRsLsbLibLgLsbLgbRgbLiLsb
LgbLgbLgbRgbLibLsbLgbLsbLgbLgbRgbLibLsbLiRsbLiRsbLsbLgLsbLsbLibLgLsbLg
LsbLsbLgLsbLsLsLgLsLsmmbLibLsbLgbRsbLibLgbRjbLibLgbRiRsmbRcbRcbLiLsbLi
bLibLcbRibLsbRhRsRgmbLsbRibLsbRiLsbRiLibRhbLobLcRsbRgRsmbLgbLgLsbRibRc
bLcbLsbLibRsLsbRjbLcbRgbLcbRibLhRsbRsbsbLibRsbLgbLgbLsbRsbLgbRsbLhbRgb
LibRgbLibLibLsbRsbLhbRgbLgbLibLsbLgbLgbLsbsbLgbLgLgbLgRsbLsbLsLsmbLgRs
bRjRhbRibLcbLcbRsbRsbsbLiLsbRjbLcbRgbRcbRibLjbRibLsbRibLsbRgbRsbRgbLsb
RiLsbLjbRcbRcbRcbRcbRiRsmbRgbRsbRibLcbLibRhRibRibLgbRobLiRsbRibLjbRgbR
ibLcbLcbLsbRgbLcLsmbRsLsbLsbLsLcbRgbRibRibRsbRibLgbLjbLcbRibRhbRgLsbRs
LsbRibRiRsmbRsLsbRgbRiRsmbRsbRgbRsbRgRsmbRsbRsbRgbRiLsbLibRgbRgbRgbRgL
sbRgbLsbRsRibRsRsmbRgbRgbRgbLsbRsRsmbRgLsbRsLsbRgbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 15; Drug: NDMC 3 µM
bLsRsLsbLsbRibRgRsmbRgbRgbRgbRgbRgLsbLgbRsRgbRgbRgbRjbsbLsbsbRgbRgLsbR
gbLhbLgbRsbLhbRgbLgbRjLiLsbRjbRibRibLgLsbRgRsmbRgbLgbRgbRgbRgbLsbRgRsm
bRsbRsbRibLgbRgbRgbLjbLobLibRjbLibRsbLgbLgbRsbLgbLgbRsRsmbLgbLsbRsbLgb
LgbLgLsbRgbLsbLgbLsbLgbLsbLgbLgLsbLsbLgbRsbLgbLgbLsRsbLgLsbRgbLgbLgbLs
bLgLsbRsLsbLgbLgbRgbLgRsbLsLgbLibRgbLjbRsbLgbRsbLgbRsbLgRsbsbLgbRsLsbL
gLsbLgLsbRsLsbLgbLgLsbLgbLgbRsbLsbLgLsbLsLsmbLgbLgRsbLgbsbLgbRsbLgbRsb
LsbLgbRsbLgbLsbLgbRsLsbLgbLgbRsbLgLsbRgbLgbLsbLsbLgbLgbLgbRjbLsbLgLsbL
gLsbRgbLgbLsbLiRsRsmbsbLgLsbLgbLgbRsbLsLsmbLsbLgbLsLsmbLgbLgbLsbLsbLgb
LsLsmbLgbRsLsLgbLgLsbLsbLgbLgbLgbLgbLsbLsbLgbLsbLsbLgbLgLsbLgLsbLgLsbL
gbRsbLgLsLsmbLsLsmbLgbLsbLgbLgbRsbLgbLsbLgLsbLsbLgbLgbLgLsLsmbLgbsbRsb
RsbLgbLgLsbLsbLgbLgLsbLgLsbLsLsmbLgbLgbLsbLgLsbRsbLgbLgbRsbLsLsmbLgbLg
bRgbLibLgbLgbLgLsLsmbLsLsmbLgbRsRsmbLgbLsbRsbLgbLgbLsLsmbLgLsbLgbLsbLs
bRsbLgbLsbLgbLsbLgbLsbLgbLsbLsbLgbLsbLgbLsbLgbLsLsmbLgbLsbLgLsbLgbLsbL
gLsbLgLsbLsbLgbLgbLsbLgLsbLsbLgbLgbRgbLibRjbLibLgRsbLgbRgbLgbLsbLgbLsL
smbLgbRsbLsbLiLsbRgbLgLsbLgLsbLsbLgLsbLgbRsLsbLgLsLsmbLgLsbLsbLgbRjbLc
bRgbLgbLgbLgbRgbLgbLgbRsbLibLgbLsbLsbLgbRsLsbLsbRjbRibRgbRgLsbRhbLibLi
bLgbRsbLgbLgbRsLsbLgbRsbLsbRsbLcLsmbRgbRgbRhbRibRsLsbLgbRcbLjbRiRsmbRg
RsmbRgbRgbRsbRgbRgbRgbLgLsbRibRgbRgbsbRgRsmbLsbRgbRgbRgbRibLgbLjbLiLsb
RjbLibRjbRjbRibRibRgbLjbLjbRsLhbRjRsmbLibLibRgbsbRjbRgbRgRsmbLsLsmbRgb
LsLsRsmbRgRsmbRsLsbRgbLsRsRgbRgbRgRsmbRsRsmbRgbRgbRgLsRsbRgLsbRgbRsbLs
bLsbRgbRgbLsbRgbRgbRgRsmbLsbRgbRgbLsbRgbRgbRibRgRsmbLsbRgbRsbRsbRgbRgR
smbLgbRhLsbLibRibLsbRhLsbLgbLsbRibRgbLsbRgbRsbRgbRgRsmbLsbRgbRgLsbRsbR
ibLgbRgbLsbRgbRgbRgbRsbRsLsbRgRsmbRgLsbLsbRgLsbRgbRsbRiRsmbRgbRgRsmbRi
bRsbRgbRgbLsLsmbRsbRgbLsbRsbRgbRsbRgbRgbRgbRsLsbRgbRgLsbRgbRgLsbLsLsmb
RibLibRgbRgRsmbLsLsmbRgbRgLsbRsbRgRsmbRsLsbRgbRgRsmbRsRsmbRgbRsbRgbRgb
RsbRgbRsbRgRsmbRgbRgbLsLsmbRgbRsRgRsmbRgbLsbRgbRgbRsbLsbRgbLjbRibLibLh
bLgbRsbRsbLibRjbsbLcbLiLsbRsbRgbRcbLjbLibLgbLgbLgbsbLibLibRgRsmbLgbLgb
LgbRgbLgbLgbLgLsbRjbRibRibLgbRcbLsbLhbRobLsLgbLjbLgbLgbLibRiLsbLibRsbL
gbRsLsbLgbLgbRsbLsbRcbRibLgbRgbRgbLsbRibLsbLgbRhbLibRiRsmbRiLsbLibRcbL
jbRibLjbLiLsbRsRgbLibRsRsmbLgbLgbLsbRjbRsRsmbRjbRibRgbRgbRgbLsbRgbRgRs
mbRgbLsbRgbRgbRgbLsbRgbRcbRibRibRiLsLsmbRsLsbLhbLsRsbLgbLsbLgbLsbLsbLg
bRsLsbLgbLgbLsRsbLsbLsbLsbLgbRsbLgLsbLgLsbLgbRsRsmbLgLsbsbLsbLgbRsbLsL
sRsmbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 16; Drug: NDMC 3 µM
bRgRsmbLsLsmbRibRgbRgbLcbRiLsbRiRsmbRgbLgbRibLsbRiRsmbRsRsmbRgbRibRgRs
mbLsbRgRsmbRgbRsbRgbRiRsmbLsbRgbLsbRibRsbRgbLsbRiRsmbRgbLsbRgbRgbLsbRi
bRgbRibLcRsbRgbRibLcbLcbRsRhbLobLhbLgbRsbLiRsbRhbRiRsmbRibLcbLcbLiLsbL
ibLibLgbRibLhbLibLhbRgRsmbRjbRibLibRcbRibLgbLcRsbLhbLgbRebLgbLcbRiRsmb
RjbRibRsRsmbRsLsbRgbRgbRsbRgbLsbRgbRgbRsbRibRsRsmbRgbRsbRgbRgbRgbRgbLg
bRiRsmbRgbRgbLsbRgbRgbLjbLcbRhbRibRsRsmbRgbLsbRgbRiRsmbRsbRgbRgbRgbRgb
RgbLgbRibRgbLgbRibRgRsRsRsmmmbLsbRgbRgbRgbLsRsbRgRsmbLsbRgbRgRsmbRgbRg
bRsbRgRsmbLgbRiRsmbRgbRibRiRsmbLjbLcbRjbRcbLhbLcbRhbLcbLcbLiLsbLcbRibR
ibRhbsbLgbRibLsbRiRsmbLjbLibRjRcbRibLjbLsbRibRsRsmbLsbRibRsRsmbRgbRsbR
gbRgbRgbRgbRgRsmbRsbRsbRgRsmbRgbRsbRibRsbRgbRgbLgRsbsbRgbLgbRiRsmbRgRs
mbLsbRgbRgbRgbRgbLsbRgRsmbRsbRibLjbLcbLsLsmbRsRcbLcbLcbRibRjbRibRgbRgR
smbRgbLsbRgbLsbRgRsmbRgbRsbRgbRsLsbRgbRgbLsLsmbRgbRgbRsbRgbRgbLsbRgRsm
bRgbLsbRgbRgbRsRsmbRgLsbRgbRgbRgbRibRsbRhbLsbRgRsmbRsRsmbRgRsmbLcLcLsm
bRjbLibLibRibLobLibRgbRibLobRcbRibLibRhbRibLsbLjbRhbLsbRiRsmbLsbRgbRgb
LsbRibRsbLsbRgbRgRsmbRsbRgbRgbRgbRgbRsRsmbRgbRgbLsbRibRibLjbRibLcbRcbR
gbRibLgRsbRibRsbRgbRsRsmbRgbRgbLgbRsbRibRsbRgbRgbRgbRgbRgbLsbRgbLjbRgR
smbRgRsmbRsbRgRsmbRgbRgbRgbRgbLsbLibLgbLgbLibRgLsbLgbLhbRibLibRjbRobLj
bRgbRgbRibLgbRgbRgbRsbRgbRgbRsbLsbRgbRgbLsbRgbRsbRibRsbRgbRgRsmbLsbRgb
RgbRgRsRsmmbRgRsmbLsbRiLsbLjbRgbRgbLgbRibRsbRsbLobLsbRsRgbRgbRgbLsbRgb
RsbRgbLsbRgRsmbRgRsRsmmbRgRgbRgLsbRgbRsLsbRibRgRsmbRgbRgbRsbRsRsmbRgbL
gbRibRgRsmbRsbLsbRibRgRsmbRgbRibRgbLjbRibRgbRgbRgbLsbRgbRgbRsbRgbRgbRg
bRgbLgbRgbRibRgRsmbRgbLsbRibRgbRgbRgbLjbLibLibLiRsbLcbLibLibRibLsbRibL
ibLcbLibRibLhbRobRcLsbLcbRibRibLsRsbRgbRgbRsRsLsmbRsRsmbLsbRiRsmbRsRgR
smbRgRsmbRsbRgbLsbRsbRibLsbRgbRgbRgLsbRgbLsbRgRsmbRgRsmbRgbLgLsbRgbRgR
smbLcbRcbLsbRibLsbRgbRsbRsRsmbRgbRgbRgbRgbRsRsmbRgbRsRsmbRgbRgbRgRsmbL
gbRgbRibLsbRcLsbLcLsmbLcbLcbRcbRebRcbLcbRiRsmbLobRgbRjbRibRgLsbLgLsbRi
bLsbLebLiRsbRjbLibRcbRcbLcRsbRiLsbRcRsmbLsbRgRsmbRsRsRsmmbRsRsmbRgbRgb
RgRsmbLsbRibRsbRibRiRsmbRsRsLsmbRgbRsbRgbRgbLgbRibRsRsmbRgbLsbRiRsmbRg
bLgbRgRsLsmbRibLgbRibRgbRsbRhbRgbLgbRgRsmbsbRgbRgRsmbLgRsbRgRsmbRsRsmb
RgbRsbRiLsbRsRsmbRsbRgbRsbRgbRibLgbRiRsmbLgbRibLsbRsbRibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 17; Drug: NDMC 3 µM
bsbRsbRgbRsbRgbRsbLgRsbLsbLsbLjbRcRsmbRsbRibRsbRsRsmbRsRsRsmmbRgbLsbRi
bLsRsbRsbRsbRibRsbLgbRibRgbRsbRgRsLsmbLsLsmbRgRsmbRgbRgRsmbRsbRgRsLsmb
RiRsmbRsbRgbRsbRsbRgbRgRsmbLsbRsbRgRsmbRsbRgbLgbRibRgRsmbRsbRsLsbRgRsm
bLsRsbRgbRgbRsRsmbRgRsRsmmbRgbRgRsmbRsRsmbRgbRgbRsbRgbRsbRgbRgbRgLsbRs
bsbRgRsmbLsbRibLsbRgRsmbRgbRsRsmbRgbRgRsmbRgLsbRgRsmbRsbRgbRsbRgbRsbRs
bRsbRgLsbRgbLsbRgbRsbRgbRgbRsbRgbLsbRgRsmbLsRsbRgRsmbRsbRgbRsbRgLsbRsb
RsRsmbRsRsmbRiRsRgmbRgbLsRgbRgbLgbRibLsbRgRsmbRsbRgbLsbsbRgbRgLsbRsbRg
RsRsmmbLsbRibRgbRgbRsbRgbLsbRgRsLsmbRsbRgbRgbRgbRgbRsbRgbRsbRgbLsRsbRi
bRsbRibLsbRgbRgLsbRsbRsbRgbRsbLsbRibRsbRgbRsbRibLsRsbRgbRgLsbRgRsmbRsR
smbRgbLsbRgbRgRsmbRobLjbRjbLibLsbRsbsbLcbLgbRgRsmbRgbRiRsmbRgbRcbRsbRi
bLcbLiLsbsbRjbLjLsLsmmbLcLsmbRcbRgLsbRsbRjbRebRibRibLibLsbRgRsmbLcbsbL
hLsbRcbLcRsbRcRsmbLgbRhbLibLsbRcRsmbRcbRgbRgRsmbRsbRgbRgbLgbLhbLibRiLs
bLebRibsbLibLibRgbLcbRhbLjbLgbLgbLibLhLsLsmbLibRcRsmbRibRgbRgRsmbLjLsm
bLibLsbLgbRiLsbLibLibRebLibRcbRibLcbReRsmbLcLsmbLcbLibLibLsbLgbLcbLiLs
bLgbLgbRsbRsbLsbLebRcbRhbRibLsbLjbRcbRcbLsbLibLgbRgbRcbLgbRgbRcbRgbRgb
RgbsbRsbRsbRibLjbRgbRibLgbLsbLcbRcbRhbLsbRibRsbRgRsmbRsbRgbLgbRibLsbRg
bRgbRgLsbLsbRsbRgbLsbRibLsbRgbRgRsRsmmbRsRsmbLsbRgbRgRsmbRgbRsbRsbRgbR
gLsbRgRsmbLsRsbRgbRsbRsRsLsmbLsLsmbRibLsbRsbRgbLsbRgbRsLsbRgRsmbRgRsLs
mbRsbLsRgbRgbRsbRsbRgbRsbRgRsmbLsbRgbRsbLsbRibRgbRgLsbRsbRsbRgbRsbRgbR
sbRgbRsbRgbRsbRgbRgbRsbRgRsmbRsbRsRsRsLsmmbRgRsmbRgbRgRsmbRgRsmbRsbRsL
sbRgbRsbRgbRsbRgbRgbLsbRgbRgbLsbRiRsRsmmbRsbRsbRgbRgbRgRsmbLsRsbRgbLsR
sbRgbRsbRgbRsbRgbRsbRsRsmbRgbRgbLsbRgRsmbRsbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 18; Drug: NDMC 3 µM
bLibRgbLiLsLsmbLsbLsbLgLsbRsbLibLsbLgLsbLsbRgRsmbRhbLsbRgbRibLgbLjbRhb
RcbRsbLsbRibRgRsLsmbRgLsbRgbRgbRgbRgbLsbRgbRibLjLsmbRgRsmbRsRebRgbLsbL
ibLgbRibRibRibRibRibRcLsbRibLiLsbLibRgbLibRgbLgbLsbRgbLgbLsbLgLsbLsbLg
LsbLgbLgRsbRcbRcbRgbRiLsbLibRgbLsbLjbLsbsbRibLgbRiLsbRgbLjbRibLjbRibRs
bRgbLsRsLsbRgbLsbRgbRiLgbRiRsmbRgLsbLjLsmbRgLsbRjbLsbsbRibRgbRgbLgbRib
RsbRibRgLsbLjbLsRibLjbRiRsmbRgbLgLsbRgbRiLsbRgbLgbRiRsmbRgbLsbRibRgbRs
bRgbLibRibRsbRsbRiLsbLjbRibLsbLsbRsLsbLsbLsRsbRgbRgbRgbLsbRobRiLsbRibR
gLsbRibLjbLsLibLibLobRgLsRsbLibRiLsbRibRgbLgbRibRgLsbLgbLsbLgbsbRsbRib
LgbRibLgbRiRsmbRsbRibRiLsbLsbLjbLgbRjbRibRgbLsLsmbRgRsmbRibLjbRibRgbLs
LsmbsbRgbRgbLgbRgbRgbRgbsbRsbRgbRgbLgbRgbRgbRsbRibRgbLgbRibRsLsLsmbRgb
RgbLgbRibRsbRgbRgbLsbRibRgRsmbLsbRgbRjRsmbLcbLcbRgbLiRsbRsbLibRsRsmbLi
LsbRgLsbLgbLsbLsbLsbLgbLsbLsbLsRsbLiLsbLgbLsbLgLsbLsLsmbLgbRsbRsbLibLs
bLsLsmbLgbRsbLibRgbLgLsRsbLsbLgbRsRsmbLgbRsbLgbLsbLgbLsbLiLsbLsbLgbLsb
LsbLgbLsbLgbLgbRsLsRsbLgbLsbRgRsmbLsbLibLsbLgRsbLsbLgLsbRgLsbLgbLgbLgb
RgbLsbLiLsbLcbsbLibRibLibRibRibLgbLoRsbLibLibRgbLhbRgbLibLibLibRsbLibR
sbRjbRibLcLsmbLcbLiLsbRsLsbRsbLibLsbRsbLsbLsLsmbLibRsLsbLibRgLsbLibLsb
LsbLgLsbRsbLibLgbRjbLibLsbRsLsbLgbLsbLsbLgbLgbRsbLsbLgbRsbRsbsbLibsbRj
bRsLgbLiRsbRsbLibLgbLiLsbLgbLgbsbLsLsmbLsbLsLsRsmbLgbLsbLgbRsbLibRsbLg
bLibRsbLgbLsbLsbLgLsbRsLsbLgbLgbRsbLgbLgbLgbLgbLgbRjbLjLsmbLsbLibLsbRs
bLgbRsbLgLsbRsbLgLsbLibRjRsmbLgbLsbRgbLgbLgbLsLsmbRsLsbRsbLsbLibLgbLsb
RsbLiLsbLgLsbLgbLgLsbRgbLibLgbLibLiLsbRgLsbRibLhbRoRsmbRhbLibLjbLibLiL
sRsbLgbLgbRhbLgbRjbRcbLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 19; Drug: NDMC 10 µM
bLgbRgbRsLcbLibRgbLibRibRcbRgRsmbRgbsbLjbRiRsmbRiRsmbRsbRgbLjbRibRsbLc
bRsbRibLgbRibRiRgbLsbRgbRgbLcbLibRobRobLiRsbLgbLibLgbLgRsbRgbLibRjbLib
LibLibRgbLgLsbLsbRcbRsbRibRsbRgbRsbRsLsbRgRsmbRsLsbRgbRgRsmbLsbRsRibRg
bRsRsmbLcbLibRgbLibRgbLcRsbRgbLcRsbRibLiLsbLgbLsbLsbLgbRsbLgbLgbLgbLgL
sbRgRsmbLgbLgbLsbLgbLsRsLsbRjbRhbRibRgbRibRjbLcbLsbRsbRhbRgbLsbLhbLcbL
cLsmbRgLsbLiLsbLjbLobLcbRgLsbRgbLsRsbRcbRgbLsbRibLsbLcbsbLhbLjbLsbRcbR
iRsmbRsbRibLsbRcbRoLsbRcbRibRcLsbLhbRibLgbRibRgbRsbRgLsbRibLsbRsbRiRsm
bRsLsRgbRsRsmbLsbRsbRgbRsRgbRgbRsbRgbRgbRsLsbRgbRgbLcbLibRcbRgbRgbRsbR
gbRsbRgRibRgLsLsmbRgRsmbRgbRgRsmbRgbRgbRsRsRsRimmbLcRibRgRgbRgbRjbRsRg
RsmbRsLsbLsbRgRsRgmbRgRsmbRgbRsLsbLibRjbLcbRebLcbRjbLiLsbRjbRjbRibLsbR
sLsbRgbLsbLgbRiRsmbRgbRgbRjbLhbRgRsmbRsbLobRsbRibRsLsbLcbLibRsbLibLgLs
bRsbRebLcbLgbLgbRsbRebLebLiLsbLjbLsLsmbRsbLgbLsbLgbLgbLgbLgLsbLsLsmbLg
bLibLsRsLsbRjbLibRobLhbLibLcbRcbLjLsmbRiRsmbRjbLhLsbRebRoRsmbLibRgbRhL
sbLjbLcbLcRsbLiLsbRsbLiLsLsmbRgbRebLcbRgbLgRsbRjbRgLsbRiRjbRsbRgbRgRgb
RsbLhbRjbLsLsmbLibRjRsmbLhbLhRsbRgRsmbRgbLgRsbRibRibLgbRhbLsbRebLhbLcb
LcbRcbRcbLiLsbRgbRjbLgbRebsbRsbRgbRgLsbRibLebRsbRsbLibRgbLsbLgbLgbRsbL
ibLcbRcbLgbLsRgRsmbRsLsbRsRsmbRgLsbRgbRsbRgbRjbRgRsmbRsbRsRsLsRsmbLsRg
RsmbRsbRsbRebLibLcbsbRcbLcbLcbLsbLsbLgLsbLgbLgbLgbLsLsmbLgbLsLsmbRsLsR
sbLibLsbLgbLsbLsbLgbLibLsLibLgbLgLibRsbLhbLibRobRgbLsbLjbRgbLeLsbRibLs
bLsbRibRgbRgbLsLsmbRgbLcbRjbLcLsmbRsbLibLsbRjbRhbRcbLsbLcbLiRsLsbLibRg
bRoLsbRhbLgbRiRsRsmmbRcLsbLibLjbLhbLgbLcbRcbLcbRsbRgbLibRsbLhbRgLsbLgb
LgLsbLgbLsRsbLsLsmbsbLgbLsbLgbLgbLsLsmbLibLsbLgbLgLsbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 20; Drug: NDMC 10 µM
bRibRgbRobRibLiLsbRsLsbRgbRibRsbRibRiRsmbRiLsbRiRsmbRibRsbRsLsbRjbRjLs
bLjbRibRsbLjbRibRsbRgbLgbLsLjbRobLjbLhbRsLsbLiRsbLgbLgbLgbLcbRibLgLsbR
gbRgbRibLjbLhbLgRsbRjbLibLiLsbLhbLgRsbRgbLgbLgbLgbLsbRgbLgbRsbLgbLgbLi
bRjbRobRibRsbLjbRhbRgbRsRsmbRiLsbLgbRibLsbRgbRibLsbRgbLsbRibRgbRibRsRs
mbLibLgbLibLibLsbRobRobRcbRibRgbRgbLebRjbLibLibLcbRibLgbRhbRibLgbRsbLi
bRjbRsRibLcbLibLgLsbLibRibLhRsbLoRsbRibLgbLgbRcbRsbLjbLibRhbRsbRobLibL
hbRibRhbLebLcbRgbLjbLibLgbRjbsbLibLibLiRsbLgbLgbRibRgLsbLgbRhbRcbRoLsb
RcbLgbLibRjRsmbLibRjbLibRgbLibRsbLsLsmbLsbLgbsbRsbLgbRsbLgbLgLsbRsbLsb
LibRgbLgbLgbRgbLgLsbLgbLgbLibRsbLgbLsbLgbLsbLgbLsbRjbsbLgbRjbLebLgbRsb
LsbRsLsRsbLgLsbRsbLgbLsbRsbLibRgbLsbLcbRsRsmbLgLsbRibLibLgbLsbLibRibLj
bRcRsRsmmbLhRsbRcbLgbRibLsbRgbRibLsbLhbLibLibLibRgbLgbRgbLibRjbRcbRsbR
ibLgbLcbRibLsRhbRibRibRgbLibLhRsbsbRgbLgRsbLgbRsbLgbLgLsLsmbLgbLibLibR
sbLibRsbLgbRjbLgLsbLsbLgbRgbLgbLgbLcbLcbRjbLibRibRsbLeLsbRgbLgRsbLgbLg
bLgbRsbLgbLsbLgbRsbRgbRcbRebRhRsmbRibLcbsbLsbLgbRgbRjbLcbLhbLhbLibLgbR
ibRibLibLgbRhbRiLsbLgLsbRibLsRsbRibRgLsbRibLhbRgRsmbRgbLsbRgbLsbRgbLjb
LhbLcbLhbLgbLgbLjbRcbLgbRibRibLsbRibLjbRiRsmbRsbRibRhLsbLibRibRgbRiLsb
LhbLobLibRsbLgRsbRgbRgbRibLjbRibRgLsbRgbRcbRhbLcbLcbLibLibRibRibRibLsL
jbLcLsmbLhbRibLgRsbRsbLiRsbRibLibLhbRcbRcRsmbLjbLibLcbLgbLsRcRsmbLgLsb
RibLgbLibRcLsbRhbRgbLgbRiLsbLsbRsLsbRibsbLgbRibLgbRiRsmbLgbRoLsbRibRob
RibLsbRibRcbRiRsmbLibRibRsbLsbRibLgbRibRcbLibRgbLsbLibsbLgbRcbRibLsLsm
bRibLsbRsRobRcbRibLgbRsbLibRhbLjbRcbLgbRgbRsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 21; Drug: NDMC 10 µM
bRibsbRibRgbRhLsbLgbRiRsmbRgbRgRsmbRsbRgbRiLsLsmbLgbRibsbRgRsmbRgbRgbL
obRebLcbLhbRibLiRsbLibLobLebRibRcLsbLgbRgbRhbLibRibRgbLsbRgbRibLjbRiRs
mbRsbRibRsbRgRsmbRjRibRobRhRsmbLjbLcbLobRobLibRgbLsbRgbLjbLiRsbLgbRjbL
ibRjbLibRgbRhbRibLjbRcbLoLsmbLhbLobLcRsbLsbRebLjbRebLgbRibLsbRgbLcbRcb
RobRobRobRhbRibLibRibRiRsmbRibLgbRsbLhRsbRgbLgbRcLsbLcbLoRsbRibLgbLiLs
bLgbRcbsbRsbLsbRcbRsRsmbsbLsbRsRsRsmmbRsbRsbRibLgbRiRsmbRgRsmbLsbRgbRg
bRgbLsbRiRsmbRgbRgbLsRsbLjbRcbLgbLjbLcbLobRhbRgbLibRibRiRsmbRibRgRsmbR
hbRcbLibRibRibLibLcbLsbLibRjbRcbLjbRgbRibRibLgbRibRgbRiRsLsmbRobLgbRib
LsbRiRsmbLjbsbRhbRsbRgRsmbRsbRibLsbRgbRibLgbRgRsmbLcbLibRcbRoRsmbLiLsb
RibRsbRcbLgbRgbRiRsmbLjbRibLsbLjbRcbRcbRobRgbLcRsbLgbRjbLcRsbRcbLebLiR
sbRsbLiRsbLibRhbLhbRgRsmbLibRsbLgbLobLobLoRsbLhLsbLibLgbRgbRibRibRsbRi
bRhLsbLgbRibLobLobRcbLibRgbRhRsmbLsbRiRsmbLsbRgbRgbLsLsmbRibLjbLibLhbR
gbLgbLgbLgLsbLgbLgbLgbRgbLgbLsbLgbRjbRobLcbLobLobRcbRibRiRsmbRgbRibLgb
RgbRcbLiLsbRibRgbRsbRiRsmbLgbRibLjbLibRcRsmbRibRgbRsbRibLibLjbRcbLgbRh
bRibRibRcbLibRibLsbLibLibRcbRiRsmbLibRiRsmbRiRsmbRsbRiRsmbRcbsbRibRgbR
hLsbLibRibRibRhbLibRibLgbRobRoLsbLibRibRibRibLjbLcbRcLsbRcbLcbRjbRiRsm
bRsbRobRobRobRcbRcbRiRsmbLibRibRibLsbLebLibRibRibLcbRcbLjbRhRsmbLcbRob
LoLsmbRsbLibLgbLobLhbRibLiRsbRcbRcbLgbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 22; Drug: NDMC 10 µM
bsbRsLsbRjbLibLgbRsRsmbLibLcbLcbLibRsbLiLsbLiLsLsmbLibLibLgbLibLgLsbRc
bLibLgbLsbLgbLjbLjbLsbLjbsbLcbLebLibsbLgLsbLjbRebRiRsmbRibRibRibRgRsRs
mmbRgbRgbRgbsbsbLsRsLsLsmbLsbRsLsLsmbRsbsbLgbRhbRgbRgbLjLsmb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 23; Drug: NDMC 10 µM
bsbRsbLgLsbLsbLgbLgbLgbLgbRsbLgbLibLgbLgbLsbLgLsbLsbLibLgbLsbLhRsRsLsm
bLgLsbLgbLsbLgbLgbRsbLgbLgbLsbLgbLgbLgbLsLsmbLsLgbLsbLgbLgLsbLgbLgbRsb
LibLsbLgbLgbLgbLsLsLsLsmmmbLsbLgbLsLsmbLgbLgbLiLsbLibLgbLsLsmbLiLsbLsb
LgbLsbLgLsbLsLsmbLgbLgbLsbLgbRgbLgLsLsmbLgbLgbLibLgbRsbLgbLsbLgLsbLsbL
gLsbLsbLgRsbLsbLgbLibLsbLgbLgbLsbLsRjbLhbLgbLgbRjbRcbRcRcbRcbRcbRhbRib
LhLsbLhbLcbLibLgbLgLsbLiLsbLgbRsbLgbLgRsbLsbLibLgbRgbLibLsbLibLsLsmbLg
LsbRsbLgbLsLsmbLgLsbLgLsbRsbLibLgbLgbLsbLsbRjRibLhbLibLsbLsbLgbsbLsbLg
LsbLgLsbRsbLgbLsbRsbLgbLsLsmbLgbLgbLsbLgLsbLgbLgbLgbLgbLgbLsbLgLsbLgbL
sbLsbLgLsbLsLsmbLgbLgbLgLsbLgLsbLgbLgbLgLsbLsbLiLsbLibLgbLgbLsbLgbLgbL
gbLgRsbLgbLgbLgLgbLgLgbLgbLsbLgLsbLgLsLsmbLgbLgbRgbLiLsbLgbLgLsbLgbLsb
LgbRsbLiLsbLsbLgbLgbLgbLgbsbLgLsbLsRsbLibLgbLgbRsLgbLsbLibLgbLgbLgbLgb
LsbLibLsbLibLgbLgLsbLsLsmbLgLiLsbLgLsbLgbLgbLsbLgbLsLiRsbLgbLibLgbLgbL
gbLsbLgLsbLsLsmbLgLsbLibLgLsbLgRsbLsLsmbLsbLsLiRsLsbLgbLsbLgbLsbLgbLsL
smbLgbLgLsbLgbLsLsmbLibLsbLibLgbLsbLsLiRsbRcbRcbLiLcbLibRcbRcbRiLsbLib
RibRibRebLsbLgbLcbsbLgbRibLgbLiLgbLgbLsbLgbLgbLsbLsbsbLgbLgbLgbLsbLgLs
bLsRsbLgbRsRsmbRsRcLsbLiLsbLibLiLsbLgbRgLsbRsLsRsbLibLibLhbLgbLibLibLg
LsbLgbLibLgbLibRjbRcbLgbLcbLibLgbLgbRobRgbLgbLjbLhbLgbLgbLsLsmbLgbLsbL
gLsbRsbLibRsbLgbRsbLgbLgbRsbLgbLsbLibRjbRcbLebLibLsbLsbLiRsLsbLgLsbLgb
LgbLgLsbLsbLgLsbRgbLibLsbLgbLsbLgLsbLgLsbLgbLgbLsbLgLsbLgLsbLgbLgbLsLs
mbLgbLsbLgbLsbLgLsbLsbLgLgLgLibLgbLgLsbLsbLibLgbLsbLiLsLsmbLgbRgbRsbLh
bLsbLsbLibLsbLiLgbLgbLgLsbLsbLgLsbLgbLibRsLsbLsbLgLsbLsbsbLsLsmbLgbRsb
LgbLgLsbLsLsmbLsbLgLgbLgLsbLgLsbLsbLgbLsbLgLsbLgbLgbLsbLgLsbLsRsbLgbLg
bLsbLgLsLgbLsLsmbLiLsbLgbLsbLgLsbLibLgLsbLgbLgbLgbLsbLgbLsbLibLgbLsbLs
LsmbLibLsbLsbLibLgbLgbLsbLiLgLgbLibLgbLgbLgLsbLsLsmbLgLsbLgbLgLsbLgbLg
bLgRsbLgLsbLgbLgLsbLibLgLsbLgLsLsmbLgbsbLgbRsbLgLsbRsbLsRcbLcbRjbLibRj
bLcbRsRsmbLgLsbsbLsbLsbsbLgbLibLhLsbLcbLiLsbRjbRhbLibLcbLibLhbRgRsLsmb
RibRgLsbLobLsLsmbLibRjbRhbRcbRibRgbLibLsbLhbLiLsbLibLgbLsbRcbLjLcbLgbL
sbRjbRiLsbLjbLcbRgbLiRsbRcbRibLgbRcbLibRibRjLsLsmbRobLhbLsRgbLibLhbLiL
sbLgbLgLsbRsbLgbLgLsLsmbLgbLgbLgbLsbLibLgbLsbLgRsbRebLcbLsbRebRibRgbRi
bRoRsmbLibRhbLibRsbLgLsbRebRgbLjLsmbLhbLgbRgbLibLgbLgbLhbRhbRiRsmbRibR
cbRhbRgbLsbLcbLibLgbLibLhbLhbLibRcbLibLjbLcbLibRsbRsbLcbRsRsmbLsRjbLib
sbLsbLgLsbLgbLgbLgbRgbLibLsLsmbLgbRsbLgLsbLsbLgbLsbLiLsbLsbLibRgbLiRsb
LgbLibRsbRgbLibLsbLsbLgLsbLgLsbRsbLgbLsLsLsmmbLgLsbLgbLsbLibLsbLgbLsbL
ibLgbLsLsmbLsbLcbRgbRjbLhRsbRjbRibRgRsmbRsbRgbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 24; Drug: NDMC 10 µM
bLsbsbsbRsbRgbRsRsmbsbRgbRcLsbLgbLsbRgbRibRgRsmbRgbLgRsbLsbRgbRibRsbRs
bRsbRibRgbRgbLgbRibRibLjbRiRsmbRsbRjbRibsbRsbRgbRsbRgRsmbRsbsbRgbRsbsb
RgbLsbRgbLgbsbLgbRsbRsbRsbRsbLjbLsLcbLsLsmbLhbRibRhbRibRibLiRsbRibRgbL
gbRgbRgRsmbLsRsbRsbRgbLsbRgRsmbRgbRsbLsbLsbLsbLgbLjbRgbRsbLsbsbRsbRgbR
gbLsbRgbsbRgLsbLgbRibRgbLgbsbRiRsmbRsbLsRsbsbsbRgRsRsmmbLsbRibRsbRgbRg
bRsbRgbLgbRsbRgbLgbLsbLsbLjbsbRgbLjbRibRgRsmbRibRsbRibsbLgbRjbRibsbLjL
smbRibRibRibRibRgbLiLsbRobLgLsbLgbRcbRiLsbRgbRsbRgRsmbLibsbRiLsbRgbReb
LibLgbRiRsmbRgRsmbRsLsbLsbLsbLsbRibLibRcRsmbRibsbRsbRibRgbLibLsbRgbRgR
smbRsbsbLsbLsbRjbLjbsbRibRsbRgRsmbLsbRgbRgLsbLgRsbRiRsmbLsbRgbLsbRsRsm
bLgLcbLibLsLobLiLsbRcbRibRsbRgbRsbRgbLsbRibLsbRibRibLgbLgLsbRibRibRsbL
ibRcRsmbRiRsmbsbRgbRgbRgbRibRibRibLsbLsbRsbRibRibRsRsmbRjRsmbRiRsmbsbL
ibLsbRgbRgRsmbLiLsbRgbRcbRsRsmbRgbRsRsmbRibRgbLgbLibRcbsbRibLgbLsLsmbs
bsbRhbLsbLgbRcbLsbLsbRjRsLsmbLibRiLsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 25; Drug: Control
bRibLhbRibRobRhbLibLibRgLsbLibRsbLsbLgbRsbLgbsbRsbRjbLsLibRgbLsbsbRibL
ibRcbLiLsbLgbRsbLebLibRsbRsbLibsbRsbRsbLsbRsbLibRsbsbsbLgRsbLgbLsbLsbL
sbLgbRsLsbLibLibRsbRgRsmbRibLebLcbRibLhbRgbLgbsbLgbLsbsbRsbLibLsRsbLib
LgbLsRsRsmbLgbLgbLgLsbRjbRsbRsbRebsbLjLsmbRsLsbLhbRibLcbRibLjbsbRsbLib
LsbsbLsbsbLsbsbLgLsbLsLsmbLsbLsbLgbRgbLgbLibLcRsbRibRgbLsbLsbLibsbRsbR
sbLgbLsbsbsbsbLgbLsbRjbRhbLjbLcLsmbLjbRgbLgRsbLsRsRsmbLibRsLibRgbLgRsb
RibLibsbRsbLgbRsbLsbLiRsbRgbLibLgbLgbLcbLcbLjbLcbLhRsRsmbLgbRgbLebRsbR
gbRibRcbLibRibsbRcbRhLsbLibLiRsbRgbLibRobRibLiLsbRhbLiLsbLcbLcbRjbRhbL
hLsbLcbRgRsmbsbLibRsbLcbRibsbsbsbLibRgbLibRgbLiLsbRgbsbRsRsmbsbLibRgbL
ibRhbLhbRsbLiRsbLgbLsLsmbRsLsbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 26; Drug: Control
bLgbRibRibRsLsbLjbRibLjbRgbRsbRgbRsbRgbLsbRibRsbRgbRsbRgRsmbRsRsmbRgbR
gbRsRsmbRsbRibRgbRgbRsbRgbRsbRsbLjLsmbLibRjbRcbRgbRsbRibRsbRgRsmbRsbRg
bLsbRgbRgbRgRsmbLsbRgbRsbRgbRgbRsbRsbRgbLsbRgbRgRsmbLsRsbLsbRibLsbRgbR
gbLsRsbRibRsbRsbRsRsmbRgLsbRgbRgbRgbsbLsLsmbLcbLgbLobLobLhbLibRjbRgbRg
RsmbRgbRibLsbRhLsbRibLoLsmbLobRgbRgbRcbRsbRibsbRibRsbRgbLjbLcbRibRibRs
bRgbLsLsmbRiRsmbRibLsbRgbLsbRiRsmbRgbRgbRgbRsbRgbRgbRgbRgbLsbRgRsmbRsb
RibRgbRsbLjbRibRgRsRsmmbRgRsmbRgbLgbRgRsmbRsRsmbRsbRgbRsbRgbRgbRsRsmbR
gbRsbLsbRgbRsbRgbRgbRgbRgbRsbLsbRgbLsbRgRsmbRsRsmbRgbRgbLsbRgbLibsbRjb
RibRgbRsbRsbRgbRsbRgbRgbLsbRgbRgbRgbRgbRgbRgbRsbRsbLsbRgbRsbRibRsbRgbR
sbRgbRsbRsbRsbRibRgLsbRgbRgbLiRsbRiLsbRgbRsbRibRsbRgbRsbRgbRgRsmbLsbRg
bRsbRsbRsbRibRcbLhbLibLgLsbLgbLcLsLsmmbLobLsbLibLiLsbRsLsbLsbLibRsbLsb
RgbLgbLiLsbLsLsmbLgbRsbsbRobRsbRibLsbRsbLgbRcbLgbRcbLgRsbRibRsbRsbRgbL
sbRsbLhbLibRgbRsbLoLsmbRgbRjbRhbLjLsmbRhbRibRgbRsLsbRobLgLsbLsbLibLsbL
gbLsbLsbLgbLgbLgbRsbLgbLgbLsbLgbLgbLsbRobLibLobRcbRsbRgbLibLsbRgbLibLi
bRjbLhbRibLsLsmbLibLsbRgbRcbLsbLsbRibLsLsmbRgbRgbRgRsmbLsbRsbRgbRsRsmb
RgbRgbRgbRsbRsbRsbRibRsbRiLsbRsbRsbRsbRgbRgbRsbLebRjbRgbRibRibRgLsbRgb
RgbRgbRgbLgbRhbLsbRiLsbLgbRibLsbRgbRgbRsbRsbRgbRgbRsbRgbRgbRsbLsRgbRgb
RsbRsbRgbRsbRsbRiLsbRgbRsbRsbRsbRgbLsbRgbRgbLsLsmbRgbLsbRgLsbLgbRgbRsb
RsbRgbRsRsRsmmbRgbRsLgbRgRsmbRsLsbRsbRgRsmbLsbRgbRgbLsbRiRsmbRgbRsbRsb
RsbRsLcbRcbRsRsmbRebRgbLibLjbLgbsbLcbRcbLhbRcbRgbRibLgbRibRcbLsbLhbLib
LgbLobRibRhbLibLibLgbLgbLsbRsbLgbLsbLgbsbLgbRjRsmbsbRcbLsbRibRsbRgbRsb
LsbRsRiRsmbRsbRgbRgbLsbRgRsmbRgbRibLsbRiLsRsbLsRsbRgbLsbRibRsbRgbRgbRs
bRgbRgbRgbRgbRgbLjbLibLsbRobRsRsmbRsbRgbRgbRgbRgbRsbRsbRgbRgbRgbRgbLsb
RgbRgRsmbRgbRgbRgbRgbRgbRgRsmbRsbRgbRsRsmbRgbRsLsbRgRsmbRsRsmbRgbRgbRs
bRgbLsbRiRsmbRgbLibRibRgbRsbRsbRgbRgbLsbRgRsmbRgbRsbRgRsmbRgbRgbRgbRsL
sbRgbRgbLgbRsbRiLsbLgbLsLsmbRibLsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 27; Drug: Control
bRjbLhbRhbRhbLhbRhRsmbRibRgbRsbRgRsmbLgRsbsbLgbRibRibRgbLgbRibRgbLsbRg
bLsbRgbRgRsLsmbLsbRgbLgbRgbRgbRgbRgbRsbLsbsbRgRsmbRgbRgbRsbLsRsbRsbRgR
smbRsbRgbRsbRgbRgbRgbRgbLgbRibRgLsbLsbRibRgbLgbRgRsmbLsbRsbRsbRiRsmbRg
bRgbLgbLgbLibRcbRibRsbLsbsbRibRibRibRgbRgbLgbRgLsbLsbRibRsbLhbLibRjbLg
bLgbRgRsmbLgbLsLsmbLgRsbLsbLgbLgbLgbLsRsbRgbLgLsbLsbLgbLsbLibRgbLgbRsb
LcRsbLcbRibLhLsbRgbRhbLibRiRsmbLsbRgLsbsbRgbLgbLsbLsbRgbRsbRgbRibsbRib
RgbRgbRgbRgbLibRibRibRgbRsbRsbRsbRsbRsRsmbLsRsbRgbLgbRgbLsbLjRsbRcbRcb
LibRibLgbRiRsmbLsbRiRsmbRsbRsbRgbRibRibRgRsmbLgbLgbRibRibLgRsbRgbLsbRg
bRgRsmbRgbRgbRibRgbRibRgRsmbRgbRsLsbRibRsbRgbRsbRsbLsRsRsmbRgbRgbRsbRg
bRgbRgbRgbRgbLgbLjbRibRibRgbLgRsbRibRgbRsbRsbRsbRgbRgbRibLjbLsbLebLcbR
jbLibLsRsbsbLgbRsbLcbLibLibRibLhbsbLjbRibRgbRsbRgbRgbRibLgbLcbLgLsbRsb
LibRibLcbRjRsmbRibRgbsbLjbRiRsmbRgbLsbRgbRgRsmbLsbsbRsRsmbLgbsbRgbRgbR
gbLjbRgbLjbRibLjbRibRgbRgbLsbRgbRgbRsbRsbRsRibLibLjbLhbRhbRibRgbRgbRsb
RsbRsbLsbRibRhbLgbLjbRsRibRgbRsbRgbRgbLsbRsbRgRsmbLsbRgbRgbRsbRsbRsbRg
RsmbRgRsmbLsRsbRibRsbRgbLgbRgbLsbRgbLsbRgbLsLsmbRibLjbLcbLcbLcbRgbLibL
sRsbLiRsbRjbLiLsbRsbLibRjbLcbRsbLibRjbLibRjbLibLhRsbRhbRgbRgbRibLjbLcb
RjbRhbRcRsmbRcbRjRibRgbLjbRibLsbRgbRsbRgbRsbRgbLsbRgbRgRsmbsbLgbRgbRgR
smbRibLgbRgbRgbLjRsbRgbRsbRgRsmbRgbRsbLgbRibLiLsbLjbLhbLibLibRjbLibLsL
smbLgbLgbRibLgbLsbRjbRibLjbRhbRibRgbLgbRgbLsbRgbRibLoRsRsmbRjbRibLsLgb
RgLsbLcbLibLgRsbRjbRhbRibLjbLcbRibRibLsbRibLsLsmbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 28; Drug: Control
bRsbRsbRsbRgRsmbRsbLsbRgbLgRsbLobLhbsbLcbLsbRgbRiRsmbRgbRibRsbRibRsbRs
bRiRsmbRgbRibLibRcRsmbRgRsmbRgbRiRsmbRsbRgbRsbRgbRibLsbRibRsbLgRsbRibR
ibRgbLsbLsbRhbLsbRhbLgbRibRsbRibRgbLsRsLsbRsbRgRsmbLsRsbRibLsRsbRsbRgb
RibRgbLiRsbRibLsbRjbRsbRibRgbRgRsmbRgbRgRsmbLibLhLsbRcbRcbRgbLgbRgbRib
LsbRgbRibLibRobRibRsbLibLsbLibLgbRsbLsbLgbLibRibRjbRhbLgRsbRibLsbRgbRg
RsmbRsbLcbLsbRsbLhbLhLsbRsbRsbLgbRsbRhbLjbLjbLgbLibRgbRcbLgLsbRiRsmbLg
bRibLgbRsRsmbRsRgbLsbRibLgbRgbRsbRgRsmbRgRsmbRgRsmbRgbLiLsbRjbLgbRgbRs
RsmbLibsbRhbRgbRgbLsbLgbRsbRcRsmbRibRebRsbLsbsbsbLsbRebLgLsbRibRsbLibR
iRsmbLsbRgRsRsmmbRsbRsbRgbRgLsbRsbRsRsmbRgbRsbRsRsmbRsbRgbLsbRsbLcbsbL
sbLsbLsbLibsbRsRobRsbRsbRibRsbRgbLsbRhbRibRgbLgbRhbRcRsmbLgbRjbRgbRsRs
mbRsbLsbRsbRgbRgbRibsbLgbLcLsmbRhbRgbLcbRobRibRgbRsRsmbRsbRgbRibRibLgb
LiRsRsmbRhRsmbLsbRhbRsbLgbRgbRibRgbRhbLgbRgbLhbLgbLibRgbLgbLgRjbRebRcb
LcbRsbLcbLgbLibRiRsmbLjbLibLcbRcRsmbsbLibLibRiRsmbRibRsRsmbRgbRsbRsbRs
bRsbRsbRibLgRsbRgRsmbRsbRsbRsRsmbRgbRgRsmbRgbRsRgbsbRgbRibRgRsmbRsbLsb
LjbRiRsmbRibLgbRiRsmbRsRsmbRsRsmbRgbRgbRgbRgbRgbRsbRgbRgbRgRsmbLibRibR
ibLsRsbRsbRsbRsbRgLsbRsRsmbRgbRgbRsbRgbRgRsmbRgbRgbRgbRgbRgbLibRibRsbR
gbLsbRibRsbRgRsmbRsRsmbRgRsmbRsbRgbRgRsmbLsRsbRgbLjbRibLibLcbLsbLhbRhb
LcbRjbRcbRiRsmbRiRsmbRsbRsbRgRsmbRjRsmbRjbRsbRcbLgbRcRsmbRibLsbLsbRcRs
mbLgbRsRsmbRibRsbRibRgbRcRsmbRibLibRjbRibRsbRgbRgbLsLobRibRcbRibLibRib
RsRsmbRsbRibRgRsmbRgbRsbRibLgbLcbRebRibRsRsmbsbRibLsbLsbRcbRsRsmbsbLib
RibRsRsmbRibRsbLsbsbRiRsmbRsbLgbRjbRgbLgbLsRsbRhbRibRibRsRsmbLcbLsbLsb
LibLsbLibRsbLgbRgbRsRsmbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 29; Drug: Control
bRgRsmbRgbRgRsRgRsmmbRgbRgLjbRgbRgRsmbRsRiRsmbRgbRibRgbRgbRgbRsRsmbRgb
RibRgRgbRgRsmbRgbRsRgbRgbRgRsmbRgRsmbRiLsbRsbRgbRsbRgRsLsmbRsbRsRgbRgb
RsLsbRgRsmbRgbRgRgbRsbLsbRgRsmbRgbRsbRgbRsbRgbRgbRgLjbLibRibRiRsRsmmbR
gRsmbRgbRgbRgRsmbRgbRsbRgbRibsbRibRibLgbRgbLibLibLibRjbLgbRjbRjbRgbRgb
RsbRgbRgRsmbRgbRiRsmbRgbRsbRgbRgbRgbRgbRgbRsRsLsmbRgLgbRibRsbRsLhbLibR
eRsmbRibRgbLsRsbRgbRibLjbRgbRhbLgRsbRhbLgbLjLsmbRobRcbRibRsRibLsbLobLi
bRibLhbLibRsbRgLsbLcbsbRibLibRjbRhbLsbRgbRgbLsRsbLhbLgbLibRcbRhbLibRcb
LgbRsbRibLjbRibRibLgbRgRsmbRgRsmbRsbRgbRgbLjbRibRsbRcbsbLhbLibLcbRibLc
bRgbLibRjbRhRsmbRhLsbLgbRoLgbRsbRibLsLsmbsbLsbRibLgRsbRibLgRsbRibRcbLg
bLsbRiRsmbLjbLhbRjbLcbLibLibLibLibRibRibRcLsbRcRsRcmbLjLjbLibLcbRibLcR
sbsbLgbRsbLibLgbRcbRhbRibLjLsLsmmbRcbLebRibRibLsbLjLsmbRjbRibLjbRibsbR
cbRhbLgbLibRgbLjbLhbLibLjbRibLgbLobLibLgbLsbRgbLjLsmbRcbLjbLibLcbLibLi
bRhbLhbLiLsbRcbLgbLibsbRhbRcRsmbRgbRsbLhLsbLiRsbLibLibLjbRiRsmbRcbRgbL
jbLgbLcbLibLsbLibLgbLhbLhbsbLsbLibRiRsmbLibRibLsbLcbLiLsbRibLsbLsLoRsb
sbLibLgbLgbLjbLiRsbLgbLibLgbLgLsbLibLgbLsbLibLiLsbLgbLgbLgbLgbLsbRibRh
RsmbRibLjbLhbLibLibLgbLsbLsbLcLsmbLgbLgbLgbLsLsLsmmbLjLgRsbLhbRcbLhbsb
RibLsbLsbLcbRsbRcbRibLgbLgbLcLsmbLcbRiRsmbLcLsmbLgbsbLibLibLibLgbLgbLi
LsbLiRsbLibLibLgbRsLiLsbLgbLgbLibLjLsmbLgbLgbLibLgbLgbLibRibRiRsmbLsRs
bRcRsmbLhbRibRgbLibRibRsLsbsbLgbLgbLgbLibRcbLsbLsLsmbLgbLsLsmbRcbRibLi
b

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 30; Drug: Control
bLgbLibLsbLgbLgbLgbRsbLgbLgbLgLsbLsbLsbLgbLgbLsbLgbLsbLgbLsbLgbLgbRjbL
iLsbLgLsbLsLsmbLgbLgbLgbLibLgbRibRgLsbRjRsmbLjbRcbLhbRcbLgbRcLsbLibRcb
RobRsbLibRibRgRsmbRibRibRcLsbRibRgbsbLgbLhbLoLsmbLgbLibRgbLibLgLsbLgbR
jbLgLsbLsbLsLsmbLgbLgbLgbRsbLgLsLsLsLsmmmbLgbLsLsmbLgbLgbLgbLsbLgbLsbL
gbLgbRsLsbLsbLibLgbLsLsmbLgLsbLgbLsbLgbLgbLsbLgbLgbLgbLgLsbLsbLibRibLh
bRsLsLsmbLgbLgbLsLsmbLgbLgbLgbLsLsmbLsbLgbLgbLgbLgbLsLsmbLgbRsbLgLsbLg
bLgLsbLgbRcbRgbsbRoLsbRebLsbsbLibLobRjbLjbRebLobRgbLsRgbRjbRgbRjbLsLcb
LgbLgLsbLsbRgbRibRgbLobLsbLibRjbLibRjbLibLibLibLsbRgbLgbLibLgbLgbLsbLg
bLgbLsbLgbLgbLsbLsbLsRsbLgbLsbLgbLgbLsbLgbLgbLgbLsbLsbLsbLgbLgRsbLgbLs
bLgbLgbLgbLsbLsbLsbLgbLgbLsLsmbLsbLgbLgbRsbLgbLgbLgbRsbLgLsbLsLsmbLgbR
ibRsbLibLgLsbLgbLgbLgbRsbLgbLsbLgbLsbLgbLgbLgbLgbLgbLgbLgbRcbLgbLgbLgb
LsbLgbRsLsbLgLsbLsbLgbLsbLgbLgRsLsbRjbRibLcbRobLcbLobRgbLgRsbLibRgbLib
LgbLgbLgbLsbLgbLgbLsbLgLsbLsbLgbLgbLgbLgLsbLgbsbLgbLgLsbRjbLiLsbLgLsbL
gbLsbLgbLgbRsRsmbLgbLsbLgLsbLgbLgbLgbLsbLgLsbLsbLgbLsLsmbLgbRsbLgbLsbL
gbRsbRhbRibLjbRhbLcbRjLsbRcbLibRibRgbLcbLhbRgLsbLibRgbLibLsbLgbLgbLgbR
sbLgbLsbLgbLgbLsbLsLsmbLgbLgbLgbRsbLgbLsbLgbLgLsbRgbLgbLgbLgbLgbLgbLgR
sbLgbLgbLgbLsbLsbLgbLsbLgLsbRsbLgbLgbLgbLgbLgbLgLsbLgLsbLsbLsLsmbLgbLi
bRobRcbRhbLibRiRsmbLjbLcbRsbLibRgbLibLgbLhbRsbRsbRsbRsbLgbLgbLiRsbLhbR
ibLibLgbLsLgbLsbLgbLgbLsbLgbLsbLgbLsbRsLsbLgbLsbLgbLgbRsbLiLsbLsbLgbLg
bLgbLgbLgbLsbLsbLgbLgLsbLsLsmbLgbLsbLgbLgbLgbLgbRobRibRobLjbRcLsbLibLc
bLibsbLsbRsbLibLibRgbLsbLgbLgbLgbLgLsLsmbLibLsbLibRcbRjbRgbLcbLcbRgbLi
LsbLibLsbLgbRgbLcbRibLsbLoLsmbLsbRgbLcbLibRgbLgbLgbLsLgbRsbLsbLgbLsbLg
bLsbLgbRsbRsbLgbLgbLgbLgbLgbLgbLgLsbRjbLgbLgbLsbLgbLsbLgbLgbLgbRsbLsbL
iLsbLgLsbLgbLgbLgbLsbLsbLgbLgbLgbRgbLsbLgbLgbLgbLgbLgLsbLgbLgbLsbLgLsb
LgbRibRibRibLibRobLhbLhbRgbLgbLsbsbLsLsmbLsLsmbLgLsbLgbLgbLsbRsbLgbLgL
sbLsLsmbRsbLgLsbLgLsbLgbLgbLsLsmbRsbLgbLgbLgbLgbLgLsbRsbLgbLsbLgLsbLsb
LgbLsbLgbLsLsmbLgbLgbLgbLgbLgbLsbLgLsbLgbLgbLgbRsbLgbLgbLsbLgbLgbLgRsb
Rgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 31; Drug: NDMC 1 µM
bRiRsmbLjbLibLibLiLsbRgLsbRgbRibRibLhbRebLcLsmbRjbLebRjbLhbLgLsbLsbRsb
LgbLsbLsbLgbLibLgbLibLibLibRibLgbLgbRgbsbRgbLjbRjbLibLibLsbLibLsbLsbLg
bRsbLgbLsbLjbRgbRjbLibLsbLgbLibRsbLgLsbLsbLgbLgbLgbLsbLsbLibLgbRjbRcbR
ibRgbLibLjbLsbLibLgbLsbLsbLgbLsbLgbLsbLgbLsbLsbLsbLjLsLsmmbRgbRibLsbRi
bLgLsbRgbRsbRgRsmbLsbRsbRibRsbRgbRgbLsRsbRsbRsbLsbRiLsbRsRsmbRgbRgbLsb
RgRsmbRsbRgRsmbRgbRsbRgbRgbRsbRgRsmbLsbRjbLcbsbLcRsRsmbLibLsbRcbRibRib
LsRsbRgbRsbLgbLibLgbLgbLsbLgbRgbLibRsbLgbLgbLgbLsLsmbLsbLsbLgbLsbRsbLi
LsbLsbRiRsmbLcbRsbRjbRibRibLsbLcLsmbsbLgbLsbLibRsbLgbLgbRsbLiLsbLsbLib
RgbLsLsmbLibRsLsbLgbLgLsbRsbLibRibLiLsLsmbLsLsmbLsbLgbLgbLgbLgbLsbRsbL
gbRjbLjbRebRiRsmbRgbRsbLsbsbLebLhbRibRsLibsbRibLcLsLsmmbRgbRsbLgLsbLgb
LibRgbLibLsbRsLgLsbRgbLgbLgbLgbLsbLgLsbLsbLgbLsbLgbLsbLgbLibRgbLsbLibR
cbRibRibRgbLgbRgLsbRgbRgbLsbRgbRsbRibLsbRibLsbRgbRsbLsLsmbRsbRgbRgbRgb
RgbRgbLgbRgbRsbRgLsbRsbRgbRgRgLsbRgbRgbRsRsmbRgbRgbRibRgbLcbLgbLibsbRj
bLibLgbLgbLsbLgbLibRjbLjbLibRsbLgLsbLgLsbLsbLgbLgbLgbRsbLgbRcLsbLcbLcb
LcbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 32; Drug: NDMC 1 µM
bLiLsbLibLibLgbLibRibLhbLibRibRjbLibRhbLcbRjbLibRjbRibLjbRcbLjbRibRsbL
jbLibLibRibRibLjbRcbLibRhbRibLjbLjbRiRsmbRcbLibLjbLibRibLibLiRsbRjbLiL
sbLsbLibLgbLsbsbRhbRsbLibLsLsLsmmbsbRcbRhbLhLsbRibLobLgLsbRibLibRsbLjL
smbRhRsmbRjRsRsRsmmmbsbRgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 33; Drug: NDMC 1 µM
bRcbLgRsbLsbRibRsbRgbLgbRhbLgbRiRsmbRsbRgRsmbRgbRgbsbRsbRsRsmbLgbRsLhb
RgbRjbRiRsRsmmbLgRsbRobRibRsbRsbRsbLcbLhbLibRgbLibRibLgbRibLjbLgbLgbLg
bLgRsbLgbLgbLgRsbRjbLgbRsbLgbLsbLgbRsbLiRsbLgbLsbLibRsbLgbLgbLgbsbLgbL
sbRsbLgLsbLgLsbLsbLsRsbLsbLsLsmbLsbLgbLsbLgbLsbLgbLgRsbRsLsbLgbRsbLibR
sbLiLsbLgbLgbRsbLsbLgbLsbLsLsmbLgbLsbRhRsmbRcLsbLgbLhbLcbLgbLcbRjbRjbR
iLsbLgbRibRgbLgbRhLsLgbsbLcbRjbRiRsmbRgRsmbRgbLsbsbRibLgbRsbRiRsmbRgbL
gbRibLsbRgbRgLsbRgbLsbRgbLsLcbLibRibRiRsmbRgbsbLcbRgbLobLgbLgbRsbRibRh
bRibRibLibRibRgbRgbRgbLgbRgbRsbRgbRsbRsbLsbRgRsRsRsmmmbLsbRgRsmbLsRsbR
gbRgbRsRsmbRgbRsbRsbRsRsmbRgRsmbRgbRsbLsbRsbRsRsmbRgbRsbRgbRgbRgRsmbRs
bRgbRsRsmbRgbLsbRsRsmbRgRsmbRsRsmbRgRsmbRgRsmbRsRsRsmmbRsbRgbLsbRgbRsR
smbRgLsbRgbRgbRsbRgbRsbRsbRgbRsbRsRsmbRsbRsRsRsmmbRsRsLsmbRgbRgbRsRsmb
RgbRgRsmbRsRsmbRsRsmbRgRsmbLsbRgRsRsRsmmmbRgbRsbRgbRsLsbRgLsbLsbRgRsmb
RgLsRsbRgRsmbRgRsmbRgbRgbRsRsRsmmbRgbLgbRibRsbRibRgbRsbRsbRgbRsRsmbRsR
sRsmmbRgRsmbLsbRgbRgLsbRgLsbRgbRgRsmbLsRsbRgRsRsmmbLsRsLsRsLsbRgRsmbRs
bRgbRgLsbRgbLsbRgRsLsmbLsRsbRgbRgbLsLsmbRgRsmbRgRsmbRgbRgbLsbRgbRsbRsb
RgbRgRsmbRgbLsbsbRgRsmbLsbsbRibLgbLsbRiRsmbRsbRsbRibRgbLgbRgRsRsLsmmbL
hbLhbLibLibRsbRgLsRsbLhbRsRsmbLsbsbLgLsRsbLgbRjRiRsmbRibLsbRsbRgbLsbRs
RsmbRgRsmbRgbLsRsbRibsbRibRgRsmbRgbLjbLibRibRsbRgbLgbsbRgRsmbRgbLsbRgb
RsbLsbRgbRsbRsLsbRgbRgbRgRsmbLsbRgbLsbRgRsmbRgbRsbRgbRsbLsbRibLsbRgbRs
RsmbLsbRgLsRsbRgLsRsbRsbRgbRsbRsbRgbLjbsbRibRgbRibRgbRsbRgbRgbRsbRgRsm
bLibRgbLsRsbRgbRgbLsRsbRibRibRibRibLgbRibRibLgbRiRsmbRgbLjbsbRibRsbRgb
sbRgbRsRsmbRgbsbRsRsmbLsbRsbRgRsmbLsbRgbLgbRibLsbRibRgRsmbRgbRgRsmbRgb
sbRgbLgbRiRsmbRgbLgbLibLiRsbLhbLhbLhbRibLsbLgbLhRsbLibLgbRjbLgbLgbLgbR
sbLgRsbLgbLsbRcRsmbLsbRgLsbLsbRibRgbLsbRiRsmbLsbRgbLgbRgbLsbRgbLsRsbRg
RsmbLsbRibLgbRgbRgbLsbsbRsRsmbRgRsmbRsRsmbRgRsmbRgbRsbRgRsmbLsbRgbRsbR
gbRgbRgbsbRgbsbLgbRgbsbRibLjLsmbRiRsmbLgbRiRsmbLibRibsbRgRsmbLgbRibLsb
RgRsRsmmbLsbRibRsbRgRsmbRgbRsRsmbLsbRgbsbLsbRsbRsbRgbRgbRsbRgRsmbRgbLg
bRgbLsRsbRgbRgbRgbRgRsmbLgbRgRsmbRgbRgbRgbRgRsmbRgbRiRsmbRgbRhbLibRsRg
bRsbRsRsmbLsbLsbRhb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 34; Drug: NDMC 1 µM
bsbLgbLgbLgRsLsbRsbLibLsbLsbRsLsbLibRsLsbLgbLgbLgbLgLsbLsbsbRcbLjbLhbR
gbLgbLgbLsbLgLsLsmbLgbRsbLgbLgbRsbRsbLgbLsbLsbLiRsbLsRsLgRsbLgLsbLsbLs
RsbLgbLgLsRsbLgbLgLsbLgbLgbLgbLgbLgbLgbLiRsbRhbRjbLibRhbRhbLcbLcbRjbLc
bRibRcbRcLsbRibRgbLgbsbLgbLhLsbLgbLgbLgbRsbLgbLgbRhbRibLjbRhRsmbRibLib
LgbRibRgbLebRsLsbLsbLsbLsbLgRsbRsbLgbLgLsbRjbLibRibLibLsbLibLsbLsbLsbL
gbLgbRsbLsbLgbRsbLgbLgRsbRgbLibRcbRgRsmbRgRsmbRgbRgbRsLsbRibRobRcbLibs
bLiLsbLibLibRibRibLcbLiLsbRcbLcRsLsbRgbLgRsbRjbRibLjbLsbRibLcLsmbRjbsb
LhbRsLsLiLsbRhbLibRsbRsbLcbLgbRgbsbRibLgbLgbRgbRsbLibLibLsbLgbRjbRcbRi
bLibLibLgbRgbLgRsbLibRjbLibLsbLgbLgRsbRgbLgLsbLgbRgbLibRsLsbsbLgbRsbLg
RsbLsbLsbLgbLgbLgbLsbLsLsmbLgbLibLibRsbLsbLgbLgbLgbLgbLgbLgbRsbLgLsbRs
RsmbLgbLgbLgbLgbRgbLgbLsbLgRsbRjbLiRsbLgbRsbLgbLjbLgbRsbLibLgbRgbLibLg
bLgbLibLsbLgbRsbLiRsbRgbLjbLgbLgbLgbLgbLgbLgbLgbRjbLgbRebLiLsbLcbRjbLc
bRgbLgbLsRsbLgLsbLgbLiRsRsmbRebRcLsbRhbRibRjbLsbLsbLibLcbRcbRjbLcbLcbR
gbRsRsmbRhbRibLcbLoRsbRiRsmbLgbLobRcbRibLibLgbRibRgbLsbRiLsbRibLjbLibL
gbLgbLgbRsbLgbLgbLsbLsbLsbLgLsbLsLsmbLgLsbLgbRgbLsbLgbLibLsbLgbRibLgbL
gLsbLsbLsbLsbsbLgbLgbLgbRsbLgbLibLgbRsbLsbLgLsbLgbRsbRcbRgbLcLsRsmbLsb
LgbLsbLgbRgbLgLsbLgbRsbLgLsbRgRsmbLgRsbLgbRsbLgbLibLgbLsbLgbRsbLibRsbL
gbRsbLibLgbRsRsmbLgbLgbLsbRibRjbRibLcbRcbLobLhRsbRhbRhbLsbRcbLibRibLib
RibRgbLebRjbRibRibRsLsbLsbLcbsbRgbRibLibLgbLsbLgLsbRsbLgbLgbLgbRhbLiLs
bRjRsmbRhbLjbRgbRcbLhbRobRoLsLsmbRibRgbLibLsbRjbRsbLibLibRgbLgLsbLgLsb
LgbRibLibLsbLgbLgbLgRsbRsbLgbLgbRsbLgbLsbLgRsLsbRgbLibRgbLgbLgbLsbRsbL
gbLsbLgbLgbRsbLgbLgbRsbLgbLgbLsbLgbLsbLgbRsbLgLsbLgbRsbLgLsbLgbLsbLsbL
sbLsbLgbLsbLgbLsbLgbLgbLgbLgbLibRibLibLgbLgbLibRsbLibLiRsbsbRibLibLobL
ibRibLibRibRgbLcbRjbLcbRibRcbRgbLobLiRsbsbRiRsmbLhbRgbLibRjbLgbLsRsbLs
bLsbLgLsbRsbLsbLgbLibRsLsbLjbRsbLsbLgbRsbLsbLiLsbLgRsbLgbRsbLgbLgLsbLs
RsbLgbLsbLgbLsRsbLibLgbRjLsbRjbRcbLebRobLebLcbRibLcRsbRgbLibLsbLgLsbLs
bLgLsbRsbLsbLgbLgbRsbLsbLgbLsbLgbLgRsbRsbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 35; Drug: NDMC 1 µM
bRibLibLjbRebRgbRgbRgbRgbRsbRsbRsbRgbRsbRgbRibRgbRgbRgbLgbRcbLiLsbLsbR
ibLibRgbRibLjbRibRibRsbRjRsmbLgbLgbRhbRgbRsbRgbLgbRsbRgbRgbLsbRgbLsbRs
bRgRsLsmbRgRsmbRsLsbRgbLgbRibRibRibRgbRibRgbLibRgRsmbRibRibLcbLibRgbLi
bRjbLiLsbLgbRgbLhLsbLsbLsbLgLsbLiLsbRgbRibRsbRibRibRibRibLgbRibLsbRibR
sbLibLibLibRjbRibsbLhbRjbRcbRibLgbRgbsbRiRsmbRsbRsbRgbRgbLsRsbRgbRibRs
bRgbRibLgbRsbLsbRgbRsbRgbLsbRiRsmbRgbLsbRibLsbLgbLsbLcRsbLibLgbLsbLgbR
sbRjbRibRgRsmbLsRsbRgRsmbRgbRgbLsbRiLsbRsbRgbRsbLsbRgbRiRsmbRsbRibRgbL
gbRsbRgbRgbRibRsbLjbRcbRibRcbRcbLjbLhRsbLibLsbLgbLibLiRsbRgbRcbLjbRhbR
gRsmbLsbRgbRgbLgbRgbRgbLjbRgbRsbRgbRgbLgbRibLcbLgbLgbRibLibLsbLibRobRc
bLjbLjbLibRjbLhbLgbLibRsbLgbLgbLgbRjbLiLsbLibRgbLibLibLgbLiRsbRgbLgRsb
RjbLgbLibLgbRcbRibLhbRibRsbRibRhbLgbRiLsbRhLsbLgbRgbRibRibLibLjbRcLsbR
ibLgbRibRsbRibLsbRgbRibLsLsmbRgRsmbRsbRsbLjbLcbLgbLjbLgbRgbLibLoLsmbLc
bLiRsbLibRsbRsRsmbLsbLgbLiRsbLgLsbRsbLgbLgbLgbRsbLibLgLsbLsbLiLsbRsRsm
bLgbLibLgbLgbLgbRsRsmbRibLibLibLgbLgbRsRsmbLgbLiRsbRgbLibRgbLgbLgbLibR
sbLsbLibLgbRgbLiLsbRgbLibLibRgbRcbRibLjbLcbRgbRhbRibRgbLgRsbLsbRgbLebL
iLsbLsbLgbLsbLiLgbLgbRsbLibRsbLibLsbRsbLgRsbLgbLgbLibRibLgbLgbRibLiLsb
LgbLgLsbLibLibRsbLibLgbLgbRsbLibLsbLibLibRibRibLibLgbLibRsbLibLgbLibLs
bLibRsbLibLgRsbLgbLgbLibRibLgbRibLibLgbLsbLgbLgbLsbLibLsbLibLgbLgbLibR
ibLiLsbRsbRhbLcbLhbRiRsmbLcbReRsmbLcbRhRsmbLcbRgbLgbLibLibRsbLsLsmbLgb
LgbRjbLibLsbLgbLgbRgbLibLgLsRsbRsbLgLsbLsbLgbRjbLgRsbLgbLgbLgbLsbLgbLg
bRgbLgbRibRibRjbLhbLibRjbLibRsRsmbLgbRjbRibLjbRibRibRsbRsbLhbLiRsbRsbR
jbRiRsmbLjbRiLsbLjbLhbLibLibLgbLibRgRsmbLibLgRsbLibLcbRhbRibLhbRibRiRs
mbRibLjbRgbRsbRibRcbRcbRcbRiRsmbLgbRiRsmbRsbRiLsbRsLgbRgbRsbRgbRsbRibL
gbsbLjbLhbRgbLibLgbLsbLiLsbLsbLiLsbRsbLibRjbLibLibRsbLibLibLgbLibRibLi
LsbLobRibRibRgbRiRsRsmmbLsbRgbLsRsbsbRgbsbRsbRgbRibRgbRsbLjbRibLhRsbLc
LsmbLsLsmbLsbLibRsbLibRjbLcbReRsmbLcbLsRsbLgbLibRsbLibRgbLibLiRsbLgbLi
bLgbLibLibLgbLgbLibRgbLgbLgbRibRcRsmbLsbLjbLibRjbLibLsbLhbLgbRjbRcbLsb
RgbLjbLibLibLibRgbRgbLgbLibRcbRgLsbLjbLcLsmbRiRsmbRsbRjbRebRsbLsbRiRsm
bLgbRibRsbRibRsbRsbRsRibRgbLjbLhbLsRsbLgbLsbLgbRsbLgbRsbLsbRsbLibLsbLi
b

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 36; Drug: NDMC 1 µM
bRsbRgbRsbLgbLibLibLibRjbLibRsbLibRibLibRgRsmbLibLsbRjbRobLobRibRsbsbs
bLobLcbLhbRobLcbLcLsmbLoRsbRcbRiLsbLibRsbRgbRibLjLsmbRibLcbLobRibLcbRc
bLgbLcbRcbRcbLcbRjRsmbRibRibLebLibLgbLsbLgbRgbLibRobRsbLhbRiRsmbRcbLeb
LibLibRgbRjbRobRcbRhbLhbLibRsbLgbLgbRcbRibLcbRhRsmbLcLsmbRhbLobRhbLobR
hLobRcbLibLhbRsbLgbRgbLhbRjbRhbLobLjbRjbLcRsbLibRcbRebsbRcbLobRibLobRj
bLcbRsbLhRsLsbLgLsbLibRsbLebLgbRibLibLgLsbLsRsbLibLgLsbLgbLibLibRcRsmb
LebRibLhbLiLsbLgbLgRsbRjbLcbRgbLibLiRsbRcbLcbLcbRgbLcLsmbRibLgbLcbLibL
ibRsbRiLsbLcbLoRsLsbLhLsbRjbLcbRgbLibLibLiLsbRhbLibLibLgbLgbRgbLgbLgbL
ibRibLgbLibRhbLcbRgbLibLobRcbLcbRsbLhbRjbLcRsbRsLsRsbLibLcbsbLiRsbRcbL
gbLhbLcbRibLibRibLcbsbRiRsmbLhbRjbLhbRsRsmbLibLibRibRcbLobRjbRcRsmbLhb
LobRibRcbLhbLjbLcbLibLoRsbRibRibLibLibLibRjbLcbRjbRcbLcbLibRjbLibLgbRg
bLcbRiLsbLgLsbLiLsLsmbRsbLibLobRsbRhbLibLgbRjbRibLcbReRsmbRhbLjbLcbRjb
LhbLsbRsbLibRjbLcbLgbLibLhbRgbRcbLjbRhbLobLcbLgbRibRobLcbLhbRjbLibLibL
hbLhbLibLebRobRoRsmbRcRsmbLebLhLsbLsbLiLsbRobRcLsbRcbRcbLcLsmbRibRcbLg
bLcLsmbRcbRoRsmbLebLcbRjbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 37; Drug: NDMC 3 µM
bLibLgLsbRjbLiRsbRsbLibLgbRsbLibRgRsmbLcbRibLibLgbRgbLibRsbLibLibRgbLi
bRsbRsbLhbLhRsLsLsLsmmbLgbLsbLcbRibLcLsmbLcbRcbLibLibLgbLcRsbLgLsbLiRs
bRibRgbRibLsbRibLjbLcbLibLgbLcbLiLsbLgRsRsmbLgbLibRgbLcbLsbRsbLibRsRsm
bLibLibLsbRhbRhbRibRgbsbRgbLibLiLsbLcbRibLcbRibRsbLiLsbRsbLhbRibRjbRcb
LhbLeLsbRebRcRsmbRgbRsbRsbRsRsmbLcbLcbLcbLhLsbsbRjbRjRsmbRgbLebRibRiRs
mbLebLcLsmbLcLsmbRibRoLsbRibRibRibLcbRibsbLebRibRsRsmbLibRibLcbRibLibs
bRhRsmbRgbLcbLebRcRsmbRjRgbRibRcbLsbRsbRsRsmbRibRsbLsbRsbsbRiRsmbRsRsm
bsbsbRebRibRibRgbLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 38; Drug: NDMC 3 µM
bRsbLsbRgbRgbRgbLsbRgbRsRsmbRgRsmbRgbRgRsmbRsRgRsmbLsbRgbRgbRgbRgbLjbL
cbLgbRgbLibLgbLgbLcbRibLcbRgbLibLgbRgbLibRsbLibRgbLcbRgbRcbRibLjLsmbRi
bRgbRgRsmbsbLgbRcbRgbRgbRgbLjbRibLcbLibRcbRhbRibRibLgbsbRgbRgbRsbRgbRg
bRgRsmbLgbRgRsmbRsbRgbRgbLsbRgbRgbLgbRgRsmbRsRsmbRgbLsRsbRgbRgbRsbRgbL
sbRgbRgbLsRsbRgRsmbLsLsmbRgbRgbRgbLsbRgRsmbRsbRgbRsbRibRgbRgbRgbRgbRib
LsbRsLsbRgbRsbRgbLsbRgbRgbRgbRsbLgbRibRsRsmbRibRgbRsbRgbRsbRsbRgbRgRsm
bRgbRgbRcbLhbRgRcbRgbRibsbRgbRgbRgbRsRcbRibRgRsmbRgbRsbRibLjbRibLjLcbR
cbRgbRibLsbRsRsmbRgRsmbRsRsmbRibLsbRgbRgLsbLjbLhRsbLiLsbLibLgbLibRjbLi
bRjRsmbLcbRgbLgLsLsmbLgbLgbRgRsmbLibLibRgbLibRjbLibLsbRgbLhbRibRjbRibL
sRibLibLibRjbRcbRcbLibRcbRsbRoLsbLhbLibRhbRcbRibRgbLibLhbRgbLcbRibLcbR
ibLoRsbRibLobsbRgbLhbRgbLcbRgbLibRgbLgLsbLsbLgbLsbLsRsbLgbLsbRsbLibRgb
LibRjbLgbLsbLgRsbRgRsmbLgLsbLibLgLsRsbRjbRjbsbRibRsbLsRgbLsbRsbRsbRgRs
mbRsbLhbLgRsbRjbRibLcbRgbLibRjbLcbRgLsbLobLgbsbRsRsmbLhbRcbRcbsbRcbLib
RibRgbRibLjbLhbLgLsbRjbLibRsbRcRsmbRibsbRgRsmbRibRsbRgbLibRibLgbRibRsR
smbRgbRibLsbRibLsbRibLsbRgbRgbLsbLoRsbRjbRibRibLjbRibLsbRgbRgbRsbRsRsR
smmbRgLsbRgLsbRiLsbRsRsmbLibRcbsbRibRhbLibRgbRsbRcbLsbRcbRgbLgbRibLsbR
gbRibRgbRgbRibLsbLgbRsbRiRsmbRibLgbRibLgbRsbRibRsbRibRiLsbRhRsmbRsbRiR
smbRibRibLjbLjLgLsbRibRibLsbRibLgLsbRibLgbRgLsbRgbRsbRsbsbRsRsmbRgbRgb
LjbRgRsmbRgbRgRsmbLgbRibLsbRibLgbRibRibRgbRibLhbRsbRhbRgbRgbLiLsbRibRi
bRgbLibRibLsRsbRibRsbRiLsbRibsbRibLsbRsbRgbsbRcbRhbRibLsLsmbRsbRibRiRs
mbRsRsmbRibLibRgbLsLsmbRgbRgbLsbRibRiRsmbLibRibLgbRibRibLgbRsbRibRibRi
bRcbRsbLgbLiLsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 39; Drug: NDMC 3 µM
bsbRgbRiLsbLibLjbLibLsRsbLgbLgbLsbLsLsmbLgbRsbLsbLsbLgbRsbLibLgbLgbLgb
RsbLgbRgLsbLgbLsbLgbLsLsmbLibRsbLgLsLsmbLsbLiLsbRsbLsLsmbLiRgbLgbLgbLg
bLsbLgLsbLsbLsbLgbLgbLgbLgbLgRsbRgbLibLsbLsbLgbLsbLcRsbRcbLiLsbLgbRsbL
gbsbRsbLgbRebRibLjbRibRibRgbRgbLjbLsbRgbRibLjbRiLsbRibLhbLibLgbLgbRsbL
ibLibRibLsbLcbRgbLibLgbRsbLgbLsLsmbLsLsmbLgbLgbLgbLgLgbLsbLgbLibLgbLgb
RsRsmbLgbLgbRsbLgbRsbLgbLgLsbRsbLgbLgbLsLsmbRsbLgbRsbLgLsbLgbLgbRsbLgb
LsbLgbLsbLibLibLsbLibLgbLsbLgbLgbLgLsbRjbRibRgbRsbRibRoLsbLcbRsbLcRsbR
gbLibLibsbRsbLgbLgbLobLobLsbRibRgRsmbRgbRsbRiLsbLsbLgRsbRhbRgLsbRobLib
RcbLsbRcbLsbLibLobLsbLcbLcbLibRibRibLcbRcbLcbLcbLgbLhLsbLibRsbLgbRibRi
RsmbRgbLgbRgbRgbRsbRgRsmbLsbRgbRgbRibLibRcbRibRgbRsbLibLgbLgbRibRgbRgb
RsbRibRgbRsRsmbRgbLsbRsbRgbRgLsbRgbRgLsbRgbLjbLobRgbLsbLsbRibLsbRgbRsb
LjbLiLsbRjbLoRsRsRsmmbRibRcbRibRgbRgbLsbLcbLcbLibRsbRibRgbRiRsmbRcbLhb
LgbLibLibLsbLcbRibLibLiLsbRsRsmbLibRsbLgbRgbLiRsbLibLgbRgbRgbRgbLhbLsb
LiLsbLgbLgbLibLsbRsRsmbLgLsbLgbLgbLgbLgbLgbLgbLgLsbLgbLgbRibLibLsLsmbL
gbRgbLgbRsLsbLsbRjbLhbLgbLgbLsbLgLsbLgbLgbLsbRjbRibRibLsbRibLjbRibRgbR
sbRgLsbLgLsbRgbRgbLcbLibLhbLcbRgbRcbLobLobRgbLiLsbRibRibRibRibLgbRgbLs
bRgRsmbRibRgbRgbRgRsmbRsbRsbLgbRgbRibLgLsbRgbRgLsbLjLsmbLobRgbLcbRjbLc
bLibLhbLibLibLcbLsbLgbLibRgbLsbLibLgLsbLgbLgbLsbLgbLgLsbLibRgbLgbRjbLh
bRjbLibLgbLsbLgbLibRgbRgbLhbRgbLibRsbLibLibLibLgbLibLsbLibRhbRibRgRsmb
LjbRcbLsbLjbRjbRibRibRobRsbRgbLsbLibLsbLgbLsLsmbLgbLgLsbLsbLgbRsbLsbRj
bRibLjbRibRgbRiLsbRcbRibLsLsmbLgbLcLsmbRjbLiLsbLsbLgbLgbLsbLgbLsbLibLc
bRhRsmbRgbRsbLgLsbLibLsLsRsmbLsbLsbLgbLgbRsbLgbRsbLgLsbLgbLsbLgbLibLgL
sbLgbRgbLcbRibLibLsRgbLobLcbRsbRgRsmbLiLsbLobRiRsmbLcbLhbLibRsbLgbLgLs
bRgbsbRibRgbRibRgbLsbRgbRiLsLsmbLgbRhbLibRobLibRgbRobRcbLibRcLsbRibRsb
RcbLgbRcbRsbRsbRsbRgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 40; Drug: NDMC 3 µM
bRgbRgLsLsmbRsbRsbRsbRgRsmbRsbRsbRsRsmbRgbRgbsbRgbRsbRgbRsRsmbRsbRgbRs
RsLsmbRgbRgbRsbRgRsmbRgbRsbRgbRgbRsRsLsmbRgRsmbRsRsmbRsbRgRsmbRsbRsRsm
bRsbRsRsmbRgbRsbRsbRgRsmbRgbRgbRsbRsbRgLsbRsLsRsbRgbRgbRgRsRsmmbRsbRsb
RsRsmbRgbRsRsRsmmbRsRsmbRgbRsbRgbLebRhbRibRgRsRsmmbRsbRsbRsRibLgbRgRsm
bRgbRgLsbRsbRgbRgbRsbRgRsmbRsbRgRsmbRsbRgRsRsmmbRgbRgLsRsbRsRsmbRsbRgb
RsRsmbRsRsmbRsbRgbRgbRsbRgRsmbRgbRsRgbRgRsmbRsbRgbRsbRgLsbRgbRgRsmbRgb
RsbRgRsmbRsbRgbRsbRgRsmbRgbRgbRsbRgRsmbRgRsmbRgbRgRsRsmmbRsbRgbRgRsmbR
gbRgbRgbRsbRgbLgbRsbRgRsmbRsbRsRsmbRsbRgbRgbRsbRsbRsbRsRsRsRsmmmbRgRsm
bRgbRgbRsRsmbRsRsmbRgbRgbRgbRgbRgbRgRsmbRgRsmbLsRsbRgRsmbRsbRgRsmbRsRs
RsLsmmbRgRsmbRsbRgRsmbLgbRgbRgbRsRsRsmmbRgbRgbRsbRgbRgbRsRsmbLjRsLcbRs
bLibLiRsbRcbsbLcbRcbRcRsmbLibsbRiRsRsmmbRgRsmbRgbRgRsmbRsbRsbRgRsmbRgb
RgbRsbRgbRgbRsbRsRsmbRgbRsRsmbRgbRgRsmbRsRsmbRgbRsbRsbLebRhbRibLjbRibL
cbLhRsbLiRsbLcbLhbRgbLibLoRsbRibRibRhbLibRibRgRsmbLsRsbRgRsRsmmbRgRsmb
RgRsmbRsbRgLsbRsbRgRsmbRsbRsbRsRsmbRsbRgRsmbRgbRgRsmbRsRsLsmbRgLsbRsbR
gRsRsmmbRsbRgRsmbRgbRsRsmbRgbRgbRgLgbRsRsmbRsRsRsmmbRgbRgLsbRgbRsbRgbR
sRsmbRgbRgRsmbRgbRsRsRsmmbRgbRsbRsRsmbRsRsmbRgbRsbRgRsmbRsRsRsmmbRsbRg
LsbRgbRsbRgbRgbRibRgbLsRsbRgbLjbRsbRibLgbsbRiRsmbRgbRsbRgRsmbRgLsRsbLg
bRgRsmbLsbRgRsmbRsbRgRsmbRsLsbRsRsmbRsbRsRsLsmbRgbRsbRgbRgRsRsmmbRsbRg
bRsbRsbRgRsmbRgRsmbLsRsbRgRsmbRsbRgLsbRgbRsRsmbRsbRgRsmbLsbRgbLsRsbRgR
smbRgbRgbLgbRgRsmbRsbRgbsbLjbRibRgbLgRsbRibLsRsbRgbLsbRgRsLsmbLsbRgRsm
bLsbRgbRgbRsRsmbRgbRgbRsbRgbLsbRgRsmbRsbRsRsmbRgRsmbRgbRsRsmbRgRsmbRsb
LsRgRsmbRsRsmbRsbRgbRsRsmbRiLsbRibsbRcbRibRibRibLjbRibRgbRgbRgRsmbRgRs
mbRibLgbRiLsRsbRcbRibRhbRibRsbsbLibLcbRibRjbRibRobRibLgbLhLsbRjbRhbRhb
RhbRgbRgbRgRsmbRiRsmbRgbLjbRibLcbLhbLibRjbLhLsbRjbRsLcbRjbLibLcbRibRib
RhRsmbLgbLsbRgRsmbRsRsmbRgLsbRsbRsbRiRsmbRsbRsbRgbLgbLsbRibRsbRgbLsbRs
bRgbRsbRgbRsRsmbRgRsmbLsbRgbRsbRsbRgbLjbLcbLgbLibRjbsbLibRjbRhbRibLgbR
gbRibRgbRsRsmbRgbRgbRibRgbLgbRibRsRsmbRgbRsbLsLsmbRiRsmbLsbRgRsmbRsbLs
bRiRsmbLgbRiRsmbRsbsbRsbRgbLgbRgRsmbRibLgbsbRcbLibRgbRsbRibRiLsbRiRsmb
RgRsmbRgbsbRgbRibRgRsmbLgbRgbRgRsmbRgbRgbRgbLsbRsbRsbRsbRgbRsbRgbRgRsm
bRsRsmbLsbRsRsRsmmbRsbRgbRsRsmbRsbRgbRsbRsbRgbRsbRgRsmbLsbRgbRsbRgbLsb
RgbRgbRgbRsbRgbLsbRgbRgRsmbRgbRsbRcLsbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 41; Drug: NDMC 3 µM
bLgbRhbLibRibLgLsbRiRsmbRgbRibRsbRgbRhbLgbRcbLiRsbLjbLiLsbLgbLibRgbLsb
LibLsbLsbLgbLgbLgbLibRgbLiLsbRsLsbLebRsRsmbLgbLgbRsbLibLgbLgbLgbLsbLgb
LgbLgbLgbLgbLsbLsbLgbLgLsbLgbLgbRgbLgLsbRsbLibLsbLgbLsbLgbLgLsbLgbLgbL
sbLibRgbLgbLgbLgbLgbLibRibLiLsbRsLsbLibLgbLgbLsbLgbLgbLsLsmbLsbLgbLsbR
sbLgLsbLgLsbRsLsbLgbRsbLgbLibLsbRsbLcbRgbRsbLibRsbLibRsRsmbLgbRsbLgbRs
bLsbLibLsbLgLsbLsbLibLsbLgbRsLgbLgbsbRjbRcbLcbRjbRibRiLsbRgRsmbRgbRgbL
gbRgbsbRhbRgLsbLgLsbRibRgRsmbRgbRgbLgbRibRgbRgbLgbRgbRibLjbRhbRibLobRi
bLibRgbLibLsbLgbLsbLgbLgbLgbLgbLgbLgbLsLsmbLgbLgbLsbLgbRsLsbLiLsbLsbLg
bLgbLgbsbLgLsbRgbLgbLgbRsbLibLsbRgbLhbRsbRjbsbLgbLgLsbLsbLgbRsbLibLibR
jbLibRgbLibLgbLsbLsbLgbLgbLgbLgbLgbRibLibRsbLgbLsLsmbLgbLgbLsLsmbLsbLg
bLgLsbLsbLgLsLsmbLibLgbLgRsbRsbRibRibRgbLhbRiRsmbRsbRibLgbRiRsmbLebLsb
LgLsbRgbLgbLgLsbRsbLsbLgbLgbLibLgRsbLgbRsbLgbLsLsmbLgbLgLsbLgbLgbLgbRs
bRgbLiLsbLsbLgLsbLiLsbRsbLibLsbLibLibLsbLsbLsLsmbLgLsbLgLsbLgbRgbLgLsb
LsbLiLsbLsbsbLgbLgLsbLgbLsbRsbLgbLsbLibLgbLgbLsbLgbLgbLsbLgbLsbLgbLgLs
bLgbLgbLsbLgbLgbLgLsbLgLsbLgbLgLsbLsbLgRsbLgbLgbLgLsbLgLsbLgRsbLsbLibR
sbLgbLgbLgbLgbLibLgRsbLgbLsbLgbLsbLgbLgbLsbLgbLgLsbLgbLgLsbLgbLsbLibLs
bLiLsbLgbLgbLgbLgbLgbLgLsbLgbLgbLgLsRgbLgRsbLibRsbLgbLgbLibRsbLgbLgbLs
LsmbLgbLibRsbLgbLibRgbLsbLiLsbRsbLgbLsLsRsmbLgbLsbLsbLgbLsbLsLsmbLgbLs
bLgbLgbLsbRjbLibRsbLibRsbRsbLgbLsbLgbRsbLgbLgbLgbLgbLsLsmbLsbLsLsmbLgb
LgbLgRsbLgbLgbLgbRsbLgbLgLsbLsbLgbLsbLgbLgbLgbRsbLgbRsLsbLgLsbLgLsLsmb
LsbLgbLgLsbLgbLibsbLsbLgbLgbLgLsbLgbLebLgLsbRsbLgLsLsmbLsLsmbLgbLgbLiL
sbLgbLgbLgbLgbLgbLgbLgbLgRsbLsRsbLgLsbLgbLgbLgbLsLsmbLhbLibRsbLibRsbLi
bLsbLgbLgbLgbLgbLgLsbRgbLiLsbLsbLibRsbLibLibLgbLgbLgRsbLsLsmbLsLsmbLgb
LgbLgbLsbLgbLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 42; Drug: NDMC 3 µM
bRsbRsbLsRsRsmbLjbLgbLgbLgbLgbRiRsRsmmbLibRebRobLgLsbLhbLsRsbRcRsmbRhb
LgbLobLcbRibLibLiRsbRibLgbLcLsLsmmbRjRsmbLibLiLsbRebRcbLsbLgbRjbLsRsbL
gbRibLsRsRsmbRsbRgLsbRgbRsbRgRsmbRsbsbRsbsbLsbRsbRjbLgLsbLsbRgLsbRibRg
bRsbRgbRgbLsbRsbRibsbRgbRibsbRsbRgbsbsbRgbLsLsmbRsbRsRsRsmmbRsRsmbsbLs
bLsLsmbRsbRgRsmbLsbRgRsRsmmbRgbRsbRjbRgbLsbRjbLsbRgbLsbLjbLsbRhRsmbRgb
RsbRgRsRsRsmmmbRsRsmbRsbRsbRgRsmbRgLsRgbRgRsmbRgbsbRgbRgRsmbRsRgbRsbRg
bRsLsbRsbRgRsmbRgbsbRgbRgbRsbsbRsRsmbRsRsmbsbLsbRsRsmbRsRgRsmbRsRsmbRs
bRgbRsbRgbRsRgbRgbLgbRjbRgbLcbRibLjbLibRjbLcbLibLgbRiRsmbRibLcbLhRsbLg
bLibRsbLcRsbRebLobLibLgbLgbLiLsbLsbLgbLsbLsbLsLsmbLsLsmbLsbRsRsLsmbLsb
RgbLgLsbLgbLjbRsLsbLsbLsbLsbRsbLgLsbLgRsbLsbRgbLsbLsbRsbLgbRsbRsLsbLgb
LsbLsbRsbLgbLsbRjRsmbLgbRibRcbLjbRsRibsbLsbRgbRgbRgbLsRsbLobLibLgbsbRj
bsbLgbRsbLhbRgbLibLiRsbRibLgbLgbRgRsmbLgbLsbLgbLibRgbLsbRsbLibRsRsmbLg
bLibRjbRjbRibRhLsbLgbLcbLiLsRsbRsbLgbRjbRebRgRsmbRgbRsbRgbRgbLsLsmbLsb
LebReLsbLsbLgbLcbLcbLcbRibLibRsbRibsbRgbRibRgbLjbRibRsbsbRgbRsLsbRgbLs
bRgbLsbRibLsRsbRgbRsbRgbRsbLgRsbRgLsbRgbsbLsbRgRsmbLsbRsRgbRsbRsbRgLsb
RsLsbsbRsbRsbRjbRgLsbLibLebLiLsbRjbLcbRibLhbRgbLcbRiRsmbLibLibLsLsmbLs
bLiRsbLgbLsbRhbRibLibLsbLiLsbsbLibRgbRcbRgbLgbRcbRgbRiLsbLgRsbLjLsmbLg
bLgbLgbLiLsbLcbLhbLcbLsbLsbRsbLibLibLgbLsbRsbLgbRgLsbLibLgbLgbLgbLsbLs
bLsbRsbLgbLgbLibRjbLsbLibRhbRcRsRsmmbLjbRibLgbsbRgbRsbRsbRjbRsbLsbRgRs
mbRgbRsbRgbLsbRgRsRsmmbRibRsRsmbRsRsmbRsbRgbRsRsmbRgbRsRsmbRsRsmbLsbRs
RsmbRgRsmbRsbLsRsbRgbRsbRsbRjbRsbLibRsbRsbRgbRsbLeRsbLibRgbLcbLiRsbRcb
RsbRiRsmbRsRsmbLgRsbRjbsbRsbRsbRgbRsLsbRgbRgbRgbLgbRsRgbRsbRiRsmbRgbRs
RsmbRsbsbLgRsbsbRgbRsRsmbRgbRgbLgbRsbsbsbRsbRsRsmbRgbLsbRgbRsbRgbRgbLs
bRgbRsRsmbRsbRibRgbRgbRsbRgbRsbRsLsbRsbLgbLsbRsbRsbRsbRgbRsbLgbRsbLsRs
bRsbLsRsbRibLiRsbRibLjLsmbRgRsmbRgbsbsbRgbRsbRsbRsbRgRsRsmmbLsbRgbRsbR
sbRsbLsbRsbRgbLsbRgRsmbLsbRsRsmbRgbsbRsRsmbLsbRsLsbRsbRgRsmbRsRsmbRsbL
sbRsRsmbRgRsmbRsbRgbRgRsmbLgbRibLsbRsRgRsmbLjbRsbRgbRsbLsRsbRsbRgbRgbR
sbRgbRsbLsbRgRsmbRgLsLsmbLibRiRsmbLjRsbLsbRgbLsbRsbRsbRsbRjRsmbLgbRsRs
mbRgRsmbRgbRgRsmbRgbRgRgbRsbLgbRgbRgLsbLjbLcbLibRibRsbsbLcbLcbReRsmbLs
LebLibLoLsmbRibRgbRiRsmbsbsbsbRibLgRsRsmbRsbRgRsmbRsRsmbsbRgLsbRgbLgbR
ibRiLsbRibRiRsmbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 43; Drug: NDMC 10 µM
bLgbRgbRgbLsRsbRgbRsRsmbRgbRsbRgbRsbRgbRgbRgRsmbRgbRsbRgRsmbRgbLjbRibR
gRsmbLgbRiRsmbLgbRgbRsbRhbLibRgbLjbLcbRhbLobRgRsmbLcbRsRsRsmmbLibRsbLh
bRibLgLsbLgbLgbLsbRgbLgbLgbLgbRjbLibLgbRsbLgbLgbRsbLgLsbsbLsbLgbRsLsbR
cbRiLsbLsbRhbLsbRobRiLsbLgbRiRsmbRsbRgbRsRsmbRiRsmbLsbRibLgbRcbLgbRibR
cbLgLsbRsbRibLgbRibLjbRiRsmbRsbLsbRiLsbLjbRibLgbRibRibLibRibLgRsbRibRs
bRgbLgbRibRgbRsbRibLsbRgbLsbRgbRgbRgbLsbRgbLsbRibRibRhRsmbRgbLgbRsRsmb
RgbRcbRcbLibRcbLgbRcbLibLsbRcbLsLsmbRsbRhbRgbRibLibRsbLjbRiRsmbLsbRcbR
sbRsbRgbRiRsmbLgbLgbRgbRhbLgbRsRiLsLsmbLjbRcbLgLsbRobRgbLgbRgbLhbRebRg
bRgLsbLsLsmbRgbRgbLgbRibLsRsbLsLsmbRsRsmbRsbRgbRgLsbLsbRgbRgbRgbLsRsbR
gbRibLgbRgbRgRsmbRgbLgLsbRibLsbRibLjbRibLsbsbRgbRsbRibRibRcbRhbLgbRsbR
cbLjbLhLsbRgbRjbLibLibLibRiRsmbLgbRcbLjbRcbLsbRibLsbRibRibRibLsbRiRsmb
RgbRsbRgbLsbRibLibRgbLgbRgbRibLjbRgbRgbsbLjbRhbLgbRibLsbRsRsmbRibLsbsb
RgbRsbsbRsbRgbRgbRgbLgbRibRsbRibLibRobLsbLgbRibRibLgRsbLgRsbRcbLgbRgbR
ibsbRibLgRsbsbRgbRgbLjbRgbRgLsbRhbLgRsbRsbRgbRgLsbLsRsbRgbRgbLsbRibLgb
RibLsbRgbRgbLsRsbRgbRsbLsbRgbLgbRiRsmbLsbRsbRgRsmbRgbRgbLsbRgbRgLsbLjb
RibLgbRgbRgbRibsbLgbRiRsmbLsbLsbRhbLgbRibsbLsbRiLsbRgbRsbRibsbRiRsmbRi
bRsbRsbRsbRsbRibLibLjbLgbLiRsbRjbLiLsbLgbLgbLgbRsbLgRsbLibLsbLgbRsRsmb
LgbRsbLobRcbRcbLjbRcLsbLsbRsbRgbLsbRgbRgbLsRsRsmbRibLibRibRsbRsbRsRsRs
mmbLgbRibLgbRgbRsbRgRsmbLsbLcbLibRcbLcLsmbLhbRgbRsbRsbLgbLcbRjbLibRjbL
ibLibLgbLgbLgbRgbLsbLgbLgbRjbLibLibLgRsbLjRsbLsRsbLsbLgbLgbsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 44; Drug: NDMC 10 µM
bLibLibRgbLibRgbLibLgbLgLsbLhbRgLsbLhRsbRibLgbLibRjbLibRsbLibRiLsbLibL
sbLibLiRsbRibRgbLiLsbLibsbRgbLcbRibLibLgbLibLsbLibLgbLibLibLibLgbLsbLi
LsbLibLsbLgbLiLsbLcRsbLiRsbLhbLhbRgbRibLhbLiRsbRoRsmbRsbRobLcbRsbLibRs
bRibRgbRsLsbRgbRgbLsbLhbLibLiRsbRgbRjbLcRsbLibLiLsbLgRsbRgbRjbLibLgbRs
bLgbLibLibRgbRgbLcbRjbLgbLcbLcbRgRsmbLsLsmbLgbLgbLibRjbLibRgbLiRsbLgbL
gbRgbLibLgLsbLgbLgbRgbLsbLiLsbLsbLibRgRsmbLgbLsLsmbLgbLgLsbRsbLgbLgLsb
RsbLgRsLsbLibRgbLibLibLsLsmbLgbRsbLgbLgbLgbLgbRsbLgbLgbLgLsRsbRgbLgLsR
sbRsbLibLsbLgLsLsmbRsbLgbRsRsmbLibRjbLibLsLsmbLibRsbLibRgbLibLgbRgbLgL
sbLsRsbLibLgbLsbLsbLgbRjRsmbLiLsbLsRsbLgLsbRsbLgbLgbRgbLgLsbLgbLgbLibR
gbLgbLsbLibRgbLibRjbLiLsbLsbLsbLgLsbLgbLibLsbRsRsmbLibLsbLgbLgbLibRibL
sbLibLibLibLibLgbLsbLiLsbLgLsbLgbRjbLhbRsbLgbLibLhbRibLiLsbLsLsmbLiLsb
RsbLibRsbLgbLgLsRsbRgbLibLsbLibLsbLsLgbLsbLgbLsbLgbLiLsbsbLibLibRibLgb
LgLsbRgbLhbLsbLsbLhbLibLibLibLhbLibsbRsbLiLsbRsLsbLibRsbRsbLibRsbLibLi
RsbLsbLibRiRsmbLibRgbLiLsbLsbLgbLsbLgbLgbLgbLgbRsbLgbLsbLibLibRsLsbLib
LgbRjbRcLsbLgbRgbRgbLsbRgbRsbRgbRiRsmbRgbRgRsmbLsLsmbRgbLsbRibLjbRibRg
RsmbRgbRgbRsbRsbRsbRgbRibLgRsbRgbLcbLibRjbLibLibRjbLibLgbLgbLsbLsLibRs
bLgbLgbRjbLibRgLsbLgLsbLsbLiRsbRibLibRjbLcbRgbLibLgbLiLsbLsbRgbLibLgbR
gbLgLsbLsbLgbRsbLgLsbLsbLgbRjbRibRgbRsbLsbRgRsmbRgbRgbLsbRgbLsbRgbRsbR
sbRgbRsbRgbLsbRgbRsbRgbRgbRsbRgbRgbRibLsbRgbRgRsmbRgbRgRsmbRgbLsbRgbLs
bRibLsLsmbRibLsbRgRsmbLsbRiRsmbLjbRsbRiRsmbLgbLobRjbRobLgbRgbRibLgbLsb
RhbLgbRgbRgbLsbRibLsbRiRsmbRsLsbRgbRsbRgRsmbRsRsmbRsbRgbLsbRiRsmbLsbRg
bRgbRgLsbRgbRgRsmbRsbRibRsbLjbRibRsLsbRsRgbRsbsbRgRsmbLsbRgbLsLsmbRibL
gbRibRsbRibLsbRgbRgbRgbRgbRsbRgbLgbRsbRibLsbRgbRgbLsbRibRibRibRibRibRi
RsmbRibRgRsmbRibLsbRibLsbRgbRibRiLsLsmbRgbLibRgbRibRgbLsbRgbRgbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 45; Drug: NDMC 10 µM
bRibLsbRsbRgRsmbLgbRsbRgbRsbRjbRcbLiLsbLjbLibLibLgbLsbLgbLgbRsbLgbLgbL
gbLgbRsLsbRsRsmbLgbLgbLgbLgbLgbRsbLgbLgbLgbLsLsmbRsbLgbRgbLsbLgbLsbLgb
LibRgbLsLsmbLgbLgbLsbLgbLsbLsLsmbLgbRjbRobLsbLsbLgbRjbLgbLgbLsbLgbLsLs
mbRsbLgbLsRebRcbRhbRgbLsbLgbRjbLcbRibRsbRibLgLsbLjbRhbRibLgbRsbRgbRsRs
mbRgbRgbLjbRsLhLsbLibLsRsbLgbLsbLgbRsRsmbLibLibLsbLgbLgbLsbRjbLgbLgbLs
bLsbLgbLgbLsbLsbRcbRgbRsRsmbRsbRgbLgbRgRsmbRgbRgbLsbRgbLsbLsbRgbRiLsLs
mbRcbRibsbLsbLiLsbLsbLgbLgbRsLsLsmbLsbLgbLgbRgbLgbLsbLibRibLcbRebRhbRi
bLsRsbRsRsmbRsbRgRsmbRgRsmbRsbRibRgbLgbRgRsmbLsbRgRsRsmmbRgbLsbRgRsmbR
sRsmbRgbsbLsLsmbRsbRgbLjbLgbsbLgbLgbLiLsbRibRgbLibLibLibLsbLgbLsbLgbLg
LsbRgbLgbLsbLgbLsRsbLgbLgbLgLsbLgbLgbLsbLsbRsbRsbLgRsbLgbLgbLgbLsRsbLg
RsbLgRsbRgRsmbRjbLibLgbRsbLgbLsbLgbLgbLgbLsbLsbLsRsbLgbLsLsmbLibRgbLgb
LgbLgbLgbLsbLgbLgbLgbRsbLgLsbLgbLgRsbLgbRgbLsbLhbRibLgRsbLgbLgbRgbLgbR
cbRcbRibRsRibRgbRsbRgbLhbLiRsbRgbRcbLjbRcbRcbsbRgbsbRsbLibRjbLiLsbLgbL
sbLsbLiRsbRgbLiLsbLgbLgbLsbLsbLsbLsbLibLsbLhbLsbRibRsbLsbRjbLgbRhbLgbL
ebLibRsbRsbLgbLgbLibRsbRsLgbLsbLgbLsLgbLsbRjbLibRgbRcbRibLsbRgbRjbRgbL
jbLcbRgbRibRibLsbRgLsbRsbRgbRsRsmbRsbRsbRgbRgbLcbLjbLcbRiRsmbLcbRgbRgb
LsbRgRsRsmmbRgbRgLsbLsbRgbRsRsmbLsbRgbLsbRiRsmbLsbRsbRgbRgRsmbLgbRgRsm
bRsbRgbRgbLsbRsbRsbLsbRgbRibRsbRgbLsbRsbsbRgbLjbLibRibRibRsbRibLsbRgbR
sbRsbLsbRgbRsbRgbRcLsbRcRsmbRebRgbRgRsmbRgbRgbLsbRjRsmbLgbLsbRgRsmbLsL
smbRgbLsRsbRgLsbRsbRgbRsbLsbRsbRgbRgbRgbRgbRiLsbLibRgbRsbRgbRgbRsbLsbL
ibLibRjbRoRsmbRcbRiRsmbRcbRhbRibRgbRsbsbRgbRibRcbLgbLsbRsbRgbRgbRgbLsb
RgbRgbLgLsbRgbsbRgbRsbRgbRgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 46; Drug: NDMC 10 µM
bRgbRgbRgbRgRsmbRsRsmbRgbRsRsmbRsRsmbRgLsbRgRsmbRgbRsRsmbRgRsRsmmbRsbR
gRsRsRsmmmbsbLoRsRsmbRgRsmbRsbRgRsmbRsRsmbRgbRsbRgRsmbRgbRsRsmbRgbRsRs
mbRgRsmbRsLsbRgbRsRsmbRgbLjbLsbRsbRcbLibRsbRcRsmbLgRsbRibRsbRgbRibLgbR
sbRibLjRsbLcbRhbLcbRcRsmbLgbRgbRsRsmbRibRsRsRsRsmmmbRgbRsbRgRgRsmbRgbR
gbRsRsmbRgbRgRsRsmmbRsbRgbRsbRgbLsbRgRsRsmmbRsbRsbRibLsRsbRgRsmbLsbRgb
RgbRsbRgRsmbRgRsmbRsbRgbRgbRgRsmbRgbRsbRgLsbLsLsmbRgbLgbLibLhbRjbLibRj
bRcbRjbLebLobLjLsmbLgbsbRjRsmbRgRsmbRgbLgbLibRjbRcbLibRibLsbRibRsbLsbR
ibLsbRgbLsRsbRgRsmbRsbRgbRgbRsRsRsmmbRgbRgbLsbRgbRgRsmbLsbLjbLibRibLcL
smbRhbRcbRsRsmbRsbRgbLsbRgRsmbRsbRgRsmbLsbRgRsmbRgbRsbRgbRsRsmbRgbRsbR
gbRsbRgbRiRsmbLsbRsRsmbRgRsmbRsbRsbRsRsmbRsbRsRsRsmmbRgRsRsmmbRgRsmbRg
bRsbRgbRsbRgbLjbLibRsbLiLsbRjbLsbLhLsLsmbRgbsbLiLsbLgRsbLibLsbRsbRcbRi
bRgbRsbLsbLjbLcbLgLsbRgRsmbRgbRibRgbLgbRibRsbRgbLebLibRgbLibLgbRcRsmbR
gbRcbLcLsmbLcbLibRsRsLsmbRibReRsmbLjLsmbLjLsmbLcLsLsmmbLibLhbLiLsbRhbL
ibLjbLcbRjRsmbLgLsbLgRsbRjbRcbLsbRgRsmbRgRsmbLsRsbRgbLgbLhbLhbsbLebLhb
LcbLiLsbLgbLgLsbLsbsbLibRibLibLgbRsbLgbRjbLibRgbLgbLgbLsLsmbLgbLibLcLs
mbLcbLibLgbLibRgRsmbRgbRibRobRcbRibRiRsmbRiLsbRsbRgbRgRsRsmmbRsbRgbLsb
RgRsmbRsbRsRsRsLsmmbRgRsmbRgbRgbRgbRsbRgbLsRsbLebLibLjbLibRcbRhRsmbRsb
RcbLiLsbRsbRibRsbRgLsbRgbRgbRgbRgRsmbRgbRgbRgbRsbRgbRgRsmbRebRgbRobRcb
RiRsmbLgbRgbRgbLsRsbRsRsmbRiRgRsmbRsRsmbRgbRibRgbRsbRgbRsRsLsmbRsRsmbL
gbRsbRibLcbLobLhbLebLebLibRsbLgbLiRsbLgbLgLsbLgbLibLebRebRobRibLsbRsbR
iRsRsmmbRgbRgbLsRgbRgbRsRsmbRgRsRsmmbRgbRgbRgRsmbLibRsbRgRsmbRsbRgRsmb
RgbRibLsRsbRibRsLobRiRsmbRgbRsbRgbRgbRsbRgbRgbRgRiRsmbRsbRibRgbRgbRsRs
mbRiRsLsmbRgRsmbRiRsRsmmbRgbRiRsRiRgRsmmbRibLsbRibLjbRobLjbLobLibRjbRc
bLjbRcbLgbLjbLcbRjbLjbsbLgbLiLsbRjbLiLsbLgRsbLgbLgbLgbLiRsbRebRibRgbLg
bRgbRsbRsbLgLsbLcRsbLibLibRgbRibLjbLibRcbRibRgbRsbRsbRsbRgRsmbLsbLsbRg
bLgbRgRsmbLsRsbRsbLsbRgRsmbRgbRgRsmbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 47; Drug: NDMC 10 µM
bLcbRibRgLcbLibRjbLibRjbLibLcbRhbRsbRcbRobRcbRiRsmbRhbLjRsbRsbRibRsbRg
bLsbRgbRsbRgbRsbRgbRsbRgRsmbRgbRgRsRgmbLgRcbRibRgRgRgLsbLcbLibLgRsbLsb
LibLibLibRibRcRsmbRcbLgbRsbLibLhbRhRsmbRibRcLsbLgbRibLjbsbRibLjbRsRgbR
gLgbRiRsRsmmbRhRsRsLsmmbRgRsmbRgRsmbRgRsmbRgRsmbRsRsRsmmbRgRsmbRgRgRgR
sRgmbRgRgbRgbRhRsmbLsRsRgbRsbLhbRibRcbRibRgbLebRibRcbLcbLibLibRsbLibLi
RsbRgbLgbRsbLibLsbLibRgbLgbLibRjbRcbsbLibRibRgRsmbRgbRoLsRsRsmbRcbRcLs
RsbRcbLibLibRgbLgbLgbRgbLiRgbLibLgbLgLsRsbRsbLgRsbLgRsbLiRsRjbLsLsLgmb
LgbLsbLgbRjRsmbRjRjbRoLsRsLsbLsbLgbRsbRibRgRsmbLsbRgLsbRgRsRsmmbRsbRgb
RsRsmbRgbRsRsmbRgbRsRsmbRgbRsRgbRiRsmbRsRgRiRsRgmbRgbRsbRgbRsbRibLjbRi
RsmbRsRsRgmbRgbRgbRsRsRsRsmmmbRobLibLcbLibLsbLgbLgbLgbLibLgbLsbLsbLibL
gRgbLibLgbRsbRcRsmbRgbRibRgbRgbRibRibLcbLcbRibRibRcbRhbRhbLjbLgbLsbLgb
LgRsbRgbLgbLgbRsLgbLgbRsbLgbLgbRsbLgbLsbLibLsbLiRsRsmbRjbRibRsbRgbRgbL
gRsbLjLiLsbRcbRibLjbRiRsmbRsRsmbRibLgbRgRiRgbLsRsbRgbRsRiRsRsmmbRgbRgb
RgRsmbRsbLsbRsbRgRsRsmmbRgbLsbRgRsmbsbRsRsmbRgRsmbRsbRgbRsbRsbRsbRgRsm
bRsbRgbRgLsbLcbLhbRjLsbLjbLiRjbLgbRgbLgbLsbRsbLhRibRjbLsbRiRsRimbRgbRs
bRgbRsbRgRgbRgRsmbRsbRgbRgbRgbRgbRsbRgRgbRgbRgbLsbRgLsbLjbRgbRgbRsbRgb
RibRgRsmbRsRsmbRgRsmbLsbRibsbRcbRsbLsbLsbRgbRgbRgbRsbRgbRgRgRsmbRgbRgb
RsbRgbRsRiRgbRgbRsbRgbLcbLibRsbLsbLgbRgbRjbRcbRobLibRgbLgbRgbRibRgbRgb
LsbRiRsmbRgbLsbRgbRsbRgbsbRiRsLsmbLibRibRgbLjbRibRgbRgLsbLebRobRsRsmbR
ibRiRsmbLcbRgbRobRhbRibLoRsRsRgmbRsbLibLgbRjRsRombRsbRibRibLsLsmbLsbRi
RibRibRgbRibLcbLibRsbLgbLibRjbsbLsLiLsbRgbLibLsLsmbLiRjbLibLsbLgRsbRsb
RibRcLsbLgbRibLgbRgbRsRsRsmmbRsbRgbRgbRsbRgbRgbLsRebLebLcRsbRgbRibRgbR
gRsRsmmbLsLebRgbLgbLgbRgbLibLsbLcRsbLibLhbRhRsmbRgbLibRgbRsbRgRsmbRibR
gbRgbRgRgbRgbRgRgbRgbRgbRsRsmbRsRsmbRsbRgbRsbRgRsmbRgbRgbLsbRgbRsRsmbR
gbRgLsRsbRgRsmbRsbRgbRgbRsbRgRsmbRsbRgbRgbRsRsmbRgbRgbRsRsmbRsbRibLgbR
gRgRsmbRgbRgbLsRsRiLsbRoLgRsbRsbLcbRjbLibLibRjLsbLibLcbLcbLcbRibLcbRjb
LhbRgbLgbLgLsRsbLgbLsbLsbLgRsbRsbLgbRsRsmbRjbLcbRcbLjbRcbRsbRgbRgbRsbR
gbRsbRgbRgbRgbRsbRibRgbRgbLibRsbLhbLhRibLgbRjRobLhbLcbLibRjbLcbRjbLibL
ibRcbRibRibRsRsmbLsbRgbRgbRgbRsbRgbRsbRgbRsRgRsRsmmbRgbRgLsbRgbRgLsbRs
bRgLsbLsbRibRsbRgbLcbLsLebRsbRjbLcRibLobLibRjbLibLcRsbRibLibLibRsbLgbR
jbRsbRgbRgRsRgmbRgbRgRsRsmmbRsbRgRsmbRgbRsRsmbRgbRsLsbRsRsmbRgbLebRhbR
gbRibRgRsmbLgbRgbRsbRiRsmbLgLsbLsbRibRibLgbRibRgbRgbLiRsbLjRsbLibRgbLg
LsbLgRsbLsbLsbRsRsLgmbLsbLgRsbsbRsRsmbLgbRsbRjbRibRibRsbRgRsmbLsbRgRsm
bRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 115741; End: 120241;
Recording: 12-1; Individual: 48; Drug: NDMC 10 µM
bLibLgLsbLgbLiRsbLibRibRsbLgbRgbLcbsbLibLobLsLsmbLibLjbLibRcbLcbLibRsR
smbLibRsbRsLsbLibRgbLibRsbLsLsmbLgbLiLsRsbRibLgbLiLsbLgbLgbRgbLiLsbRsL
sbLgbLsbLgbLsLsmbLgbLgbLgbLgbRgRsmbLcbLgbRiRsmbLibLhLsbRhRsmbLcLsmbLhL
sbLcLsmbLhbLgbLgbLibRgbRgLsbLgLsRsbLgbRsbLsbLgbRsbLibLcbLcLsmbLibLibLg
bLibLibLibRibLcLsmbRjbLcbLcbRcbRebLibsbLiLsbsbRsRsLsmbLibRjbRobRibLiRs
bLgbLsLsmbRcbLgbRibLgbRiLsbRgbRsbLibLibRiRsmbRgbLjbsbLibLgbRgRsmbLgbRi
bLgLsbRsLsRsbLsbLgbLgbRgbLgLsbRibLibLiLsbsbRgbRsbLibRibLibLiRsbRibRgbL
cbLgbsbLgbLsbRgbLjLsmbRgbLgbRgbLgbRgbLsbRibLibLsbLsbLjbLcbLibRibLibRjb
RsbLcbLcbLgLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 1; Drug: Control
bRiLsbRsbRcbLobLsbLiRsbLibLsbRibLibRibLgLsbRibLibRjbLjbRhbRsbRgLsbLjbR
jbLsbLcbLsbLgbRcRsmbLjbLhbLhbLsbLhbRsbLobLsLsmbLsbRjbLhLsbLsbLgbRsbLcb
LiLsbLgLsbRjbRobRsbLgbLibLgbRhLsbLibLgLsbRebRebRobLgLsbLibRgbRsbLsbRib
RsbRsRsmbRobRibLgbLgbLgbLgbRebRebRibsbLsbLgbLjbLibLibLibLibsbLgbRcbLsb
LibsbLgbLcbLobLib

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 2; Drug: Control
bRibRhbLcLsmbLsbLsLsmbLsbLsbLsLsmbLgbLiLsbLibLsbRsbRsbLibLsbLsbLibLsbL
sbLhbLgbLsbLsbRsbLgbLgbLsbRsbLiLsbLsbRsbLibLgLsbLhbLibLgbLgbLibRsbRsbR
ebRsbLgLsbRgbRibRsbRsRsmbRibRhbRsbLsbLgbLhLsbLibLgbLsbLiLsbRsbLibRgbLi
bRibRgbRhbLiLsbLebRibRsbRgbRsbRsbRsbRgRsmbRsbRsbRsbsbLjbLcbLiRsbRsbRib
RibRjbRsRsmbRsbRibLsLsmbLibLebLsbRsbRsbLibLibLgbRsbRgbRibRsbRgbRobRhbL
ibLcbRsbRsbLhbLibRibRsbsbRsbLiLsbLibRsbLibLibLgbLgbLibLiRsbLibRsbsbLiL
sbLsbRsbLibLiLsbLgbRsbRsRsmbLgbLsbRsbLibRibLhLsbRibRcbRcRsmbLibLcLsmbL
hRsLsbRibLibLiLsbRsbLhbLhbLibLebRgbRcbLjbLcbRibRcbRibLibRibLsbRiRsmbRs
bLcbLibRgbLibLgLsbRsbLsbLsbRsbLibRsbLsbLsbLgLsbLgbLsbLibRjbRcbRibLjbLc
LsmbRsLoLsmbLsbLsbLcbLibLgbRgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 3; Drug: Control
bLcLsmbRgbRjbRgbRgbRgbLgbRjbLcbLobRsbLhbRibRsbRhbLgbRhLsbLsLgbRobLgbLj
bRobLgbRcbsbRgLsbLgbRcbLebLiLsbLiLsbLcLsmbLibLjLsmbLgbLgbLcbLgbRgbRcRs
mbLiLsbLibLgLsLsmbRgbLgbLibRsbRsbLibsbRjbLibRsLsbLgbLibLgLsbRgbLsbLgLs
bLsbLgbLibRgbLibRsbRcbLibLsbLobRgbLsLsmbLgbLsbLgbRsbLsLsmbLsbLgbRgbLsb
LgRsbLgbLgbsbLsbRgbLgLsbLgLsbLsbsbsbLgLsbLsbLsbLsLsmbRsbRsLsbRsbRgbLib
RsbLibLsbLgbLgbRgbLgbLibLsbLgbLsbLgRsbLgLsbLsLsmbLsbLgbLsbLsbRsbLibLsb
LjLsmbLsLsmbRgLsbLsbRsLsbLgbLsbLcbLibLgbLsbRsLsbLsbLgbRsbLsbLcbLhbLgbs
bLibRsbLibLsbLibLgbRsbLsRsbLgbLsbLgbLsLsmbLsbLgbLgbRsbRsbRsRsmbLibLsbR
sLsbLgbLgbLsbLsbLsLsLsmmbLgLsbLgbLgbLsbLsbLgbLgLsbRsbRsLsRsbLgbLgLsbLs
bLsbLibLgbRgbLibLsLsLsmmbLgbLsbLibLsbLsbLsbsbLgbLsbLsLsmbLgbLsbsbLsbLg
bLsbLsbLgLsbLgbLsbLgbLsbLsbRgbLgLsbLsLsmbLgbLibLgbLgbLsbLsbLgbLsbLsbLg
bLsbLgLsbLgbLibsbLsLsmbLibLgbLoRsbLsbLsbLsbLcbLibLsLsmbLsbRgbsbLsbRcbL
sbLjLgLsbLiRsbLgLsbLsbLsbLsbLoLobsbRibsbRiLsbLgbLebLibRsbLsbLgbLibLsbL
sbLsbLsbLgbLsbLgLsbRgbLiLsbLcbsbLcbsbRgbRibRcbLibLsbRcbLgbRsbRcbLibLiL
sbLibRjbRoLsRsRibLjbLhbLibRsbLgbLsLsmbLgbRjLsbLibRgbLsbLgbLgbLgbLsbLgb
LgbsbRhRsmbLcbLibRgbLsbRibRcbLhLsbLgbLibLgLsbRgLsbLgbLgbLsbLgbLgbLgbLg
bRibLibLsRsbLgbLsbLsbLgbLgbRjbRcbLcbLcLsmbRibLobLhbLsbRcRsmbLgLsbLsbRi
bRiLsbLjbRibRcLsbLgbLcbLibLgLsbLgbLsbLgbRsbLiLsbRsbRjbLhbRgbLibLgbLsbL
sLsmbLgLsbLsLsmbRobRcLsbLeLsbLibLgLsbLsLsmbRsbLgbLsbLsbLsbRjbsbLobRcbR
iLsbRibRgbRgbRgbRsbLgbLibLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 4; Drug: Control
bRibLjbLjbRibLcbLjbLibLhbsbLibRjbLsRsbsbLobLibLgbLcbsbLjbLsLsmbLcLsmbR
gbLebLebLjbRsLsbLibLsbsbLcbLgbLgbRgbRcbRcbLjLsmbLhLsbLibsbLobLobLsbLsb
RoLsRsbRgbRibRob

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 5; Drug: Control
bRjbRcbsbLcbLcRsbLhbRhbsbLhbRjRsRsmmbLibRibsbRgbRsbLibLsLsmbRibRsbRsbL
ibsbRsbRsRsmbsbRsbLiLsbsbLgLsbRgRsmbLibRjRgRsmbRsbLgbRsbRsRsmbLiRsbRgb
LsbRsRsmbLsbLgbRsRsmbRjRsRsmmbLgbLsRsbRsbLsLsmbLhbRibRjbLibLcbRibRgbRg
bsbLjLsmbRjRsmbsbRibLjLsmbLibLsLsmbRcbsbRsbRsbLjLsmbLsbRsbRibLcbLcLsRs
mbRsbRsbRcbRibLsbRjRsRsmmbLibReRsmbLgbRsLgbLoRsbLgLsbLgbRsbLoLsmbRsbLo
bRsbLhRsbLsbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 6; Drug: Control
bLjLsmbLjLsmbLiRsbsbRjbRgLsbRjbLcbLibLobLsLcbRjbsbRiLsbLsbsbsbLibLjbLs
LjLsmbLcbRcbLebLhLsbRgbLiLsbLhLsbLjLsLsmmbLgbsbLibLsLsmbLibLsbLcRsbLiL
sbsbLibLsbLsLgLsbsbRsbLibLibRcbLiRsLsbRsLsLsLhmbLcLsmbRhbLibRsbLcbLsbL
ibLsRgbLcbLjLsLsmmbLibLsbLsLsmbLiLsbLgLsbLcLsmbRhLsbsbLsbLsLsmbLgbLgLs
bRgbRobsbRhbLgbRibRsbLjbRibRgbRcbRsbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 7; Drug: NDMC 1 µM
bLgLsbLgLsbRsbRgRsmbRsbRibLjbRjRsmbLgbRjbLgbRgbRsbRjbRhbRgRsmbLsLsmbRg
bLeLsbLjbLgbRjbRcbRgbLgbRsbRsRgbRibRhRsmbLsbLsRibLgbRgbRcbLsbRgRsmbLgb
RibRgRsmbsbsbLjbLhbRhRsmbRibLjbLhbLhLsbRjbLgbLcRsbRibRjbLsLsmbLgbLcbRg
RsmbRsbRgbRjbLcbLhbRgbLsbLibLobRsRsmbLcbLcbLsLsmbLsbLcbRsbLebLhbRjbLsb
RjRsmbRcbRhRsmbRiRsmbRgbLjbRjbsbLhLsbLjbLsbRjRsmbLcbRjLsbLgbLcbRcbRoRs
mbRjRsmbLsbLjbLjbsbRcbLgbRsbsbRsbRgbRcLsbLibLhLsbLgbRibLjbRjRsmbRcRsmb
LgbLsbRjbRjbRjbLsbLsbLsbLibRjbRjbRgRsmbRsbRgbRjbLsbLjbLsbRebRcRsmbRsbR
gbRjbRgbLjbRcbLjRsbRjbRsbRgRsmbRgbRgbLjbLcLsRsmbLsbRsbLibRgbRsbLjbRjbR
cRsmbLjbRibLsLsmbRibLjbRsbRibRsbRsbLsbRjLsbRgbLgbLsbRibLsbRgbLsLgbRsbR
gRsmbRgbLcbLcbLsRsbLcbLibRibRgRsmbLgbRjbRhbLcbRjbRjbRibLgbRibRsRsmbLsb
RgbLgbLsbLjbLibLgRsbRibRjbLibLoRsbRgbLsbRsbRgbRibRjbLibRibLjbRgbLibLob
RgbRgbLcbRibRcbLcbLcbRhbRibRibRgbLjLsmbRiRsmbLgbRgbRsbRsRsmbRsbRsbRsRs
mbRgbRsbRgbsbLgbRibLsbRgbRibLibLibRcbLcRsbRjbRcRsmbLsbRibRibRhbRsbRsbR
sbLhbRjRsmbRiRsLsmbRsbRiRsmbRsRsmbRgbRgbRsbRgbRgRsmbRsbRgRsmbRgbRgRsmb
RibLgbRgbLgbLsbRgbLgbRgbLjbRibLgbRibLsbRsbRgbLgbRibLgbRibLsbRsbRgbRgbR
gLsbRgbRgbLgbRibRsbRibLjbLibLsbLibLgbLibRibRcbRgbLjbsbRibLgbRjRsmbRiLs
bLibRsbRgLsbLsRsbRgRsmbRsbLsbRsbLsRsbRjRsmbRgbLjbRibsbRibLsRsbRgbLsbRg
bRibRsbLsbRgbRgbLgbRgLsbRgbLgbRsbRibRgbLibsbRibLsbRsRsmbRsbRsbRgbLsbLs
bRibRgbLsbRgRsmbRgbRgbRsLsRsbLsbLsbRsRgbRgbRsbRgbRgbLsbRibLgLsbLsbRibR
cbRibLibRibRsbRibRsbLgbRcbLibRgbRibLgRsbRsbRibRgbLgbRgRsmbLsbRibLgbRib
RiLsLsmbLibLobLobRgbLiLsRsbRhLsbRibLhLsbRibRgbLgRoRsLsRsmbRsbRsbRjbRoR
smbRsbLsbRjLsbRcbRjbRibRibRsbLcbRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 8; Drug: NDMC 1 µM
bLjbRjbLcbLsbLsbLgbLgbLgbLgLsbRgbsbLgbRsbsbLcbLsbLgbLsbLjLsLsmmbLsLsmb
sbLsbRjbRsbRibRsbLsbLgbRgbRsRsmbsbLgbLcLsmbRibRibRiRsmbLiLsbLgbsbRjbLs
bsbRcbRiRsmbRsbRsbRgbRsbRcbLsbRsbRsRsmbRsbLsbRhbRsbRibRgbRhbRsbRiRsmbs
bRsbRgbLsbLsbRcbRgbRsRsLsmbsbLgbLsLsmbLcbLsLsmbsbLgbRjbLgbLsbLjRsRsmbR
jbRjbRibRibRsbsbRsLsbRgbsbRsRsmbsbRgbLsbLsbRiLsbLibRhbRsbRibsbRibRsbRs
bsbRgbsbRgRsmbRsRsmbRsbLsbRsbLsbLsbRibRgbsbLsLsLsmmbRhbRibsbLsbsbRsRsR
smmbRgbRgRsmbRsRsmbRhbRsRsmbRibRsbLsbLsbLsbsbRjbLsbRsbLsbRibRsbRsRsLsm
bLsbRibLsbLebLibLobLobLiLsbLsbsbLjbLsLsmbRsbRgbLiLsbLsbRsRsmbRsLsbLgbL
gRsbRjbLibRsbRgbsbLgbLsbLgLsbLgbsbsbRgRsRsmmbLibLhbsbLibLsbRsbRsbLgbLs
bRsbLibRjRsmbLibLsbLsLsmbLgbRjbsbLibLcbRgbRgRsmbRsbsbRjbLsLsmbRibLsLsm
bRsbRiRsmbLsbRsbLcbLibLsbRsRsmbLibRjbLsRsbLgbRsbsbRsbLsRsbsbLgbRsLsbLc
bRibRsbsbLibLsLsmbLsbLsbLsbLsbLgRsbLibLsbRsbLsbLgLsbLhLsbRgbRsbLgRsbLg
bLsLsmbLgbLobLsbRgRsmbRcLsbRibRgbRsbRgbLsbRcbRgbRgbRobLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 9; Drug: NDMC 1 µM
bLibRibLjLsmbRjRsmbRhbsbRjbLjLsmbRjbLjbRibLjbRhbRibLjLsmbLjbRcbLjbRcbL
jbRhRsmbLjbLjLsmbRjbLjbRjRsmbRjbRjRsRsmmbLhbRibLsbLgbRjbRhbLjLsmbRjbRc
bLjbLibRjbRcRsmbRgbLjbRibLjbLibRibRjRsmbRsbRjbLsbLsLsmbLjLsmbRjRsmbRcb
RcbRjRsmbLjLsmbRjbLjLsmbLibRibLhLsLsmbLjbLjLsmbLcbLcbLibRiRsmbLgbRcbRi
bsbLjRsbLjbLjLsmbLjLsmbRsbRjbRgbLcbLibLjbRibLiLsbRcbLibLjLsmbLsbLibLcb
LibLhbLsbLjbLgbLgbLjbLsbLgLsbLibRcbLhLsbLcbLiLsbLiLsbRgbLibLibRibLgLsb
RobRobLsbRibLibLcbLcbRobRhbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 10; Drug: NDMC 1 µM
bRibRgbLgbLsbsbLsbRibLjbLsbRsLsbLibLgbRsRsmbsbRsbRsbRsbLgLsbRsLsbRibRs
bRsRsmbRsbRsbRsbLsRsbRgbRsbsbsbsbRsbLsbRgbLjLhbLsbsbLsbRcRsmbRiRsmbRsb
LsRoRsmbRjRsmbLibLsbLgLsLsmbRgbLsbLgbLgbLsbLibRsbLsbRgbLoLsmbLibLsbLgb
LgbLibLgRsbRhRsmbRsbRgbRhbLsbRiRsmbRsbRsRobRobLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 11; Drug: NDMC 1 µM
bRgbLibRibLgbRjbRsbRsRsmbRsRsmbLjbLjbLgbLgbLibRsbsbLgbRsLsbLibLsbsbLjb
LiLsbLgbLgbLgbLjLsmbLgbsbRgbLgLsbLhLsbRibLjbLibsbLibRibLibLibLibLibsbL
jbLibsbLibLsbLibLsbRhbLgbRhbLgbLsbLibLgbLibLsbRgRsmbRgbRcRsmbRjbRibLgb
RibRsbRjbLsbRgbRgRsmbLgbLgbLibRibRjRsmbRibRibsbRjbRsLsbLjbRjbRjbLgbRgb
sbLibLgbLibRsLsbLgbLjbRsRsmbRibLibLsbLjbLibLibLiLsbLgbLsbLibLhLsRsbsbR
gbRjbRjRsmbRsbRgbLjLsmbLhbLgLsbRibLibLibLibsbLsbsbLgbRsbLsbsbRgbRiRsmb
RjbRjbLgbRhbLsbLsLgbRsbRsbRgbRibRsRsmbsbsbRcLsbLsbLsbRsbRhbRjbRsbRgbLg
LsbLgbRjbLjbRgbLjbLsbRgbRibRsbRibRgbRibRjRsmbLsbLsLsmbLsbRsRsRsmmbRcRs
mbRgbRgRsmbRjbLcRsbRsbRsRhbLgbLiLsbLcbLjbRsbRgbLibLsRsbRibRhbRibRibsbR
gRsmbRjbsbRcbRibRsbRgbRsbRsbRgbRsbRsbRcbLibRgbRhbLibLibLgbsbLhbLgbLsbL
ibLibsbRibLgbRgbLsbLsLsmbRjRsmbRgbRibRibRjRsmbLjLsmbLsbLiLsbLgbLsbRgbL
iLsbRsbsbLobLobLsbRsbRgbRobRsbRsbLsbRsbRgbRcbRgbLsbLsbRsbRsbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 12; Drug: NDMC 1 µM
bLgLsbLgbLjbRcbRjRsmbRibRgbLjbsbRgbRibLibRcbLcbRibLibLjbRjbLibLibRjbLh
bLibLsbRgbLgbLibLibLgbLibsbRibRgRsmbLcbRhbLobRjbLibLjLsmbRhbRcbLcbRibL
jbLjbRhRsmbRcbRcbRiRsmbLgbLsbLsbLsbRcbRgRsmbLhbLcbRjRsmbRibLcbRjbLibRj
RsmbLjbRibLgLsbLibRjbLibRibLibRjbRjbLibLjbLibRibRsbsbLsbLjbLibsbLsLsmb
RsbRsbRsbRsbsbLgbRsbsbLgbLsbRsbRjbLgbRjRsmbLhbRibRjbRjbLhbLibLibRjbLsb
LgbRjbLibRjbLhbLhbRcbLsbLsLibLhbRgbRcbLjbLcbLsbsbsbLsbRsRsmbLjbLibLhLs
bRhbLhbLibRjLsbLibRjbLebRsbLjbLibsbRjbRsbRsbRgRibRjLsbRiRsmbRgbRgbRsbR
gRsRsmmbRsbLjbRiRsmbRjbRobRibRcbLibRcRsmbLhbRgbLsRgbRgbRgbLsLsmbRgbRsR
smbRsbRsbRsbRsbRgbRsbRsRsLsmbRsbRsbRsbRgbRgbRgLsbRsbRsRsRsmmbRgbRibRhb
RibLjbRcbRibLibRcbRgbRiRsmbRcRsmbLiLsbRibsbRgbRibRgbLgbRebLhRsbRibLhbL
iLsbRcbLjbLgbLgbRsbLgbLgbRsbLgbLgbLgbRibRgbLibLsbRibLiLsbRgbLgbRobRsbR
iRsmbRsRsmbRsbRibRibLibRgbLibLjbLiLsbLsLsmbsbsbRcbLcbsbRjbLsbRiRsmbLjb
RsRjbLjRsbRjbRiRsmbLibRibLjLsmbLobRobRob

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 13; Drug: NDMC 3 µM
bLibRsbLgbRjbRibLibRsbRgbRsbLgbRibsbLcbLjLsmbLsbLibLsRsbRibLcbRhbLgbRc
bLibRibRgbRsbRsLsbRgbLsRsbRgbRibRjRgbRjRsmbRibLibsbLsbLcbRsbRsbLibLhbR
ibLcbRibsbRsbRjbsbLsbsbLcbLgbLcRgRsmbRcbLibLsLsmbLhbLgbLsbLibLsbLcbLsb
LsbRsbRsbRjbLhbLjbsbLhbLcbRebRsLsbRcbLsbRjRsmbRgRsmbLoLsmbLsbLsbLobLgb
RibRcbRcbRgbRgbRsbLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 14; Drug: NDMC 3 µM
bLjbLjbLjRsbLhbRjbLibLcbLibLsbRsbRgbRgbRibRsbRibLgbLsbRgLsbRibLjbLobLi
bRgbRsLsbLibRgbRgbLibLjbRjbLibRibLhbRibLgbLibRsbRjbLiLsbLgbRjbRhbLebLi
bLgLsbRsbLibLgRsbRibLgbRsRhLsbLcbLsLsmbLsbLsbLsbLsbLgbLgRsbLgbRsbRjbLc
bRibRjbRcbLhbLsbLcbRibLcbRgbRcbLcbRgbRcbLcbLsbLgbLsbLibLsbLcLsmbLsbRib
RgbRibRcRsmbLebRibRibLjbRcRsmbLcbLcbRhLsbsbRibLcbRjbLobRhbLgbLcbRcbRjR
gbRgbRsRsmbLsbRibRibLiRsbRibLjbsbLcbsbRsbLjLgbRsbLsbLsbLgbLgbLsbRsbLgL
sbLsbLsbLgbLsLsmbLgbLcbRjbLgbLgbLgbLgbLgRsbLgbLsRsbRobRsbsbLsbRgRsmbLi
bLebRhbLcbRibRibLjLsmbRgbLibRibLgbRsLsbLibRebRibRsbRiRsmbRsbRsbRiLsbLi
bRibLcbLcbRjbRibRibLibLcbRjbLgbRcbLsLhbLcRsbRibLcbRibLibLibLgbLgbLgbRj
bRobLgbsbRcbLibRiRgRsmbRsbRgbRsbRsbRsbRsbRsbRgbRsRsmbRgbRiLcLsmbRsRsmb
LibRcbRjbRcbLibLsbLjbRcbLibLgbRjRsmbLibLgRsbLibRgbLgLsbRsRsmbLibRsLsbL
gbLsLsmbLsbLsbLgbLsbRgbLsLcbRibRsbRebRgRsmbRgbRgbRgbLsbLsbRgRsmbRsbRgb
LsbRgbRgRsmbRsRsmbLcbLsbRcRsmbRebLibLebLgLsbLsbRhbRgbRsRgbRgbRgRsmbLsb
RgbRsbRsbRgbRgRsmbRgbRgbRsbRgLsbRibLjbLcbRibsbRsbRibLgbRhbLibRhbLhbRib
RgRsmbRsbRgbRsbRsbRsbRsbRgLsbRsbRsRgbRgbRibRsbRgbsbRgLsbRibLobLibRhbRi
bLjbLcbRcLsbLibLibLgbLgbLsbLgbLgRebRjbRgbRsLsbsbRsbRgbRgbRsbLsbRjbRsbR
sbRsbRsRgbRgbRgbRsRsmbRgbLjbRiRsmbRgbRgbRsLsbRsRgbLsbRgRsRsmmbRgbRsbRs
RsmbRgbLsRgbRgbLsbRgRsmbRsbRgbRsbRsbRsbRgRsmbRsRsmbRgRsmbRsbRgRsmbRgbR
gbLjLhbLiLsbRjbRcRsmbLjbLcbLiRsbLibRcbsbRcbLjbRgRsmbRiRsmbLsRsbRsbRgbL
sbRsbRgRsmbRgbRiLsLsmbLhbLobRcbRhbLcbRjRsmbRiRsmbRgbRsbRsbRsbRsbRibRsb
RgbRsbRgRsmbRsRsmbRsRsmbRsbRgRsmbRgbRgbLsbRibRgLsbLjbRiRsmbLjbRiRsmbRg
bRsbRgbRsbRsbRsbRgRsmbRgbRgbRgbRgbRgbLibLcbRjbLcbLsbRsbLibLsbLibRjbRcb
LjbLibLibRcbRobLgbRsRsmbRgbRibLjbRhbLgbRibLgbRibLgbRhbLgLsbRibRgbRsbLs
bRgLsbRsRsmbRgbRgbRiLsbLibLjRsbLibLgbLsbRgbLcbRhbLcbRsbLsbLgbRsbLgLsbL
sbLgbLgbLgRsbRsbRjbLsLgbRcbLgbLsbLgbLgLsbLgbLsRsbLgRsRsmbLsbLgbLsbsbLg
bRsbReRsmbRobRibRsbLsbRgbRgRobRobRsRgbRgbRcbLibRsbLgLsbLsbLsbLibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 15; Drug: NDMC 3 µM
bLgbRgbLibLgbLsbLgLsbLgbLgbLgbLibLgLsbLgbLgbLgbLgLsbLgLsbLsLsmbLgbLsbL
gLsbRgRsmbRsbRcbRgbRgbRgbRiRsmbsbRgRsmbRibRgbRsbRjbsbLjbRsbLhbLjbRsbRg
RsmbsbRsbRhbLsbsbLsbLibLjLsmbRsbRsbRcbRsbRibRibRgbRgbRsbRsbLgbLibsbLsb
LsLsmbsbLgbRjbLiLsbLgbRgbLibRgbRjbRobRsbRsbRsRsmbRgbRsbLgbRgbRsbRsbRsL
sbRiLsLsmbRibLsbLibLcbLgbRgbsbLibRsRsmbLibRgbLibRsbLgbLgbLgbRcLsbRibLs
bRgbRgRsmbRsRsmbsbRibLibLhbLibLgbLsLsmbLibLgbRibRsbLibLgLsbLsbRgbLjLsm
bLobRsbRsLsbRsbRgbRgbRgbLgbLgbRcRsmbLgbRsbRgbLjbLcbRsLgbLgbLsbLgbRsbLg
LsbLgbRgbLibRjbLjbLgbRhbRcbRibLgbRibRsbRsLsbsbRhbLjbLgbLgbLibRjbRiRsmb
RgbRgbRgbRibLiLsbLjbLhLsbRjbRgbRgbRgbLjbLsbLgLsbLgbLgbLsbLsbLgRsbLsbLs
bLgbLgLsbLsbLgbRgLsbLgbLsLsmbLgbLsbLsLsmbLsbLgbLgbRgbLibRjbLhbRhbRcLsb
LhbRhbLibLibLsbLgbRsbLgLsbRsbLsbLgbLgbLgbLibRobRibRibLhbRjbRgbLjbLcbLi
bLibLgLsbLgbLgbLgbRsbLgbLgbLsLsmbRjLsbsbLibRjbLiRsbRsbRsLgbLsbLsbLgbLs
LsmbLsLsmbLgbLgbRobRiLsLsRsmbsbLsLsmbRgRsLsmbLgbRiLsbLjbRibRsbRgbRgLsL
smbLsbLjbLjRsLsbRsbLgbsbLgbLsbLgbLsLsmbRsbLgbLgbLgRsbRsLsbLsbLsLsmbLsb
LgbLgLsbLsbLsbLgbRsRsmbLgbRcbRibRibRgbRgbLsbRgbLhLsbLgbLgLsbRsRsmbLgbL
gbRsbLgbLsLsmbLsbLsbLgbLgbLsLsmbLgbLjbRsbLgLsbRsLsbLgbRsbLsbLsbLgbLsbL
sbLsbLgbLgbLgbLsbLgbRsLsbLgbRsRsmbRsLgbLsbLsbLsbLgLsbLgbLsLsmbLsbLsbLs
LsmbLsLsmbLgbLgbRgLsbLsbLsbLsbLgbLsbLsbLgbRjbRobRgbRgbRibLsbLgbRcbLibL
hbLgbLsLsmbLgbRsbLgLsbLgbLgbRsbLgbRsbLsbRsbRsbLsLsLsLgmmbLgLsbLgbRjbRh
RibRgbLsLsmbRgbLjbLibRsbLgbLsbLgbLsLsmbLsbLsLsmbLgLsbRgRsmbLiLsbRgbLib
RsbLsbLgLsbLgbLsbLgbLgbLgbLgbsbRsbLgLsbLgbLsbLgbLsbLgbLibRsbLgbLsbLgLs
bLsbLgbLibRjbRobLgbRsLgbRgbRsbRsbRgbRhbRgbRcbRhbRgbRsbRjbRibRcb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 16; Drug: NDMC 3 µM
bLibLsbRhLsbLcbLcbLibsbLgbLsbLgLsbRsbRcbLjbLebRcbRibRhbLsbLgbRhbLjbRsb
RhbLibRibRibLibRsbLibRjbRcRsmbLibRhbLgbRibLsbRsbRgbRgbLjLcbLobLhbRgbRi
bLhRsbRibRcbLhbRgbRgbRsRsmbRgbRsbLcbLiRsbRgRsmbLcRsRsmbLgbRibLibRibRob
sbLibRibRgRsmbRhbLgbRibLgbRgbRsbRsRsmbRsbRgbLjRsLcbLcbRcbLgbRjbsbLibLg
bLgbLgbLsbLgbRcbRiLsbLcRsbRcbLsbLibLhbRcbRibLjbRcRsmbLgRsbRgbRibLsbRsb
RgbLsbRgbRsbRsbRsbRgbLgbLjbLibRcbRibRsbRgRsmbLjbRibRgbLsRsbRsRsmbRgbRs
bRgbLsbRgbRsbRgLsbRsbRsbLsRsRsmbRgLsbRgbRgbRgRsmbRsbRgbRsbRsRgRsmbRgbL
cbRcbLcbRcLsbRgbRsbLsbRgRsmbLsbRibRhbLhbRgbRibRsbLsbRgbRgLsbLsbRgbRsbR
sbRiLsbLgbRsbRibRgRsmbRgbLjbRobRcbLcbRcbRjbRibLgbLibLhbRcbRjRsmbRhbLib
RsbRgbRsbLsbRgbRsbRgRsRsmmbRsbRgRsmbRgbRsbRsRsmbRgbRsbRgbRsbRsbRsRsmbR
sbRgLsbLcbLcbRcbRibLibRibRgbLcbRjbLcbRebLibRcbLibLhbLibRgbLibLibRjbLhb
RibRcbLsbRibRsbRsbLsbLebLcRsbRcbRsbRcLsbLcbLcLsmbRgbLhbRgbLgbLibLsLsmb
LgLsbRsbRcbRibLsbRgRsmbRsbRgRsmbRgbLsbRsbRgbRgRsmbLsRsbRgbRsbLcbRjbRhL
sbLibLibRsbLgbRjbRiRsmbRibRjbRibRgbLgRsbLcbLobRcbLsbLcRsbLsbLibRibLiRs
bLgbRsbLgbLibRhbLibLibRjbRcbLcbLiLsbsbRobRgRsmbRsLsbRsbRiRsmbRgbRsbRsL
sbRgbRsbRsbLsbLhbRjbLcbRibLhbLcbRibRoRsmbRiRsmbRgbRgbLjbRgbLsbRgbRsbRg
bRsbLsbRgbRgbRgbRsRsLsmbLsbRgRsmbRsbLsbLhbLhbRcbsbLhLsbRjbRoLsbLgbsbRi
bRsbRgRsmbRgbRsbRgbRgbLcbRobLjbRobLibRcLsbLibsbRiLsbRibLjbRcbLgbLsbRib
RgbLsbRsRsmbRibRibLsbRgbRgbRsbLsbRsbRiRsmbRsbRgbRgbRgRsmbRgbRgbLjbLcRs
bLcbRcbRibRgRsmbRgbRsbRsbRsRsmbRgRsmbRsbRsbRgbLcbLhbRhbRcbLibRibRsbRib
LsbRgbRsbRsbRsbsbRiRsRsmmbRgbRsRsmbRsbRgbRsRsmbRgbRsbRsbRgbRgbRgLsbRgR
smbLjbLobRjRsmbRibRgbRgbRgbRgbLcbLsbLibRcbRcbLibRibRgbLgbRgRsLsmbRsRsm
bRgbRibRgbLjbRcbLibRsbRcbLhbRibRiLsbLgbRibRsbRgRsmbRgbLiLsbRhbRgbRsbLs
bLgbRcLsbLgbLgbRibRgbRgbRgbRgbLhbRgbRibLjbRcbLcRsbLobRgbLcbLgbRgbLgbLg
bRgLobRgRsmbLgbRgRsmbLsbLsbLjLgLgbLgRsbLsRsbLsbLibLsbLibRgbLsbLgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 17; Drug: NDMC 3 µM
bRgbRgbRibRgbRibRibRjRgbRsRsmbLjLsmbRjbLebsbRsbLsLsmbRjbRjRsmbRibRibRi
bsbRibsbLibsbRhbRgbRsbRgbRsRsmbRgbRsRsmbLsbRjbLcbLiLsbRcRsmbRcbRgbRgbL
gbsbRhbRebRhbsbLsbLjLsmbRjRsmbRsbRsRsLsmbRiRsmbsbRcbRsbRgRsmbsbsbRibRs
bRsbRsbRsbLsbRcRsmbsbRibRgbRsRsmbRsbRsbRsbLgbLhbLcbLsbRsLsLsmbLgbLsbLs
bRgbRcbRibRsbRsbLgbRcbRgbRgbRiLsbRsRsmbRsbRsbLsbReLsRsbLsRsbLsRsbRibRs
bRgbRsbRsbRgbRibsbLsbLsbRibRiRsmbRibRgbLsbLibLsbLibRsbLsbLsbLibRsbRgRs
mbRibRcbRgbRsbRsbsbRgbRcbRgbRsbRsbLgbLcbLcbLibRsbRgbRsbsbLcbRsRgbLobRi
bRsRsRsmmbRgbRsbRcbRibRsbLjbLhbRsbLcbRibRibRsbLobLebRsbLgbRiLsbLgbLhbL
ibRsbLgbLcbRsbRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 18; Drug: NDMC 3 µM
bLibLibRsbRsbLsLsmbLsbLgbLiLsbRsbLsbLgbLsRsbLibLibLsbLsLsmbLsbLsbLiLsb
LiLsbLsbLsbRsbLsbLsbLhLsbLibLsbLsbLsbRsbRsRsmbLiLsbRsbRsbRjRsmbLsbRsbR
cbRcLsbRsbLjbRibRsbLhbLsbLgbRsLsbRsbLsbLgLsbLsbRsRsmbRsbLgbLsbRsbRsbRs
RsmbRjbsbRibRibRgbLgbLcbLiLsbLgbLsbLsbRgbLcbLsbLjbRcbLsLsmbLsbRsbLibLs
bRsbsbRsbLgbLsLsmbRsbRsbLibRsRsmbRsRsmbLsLsmbLibRsbRsbRsbRgbLibLsRsbsb
LibLsbLsbLsLsmbsbLibLgbRgbRsLsbLiLsbsbsbLsbRsbRsRsmbLibLsbRjbRgRsmbRsb
LibsbRsbLibRsbLiLcbLcbLsbLsbRsbLsbsbLcbLgRsbLhbLsbRsbLsbLsLsmbLsbRsRsL
smbLjLsmbLsbRsbsbRsbLibRgbLebLsbRsbRsbsbRsbLgbLgbLibLsbLsbLsbLsbsbRsRs
mbRsbLhbLgbLsLsmbRsbRsbRsbLgbLgbLsbsbLibLsbLibRsLsbLsbRsLsbRsLsbRgRsmb
LcbLsbLsbLsLsmbLsLsLsmmbLsbLgbRsRsmbLiLsbLsLsmbRsbLobsbRsbRsbLiLsbLsRs
bLgRsbRcRsLsmbRiRsmbLgbLsbLibRcbRebRsbLsbRgbLhbLsbRgbRgbRcbLibsbRsbRjR
iRsmbRgRsmbLjbLobLibRsbLsRsbsbLsLhbLsLsmbRsbLsbLibRsbRsbLhbRsbLibRgbRs
bRgRsmbRsbLcbRsbRsLsbRsbLhbLcbsbLjbLgbLibRsRsmbLsbRsRsmbLibRgbLiLsbRgb
LibRsbLsbLibLcbRsbLibRibLcbLsbLeLsbLsbRsbLsLsmbLsRsRsRsmmbLibLhbRgbLsb
LibLgLsRsLsbsbLsbsbLsbLibLibLsbLsbRsbLsbLsbLsLsmbLgLsbRsbLgbRsbRgbLibL
sLsmbRsbRsbLibRsbRjRsmbLiLsbLsLsmbLsbLsLsmbLgLsLsmbLsbRsbLcbRsbRsbRgbL
jbRgbRgbRgbRibRhbRcbRjbLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 19; Drug: NDMC 10 µM
bsbLibRcbsbsbLjbLjRsbLcbLjbRibRjbRcbLobLoLsLsmmbLjbRgLsbsbLgbLgbRjRobR
jbLjLsmbLhLsbLibRjbRcbRgRsLsmbRgbRsbsbRgbLsLhbLjLsmbLjbRgbRibRcbLobRib
RsbRgbLjbRjbRibRcbLgbRgbsbRcbLebsbLsbLibRsLsLsmbRsLsbLsLsmbRjbRiLsbRhb
LsbRjRsmbLcbLibRgbLsbLibRebRgbRgbRgLsbRgbLjbLcbLsRsbLibLobRsbRiRsmbLsb
RgbRgbRsLsLsmbRgbRgbLjLsLsmmbLcbLcbRcbLcbRgLsbLsLsmbLsbLcbLhbLcbsbLsbR
gbRsRsmbRsbRibLgbRcbRibLcbLcbRebRibRsbRibRgbLcbLcbLiRsLsbLsbRgbLiLsbLs
bLsbLgbLgbLgRsbLgbLsbLgbLsbLjbRsLsbLsbLgbLgbLgLsbLgbLgbLgbRcbLjbLiLsbR
ibRibLobLcRsbLcbRhbLgbRjbLcbLcbLiRsbRibLgbLibLiLsbLsLsmbRsbLibLiRsbLsb
RgbLiLsbRebRgbRsbRgRsmbRsbRgRsmbLsRsbRgbRgbRgbLjbLcRsbRcbRhbLjbLcbRcbR
ibRsbRobRcbRsbRgRsmbRiRsmbRgbRsbRgbRgbRsLsbRsRsmbRgbRsbRsbRgbRibLsbRgb
RgbRgbRsbRgRgbRgbRgbsbRibLcbLhbLcbRibLhbLcbRgbRjbRgbRgbRsbLsRibLhbLcbR
jbLhbRibRjbLcRsbLgbRibRjbLcbLgbLcbRhbRibRibLgbLhbRjbRhbRgRsmbRgbRgRsmb
RjbRsLsbLsRsbRgbLjLsmbLoLsmbLibLsLsLsmmbLsbLsbLsLsmbLgLsbLgLgLsLgLiRsb
LibLgbLgbLsbRsbLgLsbRsbLsbLsRcbLjLsmbLibLsbLsbLgbLgLsbLgRsLsbRhbRsRoLs
bLcbLibRsbLgbLsbLgbLsbLgbLgRsbLgbLiRsRsmbLcbLcbRibRgbLibRhbLhbRcbRgbLj
bLjbLobRiRsmbLoRsbRibLiLsbLgbLsbLsbLgRsbLsRsbLgLsbLgLsbLgbLiLsRsbLgbLg
bRsLsbLgLsbRsLsbLgLsbLsbLgbLibLsbRsbLgbLgLsbLgbLgbLgbRjbRoLsbRobRcbLiL
sbLibRjbLcbRobRobRcbLibLsbLgbLgLsbLsbRgbRsbLgbLsLsmbLgbLgLsbLgLsbLgbLs
bLgbLsbLgLsLsmbLgbLgbLibLgLsRsbLsbLsLgbLgLsbLgbLgbLgLgbLgRsbLgLgLsbLgL
sLsmbLgbLgbLgbLgLsbLgLsbLgRsbLgbLgbRobLsRibRgbRgLsbRgbRsbLcLgbLgbLsbLg
bLgbRgLsbLgbLsLsmbsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 20; Drug: NDMC 10 µM
bRjbRibLibsbRibRjRsmbLjbLgbLsbLibLsLsmbsbRibLsbLjbRsbRgbRjRsmbsbsbRgbL
cbRjbRibLibLcbRjbRibLgbLjbLoRsbLiLsbLsbLcbLgbRibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 21; Drug: NDMC 10 µM
bRhbRobRcbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 22; Drug: NDMC 10 µM
bRsbLjbRsbRsbLgbsbRiRsmbRebRibRobLsbRibLjbRgRsmbLsLsmbLjLsmbLjLsLsmmbR
hbRjRgbsbRjbRjbRsbRiLsbRobRcbRobLgbRcbLsbLhLsbLobLcb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 23; Drug: NDMC 10 µM
bLcbLhbLjLsmbLobLhbLhRsbLcLsLsmmbLibLibLgbRjbLhbLibLjLsmbLjRsbRjbLibRi
bRsbLibLibLibLgLsbLsbLsbRjbRjbLibLibLibLibLcbLibLgLsbLiLsLsmbRgbLhLsbL
hbRsbRibRgbRgbRjbRsbRiRsmbLgbLibLibLiRsbLsbLsbRsbLgbRsbLgbRjbRcRsmbReb
LjbLjbLhbLibRgRsmbLibLgbLsbLgbRjbRhbRcbRibLhbLjLsmbLibLibLsbLibRjRsmbL
jLsmbRibLibLgLsbRgRsmbRgLsbLhbRhbRcRsmbRgbLsbRcRcbsbsbRibLsbLibsbRgbsb
LgbLiLsbLgbLsbRgbLcbRcbRgbRibLgbLjLsmbLgbLsLsmbLibRgbLibRgLsbRsbLgbLgb
LsbLsbsbLsbRsbLibRhRcbRibLsbRjbLjbLsLjbRjbRsbRgbLgbLcbLibLgbRjbRcbRjbL
ibRibLgbRcbsbLibLcbRjbLcbLgRsbLsbLsLsmbLgbLgbRjRsmbRebRsRsmbRjRsmbRjbL
cbLcbLibLgbLsbLgbLibLobsbRsbsbRsbRibRibsbLjLsmbLjbLhbRsbLgbLgRsbRcbRjb
sbRjRsmbLjbRibsbLsbLibLibLjLsmbLgLsbRgbsbLibsbsbsbLsRsbLsbLsLsLsmmbLsb
RjbsbRcbsbLsRsbLhLsbRjbRcbLjbLibLsRsbLibRjbLibRsbLsbLgLsbLgbRcbRcbRiRs
mbLsbLgRsbRcbRibLsbRiRsmbLgbLsbsbRjbLsbLgbsbLgbLjbsbRjbRjbLgbLibLgLsbs
bRjbRsLibLibsbLgLsbLsbLgbLgbRcbRcbRibsbLsbLjbLcbRsbRcbLcbRcbRgbRsbLsbL
cbLcbsbLibLsbLsRsbsbLgbLibLibRhbRibLibRoLsbRgbRobRibRibLsRcbRsbLcbLhbL
ibRsbLibRgbRgbRibRcbRcbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 24; Drug: NDMC 10 µM
bRgbRsRgbRgbsbLibLcbRibRibLjbLibRjbLjLsmbRgbLgLsbRjbsbRcbRibLibRibLjbs
bLibRgbRgbRibLjbRobRibRgbRgbRgbRgRsmbLsbRgbRgbLgbsbRhbsbRsbRobRsbLsbLi
bLsLsmbLgbRgbRobRsbRgbLsRsbRsbRgbLsbLibLcbLsbRsbsbsbLjbRobRsbRibRsbRgb
RsbsbsbRsbRsbsbsbLgbRibRsbRsRsmbRsbsbRgbRiRsmbLhbRibRgbRsbsbRsbRgbRsbR
sbRibRgbLsbLoRsbLgbLgbLgbLsbLsbLgbRjbLibRgbsbRjbRgbRiRsmbRgbRsRsmbRsRs
mbRsbRgbRgbRsbRsbRgbRsbRsbRgLsbRgbRobRgbRsbLsbRgbRcbRibRsLsbRibLibRibL
jbLcbsbLiRsLsbLcRsbRgbLsbRsLibLoLsmbRibLsbRgbRgbLsbRibRiLsbLibRsbRibRg
bLgbRgLsbRsbsbRsRsRsmmbRsbRsbsbLsbRgbLgRsbRibRsbRgbRgbRsbLsbRsbRsRsLsm
bRgbRsbLsLsLsmmbRgbRsRsmbsbLsRsbLsbLcbLcbRjbLcbLibRsbRgbLhbLsRsbRsbLib
RibLcbLcbLsbRsbLgbRsbLsbLgbLibLgbLsbRsbLsbRsbRjbLsbRsbLiRsbRgbLibLgbRg
bLibRjbLhbRsbLsbLgbRsbLibRjbRobLgLsbRibRgbRgbRgbRgbRsLsbRgbRgbRgbRgbLg
LsbRibRsbRsbRgbLsbLcbRsbRjbRgbRgRsmbRgLsbRibLjbRcbLjbRhbLgbRibRgbRsbRs
bLsbRsbRsbRgRsmbRgbRgbLgbLcbLibRiLsbLibLsbLgbLgbLsbLgRsLsbLsbLgbLsbLib
RjbsbRoLsbRgbsbRgbsbRsbRsbRgbRgbRgbRgLsbRsbRsbRgbLsLsmbRgbRgbLgbRgbLjb
sbRjbRjbLcbRgbLgbLgbRsbRjbLsLibRsbLgbLsbLgbLgbRgbLgbLsbLgbRsRsmbLsRsbL
gbLibRsbLgbLibsbRjbRsLibRoRsmbRsbLsRgbRsbRsLsbRgbRgbRgbLsLsmbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 25; Drug: Control
bLcbLibLibsbsbLgbLibLibRibLsbLsbLsbRsbRibRgbRgbLiLsbLibLibLjbRcbLjbLgb
LibRsbRcbRjRsmbLibLhbLsbRsbLgbLgbRsLsbLgbRsbLsbRjbRcbLsRibLsbLcbRjbRcb
LibLhbRjbRhRsmbLcbRjbRhbLibRhbLsRsRsmbRibRgbRjbRjLsbRcbRibRibLhbLsbLgb
sbLgbsbLsbLibRjbLhbRibLiRsbLibLibRibLibLgbRgbLjbLsbLsbLsbLhLsbRibRsbsb
sbLsRsbLibRjbLcbRibLibRsbLibRgbLhbRsbRjbLcbLibRjbRcbRsbLhbRgbLibLsbLiR
sbRhRsmbRibLcbLgbLgbRcbLcbLgbsbLgbRgbLsRsbLsLsmbRsbsbLsbLsbRsRsmbRgRsm
bRcbRibLhbRiRsmbRibRgbLsbRsRsmbsbLoRsbRsbLsbLgbLgbLjbLcbLgbRibRoLsbLib
RiLsbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 26; Drug: Control
bLcbRhbRibRsbLjbLjLsmbLobLsbLjbRjbLhbRcbLcbLoRsbRcbRcbRgLsbRsbRsbRsbLc
bLcbLsbRsbRsRsmbLgbLjRsbRjRsmbRhbRibRgbRsbRgbRgbLsbRgbRgbRgbRsRsmbRgbR
sLobLibLgbLiRsbRsbRgbRjbRgbRibRgLsbLcbLobLibLsbLobLobsbRsbRgbRgbLsbRgb
LobRjbRhbLsbRgbRsRsmbRgbRgbRgbRgLsbLsLsLsmmbRsbRsbRgbsbLsbLcbLibLhbRgb
RjbRibRiLsbRgbRsbRgbRsbRgLsbLobLgbLibRgRsmbLsbLiLsbRsLsbLsLcLsmbLgbRjb
RjbRjbRgbLsbRsbRgbLjbLibLhbLsbLcRsbRibLsbLibLsbRjbLhbRgbLgbLgbRgbLsbLi
bRsbRsRsmbLsbLsbLgbLgbLsbLsRsbLiRsbRibLibLsLsmbRsbLsbRgbRebRhbLibRgbRg
bRsbLjLibLibLjbLgbLibRjbLgbLibRjbLjLsmbLgbLebRsbRsbRsbRsbRsbLcbRjbRibL
gbRgbRiLsbRsLsbLjbLobRgbRibLcbLibLsbLsLsmbRgbLsbLiLsbRjbLebLsbRsbLsbRs
bLibRsbLibLsbRsRsmbRsbLhbRgbRsbLgbLsbRsbRsbLhRsRsmbRibRsbLobRibRsbLibL
sbLgbRjbLibRibRsbLcbLgbRsbRsbRgbRsbRsbsbLibLsbRgLsbLcbLsRsLsbRibRsbRsb
LhbRsbLsbLsLsmbLsbLsbLgbRobRsbRsbLgbRhbRsbRsRibRgbRsbRgbsbLcbRgbLgbLob
RiRsmbRibRgbRgbLsRsbRgbLjbLobsbLsbLsbLsLsmbLsbRsbRcRobLsbLgbLgbLjbLoLs
mbLsbLibRjbLibRcbRhbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 27; Drug: Control
bRgbRgbLsbRibsbRibRjbLibRgbRsbRgbRsRsmbRsbRibRsbRgbLiLsbRsbLjbLgbLibRi
bLibLgLsbLgbRiRsmbLgbRibLsbLibRsLsbRgbLhbLcbLsbLgbLcbLsLsmbLgbLgbsbRsR
smbLibLsbLibRcbLgbLgbRcbRgbRibsbLjbLhLsbRibLibLsbLgRsbsbRcbRjbLgbRibRs
RsmbRsbLsbRiLsbLsbRiRsmbRsbLsbRsbRsbRgbLsbLsbRsbRsRsmbRsRsmbRsbLsbRsbR
sbLsbRgbRsbRsbRgbLoLsmbLcLsmbLgbLsbRsbRgbRsRsmbRebLsLsmbRsRsmbRsbRsbRs
bRsRsLsmbRsRsmbRsbRsbRgbRgRsmbRsbRsbRsRsmbRsRsmbRsbRsbRgbRsbRsRsmbsbLe
bLjLsmbsbLibRibLiLsbLsRsbRsbsbRjbRhbRsbRsRsmbRibRsbRsbRsbRsRsmbRsbLsRs
bRsbRsbRsbRgbRsRsmbLgbRsbRgbRgRsmbsbLsRsRsmbLsRsRsmbRsRsmbRsbRgLsbRsRi
bRhbLsbRsbLgbLgLsbLibsbLibLsbRsbLgbLsRsbLibLibLibRsbRsbLibLibRsbLgbRsb
LsbLsLsRsLsmbLibRjbLibRsbLibLsbRgbLibLsbLsbLsbLsbLgRsbLsbLgbRibLgbsbRs
bLiLsbRsbLsbsbLgbLgbLsbRgbLhbLsbLgbLsRsbRsbRgbLgbLhbRsLsbLsbLgbRsbLiRs
bRjbLibLsbsbLsLsmbLsbLsbLgbLgbRgbLibLsbRjbRcbRibRibLsRsbRsRsmbRgLsbLgb
RjRsRsmmbLibRibRsbsbRibLgbRgRsmbRsbRsRsmbRsbRsbRgbRsbRibRsbRgbRsbLgbRi
bLsbLoRsbLgLsbLgbLsbRsbRsbLsbLibLibLsbLibLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 28; Drug: Control
bLsbsbsbRsbRsLsbsbLgbLsbRgbRgbRgbLsbLsbRsbRobRsbRsbRjbRebRibRsRsmbLsRs
bLjbLcbRgbsbRsbRsbsbLibRsRsmbLiRsbRsbRsbLibLsbLsbLsbLibRsRsmbRsRsmbsbL
ibLibRgbLgLsbLibLgbRsbRsbLibRgRsmbLibLsLsmbRgbLibRjbLcbRibLgbRcbRibLsR
sbLsRsbRsbRgbRsbLsbRgbRgbLsbLgbRsRsmbsbsbsbRsbRjbRsbRsbRsbRsbRibRsbLsb
RgbRgbRsbRsRsmbRsbRsbRgbRsbRsbRsbRgbRsbRgbRsRsmbLgbRibRsbRsbLsRsbRgLsb
sbRgbRgbRsbRsbRsRsmbRsbRgbRsbRsbRgbRsRsmbRsRsmbLgbRsbLsRsbRsbRibRsbRsb
RsbRgbRsbRgbRsRsmbRsRsmbRsbRsbRsbLsbLgbLsbRsbLsbRsbRjbRsbRsbRgRsRsmmbR
ibRsRsmbRgRsmbLgbLsbRibRsRsmbLgbsbRsRsmbRsbRibRiRsmbRibRsbLsbRgbLsbRib
RsbRgbRibRsbRgbRsbRcbLgbRsbRgbRsbRiRsmbRsbRsbRibRgbLgbRhbLgbRgbRgbRsRs
mbRgbRsbRsbRgbRsRsmbRgbRsRsmbLsLsmbLgbRcbRibRsbRsbLsbLibLsbLhbRibLibRj
bLcRsbRibLiRsbLibRgbLcbRgbLgbLcbRibLibLgLsbLsRsbLiRsbRgbRjbRebLgbRgbsb
sbRibRibRsbRgbRgRsmbRsbRgRsmbRsRsmbRgbRgbRsRsmbRsbRsbLsbRsbRgbRsbLsbLj
LsmbRsbsbRhbRsbRgbRgRsmbRsbRsbRgbRsbRsbRsbRgRsmbRsbRgbRsbRsbRsbRsbLgbR
obRsbRsRsmbReRsmbRjRsmbRsRsmbLgbsbRsbLobLsRsbRsbRsbLsbLsbLgbLobRsbRsbL
cRsbLiRsbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 29; Drug: Control
bLibLsbLsbLgbsbLibRcbRoLsRsbRcRsmbRgbRjbRobRcbsbLjLsmbRjbLsbLibRjLsbRs
LgbLsbRibLgbLibLhbLcbLhbRsbLsbLjLsmbLsbLibLibRgRsmbRibLjRsbRhbLsbRibLg
bLgbRibRjbLibRcbLibRhbLgbRjRsmbLibLsbsbRgbRibLgLsbRgbsbsbLjbRcbRcbLjbL
ibRgbLgLsbRibRiRsmbLsbRibLgbRibRibLjbRibRsbLsbRsbRibLsbRibLiRobLsbRcbL
iLsbRiLsbRibRibLgbRibLgbLjbRibLibLgbLibRgbLibLgbLhbRgbLsbLgbLgbLsbLgbL
gbLsbLgbLsbLgLsbLibLibRibLibLibLiRsbRibLjLsmbLibRgbLiLhLsbLibRibRcbRib
LgbRjbRcbLiLsbRgbRcbLgbLibsbLjbRgbLibLcbRibLgbLcLsmbLibRiLhLsbLgbLgbRj
bLiRsbRgLsbLibRgbLiLsLsLsmmbLgbLibLgbLgbRibLibLibRcbRcbsbRhbLsbLjLsmbL
jbRsbRibLjbLibLgbRgLibLibRgbRsbLibLibRgbLgbLsbLgLsbLgbRsbLibLgbLiRsbRg
bRhbRcbRhbRibRibLsbLibLibLgRsbRibLiLsbLgbLsbLibRjbLcbLgLsbLgbRjbLcbLgb
LsbRsbLibLgbLgbRgbLgbRsbLibRjRsLcRimbsbLgbLgbRsbLgbLsbLibLibRibLcbLiRs
bLibLibRgbLcbLibLgRsbRibLcbRgLsbLhbRgRsRsmmbLhbsbRjbLcbRibLsLibLibLsbL
gLsLsmbLibRibLgbLsbLgbRgbRcbLhbLcbRgbLibRjbLcbRibLibRgbLibRjbRcbRibLjb
RcbRhbLgbRgbLjbLcbRcbRiRsmbRgbLhbLibLjLsmbRibLibRibLgLsbLibLibRibLiLsb
RjbRiRsRimbRsRgbRsbRsbRgbRsbRobLsbLsbRsbLsbLgbLgbLsbRsbLgbLibLgbRsbLsb
LgLsbLgbLgbLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 30; Drug: Control
bRjbLgLsbLgbLgbRjbsbLjbLcbLcbLcbLiRgbLcbLibRibRjbRjbRibLcbsbRsbLgLsbLi
bLcbLcbLcbRibLjbLcbRsbLcbLobRiLsLsmbLsbLgbRjbLcLsmbRibLibRsbsbLsbLgLsb
LhbLobLobLiLsbLibRcbLibRobRcbLibLibLibRsRsmbRsLsbLgRsbLgbRcLsbRgbRgbLj
LsmbLiLsbRgbLgbLjbRcbRobLcbLibRsbLibRsbRsbLsbLgbLgbLgbLsbLsbLsbRgbLgbL
gbLgbRjbRcbRhbRcbLcbsbLgbLobLsbLibRgbLgLsbLgbRjbLgLsbLgbLsbRsbLibRjbLg
bRsbLgbRgLsbLiRsbRjRsmbLsbLgbRsbRcbRcbRgbRgRsmbLjbLhbRibLcbRgbLgbRibLs
LsRsmbLiLsbRsbLgbLsLsLsmmbLgRsbLcRsbLcbLibLsLsmbLibLgbLsbLsbRsbLgbLgbL
sRsbRsbRsbLgLsbRsLsbRsbLgbRsLsbLgbLgLsbLgLsbRjbLjbRcbRibLjbsbLibRgbRjb
RgLsbRgRsmbRjbLcbLibLsbLibRsbLiLsbLsbLgLsbLsbLsbLgbLsLsmbLgbLgRsbRsbLg
bRgbLgbLsbLgLsbLgLsbLgRsbRgbLsbRgLsbRgbsbLsbLgbLsbLgbLgbLsbLgbLsbLgLsb
RgbLhbRibLiLsbLsbLiRsbRoRsmbRiLsbLsbLhbLcbRgbLgbLsbLsbLsbRsbLsbLgLsbLg
bLgLsbLgLsbLgbRjbLibRgbLibLgbLibLiRsRsmbRgbLgbLsbRgbLiRsbRsLsbLsbLsbLs
bLgbRsbLgbRgbLgbLgbsbRjbLibRoRibLsLsmbLibLjbLsbLiLsbRjbLibRgbLsbLjbRsb
LsLsmbLsbLsbLgLsbLgbRgbLibRgbLgLsbLgbLsLsmbLsLsmbLsbLgLsbRjbLsbRcLsbRj
bsbsbRjbRgbLibLjbsbRhbRiLsbLjLsmbLcbLsbLibLgbRsbLgbLgbLgbLgbLgbRsbLgbL
sRsbLsbRsRsmbLgLsbLsbLgbLibRsLsbRhbRcbLjbLhLsRsbRibLibLgbLsRsbLsbLgLsb
RjbLibRsbLgbLsLsmbLgbLgbLgbLsbLsbLgbRsbLgbLsRsbLsbLsbLgbLsLsmbRsbLgbLg
bLgbLgbLgbRgbLibRsbLiLsbLsLsmbLgbLgbRgbLgbLibLjbRhbLiLsbLgbLsbLsbLgbLs
bLgbLgbLgbRjbRhbLhbRcbRibLjbLibRsbLgbLsLsmbLiLsbRgbLgbLsLsmbLgLsbLsbLs
LsmbLsLsmbLsbLsbLsbLgLsbLgbRjbRcbLibRcbLcbLibLgbRsbLgLsbRsbLsbLgbLgbLg
LsbLgbLgbRjRsmbRcbRgLsLsRsmbRibLhRsLcbRjbRgbLsbRibLcbLibRibLsLsmbLsbLs
bsbLsbRsbLibRgLsbLgbLsbLgLsbRsbLibRsbLiRsbLsbsbLgbRjbLgbLsbLsbLibLiLsb
LibLsbLiLsbRsbLgbLgbLsbLgLsbLgbRjbLibRjbLibRgbLgbLgbRsbLsbLgbRsbLcbLoR
sbLsRsbLjbRibLobLsbLjbRcLsbRcbLcbLgbLgbLsLsmbLgbLsbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 31; Drug: NDMC 1 µM
bLhRsbLibLiLsbLsbRjbRhbLsbLsRsbLibLibLgbLsbRsbLgbLjLsmbRsbRibRsLsbLgRs
bLiLsbLsRsbLsLsmbRsbLgLsbLsbLsbLgbLsbLsbLsbsbLsbLsbLsbLsbLgbLsbLsbLgbL
cbLhbsbRsbLibLsLsmbLsbLcLsmbLgbLgLsbLgbLsbRibLsbLsLsmbLgbRcbRgLsbRsbRs
bRsbRibRsbRibRibLsbRsbRsbRibLsbRibRsbRgbLgbRcLsbLsbLsbsbRibRsbRiLsbLsR
sbRibRgbRgbRsbLsbLibLibLcbLsbLsbRsbLsbRgbRcRsmbRibRibRsbLsbLgLsbRibRsb
RcbLgbRibRsLsbLgbsbLsRibRsbRsbLsbLsbsbRhbRsbLsbRibRsbLsbRgbRsbsbsbRsbR
gbRibLsbLsbRiRsmbRsRsmbLsbRgbRgLsRsbLsbLgbRgbRsbRibLsbRgbLjbRiRsmbRibL
sRsbLibRcbLsbsbLsbRibLsbsbRsbRibLsLsmbLsbRibRgbLsbLgbRsbRibRsbRhbRsbLs
bLsbRcbLibRcbRsbRgbLsbRibLsbLsbLgbLhbLgLsbRsbLsbRsLsbLibRgbRcbRibRibRg
bLsbRibLgbLgbLibLibLibRibRsbRibRcbRibLibRgbRhbRgbRgbLsbLsbRcRsmbRibRsb
LgbLsbRsbReRsmbRibLibRcbLhbRcbLhbRgbLsRhRsLsmbLibRibLsbRiLsLsmbRsbRsbR
sbRgLsbLsRsbLsbRibRibLsRsbRsbRsLsbRibLsbLsbRgbRsRsmbRiLsbsbRsbLsbRsbRg
bRiLsbRsRsmbLsbRiRsmbRsbRgbRibLhLsbRiRsmbLsbRibLjbRibRsbLsbRibLgRsbRib
RgbLsbLgbRibRibLjbLoLsmbLcLsmbLiLsbRiLsbLsRsbLsbLhbLgbsbLibLobLsbRgbRg
bRsbRsbRsbRgbRgbRsbRoLsbRsLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 32; Drug: NDMC 1 µM
bRcbRibRjRsmbLibLgbLsbsbLibLhbRsbLsbLsbLsbLsbLsbRjbRcbRsbRoRsLsmbLjbLc
bRibRgRsmbRcbRhbRsbRcbLjbLobRibLgbLgbLgbRsbLsbsbRsbLoRsbLibRgbLjbLsbRi
bLibLgbRhbsbRgbRsbLsbRobLhbRibRsRsmbLjbLcbRibLhbRjbRoLsbLsbRibLjbRibLg
RsbRgbLsbRgbLsbRibLgbRgbRoLsbLgbRsRsmbRgbLsbRhbLibRcbLgbRsRsmbRobRsbLs
bLgRsbLibLgbLsbLsbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 33; Drug: NDMC 1 µM
bRgbLjbRsbRgbLjbRibLhbLgbLjbRsRsmbRjbRiRsmbRibLhbRibLcbLcbLibRebLhbLhb
LibLcbLcLsmbRsbLibLibLjbLibsbLibLjbLjbLeLsbRgbRjRsmbRsbsbLibLibLjbRjbL
jLsLsmmbLjbRcRsmbLcbRibRibsbLibLibLibLsLsmbsbLgbsbsbRjRsmbsbRibLcbLibR
sbsbRsbLcbRsRsmbLsbRsbLcbRsbLibRsbLibLsRsbLsRsbsbLgbLibLsRsbRjRgbLgbLj
bLhbLsbLsRsbLgbsbLsbLjbLsbsbLsbsbLgbLsbsbLgbLibRsbRsbLsbLgLsbRgbRobRhb
RcbRsbRsbRsbLibLhbLibLsbLgLsbRgbRgbRsbRsRsRsmmbRsbRgbRibLibRiRsRsmmbsb
sbRsbRibRsbLhbLibLsbLibLsbsbRsbLcRsbRsbRsbLsbRsRsmbLsbLibRsRsmbLsLsmbL
iRsbsbLibRsbRsRsmbLsbLibRgbLibLsbLsRsbLhbLgbRgRsmbLcbLgbLibLcbsbLsbLib
LgbLsRsbRsbRgbRsbLibRsbLsbLsbLgbLibsbsbLjbLsbRsbLsbsbLibRsRsmbLgbLsLsm
bsbRsRsmbLsRsbLcbLiRsbLgbRsbRsRsmbRsbLiLsbRsbLgbLsbLibLsbRsbRsbLsLsmbL
cbsbRibRcbLjbLcbLibLsRsbLsbLhbLgLsLsmbRgbLsRsbsbLcbsbLgLsbLobLsbLgbLhb
LjRsbLgbRgRsmbRsbRsbLsbRjb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 34; Drug: NDMC 1 µM
bLgRsbRjbRibRcbRjRsRsmmbRcbLibLgbRibRiRsmbRsbRhbRibLiLsbLgbLsbLgbLcbRh
bRsbLcbRcbLibLgbLiLsbLibLsbRsbLibRsRgbLibLgbLgbLgbRgbLiLsbLgbLgbLsbLgb
LgbLgbRobRcbRgbRgbLibRibRibLgRsbRcbLgbRibRhbLibRobRhbLsbRsbsbRgbLibRiR
smbRgbRcbLibRebRjRsmbRibRebLobRhbRcbLibRcbLiRgLsbRobLgbLcbRiRsmbRibRib
RsbLsbRsRsmbRgbRgbRsbRgbRibRjbLobRjbRgLsbRgbRgbLjLsmbRsbRgbLjbLiRsbRhb
RcbLhbsbRibLgbRgbLgbRjbRgbLsbRhbLiRsbRibRiRsmbLjbLcbLhLsbRcbLcbRiLsbRc
bLsbRiLsbLsLsmbRgbRibRgbRgbRobsbLibLsbRgLsbLgbLgbLsLsmbRgbRhbRsbRcbLcb
RgbLebRjbLibRjbLjbLgbLsbLsbRjbLcbLgbLgLsbLgRsbRsLsbRjbLsbRibLsbRjbLobL
gbLsLsmbRsbLgLsbRsbLgbLsbLgbLibRgbLgbLsbLsbLibLgbRsbRjbRibLjbRgbLsRibL
jbLhRsbRjbRgbLibLgbLsbLibRsbLgbLibRsbRcbLibLgLsbRgbLibRsbLgbRsRsmbLgbL
gbLgbLsbLgbRsbLgbLsbLsbLibLgbLgbLhbRcbLibLgbLgbLgbLgbLgbLsbLgLsbLgbLsR
sbLsbRsbLgLsbLsbLgRsbRgbLgbRsbLsRsbLgbLcbRhbRsbLiLsbsbLgbRcbRsRobLiLsb
LgbRhbLgbRhbsbRgbLcbRibRibLjbRcbLgLsbLjbLibLibRjbRibLcbRjbRcbLcbLcbRjb
LsRsbLgbLgbLsbLsbLgbRgbLgbLsbLgbLgbLsbLgLsbLgRsbRjbLibLgbLgbLsbLgbLgbL
sbLgbRobRibLhbLgbLgbLsbLibRsbLgbLsbLgbLgLsLsmbLsRsbLgbLsbLgbLgbLgbRsRs
LsmbLsLsmbLsbLgbLgLsbLgRsbRjbLhbLsbLgbLsbLgbRsbLgbLsbLgLsbRsbRsbLgLsbL
gbRsbLgLsbLgbRsbLsbsbLgRsbLgbLsbLgbRgbLsbLgbLgbRsbLgbLgbLsLsmbLgbLsbLg
bLgbLgbLsbLibRgbLgbLsbRsbLgbLgbRsRsmbLgbLsbLsbLsbRjbLhbRgbLibRsLsLsmbL
gbRsbLsbLgbLgbLibRibRgLsbRgbLcbLcLsmbRgbRiLsbLibRjbLcbRhbRcbLjbRjbRgbR
ibLibRibRgRsmbLebRgbLsbLgbLgbLgbRsLsbLgbLsbLsbLgbLgbLsRsbLgRsbLibRgbLg
bLgbLgbRgbLgbLgbRsbRsRsmbLjbLsLgbLsbRsbLsbLgbLgbRsbLgbLgbLgbLgbLsbLsbL
gbRsbLgLsbRjbsbLsbLsbRhbLcbRibRibLjbRhbLhbRibRibRiRsmbRhbRsbLibLhbRgbR
ibLibLibLibLjbRhbLibLobRibRibLsbLibLgbLsbLgLsbLobRoLsRibLsbLsbLobLgbLc
bLibLibLib

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 35; Drug: NDMC 1 µM
bRjbLibLjbLibLjbLcbRjbLjbRcbRgbRiRsmbLcbLiRsbRhbRcbLibLjbRebRjRsmbLiLs
bRjbsbLebRgbRsbRibLibLjbLcbLhLsbRsbRibRjbRibRgbRjbRcRsmbRibLiRsbRobRgb
LsbRsbLjbLibLsLsmbRgbRhbLsbRjRsmbLsbsbRibRcRsRsmmbsbLibRjbRjbRcRsmbLhL
sbLgbLcLsmbRgRsmbRgbRhbRhbRjbRjbLjbLibRjRsmbLcbRibRsbsbRsRsmbRibRcRsmb
LibRibRjRsmbRibRgbRsbLsRsLsbRsbRibLhbLjbLhbLgbLgbsbRgbLsbRhbRjbRsbLgbR
sbRgbRgbRjbRgbRiRsmbsbRgbRiRsmbRgbLibRjbRibRsbRgbRhbLiRsbRjbLcbLcbLsbL
sbLgbRjbRcRsmbRibRsRsmbRgbLhLsbLsbLsbRjbLgbLsbRjbRgRsRsmmbRhbRsbLjbRcb
RjRsmbLiLsbRibRsbLjLsmbsbRibRibsbRjbRgbRgbRsLsbLjbRgbRjbLgbsbRsbRibRsb
RgbRgRsmbLsbLgbRsbRibRsRsmbLgbRibRsRsmbLsbRgbRsbRgbRsbRebRsbRsbLsRsbRj
bRsbRsbRsLsbRsbLgbLgbLcRsLsbRsbRgbRsLsRsbLsLsmbLjLsmbLjbLsbRsbLiLsbLiL
sbLsbLgbRsbRgRsmbRgbRsbRsbRsRsmbRobRsbRsbRjbRcbRsbRiRsmbRhbRsbLsbRsbRc
b

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 36; Drug: NDMC 1 µM
bRibRcbsbRsbLjbRsbRsbLsbRsRsmbRgbRsRsmbRhbRibRibRsbRsRsRsmmbRsbRsbRgbs
bsbsbLsbsbRsRsmbsbLsbRsbRsbLjbRhbsbLsbLsLsmbsbRgbLjLsmbLsbRsbRsbRsRsmb
Rob

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 37; Drug: NDMC 3 µM
bLhbLsbRibLsbsbsbLiRsbLsbLsLsmbsbRibLsbLsbLcbRibRibLgbsbLgbLsbsbRjbsbs
bLsbLsbLibRibRsbRgbLsbRsRsmbsbRobRgbRoRsLsmbsbLsbLcbLibLcbLgbRiRsmbRib

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 38; Drug: NDMC 3 µM
bLibsbsbRgbLibLibLibsbLgbLsbLibLibLgLsbRjRsmbRibRibRsbRsbRsbRgbLcbLiLs
bLibLhbsbLjLsmbLcbLsLsmbsbLjbRsbLsLsmbLgbsbRsbLobLibLibLgbLsbLibLsLsmb
LsbsbLsbRhbRibsbRibRibLibLcbLibsbLsbLsbLsbLjRsbLgLsbLsLsmbLsbRgbLibLsb
LsLsmbRgbLsbLgbLgbRgRsmbLcRsRsmbLsbsbRsbLsLsmbsbLgbLgbsbLhbRsbLsbLgbLg
bLsLsmbLsbLsbLsRsbLibRgRsmbLibLsbLgbLsbLsbLsbLgbLsbLsbLgbRsbLsLsmbLsbL
sbLsLsmbLsbLsRsbLgbLsLsmbRsbLgbRjbRsbLcbLsbLgbsbLiLsbRsbLsbsbLsbsbsbLi
bLsLsLsmmbLgbsbRgRsmbLgbLsLsmbLgbLgbLgbLsbLsbsbLgbLibLsbLsbLsbRgbRibRs
bsbRsRsmbRcbLgbRgbRjRsmbRsbRgbRsbRsbRsRsmbLsbRjRsmbRgbsbsbRibRsbRgRsmb
RgbsbRsLsbLibLibLsbLsbsbLibLsbRsbLgbLsbLsbLsbsbsbLibLibLsbLsbLsLsmbLsL
smbLibLsbRsbRsbLsLsmbLsbLsbLgLsbLsLsmbLsLsmbLsbLgbLsbRgbLgLsbLgLsbLsbL
sbLsbLgbLgbLsbsbLgbLgbsbRsRsmbLiLsbLsRsbRsbLgbLsbLibRsLsbLsbLgbLgbLsbL
sLsmbRsbLsbsbLgbLgbLgbLsbsbLsRsLsbLgbRsbRsbLcRsbRsbLgLsbLsbLiLsbLsbLgb
LsbLsbsbLcLsRsmbLibLsbsbsbLibLsbLsbRsLsbRgRsmbRcbRjRsmbsbLsbsbsbLgbLsb
LiLsbLgLsbLsbLsbLgbRsbsbLgRsbRgbLgbLsLsmbLgbLsLsmbRsbRsbRsbLsRsbRsbLcb
LgbLsbRsbLhbLsbLsbLgbLgLsbLgLsbLsbLjLsmbRgbRsbsbLibLibLsbLsbLsbRsbLgbL
sbLgbLsRsbLsLsmbLsbLibLgLsbLsbLsbRsbLiLsbLibLsbLsbRsbRgRsmbLobLgbsbLgb
LibLsLsmbLsbRgbLibLgbLsbsbsbLgbLsbLsbRsbLsbLibLiRsbLsbLsbLsbLgLsbsbLiL
sbRsbLgbLsbsbLsbLobRsbRgbRibRgbLoRsLgRsbLgbRsbLibRsbRsRsmbLibLsbLgRsbR
sbLgbLgbLsbLsbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 39; Drug: NDMC 3 µM
bRgbLjbRsbRgbRibRgbsbLcbLibRjRsmbRsbLjbRgbRjLsbLcbLgbRibLsbRgbsbRsLsbL
jbRgRsmbsbLsbRcbRcbRibRgRsmbRsbRsbRjRsmbRsbRsbRsbRsRsmbLcbLsbLsbLibLgb
RjbRcbLgbRibLsbLgbLibLgbRjRsmbRjRsmbLjLsmbRjbRcbLsbRhLsbLhbLhLsbLiLsbR
sbRjbRjbRoRsmbLsbRjbRsbLgLsbsbRgbRcRsmbRsbLjbRibRsbRsRsmbLjLsmbRsbLobL
cbLsbRibRcbRcbLibRobRgbRgbRgbRsbRob

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 40; Drug: NDMC 3 µM
bLjRsbLiRsbLibLibLcbsbLibLsbLgbLsbLgbLibLgbRibRsbRgRsmbRgRsmbLibLsbLsL
smbLgbLjLsmbLsbRibRhbRhbLsbLebLgLsbLsbRgbRcbLcbLhRsRsmbLibLibRsbLgbRsb
RgbLoRsbLhbLsLsmbLcbRsbLibLibLgbLsbRjbsbRgbRgbLcbsbRgbRsbRgbRibRsLsbRi
bRsRsmbRsRibLsbLsbsbLsbsbsbLsbsbLsbRsRsmbRsbRsbRsRsmbRsLsbRgbLjLhbRsbR
jbRibLcbLhbReRsmbLjbLgbLjLsmbRhbRsbLsbRhbRgbRcbRibRcbRsbRsbRcbRibRibLg
bRcbRsbRibLjbLcbLcbRibRibRibLjbLsbRcbLgbRibLsbLjbRibRgbLcbLcbsbLibRsbL
gbRjbRcbRcbLcbLcbRjbLibLibRjbRcbRibLsbLsbRsbRgbLjbLcbRjbRibRcbLcbLcbLg
bLgbLsbLsLsmbLobLsbLibRgbRgbRgbRibRibLiRsbRcbLsbsbRhRsmbRsbLgLsbLsbLsb
LgbLcbRiRsmbRcbRgRsmbRjRsmbLcLcbLsbLibRjbRcbRhRsmbLcbLcbLgbsbLobLsbLgb
RsbRsbRsbLoRsbLgRsbRsbRsbLibLsbLgbLobRgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 41; Drug: NDMC 3 µM
bLgbLgbRibRsbLibLgbsbLgbLhbLsbLgbLibLsbLgbLibLsbLsbsbRjRsmbRsbLgbLgbLs
RsbLsbLibLsLsmbLsLsmbLgbLsbLsbLgLsbLsbLiLsbLsbRsbLibLgbLsbLgbLgbLibRsb
LsbLgLsbLiLsbLsbLsRsbLgbLgLsbLiLsbLsbLsbLhbLgbRgbLibRjbLhbRsbLibLgLsbL
ibLsbLgbLibLgLsbLibLsbRgbLibLibLibLsbsbLsbRgbLcbLsbLgbRsLsbLibLsbLsLsm
bLibLsbLsbRsbLhbRsLsbRgbLiLsbLgLsbRsbLgbLsbsbLsbLiLsbRsLsbLhbLsbLgbLsL
smbLsbLibLgbLibRsbLgbLibLiLsbsbLsbLibRgbLibLsRsbLibRsbLibRsbLsLsmbLiLs
bLsLsmbRgbLcbRsbLebLsbLibRsbLebLsbLsbRgbLiLsbLsbLibLgbRsbLiLsbLsbLsbLi
bLgbLsbRgbLhbLgbLibsbRsbRsbLibLsbLgbRsbLiLsbLgbLgbLgbLsbLgbRsbLgRsbLib
LsbLsbLibLgLsbLsbLibLsbRsbLhbLsbLgbLsbLsbLibLgbLiLsbRgbLsbLcRsbLsbRsbL
sbLebLsbLebsbRibLsbLsbLgbLiLsbLsbLibRhRsmbRsbLhbLsbLsbLgbLgbLsLsmbRsbL
iLsbLsbLgbLibLsbLgbLsbLibLgbLsbLgbLsRsbLibLsbRjRsmbLebLsbLsbLsbLsbLiRs
bLsbLgbLeLsbRgbRsbLgbsbLgbLgLsbLsLsmbLiLsbRsbLibLsbLgLsbLgbLsbLgbLiLsb
LiLsbLsbRgRsmbLcbLsbLgbLiLsbRhbLsbLgbLcbLsbRgbLhbLsbLgbLgRsLsbLsbLibLs
bLsbLiLsbLsbRgbLsbLeLsbLsbLibLgbRiLsbLhbLiLsbLsbRgbLhbRsbLhbRsbRsbLebL
sbLgbLibLsbRibLobLsbsbLgbRsbLsbLgbLsbRgbLcbRsbRgLsbLibsbLgbLgbRgbLcbLs
bRibLsbLibLibLsbRgbLhbRsLsbLcbRsbLsRsbLsbLiLsbRgbLgLsbLibRsbLsbLgbLsbL
iRsbRjRsmbLibLsbLsbLcbRgbLsLsmbRgbRsbLsbLsbLjbRcbRgbRibRsbRsbRibRgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 42; Drug: NDMC 3 µM
bLsLsmbLsLsmbRgbLsbLgbLgbLgbLsLsmbRgbLibLgbLibLgbLsbLsbLgbLgbRgbLibRjR
smbLibLcRsbLgbLsLgLgbRhbRjRsmbLgRsbRibRebLibLobRiRsRsmmbsbLsbRgbRgbRgb
RsbRgRsmbLjLsLsmmbLjbLsLsmbRjbRsRsmbsbsbLgbRjbLjbLsbRjbRcbsbLsbLgbRiRs
mbLibLibLibRjbLibRgbLjbRgbRobLgRsbRgbRgbRsRsRsmmbsbRoLsRsRsmbRibRsRsmb
LgbRsRsmbRjbRjRsmbRibRgbRsbsbLgbLgbRgbLgbsbRsbLibRjRsRsmmbRcbLgbRsRsmb
RsRsmbRcLsbRsbLgLsbRsRsmbRgbLsbRsRsmbRsbRgbRsLsbRsLsRsbRsLsRsbLjbRcbLi
bRjbRsbsbsbLobLcbRjbLcbsbLgbRsbLhbRebRjbRsbsbLsbsbRgbLsbRsLsRsbRgbRjbL
sLsmbRjbLibLgbsbLsbRsRsLsLsmmbsbLjbLsbRibLjbLibRcbRsbLcbLgbLsbLgbLsbLs
RsLsbLsLsmbLhbRjbLsLsmbLibRibLsbLibRsbLiLsLsmbLjbLsbLjbRhbLsbLgRsbRibR
jbLgbRsbRsbRibLjbLsbRiRsmbRsRsmbRhbLibLjbRcbLsbLsRjbLhbRebLibRsLsbLibL
jbLiRsbRibRebRibRjbLibRgbLebRjbLhbLcLsRsLgmbLgbLibLgbRsbLgbLgbLgbLgRsb
LsbLjbLsbLgbLgbLgbRsbLhbRhbLibLibLsbLhbLgbRiRsmbRgbLiLsbLgbLgLsbLgLsbL
gLsbLibRcbRcbLgbsbLsbRiRsmbLibLibRcbLjbLcLsmbLibRjbRcRsmbLgbRibsbRsbRs
bRsbLsbRibLgbRsbRhbLibLjbLiRsbLgbLsLsmbRjbRobsbLgbRiRsmbRjbsbsbRgbsbLs
bRiRsmbLibRiRsmbRsbRgbLjbLgbLsbLgbLgbLibLibRebRsbLgbRsbLgbLibLgbLhbRsb
RgbLcbLibLgbLgbLgbLibLgbRibLgbLgbLgRsbLsLgbRcLsbRsRsmbRsbLsRsLsbRjbLcb
LoLsLsmmbRgRsmbRgbRiRsmbLjbRebLibLcbLsbRjbRobLcbsbLsbRsbLjbLsbRsbLgbLs
bRsbLobRgbRgbLjRsbLjbLcbLgbRsbLsbLsbLgbLsbLgbRsbLsbLgbLgbLsbLgbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 43; Drug: NDMC 10 µM
bLiRsbLoRsbRibRiRsmbLcLsLsmmbLibRjbLjLsmbLobLsbLibRjbRcbLjbLcbRsRgbLsR
cbRsbLsLsmbLsbRibRgbLgbLsbLhbLhbRgbLgbRibLsbRsbLjLsmbRsbRgbRsbLsLsmbRj
bLibLsbRjbRibLjbRjbRhbLsbLjbLgbsbsbRhbRcbLibLgbLsbRsLsbsbRjRsRsmmbRsbR
ibsbLhbRobRcRsmbLhbLcbLebLibRhbLcbRcbRobRibLibLhbLgbLgbsbRsRsmbLsLsmbL
sbLjbRcbRcRsRsmmbRiRsmbLsbRjRsmbLobLcbLibLgbRobRsbRsLsbLsbLsbRobRgbLsb
RhbRsbLsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 44; Drug: NDMC 10 µM
bRibRgbRhbRibLibLsbLjLsmbRibRiRsmbLobRibLhbRibLjbLcLsRsmbLibRjbRcbLsbR
sbsbRibRsbLgLsLsmbLcLsmbRibRhbRgbLsbLsbRsbLjbLhRsbRcbLsbRsbRcRsmbRcbRi
bRibRgbRibRsbsbLibRibRgbLsbRiLsbRgRcbRibRgbRibRsbsbRiLsbRgbsbLibLhbRsb
RcbLsbsbRgbRgbRgbRsbLsbRibRsbLgbsbLgbRhRsmbRsbRgRsmbRsbRhbRibRcbRibRgb
RibRsLsbRsLsbRsbLsbRibLsRsbRsLsbRgbRjRsmbRibRibRsbRsbRiRsmbRsRsmbRgRsm
bRsbRgbLgbRgbsbRgRsmbRibRsbLsbRcbLsbRgbRsbRcLsbRgbLsbLsbRcbRiRsmbLsbRh
bRsbRsbRibRgbLsLsmbsbRibLsbRcbRcbRibRgbRsbRibRgbRibLsbRibRcbRibRibRcbR
gbLgbsbRibRibRgbLsbRcbRibRibRsbRgbLsbRgbLhbsbLcbRgbsbRobLsbRsbsbRibRsb
LsbRcRsRsmmbRgbLsbRsbRgbRcbRsLsbRgbLsbRibLibLgbLsbLibLibRgbRgbLjbLiLsb
LjbRjbRcbRhbLsbRgbLsbRgRsmbLsbLsbLjbLcbLsbRsbsbRgbLobLebRiRsmbRibRsLsb
RibRcbLgbRsbRgbRsRsmbRgbRsbLsbRsbRgbRgbLgbsbRcbRibLsbLsbLibRgRsmbRsbRh
bLgbRcbLsbLsbLsbRgbRsRsmbRgbLsbRgLsbRsbRsbRsbRibRhbRsRsmbRibLsbLobRsbL
sbLsbLgbLobRgbLibLgbRgbRsbLibLibLhRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 45; Drug: NDMC 10 µM
bRgbLgbRgbRsbLsbRcRsmbRjbLgbLsbLjbRcRsmbLsbLibRjRsmbRsbRibRsRsmbRsbLgb
LsbRgbLsbLsRsbRgbLjbRjRsmbLgbRgbRgbRibRibLgbRibLsbRcbRhbRgbLjbLobLgbLs
bRgbRjbRibRgbLsbRobRhbRsbsbRgbRsbRsbLsRsRsmbRgbRcbRsbLgLsbRibLgLsbLgbR
sbLjbLgbLcbRsbLsbLgbLgbRgbsbLgbRsRsmbLsbLibLsbLgbRgRsmbRsRsmbRgRsmbRib
RiRsmbRgbLgbLsbLsbRjRsmbLsbRcbRsbLsbRsbRgRsmbRsRsmbsbRsbLgbRsbLgbRsbLj
LsLsmmbLgbLsbLsbRoLsbLsbRsbRgbLsRsbRgbRgbLsbLsbRgbRibRgbLgbLsbRsbLsbRs
bLgbRsbRhbRcbRgbRgbLsbRiRsmbRsbRibLsbRgbRsbRsbLsbRgbRsbLsbLsbRgbLjbLcb
LgbLibRsbsbLgbRsRsmbRsbLgbLsLsmbLgRsbLsbRgbRjbRcbsbsbRgbRsbLsLsmbRsbRs
bRsbLgbRjRsmbLjbLcbRsbLhbLgbRgbRgRsmbRcRsmbLsLsmbRsbRibRsbRsbLsbRgbLsb
RgbLgbLcbRcbRsbLobLibLsbLsbLsbRsbLobLibLgbLgbLgb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 46; Drug: NDMC 10 µM
bRibRcbRgbRcbRhbRhbRibRsbRjbRsRgbRiRsmbRjRsmbRibRibRibRibRgRsmbRibLjLs
mbLibRgbRgbLgbRibsbRgbRibRcbLibLeLsbRjbRcbLjbLibLcbRibRibRibLebsbRcbRs
bRjbRiLsbRiRsmbLibRjbLhbLibLsLsmbLcLsmbLhbLibRibRcbRgbRgbRibRcbRcbRcbR
hbRiRsmbRsbRiRsmbRsbRcRsmbRibRibRibRgbRhbLsbRgbRibRcbLibLsbLiLsbRhbsbR
hbRibRcbRhbRcbLsRsbRhbLsbRiRsmbLgbLhbLhLsbLsbRjbLibLibsbLibLgbLsbLgbLi
LsbRibRiRsmbRgbRsbLsbRibRgbRebRhbRiRsmbRibRgbRhRsmbLcLsmbLcLsLsmmbRgbR
gbLibLhbLsbLgLsbRsLsbLgbLgbRgRsmbRibRcbRcRsmbRiRsmbRjbRhbLgbRiRsmbRgRs
RsmmbLsbRgbRsbsbRgbRgbLjbRsbRibLcbLoRsLsRsbRibRcbRgRsmbRgbLjbRsbRobLeb
RibRgRsmbRiRsmbLgbRiLsRsbLgbRibLjbRcbLgbLgbRgbRibRibRcbRsbRgbLgbLsbLsL
ibLgLsbRjbRcbRsbLibLibRiRsmbRhbRibLgbLgbRibRgbRibRibRgbRsbRibRibRiRsLs
RsmbLgbRibRhbLibRiRsmbLgbLjbLibLobLcbRsbRgbRgRsmbRibLsbLobRhbRsbRsbLgb
RgbRobRsRsmbRcbRsRsmbLgLsbRobRgbRsb

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 47; Drug: NDMC 10 µM
bRibLsLsmbLgbLibLsbRjbLsbLibLgbLgbLgbLiLsbLgbLsbLgbLsbLsbRibLsbLsbLgbL
gbLjbLsbRjbRibRgbRgbRgbRgRsmbRsbRsbLsbLsbRsbRgbLjLsmbLobLobRibRsbLjbLg
bLsLsmbRobLhbLcbRjbRsLhbRibsbLhbRhbRjbRjbRgLsbRgLsbsbRgbLoRsbLiRsbLibR
sbLib

>ZF Recording 2016-03-18; tW: 300s; Start: 120243; End: 120743;
Recording: 13-1; Individual: 48; Drug: NDMC 10 µM
bsbRsbRsLsbRsRsmbRoRsmbRgRsmbRgLsbRgbLiLsbLcbRibRibLhLsbLibsbRsbRsbsbL
gLsbRibRsbLgbLibLsLsLsmmbLgbsbRoRsmbLibLgbLibLsbLiLsbLsbLibRgbLibLsbLi
bLsLsmbLibRiRsmbLgbLsbLsbLsbLiLsbLsbLiLsRsbRsbLsbLsbLcbLcLsRsmbLgbLsLs
mbLgbLeLsbsbLsbRsbLibRsbLsbLsLsLsLsmmmbRgbLgbLgLsbLiLsbRgbLsbRsbLibRsb
LibRgLsbLgbRsbLhbLibRsbRsRsmbRgbLgbLcLsmbLoLsLsmmbLgbLibLobRsbLcLsmbLi
bLcbLiLsbLsbLsb

